A	50518	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		1473152
A	50518	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		8146154
A	50518	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		15175105
A	50518	Neoplasms	MESH:D009369	marker/mechanism		NA		1473152
A	50518	Obesity	MESH:D009765	marker/mechanism		NA		1473152|25447408|25448685|8146154
A	50518	Pigmentation Disorders	MESH:D010859	marker/mechanism		NA		8146154
A1BG	1	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
A1BG	1	Schizophrenia	MESH:D012559	marker/mechanism		NA		25821032
A2M	2	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		23052191
A2M	2	Adenoma, Liver Cell	MESH:D018248	marker/mechanism		NA		15509519
A2M	2	Alzheimer Disease	MESH:D000544	marker/mechanism		NA	104300	15023809|9697696|9811940
A2M	2	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		15509519
A2M	2	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
A2M	2	Hepatolenticular Degeneration	MESH:D006527	marker/mechanism		NA		23519153
A2M	2	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		26396155
A2M	2	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
A2M	2	Lung Diseases	MESH:D008171	marker/mechanism		NA		2475424
A2M	2	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17902193|19180532
A2M	2	Nephrotic Syndrome	MESH:D009404	marker/mechanism		NA		11304663
A2ML1	144568	Otitis Media	MESH:D010033	marker/mechanism		NA	166760	26121085
A4GALT	53947	Burkitt Lymphoma	MESH:D002051	marker/mechanism		NA		11482875
AAAS	8086	Achalasia Addisonianism Alacrimia syndrome	MESH:C536008	marker/mechanism		NA	231550	17853339|23315990
AAAS	8086	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		24763052
AADAC	13	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
AADAT	51166	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
AADAT	51166	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
AAGAB	79719	Keratoderma, Palmoplantar	MESH:D007645	marker/mechanism		NA		23064416
AAGAB	79719	Keratosis palmoplantaris papulosa	MESH:C536161	marker/mechanism		NA	148600	
AANAT	15	Sleep Disorders, Circadian Rhythm	MESH:D020178	marker/mechanism		NA		12736803
AARS1	16	Charcot-Marie-Tooth Disease, Axonal, Type 2n	MESH:C567653	marker/mechanism		NA	613287	
AARS1	16	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 29	OMIM:616339	marker/mechanism		NA	616339	
AARS2	57505	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8	OMIM:614096	marker/mechanism		NA	614096	
AARS2	57505	LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE	OMIM:615889	marker/mechanism		NA	615889	
AASS	10157	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
AASS	10157	Hyperlysinemias	MESH:D020167	marker/mechanism		NA	238700	
ABAT	18	Autistic Disorder	MESH:D001321	marker/mechanism		NA		15830322
ABAT	18	Gamma aminobutyric acid transaminase deficiency	MESH:C535407	marker/mechanism		NA	613163	10407778
ABAT	18	Gastroesophageal Reflux	MESH:D005764	marker/mechanism		NA		21552517
ABAT	18	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		21552517
ABAT	18	Lethargy	MESH:D053609	marker/mechanism		NA		10407778
ABAT	18	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ABAT	18	Muscle Hypotonia	MESH:D009123	marker/mechanism		NA		10407778
ABAT	18	Psychomotor Disorders	MESH:D011596	marker/mechanism		NA		10407778
ABAT	18	Reflex, Abnormal	MESH:D012021	marker/mechanism		NA		10407778
ABAT	18	Seizures	MESH:D012640	marker/mechanism		NA		10407778
ABCA1	19	Atherosclerosis	MESH:D050197	marker/mechanism		NA		22022523
ABCA1	19	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
ABCA1	19	Familial HDL deficiency	MESH:C538394	marker/mechanism		NA		10431236|11476965
ABCA1	19	Hypercholesterolemia	MESH:D006937	marker/mechanism		NA		22022523
ABCA1	19	Hyperlipoproteinemia Type II	MESH:D006938	marker/mechanism		NA		16030523
ABCA1	19	Hypoalphalipoproteinemias	MESH:D052456	marker/mechanism		NA	604091	
ABCA1	19	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19878707
ABCA1	19	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		21245421
ABCA1	19	Tangier Disease	MESH:D013631	marker/mechanism		NA	205400	10431236|11476965|17710129
ABCA10	10349	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
ABCA12	26154	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
ABCA12	26154	Harlequin type ichthyosis	MESH:C538424	marker/mechanism		NA	242500	
ABCA12	26154	Ichthyosis, Lamellar	MESH:D017490	marker/mechanism		NA		16675967
ABCA12	26154	Lamellar ichthyosis, type 2	MESH:C537264	marker/mechanism		NA	601277	
ABCA13	154664	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
ABCA13	154664	Disease Progression	MESH:D018450	marker/mechanism		NA		22294766
ABCA3	21	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
ABCA3	21	Emphysema	MESH:D004646	marker/mechanism		NA		26780485
ABCA3	21	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		26780485
ABCA3	21	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		26780485
ABCA3	21	Surfactant Metabolism Dysfunction, Pulmonary, 3	MESH:C567046	marker/mechanism		NA	610921	
ABCA4	24	Cleft Lip	MESH:D002971	marker/mechanism		NA		20436469
ABCA4	24	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
ABCA4	24	Cone-Rod Dystrophy 3	MESH:C565827	marker/mechanism		NA	604116	
ABCA4	24	Familial Exudative Vitreoretinopathies	MESH:D000080345	marker/mechanism		NA		29207047
ABCA4	24	Macular Degeneration	MESH:D008268	marker/mechanism		NA		16968212
ABCA4	24	Macular Degeneration, Age-Related, 2	MESH:C562479	marker/mechanism		NA	153800	
ABCA4	24	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA		16968212
ABCA4	24	Retinitis Pigmentosa 19	MESH:C566637	marker/mechanism		NA	601718	
ABCA4	24	Stargardt Disease	MESH:D000080362	marker/mechanism		NA	248200	
ABCA5	23461	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
ABCA5	23461	Hypertrichosis Terminalis, Generalized, with or without Gingival Hyperplasia	MESH:C565016	marker/mechanism		NA	135400	
ABCA6	23460	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
ABCA6	23460	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17374397
ABCA7	10347	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		21460840|25807283
ABCA7	10347	Alzheimer Disease 9	MESH:C563834	marker/mechanism		NA	608907	
ABCA7	10347	Disease Progression	MESH:D018450	marker/mechanism		NA		22294766
ABCA8	10351	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
ABCA8A	217258	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ABCA9	10350	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
ABCB1	5243	Adrenocortical Carcinoma	MESH:D018268	marker/mechanism		NA		12015757
ABCB1	5243	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		17827786
ABCB1	5243	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		20080907|22104130
ABCB1	5243	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		22311042
ABCB1	5243	Carcinoma	MESH:D002277	marker/mechanism		NA		21332314
ABCB1	5243	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		17510421
ABCB1	5243	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		20627363
ABCB1	5243	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		20623750
ABCB1	5243	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766|23977225
ABCB1	5243	Disease Progression	MESH:D018450	marker/mechanism		NA		20627363
ABCB1	5243	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		18381794|20563569|21064136|25007187
ABCB1	5243	Epilepsy	MESH:D004827	marker/mechanism		NA		19570321|8001500
ABCB1	5243	Escherichia coli Infections	MESH:D004927	marker/mechanism		NA		24498193
ABCB1	5243	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		21332314
ABCB1	5243	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		22311042
ABCB1	5243	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		23874772
ABCB1	5243	Hematologic Neoplasms	MESH:D019337	marker/mechanism		NA		22311042
ABCB1	5243	Hypotension, Orthostatic	MESH:D007024	marker/mechanism		NA		12082591
ABCB1	5243	Inflammatory Bowel Disease 13	MESH:C567384	marker/mechanism		NA	612244	
ABCB1	5243	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		22311042
ABCB1	5243	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
ABCB1	5243	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		21325069
ABCB1	5243	Marijuana Abuse	MESH:D002189	marker/mechanism		NA		19625010
ABCB1	5243	Mental Disorders	MESH:D001523	marker/mechanism		NA		17015054
ABCB1	5243	Nausea	MESH:D009325	marker/mechanism		NA		21840870
ABCB1	5243	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		12015757
ABCB1	5243	Neoplasms	MESH:D009369	marker/mechanism		NA		22269388
ABCB1	5243	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		17015054|21064136
ABCB1	5243	Neuroblastoma	MESH:D009447	marker/mechanism		NA		8761367
ABCB1	5243	Neurotoxicity Syndromes	MESH:D020258	marker/mechanism		NA		12352921
ABCB1	5243	Neutropenia	MESH:D009503	marker/mechanism		NA		16950614|25007187
ABCB1	5243	Pain, Postoperative	MESH:D010149	therapeutic		NA		20627697
ABCB1	5243	Parkinson Disease	MESH:D010300	marker/mechanism		NA		20558393
ABCB1	5243	Parkinson Disease, Secondary	MESH:D010302	marker/mechanism		NA		26457621
ABCB1	5243	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		16950614
ABCB1	5243	Poisoning	MESH:D011041	therapeutic		NA		23562926
ABCB1	5243	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		22674224
ABCB1	5243	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		25275603
ABCB1	5243	Translocation, Genetic	MESH:D014178	marker/mechanism		NA		21325069
ABCB1	5243	Vomiting	MESH:D014839	marker/mechanism		NA		21840870
ABCB10	23456	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
ABCB11	8647	Afibrinogenemia	MESH:D000347	marker/mechanism		NA		22120137
ABCB11	8647	Cholestasis	MESH:D002779	marker/mechanism		NA		11179459|22461449|24713091
ABCB11	8647	CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2	OMIM:605479	marker/mechanism		NA	605479	
ABCB11	8647	Cholestasis, Intrahepatic	MESH:D002780	marker/mechanism		NA		18049162
ABCB11	8647	Cholestasis, progressive familial intrahepatic 1	MESH:C535933	marker/mechanism		NA		21056966
ABCB11	8647	Cholestasis, progressive familial intrahepatic 2	MESH:C535934	marker/mechanism		NA	601847	
ABCB11	8647	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
ABCB11	8647	Pruritus	MESH:D011537	marker/mechanism		NA		18049162
ABCB1A	18671	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		26134275
ABCB1A	18671	Diarrhea	MESH:D003967	marker/mechanism		NA		32387182
ABCB1A	18671	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		24502637|28193520|32387182
ABCB1A	18671	Heart Diseases	MESH:D006331	marker/mechanism		NA		16844662
ABCB1A	18671	Hyperlipidemias	MESH:D006949	marker/mechanism		NA		24502637
ABCB1A	18671	Kidney Diseases	MESH:D007674	marker/mechanism		NA		24502637
ABCB1A	18671	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		16182555
ABCB1A	18671	Pain	MESH:D010146	therapeutic		NA		28193520
ABCB1A	18671	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		22749977
ABCB1A	18671	Seizures	MESH:D012640	marker/mechanism		NA		17437408
ABCB1A	18671	Status Epilepticus	MESH:D013226	marker/mechanism		NA		14706787
ABCB1B	18669	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
ABCB1B	18669	Breast Neoplasms	MESH:D001943	therapeutic		NA		14633655
ABCB1B	18669	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		27193730
ABCB1B	18669	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
ABCB1B	18669	Endotoxemia	MESH:D019446	marker/mechanism		NA		20300455
ABCB1B	18669	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		27193730
ABCB1B	18669	Mammary Neoplasms, Experimental	MESH:D008325	therapeutic		NA		14633655
ABCB1B	18669	Status Epilepticus	MESH:D013226	marker/mechanism		NA		14706787
ABCB4	5244	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		22022477
ABCB4	5244	Cholangitis	MESH:D002761	marker/mechanism		NA		8698195
ABCB4	5244	Cholangitis, Sclerosing	MESH:D015209	marker/mechanism		NA		16472600|29808285
ABCB4	5244	Cholestasis, progressive familial intrahepatic 1	MESH:C535933	marker/mechanism		NA		21056966
ABCB4	5244	Cholestasis, progressive familial intrahepatic 3	MESH:C535935	marker/mechanism		NA	602347	22184139|28552422
ABCB4	5244	Chronic Disease	MESH:D002908	marker/mechanism		NA		29808285
ABCB4	5244	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
ABCB4	5244	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		16472600|29808285
ABCB4	5244	Disease Progression	MESH:D018450	marker/mechanism		NA		22294766
ABCB4	5244	End Stage Liver Disease	MESH:D058625	marker/mechanism		NA		22022477
ABCB4	5244	GALLBLADDER DISEASE 1	OMIM:600803	marker/mechanism		NA	600803	
ABCB4	5244	Inflammation	MESH:D007249	marker/mechanism		NA		22022477
ABCB4	5244	Intrahepatic Cholestasis of Pregnancy	MESH:C535932	marker/mechanism		NA	614972	
ABCB4	5244	Jaundice, Obstructive	MESH:D041781	marker/mechanism		NA		22022477
ABCB4	5244	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		18221819|8698195
ABCB4	5244	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		20040336|30682444
ABCB4	5244	Liver Diseases	MESH:D008107	marker/mechanism		NA		29808285
ABCB4	5244	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		20040336
ABCB5	340273	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
ABCB5	340273	Melanoma	MESH:D008545	marker/mechanism		NA		15899824
ABCB6	10058	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
ABCB6	10058	DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 3	OMIM:615402	marker/mechanism		NA	615402	
ABCB6	10058	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 7	OMIM:614497	marker/mechanism		NA	614497	
ABCB6	10058	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
ABCB6	10058	Pseudohyperkalemia, Familial, 2, due to Red Cell Leak	MESH:C563785	marker/mechanism		NA	609153	
ABCB7	22	Anemia, Sideroblastic	MESH:D000756	marker/mechanism		NA		16892088|18637800
ABCB7	22	Anemia, sideroblastic spinocerebellar ataxia	MESH:C536358	marker/mechanism		NA	301310	21326867
ABCB7	22	Ataxia	MESH:D001259	marker/mechanism		NA		16892088
ABCC1	4363	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25078270
ABCC1	4363	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		18466103
ABCC1	4363	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
ABCC1	4363	Disease Progression	MESH:D018450	marker/mechanism		NA		25078270
ABCC1	4363	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		18256692
ABCC1	4363	Heart Diseases	MESH:D006331	marker/mechanism		NA		16330681
ABCC1	4363	Hypertension	MESH:D006973	marker/mechanism		NA		17272743
ABCC1	4363	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		20864405
ABCC1	4363	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		25275603
ABCC11	85320	Disease Progression	MESH:D018450	marker/mechanism		NA		22294766
ABCC12	94160	Bone Marrow Diseases	MESH:D001855	marker/mechanism		NA		18466103
ABCC12	94160	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		18466103
ABCC13	150000	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
ABCC2	1244	Alopecia	MESH:D000505	marker/mechanism		NA		18381794
ABCC2	1244	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		23897011
ABCC2	1244	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		18381794|18466103
ABCC2	1244	Cholestasis	MESH:D002779	marker/mechanism		NA		10869290|17681005|22521610
ABCC2	1244	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
ABCC2	1244	Diarrhea	MESH:D003967	marker/mechanism		NA		32387182
ABCC2	1244	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		20216337
ABCC2	1244	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		20216337|23222202|25007187|32387182
ABCC2	1244	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21206495
ABCC2	1244	Gastrointestinal Diseases	MESH:D005767	marker/mechanism		NA		18381794
ABCC2	1244	Heart Diseases	MESH:D006331	marker/mechanism		NA		16330681
ABCC2	1244	Hyperbilirubinemia	MESH:D006932	marker/mechanism		NA		16611851
ABCC2	1244	Jaundice, Chronic Idiopathic	MESH:D007566	marker/mechanism		NA	237500	16952291
ABCC2	1244	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		15542527
ABCC2	1244	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ABCC2	1244	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		21064136
ABCC2	1244	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		29341352
ABCC2	1244	Seizures	MESH:D012640	marker/mechanism		NA		16504477
ABCC2	1244	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		25275603
ABCC2	1244	Status Epilepticus	MESH:D013226	marker/mechanism		NA		16504477
ABCC3	8714	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		23897011
ABCC3	8714	Cholestasis	MESH:D002779	marker/mechanism		NA		22461449
ABCC3	8714	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
ABCC3	8714	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
ABCC4	10257	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		23897011
ABCC4	10257	Cognition Disorders	MESH:D003072	marker/mechanism		NA		29382564
ABCC4	10257	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
ABCC4	10257	Diabetes Complications	MESH:D048909	marker/mechanism		NA		29382564
ABCC4	10257	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		23222202
ABCC4	10257	Endometriosis	MESH:D004715	marker/mechanism		NA		25446850
ABCC4	10257	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17003774
ABCC4	10257	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17003774
ABCC4	10257	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
ABCC5	10057	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		23897011
ABCC5	10057	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
ABCC5	10057	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ABCC6	368	Arterial calcification of infancy	MESH:C537440	marker/mechanism		NA	614473	25758222
ABCC6	368	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
ABCC6	368	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		23415960
ABCC6	368	Disease Progression	MESH:D018450	marker/mechanism		NA		22294766
ABCC6	368	Pseudoxanthoma Elasticum	MESH:D011561	marker/mechanism		NA	177850|264800	11880368|12069597|14667841|16571645|17045963|18049453|23415960|25758222
ABCC6A	566555	Arterial calcification of infancy	MESH:C537440	marker/mechanism		NA		25758222
ABCC6A	566555	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		25758222
ABCC6A	566555	Pseudoxanthoma Elasticum	MESH:D011561	marker/mechanism		NA		25758222
ABCC8	6833	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
ABCC8	6833	Congenital Hyperinsulinism	MESH:D044903	marker/mechanism		NA	256450	10334322|15579781
ABCC8	6833	Diabetes Mellitus, Permanent Neonatal	MESH:C563425	marker/mechanism		NA	606176	
ABCC8	6833	Diabetes Mellitus, Transient Neonatal, 2	MESH:C563672	marker/mechanism		NA	610374	
ABCC8	6833	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		18025464
ABCC8	6833	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA	125853	22209866|9568693
ABCC8	6833	Hypoglycemia, leucine-induced	MESH:C537150	marker/mechanism		NA	240800	
ABCC9	10060	ATRIAL FIBRILLATION, FAMILIAL, 12	OMIM:614050	marker/mechanism		NA	614050	
ABCC9	10060	Cantu syndrome	MESH:C535572	marker/mechanism		NA	239850	22610116|28842488
ABCC9	10060	Cardiomyopathy, Dilated, 1o	MESH:C563906	marker/mechanism		NA	608569	
ABCC9	10060	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		23104009
ABCC9	10060	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
ABCD1	215	Adrenoleukodystrophy	MESH:D000326	marker/mechanism		NA	300100	16319717|17602313|22057157
ABCD2	225	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
ABCD3	5825	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5	OMIM:616278	marker/mechanism		NA	616278	
ABCD3	5825	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
ABCD3	5825	Zellweger Syndrome	MESH:D015211	marker/mechanism		NA		1301993
ABCD4	5826	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
ABCD4	5826	Disease Progression	MESH:D018450	marker/mechanism		NA		22294766
ABCD4	5826	Metabolism, Inborn Errors	MESH:D008661	marker/mechanism		NA		22922874
ABCD4	5826	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE	OMIM:614857	marker/mechanism		NA	614857	
ABCD4	5826	Vitamin B 12 Deficiency	MESH:D014806	marker/mechanism		NA		22922874
ABCE1	6059	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
ABCF1	23	Disease Progression	MESH:D018450	marker/mechanism		NA		22294766
ABCF1	23	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
ABCF1	23	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
ABCF2	10061	Disease Progression	MESH:D018450	marker/mechanism		NA		22294766
ABCG1	9619	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
ABCG1	9619	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19878707
ABCG1	9619	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ABCG1	9619	Weight Gain	MESH:D015430	marker/mechanism		NA		17194745
ABCG2	9429	Adenoma	MESH:D000236	marker/mechanism		NA		21544799
ABCG2	9429	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		23897011
ABCG2	9429	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		10930538
ABCG2	9429	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		21544799|22294766
ABCG2	9429	Diarrhea	MESH:D003967	marker/mechanism		NA		32387182
ABCG2	9429	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		21064136|32387182
ABCG2	9429	Gout	MESH:D006073	marker/mechanism		NA		21821808|31578528
ABCG2	9429	Hyperuricemia	MESH:D033461	marker/mechanism		NA		21821808
ABCG2	9429	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		15542527
ABCG2	9429	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		21625222
ABCG2	9429	Mammary Neoplasms, Experimental	MESH:D008325	therapeutic		NA		22767648
ABCG2	9429	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		21064136
ABCG2	9429	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054218	marker/mechanism		NA		20019844
ABCG2	9429	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		25275603
ABCG2	9429	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1	OMIM:138900	marker/mechanism		NA	138900	
ABCG5	64240	Atherosclerosis	MESH:D050197	marker/mechanism		NA		11138003
ABCG5	64240	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		11099417|11138003
ABCG5	64240	Coronary Disease	MESH:D003327	marker/mechanism		NA		19060911
ABCG5	64240	Dyslipidemias	MESH:D050171	marker/mechanism		NA		19060911
ABCG5	64240	Lipid Metabolism, Inborn Errors	MESH:D008052	marker/mechanism		NA		11138003
ABCG5	64240	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ABCG5	64240	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		22919386
ABCG5	64240	Sitosterolemia	MESH:C537345	marker/mechanism		NA		11099417|11138003
ABCG5	64240	Xanthomatosis	MESH:D014973	marker/mechanism		NA		11138003
ABCG8	64241	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		11099417
ABCG8	64241	Gallbladder Disease 4	MESH:C566936	marker/mechanism		NA	611465	
ABCG8	64241	Gallstones	MESH:D042882	marker/mechanism		NA		17632509
ABCG8	64241	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ABCG8	64241	Sitosterolemia	MESH:C537345	marker/mechanism		NA	210250	11099417
ABHD12	26090	Polyneuropathy, Hearing Loss, Ataxia, Retinitis Pigmentosa, And Cataract	MESH:C567203	marker/mechanism		NA	612674	
ABHD5	51099	Chanarin-Dorfman Syndrome	MESH:C536560	marker/mechanism		NA	275630	
ABI1	10006	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
ABI3	51225	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		28714976
ABI3BP	25890	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
ABL1	25	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		21472143
ABL1	25	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		28288113
ABL1	25	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20234815
ABL1	25	Carcinogenesis	MESH:D063646	marker/mechanism		NA		23968727
ABL1	25	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		21472143
ABL1	25	Failure to Thrive	MESH:D005183	marker/mechanism		NA		28288113
ABL1	25	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		28288113
ABL1	25	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	MESH:D015464	marker/mechanism		NA	608232	15604220|18673174|21908430
ABL1	25	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
ABL1	25	Musculoskeletal Abnormalities	MESH:D009139	marker/mechanism		NA		28288113
ABL1	25	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		19878872
ABL1	25	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		19233941
ABL1	25	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		11984797|21898527
ABLIM1	3983	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
ABLIM3	22885	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ABO	28	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		25581431
ABO	28	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		21378990
ABO	28	COVID-19	MESH:C000657245	marker/mechanism		NA		32558485
ABO	28	Critical Illness	MESH:D016638	marker/mechanism		NA		32558485
ABO	28	Diverticular Diseases	MESH:D000076385	marker/mechanism		NA		30177863
ABO	28	Duodenal Ulcer	MESH:D004381	marker/mechanism		NA		22387998
ABO	28	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		19648918|26098869
ABO	28	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
ABO	28	Respiratory Insufficiency	MESH:D012131	marker/mechanism		NA		32558485
ABO	28	Stroke	MESH:D020521	marker/mechanism		NA		29531354
ABR	29	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		24763052
ABRA	137735	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		16243910
ABT1	29777	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
ABT1	29777	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
ACAA1B	235674	Heart Failure	MESH:D006333	marker/mechanism		NA		26670611
ACAA2	10449	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
ACAA2	10449	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
ACACA	31	Acetyl-Coa Carboxylase Deficiency	MESH:C562678	marker/mechanism		NA	613933	
ACACA	31	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21147110
ACACA	31	Heart Failure	MESH:D006333	marker/mechanism		NA		26670611
ACACB	32	Insulin Resistance	MESH:D007333	marker/mechanism		NA		22658938
ACACB	32	Obesity	MESH:D009765	marker/mechanism		NA		20882379
ACAD8	27034	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
ACAD8	27034	Isobutyryl-CoA dehydrogenase deficiency	MESH:C535541	marker/mechanism		NA	611283	
ACAD8	27034	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
ACAD9	28976	Acyl-CoA Dehydrogenase Family, Member 9, Deficiency of	MESH:C567006	marker/mechanism		NA	611126	21057504
ACADM	34	Enterocolitis, Necrotizing	MESH:D020345	marker/mechanism		NA		18806098
ACADM	34	Liver Failure	MESH:D017093	marker/mechanism		NA		9090694
ACADM	34	Medium chain acyl CoA dehydrogenase deficiency	MESH:C536038	marker/mechanism		NA	201450	
ACADM	34	Obesity	MESH:D009765	marker/mechanism		NA		20882379
ACADM	34	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
ACADS	35	Heart Failure	MESH:D006333	marker/mechanism		NA		30827304
ACADS	35	Short chain Acyl CoA dehydrogenase deficiency	MESH:C537596	marker/mechanism		NA	201470	
ACADSB	36	2-Methylbutyryl-CoA Dehydrogenase Deficiency	MESH:C566487	marker/mechanism		NA	610006	
ACADSB	36	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17883863
ACADVL	37	Hypoxia	MESH:D000860	marker/mechanism		NA		18258771
ACADVL	37	VLCAD deficiency	MESH:C536353	marker/mechanism		NA	201475	20060901
ACAN	176	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		15292528
ACAN	176	Muscular Dystrophy, Facioscapulohumeral	MESH:D020391	marker/mechanism		NA		12868502
ACAN	176	Pneumoconiosis	MESH:D011009	marker/mechanism		NA		25445010
ACAN	176	SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS	OMIM:165800	marker/mechanism		NA	165800	
ACAN	176	Spondyloepimetaphyseal Dysplasia, Aggrecan Type	MESH:C567558	marker/mechanism		NA	612813	
ACAN	176	Spondyloepiphyseal Dysplasia, Kimberley Type	MESH:C564252	marker/mechanism		NA	608361	
ACAT1	38	Beta ketothiolase deficiency	MESH:C535434	marker/mechanism		NA	203750	
ACAT1	38	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19878707
ACAT1	38	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ACAT1	38	Seizures	MESH:D012640	marker/mechanism		NA		23266720
ACAT2	39	Cytosolic acetoacetyl-CoA thiolase deficiency	MESH:C536005	marker/mechanism		NA	614055	
ACBD4	79777	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ACBD6	84320	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
ACD	65057	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6	OMIM:616553	marker/mechanism		NA	616553	
ACE	1636	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		21552421
ACE	1636	Albuminuria	MESH:D000419	marker/mechanism		NA		23733546
ACE	1636	Allanson Pantzar McLeod syndrome	MESH:C537048	marker/mechanism		NA		16116425
ACE	1636	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		10643899|14872014|17192785|30820047|9916793
ACE	1636	Arrhythmias, Cardiac	MESH:D001145	marker/mechanism		NA		15331425
ACE	1636	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		15331425
ACE	1636	Autistic Disorder	MESH:D001321	marker/mechanism		NA		27082637
ACE	1636	Berylliosis	MESH:D001607	marker/mechanism		NA		10194187
ACE	1636	Brain Ischemia	MESH:D002545	marker/mechanism		NA		15534175
ACE	1636	Carcinoma, Hepatocellular	MESH:D006528	therapeutic		NA		16328049
ACE	1636	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		11498459|14657821|16544732
ACE	1636	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
ACE	1636	Cerebral Hemorrhage	MESH:D002543	marker/mechanism		NA	614519	15277638
ACE	1636	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		14989558
ACE	1636	Coronary Disease	MESH:D003327	marker/mechanism		NA		8170965
ACE	1636	Coronary Restenosis	MESH:D023903	marker/mechanism		NA		9236417
ACE	1636	Cough	MESH:D003371	marker/mechanism		NA		12848919|15498266
ACE	1636	Death, Sudden	MESH:D003645	marker/mechanism		NA		15331425
ACE	1636	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		22191573
ACE	1636	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		10099885|10857950|23733546|7909524
ACE	1636	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		18727619
ACE	1636	Gaucher Disease	MESH:D005776	marker/mechanism		NA		12359135
ACE	1636	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		18727619
ACE	1636	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		7593601|9259580
ACE	1636	Glycogen Storage Disease Type V	MESH:D006012	marker/mechanism		NA		12666117
ACE	1636	Heart Failure	MESH:D006333	marker/mechanism		NA		18586661
ACE	1636	Hypertension	MESH:D006973	marker/mechanism		NA		15773232|17473847|20237592|27847271
ACE	1636	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		12359135
ACE	1636	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		8349331
ACE	1636	Hypotension	MESH:D007022	therapeutic		NA		3544871
ACE	1636	Infant, Premature, Diseases	MESH:D007235	marker/mechanism		NA		14657821
ACE	1636	Infertility, Male	MESH:D007248	marker/mechanism		NA		12075344|8642790
ACE	1636	Kidney Diseases	MESH:D007674	marker/mechanism		NA		8642790
ACE	1636	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		10099885|7593601
ACE	1636	Lung Diseases	MESH:D008171	marker/mechanism		NA		18702808
ACE	1636	Lung Injury	MESH:D055370	marker/mechanism		NA		16001071
ACE	1636	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		21552421
ACE	1636	Meningococcal Infections	MESH:D008589	marker/mechanism		NA		11956052
ACE	1636	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3	OMIM:612624	marker/mechanism		NA	612624	
ACE	1636	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		1328889|8131300
ACE	1636	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		18059164
ACE	1636	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		21664615
ACE	1636	Pneumonia, Viral	MESH:D011024	marker/mechanism		NA		15381116
ACE	1636	Pre-Eclampsia	MESH:D011225	marker/mechanism		NA		17114810
ACE	1636	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17465223
ACE	1636	Psychoses, Substance-Induced	MESH:D011605	marker/mechanism		NA		17196621
ACE	1636	Renal Insufficiency	MESH:D051437	marker/mechanism		NA		9259580
ACE	1636	RENAL TUBULAR DYSGENESIS	OMIM:267430	marker/mechanism		NA	267430	20454656
ACE	1636	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		12204859|22009550
ACE	1636	Respiratory Tract Diseases	MESH:D012140	marker/mechanism		NA		14657821
ACE	1636	Severe Acute Respiratory Syndrome	MESH:D045169	marker/mechanism		NA		15381116
ACE	1636	Staphylococcal Infections	MESH:D013203	marker/mechanism		NA		8186310
ACE	1636	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		18059164
ACE	1636	Stroke	MESH:D020521	marker/mechanism		NA		15534175
ACE	1636	Vascular System Injuries	MESH:D057772	marker/mechanism		NA		19258495
ACE	1636	Weight Gain	MESH:D015430	marker/mechanism		NA		25322899
ACE2	59272	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
ACE2	59272	Aortic Aneurysm, Abdominal	MESH:D017544	therapeutic		NA		25301841
ACE2	59272	Cardiomyopathies	MESH:D009202	therapeutic		NA		28445944
ACE2	59272	Coronavirus Infections	MESH:D018352	marker/mechanism		NA		14647384|16007097|19453650|19625462|22496216|23678171|24172901|24227843|25187545
ACE2	59272	COVID-19	MESH:C000657245	marker/mechanism|therapeutic		NA		31996437|32061198|32081428|32092392|32117569|32129518|32132184|32133153|32142651|32149769|32201080|32203189|32275855|32286790|32404436
ACE2	59272	Diabetic Nephropathies	MESH:D003928	marker/mechanism|therapeutic		NA		12623933|17600118|20844835
ACE2	59272	Diabetic Retinopathy	MESH:D003930	therapeutic		NA		31380462
ACE2	59272	Endomyocardial Fibrosis	MESH:D004719	marker/mechanism		NA		19221212
ACE2	59272	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA		16723697
ACE2	59272	Heart Failure	MESH:D006333	marker/mechanism		NA		25973029
ACE2	59272	Hypertension	MESH:D006973	marker/mechanism|therapeutic		NA		12075344|15833808|17473847|18391097|19221212|20559404|21859683
ACE2	59272	Hypertension, Pulmonary	MESH:D006976	therapeutic		NA		31931441
ACE2	59272	Inflammation	MESH:D007249	marker/mechanism		NA		19453650
ACE2	59272	Lung Injury	MESH:D055370	marker/mechanism|therapeutic		NA		16001071|19864379|20484496
ACE2	59272	Pulmonary Fibrosis	MESH:D011658	therapeutic		NA		27550926
ACE2	59272	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		22009550
ACE2	59272	Severe Acute Respiratory Syndrome	MESH:D045169	marker/mechanism		NA		14647384|16007097|16166518|16339146|19453650|19625462|23678171|24172901|24227843|26801988|31996437|32092392|32201080
ACER3	55331	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
ACHE	43	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		22944069|23047022
ACHE	43	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		16470869
ACHE	43	Amyloidosis	MESH:D000686	marker/mechanism		NA		23047022
ACHE	43	Anemia	MESH:D000740	marker/mechanism		NA		31170385
ACHE	43	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		23063927
ACHE	43	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		18482720
ACHE	43	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	therapeutic		NA		27083141
ACHE	43	Growth Disorders	MESH:D006130	marker/mechanism		NA		22898132
ACHE	43	Learning Disabilities	MESH:D007859	marker/mechanism		NA		18533140
ACHE	43	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		16496349
ACHE	43	Memory Disorders	MESH:D008569	marker/mechanism		NA		18599028
ACHE	43	Movement Disorders	MESH:D009069	marker/mechanism		NA		19628251
ACHE	43	Muscular Dystrophies	MESH:D009136	marker/mechanism		NA		22906800
ACHE	43	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		22240983
ACHE	43	Obesity	MESH:D009765	marker/mechanism		NA		29273807
ACHE	43	Organophosphate Poisoning	MESH:D062025	marker/mechanism|therapeutic		NA		23000449|3669600|8359835
ACHE	43	Poisoning	MESH:D011041	marker/mechanism		NA		17098105
ACHE	43	Prenatal Injuries	MESH:D049188	marker/mechanism		NA		14657522
ACHE	43	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		20356562
ACHE	43	Seizures	MESH:D012640	marker/mechanism|therapeutic		NA		19941057|27083141
ACHE	43	Tremor	MESH:D014202	therapeutic		NA		27083141
ACHE	43	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		29644616
ACKR1	2532	Malaria	MESH:D008288	marker/mechanism		NA	611162	
ACKR3	57007	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		19192274
ACKR3	57007	Carcinoma	MESH:D002277	marker/mechanism		NA		22180778
ACKR3	57007	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22180778
ACKR3	57007	Kidney Diseases	MESH:D007674	marker/mechanism		NA		22880115
ACKR3	57007	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ACKR3	57007	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		22180778
ACKR4	51554	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
ACLY	47	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21147110
ACLY	47	Heart Failure	MESH:D006333	marker/mechanism		NA		26670611
ACLY	47	Obesity	MESH:D009765	marker/mechanism		NA		20882379
ACO1	48	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		20390345
ACO1	48	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
ACO2	50	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
ACO2	50	INFANTILE CEREBELLAR-RETINAL DEGENERATION	OMIM:614559	marker/mechanism		NA	614559	
ACO2	50	OPTIC ATROPHY 9	OMIM:616289	marker/mechanism		NA	616289	
ACO2	50	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
ACOT1	641371	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		14563825
ACOT1	641371	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
ACOT1	641371	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		25058030
ACOT2	10965	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
ACOT6	641372	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
ACOT9	23597	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ACOX1	51	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		12771043|15565109
ACOX1	51	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		14563825
ACOX1	51	Peroxisomal ACYL-COA oxidase deficiency	MESH:C536662	marker/mechanism		NA	264470	
ACOX2	8309	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	OMIM:617308	marker/mechanism		NA	617308	
ACOX2	8309	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ACOX3	8310	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
ACOXL	55289	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		23770605
ACP2	53	Acid Phosphatase Deficiency	MESH:C562645	marker/mechanism		NA	200950	
ACP3	55	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
ACP4	93650	AMELOGENESIS IMPERFECTA, TYPE IJ	OMIM:617297	marker/mechanism		NA	617297	
ACP5	54	Combined Immunodeficiency with Autoimmunity and Spondylometaphyseal Dysplasia	MESH:C564307	marker/mechanism		NA	607944	
ACP5	54	Hyperparathyroidism, Secondary	MESH:D006962	marker/mechanism		NA		21985997|22373954
ACP5	54	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ACP5	54	Obesity	MESH:D009765	marker/mechanism		NA		20882379
ACP5	54	Spondyloenchondrodysplasia	MESH:C535782	marker/mechanism		NA		21217752|21217755
ACRBP	84519	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
ACRBP	84519	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
ACSF3	197322	Combined Malonic and Methylmalonic Aciduria	MESH:C580002	marker/mechanism		NA	614265	
ACSF3	197322	Malonic aciduria	MESH:C535702	marker/mechanism		NA		21841779
ACSF3	197322	Methylmalonic acidemia	MESH:C537358	marker/mechanism		NA		21841779
ACSL1	2180	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		18988084
ACSL1	2180	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
ACSL1	2180	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
ACSL1	2180	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		9452481
ACSL1	2180	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ACSL1	2180	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
ACSL1	2180	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
ACSL1	2180	Obesity	MESH:D009765	marker/mechanism		NA		20882379
ACSL4	2182	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
ACSL4	2182	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		18988084
ACSL4	2182	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		19363144
ACSL4	2182	Depressive Disorder	MESH:D003866	marker/mechanism		NA		15108178
ACSL4	2182	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
ACSL4	2182	Erythema	MESH:D004890	marker/mechanism		NA		15108178
ACSL4	2182	Mental Retardation, X-Linked 63	MESH:C564522	marker/mechanism		NA	300387	
ACSL4	2182	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
ACSL5	51703	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		18988084
ACSL6	23305	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
ACSM1	116285	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17114358
ACSM3	6296	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		19208208
ACTA1	58	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		10601118
ACTA1	58	Myopathies, Structural, Congenital	MESH:D020914	marker/mechanism		NA	255310	
ACTA1	58	MYOPATHY, SCAPULOHUMEROPERONEAL	OMIM:616852	marker/mechanism		NA	616852	
ACTA1	58	NEMALINE MYOPATHY 3;NEM3 MYOPATHY, ACTIN, CONGENITAL, WITH EXCESS OF THIN MYOFILAMENTS,	OMIM:161800	marker/mechanism		NA	161800	
ACTA2	59	Aortic Aneurysm, Familial Thoracic 6	MESH:C567085	marker/mechanism		NA	611788	
ACTA2	59	Aortic Aneurysm, Thoracic	MESH:D017545	marker/mechanism		NA		17994018
ACTA2	59	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25330770
ACTA2	59	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		28789951
ACTA2	59	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
ACTA2	59	Copper-Overload Cirrhosis	MESH:C566858	marker/mechanism		NA		22879914
ACTA2	59	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
ACTA2	59	Fetal Growth Retardation	MESH:D005317	marker/mechanism		NA		28157488
ACTA2	59	Fibrosis	MESH:D005355	marker/mechanism		NA		31697999
ACTA2	59	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA		20493835
ACTA2	59	Hepatitis, Chronic	MESH:D006521	marker/mechanism		NA		22879914
ACTA2	59	Ischemia	MESH:D007511	marker/mechanism		NA		19458120
ACTA2	59	Kidney Diseases	MESH:D007674	marker/mechanism		NA		19913069|31697999
ACTA2	59	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		24239723|24321339|30097701|32659284
ACTA2	59	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		26435214|26739621
ACTA2	59	Liver Diseases	MESH:D008107	marker/mechanism		NA		11738102
ACTA2	59	MOYAMOYA DISEASE 5	OMIM:614042	marker/mechanism		NA	614042	
ACTA2	59	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		24358288
ACTA2	59	Nephrogenic Fibrosing Dermopathy	MESH:D054989	marker/mechanism		NA		20570839
ACTA2	59	Nephrosclerosis	MESH:D009400	marker/mechanism		NA		30818366
ACTA2	59	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		30639579
ACTA2	59	Scleroderma, Systemic	MESH:D012595	marker/mechanism		NA		24706986
ACTA2	59	Ureteral Obstruction	MESH:D014517	marker/mechanism		NA		28318631
ACTB	60	BARAITSER-WINTER SYNDROME 1	OMIM:243310	marker/mechanism		NA	243310	
ACTB	60	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
ACTB	60	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		19363144|21472284
ACTB	60	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
ACTB	60	Coloboma	MESH:D003103	marker/mechanism		NA		22366783
ACTB	60	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		22366783
ACTB	60	Dysostoses	MESH:D004413	marker/mechanism		NA		16685646
ACTB	60	Dystonia	MESH:D004421	marker/mechanism		NA		16685646
ACTB	60	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		15986332
ACTB	60	Hearing Loss, Sensorineural	MESH:D006319	marker/mechanism		NA		16685646
ACTB	60	Hypoxia	MESH:D000860	marker/mechanism		NA		19579223
ACTB	60	Juvenile-onset dystonia	MESH:C537704	marker/mechanism		NA	607371	
ACTB	60	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		23692979
ACTB	60	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
ACTB	60	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
ACTB	60	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
ACTB	60	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		15654357
ACTB	60	Nervous System Malformations	MESH:D009421	marker/mechanism		NA		22366783
ACTB	60	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
ACTC1	70	Atrial Septal Defect 5	MESH:C567561	marker/mechanism		NA	612794	
ACTC1	70	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA	613424	
ACTC1	70	Cardiomyopathy, Familial Hypertrophic, 11	MESH:C567419	marker/mechanism		NA	612098	
ACTC1	70	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21472284
ACTC1	70	Refractive Errors	MESH:D012030	marker/mechanism		NA		20835239
ACTC1	70	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		19424620
ACTG1	71	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		21751358
ACTG1	71	BARAITSER-WINTER SYNDROME 2	OMIM:614583	marker/mechanism		NA	614583	
ACTG1	71	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
ACTG1	71	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		25401301
ACTG1	71	Coloboma	MESH:D003103	marker/mechanism		NA		22366783
ACTG1	71	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		22366783
ACTG1	71	Deafness, Autosomal Dominant 20	MESH:C565754	marker/mechanism		NA	604717	
ACTG1	71	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
ACTG1	71	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
ACTG1	71	Nervous System Malformations	MESH:D009421	marker/mechanism		NA		22366783
ACTG1	71	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
ACTG2	72	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
ACTG2	72	Megacystis microcolon intestinal hypoperistalsis syndrome	MESH:C536138	marker/mechanism		NA		24337657|24676022
ACTG2	72	VISCERAL MYOPATHY	OMIM:155310	marker/mechanism		NA	155310	
ACTG2	72	Visceral Myopathy, Familial	MESH:C562574	marker/mechanism		NA		22960657
ACTL9	284382	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		23042114
ACTN1	87	BLEEDING DISORDER, PLATELET-TYPE, 15	OMIM:615193	marker/mechanism		NA	615193	
ACTN1	87	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ACTN2	88	Cardiomyopathy, Dilated, 1AA	MESH:C567407	marker/mechanism		NA	612158	
ACTN4	81	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
ACTN4	81	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
ACTN4	81	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA	603278	
ACTN4	81	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
ACTN4	81	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
ACTR3	10096	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
ACTRT2	140625	Keloid	MESH:D007627	marker/mechanism		NA		20128793
ACVR1	90	Acute Lung Injury	MESH:D055371	marker/mechanism		NA		21297076
ACVR1	90	Astrocytoma	MESH:D001254	marker/mechanism		NA		24705250
ACVR1	90	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		23180569
ACVR1	90	Glioma	MESH:D005910	marker/mechanism		NA		24705251|24705252|24705254
ACVR1	90	Myositis Ossificans	MESH:D009221	marker/mechanism		NA	135100	
ACVR2A	92	Microsatellite Instability	MESH:D053842	marker/mechanism		NA		25701956
ACVR2B	93	Heterotaxy Syndrome	MESH:D059446	marker/mechanism		NA		9916847
ACVR2B	93	HETEROTAXY, VISCERAL, 4, AUTOSOMAL	OMIM:613751	marker/mechanism		NA	613751	
ACVR2B	93	Situs Inversus	MESH:D012857	marker/mechanism		NA		9916847
ACVRL1	94	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		26540443
ACVRL1	94	Osler-rendu-weber syndrome 2	MESH:C537139	marker/mechanism		NA	600376	
ACVRL1	94	Telangiectasia, Hereditary Hemorrhagic	MESH:D013683	marker/mechanism		NA		20135064
ACVRL1	94	Vascular Remodeling	MESH:D066253	marker/mechanism		NA		26540443
ACY1	95	Aminoacylase 1 deficiency	MESH:C538246	marker/mechanism		NA	609924	
ACY1	95	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		15108329
ACY1	95	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21472284
ACYP2	98	HEARING LOSS, CISPLATIN-INDUCED, SUSCEPTIBILITY TO	OMIM:613290	marker/mechanism		NA		25665007
ADA	100	Autistic Disorder	MESH:D001321	marker/mechanism		NA		11354825
ADA	100	Hyperemia	MESH:D006940	therapeutic		NA		2502780|7949234
ADA	100	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ADA	100	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		2305558
ADA	100	Severe combined immunodeficiency due to adenosine deaminase deficiency	MESH:C531816	marker/mechanism		NA	102700	
ADA	100	Spinal Cord Diseases	MESH:D013118	marker/mechanism		NA		16325979
ADA2	51816	Sneddon Syndrome	MESH:D018860	marker/mechanism		NA	182410	
ADAM10	102	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		30820047
ADAM10	102	ALZHEIMER DISEASE 18	OMIM:615590	marker/mechanism		NA	615590	
ADAM10	102	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16583263
ADAM10	102	Dowling-Degos Disease	MESH:C562924	marker/mechanism		NA	615537	
ADAM17	6868	Blister	MESH:D001768	marker/mechanism		NA		19167455
ADAM17	6868	Colitis	MESH:D003092	marker/mechanism		NA		24548422
ADAM17	6868	INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 1	OMIM:614328	marker/mechanism		NA	614328	
ADAM17	6868	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ADAM26A	13525	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
ADAM28	10863	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		20544843
ADAM28	10863	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29662167
ADAM33	80332	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		30226539
ADAM33	80332	Bronchial Hyperreactivity	MESH:D016535	marker/mechanism		NA		17061022
ADAM3A	1587	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
ADAM8	101	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		24646716
ADAM9	8754	CONE-ROD DYSTROPHY 9	OMIM:612775	marker/mechanism		NA	612775	
ADAM9	8754	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17018608
ADAMTS1	9510	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		30820047
ADAMTS1	9510	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		23289900
ADAMTS1	9510	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		19514085
ADAMTS1	9510	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		19027488
ADAMTS1	9510	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		23289900
ADAMTS10	81794	Weill-Marchesani Syndrome	MESH:D056846	marker/mechanism		NA	277600	
ADAMTS13	11093	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
ADAMTS13	11093	Purpura, Thrombocytopenic, Idiopathic	MESH:D016553	marker/mechanism		NA		19260037
ADAMTS13	11093	Purpura, Thrombotic Thrombocytopenic	MESH:D011697	marker/mechanism		NA	274150	12656756
ADAMTS13	11093	Thrombotic Microangiopathies	MESH:D057049	marker/mechanism		NA		14625834|16388419
ADAMTS17	170691	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
ADAMTS17	170691	Weill-Marchesani-Like Syndrome	MESH:C567710	marker/mechanism		NA	613195	
ADAMTS18	170692	MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS	OMIM:615458	marker/mechanism		NA	615458	
ADAMTS19	171019	Heart Valve Diseases	MESH:D006349	marker/mechanism		NA		31844321
ADAMTS2	9509	Ehlers-Danlos Syndrome, Type VII, Autosomal Recessive	MESH:C567527	marker/mechanism		NA	225410	
ADAMTS2	9509	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		26139392
ADAMTS20	80070	Melanoma	MESH:D008545	marker/mechanism		NA		21559390
ADAMTS3	9508	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
ADAMTS5	11096	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
ADAMTS7	11173	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		21378990
ADAMTS7	11173	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
ADAMTS8	11095	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
ADAMTS9	56999	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		18372903|23967108
ADAMTSL2	9719	Acromicric dysplasia	MESH:C535662	marker/mechanism		NA	231050	18677313
ADAMTSL2	9719	Contracture	MESH:D003286	marker/mechanism		NA		18677313
ADAMTSL2	9719	Facies	MESH:D019066	marker/mechanism		NA		18677313
ADAMTSL2	9719	Growth Disorders	MESH:D006130	marker/mechanism		NA		18677313
ADAMTSL2	9719	Hand Deformities, Congenital	MESH:D006228	marker/mechanism		NA		18677313
ADAMTSL2	9719	Heart Valve Diseases	MESH:D006349	marker/mechanism		NA		18677313
ADAMTSL2	9719	Hepatomegaly	MESH:D006529	marker/mechanism		NA		18677313
ADAMTSL2	9719	Metabolism, Inborn Errors	MESH:D008661	marker/mechanism		NA		18677313
ADAMTSL2	9719	Osteochondrodysplasias	MESH:D010009	marker/mechanism		NA		18677313
ADAMTSL4	54507	ECTOPIA LENTIS 2, ISOLATED, AUTOSOMAL RECESSIVE	OMIM:225100	marker/mechanism		NA	225100	
ADAMTSL4	54507	Ectopia Lentis with Ectopia of Pupil	MESH:C563268	marker/mechanism		NA	225200	
ADAR	103	Aicardi-Goutieres syndrome	MESH:C535607	marker/mechanism		NA	615010	23001123
ADAR	103	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		28188287
ADAR	103	Dyschromatosis symmetrica hereditaria 1	MESH:C535729	marker/mechanism		NA	127400	
ADARB1	104	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
ADARB2	105	Parkinson Disease	MESH:D010300	marker/mechanism		NA		25475535
ADARB2	105	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
ADAT3	113179	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36	OMIM:615286	marker/mechanism		NA	615286	
ADCY1	107	Deafness, Autosomal Recessive 44	MESH:C565716	marker/mechanism		NA	610154	
ADCY1	107	Hyperkinesis	MESH:D006948	marker/mechanism		NA		16914643
ADCY1	107	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941189
ADCY1	107	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		16914643
ADCY10	55811	Hypercalciuria, Absorptive, 2	MESH:C562790	marker/mechanism		NA	143870	
ADCY2	108	Asthma	MESH:D001249	marker/mechanism		NA		21912604
ADCY2	108	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		31043756
ADCY3	109	Diabetic Angiopathies	MESH:D003925	marker/mechanism		NA		25381014
ADCY3	109	Obesity	MESH:D009765	marker/mechanism		NA		29311635
ADCY3	109	Obesity, Morbid	MESH:D009767	marker/mechanism		NA		29311637
ADCY5	111	Birth Weight	MESH:D001724	marker/mechanism		NA		23202124
ADCY5	111	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
ADCY5	111	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		18029912|23536361
ADCY5	111	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		20081858|23202124
ADCY5	111	Dyskinesia, Familial, with Facial Myokymia	MESH:C564676	marker/mechanism		NA	606703	
ADCY5	111	Fibrosis	MESH:D005355	therapeutic		NA		25193472
ADCY5	111	Hypertension	MESH:D006973	marker/mechanism		NA		12717102
ADCY5	111	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
ADCY5	111	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
ADCY5	111	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
ADCY5	111	Osteoporosis	MESH:D010024	marker/mechanism		NA		18029912
ADCY5	111	Ventricular Dysfunction, Left	MESH:D018487	therapeutic		NA		25193472
ADCY6	112	LETHAL CONGENITAL CONTRACTURE SYNDROME 8	OMIM:616287	marker/mechanism		NA	616287	
ADCY7	113	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
ADCY7	113	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		28067910
ADCY7	113	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		18206229
ADCY7	113	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
ADCY8	114	Diabetic Angiopathies	MESH:D003925	marker/mechanism		NA		25381014
ADCY8	114	Hyperkinesis	MESH:D006948	marker/mechanism		NA		16914643
ADCY8	114	Mood Disorders	MESH:D019964	marker/mechanism		NA		19691954
ADCY8	114	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		16914643
ADCYAP1	116	Cardiomyopathies	MESH:D009202	therapeutic		NA		20378996
ADCYAP1	116	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
ADCYAP1	116	Hyperemia	MESH:D006940	marker/mechanism		NA		8637627
ADCYAP1	116	Miosis	MESH:D015877	marker/mechanism		NA		8637627
ADCYAP1	116	Neurotoxicity Syndromes	MESH:D020258	therapeutic		NA		29604313
ADCYAP1	116	Psychomotor Agitation	MESH:D011595	marker/mechanism		NA		17658665
ADCYAP1	116	Seizures	MESH:D012640	marker/mechanism		NA		29673861
ADCYAP1	116	Urinary Bladder, Overactive	MESH:D053201	therapeutic		NA		16322346
ADCYAP1R1	117	Asthma	MESH:D001249	marker/mechanism		NA		21059121
ADD1	118	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		19363144
ADD1	118	Essential Hypertension	MESH:D000075222	marker/mechanism		NA	145500	
ADD1	118	Hypertension	MESH:D006973	marker/mechanism		NA		15773232|19199261
ADD3	120	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		31043756
ADD3	120	Brain Ischemia	MESH:D002545	marker/mechanism		NA		17901229
ADD3	120	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3	OMIM:617008	marker/mechanism		NA	617008	
ADD3	120	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ADD3	120	Neurotoxicity Syndromes	MESH:D020258	marker/mechanism		NA		19784758
ADGRD2	347088	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
ADGRE1	2015	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ADGRE2	30817	Familial dermographism	MESH:C536612	marker/mechanism		NA	125630	
ADGRE5	976	Lung Diseases	MESH:D008171	marker/mechanism		NA		21602193
ADGRF4	221393	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
ADGRG1	9289	Polymicrogyria, Bilateral Frontoparietal	MESH:C564652	marker/mechanism		NA	606854	
ADGRG1	9289	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
ADGRG2	10149	Congenital bilateral aplasia of vas deferens	MESH:C535984	marker/mechanism		NA	300985	
ADGRG2	10149	Osteoarthritis	MESH:D010003	marker/mechanism		NA		17568789
ADGRG6	57211	LETHAL CONGENITAL CONTRACTURE SYNDROME 9	OMIM:616503	marker/mechanism		NA	616503	
ADGRG6	57211	SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 1	OMIM:181800	marker/mechanism		NA		23666238
ADGRG7	84873	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
ADGRL3	23284	Attention Deficit Disorder with Hyperactivity	MESH:D001289	marker/mechanism		NA		22405201
ADGRV1	84059	Febrile Convulsions, Familial, 4	MESH:C565788	marker/mechanism		NA	604352	
ADGRV1	84059	Usher syndrome, type 2C	MESH:C536492	marker/mechanism		NA	605472	
ADH1	11522	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ADH1A	124	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		29718361
ADH1B	125	Alcoholism	MESH:D000437	marker/mechanism		NA	103780	16404797|17590986|21168396
ADH1B	125	Cerebral Infarction	MESH:D002544	marker/mechanism		NA		15534263
ADH1B	125	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		16332725
ADH1B	125	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		18500343
ADH1B	125	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		22960999
ADH1B	125	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		16404797|17590986
ADH1B	125	Laryngeal Neoplasms	MESH:D007822	marker/mechanism		NA		18500343
ADH1B	125	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		18500343
ADH1B	125	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		29718361
ADH1B	125	Obesity	MESH:D009765	marker/mechanism		NA		20882379
ADH1B	125	Pharyngeal Neoplasms	MESH:D010610	marker/mechanism		NA		18500343
ADH1C	126	Alcoholism	MESH:D000437	marker/mechanism		NA	103780	16404797
ADH1C	126	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		16404797
ADH1C	126	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		15138216
ADH1C	126	PARKINSON DISEASE, LATE-ONSET	OMIM:168600	marker/mechanism		NA	168600	
ADH4	127	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
ADH4	127	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
ADH4	127	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		29718361
ADH7	131	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		18500343
ADH7	131	Laryngeal Neoplasms	MESH:D007822	marker/mechanism		NA		18500343
ADH7	131	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		18500343
ADH7	131	Pharyngeal Neoplasms	MESH:D010610	marker/mechanism		NA		18500343
ADHFE1	137872	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ADI1	55256	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17786183
ADIPOQ	9370	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 2	OMIM:606770	marker/mechanism		NA		11549668
ADIPOQ	9370	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 3	OMIM:606771	marker/mechanism		NA		11549668
ADIPOQ	9370	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		23326410
ADIPOQ	9370	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		12833524
ADIPOQ	9370	Atherosclerosis	MESH:D050197	therapeutic		NA		18931039
ADIPOQ	9370	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		29723618
ADIPOQ	9370	Chemical and Drug Induced Liver Injury	MESH:D056486	therapeutic		NA		20709802
ADIPOQ	9370	Coronary Restenosis	MESH:D023903	therapeutic		NA		12138120
ADIPOQ	9370	Crohn Disease	MESH:D003424	marker/mechanism		NA		21829567
ADIPOQ	9370	Diabetes, Gestational	MESH:D016640	marker/mechanism		NA		15126557
ADIPOQ	9370	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		12860835
ADIPOQ	9370	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		12114044|12354786|15734870
ADIPOQ	9370	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		17942768
ADIPOQ	9370	Heart Failure	MESH:D006333	marker/mechanism|therapeutic		NA		19367012|26670611
ADIPOQ	9370	Heroin Dependence	MESH:D006556	marker/mechanism		NA		15717844
ADIPOQ	9370	Hyperemia	MESH:D006940	marker/mechanism		NA		12860835
ADIPOQ	9370	Hyperglycemia	MESH:D006943	therapeutic		NA		29991592
ADIPOQ	9370	Hypertension	MESH:D006973	marker/mechanism		NA		12860835
ADIPOQ	9370	Hypoadiponectinemia	MESH:C567258	marker/mechanism		NA	612556	
ADIPOQ	9370	Inflammation	MESH:D007249	therapeutic		NA		12860835
ADIPOQ	9370	Insulin Resistance	MESH:D007333	therapeutic		NA		18931039|21484566
ADIPOQ	9370	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19539174
ADIPOQ	9370	Liver Cirrhosis, Experimental	MESH:D008106	therapeutic		NA		14724832
ADIPOQ	9370	Metabolic Syndrome	MESH:D024821	marker/mechanism		NA		16793964|17618945|18162013|20833989
ADIPOQ	9370	Myocardial Ischemia	MESH:D017202	therapeutic		NA		16155579
ADIPOQ	9370	Myocardial Reperfusion Injury	MESH:D015428	therapeutic		NA		16155579
ADIPOQ	9370	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		20415685
ADIPOQ	9370	Obesity	MESH:D009765	marker/mechanism|therapeutic		NA		10092513|14617771
ADIPOQ	9370	Pulmonary Edema	MESH:D011654	therapeutic		NA		25945502
ADIPOQ	9370	Pulmonary Fibrosis	MESH:D011658	therapeutic		NA		25945502
ADIPOQ	9370	Weight Gain	MESH:D015430	marker/mechanism		NA		12860835
ADIPOQ	9370	Weight Loss	MESH:D015431	marker/mechanism		NA		18230824
ADIPOR1	51094	Infertility, Female	MESH:D007247	marker/mechanism		NA		22265003
ADIPOR1	51094	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19539174
ADIPOR2	79602	Infertility, Female	MESH:D007247	marker/mechanism		NA		22265003
ADIPQTL2	171511	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 2	OMIM:606770	marker/mechanism		NA		11549668
ADIPQTL3	171512	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 3	OMIM:606771	marker/mechanism		NA		11549668
ADK	132	HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	OMIM:614300	marker/mechanism		NA	614300	21963049
ADK	132	Hypoxia	MESH:D000860	marker/mechanism		NA		19579223
ADK	132	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
ADM	133	Autistic Disorder	MESH:D001321	marker/mechanism		NA		12579522
ADM	133	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		15063164|15680492
ADM	133	Hyperalgesia	MESH:D006930	marker/mechanism		NA		17043245
ADM	133	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		15370692|16610064
ADM	133	Pain	MESH:D010146	marker/mechanism		NA		17043245
ADM	133	Sepsis	MESH:D018805	marker/mechanism		NA		14766677
ADM	133	Stomach Ulcer	MESH:D013276	therapeutic		NA		9845272
ADM2	79924	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16987513
ADM2	79924	Vascular Diseases	MESH:D014652	therapeutic		NA		19910445
ADNP	23394	Autistic Disorder	MESH:D001321	marker/mechanism		NA		24531329
ADNP	23394	HELSMOORTEL-VAN DER AA SYNDROME	OMIM:615873	marker/mechanism		NA	615873	
ADNP	23394	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
ADORA1	134	Bradycardia	MESH:D001919	marker/mechanism		NA		18313046
ADORA1	134	Catalepsy	MESH:D002375	therapeutic		NA		9407998
ADORA1	134	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		19019667
ADORA1	134	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		15641640
ADORA1	134	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		19019667
ADORA1	134	Hypotension	MESH:D007022	marker/mechanism		NA		15641640|18313046
ADORA1	134	Infarction, Middle Cerebral Artery	MESH:D020244	therapeutic		NA		23437309
ADORA1	134	Ischemia	MESH:D007511	marker/mechanism		NA		18950269
ADORA1	134	Ischemic Attack, Transient	MESH:D002546	therapeutic		NA		23437309
ADORA1	134	Myocardial Infarction	MESH:D009203	therapeutic		NA		12160945
ADORA1	134	Nerve Degeneration	MESH:D009410	therapeutic		NA		23437309
ADORA1	134	Prenatal Exposure Delayed Effects	MESH:D011297	marker/mechanism		NA		19092996
ADORA1	134	Subarachnoid Hemorrhage	MESH:D013345	marker/mechanism		NA		18950269
ADORA1	134	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		16226742
ADORA1	134	Ventricular Dysfunction	MESH:D018754	marker/mechanism		NA		15641640
ADORA2A	135	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		20799992
ADORA2A	135	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		12825092|16118787|18305461|20532872
ADORA2A	135	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		19192274
ADORA2A	135	Cardiomyopathies	MESH:D009202	therapeutic		NA		20363887
ADORA2A	135	Depressive Disorder	MESH:D003866	marker/mechanism		NA		26860412
ADORA2A	135	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		19019667
ADORA2A	135	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		15641640
ADORA2A	135	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		19019667
ADORA2A	135	Hyperkinesis	MESH:D006948	therapeutic		NA		15187444
ADORA2A	135	Hypotension	MESH:D007022	marker/mechanism		NA		15641640|1592228|18313046
ADORA2A	135	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		16783407
ADORA2A	135	Movement Disorders	MESH:D009069	marker/mechanism		NA		26526685
ADORA2A	135	Panic Disorder	MESH:D016584	marker/mechanism		NA		12825092
ADORA2A	135	Psychoses, Substance-Induced	MESH:D011605	marker/mechanism		NA		20799992
ADORA2A	135	Reperfusion Injury	MESH:D015427	therapeutic		NA		27757725
ADORA2A	135	Seizures	MESH:D012640	marker/mechanism		NA		19488739
ADORA2A	135	Sepsis	MESH:D018805	marker/mechanism		NA		27757725
ADORA2A	135	Sleep Initiation and Maintenance Disorders	MESH:D007319	marker/mechanism		NA		20532872
ADORA2A	135	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		14756803|16226742|16470403
ADORA2A	135	Tremor	MESH:D014202	marker/mechanism		NA		16780890
ADORA2A	135	Ventricular Dysfunction	MESH:D018754	marker/mechanism		NA		15641640
ADORA2A	135	Weight Loss	MESH:D015431	marker/mechanism		NA		26526685
ADORA2B	136	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		27590504
ADORA2B	136	Reperfusion Injury	MESH:D015427	therapeutic		NA		27757725
ADORA2B	136	Sepsis	MESH:D018805	marker/mechanism		NA		27757725
ADORA3	140	Ischemia	MESH:D007511	marker/mechanism		NA		7774659
ADORA3	140	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ADORA3	140	Myocardial Infarction	MESH:D009203	therapeutic		NA		12160945|20132822
ADRA1A	148	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
ADRA1A	148	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		19133277
ADRA1A	148	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		16782692
ADRA1A	148	Ventricular Remodeling	MESH:D020257	marker/mechanism		NA		20668454
ADRA1B	147	Cardiomegaly	MESH:D006332	marker/mechanism		NA		11278430|11940550
ADRA1B	147	Hypotension	MESH:D007022	marker/mechanism		NA		11278430
ADRA1B	147	Kidney Diseases	MESH:D007674	marker/mechanism		NA		18257748
ADRA1B	147	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ADRA1B	147	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		12871582
ADRA1B	147	Neurotoxicity Syndromes	MESH:D020258	marker/mechanism		NA		19125850
ADRA1B	147	Seizures	MESH:D012640	marker/mechanism		NA		19125850
ADRA1D	146	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
ADRA2A	150	Cardiomegaly	MESH:D006332	therapeutic		NA		20083574
ADRA2A	150	Epilepsy	MESH:D004827	therapeutic		NA		17341653
ADRA2A	150	Fibrosis	MESH:D005355	therapeutic		NA		20083574
ADRA2A	150	Heart Diseases	MESH:D006331	marker/mechanism		NA		16844662
ADRA2A	150	Hypertension	MESH:D006973	marker/mechanism		NA		10694191
ADRA2A	150	Hypotension	MESH:D007022	marker/mechanism		NA		16595736|18849358
ADRA2A	150	Panic Disorder	MESH:D016584	marker/mechanism		NA		14656453
ADRA2B	151	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
ADRA2B	151	Cyanosis	MESH:D003490	marker/mechanism		NA		20729197
ADRA2B	151	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
ADRA2B	151	Lung Diseases	MESH:D008171	marker/mechanism		NA		20729197
ADRA2C	152	Cardiomegaly	MESH:D006332	marker/mechanism		NA		20083574
ADRA2C	152	Fibrosis	MESH:D005355	marker/mechanism		NA		20083574
ADRA2C	152	Heart Failure	MESH:D006333	marker/mechanism		NA		12374873
ADRB1	153	Birth Weight	MESH:D001724	marker/mechanism		NA		23202124
ADRB1	153	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		9554809
ADRB1	153	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		11436944
ADRB1	153	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		18378355
ADRB1	153	Endomyocardial Fibrosis	MESH:D004719	marker/mechanism		NA		14502278
ADRB1	153	Heart Failure	MESH:D006333	marker/mechanism		NA		12374873|14502278|15816327|21516734|7586371
ADRB1	153	Hyperemia	MESH:D006940	marker/mechanism		NA		17345787
ADRB1	153	Hypertension	MESH:D006973	marker/mechanism		NA		10673262|9260993
ADRB1	153	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		9554809
ADRB1	153	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		10900253
ADRB1	153	Obesity	MESH:D009765	marker/mechanism		NA		12032746
ADRB1	153	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		17003101
ADRB1	153	Ventricular Dysfunction	MESH:D018754	marker/mechanism		NA		14502278
ADRB2	154	AIDS Dementia Complex	MESH:D015526	marker/mechanism		NA		27400929
ADRB2	154	Asthma	MESH:D001249	marker/mechanism		NA	600807	
ADRB2	154	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17199132
ADRB2	154	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		25193472
ADRB2	154	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		11986409
ADRB2	154	Encephalitis, Viral	MESH:D018792	marker/mechanism		NA		27400929
ADRB2	154	Fibrosis	MESH:D005355	marker/mechanism		NA		25193472
ADRB2	154	HIV Infections	MESH:D015658	marker/mechanism		NA		27400929
ADRB2	154	Hyperlipidemias	MESH:D006949	marker/mechanism		NA		16027735
ADRB2	154	Hypokalemia	MESH:D007008	marker/mechanism		NA		17292646|1848636|2826064
ADRB2	154	Insulin Resistance	MESH:D007333	marker/mechanism		NA		19034036
ADRB2	154	Lung Diseases	MESH:D008171	marker/mechanism		NA		11436944
ADRB2	154	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		9554809
ADRB2	154	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		21245421
ADRB2	154	Obesity	MESH:D009765	marker/mechanism		NA	601665	15687340
ADRB2	154	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		18454446
ADRB2	154	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		17003101
ADRB2	154	Tremor	MESH:D014202	marker/mechanism|therapeutic		NA		190674|7902979|8102213|9151294
ADRB2	154	Ventricular Dysfunction, Left	MESH:D018487	marker/mechanism		NA		25193472
ADRB3	155	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		17622774
ADRB3	155	Heart Failure	MESH:D006333	marker/mechanism		NA		15009959|17440824
ADRB3	155	Hyperlipidemias	MESH:D006949	marker/mechanism		NA		16027735
ADRB3	155	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		17345787
ADRB3	155	Obesity	MESH:D009765	marker/mechanism		NA	601665	
ADSL	158	Adenylosuccinate lyase deficiency	MESH:C538235	marker/mechanism		NA	103050	10888601|10958654|12833398
ADSL	158	Autistic Disorder	MESH:D001321	marker/mechanism		NA		15471876
ADSS1	122622	MYOPATHY, DISTAL, 5	OMIM:617030	marker/mechanism		NA	617030	
ADTRP	84830	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		21378986
AEN	64782	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
AFAP1-AS1	84740	Hirschsprung Disease	MESH:D006627	marker/mechanism		NA		28924375
AFAP1L2	84632	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		29059373
AFF2	2334	Fragile X Syndrome	MESH:D005600	marker/mechanism		NA	309548	
AFF3	3899	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		20453842|23143596
AFF3	3899	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
AFF4	27125	Abnormalities, Multiple	MESH:D000015	marker/mechanism		NA		25730767
AFF4	27125	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		25730767
AFF4	27125	CHOPS SYNDROME	OMIM:616368	marker/mechanism		NA	616368	
AFF4	27125	Cognition Disorders	MESH:D003072	marker/mechanism		NA		25730767
AFF4	27125	Facies	MESH:D019066	marker/mechanism		NA		25730767
AFF4	27125	Growth Disorders	MESH:D006130	marker/mechanism		NA		25730767
AFF4	27125	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		25730767
AFF4	27125	Lung Diseases	MESH:D008171	marker/mechanism		NA		25730767
AFF4	27125	Obesity	MESH:D009765	marker/mechanism		NA		25730767
AFG3L2	10939	Myoclonic Epilepsies, Progressive	MESH:D020191	marker/mechanism		NA		25401298
AFG3L2	10939	SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	OMIM:614487	marker/mechanism		NA	614487	
AFG3L2	10939	Spinocerebellar ataxia 28	MESH:C537205	marker/mechanism		NA	610246	
AFG3L2	10939	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA		20208537
AFM	173	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		28885000
AFM	173	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		28885000
AFM	173	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
AFP	174	alpha-Fetoprotein Deficiency	MESH:C566300	marker/mechanism		NA	615969	
AFP	174	Breast Neoplasms	MESH:D001943	therapeutic		NA		18497072
AFP	174	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		15276417|24012840|28284560|9029167
AFP	174	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
AFP	174	Liver Diseases	MESH:D008107	marker/mechanism		NA		16965562
AFP	174	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		24012840
AFP	174	Mammary Neoplasms, Experimental	MESH:D008325	therapeutic		NA		16322315
AFP	174	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		23382965
AGA	175	Aspartylglucosaminuria	MESH:D054880	marker/mechanism		NA	208400	
AGAP1	116987	Autistic Disorder	MESH:D001321	marker/mechanism		NA		15892143
AGBL1	123624	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 8	OMIM:615523	marker/mechanism		NA	615523	
AGBL4	84871	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
AGBL4	84871	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
AGBL5	60509	RETINITIS PIGMENTOSA 75	OMIM:617023	marker/mechanism		NA	617023	
AGER	177	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		16385501
AGER	177	Atherosclerosis	MESH:D050197	marker/mechanism		NA		19939336|20372816
AGER	177	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		28811376
AGER	177	Diabetic Angiopathies	MESH:D003925	marker/mechanism		NA		20372816
AGER	177	Hyperalgesia	MESH:D006930	marker/mechanism		NA		25014009
AGER	177	Hyperglycemia	MESH:D006943	marker/mechanism		NA		24036142
AGER	177	Hypertension	MESH:D006973	marker/mechanism		NA		32147540
AGER	177	Hypertrophy	MESH:D006984	marker/mechanism		NA		19553346
AGER	177	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		25446913
AGER	177	Inflammation	MESH:D007249	marker/mechanism		NA		22178603
AGER	177	Lewy Body Disease	MESH:D020961	marker/mechanism		NA		16141792
AGER	177	Neuralgia	MESH:D009437	marker/mechanism		NA		25014009
AGER	177	Osteoarthritis	MESH:D010003	marker/mechanism		NA		16948116
AGER	177	Pancreatic Diseases	MESH:D010182	marker/mechanism		NA		24036142
AGER	177	Peripheral Nerve Injuries	MESH:D059348	marker/mechanism		NA		25014009
AGER	177	Pulmonary Emphysema	MESH:D011656	marker/mechanism		NA		30659203
AGFG1	3267	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
AGK	55750	CATARACT 38	OMIM:614691	marker/mechanism		NA	614691	
AGK	55750	Cataract and cardiomyopathy	MESH:C538280	marker/mechanism		NA	212350	23266196
AGL	178	Glycogen Storage Disease Type III	MESH:D006010	marker/mechanism		NA	232400	24700805|8755644|8990006
AGL	178	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
AGO1	26523	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
AGO2	27161	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		20643829
AGO2	27161	Leukemia, Myeloid	MESH:D007951	marker/mechanism		NA		21535412
AGO2	27161	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
AGPAT1	10554	Exfoliation Syndrome	MESH:D017889	marker/mechanism		NA		28553957
AGPAT2	10555	Lipodystrophy, Congenital Generalized	MESH:D052497	marker/mechanism		NA	608594	
AGPAT3	56894	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		15964507
AGPS	8540	Rhizomelic chondrodysplasia punctata, type 3	MESH:C537608	marker/mechanism		NA	600121	
AGR2	10551	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20531310
AGR2	10551	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881|25237833
AGRN	375790	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
AGRN	375790	Myasthenic Syndromes, Congenital	MESH:D020294	marker/mechanism		NA	615120	
AGRP	181	Obesity	MESH:D009765	marker/mechanism		NA	601665	
AGT	183	Albuminuria	MESH:D000419	marker/mechanism		NA		12414515|18679781|21896938
AGT	183	Alkalosis	MESH:D000471	therapeutic		NA		7182184
AGT	183	Allanson Pantzar McLeod syndrome	MESH:C537048	marker/mechanism		NA		16116425|17036344
AGT	183	Anemia	MESH:D000740	marker/mechanism		NA		3524928
AGT	183	Aneurysm, Dissecting	MESH:D000784	marker/mechanism		NA		17502491
AGT	183	Anuria	MESH:D001002	therapeutic		NA		8527259
AGT	183	Aortic Aneurysm	MESH:D001014	marker/mechanism		NA		21925196
AGT	183	Aortic Aneurysm, Abdominal	MESH:D017544	marker/mechanism		NA		16514081|20937366|22539767|25301841|30354818
AGT	183	Arrhythmias, Cardiac	MESH:D001145	marker/mechanism|therapeutic		NA		1654493|2535056
AGT	183	Atherosclerosis	MESH:D050197	marker/mechanism		NA		21925196|22539767
AGT	183	Bradycardia	MESH:D001919	therapeutic		NA		9519251
AGT	183	Cardiomegaly	MESH:D006332	marker/mechanism|therapeutic		NA		11403367|15226216|15851630|15870116|17124262|18400235|19794523|20190099|20409916|20429690|20616315|20811386|22291909|22335191|24342267|25139994|25488910|27099261|29353218|30703374|31016362
AGT	183	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		12145768
AGT	183	Cardiomyopathy, Alcoholic	MESH:D002310	marker/mechanism		NA		22497828
AGT	183	Cardiovascular Abnormalities	MESH:D018376	marker/mechanism		NA		25807386
AGT	183	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		16544732
AGT	183	Carotid Artery Diseases	MESH:D002340	marker/mechanism		NA		12911327
AGT	183	Catalepsy	MESH:D002375	therapeutic		NA		1034924
AGT	183	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		29499335
AGT	183	Cholestasis	MESH:D002779	marker/mechanism		NA		27989131
AGT	183	Cognition Disorders	MESH:D003072	marker/mechanism		NA		22982863
AGT	183	COVID-19	MESH:C000657245	marker/mechanism		NA		32048163
AGT	183	Death, Sudden	MESH:D003645	marker/mechanism		NA		17502491
AGT	183	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		15831366|17177138|18829990
AGT	183	Diabetic Cardiomyopathies	MESH:D058065	marker/mechanism		NA		29353218
AGT	183	Diabetic Nephropathies	MESH:D003928	therapeutic		NA		17890855|20383342
AGT	183	Diabetic Retinopathy	MESH:D003930	marker/mechanism		NA		15387897
AGT	183	Drug Overdose	MESH:D062787	therapeutic		NA		8527259
AGT	183	Endomyocardial Fibrosis	MESH:D004719	marker/mechanism|therapeutic		NA		20837116|25139994|25488910|27099261|30703374
AGT	183	Essential Hypertension	MESH:D000075222	marker/mechanism		NA	145500	
AGT	183	Fetal Growth Retardation	MESH:D005317	marker/mechanism		NA		17537837
AGT	183	Fibrosis	MESH:D005355	marker/mechanism		NA		12414515|18785976|19373235|25398788|25807386
AGT	183	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		11459117
AGT	183	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		9259580
AGT	183	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA		19858406
AGT	183	Glucose Intolerance	MESH:D018149	therapeutic		NA		26704350
AGT	183	Heart Diseases	MESH:D006331	marker/mechanism		NA		19373235
AGT	183	Heart Failure	MESH:D006333	marker/mechanism		NA		12025466|1330361|20811386
AGT	183	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		16292651
AGT	183	Hyperalgesia	MESH:D006930	marker/mechanism		NA		9613798
AGT	183	Hyperemia	MESH:D006940	marker/mechanism		NA		15815331
AGT	183	Hyperhomocysteinemia	MESH:D020138	marker/mechanism		NA		24386282
AGT	183	Hypertension	MESH:D006973	marker/mechanism|therapeutic		NA		10400907|10526905|11459117|11501062|12084390|12121858|12414515|12600921|12676074|1394429|1432030|14751847|15243307|15302986|15699457|15833808|15851630|16618834|16788141|16868307|17272743|17537837|17989111|18420994|1849535|1860718|18679781|1875449|18768397|18785976|18847324|19109942|19133994|19373235|19770776|19858406|20231528|20429690|20713914|20811386|20837116|20937366|21289285|21393355|21420289|21501650|22083158|22214961|22452651|22753205|22982863|24342267|24347665|24386282|24935938|24965170|25139994|25259750|25398788|25874449|26564064|26781276|27225954|27678262|27798352|27889505|2831029|2835134|30354818|31016362|31098697|3158602|43064|6742791|7323490|8021468|8109997|8505092|9024144|9260993
AGT	183	Hypertension, Malignant	MESH:D006974	marker/mechanism		NA		2493837|27428043
AGT	183	Hypertension, Renal	MESH:D006977	marker/mechanism		NA		8763405
AGT	183	Hypertrophy	MESH:D006984	marker/mechanism		NA		12054679|12237323|18785976|21071431|24039778|26955731
AGT	183	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism|therapeutic		NA		10805403|14644620|14751847|18679781|20837116|24688123|31016362
AGT	183	Hypokalemia	MESH:D007008	therapeutic		NA		7182184
AGT	183	Hypotension	MESH:D007022	therapeutic		NA		3078272|8527259|9323291
AGT	183	Inflammation	MESH:D007249	marker/mechanism		NA		15944212|16868307|27436852|29353218
AGT	183	Kidney Diseases	MESH:D007674	marker/mechanism		NA		12414515|15213268|17989111|21896938|31098697
AGT	183	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		15613622
AGT	183	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		12667390
AGT	183	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		16413583|1668233
AGT	183	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16775501
AGT	183	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism|therapeutic		NA		19166939|2535056
AGT	183	Necrosis	MESH:D009336	marker/mechanism		NA		12606818|1535655
AGT	183	Neointima	MESH:D058426	marker/mechanism		NA		19258495|29609002
AGT	183	Nephrosis	MESH:D009401	marker/mechanism		NA		2046802
AGT	183	Neurobehavioral Manifestations	MESH:D019954	marker/mechanism		NA		26954031
AGT	183	Peptic Ulcer Hemorrhage	MESH:D010438	marker/mechanism		NA		20824505
AGT	183	Pneumonia	MESH:D011014	therapeutic		NA		28960804
AGT	183	Pre-Eclampsia	MESH:D011225	marker/mechanism		NA		8513325
AGT	183	Proteinuria	MESH:D011507	marker/mechanism|therapeutic		NA		12937228|17890855|2046802|25398788|464098|9259580
AGT	183	Pulmonary Fibrosis	MESH:D011658	therapeutic		NA		28960804|31181250
AGT	183	Renal Insufficiency	MESH:D051437	marker/mechanism		NA		9259580
AGT	183	RENAL TUBULAR DYSGENESIS	OMIM:267430	marker/mechanism		NA	267430	
AGT	183	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		23875703
AGT	183	Retinopathy of Prematurity	MESH:D012178	marker/mechanism		NA		15387897
AGT	183	Seizures	MESH:D012640	marker/mechanism		NA		16771832
AGT	183	Thrombosis	MESH:D013927	marker/mechanism|therapeutic		NA		11881036|21501650
AGT	183	Ureteral Obstruction	MESH:D014517	marker/mechanism		NA		26207612
AGT	183	Vascular Remodeling	MESH:D066253	marker/mechanism		NA		25259750|27678262
AGT	183	Ventricular Dysfunction, Left	MESH:D018487	marker/mechanism		NA		24688123|29353218|30703374
AGT	183	Ventricular Remodeling	MESH:D020257	marker/mechanism		NA		29353218
AGTPBP1	23287	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		16952463
AGTR1	185	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
AGTR1	185	Allanson Pantzar McLeod syndrome	MESH:C537048	marker/mechanism		NA		16116425
AGTR1	185	Aortic Aneurysm, Abdominal	MESH:D017544	marker/mechanism		NA		22539767
AGTR1	185	Carcinoma, Pancreatic Ductal	MESH:D021441	marker/mechanism		NA		17481528
AGTR1	185	Diabetic Retinopathy	MESH:D003930	marker/mechanism		NA		16601577
AGTR1	185	Ductus Arteriosus, Patent	MESH:D004374	marker/mechanism		NA		12904590|19336370
AGTR1	185	Essential Hypertension	MESH:D000075222	marker/mechanism		NA	145500	
AGTR1	185	Heart Failure	MESH:D006333	marker/mechanism		NA		17208988|18214293|18586661
AGTR1	185	Hypertension	MESH:D006973	marker/mechanism		NA		19047579|23603059|27292124|8952600
AGTR1	185	Kidney Diseases	MESH:D007674	marker/mechanism		NA		15213268
AGTR1	185	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		18059164
AGTR1	185	Pituitary Neoplasms	MESH:D010911	marker/mechanism		NA		16977796
AGTR1	185	Proteinuria	MESH:D011507	marker/mechanism		NA		17021606
AGTR1	185	RENAL TUBULAR DYSGENESIS	OMIM:267430	marker/mechanism		NA	267430	
AGTR1A	11607	Carcinoma, Ductal	MESH:D044584	marker/mechanism		NA		8389152
AGTR1A	11607	Carcinoma, Lobular	MESH:D018275	marker/mechanism		NA		8389152
AGTR1A	11607	Cardiomegaly	MESH:D006332	marker/mechanism		NA		17350036
AGTR1A	11607	Fibrosis	MESH:D005355	marker/mechanism		NA		9596920
AGTR1A	11607	Glucose Intolerance	MESH:D018149	marker/mechanism		NA		11564974
AGTR1A	11607	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		16292651
AGTR1A	11607	Kidney Diseases	MESH:D007674	marker/mechanism		NA		9596920
AGTR1A	11607	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		12890498|25380136
AGTR1A	11607	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		8389152
AGTR1A	11607	Vascular System Injuries	MESH:D057772	marker/mechanism		NA		16982965
AGTR1B	11608	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		16292651
AGTR1B	11608	Hypertension	MESH:D006973	marker/mechanism		NA		22728133|27847271
AGTR1B	11608	Prenatal Exposure Delayed Effects	MESH:D011297	marker/mechanism		NA		22728133
AGTR2	186	Carcinoma, Lobular	MESH:D018275	marker/mechanism		NA		8389152
AGTR2	186	Diabetic Cardiomyopathies	MESH:D058065	marker/mechanism		NA		15587404|16025228
AGTR2	186	Hypertension	MESH:D006973	marker/mechanism		NA		15710752
AGTR2	186	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		20467270
AGTR2	186	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		8389152
AGTR2	186	Mental Retardation, X-Linked	MESH:D038901	marker/mechanism		NA		12089445
AGTR2	186	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		18059164
AGTR2	186	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
AGTR2	186	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		18059164
AGTR2	186	Vascular System Injuries	MESH:D057772	marker/mechanism		NA		16982965
AGXT	189	Primary hyperoxaluria type 1	MESH:C536414	marker/mechanism		NA	259900	
AGXT2	64902	Metabolism, Inborn Errors	MESH:D008661	marker/mechanism		NA		21572414
AHCY	191	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
AHCY	191	Amino Acid Metabolism, Inborn Errors	MESH:D000592	marker/mechanism		NA		15024124
AHCY	191	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
AHCY	191	Hepatolenticular Degeneration	MESH:D006527	marker/mechanism		NA		23519153
AHCY	191	Hypermethioninemia	MESH:C564683	marker/mechanism		NA	613752	26974671
AHCY	191	Hypoxia	MESH:D000860	marker/mechanism		NA		19579223
AHCY	191	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		29127188
AHCYL2	23382	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		24763052
AHDC1	27245	XIA-GIBBS SYNDROME	OMIM:615829	marker/mechanism		NA	615829	
AHI1	54806	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18782849
AHI1	54806	Cerebellar Diseases	MESH:D002526	marker/mechanism		NA		20371615
AHI1	54806	IgA Deficiency	MESH:D017098	marker/mechanism		NA		27723758
AHI1	54806	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
AHI1	54806	Joubert syndrome 3	MESH:C536295	marker/mechanism		NA	608629	
AHI1	54806	Retinal Degeneration	MESH:D012162	marker/mechanism		NA		20081859
AHI1	54806	Schizophrenia	MESH:D012559	marker/mechanism		NA		20371615
AHNAK	79026	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		22138691
AHNAK	79026	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
AHNAK	79026	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
AHNAK	79026	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		20388789
AHR	196	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		26593447
AHR	196	Acanthosis Nigricans	MESH:D000052	marker/mechanism		NA		27869817
AHR	196	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		12597446
AHR	196	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		25194622
AHR	196	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		18617548
AHR	196	Atherosclerosis	MESH:D050197	marker/mechanism		NA		22228805
AHR	196	Atrophy	MESH:D001284	marker/mechanism		NA		20961953|7826670
AHR	196	Behcet Syndrome	MESH:D001528	marker/mechanism		NA		25045206
AHR	196	Birth Weight	MESH:D001724	marker/mechanism		NA		27592400
AHR	196	Bone Resorption	MESH:D001862	marker/mechanism		NA		19934163
AHR	196	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21515334|22296396
AHR	196	Cardiomegaly	MESH:D006332	marker/mechanism		NA		24247421
AHR	196	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		21890736
AHR	196	Chronobiology Disorders	MESH:D021081	marker/mechanism		NA		23291558
AHR	196	Colitis	MESH:D003092	therapeutic		NA		27783946
AHR	196	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		27869817
AHR	196	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
AHR	196	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27869817
AHR	196	Dyslipidemias	MESH:D050171	marker/mechanism		NA		21890736
AHR	196	Glucose Intolerance	MESH:D018149	therapeutic		NA		31306034
AHR	196	Growth Disorders	MESH:D006130	marker/mechanism		NA		20961953
AHR	196	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		19261855
AHR	196	Hepatomegaly	MESH:D006529	marker/mechanism|therapeutic		NA		26278112|28487374
AHR	196	Hyperoxia	MESH:D018496	marker/mechanism		NA		23337360
AHR	196	Hyperpigmentation	MESH:D017495	marker/mechanism		NA		28029781
AHR	196	Hypertension	MESH:D006973	marker/mechanism		NA		21115475
AHR	196	Hypertrophy	MESH:D006984	marker/mechanism		NA		20961953
AHR	196	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		14644620|31016362
AHR	196	Hyperventilation	MESH:D006985	marker/mechanism		NA		21115475
AHR	196	Infertility, Male	MESH:D007248	marker/mechanism		NA		21613234
AHR	196	Inflammation	MESH:D007249	marker/mechanism		NA		22273745|25768209
AHR	196	Insulin Resistance	MESH:D007333	marker/mechanism		NA		25734695
AHR	196	Keratosis	MESH:D007642	marker/mechanism		NA		27869817
AHR	196	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		29416063
AHR	196	Liver Diseases	MESH:D008107	marker/mechanism		NA		20961953|8692887
AHR	196	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19996281|30346592
AHR	196	Lung Injury	MESH:D055370	therapeutic		NA		25831079
AHR	196	Metabolic Diseases	MESH:D008659	marker/mechanism		NA		25768209
AHR	196	Necrosis	MESH:D009336	marker/mechanism		NA		25831079
AHR	196	Neoplasm Invasiveness	MESH:D009361	therapeutic		NA		25826687|27752740
AHR	196	Neoplasm Metastasis	MESH:D009362	therapeutic		NA		21948867
AHR	196	Neoplasms	MESH:D009369	marker/mechanism		NA		22037238
AHR	196	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		9496914
AHR	196	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		29416063
AHR	196	Nystagmus, Congenital	MESH:D020417	marker/mechanism		NA		23301081
AHR	196	Obesity	MESH:D009765	marker/mechanism		NA		27020609|30813227|31306034
AHR	196	Pancreatic cancer, adult	MESH:C535836	marker/mechanism		NA		12203118
AHR	196	Pancreatic Neoplasms	MESH:D010190	marker/mechanism|therapeutic		NA		12203118|25826687
AHR	196	Peanut Hypersensitivity	MESH:D021183	marker/mechanism		NA		21804081
AHR	196	Pneumonia	MESH:D011014	marker/mechanism		NA		23337360
AHR	196	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		20140206
AHR	196	Pruritus	MESH:D011537	marker/mechanism		NA		27869817
AHR	196	Silicosis	MESH:D012829	marker/mechanism		NA		22273745
AHR	196	Splenic Diseases	MESH:D013158	marker/mechanism		NA		20961953
AHR	196	Splenomegaly	MESH:D013163	marker/mechanism		NA		8692887
AHR	196	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		12107286
AHR	196	Tachycardia	MESH:D013610	marker/mechanism		NA		21115475
AHR	196	Tobacco Use Disorder	MESH:D014029	marker/mechanism		NA		25482063
AHR	196	Ureteral Neoplasms	MESH:D014516	marker/mechanism		NA		19755661
AHR	196	Urinary Bladder Calculi	MESH:D001744	marker/mechanism		NA		22232670
AHR	196	Vascular Diseases	MESH:D014652	marker/mechanism		NA		25482063
AHR	196	Weight Gain	MESH:D015430	marker/mechanism		NA		27020609|30813227|31306034
AHR2	30517	Abnormalities, Drug-Induced	MESH:D000014	marker/mechanism		NA		27576004
AHR2	30517	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		30907958
AHR2	30517	Edema	MESH:D004487	marker/mechanism		NA		12711302
AHR2	30517	Embryo Loss	MESH:D020964	marker/mechanism		NA		27576004
AHR2	30517	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		27576004
AHR2	30517	Heart Diseases	MESH:D006331	marker/mechanism		NA		20605646
AHR2	30517	Hemorrhage	MESH:D006470	marker/mechanism		NA		27576004
AHR2	30517	Musculoskeletal Abnormalities	MESH:D009139	marker/mechanism		NA		22242167
AHSG	197	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		28885000
AHSG	197	AMR Syndrome	MESH:C565965	marker/mechanism		NA	203650	
AHSG	197	Calcinosis	MESH:D002114	marker/mechanism		NA		16177000
AHSG	197	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		28885000
AICDA	57379	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		21305519
AICDA	57379	Blast Crisis	MESH:D001752	marker/mechanism		NA		21570118
AICDA	57379	Hyper-IgM Immunodeficiency Syndrome	MESH:D053306	marker/mechanism		NA	605258	
AICDA	57379	Leukemia, Lymphoid	MESH:D007945	marker/mechanism		NA		23589568
AIDA	64853	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
AIF1	199	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27093858
AIF1	199	Hyperalgesia	MESH:D006930	marker/mechanism		NA		27093858
AIF1	199	Hypertension	MESH:D006973	marker/mechanism		NA		32147540
AIF1	199	Lewy Body Disease	MESH:D020961	marker/mechanism		NA		19276553
AIF1	199	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
AIF1	199	Parkinson Disease	MESH:D010300	marker/mechanism		NA		19276553
AIF1	199	Subarachnoid Hemorrhage	MESH:D013345	marker/mechanism		NA		27157545
AIF1	199	Trigeminal Neuralgia	MESH:D014277	marker/mechanism		NA		27093858
AIFM1	9131	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25743375
AIFM1	9131	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6	OMIM:300816	marker/mechanism		NA	300816	
AIFM1	9131	Cowchock syndrome	MESH:C536450	marker/mechanism		NA	310490	
AIFM1	9131	Deafness, X-Linked 5	MESH:C564472	marker/mechanism		NA	300614	
AIFM1	9131	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		23499715
AIFM1	9131	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		23499715
AIFM1	9131	Huntington Disease	MESH:D006816	marker/mechanism		NA		12930891
AIFM1	9131	Necrosis	MESH:D009336	therapeutic		NA		16532269
AIFM1	9131	Retinal Detachment	MESH:D012163	marker/mechanism		NA		18497877
AIFM1	9131	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH HYPOMYELINATING LEUKODYSTROPHY	OMIM:300232	marker/mechanism		NA	300232	
AIMP1	9255	LEUKODYSTROPHY, HYPOMYELINATING, 3	OMIM:260600	marker/mechanism		NA	260600	
AIP	9049	ACTH-Secreting Pituitary Adenoma	MESH:D049913	marker/mechanism		NA	219090	
AIP	9049	Adenoma	MESH:D000236	marker/mechanism		NA		22975028
AIP	9049	Growth Hormone-Secreting Pituitary Adenoma	MESH:D049912	marker/mechanism		NA	102200	
AIPL1	23746	Leber Congenital Amaurosis 4	MESH:C565778	marker/mechanism		NA	604393	
AIPL1	23746	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA	268000	16272259
AIRE	326	Autoimmune polyendocrinopathy syndrome, type 1	MESH:C538275	marker/mechanism		NA	240300	
AIRE	326	Candidiasis	MESH:D002177	marker/mechanism		NA		12050215
AIRE	326	Polyendocrinopathies, Autoimmune	MESH:D016884	marker/mechanism		NA		16982213
AIRE	326	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		26168014
AJUBA	84962	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		25151357
AK1	203	Adenylate Kinase Deficiency, Hemolytic Anemia Due To	MESH:C567228	marker/mechanism		NA	612631	
AK1	203	Lymphoma, Mantle-Cell	MESH:D020522	marker/mechanism		NA		23676220
AK1	203	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
AK2	204	Deafness	MESH:D003638	marker/mechanism		NA		19043416
AK2	204	Reticular dysgenesis	MESH:C538361	marker/mechanism		NA	267500	
AK2	204	Severe Combined Immunodeficiency	MESH:D016511	marker/mechanism		NA		19043416|19043417
AK4	205	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
AK5	26289	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
AKAP1	8165	Obesity	MESH:D009765	marker/mechanism		NA		20975297
AKAP10	11216	CARDIAC CONDUCTION DEFECT	OMIM:115080	marker/mechanism		NA	115080	
AKAP12	9590	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037
AKAP13	11214	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		22138691
AKAP13	11214	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		17068819
AKAP13	11214	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		28319090
AKAP5	9495	Cardiomegaly	MESH:D006332	therapeutic		NA		11248077
AKAP5	9495	Memory Disorders	MESH:D008569	marker/mechanism		NA		18711127
AKAP5	9495	Motor Skills Disorders	MESH:D019957	marker/mechanism		NA		18711127
AKAP6	9472	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
AKAP7	9465	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
AKAP9	10142	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
AKAP9	10142	Long Qt Syndrome 11	MESH:C567513	marker/mechanism		NA	611820	
AKAP9	10142	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
AKIP1	56672	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
AKR1A1	10327	Enterocolitis, Necrotizing	MESH:D020345	marker/mechanism		NA		18806098
AKR1B1	231	Cataract	MESH:D002386	marker/mechanism		NA		21329682|21376710|25541468|28137510
AKR1B1	231	Diabetes Complications	MESH:D048909	marker/mechanism		NA		25304492|25541468
AKR1B1	231	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		23146748
AKR1B1	231	Endometriosis	MESH:D004715	marker/mechanism		NA		25446850
AKR1B1	231	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
AKR1B1	231	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
AKR1B10	57016	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
AKR1B10	57016	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17597105
AKR1B10	57016	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
AKR1B10	57016	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		23146748
AKR1B10	57016	Melanoma	MESH:D008545	marker/mechanism		NA		21499247
AKR1B10	57016	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		25686905
AKR1B10	57016	Neoplasms	MESH:D009369	therapeutic		NA		17329238
AKR1C1	1645	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		17094902
AKR1C1	1645	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		19696165
AKR1C1	1645	Disorders of Sex Development	MESH:D012734	marker/mechanism		NA		25304492
AKR1C1	1645	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		16338060
AKR1C1	1645	Endometriosis	MESH:D004715	marker/mechanism		NA		21232532
AKR1C1	1645	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
AKR1C1	1645	Neoplasms, Hormone-Dependent	MESH:D009376	marker/mechanism		NA		25304492
AKR1C1	1645	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
AKR1C1	1645	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		22381227
AKR1C19	432720	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
AKR1C2	1646	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
AKR1C2	1646	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		19696165
AKR1C2	1646	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
AKR1C2	1646	Disorders of Sex Development	MESH:D012734	marker/mechanism		NA		25304492
AKR1C2	1646	Endometriosis	MESH:D004715	marker/mechanism		NA		21232532
AKR1C2	1646	Male Pseudohermaphroditism due to Deficiency of Testicular 17,20-Desmolase	MESH:C564109	marker/mechanism		NA	614279	
AKR1C2	1646	Neoplasms, Hormone-Dependent	MESH:D009376	marker/mechanism		NA		25304492
AKR1C2	1646	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
AKR1C2	1646	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		22381227
AKR1C2	1646	Weight Gain	MESH:D015430	marker/mechanism		NA		25322899
AKR1C3	8644	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		19696165
AKR1C3	8644	Disorders of Sex Development	MESH:D012734	marker/mechanism		NA		25304492
AKR1C3	8644	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		16338060
AKR1C3	8644	Endometriosis	MESH:D004715	marker/mechanism		NA		21232532|25446850
AKR1C3	8644	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
AKR1C3	8644	Neoplasms, Hormone-Dependent	MESH:D009376	marker/mechanism		NA		25304492
AKR1C3	8644	Obesity	MESH:D009765	marker/mechanism		NA		20882379
AKR1C3	8644	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		16263811|21262361|22381227
AKR1C3	8644	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17507624|18306354
AKR1C3	8644	Prostatic Neoplasms, Castration-Resistant	MESH:D064129	marker/mechanism		NA		25555457
AKR1C3	8644	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		19424620
AKR1C4	1109	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		21570127
AKR1C4	1109	Male Pseudohermaphroditism due to Deficiency of Testicular 17,20-Desmolase	MESH:C564109	marker/mechanism		NA	614279	
AKR1C4	1109	Paranoid Disorders	MESH:D010259	marker/mechanism		NA		22356824
AKR1D1	6718	Bile acid synthesis defect, congenital, 2	MESH:C535443	marker/mechanism		NA	235555	21185810|25304492
AKR1D1	6718	Hemochromatosis	MESH:D006432	marker/mechanism		NA		18624455
AKR7A3	22977	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
AKT1	207	Adenomatous Polyposis Coli	MESH:D011125	marker/mechanism		NA		17942926
AKT1	207	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		15982448
AKT1	207	Aortic Valve, Calcification of	MESH:C562942	marker/mechanism		NA		23308213
AKT1	207	Breast Neoplasms	MESH:D001943	marker/mechanism		NA	114480	20228224
AKT1	207	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		21351258
AKT1	207	Cardiomegaly	MESH:D006332	marker/mechanism		NA		24448315
AKT1	207	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		24448315
AKT1	207	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	114500	
AKT1	207	COWDEN SYNDROME 6	OMIM:615109	marker/mechanism		NA	615109	
AKT1	207	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		31626838
AKT1	207	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		25658812
AKT1	207	Epilepsy	MESH:D004827	therapeutic		NA		20064661
AKT1	207	Fibrosis	MESH:D005355	marker/mechanism		NA		24448315
AKT1	207	Hyperplasia	MESH:D006965	marker/mechanism		NA		20530298
AKT1	207	Inflammation	MESH:D007249	marker/mechanism		NA		24448315|26297436
AKT1	207	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		12556562
AKT1	207	Lung Neoplasms	MESH:D008175	marker/mechanism|therapeutic		NA		12511591|21911043|22619562
AKT1	207	Lymphoma, T-Cell	MESH:D016399	marker/mechanism		NA		25658812
AKT1	207	Marijuana Abuse	MESH:D002189	marker/mechanism		NA		21041608
AKT1	207	Meningioma	MESH:D008579	marker/mechanism		NA		23334667
AKT1	207	Muscular Atrophy	MESH:D009133	therapeutic		NA		18467435
AKT1	207	Obesity	MESH:D009765	marker/mechanism		NA		23954404
AKT1	207	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA	167000	16211241|21266360
AKT1	207	Pain	MESH:D010146	marker/mechanism		NA		17084039
AKT1	207	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		26297436
AKT1	207	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		15682402|29610475
AKT1	207	Proteus Syndrome	MESH:D016715	marker/mechanism		NA	176920	
AKT1	207	Psychoses, Substance-Induced	MESH:D011605	marker/mechanism		NA		21041608
AKT1	207	Schizophrenia	MESH:D012559	marker/mechanism		NA		14745448|15982448|17915974|21187413
AKT1	207	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		21351258
AKT1	207	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		23873848
AKT1S1	84335	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		16397181
AKT1S1	84335	Spinal Cord Injuries	MESH:D013119	therapeutic		NA		17457363
AKT2	208	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19075277
AKT2	208	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA	125853	
AKT2	208	HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY	OMIM:240900	marker/mechanism		NA	240900	
AKT2	208	Lipodystrophy, Familial Partial	MESH:D052496	marker/mechanism		NA		19793595
AKT2	208	Nasopharyngeal Carcinoma	MESH:D000077274	marker/mechanism		NA		24952746
AKT3	10000	Malformations of Cortical Development	MESH:D054220	marker/mechanism		NA		22729223
AKT3	10000	Megalancephaly Polymicrogyria-Polydactyly Hydrocephalus Syndrome	MESH:C566381	marker/mechanism		NA	615937	22729224
AKTIP	64400	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ALAD	210	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		21799727
ALAD	210	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		20123609
ALAD	210	Hematologic Diseases	MESH:D006402	marker/mechanism		NA		24631795
ALAD	210	Hypertension	MESH:D006973	marker/mechanism		NA		20123609
ALAD	210	Kidney Diseases	MESH:D007674	marker/mechanism		NA		23792432|24631795
ALAD	210	Lead Poisoning	MESH:D007855	marker/mechanism		NA		21396434|23792432|24631795
ALAD	210	Lead Poisoning, Nervous System	MESH:D020263	marker/mechanism		NA		21439310
ALAD	210	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		25226513
ALAD	210	Liver Diseases	MESH:D008107	marker/mechanism		NA		24631795
ALAD	210	Meningioma	MESH:D008579	marker/mechanism		NA		16140629
ALAD	210	Porphyria, Acute Hepatic	MESH:C562618	marker/mechanism		NA	612740	
ALAD	210	Porphyrias, Hepatic	MESH:D017094	marker/mechanism		NA		1905639|3684400
ALAD	210	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		24500903
ALAD	210	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
ALAD	210	Seizures	MESH:D012640	marker/mechanism		NA		19798568
ALAS1	211	Porphyrias	MESH:D011164	marker/mechanism		NA		9222176
ALAS2	212	Anemia, Sideroblastic	MESH:D000756	marker/mechanism		NA		16716198|16892088
ALAS2	212	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		11420682
ALAS2	212	PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED	OMIM:300752	marker/mechanism		NA	300752	
ALAS2	212	X-linked sideroblastic anemia	MESH:C536761	marker/mechanism		NA	300751	18637800
ALB	213	Acute Kidney Injury	MESH:D058186	marker/mechanism|therapeutic		NA		2048579|21259293|24361871|28885000
ALB	213	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		19381893
ALB	213	Angioedema	MESH:D000799	marker/mechanism		NA		8458210
ALB	213	Anuria	MESH:D001002	marker/mechanism		NA		6734075
ALB	213	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		20472598
ALB	213	Azoospermia	MESH:D053713	therapeutic		NA		27289041
ALB	213	Brain Diseases	MESH:D001927	marker/mechanism		NA		15923801
ALB	213	Brain Injuries	MESH:D001930	marker/mechanism		NA		17188501|7909931
ALB	213	Brain Ischemia	MESH:D002545	therapeutic		NA		16809570
ALB	213	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		8431628
ALB	213	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		18779383|22310181
ALB	213	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		30026087
ALB	213	Depressive Disorder	MESH:D003866	marker/mechanism		NA		9029664
ALB	213	Diabetic Angiopathies	MESH:D003925	marker/mechanism		NA		19733855
ALB	213	Diabetic Nephropathies	MESH:D003928	therapeutic		NA		16380483
ALB	213	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		16642209|17963606
ALB	213	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		24361871|28885000
ALB	213	Echinococcosis	MESH:D004443	marker/mechanism		NA		24270252
ALB	213	Epilepsy	MESH:D004827	marker/mechanism		NA		15356194|17121744
ALB	213	Fibrosis	MESH:D005355	marker/mechanism		NA		24309158
ALB	213	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		17161813|17464766|18462998|19524415|3160244|6343549|6769622|8501856
ALB	213	Glomerulonephritis, Membranoproliferative	MESH:D015432	marker/mechanism		NA		1556257
ALB	213	Glomerulonephritis, Membranous	MESH:D015433	marker/mechanism		NA		11938814|12776520|1342223|15385633|17622271|9794552
ALB	213	Heart Diseases	MESH:D006331	marker/mechanism		NA		24309158
ALB	213	Heart Failure	MESH:D006333	marker/mechanism		NA		11771600
ALB	213	Hemolytic-Uremic Syndrome	MESH:D006463	marker/mechanism		NA		6734075
ALB	213	Hepatic Insufficiency	MESH:D048550	marker/mechanism		NA		30026087
ALB	213	Hepatitis	MESH:D006505	marker/mechanism		NA		21851314
ALB	213	Hepatomegaly	MESH:D006529	marker/mechanism		NA		30026087
ALB	213	HIV Infections	MESH:D015658	marker/mechanism		NA		16903978
ALB	213	HIV Seropositivity	MESH:D006679	marker/mechanism		NA		17209195
ALB	213	Hypersensitivity	MESH:D006967	marker/mechanism		NA		8431628
ALB	213	Hypersensitivity, Delayed	MESH:D006968	marker/mechanism		NA		19376187
ALB	213	Hypertension	MESH:D006973	therapeutic		NA		2526952
ALB	213	Hyperthyroxinemia, Familial Dysalbuminemic	MESH:D050010	marker/mechanism		NA	615999	8048949|8064810|9329347
ALB	213	Hypoalbuminemia	MESH:D034141	marker/mechanism		NA	616000	10337936
ALB	213	Hypotension	MESH:D007022	marker/mechanism		NA		11229087|4463119
ALB	213	Keloid	MESH:D007627	marker/mechanism		NA		20128793
ALB	213	Kidney Diseases	MESH:D007674	marker/mechanism		NA		16316336|17303580|20438795|21338618|2386429|24863737|350256|7297036
ALB	213	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		11938814
ALB	213	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		17977396|21851314
ALB	213	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		30026087
ALB	213	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		16642209|17963606|21163135
ALB	213	Liver Failure, Acute	MESH:D017114	marker/mechanism|therapeutic		NA		16750869|18609519
ALB	213	Lung Injury	MESH:D055370	marker/mechanism		NA		30953400
ALB	213	Meningitis, Aseptic	MESH:D008582	marker/mechanism		NA		5108595|5109917|5536438
ALB	213	Muscular Diseases	MESH:D009135	therapeutic		NA		4126124
ALB	213	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		9572063
ALB	213	Nephritis	MESH:D009393	marker/mechanism		NA		161594|16326737|2945356|3656695|4065304|9380243
ALB	213	Nephritis, Interstitial	MESH:D009395	marker/mechanism		NA		10916085|12217854|18176075|23994741
ALB	213	Nephrosis	MESH:D009401	marker/mechanism		NA		3301049
ALB	213	Nephrotic Syndrome	MESH:D009404	marker/mechanism		NA		1556257|17178036
ALB	213	Occupational Diseases	MESH:D009784	marker/mechanism		NA		23791970
ALB	213	Pain	MESH:D010146	therapeutic		NA		4126124
ALB	213	Pancreatic Diseases	MESH:D010182	marker/mechanism		NA		17169978
ALB	213	Pancreatitis	MESH:D010195	marker/mechanism		NA		17169977
ALB	213	Poisoning	MESH:D011041	marker/mechanism		NA		10511253
ALB	213	Proteinuria	MESH:D011507	marker/mechanism		NA		1011057|10916085|12217854|14514721|16326737|18176075|7288527|7297036|839733
ALB	213	Respiratory Distress Syndrome, Adult	MESH:D012128	therapeutic		NA		12394941
ALB	213	Respiratory Tract Diseases	MESH:D012140	marker/mechanism		NA		8431628
ALB	213	Rhinitis, Allergic, Perennial	MESH:D012221	marker/mechanism		NA		19389874
ALB	213	Serum Sickness	MESH:D012713	marker/mechanism		NA		350256|9380243
ALB	213	Stevens-Johnson Syndrome	MESH:D013262	therapeutic		NA		12239465
ALB	213	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		19424620
ALB	213	Stroke	MESH:D020521	marker/mechanism|therapeutic		NA		14514741|16174931|16809570|17270091
ALB	213	Thrombocytopenia	MESH:D013921	marker/mechanism		NA		6734075
ALB	213	Urticaria	MESH:D014581	marker/mechanism		NA		8458210
ALB	213	Uveitis	MESH:D014605	marker/mechanism		NA		1556257
ALCAM	214	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
ALCAM	214	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
ALCAM	214	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
ALDH16A1	126133	Gout	MESH:D006073	marker/mechanism		NA		21983786
ALDH16A1	126133	Gout, HPRT-Related	MESH:C562583	marker/mechanism		NA		23348497
ALDH16A1	126133	Hyperuricemia	MESH:D033461	marker/mechanism		NA		23348497
ALDH18A1	5832	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
ALDH18A1	5832	Cutis Laxa, Autosomal Dominant	MESH:C562627	marker/mechanism		NA	616603	
ALDH18A1	5832	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	OMIM:219150	marker/mechanism		NA	219150	
ALDH18A1	5832	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
ALDH18A1	5832	Spastic paraplegia 9, autosomal dominant	MESH:C536868	marker/mechanism		NA	601162	
ALDH18A1	5832	SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE	OMIM:616586	marker/mechanism		NA	616586	
ALDH1A1	216	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		15108329
ALDH1A1	216	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		29626521
ALDH1A1	216	Creutzfeldt-Jakob Syndrome	MESH:D007562	marker/mechanism		NA		23349890
ALDH1A1	216	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
ALDH1A1	216	Liver Diseases	MESH:D008107	marker/mechanism		NA		31651977
ALDH1A1	216	Melanoma	MESH:D008545	marker/mechanism		NA		31580832
ALDH1A1	216	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		29718361
ALDH1A1	216	Parkinsonian Disorders	MESH:D020734	marker/mechanism		NA		25045800
ALDH1A2	8854	Meningomyelocele	MESH:D008591	marker/mechanism		NA		16237707
ALDH1A2	8854	Osteoarthritis	MESH:D010003	marker/mechanism		NA		24728293
ALDH1A2	8854	Parkinsonian Disorders	MESH:D020734	marker/mechanism		NA		25045800
ALDH1A2	8854	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16166285
ALDH1A3	220	Melanoma	MESH:D008545	marker/mechanism		NA		31580832
ALDH1A3	220	MICROPHTHALMIA, ISOLATED 8	OMIM:615113	marker/mechanism		NA	615113	
ALDH1A3	220	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
ALDH1A7	26358	Heart Failure	MESH:D006333	marker/mechanism		NA		26670611
ALDH1A7	26358	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ALDH1B1	219	Cholestasis	MESH:D002779	marker/mechanism		NA		27989131
ALDH1B1	219	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		25641190
ALDH1B1	219	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
ALDH1B1	219	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		15650968|25380136
ALDH1B1	219	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		29718361
ALDH1L1	10840	Hypoxia	MESH:D000860	marker/mechanism		NA		19579223
ALDH1L1	10840	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		15650968
ALDH1L1	10840	Obesity	MESH:D009765	marker/mechanism		NA		20882379
ALDH1L2	160428	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
ALDH1L2	160428	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ALDH2	217	Alcohol-Induced Disorders	MESH:D020751	marker/mechanism		NA		26711020
ALDH2	217	Alcoholism	MESH:D000437	marker/mechanism		NA		16404797|17590986
ALDH2	217	ALCOHOL SENSITIVITY, ACUTE	OMIM:610251	marker/mechanism		NA	610251	10627091
ALDH2	217	Asthma	MESH:D001249	marker/mechanism		NA		11506308|9600491
ALDH2	217	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		16332725
ALDH2	217	Dermatitis, Occupational	MESH:D009783	marker/mechanism		NA		16758956
ALDH2	217	Diabetes Complications	MESH:D048909	therapeutic		NA		23500772
ALDH2	217	Enterocolitis, Necrotizing	MESH:D020345	marker/mechanism		NA		18806098
ALDH2	217	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		8850269
ALDH2	217	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		16639733|22960999
ALDH2	217	Flushing	MESH:D005483	marker/mechanism		NA		8903321
ALDH2	217	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		16404797|17590986
ALDH2	217	Heart Injuries	MESH:D006335	therapeutic		NA		23500772
ALDH2	217	Infertility, Male	MESH:D007248	marker/mechanism		NA		24448831
ALDH2	217	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		15650968
ALDH2	217	Melanosis	MESH:D008548	marker/mechanism		NA		30721697
ALDH2	217	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		29718361
ALDH2	217	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21472284
ALDH2	217	Vascular Diseases	MESH:D014652	marker/mechanism		NA		18596060
ALDH2	217	Ventricular Dysfunction	MESH:D018754	therapeutic		NA		23500772
ALDH3A1	218	Cataract	MESH:D002386	marker/mechanism		NA		28038895
ALDH3A1	218	Corneal Injuries	MESH:D065306	marker/mechanism		NA		28038895
ALDH3A2	224	Sjogren-Larsson Syndrome	MESH:D016111	marker/mechanism		NA	270200	16837225|25641190
ALDH4A1	8659	Hyperprolinemia type 2	MESH:C538385	marker/mechanism		NA	239510	25641190
ALDH4A1	8659	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		29718361
ALDH4A1	8659	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21472284
ALDH5A1	7915	Brain Diseases, Metabolic	MESH:D001928	marker/mechanism		NA		17438226
ALDH5A1	7915	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		29031482
ALDH5A1	7915	Dystonic Disorders	MESH:D020821	marker/mechanism		NA		17438226
ALDH5A1	7915	Intellectual Disability	MESH:D008607	marker/mechanism		NA		23825041
ALDH5A1	7915	Neurologic Manifestations	MESH:D009461	marker/mechanism		NA		29031482
ALDH5A1	7915	succinic semialdehyde dehydrogenase deficiency	MESH:C535803	marker/mechanism		NA	271980	20018576|23825041|25641190|29031482
ALDH6A1	4329	Amino Acid Metabolism, Inborn Errors	MESH:D000592	marker/mechanism		NA		10947204
ALDH6A1	4329	Methylmalonate Semialdehyde Dehydrogenase Deficiency	MESH:C566402	marker/mechanism		NA	614105	
ALDH6A1	4329	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
ALDH6A1	4329	Obesity	MESH:D009765	marker/mechanism		NA		20882379
ALDH7A1	501	Bone Diseases	MESH:D001847	marker/mechanism		NA		25004007
ALDH7A1	501	Coloboma	MESH:D003103	marker/mechanism		NA		25004007
ALDH7A1	501	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
ALDH7A1	501	Pyridoxine-dependent epilepsy	MESH:C536254	marker/mechanism		NA	266100	28087462
ALDH7A1	501	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
ALDH8A1	64577	Cholestasis	MESH:D002779	marker/mechanism		NA		27989131
ALDH9A1	223	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
ALDOA	226	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		19381893
ALDOA	226	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20562527
ALDOA	226	Glycogen Storage Disease XII	MESH:C562718	marker/mechanism		NA	611881	
ALDOA	226	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
ALDOA	226	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		15654357
ALDOA	226	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		20562527
ALDOB	229	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		16115720
ALDOB	229	Fructose Intolerance	MESH:D005633	marker/mechanism		NA	229600	15733923|18035330|3383242
ALDOB	229	Hepatitis, Autoimmune	MESH:D019693	marker/mechanism		NA		16115720
ALDOB	229	Hypoxia	MESH:D000860	marker/mechanism		NA		19579223
ALDOB	229	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		19424620
ALG1	56052	Congenital disorder of glycosylation type 1K	MESH:C535749	marker/mechanism		NA	608540	
ALG10B	144245	Long Qt Syndrome 2	MESH:C563614	marker/mechanism		NA	613688	
ALG11	440138	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip	OMIM:613661	marker/mechanism		NA	613661	
ALG12	79087	Congenital disorder of glycosylation type 1G	MESH:C535745	marker/mechanism		NA	607143	
ALG13	79868	Epilepsy	MESH:D004827	marker/mechanism		NA		29942082
ALG13	79868	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36	OMIM:300884	marker/mechanism		NA	300884	
ALG13	79868	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		29942082
ALG14	199857	Myasthenic Syndromes, Congenital	MESH:D020294	marker/mechanism		NA	616227	
ALG2	85365	Congenital disorder of glycosylation type II	MESH:C535747	marker/mechanism		NA	607906	
ALG2	85365	Myasthenic Syndromes, Congenital	MESH:D020294	marker/mechanism		NA	616228	
ALG3	10195	Congenital disorder of glycosylation type 1D	MESH:C535742	marker/mechanism		NA	601110	
ALG6	29929	Congenital disorder of glycosylation type 1C	MESH:C535741	marker/mechanism		NA	603147	
ALG8	79053	Congenital disorder of glycosylation type 1H	MESH:C535746	marker/mechanism		NA	608104	
ALG9	79796	Congenital disorder of glycosylation type 1L	MESH:C535750	marker/mechanism		NA	608776	
ALG9	79796	Polycystic Kidney Disease, Potter Type I, with Microbrachycephaly, Hypertelorism, and Brachymelia	MESH:C564881	marker/mechanism		NA	263210	
ALK	238	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		20979469|21823889|22071784|22135231|22153831|22743652|22980554|22999080
ALK	238	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		22986231
ALK	238	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
ALK	238	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		17625570|20979469|20979473|21102269|21336183|21587085|21757253|21767331|21791641|21823889|21904575|21933749|22215748|22277784|22282074|22286583|22508824|22568572|22617245|22713522|22787409|22887466|22920921|22954507|22968692|22986231|23020724|23686600
ALK	238	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		22743654
ALK	238	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22286764|23104988
ALK	238	Granuloma, Plasma Cell	MESH:D006104	marker/mechanism		NA		20979472|21030459|22920921
ALK	238	Inflammatory Breast Neoplasms	MESH:D058922	marker/mechanism		NA		22215853
ALK	238	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		22474449
ALK	238	Lymphoma, Large-Cell, Anaplastic	MESH:D017728	marker/mechanism		NA		16151469|19503098|21345110|22155737|22920921|22968692
ALK	238	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		22986231|22999080
ALK	238	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		22277784
ALK	238	Neuroblastoma	MESH:D009447	marker/mechanism		NA	613014	20576349|21823617|21859094|22072639|22286764|22588779|22789543|22920921|22932897|22968692|23104988|23334666
ALK	238	Plasma Cell Granuloma, Pulmonary	MESH:D016726	marker/mechanism		NA		21430068
ALKBH8	91801	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		27811057
ALKBH8	91801	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		27811057
ALMS1	7840	Alstrom Syndrome	MESH:D056769	marker/mechanism		NA	203800	22447358
ALMS1	7840	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		22447358
ALOX12	239	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
ALOX12	239	Burns, Chemical	MESH:D002057	marker/mechanism		NA		22533443
ALOX12	239	Hyperalgesia	MESH:D006930	marker/mechanism		NA		12582831
ALOX12	239	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		20864405
ALOX12	239	Skin Diseases	MESH:D012871	marker/mechanism		NA		22533443
ALOX12B	242	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		30258081
ALOX12B	242	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		30258081
ALOX12B	242	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		30258081
ALOX12B	242	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		30258081
ALOX12B	242	Ichthyosiform erythroderma, Brocq congenital, nonbullous form	MESH:C538603	marker/mechanism		NA	242100	
ALOX12B	242	Ichthyosis, Lamellar	MESH:D017490	marker/mechanism		NA		21739938
ALOX12B	242	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		30258081
ALOX12B	242	Pancreatic Carcinoma	MESH:C562463	marker/mechanism		NA		30258081
ALOX12B	242	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		30258081
ALOX12B	242	Testicular Germ Cell Tumor	MESH:C563236	marker/mechanism		NA		30258081
ALOX15	246	Atherosclerosis	MESH:D050197	therapeutic		NA		16303615
ALOX15	246	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		11406566
ALOX15	246	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
ALOX15	246	Hypertension	MESH:D006973	marker/mechanism		NA		22467300
ALOX15	246	Nasal Polyps	MESH:D009298	marker/mechanism		NA		30643255
ALOX5	240	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		30258081
ALOX5	240	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		30258081
ALOX5	240	Adenoma	MESH:D000236	marker/mechanism		NA		18927292
ALOX5	240	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		12833524
ALOX5	240	Asthma	MESH:D001249	marker/mechanism		NA	600807	
ALOX5	240	Atherosclerosis	MESH:D050197	marker/mechanism		NA		16698924
ALOX5	240	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		30258081
ALOX5	240	Colitis	MESH:D003092	marker/mechanism		NA		15821759
ALOX5	240	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		14569062|18927292|30258081
ALOX5	240	Colonic Polyps	MESH:D003111	marker/mechanism		NA		18927292
ALOX5	240	Drug Eruptions	MESH:D003875	marker/mechanism		NA		16502481
ALOX5	240	Endotoxemia	MESH:D019446	marker/mechanism		NA		15328337
ALOX5	240	Fractures, Closed	MESH:D005596	marker/mechanism		NA		19544365
ALOX5	240	Hyperalgesia	MESH:D006930	marker/mechanism		NA		12582831
ALOX5	240	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		14726295
ALOX5	240	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		19309543
ALOX5	240	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	MESH:D015464	therapeutic		NA		19503090|19823023
ALOX5	240	Multiple Organ Failure	MESH:D009102	marker/mechanism		NA		15241586
ALOX5	240	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		20061081
ALOX5	240	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		20061081
ALOX5	240	Nephrosclerosis	MESH:D009400	marker/mechanism		NA		30818366
ALOX5	240	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		30258081
ALOX5	240	Pancreatic Carcinoma	MESH:C562463	marker/mechanism		NA		30258081
ALOX5	240	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		30258081
ALOX5	240	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		15266012
ALOX5	240	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		20061081
ALOX5	240	Testicular Germ Cell Tumor	MESH:C563236	marker/mechanism		NA		30258081
ALOX5	240	Urticaria	MESH:D014581	marker/mechanism		NA		16502481
ALOX5AP	241	Atherosclerosis	MESH:D050197	marker/mechanism		NA		16698924
ALOX5AP	241	Cerebral Infarction	MESH:D002544	marker/mechanism		NA	601367	
ALOX5AP	241	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
ALOX5AP	241	Neurotoxicity Syndromes	MESH:D020258	marker/mechanism		NA		19784758
ALOX5AP	241	Proteinuria	MESH:D011507	marker/mechanism		NA		12649539
ALOXE3	59344	Ichthyosiform erythroderma, Brocq congenital, nonbullous form	MESH:C538603	marker/mechanism		NA	242100	
ALOXE3	59344	Ichthyosis, Lamellar	MESH:D017490	marker/mechanism		NA		21739938
ALOXE3	59344	Ichthyosis, Lamellar, 5	MESH:C564699	marker/mechanism		NA	606545	
ALOXE3	59344	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		22919386
ALPG	251	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
ALPK1	80216	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		27542954
ALPK1	80216	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		27542954
ALPK1	80216	Gout	MESH:D006073	marker/mechanism		NA		27542954
ALPK1	80216	Nephrosclerosis	MESH:D009400	marker/mechanism		NA		27542954
ALPK1	80216	Weight Loss	MESH:D015431	marker/mechanism		NA		27542954
ALPL	249	Alveolar Bone Loss	MESH:D016301	marker/mechanism		NA		20630305
ALPL	249	Bone Diseases, Metabolic	MESH:D001851	marker/mechanism		NA		26773408
ALPL	249	Calcinosis	MESH:D002114	marker/mechanism		NA		21193197
ALPL	249	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27466191
ALPL	249	Heat Stroke	MESH:D018883	marker/mechanism		NA		16878031
ALPL	249	Hyperparathyroidism, Secondary	MESH:D006962	marker/mechanism		NA		22373954
ALPL	249	Hypophosphatasia	MESH:D007014	marker/mechanism		NA		27466191
ALPL	249	Hypophosphatasia, Adult	MESH:C562647	marker/mechanism		NA	146300	
ALPL	249	Hypophosphatasia, Childhood	MESH:C562440	marker/mechanism		NA	241510	
ALPL	249	Hypophosphatasia, Infantile	MESH:C562646	marker/mechanism		NA	241500	
ALPL	249	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
ALPL	249	Seizures	MESH:D012640	marker/mechanism|therapeutic		NA		27466191|7550313
ALS2	57679	Amyotrophic Lateral Sclerosis 2, Juvenile	MESH:C565957	marker/mechanism		NA	205100	
ALS2	57679	Hereditary spastic paralysis, infantile onset ascending	MESH:C537217	marker/mechanism		NA	607225	
ALS2	57679	Primary lateral sclerosis juvenile	MESH:C536416	marker/mechanism		NA	606353	
ALS2CL	259173	Schizophrenia	MESH:D012559	marker/mechanism		NA		21743468
ALX1	8092	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		9847249
ALX1	8092	Frontonasal dysplasia	MESH:C538065	marker/mechanism		NA	613456	
ALX3	257	Frontonasal dysplasia	MESH:C538065	marker/mechanism		NA	136760	19409524
ALX3	257	Neural Tube Defects	MESH:D009436	marker/mechanism		NA		20534379
ALX4	60529	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		9847249
ALX4	60529	Craniosynostoses	MESH:D003398	marker/mechanism		NA	615529	
ALX4	60529	Frontonasal dysplasia	MESH:C538065	marker/mechanism		NA	613451	
ALX4	60529	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		24037716
ALX4	60529	Parietal Foramina	MESH:C566826	marker/mechanism		NA		11137991
ALX4	60529	Parietal Foramina 2	MESH:C566510	marker/mechanism		NA	609597	
ALX4	60529	Polydactyly	MESH:D017689	marker/mechanism		NA		9847249
ALYREF	10189	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
AMACR	23600	Adenoma	MESH:D000236	marker/mechanism		NA		17684125
AMACR	23600	Alpha-Methylacyl-CoA Racemase Deficiency	MESH:C565768	marker/mechanism		NA	614307	
AMACR	23600	Bile acid synthesis defect, congenital, 4	MESH:C535444	marker/mechanism		NA	214950	
AMACR	23600	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17684125
AMACR	23600	Hereditary Sensory and Motor Neuropathy	MESH:D015417	marker/mechanism		NA		10655068
AMACR	23600	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980|25380136
AMACR	23600	Liver Diseases	MESH:D008107	marker/mechanism		NA		12512044
AMACR	23600	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17173048|22919386|24763052
AMBN	258	AMELOGENESIS IMPERFECTA, TYPE IF	OMIM:616270	marker/mechanism		NA	616270	
AMBP	259	Acute Kidney Injury	MESH:D058186	marker/mechanism|therapeutic		NA		28885000|8963945
AMBP	259	Carcinoma, Transitional Cell	MESH:D002295	therapeutic		NA		14644129
AMBP	259	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		18779383
AMBP	259	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		28885000
AMBP	259	Mood Disorders	MESH:D019964	marker/mechanism		NA		29987918
AMBP	259	Neoplasm Invasiveness	MESH:D009361	therapeutic		NA		14644129
AMBRA1	55626	Spinal Cord Injuries	MESH:D013119	marker/mechanism		NA		29793971
AMELX	265	Amelogenesis imperfecta, hypoplastic-hypomaturation, X-linked 1	MESH:C538243	marker/mechanism		NA	301200	
AMELY	266	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
AMER1	139285	Osteopathia striata cranial sclerosis	MESH:C536053	marker/mechanism		NA	300373	19079258
AMER1	139285	Wilms Tumor	MESH:D009396	marker/mechanism		NA		28825729
AMFR	267	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		22313999
AMFR	267	Disease Progression	MESH:D018450	marker/mechanism		NA		9241080
AMFR	267	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		9241080
AMH	268	Female Urogenital Diseases	MESH:D052776	marker/mechanism		NA		16002989
AMH	268	Persistent Mullerian duct syndrome	MESH:C536665	marker/mechanism		NA	261550	
AMHR2	269	Female Urogenital Diseases	MESH:D052776	marker/mechanism		NA		16002989
AMHR2	269	Persistent Mullerian duct syndrome	MESH:C536665	marker/mechanism		NA	261550	
AMMECR1	9949	MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS	OMIM:300990	marker/mechanism		NA	300990	
AMN	81693	Acute Kidney Injury	MESH:D058186	therapeutic		NA		20514524
AMN	81693	Edema	MESH:D004487	therapeutic		NA		17698245
AMN	81693	Extravasation of Diagnostic and Therapeutic Materials	MESH:D005119	therapeutic		NA		17698245
AMN	81693	Neurogenic Inflammation	MESH:D020078	therapeutic		NA		16938409|17698245
AMOT	154796	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		27935819
AMPD1	270	Adenosine monophosphate deaminase deficiency	MESH:C538234	marker/mechanism		NA		10996775|11102975|1631143
AMPD1	270	Muscle Weakness	MESH:D018908	marker/mechanism		NA		10996775
AMPD1	270	Muscular Atrophy	MESH:D009133	marker/mechanism		NA		10996775
AMPD1	270	Muscular Diseases	MESH:D009135	marker/mechanism		NA		11102975|18380285
AMPD1	270	MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	OMIM:615511	marker/mechanism		NA	615511	
AMPD2	271	PONTOCEREBELLAR HYPOPLASIA, TYPE 9	OMIM:615809	marker/mechanism		NA	615809	
AMPD2	271	SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE	OMIM:615686	marker/mechanism		NA	615686	
AMPD3	272	Erythrocyte Amp Deaminase Deficiency	MESH:C567878	marker/mechanism		NA	612874	
AMT	275	Hyperglycinemia, Nonketotic	MESH:D020158	marker/mechanism		NA	605899	16450403
AMZ2P1	201283	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		25944804
ANG	283	Acute-Phase Reaction	MESH:D000210	marker/mechanism		NA		9464241
ANG	283	Amyotrophic Lateral Sclerosis 9	MESH:C567499	marker/mechanism		NA	611895	
ANG	283	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
ANGPT1	284	Fibrosis	MESH:D005355	marker/mechanism		NA		18480750|18626492
ANGPT1	284	Hypertrophy	MESH:D006984	therapeutic		NA		18502941
ANGPT1	284	Inflammation	MESH:D007249	marker/mechanism		NA		18480750
ANGPT1	284	Sepsis	MESH:D018805	therapeutic		NA		16005988
ANGPT2	285	Hemangiosarcoma	MESH:D006394	marker/mechanism		NA		17569031
ANGPTL3	27329	Hypobetalipoproteinemia, Familial, 2	MESH:C565732	marker/mechanism		NA	605019	
ANGPTL3	27329	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ANGPTL4	51129	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21489049
ANGPTL4	51129	Carcinoma	MESH:D002277	marker/mechanism		NA		21489049
ANGPTL4	51129	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		27135400
ANGPTL4	51129	Dyslipidemias	MESH:D050171	marker/mechanism		NA		17322881
ANGPTL4	51129	Fatty Liver	MESH:D005234	marker/mechanism		NA		28842503
ANGPTL4	51129	Hypertriglyceridemia	MESH:D015228	marker/mechanism		NA		28842503
ANGPTL4	51129	Lymphatic Metastasis	MESH:D008207	therapeutic		NA		17130448
ANGPTL4	51129	Neoplasm Invasiveness	MESH:D009361	therapeutic		NA		17130448
ANGPTL4	51129	Neoplasm Metastasis	MESH:D009362	therapeutic		NA		17130448
ANGPTL4	51129	Obesity	MESH:D009765	therapeutic		NA		28842503
ANGPTL6	83854	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
ANK1	286	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		18728347
ANK1	286	Spherocytosis, Type 1	MESH:C567159	marker/mechanism		NA	182900	
ANK2	287	Cardiac Arrhythmia, Ankyrin-B-Related	MESH:C566996	marker/mechanism		NA	600919	
ANK2	287	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
ANK2	287	Stroke	MESH:D020521	marker/mechanism		NA		29531354
ANK3	288	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		18711365|21926974|31043756
ANK3	288	Fetal Alcohol Spectrum Disorders	MESH:D063647	marker/mechanism		NA		29109170
ANK3	288	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
ANK3	288	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	OMIM:615493	marker/mechanism		NA	615493	
ANK3	288	Progeria	MESH:D011371	marker/mechanism		NA		27217151
ANK3	288	Status Epilepticus	MESH:D013226	marker/mechanism		NA		19306853
ANKFY1	51479	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		26039340
ANKH	56172	Chondrocalcinosis 2	MESH:C563162	marker/mechanism		NA	118600	
ANKH	56172	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		18027777
ANKH	56172	Craniometaphyseal Dysplasia, Autosomal Dominant	MESH:C565145	marker/mechanism		NA	123000	
ANKH	56172	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
ANKH	56172	Tooth Abnormalities	MESH:D014071	marker/mechanism		NA		18027777
ANKK1	255239	Language Disorders	MESH:D007806	marker/mechanism		NA		23691092
ANKLE2	23141	MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	OMIM:616681	marker/mechanism		NA	616681	
ANKRD1	27063	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
ANKRD11	29123	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		18252227
ANKRD11	29123	Bone Diseases, Metabolic	MESH:D001851	marker/mechanism		NA		17986521
ANKRD11	29123	Epilepsy	MESH:D004827	marker/mechanism		NA		29942082
ANKRD11	29123	KBG syndrome	MESH:C537015	marker/mechanism		NA	148050	
ANKRD11	29123	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889|29942082
ANKRD18A	253650	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		23131552
ANKRD20A2P	441430	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		29054765
ANKRD20A2P	441430	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		29054765
ANKRD23	200539	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
ANKRD26	22852	THROMBOCYTOPENIA 2	OMIM:188000	marker/mechanism		NA	188000	
ANKRD34A	284615	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
ANKRD55	79722	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		23143596
ANKRD55	79722	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
ANKRD9	122416	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
ANKS1A	23294	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		21378990
ANKS1B	56899	Hepatolenticular Degeneration	MESH:D006527	marker/mechanism		NA		23519153
ANKS6	203286	Cardiovascular Abnormalities	MESH:D018376	marker/mechanism		NA		23793029
ANKS6	203286	Kidney Diseases, Cystic	MESH:D052177	marker/mechanism		NA		23793029
ANKS6	203286	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		23793029
ANKS6	203286	NEPHRONOPHTHISIS 16	OMIM:615382	marker/mechanism		NA	615382	
ANKS6	203286	Polycystic Kidney, Autosomal Dominant	MESH:D016891	marker/mechanism		NA		12089381
ANKS6	203286	Situs Inversus	MESH:D012857	marker/mechanism		NA		23793029
ANLN	54443	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
ANLN	54443	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA	616032	
ANLN	54443	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
ANO10	55129	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA	613728	
ANO3	63982	Dystonia	MESH:D004421	marker/mechanism		NA	615034	
ANO3	63982	Seizures, Febrile	MESH:D003294	marker/mechanism		NA		25344690
ANO4	121601	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
ANO4	121601	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
ANO5	203859	GNATHODIAPHYSEAL DYSPLASIA	OMIM:166260	marker/mechanism		NA	166260	
ANO5	203859	Miyoshi Muscular Dystrophy 3	MESH:C567645	marker/mechanism		NA	613319	
ANO5	203859	Muscular Dystrophy, Limb-Girdle, Type 2L	MESH:C566968	marker/mechanism		NA	611307	
ANO6	196527	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ANO6	196527	Scott Syndrome	MESH:C563120	marker/mechanism		NA	262890	
ANO6	196527	Spondylitis, Ankylosing	MESH:D013167	marker/mechanism		NA		22138694
ANOS1	3730	Kallmann Syndrome	MESH:D017436	marker/mechanism		NA	308700	
ANP32A	8125	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
ANP32A	8125	Clinical Deterioration	MESH:D000075902	marker/mechanism		NA		27602772
ANP32A	8125	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		25944804
ANP32A	8125	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
ANPEP	290	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		26039340
ANTXR1	84168	Growth retardation, Alopecia, Pseudoanodontia and Optic atrophy	MESH:C535642	marker/mechanism		NA	230740	
ANTXR1	84168	Hemangioma, capillary infantile	MESH:C535860	marker/mechanism		NA	602089	
ANTXR2	118429	Contracture	MESH:D003286	marker/mechanism		NA		12973667|14508707
ANTXR2	118429	Fibroma	MESH:D005350	marker/mechanism		NA		12973667|14508707
ANTXR2	118429	Gingival Hypertrophy	MESH:D005886	marker/mechanism		NA		12973667|14508707
ANTXR2	118429	Hyalinosis, Systemic	MESH:D057770	marker/mechanism		NA	228600	12973667|14508707
ANTXR2	118429	Osteolysis	MESH:D010014	marker/mechanism		NA		12973667
ANTXR2	118429	Osteoporosis	MESH:D010024	marker/mechanism		NA		12973667
ANTXR2	118429	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29662167
ANTXR2	118429	Spondylitis, Ankylosing	MESH:D013167	marker/mechanism		NA		20062062|21743469
ANXA1	301	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		19381893
ANXA1	301	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462|16316942
ANXA1	301	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		15274141
ANXA1	301	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		17405164
ANXA1	301	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
ANXA1	301	Hypertension	MESH:D006973	marker/mechanism		NA		22228705
ANXA1	301	Kidney Diseases	MESH:D007674	therapeutic		NA		20484890
ANXA1	301	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ANXA1	301	Lymphatic Metastasis	MESH:D008207	marker/mechanism		NA		19381893
ANXA1	301	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462|16316942|22248470
ANXA1	301	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462|16316942
ANXA1	301	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		15274141
ANXA1	301	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		15654357
ANXA1	301	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		20308542
ANXA1	301	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17566973
ANXA1	301	Stomach Diseases	MESH:D013272	therapeutic		NA		15472012
ANXA10	11199	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		28369074
ANXA11	311	Sarcoidosis	MESH:D012507	marker/mechanism		NA		19165924
ANXA2	302	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		15274141
ANXA2	302	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
ANXA2	302	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
ANXA2	302	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ANXA2	302	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
ANXA2	302	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		20682992
ANXA2	302	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		22248470
ANXA2	302	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		20682992
ANXA2	302	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		15274141
ANXA2	302	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		15654357
ANXA2	302	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
ANXA2	302	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
ANXA2R	389289	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		26039340
ANXA3	306	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		22446963
ANXA3	306	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ANXA3	306	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		22446963
ANXA3	306	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		21435174
ANXA3	306	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
ANXA4	307	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
ANXA4	307	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
ANXA4	307	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		15108329
ANXA4	307	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
ANXA4	307	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ANXA4	307	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
ANXA4	307	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
ANXA4	307	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
ANXA4	307	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17085005
ANXA4	307	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		19233941
ANXA4	307	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
ANXA5	308	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		19381893
ANXA5	308	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		15274141
ANXA5	308	Hepatolenticular Degeneration	MESH:D006527	marker/mechanism		NA		21751376
ANXA5	308	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
ANXA5	308	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ANXA5	308	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		15274141
ANXA5	308	Pre-Eclampsia	MESH:D011225	therapeutic		NA		19837457
ANXA5	308	PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 3	OMIM:614391	marker/mechanism		NA	614391	
ANXA5	308	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
ANXA5	308	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
ANXA6	309	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
ANXA6	309	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
ANXA7	310	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		25058030
AOAH	313	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
AOC1	26	Cardiomegaly	MESH:D006332	marker/mechanism		NA		6218830
AOC1	26	Hypertension	MESH:D006973	marker/mechanism		NA		6218830
AOC3	8639	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		23154672
AOC3	8639	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		14977883
AOC3	8639	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		14977883
AOC3	8639	Hypertension	MESH:D006973	marker/mechanism		NA		23154672
AOC3	8639	Paratuberculosis	MESH:D010283	marker/mechanism		NA		22633222
AOC3	8639	Renal Insufficiency, Chronic	MESH:D051436	marker/mechanism		NA		23154672
AOC4P	90586	Lung Neoplasms	MESH:D008175	therapeutic		NA		32325081
AOC4P	90586	Neoplasm Invasiveness	MESH:D009361	therapeutic		NA		32325081
AOC4P	90586	Neoplasms, Experimental	MESH:D009374	therapeutic		NA		32325081
AOPEP	84909	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
AOPEP	84909	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		22544366|29892015|30061737
AOPEP	84909	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21472284
AOX1	316	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		19208208
AP1S1	1174	Cholestasis, Intrahepatic	MESH:D002780	marker/mechanism		NA		23423674
AP1S1	1174	Erythrokeratodermia Variabilis 3	MESH:C563739	marker/mechanism		NA	609313	23423674
AP1S1	1174	Lipidoses	MESH:D008064	marker/mechanism		NA		17175557
AP1S2	8905	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
AP1S2	8905	Mental retardation, X-linked, syndromic 5	MESH:C535773	marker/mechanism		NA	304340	17186471|17617514|23756445
AP1S3	130340	Psoriasis	MESH:D011565	marker/mechanism		NA	616106	
AP2S1	1175	Familial benign hypercalcemia, type 3	MESH:C537147	marker/mechanism		NA	600740	23222959
AP3B1	8546	Hermansky Pudlak syndrome 2	MESH:C537709	marker/mechanism		NA	608233	
AP3B2	8120	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	OMIM:617276	marker/mechanism		NA	617276	
AP3D1	8943	Hermanski-Pudlak Syndrome	MESH:D022861	marker/mechanism		NA	617050	
AP3S1	1176	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
AP3S2	10239	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		21874001
AP4B1	10717	SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE	OMIM:614066	marker/mechanism		NA	614066	
AP4E1	23431	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
AP4E1	23431	SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE	OMIM:613744	marker/mechanism		NA	613744	
AP4E1	23431	STUTTERING, FAMILIAL PERSISTENT, 1	OMIM:184450	marker/mechanism		NA	184450	
AP4M1	9179	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
AP4M1	9179	Spastic Paraplegia-50, Autosomal Recessive	MESH:C567858	marker/mechanism		NA	612936	
AP4S1	11154	SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	OMIM:614067	marker/mechanism		NA	614067	
AP5M1	55745	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		23797736
AP5Z1	9907	SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE	OMIM:613647	marker/mechanism		NA	613647	
APAF1	317	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		17133271
APAF1	317	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		17133271
APAF1	317	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		9753320|9753321
APAF1	317	Eye Abnormalities	MESH:D005124	marker/mechanism		NA		9753320
APAF1	317	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
APAF1	317	Retinal Detachment	MESH:D012163	marker/mechanism		NA		18497877
APAF1	317	Skin Abnormalities	MESH:D012868	marker/mechanism		NA		9753320
APBA2	321	Skin Diseases	MESH:D012871	marker/mechanism		NA		28720099
APBB1IP	54518	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
APBB2	323	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
APC	324	Aberrant Crypt Foci	MESH:D058739	marker/mechanism		NA		14507667
APC	324	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		15639718|9111214
APC	324	Adenoma	MESH:D000236	marker/mechanism		NA		10383901|12034317|19092804|30188895|9111214
APC	324	Adenomatous Polyposis Coli	MESH:D011125	marker/mechanism		NA	175100	11040535|11420398|11588890|11766074|12394442|17942926|18704758|25200834|25280562|28414304|8071957
APC	324	Adenomatous Polyps	MESH:D018256	marker/mechanism		NA		12810952
APC	324	Anemia, Macrocytic	MESH:D000748	marker/mechanism		NA		27725143
APC	324	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17221838|8071957
APC	324	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA	114550	
APC	324	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		18337602
APC	324	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		19092804|21967605
APC	324	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		10383901|12034317|17192441|25200834|26335331|7846077|8608549
APC	324	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	114500	12907644|17116713|18716850|19309276|21291235|21531761|21967605
APC	324	Colorectal Neoplasms, Hereditary Nonpolyposis	MESH:D003123	marker/mechanism		NA		7661930
APC	324	Desmoid disease, hereditary	MESH:C535944	marker/mechanism		NA	135290	
APC	324	Eye Abnormalities	MESH:D005124	marker/mechanism		NA		16938888
APC	324	Fibromatosis, Abdominal	MESH:D018221	marker/mechanism		NA		10686957
APC	324	Fibromatosis, Aggressive	MESH:D018222	marker/mechanism		NA		11816139
APC	324	Gastrointestinal Hemorrhage	MESH:D006471	marker/mechanism		NA		24430131
APC	324	Gastrointestinal Neoplasms	MESH:D005770	marker/mechanism		NA		21297660
APC	324	Glioblastoma	MESH:D005909	marker/mechanism		NA		7661930
APC	324	Hyperlipidemias	MESH:D006949	marker/mechanism		NA		17546600
APC	324	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA		18716850
APC	324	Intellectual Disability	MESH:D008607	marker/mechanism		NA		8071957
APC	324	Intestinal Neoplasms	MESH:D007414	marker/mechanism		NA		14706516|16962818|19092804|26335331|27840820|9111214
APC	324	Intestinal Polyps	MESH:D007417	marker/mechanism		NA		12189188|14991580|15063141|26262998|31715269|8561861
APC	324	Leukocytosis	MESH:D007964	marker/mechanism		NA		27725143
APC	324	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		27064257
APC	324	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		18337602
APC	324	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		9111214
APC	324	Medulloblastoma	MESH:D008527	marker/mechanism		NA		7661930
APC	324	Mesothelioma	MESH:D008654	marker/mechanism		NA		17659810
APC	324	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17363566|29610475
APC	324	Rectal Neoplasms	MESH:D012004	marker/mechanism		NA		11766074|8071957
APC	324	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
APC	324	Splenomegaly	MESH:D013163	marker/mechanism		NA		27725143
APC	324	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA	613659	
APC	324	Turcot syndrome	MESH:C536928	marker/mechanism		NA		7661930
APC2	10297	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18507500
APC2	10297	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18507500|18716850|21278247
APC2	10297	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA		18716850
APCDD1	147495	Hypotrichosis simplex	MESH:C537160	marker/mechanism		NA	605389	20393562
APCDD1	147495	Obesity	MESH:D009765	marker/mechanism		NA		28242765
APCS	325	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		19363144
APCS	325	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		12714198
APCS	325	Heart Failure	MESH:D006333	marker/mechanism		NA		16129801
APCS	325	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		20195826
APEX1	328	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
APEX1	328	Brain Injuries	MESH:D001930	marker/mechanism		NA		11447995
APEX1	328	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		25109342
APEX1	328	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
APEX1	328	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
APEX1	328	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		24036326
APEX1	328	Heart Diseases	MESH:D006331	marker/mechanism		NA		22262564
APEX1	328	Melanoma	MESH:D008545	marker/mechanism		NA		16373707
APEX1	328	Micronuclei, Chromosome-Defective	MESH:D048629	marker/mechanism		NA		22245109
APEX1	328	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16406883|29541389
APEX1	328	Seizures	MESH:D012640	marker/mechanism		NA		20446108
APEX1	328	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
APL-1	180783	Nerve Degeneration	MESH:D009410	therapeutic		NA		11784781
APLN	8862	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
APLN	8862	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
APLN	8862	Hyperuricemia	MESH:D033461	therapeutic		NA		30710622
APLP2	334	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
APLP2	334	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		11784781
APMAP	57136	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
APOA1	335	Acute Lung Injury	MESH:D055371	therapeutic		NA		20972769
APOA1	335	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		15378696
APOA1	335	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		19381893
APOA1	335	Amyloidosis, familial visceral	MESH:C538249	marker/mechanism		NA	105200	
APOA1	335	Ataxia with vitamin E deficiency	MESH:C535393	marker/mechanism		NA		18458655
APOA1	335	Behcet Syndrome	MESH:D001528	marker/mechanism		NA		12074830
APOA1	335	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
APOA1	335	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		16099942
APOA1	335	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		27135400
APOA1	335	Death	MESH:D003643	therapeutic		NA		20972769
APOA1	335	Diabetic Cardiomyopathies	MESH:D058065	therapeutic		NA		18332268
APOA1	335	Drug Eruptions	MESH:D003875	marker/mechanism		NA		21055120
APOA1	335	Edema	MESH:D004487	therapeutic		NA		20972769
APOA1	335	Glomerulonephritis, Membranous	MESH:D015433	marker/mechanism		NA		7900854
APOA1	335	HIV Infections	MESH:D015658	marker/mechanism		NA		12646808
APOA1	335	Hypertension	MESH:D006973	marker/mechanism		NA		18224302
APOA1	335	Hypoxia	MESH:D000860	marker/mechanism		NA		18258771
APOA1	335	Inflammation	MESH:D007249	therapeutic		NA		20972769
APOA1	335	Lipid Metabolism Disorders	MESH:D052439	marker/mechanism		NA		6816881
APOA1	335	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		19180532
APOA1	335	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		23056237
APOA1	335	Pediatric Obesity	MESH:D063766	marker/mechanism		NA		25137265
APOA1	335	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		15378696|19424620
APOA1	335	Stroke	MESH:D020521	marker/mechanism		NA		19433014
APOA2	336	HYPERCHOLESTEROLEMIA, FAMILIAL, 1	OMIM:143890	marker/mechanism		NA	143890	
APOA2	336	Hyperlipoproteinemia Type II	MESH:D006938	marker/mechanism		NA		12522687
APOA4	337	Atherosclerosis	MESH:D050197	therapeutic		NA		15822908
APOA4	337	Hyperlipoproteinemia Type II	MESH:D006938	marker/mechanism		NA		16030523
APOA4	337	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
APOA4	337	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		11420682
APOA4	337	Schizophrenia	MESH:D012559	marker/mechanism		NA		25821032
APOA5	116519	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		24097064
APOA5	116519	Hyperlipoproteinemia Type III	MESH:D006952	marker/mechanism		NA		16143024
APOA5	116519	Hyperlipoproteinemia Type IV	MESH:D006953	marker/mechanism		NA	145750	
APOA5	116519	Hyperlipoproteinemia Type V	MESH:D006954	marker/mechanism		NA	144650	
APOA5	116519	Hypertriglyceridemia	MESH:D015228	marker/mechanism		NA		20657596
APOA5	116519	Pediatric Obesity	MESH:D063766	marker/mechanism		NA		25137265
APOB	338	Ataxia with vitamin E deficiency	MESH:C535393	marker/mechanism		NA		18458655
APOB	338	Behcet Syndrome	MESH:D001528	marker/mechanism		NA		12074830
APOB	338	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		16544732|17002798
APOB	338	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
APOB	338	Coronary Disease	MESH:D003327	marker/mechanism		NA		17658632
APOB	338	Dyslipidemias	MESH:D050171	therapeutic		NA		18230960
APOB	338	Fatty Liver	MESH:D005234	marker/mechanism		NA		12048068|17303181
APOB	338	Hypercholesterolemia	MESH:D006937	marker/mechanism		NA		1600334
APOB	338	Hyperlipidemias	MESH:D006949	marker/mechanism		NA		17658632
APOB	338	Hyperlipoproteinemia Type II	MESH:D006938	marker/mechanism		NA	144010	10952765
APOB	338	Hypertriglyceridemia	MESH:D015228	marker/mechanism		NA		20657596
APOB	338	Hypobetalipoproteinemia, Familial, 1	MESH:C566267	marker/mechanism		NA	615558	
APOB	338	Hypobetalipoproteinemia, Familial, Apolipoprotein B	MESH:D052476	marker/mechanism		NA		2567736|2843815|3473077
APOBEC1	339	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
APOBEC3A	200315	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
APOBEC3A	200315	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		24728294
APOBEC3A	200315	Neoplasms	MESH:D009369	marker/mechanism		NA		26258849
APOBEC3A	200315	Neoplastic Processes	MESH:D009385	marker/mechanism		NA		26258849
APOBEC3B	9582	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		23852168
APOBEC3B	9582	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		23389445|23852168|24728294|27643540
APOBEC3B	9582	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		23852168
APOBEC3B	9582	Head and Neck Neoplasms	MESH:D006258	marker/mechanism		NA		23852168
APOBEC3B	9582	Neoplasms	MESH:D009369	marker/mechanism		NA		26258849
APOBEC3B	9582	Neoplastic Processes	MESH:D009385	marker/mechanism		NA		26258849
APOBEC3B	9582	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		23852168|27643540
APOBEC3B	9582	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		23852168
APOC1	341	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		29107063|30319691
APOC1	341	Heart Failure	MESH:D006333	marker/mechanism		NA		26670611
APOC2	344	Drug Eruptions	MESH:D003875	marker/mechanism		NA		21055120
APOC2	344	Hyperlipoproteinemia Type I	MESH:D008072	marker/mechanism		NA	207750	
APOC2	344	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		11420682
APOC3	345	Apolipoprotein C-III Deficiency	MESH:C566270	marker/mechanism		NA	614028	
APOC3	345	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		16544732
APOC3	345	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
APOC3	345	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		24097064
APOC3	345	Drug Eruptions	MESH:D003875	marker/mechanism		NA		21055120
APOC3	345	Hyperlipoproteinemias	MESH:D006951	marker/mechanism		NA		2022742
APOC3	345	Hyperlipoproteinemia Type II	MESH:D006938	marker/mechanism		NA		16030523
APOC3	345	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		19180532
APOD	347	Glioma	MESH:D005910	marker/mechanism		NA		16865689
APOD	347	Hypokinesia	MESH:D018476	marker/mechanism		NA		21688324
APOD	347	Learning Disabilities	MESH:D007859	marker/mechanism		NA		18419796
APOD	347	Neurodegenerative Diseases	MESH:D019636	therapeutic		NA		18458334
APOE	348	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		22266326
APOE	348	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		20430468
APOE	348	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		19734902|20819998|24162737|24473795|27023435|29107063|30319691|30320580|8346443
APOE	348	Alzheimer disease type 2	MESH:C536595	marker/mechanism		NA	104310	
APOE	348	Alzheimer disease type 4	MESH:C536596	marker/mechanism		NA	606889	
APOE	348	Amyloidosis	MESH:D000686	marker/mechanism		NA		15993987
APOE	348	Arteriosclerosis	MESH:D001161	marker/mechanism		NA		17118406|18287887
APOE	348	Atherosclerosis	MESH:D050197	marker/mechanism		NA		11095717|11231916|11947894|12871831|14594625|16020748|16303615|17438151|18093987|18269830|19124646|19682479|20093625|21043830|21512104|21908651|22005275|22022523|22228805|23148895|23639522|24017971|24096154|24330719|25020133|28483571|30376133|9169506|9409251|9649566
APOE	348	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		16544732
APOE	348	Carotid Artery Diseases	MESH:D002340	marker/mechanism		NA		18022660
APOE	348	Carotid Stenosis	MESH:D016893	marker/mechanism		NA		17243563
APOE	348	Cerebral Amyloid Angiopathy	MESH:D016657	marker/mechanism		NA		11061249
APOE	348	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		16099942
APOE	348	Cognition Disorders	MESH:D003072	marker/mechanism		NA		18239197
APOE	348	Coronary Disease	MESH:D003327	marker/mechanism		NA		10736278
APOE	348	Disease Progression	MESH:D018450	marker/mechanism		NA		24473795
APOE	348	Dyslipidemias	MESH:D050171	marker/mechanism		NA		25037058
APOE	348	Emphysema	MESH:D004646	marker/mechanism		NA		24096154
APOE	348	Hearing Loss	MESH:D034381	marker/mechanism		NA		19738398
APOE	348	Hepatolenticular Degeneration	MESH:D006527	marker/mechanism		NA		10686180
APOE	348	Hypercholesterolemia	MESH:D006937	marker/mechanism		NA		11397713|21043830|22022523|22228805
APOE	348	Hyperlipidemias	MESH:D006949	marker/mechanism		NA		11947894|12871831|20530721|20937366
APOE	348	Hyperlipoproteinemia Type II	MESH:D006938	marker/mechanism		NA		16030523
APOE	348	Hyperlipoproteinemia Type III	MESH:D006952	marker/mechanism		NA	617347	12506591|16143024|9649566
APOE	348	Hypertension	MESH:D006973	marker/mechanism		NA		20720404|22228705
APOE	348	Lipoprotein Glomerulopathy	MESH:C567089	marker/mechanism		NA	611771	10432380|9176854
APOE	348	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		19180532|20430468
APOE	348	Macular Degeneration	MESH:D008268	marker/mechanism		NA		16453339
APOE	348	Macular Degeneration, Age-Related, 1	MESH:C566411	marker/mechanism		NA	603075	
APOE	348	Mercury Poisoning	MESH:D008630	marker/mechanism		NA		16891999
APOE	348	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		15048896
APOE	348	Multiple Sclerosis, Relapsing-Remitting	MESH:D020529	marker/mechanism		NA		15096402
APOE	348	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		10587578
APOE	348	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		19522546
APOE	348	Obesity	MESH:D009765	marker/mechanism		NA		20975297
APOE	348	Plaque, Atherosclerotic	MESH:D058226	marker/mechanism		NA		17438151|18093987|19124646|20720404|22770994|22869926|24330719|24933211|29355567|29425287|30376133|30533443
APOE	348	Proteinuria	MESH:D011507	marker/mechanism		NA		20842518
APOE	348	Psoriasis	MESH:D011565	marker/mechanism		NA		16433808
APOE	348	Renal Insufficiency	MESH:D051437	marker/mechanism		NA		20842518
APOE	348	Schizophrenia	MESH:D012559	marker/mechanism		NA		18583979
APOE	348	Sea-Blue Histiocyte Syndrome	MESH:D012618	marker/mechanism		NA	269600	11095479
APOE	348	Seizures	MESH:D012640	marker/mechanism		NA		23266720
APOE	348	Splenomegaly	MESH:D013163	marker/mechanism		NA		11095479
APOF	319	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
APOH	350	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		16099942
APOL1	8542	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA	612551	
APOL2	23780	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		17205118
APOL2	23780	Marijuana Abuse	MESH:D002189	marker/mechanism		NA		17205118
APOL2	23780	Phencyclidine Abuse	MESH:D010623	marker/mechanism		NA		17205118
APOL2	23780	Schizophrenia	MESH:D012559	marker/mechanism		NA	181500	
APOL4	80832	Schizophrenia	MESH:D012559	marker/mechanism		NA	181500	
APOL6	80830	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
APOL9A	223672	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
APON	28194	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
APP	351	Aging, Premature	MESH:D019588	marker/mechanism		NA		23129026
APP	351	Alzheimer Disease	MESH:D000544	marker/mechanism		NA	104300	12192006|12572668|12746438|12852432|1497677|15590663|15591071|15993441|16204253|16266835|16325427|16492752|16651627|1671712|1678058|16969627|17239395|17430250|18583042|19286555|19818510|20111991|20157255|20640797|21157020|21209907|21980910|22507317|23827522|25352456|25714973|27117003|28448946|29420472|30320580
APP	351	Amnesia	MESH:D000647	marker/mechanism		NA		12642396
APP	351	Amyloid angiopathy	MESH:C538248	marker/mechanism		NA		31939705
APP	351	Amyloidosis	MESH:D000686	marker/mechanism		NA		23541064
APP	351	Amyloidosis, Cerebroarterial, App-Related	MESH:C537944	marker/mechanism		NA	605714	10821838|2111584
APP	351	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		19664757
APP	351	Brain Diseases	MESH:D001927	marker/mechanism		NA		11800653
APP	351	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		29068127
APP	351	Cerebral Amyloid Angiopathy	MESH:D016657	marker/mechanism		NA		21520056
APP	351	Cognition Disorders	MESH:D003072	marker/mechanism		NA		17406652|17600377|21350020|24189446|26945731|32522471
APP	351	Cognitive Dysfunction	MESH:D060825	marker/mechanism		NA		25288670
APP	351	Dementia	MESH:D003704	marker/mechanism		NA		22300406
APP	351	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		12746438|16651627|25881725|31939705
APP	351	Fragile X Syndrome	MESH:D005600	therapeutic		NA		22046307
APP	351	Learning Disabilities	MESH:D007859	marker/mechanism		NA		16474004|18533140|20816828|22484447|25213453|26420483|27306655|29729307
APP	351	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
APP	351	Memory Disorders	MESH:D008569	marker/mechanism		NA		15364477|18191838|18599028|19664757|19770021|20816828|22484447|23827522|24858312|25213453|25881725|26420483|26480858|27306655|28448946|29729307
APP	351	Necrosis	MESH:D009336	marker/mechanism		NA		21839817
APP	351	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		11784781|11800653|12396081|12963085|16951259|17600377|19631677|20111991|20359466|23726866|23827522
APP	351	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		16122394|23541064
APP	351	Neurogenic Inflammation	MESH:D020078	marker/mechanism		NA		20816828|25288670
APP	351	Paralysis	MESH:D010243	marker/mechanism		NA		16122394|18762355|21706413|22952840|28915354
APP	351	Plaque, Amyloid	MESH:D058225	marker/mechanism		NA		19818510|29729307|31939705
APP	351	Spinal Cord Diseases	MESH:D013118	marker/mechanism		NA		11800653
APP	351	Splenomegaly	MESH:D013163	marker/mechanism		NA		27117003
APP	351	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
APPA	58083	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		26297436
APPL	31002	Neurodegenerative Diseases	MESH:D019636	therapeutic		NA		22266106
APPL1	26060	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
APPL1	26060	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 14	OMIM:616511	marker/mechanism		NA	616511	
APPL2	55198	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
APPL2	55198	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
APRT	353	Adenine phosphoribosyltransferase deficiency	MESH:C538228	marker/mechanism		NA	614723	
APRT	353	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17659439
APRT	353	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		15108329
APRT	353	Urolithiasis	MESH:D052878	marker/mechanism		NA		3876264|7766
APTX	54840	Early-onset ataxia with oculomotor apraxia and hypoalbuminemia	MESH:C538013	marker/mechanism		NA	208920	
AQP1	358	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
AQP1	358	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
AQP1	358	Choledochal Cyst	MESH:D015529	marker/mechanism		NA		18988797
AQP1	358	Edema, Cardiac	MESH:D004489	marker/mechanism		NA		22865611
AQP1	358	Hypertension	MESH:D006973	marker/mechanism		NA		22228705
AQP1	358	Hyperthyroidism	MESH:D006980	marker/mechanism		NA		12621104
AQP1	358	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
AQP1	358	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
AQP1	358	Pain	MESH:D010146	marker/mechanism		NA		20018876
AQP1	358	Polycystic Kidney, Autosomal Recessive	MESH:D017044	marker/mechanism		NA		18988797
AQP1	358	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
AQP1	358	Shock, Septic	MESH:D012772	marker/mechanism		NA		24028651
AQP1	358	Spinal Cord Injuries	MESH:D013119	marker/mechanism		NA		21092735
AQP2	359	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		12145768
AQP2	359	Diabetes Insipidus, Nephrogenic	MESH:D018500	marker/mechanism|therapeutic		NA	125800	16121255|18653713|18854434|20374732
AQP3	360	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		21401805
AQP3	360	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		21401805
AQP3	360	Lymphatic Metastasis	MESH:D008207	marker/mechanism		NA		21401805
AQP3	360	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		18214481
AQP3	360	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		21401805
AQP3	360	Tongue Neoplasms	MESH:D014062	marker/mechanism		NA		21401805
AQP3	360	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		22306368
AQP4	361	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
AQP4	361	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18435417
AQP4	361	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
AQP4	361	Neuromyelitis Optica	MESH:D009471	marker/mechanism		NA		18509235|24070676
AQP4	361	Spinal Cord Injuries	MESH:D013119	marker/mechanism		NA		21092735
AQP4	361	Status Epilepticus	MESH:D013226	marker/mechanism		NA		20886625
AQP5	362	Diffuse palmoplantar keratoderma, Bothnian type	MESH:C536173	marker/mechanism		NA	600231	
AQP5	362	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		17245593|17270560
AQP7	364	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980|25380136
AQP7	364	Obesity	MESH:D009765	marker/mechanism		NA		16325777
AQP9	366	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		19805235
AQP9	366	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
AQP9	366	Leukemia	MESH:D007938	therapeutic		NA		15336539
AQP9	366	Leukemia, Myeloid, Acute	MESH:D015470	therapeutic		NA		16968895
AQP9	366	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		23563754
AR	367	Alopecia	MESH:D000505	marker/mechanism		NA		15902657
AR	367	Androgen-Insensitivity Syndrome	MESH:D013734	marker/mechanism		NA	300068|312300	1303262|8281139
AR	367	Astrocytoma	MESH:D001254	marker/mechanism		NA		24680642
AR	367	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19167832
AR	367	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21633166|22174584
AR	367	Breast Neoplasms, Male	MESH:D018567	marker/mechanism		NA		1303262|8281139
AR	367	Bulbospinal neuronopathy, X-linked recessive	MESH:C537017	marker/mechanism		NA	313200	
AR	367	Carcinoma, Hepatocellular	MESH:D006528	therapeutic		NA		18639551
AR	367	Diabetes, Gestational	MESH:D016640	marker/mechanism		NA		20421132
AR	367	Genital Diseases, Male	MESH:D005832	marker/mechanism		NA		25434310
AR	367	Hypertension	MESH:D006973	marker/mechanism		NA		10523385
AR	367	Hypospadias 1, X-Linked	MESH:C567482	marker/mechanism		NA	300633	
AR	367	Infertility, Female	MESH:D007247	marker/mechanism		NA		23710174
AR	367	Infertility, Male	MESH:D007248	marker/mechanism		NA		12220434|18554162|20164437
AR	367	Insulin Resistance	MESH:D007333	marker/mechanism		NA		21444647
AR	367	Leukemia	MESH:D007938	marker/mechanism		NA		19235587
AR	367	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		30008631
AR	367	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		11742035
AR	367	Prostatic Intraepithelial Neoplasia	MESH:D019048	marker/mechanism		NA		20601956
AR	367	Prostatic Neoplasms	MESH:D011471	marker/mechanism|therapeutic		NA	176807	11742035|12237244|15389811|15790600|16266977|16877366|16934689|16998812|17003774|17141945|18829485|19011039|20729295|22610119|22666205|23704919|25062956|25735316|25908785|25970160|29610475
AR	367	Prostatic Neoplasms, Castration-Resistant	MESH:D064129	marker/mechanism		NA		18985049|24740322|28500234|28757136
ARAF	369	Breast Neoplasms	MESH:D001943	therapeutic		NA		12432273
ARAP3	64411	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
ARC	23237	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		18503570
ARC	23237	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		18311559
ARC	23237	Movement Disorders	MESH:D009069	marker/mechanism		NA		20298714
ARCN1	372	Ataxia	MESH:D001259	marker/mechanism		NA		20502676
AREG	374	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
AREG	374	Asthma	MESH:D001249	marker/mechanism		NA		15696081
AREG	374	Breast Neoplasms	MESH:D001943	therapeutic		NA		11237771
AREG	374	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		15496427|16230376
AREG	374	Carcinoma, Squamous Cell	MESH:D002294	therapeutic		NA		11237771
AREG	374	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
AREG	374	Head and Neck Neoplasms	MESH:D006258	marker/mechanism		NA		15342401
AREG	374	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
AREG	374	Ovarian Neoplasms	MESH:D010051	therapeutic		NA		15313392
AREG	374	Protoporphyria, Erythropoietic	MESH:D046351	marker/mechanism		NA		19267999
AREG	374	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		26817844
AREG	374	Stomach Neoplasms	MESH:D013274	marker/mechanism|therapeutic		NA		15723263|15940630|16367923
ARF1	375	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		27517156
ARF1	375	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		27517156
ARFGAP1	55738	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		20805988
ARFGAP1	55738	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		20805988
ARFGAP2	84364	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
ARFGAP2	84364	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
ARFGEF2	10564	Heterotopia, Periventricular, Autosomal Recessive	MESH:C564292	marker/mechanism		NA	608097	
ARG1	383	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
ARG1	383	Amino Acid Metabolism, Inborn Errors	MESH:D000592	marker/mechanism		NA		21239484
ARG1	383	Asbestosis	MESH:D001195	marker/mechanism		NA		26699812
ARG1	383	Asthma	MESH:D001249	marker/mechanism		NA		19281908|19800904
ARG1	383	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22872058
ARG1	383	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
ARG1	383	Hair Diseases	MESH:D006201	marker/mechanism		NA		21239484
ARG1	383	Hyperargininemia	MESH:D020162	marker/mechanism		NA	207800	
ARG1	383	Immune System Diseases	MESH:D007154	marker/mechanism		NA		21239484
ARG1	383	Leishmaniasis	MESH:D007896	marker/mechanism		NA		21232540
ARG1	383	Muscular Diseases	MESH:D009135	marker/mechanism		NA		21239484
ARG1	383	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21472284
ARG1	383	Silicosis	MESH:D012829	marker/mechanism		NA		15292275
ARG2	384	Asthma	MESH:D001249	marker/mechanism		NA		19281908
ARG2	384	Carcinoma, Pancreatic Ductal	MESH:D021441	marker/mechanism		NA		23424623
ARG2	384	Disease Progression	MESH:D018450	marker/mechanism		NA		23424623
ARG2	384	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		24951775
ARG2	384	Necrosis	MESH:D009336	marker/mechanism		NA		23424623
ARG2	384	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		30618589
ARG2	384	Optic Nerve Injuries	MESH:D020221	marker/mechanism		NA		30618589
ARG2	384	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		23424623
ARG2	384	Retinal Degeneration	MESH:D012162	marker/mechanism		NA		30618589
ARHGAP10	79658	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
ARHGAP11A	9824	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
ARHGAP15	55843	Diverticular Diseases	MESH:D000076385	marker/mechanism		NA		28585551|30177863
ARHGAP23	57636	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
ARHGAP26	23092	Leukemia, Myelomonocytic, Juvenile	MESH:D054429	marker/mechanism		NA	607785	
ARHGAP28	79822	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
ARHGAP29	9411	Lymphoma, Mantle-Cell	MESH:D020522	marker/mechanism		NA		17488656
ARHGAP30	257106	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ARHGAP30	257106	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
ARHGAP31	57514	Adams Oliver syndrome	MESH:C538225	marker/mechanism		NA	100300	
ARHGAP35	2909	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27158780
ARHGAP4	393	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
ARHGAP45	23526	Neoplasms	MESH:D009369	marker/mechanism		NA		19096014
ARHGAP45	23526	Pre-Eclampsia	MESH:D011225	marker/mechanism		NA		26095815
ARHGAP6	395	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
ARHGAP9	64333	Coronary Vasospasm	MESH:D003329	marker/mechanism		NA		19911011
ARHGAP9	64333	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ARHGDIA	396	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20562527
ARHGDIA	396	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
ARHGDIA	396	Keloid	MESH:D007627	marker/mechanism		NA		20128793
ARHGDIA	396	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		20562527
ARHGDIA	396	NEPHROTIC SYNDROME, TYPE 8	OMIM:615244	marker/mechanism		NA	615244	
ARHGDIB	397	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		21751358
ARHGDIB	397	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
ARHGDIB	397	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ARHGEF10	9639	Slowed Nerve Conduction Velocity, Autosomal Dominant	MESH:C564269	marker/mechanism		NA	608236	
ARHGEF12	23365	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
ARHGEF18	23370	RETINITIS PIGMENTOSA 78	OMIM:617433	marker/mechanism		NA	617433	
ARHGEF39	84904	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
ARHGEF5	7984	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		29054765
ARHGEF5	7984	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		29054765
ARHGEF5	7984	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
ARHGEF9	23229	Hyperekplexia and Epilepsy	MESH:C564474	marker/mechanism		NA	300607	
ARHGEF9	23229	Mental Retardation, X-Linked	MESH:D038901	marker/mechanism		NA		21807943
ARID1A	8289	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		22484628
ARID1A	8289	Adenocarcinoma Of Esophagus	MESH:C562730	marker/mechanism		NA		23525077
ARID1A	8289	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		31932695
ARID1A	8289	Burkitt Lymphoma	MESH:D002051	marker/mechanism		NA		23143597
ARID1A	8289	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
ARID1A	8289	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		22561517|22634756|22922871
ARID1A	8289	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		21822268
ARID1A	8289	Cholangiocarcinoma	MESH:D018281	marker/mechanism		NA		24185509
ARID1A	8289	Coffin-Siris syndrome	MESH:C536436	marker/mechanism		NA	614607	22426308
ARID1A	8289	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		27941798
ARID1A	8289	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		23104009
ARID1A	8289	Lymphoma, T-Cell	MESH:D016399	marker/mechanism		NA		26192917
ARID1A	8289	Lymphoma, T-Cell, Cutaneous	MESH:D016410	marker/mechanism		NA		26192916
ARID1A	8289	Microsatellite Instability	MESH:D053842	marker/mechanism		NA		25701956
ARID1A	8289	Nasopharyngeal Carcinoma	MESH:D000077274	marker/mechanism		NA		24952746
ARID1A	8289	Neuroblastoma	MESH:D009447	marker/mechanism		NA		23202128
ARID1A	8289	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475|29662167
ARID1A	8289	Rhabdomyosarcoma, Embryonal	MESH:D018233	marker/mechanism		NA		29376028
ARID1A	8289	Sezary Syndrome	MESH:D012751	marker/mechanism		NA		26551670
ARID1A	8289	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		22037554|22484628|24816253
ARID1A	8289	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		21822268
ARID1A	8289	Wilms Tumor	MESH:D009396	marker/mechanism		NA		28825729
ARID1B	57492	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		22634756
ARID1B	57492	Coffin-Siris syndrome	MESH:C536436	marker/mechanism		NA	135900	22426308|22426309
ARID1B	57492	Epilepsy	MESH:D004827	marker/mechanism		NA		29942082
ARID1B	57492	Neuroblastoma	MESH:D009447	marker/mechanism		NA		23202128
ARID1B	57492	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889|29942082
ARID2	196528	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21822264|22634756
ARID2	196528	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
ARID4A	5926	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
ARID4B	51742	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
ARID5B	84159	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		22446963|23143596
ARID5B	84159	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
ARID5B	84159	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		24712521
ARID5B	84159	Graves Disease	MESH:D006111	marker/mechanism		NA		22446963
ARID5B	84159	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		19684603|19684604
ARL11	115761	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ARL11	115761	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		17079447
ARL13B	200894	Joubert Syndrome 8	MESH:C567358	marker/mechanism		NA	612291	
ARL14EP	120534	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
ARL2	402	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
ARL2BP	23568	RETINITIS PIGMENTOSA 82 WITH OR WITHOUT SITUS INVERSUS	OMIM:615434	marker/mechanism		NA	615434	
ARL5B	221079	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
ARL6	84100	Bardet-Biedl syndrome 1	MESH:C537909	marker/mechanism		NA	209900	
ARL6	84100	Bardet-Biedl syndrome 3	MESH:C537911	marker/mechanism		NA	600151	
ARL6	84100	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA	268000	
ARL6	84100	RETINITIS PIGMENTOSA 55	OMIM:613575	marker/mechanism		NA	613575	
ARL6IP1	23204	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
ARL6IP1	23204	SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE	OMIM:615685	marker/mechanism		NA	615685	
ARL6IP5	10550	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		29545876
ARL6IP5	10550	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		29545876
ARL6IP5	10550	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		22452940
ARL6IP5	10550	Substance Withdrawal Syndrome	MESH:D013375	therapeutic		NA		21600884
ARL8A	127829	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ARMC5	79798	Acth-Independent Macronodular Adrenal Hyperplasia	MESH:C565662	marker/mechanism		NA	615954	
ARMCX1	51309	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ARMH3	79591	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
ARMS2	387715	Macular Degeneration	MESH:D008268	marker/mechanism		NA		17884985|18511946|21909106
ARMS2	387715	MACULAR DEGENERATION, AGE-RELATED, 8	OMIM:613778	marker/mechanism		NA	613778	
ARNT	405	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
ARNT	405	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		20935161
ARNT	405	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		21081473
ARNT	405	Endometriosis	MESH:D004715	marker/mechanism		NA		22138541
ARNT	405	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		22271822
ARNT	405	Melanoma	MESH:D008545	marker/mechanism		NA		21983785
ARNT	405	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		9496914
ARNT	405	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		22674224
ARNT2	9915	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
ARNT2	9915	WEBB-DATTANI SYNDROME	OMIM:615926	marker/mechanism		NA	615926	
ARNTL	406	Abnormalities, Multiple	MESH:D000015	marker/mechanism		NA		24652800
ARNTL	406	Hyperargininemia	MESH:D020162	marker/mechanism		NA		27056296
ARNTL	406	Infertility, Female	MESH:D007247	marker/mechanism		NA		20200203
ARNTL	406	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	MESH:D015464	marker/mechanism		NA		16999817
ARNTL	406	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
ARPC1B	10095	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ARPC2	10109	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		18836448
ARRB1	408	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		26396155
ARRB2	409	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		17233643
ARRB2	409	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ARRDC3	57561	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25038754
ARSA	410	Leukodystrophy, Metachromatic	MESH:D007966	marker/mechanism		NA	250100	
ARSB	411	Mucopolysaccharidosis VI	MESH:D009087	marker/mechanism		NA	253200	17458871
ARSL	415	X-Linked Chondrodysplasia Punctata 1	MESH:C580533	marker/mechanism		NA	302950	18348268|7720070
ARTN	9048	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20305694
ARTN	9048	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		27869817
ARTN	9048	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27869817
ARTN	9048	Pruritus	MESH:D011537	marker/mechanism		NA		27869817
ARV1	64801	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 38	OMIM:617020	marker/mechanism		NA	617020	
ARX	170302	Infantile Epileptic-Dyskinetic Encephalopathy	MESH:C567924	marker/mechanism		NA	308350	
ARX	170302	Lissencephaly, X-Linked, 2	MESH:C564563	marker/mechanism		NA	300215	
ARX	170302	Mental Retardation, X-Linked, With Or Without Seizures, Arx-Related	MESH:C563150	marker/mechanism		NA	300419	
ARX	170302	Partington X-linked mental retardation syndrome	MESH:C536300	marker/mechanism		NA	309510	
ARX	170302	Proud Syndrome	MESH:C563110	marker/mechanism		NA	300004	
AS3MT	57412	Arsenic Poisoning	MESH:D020261	therapeutic		NA		21447609|26366667
AS3MT	57412	Attention Deficit Disorder with Hyperactivity	MESH:D001289	marker/mechanism		NA		25461954
AS3MT	57412	Birth Weight	MESH:D001724	marker/mechanism		NA		26928318
AS3MT	57412	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		28235556
AS3MT	57412	Neoplasms, Glandular and Epithelial	MESH:D009375	marker/mechanism		NA		21447609
AS3MT	57412	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		22747749|29669044|29859237|32539094
ASAH1	427	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
ASAH1	427	Farber Lipogranulomatosis	MESH:D055577	marker/mechanism		NA	228000	
ASAH1	427	Lipidoses	MESH:D008064	marker/mechanism		NA		15342952|16919414
ASAH1	427	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ASAH1	427	SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	OMIM:159950	marker/mechanism		NA	159950	
ASAH2	56624	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
ASAH2	56624	Liver Diseases	MESH:D008107	therapeutic		NA		15946935
ASAP1	50807	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
ASAP1	50807	Tuberculosis, Pulmonary	MESH:D014397	marker/mechanism		NA		25774636
ASAP1	50807	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		26039340
ASB10	136371	Glaucoma 1, Open Angle, F	MESH:C566383	marker/mechanism		NA	603383	
ASB15	142685	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		22138691
ASCC1	51008	Barrett Esophagus	MESH:D001471	marker/mechanism		NA	614266	
ASCC1	51008	SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	OMIM:616867	marker/mechanism		NA	616867	
ASCC3	10973	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
ASCL1	429	Acute Lung Injury	MESH:D055371	therapeutic		NA		20554700
ASCL1	429	Congenital central hypoventilation syndrome	MESH:C536209	marker/mechanism		NA	209880	
ASCL1	429	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
ASCL1	429	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		23203475
ASCL1	429	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		26253517
ASCL2	430	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
ASF1A	25842	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
ASF1B	55723	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
ASF1B	55723	Prostatic Neoplasms, Castration-Resistant	MESH:D064129	marker/mechanism		NA		29581250
ASH1L	55870	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		27064257
ASH1L	55870	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
ASH1L	55870	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29662167
ASIC1	41	Brain Injuries	MESH:D001930	marker/mechanism		NA		21307247
ASIC1	41	Brain Ischemia	MESH:D002545	marker/mechanism		NA		21307247
ASIC1	41	Inflammation	MESH:D007249	marker/mechanism		NA		11588175
ASIC2	40	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17376794
ASIC2	40	Inflammation	MESH:D007249	marker/mechanism		NA		11588175
ASIC3	9311	Inflammation	MESH:D007249	marker/mechanism		NA		11588175
ASIP	434	Carcinoma, Basal Cell	MESH:D002280	marker/mechanism		NA		18488027
ASIP	434	Melanoma	MESH:D008545	marker/mechanism		NA		18488027|18641652|21983785
ASIP	434	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		18488027
ASL	435	Argininosuccinic Aciduria	MESH:D056807	marker/mechanism		NA	207900	3106853
ASMT	438	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17505466
ASMT	438	Hepatolenticular Degeneration	MESH:D006527	marker/mechanism		NA		23519153
ASMTL	8623	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
ASNS	440	ASPARAGINE SYNTHETASE DEFICIENCY	OMIM:615574	marker/mechanism		NA	615574	
ASNS	440	Lipidoses	MESH:D008064	marker/mechanism		NA		17175557
ASNS	440	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ASNS	440	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		28108177
ASPA	443	Canavan Disease	MESH:D017825	marker/mechanism		NA	271900	17027983|17194761
ASPG	374569	Anaphylaxis	MESH:D000707	marker/mechanism		NA		65671
ASPG	374569	Anemia	MESH:D000740	marker/mechanism		NA		2187653
ASPG	374569	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
ASPG	374569	Choledocholithiasis	MESH:D042883	marker/mechanism		NA		12902918
ASPG	374569	Cholelithiasis	MESH:D002769	marker/mechanism		NA		12902918
ASPG	374569	Fever	MESH:D005334	marker/mechanism		NA		2187653
ASPG	374569	Hematuria	MESH:D006417	marker/mechanism		NA		2187653
ASPG	374569	Leukopenia	MESH:D007970	marker/mechanism		NA		2187653
ASPG	374569	Thrombocytopenia	MESH:D013921	marker/mechanism		NA		2187653
ASPG	374569	Vomiting	MESH:D014839	marker/mechanism		NA		2187653
ASPH	444	Ectopia Lentis, Spontaneous Filtering Blebs, and Craniofacial Dysmorphism	MESH:C563293	marker/mechanism		NA	601552	
ASPM	259266	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
ASPM	259266	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
ASPM	259266	Microcephaly, Primary Autosomal Recessive, 5	MESH:C563871	marker/mechanism		NA	608716	
ASPM	259266	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
ASPM	259266	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
ASPN	54829	Intervertebral disc disease	MESH:C535531	marker/mechanism		NA	603932	
ASPN	54829	Keloid	MESH:D007627	marker/mechanism		NA		20128793
ASPN	54829	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ASPN	54829	Osteoarthritis	MESH:D010003	marker/mechanism		NA	607850	
ASPSCR1	79058	Sarcoma, Alveolar Soft Part	MESH:D018234	marker/mechanism		NA	606243	
ASRGL1	80150	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		16033404
ASS1	445	Citrullinemia	MESH:D020159	marker/mechanism		NA	215700	
ASS1	445	Diabetic Angiopathies	MESH:D003925	therapeutic		NA		25033204
ASS1	445	Liver Diseases	MESH:D008107	marker/mechanism		NA		31651977
ASTN1	460	Brain Injuries	MESH:D001930	marker/mechanism		NA		14499481
ASTN2	23245	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
ASTN2	23245	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19404257
ASTN2	23245	Migraine without Aura	MESH:D020326	marker/mechanism		NA		22683712
ASTN2	23245	Osteoarthritis, Hip	MESH:D015207	marker/mechanism		NA		30374069
ASXL1	171023	Bohring syndrome	MESH:C537419	marker/mechanism		NA	605039	21706002
ASXL1	171023	Leukemia, Myelomonocytic, Juvenile	MESH:D054429	marker/mechanism		NA		26457647
ASXL1	171023	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		26285909
ASXL1	171023	Myelodysplastic Syndromes	MESH:D009190	marker/mechanism		NA	614286	27992414
ASXL1	171023	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		26285909
ASXL1	171023	Wilms Tumor	MESH:D009396	marker/mechanism		NA		28825729
ASXL2	55252	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		27798625
ASXL2	55252	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		24121791
ASXL3	80816	BAINBRIDGE-ROPERS SYNDROME	OMIM:615485	marker/mechanism		NA	615485	
ASXL3	80816	Epilepsy	MESH:D004827	marker/mechanism		NA		29942082
ASXL3	80816	Lymphoma, T-Cell	MESH:D016399	marker/mechanism		NA		26192917
ASXL3	80816	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889|29942082
ASZ1	136991	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
ATAD3A	55210	HAREL-YOON SYNDROME	OMIM:617183	marker/mechanism		NA	617183	
ATAD3A	55210	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		21584487
ATAD5	79915	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		25581431
ATAT1	79969	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
ATCAY	85300	Cerebellar Ataxia, Cayman Type	MESH:C563363	marker/mechanism		NA	601238	
ATF1	466	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
ATF2	1386	Disease Progression	MESH:D018450	marker/mechanism		NA		23591579
ATF2	1386	Neoplasms	MESH:D009369	marker/mechanism		NA		23591579
ATF3	467	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		17043644
ATF3	467	Cardiomyopathies	MESH:D009202	therapeutic		NA		25136830
ATF3	467	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		16123366
ATF3	467	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		16123366
ATF3	467	Hypospadias	MESH:D007021	marker/mechanism		NA		18001166
ATF3	467	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		12374626
ATF3	467	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
ATF3	467	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ATF3	467	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		21159647
ATF3	467	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		18701217|18754875
ATF3	467	Ovarian Neoplasms	MESH:D010051	therapeutic		NA		15674352
ATF3	467	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		17686523
ATF3	467	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16516039
ATF4	468	Carcinoma, Ductal, Breast	MESH:D018270	marker/mechanism		NA		14604972
ATF4	468	Fatty Liver	MESH:D005234	marker/mechanism		NA		27664470
ATF4	468	Hypoxia	MESH:D000860	marker/mechanism		NA		14604972
ATF4	468	Necrosis	MESH:D009336	marker/mechanism		NA		14604972
ATF4	468	Spinal Cord Injuries	MESH:D013119	marker/mechanism		NA		29793971
ATF6	22926	ACHROMATOPSIA 7	OMIM:616517	marker/mechanism		NA	616517	
ATF6	22926	Asbestosis	MESH:D001195	marker/mechanism		NA		25324550
ATF6	22926	Color Vision Defects	MESH:D003117	marker/mechanism		NA		26029869
ATF6	22926	Creutzfeldt-Jakob Syndrome	MESH:D007562	marker/mechanism		NA		23349890
ATF6	22926	Nystagmus, Congenital	MESH:D020417	marker/mechanism		NA		26029869
ATF6	22926	Photophobia	MESH:D020795	marker/mechanism		NA		26029869
ATF6	22926	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA		26029869
ATF6	22926	Scrapie	MESH:D012608	marker/mechanism		NA		23349890
ATF7IP	55729	Neoplasms, Germ Cell and Embryonal	MESH:D009373	marker/mechanism		NA		20543847
ATF7IP	55729	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D015452	marker/mechanism		NA		24413735
ATF7IP	55729	Testicular Neoplasms	MESH:D013736	marker/mechanism		NA		20543847
ATG10	83734	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
ATG101	60673	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
ATG16L1	55054	Crohn Disease	MESH:D003424	marker/mechanism		NA		17435756|18438406
ATG16L1	55054	Inflammatory Bowel Disease 10	MESH:C567021	marker/mechanism		NA	611081	
ATG16L1	55054	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA		26192919
ATG16L1	55054	Zika Virus Infection	MESH:D000071243	therapeutic		NA		28694387
ATG2B	55102	Leukemia, Myeloid	MESH:D007951	marker/mechanism		NA		26280900
ATG2B	55102	Myeloproliferative Disorders	MESH:D009196	marker/mechanism		NA		26280900
ATG5	9474	Anemia	MESH:D000740	marker/mechanism		NA		26568842
ATG5	9474	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22491424
ATG5	9474	Hepatomegaly	MESH:D006529	marker/mechanism		NA		22491424
ATG5	9474	Lethargy	MESH:D053609	marker/mechanism		NA		26568842
ATG5	9474	Lymphopenia	MESH:D008231	marker/mechanism		NA		26568842
ATG5	9474	Necrosis	MESH:D009336	marker/mechanism		NA		20578144
ATG5	9474	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		28408137
ATG5	9474	Spinal Cord Injuries	MESH:D013119	marker/mechanism		NA		29793971
ATG5	9474	Weight Loss	MESH:D015431	marker/mechanism		NA		26568842
ATG7	10533	Anemia	MESH:D000740	marker/mechanism		NA		26568842
ATG7	10533	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		29191453
ATG7	10533	Lethargy	MESH:D053609	marker/mechanism		NA		26568842
ATG7	10533	Lymphopenia	MESH:D008231	marker/mechanism		NA		26568842
ATG7	10533	Necrosis	MESH:D009336	therapeutic		NA		21081844
ATG7	10533	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		28408137
ATG7	10533	Weight Loss	MESH:D015431	marker/mechanism		NA		26568842
ATIC	471	AICAR Transformylase Inosine Monophosphate Cyclohydrolase Deficiency	MESH:C563876	marker/mechanism		NA	608688	15114530
ATIC	471	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		19193698
ATIC	471	Blindness	MESH:D001766	marker/mechanism		NA		15114530
ATIC	471	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		16947783
ATIC	471	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
ATL1	51062	NEUROPATHY, HEREDITARY SENSORY, TYPE ID	OMIM:613708	marker/mechanism		NA	613708	
ATL1	51062	Spastic paraplegia 3, autosomal dominant	MESH:C536864	marker/mechanism		NA	182600	
ATL3	25923	NEUROPATHY, HEREDITARY SENSORY, TYPE IF	OMIM:615632	marker/mechanism		NA	615632	
ATM	472	Ataxia Telangiectasia	MESH:D001260	marker/mechanism		NA	208900	11507241|11507245|15177039|15498871|8958160
ATM	472	Breast Neoplasms	MESH:D001943	marker/mechanism		NA	114480	
ATM	472	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
ATM	472	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		19919837
ATM	472	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		25125259
ATM	472	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		24358288
ATM	472	Cataract	MESH:D002386	marker/mechanism		NA		16799786
ATM	472	Fibrosis	MESH:D005355	marker/mechanism		NA		24358288
ATM	472	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		17968022
ATM	472	Lymphoma, T-Cell, Cutaneous	MESH:D016410	marker/mechanism		NA		26192916
ATM	472	Lymphoma, T-Cell, Peripheral	MESH:D016411	marker/mechanism		NA		24413734
ATM	472	Melanoma	MESH:D008545	marker/mechanism		NA		21983787
ATM	472	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		24358288
ATM	472	Neoplasms	MESH:D009369	marker/mechanism		NA		21177254
ATM	472	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		26098866|26098869
ATM	472	Prenatal Exposure Delayed Effects	MESH:D011297	marker/mechanism		NA		21177254
ATM	472	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
ATM	472	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17502119|25415046|26098866|29610475
ATM	472	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		26098866
ATM	472	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		24121791
ATM	472	Ventricular Dysfunction, Left	MESH:D018487	marker/mechanism		NA		24358288
ATN1	1822	Myoclonic Epilepsies, Progressive	MESH:D020191	marker/mechanism		NA	125370	10814707
ATOH1	474	Medulloblastoma	MESH:D008527	marker/mechanism		NA		18347096
ATOH7	220202	Retinal Nonattachment, Nonsyndromic Congenital	MESH:C565633	marker/mechanism		NA	221900	
ATOH8	84913	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
ATOX1	475	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		31961892
ATOX1	475	Hepatitis, Chronic	MESH:D006521	marker/mechanism		NA		25053573
ATOX1	475	Hypertension	MESH:D006973	therapeutic		NA		22753205
ATOX1	475	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		23624903
ATP10A	57194	Autistic Disorder	MESH:D001321	marker/mechanism		NA		12851639
ATP10D	57205	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ATP11A	23250	Idiopathic Pulmonary Fibrosis	MESH:D054990	marker/mechanism		NA		23583980
ATP13A2	23400	Kufor-Rakeb syndrome	MESH:C537177	marker/mechanism		NA	606693	22022275|22768177|22847264
ATP13A2	23400	Manganese Poisoning	MESH:D020149	marker/mechanism		NA		22285144
ATP13A2	23400	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		22847264
ATP13A2	23400	Neuronal Ceroid-Lipofuscinoses	MESH:D009472	marker/mechanism		NA		22022275|22847264
ATP13A2	23400	Parkinson Disease	MESH:D010300	marker/mechanism		NA		23628791|25149416
ATP13A2	23400	Parkinson Disease, Secondary	MESH:D010302	marker/mechanism		NA		22285144
ATP13A2	23400	Parkinsonian Disorders	MESH:D020734	marker/mechanism		NA		23046578
ATP13A2	23400	SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	OMIM:617225	marker/mechanism		NA	617225	
ATP1A1	476	Adenoma	MESH:D000236	marker/mechanism		NA		23416519|23913004
ATP1A1	476	Gastroenteritis, Transmissible, of Swine	MESH:D005761	marker/mechanism		NA		28438630
ATP1A1	476	Hyperaldosteronism	MESH:D006929	marker/mechanism		NA		23416519
ATP1A1	476	Hypertension	MESH:D006973	marker/mechanism		NA		23416519
ATP1A1	476	Myocardial Infarction	MESH:D009203	therapeutic		NA		29702141
ATP1A1	476	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
ATP1A1	476	Myocardial Reperfusion Injury	MESH:D015428	therapeutic		NA		29702141
ATP1A1	476	Vestibular Diseases	MESH:D015837	marker/mechanism		NA		21269433
ATP1A2	477	Alternating hemiplegia of childhood	MESH:C536589	marker/mechanism		NA	104290	
ATP1A2	477	Hemiplegic migraine, familial type 2	MESH:C537246	marker/mechanism		NA	602481	23954377
ATP1A2	477	Hypertension	MESH:D006973	marker/mechanism		NA		16166162|16243970
ATP1A3	478	Alternating hemiplegia of childhood	MESH:C536589	marker/mechanism		NA	614820	22842232|24631656
ATP1A3	478	CAPOS syndrome	MESH:C535351	marker/mechanism		NA	601338	
ATP1A3	478	Dystonia	MESH:D004421	marker/mechanism		NA		15260953
ATP1A3	478	Dystonia 12	MESH:C538001	marker/mechanism		NA	128235	15260953|24631656
ATP1A3	478	Heart Failure	MESH:D006333	marker/mechanism		NA		18418421
ATP1A3	478	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
ATP1A3	478	Parkinsonian Disorders	MESH:D020734	marker/mechanism		NA		15260953
ATP1A3	478	Ventricular Dysfunction, Left	MESH:D018487	marker/mechanism		NA		18418421
ATP1A4	480	Anthracosis	MESH:D055008	marker/mechanism		NA		29394417
ATP1B1	481	Essential Hypertension	MESH:D000075222	marker/mechanism		NA	145500	
ATP1B1	481	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
ATP1B1	481	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
ATP1B2	482	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		25129146
ATP1B2	482	Glioma	MESH:D005910	marker/mechanism		NA		16865689
ATP2A1	487	Brody myopathy	MESH:C536607	marker/mechanism		NA	601003	
ATP2A1	487	Heart Failure	MESH:D006333	marker/mechanism		NA		19776660
ATP2A2	488	Cardiomegaly	MESH:D006332	marker/mechanism		NA		11679415
ATP2A2	488	Darier Disease	MESH:D007644	marker/mechanism		NA	101900|124200	16733453|20338123
ATP2A2	488	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		16123366
ATP2A2	488	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		16123366
ATP2A2	488	Diabetic Cardiomyopathies	MESH:D058065	marker/mechanism		NA		16685413
ATP2A2	488	Heart Diseases	MESH:D006331	marker/mechanism		NA		19328205
ATP2A2	488	Heart Failure	MESH:D006333	marker/mechanism		NA		19776660
ATP2A2	488	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		10734148
ATP2A2	488	Myocardial Stunning	MESH:D017682	marker/mechanism		NA		16317512
ATP2A2	488	Status Epilepticus	MESH:D013226	marker/mechanism		NA		15288437
ATP2A2	488	Ventricular Dysfunction, Left	MESH:D018487	therapeutic		NA		21217071
ATP2A3	489	Adenoma	MESH:D000236	marker/mechanism		NA		23913004
ATP2A3	489	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		16123366
ATP2A3	489	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		16123366
ATP2B1	490	Cataract	MESH:D002386	marker/mechanism		NA		15003327
ATP2B1	490	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		22751097
ATP2B1	490	Hypertension	MESH:D006973	marker/mechanism		NA		19430479
ATP2B2	491	Deafness, Autosomal Recessive 12	MESH:C563327	marker/mechanism		NA	601386	
ATP2B3	492	Adenoma	MESH:D000236	marker/mechanism		NA		23416519
ATP2B3	492	Hyperaldosteronism	MESH:D006929	marker/mechanism		NA		23416519
ATP2B3	492	Hypertension	MESH:D006973	marker/mechanism		NA		23416519
ATP2B3	492	Spinocerebellar Ataxia, X-Linked 1	MESH:C563134	marker/mechanism		NA	302500	
ATP2C1	27032	Pemphigus, Benign Familial	MESH:D016506	marker/mechanism		NA	169600	11450592|16621454|20338123
ATP5B	11947	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		25666834
ATP5B	11947	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		25666834
ATP5F1A	498	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		19374891
ATP5F1A	498	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	OMIM:616045	marker/mechanism		NA	616045	
ATP5F1A	498	Endotoxemia	MESH:D019446	marker/mechanism		NA		16741687
ATP5F1A	498	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4	OMIM:615228	marker/mechanism		NA	615228	
ATP5F1B	506	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		25666834
ATP5F1B	506	Hypoxia	MESH:D000860	marker/mechanism		NA		19579223
ATP5F1B	506	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21472284
ATP5F1B	506	Spinocerebellar Ataxia 17	MESH:C564616	marker/mechanism		NA		24413982
ATP5F1D	513	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		26039340
ATP5F1E	514	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3	OMIM:614053	marker/mechanism		NA	614053	
ATP5K	11958	Heart Diseases	MESH:D006331	marker/mechanism		NA		16844662
ATP5PD	10476	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		19381893
ATP5PD	10476	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
ATP5PF	522	Heart Diseases	MESH:D006331	marker/mechanism		NA		16844662
ATP6	4508	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		18273840
ATP6	4508	Glucose Intolerance	MESH:D018149	marker/mechanism		NA		18273840
ATP6	4508	Hypertrophy	MESH:D006984	marker/mechanism		NA		18273840
ATP6	4508	Maternally Inherited Leigh Syndrome	MESH:C536035	marker/mechanism		NA		27129022
ATP6	4508	Neuropathy ataxia and retinitis pigmentosa	MESH:C537396	marker/mechanism		NA	551500	27129022
ATP6	4508	Optic Atrophy, Hereditary, Leber	MESH:D029242	marker/mechanism		NA	535000	
ATP6AP1	537	IMMUNODEFICIENCY 47	OMIM:300972	marker/mechanism		NA	300972	
ATP6AP1	537	Lymphoma, Follicular	MESH:D008224	marker/mechanism		NA		26691987
ATP6AP1L	92270	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
ATP6AP2	10159	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		16759393
ATP6AP2	10159	Fibrosis	MESH:D005355	marker/mechanism		NA		21795644
ATP6AP2	10159	Mental Retardation, X-Linked, with Epilepsy	MESH:C564516	marker/mechanism		NA	300423	
ATP6AP2	10159	PARKINSONISM WITH SPASTICITY, X-LINKED	OMIM:300911	marker/mechanism		NA	300911	
ATP6V0A2	23545	Cutis Laxa, Autosomal Recessive, Type IIA	MESH:C562632	marker/mechanism		NA	219200	
ATP6V0A2	23545	Wrinkly skin syndrome	MESH:C536750	marker/mechanism		NA	278250	18157129
ATP6V0A4	50617	Renal tubular acidosis, distal, autosomal recessive	MESH:C537758	marker/mechanism		NA	602722	
ATP6V0D2	245972	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
ATP6V0D2	245972	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		25279216
ATP6V1A	523	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID	OMIM:617403	marker/mechanism		NA	617403	
ATP6V1B1	525	Renal Tubular Acidosis, Distal, with Progressive Nerve Deafness	MESH:C562897	marker/mechanism		NA	267300	
ATP6V1B2	526	Deafness, Congenital, and Onychodystrophy, Autosomal Dominant	MESH:C567274	marker/mechanism		NA	124480	
ATP6V1B2	526	Lymphoma, Follicular	MESH:D008224	marker/mechanism		NA		26691987
ATP6V1B2	526	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
ATP6V1B2	526	Zimmerman Laband syndrome	MESH:C536725	marker/mechanism		NA	616455	25915598
ATP6V1D	51382	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
ATP6V1D	51382	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ATP6V1E1	529	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC	OMIM:617402	marker/mechanism		NA	617402	
ATP7	32142	Alzheimer Disease	MESH:D000544	therapeutic		NA		23827522
ATP7A	538	Anemia	MESH:D000740	marker/mechanism		NA		23776592
ATP7A	538	Aortic Rupture	MESH:D001019	marker/mechanism		NA		2346371|25449986
ATP7A	538	Ataxia	MESH:D001259	marker/mechanism		NA		22815746
ATP7A	538	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		17510416
ATP7A	538	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		17483305
ATP7A	538	Growth Disorders	MESH:D006130	marker/mechanism		NA		23064757
ATP7A	538	Hemolysis	MESH:D006461	marker/mechanism		NA		25247420
ATP7A	538	Hepatitis, Chronic	MESH:D006521	marker/mechanism		NA		25053573
ATP7A	538	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		24614111
ATP7A	538	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		23792645
ATP7A	538	Menkes Kinky Hair Syndrome	MESH:D007706	marker/mechanism		NA	309400	11092760|11157799|11350187|12221109|12228238|14579150|15923132|16435190|16824500|17003121|17009961|17483305|18779302|20831904|21242307|21667063|22130675|22455587|22664332|22695177|22728746|22815746|22981378|23064757|24627433|25003971|25247420|26199316
ATP7A	538	Neointima	MESH:D058426	marker/mechanism		NA		20671235
ATP7A	538	Neurologic Manifestations	MESH:D009461	marker/mechanism		NA		22815746|23064757
ATP7A	538	Occipital horn syndrome	MESH:C537860	marker/mechanism		NA	304150	
ATP7A	538	Paralysis	MESH:D010243	marker/mechanism		NA		22815746
ATP7A	538	Prenatal Injuries	MESH:D049188	marker/mechanism		NA		25456742
ATP7A	538	Recurrence	MESH:D012008	marker/mechanism		NA		22304828
ATP7A	538	Seizures	MESH:D012640	marker/mechanism		NA		22815746
ATP7A	538	Spinal Muscular Atrophy, Distal, X-Linked 3	MESH:C564506	marker/mechanism		NA	300489	
ATP7A	538	Tremor	MESH:D014202	marker/mechanism		NA		22815746
ATP7A	538	Vascular System Injuries	MESH:D057772	marker/mechanism		NA		20671235
ATP7B	540	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		11802810
ATP7B	540	Carcinoma	MESH:D002277	marker/mechanism		NA		11802810|12216079
ATP7B	540	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		19296535
ATP7B	540	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		11803042|15911138|21146535|21364284
ATP7B	540	Disease Progression	MESH:D018450	marker/mechanism		NA		12216079|12509969|19296535
ATP7B	540	Dyslipidemias	MESH:D050171	marker/mechanism		NA		17303181
ATP7B	540	Fatty Liver	MESH:D005234	marker/mechanism		NA		17303181
ATP7B	540	Hepatitis	MESH:D006505	marker/mechanism		NA		14574444|15135151
ATP7B	540	Hepatolenticular Degeneration	MESH:D006527	marker/mechanism		NA	277900	10686180|10790207|10830865|10982773|11157799|11405812|11472373|11803042|11854914|11985593|12228238|12544487|12820478|14574444|14579150|14998371|15135151|15147237|15911138|16133174|16607473|16824500|16932613|17182432|17276780|17634212|17919502|18371106|18779302|19888908|20647314|21146535|21242307|21364284|21406592|22130675|22455587|22565294|22677543|22802922|22945834|22981378|23235335|23333878|23789284|23843956|23963605|24094725|24892424|25003971|25134866
ATP7B	540	Inflammation	MESH:D007249	marker/mechanism		NA		22945834
ATP7B	540	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		11509115
ATP7B	540	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		25134866
ATP7B	540	Liver Diseases	MESH:D008107	marker/mechanism		NA		21364284
ATP7B	540	Liver Failure, Acute	MESH:D017114	marker/mechanism		NA		25134866
ATP7B	540	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		11509115
ATP7B	540	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		23792645
ATP7B	540	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		12509969
ATP7B	540	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		12216079
ATP7B	540	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		25320179
ATP7B	540	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		12509969
ATP8A2	51761	Dysequilibrium syndrome	MESH:C535731	marker/mechanism		NA	615268	
ATP8B1	5205	Cholestasis, Intrahepatic	MESH:D002780	marker/mechanism		NA		18379143
ATP8B1	5205	Cholestasis, progressive familial intrahepatic 1	MESH:C535933	marker/mechanism		NA	211600|243300	
ATP8B1	5205	Intrahepatic Cholestasis of Pregnancy	MESH:C535932	marker/mechanism		NA	147480	
ATP9B	374868	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		18438686
ATPAF1	64756	Obesity	MESH:D009765	marker/mechanism		NA		20882379
ATPAF2	91647	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1	OMIM:604273	marker/mechanism		NA	604273	
ATPIF1	11983	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462|16316942
ATPIF1	11983	Fatty Liver	MESH:D005234	marker/mechanism		NA		25226513
ATPIF1	11983	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462|16316942
ATPIF1	11983	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462|16316942
ATPSYNBETA	43829	Parkinson Disease	MESH:D010300	marker/mechanism		NA		18353766
ATR	545	CUTANEOUS TELANGIECTASIA AND CANCER SYNDROME, FAMILIAL	OMIM:614564	marker/mechanism		NA	614564	
ATR	545	Pneumoconiosis	MESH:D011009	marker/mechanism		NA		25445010
ATR	545	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		25415046
ATR	545	Seckel syndrome 1	MESH:C537533	marker/mechanism		NA	210600	
ATR	545	Urologic Neoplasms	MESH:D014571	marker/mechanism		NA		23618899
ATRN	8455	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ATRN	8455	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		16860906
ATRX	546	Alpha-Thalassemia Myelodysplasia Syndrome	MESH:C563023	marker/mechanism		NA	300448	
ATRX	546	ATR-X syndrome	MESH:C538258	marker/mechanism		NA	301040	
ATRX	546	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
ATRX	546	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		19291773
ATRX	546	Cryptorchidism	MESH:D003456	marker/mechanism		NA		19291773
ATRX	546	Glioma	MESH:D005910	marker/mechanism		NA		23583981|24705251
ATRX	546	Growth Disorders	MESH:D006130	marker/mechanism		NA		19291773
ATRX	546	Mental retardation-hypotonic facies syndrome, x-linked, 1	MESH:C537457	marker/mechanism		NA	309580	
ATRX	546	Mental Retardation, X-Linked	MESH:D038901	marker/mechanism		NA		19291773
ATRX	546	Myelodysplastic Syndromes	MESH:D009190	marker/mechanism		NA		19157545
ATRX	546	Neuroblastoma	MESH:D009447	marker/mechanism		NA		23334666|26523776
ATRX	546	Neuroendocrine Tumors	MESH:D018358	marker/mechanism		NA		21252315
ATRX	546	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		21252315
ATRX	546	Penile Diseases	MESH:D010409	marker/mechanism		NA		19291773
ATRX	546	Thoracic Diseases	MESH:D013896	marker/mechanism		NA		19291773
ATXN1	6310	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
ATXN1	6310	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		28182653
ATXN1	6310	Retinal Diseases	MESH:D012164	marker/mechanism		NA		28182653
ATXN1	6310	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA	164400	11719269|16122429|17322884|18337722
ATXN10	25814	Spinocerebellar Ataxia 10	MESH:C566874	marker/mechanism		NA	603516	
ATXN1L	342371	Spinocerebellar Ataxias	MESH:D020754	therapeutic		NA		17322884
ATXN2	6311	Amyotrophic Lateral Sclerosis	MESH:D000690	marker/mechanism		NA		27377857
ATXN2	6311	Glaucoma, Open-Angle	MESH:D005902	marker/mechanism		NA		26752265
ATXN2	6311	PARKINSON DISEASE, LATE-ONSET	OMIM:168600	marker/mechanism		NA	168600	
ATXN2	6311	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA	183090	19224595|20065139
ATXN3	4287	Machado-Joseph Disease	MESH:D017827	marker/mechanism		NA	109150	31378764
ATXN3	4287	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		9635424
ATXN7	6314	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
ATXN7	6314	Gait Ataxia	MESH:D020234	marker/mechanism		NA		25664129
ATXN7	6314	Movement Disorders	MESH:D009069	marker/mechanism		NA		25664129
ATXN7	6314	Reflex, Abnormal	MESH:D012021	marker/mechanism		NA		25664129
ATXN7	6314	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
ATXN7	6314	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA	164500	25664129
ATXN7	6314	Vision Disorders	MESH:D014786	marker/mechanism		NA		25664129
ATXN8	724066	Spinocerebellar ataxia 8	MESH:C537307	marker/mechanism		NA	608768	
ATXN8OS	6315	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		12470185
ATXN8OS	6315	PARKINSON DISEASE, LATE-ONSET	OMIM:168600	marker/mechanism		NA	168600	
ATXN8OS	6315	Spinocerebellar ataxia 8	MESH:C537307	marker/mechanism		NA	608768	
AUH	549	3-Methylglutaconic Aciduria, Type I	MESH:C562801	marker/mechanism		NA	250950	
AURKA	6790	Aneuploidy	MESH:D000782	marker/mechanism		NA		24976383
AURKA	6790	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18497064
AURKA	6790	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
AURKA	6790	Chromosomal Instability	MESH:D043171	marker/mechanism		NA		24976383
AURKA	6790	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	114500	24976383
AURKA	6790	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		18497064
AURKA	6790	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12124350
AURKA	6790	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
AURKA	6790	Neuroblastoma	MESH:D009447	marker/mechanism		NA		22588779
AURKA	6790	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		20864405
AURKA	6790	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17898866
AURKB	9212	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
AURKB	9212	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		25133636
AURKB	9212	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		15993841
AURKC	6795	Infertility, Male	MESH:D007248	marker/mechanism		NA		17435757
AURKC	6795	Male Infertility with Large-Headed, Multiflagellar, Polyploid Spermatozoa	MESH:C562903	marker/mechanism		NA	243060	
AUTS2	26053	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		30718926
AUTS2	26053	Epilepsy	MESH:D004827	marker/mechanism		NA		20502679
AUTS2	26053	MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	OMIM:615834	marker/mechanism		NA	615834	
AVEN	57099	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		15496427
AVL9	23080	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
AVP	551	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		2139164
AVP	551	Amnesia	MESH:D000647	therapeutic		NA		7562510
AVP	551	Angina Pectoris	MESH:D000787	marker/mechanism		NA		11128043|11791009
AVP	551	Arrhythmias, Cardiac	MESH:D001145	marker/mechanism		NA		6983645
AVP	551	Autistic Disorder	MESH:D001321	marker/mechanism		NA		8570775
AVP	551	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		12145768
AVP	551	Dehydration	MESH:D003681	therapeutic		NA		2554359
AVP	551	Diabetes Insipidus	MESH:D003919	marker/mechanism		NA		15169711|6945054
AVP	551	Diabetes Insipidus, Neurogenic	MESH:D020790	marker/mechanism		NA	125700	7057320
AVP	551	Drug Overdose	MESH:D062787	therapeutic		NA		11914425
AVP	551	Dysmenorrhea	MESH:D004412	marker/mechanism		NA		10440088
AVP	551	Gastrointestinal Hemorrhage	MESH:D006471	therapeutic		NA		6983645
AVP	551	Heart Failure	MESH:D006333	marker/mechanism		NA		18179782
AVP	551	Hyperalgesia	MESH:D006930	marker/mechanism		NA		9613798
AVP	551	Hypertension	MESH:D006973	marker/mechanism		NA		1663982|19133994|3346065|4040330|6367368
AVP	551	Hypertension, Portal	MESH:D006975	therapeutic		NA		6696534
AVP	551	Hyponatremia	MESH:D007010	marker/mechanism		NA		6920297
AVP	551	Hypotension	MESH:D007022	therapeutic		NA		11171655|12019395|17357383|2485266|3544871
AVP	551	Inappropriate ADH Syndrome	MESH:D007177	marker/mechanism		NA		112579|6920297
AVP	551	Ischemia	MESH:D007511	marker/mechanism		NA		10440088|2139164
AVP	551	Memory Disorders	MESH:D008569	therapeutic		NA		11553362
AVP	551	Pain	MESH:D010146	therapeutic		NA		2271928|6094376
AVP	551	Polyuria	MESH:D011141	therapeutic		NA		11012637
AVP	551	Psychotic Disorders	MESH:D011618	marker/mechanism		NA		3567260
AVP	551	Schizophrenia	MESH:D012559	marker/mechanism		NA		3567260
AVP	551	Shock	MESH:D012769	therapeutic		NA		10570779
AVP	551	Shy-Drager Syndrome	MESH:D012791	marker/mechanism		NA		6850280
AVP	551	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		2832203
AVP	551	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		4040330
AVPI1	60370	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
AVPR1A	552	Adrenal Hyperplasia, Congenital	MESH:D000312	marker/mechanism		NA		17218722
AVPR1A	552	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		20546835
AVPR1A	552	Autistic Disorder	MESH:D001321	marker/mechanism		NA		16520824
AVPR2	554	Adrenal Hyperplasia, Congenital	MESH:D000312	marker/mechanism		NA		17218722
AVPR2	554	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		12145768
AVPR2	554	Diabetes Insipidus, Nephrogenic	MESH:D018500	marker/mechanism		NA	304800	12414899|14998935|19703807|19729836|20374732
AVPR2	554	Genetic Diseases, X-Linked	MESH:D040181	marker/mechanism		NA		19703807
AVPR2	554	Growth Disorders	MESH:D006130	marker/mechanism		NA		19703807
AVPR2	554	Heart Failure	MESH:D006333	marker/mechanism		NA		12145768
AVPR2	554	Nephrogenic Syndrome of Inappropriate Antidiuresis	MESH:C564491	marker/mechanism		NA	300539	
AVPR2	554	Oliguria	MESH:D009846	marker/mechanism		NA		7977526
AXIN1	8312	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA	114550	25822088
AXIN1	8312	Caudal Duplication Anomaly	MESH:C564315	marker/mechanism		NA	607864	
AXIN2	8313	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		29394407
AXIN2	8313	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		21188121
AXIN2	8313	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	114500	
AXIN2	8313	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		29394407
AXIN2	8313	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		29394407
AXIN2	8313	Oligodontia-Colorectal Cancer Syndrome	MESH:C563898	marker/mechanism		NA	608615	
AXIN2	8313	Ventricular Remodeling	MESH:D020257	marker/mechanism		NA		29394407
AXL	558	Carcinoma, Non-Small-Cell Lung	MESH:D002289	therapeutic		NA		22751098
AXL	558	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		12644472
AXL	558	Idiopathic Hypogonadotropic Hypogonadism	MESH:C562785	marker/mechanism		NA	146110	
AXL	558	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		25551830
AXL	558	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
AXL	558	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		26206560
AXL	558	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		26206560
AXL	558	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		26206560
AXL	558	Neurilemmoma	MESH:D009442	marker/mechanism		NA		25551830
AXL	558	Neurofibroma, Plexiform	MESH:D018318	marker/mechanism		NA		25551830
AXL	558	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		26206560
AZGP1	563	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		18978557
AZGP1	563	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		18978557
AZGP1	563	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
AZGP1	563	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17173048
AZGP1	563	Sinusitis	MESH:D012852	marker/mechanism		NA		18391768
B2M	567	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		22005293|2689182|28885000
B2M	567	Amyloidosis, familial visceral	MESH:C538249	marker/mechanism		NA	105200	
B2M	567	Autoimmune Diseases	MESH:D001327	therapeutic		NA		21793797
B2M	567	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		28885000
B2M	567	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
B2M	567	Heart Diseases	MESH:D006331	marker/mechanism		NA		16844662
B2M	567	Hypergammaglobulinemia	MESH:D006942	therapeutic		NA		21793797
B2M	567	Hypoproteinemia, Hypercatabolic	MESH:C565476	marker/mechanism		NA	241600	
B2M	567	Kidney Diseases	MESH:D007674	marker/mechanism		NA		17303580|2202081|24863737
B2M	567	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		7688627
B2M	567	Lymphoma, T-Cell, Peripheral	MESH:D016411	marker/mechanism		NA		24413734
B2M	567	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17404077
B3GALNT2	148789	Walker-Warburg Syndrome	MESH:D058494	marker/mechanism		NA	615181	
B3GALT6	126792	Ehlers-Danlos syndrome, progeroid form	MESH:C536201	marker/mechanism		NA	615349	
B3GALT6	126792	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES	OMIM:271640	marker/mechanism		NA	271640	
B3GAT1	27087	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		24211274
B3GAT1	27087	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
B3GAT3	26229	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		16759393
B3GAT3	26229	MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	OMIM:245600	marker/mechanism		NA	245600	
B3GLCT	145173	Krause-Kivlin syndrome	MESH:C537617	marker/mechanism		NA	261540	16909395
B3GNT2	10678	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		22446963
B3GNT2	10678	Graves Disease	MESH:D006111	marker/mechanism		NA		22446963
B3GNT9	84752	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		17379860
B4GALNT1	2583	Spastic paraplegia 26, autosomal recessive	MESH:C536862	marker/mechanism		NA	609195	
B4GALT1	2683	Congenital disorder of glycosylation type 2D	MESH:C535753	marker/mechanism		NA	607091	
B4GALT4	8702	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
B4GALT5	9334	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
B4GALT5	9334	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
B4GALT7	11285	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		16759393
B4GALT7	11285	Ehlers-Danlos syndrome, progeroid form	MESH:C536201	marker/mechanism		NA	130070	
B4GAT1	11041	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
B4GAT1	11041	Walker-Warburg Syndrome	MESH:D058494	marker/mechanism		NA	615287	
B9D1	27077	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
B9D1	27077	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
BAALC	79870	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		19822134
BAAT	570	Hypercholanemia, Familial	MESH:C564336	marker/mechanism		NA	607748	
BABAM1	29086	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		20852633
BACE1	23621	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		16407166
BACH2	60468	Celiac Disease	MESH:D002446	marker/mechanism		NA		20190752
BACH2	60468	Crohn Disease	MESH:D003424	marker/mechanism		NA		21102463
BACH2	60468	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		18978792
BACH2	60468	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		21441929
BACH2	60468	Vitiligo	MESH:D014820	marker/mechanism		NA		22561518
BAD	572	Ischemic Attack, Transient	MESH:D002546	marker/mechanism		NA		12629175
BAD	572	Leukemia	MESH:D007938	marker/mechanism		NA		12970779
BAD	572	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17542986|19593445
BAG1	573	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19066611
BAG1	573	Carcinoma, Ductal, Breast	MESH:D018270	marker/mechanism		NA		19066611
BAG3	9531	CARDIOMYOPATHY, DILATED, 1HH	OMIM:613881	marker/mechanism		NA	613881	
BAG3	9531	HIV Infections	MESH:D015658	marker/mechanism		NA		17187345
BAG3	9531	Myofibrillar Myopathy	MESH:C580316	marker/mechanism		NA	612954	
BAG5	9529	Parkinson Disease	MESH:D010300	marker/mechanism		NA		28348719
BAIAP2L1	55971	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		17568789
BAK1	578	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		18349538
BAK1	578	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		28100771
BAK1	578	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		29122578
BAK1	578	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		19740541
BAMBI	25805	Cardiomegaly	MESH:D006332	marker/mechanism		NA		29394407
BAMBI	25805	Heart Failure	MESH:D006333	marker/mechanism		NA		29394407
BAMBI	25805	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		30097701
BANF1	8815	NESTOR-GUILLERMO PROGERIA SYNDROME	OMIM:614008	marker/mechanism		NA	614008	
BANK1	55024	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		18204447
BAP1	8314	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		25231345
BAP1	8314	Adrenocortical Carcinoma	MESH:D018268	marker/mechanism		NA		25231345
BAP1	8314	Bone Neoplasms	MESH:D001859	marker/mechanism		NA		25231345
BAP1	8314	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25231345|26719535
BAP1	8314	Carcinoma, Basal Cell	MESH:D002280	marker/mechanism		NA		26719535
BAP1	8314	Carcinoma, Mucoepidermoid	MESH:D018277	marker/mechanism		NA		25231345
BAP1	8314	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		22138691|22683710|23797736|25231345
BAP1	8314	Central Nervous System Neoplasms	MESH:D016543	marker/mechanism		NA		25231345
BAP1	8314	Cholangiocarcinoma	MESH:D018281	marker/mechanism		NA		24185509|25231345
BAP1	8314	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		25231345
BAP1	8314	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		24928783
BAP1	8314	Head and Neck Neoplasms	MESH:D006258	marker/mechanism		NA		25231345
BAP1	8314	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		26719535
BAP1	8314	Leukemia	MESH:D007938	marker/mechanism		NA		25231345
BAP1	8314	Lipoma	MESH:D008067	marker/mechanism		NA		25231345
BAP1	8314	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		25231345
BAP1	8314	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		26719535
BAP1	8314	Melanoma, Cutaneous Malignant	MESH:C562393	marker/mechanism		NA		25231345|26719535
BAP1	8314	Meningioma	MESH:D008579	marker/mechanism		NA		25231345
BAP1	8314	Mesothelioma	MESH:D008654	marker/mechanism		NA		21642991|21874000|26119930|26719535
BAP1	8314	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		24928783|25231345|26463840|26928227|29112861
BAP1	8314	Nasopharyngeal Carcinoma	MESH:D000077274	marker/mechanism		NA		24952746
BAP1	8314	Neuroendocrine Tumors	MESH:D018358	marker/mechanism		NA		25231345
BAP1	8314	Nevi and Melanomas	MESH:D018326	marker/mechanism		NA		21874003
BAP1	8314	Nevus, Epithelioid and Spindle Cell	MESH:D018332	marker/mechanism		NA		25231345
BAP1	8314	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		25231345
BAP1	8314	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		25231345
BAP1	8314	Paraganglioma	MESH:D010235	marker/mechanism		NA		25231345
BAP1	8314	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		25231345
BAP1	8314	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		25231345|26719535
BAP1	8314	Testicular Neoplasms	MESH:D013736	marker/mechanism		NA		25231345
BAP1	8314	Thymoma	MESH:D013945	marker/mechanism		NA		24974848
BAP1	8314	TUMOR PREDISPOSITION SYNDROME	OMIM:614327	marker/mechanism		NA	614327	
BAP1	8314	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		25231345
BAP1	8314	Uterine Neoplasms	MESH:D014594	marker/mechanism		NA		25231345
BAP1	8314	Uveal melanoma	MESH:C536494	marker/mechanism		NA		21874000|25231345|26719535
BARD1	580	Breast Neoplasms	MESH:D001943	marker/mechanism		NA	114480	
BARD1	580	Neuroblastoma	MESH:D009447	marker/mechanism		NA		19412175|23334666
BARX1	56033	Adenocarcinoma Of Esophagus	MESH:C562730	marker/mechanism		NA		24121790
BASP1	10409	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
BASP1	10409	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
BASP1	10409	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
BATF2	116071	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
BATF3	55509	Leprosy	MESH:D007918	marker/mechanism		NA		25642632
BAX	581	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		20623750
BAX	581	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		18077176
BAX	581	Breast Neoplasms	MESH:D001943	therapeutic		NA		22572619
BAX	581	Cerebral Hemorrhage	MESH:D002543	marker/mechanism		NA		12721362
BAX	581	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		17906064
BAX	581	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		17404573
BAX	581	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	114500	
BAX	581	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		23090186
BAX	581	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		31626838
BAX	581	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		17634542
BAX	581	HIV Infections	MESH:D015658	marker/mechanism		NA		12878215
BAX	581	Infertility, Male	MESH:D007248	marker/mechanism		NA		24723216
BAX	581	Intestinal Neoplasms	MESH:D007414	marker/mechanism		NA		12663524
BAX	581	Ischemia	MESH:D007511	marker/mechanism		NA		15172883
BAX	581	Lymphoma, T-Cell, Cutaneous	MESH:D016410	marker/mechanism		NA		12754746
BAX	581	Microsatellite Instability	MESH:D053842	marker/mechanism		NA		25701956
BAX	581	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		20079142|25450231
BAX	581	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		20026869
BAX	581	Nerve Degeneration	MESH:D009410	therapeutic		NA		20385067
BAX	581	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21062263
BAX	581	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA	613065	
BAX	581	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17542986
BAZ1B	9031	Williams Syndrome	MESH:D018980	marker/mechanism		NA		16448863
BAZ2A	11176	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		25485837
BBC3	27113	Brain Ischemia	MESH:D002545	marker/mechanism		NA		19095966
BBC3	27113	Burkitt Lymphoma	MESH:D002051	marker/mechanism		NA		18573879
BBC3	27113	Esophageal Neoplasms	MESH:D004938	therapeutic		NA		16481741
BBC3	27113	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		28100771
BBIP1	92482	BARDET-BIEDL SYNDROME 18	OMIM:615995	marker/mechanism		NA	615995	
BBOF1	80127	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
BBOX1	8424	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
BBS1	582	Bardet-Biedl syndrome 1	MESH:C537909	marker/mechanism		NA	209900	
BBS10	79738	Bardet-Biedl Syndrome 10	MESH:C565919	marker/mechanism		NA	615987	
BBS12	166379	Bardet-Biedl Syndrome 12	MESH:C565921	marker/mechanism		NA	615989	
BBS2	583	Bardet-Biedl syndrome 2	MESH:C537910	marker/mechanism		NA	615981	
BBS2	583	RETINITIS PIGMENTOSA 74	OMIM:616562	marker/mechanism		NA	616562	
BBS4	585	Bardet-Biedl syndrome 4	MESH:C537912	marker/mechanism		NA	615982	
BBS5	129880	BARDET-BIEDL SYNDROME 5	OMIM:615983	marker/mechanism		NA	615983	
BBS7	55212	Bardet-Biedl Syndrome 7	MESH:C565916	marker/mechanism		NA	615984	
BBS7	55212	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
BBS9	27241	Bardet-Biedl Syndrome 9	MESH:C565918	marker/mechanism		NA	615986	
BBS9	27241	Craniosynostoses	MESH:D003398	marker/mechanism		NA		23160099
BCAP31	10134	Contiguous Abcd1-Dxs1375e Deletion Syndrome	MESH:C564508	marker/mechanism		NA	300475	
BCAR1	9564	Carcinoma, Ductal	MESH:D044584	marker/mechanism		NA		29295717
BCAR1	9564	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		21291860
BCAR1	9564	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		26098869
BCAR1	9564	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29295717
BCAR3	8412	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19075277
BCAR3	8412	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
BCAR4	400500	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20859285|21506106
BCAS1	8537	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
BCAS1	8537	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		15583422
BCAS2	10286	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		27356265
BCAT1	586	Cholestasis	MESH:D002779	marker/mechanism		NA		27989131
BCAT1	586	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
BCAT2	587	Maple Syrup Urine Disease	MESH:D008375	marker/mechanism		NA		14755340
BCAT2	587	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		19233941
BCHE	590	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		23022600
BCHE	590	Apnea	MESH:D001049	marker/mechanism|therapeutic		NA		1058931|12392308|12881446|15826794|1734774|21029050|25054547|38703|4319258|4347326|4698763|4728581|4746059|4850696|4959505|4998912|5365519|5412891|5488351|5667302|6039104|6465587|6859614|6928942|7069741|726855|7378868|7788839|7793179|900467|987736
BCHE	590	Bamforth syndrome	MESH:C537901	marker/mechanism		NA		16884476
BCHE	590	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		23063927
BCHE	590	Butyrylcholinesterase deficiency	MESH:C537417	marker/mechanism		NA		12881446|16788378|18075469|25054547|9110359
BCHE	590	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		18482720
BCHE	590	Cardiotoxicity	MESH:D066126	therapeutic		NA		26145887
BCHE	590	Cocaine-Related Disorders	MESH:D019970	therapeutic		NA		18292872|18514640|20060817|20971807|22935511|22960160|23000451|25814464
BCHE	590	Cognition Disorders	MESH:D003072	marker/mechanism|therapeutic		NA		12003252|20513442
BCHE	590	Death	MESH:D003643	therapeutic		NA		18597747
BCHE	590	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		3111302
BCHE	590	Epilepsy, Tonic-Clonic	MESH:D004830	marker/mechanism		NA		15121994
BCHE	590	Fasciculation	MESH:D005207	marker/mechanism		NA		6465587
BCHE	590	Glioblastoma	MESH:D005909	marker/mechanism		NA		2317787
BCHE	590	Hyperkinesis	MESH:D006948	therapeutic		NA		12019200
BCHE	590	Hypertriglyceridemia	MESH:D015228	marker/mechanism		NA		23000450
BCHE	590	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		20122907
BCHE	590	Muscular Dystrophies	MESH:D009136	marker/mechanism		NA		22906800
BCHE	590	Neuroblastoma	MESH:D009447	marker/mechanism		NA		2317787
BCHE	590	Neurotoxicity Syndromes	MESH:D020258	therapeutic		NA		21620937
BCHE	590	Obesity	MESH:D009765	marker/mechanism|therapeutic		NA		18452903|23000450|23073171|27163854
BCHE	590	Organophosphate Poisoning	MESH:D062025	marker/mechanism|therapeutic		NA		22981459|22982776|23044488|23123253|23178380|23220586|26239905|31201777
BCHE	590	Paralysis	MESH:D010243	marker/mechanism		NA		1218179|122883|1734774|21228368|4319258|4347326|4362560|4728581|5021954|910611
BCHE	590	Paresis	MESH:D010291	marker/mechanism		NA		2249680
BCHE	590	Parkinson Disease, Secondary	MESH:D010302	marker/mechanism		NA		30410011
BCHE	590	Poisoning	MESH:D011041	therapeutic		NA		20176007|20513442|21620937|21683774|29183815
BCHE	590	Postoperative Complications	MESH:D011183	marker/mechanism		NA		6039104
BCHE	590	Seizures	MESH:D012640	therapeutic		NA		18597747|20971807|8667461
BCHE	590	Sleep Apnea Syndromes	MESH:D012891	marker/mechanism		NA		18555211
BCHE	590	Tachycardia	MESH:D013610	therapeutic		NA		18597747
BCHE	590	Trismus	MESH:D014313	marker/mechanism		NA		7378868
BCKDHA	593	Maple Syrup Urine Disease	MESH:D008375	marker/mechanism		NA	248600	
BCKDHB	594	Maple Syrup Urine Disease	MESH:D008375	marker/mechanism		NA	248600	
BCKDK	10295	BRANCHED-CHAIN KETO ACID DEHYDROGENASE KINASE DEFICIENCY	OMIM:614923	marker/mechanism		NA	614923	
BCL10	8915	IMMUNODEFICIENCY 37	OMIM:616098	marker/mechanism		NA	616098	
BCL10	8915	Lymphoma, B-Cell, Marginal Zone	MESH:D018442	marker/mechanism		NA	137245	
BCL10	8915	Lymphoma, Non-Hodgkin	MESH:D008228	marker/mechanism		NA	605027	
BCL10	8915	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA	156240	
BCL10	8915	Testicular Germ Cell Tumor	MESH:C563236	marker/mechanism		NA	273300	
BCL11A	53335	Apraxias	MESH:D001072	marker/mechanism		NA		27120335
BCL11A	53335	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
BCL11A	53335	INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	OMIM:617101	marker/mechanism		NA	617101	
BCL11A	53335	Language Development Disorders	MESH:D007805	marker/mechanism		NA		27120335
BCL11A	53335	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
BCL11A	53335	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
BCL11B	64919	IMMUNODEFICIENCY 49	OMIM:617237	marker/mechanism		NA	617237	
BCL11B	64919	Lymphoma	MESH:D008223	marker/mechanism		NA		17941976
BCL11B	64919	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054218	marker/mechanism		NA		20972433
BCL2	596	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		21472143
BCL2	596	Adenocarcinoma, Clear Cell	MESH:D018262	marker/mechanism		NA		9754764
BCL2	596	Adenoma	MESH:D000236	marker/mechanism		NA		10223192|10426811
BCL2	596	AIDS-related Kaposi sarcoma	MESH:C554498	marker/mechanism		NA		10861090
BCL2	596	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		18077176
BCL2	596	Asthma	MESH:D001249	marker/mechanism		NA		18357729
BCL2	596	Autistic Disorder	MESH:D001321	marker/mechanism		NA		11814262|20375269
BCL2	596	Azoospermia	MESH:D053713	marker/mechanism		NA		20610805
BCL2	596	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		12517783|16954440|23621182
BCL2	596	Carcinoma	MESH:D002277	marker/mechanism		NA		10426811
BCL2	596	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22666341|2543982|2848196
BCL2	596	Cerebral Hemorrhage	MESH:D002543	marker/mechanism		NA		12721362
BCL2	596	Chondrosarcoma, Mesenchymal	MESH:D018211	marker/mechanism		NA		12817616
BCL2	596	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		10223192|17404573|19147571
BCL2	596	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18949393
BCL2	596	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		16033404
BCL2	596	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
BCL2	596	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		16959961|23090186
BCL2	596	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		16959961|31626838
BCL2	596	Disease Progression	MESH:D018450	marker/mechanism		NA		16081686|21750559
BCL2	596	Erectile Dysfunction	MESH:D007172	marker/mechanism		NA		12394778
BCL2	596	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		21472143
BCL2	596	Gallbladder Neoplasms	MESH:D005706	therapeutic		NA		16904648
BCL2	596	Head and Neck Neoplasms	MESH:D006258	marker/mechanism		NA		18566236
BCL2	596	Hypertension	MESH:D006973	marker/mechanism		NA		10075388
BCL2	596	Infertility, Male	MESH:D007248	marker/mechanism		NA		24723216
BCL2	596	Intestinal Neoplasms	MESH:D007414	marker/mechanism		NA		10223192
BCL2	596	Learning Disabilities	MESH:D007859	marker/mechanism		NA		17967740
BCL2	596	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		21750559|23770605
BCL2	596	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		23906301
BCL2	596	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		23274713
BCL2	596	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		10426811|28100771
BCL2	596	Lymphoma, Follicular	MESH:D008224	marker/mechanism		NA		12855623|3287162
BCL2	596	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		16081686
BCL2	596	Lymphoma, Non-Hodgkin	MESH:D008228	marker/mechanism		NA		26239085|3287162
BCL2	596	Memory Disorders	MESH:D008569	marker/mechanism		NA		17967740
BCL2	596	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		16850164
BCL2	596	Metaplasia	MESH:D008679	marker/mechanism		NA		12704018
BCL2	596	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		12429644
BCL2	596	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		19027736
BCL2	596	Necrosis	MESH:D009336	therapeutic		NA		11781163|16532269
BCL2	596	Nerve Degeneration	MESH:D009410	marker/mechanism|therapeutic		NA		11146106|17967740
BCL2	596	Osteochondrodysplasias	MESH:D010009	marker/mechanism		NA		17954590
BCL2	596	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21062263
BCL2	596	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054218	marker/mechanism		NA		23471820
BCL2	596	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
BCL2	596	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16733517
BCL2	596	Reperfusion Injury	MESH:D015427	therapeutic		NA		15449323
BCL2	596	Retinal Degeneration	MESH:D012162	therapeutic		NA		8692941
BCL2	596	Sarcoma, Synovial	MESH:D013584	therapeutic		NA		16450387
BCL2	596	Soft Tissue Neoplasms	MESH:D012983	therapeutic		NA		16450387
BCL2A1	597	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		19192274
BCL2A1	597	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037|17659439
BCL2A1	597	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		17634542
BCL2A1D	12047	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
BCL2L1	598	Adenoma	MESH:D000236	marker/mechanism		NA		10426811
BCL2L1	598	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
BCL2L1	598	Carcinoma	MESH:D002277	marker/mechanism		NA		10426811
BCL2L1	598	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism|therapeutic		NA		10629087|11509945
BCL2L1	598	Cerebral Hemorrhage	MESH:D002543	marker/mechanism		NA		12721362
BCL2L1	598	Cryptorchidism	MESH:D003456	marker/mechanism		NA		26050606
BCL2L1	598	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		16959961
BCL2L1	598	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		16959961
BCL2L1	598	Erectile Dysfunction	MESH:D007172	marker/mechanism		NA		12394778
BCL2L1	598	Head and Neck Neoplasms	MESH:D006258	marker/mechanism		NA		18566236
BCL2L1	598	Hearing Loss	MESH:D034381	therapeutic		NA		17697574
BCL2L1	598	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
BCL2L1	598	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		10426811|28100771
BCL2L1	598	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		16007126
BCL2L1	598	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		12429644
BCL2L1	598	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		20079142
BCL2L1	598	Neurotoxicity Syndromes	MESH:D020258	marker/mechanism		NA		19784758
BCL2L1	598	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		16904634
BCL2L1	598	Stomach Neoplasms	MESH:D013274	therapeutic		NA		26401016
BCL2L11	10018	Cholangitis, Sclerosing	MESH:D015209	marker/mechanism		NA		21151127
BCL2L11	10018	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28869590
BCL2L11	10018	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
BCL3	602	Atherosclerosis	MESH:D050197	marker/mechanism		NA		25374339
BCL3	602	Dyslipidemias	MESH:D050171	marker/mechanism		NA		29670124
BCL6	604	Lymphoma, Non-Hodgkin	MESH:D008228	marker/mechanism		NA		25543051
BCL6	604	Lymphoma, T-Cell	MESH:D016399	marker/mechanism		NA		15375218
BCL7C	9274	Ependymoma	MESH:D004806	marker/mechanism		NA		26075792
BCL9	607	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		22024689
BCLAF1	9774	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941189
BCO1	53630	Hypercarotenemia And Vitamin A Deficiency, Autosomal Dominant	MESH:C567296	marker/mechanism		NA	115300	
BCO2	83875	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
BCOR	54880	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
BCOR	54880	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		26098867
BCOR	54880	Microphthalmia, syndromic 1	MESH:C537464	marker/mechanism		NA	309800	
BCOR	54880	Microphthalmia, syndromic 2	MESH:C537465	marker/mechanism		NA	300166	17517692
BCOR	54880	Osteosarcoma	MESH:D012516	marker/mechanism		NA		22387997
BCOR	54880	Rhabdomyosarcoma, Embryonal	MESH:D018233	marker/mechanism		NA		29376028
BCOR	54880	Sarcoma, Clear Cell	MESH:D018227	marker/mechanism		NA		26098867
BCOR	54880	Wilms Tumor	MESH:D009396	marker/mechanism		NA		28825729
BCORL1	63035	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
BCORL1	63035	Wilms Tumor	MESH:D009396	marker/mechanism		NA		28825729
BCR	613	Blast Crisis	MESH:D001752	marker/mechanism		NA		21570118
BCR	613	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	MESH:D015464	marker/mechanism		NA	608232	15604220|18673174|21908430
BCR	613	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
BCR	613	Myeloproliferative Disorders	MESH:D009196	marker/mechanism		NA		22875613
BCR	613	Necrosis	MESH:D009336	marker/mechanism		NA		23211037
BCR	613	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		19878872
BCR	613	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA	613065	
BCRP3	644165	Thrombosis	MESH:D013927	marker/mechanism		NA		16932337
BCS1L	617	Bjornstad syndrome	MESH:C537633	marker/mechanism		NA	262000	
BCS1L	617	Finnish lethal neonatal metabolic syndrome	MESH:C537934	marker/mechanism		NA	603358	
BCS1L	617	Leigh Disease	MESH:D007888	marker/mechanism		NA	256000	
BCS1L	617	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	OMIM:124000	marker/mechanism		NA	124000	
BDH1	622	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
BDH1	622	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980|25380136
BDKRB1	623	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		21430409
BDKRB1	623	Epilepsy, Temporal Lobe	MESH:D004833	marker/mechanism		NA		15196965
BDKRB1	623	Hyperalgesia	MESH:D006930	marker/mechanism		NA		17989505|19300402|19815945
BDKRB1	623	Inflammation	MESH:D007249	marker/mechanism		NA		20152050
BDKRB1	623	Pain	MESH:D010146	marker/mechanism		NA		20152050
BDKRB1	623	Splenomegaly	MESH:D013163	marker/mechanism		NA		20096676
BDKRB1	623	Vascular System Injuries	MESH:D057772	marker/mechanism		NA		16982965
BDKRB2	624	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		24975837
BDKRB2	624	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		12833524
BDKRB2	624	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		10614985
BDKRB2	624	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		30685357
BDKRB2	624	Dermatitis, Occupational	MESH:D009783	marker/mechanism		NA		30685357
BDKRB2	624	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		30685357
BDKRB2	624	Epilepsy, Temporal Lobe	MESH:D004833	therapeutic		NA		15196965
BDKRB2	624	Extravasation of Diagnostic and Therapeutic Materials	MESH:D005119	marker/mechanism		NA		9622145
BDKRB2	624	Hemorrhage	MESH:D006470	marker/mechanism		NA		16514058
BDKRB2	624	Hyperalgesia	MESH:D006930	marker/mechanism		NA		17989505|19300402|19815945
BDKRB2	624	Hyperemia	MESH:D006940	marker/mechanism		NA		11837250
BDKRB2	624	Hypertension	MESH:D006973	marker/mechanism		NA		10614985
BDKRB2	624	Hypotension	MESH:D007022	marker/mechanism		NA		1334354|16321614
BDKRB2	624	Inflammation	MESH:D007249	marker/mechanism		NA		20152050
BDKRB2	624	Pain	MESH:D010146	marker/mechanism		NA		20152050
BDKRB2	624	Thrombosis	MESH:D013927	marker/mechanism		NA		16514058
BDKRB2	624	Vascular System Injuries	MESH:D057772	marker/mechanism		NA		16982965
BDNF	627	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		17344400
BDNF	627	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		20736000
BDNF	627	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		24781735
BDNF	627	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17349978|20662941
BDNF	627	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		14708030|19018715
BDNF	627	Body Weight	MESH:D001835	marker/mechanism		NA		22344219|22344221
BDNF	627	Brain Injuries	MESH:D001930	marker/mechanism|therapeutic		NA		15500971|21269288
BDNF	627	Brain Ischemia	MESH:D002545	marker/mechanism		NA		19922383
BDNF	627	Cocaine-Related Disorders	MESH:D019970	marker/mechanism|therapeutic		NA		14973246|17618281|17651427|18311559|19321768|20711185|20810894
BDNF	627	Deafness	MESH:D003638	therapeutic		NA		18607918|19365690
BDNF	627	Depressive Disorder	MESH:D003866	marker/mechanism|therapeutic		NA		16330021|21945287
BDNF	627	Epilepsy	MESH:D004827	marker/mechanism		NA		15282290
BDNF	627	Epilepsy, Tonic-Clonic	MESH:D004830	marker/mechanism		NA		16023256
BDNF	627	Gliosis	MESH:D005911	therapeutic		NA		21087489
BDNF	627	Heroin Dependence	MESH:D006556	marker/mechanism		NA		17715210
BDNF	627	Hypoxia	MESH:D000860	marker/mechanism		NA		16553631
BDNF	627	Inflammation	MESH:D007249	therapeutic		NA		21087489
BDNF	627	Intellectual Disability	MESH:D008607	marker/mechanism		NA		11357950
BDNF	627	Nerve Degeneration	MESH:D009410	marker/mechanism|therapeutic		NA		15372491|19457078|19686240|8921280|8978711
BDNF	627	Nervous System Diseases	MESH:D009422	therapeutic		NA		22240983
BDNF	627	Obesity, Morbid	MESH:D009767	marker/mechanism		NA		21708048
BDNF	627	Parkinson Disease	MESH:D010300	marker/mechanism		NA		19276553
BDNF	627	Psychotic Disorders	MESH:D011618	marker/mechanism		NA		14708030
BDNF	627	Schizophrenia	MESH:D012559	marker/mechanism		NA		12951204|14708030|17442489|18408624
BDNF	627	Seizures	MESH:D012640	marker/mechanism|therapeutic		NA		15781040|21269288|9073163
BDNF	627	Status Epilepticus	MESH:D013226	marker/mechanism		NA		8635431|8821376
BDNF	627	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
BDNF	627	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		12574402
BDNF	627	TOBACCO ADDICTION, SUSCEPTIBILITY TO	OMIM:188890	marker/mechanism		NA		20418890
BDNF	627	Tobacco Use Disorder	MESH:D014029	marker/mechanism		NA		17186223
BEAN1	146227	Spinocerebellar Ataxia 31	MESH:C566146	marker/mechanism		NA	117210	
BECN1	8678	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		20876807
BECN1	8678	Lewy Body Disease	MESH:D020961	marker/mechanism		NA		19628769
BECN1	8678	Lung Neoplasms	MESH:D008175	therapeutic		NA		22481206|23790316
BECN1	8678	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		20079142
BECN1	8678	Spinal Cord Injuries	MESH:D013119	marker/mechanism		NA		29793971
BECN1	8678	Status Epilepticus	MESH:D013226	marker/mechanism		NA		19138675
BEGAIN	57596	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
BEND2	139105	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
BEST1	7439	BESTROPHINOPATHY, AUTOSOMAL RECESSIVE	OMIM:611809	marker/mechanism		NA	611809	
BEST1	7439	RETINITIS PIGMENTOSA 50	OMIM:613194	marker/mechanism		NA	613194	
BEST1	7439	Vitelliform Macular Dystrophy	MESH:D057826	marker/mechanism		NA	153700	
BEST1	7439	Vitreoretinochoroidopathy	MESH:C536352	marker/mechanism		NA	193220	
BEST3	144453	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
BEX4	56271	Cholestasis	MESH:D002779	marker/mechanism		NA		27989131
BFSP1	631	Cataract, Cortical, Juvenile-Onset	MESH:C566955	marker/mechanism		NA	611391	
BFSP2	8419	Cataract, Autosomal Dominant, Multiple Types 1	MESH:C566909	marker/mechanism		NA	611597	
BGLAP	632	Asthma	MESH:D001249	marker/mechanism		NA		8429434
BGLAP	632	Calcinosis	MESH:D002114	marker/mechanism		NA		21335463
BGLAP	632	Heart Valve Diseases	MESH:D006349	marker/mechanism		NA		21335463
BGLAP	632	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		14666681
BGN	633	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		15292528
BGN	633	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
BGN	633	MEESTER-LOEYS SYNDROME	OMIM:300989	marker/mechanism		NA	300989	
BGN	633	Spondyloepimetaphyseal Dysplasia, X-Linked	MESH:C564714	marker/mechanism		NA	300106	
BHLHA9	727857	Camptosynpolydactyly, Complex	MESH:C564383	marker/mechanism		NA	607539	
BHLHA9	727857	Syndactyly, Mesoaxial Synostotic, with Phalangeal Reduction	MESH:C563721	marker/mechanism		NA	609432	
BHLHE40	8553	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		25395965
BHLHE40	8553	Glioblastoma	MESH:D005909	marker/mechanism		NA		23582323
BHLHE40	8553	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
BHLHE40	8553	Sleep Disorders, Circadian Rhythm	MESH:D020178	marker/mechanism		NA		25395965
BHLHE41	79365	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
BHLHE41	79365	Sleep Wake Disorders	MESH:D012893	marker/mechanism		NA	612975	
BHMT	635	Abruptio Placentae	MESH:D000037	marker/mechanism		NA		17376725
BHMT	635	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		23665415
BHMT	635	Hepatolenticular Degeneration	MESH:D006527	marker/mechanism		NA		23519153
BHMT	635	Lymphoma, Non-Hodgkin	MESH:D008228	marker/mechanism		NA		17119116
BHMT	635	Neural Tube Defects	MESH:D009436	marker/mechanism		NA		17035141
BHMT2	23743	Cleft Lip	MESH:D002971	marker/mechanism		NA		21254359
BHMT2	23743	Cleft Palate	MESH:D002972	marker/mechanism		NA		21254359
BICD2	23299	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
BID	637	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		15289866
BID	637	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		15095271
BIN1	274	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		21460841
BIN1	274	Cognitive Dysfunction	MESH:D060825	marker/mechanism		NA		30503753
BIN1	274	Myopathies, Structural, Congenital	MESH:D020914	marker/mechanism		NA		17676042
BIN1	274	Myopathy, Centronuclear, Autosomal Recessive	MESH:C562934	marker/mechanism		NA	255200	
BIRC2	329	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25330770
BIRC2	329	HIV Infections	MESH:D015658	marker/mechanism		NA		12878215
BIRC2	329	Leukemia	MESH:D007938	marker/mechanism		NA		12970779
BIRC2	329	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		14647439
BIRC3	330	Fatty Liver	MESH:D005234	marker/mechanism		NA		21664615
BIRC3	330	HIV Infections	MESH:D015658	marker/mechanism		NA		12878215
BIRC3	330	Leukemia	MESH:D007938	marker/mechanism		NA		12970779
BIRC3	330	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
BIRC3	330	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		12926068
BIRC5	332	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		26432044
BIRC5	332	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16322251|16818634
BIRC5	332	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism|therapeutic		NA		16086872|20514400
BIRC5	332	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		16382892
BIRC5	332	Carcinoma, Renal Cell	MESH:D002292	therapeutic		NA		16188142
BIRC5	332	Carcinoma, Small Cell	MESH:D018288	marker/mechanism		NA		15981204
BIRC5	332	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		26432044
BIRC5	332	Colonic Neoplasms	MESH:D003110	marker/mechanism|therapeutic		NA		16224667|19147571
BIRC5	332	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		16364925
BIRC5	332	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		19363521
BIRC5	332	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		16497974
BIRC5	332	Leukemia, Megakaryoblastic, Acute	MESH:D007947	therapeutic		NA		16166298
BIRC5	332	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	MESH:D015464	therapeutic		NA		16254145
BIRC5	332	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		27770503
BIRC5	332	Lung Neoplasms	MESH:D008175	marker/mechanism|therapeutic		NA		15981204|16108013
BIRC5	332	Ovarian Neoplasms	MESH:D010051	marker/mechanism|therapeutic		NA		15970709|16202317|16211241|18567002
BIRC5	332	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29541389
BIRC5	332	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		15993841
BIRC5	332	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		26432044
BIRC6	57448	Neoplasms	MESH:D009369	marker/mechanism		NA		18239605
BIRC7	79444	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		17437058|25401301
BLA-DQB	539241	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
BLI-3	171608	Manganese Poisoning	MESH:D020149	marker/mechanism		NA		20865164
BLI-3	171608	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		20865164
BLK	640	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		20453842|23143596
BLK	640	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		19838193
BLK	640	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11	OMIM:613375	marker/mechanism		NA	613375	
BLK	640	Mucocutaneous Lymph Node Syndrome	MESH:D009080	marker/mechanism		NA		22446961
BLM	641	Bloom Syndrome	MESH:D001816	marker/mechanism		NA	210900	21440839
BLNK	29760	Agammaglobulinemia	MESH:D000361	marker/mechanism		NA	613502	
BLOC1S2	282991	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
BLOC1S3	388552	Hermanski-Pudlak Syndrome	MESH:D022861	marker/mechanism		NA	614077	
BLOC1S3	388552	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
BLOC1S6	26258	Hermanski-Pudlak Syndrome	MESH:D022861	marker/mechanism		NA	614171	
BLVRA	644	Cholestasis	MESH:D002779	marker/mechanism		NA		18706437
BLVRA	644	HYPERBILIVERDINEMIA	OMIM:614156	marker/mechanism		NA	614156	
BLVRA	644	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
BLVRB	645	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
BLVRB	645	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
BLVRB	645	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		19424620
BMF	90427	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		23770605
BMF	90427	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
BMI1	648	Disease Progression	MESH:D018450	marker/mechanism		NA		24571310
BMI1	648	Glioblastoma	MESH:D005909	marker/mechanism		NA		19823589
BMI1	648	Glioma	MESH:D005910	marker/mechanism		NA		23383216
BMI1	648	Hirschsprung Disease	MESH:D006627	marker/mechanism		NA		29429387
BMI1	648	Leukemia, Myeloid, Accelerated Phase	MESH:D015465	marker/mechanism		NA		24571310
BMI1	648	Myelodysplastic Syndromes	MESH:D009190	marker/mechanism		NA		24571310
BMI1	648	Neovascularization, Pathologic	MESH:D009389	marker/mechanism		NA		23383216
BMI1	648	Osteosarcoma	MESH:D012516	marker/mechanism		NA		21311599
BMP1	649	OSTEOGENESIS IMPERFECTA, TYPE XIII	OMIM:614856	marker/mechanism		NA	614856	
BMP10	27302	Fibrosis	MESH:D005355	therapeutic		NA		31712309
BMP10	27302	Heart Failure, Systolic	MESH:D054143	therapeutic		NA		31712309
BMP15	9210	Ovarian Dysgenesis 2	MESH:C564499	marker/mechanism		NA	300510	
BMP15	9210	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		22825968
BMP2	650	Bone Diseases	MESH:D001847	therapeutic		NA		22023753
BMP2	650	Brachydactyly type A2	MESH:C537089	marker/mechanism		NA	112600	
BMP2	650	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037
BMP2	650	Calcinosis	MESH:D002114	marker/mechanism		NA		31843813
BMP2	650	Cardiotoxicity	MESH:D066126	therapeutic		NA		29800642
BMP2	650	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		30510241
BMP2	650	Craniosynostoses	MESH:D003398	marker/mechanism		NA		23160099
BMP2	650	Fractures, Bone	MESH:D050723	therapeutic		NA		27394662
BMP2	650	Hemochromatosis	MESH:D006432	marker/mechanism		NA	235200	
BMP2	650	Myopia	MESH:D009216	marker/mechanism		NA		23396134
BMP2	650	Peripheral Arterial Disease	MESH:D058729	marker/mechanism		NA		27082954
BMP2	650	Prenatal Exposure Delayed Effects	MESH:D011297	therapeutic		NA		29800642
BMP2	650	Right ventricle hypoplasia	MESH:C535682	therapeutic		NA		29800642
BMP2	650	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16314833
BMP2	650	Uremia	MESH:D014511	marker/mechanism		NA		19092814
BMP4	652	ACTH-Secreting Pituitary Adenoma	MESH:D049913	marker/mechanism		NA		16195406
BMP4	652	Arthritis, Psoriatic	MESH:D015535	marker/mechanism		NA		20008919
BMP4	652	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		20008919
BMP4	652	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		23180569
BMP4	652	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		19011631
BMP4	652	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		18280291
BMP4	652	Microphthalmia, Syndromic 6	MESH:C566440	marker/mechanism		NA	607932	
BMP4	652	Orofacial Cleft 11	MESH:C567410	marker/mechanism		NA	600625	
BMP4	652	Osteoarthritis	MESH:D010003	marker/mechanism		NA		20008919
BMP4	652	Prolactinoma	MESH:D015175	marker/mechanism		NA		16809920
BMP4	652	Vitamin A Deficiency	MESH:D014802	marker/mechanism		NA		16120438
BMP6	654	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		20008919
BMP6	654	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17374397
BMP6	654	Hemochromatosis	MESH:D006432	marker/mechanism		NA		19252486|19252488
BMP6	654	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		18688853
BMP6	654	Osteoarthritis	MESH:D010003	marker/mechanism		NA		20008919
BMP7	655	Bone Resorption	MESH:D001862	therapeutic		NA		17513972
BMP7	655	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
BMP7	655	Femoral Fractures	MESH:D005264	therapeutic		NA		16234978
BMP7	655	Fractures, Bone	MESH:D050723	therapeutic		NA		27394662
BMP7	655	Liver Cirrhosis, Experimental	MESH:D008106	therapeutic		NA		17127702
BMP7	655	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881|19283074
BMP7	655	Pulmonary Fibrosis	MESH:D011658	therapeutic		NA		17975199
BMP7	655	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
BMP8A	353500	Peripheral Arterial Disease	MESH:D058729	marker/mechanism		NA		27082954
BMPER	168667	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
BMPER	168667	Diaphanospondylodysostosis	MESH:C564305	marker/mechanism		NA	608022	
BMPER	168667	Opioid-Related Disorders	MESH:D009293	marker/mechanism		NA		18438686
BMPR1A	657	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		15804571
BMPR1A	657	Eye Abnormalities	MESH:D005124	marker/mechanism		NA		15804571
BMPR1A	657	Female Urogenital Diseases	MESH:D052776	marker/mechanism		NA		16002989
BMPR1A	657	Juvenile polyposis syndrome	MESH:C537702	marker/mechanism		NA	174900	
BMPR1A	657	Polyposis Syndrome, Hereditary Mixed, 2	MESH:C566451	marker/mechanism		NA	610069	
BMPR1B	658	ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	OMIM:201250	marker/mechanism		NA		29322508
BMPR1B	658	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		15805157
BMPR1B	658	BRACHYDACTYLY, TYPE A1, D	OMIM:616849	marker/mechanism		NA	616849	
BMPR1B	658	Brachydactyly type A2	MESH:C537089	marker/mechanism		NA	112600	
BMPR1B	658	Chondrodysplasia, acromesomelic, with genital anomalies	MESH:C537913	marker/mechanism		NA	609441	15805157
BMPR1B	658	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		15804571
BMPR1B	658	Diverticular Diseases	MESH:D000076385	marker/mechanism		NA		30177863
BMPR1B	658	Eye Abnormalities	MESH:D005124	marker/mechanism		NA		15804571
BMPR1B	658	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
BMPR2	659	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		23180569
BMPR2	659	Familial Primary Pulmonary Hypertension	MESH:D065627	marker/mechanism		NA		25460361
BMPR2	659	Hyperandrogenism	MESH:D017588	marker/mechanism		NA		22825968
BMPR2	659	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA	178600	11590841|11893684|12358323|16297860|20496075|20522807|23383100|23502781|24224048
BMPR2	659	Pulmonary Arterial Hypertension	MESH:D000081029	marker/mechanism		NA		28415675
BMPR2	659	Pulmonary Veno-Occlusive Disease	MESH:D011668	marker/mechanism		NA	265450	
BMS1	9790	Ectodermal Dysplasia	MESH:D004476	marker/mechanism		NA	107600	
BNC2	54796	Cleft Palate	MESH:D002972	marker/mechanism		NA		19706529
BNC2	54796	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		19706529
BNC2	54796	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		20852632
BNIP3	664	Manganese Poisoning	MESH:D020149	marker/mechanism		NA		19442826
BNIP3	664	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		18172295
BNIP3	664	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		18163427
BNIP3	664	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
BOC	91653	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		30510241
BOC	91653	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
BOLA3	388962	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA	OMIM:614299	marker/mechanism		NA	614299	
BOLA-DRA	506214	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
BOLA-DRB3	282530	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
BOLL	66037	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17892325
BOP1	23246	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
BOP1	23246	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
BPGM	669	ERYTHROCYTOSIS, FAMILIAL, 8	OMIM:222800	marker/mechanism		NA	222800	
BPIFA1	51297	Fetal Alcohol Spectrum Disorders	MESH:D063647	marker/mechanism		NA		15513904
BPIFA2	140683	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
BPNT1	10380	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
BPNT2	54928	CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	OMIM:614078	marker/mechanism		NA	614078	
BPTF	2186	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		24121791
BPY2	9083	Spermatogenic Failure, Nonobstructive, Y-Linked	MESH:C564030	marker/mechanism		NA	415000	
BRAF	673	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		22135231|26463840
BRAF	673	Adrenocortical Carcinoma	MESH:D018268	marker/mechanism		NA		23585556
BRAF	673	Ameloblastoma	MESH:D000564	marker/mechanism		NA		24859340
BRAF	673	Astrocytoma	MESH:D001254	marker/mechanism		NA		23817572
BRAF	673	Carcinogenesis	MESH:D063646	marker/mechanism		NA		24717435
BRAF	673	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		27222248
BRAF	673	Cardiofaciocutaneous syndrome	MESH:C535579	marker/mechanism		NA	115150	16439621|17703371
BRAF	673	Clinical Deterioration	MESH:D000075902	marker/mechanism		NA		29438700
BRAF	673	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18718023|25280562|25701956|27222248
BRAF	673	Costello Syndrome	MESH:D056685	marker/mechanism		NA		17703371
BRAF	673	Craniopharyngioma	MESH:D003397	marker/mechanism		NA		24413733
BRAF	673	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28869590
BRAF	673	Glioma	MESH:D005910	marker/mechanism		NA		23583981
BRAF	673	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		21813464
BRAF	673	LEOPARD SYNDROME 3	OMIM:613707	marker/mechanism		NA	613707	
BRAF	673	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		17514646
BRAF	673	Lung Neoplasms	MESH:D008175	marker/mechanism		NA	211980	
BRAF	673	Lymphatic Metastasis	MESH:D008207	marker/mechanism		NA		29426936
BRAF	673	Lymphoma, T-Cell, Cutaneous	MESH:D016410	marker/mechanism		NA		26192916
BRAF	673	Mandibular Neoplasms	MESH:D008339	marker/mechanism		NA		24859340
BRAF	673	Melanoma	MESH:D008545	marker/mechanism		NA		18421705|19282848|20973932|21499247|21606968|21639808|21656352|21770473|21802280|22535842|22842228|23237741|23432625|23584600|23587417|24154489|25043973|26192916|26214590|27222248|27689874|29426936|29574239|31580832
BRAF	673	Melanoma, Experimental	MESH:D008546	marker/mechanism		NA		29179997|29438700
BRAF	673	Microsatellite Instability	MESH:D053842	marker/mechanism		NA		25701956
BRAF	673	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		28030816
BRAF	673	Neuroendocrine Tumors	MESH:D018358	marker/mechanism		NA		17341847
BRAF	673	Noonan Syndrome	MESH:D009634	marker/mechanism		NA	163950	17703371
BRAF	673	NOONAN SYNDROME 7	OMIM:613706	marker/mechanism		NA	613706	
BRAF	673	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		25735316|29610475
BRAF	673	Sezary Syndrome	MESH:D012751	marker/mechanism		NA		26551667
BRAF	673	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		27222248|28030816
BRAF	673	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		16940797|19878585|21185263|26751190|30621213|30935902
BRAP	8315	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		19198608
BRCA1	672	Breast Neoplasms	MESH:D001943	marker/mechanism		NA	114480	10788334|15750629|15894690|18066063|20135344|20941507|21781528|22614657|26379698|26629949|28825726|7894491
BRCA1	672	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	OMIM:604370	marker/mechanism		NA	604370	
BRCA1	672	Carcinoma	MESH:D002277	marker/mechanism		NA		12203372
BRCA1	672	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
BRCA1	672	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22048643
BRCA1	672	Chromosome Breakage	MESH:D019457	marker/mechanism		NA		15894690
BRCA1	672	Hereditary Breast and Ovarian Cancer Syndrome	MESH:D061325	marker/mechanism		NA		21597964|8644702
BRCA1	672	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12203372
BRCA1	672	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12203372|22767648
BRCA1	672	Mouth Diseases	MESH:D009059	marker/mechanism		NA		17682004
BRCA1	672	Neoplasms	MESH:D009369	therapeutic		NA		15520196
BRCA1	672	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		10788334|15894690|17688236|7795652|7894491
BRCA1	672	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA	614320	26098869
BRCA1	672	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17585057
BRCA2	675	Breast Neoplasms	MESH:D001943	marker/mechanism		NA	114480	20135344|22614657|28825726
BRCA2	675	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2	OMIM:612555	marker/mechanism		NA	612555	
BRCA2	675	Fanconi Anemia, Complementation Group D1	MESH:C563980	marker/mechanism		NA	605724	
BRCA2	675	Glioma	MESH:D005910	marker/mechanism		NA	613029	
BRCA2	675	Hereditary Breast and Ovarian Cancer Syndrome	MESH:D061325	marker/mechanism		NA		21597964
BRCA2	675	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		24880342
BRCA2	675	Medulloblastoma	MESH:D008527	marker/mechanism		NA	155255	
BRCA2	675	Neoplasms, Squamous Cell	MESH:D018307	marker/mechanism		NA		24880342
BRCA2	675	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		17688236
BRCA2	675	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA	613347	21613821|26098869
BRCA2	675	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA	176807	29610475
BRCA2	675	Wilms Tumor	MESH:D009396	marker/mechanism		NA	194070	
BRD1	23774	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
BRD2	6046	Glioblastoma	MESH:D005909	marker/mechanism		NA		27388964
BRD2	6046	Medulloblastoma	MESH:D008527	marker/mechanism		NA		24231268
BRD3	8019	Medulloblastoma	MESH:D008527	marker/mechanism		NA		24231268
BRD4	23476	Alopecia	MESH:D000505	marker/mechanism		NA		25242322
BRD4	23476	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
BRD4	23476	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		26752646
BRD4	23476	De Lange Syndrome	MESH:D003635	marker/mechanism		NA		29379197
BRD4	23476	Glioblastoma	MESH:D005909	marker/mechanism		NA		26455392|27388964
BRD4	23476	Hyperplasia	MESH:D006965	marker/mechanism		NA		25242322
BRD4	23476	Hypertension, Pulmonary	MESH:D006976	therapeutic		NA		26224795
BRD4	23476	Medulloblastoma	MESH:D008527	marker/mechanism		NA		24231268
BRD4	23476	Osteosarcoma	MESH:D012516	marker/mechanism		NA		24646477
BRD4	23476	Polycystic Kidney, Autosomal Dominant	MESH:D016891	marker/mechanism		NA		25877301
BRD4	23476	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		24763052
BRD4	23476	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		26707881
BRD8	10902	Endometriosis	MESH:D004715	marker/mechanism		NA		22138541
BRD9	65980	Sezary Syndrome	MESH:D012751	marker/mechanism		NA		26551667
BRF1	2972	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		32198086
BRF1	2972	CEREBELLOFACIODENTAL SYNDROME	OMIM:616202	marker/mechanism		NA	616202	
BRIP1	83990	Breast Neoplasms	MESH:D001943	marker/mechanism		NA	114480	
BRIP1	83990	Fanconi Anemia	MESH:D005199	marker/mechanism		NA		20639400
BRIP1	83990	Fanconi Anemia, Complementation Group J	MESH:C563801	marker/mechanism		NA	609054	
BRIP1	83990	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		21964575
BRMS1	25855	Neoplasm Invasiveness	MESH:D009361	therapeutic		NA		27501413
BRMS1	25855	Neoplasm Metastasis	MESH:D009362	therapeutic		NA		27501413
BRPF1	7862	INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS	OMIM:617333	marker/mechanism		NA	617333	
BRPF1	7862	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
BRWD1	54014	Oligospermia	MESH:D009845	marker/mechanism		NA		18353305
BRWD3	254065	Mental Retardation, X-Linked 93	MESH:C567066	marker/mechanism		NA	300659	
BSCL2	26580	Asthenozoospermia	MESH:D053627	marker/mechanism		NA		26181198
BSCL2	26580	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		25462787
BSCL2	26580	ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY	OMIM:615924	marker/mechanism		NA	615924	
BSCL2	26580	Lipodystrophy	MESH:D008060	marker/mechanism		NA		25462787
BSCL2	26580	Lipodystrophy, Congenital Generalized	MESH:D052497	marker/mechanism		NA	269700	
BSCL2	26580	Neuronopathy, Distal Hereditary Motor, Type V	MESH:C563443	marker/mechanism		NA	600794	
BSCL2	26580	Oligospermia	MESH:D009845	marker/mechanism		NA		26181198
BSCL2	26580	Puberty, Delayed	MESH:D011628	marker/mechanism		NA		25462787
BSCL2	26580	Spastic paraplegia 17	MESH:C536644	marker/mechanism		NA	270685	
BSG	682	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
BSG	682	COVID-19	MESH:C000657245	therapeutic		NA		32307653
BSG	682	Malaria, Falciparum	MESH:D016778	therapeutic		NA		22080952|26195724
BSG	682	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		21165561
BSG	682	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		21956400
BSG	682	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		21165561
BSG	682	Plaque, Atherosclerotic	MESH:D058226	marker/mechanism		NA		18647594
BSN	8927	Heart Diseases	MESH:D006331	marker/mechanism		NA		16844662
BSND	7809	Bartter Syndrome, Type 4A	MESH:C566530	marker/mechanism		NA	602522	
BST1	683	Lung Diseases	MESH:D008171	marker/mechanism		NA		21602193
BST1	683	Parkinson Disease	MESH:D010300	marker/mechanism		NA		19915576
BTBD1	53339	Delayed Emergence from Anesthesia	MESH:D055191	marker/mechanism		NA		16115977
BTBD11	121551	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
BTBD9	114781	Restless Legs Syndrome	MESH:D012148	marker/mechanism		NA		17637780
BTC	685	Protoporphyria, Erythropoietic	MESH:D046351	marker/mechanism		NA		19267999
BTD	686	Autistic Disorder	MESH:D001321	marker/mechanism		NA		13680408
BTD	686	Biotinidase Deficiency	MESH:D028921	marker/mechanism		NA	253260	
BTD	686	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		15469856
BTG1	694	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
BTG1	694	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		16918137
BTG1	694	Schizophrenia	MESH:D012559	marker/mechanism		NA		16223876
BTG2	7832	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		18393292
BTG2	7832	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
BTG3	10950	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
BTG3	10950	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		19221000
BTG3	10950	Cholestasis	MESH:D002779	marker/mechanism		NA		27989131
BTK	695	Agammaglobulinemia	MESH:D000361	therapeutic		NA		15142874
BTK	695	Bruton type agammaglobulinemia	MESH:C537409	marker/mechanism		NA	300755	
BTK	695	COVID-19	MESH:C000657245	marker/mechanism		NA		32503877
BTK	695	Hypogammaglobulinemia and Isolated growth hormone deficiency, X-linked	MESH:C537149	marker/mechanism		NA	307200	
BTN3A2	11118	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
BTNL2	56244	Berylliosis	MESH:D001607	marker/mechanism		NA		17927685
BTNL2	56244	Sarcoidosis	MESH:D012507	marker/mechanism		NA	612387	
BUB1	699	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
BUB1	699	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	114500	
BUB1B	701	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
BUB1B	701	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	114500	
BUB1B	701	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		18691855
BUB1B	701	Growth Disorders	MESH:D006130	marker/mechanism		NA		15475955
BUB1B	701	Microcephaly	MESH:D008831	marker/mechanism		NA		15475955
BUB1B	701	Mosaic variegated aneuploidy syndrome	MESH:C536987	marker/mechanism		NA	257300	15475955
BUB1B	701	Neoplasms, Germ Cell and Embryonal	MESH:D009373	marker/mechanism		NA		28553959
BUB1B	701	PREMATURE CHROMATID SEPARATION TRAIT	OMIM:176430	marker/mechanism		NA	176430	
BUB1B	701	Rhabdomyosarcoma, Embryonal	MESH:D018233	marker/mechanism		NA		15475955
BVES	11149	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 25	OMIM:616812	marker/mechanism		NA	616812	
BZW1	9689	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
BZW2	28969	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
BZW2	28969	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
C10ORF82	143379	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
C11ORF21	29125	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		23770605
C11ORF68	83638	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
C12ORF57	113246	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
C12ORF57	113246	Temtamy syndrome	MESH:C536959	marker/mechanism		NA	218340	
C12ORF65	91574	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7	OMIM:613559	marker/mechanism		NA	613559	
C12ORF65	91574	Mitochondrial Encephalomyopathies	MESH:D017237	marker/mechanism		NA		20598281
C12ORF66	144577	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
C14ORF180	400258	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
C19ORF12	83636	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4	OMIM:614298	marker/mechanism		NA	614298	
C19ORF12	83636	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		21397856
C19ORF12	83636	SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE	OMIM:615043	marker/mechanism		NA	615043	
C19ORF18	147685	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
C1GALT1C1	29071	Tn Syndrome	MESH:C562719	marker/mechanism		NA	300622	
C1ORF185	284546	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
C1QA	712	C1q DEFICIENCY	OMIM:613652	marker/mechanism		NA	613652	
C1QA	712	Exanthema	MESH:D005076	marker/mechanism		NA		8840296
C1QA	712	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		25133636|8840296
C1QA	712	Glomerulonephritis, Membranoproliferative	MESH:D015432	marker/mechanism		NA		8840296
C1QA	712	Immune Complex Diseases	MESH:D007105	marker/mechanism		NA		8840296
C1QA	712	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
C1QA	712	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		8840296
C1QB	713	C1q DEFICIENCY	OMIM:613652	marker/mechanism		NA	613652	
C1QB	713	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		25133636
C1QB	713	Immunologic Deficiency Syndromes	MESH:D007153	marker/mechanism		NA		2894352
C1QB	713	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		26396155
C1QB	713	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
C1QB	713	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
C1QB	713	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
C1QBP	708	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21466612
C1QC	714	C1q DEFICIENCY	OMIM:613652	marker/mechanism		NA	613652	
C1QC	714	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
C1QTNF5	114902	Late-Onset Retinal Degeneration	MESH:C565309	marker/mechanism		NA	605670	
C1QTNF5	114902	Lens Diseases	MESH:D007905	marker/mechanism		NA		16123441
C1QTNF5	114902	Macular Degeneration	MESH:D008268	marker/mechanism		NA		16123441
C1QTNF6	114904	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		18978792
C1R	715	Ehlers-Danlos Syndrome, Type VIII	MESH:C562626	marker/mechanism		NA	130080	
C1R	715	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
C1R	715	Paratuberculosis	MESH:D010283	marker/mechanism		NA		22633222
C1S	716	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		11390518
C1S	716	Complement Component C1s Deficiency	MESH:C565170	marker/mechanism		NA	613783	
C1S	716	EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2	OMIM:617174	marker/mechanism		NA	617174	
C1S	716	Hashimoto Disease	MESH:D050031	marker/mechanism		NA		11390518
C1S	716	Hepatitis, Autoimmune	MESH:D019693	marker/mechanism		NA		11390518
C1S	716	Hereditary Angioedema Types I and II	MESH:D056829	marker/mechanism		NA		3184114
C2	717	COMPLEMENT COMPONENT 2 DEFICIENCY	OMIM:217000	marker/mechanism		NA	217000	
C2	717	Dermatitis, Irritant	MESH:D017453	marker/mechanism		NA		27258892
C2	717	Dermatomyositis	MESH:D003882	marker/mechanism		NA		3501473
C2	717	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		25133636
C2	717	Macular Degeneration	MESH:D008268	marker/mechanism		NA		16518403
C2	717	MACULAR DEGENERATION, AGE-RELATED, 14	OMIM:615489	marker/mechanism		NA	615489	
C2CD3	26005	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
C2CD3	26005	Orofaciodigital Syndromes	MESH:D009958	marker/mechanism		NA		24997988
C2CD3	26005	OROFACIODIGITAL SYNDROME XIV	OMIM:615948	marker/mechanism		NA	615948	
C2CD4A	145741	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		20818381
C2CD4B	388125	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		20818381
C2ORF88	84281	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
C3	718	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		28885000
C3	718	Atypical Hemolytic Uremic Syndrome	MESH:D065766	marker/mechanism		NA	612925	
C3	718	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		16099942
C3	718	Complement Component 3 Deficiency, Autosomal Recessive	MESH:C565169	marker/mechanism		NA	613779	
C3	718	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		20504758
C3	718	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		28885000
C3	718	Glomerulonephritis, Membranous	MESH:D015433	marker/mechanism		NA		25954969
C3	718	Immunologic Deficiency Syndromes	MESH:D007153	marker/mechanism		NA		1350678
C3	718	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		23199288
C3	718	Insulin Resistance	MESH:D007333	marker/mechanism		NA		18615583
C3	718	Ischemic Attack, Transient	MESH:D002546	marker/mechanism		NA		23199288
C3	718	Macular Degeneration	MESH:D008268	marker/mechanism		NA		17767156|24036949|24036950|24036952
C3	718	Macular Degeneration, Age-Related, 9	MESH:C566958	marker/mechanism		NA	611378	
C3	718	Paratuberculosis	MESH:D010283	marker/mechanism		NA		22633222
C3	718	Pemphigus	MESH:D010392	marker/mechanism		NA		74171
C3	718	Purpura, Schoenlein-Henoch	MESH:D011695	marker/mechanism		NA		1353212
C4A	720	Complement Component 4a Deficiency	MESH:C565167	marker/mechanism		NA	614380	
C4A	720	Immunologic Deficiency Syndromes	MESH:D007153	marker/mechanism		NA		8473511
C4B	721	Autistic Disorder	MESH:D001321	marker/mechanism		NA		15694999|20452682
C4B	721	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		20452682
C4B	721	COMPLEMENT COMPONENT 4B DEFICIENCY	OMIM:614379	marker/mechanism		NA	614379	
C4B	721	Drug Eruptions	MESH:D003875	marker/mechanism		NA		21055120
C4ORF19	55286	Cholestasis	MESH:D002779	marker/mechanism		NA		27989131
C5	727	Complement component 5 deficiency	MESH:C537005	marker/mechanism		NA	609536	
C5	727	Immunologic Deficiency Syndromes	MESH:D007153	marker/mechanism		NA		7730648
C5	727	Peritonitis	MESH:D010538	marker/mechanism		NA		19284563|19346296
C5AR1	728	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
C5AR1	728	Shock, Septic	MESH:D012772	marker/mechanism		NA		18063050
C5ORF63	401207	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
C6	729	Calcinosis	MESH:D002114	marker/mechanism		NA		21335463
C6	729	Complement Component 6 Deficiency	MESH:C567307	marker/mechanism		NA	612446	
C6	729	Heart Valve Diseases	MESH:D006349	marker/mechanism		NA		21335463
C7	730	Complement Component 7 Deficiency	MESH:C566443	marker/mechanism		NA	610102	
C7	730	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
C8A	731	COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE I	OMIM:613790	marker/mechanism		NA	613790	
C8A	731	Immunologic Deficiency Syndromes	MESH:D007153	marker/mechanism		NA		9759902
C8A	731	Meningitis	MESH:D008581	marker/mechanism		NA		9759902
C8A	731	Neisseriaceae Infections	MESH:D016870	marker/mechanism		NA		9759902
C8B	732	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		7980680
C8B	732	COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE II	OMIM:613789	marker/mechanism		NA	613789	
C8B	732	Immunologic Deficiency Syndromes	MESH:D007153	marker/mechanism		NA		8098723
C8B	732	Meningitis	MESH:D008581	marker/mechanism		NA		8098723
C8B	732	Neisseriaceae Infections	MESH:D016870	marker/mechanism		NA		8098723
C8G	733	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
C8ORF37	157657	BARDET-BIEDL SYNDROME 21	OMIM:617406	marker/mechanism		NA	617406	
C8ORF37	157657	CONE-ROD DYSTROPHY 16	OMIM:614500	marker/mechanism		NA	614500	
C8ORF37	157657	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA	268000	
C9	735	C9 Deficiency	MESH:C565165	marker/mechanism		NA	613825	
C9	735	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		19363144|28284560
C9	735	Dermatomyositis	MESH:D003882	marker/mechanism		NA		11359403
C9	735	Erythema	MESH:D004890	marker/mechanism		NA		11359403
C9	735	Facial Dermatoses	MESH:D005148	marker/mechanism		NA		11359403
C9	735	Immunologic Deficiency Syndromes	MESH:D007153	marker/mechanism		NA		11359403|9570574
C9	735	Macular Degeneration	MESH:D008268	marker/mechanism		NA		24036952
C9	735	MACULAR DEGENERATION, AGE-RELATED, 15	OMIM:615591	marker/mechanism		NA	615591	
C9	735	Meningitis, Meningococcal	MESH:D008585	marker/mechanism		NA		9570574
C9	735	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		23056237
C9	735	Opioid-Related Disorders	MESH:D009293	marker/mechanism		NA		18438686
C9ORF72	203228	Amyotrophic Lateral Sclerosis	MESH:D000690	marker/mechanism		NA		27713094
C9ORF72	203228	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
C9ORF72	203228	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 1	OMIM:105550	marker/mechanism		NA	105550	
C9ORF72	203228	Frontotemporal Dementia With Motor Neuron Disease	MESH:C566288	marker/mechanism		NA		26769963
C9ORF72	203228	Frontotemporal Lobar Degeneration	MESH:D057174	marker/mechanism		NA		27713094
CA1	759	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		15378696
CA1	759	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
CA1	759	Pneumoconiosis	MESH:D011009	marker/mechanism		NA		25445010
CA1	759	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		15378696|19424620
CA12	771	HYPERCHLORHIDROSIS, ISOLATED	OMIM:143860	marker/mechanism		NA	143860	
CA12	771	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
CA2	760	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		15378696
CA2	760	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		31209396
CA2	760	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
CA2	760	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
CA2	760	Osteopetrosis with renal tubular acidosis	MESH:C536058	marker/mechanism		NA	259730	
CA2	760	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
CA2	760	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		15378696
CA3	761	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
CA3	761	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
CA3	761	Obesity	MESH:D009765	marker/mechanism		NA		20882379
CA3	761	Pneumoconiosis	MESH:D011009	marker/mechanism		NA		25445010
CA4	762	Retinitis Pigmentosa 17	MESH:C563437	marker/mechanism		NA	600852	
CA5A	763	CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	OMIM:615751	marker/mechanism		NA	615751	
CA8	767	Cerebellar Ataxia, Mental Retardation, And Dysequilibrium Syndrome 3	MESH:C567690	marker/mechanism		NA	613227	
CA8	767	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
CA9	768	Anaplasia	MESH:D000708	marker/mechanism		NA		19808899
CA9	768	Carcinoma, Ductal	MESH:D044584	marker/mechanism		NA		20526721
CA9	768	Carcinoma, Intraductal, Noninfiltrating	MESH:D002285	marker/mechanism		NA		20526721
CA9	768	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		30381462
CA9	768	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		20110409
CA9	768	Hypoxia	MESH:D000860	marker/mechanism		NA		16954440
CA9	768	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	MESH:D015464	marker/mechanism		NA		17157168
CABCOCO1	219621	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
CABIN1	23523	Cardiomegaly	MESH:D006332	therapeutic		NA		11248077
CABLES1	91768	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17982127
CABP2	51475	DEAFNESS, AUTOSOMAL RECESSIVE 93	OMIM:614899	marker/mechanism		NA	614899	
CABP4	57010	CONE-ROD SYNAPTIC DISORDER, CONGENITAL NONPROGRESSIVE	OMIM:610427	marker/mechanism		NA	610427	
CABYR	26256	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17892325
CACNA1A	773	Ataxia	MESH:D001259	marker/mechanism		NA		17376154
CACNA1A	773	Epilepsy, Absence	MESH:D004832	marker/mechanism		NA		17196942
CACNA1A	773	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42	OMIM:617106	marker/mechanism		NA	617106	
CACNA1A	773	Episodic Ataxia, Type 2	MESH:C535506	marker/mechanism		NA	108500	11985388
CACNA1A	773	Exfoliation Syndrome	MESH:D017889	marker/mechanism		NA		25706626
CACNA1A	773	Hemiplegic migraine, familial type 1	MESH:C536890	marker/mechanism		NA	141500	11985388|24849341
CACNA1A	773	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA	183086	11985388|16899342
CACNA1B	774	Peripheral Nervous System Diseases	MESH:D010523	therapeutic		NA		22891239
CACNA1C	775	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		28696432
CACNA1C	775	Arrhythmias, Cardiac	MESH:D001145	marker/mechanism		NA		15454078
CACNA1C	775	Autistic Disorder	MESH:D001321	marker/mechanism		NA		15454078
CACNA1C	775	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		18711365|21926972|21926974|31043756
CACNA1C	775	Brugada Syndrome 3	MESH:C567509	marker/mechanism		NA	611875	
CACNA1C	775	Cognitive Dysfunction	MESH:D060825	marker/mechanism		NA		28696432
CACNA1C	775	Depressive Disorder, Major	MESH:D003865	marker/mechanism		NA		28696432
CACNA1C	775	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		28696432
CACNA1C	775	Hypertension	MESH:D006973	marker/mechanism		NA		22949532
CACNA1C	775	Hypoglycemia	MESH:D007003	marker/mechanism		NA		15454078
CACNA1C	775	Immunologic Deficiency Syndromes	MESH:D007153	marker/mechanism		NA		15454078
CACNA1C	775	Limb Deformities, Congenital	MESH:D017880	marker/mechanism		NA		15454078
CACNA1C	775	Psychomotor Agitation	MESH:D011595	marker/mechanism		NA		28696432
CACNA1C	775	Stress Disorders, Traumatic	MESH:D040921	marker/mechanism		NA		28696432
CACNA1C	775	Timothy syndrome	MESH:C536962	marker/mechanism		NA	601005	15454078
CACNA1D	776	Adenoma	MESH:D000236	marker/mechanism		NA		23913001|23913004
CACNA1D	776	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		28194001
CACNA1D	776	Bradycardia	MESH:D001919	marker/mechanism		NA		26831068
CACNA1D	776	Deafness	MESH:D003638	marker/mechanism		NA		15357422
CACNA1D	776	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		26831068
CACNA1D	776	Heart Block	MESH:D006327	marker/mechanism		NA		26831068
CACNA1D	776	Hyperaldosteronism	MESH:D006929	marker/mechanism		NA		23913001
CACNA1D	776	Sick Sinus Syndrome	MESH:D012804	marker/mechanism		NA		26831068
CACNA1D	776	Tachycardia, Supraventricular	MESH:D013617	marker/mechanism		NA		26831068
CACNA1F	778	Aland Island Eye Disease	MESH:C562664	marker/mechanism		NA	300600	
CACNA1F	778	Cone-Rod Dystrophy, X-Linked, 3	MESH:C564507	marker/mechanism		NA	300476	
CACNA1F	778	Night blindness, congenital stationary	MESH:C536122	marker/mechanism		NA	300071	
CACNA1G	8913	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
CACNA1G	8913	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA	616795	
CACNA1H	8912	Autistic Disorder	MESH:D001321	marker/mechanism		NA		16754686
CACNA1H	8912	beta-Thalassemia	MESH:D017086	marker/mechanism		NA		31542421
CACNA1H	8912	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		30552955
CACNA1H	8912	Epilepsy, Absence	MESH:D004832	marker/mechanism		NA	611942	
CACNA1H	8912	HYPERALDOSTERONISM, FAMILIAL, TYPE IV	OMIM:617027	marker/mechanism		NA	617027	
CACNA1H	8912	Hyperalgesia	MESH:D006930	marker/mechanism		NA		19577366|30552955
CACNA1H	8912	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		30552955
CACNA1S	779	Hypokalemic Periodic Paralysis	MESH:D020514	marker/mechanism		NA		11912116|19822448
CACNA1S	779	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1	OMIM:170400	marker/mechanism		NA	170400	
CACNA1S	779	Malignant hyperthermia susceptibility type 5	MESH:C535698	marker/mechanism		NA	601887	
CACNA1S	779	Respiratory Insufficiency	MESH:D012131	marker/mechanism		NA		19822448
CACNA1S	779	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1	OMIM:188580	marker/mechanism		NA	188580	
CACNA2D1	781	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
CACNA2D1	781	Hyperalgesia	MESH:D006930	marker/mechanism		NA		11245671|17881535|24133248
CACNA2D1	781	Hypertension	MESH:D006973	marker/mechanism		NA		22949532
CACNA2D1	781	Neuralgia	MESH:D009437	marker/mechanism		NA		17442347|18400411|19339603|24133248
CACNA2D1	781	Pain	MESH:D010146	marker/mechanism		NA		17088553
CACNA2D2	9254	Ataxia	MESH:D001259	marker/mechanism		NA		14660671
CACNA2D2	9254	Chorea	MESH:D002819	marker/mechanism		NA		14660671
CACNA2D2	9254	Epilepsy, Absence	MESH:D004832	marker/mechanism		NA		14660671
CACNA2D2	9254	Hearing Loss	MESH:D034381	marker/mechanism		NA		27798183
CACNA2D2	9254	Infertility, Female	MESH:D007247	marker/mechanism		NA		14660671
CACNA2D3	55799	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
CACNA2D4	93589	Retinal Cone Dystrophy 4	MESH:C566470	marker/mechanism		NA	610478	
CACNB2	783	Brugada Syndrome 4	MESH:C567508	marker/mechanism		NA	611876	
CACNB3	784	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
CACNB4	785	Ataxia	MESH:D001259	marker/mechanism		NA		10762541
CACNB4	785	Epilepsy, Generalized	MESH:D004829	marker/mechanism		NA		10762541
CACNB4	785	Epilepsy, Idiopathic Generalized	MESH:C562694	marker/mechanism		NA	607682	
CACNB4	785	Episodic Ataxia, Type 5	MESH:C566601	marker/mechanism		NA	613855	
CACNB4	785	Myoclonic Epilepsy, Juvenile	MESH:D020190	marker/mechanism		NA		10762541
CACNG2	10369	MENTAL RETARDATION, AUTOSOMAL DOMINANT 10	OMIM:614256	marker/mechanism		NA	614256	
CACUL1	143384	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		25944804
CAD	790	Anemia, Hypoplastic, Congenital	MESH:D029502	marker/mechanism		NA		38827
CAD	790	Anemia, Sickle Cell	MESH:D000755	marker/mechanism		NA		38827
CAD	790	beta-Thalassemia	MESH:D017086	marker/mechanism		NA		38827
CAD	790	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50	OMIM:616457	marker/mechanism		NA	616457	
CAD	790	Leukemia, Erythroblastic, Acute	MESH:D004915	marker/mechanism		NA		38827
CAD	790	Spherocytosis, Hereditary	MESH:D013103	marker/mechanism		NA		38827
CADM1	23705	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18957284
CADM1	23705	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17260099
CADM1	23705	Depressive Disorder	MESH:D003866	marker/mechanism		NA		22113448
CADPS2	93664	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17380209
CADPS2	93664	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		26881866
CADPS2	93664	Cholestasis	MESH:D002779	marker/mechanism		NA		26881866
CADPS2	93664	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
CALB1	793	Kidney Diseases	MESH:D007674	marker/mechanism		NA		21258088|21865292
CALB2	794	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
CALB2	794	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		22784439
CALB2	794	Peritoneal Neoplasms	MESH:D010534	marker/mechanism		NA		22784439
CALB2	794	Uveitis	MESH:D014605	marker/mechanism		NA		19578012
CALCA	796	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		16690336
CALCA	796	Autistic Disorder	MESH:D001321	marker/mechanism		NA		11357950
CALCA	796	Bronchial Hyperreactivity	MESH:D016535	marker/mechanism		NA		15127121|16777450
CALCA	796	Catalepsy	MESH:D002375	marker/mechanism		NA		6293644|6303368|6686863
CALCA	796	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27093858
CALCA	796	Down Syndrome	MESH:D004314	marker/mechanism		NA		16289943
CALCA	796	Edema	MESH:D004487	marker/mechanism		NA		7508328
CALCA	796	Hyperalgesia	MESH:D006930	marker/mechanism|therapeutic		NA		12787826|12855330|15265675|27093858
CALCA	796	Hypercalcemia	MESH:D006934	therapeutic		NA		1115441|12637657
CALCA	796	Hyperkinesis	MESH:D006948	therapeutic		NA		6293644|6686863
CALCA	796	Hypertension	MESH:D006973	therapeutic		NA		1849535|9887042
CALCA	796	Hypertension, Pulmonary	MESH:D006976	therapeutic		NA		1357980
CALCA	796	Inflammation	MESH:D007249	marker/mechanism		NA		11588175
CALCA	796	Intellectual Disability	MESH:D008607	marker/mechanism		NA		11357950
CALCA	796	Migraine Disorders	MESH:D008881	marker/mechanism		NA		12574409|17635592
CALCA	796	Migraine without Aura	MESH:D020326	marker/mechanism		NA		11304026|14659530
CALCA	796	Neurogenic Inflammation	MESH:D020078	marker/mechanism		NA		17961222
CALCA	796	Osteoarthritis	MESH:D010003	marker/mechanism		NA		16690336
CALCA	796	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16222118
CALCA	796	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		17365031
CALCA	796	Sciatic Neuropathy	MESH:D020426	therapeutic		NA		19852068
CALCA	796	Trigeminal Neuralgia	MESH:D014277	marker/mechanism		NA		27093858
CALCA	796	Wounds and Injuries	MESH:D014947	therapeutic		NA		18430544
CALCOCO2	10241	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		25944804
CALCR	799	Hypercalcemia	MESH:D006934	therapeutic		NA		18627265
CALCR	799	Osteoporosis	MESH:D010024	marker/mechanism		NA	166710	
CALCRL	10203	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17374397
CALD1	800	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
CALD1	800	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		15292528
CALHM1	255022	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		26039340
CALM1	801	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		11470324
CALM1	801	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		17205118
CALM1	801	LONG QT SYNDROME 14	OMIM:616247	marker/mechanism		NA	616247	
CALM1	801	Marijuana Abuse	MESH:D002189	marker/mechanism		NA		17205118
CALM1	801	Phencyclidine Abuse	MESH:D010623	marker/mechanism		NA		17205118
CALM1	801	Polymorphic catecholergic ventricular tachycardia	MESH:C536334	marker/mechanism		NA	614916	
CALM1	801	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
CALM2	805	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		17205118
CALM2	805	LONG QT SYNDROME 15	OMIM:616249	marker/mechanism		NA	616249	
CALM2	805	Marijuana Abuse	MESH:D002189	marker/mechanism		NA		17205118
CALM2	805	Phencyclidine Abuse	MESH:D010623	marker/mechanism		NA		17205118
CALML3	810	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
CALR	811	Colorectal Neoplasms	MESH:D015179	therapeutic		NA		17187072
CALR	811	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
CALR	811	Melanoma, Experimental	MESH:D008546	therapeutic		NA		16388313
CALR	811	Myeloproliferative Disorders	MESH:D009196	marker/mechanism		NA		29047144
CALR	811	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
CALR	811	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		15048980
CALR	811	Primary Myelofibrosis	MESH:D055728	marker/mechanism		NA	254450	
CALR	811	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17566973
CALR	811	Thrombocytosis	MESH:D013922	marker/mechanism		NA	187950	
CALU	813	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
CALU	813	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		15048980
CALY	50632	Attention Deficit Disorder with Hyperactivity	MESH:D001289	marker/mechanism		NA		30753204
CALY	50632	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		30753204
CALY	50632	Essential Hypertension	MESH:D000075222	marker/mechanism		NA		30753204
CALY	50632	Memory Disorders	MESH:D008569	marker/mechanism		NA		30753204
CAMK1G	57172	Amyotrophic Lateral Sclerosis	MESH:D000690	marker/mechanism		NA		23624525
CAMK2A	815	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		14725635
CAMK2A	815	Hepatolenticular Degeneration	MESH:D006527	marker/mechanism		NA		23519153
CAMK2A	815	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
CAMK2A	815	Hyperalgesia	MESH:D006930	marker/mechanism		NA		20053885
CAMK2B	816	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		17205118
CAMK2B	816	Marijuana Abuse	MESH:D002189	marker/mechanism		NA		17205118
CAMK2B	816	Phencyclidine Abuse	MESH:D010623	marker/mechanism		NA		17205118
CAMK2B	816	Psychoses, Substance-Induced	MESH:D011605	marker/mechanism		NA		17603807
CAMK2B	816	Schizophrenia	MESH:D012559	marker/mechanism		NA		11042361|20336626
CAMK2D	817	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
CAMK2D	817	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CAMK2D	817	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
CAMK2D	817	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
CAMK4	814	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		19001277
CAMKK1	84254	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		21245421
CAMKK2	10645	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		28634229
CAMKK2	10645	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		28634229
CAMKMT	79823	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		26247364
CAMKMT	79823	Hypotonia-Cystinuria Syndrome	MESH:C564710	marker/mechanism		NA		26247364
CAMKMT	79823	Learning Disabilities	MESH:D007859	marker/mechanism		NA		26247364
CAMKMT	79823	Mitochondrial Myopathies	MESH:D017240	marker/mechanism		NA		26247364
CAMKMT	79823	Motor Skills Disorders	MESH:D019957	marker/mechanism		NA		26247364
CAMKMT	79823	Muscle Weakness	MESH:D018908	marker/mechanism		NA		26247364
CAMSAP1	157922	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
CAMTA1	23261	CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION	OMIM:614756	marker/mechanism		NA	614756	
CAND2	23066	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
CANT1	124583	Desbuquois syndrome	MESH:C535943	marker/mechanism		NA	251450	
CANX	821	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
CANX	821	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
CAP1	10487	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
CAP1	10487	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
CAP2	10486	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CAPG	822	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		19381893
CAPG	822	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		15108329
CAPG	822	Keloid	MESH:D007627	marker/mechanism		NA		20128793
CAPG	822	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		18206229
CAPG	822	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CAPN1	823	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
CAPN1	823	Neoplasms	MESH:D009369	therapeutic		NA		19266085
CAPN1	823	Optic Neuritis	MESH:D009902	marker/mechanism		NA		23860028
CAPN1	823	SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	OMIM:616907	marker/mechanism		NA	616907	
CAPN10	11132	Diabetes Mellitus, Noninsulin-Dependent, 1	MESH:C563359	marker/mechanism		NA	601283	
CAPN10	11132	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		23349674
CAPN10	11132	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
CAPN14	440854	Eosinophilic Esophagitis	MESH:D057765	marker/mechanism		NA		25017104
CAPN2	824	Cognition Disorders	MESH:D003072	therapeutic		NA		31672664
CAPN2	824	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
CAPN3	825	Limb-girdle muscular dystrophy type 2A	MESH:C535895	marker/mechanism		NA	253600	
CAPN5	726	VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY	OMIM:193235	marker/mechanism		NA	193235	
CAPN8	388743	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
CAPNS1	826	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
CAPZA1	829	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
CAPZB	832	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		21751358
CAPZB	832	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
CAPZB	832	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
CAPZB	832	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
CAR2	12349	Cholangitis	MESH:D002761	marker/mechanism		NA		15816485
CAR2	12349	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		15816485
CAR3	12350	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
CAR3	12350	Fatty Liver	MESH:D005234	marker/mechanism		NA		25226513
CAR3	12350	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CAR3	12350	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		11420682
CAR4	12351	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
CAR5A	12352	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CARD11	84433	B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY	OMIM:616452	marker/mechanism		NA	616452	
CARD11	84433	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		22138691
CARD11	84433	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		23042114|28628108
CARD11	84433	IMMUNODEFICIENCY 11	OMIM:615206	marker/mechanism		NA	615206	
CARD11	84433	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		26437031
CARD11	84433	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		25049379|26192916
CARD11	84433	Lymphoma, T-Cell, Cutaneous	MESH:D016410	marker/mechanism		NA		26192916
CARD11	84433	Sezary Syndrome	MESH:D012751	marker/mechanism		NA		26551667|26551670
CARD14	79092	Pityriasis Rubra Pilaris	MESH:D010916	marker/mechanism		NA	173200	
CARD14	79092	Psoriasis	MESH:D011565	marker/mechanism		NA	602723	23143594|24212883
CARD18	59082	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		22514692
CARD18	59082	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		22514692
CARD8	22900	Gout	MESH:D006073	marker/mechanism		NA		26462562
CARD8	22900	Occupational Diseases	MESH:D009784	marker/mechanism		NA		24142982
CARD8	22900	Pleural Diseases	MESH:D010995	marker/mechanism		NA		24142982
CARD9	64170	CANDIDIASIS, FAMILIAL, 2	OMIM:212050	marker/mechanism		NA	212050	
CARD9	64170	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		20228799
CARD9	64170	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		25305756
CARD9	64170	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA		21983784
CARD9	64170	Spondylitis, Ankylosing	MESH:D013167	marker/mechanism		NA		21743469
CARM1	10498	Psoriasis	MESH:D011565	marker/mechanism		NA		23143594
CARMIL3	90668	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
CARS2	79587	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27	OMIM:616672	marker/mechanism		NA	616672	
CARTPT	9607	Alcohol-Related Disorders	MESH:D019973	marker/mechanism		NA		22823101
CARTPT	9607	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		12600694
CARTPT	9607	Cocaine-Related Disorders	MESH:D019970	therapeutic		NA		20886038
CARTPT	9607	Hyperalgesia	MESH:D006930	therapeutic		NA		21167239
CARTPT	9607	Hyperthyroidism	MESH:D006980	marker/mechanism		NA		12395121
CARTPT	9607	Obesity	MESH:D009765	marker/mechanism		NA	601665	
CASC1	320662	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		15064703
CASK	8573	ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	OMIM:300908	marker/mechanism		NA	300908	
CASK	8573	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
CASK	8573	Cerebellar Diseases	MESH:D002526	marker/mechanism		NA		19165920
CASK	8573	Cleft Palate	MESH:D002972	marker/mechanism		NA		9787075
CASK	8573	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
CASK	8573	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
CASK	8573	Mental Retardation And Microcephaly With Pontine And Cerebellar Hypoplasia	MESH:C567466	marker/mechanism		NA	300749	
CASK	8573	Mental Retardation, X-Linked	MESH:D038901	marker/mechanism		NA		19165920|19377476
CASK	8573	Microcephaly	MESH:D008831	marker/mechanism		NA		19165920
CASK	8573	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
CASK	8573	Opitz-Kaveggia syndrome	MESH:C537923	marker/mechanism		NA	300422	
CASP1	834	Albuminuria	MESH:D000419	marker/mechanism		NA		22647887
CASP1	834	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
CASP1	834	Hyperhomocysteinemia	MESH:D020138	marker/mechanism		NA		22647887
CASP1	834	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
CASP1	834	Inflammation	MESH:D007249	marker/mechanism		NA		22325453
CASP1	834	Insulin Resistance	MESH:D007333	marker/mechanism		NA		22325453
CASP1	834	Kidney Diseases	MESH:D007674	marker/mechanism		NA		22647887
CASP1	834	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CASP1	834	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		25458313
CASP1	834	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		14998631
CASP1	834	Obesity	MESH:D009765	marker/mechanism		NA		22325453
CASP1	834	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
CASP1	834	Status Epilepticus	MESH:D013226	marker/mechanism		NA		18571097
CASP10	843	Autoimmune Lymphoproliferative Syndrome, Type IIA	MESH:C565833	marker/mechanism		NA	603909	
CASP10	843	Lymphoma, Non-Hodgkin	MESH:D008228	marker/mechanism		NA	605027	
CASP10	843	Melanoma	MESH:D008545	marker/mechanism		NA		18563783
CASP10	843	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		18563783
CASP10	843	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA	613659	
CASP12	100506742	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		23499715
CASP12	100506742	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CASP12	100506742	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		14998631
CASP14	23581	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 12	OMIM:617320	marker/mechanism		NA	617320	
CASP2	835	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		20208132
CASP2	835	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
CASP3	836	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		18077176
CASP3	836	Brain Ischemia	MESH:D002545	marker/mechanism		NA		11756504|17901229
CASP3	836	Calcinosis	MESH:D002114	marker/mechanism		NA		21335463
CASP3	836	Cerebral Hemorrhage	MESH:D002543	marker/mechanism		NA		17971790
CASP3	836	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		24055189
CASP3	836	Copper-Overload Cirrhosis	MESH:C566858	marker/mechanism		NA		22879914
CASP3	836	Cryptorchidism	MESH:D003456	marker/mechanism		NA		26050606
CASP3	836	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		20654064
CASP3	836	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		15531508
CASP3	836	Diabetic Angiopathies	MESH:D003925	marker/mechanism		NA		25381014
CASP3	836	Diabetic Neuropathies	MESH:D003929	marker/mechanism		NA		12502508
CASP3	836	Diabetic Retinopathy	MESH:D003930	marker/mechanism		NA		20654064
CASP3	836	Edema	MESH:D004487	marker/mechanism		NA		19874808
CASP3	836	Heart Valve Diseases	MESH:D006349	marker/mechanism		NA		21335463
CASP3	836	Hepatitis, Chronic	MESH:D006521	marker/mechanism		NA		22879914
CASP3	836	Mycoplasma Infections	MESH:D009175	marker/mechanism		NA		20179380
CASP3	836	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		25450231
CASP3	836	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		14998631
CASP3	836	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		14999069
CASP3	836	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		12196588
CASP3	836	Neurotoxicity Syndromes	MESH:D020258	marker/mechanism		NA		21972528
CASP3	836	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		23875703
CASP3	836	Retinal Detachment	MESH:D012163	marker/mechanism		NA		18497877
CASP3	836	Sepsis	MESH:D018805	marker/mechanism		NA		16003065
CASP3	836	Spinal Cord Injuries	MESH:D013119	marker/mechanism		NA		14588118
CASP3	836	Status Epilepticus	MESH:D013226	marker/mechanism		NA		16679645|18571097
CASP3	836	Subarachnoid Hemorrhage	MESH:D013345	marker/mechanism		NA		24602480
CASP4	837	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CASP4	837	Schizophrenia	MESH:D012559	marker/mechanism		NA		21743468
CASP7	840	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16583263
CASP7	840	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
CASP7	840	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CASP7	840	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		14998631
CASP7	840	Vitiligo	MESH:D014820	marker/mechanism		NA		22561518
CASP8	841	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		21472143
CASP8	841	Autoimmune Lymphoproliferative Syndrome	MESH:D056735	marker/mechanism		NA	607271	
CASP8	841	Breast Neoplasms	MESH:D001943	marker/mechanism		NA	114480	15601643|17293864|17450141|29915430
CASP8	841	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA	114550	
CASP8	841	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		20471133
CASP8	841	Cerebral Hemorrhage	MESH:D002543	marker/mechanism		NA		17971790
CASP8	841	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17450141
CASP8	841	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		16033404
CASP8	841	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
CASP8	841	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		15531508
CASP8	841	Edema	MESH:D004487	marker/mechanism		NA		19874808
CASP8	841	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		17450141|21472143
CASP8	841	Lung Neoplasms	MESH:D008175	marker/mechanism		NA	211980	17450141
CASP8	841	Melanoma	MESH:D008545	marker/mechanism		NA		18563783|21983787
CASP8	841	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		14998631
CASP8	841	Papillomavirus Infections	MESH:D030361	marker/mechanism		NA		23358896
CASP8	841	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	therapeutic		NA		22010212
CASP8	841	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
CASP8	841	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		23875703
CASP8	841	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		18563783
CASP8	841	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		23358896
CASP8	841	Status Epilepticus	MESH:D013226	marker/mechanism		NA		18571097
CASP8	841	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		17450141
CASP8	841	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		17450141
CASP9	842	Brain Ischemia	MESH:D002545	marker/mechanism		NA		11756504
CASP9	842	Edema	MESH:D004487	marker/mechanism		NA		19874808
CASP9	842	Ischemic Attack, Transient	MESH:D002546	marker/mechanism		NA		11333366
CASP9	842	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		14998631
CASP9	842	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		11150333
CASP9	842	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		20864405
CASP9	842	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
CASP9	842	Retinal Detachment	MESH:D012163	marker/mechanism		NA		18497877
CASQ1	844	MYOPATHY, VACUOLAR, WITH CASQ1 AGGREGATES	OMIM:616231	marker/mechanism		NA	616231	
CASQ2	845	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
CASQ2	845	Polymorphic catecholergic ventricular tachycardia	MESH:C536334	marker/mechanism		NA	611938	20513597
CASQ2	845	Tachycardia, Ventricular	MESH:D017180	marker/mechanism		NA		18052993
CASQ2	845	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY	OMIM:604772	marker/mechanism		NA	604772	
CASR	846	Epilepsy, Idiopathic Generalized	MESH:C562694	marker/mechanism		NA	612899	
CASR	846	Hypercalcemia	MESH:D006934	marker/mechanism		NA		9011580
CASR	846	Hyperparathyroidism	MESH:D006961	marker/mechanism		NA		11589681|9011580
CASR	846	Hyperparathyroidism, Neonatal Severe Primary	MESH:C563375	marker/mechanism		NA	239200	7916660
CASR	846	Hypocalcemia	MESH:D006996	marker/mechanism		NA		11701698|7874174
CASR	846	Hypocalcemia, Autosomal Dominant, with Bartter Syndrome	MESH:C563374	marker/mechanism		NA	601198	
CASR	846	Hypocalciuric hypercalcemia, familial, type 1	MESH:C537145	marker/mechanism		NA	145980	7916660
CASR	846	Hypoparathyroidism	MESH:D007011	marker/mechanism		NA		11701698
CASR	846	Hypoparathyroidism familial isolated	MESH:C537156	marker/mechanism		NA		20119591
CASS4	57091	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		30320580
CAST	831	Liver Failure, Acute	MESH:D017114	therapeutic		NA		16871587
CAST	831	Necrosis	MESH:D009336	therapeutic		NA		17323976
CAST	831	PEELING SKIN WITH LEUKONYCHIA, ACRAL PUNCTATE KERATOSES, CHEILITIS, AND KNUCKLE PADS	OMIM:616295	marker/mechanism		NA	616295	
CASZ1	54897	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
CASZ1	54897	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29662167
CASZ1	54897	Stroke	MESH:D020521	marker/mechanism		NA		29531354
CAT	847	Abnormalities, Drug-Induced	MESH:D000014	therapeutic		NA		21252394|26074427
CAT	847	Acatalasia	MESH:D020642	marker/mechanism|therapeutic		NA	614097	11001624|11117918|1551654|2308162|26074427
CAT	847	Acute Lung Injury	MESH:D055371	therapeutic		NA		15612528
CAT	847	Aortic Diseases	MESH:D001018	marker/mechanism		NA		25101153
CAT	847	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		22450443
CAT	847	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		22450443
CAT	847	Asphyxia Neonatorum	MESH:D001238	marker/mechanism		NA		17963755
CAT	847	Asthma	MESH:D001249	marker/mechanism		NA		18048809
CAT	847	Autistic Disorder	MESH:D001321	marker/mechanism		NA		15205966
CAT	847	Behcet Syndrome	MESH:D001528	marker/mechanism		NA		12074830
CAT	847	Brain Ischemia	MESH:D002545	marker/mechanism		NA		17564305
CAT	847	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25322848
CAT	847	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		11731445
CAT	847	Cardiomyopathies	MESH:D009202	therapeutic		NA		11800590
CAT	847	Cell Transformation, Neoplastic	MESH:D002471	therapeutic		NA		20516118|21742780|23518002|25448439|27323401|28881718
CAT	847	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		20623750|25231249
CAT	847	Cholestasis	MESH:D002779	marker/mechanism		NA		27989131
CAT	847	Chromosome Breakage	MESH:D019457	therapeutic		NA		25172298
CAT	847	Depressive Disorder, Major	MESH:D003865	marker/mechanism		NA		20471444
CAT	847	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		11117918
CAT	847	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism|therapeutic		NA		12123627|15855331|20709041
CAT	847	Diabetes Mellitus, Type 1	MESH:D003922	therapeutic		NA		15111504
CAT	847	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism|therapeutic		NA		15111504|15531508
CAT	847	Diabetic Neuropathies	MESH:D003929	marker/mechanism		NA		10780678
CAT	847	Disease Progression	MESH:D018450	marker/mechanism|therapeutic		NA		10673208|11283936|16081686
CAT	847	Dyskinesia, Drug-Induced	MESH:D004409	marker/mechanism		NA		19109989
CAT	847	Edema	MESH:D004487	marker/mechanism		NA		19874808
CAT	847	Fatty Liver	MESH:D005234	marker/mechanism		NA		10860543
CAT	847	Fetal Alcohol Spectrum Disorders	MESH:D063647	therapeutic		NA		26074427
CAT	847	Glioma	MESH:D005910	marker/mechanism		NA		21138464
CAT	847	Heart Failure	MESH:D006333	marker/mechanism		NA		16105639
CAT	847	Hepatitis	MESH:D006505	marker/mechanism		NA		1937386
CAT	847	Hepatitis, Chronic	MESH:D006521	marker/mechanism		NA		25053573
CAT	847	Hyperemia	MESH:D006940	therapeutic		NA		10792963
CAT	847	Hypertension	MESH:D006973	marker/mechanism		NA		11479740|20667508|21593737|22228705
CAT	847	Hyperthyroidism	MESH:D006980	marker/mechanism		NA		23391542
CAT	847	Hypotension	MESH:D007022	therapeutic		NA		15612528
CAT	847	Keratosis	MESH:D007642	marker/mechanism		NA		14580687
CAT	847	Kidney Calculi	MESH:D007669	marker/mechanism		NA		24360074
CAT	847	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		16518626|19420110
CAT	847	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		23274713
CAT	847	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		27497885
CAT	847	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		16081686
CAT	847	Marfan Syndrome	MESH:D008382	marker/mechanism		NA		25101153
CAT	847	Mesothelioma	MESH:D008654	marker/mechanism		NA		11283936
CAT	847	Myocardial Infarction	MESH:D009203	therapeutic		NA		21600015
CAT	847	Myocardial Reperfusion Injury	MESH:D015428	therapeutic		NA		21600015
CAT	847	Necrosis	MESH:D009336	therapeutic		NA		17309078|9548797
CAT	847	Neoplasm Invasiveness	MESH:D009361	therapeutic		NA		21749277|22580338
CAT	847	Neoplasm Metastasis	MESH:D009362	therapeutic		NA		12538496|22580338|23518002
CAT	847	Neoplasms	MESH:D009369	therapeutic		NA		21854796
CAT	847	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		29718361
CAT	847	Osteoporosis, Postmenopausal	MESH:D015663	marker/mechanism		NA		17227729
CAT	847	Phobic Disorders	MESH:D010698	marker/mechanism		NA		15309392
CAT	847	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		14580687
CAT	847	Premature Birth	MESH:D047928	marker/mechanism		NA		26055944
CAT	847	Protein Deficiency	MESH:D011488	marker/mechanism		NA		15865262
CAT	847	Psoriasis	MESH:D011565	marker/mechanism		NA		12559600
CAT	847	Pulmonary Edema	MESH:D011654	therapeutic		NA		15612528
CAT	847	Pulmonary Embolism	MESH:D011655	therapeutic		NA		2510358
CAT	847	Pulmonary Fibrosis	MESH:D011658	therapeutic		NA		19684199
CAT	847	Reperfusion Injury	MESH:D015427	marker/mechanism|therapeutic		NA		16682413|23743330|23875703|8215636
CAT	847	Rhinitis, Allergic	MESH:D065631	marker/mechanism		NA		29028686
CAT	847	Seizures	MESH:D012640	marker/mechanism|therapeutic		NA		18096215|19616071|20592767
CAT	847	Status Epilepticus	MESH:D013226	marker/mechanism|therapeutic		NA		15245787|15752349|17383094|18096215
CAT	847	Stomach Ulcer	MESH:D013276	therapeutic		NA		1887894
CAT	847	Turner Syndrome	MESH:D014424	marker/mechanism		NA		25101153
CAT	847	Ureteral Calculi	MESH:D014514	marker/mechanism		NA		24360074
CAT-2	173411	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		18514411
CAT-2	173411	Parkinsonian Disorders	MESH:D020734	marker/mechanism		NA		22483307
CATSPER1	117144	Spermatogenic Failure 7	MESH:C567832	marker/mechanism		NA	612997	
CATSPER2	117155	Deafness, Sensorineural, And Male Infertility	MESH:C567010	marker/mechanism		NA	611102	
CATSPER2	117155	Spermatogenic Failure 7	MESH:C567832	marker/mechanism		NA	612997	
CAV1	857	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		20062060|22544366|29892015
CAV1	857	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19234134|19288272|20562527|21501481
CAV1	857	Carcinogenesis	MESH:D063646	marker/mechanism		NA		29247004
CAV1	857	Cardiomegaly	MESH:D006332	marker/mechanism		NA		17487232
CAV1	857	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		18266981
CAV1	857	Familial Primary Pulmonary Hypertension	MESH:D065627	marker/mechanism		NA	615343	
CAV1	857	Glaucoma, Open-Angle	MESH:D005902	marker/mechanism		NA		20835238
CAV1	857	Hypertension	MESH:D006973	marker/mechanism		NA		1798635
CAV1	857	Lipodystrophy, Congenital Generalized, Type 3	MESH:C567282	marker/mechanism		NA	612526	
CAV1	857	Lipodystrophy, Familial Partial	MESH:D052496	marker/mechanism		NA		19793595
CAV1	857	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7	OMIM:606721	marker/mechanism		NA	606721	
CAV1	857	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CAV1	857	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		29247004
CAV1	857	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		20562527
CAV1	857	Ovarian Neoplasms	MESH:D010051	therapeutic		NA		15674352
CAV1	857	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		15948133|22159333
CAV1	857	Stevens-Johnson Syndrome	MESH:D013262	marker/mechanism		NA		25811541
CAV1	857	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
CAV1	857	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
CAV2	858	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		17379860
CAV2	858	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		20062060
CAV2	858	Glaucoma, Open-Angle	MESH:D005902	marker/mechanism		NA		20835238
CAV2	858	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		15583422
CAV3	859	Cardiomegaly	MESH:D006332	marker/mechanism		NA		19299911
CAV3	859	Cardiomyopathy, Familial Hypertrophic, 1	MESH:C566005	marker/mechanism		NA	192600	
CAV3	859	Chromosome 3, monosomy 3p25	MESH:C536807	marker/mechanism		NA		21082655
CAV3	859	CREATINE PHOSPHOKINASE, ELEVATED SERUM	OMIM:123320	marker/mechanism		NA	123320	
CAV3	859	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		18266981
CAV3	859	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		21082655
CAV3	859	Long Qt Syndrome 9	MESH:C567515	marker/mechanism		NA	611818	
CAV3	859	Muscular Dystrophies, Limb-Girdle	MESH:D049288	marker/mechanism		NA		12847114
CAV3	859	Muscular Dystrophy, Limb-Girdle, Type 1C	MESH:C563362	marker/mechanism		NA		30055862
CAV3	859	MYOPATHY, DISTAL, TATEYAMA TYPE	OMIM:614321	marker/mechanism		NA	614321	
CAV3	859	Rippling muscle disease, 1	MESH:C535686	marker/mechanism		NA	606072	11431690|15668980|16247063|21294223|30055862
CAVIN1	284119	Lipodystrophy, Congenital Generalized, Type 4	MESH:C567642	marker/mechanism		NA	613327	
CAVIN1	284119	Methylmalonic acidemia	MESH:C537358	marker/mechanism		NA		16823967
CAVIN1	284119	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
CAVIN2	8436	Hirschsprung Disease	MESH:D006627	marker/mechanism		NA		25792468
CBFB	865	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		17022082
CBFB	865	Cleft Palate	MESH:D002972	marker/mechanism		NA		17022082
CBFB	865	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		17022082
CBFB	865	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA	601626	18206229|27798625
CBFB	865	Leukemia, Myelomonocytic, Acute	MESH:D015479	marker/mechanism		NA		10958941
CBFB	865	Ossification, Heterotopic	MESH:D009999	marker/mechanism		NA		17022082
CBL	867	Cryptorchidism	MESH:D003456	marker/mechanism		NA		20694012
CBL	867	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		20694012
CBL	867	Growth Disorders	MESH:D006130	marker/mechanism		NA		20694012
CBL	867	Infertility, Male	MESH:D007248	marker/mechanism		NA		16301331
CBL	867	Leukemia, Myelomonocytic, Juvenile	MESH:D054429	marker/mechanism		NA	607785	20694012|22315502|26457647
CBL	867	NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	OMIM:613563	marker/mechanism		NA	613563	
CBL	867	Vasculitis	MESH:D014657	marker/mechanism		NA		20694012
CBLB	868	Encephalomyelitis, Autoimmune, Experimental	MESH:D004681	marker/mechanism		NA		20453840
CBLB	868	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		20453840
CBLIF	2694	Intrinsic Factor Deficiency	MESH:C563242	marker/mechanism		NA	261000	
CBLIF	2694	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
CBLN2	147381	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		23502781
CBR1	873	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21056497
CBR1	873	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		11016643
CBR1	873	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		21056497
CBR1	873	Dermatitis, Irritant	MESH:D017453	therapeutic		NA		25818598
CBR1	873	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		26282591
CBR1	873	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
CBR2	12409	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		18597497
CBS	875	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		16791140
CBS	875	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		23665415
CBS	875	Homocystinuria	MESH:D006712	marker/mechanism		NA	236200	
CBS	875	Hyperhomocysteinemia	MESH:D020138	marker/mechanism		NA		17292331|19028542|19204075
CBS	875	Hypertension	MESH:D006973	marker/mechanism		NA		18224302
CBS	875	Lymphoma, Non-Hodgkin	MESH:D008228	marker/mechanism		NA		17119116
CBS	875	Malnutrition	MESH:D044342	marker/mechanism		NA		16709328
CBS	875	Melanoma	MESH:D008545	marker/mechanism		NA		25205294
CBX1	10951	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
CBX2	84733	46, XY Sex Reversal 5	MESH:C567766	marker/mechanism		NA	613080	
CBX5	23468	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		25944804
CBX7	23492	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		23955597
CC2D1A	54862	Mental Retardation, Autosomal Recessive 3	MESH:C563929	marker/mechanism		NA	608443	
CC2D2A	57545	COACH syndrome	MESH:C536430	marker/mechanism		NA	216360	
CC2D2A	57545	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
CC2D2A	57545	Joubert Syndrome 9	MESH:C567364	marker/mechanism		NA	612285	
CC2D2A	57545	Meckel Syndrome, Type 6	MESH:C567365	marker/mechanism		NA	612284	
CCAR2	57805	Wallerian Degeneration	MESH:D014855	marker/mechanism		NA		24252177
CCAT1	100507056	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		26752646
CCAT1	100507056	Gallbladder Neoplasms	MESH:D005706	marker/mechanism		NA		26752646
CCAT1	100507056	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		26752646
CCAT1	100507056	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		26752646
CCAT1	100507056	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		26752646|31945315
CCBE1	147372	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CCBE1	147372	Facies	MESH:D019066	marker/mechanism		NA		19935664
CCBE1	147372	Hennekam lymphangiectasia lymphedema syndrome	MESH:C537255	marker/mechanism		NA	235510	19911200|19935664
CCBE1	147372	Hydrops Fetalis	MESH:D015160	marker/mechanism		NA		19911200
CCBE1	147372	Intellectual Disability	MESH:D008607	marker/mechanism		NA		19935664
CCDC103	388389	CILIARY DYSKINESIA, PRIMARY, 17	OMIM:614679	marker/mechanism		NA	614679	
CCDC103	388389	Kartagener Syndrome	MESH:D007619	marker/mechanism		NA		22581229
CCDC115	84317	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIo	OMIM:616828	marker/mechanism		NA	616828	
CCDC126	90693	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CCDC134	79879	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
CCDC134	79879	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		19233941
CCDC137	339230	Schizophrenia	MESH:D012559	marker/mechanism		NA		21743468
CCDC141	285025	Idiopathic Hypogonadotropic Hypogonadism	MESH:C562785	marker/mechanism		NA	146110	
CCDC174	51244	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION	OMIM:616816	marker/mechanism		NA	616816	
CCDC22	28952	3C syndrome	MESH:C535313	marker/mechanism		NA	300963	
CCDC26	137196	Glioma	MESH:D005910	marker/mechanism		NA		19578367
CCDC28B	79140	Bardet-Biedl syndrome 1	MESH:C537909	marker/mechanism		NA	209900	
CCDC39	339829	CILIARY DYSKINESIA, PRIMARY, 14	OMIM:613807	marker/mechanism		NA	613807	
CCDC40	55036	CILIARY DYSKINESIA, PRIMARY, 15	OMIM:613808	marker/mechanism		NA	613808	
CCDC40	55036	Kartagener Syndrome	MESH:D007619	marker/mechanism		NA		21131974
CCDC50	152137	Deafness, Autosomal Dominant 44	MESH:C564399	marker/mechanism		NA	607453	
CCDC6	8030	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
CCDC63	160762	Melanoma	MESH:D008545	marker/mechanism		NA		21499247
CCDC65	85478	CILIARY DYSKINESIA, PRIMARY, 27	OMIM:615504	marker/mechanism		NA	615504	
CCDC78	124093	Myopathies, Structural, Congenital	MESH:D020914	marker/mechanism		NA	614807	
CCDC80	151887	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
CCDC80	151887	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		23042114
CCDC86	79080	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		23828858
CCDC88B	283234	Leprosy	MESH:D007918	marker/mechanism		NA		25642632
CCDC88C	440193	Hydrocephalus	MESH:D006849	marker/mechanism		NA	236600	
CCDC88C	440193	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA	616053	
CCDC91	55297	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
CCDC92	80212	Coronary Disease	MESH:D003327	marker/mechanism		NA		28869590
CCDC92	80212	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28869590
CCHCR1	54535	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
CCHCR1	54535	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		29379198
CCHCR1	54535	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		21743467
CCK	885	Anorexia	MESH:D000855	marker/mechanism		NA		22903826|24385417
CCK	885	Catalepsy	MESH:D002375	therapeutic		NA		2862602|4040614
CCK	885	Dyskinesia, Drug-Induced	MESH:D004409	therapeutic		NA		2320253
CCK	885	Fever	MESH:D005334	therapeutic		NA		27565679
CCK	885	Gallstones	MESH:D042882	marker/mechanism		NA		1631261
CCK	885	Gastrointestinal Diseases	MESH:D005767	therapeutic		NA		7481522
CCK	885	Hyperkinesis	MESH:D006948	therapeutic		NA		3561887|3735805
CCK	885	Inflammation	MESH:D007249	therapeutic		NA		14599722
CCK	885	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
CCK	885	Neurobehavioral Manifestations	MESH:D019954	therapeutic		NA		27565679
CCK	885	Neurotoxicity Syndromes	MESH:D020258	marker/mechanism		NA		19784758
CCK	885	Pancreatitis	MESH:D010195	marker/mechanism		NA		16187300|16499907
CCK	885	Seizures	MESH:D012640	therapeutic		NA		6265841
CCK	885	Stomach Ulcer	MESH:D013276	marker/mechanism|therapeutic		NA		10422768|10458643|11025360|11787760|15024038|9872509
CCK	885	Unconsciousness	MESH:D014474	marker/mechanism		NA		6281507
CCKAR	886	Alcoholism	MESH:D000437	marker/mechanism		NA		9922984
CCKAR	886	Gallbladder Neoplasms	MESH:D005706	marker/mechanism		NA		25025063
CCKBR	887	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		9922984
CCKBR	887	Hyperalgesia	MESH:D006930	marker/mechanism		NA		11880531
CCKBR	887	Obsessive-Compulsive Disorder	MESH:D009771	marker/mechanism		NA		8878350
CCKBR	887	Panic Disorder	MESH:D016584	marker/mechanism		NA		8878350
CCKBR	887	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		11880531|9496717
CCL1	6346	Endometriosis	MESH:D004715	marker/mechanism		NA		30579999
CCL1	6346	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		10385480
CCL1	6346	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		22507635
CCL1	6346	Nephritis, Interstitial	MESH:D009395	marker/mechanism		NA		10385480
CCL11	6356	Asthma	MESH:D001249	marker/mechanism		NA	600807	
CCL11	6356	Brain Ischemia	MESH:D002545	marker/mechanism		NA		15829914
CCL11	6356	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		18249437
CCL11	6356	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		14616128
CCL11	6356	Endometriosis	MESH:D004715	marker/mechanism		NA		30579999
CCL11	6356	HIV Infections	MESH:D015658	marker/mechanism		NA	609423	
CCL11	6356	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
CCL11	6356	Inflammation	MESH:D007249	marker/mechanism		NA		23707484
CCL11	6356	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
CCL11	6356	Polyomavirus Infections	MESH:D027601	marker/mechanism		NA		25162674
CCL11	6356	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		16314464|17620002
CCL11	6356	Respiratory Hypersensitivity	MESH:D012130	marker/mechanism		NA		17085522
CCL12	20293	Brain Ischemia	MESH:D002545	marker/mechanism		NA		15829914
CCL12	20293	Bronchial Hyperreactivity	MESH:D016535	marker/mechanism		NA		12388339
CCL12	20293	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
CCL12	20293	Idiopathic Pulmonary Fibrosis	MESH:D054990	therapeutic		NA		28434932
CCL12	20293	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
CCL14	6358	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CCL17	6361	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		18249437
CCL17	6361	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
CCL17	6361	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
CCL18	6362	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		23349697
CCL18	6362	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		23349697
CCL19	6363	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17597826
CCL19	6363	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
CCL19	6363	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
CCL2	6347	Asthma	MESH:D001249	marker/mechanism		NA		19373627
CCL2	6347	Atherosclerosis	MESH:D050197	marker/mechanism		NA		12677255|12928151|20720404
CCL2	6347	Brain Injuries	MESH:D001930	marker/mechanism		NA		21549006
CCL2	6347	Brain Ischemia	MESH:D002545	marker/mechanism		NA		15829914|17394460
CCL2	6347	Bronchial Hyperreactivity	MESH:D016535	marker/mechanism		NA		12388339
CCL2	6347	Calcinosis	MESH:D002114	marker/mechanism		NA		21193197|21335463
CCL2	6347	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		25199511
CCL2	6347	Cardiotoxicity	MESH:D066126	marker/mechanism		NA		29959987
CCL2	6347	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		16332659
CCL2	6347	Carotid Artery Diseases	MESH:D002340	marker/mechanism		NA		18022660
CCL2	6347	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		20623750
CCL2	6347	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		11500196|16934270
CCL2	6347	Coronavirus Infections	MESH:D018352	marker/mechanism		NA		20484496
CCL2	6347	COVID-19	MESH:C000657245	marker/mechanism		NA		31986264
CCL2	6347	Crohn Disease	MESH:D003424	marker/mechanism		NA		21829567
CCL2	6347	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		16374426
CCL2	6347	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		31557154
CCL2	6347	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		17380299
CCL2	6347	Fatty Liver	MESH:D005234	marker/mechanism		NA		29684222
CCL2	6347	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		10385480
CCL2	6347	Heart Failure	MESH:D006333	marker/mechanism		NA		29959987
CCL2	6347	Heart Valve Diseases	MESH:D006349	marker/mechanism		NA		21335463
CCL2	6347	Hepatitis, Autoimmune	MESH:D019693	marker/mechanism		NA		21227906
CCL2	6347	Hernias, Diaphragmatic, Congenital	MESH:D065630	marker/mechanism		NA		30418988
CCL2	6347	HIV Infections	MESH:D015658	marker/mechanism		NA	609423	
CCL2	6347	Hyperalgesia	MESH:D006930	marker/mechanism		NA		17881535
CCL2	6347	Hyperglycemia	MESH:D006943	marker/mechanism		NA		29035695
CCL2	6347	Hyperinsulinism	MESH:D006946	marker/mechanism		NA		29035695
CCL2	6347	Hyperoxaluria	MESH:D006959	marker/mechanism		NA		16284884
CCL2	6347	Hypersensitivity	MESH:D006967	marker/mechanism		NA		15585374|21625544
CCL2	6347	Hypertension	MESH:D006973	marker/mechanism		NA		20667508|27292124
CCL2	6347	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		15302794|30418988
CCL2	6347	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism|therapeutic		NA		12374626|23043544|25257527
CCL2	6347	Inflammation	MESH:D007249	marker/mechanism		NA		14570645|19762220|20816778
CCL2	6347	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
CCL2	6347	Insulin Resistance	MESH:D007333	marker/mechanism		NA		29035695
CCL2	6347	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19420110|19539174
CCL2	6347	Leishmaniasis, Cutaneous	MESH:D016773	marker/mechanism		NA		20102417
CCL2	6347	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		20697377
CCL2	6347	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		15492853
CCL2	6347	Liver Diseases	MESH:D008107	marker/mechanism		NA		17125873
CCL2	6347	Lung Injury	MESH:D055370	marker/mechanism		NA		19762220
CCL2	6347	Metabolic Syndrome	MESH:D024821	marker/mechanism		NA		16188961|18486454
CCL2	6347	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		25199511
CCL2	6347	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		16918137
CCL2	6347	Muscular Dystrophy, Duchenne	MESH:D020388	marker/mechanism		NA		21641384
CCL2	6347	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO	OMIM:607948	marker/mechanism		NA	607948	
CCL2	6347	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
CCL2	6347	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		12087064
CCL2	6347	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		25199511
CCL2	6347	Nephritis, Interstitial	MESH:D009395	marker/mechanism		NA		10385480
CCL2	6347	Neural Tube Defects	MESH:D009436	marker/mechanism		NA	182940	
CCL2	6347	Obesity	MESH:D009765	marker/mechanism		NA		29035695
CCL2	6347	Obstetric Labor, Premature	MESH:D007752	marker/mechanism		NA		18606702
CCL2	6347	Pleural Diseases	MESH:D010995	marker/mechanism		NA		10923243
CCL2	6347	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
CCL2	6347	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		16324872|17720292|26163174
CCL2	6347	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		12468449|15829914
CCL2	6347	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
CCL2	6347	Retinal Degeneration	MESH:D012162	marker/mechanism		NA		20361964
CCL2	6347	Schizophrenia	MESH:D012559	marker/mechanism		NA		18486454
CCL2	6347	Severe Acute Respiratory Syndrome	MESH:D045169	marker/mechanism		NA		20484496
CCL2	6347	Silicosis	MESH:D012829	marker/mechanism		NA		26163174
CCL2	6347	Spinal Cord Compression	MESH:D013117	marker/mechanism		NA		15135227
CCL2	6347	Spinal Dysraphism	MESH:D016135	marker/mechanism		NA		16596675
CCL2	6347	Status Epilepticus	MESH:D013226	marker/mechanism		NA		19490431|20034406
CCL2	6347	Thyroid Diseases	MESH:D013959	marker/mechanism		NA		23397585
CCL2	6347	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		26037280
CCL2	6347	Tuberculosis, Pulmonary	MESH:D014397	marker/mechanism		NA		16352737|18940815
CCL2	6347	Ureteral Obstruction	MESH:D014517	marker/mechanism		NA		28318631
CCL20	6364	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
CCL20	6364	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037
CCL20	6364	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		16306769
CCL20	6364	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
CCL20	6364	Diabetes Mellitus, Experimental	MESH:D003921	therapeutic		NA		21340626
CCL20	6364	Diabetes Mellitus, Type 1	MESH:D003922	therapeutic		NA		21340626
CCL20	6364	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
CCL20	6364	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		30603057
CCL20	6364	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		30603057
CCL20	6364	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		30603057
CCL20	6364	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
CCL20	6364	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
CCL20	6364	Ureteral Obstruction	MESH:D014517	marker/mechanism		NA		28318631
CCL21	6366	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		18794853|20453842|23143596
CCL22	6367	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		18249437|22125604
CCL22	6367	Endometriosis	MESH:D004715	marker/mechanism		NA		30579999
CCL23	6368	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		23056237
CCL24	6369	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		18249437
CCL24	6369	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		14616128
CCL24	6369	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
CCL24	6369	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
CCL27	10850	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
CCL27	10850	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25162674
CCL3	6348	Atherosclerosis	MESH:D050197	marker/mechanism		NA		24370436
CCL3	6348	Brain Ischemia	MESH:D002545	marker/mechanism		NA		15829914|17394460
CCL3	6348	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		16284949
CCL3	6348	COVID-19	MESH:C000657245	marker/mechanism		NA		31986264
CCL3	6348	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		10385480
CCL3	6348	HIV Infections	MESH:D015658	marker/mechanism		NA	609423	
CCL3	6348	Hypersensitivity	MESH:D006967	marker/mechanism		NA		15585374|23624239
CCL3	6348	Inflammation	MESH:D007249	marker/mechanism		NA		19762220
CCL3	6348	Lung Injury	MESH:D055370	marker/mechanism		NA		19762220
CCL3	6348	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25162674
CCL3	6348	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
CCL3	6348	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		16324872|17720292
CCL3	6348	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		15829914
CCL3	6348	Status Epilepticus	MESH:D013226	marker/mechanism		NA		19490431
CCL3L1	6349	HIV Infections	MESH:D015658	marker/mechanism		NA	609423	
CCL3L3	414062	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
CCL3L3	414062	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
CCL4	6351	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
CCL4	6351	Atherosclerosis	MESH:D050197	marker/mechanism		NA		24370436
CCL4	6351	Brain Ischemia	MESH:D002545	marker/mechanism		NA		15829914
CCL4	6351	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		31557154
CCL4	6351	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		10385480
CCL4	6351	Hypersensitivity	MESH:D006967	marker/mechanism		NA		15585374|21625544
CCL4	6351	Inflammation	MESH:D007249	marker/mechanism		NA		19762220
CCL4	6351	Lung Injury	MESH:D055370	marker/mechanism		NA		19762220
CCL4	6351	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
CCL4	6351	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
CCL4	6351	Polyomavirus Infections	MESH:D027601	marker/mechanism		NA		25162674
CCL4	6351	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		17720292
CCL4	6351	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
CCL5	6352	Asthma	MESH:D001249	marker/mechanism		NA		8534483
CCL5	6352	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		18249437
CCL5	6352	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		10385480
CCL5	6352	Hepatitis, Alcoholic	MESH:D006519	marker/mechanism		NA		12586603
CCL5	6352	Hepatitis, Autoimmune	MESH:D019693	marker/mechanism		NA		21227906
CCL5	6352	Hyperoxaluria	MESH:D006959	marker/mechanism		NA		16284884
CCL5	6352	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		12126966
CCL5	6352	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CCL5	6352	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25162674
CCL5	6352	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		18985009
CCL5	6352	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		17620002
CCL6	20305	Calcinosis	MESH:D002114	marker/mechanism		NA		21335463
CCL6	20305	Heart Valve Diseases	MESH:D006349	marker/mechanism		NA		21335463
CCL6	20305	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CCL6	20305	Respiratory Hypersensitivity	MESH:D012130	marker/mechanism		NA		17085522
CCL7	6354	Cholestasis	MESH:D002779	marker/mechanism		NA		21224055
CCL7	6354	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		10385480
CCL7	6354	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
CCL7	6354	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		12374626
CCL7	6354	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25162674
CCL7	6354	Nephritis, Interstitial	MESH:D009395	marker/mechanism		NA		10385480
CCL7	6354	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
CCL8	6355	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		17568789
CCL8	6355	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
CCL8	6355	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
CCL8	6355	Nephrogenic Fibrosing Dermopathy	MESH:D054989	marker/mechanism		NA		20959327
CCL8	6355	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
CCL8	6355	Respiratory Hypersensitivity	MESH:D012130	marker/mechanism		NA		17085522
CCL9	20308	Brain Ischemia	MESH:D002545	marker/mechanism		NA		15829914
CCL9	20308	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
CCL9	20308	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
CCL9	20308	Respiratory Hypersensitivity	MESH:D012130	marker/mechanism		NA		17085522
CCM2	83605	Cerebral Cavernous Malformations 2	MESH:C566394	marker/mechanism		NA	603284	
CCM2	83605	Hemangioma, Cavernous, Central Nervous System	MESH:D020786	marker/mechanism		NA		18154020
CCN1	3491	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		19192274
CCN1	3491	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		17699798
CCN1	3491	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
CCN1	3491	Scleroderma, Systemic	MESH:D012595	marker/mechanism		NA		27482699
CCN2	1490	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		21552421
CCN2	1490	Aortic Valve Insufficiency	MESH:D001022	marker/mechanism		NA		21216836
CCN2	1490	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		19192274
CCN2	1490	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		28789951
CCN2	1490	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
CCN2	1490	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA		17121042
CCN2	1490	Heart Failure	MESH:D006333	marker/mechanism		NA		17229371
CCN2	1490	Hepatitis B, Chronic	MESH:D019694	marker/mechanism		NA		17657819
CCN2	1490	Hernias, Diaphragmatic, Congenital	MESH:D065630	marker/mechanism		NA		20939759|21258935
CCN2	1490	Hypertension	MESH:D006973	marker/mechanism		NA		16685210
CCN2	1490	Infertility, Female	MESH:D007247	marker/mechanism		NA		21868453
CCN2	1490	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		16652398|17657819|26396155
CCN2	1490	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CCN2	1490	Lung Diseases	MESH:D008171	marker/mechanism		NA		20939759|21258935
CCN2	1490	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		21552421
CCN2	1490	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D015452	marker/mechanism		NA		24154679
CCN2	1490	Prenatal Exposure Delayed Effects	MESH:D011297	marker/mechanism		NA		21258935
CCN2	1490	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		15298857|15677772|25815693|26817844
CCN2	1490	Scleroderma, Systemic	MESH:D012595	marker/mechanism		NA		24706986
CCN2A	321449	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		27935819
CCN4	8840	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		30723155
CCN6	8838	Arthropathy, progressive pseudorheumatoid, of childhood	MESH:C535387	marker/mechanism		NA	208230	
CCNA1	8900	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		12029619
CCNA1	8900	Papillomavirus Infections	MESH:D030361	marker/mechanism		NA		23358896
CCNA1	8900	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		23358896|29464035
CCNA2	890	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
CCNA2	890	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CCNA2	890	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		29464035
CCNB1	891	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CCNB1	891	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
CCNB1	891	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		29464035
CCNB2	9133	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CCNB2	9133	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CCNB3	85417	Osteosarcoma	MESH:D012516	marker/mechanism		NA		22387997
CCND1	595	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		26432044
CCND1	595	Bowen's Disease	MESH:D001913	marker/mechanism		NA		29103775
CCND1	595	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		20932960|27935819
CCND1	595	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		12839951|17255770|19636701|20948315|23839043|25267515
CCND1	595	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462|14522882|16316942|17173897
CCND1	595	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
CCND1	595	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		12029619|19919837|22649188|25822088|26189965
CCND1	595	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		26432044
CCND1	595	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		12151359
CCND1	595	Cecal Neoplasms	MESH:D002430	marker/mechanism		NA		14688030
CCND1	595	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism|therapeutic		NA		21726611|24362009
CCND1	595	Clinical Deterioration	MESH:D000075902	marker/mechanism		NA		29464035
CCND1	595	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		18283038|19147571|21081470|21188121
CCND1	595	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	114500	
CCND1	595	Disease Progression	MESH:D018450	marker/mechanism		NA		29103775
CCND1	595	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		29232554
CCND1	595	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		12235107
CCND1	595	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		25151357
CCND1	595	Genomic Instability	MESH:D042822	marker/mechanism		NA		8548770
CCND1	595	Hemangiosarcoma	MESH:D006394	marker/mechanism		NA		17569031
CCND1	595	Hyperparathyroidism	MESH:D006961	marker/mechanism		NA		21541686
CCND1	595	Hyperplasia	MESH:D006965	marker/mechanism		NA		12151359|21541686
CCND1	595	Intestinal Polyps	MESH:D007417	marker/mechanism		NA		12584176
CCND1	595	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		21693435
CCND1	595	Leukemia	MESH:D007938	marker/mechanism		NA		10602166
CCND1	595	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		27064257
CCND1	595	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		28100771
CCND1	595	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		11307925|16289808
CCND1	595	Lymphoma, Mantle-Cell	MESH:D020522	marker/mechanism		NA		22383795|26174628
CCND1	595	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462|14522882|16316942|17173897
CCND1	595	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462|14522882|16316942
CCND1	595	Multiple Myeloma	MESH:D009101	marker/mechanism		NA	254500	23502783
CCND1	595	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
CCND1	595	Nasopharyngeal Carcinoma	MESH:D000077274	marker/mechanism		NA		24952746
CCND1	595	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		20932960
CCND1	595	Papilloma	MESH:D010212	marker/mechanism		NA		12151359
CCND1	595	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		12151359
CCND1	595	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17606477
CCND1	595	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
CCND1	595	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		26909611|29464035
CCND1	595	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21628965
CCND1	595	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		23811263
CCND1	595	Urologic Neoplasms	MESH:D014571	marker/mechanism		NA		21040761
CCND1	595	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		26432044
CCND1	595	von Hippel-Lindau Disease	MESH:D006623	marker/mechanism		NA	193300	
CCND2	894	Cardiomegaly	MESH:D006332	therapeutic		NA		15576649
CCND2	894	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
CCND2	894	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		30510241
CCND2	894	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		24464100
CCND2	894	Fibrosis	MESH:D005355	therapeutic		NA		16306446
CCND2	894	Hydrocephalus	MESH:D006849	marker/mechanism		NA		29642246
CCND2	894	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		27798625
CCND2	894	Megalancephaly Polymicrogyria-Polydactyly Hydrocephalus Syndrome	MESH:C566381	marker/mechanism		NA	615938	24705253|29642246
CCND2	894	Megalencephaly	MESH:D058627	marker/mechanism		NA		29642246
CCND2	894	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
CCND2	894	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		17270028
CCND2	894	Perisylvian syndrome	MESH:C536658	marker/mechanism		NA		29642246
CCND2	894	Polydactyly, Postaxial	MESH:C562429	marker/mechanism		NA		29642246
CCND2	894	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17016690
CCND3	896	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054218	marker/mechanism		NA		28671688
CCNDBP1	23582	Liver Neoplasms, Experimental	MESH:D008114	therapeutic		NA		16501603
CCNE1	898	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19385967|23624423
CCNE1	898	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		12029619|22634754
CCNE1	898	Disease Progression	MESH:D018450	marker/mechanism		NA		19385967
CCNE1	898	Medulloblastoma	MESH:D008527	marker/mechanism		NA		19270706
CCNE1	898	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		21397856
CCNE1	898	Recurrence	MESH:D012008	marker/mechanism		NA		19385967
CCNE1	898	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		29464035
CCNE1	898	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		20972438|27514407
CCNE2	9134	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
CCNE2	9134	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
CCNE2	9134	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
CCNE2	9134	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		29464035
CCNF	899	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CCNG1	900	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CCNG1	900	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		16289808
CCNH	902	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		30705370
CCNH	902	Carcinoma	MESH:D002277	marker/mechanism		NA		12606953
CCNH	902	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		30705370
CCNH	902	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		30705370
CCNH	902	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		30705370
CCNH	902	Glioblastoma	MESH:D005909	marker/mechanism		NA		30705370
CCNH	902	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		30705370
CCNH	902	Lymphatic Metastasis	MESH:D008207	marker/mechanism		NA		30705370
CCNH	902	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12606953
CCNH	902	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12606953
CCNH	902	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		30705370
CCNH	902	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		30705370
CCNO	10309	CILIARY DYSKINESIA, PRIMARY, 29	OMIM:615872	marker/mechanism		NA	615872	
CCNO	10309	Lung Diseases, Obstructive	MESH:D008173	marker/mechanism		NA		24747639
CCNQ	92002	Toe Syndactyly, Telecanthus, and Anogenital and Renal Malformations	MESH:C567475	marker/mechanism		NA	300707	18297069
CCNY	219771	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		18438405
CCNY	219771	Crohn Disease	MESH:D003424	marker/mechanism		NA		18438405
CCR1	1230	Behcet Syndrome	MESH:D001528	marker/mechanism		NA		23291587
CCR1	1230	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		16284949
CCR1	1230	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
CCR1	1230	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
CCR1	1230	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
CCR1	1230	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
CCR10	2826	Status Epilepticus	MESH:D013226	marker/mechanism		NA		17181556
CCR2	729230	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		20623750
CCR2	729230	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17374397
CCR2	729230	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
CCR2	729230	Liver Diseases	MESH:D008107	marker/mechanism		NA		12845637
CCR2	729230	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
CCR2	729230	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		14609568
CCR2	729230	Status Epilepticus	MESH:D013226	marker/mechanism		NA		19490431|20034406
CCR3	1232	Asthma, Aspirin-Induced	MESH:D055963	marker/mechanism		NA		20485159
CCR3	1232	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		18249437
CCR3	1232	HIV Infections	MESH:D015658	marker/mechanism		NA		10202824
CCR3	1232	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		16314464
CCR3	1232	Respiratory Hypersensitivity	MESH:D012130	marker/mechanism		NA		20022477
CCR3	1232	Status Epilepticus	MESH:D013226	marker/mechanism		NA		19490431
CCR4	1233	Brain Ischemia	MESH:D002545	marker/mechanism		NA		15829914
CCR4	1233	Celiac Disease	MESH:D002446	marker/mechanism		NA		20190752
CCR4	1233	Glioma	MESH:D005910	marker/mechanism		NA		17522861
CCR4	1233	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		26437031
CCR4	1233	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
CCR4	1233	Sezary Syndrome	MESH:D012751	marker/mechanism		NA		26551670
CCR5	1234	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		26055553
CCR5	1234	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		18249437
CCR5	1234	Diabetes Mellitus, Insulin-Dependent, 22	MESH:C567284	marker/mechanism		NA	612522	
CCR5	1234	Hepatitis C	MESH:D006526	marker/mechanism		NA	609532	
CCR5	1234	Nephritis	MESH:D009393	marker/mechanism		NA		26055553
CCR5	1234	West Nile Fever	MESH:D014901	marker/mechanism		NA	610379	
CCR6	1235	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		20453841|20453842|23143596
CCR6	1235	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		16306769
CCR6	1235	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
CCR6	1235	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
CCR6	1235	Vitiligo	MESH:D014820	marker/mechanism		NA		20526340
CCR7	1236	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		26437031
CCR7	1236	Status Epilepticus	MESH:D013226	marker/mechanism		NA		17181556
CCR8	1237	Status Epilepticus	MESH:D013226	marker/mechanism		NA		17181556
CCR9	10803	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
CCR9	10803	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
CCR9	10803	Status Epilepticus	MESH:D013226	marker/mechanism		NA		17181556
CCRL2	9034	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
CCRL2	9034	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
CCS	9973	Deficiency Diseases	MESH:D003677	marker/mechanism		NA		12514262
CCS	9973	Hepatitis, Chronic	MESH:D006521	marker/mechanism		NA		25053573
CCSER1	401145	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		18438686
CCT2	10576	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
CCT3	7203	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
CCT3	7203	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
CCT5	22948	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
CCT5	22948	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17659439
CCT5	22948	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
CCT5	22948	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
CCT5	22948	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
CCT5	22948	Neuropathy, Hereditary Sensory, with Spastic Paraplegia, Autosomal Recessive	MESH:C564948	marker/mechanism		NA	256840	
CCT6B	10693	Burkitt Lymphoma	MESH:D002051	marker/mechanism		NA		23143597
CCT7	10574	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		31825490
CCT7	10574	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
CCT7	10574	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
CCT7	10574	Kidney Tubular Necrosis, Acute	MESH:D007683	marker/mechanism		NA		31825490
CCT7	10574	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
CD109	135228	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18507500
CD109	135228	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18507500|21278247
CD14	929	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
CD14	929	Asthma	MESH:D001249	marker/mechanism		NA		17607003
CD14	929	Brain Injuries	MESH:D001930	marker/mechanism		NA		21549006
CD14	929	Diarrhea	MESH:D003967	marker/mechanism		NA		21596674
CD14	929	Eczema	MESH:D004485	marker/mechanism		NA		19759553
CD14	929	Gout	MESH:D006073	marker/mechanism		NA		26462562
CD14	929	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		20353583
CD14	929	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		20353583
CD14	929	Weight Loss	MESH:D015431	marker/mechanism		NA		28411859
CD151	977	Nephropathy with Pretibial Epidermolysis Bullosa and Deafness	MESH:C563798	marker/mechanism		NA	609057	
CD163	9332	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
CD163	9332	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CD163	9332	Carotid Artery Diseases	MESH:D002340	marker/mechanism		NA		17095719
CD163	9332	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		25133636
CD163	9332	Hyperglycemia	MESH:D006943	marker/mechanism		NA		29035695
CD163	9332	Hyperinsulinism	MESH:D006946	marker/mechanism		NA		29035695
CD163	9332	Insulin Resistance	MESH:D007333	marker/mechanism		NA		29035695
CD163	9332	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CD163	9332	Obesity	MESH:D009765	marker/mechanism		NA		29035695
CD163L1	283316	Melanoma	MESH:D008545	marker/mechanism		NA		22842228
CD164	8763	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
CD164	8763	DEAFNESS, AUTOSOMAL DOMINANT 66	OMIM:616969	marker/mechanism		NA	616969	
CD19	930	Agammaglobulinemia	MESH:D000361	marker/mechanism		NA		16672701
CD19	930	Common Variable Immunodeficiency	MESH:D017074	marker/mechanism		NA	240500|613493	16672701
CD2	914	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		23143596
CD2	914	Nephrotic Syndrome	MESH:D009404	marker/mechanism		NA		2465858
CD2	914	Thrombosis	MESH:D013927	marker/mechanism		NA		16932337
CD200R1	131450	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CD200R2	271375	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CD209	30835	Dengue	MESH:D003715	marker/mechanism		NA	614371	15838506
CD209	30835	Hepatitis C	MESH:D006526	marker/mechanism		NA		27385120
CD209	30835	HIV Infections	MESH:D015658	marker/mechanism		NA	609423	15564514
CD209	30835	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO	OMIM:607948	marker/mechanism		NA	607948	
CD209	30835	Tuberculosis, Pulmonary	MESH:D014397	marker/mechanism		NA		16379498
CD226	10666	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
CD226	10666	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		16015041
CD226	10666	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
CD226	10666	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		26808113
CD24	100133941	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CD24	100133941	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		28369074
CD244	51744	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA	180300	18794858
CD247	919	Immunodeficiency due to Defect in CD3-Zeta	MESH:C565712	marker/mechanism		NA	610163	
CD247	919	Scleroderma, Systemic	MESH:D012595	marker/mechanism		NA		20383147
CD27	939	Cachexia	MESH:D002100	marker/mechanism		NA		17878525
CD27	939	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		12031769
CD27	939	LYMPHOPROLIFERATIVE SYNDROME 2	OMIM:615122	marker/mechanism		NA	615122	
CD27	939	Myocarditis	MESH:D009205	marker/mechanism		NA		12031769
CD27	939	Virus Diseases	MESH:D014777	marker/mechanism		NA		12031769
CD274	29126	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		22396772
CD274	29126	Disease Progression	MESH:D018450	marker/mechanism		NA		27692344
CD274	29126	Hypersensitivity	MESH:D006967	marker/mechanism		NA		20488241|23624239
CD274	29126	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27692344
CD274	29126	Lymphoma	MESH:D008223	marker/mechanism		NA		28736328
CD274	29126	Neoplasms, Radiation-Induced	MESH:D009381	marker/mechanism		NA		28736328
CD274	29126	Recurrence	MESH:D012008	marker/mechanism		NA		22396772
CD274	29126	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
CD274	29126	Thymus Neoplasms	MESH:D013953	marker/mechanism		NA		28736328
CD276	80381	Carcinoma, Hepatocellular	MESH:D006528	therapeutic		NA		16217749
CD276	80381	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CD276	80381	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		30614027
CD28	940	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		19898481|20453842|23143596
CD28	940	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		15494542|19077085
CD28	940	Berylliosis	MESH:D001607	marker/mechanism		NA		12952926
CD28	940	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
CD28	940	HIV Infections	MESH:D015658	marker/mechanism		NA		7492435
CD28	940	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		26437031
CD28	940	Lymphoma, T-Cell, Cutaneous	MESH:D016410	marker/mechanism		NA		26192916|26258847
CD28	940	Lymphoma, T-Cell, Peripheral	MESH:D016411	marker/mechanism		NA		26192916
CD2AP	23607	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		21460840|21460841|30320580
CD2AP	23607	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA	607832	
CD320	51293	METHYLMALONIC ACIDURIA, TRANSIENT, DUE TO TRANSCOBALAMIN RECEPTOR DEFECT	OMIM:613646	marker/mechanism		NA	613646	
CD33	945	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		21460840|21460841
CD33	945	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		12921496
CD34	947	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CD34	947	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22011395
CD36	948	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		10981864
CD36	948	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
CD36	948	Coronary Disease	MESH:D003327	marker/mechanism		NA	610938	
CD36	948	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17374397
CD36	948	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		31626838
CD36	948	Glucose Intolerance	MESH:D018149	marker/mechanism		NA		14640889
CD36	948	Hypertension	MESH:D006973	marker/mechanism		NA		18587397
CD36	948	Immunologic Deficiency Syndromes	MESH:D007153	marker/mechanism		NA		15690042
CD36	948	Insulin Resistance	MESH:D007333	marker/mechanism		NA		14640889
CD36	948	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CD36	948	Malaria	MESH:D008288	marker/mechanism		NA	611162	
CD36	948	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
CD36	948	Platelet Glycoprotein IV Deficiency	MESH:C564245	marker/mechanism		NA	608404	
CD36	948	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		16526316
CD36	948	Staphylococcal Infections	MESH:D013203	marker/mechanism		NA		15690042
CD36	948	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
CD38	952	Albuminuria	MESH:D000419	marker/mechanism		NA		21992601
CD38	952	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CD38	952	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
CD3D	915	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17597826
CD3D	915	IMMUNODEFICIENCY 19	OMIM:615617	marker/mechanism		NA	615617	
CD3D	915	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		18422935
CD3D	915	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
CD3D	915	Neurotoxicity Syndromes	MESH:D020258	marker/mechanism		NA		19784758
CD3D	915	Severe Combined Immunodeficiency	MESH:D016511	marker/mechanism		NA		15546002
CD3E	916	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		12833524
CD3E	916	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
CD3E	916	IMMUNODEFICIENCY 18	OMIM:615615	marker/mechanism		NA	615615	
CD3E	916	Immunologic Deficiency Syndromes	MESH:D007153	marker/mechanism		NA		8490660
CD3E	916	Inflammation	MESH:D007249	marker/mechanism		NA		22325453
CD3E	916	Severe Combined Immunodeficiency	MESH:D016511	marker/mechanism		NA		15546002
CD3G	917	IMMUNODEFICIENCY 17	OMIM:615607	marker/mechanism		NA	615607	
CD4	920	AIDS-Related Opportunistic Infections	MESH:D017088	marker/mechanism		NA		9546790
CD4	920	Muscular Dystrophy, Duchenne	MESH:D020388	marker/mechanism		NA		21641384
CD4	920	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		9546790
CD40	958	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		18794853|20453842|23143596
CD40	958	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17043144
CD40	958	Hodgkin Disease	MESH:D006689	marker/mechanism		NA		7621881
CD40	958	Hyperglycemia	MESH:D006943	marker/mechanism		NA		29035695
CD40	958	Hyper-IgM Immunodeficiency Syndrome	MESH:D053306	marker/mechanism		NA	606843	
CD40	958	Hyperinsulinism	MESH:D006946	marker/mechanism		NA		29035695
CD40	958	Insulin Resistance	MESH:D007333	marker/mechanism		NA		29035695
CD40	958	Mucocutaneous Lymph Node Syndrome	MESH:D009080	marker/mechanism		NA		22446961|22446962
CD40	958	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		19525955
CD40	958	Obesity	MESH:D009765	marker/mechanism		NA		29035695
CD40	958	Status Epilepticus	MESH:D013226	marker/mechanism		NA		18455351
CD40LG	959	Amyotrophic Lateral Sclerosis	MESH:D000690	therapeutic		NA		20348957
CD40LG	959	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		15494542
CD40LG	959	Chromosome Breakage	MESH:D019457	marker/mechanism		NA		27634759
CD40LG	959	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		16368305
CD40LG	959	Hodgkin Disease	MESH:D006689	marker/mechanism		NA		7621881|8656679
CD40LG	959	Hyper-IgM Immunodeficiency Syndrome, Type 1	MESH:D053307	marker/mechanism		NA	308230	15611226
CD40LG	959	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
CD40LG	959	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		15302794
CD40LG	959	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		28793932
CD40LG	959	Necrosis	MESH:D009336	marker/mechanism		NA		22295117
CD40LG	959	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
CD44	960	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		23052191
CD44	960	Adenomatous Polyposis Coli	MESH:D011125	marker/mechanism		NA		28255344
CD44	960	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
CD44	960	Colorectal Neoplasms, Hereditary Nonpolyposis	MESH:D003123	marker/mechanism		NA		28255344
CD44	960	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
CD44	960	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		25133636
CD44	960	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		23098472
CD44	960	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism|therapeutic		NA		16208414|17349212
CD44	960	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		21283680
CD44	960	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		23098472
CD44	960	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		15191797
CD44	960	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		17446842
CD44	960	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
CD44	960	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21471434
CD44	960	Vitiligo	MESH:D014820	marker/mechanism		NA		22561518
CD46	4179	Atypical Hemolytic Uremic Syndrome	MESH:D065766	marker/mechanism		NA	612922	14615110
CD46	4179	Measles	MESH:D008457	marker/mechanism		NA		8402913
CD46	4179	Prostatic Neoplasms, Castration-Resistant	MESH:D064129	marker/mechanism		NA		30185663
CD47	961	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		31043756
CD48	962	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CD5	921	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		23143596
CD5	921	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		18006695
CD53	963	Gastro-enteropancreatic neuroendocrine tumor	MESH:C535650	marker/mechanism		NA		29915428
CD53	963	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CD55	1604	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
CD55	1604	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
CD55	1604	Protein-Losing Enteropathies	MESH:D011504	marker/mechanism		NA	226300	
CD58	965	Lymphoma, T-Cell, Peripheral	MESH:D016411	marker/mechanism		NA		24413734
CD58	965	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		19525955|24076602
CD59	966	CD59 Deficiency	MESH:C567355	marker/mechanism		NA	612300	
CD59	966	Kidney Diseases	MESH:D007674	therapeutic		NA		31618666
CD59	966	Skin Manifestations	MESH:D012877	marker/mechanism		NA		31618666
CD5L	922	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CD5L	922	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CD6	923	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		19525953|24076602
CD63	967	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CD63	967	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		11420682
CD68	968	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
CD68	968	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
CD68	968	Arthritis, Psoriatic	MESH:D015535	marker/mechanism		NA		19732956
CD68	968	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		28789951
CD68	968	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		20388520
CD68	968	Hyperinsulinism	MESH:D006946	marker/mechanism		NA		29035695
CD68	968	Insulin Resistance	MESH:D007333	marker/mechanism		NA		29035695
CD68	968	Ischemia	MESH:D007511	marker/mechanism		NA		19458120
CD68	968	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19539174
CD68	968	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CD68	968	Obesity	MESH:D009765	marker/mechanism		NA		29035695
CD69	969	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
CD69	969	Arthritis	MESH:D001168	therapeutic		NA		12882836
CD69	969	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		12882836
CD69	969	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		19430480
CD7	924	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
CD7	924	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
CD7	924	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CD70	970	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		12031769
CD70	970	Myocarditis	MESH:D009205	marker/mechanism		NA		12031769
CD70	970	Virus Diseases	MESH:D014777	marker/mechanism		NA		12031769
CD74	972	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19602265
CD74	972	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		22919003
CD74	972	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CD74	972	Liver Failure, Acute	MESH:D017114	marker/mechanism		NA		16799971
CD79A	973	Agammaglobulinemia	MESH:D000361	marker/mechanism		NA	613501	
CD79A	973	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		25049379
CD79B	974	Agammaglobulinemia	MESH:D000361	marker/mechanism		NA	612692	
CD79B	974	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
CD79B	974	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		21173233
CD80	941	Celiac Disease	MESH:D002446	marker/mechanism		NA		20190752
CD80	941	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		21399635
CD80	941	Vitiligo	MESH:D014820	marker/mechanism		NA		22561518
CD81	975	Common Variable Immunodeficiency	MESH:D017074	marker/mechanism		NA	613496	
CD81	975	Hepatitis C	MESH:D006526	marker/mechanism		NA		17517063
CD82	3732	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		20075392
CD82	3732	Neoplasm Invasiveness	MESH:D009361	therapeutic		NA		20075392
CD82	3732	Neoplasm Metastasis	MESH:D009362	therapeutic		NA		20075392
CD83	9308	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
CD83	9308	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
CD83	9308	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		22446963
CD83	9308	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CD83	9308	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
CD84	8832	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
CD86	942	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
CD86	942	Gastro-enteropancreatic neuroendocrine tumor	MESH:C535650	marker/mechanism		NA		29915428
CD86	942	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CD86	942	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
CD86	942	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		16611307
CD8A	925	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
CD8A	925	CD8 Deficiency, Familial	MESH:C563824	marker/mechanism		NA	608957	
CD8A	925	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		17950725
CD8B	926	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
CD9	928	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		17043644
CD9	928	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		24836286
CD9	928	Glioblastoma	MESH:D005909	marker/mechanism		NA		26573230
CD9	928	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
CD9	928	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		26396155
CD9	928	Neoplasms, Germ Cell and Embryonal	MESH:D009373	marker/mechanism		NA		16168501
CD9	928	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		19522546
CD9	928	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
CD96	10225	C SYNDROME	OMIM:211750	marker/mechanism		NA	211750	17847009
CD99	4267	Chondrosarcoma, Mesenchymal	MESH:D018211	marker/mechanism		NA		12817616
CDA	978	Breast Neoplasms	MESH:D001943	marker/mechanism|therapeutic		NA		10811482|25330770
CDAN1	146059	Anemia, Dyserythropoietic, Congenital	MESH:D000742	marker/mechanism		NA	224120	
CDC14A	8556	Deafness	MESH:D003638	marker/mechanism		NA		29293958
CDC14A	8556	Deafness, Autosomal Recessive 32	MESH:C563884	marker/mechanism		NA	608653	27259055|29293958
CDC14A	8556	Infertility, Male	MESH:D007248	marker/mechanism		NA		29293958
CDC14A	8556	Oligospermia	MESH:D009845	marker/mechanism		NA		29293958
CDC20	991	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CDC25B	994	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
CDC25B	994	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
CDC25C	995	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CDC27	996	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
CDC42	998	Adrenal Gland Neoplasms	MESH:D000310	marker/mechanism		NA		24747643
CDC42	998	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
CDC42	998	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
CDC42	998	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
CDC42	998	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
CDC42	998	Necrosis	MESH:D009336	marker/mechanism		NA		19430526
CDC42	998	TAKENOUCHI-KOSAKI SYNDROME	OMIM:616737	marker/mechanism		NA	616737	
CDC42BPB	9578	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
CDC42SE1	56882	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CDC45	8318	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CDC45	8318	Meier-Gorlin syndrome	MESH:C538012	marker/mechanism		NA	617063	
CDC6	990	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CDC6	990	Meier-Gorlin syndrome	MESH:C538012	marker/mechanism		NA	613805	21358632
CDC6	990	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
CDC73	79577	Hyperparathyroidism 1	MESH:C564166	marker/mechanism		NA	145000	
CDC73	79577	Hyperparathyroidism 2	MESH:C563273	marker/mechanism		NA	145001	
CDC73	79577	Parathyroid Neoplasms	MESH:D010282	marker/mechanism		NA	608266	
CDCA2	157313	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CDCA3	83461	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CDCA5	113130	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CDCA7	83879	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3	OMIM:616910	marker/mechanism		NA	616910	
CDCA7	83879	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
CDCA8	55143	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CDCP1	64866	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
CDH1	999	Breast Neoplasms	MESH:D001943	marker/mechanism|therapeutic		NA	114480	17520682|19839049|23921149|24014025
CDH1	999	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942|17520682|8075649
CDH1	999	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		17520682
CDH1	999	Carcinoma, Ductal	MESH:D044584	marker/mechanism		NA		29295717
CDH1	999	Carcinoma, Ductal, Breast	MESH:D018270	marker/mechanism		NA		17660459|8557030
CDH1	999	Carcinoma, Lobular	MESH:D018275	marker/mechanism		NA		17660459|8557030
CDH1	999	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		17520682
CDH1	999	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		24014025
CDH1	999	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		19915572
CDH1	999	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		10072428|19011631
CDH1	999	Disease Progression	MESH:D018450	marker/mechanism		NA		19839049
CDH1	999	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA	608089	8075649
CDH1	999	Fibrosis	MESH:D005355	marker/mechanism		NA		31697999
CDH1	999	Helicobacter Infections	MESH:D016481	marker/mechanism		NA		19184424
CDH1	999	Kidney Diseases	MESH:D007674	marker/mechanism		NA		31697999
CDH1	999	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		32659284
CDH1	999	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		20118494|25319454
CDH1	999	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
CDH1	999	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
CDH1	999	Mesothelioma	MESH:D008654	marker/mechanism		NA		15639718
CDH1	999	Mycoplasma Infections	MESH:D009175	marker/mechanism		NA		20179380
CDH1	999	Neoplasm Invasiveness	MESH:D009361	marker/mechanism|therapeutic		NA		19839049|22580338
CDH1	999	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17520682|22580338
CDH1	999	Neoplasm Seeding	MESH:D009366	marker/mechanism		NA		27224422
CDH1	999	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		27224422
CDH1	999	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		12387456
CDH1	999	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA	167000	8075649
CDH1	999	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		18223216
CDH1	999	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		19184424
CDH1	999	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		14961571|16189707
CDH1	999	Prostatic Intraepithelial Neoplasia	MESH:D019048	marker/mechanism		NA		22581815
CDH1	999	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA	176807	16813949|22581815|29295717|29610475
CDH1	999	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		17520682
CDH1	999	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA	137215	10072428|12588804|19168852|19184424|24816253|9537325
CDH1	999	Ureteral Obstruction	MESH:D014517	marker/mechanism		NA		31697999
CDH1	999	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		17520682|26901067
CDH10	1008	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		28191889
CDH10	1008	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19404256
CDH12	1010	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29662167
CDH13	1012	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
CDH13	1012	Barrett Esophagus	MESH:D001471	marker/mechanism		NA		18729198
CDH13	1012	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		18425332|18553387|28284560
CDH13	1012	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		18337602
CDH13	1012	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		18729198
CDH13	1012	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		18337602
CDH13	1012	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17288544|18264096
CDH13	1012	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
CDH15	1013	Mental Retardation, Autosomal Dominant 3	MESH:C567241	marker/mechanism		NA	612580	
CDH15	1013	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
CDH17	1015	Asthma, Occupational	MESH:D059366	marker/mechanism		NA		25918132
CDH2	1000	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		27811057
CDH2	1000	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27811057
CDH2	1000	Disease Progression	MESH:D018450	marker/mechanism		NA		23876460
CDH2	1000	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
CDH2	1000	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		27811057
CDH2	1000	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		23876460
CDH2	1000	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		12387456
CDH2	1000	Status Epilepticus	MESH:D013226	marker/mechanism		NA		12125071
CDH2	1000	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
CDH22	64405	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		25944804
CDH23	64072	Deafness, Autosomal Recessive 12	MESH:C563327	marker/mechanism		NA	601386	
CDH23	64072	Pneumoconiosis	MESH:D011009	marker/mechanism		NA		25445010
CDH23	64072	Usher syndrome, type 1D	MESH:C536487	marker/mechanism		NA	601067	
CDH3	1001	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		19915572
CDH3	1001	Ectodermal dysplasia, ectrodactyly, and macular dystrophy	MESH:C536190	marker/mechanism		NA	225280	
CDH3	1001	Juvenile macular degeneration and hypotrichosis	MESH:C537698	marker/mechanism		NA	601553	
CDH3	1001	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
CDH5	1003	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18507500
CDH5	1003	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18507500
CDH5	1003	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		18422935
CDH5	1003	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CDH5	1003	No-Reflow Phenomenon	MESH:D054318	therapeutic		NA		16824628
CDH6	1004	Cachexia	MESH:D002100	marker/mechanism		NA		17878525
CDH7	1005	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		16015041
CDH9	1007	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19404256
CDHR1	92211	CONE-ROD DYSTROPHY 15	OMIM:613660	marker/mechanism		NA	613660	
CDHR3	222256	Asthma	MESH:D001249	marker/mechanism		NA		24241537
CDIN1	84529	Anemia, Dyserythropoietic, Congenital	MESH:D000742	marker/mechanism		NA	615631	
CDK1	983	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CDK1	983	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CDK1	983	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		19223503
CDK12	51755	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
CDK13	8621	CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	OMIM:617360	marker/mechanism		NA	617360	
CDK14	5218	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		22922871
CDK2	1017	Melanoma	MESH:D008545	marker/mechanism		NA		21559390
CDK2	1017	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		29464035
CDK20	23552	Alcoholism	MESH:D000437	marker/mechanism		NA		18438686
CDK2AP2	10263	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
CDK4	1019	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		20932960
CDK4	1019	Brain Stem Neoplasms	MESH:D020295	marker/mechanism		NA		24098593
CDK4	1019	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462|14522882
CDK4	1019	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		26189965
CDK4	1019	Liposarcoma	MESH:D008080	marker/mechanism|therapeutic		NA		20601955|23569312
CDK4	1019	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462|14522882
CDK4	1019	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462|14522882|25221644
CDK4	1019	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3	OMIM:609048	marker/mechanism		NA	609048	
CDK4	1019	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		20932960
CDK4	1019	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		29464035
CDK4	1019	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21628965
CDK5	1020	LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA	OMIM:616342	marker/mechanism		NA	616342	
CDK5	1020	Tauopathies	MESH:D024801	marker/mechanism		NA		26945731
CDK5R1	8851	Brain Diseases	MESH:D001927	marker/mechanism		NA		15665076
CDK5R1	8851	Cognition Disorders	MESH:D003072	marker/mechanism		NA		17581637
CDK5R1	8851	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		17581637
CDK5RAP2	55755	Microcephaly, Primary Autosomal Recessive, 3	MESH:C565746	marker/mechanism		NA	604804	
CDK6	1021	Anemia	MESH:D000740	marker/mechanism		NA		28255017
CDK6	1021	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		18794853
CDK6	1021	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
CDK6	1021	Brain Stem Neoplasms	MESH:D020295	marker/mechanism		NA		24098593
CDK6	1021	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
CDK6	1021	Chromosome Aberrations	MESH:D002869	marker/mechanism		NA		24736461
CDK6	1021	Clinical Deterioration	MESH:D000075902	marker/mechanism		NA		29464035
CDK6	1021	Glioblastoma	MESH:D005909	marker/mechanism		NA		20534551
CDK6	1021	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		18206229
CDK6	1021	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		25221644
CDK6	1021	Medulloblastoma	MESH:D008527	marker/mechanism		NA		19270706|23138228
CDK6	1021	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
CDK6	1021	MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE	OMIM:616080	marker/mechanism		NA	616080	
CDK6	1021	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		24736461
CDK6	1021	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		29464035
CDK6	1021	Stroke	MESH:D020521	marker/mechanism		NA		29531354
CDKAL1	54901	Acquired Hyperostosis Syndrome	MESH:D020083	marker/mechanism		NA		27936930
CDKAL1	54901	Birth Weight	MESH:D001724	marker/mechanism		NA		23202124
CDKAL1	54901	Body Weight	MESH:D001835	marker/mechanism		NA		22344219|22344221
CDKAL1	54901	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		17460697|23104008|23202124
CDKL2	8999	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		25333262
CDKL2	8999	Disease Progression	MESH:D018450	marker/mechanism		NA		25333262
CDKL2	8999	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		25333262
CDKL2	8999	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		25333262
CDKL5	6792	Angelman Syndrome	MESH:D017204	marker/mechanism		NA		19241098
CDKL5	6792	CDKL5 deficiency disorder	MESH:C564064	marker/mechanism		NA	300672	
CDKL5	6792	Epilepsy	MESH:D004827	marker/mechanism		NA		29942082
CDKL5	6792	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		29942082
CDKL5	6792	Rett Syndrome	MESH:D015518	marker/mechanism		NA		19241098
CDKL5	6792	Seizures	MESH:D012640	marker/mechanism		NA		22264704
CDKN1A	1026	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
CDKN1A	1026	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		12151359|18640142
CDKN1A	1026	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		20876807
CDKN1A	1026	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		27652271
CDKN1A	1026	Esophageal Squamous Cell Carcinoma	MESH:D000077277	therapeutic		NA		15375580
CDKN1A	1026	HIV Infections	MESH:D015658	marker/mechanism		NA		12878215
CDKN1A	1026	Hypertrophy	MESH:D006984	marker/mechanism		NA		27652271
CDKN1A	1026	Intestinal Neoplasms	MESH:D007414	marker/mechanism|therapeutic		NA		11535846|12468628
CDKN1A	1026	Kidney Diseases	MESH:D007674	marker/mechanism		NA		16968891
CDKN1A	1026	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CDKN1A	1026	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		12466968|18508827
CDKN1A	1026	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		11453316
CDKN1A	1026	Muscular Dystrophy, Facioscapulohumeral	MESH:D020391	marker/mechanism		NA		12868502
CDKN1A	1026	Papilloma	MESH:D010212	marker/mechanism		NA		12151359
CDKN1A	1026	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		12727815|15598783
CDKN1A	1026	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		16968891
CDKN1A	1026	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		14647439
CDKN1A	1026	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		18640142
CDKN1B	1027	Adenoma, Liver Cell	MESH:D018248	marker/mechanism		NA		17620307
CDKN1B	1027	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17092400
CDKN1B	1027	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		20698225
CDKN1B	1027	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
CDKN1B	1027	Helicobacter Infections	MESH:D016481	marker/mechanism		NA		15138205
CDKN1B	1027	Intestinal Neoplasms	MESH:D007414	marker/mechanism		NA		24185511
CDKN1B	1027	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		21693435
CDKN1B	1027	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		16391232
CDKN1B	1027	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		12466968|16391232|20512841
CDKN1B	1027	Mesothelioma	MESH:D008654	marker/mechanism		NA		18301454
CDKN1B	1027	Multiple Endocrine Neoplasia, Type IV	MESH:C567059	marker/mechanism		NA	610755	
CDKN1B	1027	Neuroendocrine Tumors	MESH:D018358	marker/mechanism		NA		24185511
CDKN1B	1027	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		16391232
CDKN1B	1027	Pituitary Neoplasms	MESH:D010911	marker/mechanism		NA		16391232
CDKN1B	1027	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
CDKN1B	1027	Prostatic Intraepithelial Neoplasia	MESH:D019048	therapeutic		NA		20932324
CDKN1B	1027	Prostatic Neoplasms	MESH:D011471	marker/mechanism|therapeutic		NA		12727815|20932324|29610475
CDKN1B	1027	Rectal Neoplasms	MESH:D012004	marker/mechanism		NA		15525823
CDKN1B	1027	Sezary Syndrome	MESH:D012751	marker/mechanism		NA		26551667
CDKN1B	1027	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		15138205
CDKN1B	1027	Uterine Neoplasms	MESH:D014594	marker/mechanism		NA		16391232
CDKN1C	1028	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		21552421
CDKN1C	1028	Beckwith-Wiedemann Syndrome	MESH:D001506	marker/mechanism		NA	130650	22634751
CDKN1C	1028	Endometrial Hyperplasia	MESH:D004714	marker/mechanism		NA		22064387
CDKN1C	1028	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		22064387
CDKN1C	1028	Intrauterine Growth Retardation, Metaphyseal Dysplasia, Adrenal Hypoplasia Congenita, And Genital Anomalies	MESH:C564543	marker/mechanism		NA	614732	22634751
CDKN1C	1028	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		20512841|21552421
CDKN1C	1028	Melanoma	MESH:D008545	marker/mechanism		NA		17145863
CDKN2A	1029	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		20135361
CDKN2A	1029	Adenocarcinoma Of Esophagus	MESH:C562730	marker/mechanism		NA		23525077
CDKN2A	1029	Adrenal Gland Neoplasms	MESH:D000310	marker/mechanism		NA		24747643
CDKN2A	1029	Adrenocortical Carcinoma	MESH:D018268	marker/mechanism		NA		24747642
CDKN2A	1029	Bone Diseases	MESH:D001847	marker/mechanism		NA		30259626
CDKN2A	1029	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		15144691|16860786
CDKN2A	1029	Brain Stem Neoplasms	MESH:D020295	marker/mechanism		NA		24098593
CDKN2A	1029	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20948315
CDKN2A	1029	Carcinogenesis	MESH:D063646	marker/mechanism		NA		21526190
CDKN2A	1029	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		25822088|28284560
CDKN2A	1029	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		18337602|19375815
CDKN2A	1029	Carcinoma, Pancreatic Ductal	MESH:D021441	marker/mechanism		NA		24986516
CDKN2A	1029	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		25125259
CDKN2A	1029	Chromosome Deletion	MESH:D002872	marker/mechanism		NA		21526190
CDKN2A	1029	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		18410530
CDKN2A	1029	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		25151357
CDKN2A	1029	Fluoride Poisoning	MESH:D005458	marker/mechanism		NA		30259626
CDKN2A	1029	Glaucoma	MESH:D005901	marker/mechanism		NA		21532571
CDKN2A	1029	Glioma	MESH:D005910	marker/mechanism		NA		15814359|19578367
CDKN2A	1029	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		12378512|16317707|27064257
CDKN2A	1029	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		11872642|12115568|18337602|20135361
CDKN2A	1029	Lymphatic Metastasis	MESH:D008207	marker/mechanism		NA		29426936
CDKN2A	1029	Lymphoma	MESH:D008223	marker/mechanism		NA		9488045
CDKN2A	1029	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		21325069
CDKN2A	1029	Lymphoma, T-Cell, Cutaneous	MESH:D016410	marker/mechanism		NA		26192916
CDKN2A	1029	Melanoma	MESH:D008545	marker/mechanism		NA		24495407|29426936
CDKN2A	1029	Melanoma astrocytoma syndrome	MESH:C536149	marker/mechanism		NA	155755	
CDKN2A	1029	Melanoma, Cutaneous Malignant	MESH:C562393	marker/mechanism		NA		22080950
CDKN2A	1029	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2	OMIM:155601	marker/mechanism		NA	155601	
CDKN2A	1029	Melanoma-Pancreatic Cancer Syndrome	MESH:C563985	marker/mechanism		NA	606719	
CDKN2A	1029	Mesothelioma	MESH:D008654	marker/mechanism		NA		18379362
CDKN2A	1029	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		19223589|21526190|29112861
CDKN2A	1029	Micronuclei, Chromosome-Defective	MESH:D048629	marker/mechanism		NA		26410583
CDKN2A	1029	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		24991542
CDKN2A	1029	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		16008847
CDKN2A	1029	Nasopharyngeal Carcinoma	MESH:D000077274	marker/mechanism		NA		24952746
CDKN2A	1029	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		24495407
CDKN2A	1029	Neoplasms	MESH:D009369	marker/mechanism		NA		11544531|19223589
CDKN2A	1029	Nerve Sheath Neoplasms	MESH:D018317	marker/mechanism		NA		25240281
CDKN2A	1029	Neuroblastoma	MESH:D009447	marker/mechanism		NA		15814359
CDKN2A	1029	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		10627132|26098869
CDKN2A	1029	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		23872714
CDKN2A	1029	Poisoning	MESH:D011041	marker/mechanism		NA		20044985
CDKN2A	1029	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		24991542
CDKN2A	1029	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		20453839
CDKN2A	1029	Sezary Syndrome	MESH:D012751	marker/mechanism		NA		26551670
CDKN2A	1029	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		24991542|26192916|26909611
CDKN2A	1029	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
CDKN2A	1029	Thymoma	MESH:D013945	marker/mechanism		NA		24974848
CDKN2A	1029	Translocation, Genetic	MESH:D014178	marker/mechanism		NA		21325069|21526190
CDKN2A	1029	Trisomy	MESH:D014314	marker/mechanism		NA		21526190
CDKN2A	1029	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism|therapeutic		NA		12973940|15987713
CDKN2A	1029	Urogenital Neoplasms	MESH:D014565	marker/mechanism		NA		17300232
CDKN2A	1029	Vulvar Lichen Sclerosus	MESH:D007724	marker/mechanism		NA		17300232
CDKN2AIPNL	91368	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CDKN2B	1030	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		23104008
CDKN2B	1030	Glaucoma	MESH:D005901	marker/mechanism		NA		21532571
CDKN2B	1030	Glioma	MESH:D005910	marker/mechanism		NA		19578366|19578367
CDKN2B	1030	Lymphoma	MESH:D008223	marker/mechanism		NA		9488045
CDKN2B	1030	Myelodysplastic Syndromes	MESH:D009190	marker/mechanism		NA		17294728
CDKN2B	1030	Poisoning	MESH:D011041	marker/mechanism		NA		20044985
CDKN2B-AS1	100048912	Chromosome Breakage	MESH:D019457	therapeutic		NA		28117929
CDKN2B-AS1	100048912	Endometriosis	MESH:D004715	marker/mechanism		NA		20601957
CDKN2B-AS1	100048912	Glaucoma, Open-Angle	MESH:D005902	marker/mechanism		NA		21532571
CDKN2B-AS1	100048912	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		23770605
CDKN2B-AS1	100048912	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		27749845
CDKN2B-AS1	100048912	Nasopharyngeal Carcinoma	MESH:D000077274	marker/mechanism		NA		28117929
CDKN2C	1031	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CDKN2D	1032	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
CDKN3	1033	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CDKN3	1033	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CDO1	1036	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		23665415
CDO1	1036	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
CDON	50937	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
CDON	50937	HOLOPROSENCEPHALY 11	OMIM:614226	marker/mechanism		NA	614226	
CDR3	8163	CEREBELLAR DEGENERATION-RELATED AUTOANTIGEN 3	OMIM:602197	marker/mechanism		NA	602197	
CDS1	1040	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
CDS1	1040	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
CDS1	1040	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
CDS1	1040	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
CDSN	1041	HYPOTRICHOSIS 2	OMIM:146520	marker/mechanism		NA	146520	
CDSN	1041	Peeling Skin Syndrome	MESH:C564818	marker/mechanism		NA	270300	
CDT1	81620	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CDT1	81620	Meier-Gorlin syndrome	MESH:C538012	marker/mechanism		NA	613804	21358632
CDX2	1045	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		29439001
CDX2	1045	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		29439001
CDY1	9085	Spermatogenic Failure, Nonobstructive, Y-Linked	MESH:C564030	marker/mechanism		NA	415000	
CDY2A	9426	Spermatogenic Failure, Nonobstructive, Y-Linked	MESH:C564030	marker/mechanism		NA	415000	
CDYL	9425	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941189
CEACAM1	634	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
CEACAM1	634	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		21552421
CEACAM1	634	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		21552421
CEACAM16	388551	DEAFNESS, AUTOSOMAL DOMINANT 4B	OMIM:614614	marker/mechanism		NA	614614	
CEACAM5	1048	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
CEACAM6	4680	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
CEACAM6	4680	Parkinson Disease	MESH:D010300	marker/mechanism		NA		25475535
CEBPA	1050	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		16288022|21785164
CEBPA	1050	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		17510391|21346772
CEBPA	1050	Emphysema	MESH:D004646	therapeutic		NA		29078374
CEBPA	1050	Head and Neck Neoplasms	MESH:D006258	marker/mechanism		NA		17510391
CEBPA	1050	Infertility, Female	MESH:D007247	marker/mechanism		NA		21177758
CEBPA	1050	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA	601626	18987666|19822134|30420649
CEBPA	1050	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism|therapeutic		NA		16788101|26285909
CEBPA	1050	Neoplasms, Radiation-Induced	MESH:D009381	marker/mechanism		NA		21346772
CEBPA	1050	Obesity	MESH:D009765	marker/mechanism		NA		28242765
CEBPA	1050	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21785164
CEBPA	1050	Pulmonary Fibrosis	MESH:D011658	therapeutic		NA		29078374
CEBPA	1050	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		21346772
CEBPA-DT	80054	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		25944804
CEBPB	1051	Brain Injuries	MESH:D001930	marker/mechanism		NA		21549006
CEBPB	1051	Brain Ischemia	MESH:D002545	marker/mechanism		NA		17394460
CEBPB	1051	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		14563831
CEBPB	1051	Fatty Liver	MESH:D005234	marker/mechanism		NA		24469900
CEBPB	1051	Infertility, Female	MESH:D007247	marker/mechanism		NA		21177758
CEBPB	1051	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		17177178
CEBPD	1052	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		14563831
CEBPD	1052	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17234736
CEBPD	1052	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CEBPD	1052	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
CEBPD	1052	Prolactinoma	MESH:D015175	marker/mechanism		NA		21980073
CEBPE	1053	Leukemia, Promyelocytic, Acute	MESH:D015473	therapeutic		NA		16788101
CEBPE	1053	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		19684604
CEBPE	1053	Specific Granule Deficiency	MESH:C562873	marker/mechanism		NA	245480	28369034
CECR	1055	Abnormalities, Multiple	MESH:D000015	marker/mechanism		NA		11693792
CECR	1055	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		11693792
CECR	1055	Eye Abnormalities	MESH:D005124	marker/mechanism		NA		11693792
CECR	1055	Schmid-Fraccaro syndrome	MESH:C535918	marker/mechanism		NA	115470	11693792
CECR2	27443	Neural Tube Defects	MESH:D009436	marker/mechanism		NA		15640247
CED-4	175643	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		23106139
CEL	1056	Maturity-Onset Diabetes of the Young, Type 8, with Exocrine Dysfunction	MESH:C565225	marker/mechanism		NA	609812	
CEL	1056	Pancreatitis, Chronic	MESH:D050500	marker/mechanism		NA		25774637
CELA1	1990	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
CELA1	1990	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980|25380136
CELA2A	63036	Atherosclerosis	MESH:D050197	marker/mechanism		NA		31358993
CELA2A	63036	Hypertension	MESH:D006973	marker/mechanism		NA		21602471
CELA2A	63036	Metabolic Syndrome	MESH:D024821	marker/mechanism		NA		31358993
CELA3B	23436	Exocrine Pancreatic Insufficiency	MESH:D010188	marker/mechanism		NA		14687815
CELF2	10659	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CELF2	10659	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		28319090
CELF2	10659	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
CELF2	10659	Stevens-Johnson Syndrome	MESH:D013262	marker/mechanism		NA		25811541
CELP	1057	Pancreatitis, Chronic	MESH:D050500	marker/mechanism		NA		25774637
CELSR2	1952	Endometrial Hyperplasia	MESH:D004714	marker/mechanism		NA		22248470
CELSR3	1951	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CEMIP2	23670	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CENPA	1058	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CENPCP1	1061	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
CENPE	1062	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CENPE	1062	MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE	OMIM:616051	marker/mechanism		NA	616051	
CENPF	1063	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17659439
CENPF	1063	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CENPF	1063	Jejunal Atresia with Microcephaly and Ocular Anomalies	MESH:C565460	marker/mechanism		NA	243605	
CENPF	1063	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29581250
CENPJ	55835	Microcephaly, Primary Autosomal Recessive, 6	MESH:C564247	marker/mechanism		NA	608393	
CENPJ	55835	SECKEL SYNDROME 4	OMIM:613676	marker/mechanism		NA	613676	
CENPK	64105	Prostatic Neoplasms, Castration-Resistant	MESH:D064129	marker/mechanism		NA		29581250
CENPM	79019	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CENPU	79682	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CENPW	387103	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CEP120	153241	Short Rib-Polydactyly Syndrome	MESH:D012779	marker/mechanism		NA	616300	
CEP131	22994	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CEP135	9662	MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE	OMIM:614673	marker/mechanism		NA	614673	
CEP152	22995	MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE	OMIM:614852	marker/mechanism		NA	614852	
CEP152	22995	Seckel syndrome 1	MESH:C537533	marker/mechanism		NA		21131973
CEP164	22897	NEPHRONOPHTHISIS 15	OMIM:614845	marker/mechanism		NA	614845	
CEP19	84984	MORBID OBESITY AND SPERMATOGENIC FAILURE	OMIM:615703	marker/mechanism		NA	615703	
CEP290	80184	Bardet-Biedl Syndrome	MESH:D020788	marker/mechanism		NA		18327255
CEP290	80184	Bardet-Biedl Syndrome 14	MESH:C567141	marker/mechanism		NA	615991	
CEP290	80184	Joubert syndrome 5	MESH:C537688	marker/mechanism		NA	610188	
CEP290	80184	Leber Congenital Amaurosis 10	MESH:C565720	marker/mechanism		NA	611755	
CEP290	80184	Meckel Syndrome, Type 4	MESH:C567003	marker/mechanism		NA	611134	
CEP290	80184	Senior-Loken Syndrome 6	MESH:C565708	marker/mechanism		NA	610189	
CEP41	95681	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		21438139
CEP55	55165	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CEP55	55165	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
CEP57	9702	Mosaic variegated aneuploidy syndrome	MESH:C536987	marker/mechanism		NA	614114	21552266|28553959
CEP63	80254	Microcephaly	MESH:D008831	marker/mechanism		NA		21983783
CEP68	23177	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
CEP78	84131	CONE-ROD DYSTROPHY AND HEARING LOSS 1	OMIM:617236	marker/mechanism		NA	617236	
CEP83	51134	NEPHRONOPHTHISIS 18	OMIM:615862	marker/mechanism		NA	615862	
CERK	64781	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CERKL	375298	Retinitis Pigmentosa 26	MESH:C564249	marker/mechanism		NA	608380	
CERS1	10715	Myoclonic Epilepsies, Progressive	MESH:D020191	marker/mechanism		NA	616230	
CERS3	204219	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 9	OMIM:615023	marker/mechanism		NA	615023	
CERS6	253782	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
CERT1	10087	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		15496427
CERT1	10087	Epilepsy	MESH:D004827	marker/mechanism		NA		29942082
CERT1	10087	MENTAL RETARDATION, AUTOSOMAL DOMINANT 34	OMIM:616351	marker/mechanism		NA	616351	
CERT1	10087	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889|29942082
CES1	1066	Brain Injuries	MESH:D001930	marker/mechanism		NA		23159883
CES1	1066	Cocaine-Related Disorders	MESH:D019970	therapeutic		NA		12679808|12773168
CES1	1066	Hypercholesterolemia	MESH:D006937	therapeutic		NA		12773168
CES1	1066	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17114358|17311802
CES1	1066	Metabolism, Inborn Errors	MESH:D008661	marker/mechanism		NA		18485328
CES1	1066	Obesity	MESH:D009765	marker/mechanism		NA		20975297
CES1	1066	Opioid-Related Disorders	MESH:D009293	therapeutic		NA		12679808
CES1C	13884	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		28885000
CES1C	13884	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		28885000
CES1F	234564	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17311802
CES1G	12623	Fatty Liver	MESH:D005234	marker/mechanism		NA		24597639
CES1G	12623	Hyperlipidemias	MESH:D006949	marker/mechanism		NA		24597639
CES1G	12623	Obesity	MESH:D009765	marker/mechanism		NA		24597639
CES2	8824	Cocaine-Related Disorders	MESH:D019970	therapeutic		NA		19710369
CES2	8824	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		19931604
CES2	8824	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
CES3	23491	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
CES3	23491	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
CES3	23491	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
CETP	1071	Atherosclerosis	MESH:D050197	therapeutic		NA		28096968
CETP	1071	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CETP	1071	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		16544732
CETP	1071	Disease Models, Animal	MESH:D004195	therapeutic		NA		28096968
CETP	1071	Dyslipidemias	MESH:D050171	marker/mechanism		NA		17952847
CETP	1071	HYPERALPHALIPOPROTEINEMIA 1	OMIM:143470	marker/mechanism		NA	143470	
CETP	1071	Hyperlipidemias	MESH:D006949	marker/mechanism		NA		10519734
CETP	1071	Hyperlipoproteinemias	MESH:D006951	marker/mechanism		NA		2215607|8408659
CETP	1071	Hyperlipoproteinemia Type II	MESH:D006938	marker/mechanism		NA		16030523
CETP	1071	Hypertension	MESH:D006973	marker/mechanism		NA		20511482
CETP	1071	Hypertriglyceridemia	MESH:D015228	marker/mechanism		NA		12754275
CETP	1071	Pediatric Obesity	MESH:D063766	marker/mechanism		NA		25137265
CFAP20	29105	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
CFAP298	56683	CILIARY DYSKINESIA, PRIMARY, 26	OMIM:615500	marker/mechanism		NA	615500	
CFAP410	755	Amyotrophic Lateral Sclerosis	MESH:D000690	marker/mechanism		NA		27455348
CFAP43	80217	Hydrocephalus, Normal Pressure	MESH:D006850	marker/mechanism		NA	236690	
CFAP45	25790	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		26928227
CFAP53	220136	HETEROTAXY, VISCERAL, 6, AUTOSOMAL	OMIM:614779	marker/mechanism		NA	614779	
CFAP65	255101	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
CFB	629	Atypical Hemolytic Uremic Syndrome	MESH:D065766	marker/mechanism		NA	612924	17182750
CFB	629	Brain Injuries	MESH:D001930	marker/mechanism		NA		17474994
CFB	629	COMPLEMENT FACTOR B DEFICIENCY	OMIM:615561	marker/mechanism		NA	615561	
CFB	629	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		19838195
CFB	629	Macular Degeneration	MESH:D008268	marker/mechanism		NA		16518403
CFB	629	MACULAR DEGENERATION, AGE-RELATED, 14	OMIM:615489	marker/mechanism		NA	615489	
CFB	629	Myasthenia Gravis	MESH:D009157	marker/mechanism		NA		6605118
CFC1	55997	Double Outlet Right Ventricle	MESH:D004310	marker/mechanism		NA		11799476
CFC1	55997	HETEROTAXY, VISCERAL, 2, AUTOSOMAL	OMIM:605376	marker/mechanism		NA	605376	
CFC1	55997	Transposition of Great Vessels	MESH:D014188	marker/mechanism		NA		11799476
CFD	1675	Asbestosis	MESH:D001195	marker/mechanism		NA		22832039
CFD	1675	Complement Factor D Deficiency	MESH:C565027	marker/mechanism		NA	613912	
CFD	1675	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
CFD	1675	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		14675043
CFD	1675	Heart Failure	MESH:D006333	marker/mechanism		NA		26670611
CFD	1675	Immunologic Deficiency Syndromes	MESH:D007153	marker/mechanism		NA		11457876|16527897
CFD	1675	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CFD	1675	Meningococcal Infections	MESH:D008589	marker/mechanism		NA		16527897
CFD	1675	Neisseriaceae Infections	MESH:D016870	marker/mechanism		NA		11457876
CFD	1675	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
CFD	1675	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		22832039
CFH	3075	Atypical Hemolytic Uremic Syndrome	MESH:D065766	marker/mechanism		NA	235400	14978182|22019782
CFH	3075	Basal Laminar Drusen	MESH:C563034	marker/mechanism		NA	126700	
CFH	3075	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
CFH	3075	Complement Factor H Deficiency	MESH:C562875	marker/mechanism		NA	609814	
CFH	3075	Glomerulonephritis, Membranoproliferative	MESH:D015432	marker/mechanism		NA		14978182
CFH	3075	Immunologic Deficiency Syndromes	MESH:D007153	marker/mechanism		NA		14978182
CFH	3075	Macular Degeneration	MESH:D008268	marker/mechanism		NA		16518403|16754848|17554167|21909106|22019782|26691988
CFH	3075	Macular Degeneration, Age-Related, 4	MESH:C565196	marker/mechanism		NA	610698	
CFH	3075	Meningococcal Infections	MESH:D008589	marker/mechanism		NA		20694013
CFHR1	3078	Atypical Hemolytic Uremic Syndrome	MESH:D065766	marker/mechanism		NA	235400	
CFHR1	3078	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		21399633
CFHR1	3078	Macular Degeneration, Age-Related, 1	MESH:C566411	marker/mechanism		NA	603075	
CFHR3	10878	Atypical Hemolytic Uremic Syndrome	MESH:D065766	marker/mechanism		NA	235400	
CFHR3	10878	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		21399633
CFHR3	10878	Macular Degeneration, Age-Related, 1	MESH:C566411	marker/mechanism		NA	603075	
CFHR3	10878	Meningococcal Infections	MESH:D008589	marker/mechanism		NA		20694013
CFHR5	81494	CFHR5 DEFICIENCY	OMIM:614809	marker/mechanism		NA	614809	
CFHR5	81494	Cholestasis	MESH:D002779	marker/mechanism		NA		27989131
CFI	3426	Atypical Hemolytic Uremic Syndrome	MESH:D065766	marker/mechanism		NA	612923	
CFI	3426	Complement Factor I Deficiency	MESH:C572568	marker/mechanism		NA	610984	
CFI	3426	Macular Degeneration	MESH:D008268	marker/mechanism		NA		23685748|24036952|26691988
CFI	3426	MACULAR DEGENERATION, AGE-RELATED, 13	OMIM:615439	marker/mechanism		NA	615439	
CFL1	1072	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20562527
CFL1	1072	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
CFL1	1072	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		15048980
CFL1	1072	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		20562527
CFL1	1072	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21472284
CFL1	1072	Spinal Dysraphism	MESH:D016135	marker/mechanism		NA		17352815
CFL2	1073	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
CFL2	1073	Nemaline Myopathy 7	MESH:C565198	marker/mechanism		NA	610687	
CFLAR	8837	Hodgkin Disease	MESH:D006689	marker/mechanism		NA		17659339
CFLAR	8837	Leukemia	MESH:D007938	marker/mechanism		NA		12970779
CFLAR	8837	Lymphoma, Extranodal NK-T-Cell	MESH:D054391	marker/mechanism		NA		15924153
CFLAR	8837	Myelodysplastic Syndromes	MESH:D009190	marker/mechanism		NA		16105982
CFLAR	8837	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		20876774
CFM1	10167	CYSTIC FIBROSIS, MODIFIER OF, 1	OMIM:603855	marker/mechanism		NA	603855	
CFP	5199	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CFP	5199	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CFP	5199	Meningitis, Meningococcal	MESH:D008585	marker/mechanism		NA		10909851|8530058
CFP	5199	Properdin deficiency, X-linked	MESH:C537241	marker/mechanism		NA	312060	10909851|8530058
CFTR	1080	Azoospermia	MESH:D053713	marker/mechanism		NA		10856487
CFTR	1080	Bronchiectasis With Or Without Elevated Sweat Chloride 1	MESH:C567618	marker/mechanism		NA	211400	
CFTR	1080	Choledochal Cyst	MESH:D015529	marker/mechanism		NA		18988797
CFTR	1080	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22294766
CFTR	1080	Congenital bilateral aplasia of vas deferens	MESH:C535984	marker/mechanism		NA	277180	10875853|11119745
CFTR	1080	Cystic Fibrosis	MESH:D003550	marker/mechanism		NA	219700	11401894|11786964|16463024|16763370|1718974|17290305|17347447|17541014|18230692|19309154|19846789|21083385|21303308|21602569|31251792|7560099
CFTR	1080	Hereditary pancreatitis	MESH:C537262	marker/mechanism		NA	167800	
CFTR	1080	Hereditary renal agenesis	MESH:C536482	marker/mechanism		NA		11119745
CFTR	1080	Hernia, Diaphragmatic	MESH:D006548	therapeutic		NA		16473863
CFTR	1080	Infertility, Male	MESH:D007248	marker/mechanism		NA		17823699|18554162
CFTR	1080	Pancreatitis	MESH:D010195	marker/mechanism		NA		18360295|23143602
CFTR	1080	Pancreatitis, Chronic	MESH:D050500	marker/mechanism		NA		18206817
CFTR	1080	Polycystic Kidney, Autosomal Recessive	MESH:D017044	marker/mechanism		NA		18988797
CFTR	1080	Rhinitis	MESH:D012220	marker/mechanism		NA		16083808
CFTR	1080	Sinusitis	MESH:D012852	marker/mechanism		NA		16083808
CFTR	1080	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
CGA	1081	Adrenal Gland Diseases	MESH:D000307	therapeutic		NA		20146381
CGA	1081	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
CGA	1081	Disease Progression	MESH:D018450	marker/mechanism		NA		10566621
CGA	1081	Hemiplegia	MESH:D006429	marker/mechanism		NA		10566621
CGA	1081	Oligospermia	MESH:D009845	therapeutic		NA		16483355
CGA	1081	Ovarian Diseases	MESH:D010049	therapeutic		NA		20146381
CGA	1081	Thyroid cancer, follicular	MESH:C572845	marker/mechanism		NA		10566621
CGA	1081	Uterine Diseases	MESH:D014591	therapeutic		NA		20146381
CGB3	1082	Fetal Resorption	MESH:D005327	therapeutic		NA		3816235
CGB3	1082	Hypogonadism	MESH:D007006	therapeutic		NA		8263139|9334596
CGB5	93659	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
CGREF1	10669	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		28108177
CHADL	150356	Osteoarthritis, Hip	MESH:D015207	marker/mechanism		NA		28319091|30374069
CHAF1A	10036	Mouth Diseases	MESH:D009059	marker/mechanism		NA		17682004
CHAF1B	8208	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CHAF1B	8208	Mouth Diseases	MESH:D009059	marker/mechanism		NA		17682004
CHAMP1	283489	MENTAL RETARDATION, AUTOSOMAL DOMINANT 40	OMIM:616579	marker/mechanism		NA	616579	
CHAT	1103	Congenital myasthenic syndrome with episodic apnea	MESH:C535759	marker/mechanism		NA	254210	
CHAT	1103	Glaucoma, Angle-Closure	MESH:D015812	marker/mechanism		NA		27064256
CHAT	1103	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		23075401
CHAT	1103	Retinal Diseases	MESH:D012164	marker/mechanism		NA		23075401
CHAT	1103	Seizures	MESH:D012640	marker/mechanism		NA		19941057
CHC-1	176434	Infertility	MESH:D007246	marker/mechanism		NA		31369748
CHCHD10	400916	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2	OMIM:615911	marker/mechanism		NA	615911	
CHCHD10	400916	MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT	OMIM:616209	marker/mechanism		NA	616209	
CHCHD10	400916	SPINAL MUSCULAR ATROPHY, JOKELA TYPE	OMIM:615048	marker/mechanism		NA	615048	
CHCHD2	51142	PARKINSON DISEASE 22, AUTOSOMAL DOMINANT	OMIM:616710	marker/mechanism		NA	616710	
CHCHD3	54927	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
CHD1	1105	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		30510241
CHD1	1105	Memory Disorders	MESH:D008569	marker/mechanism		NA		30728766
CHD1	1105	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
CHD1L	9557	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
CHD2	1106	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		28191889
CHD2	1106	Epilepsy	MESH:D004827	marker/mechanism		NA		23708187|29942082
CHD2	1106	Myoclonic Epilepsies, Progressive	MESH:D020191	marker/mechanism		NA	615369	
CHD2	1106	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		29942082
CHD3	1107	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
CHD3	1107	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
CHD3	1107	Sezary Syndrome	MESH:D012751	marker/mechanism		NA		26551667
CHD4	1108	Autistic Disorder	MESH:D001321	marker/mechanism		NA		30559488
CHD4	1108	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		30559488
CHD4	1108	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		23104009
CHD4	1108	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		30008631
CHD4	1108	Schizophrenia	MESH:D012559	marker/mechanism		NA		21743468
CHD5	26038	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		21278247
CHD5	26038	Neuroblastoma	MESH:D009447	marker/mechanism		NA		26121086
CHD5	26038	Recurrence	MESH:D012008	marker/mechanism		NA		26121086
CHD6	84181	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		21822268
CHD6	84181	Neuroblastoma	MESH:D009447	marker/mechanism		NA		18577749
CHD6	84181	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
CHD6	84181	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		21822268
CHD7	55636	CHARGE Syndrome	MESH:D058747	marker/mechanism		NA	214800	16615981|21532573
CHD7	55636	Kallmann Syndrome	MESH:D017436	marker/mechanism		NA	612370	
CHD7	55636	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
CHD8	57680	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		24998929|28191889|30670789
CHD8	57680	Autistic Disorder	MESH:D001321	marker/mechanism		NA	615032	25961944
CHD8	57680	Facies	MESH:D019066	marker/mechanism		NA		30670789
CHD8	57680	Gastrointestinal Diseases	MESH:D005767	marker/mechanism		NA		24998929
CHD8	57680	Intellectual Disability	MESH:D008607	marker/mechanism		NA		30670789
CHD8	57680	Megalencephaly	MESH:D058627	marker/mechanism		NA		24998929|30670789
CHEK1	1111	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25688741
CHEK1	1111	Polyploidy	MESH:D011123	marker/mechanism		NA		25123929
CHEK2	11200	Breast Neoplasms	MESH:D001943	marker/mechanism		NA	114480	11967536|12690581|15122511|18297428
CHEK2	11200	Breast Neoplasms, Male	MESH:D018567	marker/mechanism		NA		11967536
CHEK2	11200	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		12690581
CHEK2	11200	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
CHEK2	11200	Li-Fraumeni Syndrome	MESH:D016864	marker/mechanism		NA		10617473|11719428
CHEK2	11200	Li-Fraumeni Syndrome 2	MESH:C563755	marker/mechanism		NA	609265	
CHEK2	11200	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		24880342
CHEK2	11200	Lymphoma, Non-Hodgkin	MESH:D008228	marker/mechanism		NA		26506619
CHEK2	11200	Neoplasms, Squamous Cell	MESH:D018307	marker/mechanism		NA		24880342
CHEK2	11200	Neuroblastoma	MESH:D009447	marker/mechanism		NA		23334666
CHEK2	11200	Osteosarcoma	MESH:D012516	marker/mechanism		NA	259500	11746983
CHEK2	11200	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		12533788
CHEK2	11200	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA	176807	12533788
CHEK2	11200	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
CHES1	555843	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
CHFR	55743	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		20705357
CHFR	55743	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		17143476
CHFR	55743	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
CHGA	1113	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		21595568
CHGA	1113	Pheochromocytoma	MESH:D010673	marker/mechanism		NA		11116123
CHI3L1	1116	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7	OMIM:611960	marker/mechanism		NA	611960	
CHI3L1	1116	Glioblastoma	MESH:D005909	marker/mechanism		NA		21029458
CHI3L1	1116	Glioma	MESH:D005910	marker/mechanism		NA		20506295
CHI3L1	1116	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		21029458
CHI3L1	1116	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
CHI3L1	1116	Schizophrenia	MESH:D012559	marker/mechanism		NA	181500	
CHIA	27159	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
CHIC2	26511	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA	601626	
CHIT1	1118	Gaucher Disease	MESH:D005776	marker/mechanism		NA		17464953
CHKA	1119	Spinal Dysraphism	MESH:D016135	marker/mechanism		NA		17184542
CHKB	1120	Muscular Dystrophy, Congenital, Megaconial Type	MESH:C566527	marker/mechanism		NA	602541	
CHKB	1120	Narcolepsy	MESH:D009290	marker/mechanism		NA		18820697
CHL1	10752	Intellectual Disability	MESH:D008607	marker/mechanism		NA		12812975
CHL1	10752	Schizophrenia	MESH:D012559	marker/mechanism		NA		11986985|15653271
CHM	1121	Choroideremia	MESH:D015794	marker/mechanism		NA	303100	
CHMP1A	5119	PONTOCEREBELLAR HYPOPLASIA, TYPE 8	OMIM:614961	marker/mechanism		NA	614961	
CHMP2B	25978	Amyotrophic Lateral Sclerosis	MESH:D000690	marker/mechanism		NA		16807408
CHMP2B	25978	AMYOTROPHIC LATERAL SCLEROSIS 17	OMIM:614696	marker/mechanism		NA	614696	
CHMP2B	25978	Chromosome 3-Linked Frontotemporal Dementia	MESH:C579991	marker/mechanism		NA	600795	
CHMP2B	25978	Frontotemporal Dementia	MESH:D057180	marker/mechanism		NA		16041373
CHMP2B	25978	Frontotemporal Lobar Degeneration	MESH:D057174	marker/mechanism		NA		17956895
CHMP4B	128866	Cataract, posterior polar, 3	MESH:C535343	marker/mechanism		NA	605387	
CHMP4C	92421	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		23535730|31043753
CHMP5	51510	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17708794
CHN1	1123	Duane Retraction Syndrome	MESH:D004370	marker/mechanism		NA	604356	
CHN2	1124	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
CHN2	1124	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		19233941
CHP	43690	Parkinson Disease	MESH:D010300	marker/mechanism		NA		18353766
CHPT1	56994	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		16292752
CHRDL1	91851	Megalocornea	MESH:C562829	marker/mechanism		NA	309300	
CHRM1	1128	Brain Ischemia	MESH:D002545	marker/mechanism		NA		18501976
CHRM1	1128	Epilepsy	MESH:D004827	marker/mechanism		NA		18333967
CHRM1	1128	Memory Disorders	MESH:D008569	marker/mechanism		NA		21682298
CHRM1	1128	Seizures	MESH:D012640	marker/mechanism		NA		10069499|11392617|12091480|12713643|8028781
CHRM2	1129	Bradycardia	MESH:D001919	marker/mechanism		NA		11181912
CHRM2	1129	Brain Injuries	MESH:D001930	marker/mechanism		NA		23159883
CHRM2	1129	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		18603373
CHRM2	1129	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		18603373
CHRM2	1129	Diabetic Neuropathies	MESH:D003929	therapeutic		NA		20624991
CHRM2	1129	Epilepsy	MESH:D004827	marker/mechanism		NA		18333967
CHRM2	1129	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20393457
CHRM2	1129	Urinary Bladder, Neurogenic	MESH:D001750	therapeutic		NA		20624991
CHRM2A	352938	Bradycardia	MESH:D001919	marker/mechanism		NA		12411408
CHRM3	1131	Ascites	MESH:D001201	marker/mechanism		NA		20197374
CHRM3	1131	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		20197374
CHRM3	1131	Cryptorchidism	MESH:D003456	marker/mechanism		NA		22077972
CHRM3	1131	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		20197374
CHRM3	1131	Prune Belly Syndrome	MESH:D011535	marker/mechanism		NA	100100	22077972
CHRM3	1131	Urinary Bladder Diseases	MESH:D001745	marker/mechanism		NA		22077972
CHRM4	1132	Catatonia	MESH:D002389	therapeutic		NA		15273762
CHRM4	1132	Tremor	MESH:D014202	marker/mechanism		NA		9920179
CHRM5	1133	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		13130510
CHRM5	1133	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		12154229
CHRNA1	1134	Fibrosis	MESH:D005355	marker/mechanism		NA		19690163
CHRNA1	1134	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	OMIM:253290	marker/mechanism		NA	253290	
CHRNA1	1134	Myasthenic Syndrome, Congenital, Fast-Channel	MESH:C563832	marker/mechanism		NA	608930	
CHRNA2	1135	Epilepsy, Nocturnal Frontal Lobe, Type 4	MESH:C563679	marker/mechanism		NA	610353	19383498
CHRNA2	1135	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		28604730
CHRNA3	1136	Alcoholism	MESH:D000437	marker/mechanism		NA		18414406
CHRNA3	1136	Lung Neoplasms	MESH:D008175	marker/mechanism		NA	612052	18385738
CHRNA3	1136	Seizures	MESH:D012640	marker/mechanism		NA		15275829
CHRNA3	1136	TOBACCO ADDICTION, SUSCEPTIBILITY TO	OMIM:188890	marker/mechanism		NA		20372150|20418890
CHRNA3	1136	Tobacco Use Disorder	MESH:D014029	marker/mechanism		NA		18414406|29666375
CHRNA4	1137	Attention Deficit Disorder with Hyperactivity	MESH:D001289	marker/mechanism		NA		21748252
CHRNA4	1137	Autistic Disorder	MESH:D001321	marker/mechanism		NA		15046869
CHRNA4	1137	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		20805988
CHRNA4	1137	Dystonia	MESH:D004421	marker/mechanism		NA		19404753
CHRNA4	1137	Epilepsy, Frontal Lobe	MESH:D017034	marker/mechanism		NA		12823585|14996991|17881519
CHRNA4	1137	Epilepsy, Nocturnal Frontal Lobe, Type 1	MESH:C563930	marker/mechanism		NA	600513	
CHRNA4	1137	Inflammation	MESH:D007249	therapeutic		NA		20943775
CHRNA4	1137	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		20805988
CHRNA4	1137	Seizures	MESH:D012640	marker/mechanism		NA		10942032|16339034
CHRNA4	1137	Sleep Wake Disorders	MESH:D012893	marker/mechanism		NA		16339034
CHRNA4	1137	TOBACCO ADDICTION, SUSCEPTIBILITY TO	OMIM:188890	marker/mechanism		NA	188890	
CHRNA5	1138	Alcoholism	MESH:D000437	marker/mechanism		NA		18414406
CHRNA5	1138	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		19220484|29944862
CHRNA5	1138	Lung Neoplasms	MESH:D008175	marker/mechanism		NA	612052	18385738
CHRNA5	1138	Seizures	MESH:D012640	marker/mechanism		NA		14996991|9495872
CHRNA5	1138	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20438829
CHRNA5	1138	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		18184829
CHRNA5	1138	TOBACCO ADDICTION, SUSCEPTIBILITY TO	OMIM:188890	marker/mechanism		NA		20372150
CHRNA5	1138	Tobacco Use Disorder	MESH:D014029	marker/mechanism		NA		18414406|18519132|28472521
CHRNA6	8973	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		19644040
CHRNA6	8973	TOBACCO ADDICTION, SUSCEPTIBILITY TO	OMIM:188890	marker/mechanism		NA		20418888
CHRNA6	8973	Tobacco Use Disorder	MESH:D014029	marker/mechanism		NA		28851948
CHRNA7	1139	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		18071042
CHRNA7	1139	Auditory Perceptual Disorders	MESH:D001308	therapeutic		NA		10578459
CHRNA7	1139	Autistic Disorder	MESH:D001321	marker/mechanism		NA		15046869
CHRNA7	1139	Brain Injuries	MESH:D001930	marker/mechanism		NA		23159883
CHRNA7	1139	Chromosome 15q13.3 Microdeletion Syndrome	MESH:C567439	marker/mechanism		NA	612001	
CHRNA7	1139	Epilepsy, Generalized	MESH:D004829	marker/mechanism		NA		19136953
CHRNA7	1139	Hernia, Umbilical	MESH:D006554	marker/mechanism		NA		22473653
CHRNA7	1139	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		24089524
CHRNA7	1139	Memory Disorders	MESH:D008569	therapeutic		NA		18848931
CHRNA7	1139	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		18844224
CHRNA7	1139	Nerve Degeneration	MESH:D009410	therapeutic		NA		21715663
CHRNA7	1139	Neurobehavioral Manifestations	MESH:D019954	marker/mechanism		NA		19898479
CHRNA7	1139	Seizures	MESH:D012640	marker/mechanism		NA		10565853|10942032|11893908|14996991|9495872
CHRNA7	1139	Spina Bifida Cystica	MESH:D016137	marker/mechanism		NA		22473653
CHRNA7	1139	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		18184829
CHRNA7	1139	Sudden Infant Death	MESH:D013398	marker/mechanism		NA		22000980
CHRNA7	1139	Tobacco Use Disorder	MESH:D014029	marker/mechanism		NA		24289814
CHRNA9	55584	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		30259641
CHRNB1	1140	Myasthenic Syndrome, Congenital, with Facial Dysmorphism, associated with Acetylcholine Receptor Deficiency	MESH:C563829	marker/mechanism		NA	616314	
CHRNB1	1140	Myasthenic Syndromes, Congenital	MESH:D020294	marker/mechanism		NA	616313	
CHRNB2	1141	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		17192785
CHRNB2	1141	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		23419392
CHRNB2	1141	Attention Deficit Disorder with Hyperactivity	MESH:D001289	marker/mechanism		NA		21748252
CHRNB2	1141	Autistic Disorder	MESH:D001321	marker/mechanism		NA		15046869
CHRNB2	1141	Epilepsy, Frontal Lobe	MESH:D017034	marker/mechanism		NA		14996991
CHRNB2	1141	Epilepsy, Nocturnal Frontal Lobe, Type 3	MESH:C565334	marker/mechanism		NA	605375	
CHRNB2	1141	Hypothermia	MESH:D007035	marker/mechanism		NA		14982698
CHRNB2	1141	Inflammation	MESH:D007249	therapeutic		NA		20943775
CHRNB2	1141	Nerve Degeneration	MESH:D009410	therapeutic		NA		21715663
CHRNB2	1141	Reflex, Abnormal	MESH:D012021	therapeutic		NA		23419392
CHRNB2	1141	Sleep Wake Disorders	MESH:D012893	marker/mechanism		NA		12228730
CHRNB2	1141	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		18184829
CHRNB2	1141	Sudden Infant Death	MESH:D013398	marker/mechanism		NA		22000980
CHRNB3	1142	TOBACCO ADDICTION, SUSCEPTIBILITY TO	OMIM:188890	marker/mechanism		NA		20418888
CHRNB3	1142	Tobacco Use Disorder	MESH:D014029	marker/mechanism		NA		28851948
CHRNB4	1143	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		18385738
CHRNB4	1143	Seizures	MESH:D012640	marker/mechanism		NA		14996991|15275829
CHRNB4	1143	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		15537871
CHRNB4	1143	Tobacco Use Disorder	MESH:D014029	marker/mechanism		NA		29666375
CHRND	1144	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	OMIM:253290	marker/mechanism		NA	253290	
CHRND	1144	Myasthenic Syndrome, Congenital, Fast-Channel	MESH:C563832	marker/mechanism		NA	616322	
CHRND	1144	Myasthenic Syndrome, Congenital, with Facial Dysmorphism, associated with Acetylcholine Receptor Deficiency	MESH:C563829	marker/mechanism		NA	616323	
CHRND	1144	Myasthenic Syndromes, Congenital	MESH:D020294	marker/mechanism		NA	616321	
CHRND	1144	Paralysis	MESH:D010243	marker/mechanism		NA		18694773
CHRNE	1145	Myasthenia, Familial Infantile, 1	MESH:C565289	marker/mechanism		NA	605809	
CHRNE	1145	Myasthenic Syndrome, Congenital, Fast-Channel	MESH:C563832	marker/mechanism		NA	616324	
CHRNE	1145	Myasthenic syndrome, congenital, type Id	MESH:C536090	marker/mechanism		NA	608931	
CHRNG	1146	Arthrogryposis	MESH:D001176	marker/mechanism		NA		16826520|16826531
CHRNG	1146	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		16826531
CHRNG	1146	Multiple pterygium syndrome	MESH:C537377	marker/mechanism		NA	265000	16826520|16826531
CHRNG	1146	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	OMIM:253290	marker/mechanism		NA	253290	
CHRNG	1146	Myasthenic Syndromes, Congenital	MESH:D020294	marker/mechanism		NA		16826520
CHST14	113189	Adducted Thumbs Syndrome	MESH:C562949	marker/mechanism		NA		20004762
CHST14	113189	Clubfoot	MESH:D003025	marker/mechanism		NA		20004762
CHST14	113189	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		20842734
CHST14	113189	Ehlers-Danlos Syndrome, musculocontractural type 1	MESH:C000600608	marker/mechanism		NA	601776	20004762|20842734
CHST14	113189	Joint Instability	MESH:D007593	marker/mechanism		NA		20842734
CHST14	113189	Muscle Hypotonia	MESH:D009123	marker/mechanism		NA		20842734
CHST14	113189	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		27415467
CHST14	113189	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		27415467
CHST15	51363	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
CHST3	9469	MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	OMIM:245600	marker/mechanism		NA	245600	
CHST3	9469	Osteochondrodysplasias	MESH:D010009	marker/mechanism		NA		30200136
CHST3	9469	SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	OMIM:143095	marker/mechanism		NA	143095	
CHST6	4166	Macular dystrophy, corneal type 1	MESH:C537834	marker/mechanism		NA	217800	
CHST8	64377	Peeling Skin Syndrome	MESH:C564818	marker/mechanism		NA	616265	
CHSY1	22856	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CHSY1	22856	Temtamy preaxial brachydactyly syndrome	MESH:C536958	marker/mechanism		NA	605282	
CHUK	1147	Abnormalities, Multiple	MESH:D000015	marker/mechanism		NA		20961246
CHUK	1147	Autistic Disorder	MESH:D001321	marker/mechanism		NA		20957522
CHUK	1147	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		10346820
CHUK	1147	Cleft Palate	MESH:D002972	marker/mechanism		NA		10346820
CHUK	1147	Fetal Diseases	MESH:D005315	marker/mechanism		NA		10195895|10195896|10346820|20961246
CHUK	1147	FETAL ENCASEMENT SYNDROME	OMIM:613630	marker/mechanism		NA	613630	
CHUK	1147	Limb Deformities, Congenital	MESH:D017880	marker/mechanism		NA		10195895|10195896|10346820|20961246
CHUK	1147	Skin Abnormalities	MESH:D012868	marker/mechanism		NA		10195895|10195896|10346820
CIB2	10518	Deafness, Autosomal Recessive 48	MESH:C563720	marker/mechanism		NA	609439	23023331
CIB2	10518	USHER SYNDROME, TYPE IJ	OMIM:614869	marker/mechanism		NA	614869	23023331
CIBAR1	137392	Ciliopathies	MESH:D000072661	marker/mechanism		NA		30395363
CIBAR1	137392	Polydactyly, Postaxial	MESH:C562429	marker/mechanism		NA		30395363
CIBAR1	137392	Syndactyly	MESH:D013576	marker/mechanism		NA		30395363
CIBAR2	339145	Crohn Disease	MESH:D003424	marker/mechanism		NA		17435756
CIC	23152	Attention Deficit Disorder with Hyperactivity	MESH:D001289	marker/mechanism		NA		28288114
CIC	23152	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		28288114
CIC	23152	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21076407|28288114
CIC	23152	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		27869830
CIC	23152	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA		18337722
CIDEA	1149	Heart Failure	MESH:D006333	marker/mechanism		NA		26670611
CIDEA	1149	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CIDEA	1149	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		25058030|28108177
CIDEA	1149	Obesity	MESH:D009765	marker/mechanism		NA		20975297
CIDEC	63924	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17374397
CIDEC	63924	Lipodystrophy, Familial Partial	MESH:D052496	marker/mechanism		NA	615238	
CIITA	4261	Addison Disease	MESH:D000224	marker/mechanism		NA		18593762
CIITA	4261	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA	180300	
CIITA	4261	Bare lymphocyte syndrome 2	MESH:C537079	marker/mechanism		NA	209920	
CIITA	4261	Gastro-enteropancreatic neuroendocrine tumor	MESH:C535650	marker/mechanism		NA		29915428
CILK1	22858	Endocrine-Cerebroosteodysplasia	MESH:C567210	marker/mechanism		NA	612651	
CILP	8483	Intervertebral disc disease	MESH:C535531	marker/mechanism		NA	603932	
CIRBP	1153	Alcohol-Induced Disorders, Nervous System	MESH:D020268	marker/mechanism		NA		24223948
CIRBP	1153	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		24781735
CIRBP	1153	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
CIRBP	1153	Neurogenic Inflammation	MESH:D020078	marker/mechanism		NA		24223948
CISD2	493856	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28869590
CISD2	493856	Wolfram Syndrome 2	MESH:C565733	marker/mechanism		NA	604928	24705017
CISH	1154	Bacteremia	MESH:D016470	marker/mechanism		NA	614383	
CISH	1154	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		16033404
CISH	1154	Malaria	MESH:D008288	marker/mechanism		NA	611162	
CISH	1154	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO	OMIM:607948	marker/mechanism		NA	607948	
CISH	1154	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		26297436
CIT	11113	MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE	OMIM:617090	marker/mechanism		NA	617090	
CITED2	10370	ATRIAL SEPTAL DEFECT 8	OMIM:614433	marker/mechanism		NA	614433	
CITED2	10370	Heart Septal Defects	MESH:D006343	marker/mechanism		NA		16287139
CITED2	10370	Heart Septal Defects, Ventricular	MESH:D006345	marker/mechanism		NA	614431	
CITED2	10370	Muscular Atrophy	MESH:D009133	therapeutic		NA		19032942
CITED2	10370	Neoplasms	MESH:D009369	marker/mechanism		NA		21660965
CIZ1	25792	Cervical Dystonia, Primary	MESH:C566572	marker/mechanism		NA		22447717
CIZ1	25792	Dystonia	MESH:D004421	marker/mechanism		NA		23222958
CIZ1	25792	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		24763052
CIZ1	25792	Sarcoma, Ewing	MESH:D012512	marker/mechanism		NA		17508423
CKAP2L	150468	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CKAP2L	150468	Filippi syndrome	MESH:C538152	marker/mechanism		NA	272440	
CKAP5	9793	Aneuploidy	MESH:D000782	marker/mechanism		NA		24976383
CKAP5	9793	Chromosomal Instability	MESH:D043171	marker/mechanism		NA		24976383
CKB	1152	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		15966572
CKB	1152	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		15378696
CKB	1152	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
CKB	1152	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		11406506
CKB	1152	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		12359538
CKB	1152	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		2828370
CKB	1152	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		15378696
CKLF	51192	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CKM	1158	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		15966572
CKM	1158	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
CKM	1158	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		11406506
CKM	1158	Ischemia	MESH:D007511	marker/mechanism		NA		21912612
CKM	1158	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		12359538|3279722
CKS2	1164	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
CLCA2	9635	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
CLCC1	23155	Retinitis Pigmentosa 32	MESH:C563689	marker/mechanism		NA	609913	
CLCF1	23529	Crisponi syndrome	MESH:C536214	marker/mechanism		NA	610313	
CLCN1	1180	Myotonia Congenita	MESH:D009224	marker/mechanism		NA	255700	20399394
CLCN1	1180	MYOTONIA CONGENITA, AUTOSOMAL DOMINANT	OMIM:160800	marker/mechanism		NA	160800	
CLCN2	1181	Epilepsy, Idiopathic Generalized	MESH:C562694	marker/mechanism		NA	607628	
CLCN2	1181	Glioma	MESH:D005910	marker/mechanism		NA		12843258
CLCN2	1181	Hyperaldosteronism	MESH:D006929	marker/mechanism		NA		29403012
CLCN2	1181	Hyperaldosteronism, Familial, Type II	MESH:C565312	marker/mechanism		NA	605635	29403011
CLCN2	1181	LEUKOENCEPHALOPATHY WITH ATAXIA	OMIM:615651	marker/mechanism		NA	615651	
CLCN3	1182	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
CLCN3	1182	Glioma	MESH:D005910	marker/mechanism		NA		12843258
CLCN3	1182	Nasopharyngeal Carcinoma	MESH:D000077274	marker/mechanism		NA		22108225
CLCN3	1182	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
CLCN4	1183	RAYNAUD-CLAES SYNDROME	OMIM:300114	marker/mechanism		NA	300114	
CLCN5	1184	Dent Disease	MESH:D057973	marker/mechanism		NA		10561751|15719255|20804101
CLCN5	1184	Dent disease 1	MESH:C538212	marker/mechanism		NA	300009	
CLCN5	1184	Familial Hypophosphatemic Rickets	MESH:D053098	marker/mechanism		NA	300554	
CLCN5	1184	Glioma	MESH:D005910	marker/mechanism		NA		12843258
CLCN5	1184	Goiter	MESH:D006042	marker/mechanism		NA		16306076
CLCN5	1184	Low Molecular Weight Proteinuria with Hypercalciuria and Nephrocalcinosis	MESH:C545036	marker/mechanism		NA	308990	
CLCN5	1184	Nephrolithiasis, X-Linked Recessive, with Renal Failure	MESH:C562901	marker/mechanism		NA	310468	
CLCN5	1184	Proteinuria	MESH:D011507	marker/mechanism		NA		15719255
CLCN7	1186	Osteopetrosis	MESH:D010022	marker/mechanism		NA	166600	
CLCN7	1186	Osteopetrosis, Autosomal Recessive 4	MESH:C566933	marker/mechanism		NA	611490	
CLCNKA	1187	Bartter Syndrome, Type 4b	MESH:C567762	marker/mechanism		NA	613090	
CLCNKA	1187	Hypertension	MESH:D006973	marker/mechanism		NA		18480177
CLCNKB	1188	Bartter Syndrome	MESH:D001477	marker/mechanism		NA		10561751
CLCNKB	1188	Bartter syndrome, type 3	MESH:C537653	marker/mechanism		NA	607364	
CLCNKB	1188	Bartter Syndrome, Type 4b	MESH:C567762	marker/mechanism		NA	613090	
CLDN1	9076	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19579870|24014025
CLDN1	9076	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		24014025
CLDN1	9076	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		23136956
CLDN1	9076	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
CLDN1	9076	Ichthyosis, Leukocyte Vacuoles, Alopecia, And Sclerosing Cholangitis	MESH:C564365	marker/mechanism		NA	607626	
CLDN11	5010	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		25911099
CLDN11	5010	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		25911099
CLDN14	23562	Deafness	MESH:D003638	marker/mechanism		NA		11163249
CLDN14	23562	DEAFNESS, AUTOSOMAL RECESSIVE 29	OMIM:614035	marker/mechanism		NA	614035	
CLDN14	23562	Kidney Calculi	MESH:D007669	marker/mechanism		NA		19561606
CLDN16	10686	Hypomagnesemia primary	MESH:C537153	marker/mechanism		NA	248250	
CLDN19	149461	Hypomagnesemia 5, Renal, with Ocular Involvement	MESH:C565423	marker/mechanism		NA	248190	
CLDN2	9075	Pancreatitis	MESH:D010195	marker/mechanism		NA		23143602
CLDN3	1365	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
CLDN3	1365	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
CLDN4	1364	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19142967
CLDN4	1364	Carcinoma, Ductal, Breast	MESH:D018270	marker/mechanism		NA		19142967
CLDN4	1364	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		19142967
CLDN4	1364	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
CLDN4	1364	Respiratory Hypersensitivity	MESH:D012130	marker/mechanism		NA		30608172
CLDN5	7122	Respiratory Hypersensitivity	MESH:D012130	marker/mechanism		NA		30608172
CLDN7	1366	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		21134740
CLDN7	1366	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
CLDN9	9080	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
CLEC10A	10462	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
CLEC11A	6320	Anemia	MESH:D000740	marker/mechanism		NA		19884328
CLEC11A	6320	Carotid Stenosis	MESH:D016893	marker/mechanism		NA		26564003
CLEC11A	6320	Malaria, Falciparum	MESH:D016778	marker/mechanism		NA		19884328
CLEC11A	6320	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25162674
CLEC11A	6320	Osteoporosis	MESH:D010024	marker/mechanism		NA		27976999
CLEC12A	160364	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		17568789
CLEC16A	23274	Addison Disease	MESH:D000224	marker/mechanism		NA		18593762
CLEC16A	23274	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		17632545|18946483
CLEC16A	23274	IgA Deficiency	MESH:D017098	marker/mechanism		NA		20694011|27723758
CLEC16A	23274	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		21399635
CLEC16A	23274	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		19838195
CLEC16A	23274	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		18946483|19525955
CLEC1A	51267	Aspergillosis	MESH:D001228	marker/mechanism		NA	614079	
CLEC1B	51266	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CLEC4A	50856	Hypersensitivity	MESH:D006967	marker/mechanism		NA		23624239
CLEC4A	50856	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CLEC4A1	269799	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CLEC4A3	73149	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CLEC4B2	381809	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
CLEC4D	338339	Lung Diseases	MESH:D008171	marker/mechanism		NA		21602193
CLEC4E	26253	Brain Injuries	MESH:D001930	marker/mechanism		NA		21549006
CLEC4E	26253	Lung Diseases	MESH:D008171	marker/mechanism		NA		21602193
CLEC4F	165530	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CLEC4G	339390	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CLEC4M	10332	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CLEC5A	23601	Severe Dengue	MESH:D019595	therapeutic		NA		18496526
CLEC7A	64581	Aspergillosis	MESH:D001228	marker/mechanism		NA	614079	
CLEC7A	64581	Candidiasis familial chronic mucocutaneous, autosomal recessive	MESH:C537979	marker/mechanism		NA	613108	
CLIC1	1192	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20562527
CLIC1	1192	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
CLIC1	1192	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
CLIC1	1192	Keloid	MESH:D007627	marker/mechanism		NA		20128793
CLIC1	1192	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CLIC1	1192	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		20562527
CLIC1	1192	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
CLIC2	1193	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CLIC2	1193	MENTAL RETARDATION, X-LINKED, SYNDROMIC 32	OMIM:300886	marker/mechanism		NA	300886	
CLIC4	25932	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
CLIC4	25932	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
CLIC4	25932	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
CLIC5	53405	DEAFNESS, AUTOSOMAL RECESSIVE 103	OMIM:616042	marker/mechanism		NA	616042	
CLMP	79827	Intestinal Pseudo-Obstruction	MESH:D007418	marker/mechanism		NA	615237	
CLN3	1201	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
CLN3	1201	Neuronal Ceroid-Lipofuscinoses	MESH:D009472	marker/mechanism		NA	204200	
CLN3	1201	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
CLN5	1203	Ceroid lipofuscinosis, neuronal 5	MESH:C575534	marker/mechanism		NA	256731	
CLN6	54982	Atrophy	MESH:D001284	marker/mechanism		NA		23789114
CLN6	54982	Ceroid Lipofuscinosis, Neuronal, 6	MESH:C566627	marker/mechanism		NA	601780	23516525
CLN6	54982	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		23789114
CLN6	54982	Inflammation	MESH:D007249	marker/mechanism		NA		23789114
CLN6	54982	Motor Skills Disorders	MESH:D019957	marker/mechanism		NA		23789114
CLN6	54982	Myoclonic Epilepsies, Progressive	MESH:D020191	marker/mechanism		NA		25401298
CLN6	54982	Neuronal Ceroid-Lipofuscinoses	MESH:D009472	marker/mechanism		NA	204300	23789114
CLN6	54982	Vision Disorders	MESH:D014786	marker/mechanism		NA		23789114
CLN6	54982	Weight Loss	MESH:D015431	marker/mechanism		NA		23789114
CLN8	2055	Ceroid lipofuscinosis, neuronal 8	MESH:C537952	marker/mechanism		NA	600143|610003	
CLNK	116449	Vitiligo	MESH:D014820	marker/mechanism		NA		22561518
CLNS1A	1207	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
CLP1	10978	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CLP1	10978	PONTOCEREBELLAR HYPOPLASIA, TYPE 10	OMIM:615803	marker/mechanism		NA	615803	
CLPB	81570	3-METHYLGLUTACONIC ACIDURIA, TYPE VII	OMIM:616271	marker/mechanism		NA	616271	
CLPP	8192	PERRAULT SYNDROME 3	OMIM:614129	marker/mechanism		NA	614129	
CLPTM1	1209	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		26098869
CLPTM1L	81037	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		22675468
CLPTM1L	81037	Carcinoma, Basal Cell	MESH:D002280	marker/mechanism		NA		19151717
CLPTM1L	81037	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		22675468
CLPTM1L	81037	Leukemia, Lymphoid	MESH:D007945	marker/mechanism		NA		24292274
CLPTM1L	81037	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		18978787|19151717|24366883
CLPTM1L	81037	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		27749845
CLPTM1L	81037	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		19151717
CLPTM1L	81037	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		19151717
CLPTM1L	81037	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		19151717
CLRN1	7401	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA	268000	
CLRN1	7401	RETINITIS PIGMENTOSA 61	OMIM:614180	marker/mechanism		NA	614180	
CLRN1	7401	USHER SYNDROME, TYPE IIIA	OMIM:276902	marker/mechanism		NA	276902	
CLSTN2	64084	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
CLTB	1212	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
CLTC	1213	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		22474449
CLTRN	57393	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CLTRN	57393	Ureteral Obstruction	MESH:D014517	marker/mechanism		NA		12887829
CLU	1191	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		20118187|20623750|22005293|23052191|24361871|28885000
CLU	1191	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		19734902|19734903|21460841
CLU	1191	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
CLU	1191	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
CLU	1191	Atrophy	MESH:D001284	marker/mechanism		NA		21536718
CLU	1191	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		20623750
CLU	1191	Cognitive Dysfunction	MESH:D060825	marker/mechanism		NA		30503753
CLU	1191	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		24361871|28885000
CLU	1191	Kidney Diseases	MESH:D007674	marker/mechanism		NA		21258088|21593213|24863737
CLU	1191	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		15304052
CLU	1191	Melanoma	MESH:D008545	therapeutic		NA		15955107
CLU	1191	Neovascularization, Pathologic	MESH:D009389	therapeutic		NA		16308731
CLU	1191	Osteoarthritis	MESH:D010003	marker/mechanism		NA		17568789|18784066
CLU	1191	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17148459
CLU	1191	Seizures	MESH:D012640	marker/mechanism		NA		23266720
CLUL1	27098	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21466612
CMA1	1215	Hypertension	MESH:D006973	marker/mechanism		NA		14620933
CMA1	1215	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		14620933
CMA1	1215	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		15297733
CMC2	56942	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17659439
CMIP	80790	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28869590
CMKLR1	1240	Granulosa Cell Tumor	MESH:D006106	marker/mechanism		NA		29653259
CMTM2	146225	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
CMTM3	123920	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CMTR2	55783	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27158780
CMTR2	55783	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
CMTR2	55783	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
CNBP	7555	Myotonic Dystrophy	MESH:D009223	marker/mechanism		NA	602668	
CNDP1	84735	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CNDP1	84735	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		17942768|21393041|21573905
CNDP1	84735	Homocarnosinosis	MESH:C535328	marker/mechanism		NA		4172777
CNDP1	84735	Intellectual Disability	MESH:D008607	marker/mechanism		NA		4673339|4718759
CNDP1	84735	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CNDP1	84735	Neurologic Manifestations	MESH:D009461	marker/mechanism		NA		4673339
CNDP2	55748	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		21573905
CNDP2	55748	Fatty Liver	MESH:D005234	marker/mechanism		NA		25226513
CNGA1	1259	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA	268000	7479749
CNGA1	1259	RETINITIS PIGMENTOSA 49	OMIM:613756	marker/mechanism		NA	613756	
CNGA3	1261	Achromatopsia 2	MESH:C536128	marker/mechanism		NA	216900	
CNGA3	1261	Color Vision Defects	MESH:D003117	marker/mechanism		NA		30418171
CNGB1	1258	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA		11379879
CNGB1	1258	RETINITIS PIGMENTOSA 45	OMIM:613767	marker/mechanism		NA	613767	
CNGB3	54714	Achromatopsia 3	MESH:C536129	marker/mechanism		NA	262300	
CNGB3	54714	Color Vision Defects	MESH:D003117	marker/mechanism		NA		30418171
CNIH3	149111	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
CNKSR1	10256	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
CNKSR2	22866	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		30718926
CNN2	1265	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		15108329
CNN3	1266	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
CNN3	1266	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
CNN3	1266	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
CNN3	1266	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
CNNM1	26507	Melanoma	MESH:D008545	marker/mechanism		NA		16778180
CNNM2	54805	Arrhythmias, Cardiac	MESH:D001145	marker/mechanism		NA		23027747
CNNM2	54805	HYPOMAGNESEMIA 6, RENAL	OMIM:613882	marker/mechanism		NA	613882	
CNNM2	54805	HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 1	OMIM:616418	marker/mechanism		NA	616418	
CNNM2	54805	Kidney Diseases	MESH:D007674	marker/mechanism		NA		23027747
CNNM2	54805	Seizures	MESH:D012640	marker/mechanism		NA		23027747
CNNM2	54805	Tetany	MESH:D013746	marker/mechanism		NA		23027747
CNNM4	26504	Amaurosis hypertrichosis	MESH:C536604	marker/mechanism		NA	217080	
CNOT3	4849	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054218	marker/mechanism		NA		23263491
CNOT3	4849	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475|29662167
CNP	1267	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CNPPD1	27013	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		25944804
CNPY2	10330	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
CNPY2	10330	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
CNPY4	245812	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CNR1	1268	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		15081793|18690112
CNR1	1268	Attention Deficit Disorder with Hyperactivity	MESH:D001289	marker/mechanism		NA		22034972
CNR1	1268	Binge-Eating Disorder	MESH:D056912	marker/mechanism		NA		23072421
CNR1	1268	Catalepsy	MESH:D002375	marker/mechanism		NA		10318961
CNR1	1268	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		16314880|17596442|19052543
CNR1	1268	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		23072421
CNR1	1268	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
CNR1	1268	Epilepsy, Temporal Lobe	MESH:D004833	therapeutic		NA		20498848
CNR1	1268	Huntington Disease	MESH:D006816	marker/mechanism		NA		20929960
CNR1	1268	Hyperalgesia	MESH:D006930	therapeutic		NA		17572696
CNR1	1268	Hypotension	MESH:D007022	marker/mechanism		NA		9888857
CNR1	1268	Hypothermia	MESH:D007035	marker/mechanism		NA		9888857
CNR1	1268	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		11433348|21863215
CNR1	1268	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17043671
CNR1	1268	Marijuana Abuse	MESH:D002189	marker/mechanism		NA		19016476
CNR1	1268	Melanoma, Cutaneous Malignant	MESH:C562393	marker/mechanism		NA		28131817
CNR1	1268	Movement Disorders	MESH:D009069	therapeutic		NA		10802025
CNR1	1268	Multiple Sclerosis	MESH:D009103	therapeutic		NA		12876144
CNR1	1268	Muscle Spasticity	MESH:D009128	marker/mechanism		NA		17220914
CNR1	1268	Nerve Degeneration	MESH:D009410	marker/mechanism|therapeutic		NA		11517236|24211273
CNR1	1268	Obesity	MESH:D009765	marker/mechanism		NA		18722357
CNR1	1268	Pain	MESH:D010146	therapeutic		NA		19193902
CNR1	1268	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		16818650
CNR1	1268	Pancreatitis	MESH:D010195	marker/mechanism		NA		17484889
CNR1	1268	Rhabdomyosarcoma	MESH:D012208	marker/mechanism		NA		19509271
CNR1	1268	Schizophrenia	MESH:D012559	marker/mechanism		NA		21513772
CNR1	1268	Seizures	MESH:D012640	marker/mechanism		NA		12954810
CNR1	1268	Status Epilepticus	MESH:D013226	marker/mechanism		NA		19368833
CNR1	1268	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		18690112|21513772|9888857
CNR1	1268	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		18705688
CNR1	1268	Weight Gain	MESH:D015430	marker/mechanism		NA		20107430
CNR2	1269	Atherosclerosis	MESH:D050197	therapeutic		NA		15815632
CNR2	1269	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16818634
CNR2	1269	Depressive Disorder	MESH:D003866	marker/mechanism		NA		18286196
CNR2	1269	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27317300
CNR2	1269	Hyperalgesia	MESH:D006930	marker/mechanism|therapeutic		NA		17572696|18664590
CNR2	1269	Immune System Diseases	MESH:D007154	marker/mechanism		NA		16924491
CNR2	1269	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		15039279
CNR2	1269	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		15765409
CNR2	1269	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		16818650
CNR2	1269	Pancreatitis	MESH:D010195	marker/mechanism		NA		17484889
CNR2	1269	Parkinson Disease, Secondary	MESH:D010302	marker/mechanism		NA		27317300
CNST	163882	Thyroid Diseases	MESH:D013959	marker/mechanism		NA		23397585
CNTF	1270	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11951178
CNTF	1270	Cerebral Hemorrhage	MESH:D002543	therapeutic		NA		11701153
CNTF	1270	Nerve Degeneration	MESH:D009410	therapeutic		NA		15372491
CNTN1	1272	Myopathy, Congenital, Compton-North	MESH:C567261	marker/mechanism		NA	612540	
CNTN2	6900	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5	OMIM:615400	marker/mechanism		NA	615400	
CNTN3	5067	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18621663
CNTN3	5067	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17597826
CNTN4	152330	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18349135
CNTN4	152330	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		15106122
CNTN4	152330	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		15106122
CNTN4	152330	Growth Disorders	MESH:D006130	marker/mechanism		NA		15106122
CNTN6	27255	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
CNTNAP1	8506	LETHAL CONGENITAL CONTRACTURE SYNDROME 7	OMIM:616286	marker/mechanism		NA	616286	
CNTNAP2	26047	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		20176116|21082657|21572417|21962519
CNTNAP2	26047	Autistic Disorder	MESH:D001321	marker/mechanism		NA	612100	18179894|18621663|20157312|21310003
CNTNAP2	26047	Cortical Dysplasia-Focal Epilepsy Syndrome	MESH:C567657	marker/mechanism		NA	610042	
CNTNAP2	26047	Epilepsy	MESH:D004827	marker/mechanism		NA		20502679|21962519
CNTNAP2	26047	Hyperkinesis	MESH:D006948	marker/mechanism		NA		21962519
CNTNAP2	26047	Language Development Disorders	MESH:D007805	marker/mechanism		NA		20157312|21082657|21310003
CNTNAP2	26047	Parkinson Disease	MESH:D010300	marker/mechanism		NA		25475535
CNTNAP2	26047	Pitt-Hopkins syndrome	MESH:C537403	marker/mechanism		NA		19896112
CNTNAP2	26047	Schizophrenia	MESH:D012559	marker/mechanism		NA		20157312
CNTNAP2	26047	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941189
CNTNAP2	26047	Stuttering	MESH:D013342	marker/mechanism		NA		21108403
CNTNAP4	85445	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CNTROB	116840	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
CNX99A	44643	Parkinson Disease	MESH:D010300	marker/mechanism		NA		18353766
COA5	493753	Cardioencephalomyopathy, Fatal Infantile, due to Cytochrome C Oxidase Deficiency	MESH:C565784	marker/mechanism		NA	616500	
COA6	388753	Cardioencephalomyopathy, Fatal Infantile, due to Cytochrome C Oxidase Deficiency	MESH:C565784	marker/mechanism		NA	616501	
COASY	80347	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6	OMIM:615643	marker/mechanism		NA	615643	
COCH	1690	Deafness, Autosomal Dominant 9	MESH:C563335	marker/mechanism		NA	601369	
COG1	9382	Congenital disorder of glycosylation, type 2G	MESH:C535756	marker/mechanism		NA	611209	
COG1	9382	Enterovirus Infections	MESH:D004769	marker/mechanism		NA		28446605
COG2	22796	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq	OMIM:617395	marker/mechanism		NA	617395	
COG4	25839	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj	OMIM:613489	marker/mechanism		NA	613489	
COG4	25839	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21472284
COG5	10466	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
COG5	10466	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi	OMIM:613612	marker/mechanism		NA	613612	
COG5	10466	Enterovirus Infections	MESH:D004769	marker/mechanism		NA		28446605
COG6	57511	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl	OMIM:614576	marker/mechanism		NA	614576	
COG7	91949	Congenital disorder of glycosylation type 2E	MESH:C535754	marker/mechanism		NA	608779	
COG8	84342	Congenital Disorder Of Glycosylation, Type IIH	MESH:C566987	marker/mechanism		NA	611182	
COL10A1	1300	Metaphyseal chondrodysplasia Schmid type	MESH:C537352	marker/mechanism		NA	156500	19035365
COL11A1	1301	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		19638309
COL11A1	1301	Fibrochondrogenesis	MESH:C562524	marker/mechanism		NA	228520	
COL11A1	1301	Glaucoma, Angle-Closure	MESH:D015812	marker/mechanism		NA		22922875|27064256
COL11A1	1301	Intervertebral disc disease	MESH:C535531	marker/mechanism		NA	603932	
COL11A1	1301	Intervertebral Disc Displacement	MESH:D007405	marker/mechanism		NA		17999364
COL11A1	1301	Marshall syndrome	MESH:C536025	marker/mechanism		NA	154780	9529347
COL11A1	1301	Osteoarthritis, Hip	MESH:D015207	marker/mechanism		NA		30374069
COL11A1	1301	Osteochondrodysplasias	MESH:D010009	marker/mechanism		NA		19638309
COL11A1	1301	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
COL11A1	1301	Stickler syndrome, type 2	MESH:C537493	marker/mechanism		NA	604841	
COL11A2	1302	Cartilage Diseases	MESH:D002357	marker/mechanism		NA		11668593
COL11A2	1302	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		16637051
COL11A2	1302	Deafness, Autosomal Dominant 13	MESH:C566612	marker/mechanism		NA	601868	
COL11A2	1302	Deafness, Autosomal Recessive 53	MESH:C566453	marker/mechanism		NA	609706	
COL11A2	1302	Fibrochondrogenesis	MESH:C562524	marker/mechanism		NA	614524	
COL11A2	1302	Hearing Loss, Sensorineural	MESH:D006319	marker/mechanism		NA		16637051
COL11A2	1302	Limb Deformities, Congenital	MESH:D017880	marker/mechanism		NA		16637051
COL11A2	1302	Megaepiphyseal dwarfism	MESH:C536140	marker/mechanism		NA		16637051
COL11A2	1302	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE	OMIM:215150	marker/mechanism		NA	215150	
COL11A2	1302	Pierre Robin syndrome with fetal chondrodysplasia	MESH:C535776	marker/mechanism		NA	184840	
COL12A1	1303	Bethlem myopathy	MESH:C535436	marker/mechanism		NA	616471	
COL12A1	1303	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
COL12A1	1303	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
COL12A1	1303	Scleroatonic muscular dystrophy	MESH:C537521	marker/mechanism		NA	616470	
COL13A1	1305	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
COL13A1	1305	Myasthenic Syndromes, Congenital	MESH:D020294	marker/mechanism		NA	616720	
COL14A1	7373	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
COL15A1	1306	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
COL15A1	1306	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
COL17A1	1308	Epidermolysis Bullosa, Junctional, Non-Herlitz Type	MESH:C562639	marker/mechanism		NA	226650	24550734
COL17A1	1308	Epithelial Recurrent Erosion Dystrophy	MESH:C565155	marker/mechanism		NA	122400	
COL18A1	80781	Calcinosis	MESH:D002114	marker/mechanism		NA		21335463
COL18A1	80781	Heart Valve Diseases	MESH:D006349	marker/mechanism		NA		21335463
COL18A1	80781	Hemangiosarcoma	MESH:D006394	marker/mechanism		NA		17569031
COL18A1	80781	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
COL18A1	80781	Knobloch syndrome	MESH:C537209	marker/mechanism		NA	267750	
COL19A1	1310	Parkinson Disease	MESH:D010300	marker/mechanism		NA		25475535
COL1A1	1277	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
COL1A1	1277	Aneurysm, Dissecting	MESH:D000784	marker/mechanism		NA		8757037
COL1A1	1277	Aortic Valve Insufficiency	MESH:D001022	marker/mechanism		NA		21216836
COL1A1	1277	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		25055964
COL1A1	1277	Calcinosis	MESH:D002114	marker/mechanism		NA		21335463
COL1A1	1277	Cholangitis	MESH:D002761	marker/mechanism		NA		25055964
COL1A1	1277	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		28789951
COL1A1	1277	Ehlers-Danlos Syndrome, Type VII, Autosomal Dominant	MESH:C562625	marker/mechanism		NA	130060	
COL1A1	1277	Fibrosis	MESH:D005355	marker/mechanism		NA		20388698
COL1A1	1277	Heart Valve Diseases	MESH:D006349	marker/mechanism		NA		21335463
COL1A1	1277	Hyperostosis, Cortical, Congenital	MESH:D006958	marker/mechanism		NA	114000	
COL1A1	1277	Hypertension	MESH:D006973	marker/mechanism		NA		11682445
COL1A1	1277	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		11181017
COL1A1	1277	Keloid	MESH:D007627	marker/mechanism		NA		20128793
COL1A1	1277	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		21863215|24239723|24321339|26396155|32659284
COL1A1	1277	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136|26435214|26739621
COL1A1	1277	Nephrogenic Fibrosing Dermopathy	MESH:D054989	marker/mechanism		NA		20570839
COL1A1	1277	Nephrosclerosis	MESH:D009400	marker/mechanism		NA		30818366
COL1A1	1277	Nephrotic Syndrome	MESH:D009404	marker/mechanism		NA		1281619
COL1A1	1277	Oral Submucous Fibrosis	MESH:D009914	marker/mechanism		NA		16311067
COL1A1	1277	Osteogenesis Imperfecta	MESH:D010013	marker/mechanism		NA	166200	8757037
COL1A1	1277	Osteogenesis imperfecta, type 2A	MESH:C536042	marker/mechanism		NA	166210	
COL1A1	1277	Osteogenesis imperfecta, type 3	MESH:C536044	marker/mechanism		NA	259420	
COL1A1	1277	Osteogenesis Imperfecta, Type IV	MESH:C000631847	marker/mechanism		NA	166220	
COL1A1	1277	Osteoporosis	MESH:D010024	marker/mechanism		NA	166710	
COL1A2	1278	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
COL1A2	1278	Ehlers-Danlos syndrome, cardiac valvular form	MESH:C536200	marker/mechanism		NA	225320	15077201
COL1A2	1278	Fibrosis	MESH:D005355	marker/mechanism		NA		20388698
COL1A2	1278	Heart Valve Diseases	MESH:D006349	marker/mechanism		NA		15077201
COL1A2	1278	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		26396155
COL1A2	1278	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
COL1A2	1278	Oral Submucous Fibrosis	MESH:D009914	marker/mechanism		NA		16311067
COL1A2	1278	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
COL1A2	1278	Osteogenesis imperfecta, type 2A	MESH:C536042	marker/mechanism		NA	166210	
COL1A2	1278	Osteogenesis imperfecta, type 3	MESH:C536044	marker/mechanism		NA	259420	
COL1A2	1278	Osteogenesis Imperfecta, Type IV	MESH:C000631847	marker/mechanism		NA	166220	
COL1A2	1278	Osteoporosis	MESH:D010024	marker/mechanism		NA	166710	
COL1A2	1278	Scleroderma, Systemic	MESH:D012595	marker/mechanism		NA		24706986
COL21A1	81578	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		18438686
COL22A1	169044	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941189
COL23A1	91522	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21472284
COL23A1	91522	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
COL25A1	84570	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 5	OMIM:616219	marker/mechanism		NA	616219	
COL28A1	340267	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
COL2A1	1280	Achondrogenesis type 2	MESH:C536017	marker/mechanism		NA	200610	7741714
COL2A1	1280	Arthritis	MESH:D001168	marker/mechanism		NA		17299831|24144632|26640276
COL2A1	1280	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		16200597|21188452|23326410|24709313|25194622|25481498|26070417|29908986|29935983
COL2A1	1280	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		27028940|29935983
COL2A1	1280	Bone Resorption	MESH:D001862	marker/mechanism		NA		27028940
COL2A1	1280	Cartilage Diseases	MESH:D002357	marker/mechanism		NA		27028940
COL2A1	1280	Cataract	MESH:D002386	marker/mechanism		NA		8317498
COL2A1	1280	Chondrosarcoma	MESH:D002813	marker/mechanism		NA		23770606
COL2A1	1280	Cleft Palate	MESH:D002972	marker/mechanism		NA		15562585
COL2A1	1280	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		15562585|9061443
COL2A1	1280	Czech dysplasia, metatarsal type	MESH:C535766	marker/mechanism		NA	609162	
COL2A1	1280	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		17299831
COL2A1	1280	Edema	MESH:D004487	marker/mechanism		NA		25194622|27028940|29908986|29935983
COL2A1	1280	Epiphyseal Dysplasia, Multiple, with Myopia and Conductive Deafness	MESH:C565046	marker/mechanism		NA	132450	
COL2A1	1280	Erythema	MESH:D004890	marker/mechanism		NA		25194622|27028940
COL2A1	1280	Femur Head Necrosis	MESH:D005271	marker/mechanism		NA	608805	
COL2A1	1280	Hearing Loss, Sensorineural	MESH:D006319	marker/mechanism		NA		16189708
COL2A1	1280	Hyaloideoretinal degeneration of Wagner	MESH:C536075	marker/mechanism		NA		11812423
COL2A1	1280	Hyperplasia	MESH:D006965	marker/mechanism		NA		25481498
COL2A1	1280	Inflammation	MESH:D007249	marker/mechanism		NA		24144632|27028940
COL2A1	1280	Kniest dysplasia	MESH:C537207	marker/mechanism		NA	156550	11297324
COL2A1	1280	Legg-Calve-Perthes Disease	MESH:D007873	marker/mechanism		NA	150600	
COL2A1	1280	Megaepiphyseal dwarfism	MESH:C536140	marker/mechanism		NA		16189708
COL2A1	1280	Melanoma	MESH:D008545	marker/mechanism		NA		16778180
COL2A1	1280	Myopia	MESH:D009216	marker/mechanism		NA		17653045
COL2A1	1280	Osteoarthritis	MESH:D010003	marker/mechanism		NA		16189708|9061443
COL2A1	1280	Osteoarthritis with Mild Chondrodysplasia	MESH:C565740	marker/mechanism		NA	604864	
COL2A1	1280	Osteochondrodysplasias	MESH:D010009	marker/mechanism		NA		8486375
COL2A1	1280	Platyspondylic Lethal Skeletal Dysplasia, Torrance Type	MESH:C563627	marker/mechanism		NA	151210	
COL2A1	1280	Retinal Detachment	MESH:D012163	marker/mechanism		NA		8317498
COL2A1	1280	Spondyloepiphyseal dysplasia, congenita	MESH:C535788	marker/mechanism		NA	183900	
COL2A1	1280	SPONDYLOPERIPHERAL DYSPLASIA	OMIM:271700	marker/mechanism		NA	271700	
COL2A1	1280	Stickler syndrome, type 1	MESH:C537492	marker/mechanism		NA	108300	
COL2A1	1280	Stickler Syndrome, Type I, Nonsyndromic Ocular	MESH:C563709	marker/mechanism		NA	609508	
COL2A1	1280	Strudwick syndrome	MESH:C537501	marker/mechanism		NA	184250	
COL2A1	1280	Synovitis	MESH:D013585	marker/mechanism		NA		25194622
COL2A1	1280	Weight Loss	MESH:D015431	marker/mechanism		NA		26070417|29908986
COL3A1	1281	Aortic Valve Insufficiency	MESH:D001022	marker/mechanism		NA		21216836
COL3A1	1281	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		16679477
COL3A1	1281	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		28789951
COL3A1	1281	Ehlers-Danlos Syndrome	MESH:D004535	marker/mechanism		NA	130050	
COL3A1	1281	Endomyocardial Fibrosis	MESH:D004719	marker/mechanism		NA		11300427
COL3A1	1281	Fatty Liver	MESH:D005234	marker/mechanism		NA		15787813
COL3A1	1281	Fibrosis	MESH:D005355	marker/mechanism		NA		20388698
COL3A1	1281	Hypercholesterolemia	MESH:D006937	marker/mechanism		NA		21852083
COL3A1	1281	Hyperglycemia	MESH:D006943	marker/mechanism		NA		20836762
COL3A1	1281	Hyperinsulinism	MESH:D006946	marker/mechanism		NA		20836762
COL3A1	1281	Hypertension	MESH:D006973	marker/mechanism		NA		11682445
COL3A1	1281	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		11181017
COL3A1	1281	Keloid	MESH:D007627	marker/mechanism		NA		20128793
COL3A1	1281	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		11167689|15787813|16679477|1880254|2566230
COL3A1	1281	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		23274713
COL3A1	1281	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		11788567|25380136
COL3A1	1281	Liver Diseases	MESH:D008107	marker/mechanism		NA		11738102
COL3A1	1281	Muscular Dystrophy, Facioscapulohumeral	MESH:D020391	marker/mechanism		NA		12868502
COL3A1	1281	Nephrosclerosis	MESH:D009400	marker/mechanism		NA		30818366
COL3A1	1281	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		26817844
COL3A1	1281	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
COL3A1	1281	Ureteral Obstruction	MESH:D014517	marker/mechanism		NA		17164399
COL4A1	1282	Anemia, Hemolytic	MESH:D000743	marker/mechanism		NA		23225343
COL4A1	1282	Angiopathy, Hereditary, With Nephropathy, Aneurysms, And Muscle Cramps	MESH:C567088	marker/mechanism		NA	611773	
COL4A1	1282	Axenfeld-Rieger syndrome	MESH:C535679	marker/mechanism		NA		17696175|20385946
COL4A1	1282	BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES	OMIM:175780	marker/mechanism		NA	175780	
COL4A1	1282	Cerebral Hemorrhage	MESH:D002543	marker/mechanism		NA	614519	16598045
COL4A1	1282	Cerebral Small Vessel Diseases	MESH:D059345	marker/mechanism		NA		16598045|17696175
COL4A1	1282	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		18682491|27997345
COL4A1	1282	Eye Abnormalities	MESH:D005124	marker/mechanism		NA		20385946
COL4A1	1282	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA		16191423|18682491
COL4A1	1282	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
COL4A1	1282	Leukoencephalopathies	MESH:D056784	marker/mechanism		NA		20385946
COL4A1	1282	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
COL4A1	1282	Nephrotic Syndrome	MESH:D009404	marker/mechanism		NA		1281619
COL4A1	1282	Porencephaly	MESH:D065708	marker/mechanism		NA		23225343|607595
COL4A1	1282	RETINAL ARTERIES, TORTUOSITY OF	OMIM:180000	marker/mechanism		NA	180000	
COL4A1	1282	Schizencephaly	MESH:D065707	marker/mechanism		NA		23225343
COL4A2	1284	Cerebral Hemorrhage	MESH:D002543	marker/mechanism		NA	614519	
COL4A2	1284	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
COL4A2	1284	Nephrotic Syndrome	MESH:D009404	marker/mechanism		NA		1281619
COL4A2	1284	Porencephaly	MESH:D065708	marker/mechanism		NA	614483	
COL4A2	1284	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941189
COL4A3	1285	Alport syndrome, dominant type	MESH:C536586	marker/mechanism		NA	104200	
COL4A3	1285	Alport syndrome, recessive type	MESH:C536587	marker/mechanism		NA	203780	
COL4A3	1285	Hematuria, Benign Familial	MESH:C562476	marker/mechanism		NA	141200	
COL4A3	1285	Nephritis, Hereditary	MESH:D009394	marker/mechanism		NA		12631109
COL4A4	1286	Alport syndrome, recessive type	MESH:C536587	marker/mechanism		NA	203780	
COL4A4	1286	Hematuria, Benign Familial	MESH:C562476	marker/mechanism		NA	141200	
COL4A5	1287	ALPORT SYNDROME 1, X-LINKED	OMIM:301050	marker/mechanism		NA	301050	
COL4A5	1287	Leiomyoma, Epithelioid	MESH:D018230	marker/mechanism		NA		17069596
COL4A6	1288	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
COL4A6	1288	DEAFNESS, X-LINKED 6	OMIM:300914	marker/mechanism		NA	300914	
COL4A6	1288	Leiomyoma, Epithelioid	MESH:D018230	marker/mechanism		NA		17069596
COL5A1	1289	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
COL5A1	1289	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
COL5A1	1289	Ehlers-Danlos syndrome type 1	MESH:C536194	marker/mechanism		NA	130000	20635400|8752669|9042913
COL5A1	1289	Ehlers-Danlos syndrome type 2	MESH:C536195	marker/mechanism		NA		8752669|9042913
COL5A1	1289	Keloid	MESH:D007627	marker/mechanism		NA		20128793
COL5A1	1289	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
COL5A1	1289	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
COL5A1	1289	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
COL5A1	1289	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
COL5A1	1289	Rupture, Spontaneous	MESH:D012422	marker/mechanism		NA		20635400
COL5A2	1290	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
COL5A2	1290	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		26396155
COL5A2	1290	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
COL5A3	50509	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
COL6A1	1291	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
COL6A1	1291	Bethlem myopathy	MESH:C535436	marker/mechanism		NA	158810	
COL6A1	1291	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
COL6A1	1291	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
COL6A1	1291	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		23692979
COL6A1	1291	Muscular Dystrophies	MESH:D009136	marker/mechanism		NA		20716577
COL6A1	1291	Scleroatonic muscular dystrophy	MESH:C537521	marker/mechanism		NA	254090	
COL6A2	1292	Bethlem myopathy	MESH:C535436	marker/mechanism		NA	158810	
COL6A2	1292	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
COL6A2	1292	Myosclerosis, Autosomal Recessive	MESH:C564968	marker/mechanism		NA	255600	
COL6A2	1292	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
COL6A2	1292	Scleroatonic muscular dystrophy	MESH:C537521	marker/mechanism		NA	254090	
COL6A3	1293	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
COL6A3	1293	Bethlem myopathy	MESH:C535436	marker/mechanism		NA	158810	
COL6A3	1293	Dystonia	MESH:D004421	marker/mechanism		NA	616411	
COL6A3	1293	Scleroatonic muscular dystrophy	MESH:C537521	marker/mechanism		NA	254090	
COL6A3	1293	Wilms Tumor	MESH:D009396	marker/mechanism		NA		28825729
COL7A1	1294	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18507500
COL7A1	1294	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		30381462
COL7A1	1294	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18507500
COL7A1	1294	Disease Progression	MESH:D018450	marker/mechanism		NA		30381462
COL7A1	1294	Epidermolysis Bullosa Dystrophica	MESH:D016108	marker/mechanism		NA	226600	
COL7A1	1294	Epidermolysis bullosa dystrophica, Pasini type	MESH:C535956	marker/mechanism		NA	131750	
COL7A1	1294	Epidermolysis bullosa, pretibial	MESH:C535494	marker/mechanism		NA	131850	
COL7A1	1294	Epidermolysis Bullosa Pruriginosa	MESH:C563192	marker/mechanism		NA	604129	
COL7A1	1294	Epidermolysis Bullosa With Congenital Localized Absence Of Skin And Deformity Of Nails	MESH:C562638	marker/mechanism		NA	132000	
COL7A1	1294	Toenail Dystrophy, Isolated	MESH:C564384	marker/mechanism		NA	607523	
COL7A1	1294	Transient bullous dermolysis of the newborn	MESH:C536979	marker/mechanism		NA	131705	
COL8A1	1295	Congenital Abnormalities	MESH:D000013	marker/mechanism		NA		19035365
COL8A1	1295	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
COL8A2	1296	Corneal dystrophy, Fuchs' endothelial, 1	MESH:C535478	marker/mechanism		NA	136800	
COL8A2	1296	Corneal Dystrophy, Posterior Polymorphous, 2	MESH:C565176	marker/mechanism		NA	609140	
COL9A1	1297	EPIPHYSEAL DYSPLASIA, MULTIPLE, 6	OMIM:614135	marker/mechanism		NA	614135	
COL9A1	1297	Hearing Loss, Sensorineural	MESH:D006319	marker/mechanism		NA		16909383
COL9A1	1297	Myopia	MESH:D009216	marker/mechanism		NA		16909383
COL9A1	1297	Osteochondrodysplasias	MESH:D010009	marker/mechanism		NA		11565064|16909383
COL9A1	1297	Retinal Diseases	MESH:D012164	marker/mechanism		NA		16909383
COL9A1	1297	STICKLER SYNDROME, TYPE IV	OMIM:614134	marker/mechanism		NA	614134	
COL9A2	1298	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
COL9A2	1298	Epiphyseal dysplasia, multiple, 2	MESH:C535502	marker/mechanism		NA	600204	
COL9A2	1298	STICKLER SYNDROME, TYPE V	OMIM:614284	marker/mechanism		NA	614284	
COL9A3	1299	Epiphyseal dysplasia, multiple, 3	MESH:C535503	marker/mechanism		NA	600969	
COL9A3	1299	Intervertebral disc disease	MESH:C535531	marker/mechanism		NA	603932	
COLEC10	10584	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
COLEC10	10584	Malpuech facial clefting syndrome	MESH:C535704	marker/mechanism		NA	248340	
COLEC11	78989	Carnevale syndrome	MESH:C535586	marker/mechanism		NA	265050	21258343
COLEC11	78989	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		21258343
COLEC11	78989	Malpuech facial clefting syndrome	MESH:C535704	marker/mechanism		NA		21258343
COLEC11	78989	Oculopalatoskeletal syndrome	MESH:C537738	marker/mechanism		NA		21258343
COLEC11	78989	Pigmentation Disorders	MESH:D010859	marker/mechanism		NA		21258343
COLEC12	81035	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
COLEC12	81035	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
COLQ	8292	Diverticular Diseases	MESH:D000076385	marker/mechanism		NA		28585551
COLQ	8292	Endplate Acetylcholinesterase Deficiency	MESH:C566415	marker/mechanism|therapeutic		NA	603034	22981737
COMMD1	150684	Copper-Overload Cirrhosis	MESH:C566858	marker/mechanism		NA		22879914
COMMD1	150684	Dog Diseases	MESH:D004283	marker/mechanism		NA		17919502
COMMD1	150684	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		23583003
COMMD1	150684	Hepatitis, Chronic	MESH:D006521	marker/mechanism		NA		22879914|25053573
COMMD1	150684	Hypersensitivity	MESH:D006967	marker/mechanism		NA		22216203
COMMD1	150684	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		17919502
COMP	1311	Epiphyseal dysplasia, multiple, 1	MESH:C535501	marker/mechanism		NA	132400	7670472|9887340
COMP	1311	Joint Instability	MESH:D007593	marker/mechanism		NA		9887340
COMP	1311	Osteoarthritis	MESH:D010003	marker/mechanism		NA		7670472
COMP	1311	Osteoarthritis, Hip	MESH:D015207	marker/mechanism		NA		28319091
COMP	1311	Pseudoachondroplasia	MESH:C535819	marker/mechanism		NA	177170	7670471|7670472|9887340
COMT	1312	Alcoholism	MESH:D000437	marker/mechanism		NA		10395222
COMT	1312	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		15274053
COMT	1312	Attention Deficit Disorder with Hyperactivity	MESH:D001289	marker/mechanism		NA		10490706
COMT	1312	Autistic Disorder	MESH:D001321	marker/mechanism		NA		16917939
COMT	1312	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		11772685
COMT	1312	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		15455371|16077979|9407957
COMT	1312	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		15341023
COMT	1312	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		18704099
COMT	1312	Cognition Disorders	MESH:D003072	marker/mechanism		NA		17123785
COMT	1312	DiGeorge Syndrome	MESH:D004062	marker/mechanism		NA		8886163
COMT	1312	Fetal Growth Retardation	MESH:D005317	marker/mechanism		NA		23667712
COMT	1312	HEARING LOSS, CISPLATIN-INDUCED, SUSCEPTIBILITY TO	OMIM:613290	marker/mechanism		NA		19898482
COMT	1312	Hyperalgesia	MESH:D006930	marker/mechanism		NA		28195063
COMT	1312	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		18424824
COMT	1312	Memory Disorders	MESH:D008569	marker/mechanism		NA		28195063
COMT	1312	Mental Disorders	MESH:D001523	marker/mechanism		NA		16780746
COMT	1312	Musculoskeletal Pain	MESH:D059352	marker/mechanism		NA		25218601
COMT	1312	Pain	MESH:D010146	marker/mechanism		NA		20561508
COMT	1312	Panic Disorder	MESH:D016584	marker/mechanism		NA	167870	
COMT	1312	Pheochromocytoma	MESH:D010673	marker/mechanism		NA		22569243
COMT	1312	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
COMT	1312	Schizophrenia	MESH:D012559	marker/mechanism		NA	181500	16234811|17123785|18583979|20561508
COMT	1312	Schizophrenia Spectrum and Other Psychotic Disorders	MESH:D019967	marker/mechanism		NA		28195063
COMT	1312	Temporomandibular Joint Disorders	MESH:D013705	marker/mechanism		NA		25218601
COP1	64326	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19404257
COPA	1314	Arthritis	MESH:D001168	marker/mechanism		NA		25894502
COPA	1314	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		25894502
COPA	1314	AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE	OMIM:616414	marker/mechanism		NA	616414	
COPA	1314	Lung Diseases, Interstitial	MESH:D017563	marker/mechanism		NA		25894502
COPG1	22820	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		26463840
COPG2	26958	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
COPS2	9318	Endometriosis	MESH:D004715	marker/mechanism		NA		22138541
COPS3	8533	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
COPS5	10987	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		20698225
COPS5	10987	Stevens-Johnson Syndrome	MESH:D013262	marker/mechanism		NA		25811541
COPS6	10980	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
COPS7A	50813	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
COPS7A	50813	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
COQ10A	93058	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
COQ2	27235	COENZYME Q10 DEFICIENCY, PRIMARY, 1	OMIM:607426	marker/mechanism		NA	607426	
COQ2	27235	Multiple System Atrophy	MESH:D019578	marker/mechanism		NA	146500	
COQ4	51117	COENZYME Q10 DEFICIENCY, PRIMARY, 7	OMIM:616276	marker/mechanism		NA	616276	
COQ5	84274	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
COQ6	51004	COENZYME Q10 DEFICIENCY, PRIMARY, 6	OMIM:614650	marker/mechanism		NA	614650	
COQ7	10229	COENZYME Q10 DEFICIENCY, PRIMARY, 8	OMIM:616733	marker/mechanism		NA	616733	
COQ8A	56997	COENZYME Q10 DEFICIENCY, PRIMARY, 1	OMIM:607426	marker/mechanism		NA		18319072
COQ8A	56997	COENZYME Q10 DEFICIENCY, PRIMARY, 4	OMIM:612016	marker/mechanism		NA	612016	
COQ8B	79934	NEPHROTIC SYNDROME, TYPE 9	OMIM:615573	marker/mechanism		NA	615573	
COQ9	57017	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
COQ9	57017	COENZYME Q10 DEFICIENCY, PRIMARY, 5	OMIM:614654	marker/mechanism		NA	614654	
CORIN	10699	Pre-Eclampsia	MESH:D011225	marker/mechanism		NA	614595	
CORO1A	11151	Carcinoma	MESH:D002277	marker/mechanism		NA		21489049
CORO1A	11151	IMMUNODEFICIENCY 8	OMIM:615401	marker/mechanism		NA	615401	
CORO1A	11151	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		21489049
CORO1A	11151	Tuberculosis	MESH:D014376	marker/mechanism		NA		16040207
CORO1C	23603	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		15496427
CORO1C	23603	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		25133636
COTL1	23406	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20562527
COTL1	23406	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
COX1	4512	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
COX1	4512	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		14568902
COX1	4512	Deafness, Sensorineural, Autosomal-Mitochondrial Type	MESH:C565637	marker/mechanism		NA	500008	
COX1	4512	Hypertrophy	MESH:D006984	therapeutic		NA		20582486
COX1	4512	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
COX1	4512	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
COX1	4512	MELAS Syndrome	MESH:D017241	marker/mechanism		NA	540000	
COX15	1355	Cardioencephalomyopathy, Fatal Infantile, due to Cytochrome C Oxidase Deficiency	MESH:C565784	marker/mechanism		NA	615119	
COX17	10063	Hepatitis, Chronic	MESH:D006521	marker/mechanism		NA		25053573
COX17	10063	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		23624903
COX2	4513	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		14563825
COX2	4513	MELAS Syndrome	MESH:D017241	marker/mechanism		NA	540000	
COX2	4513	Neuroblastoma	MESH:D009447	marker/mechanism		NA		15492235
COX3	4514	Epilepsy, Temporal Lobe	MESH:D004833	marker/mechanism		NA		17092649
COX3	4514	MELAS Syndrome	MESH:D017241	marker/mechanism		NA	540000	
COX3	4514	Optic Atrophy, Hereditary, Leber	MESH:D029242	marker/mechanism		NA	535000	
COX4I2	84701	Exocrine Pancreatic Insufficiency, Dyserythropoietic Anemia, and Calvarial Hyperostosis	MESH:C567195	marker/mechanism		NA	612714	
COX5B	1329	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
COX6A1	1337	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D	OMIM:616039	marker/mechanism		NA	616039	
COX7B	1349	LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2	OMIM:300887	marker/mechanism		NA	300887	
COX7B	1349	Microphthalmia, syndromic 7	MESH:C537466	marker/mechanism		NA	309801	
COX7B2	170712	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
COX7C	1350	Obesity	MESH:D009765	marker/mechanism		NA		20882379
CP	1356	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		28885000
CP	1356	Albuminuria	MESH:D000419	marker/mechanism		NA		21752484
CP	1356	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		19330884
CP	1356	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		26001728
CP	1356	Ataxia	MESH:D001259	marker/mechanism		NA		12572680
CP	1356	Autistic Disorder	MESH:D001321	marker/mechanism		NA		15363659
CP	1356	Brain Diseases	MESH:D001927	marker/mechanism		NA		19005224
CP	1356	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		19229483
CP	1356	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
CP	1356	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		23792645
CP	1356	Deficiency Diseases	MESH:D003677	marker/mechanism		NA		12514262
CP	1356	Dementia	MESH:D003704	marker/mechanism		NA		12572680
CP	1356	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		12572680
CP	1356	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		20012460
CP	1356	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		28885000
CP	1356	Dyskinesias	MESH:D020820	marker/mechanism		NA		12572680
CP	1356	Familial apoceruloplasmin deficiency	MESH:C536004	marker/mechanism		NA	604290	12572680|20801540|22243965
CP	1356	Hemochromatosis	MESH:D006432	marker/mechanism		NA		17258727
CP	1356	Hepatitis, Chronic	MESH:D006521	marker/mechanism		NA		25053573
CP	1356	Hepatolenticular Degeneration	MESH:D006527	marker/mechanism		NA		22243965|23519153|7849148
CP	1356	Iron Metabolism Disorders	MESH:D019189	marker/mechanism		NA		16988052
CP	1356	Iron Overload	MESH:D019190	marker/mechanism		NA		20801540
CP	1356	Ischemia	MESH:D007511	marker/mechanism		NA		15668637|18091701
CP	1356	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		25226513|26396155
CP	1356	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		23792645
CP	1356	Melanoma	MESH:D008545	marker/mechanism		NA		23792645
CP	1356	Menkes Kinky Hair Syndrome	MESH:D007706	marker/mechanism		NA		22243965
CP	1356	Nerve Degeneration	MESH:D009410	therapeutic		NA		18804145
CP	1356	Parkinson Disease	MESH:D010300	marker/mechanism		NA		19159062|25758665
CP	1356	Pasteurellaceae Infections	MESH:D016871	marker/mechanism		NA		16755360
CP	1356	Pre-Eclampsia	MESH:D011225	marker/mechanism		NA		18679377
CP	1356	Psoriasis	MESH:D011565	marker/mechanism		NA		12559600
CP	1356	Retinal Degeneration	MESH:D012162	marker/mechanism		NA		12572680
CP	1356	Schizophrenia	MESH:D012559	marker/mechanism		NA		16842975
CPA1	1357	Pancreatitis, Chronic	MESH:D050500	marker/mechanism		NA		23955596
CPA2	1358	Hypoxia	MESH:D000860	marker/mechanism		NA		19579223
CPA6	57094	EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	OMIM:614417	marker/mechanism		NA	614417	
CPA6	57094	FEBRILE SEIZURES, FAMILIAL, 11	OMIM:614418	marker/mechanism		NA	614418	
CPAMD8	27151	Anterior segment mesenchymal dysgenesis	MESH:C537775	marker/mechanism		NA	617319	
CPAMD8	27151	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		21278247
CPB2	1361	Amenorrhea	MESH:D000568	marker/mechanism		NA		16167916
CPB2	1361	Obesity	MESH:D009765	marker/mechanism		NA		16959692
CPE	1363	Endocrine System Diseases	MESH:D004700	marker/mechanism		NA		15358678
CPE	1363	Insulin Resistance	MESH:D007333	marker/mechanism		NA		15358678
CPE	1363	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
CPE	1363	Obesity	MESH:D009765	marker/mechanism		NA		15358678|23434795
CPEB1	64506	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		20062064
CPEB3	22849	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CPED1	79974	Creutzfeldt-Jakob Syndrome	MESH:D007562	marker/mechanism		NA		23349890
CPLANE1	65250	Orofaciodigital syndrome 6	MESH:C536531	marker/mechanism		NA	277170	
CPLX1	10815	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		14708030
CPLX1	10815	Psychotic Disorders	MESH:D011618	marker/mechanism		NA		14708030
CPLX1	10815	Schizophrenia	MESH:D012559	marker/mechanism		NA		14708030
CPLX1	10815	Wolf-Hirschhorn Syndrome	MESH:D054877	marker/mechanism		NA	194190	
CPLX2	10814	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		14708030
CPLX2	10814	Psychotic Disorders	MESH:D011618	marker/mechanism		NA		14708030
CPLX2	10814	Schizophrenia	MESH:D012559	marker/mechanism		NA		11483314|14708030
CPM	1368	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
CPM	1368	Silicosis	MESH:D012829	marker/mechanism		NA		24986923
CPN1	1369	Carboxypeptidase N Deficiency	MESH:C562876	marker/mechanism		NA	212070	
CPNE3	8895	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		18264096
CPOX	1371	Coproporphyria, Hereditary	MESH:D046349	marker/mechanism		NA	121300	11831056
CPOX	1371	Porphyria Cutanea Tarda	MESH:D017119	marker/mechanism		NA		11831056
CPQ	10404	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		25401301
CPQ	10404	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CPR	33883	Parkinson Disease	MESH:D010300	marker/mechanism		NA		18353766
CPR64AA	38508	Parkinson Disease	MESH:D010300	marker/mechanism		NA		18353766
CPR66D	38990	Parkinson Disease	MESH:D010300	marker/mechanism		NA		18353766
CPS1	1373	Carbamoyl-Phosphate Synthase I Deficiency Disease	MESH:D020165	marker/mechanism		NA	237300	17310273|8486760
CPS1	1373	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
CPS1	1373	Coma	MESH:D003128	marker/mechanism		NA		8438805
CPS1	1373	Endotoxemia	MESH:D019446	marker/mechanism		NA		16741687
CPS1	1373	Hyperammonemia	MESH:D022124	marker/mechanism		NA		17310273|8486760
CPS1	1373	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		15650968
CPS1	1373	Persistent Fetal Circulation Syndrome	MESH:D010547	marker/mechanism		NA		11407344
CPS1	1373	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21472284
CPS1	1373	PULMONARY HYPERTENSION, NEONATAL, SUSCEPTIBILITY TO	OMIM:615371	marker/mechanism		NA	615371	
CPSF1	29894	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
CPSF1	29894	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
CPT1A	1374	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25151356
CPT1A	1374	Carnitine palmitoyl transferase 1A deficiency	MESH:C535588	marker/mechanism		NA	255120	
CPT1A	1374	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		19233164
CPT1A	1374	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		16123366
CPT1A	1374	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		16123366
CPT1A	1374	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19878707
CPT1A	1374	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		29289645
CPT1B	1375	Cardiomegaly	MESH:D006332	marker/mechanism		NA		24330405
CPT1B	1375	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		14563825
CPT1B	1375	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		25058030
CPT1B	1375	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
CPT1B	1375	Narcolepsy	MESH:D009290	marker/mechanism		NA		18820697
CPT1C	126129	Melanoma	MESH:D008545	marker/mechanism		NA		16778180
CPT1C	126129	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		20864405
CPT1C	126129	SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT	OMIM:616282	marker/mechanism		NA	616282	
CPT2	1376	Brain Diseases, Metabolic	MESH:D001928	marker/mechanism		NA		21816645
CPT2	1376	Carnitine Palmitoyltransferase II Deficiency, Infantile	MESH:C563462	marker/mechanism		NA	600649	
CPT2	1376	Carnitine Palmitoyltransferase II Deficiency, Late-Onset	MESH:C563461	marker/mechanism		NA	255110	
CPT2	1376	Carnitine Palmitoyltransferase II Deficiency, Lethal Neonatal	MESH:C563463	marker/mechanism		NA	608836	
CPT2	1376	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4	OMIM:614212	marker/mechanism		NA	614212	
CPT2	1376	Muscular Diseases	MESH:D009135	marker/mechanism		NA		18380285
CR1	1378	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		19734903|21460841
CR1	1378	Cognitive Dysfunction	MESH:D060825	marker/mechanism		NA		30503753
CR1	1378	Malaria	MESH:D008288	marker/mechanism		NA	611162	
CR1	1378	Malaria, Falciparum	MESH:D016778	marker/mechanism		NA		11724985|9230440
CR2	1380	Common Variable Immunodeficiency	MESH:D017074	marker/mechanism		NA	240500|614699	
CR2	1380	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA	610927	
CRABP1	1381	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		16254461
CRABP1	1381	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		17438526
CRABP1	1381	Keloid	MESH:D007627	marker/mechanism		NA		20128793
CRABP1	1381	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
CRABP2	1382	Methylmalonic acidemia	MESH:C537358	marker/mechanism		NA		16823967
CRABP2	1382	Recurrence	MESH:D012008	marker/mechanism		NA		8400267
CRADD	8738	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		20208132
CRADD	8738	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY	OMIM:614499	marker/mechanism		NA	614499	
CRB1	23418	Leber Congenital Amaurosis	MESH:D057130	marker/mechanism		NA		11389483
CRB1	23418	LEBER CONGENITAL AMAUROSIS 8	OMIM:613835	marker/mechanism		NA	613835	
CRB1	23418	Pigmented Paravenous Chorioretinal Atrophy	MESH:C566801	marker/mechanism		NA	172870	
CRB1	23418	Retinal Detachment	MESH:D012163	marker/mechanism		NA		11389483
CRB1	23418	Retinal Telangiectasis	MESH:D058456	marker/mechanism		NA		11389483
CRB1	23418	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA		10508521|11389483|16272259
CRB1	23418	Retinitis Pigmentosa 12	MESH:C563999	marker/mechanism		NA	600105	
CRB2	286204	Cystic Kidney Disease with Ventriculomegaly	MESH:C565657	marker/mechanism		NA	219730	
CRB2	286204	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA	616220	
CRBN	51185	Abnormalities, Drug-Induced	MESH:D000014	marker/mechanism		NA		27751757
CRBN	51185	Mental Retardation, Autosomal Recessive 2	MESH:C564404	marker/mechanism		NA	607417	
CRBN	51185	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		26186254
CRBN	51185	Nervous System Malformations	MESH:D009421	marker/mechanism		NA		27751757
CREB1	1385	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		11717377|16359811|18596687
CREB1	1385	Histiocytoma, Angiomatoid Fibrous	MESH:C563181	marker/mechanism		NA	612160	
CREB1	1385	Melanoma, Cutaneous Malignant	MESH:C562393	marker/mechanism		NA		29179997
CREB1	1385	Morphine Dependence	MESH:D009021	marker/mechanism		NA		11717377
CREB1	1385	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		19027736
CREB1	1385	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		29179997
CREB1	1385	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		18596687
CREB1.S	379764	Hyperpigmentation	MESH:D017495	marker/mechanism		NA		26443706
CREB3L4	148327	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		27415467
CREB3L4	148327	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		27415467
CREB5	9586	Abortion, Habitual	MESH:D000026	marker/mechanism		NA		30100398
CREB5	9586	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
CREBBP	1387	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27158780
CREBBP	1387	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
CREBBP	1387	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
CREBBP	1387	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		27158780
CREBBP	1387	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		21822268
CREBBP	1387	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		25151357
CREBBP	1387	Lymphoma, Follicular	MESH:D008224	marker/mechanism		NA		24362818
CREBBP	1387	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		15378487|25735316
CREBBP	1387	Rubinstein-Taybi Syndrome	MESH:D012415	marker/mechanism		NA	180849	
CREBBP	1387	Sezary Syndrome	MESH:D012751	marker/mechanism		NA		26551667
CREBBP	1387	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941188
CREBBP	1387	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		21822268
CREG1	8804	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
CREG1	8804	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
CRELD1	78987	Atrioventricular Septal Defect, Partial, with Heterotaxy Syndrome	MESH:C565249	marker/mechanism		NA	606217	
CREM	1390	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
CREM	1390	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
CREM	1390	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17374397
CREM	1390	Diabetic Angiopathies	MESH:D003925	marker/mechanism		NA		25381014
CREM	1390	Hypertrophy	MESH:D006984	therapeutic		NA		12791704
CREM	1390	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		19027736
CRH	1392	Alopecia	MESH:D000505	marker/mechanism		NA		21359208
CRH	1392	Alzheimer Disease	MESH:D000544	therapeutic		NA		7477348
CRH	1392	Anorexia	MESH:D000855	marker/mechanism		NA		16420149
CRH	1392	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		11440811|11875628|12424556|12438692|14575894|16495007|17293045|21268831|22231481|7816204|8736133
CRH	1392	Bradycardia	MESH:D001919	marker/mechanism		NA		6093200
CRH	1392	Chest Pain	MESH:D002637	marker/mechanism		NA		2563132
CRH	1392	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		10516337|11797056|18596687|19349312|7796157
CRH	1392	Cognition Disorders	MESH:D003072	marker/mechanism		NA		16039799
CRH	1392	Cushing Syndrome	MESH:D003480	marker/mechanism		NA		21359208
CRH	1392	Depressive Disorder	MESH:D003866	marker/mechanism		NA		12438692|18698320
CRH	1392	Fever	MESH:D005334	marker/mechanism		NA		11852909
CRH	1392	Hypotension	MESH:D007022	marker/mechanism		NA		1320258|6093200
CRH	1392	Movement Disorders	MESH:D009069	marker/mechanism		NA		21618986
CRH	1392	Pain	MESH:D010146	therapeutic		NA		16495007
CRH	1392	Pituitary Apoplexy	MESH:D010899	marker/mechanism		NA		12699433|12699434
CRH	1392	Psychomotor Disorders	MESH:D011596	therapeutic		NA		1335535
CRH	1392	Puberty, Delayed	MESH:D011628	marker/mechanism		NA		20002962
CRH	1392	Retinitis	MESH:D012173	marker/mechanism		NA		11384150
CRH	1392	Seizures	MESH:D012640	marker/mechanism		NA		11074187|1596084|1700951|1914160|7821275|8923670
CRH	1392	Spasms, Infantile	MESH:D013036	marker/mechanism		NA		11341487
CRH	1392	Status Epilepticus	MESH:D013226	marker/mechanism		NA		7756609
CRH	1392	Stereotypic Movement Disorder	MESH:D019956	marker/mechanism		NA		1914160
CRH	1392	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		12968131|18596687
CRH	1392	Weight Loss	MESH:D015431	marker/mechanism		NA		8986836
CRHBP	1393	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CRHBP	1393	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		17437087
CRHR1	1394	Anorexia	MESH:D000855	marker/mechanism		NA		16420149
CRHR1	1394	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		22231481|9299637
CRHR1	1394	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
CRHR1	1394	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		19339610
CRHR1	1394	Depressive Disorder, Major	MESH:D003865	marker/mechanism		NA		23529111
CRHR1	1394	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		12631246
CRHR1	1394	Hyperalgesia	MESH:D006930	marker/mechanism		NA		28434951
CRHR1	1394	Hyperkinesis	MESH:D006948	marker/mechanism		NA		19339610
CRHR1	1394	Osteoarthritis, Hip	MESH:D015207	marker/mechanism		NA		30664745
CRHR1	1394	Pain, Postoperative	MESH:D010149	marker/mechanism		NA		28434951
CRHR2	1395	Anorexia	MESH:D000855	marker/mechanism		NA		17627984
CRHR2	1395	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		10742108
CRHR2	1395	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		17437087
CRHR2	1395	Hypertension	MESH:D006973	marker/mechanism		NA		10742107
CRHR2	1395	Inflammation	MESH:D007249	therapeutic		NA		16855006
CRHR2	1395	Lung Diseases	MESH:D008171	therapeutic		NA		16855006
CRIP	44892	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CRISP3	10321	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
CRISP3	10321	Pregnancy, Ectopic	MESH:D011271	marker/mechanism		NA		19282327
CRISPLD2	83716	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
CRISPLD2	83716	Lung Diseases	MESH:D008171	marker/mechanism		NA		21069352
CRISPLD2	83716	Neurotoxicity Syndromes	MESH:D020258	marker/mechanism		NA		19784758
CRK	1398	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
CRKL	1399	DiGeorge Syndrome	MESH:D004062	marker/mechanism		NA		16399080
CRLF1	9244	Crisponi syndrome	MESH:C536214	marker/mechanism		NA	272430	
CRLF2	64109	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D015452	marker/mechanism		NA		24141364
CRLF2	64109	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		19838194
CRLF2	64109	Recurrence	MESH:D012008	marker/mechanism		NA		22904298
CRMP	40675	Purine-Pyrimidine Metabolism, Inborn Errors	MESH:D011686	marker/mechanism		NA		16361227
CRN	12935	Neural Tube Defects	MESH:D009436	marker/mechanism		NA		3902948
CROT	54677	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CRP	1401	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		15966572|23305094
CRP	1401	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		20194079
CRP	1401	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		22521605
CRP	1401	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		19330884
CRP	1401	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		1568518
CRP	1401	Atherosclerosis	MESH:D050197	marker/mechanism		NA		16931792
CRP	1401	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		19363144
CRP	1401	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		12876635|16332659|29114965
CRP	1401	Cerebrovascular Disorders	MESH:D002561	marker/mechanism		NA		29114965
CRP	1401	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
CRP	1401	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		24868163
CRP	1401	COVID-19	MESH:C000657245	marker/mechanism		NA		32534021
CRP	1401	Crohn Disease	MESH:D003424	marker/mechanism		NA		11339241
CRP	1401	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		20012460
CRP	1401	Diabetic Retinopathy	MESH:D003930	marker/mechanism		NA		20012460
CRP	1401	Heart Diseases	MESH:D006331	marker/mechanism		NA		17388968
CRP	1401	Heart Failure	MESH:D006333	marker/mechanism		NA		16360360
CRP	1401	Hyperparathyroidism, Secondary	MESH:D006962	marker/mechanism		NA		21350317
CRP	1401	Hypertension	MESH:D006973	marker/mechanism		NA		14620923|16680063|19770776|20667508
CRP	1401	Hypertriglyceridemia	MESH:D015228	therapeutic		NA		11893366
CRP	1401	Infections	MESH:D007239	marker/mechanism		NA		3285537
CRP	1401	Inflammation	MESH:D007249	marker/mechanism		NA		14970111|16125490|21437516
CRP	1401	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19539174
CRP	1401	Leishmaniasis	MESH:D007896	marker/mechanism		NA		17218153
CRP	1401	Leishmaniasis, Visceral	MESH:D007898	marker/mechanism		NA		10467834
CRP	1401	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17114654
CRP	1401	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		17718048
CRP	1401	Malaria	MESH:D008288	marker/mechanism		NA		8730300
CRP	1401	Meningitis	MESH:D008581	marker/mechanism		NA		14513990
CRP	1401	Metabolic Diseases	MESH:D008659	marker/mechanism		NA		19131468
CRP	1401	Metabolic Syndrome	MESH:D024821	marker/mechanism		NA		16644639
CRP	1401	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		11840375
CRP	1401	Myocarditis	MESH:D009205	marker/mechanism		NA		20361910
CRP	1401	Nephritis, Interstitial	MESH:D009395	marker/mechanism		NA		17014549
CRP	1401	Obesity	MESH:D009765	marker/mechanism		NA		24042701
CRP	1401	Pasteurellaceae Infections	MESH:D016871	marker/mechanism		NA		16755360
CRP	1401	Periodontitis	MESH:D010518	marker/mechanism		NA		20011938
CRP	1401	Psoriasis	MESH:D011565	marker/mechanism		NA		12559600
CRP	1401	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		29329563
CRP	1401	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		12858318
CRP	1401	Thrombosis	MESH:D013927	marker/mechanism		NA		16931792
CRPPA	729920	Eye Abnormalities	MESH:D005124	marker/mechanism		NA		22522421
CRPPA	729920	Hydrocephalus	MESH:D006849	marker/mechanism		NA		22522421
CRPPA	729920	Muscular Diseases	MESH:D009135	marker/mechanism		NA		22522421
CRPPA	729920	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7	OMIM:616052	marker/mechanism		NA	616052	
CRPPA	729920	Walker-Warburg Syndrome	MESH:D058494	marker/mechanism		NA	614643	22522420|22522421
CRTAP	10491	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CRTAP	10491	Osteogenesis Imperfecta	MESH:D010013	marker/mechanism		NA		18566967
CRTAP	10491	Osteogenesis Imperfecta Type VII	MESH:C565200	marker/mechanism		NA	610682	
CRTC1	23373	Adenocarcinoma Of Esophagus	MESH:C562730	marker/mechanism		NA		24121790
CRX	1406	CONE-ROD DYSTROPHY 2	OMIM:120970	marker/mechanism		NA	120970	
CRX	1406	Leber Congenital Amaurosis	MESH:D057130	marker/mechanism		NA		9537410|9931337
CRX	1406	LEBER CONGENITAL AMAUROSIS 7	OMIM:613829	marker/mechanism		NA	613829	
CRX	1406	Retinal Degeneration	MESH:D012162	marker/mechanism		NA		9792858
CRX	1406	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA	268000	
CRY1	1407	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	MESH:D015464	marker/mechanism		NA		16999817
CRY1	1407	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CRY1	1407	Sleep Disorders, Circadian Rhythm	MESH:D020178	marker/mechanism		NA	614163	
CRY2	1408	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	MESH:D015464	marker/mechanism		NA		16999817
CRYAA	1409	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		21850155
CRYAA	1409	Cataract	MESH:D002386	marker/mechanism		NA		9467006
CRYAA	1409	Cataract, Autosomal Dominant	MESH:C565815	marker/mechanism		NA	604219	
CRYAA	1409	Uveitis	MESH:D014605	marker/mechanism		NA		19578012|21850155
CRYAB	1410	Alpha-B Crystallinopathy	MESH:C563848	marker/mechanism		NA	608810	
CRYAB	1410	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		15108329
CRYAB	1410	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		15274141
CRYAB	1410	CARDIOMYOPATHY, DILATED, 1II	OMIM:615184	marker/mechanism		NA	615184	
CRYAB	1410	Cataract	MESH:D002386	marker/mechanism		NA		11577372
CRYAB	1410	CATARACT 16, MULTIPLE TYPES	OMIM:613763	marker/mechanism		NA	613763	
CRYAB	1410	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
CRYAB	1410	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		15986332
CRYAB	1410	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CRYAB	1410	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		15274141
CRYAB	1410	MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED	OMIM:613869	marker/mechanism		NA	613869	
CRYAB	1410	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		15964507
CRYAB	1410	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
CRYAB	1410	Tongue Neoplasms	MESH:D014062	marker/mechanism		NA		19840781
CRYBA1	1411	Cataract, Congenital Zonular, with Sutural Opacities	MESH:C563435	marker/mechanism		NA	600881	
CRYBA2	1412	CATARACT 42	OMIM:115900	marker/mechanism		NA	115900	
CRYBA4	1413	CATARACT 23, MULTIPLE TYPES	OMIM:610425	marker/mechanism		NA	610425	
CRYBB1	1414	Cataract	MESH:D002386	marker/mechanism		NA		12360425
CRYBB1	1414	Cataract, Congenital Nuclear, Autosomal Recessive 3	MESH:C566923	marker/mechanism		NA	611544	
CRYBB2	1415	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		21850155
CRYBB2	1415	CATARACT 3, MULTIPLE TYPES	OMIM:601547	marker/mechanism		NA	601547	
CRYBB2	1415	Cerulean cataract	MESH:C537955	marker/mechanism		NA		9158139
CRYBB2	1415	Uveitis	MESH:D014605	marker/mechanism		NA		19578012|21850155
CRYBB3	1417	Cataract, Congenital Nuclear, Autosomal Recessive 2	MESH:C565725	marker/mechanism		NA	609741	
CRYBG1	202	Disease Progression	MESH:D018450	marker/mechanism		NA		22402438
CRYBG1	202	Melanoma	MESH:D008545	marker/mechanism		NA		22402438
CRYGB	1419	CATARACT 39, MULTIPLE TYPES	OMIM:615188	marker/mechanism		NA	615188	
CRYGC	1420	Cataract	MESH:D002386	marker/mechanism		NA		10914683|11773036
CRYGC	1420	Cataract, Coppock-Like	MESH:C565133	marker/mechanism		NA	604307	
CRYGD	1421	Cataract	MESH:D002386	marker/mechanism		NA		30242128|9927684
CRYGD	1421	CATARACT 4, MULTIPLE TYPES	OMIM:115700	marker/mechanism		NA	115700	
CRYGD	1421	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
CRYGF	12969	Cataract	MESH:D002386	marker/mechanism		NA		12202521
CRYGS	1427	Cataract	MESH:D002386	marker/mechanism		NA		16141006
CRYGS	1427	CATARACT 20, MULTIPLE TYPES	OMIM:116100	marker/mechanism		NA	116100	
CRYL1	51084	Enterocolitis, Necrotizing	MESH:D020345	marker/mechanism		NA		18806098
CRYL1	51084	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
CRYM	1428	DEAFNESS, AUTOSOMAL DOMINANT 40	OMIM:616357	marker/mechanism		NA	616357	
CS	1431	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		14568902
CS	1431	Heart Failure	MESH:D006333	marker/mechanism		NA		8922916
CS	1431	Hypoxia	MESH:D000860	marker/mechanism		NA		19579223
CS	1431	Obesity	MESH:D009765	marker/mechanism		NA		20882379
CSAD	51380	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
CSF1	1435	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16618760
CSF1	1435	Cardiotoxicity	MESH:D066126	marker/mechanism		NA		32068018
CSF1	1435	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25162674
CSF1	1435	Osteitis Deformans	MESH:D010001	marker/mechanism		NA		20436471
CSF1R	1436	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16618760
CSF1R	1436	Hereditary Diffuse Leukoencephalopathy with Spheroids	MESH:C580150	marker/mechanism		NA	221820	
CSF1R	1436	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		1390197
CSF1R	1436	Leukoencephalopathies	MESH:D056784	marker/mechanism		NA		22197934
CSF1R	1436	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CSF1R	1436	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		1390197
CSF1R	1436	Neoplasms	MESH:D009369	marker/mechanism		NA		1390197
CSF2	1437	Agranulocytosis	MESH:D000380	marker/mechanism		NA		11732872|8120554
CSF2	1437	Amnesia	MESH:D000647	therapeutic		NA		8877002
CSF2	1437	Anemia	MESH:D000740	marker/mechanism		NA		11732872|8297739
CSF2	1437	Anemia, Aplastic	MESH:D000741	therapeutic		NA		12221670|9885444
CSF2	1437	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		22446963
CSF2	1437	Breast Neoplasms	MESH:D001943	therapeutic		NA		11325840
CSF2	1437	Carcinoma	MESH:D002277	therapeutic		NA		11605069
CSF2	1437	Colorectal Neoplasms	MESH:D015179	therapeutic		NA		15289873
CSF2	1437	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	therapeutic		NA		7960606
CSF2	1437	Eyelid Diseases	MESH:D005141	therapeutic		NA		17075842
CSF2	1437	Gastrointestinal Hemorrhage	MESH:D006471	marker/mechanism		NA		11732872
CSF2	1437	Heart Failure	MESH:D006333	marker/mechanism		NA		11732872
CSF2	1437	Inflammation	MESH:D007249	marker/mechanism		NA		23159501
CSF2	1437	Leishmaniasis, Visceral	MESH:D007898	marker/mechanism		NA		17404324
CSF2	1437	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		21441929
CSF2	1437	Leukemia, Myelomonocytic, Juvenile	MESH:D054429	marker/mechanism		NA		22315502
CSF2	1437	Liver Neoplasms	MESH:D008113	therapeutic		NA		17326190
CSF2	1437	Lymphoma, AIDS-Related	MESH:D016483	therapeutic		NA		7680712|9817281
CSF2	1437	Lymphoma, Non-Hodgkin	MESH:D008228	therapeutic		NA		11486401|11732872|7680712
CSF2	1437	Melanoma	MESH:D008545	therapeutic		NA		11061616
CSF2	1437	Mucositis	MESH:D052016	marker/mechanism		NA		8120554
CSF2	1437	Multiple Myeloma	MESH:D009101	therapeutic		NA		7540856|8104070|8555506
CSF2	1437	Muscle Weakness	MESH:D018908	marker/mechanism		NA		8622042
CSF2	1437	Neoplasm, Residual	MESH:D018365	therapeutic		NA		14654953
CSF2	1437	Neural Tube Defects	MESH:D009436	therapeutic		NA		17075842
CSF2	1437	Neutropenia	MESH:D009503	therapeutic		NA		11264156|7875148
CSF2	1437	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		21664615
CSF2	1437	Pain	MESH:D010146	marker/mechanism		NA		8622042
CSF2	1437	Pneumonia	MESH:D011014	marker/mechanism		NA		11732872
CSF2	1437	Psoriasis	MESH:D011565	marker/mechanism		NA		7744320
CSF2	1437	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		17894541
CSF2	1437	Sarcoma	MESH:D012509	therapeutic		NA		11605069
CSF2	1437	Thrombocytopenia	MESH:D013921	marker/mechanism		NA		8297739
CSF2	1437	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		26037280
CSF2	1437	Venous Thrombosis	MESH:D020246	marker/mechanism		NA		8120554
CSF2RA	1438	Pulmonary Alveolar Proteinosis	MESH:D011649	marker/mechanism		NA		29484482
CSF2RA	1438	Surfactant Metabolism Dysfunction, Pulmonary, 4	MESH:C567461	marker/mechanism		NA	300770	
CSF2RB	1439	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 5	OMIM:614370	marker/mechanism		NA	614370	
CSF3	1440	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
CSF3	1440	Agranulocytosis	MESH:D000380	therapeutic		NA		15999287
CSF3	1440	Anemia	MESH:D000740	marker/mechanism		NA		12085204|16076697|17047649
CSF3	1440	Anemia, Aplastic	MESH:D000741	marker/mechanism|therapeutic		NA		10544668|10629575|15863969|1642096|16553037|9777751
CSF3	1440	Arthralgia	MESH:D018771	marker/mechanism		NA		7543699
CSF3	1440	Bone Marrow Neoplasms	MESH:D019046	marker/mechanism		NA		20026017
CSF3	1440	Brain Injuries	MESH:D001930	marker/mechanism		NA		21549006
CSF3	1440	Breast Neoplasms	MESH:D001943	marker/mechanism|therapeutic		NA		12926135|16076697|16298037|17047649|7541186|7543699|7692001|9018096
CSF3	1440	Carcinoma	MESH:D002277	therapeutic		NA		9018096
CSF3	1440	Carcinoma, Non-Small-Cell Lung	MESH:D002289	therapeutic		NA		7692001
CSF3	1440	Carcinoma, Transitional Cell	MESH:D002295	therapeutic		NA		7525883|7543010
CSF3	1440	Cardiomyopathy, Dilated	MESH:D002311	therapeutic		NA		17334414
CSF3	1440	Chemical and Drug Induced Liver Injury	MESH:D056486	therapeutic		NA		20005281
CSF3	1440	COVID-19	MESH:C000657245	marker/mechanism		NA		31986264
CSF3	1440	Depressive Disorder	MESH:D003866	marker/mechanism		NA		9018096
CSF3	1440	Diarrhea	MESH:D003967	marker/mechanism		NA		7543699
CSF3	1440	Disease Models, Animal	MESH:D004195	therapeutic		NA		27737899
CSF3	1440	Disease Susceptibility	MESH:D004198	marker/mechanism		NA		20026017
CSF3	1440	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism|therapeutic		NA		27737899|31557154|7692001
CSF3	1440	Esophageal Neoplasms	MESH:D004938	therapeutic		NA		7692001
CSF3	1440	Fever	MESH:D005334	marker/mechanism		NA		9740541
CSF3	1440	Fibrosis	MESH:D005355	therapeutic		NA		18785976|20005281
CSF3	1440	Gastrointestinal Diseases	MESH:D005767	marker/mechanism		NA		17047649
CSF3	1440	Headache	MESH:D006261	marker/mechanism		NA		10864982
CSF3	1440	Head and Neck Neoplasms	MESH:D006258	therapeutic		NA		7692001
CSF3	1440	Heart Diseases	MESH:D006331	therapeutic		NA		19429242
CSF3	1440	Heart Failure	MESH:D006333	marker/mechanism		NA		15585077
CSF3	1440	Hemangiosarcoma	MESH:D006394	therapeutic		NA		9774950
CSF3	1440	Hepatic Veno-Occlusive Disease	MESH:D006504	marker/mechanism		NA		8602625
CSF3	1440	Hodgkin Disease	MESH:D006689	therapeutic		NA		17562247
CSF3	1440	Hyperbilirubinemia	MESH:D006932	marker/mechanism		NA		8602625
CSF3	1440	Hypertrophy	MESH:D006984	therapeutic		NA		18785976
CSF3	1440	Infarction	MESH:D007238	therapeutic		NA		15135374
CSF3	1440	Kidney Diseases	MESH:D007674	therapeutic		NA		19429242
CSF3	1440	Leiomyosarcoma	MESH:D007890	therapeutic		NA		9774950
CSF3	1440	Leukemia, Myeloid, Acute	MESH:D015470	therapeutic		NA		7528855
CSF3	1440	Leukopenia	MESH:D007970	marker/mechanism|therapeutic		NA		16076697|16120623|16937080|7543699
CSF3	1440	Liver Cirrhosis, Experimental	MESH:D008106	therapeutic		NA		15661404
CSF3	1440	Liver Diseases	MESH:D008107	therapeutic		NA		19429242
CSF3	1440	Liver Failure, Acute	MESH:D017114	marker/mechanism		NA		21550386
CSF3	1440	Liver Neoplasms	MESH:D008113	therapeutic		NA		9018096
CSF3	1440	Lymphoma, AIDS-Related	MESH:D016483	therapeutic		NA		12176798
CSF3	1440	Lymphoma, B-Cell	MESH:D016393	therapeutic		NA		11042651
CSF3	1440	Lymphoma, Non-Hodgkin	MESH:D008228	therapeutic		NA		11911406
CSF3	1440	Melanoma	MESH:D008545	therapeutic		NA		16120623|16260693
CSF3	1440	Mucositis	MESH:D052016	marker/mechanism		NA		17047649|7543699
CSF3	1440	Multiple Myeloma	MESH:D009101	therapeutic		NA		7534716|7540856
CSF3	1440	Muscle Weakness	MESH:D018908	marker/mechanism		NA		8622042
CSF3	1440	Muscular Diseases	MESH:D009135	marker/mechanism		NA		7543699
CSF3	1440	Neoplasm Metastasis	MESH:D009362	therapeutic		NA		7543699|9018096
CSF3	1440	Neoplasms, Second Primary	MESH:D016609	marker/mechanism		NA		20026017
CSF3	1440	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		17047649
CSF3	1440	Neutropenia	MESH:D009503	marker/mechanism|therapeutic		NA		11712802|12085204|12884814|12926135|15585077|16761898|27737899|7524159|7529132|7543699|7688884|9740541|9774950
CSF3	1440	Pain	MESH:D010146	marker/mechanism		NA		10864982|7541186|8622042
CSF3	1440	Pancytopenia	MESH:D010198	therapeutic		NA		17505274|9051142
CSF3	1440	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		9740541
CSF3	1440	Poisoning	MESH:D011041	therapeutic		NA		15727166
CSF3	1440	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		17894541
CSF3	1440	Scleroderma, Localized	MESH:D012594	therapeutic		NA		15863969
CSF3	1440	Sepsis	MESH:D018805	therapeutic		NA		17505274
CSF3	1440	Skin Neoplasms	MESH:D012878	therapeutic		NA		9774950
CSF3	1440	Small Cell Lung Carcinoma	MESH:D055752	therapeutic		NA		9093707
CSF3	1440	Soft Tissue Neoplasms	MESH:D012983	therapeutic		NA		7543699
CSF3	1440	Somatosensory Disorders	MESH:D020886	marker/mechanism		NA		7543699
CSF3	1440	Staphylococcal Infections	MESH:D013203	therapeutic		NA		27737899
CSF3	1440	Stevens-Johnson Syndrome	MESH:D013262	therapeutic		NA		11321886
CSF3	1440	Stomatitis	MESH:D013280	marker/mechanism		NA		12085204
CSF3	1440	Thrombocytopenia	MESH:D013921	marker/mechanism		NA		12085204|7543699
CSF3	1440	Urinary Bladder Neoplasms	MESH:D001749	therapeutic		NA		17515069|7525883
CSF3	1440	Uterine Neoplasms	MESH:D014594	therapeutic		NA		9774950
CSF3	1440	Ventricular Dysfunction, Left	MESH:D018487	marker/mechanism|therapeutic		NA		12926135|17334414
CSF3R	1441	Leukocytosis	MESH:D007964	marker/mechanism		NA		19620628
CSF3R	1441	NEUTROPENIA, SEVERE CONGENITAL, 7, AUTOSOMAL RECESSIVE	OMIM:617014	marker/mechanism		NA	617014	
CSGALNACT1	55790	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CSH1	1442	Silver-Russell Syndrome	MESH:D056730	marker/mechanism		NA		14642004
CSK	1445	Hyperalgesia	MESH:D006930	marker/mechanism		NA		16769263
CSK	1445	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		23042117
CSMD1	64478	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
CSMD1	64478	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CSMD1	64478	Psoriasis	MESH:D011565	marker/mechanism		NA		20953187
CSMD1	64478	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
CSMD3	114788	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18270536
CSMD3	114788	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		22138691|23797736
CSMD3	114788	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
CSN2	1447	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942|9879772
CSN2	1447	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942|9879772
CSN2	1447	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942|9879772
CSN3	1448	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
CSN3	1448	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
CSN3	1448	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
CSNK1A1	1452	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		16759393
CSNK1A1	1452	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		26437031
CSNK1D	1453	Advanced Sleep-Phase Syndrome, Familial	MESH:C565789	marker/mechanism		NA	615224	
CSNK2A1	1457	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		18572023
CSNK2A1	1457	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		26437031
CSNK2A1	1457	OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME	OMIM:617062	marker/mechanism		NA	617062	
CSNK2A1	1457	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		18572023
CSNK2A2	1459	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		18572023
CSNK2A2	1459	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		18572023
CSNK2B	1460	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		18572023
CSNK2B	1460	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		26437031
CSNK2B	1460	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		18572023
CSPG4	1464	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CSRNP1	64651	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CSRNP1	64651	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		16243910
CSRNP3	80034	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
CSRNP3	80034	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
CSRP1	1465	Endometrial Hyperplasia	MESH:D004714	marker/mechanism		NA		22248470
CSRP1	1465	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
CSRP3	8048	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
CSRP3	8048	Cardiomyopathy, Dilated, 1M	MESH:C564390	marker/mechanism		NA	607482	
CSRP3	8048	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 12	OMIM:612124	marker/mechanism		NA	612124	
CSRP3	8048	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
CSRP3	8048	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
CST1	1469	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		19208208
CST1	1469	Rhinitis, Allergic, Seasonal	MESH:D006255	marker/mechanism		NA		23950865
CST1	1469	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		19463800
CST3	1471	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		22005293|28885000
CST3	1471	Alzheimer Disease	MESH:D000544	marker/mechanism|therapeutic		NA		17192785|18026100
CST3	1471	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
CST3	1471	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		21356263
CST3	1471	Cerebral Amyloid Angiopathy, Familial	MESH:D028243	marker/mechanism		NA	105150	18566660
CST3	1471	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		28885000
CST3	1471	Kidney Diseases	MESH:D007674	marker/mechanism		NA		22525860|24863737
CST3	1471	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
CST3	1471	Macular Degeneration, Age-Related, 11	MESH:C567450	marker/mechanism		NA	611953	
CST3	1471	Meningioma	MESH:D008579	marker/mechanism		NA		19747051
CST3	1471	Oral Submucous Fibrosis	MESH:D009914	marker/mechanism		NA		16311067
CST3	1471	Poisoning	MESH:D011041	marker/mechanism		NA		22525860
CST3	1471	Recurrence	MESH:D012008	marker/mechanism		NA		19747051
CST6	1474	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17043665
CST6	1474	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		17043644
CST6	1474	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
CST6	1474	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		19503093
CST7	8530	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
CST8	10047	Infertility, Male	MESH:D007248	marker/mechanism		NA		20811015
CSTA	1475	Disease Progression	MESH:D018450	marker/mechanism		NA		20461718|22287159
CSTA	1475	Exfoliative Ichthyosis, Autosomal Recessive, Ichthyosis Bullosa of Siemens-like	MESH:C564309	marker/mechanism		NA	607936	
CSTA	1475	Glioblastoma	MESH:D005909	marker/mechanism		NA		22287159
CSTA	1475	Nasopharyngeal Carcinoma	MESH:D000077274	marker/mechanism		NA		20461718
CSTA	1475	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		20461718
CSTB	1476	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
CSTB	1476	Glioblastoma	MESH:D005909	marker/mechanism		NA		22287159
CSTB	1476	Meningioma	MESH:D008579	marker/mechanism		NA		19747051
CSTB	1476	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		19747051|22287159
CSTB	1476	Recurrence	MESH:D012008	marker/mechanism		NA		19747051
CSTB	1476	Unverricht-Lundborg Syndrome	MESH:D020194	marker/mechanism		NA	254800	11814737|25288807
CTBP1	1487	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17028196
CTBP1	1487	Wolf-Hirschhorn Syndrome	MESH:D054877	marker/mechanism		NA	194190	
CTBP2	1488	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		28414304
CTBP2	1488	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		28414304
CTBP2	1488	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		18264096
CTC1	80169	Bone Diseases, Metabolic	MESH:D001851	marker/mechanism		NA		22267198
CTC1	80169	Brain Diseases	MESH:D001927	marker/mechanism		NA		22267198
CTC1	80169	Calcinosis	MESH:D002114	marker/mechanism		NA		22267198
CTC1	80169	Cerebroretinal Microangiopathy with Calcifications and Cysts	MESH:C567401	marker/mechanism		NA	612199	
CTC1	80169	Gastric Antral Vascular Ectasia	MESH:D020252	marker/mechanism		NA		22267198
CTC1	80169	Retinal Telangiectasis	MESH:D058456	marker/mechanism		NA		22267198
CTCF	10664	Leukemia, Megakaryoblastic, of Down Syndrome	MESH:C566025	marker/mechanism		NA		24056718
CTCF	10664	Lymphoma, T-Cell, Cutaneous	MESH:D016410	marker/mechanism		NA		26192916
CTCF	10664	MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	OMIM:615502	marker/mechanism		NA	615502	
CTCF	10664	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054218	marker/mechanism		NA		28671688
CTDP1	9150	Congenital Cataracts, Facial Dysmorphism, And Neuropathy	MESH:C565822	marker/mechanism		NA	604168	16194727
CTF1	1489	Cardiomegaly	MESH:D006332	marker/mechanism		NA		18400235|19100119
CTF1	1489	Hypercholesterolemia	MESH:D006937	marker/mechanism		NA		21803294
CTF1	1489	Hypotension	MESH:D007022	marker/mechanism		NA		11304496
CTF1	1489	Insulin Resistance	MESH:D007333	marker/mechanism		NA		21803294
CTF1	1489	Kidney Diseases	MESH:D007674	therapeutic		NA		23335628
CTF1	1489	Necrosis	MESH:D009336	therapeutic		NA		23335628
CTF1	1489	Obesity	MESH:D009765	marker/mechanism		NA		21803294
CTGF	100194970	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		30365097
CTH	1491	Fetal Growth Retardation	MESH:D005317	marker/mechanism		NA		28157488
CTH	1491	Gamma-cystathionase deficiency	MESH:C535408	marker/mechanism		NA	219500	
CTH	1491	Melanoma	MESH:D008545	marker/mechanism		NA		25205294
CTH	1491	Retinal Neovascularization	MESH:D015861	marker/mechanism		NA		27273718
CTHRC1	115908	Barrett Esophagus	MESH:D001471	marker/mechanism		NA	614266	
CTLA2A	13024	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CTLA4	1493	Alopecia Areata	MESH:D000506	marker/mechanism		NA		20596022
CTLA4	1493	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
CTLA4	1493	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		20453842|23143596
CTLA4	1493	Asthma	MESH:D001249	marker/mechanism		NA		28807506
CTLA4	1493	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V	OMIM:616100	marker/mechanism		NA	616100	
CTLA4	1493	Celiac Disease	MESH:D002446	marker/mechanism		NA	609755	
CTLA4	1493	Diabetes Mellitus, Insulin-Dependent, 12	MESH:C563326	marker/mechanism		NA	601388	
CTLA4	1493	Graft vs Host Disease	MESH:D006086	therapeutic		NA		14642129
CTLA4	1493	Graves Disease	MESH:D006111	marker/mechanism		NA		19731979|21841780|23104008
CTLA4	1493	Hashimoto Disease	MESH:D050031	marker/mechanism		NA	140300	
CTLA4	1493	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		26437031
CTLA4	1493	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA	152700	
CTLA4	1493	Lymphoma, T-Cell, Cutaneous	MESH:D016410	marker/mechanism		NA		26258847
CTLA4	1493	Melanoma	MESH:D008545	therapeutic		NA		21802280
CTLA4	1493	Oral Submucous Fibrosis	MESH:D009914	marker/mechanism		NA		16311067
CTLA4	1493	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		21228734
CTNNA1	1495	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
CTNNA1	1495	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
CTNNA1	1495	Myelodysplastic Syndromes	MESH:D009190	marker/mechanism		NA		17330099
CTNNA1	1495	Patterned dystrophy of retinal pigment epithelium	MESH:C536309	marker/mechanism		NA	608970	26691986
CTNNA2	1496	Lissencephaly	MESH:D054082	marker/mechanism		NA		30013181
CTNNA2	1496	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		24816253
CTNNA3	29119	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 13	OMIM:615616	marker/mechanism		NA	615616	
CTNNA3	29119	Asthma	MESH:D001249	marker/mechanism		NA		19187332
CTNNA3	29119	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
CTNNB1	1499	Aberrant Crypt Foci	MESH:D058739	marker/mechanism		NA		10965019|12351151|14507667
CTNNB1	1499	Abnormalities, Multiple	MESH:D000015	marker/mechanism		NA		22975441
CTNNB1	1499	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		10965019|14507667|15459021
CTNNB1	1499	Adenoma	MESH:D000236	marker/mechanism		NA		10223192|10965019
CTNNB1	1499	Adenoma, Liver Cell	MESH:D018248	marker/mechanism		NA		21147764
CTNNB1	1499	Adrenal Gland Neoplasms	MESH:D000310	marker/mechanism		NA		24747643
CTNNB1	1499	Adrenocortical Carcinoma	MESH:D018268	marker/mechanism		NA		24747642
CTNNB1	1499	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		12165863|25330770
CTNNB1	1499	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA	114550	20118494|21147764|25822088|27738331|28284560
CTNNB1	1499	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		29394407
CTNNB1	1499	Cecal Neoplasms	MESH:D002430	marker/mechanism		NA		14688030
CTNNB1	1499	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		29626521
CTNNB1	1499	Chemical and Drug Induced Liver Injury	MESH:D056486	therapeutic		NA		19679878
CTNNB1	1499	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		12628520|12800193|14507667|15459021|17404573|18283038|21081470|22323126|9515794
CTNNB1	1499	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	114500	10965019|12907644|21291235|25280562
CTNNB1	1499	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		11262227
CTNNB1	1499	Craniopharyngioma	MESH:D003397	marker/mechanism		NA		24413733
CTNNB1	1499	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		29394407
CTNNB1	1499	Disease Progression	MESH:D018450	marker/mechanism		NA		27738331|29106415
CTNNB1	1499	Fibrosis	MESH:D005355	marker/mechanism		NA		29394407
CTNNB1	1499	Hemangiosarcoma	MESH:D006394	marker/mechanism		NA		13678655
CTNNB1	1499	Hepatoblastoma	MESH:D018197	marker/mechanism		NA		21237236
CTNNB1	1499	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		29394407
CTNNB1	1499	Intestinal Neoplasms	MESH:D007414	marker/mechanism		NA		10223192
CTNNB1	1499	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		21047994
CTNNB1	1499	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		10467420|21047994
CTNNB1	1499	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		11280770|20118494|21147764
CTNNB1	1499	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		18372914
CTNNB1	1499	Lymphoma, Mantle-Cell	MESH:D020522	marker/mechanism		NA		18787224
CTNNB1	1499	Medulloblastoma	MESH:D008527	marker/mechanism		NA	155255	
CTNNB1	1499	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		22784439
CTNNB1	1499	Muscular Atrophy	MESH:D009133	therapeutic		NA		18467435
CTNNB1	1499	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		29394407
CTNNB1	1499	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		23707762|26990689
CTNNB1	1499	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		29106415
CTNNB1	1499	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		12387456
CTNNB1	1499	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
CTNNB1	1499	NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS	OMIM:615075	marker/mechanism		NA	615075	
CTNNB1	1499	No-Reflow Phenomenon	MESH:D054318	therapeutic		NA		16824628
CTNNB1	1499	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA	167000	22000491
CTNNB1	1499	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		18223216
CTNNB1	1499	Peritoneal Neoplasms	MESH:D010534	marker/mechanism		NA		22784439
CTNNB1	1499	Pilomatrixoma	MESH:D018296	marker/mechanism		NA	132600	
CTNNB1	1499	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17363566|29610475
CTNNB1	1499	Stevens-Johnson Syndrome	MESH:D013262	marker/mechanism		NA		25811541
CTNNB1	1499	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		25061499
CTNNB1	1499	Vascular Calcification	MESH:D061205	therapeutic		NA		23223575
CTNNB1	1499	Ventricular Dysfunction, Left	MESH:D018487	marker/mechanism		NA		29394407
CTNNB1	1499	Ventricular Remodeling	MESH:D020257	marker/mechanism		NA		29394407
CTNNB1	1499	Wilms Tumor	MESH:D009396	marker/mechanism		NA		21237236|28825729
CTNND2	1501	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		23917401
CTNND2	1501	Glioblastoma	MESH:D005909	marker/mechanism		NA		23917401
CTNS	1497	Cystinosis	MESH:D003554	marker/mechanism		NA	219800	15879904
CTNS	1497	Cystinosis, Late-Onset Juvenile or Adolescent Nephropathic Type	MESH:C562683	marker/mechanism		NA	219900	
CTNS	1497	Cystinosis, ocular nonnephropathic	MESH:C535765	marker/mechanism		NA	219750	
CTPS1	1503	IMMUNODEFICIENCY 24	OMIM:615897	marker/mechanism		NA	615897	
CTR1B	40989	Alzheimer Disease	MESH:D000544	therapeutic		NA		23827522
CTR1C	43668	Alzheimer Disease	MESH:D000544	therapeutic		NA		23827522
CTR1C	43668	Nerve Degeneration	MESH:D009410	therapeutic		NA		23827522
CTRB1	1504	Hypoxia	MESH:D000860	marker/mechanism		NA		19579223
CTRC	11330	Hereditary pancreatitis	MESH:C537262	marker/mechanism		NA	167800	
CTRC	11330	Pancreatitis, Chronic	MESH:D050500	marker/mechanism		NA		18059268
CTSA	5476	Neuraminidase deficiency with beta-galactosidase deficiency	MESH:C536411	marker/mechanism		NA	256540	
CTSB	1508	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		15108329
CTSB	1508	Disease Progression	MESH:D018450	marker/mechanism		NA		22287159
CTSB	1508	Glioblastoma	MESH:D005909	marker/mechanism		NA		22287159
CTSB	1508	Keratolytic winter erythema	MESH:C536155	marker/mechanism		NA	148370	
CTSB	1508	Muscular Diseases	MESH:D009135	marker/mechanism		NA		7099197
CTSB	1508	Necrosis	MESH:D009336	marker/mechanism		NA		22287159
CTSB	1508	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		19700239|19747051
CTSB	1508	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		19503093
CTSB	1508	Proteinuria	MESH:D011507	marker/mechanism		NA		3669494
CTSC	1075	Aggressive Periodontitis	MESH:D010520	marker/mechanism		NA	170650	
CTSC	1075	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17374397
CTSC	1075	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
CTSC	1075	Keratosis palmoplantaris with periodontopathia and onychogryposis	MESH:C537627	marker/mechanism		NA	245010	10662807
CTSC	1075	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
CTSC	1075	Papillon-Lefevre Disease	MESH:D010214	marker/mechanism		NA	245000	10662807|16008657
CTSC	1075	Periodontal Diseases	MESH:D010510	marker/mechanism		NA		10662807
CTSC	1075	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
CTSD	1509	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
CTSD	1509	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		12833524
CTSD	1509	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
CTSD	1509	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		15108329
CTSD	1509	Ceroid Lipofuscinosis, Neuronal, 10	MESH:C566438	marker/mechanism		NA	610127	
CTSD	1509	Kidney Diseases	MESH:D007674	marker/mechanism		NA		15213268
CTSD	1509	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		15048980
CTSD	1509	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
CTSD	1509	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
CTSD	1509	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
CTSE	1510	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
CTSE	1510	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CTSF	8722	CEROID LIPOFUSCINOSIS, NEURONAL, 13	OMIM:615362	marker/mechanism		NA	615362	
CTSH	1512	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		18978792
CTSH	1512	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
CTSK	1513	Glioblastoma	MESH:D005909	marker/mechanism		NA		25356585
CTSK	1513	Osteoarthritis	MESH:D010003	marker/mechanism		NA		30664745
CTSK	1513	Pycnodysostosis	MESH:D058631	marker/mechanism		NA	265800	15163881
CTSL	1514	Coronavirus Infections	MESH:D018352	marker/mechanism		NA		16081529|23678171|27733646
CTSL	1514	Meningioma	MESH:D008579	marker/mechanism		NA		19747051
CTSL	1514	Proteinuria	MESH:D011507	marker/mechanism		NA		3669494
CTSL	1514	Recurrence	MESH:D012008	marker/mechanism		NA		19747051
CTSL	1514	Severe Acute Respiratory Syndrome	MESH:D045169	marker/mechanism		NA		16081529|16339146|22496216|23678171
CTSL	1514	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
CTSS	1520	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
CTSS	1520	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CTSS	1520	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		19700239
CTSS	1520	Obesity	MESH:D009765	marker/mechanism		NA		21156398
CTSZ	1522	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
CTSZ	1522	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CTTN	2017	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
CTTN	2017	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		27148699
CTTN	2017	Leukoplakia	MESH:D007971	marker/mechanism		NA		27148699
CTTNBP2	83992	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		28191889
CTTNBP2	83992	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
CTTNBP2NL	55917	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CTU1	90353	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		27811057
CTU1	90353	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27811057
CTU1	90353	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		27811057
CTU1	90353	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		27811057
CTU2	348180	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		27811057
CTU2	348180	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27811057
CTU2	348180	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		27811057
CTU2	348180	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		27811057
CUBN	8029	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
CUBN	8029	Imerslund-Grasbeck syndrome	MESH:C538556	marker/mechanism		NA	261100	
CUBN	8029	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
CUL1	8454	Stevens-Johnson Syndrome	MESH:D013262	marker/mechanism		NA		25811541
CUL2	8453	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA		21983784
CUL3	8452	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
CUL3	8452	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
CUL3	8452	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
CUL3	8452	PSEUDOHYPOALDOSTERONISM, TYPE IIE	OMIM:614496	marker/mechanism		NA	614496	
CUL4A	8451	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
CUL4A	8451	Stevens-Johnson Syndrome	MESH:D013262	marker/mechanism		NA		25811541
CUL4B	8450	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE	OMIM:300354	marker/mechanism		NA	300354	
CUL5	8065	Breast Neoplasms	MESH:D001943	therapeutic		NA		20949323
CUL7	9820	Autistic Disorder	MESH:D001321	marker/mechanism		NA		25961944
CUL7	9820	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		22138691
CUL7	9820	Miller-McKusick-Malvaux-Syndrome (3M Syndrome)	MESH:C535314	marker/mechanism		NA	273750	
CUX1	1523	Carcinogenesis	MESH:D063646	marker/mechanism		NA		24316979
CWC27	10283	Metaphyseal Chondrodysplasia with Retinitis Pigmentosa	MESH:C565398	marker/mechanism		NA	250410	
CWF19L1	55280	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA	616127	
CWH43	80157	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
CX3CL1	6376	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		20388520
CX3CL1	6376	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
CX3CL1	6376	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
CX3CL1	6376	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
CX3CL1	6376	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
CX3CR1	1524	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
CX3CR1	1524	Coronary Disease	MESH:D003327	marker/mechanism		NA	607339	
CX3CR1	1524	HIV Infections	MESH:D015658	marker/mechanism		NA	609423	
CX3CR1	1524	MACULAR DEGENERATION, AGE-RELATED, 12	OMIM:613784	marker/mechanism		NA	613784	
CX3CR1	1524	Retinal Degeneration	MESH:D012162	marker/mechanism		NA		20361964
CXADR	1525	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CXCL1	2919	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
CXCL1	2919	Bronchial Hyperreactivity	MESH:D016535	marker/mechanism		NA		12388339
CXCL1	2919	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		16118408
CXCL1	2919	Hepatitis, Autoimmune	MESH:D019693	marker/mechanism		NA		21227906
CXCL1	2919	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
CXCL1	2919	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CXCL1	2919	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
CXCL1	2919	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		23099361
CXCL1	2919	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		16526316
CXCL1	2919	Respiratory Hypersensitivity	MESH:D012130	therapeutic		NA		23056391
CXCL1	2919	Shock, Hemorrhagic	MESH:D012771	marker/mechanism		NA		21192278
CXCL1	2919	Wounds and Injuries	MESH:D014947	marker/mechanism		NA		21192278
CXCL10	3627	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
CXCL10	3627	Alopecia Areata	MESH:D000506	marker/mechanism		NA		22358057
CXCL10	3627	Brain Injuries	MESH:D001930	marker/mechanism		NA		21549006
CXCL10	3627	Brain Ischemia	MESH:D002545	marker/mechanism		NA		15829914
CXCL10	3627	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		29114965
CXCL10	3627	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
CXCL10	3627	Cerebrovascular Disorders	MESH:D002561	marker/mechanism		NA		29114965
CXCL10	3627	Chemical and Drug Induced Liver Injury	MESH:D056486	therapeutic		NA		11739529
CXCL10	3627	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
CXCL10	3627	COVID-19	MESH:C000657245	marker/mechanism		NA		31986264
CXCL10	3627	Cystitis, Interstitial	MESH:D018856	marker/mechanism		NA		18957084
CXCL10	3627	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		18249437
CXCL10	3627	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
CXCL10	3627	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		18422935
CXCL10	3627	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CXCL10	3627	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
CXCL10	3627	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		26037280
CXCL11	6373	Carcinoma, Pancreatic Ductal	MESH:D021441	marker/mechanism		NA		24979617
CXCL11	6373	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
CXCL11	6373	Cystitis, Interstitial	MESH:D018856	marker/mechanism		NA		18957084
CXCL12	6387	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18521742
CXCL12	6387	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		19363144|28284560
CXCL12	6387	Chronic Periodontitis	MESH:D055113	marker/mechanism		NA		20731768
CXCL12	6387	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		21378990
CXCL12	6387	Dermatitis	MESH:D003872	marker/mechanism		NA		27206134
CXCL12	6387	HIV Infections	MESH:D015658	marker/mechanism		NA	609423	
CXCL12	6387	Ischemia	MESH:D007511	marker/mechanism		NA		18227068
CXCL12	6387	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CXCL12	6387	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25162674
CXCL12	6387	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		19700239|25231984|25753200
CXCL12	6387	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		21312072|23743303
CXCL12	6387	Nephrosclerosis	MESH:D009400	marker/mechanism		NA		30818366
CXCL12	6387	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17785557
CXCL12	6387	Recurrence	MESH:D012008	therapeutic		NA		22607768
CXCL13	10563	Endometriosis	MESH:D004715	marker/mechanism		NA		30579999
CXCL13	10563	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CXCL13	10563	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		23056237
CXCL13	10563	Recurrence	MESH:D012008	therapeutic		NA		22607768
CXCL14	9547	Asthma	MESH:D001249	marker/mechanism		NA		21150878
CXCL14	9547	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CXCL14	9547	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
CXCL14	9547	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
CXCL14	9547	Lung Neoplasms	MESH:D008175	therapeutic		NA		20562917
CXCL14	9547	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
CXCL15	20309	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
CXCL15	20309	Liver Cirrhosis	MESH:D008103	therapeutic		NA		15763341
CXCL15	20309	Pemphigoid, Bullous	MESH:D010391	marker/mechanism		NA		11359455
CXCL15	20309	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
CXCL16	58191	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CXCL2	2920	Acute Lung Injury	MESH:D055371	marker/mechanism		NA		27525872
CXCL2	2920	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
CXCL2	2920	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		15292528
CXCL2	2920	Bone Resorption	MESH:D001862	therapeutic		NA		21507677
CXCL2	2920	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037
CXCL2	2920	Cholestasis	MESH:D002779	marker/mechanism		NA		21224055
CXCL2	2920	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		23178550
CXCL2	2920	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		21509778
CXCL2	2920	Heart Failure	MESH:D006333	marker/mechanism		NA		22352330
CXCL2	2920	Hypertension	MESH:D006973	marker/mechanism		NA		22352330
CXCL2	2920	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		12374626
CXCL2	2920	Inflammation	MESH:D007249	marker/mechanism		NA		23451061
CXCL2	2920	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
CXCL2	2920	Osteoarthritis	MESH:D010003	marker/mechanism		NA		15292528
CXCL2	2920	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		23099361
CXCL2	2920	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		16324872
CXCL2	2920	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		12468449
CXCL2	2920	Shock, Hemorrhagic	MESH:D012771	marker/mechanism		NA		21192278
CXCL2	2920	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
CXCL2	2920	Wounds and Injuries	MESH:D014947	marker/mechanism		NA		21192278
CXCL3	2921	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
CXCL3	2921	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037
CXCL3	2921	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
CXCL3	2921	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
CXCL5	6374	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
CXCL5	6374	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
CXCL5	6374	Recurrence	MESH:D012008	therapeutic		NA		22607768
CXCL6	6372	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		15292528
CXCL6	6372	Osteoarthritis	MESH:D010003	marker/mechanism		NA		15292528
CXCL8	3576	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		18307536
CXCL8	3576	Angina, Unstable	MESH:D000789	marker/mechanism		NA		10660968
CXCL8	3576	Arthritis, Psoriatic	MESH:D015535	marker/mechanism		NA		19732956
CXCL8	3576	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		17379860|19192274
CXCL8	3576	Barrett Esophagus	MESH:D001471	marker/mechanism		NA		15387324
CXCL8	3576	Behcet Syndrome	MESH:D001528	marker/mechanism		NA		8712863
CXCL8	3576	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037|17516992
CXCL8	3576	Cachexia	MESH:D002100	marker/mechanism		NA		17878525
CXCL8	3576	Carcinoma, Hepatocellular	MESH:D006528	therapeutic		NA		12432545
CXCL8	3576	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		15956251
CXCL8	3576	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		15956251
CXCL8	3576	Cardiotoxicity	MESH:D066126	marker/mechanism		NA		29959987
CXCL8	3576	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22015448
CXCL8	3576	Cholestasis	MESH:D002779	marker/mechanism		NA		21224055
CXCL8	3576	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		12133438|15955209
CXCL8	3576	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		20065508
CXCL8	3576	COVID-19	MESH:C000657245	marker/mechanism		NA		32161940
CXCL8	3576	Down Syndrome	MESH:D004314	marker/mechanism		NA		16289943
CXCL8	3576	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		31557154
CXCL8	3576	Edema	MESH:D004487	marker/mechanism		NA		19874808
CXCL8	3576	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		17380299
CXCL8	3576	Esophagitis, Peptic	MESH:D004942	marker/mechanism		NA		18193101
CXCL8	3576	Eye Infections, Bacterial	MESH:D015818	marker/mechanism		NA		23661603
CXCL8	3576	Fatty Liver	MESH:D005234	marker/mechanism		NA		23348005
CXCL8	3576	Fever	MESH:D005334	marker/mechanism		NA		11852909
CXCL8	3576	Gastroesophageal Reflux	MESH:D005764	marker/mechanism		NA		18193101|20616304
CXCL8	3576	Glioblastoma	MESH:D005909	marker/mechanism		NA		16356833
CXCL8	3576	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		10910440|9403216
CXCL8	3576	Heart Failure	MESH:D006333	marker/mechanism		NA		29959987
CXCL8	3576	Hepatitis, Alcoholic	MESH:D006519	marker/mechanism		NA		26220752
CXCL8	3576	Hepatolenticular Degeneration	MESH:D006527	marker/mechanism		NA		25002079
CXCL8	3576	Hyperalgesia	MESH:D006930	marker/mechanism		NA		10401557|7881729
CXCL8	3576	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		15302794
CXCL8	3576	Inflammation	MESH:D007249	marker/mechanism		NA		20578705|24795235
CXCL8	3576	Keratitis	MESH:D007634	marker/mechanism		NA		23661603
CXCL8	3576	Leishmaniasis, Cutaneous	MESH:D016773	marker/mechanism		NA		20102417
CXCL8	3576	Leishmaniasis, Visceral	MESH:D007898	marker/mechanism		NA		22461696
CXCL8	3576	Lichenoid Eruptions	MESH:D017512	marker/mechanism		NA		18393961
CXCL8	3576	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25162674
CXCL8	3576	Neuralgia, Postherpetic	MESH:D051474	marker/mechanism		NA		11280320
CXCL8	3576	Oral Submucous Fibrosis	MESH:D009914	marker/mechanism		NA		28984080
CXCL8	3576	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		19401270|21742513
CXCL8	3576	Pain, Intractable	MESH:D010148	marker/mechanism		NA		11280320
CXCL8	3576	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		18307536
CXCL8	3576	Pemphigoid, Bullous	MESH:D010391	marker/mechanism		NA		11359455
CXCL8	3576	Pneumonia, Pneumococcal	MESH:D011018	marker/mechanism		NA		24894820
CXCL8	3576	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16606632|17606477
CXCL8	3576	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		15337792|23099361|28864214
CXCL8	3576	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		17266442|17894541
CXCL8	3576	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		12865660
CXCL8	3576	Salmonella Infections, Animal	MESH:D012481	marker/mechanism		NA		29421334
CXCL8	3576	Staphylococcal Infections	MESH:D013203	marker/mechanism		NA		23661603
CXCL8	3576	Stomach Neoplasms	MESH:D013274	marker/mechanism|therapeutic		NA		15492468|15723263
CXCL8	3576	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		26037280
CXCL8	3576	Tobacco Use Disorder	MESH:D014029	marker/mechanism		NA		28864214
CXCL8	3576	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		22015448
CXCL9	4283	Alopecia Areata	MESH:D000506	marker/mechanism		NA		22358057
CXCL9	4283	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18925433
CXCL9	4283	Carotid Stenosis	MESH:D016893	marker/mechanism		NA		26564003
CXCL9	4283	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
CXCL9	4283	Cystitis, Interstitial	MESH:D018856	marker/mechanism		NA		18957084
CXCL9	4283	Endometriosis	MESH:D004715	marker/mechanism		NA		30579999
CXCL9	4283	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
CXCL9	4283	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		18422935
CXCL9	4283	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CXCL9	4283	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		11420682
CXCL9	4283	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25162674
CXCL9	4283	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		18925433
CXCL9	4283	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
CXCR1	3577	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		21297633
CXCR1	3577	HIV Infections	MESH:D015658	marker/mechanism		NA	609423	
CXCR2	3579	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
CXCR2	3579	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		21297633
CXCR2	3579	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
CXCR2	3579	Hypertension	MESH:D006973	marker/mechanism		NA		27678262
CXCR2	3579	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		25257527
CXCR2	3579	Mastitis	MESH:D008413	marker/mechanism		NA		16041010
CXCR2	3579	Neuralgia	MESH:D009437	marker/mechanism		NA		31432094
CXCR2	3579	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
CXCR2	3579	Sepsis	MESH:D018805	marker/mechanism		NA		17138957
CXCR2	3579	Vascular Remodeling	MESH:D066253	marker/mechanism		NA		27678262
CXCR3	2833	Alopecia Areata	MESH:D000506	marker/mechanism		NA		22358057
CXCR3	2833	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		12517959
CXCR3	2833	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		18249437
CXCR3	2833	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
CXCR3	2833	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		12517959
CXCR3	2833	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
CXCR3	2833	Inflammation	MESH:D007249	marker/mechanism		NA		12517959
CXCR3	2833	Ischemia	MESH:D007511	marker/mechanism		NA		12517959
CXCR3	2833	Pleural Diseases	MESH:D010995	marker/mechanism		NA		21357438
CXCR3	2833	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
CXCR3	2833	Stroke	MESH:D020521	marker/mechanism		NA		12374626
CXCR4	7852	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504|26387944
CXCR4	7852	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		19192274
CXCR4	7852	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25753200
CXCR4	7852	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		23743303
CXCR4	7852	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		25753200
CXCR4	7852	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		21312072|23743303
CXCR4	7852	Nephrosclerosis	MESH:D009400	marker/mechanism		NA		30818366
CXCR4	7852	Neuralgia	MESH:D009437	marker/mechanism		NA		17292584
CXCR4	7852	WHIM syndrome	MESH:C536697	marker/mechanism		NA	193670	23734232
CXCR5	643	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		21399635
CYB5A	1528	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
CYB5A	1528	Methemoglobinemia Type IV	MESH:C567102	marker/mechanism		NA	250790	
CYB5A	1528	Obesity	MESH:D009765	marker/mechanism		NA		20882379
CYB5A	1528	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
CYB5R3	1727	Cyanosis	MESH:D003490	marker/mechanism		NA		16469290
CYB5R3	1727	Methemoglobinemia	MESH:D008708	marker/mechanism		NA		16469290
CYB5R3	1727	NADH cytochrome B5 reductase deficiency	MESH:C537841	marker/mechanism		NA	250800	
CYBA	1535	Atherosclerosis	MESH:D050197	marker/mechanism		NA		20720404
CYBA	1535	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		11812764|12967931
CYBA	1535	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		15531508
CYBA	1535	Granulomatous Disease, Chronic	MESH:D006105	marker/mechanism		NA		2243141
CYBA	1535	Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Negative	MESH:C565533	marker/mechanism		NA	233690	
CYBA	1535	Heart Diseases	MESH:D006331	marker/mechanism		NA		16330681
CYBA	1535	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
CYBA	1535	Hypertension	MESH:D006973	marker/mechanism		NA		16685210|17324946|20505675|32147540
CYBA	1535	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19420110
CYBA	1535	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		25226513
CYBA	1535	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CYBA	1535	Renal Insufficiency	MESH:D051437	marker/mechanism		NA		23325087
CYBB	1536	Atypical Mycobacteriosis, Familial, X-Linked 2	MESH:C567068	marker/mechanism		NA	300645	
CYBB	1536	Brain Infarction	MESH:D020520	marker/mechanism		NA		19417757
CYBB	1536	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		23723366
CYBB	1536	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		19478208
CYBB	1536	Granulomatous Disease, Chronic	MESH:D006105	marker/mechanism|therapeutic		NA	306400	11045425|11122248|11498749
CYBB	1536	Heart Failure	MESH:D006333	marker/mechanism		NA		20304815
CYBB	1536	Hypertension	MESH:D006973	marker/mechanism		NA		16685210|21593737|27659729|27847271|32147540|32165127
CYBB	1536	Kidney Diseases	MESH:D007674	marker/mechanism		NA		20116427
CYBB	1536	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19420110
CYBB	1536	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CYBB	1536	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		19207477
CYBB	1536	Proteinuria	MESH:D011507	marker/mechanism		NA		20116427
CYBB	1536	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		19193722
CYC1	1537	Mitochondrial Complex III Deficiency	MESH:C565128	marker/mechanism		NA	615453	
CYCE	34924	Eye Abnormalities	MESH:D005124	therapeutic		NA		17517339
CYCS	54205	Brain Ischemia	MESH:D002545	marker/mechanism		NA		11756504
CYCS	54205	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
CYCS	54205	Fatty Liver	MESH:D005234	marker/mechanism		NA		10860543
CYCS	54205	Ischemia	MESH:D007511	marker/mechanism		NA		15172883
CYCS	54205	Ischemic Attack, Transient	MESH:D002546	marker/mechanism		NA		11333366
CYCS	54205	Methylmalonic acidemia	MESH:C537358	marker/mechanism		NA		16823967
CYCS	54205	Obesity	MESH:D009765	marker/mechanism		NA		16317704
CYCS	54205	Thrombocytopenia	MESH:D013921	marker/mechanism		NA		18345000
CYCS	54205	Thrombocytopenia 4	MESH:C567438	marker/mechanism		NA	612004	
CYGB	114757	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		30026087
CYGB	114757	Hepatic Insufficiency	MESH:D048550	marker/mechanism		NA		30026087
CYGB	114757	Hepatomegaly	MESH:D006529	marker/mechanism		NA		30026087
CYGB	114757	Heredodegenerative Disorders, Nervous System	MESH:D020271	marker/mechanism		NA		16825958
CYGB	114757	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		30026087
CYGB	114757	Liver Cirrhosis, Experimental	MESH:D008106	therapeutic		NA		16581302
CYLD	1540	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21109933
CYLD	1540	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		17043644
CYLD	1540	Familial cylindromatosis	MESH:C536611	marker/mechanism		NA	132700|601606|605041	18234730
CYLD	1540	Listeriosis	MESH:D008088	marker/mechanism		NA		23825949
CYLD	1540	Thymoma	MESH:D013945	marker/mechanism		NA		24974848
CYLD	1540	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		29477382
CYP11A1	1583	Adrenal Insufficiency	MESH:D000309	marker/mechanism		NA		11502818
CYP11A1	1583	Adrenal Insufficiency, Congenital, With 46,Xy Sex Reversal	MESH:C566131	marker/mechanism		NA	613743	
CYP11A1	1583	Disorder of Sex Development, 46,XY	MESH:D058490	marker/mechanism		NA		11502818
CYP11A1	1583	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		23200943
CYP11A1	1583	Lipoid congenital adrenal hyperplasia	MESH:C537027	marker/mechanism		NA		11502818
CYP11A1	1583	Seizures	MESH:D012640	therapeutic		NA		19125849
CYP11B1	1584	Congenital adrenal hyperplasia due to 11-Beta-hydroxylase deficiency	MESH:C535978	marker/mechanism		NA	202010	
CYP11B1	1584	Glucocorticoid-Remediable Aldosteronism	MESH:C563177	marker/mechanism		NA	103900	1472060|1731223
CYP11B1	1584	Hyperaldosteronism	MESH:D006929	marker/mechanism		NA		11085685
CYP11B2	1585	18-Hydroxylase deficiency	MESH:C537806	marker/mechanism		NA	203400|610600	
CYP11B2	1585	Glucocorticoid-Remediable Aldosteronism	MESH:C563177	marker/mechanism		NA		1472060|1731223
CYP11B2	1585	Hyperaldosteronism	MESH:D006929	marker/mechanism		NA		11085685
CYP11B2	1585	Hypoaldosteronism	MESH:D006994	marker/mechanism		NA		11238478
CYP11B2	1585	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		25735316
CYP17A1	1586	Adrenal Hyperplasia, Congenital	MESH:D000312	marker/mechanism		NA		18645707
CYP17A1	1586	Adrenal hyperplasia, congenital, type 5	MESH:C538237	marker/mechanism		NA	202110	
CYP17A1	1586	Amenorrhea	MESH:D000568	marker/mechanism		NA		18645707
CYP17A1	1586	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19913079
CYP17A1	1586	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		15341023
CYP17A1	1586	Hyperkalemia	MESH:D006947	marker/mechanism		NA		18645707
CYP17A1	1586	Hypertension, Malignant	MESH:D006974	marker/mechanism		NA		3142437
CYP17A1	1586	Hypogonadism	MESH:D007006	marker/mechanism		NA		18645707
CYP17A1	1586	Hypopituitarism	MESH:D007018	marker/mechanism		NA		12970278
CYP17A1	1586	Infertility, Female	MESH:D007247	marker/mechanism		NA		18645707
CYP17A1	1586	Infertility, Male	MESH:D007248	marker/mechanism		NA		15890676
CYP17A1	1586	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
CYP17A1	1586	Neuralgia	MESH:D009437	marker/mechanism		NA		17720801
CYP17A1	1586	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		15706422
CYP17A1	1586	Oligomenorrhea	MESH:D009839	marker/mechanism		NA		18645707
CYP17A1	1586	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		18645707
CYP17A1	1586	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		15538743|16424004|16859836|16998812|17592021
CYP17A1	1586	Sexual Dysfunctions, Psychological	MESH:D020018	marker/mechanism		NA		15890676
CYP19A1	1588	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		21472143
CYP19A1	1588	Amenorrhea	MESH:D000568	marker/mechanism		NA		8265607
CYP19A1	1588	Aromatase deficiency	MESH:C537436	marker/mechanism		NA	139300|613546	10566648|8265607|9177373
CYP19A1	1588	Autistic Disorder	MESH:D001321	marker/mechanism		NA		21359227
CYP19A1	1588	Bone Resorption	MESH:D001862	marker/mechanism		NA		11985600
CYP19A1	1588	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		11850205|19639193|23342035|28112739|29701941
CYP19A1	1588	Critical Illness	MESH:D016638	marker/mechanism		NA		16670151
CYP19A1	1588	Diabetes, Gestational	MESH:D016640	marker/mechanism		NA		20421132
CYP19A1	1588	Endometriosis	MESH:D004715	marker/mechanism		NA		18815356|21958689
CYP19A1	1588	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		21472143
CYP19A1	1588	Fatty Liver	MESH:D005234	marker/mechanism		NA		11929713
CYP19A1	1588	Fibrosis	MESH:D005355	marker/mechanism		NA		22028442
CYP19A1	1588	Hypogonadism	MESH:D007006	marker/mechanism		NA		9177373
CYP19A1	1588	Hypopituitarism	MESH:D007018	marker/mechanism		NA		12970278
CYP19A1	1588	Infertility, Female	MESH:D007247	marker/mechanism		NA		14684609
CYP19A1	1588	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		28112739
CYP19A1	1588	Osteoporosis	MESH:D010024	marker/mechanism		NA		20723554
CYP19A1	1588	Ovarian Diseases	MESH:D010049	marker/mechanism		NA		11985600
CYP19A1	1588	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21262361|22381227|8265607|9177373
CYP19A1	1588	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16424004|17704407
CYP19A1	1588	Recurrence	MESH:D012008	marker/mechanism		NA		28112739
CYP19A1	1588	Sexual Infantilism	MESH:D050035	marker/mechanism		NA		8265607
CYP1A	140634	Edema	MESH:D004487	marker/mechanism		NA		12711302
CYP1A1	1543	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		19022366|26593447
CYP1A1	1543	Arteritis	MESH:D001167	marker/mechanism		NA		19022366
CYP1A1	1543	Birth Weight	MESH:D001724	marker/mechanism		NA		27592400
CYP1A1	1543	Bradycardia	MESH:D001919	marker/mechanism		NA		26988683
CYP1A1	1543	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16792888
CYP1A1	1543	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		15341023
CYP1A1	1543	Cardiomegaly	MESH:D006332	marker/mechanism		NA		18725507
CYP1A1	1543	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		11312644|19022366
CYP1A1	1543	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		27869817
CYP1A1	1543	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
CYP1A1	1543	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		22342832
CYP1A1	1543	Drug Eruptions	MESH:D003875	marker/mechanism		NA		19351467
CYP1A1	1543	Hamartoma	MESH:D006222	marker/mechanism		NA		21998131
CYP1A1	1543	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
CYP1A1	1543	Hyperoxia	MESH:D018496	marker/mechanism		NA		24893714
CYP1A1	1543	Hypersensitivity	MESH:D006967	marker/mechanism		NA		19022366
CYP1A1	1543	Hypertension	MESH:D006973	marker/mechanism		NA		20634294|22995157
CYP1A1	1543	Infertility, Male	MESH:D007248	marker/mechanism		NA		19303595
CYP1A1	1543	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		15003126
CYP1A1	1543	Long QT Syndrome	MESH:D008133	marker/mechanism		NA		26988683
CYP1A1	1543	Lung Injury	MESH:D055370	marker/mechanism		NA		24893714|25703676
CYP1A1	1543	Micronuclei, Chromosome-Defective	MESH:D048629	marker/mechanism		NA		23138419
CYP1A1	1543	Occupational Diseases	MESH:D009784	marker/mechanism		NA		16737584
CYP1A1	1543	Peripheral Vascular Diseases	MESH:D016491	marker/mechanism		NA		19022366
CYP1A1	1543	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		11275366|17919073
CYP1A1	1543	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		19022366
CYP1A1	1543	Tachycardia, Sinus	MESH:D013616	marker/mechanism		NA		26988683
CYP1A2	1544	Atrophy	MESH:D001284	marker/mechanism		NA		20961953
CYP1A2	1544	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CYP1A2	1544	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		22072123
CYP1A2	1544	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28762043
CYP1A2	1544	Cholestasis	MESH:D002779	marker/mechanism		NA		27565560
CYP1A2	1544	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		21081473
CYP1A2	1544	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		22244987
CYP1A2	1544	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		10445756
CYP1A2	1544	Growth Disorders	MESH:D006130	marker/mechanism		NA		20961953
CYP1A2	1544	Hepatomegaly	MESH:D006529	marker/mechanism		NA		10445756
CYP1A2	1544	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		27565560
CYP1A2	1544	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
CYP1A2	1544	Liver Diseases	MESH:D008107	marker/mechanism		NA		12969438
CYP1A2	1544	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		11376689|21147764
CYP1A2	1544	Lung Injury	MESH:D055370	marker/mechanism		NA		25703676
CYP1A2	1544	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		22072123
CYP1A2	1544	Methemoglobinemia	MESH:D008708	marker/mechanism		NA		12030840
CYP1A2	1544	Neural Tube Defects	MESH:D009436	marker/mechanism		NA		20641098
CYP1A2	1544	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		27565560
CYP1A2	1544	Porphyria Cutanea Tarda	MESH:D017119	marker/mechanism		NA		11153915
CYP1A2	1544	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		22674224
CYP1A2	1544	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		20797314
CYP1A2	1544	Splenic Diseases	MESH:D013158	marker/mechanism		NA		20961953
CYP1A2	1544	Splenomegaly	MESH:D013163	marker/mechanism		NA		10445756
CYP1B1	1545	Adenoma	MESH:D000236	marker/mechanism		NA		11376689
CYP1B1	1545	Anterior segment mesenchymal dysgenesis	MESH:C537775	marker/mechanism		NA	617315	
CYP1B1	1545	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037|17297925
CYP1B1	1545	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		22114726
CYP1B1	1545	Cardiomegaly	MESH:D006332	marker/mechanism		NA		18725507
CYP1B1	1545	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		20878130
CYP1B1	1545	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
CYP1B1	1545	Fatty Liver	MESH:D005234	therapeutic		NA		27036855
CYP1B1	1545	Glaucoma 3, Primary Congenital, A	MESH:C565547	marker/mechanism		NA	231300	
CYP1B1	1545	Glaucoma 3, primary infantile, B	MESH:C536824	marker/mechanism		NA	600975	
CYP1B1	1545	Glucose Intolerance	MESH:D018149	therapeutic		NA		27036855
CYP1B1	1545	Hepatomegaly	MESH:D006529	therapeutic		NA		27036855
CYP1B1	1545	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		11376689
CYP1B1	1545	Melanoma	MESH:D008545	marker/mechanism		NA		17145863
CYP1B1	1545	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		22114726
CYP1B1	1545	Obesity	MESH:D009765	therapeutic		NA		27036855
CYP1B1	1545	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		17372243
CYP1B1	1545	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		22674224
CYP1B1	1545	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17704407
CYP21A2	1589	Adrenal Hyperplasia, Congenital	MESH:D000312	marker/mechanism		NA		16705555|18445671
CYP21A2	1589	Congenital adrenal hyperplasia due to 21 hydroxylase deficiency	MESH:C535979	marker/mechanism		NA	201910	
CYP24A1	1591	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
CYP24A1	1591	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16280049
CYP24A1	1591	Hypercalcemia	MESH:D006934	marker/mechanism		NA		22337913
CYP24A1	1591	Hypercalcemia, Infantile	MESH:C562999	marker/mechanism		NA	143880	
CYP24A1	1591	Hypercalciuria	MESH:D053565	marker/mechanism		NA		22337913
CYP24A1	1591	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		22797725
CYP24A1	1591	Nephrolithiasis	MESH:D053040	marker/mechanism		NA		22337913
CYP24A1	1591	Osteoporosis	MESH:D010024	marker/mechanism		NA		22337913
CYP24A1	1591	Renal Insufficiency	MESH:D051437	marker/mechanism		NA		8164439
CYP26A1	1592	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		18059332
CYP26A1	1592	Adenomatous Polyposis Coli	MESH:D011125	marker/mechanism		NA		16885356
CYP26A1	1592	Barrett Esophagus	MESH:D001471	marker/mechanism		NA		18059332
CYP26A1	1592	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		16885356
CYP26A1	1592	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
CYP26A1	1592	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		18059332
CYP26A1	1592	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CYP26B1	56603	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		29379198
CYP26B1	56603	Mouth Diseases	MESH:D009059	marker/mechanism		NA		17682004
CYP26B1	56603	Obesity	MESH:D009765	marker/mechanism		NA		20882379
CYP26C1	340665	Focal facial dermal dysplasia	MESH:C537068	marker/mechanism		NA	614974	
CYP27A1	1593	Atherosclerosis	MESH:D050197	marker/mechanism		NA		11166758|19801147
CYP27A1	1593	Bone Diseases, Metabolic	MESH:D001851	marker/mechanism		NA		24381012
CYP27A1	1593	Cholestasis	MESH:D002779	marker/mechanism		NA		15795599
CYP27A1	1593	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		24381012
CYP27A1	1593	Xanthomatosis, Cerebrotendinous	MESH:D019294	marker/mechanism		NA	213700	12117727|15795599|17444890|19801147
CYP27B1	1594	Hypercalcemia	MESH:D006934	marker/mechanism		NA		20427501
CYP27B1	1594	Polymyositis	MESH:D017285	marker/mechanism		NA		20427501
CYP27B1	1594	Rickets	MESH:D012279	marker/mechanism		NA		16494812
CYP27B1	1594	Vitamin D Hydroxylation-Deficient Rickets, Type 1A	MESH:C562688	marker/mechanism		NA	264700	
CYP2A13	1553	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		18669584
CYP2A13	1553	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		26084420
CYP2A2	24895	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CYP2A4	13086	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		11420682
CYP2A5	13087	Chemical and Drug Induced Liver Injury	MESH:D056486	therapeutic		NA		23628428
CYP2A6	1548	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		12115524
CYP2A6	1548	Brain Diseases	MESH:D001927	marker/mechanism		NA		22498344
CYP2A6	1548	Carcinoma, Large Cell	MESH:D018287	marker/mechanism		NA		17549345
CYP2A6	1548	Carcinoma, Small Cell	MESH:D018288	marker/mechanism		NA		17549345
CYP2A6	1548	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		21741958
CYP2A6	1548	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17683511
CYP2A6	1548	Coumarin Resistance	MESH:C563039	marker/mechanism		NA	122700	
CYP2A6	1548	Disease Progression	MESH:D018450	marker/mechanism		NA		21364592
CYP2A6	1548	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		11241319
CYP2A6	1548	Hepatitis B	MESH:D006509	marker/mechanism		NA		8864187
CYP2A6	1548	Hepatitis C	MESH:D006526	marker/mechanism		NA		8864187
CYP2A6	1548	Liver Diseases, Parasitic	MESH:D008109	marker/mechanism		NA		8896890
CYP2A6	1548	Lung Neoplasms	MESH:D008175	marker/mechanism		NA	211980	10441482|11241319|12214673|16176798|17549345|26132489
CYP2A6	1548	Nasopharyngeal Neoplasms	MESH:D009303	marker/mechanism		NA		16377082
CYP2A6	1548	Opisthorchiasis	MESH:D009889	marker/mechanism		NA		8896890
CYP2A6	1548	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		21716162
CYP2A6	1548	Pulmonary Emphysema	MESH:D011656	marker/mechanism		NA		12832682
CYP2A6	1548	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		12115524|21364592
CYP2A6	1548	TOBACCO ADDICTION, SUSCEPTIBILITY TO	OMIM:188890	marker/mechanism|therapeutic		NA	188890	11259349|20418888
CYP2A6	1548	Tobacco Use Disorder	MESH:D014029	marker/mechanism		NA		15564629|16720336|22569203|26644138|28472521
CYP2B1	24300	Breast Neoplasms	MESH:D001943	therapeutic		NA		10811482|8640822
CYP2B1	24300	Glioma	MESH:D005910	therapeutic		NA		7834628
CYP2B1	24300	Hepatitis C	MESH:D006526	marker/mechanism		NA		8864187
CYP2B1	24300	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
CYP2B1	24300	Inflammation	MESH:D007249	marker/mechanism		NA		21467745
CYP2B1	24300	Necrosis	MESH:D009336	marker/mechanism		NA		11332993
CYP2B1	24300	Pancreatic Neoplasms	MESH:D010190	therapeutic		NA		10026857|10326030|10415878|11332152|11377651|12042985|12649565|12698877
CYP2B10	13088	Cholestasis	MESH:D002779	marker/mechanism		NA		22461449
CYP2B10	13088	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		22342832
CYP2B2	361523	Inflammation	MESH:D007249	marker/mechanism		NA		21467745
CYP2B6	1555	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CYP2B6	1555	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28762043
CYP2B6	1555	EFAVIRENZ, POOR METABOLISM OF	OMIM:614546	marker/mechanism		NA	614546	
CYP2B6	1555	Gliosarcoma	MESH:D018316	therapeutic		NA		11389073|9766669
CYP2B6	1555	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		15248218
CYP2B6	1555	TOBACCO ADDICTION, SUSCEPTIBILITY TO	OMIM:188890	marker/mechanism		NA		20418888
CYP2B9	13094	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		22342832
CYP2C	100328933	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
CYP2C11	29277	Cardiomegaly	MESH:D006332	marker/mechanism		NA		18725507
CYP2C11	29277	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
CYP2C11	29277	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CYP2C18	1562	Gliosarcoma	MESH:D018316	therapeutic		NA		9766669
CYP2C18	1562	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		21716162
CYP2C19	1557	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		19814645
CYP2C19	1557	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		27356304
CYP2C19	1557	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		20978260
CYP2C19	1557	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		12963435|28762043
CYP2C19	1557	Drug Metabolism, Poor, CYP2C19-Related	MESH:C563703	marker/mechanism		NA	609535	20435227
CYP2C19	1557	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		27356304
CYP2C19	1557	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		15248218
CYP2C19	1557	Primary Ovarian Insufficiency	MESH:D016649	marker/mechanism		NA		15248218
CYP2C19	1557	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		21716162
CYP2C19	1557	Thrombosis	MESH:D013927	marker/mechanism		NA		20978260
CYP2C29	13095	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		11420682
CYP2C8	1558	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CYP2C8	1558	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		27736846
CYP2C8	1558	Kidney Diseases	MESH:D007674	marker/mechanism		NA		18769365
CYP2C8	1558	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		21245421
CYP2C8	1558	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		27736846
CYP2C8	1558	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		22674224
CYP2C8	1558	Rhabdomyolysis	MESH:D012206	marker/mechanism		NA		15365880
CYP2C9	1559	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		19814645
CYP2C9	1559	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		16475710
CYP2C9	1559	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		16580879
CYP2C9	1559	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		14971821|21741958|28762043
CYP2C9	1559	Coumarin Resistance	MESH:C563039	marker/mechanism		NA	122700	19899329|20210733|20386359
CYP2C9	1559	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		20485159
CYP2C9	1559	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		11740344|19925388|23104259
CYP2C9	1559	Hemorrhage	MESH:D006470	marker/mechanism		NA		18429757|18756910|20597268|25521356|27581200
CYP2C9	1559	Nephritis, Interstitial	MESH:D009395	marker/mechanism		NA		19814645
CYP2C9	1559	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		21245421
CYP2C9	1559	Peptic Ulcer Hemorrhage	MESH:D010438	marker/mechanism		NA		17681167
CYP2C9	1559	Warfarin Sensitivity	MESH:C567080	marker/mechanism		NA		27581200
CYP2D22	56448	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
CYP2D4	171522	Cognition Disorders	MESH:D003072	marker/mechanism		NA		20727252
CYP2D4	171522	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CYP2D6	1565	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		19814645
CYP2D6	1565	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		7574463
CYP2D6	1565	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18280655
CYP2D6	1565	Basal Ganglia Diseases	MESH:D001480	marker/mechanism		NA		16000684
CYP2D6	1565	Bradycardia	MESH:D001919	marker/mechanism		NA		19284319
CYP2D6	1565	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19597703
CYP2D6	1565	Coma	MESH:D003128	marker/mechanism		NA		18359183
CYP2D6	1565	Drug Metabolism, Poor, CYP2D6-Related	MESH:C563835	marker/mechanism		NA	608902	
CYP2D6	1565	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		23609392
CYP2D6	1565	Dystonia	MESH:D004421	marker/mechanism		NA		16702617
CYP2D6	1565	Epilepsy, Tonic-Clonic	MESH:D004830	marker/mechanism		NA		16835697
CYP2D6	1565	Manganese Poisoning	MESH:D020149	marker/mechanism		NA		12171760
CYP2D6	1565	Muscle Rigidity	MESH:D009127	marker/mechanism		NA		15570195
CYP2D6	1565	Nephritis, Interstitial	MESH:D009395	marker/mechanism		NA		19814645
CYP2D6	1565	Occupational Diseases	MESH:D009784	marker/mechanism		NA		16737584
CYP2D6	1565	Parkinson Disease	MESH:D010300	marker/mechanism		NA		14991823|15174030
CYP2D6	1565	Prenatal Exposure Delayed Effects	MESH:D011297	marker/mechanism		NA		15570195
CYP2D6	1565	Sexual Dysfunctions, Psychological	MESH:D020018	marker/mechanism		NA		12378847|17541852
CYP2D6	1565	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		17089107
CYP2D6	1565	Tremor	MESH:D014202	marker/mechanism		NA		15570195
CYP2D6	1565	Weight Gain	MESH:D015430	marker/mechanism		NA		19997080
CYP2E1	1571	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		16142352
CYP2E1	1571	Alcoholism	MESH:D000437	marker/mechanism		NA		20843640
CYP2E1	1571	Asthma	MESH:D001249	marker/mechanism		NA		28807506
CYP2E1	1571	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		15162526
CYP2E1	1571	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		16142352
CYP2E1	1571	Cardiomegaly	MESH:D006332	marker/mechanism		NA		18725507
CYP2E1	1571	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		12668988|16770646|21741958|28762043
CYP2E1	1571	Drug Eruptions	MESH:D003875	marker/mechanism		NA		19351467
CYP2E1	1571	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		18990727
CYP2E1	1571	Fatty Liver	MESH:D005234	marker/mechanism		NA		18952117
CYP2E1	1571	Fatty Liver, Alcoholic	MESH:D005235	marker/mechanism		NA		26428356
CYP2E1	1571	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		20843640
CYP2E1	1571	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		17093202
CYP2E1	1571	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		18056438
CYP2E1	1571	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		1673675|17093202
CYP2E1	1571	Lymphoma, Non-Hodgkin	MESH:D008228	marker/mechanism		NA		11406608
CYP2E1	1571	Micronuclei, Chromosome-Defective	MESH:D048629	marker/mechanism		NA		22156006
CYP2E1	1571	Necrosis	MESH:D009336	marker/mechanism		NA		12086689|12566070
CYP2E1	1571	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		26213588
CYP2E1	1571	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		26428356
CYP2E1	1571	Obesity	MESH:D009765	marker/mechanism		NA		23954404
CYP2E1	1571	Parkinson Disease	MESH:D010300	marker/mechanism		NA		16510128
CYP2E1	1571	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		11774269
CYP2E1	1571	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		12771559
CYP2F2	13107	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		11420682
CYP2K18	393484	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28069987
CYP2R1	120227	Bone Diseases, Metabolic	MESH:D001851	marker/mechanism		NA		24381012
CYP2R1	120227	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		24381012
CYP2R1	120227	Vitamin D Hydroxylation-Deficient Rickets, Type 1B	MESH:C564005	marker/mechanism		NA	600081	
CYP2S1	29785	Psoriasis	MESH:D011565	marker/mechanism		NA		12711469
CYP2T1	171380	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CYP2U1	113612	SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE	OMIM:615030	marker/mechanism		NA	615030	
CYP39A1	51302	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CYP3A11	13112	Cholestasis	MESH:D002779	marker/mechanism		NA		22461449
CYP3A11	13112	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		22342832
CYP3A11	13112	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
CYP3A13	13113	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
CYP3A16	13114	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		11420682
CYP3A18	252931	Nephrosis	MESH:D009401	marker/mechanism		NA		18725544
CYP3A2	266682	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		22244987
CYP3A2	266682	Inflammation	MESH:D007249	marker/mechanism		NA		21467745
CYP3A23-3A1	25642	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		20623750
CYP3A23-3A1	25642	Adenoma, Liver Cell	MESH:D018248	marker/mechanism		NA		10959800
CYP3A23-3A1	25642	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		20623750
CYP3A23-3A1	25642	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		22244987
CYP3A23-3A1	25642	Inflammation	MESH:D007249	marker/mechanism		NA		21467745
CYP3A37	678669	Escherichia coli Infections	MESH:D004927	marker/mechanism		NA		24498193
CYP3A4	1576	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		15496535
CYP3A4	1576	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28762043
CYP3A4	1576	Hepatitis C	MESH:D006526	marker/mechanism		NA		8864187
CYP3A4	1576	Osteosarcoma	MESH:D012516	marker/mechanism		NA		17279585
CYP3A4	1576	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		15496535
CYP3A4	1576	Torsades de Pointes	MESH:D016171	marker/mechanism		NA		15875343
CYP3A43	64816	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		15894682
CYP3A5	1577	Essential Hypertension	MESH:D000075222	marker/mechanism		NA	145500	
CYP3A5	1577	Kidney Diseases	MESH:D007674	marker/mechanism		NA		18408564|20526235
CYP3A5	1577	Neurotoxicity Syndromes	MESH:D020258	therapeutic		NA		21225912
CYP3A5	1577	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		18306354
CYP3A5	1577	Thrombosis	MESH:D013927	marker/mechanism		NA		16754899
CYP3A62	170509	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		22749977
CYP3A9	171352	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CYP3A9	171352	Nephrosis	MESH:D009401	marker/mechanism		NA		18725544
CYP3A9	171352	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		22749977
CYP46A1	10858	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		19286353
CYP4A10	13117	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		22342832
CYP4A10	13117	Hypertension	MESH:D006973	marker/mechanism		NA		16691295
CYP4A11	1579	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
CYP4A14	13119	Cholestasis	MESH:D002779	marker/mechanism		NA		22461449
CYP4A14	13119	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		22342832
CYP4A14	13119	Hepatitis, Animal	MESH:D006520	marker/mechanism		NA		18559427
CYP4A3	298423	Cardiomegaly	MESH:D006332	marker/mechanism		NA		18725507
CYP4A3	298423	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
CYP4B1	1580	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		18713828
CYP4F22	126410	Lamellar ichthyosis, type 3	MESH:C537265	marker/mechanism		NA	604777	
CYP4F3	4051	Poisoning	MESH:D011041	marker/mechanism		NA		20036648
CYP4V2	285440	Bietti Crystalline Dystrophy	MESH:C535440	marker/mechanism		NA	210370	
CYP7A1	1581	Cholestasis	MESH:D002779	marker/mechanism		NA		22461449|9797378
CYP7A1	1581	Hypercholesterolemia	MESH:D006937	therapeutic		NA		8245718
CYP7B1	9420	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		17639508
CYP7B1	9420	Bile Acid Synthesis Defect, Congenital, 3	MESH:C566340	marker/mechanism		NA	613812	
CYP7B1	9420	Cholestasis	MESH:D002779	marker/mechanism		NA		9802883
CYP7B1	9420	Fatty Liver	MESH:D005234	marker/mechanism		NA		23391614
CYP7B1	9420	Lipid Metabolism, Inborn Errors	MESH:D008052	marker/mechanism		NA		18252231
CYP7B1	9420	Liver Diseases	MESH:D008107	marker/mechanism		NA		9802883
CYP7B1	9420	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17639508
CYP7B1	9420	Spastic Paraplegia, Hereditary	MESH:D015419	marker/mechanism		NA		18252231
CYP7B1	9420	Spastic paraplegia type 5A, recessive	MESH:C536871	marker/mechanism		NA	270800	19812052
CYP8B1	1582	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25448281
CYP8B1	1582	Cholestasis	MESH:D002779	marker/mechanism		NA		22461449
CYRIA	81553	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CYRIB	51571	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
CYRIB	51571	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CYSLTR1	10800	Asthma, Aspirin-Induced	MESH:D055963	marker/mechanism		NA		16502481|17641958|20485159
CYSLTR1	10800	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		16630147
CYSLTR1	10800	Fractures, Closed	MESH:D005596	marker/mechanism		NA		19544365
CYSLTR2	57105	Asthma, Aspirin-Induced	MESH:D055963	marker/mechanism		NA		16502481|20485159
CYSLTR2	57105	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		15970796
CYSLTR2	57105	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		15328359
CYSLTR2	57105	Uveal melanoma	MESH:C536494	marker/mechanism		NA		27089179
CYSTM1	84418	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
CYTB	4519	MELAS Syndrome	MESH:D017241	marker/mechanism		NA	540000	
CYTB	4519	Optic Atrophy, Hereditary, Leber	MESH:D029242	marker/mechanism		NA	535000	
CYTH1	9267	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
D2HGDH	728294	2-Hydroxyglutaricaciduria	MESH:C535306	marker/mechanism		NA	600721	
D2HGDH	728294	Amino Acid Metabolism, Inborn Errors	MESH:D000592	marker/mechanism		NA		15609246
DAAM2	23500	Osteoporosis	MESH:D010024	marker/mechanism		NA		30598549
DAB1	1600	Autistic Disorder	MESH:D001321	marker/mechanism		NA		15820235
DAB2IP	153090	Aortic Aneurysm, Abdominal	MESH:D017544	marker/mechanism		NA		20622881
DAB2IP	153090	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		22046421
DAB2IP	153090	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		20622881
DAB2IP	153090	Peripheral Vascular Diseases	MESH:D016491	marker/mechanism		NA		20622881
DAB2IP	153090	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		18073375
DAB2IP	153090	Pulmonary Embolism	MESH:D011655	marker/mechanism		NA		20622881
DACT1	51339	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		30510241
DACT1	51339	Townes-Brocks syndrome	MESH:C536974	marker/mechanism		NA	617466	
DACT2	168002	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		25058030
DACT3	147906	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
DAF-2	175410	Hypoxia	MESH:D000860	therapeutic		NA		19936206
DAG1	1605	Lassa Fever	MESH:D007835	marker/mechanism		NA		17287727
DAG1	1605	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9	OMIM:613818	marker/mechanism		NA	613818	
DAG1	1605	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
DAG1	1605	Walker-Warburg Syndrome	MESH:D058494	marker/mechanism		NA	616538	
DAO	1610	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17629951
DAO	1610	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
DAO	1610	Schizophrenia	MESH:D012559	marker/mechanism		NA		18583979
DAOA	267012	Schizophrenia	MESH:D012559	marker/mechanism		NA	181500	
DAP	1611	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		21297633
DAP3	7818	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21466612
DAPK1	1612	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		15172992
DAPK1	1612	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
DAPK1	1612	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		17319784
DAPK1	1612	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
DAPK1	1612	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		11313923
DAPK1	1612	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		17133271
DAPK1	1612	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		17133271
DAPK1	1612	Conjunctival Diseases	MESH:D003229	marker/mechanism		NA		23872714
DAPK1	1612	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		19874806
DAPK1	1612	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		15172992
DAPK1	1612	Myelodysplastic Syndromes	MESH:D009190	marker/mechanism		NA		19874806
DAPK1	1612	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17319784
DAPK1	1612	Neoplasms, Second Primary	MESH:D016609	marker/mechanism		NA		19874806
DAPK1	1612	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		23872714
DAPK1	1612	Respiratory Tract Diseases	MESH:D012140	marker/mechanism		NA		23872714
DAPK1	1612	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
DAPK2	23604	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
DAPK2	23604	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		28978663
DAPP1	27071	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
DARS1	1615	HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY	OMIM:615281	marker/mechanism		NA	615281	
DARS2	55157	Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation	MESH:C567009	marker/mechanism		NA	611105	
DAT-1	176304	Manganese Poisoning	MESH:D020149	marker/mechanism		NA		20865164
DAT-1	176304	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		20865164
DAXX	1616	Adrenocortical Carcinoma	MESH:D018268	marker/mechanism		NA		24747642
DAXX	1616	Neuroendocrine Tumors	MESH:D018358	marker/mechanism		NA		21252315
DAXX	1616	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		21252315
DAZ1	1617	Spermatogenic Failure, Nonobstructive, Y-Linked	MESH:C564030	marker/mechanism		NA	415000	
DAZ2	57055	Spermatogenic Failure, Nonobstructive, Y-Linked	MESH:C564030	marker/mechanism		NA	415000	
DAZ3	57054	Spermatogenic Failure, Nonobstructive, Y-Linked	MESH:C564030	marker/mechanism		NA	415000	
DAZL	1618	Testicular Germ Cell Tumor	MESH:C563236	marker/mechanism		NA		23666240
DBH	1621	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
DBH	1621	dopamine beta hydroxylase deficiency	MESH:C535600	marker/mechanism		NA	223360	
DBH	1621	Neuroblastoma	MESH:D009447	marker/mechanism		NA		25174395
DBH	1621	Paranoid Disorders	MESH:D010259	marker/mechanism		NA		10673769|12555232|17157269
DBH	1621	Pheochromocytoma	MESH:D010673	marker/mechanism		NA		22569243
DBI	1622	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
DBI	1622	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
DBI	1622	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
DBNDD2	55861	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
DBR1	51163	Amyotrophic Lateral Sclerosis	MESH:D000690	therapeutic		NA		23104007
DBT	1629	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
DBT	1629	Maple Syrup Urine Disease	MESH:D008375	marker/mechanism		NA	248600	
DBX1	120237	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
DCAF17	80067	Woodhouse Sakati syndrome	MESH:C536742	marker/mechanism		NA	241080	
DCAF4L2	138009	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
DCAF6	55827	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		24763052
DCAF7	10238	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		16759393
DCAF7	10238	Leukemia, Megakaryoblastic, of Down Syndrome	MESH:C566025	marker/mechanism		NA		24056718
DCAF8	50717	Giant Axonal Neuropathy, Autosomal Dominant	MESH:C566444	marker/mechanism		NA	610100	
DCBLD1	285761	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
DCBLD2	131566	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
DCBLD2	131566	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		18314483
DCC	1630	Agenesis of Corpus Callosum	MESH:D061085	marker/mechanism		NA		28250454
DCC	1630	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	114500	15365072
DCC	1630	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA	133239	
DCC	1630	Gaze Palsy, Familial Horizontal, with Progressive Scoliosis	MESH:C564593	marker/mechanism		NA		28250456
DCC	1630	Intellectual Disability	MESH:D008607	marker/mechanism		NA		28250456
DCC	1630	Melanoma	MESH:D008545	marker/mechanism		NA		22842228
DCC	1630	MIRROR MOVEMENTS 1	OMIM:157600	marker/mechanism		NA	157600	
DCD	117159	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		20195826
DCDC2	51473	Deafness, Autosomal Recessive 66	MESH:C565701	marker/mechanism		NA	610212	
DCDC2	51473	NEPHRONOPHTHISIS 19	OMIM:616217	marker/mechanism		NA	616217	
DCDC2	51473	SCLEROSING CHOLANGITIS, NEONATAL	OMIM:617394	marker/mechanism		NA	617394	
DCHS1	8642	Heterotopia, Periventricular, Autosomal Recessive	MESH:C564292	marker/mechanism		NA		24056717
DCHS1	8642	Mitral Valve Prolapse, Myxomatous 2	MESH:C564326	marker/mechanism		NA	607829	
DCHS1	8642	Van Maldergem Wetzburger Verloes syndrome	MESH:C536530	marker/mechanism		NA	601390	24056717
DCLK1	9201	Colorectal Neoplasms	MESH:D015179	therapeutic		NA		23202126
DCLRE1C	64421	Reticuloendotheliosis, familial, with eosinophilia	MESH:C538564	marker/mechanism		NA	603554	
DCLRE1C	64421	Severe combined immunodeficiency with sensitivity to ionizing radiation	MESH:C537589	marker/mechanism		NA	602450	
DCN	1634	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
DCN	1634	Corneal Dystrophy, Congenital Stromal	MESH:C566452	marker/mechanism		NA	610048	
DCN	1634	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		16804899
DCN	1634	Fibrosis	MESH:D005355	marker/mechanism		NA		16005714
DCN	1634	Muscular Dystrophy, Facioscapulohumeral	MESH:D020391	marker/mechanism		NA		12868502
DCN	1634	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
DCN	1634	Nephritis, Interstitial	MESH:D009395	marker/mechanism		NA		16005714
DCPS	28960	AL-RAQAD SYNDROME	OMIM:616459	marker/mechanism		NA	616459	
DCR	1637	Down Syndrome	MESH:D004314	marker/mechanism		NA	190685	
DCSTAMP	81501	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
DCSTAMP	81501	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
DCSTAMP	81501	Osteitis Deformans	MESH:D010001	marker/mechanism		NA		21623375
DCTN1	1639	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA	105400	
DCTN1	1639	Hypoventilation	MESH:D007040	marker/mechanism		NA		19136952
DCTN1	1639	Mood Disorders	MESH:D019964	marker/mechanism		NA		19136952
DCTN1	1639	Neuronopathy, Distal Hereditary Motor, Type Viib	MESH:C564362	marker/mechanism		NA	607641	
DCTN1	1639	Parkinsonian Disorders	MESH:D020734	marker/mechanism		NA		19136952
DCTN1	1639	Perry Syndrome	MESH:C566822	marker/mechanism		NA	168605	
DCTN4	51164	Cystic Fibrosis	MESH:D003550	marker/mechanism		NA		22772370
DCTN4	51164	Pseudomonas Infections	MESH:D011552	marker/mechanism		NA		22772370
DCX	1641	Classical Lissencephalies and Subcortical Band Heterotopias	MESH:D054221	marker/mechanism		NA	300067	
DCXR	51181	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
DCXR	51181	Obesity	MESH:D009765	marker/mechanism		NA		20882379
DCXR	51181	Pentosuria	MESH:C536652	marker/mechanism		NA	260800	25526675|28595002
DCXR	51181	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
DDAH1	23576	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
DDAH2	23564	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		17267746
DDAH2	23564	Pre-Eclampsia	MESH:D011225	marker/mechanism		NA		22285683
DDB1	1642	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
DDB1	1642	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
DDB1	1642	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
DDB2	1643	Xeroderma Pigmentosum, Complementation Group E	MESH:C564732	marker/mechanism		NA	278740	24753253
DDC	1644	Aromatic amino acid decarboxylase deficiency	MESH:C537437	marker/mechanism		NA	608643	
DDC	1644	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
DDC	1644	Mental Disorders	MESH:D001523	marker/mechanism		NA		2969953
DDC	1644	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		19522546
DDC	1644	Parkinson Disease	MESH:D010300	therapeutic		NA		11445284|2969953
DDC	1644	Parkinsonian Disorders	MESH:D020734	therapeutic		NA		16269145
DDC	1644	Pheochromocytoma	MESH:D010673	marker/mechanism		NA		22569243
DDHD1	80821	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		31209396
DDHD1	80821	Spastic Paraplegia 28, Autosomal Recessive	MESH:C563732	marker/mechanism		NA	609340	
DDHD2	23259	SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE	OMIM:615033	marker/mechanism		NA	615033	
DDIT3	1649	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
DDIT3	1649	Asbestosis	MESH:D001195	marker/mechanism		NA		25324550
DDIT3	1649	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		14604972
DDIT3	1649	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
DDIT3	1649	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		23499715
DDIT3	1649	Fatty Liver	MESH:D005234	marker/mechanism		NA		27664470
DDIT3	1649	Intestinal Diseases	MESH:D007410	marker/mechanism		NA		20668000
DDIT3	1649	Liposarcoma, Myxoid	MESH:D018208	marker/mechanism		NA		1283316|7503811|8510758
DDIT3	1649	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		25450231
DDIT3	1649	Nephrosis	MESH:D009401	marker/mechanism		NA		16400006
DDIT3	1649	Obesity	MESH:D009765	marker/mechanism		NA		26655953
DDIT3	1649	Ocular Hypertension	MESH:D009798	therapeutic		NA		24691439
DDIT3	1649	Spinal Cord Injuries	MESH:D013119	marker/mechanism		NA		29793971
DDIT3	1649	Ulcer	MESH:D014456	marker/mechanism		NA		20668000
DDIT4	54541	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		17379860
DDIT4	54541	Leukemia	MESH:D007938	therapeutic		NA		17379067
DDIT4	54541	Mouth Diseases	MESH:D009059	marker/mechanism		NA		17682004
DDIT4	54541	Nerve Degeneration	MESH:D009410	therapeutic		NA		17005863
DDIT4	54541	Parkinson Disease	MESH:D010300	therapeutic		NA		17005863
DDIT4L	115265	Melanoma	MESH:D008545	marker/mechanism		NA		16778180
DDOST	1650	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ir	OMIM:614507	marker/mechanism		NA	614507	
DDR1	780	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		21552421
DDR1	780	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		21552421
DDR1	780	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		21283680
DDR1	780	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		24763052
DDR2	4921	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		26206333
DDR2	4921	Spondylometaepiphyseal Dysplasia, Short Limb-Hand Type	MESH:C564794	marker/mechanism		NA	271665	
DDR2	4921	Tobacco Use Disorder	MESH:D014029	marker/mechanism		NA		29216386
DDX1	1653	Endometrial Hyperplasia	MESH:D004714	marker/mechanism		NA		22248470
DDX1	1653	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
DDX11	1663	Chromosome Breakage	MESH:D019457	marker/mechanism		NA		25561740
DDX11	1663	WARSAW BREAKAGE SYNDROME	OMIM:613398	marker/mechanism		NA	613398	
DDX3X	1654	Epilepsy	MESH:D004827	marker/mechanism		NA		29942082
DDX3X	1654	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE	OMIM:300958	marker/mechanism		NA	300958	
DDX3X	1654	Lymphoma, T-Cell	MESH:D016399	marker/mechanism		NA		26192917
DDX3X	1654	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		26928227
DDX3X	1654	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889|29942082
DDX3X	1654	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
DDX3Y	8653	Spermatogenic Failure, Nonobstructive, Y-Linked	MESH:C564030	marker/mechanism		NA	415000	
DDX41	51428	Acute erythroleukemia	MESH:C535673	marker/mechanism		NA		30926971
DDX41	51428	MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO	OMIM:616871	marker/mechanism		NA	616871	
DDX5	1655	Endometriosis	MESH:D004715	marker/mechanism		NA		22138541
DDX51	317781	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		26928227
DDX54	79039	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
DDX54	79039	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
DDX54	79039	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		19233941
DDX58	23586	Disease Progression	MESH:D018450	marker/mechanism		NA		20170495
DDX58	23586	Hepatitis C	MESH:D006526	marker/mechanism		NA		20170495
DDX58	23586	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
DDX58	23586	Orthomyxoviridae Infections	MESH:D009976	marker/mechanism		NA		25780039
DDX58	23586	Psoriasis	MESH:D011565	marker/mechanism		NA		23143594
DDX59	83479	Orofaciodigital syndrome 5	MESH:C557819	marker/mechanism		NA	174300	
DDX6	1656	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		23143596
DDX60	55601	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
DEAF1	10522	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21076407
DEAF1	10522	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND IMPAIRED EXPRESSIVE LANGUAGE AND WITH OR WITHOUT SEIZURES	OMIM:617171	marker/mechanism		NA	617171	
DEAF1	10522	VULTO-VAN SILFHOUT-DE VRIES SYNDROME	OMIM:615828	marker/mechanism		NA	615828	
DECR1	1666	2,4-Dienoyl-CoA Reductase Deficiency	MESH:C565624	marker/mechanism		NA		25526675
DECR1	1666	Lipid Metabolism, Inborn Errors	MESH:D008052	marker/mechanism		NA		2332510
DEF4	3289964	Parkinson Disease	MESH:D010300	marker/mechanism		NA		25475535
DEF6	50619	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		26808113
DEFA24	503491	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
DEFA3	1668	Leukemia, Promyelocytic, Acute	MESH:D015473	therapeutic		NA		16019513
DEFA5	1670	Adenomatous Polyps	MESH:D018256	marker/mechanism		NA		15844706
DEFA5	1670	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		20452301
DEFA5	1670	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15844706
DEFA5	1670	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		22197929|25305756
DEFA5	1670	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA		18394979
DEFA5	1670	Peutz-Jeghers Syndrome	MESH:D010580	marker/mechanism		NA		17934846
DEFA6	1671	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		20452301
DEFAL1	613220	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
DEFB1	1672	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
DEFB1	1672	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
DEFB4A	1673	Pneumonia, Pneumococcal	MESH:D011018	marker/mechanism		NA		24894820
DEGS1	8560	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
DEK	7913	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		27811057
DEK	7913	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27811057
DEK	7913	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		21291860|27811057
DEK	7913	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		27811057
DENND1B	163486	Crohn Disease	MESH:D003424	marker/mechanism		NA		21102463
DENND1B	163486	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		21399635
DENND4B	9909	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
DENND5A	23258	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49	OMIM:617281	marker/mechanism		NA	617281	
DEPDC1	55635	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
DEPDC1B	55789	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
DEPDC5	9681	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21725309
DEPDC5	9681	Epilepsy, Partial, with Variable Foci	MESH:C565785	marker/mechanism		NA	604364	23542697|23542701
DEPDC7	91614	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
DEPP1	11067	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037
DEPP1	11067	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
DEPP1	11067	Lipidoses	MESH:D008064	marker/mechanism		NA		15342952|16919414|17175557
DERL1	79139	Stevens-Johnson Syndrome	MESH:D013262	marker/mechanism		NA		25811541
DES	1674	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		20137276
DES	1674	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25330770
DES	1674	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
DES	1674	Cardiomyopathy, Dilated, 1i	MESH:C565752	marker/mechanism		NA	604765	
DES	1674	Fetal Growth Retardation	MESH:D005317	marker/mechanism		NA		28157488
DES	1674	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		20962747
DES	1674	Hernias, Diaphragmatic, Congenital	MESH:D065630	marker/mechanism		NA		27651373
DES	1674	Hyperhomocysteinemia	MESH:D020138	marker/mechanism		NA		20116427
DES	1674	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
DES	1674	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
DES	1674	Muscular Dystrophies, Limb-Girdle	MESH:D049288	marker/mechanism		NA		23687351|30055862
DES	1674	Myofibrillar Myopathy	MESH:C580316	marker/mechanism		NA	601419	20718792|30055862
DES	1674	Myopathy, Myofibrillar, Desmin-Related	MESH:C563319	marker/mechanism		NA		20718792|30055862
DES	1674	Nephrosis	MESH:D009401	marker/mechanism		NA		16418842
DES	1674	Scapuloperoneal Syndrome, Neurogenic, Kaeser Type	MESH:C566695	marker/mechanism		NA	181400	
DES	1674	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		19424620
DESI2	51029	Ovarian Neoplasms	MESH:D010051	therapeutic		NA		21667029
DEUP1	159989	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		30705370
DEUP1	159989	Glioblastoma	MESH:D005909	marker/mechanism		NA		30705370
DFFB	1677	Chromosome Breakage	MESH:D019457	marker/mechanism		NA		31401084
DGAT1	8694	Diarrhea	MESH:D003967	marker/mechanism		NA	615863	
DGAT2	84649	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		17984051
DGAT2	84649	Cholestasis	MESH:D002779	marker/mechanism		NA		27989131
DGCR	1714	DiGeorge Syndrome	MESH:D004062	marker/mechanism		NA	188400	
DGCR2	9993	DiGeorge Syndrome	MESH:D004062	marker/mechanism		NA	192430	
DGCR2	9993	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
DGCR6	8214	DiGeorge Syndrome	MESH:D004062	marker/mechanism		NA	192430	
DGCR8	54487	DiGeorge Syndrome	MESH:D004062	marker/mechanism		NA	192430	
DGCR8	54487	Mental Disorders	MESH:D001523	marker/mechanism		NA		18469815
DGCR8	54487	Wilms Tumor	MESH:D009396	marker/mechanism		NA		28825729
DGKB	1607	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
DGKD	8527	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		30718926
DGKE	8526	Atypical Hemolytic Uremic Syndrome	MESH:D065766	marker/mechanism		NA		23542698
DGKE	8526	NEPHROTIC SYNDROME, TYPE 7	OMIM:615008	marker/mechanism		NA	615008	
DGKH	160851	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		20665664
DGKK	139189	Hypospadias	MESH:D007021	marker/mechanism		NA		21113153|27098078
DGKQ	1609	Sjogren's Syndrome	MESH:D012859	marker/mechanism		NA		24097067
DGKZ	8525	Myocardial Infarction	MESH:D009203	therapeutic		NA		17071729
DGUOK	1716	Deoxyguanosine Kinase Deficiency	MESH:C580039	marker/mechanism		NA		26342080
DGUOK	1716	Hypertension, Portal	MESH:D006975	marker/mechanism		NA	617068	
DGUOK	1716	MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	OMIM:251880	marker/mechanism		NA	251880	
DGUOK	1716	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	OMIM:617070	marker/mechanism		NA	617070	
DHCR24	1718	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		23042211
DHCR24	1718	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		24781735
DHCR24	1718	Desmosterolosis	MESH:C566555	marker/mechanism		NA	602398	16410790
DHCR24	1718	Q Fever	MESH:D011778	marker/mechanism		NA		16469060
DHCR7	1717	Autistic Disorder	MESH:D001321	marker/mechanism		NA		14659996
DHCR7	1717	Bone Diseases, Metabolic	MESH:D001851	marker/mechanism		NA		24381012
DHCR7	1717	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		29698737
DHCR7	1717	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		24381012
DHCR7	1717	Smith-Lemli-Opitz Syndrome	MESH:D019082	marker/mechanism		NA	270400	11254748|12818773|12906934|14659996|15896653|16446309|16814115|17994283|19365639|27097157|29698737
DHDDS	79947	RETINITIS PIGMENTOSA 59	OMIM:613861	marker/mechanism		NA	613861	
DHDH	27294	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		21716162
DHFR	1719	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
DHFR	1719	Anemia, Megaloblastic	MESH:D000749	marker/mechanism		NA		21310276|21310277
DHFR	1719	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		23897011
DHFR	1719	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17597297
DHFR	1719	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21501481|28188287
DHFR	1719	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		19648163
DHFR	1719	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		15814641
DHFR	1719	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		21064136
DHFR	1719	Folic Acid Deficiency	MESH:D005494	marker/mechanism		NA		21310277
DHFR	1719	Infertility, Female	MESH:D007247	therapeutic		NA		17519396
DHFR	1719	Megaloblastic Anemia due to Dihydrofolate Reductase Deficiency	MESH:C565095	marker/mechanism		NA	613839	
DHFR	1719	Metabolism, Inborn Errors	MESH:D008661	marker/mechanism		NA		21310276|21310277
DHFR	1719	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19159907
DHFR	1719	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		21064136|21310277
DHFR	1719	Osteosarcoma	MESH:D012516	marker/mechanism		NA		19159907
DHFR	1719	Pancytopenia	MESH:D010198	marker/mechanism		NA		21310276
DHH	50846	46,XY Gonadal Dysgenesis, Complete or Partial, DHH-Related	MESH:C565537	marker/mechanism		NA	233420	
DHH	50846	46,Xy Gonadal Dysgenesis, Partial, With Minifascicular Neuropathy	MESH:C567773	marker/mechanism		NA	607080	
DHODH	1723	Anemia, Sickle Cell	MESH:D000755	marker/mechanism		NA		38827
DHODH	1723	beta-Thalassemia	MESH:D017086	marker/mechanism		NA		38827
DHODH	1723	Genee-Wiedemann syndrome	MESH:C537680	marker/mechanism		NA	263750	
DHODH	1723	Leukemia, Erythroblastic, Acute	MESH:D004915	marker/mechanism		NA		38827
DHODH	1723	Spherocytosis, Hereditary	MESH:D013103	marker/mechanism		NA		38827
DHRS3	9249	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
DHRS7	51635	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
DHRS7	51635	Fatty Liver	MESH:D005234	marker/mechanism		NA		25226513
DHRS7	51635	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
DHRS7	51635	Tobacco Use Disorder	MESH:D014029	marker/mechanism		NA		29216386
DHS6S1	107305681	Macular dystrophy, retinal, 1, North Carolina type	MESH:C537835	marker/mechanism		NA	136550	
DHTKD1	55526	2-AMINOADIPIC 2-OXOADIPIC ACIDURIA	OMIM:204750	marker/mechanism		NA	204750	
DHTKD1	55526	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Q	OMIM:615025	marker/mechanism		NA	615025	
DHTKD1	55526	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
DHX15	1665	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		27798625|29163777
DHX30	22907	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
DHX38	9785	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA		30208423
DIABLO	56616	Brain Ischemia	MESH:D002545	marker/mechanism		NA		11756504
DIABLO	56616	DEAFNESS, AUTOSOMAL DOMINANT 64	OMIM:614152	marker/mechanism		NA	614152	
DIABLO	56616	Huntington Disease	MESH:D006816	marker/mechanism		NA		12930891
DIABLO	56616	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		14998631
DIABLO	56616	Osteoarthritis, Hip	MESH:D015207	marker/mechanism		NA		30664745
DIABLO	56616	Prostatic Neoplasms	MESH:D011471	therapeutic		NA		17718901
DIAPH1	1729	Deafness, Autosomal Dominant 1	MESH:C565121	marker/mechanism		NA	124900	
DIAPH1	1729	SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	OMIM:616632	marker/mechanism		NA	616632	
DIAPH2	1730	Premature Ovarian Failure 2a	MESH:C564498	marker/mechanism		NA	300511	
DIAPH2-AS1	10824	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
DIAPH3	81624	Auditory Neuropathy, Autosomal Dominant, 1	MESH:C563790	marker/mechanism		NA	609129	
DICER1	23405	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
DICER1	23405	GOITER, MULTINODULAR 1, WITH OR WITHOUT SERTOLI-LEYDIG CELL TUMORS	OMIM:138800	marker/mechanism		NA	138800	
DICER1	23405	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		24478143
DICER1	23405	Oligospermia	MESH:D009845	marker/mechanism		NA		22381205
DICER1	23405	Pleuropulmonary blastoma	MESH:C537516	marker/mechanism		NA	601200	
DICER1	23405	Rhabdomyosarcoma, Embryonal, 2	MESH:C566709	marker/mechanism		NA	180295	
DICER1	23405	Wilms Tumor	MESH:D009396	marker/mechanism		NA		28825729
DIDO1	11083	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		30431698
DIO1	1733	Hyperthyroxinemia	MESH:D006981	marker/mechanism		NA		3346351
DIO1	1733	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980|25380136
DIO1	1733	Metabolism, Inborn Errors	MESH:D008661	marker/mechanism		NA		17105838
DIO1	1733	Thyroid Diseases	MESH:D013959	marker/mechanism		NA		17105838
DIO2	1734	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		24781735
DIO2	1734	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
DIO2	1734	Mesothelioma	MESH:D008654	marker/mechanism		NA		11425850
DIO2	1734	Thyroid Diseases	MESH:D013959	marker/mechanism		NA		23397585
DIO3	1735	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		24781735
DIO3	1735	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25330770
DIO3	1735	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		26825960
DIO3	1735	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
DIO3OS	64150	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
DIP2A	23181	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		28191889
DIP2B	57609	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		31557154
DIP2B	57609	Mental Retardation, Fra12a Type	MESH:C566980	marker/mechanism		NA	136630	
DIP2C	22982	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941189
DIPK2A	205428	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		21283809
DIPK2A	205428	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18621663
DIPK2A	205428	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
DIPK2B	79742	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		21264219|21283809
DIPK2B	79742	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
DIPK2B	79742	Mental Retardation, X-Linked	MESH:D038901	marker/mechanism		NA		21264219
DIRAS3	9077	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
DIS3L2	129563	Nephroblastomatosis, fetal ascites, macrosomia and Wilms tumor	MESH:C536399	marker/mechanism		NA	267000	22306653
DISC1	27185	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		29643356
DISC1	27185	Asperger Syndrome	MESH:D020817	marker/mechanism		NA		17579608
DISC1	27185	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17579608|20002455
DISC1	27185	Depressive Disorder	MESH:D003866	marker/mechanism		NA		29643356
DISC1	27185	Hyperkinesis	MESH:D006948	marker/mechanism		NA		26754951
DISC1	27185	Intellectual Disability	MESH:D008607	marker/mechanism		NA		20002455
DISC1	27185	Motor Skills Disorders	MESH:D019957	marker/mechanism		NA		26754951
DISC1	27185	Pain	MESH:D010146	marker/mechanism		NA		20561508
DISC1	27185	Schizophrenia	MESH:D012559	marker/mechanism		NA	604906	20531374|20561508
DISC2	27184	Schizophrenia	MESH:D012559	marker/mechanism		NA	181500	
DISP1	84976	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
DIXDC1	85458	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		27752079
DIXDC1	85458	Autistic Disorder	MESH:D001321	marker/mechanism		NA		27752079
DIXDC1	85458	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		27752079
DIXDC1	85458	Depressive Disorder	MESH:D003866	marker/mechanism		NA		27752079
DIXDC1	85458	Schizophrenia	MESH:D012559	marker/mechanism		NA		27752079
DJ-1BETA	43652	Parkinsonian Disorders	MESH:D020734	marker/mechanism		NA		20423725
DKC1	1736	Dyskeratosis Congenita	MESH:D019871	marker/mechanism		NA	305000	17785587|22299032
DKK1	22943	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18283316
DKK1	22943	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
DKK1	22943	Fractures, Bone	MESH:D050723	marker/mechanism		NA		22504420
DLAT	1737	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
DLAT	1737	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
DLAT	1737	Pyruvate Dehydrogenase E2 Deficiency	MESH:C565448	marker/mechanism		NA	245348	
DLC1	10395	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	114500	
DLC1	10395	Neoplasms	MESH:D009369	marker/mechanism		NA		21455586
DLC1	10395	Ovarian Neoplasms	MESH:D010051	therapeutic		NA		15674352
DLC1	10395	Stomach Neoplasms	MESH:D013274	therapeutic		NA		26401016
DLD	1738	Lactic Acidosis, Congenital Infantile, Due To LAD Deficiency	MESH:C573012	marker/mechanism		NA	246900	
DLEU2	8847	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		21441929
DLG1	1739	Cleft Palate	MESH:D002972	marker/mechanism		NA		11238884
DLG1	1739	Schizophrenia	MESH:D012559	marker/mechanism		NA		12421351|18665322|20691406
DLG2	1740	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
DLG3	1741	Mental Retardation, X-Linked	MESH:D038901	marker/mechanism		NA		15185169
DLG3	1741	MENTAL RETARDATION, X-LINKED 90	OMIM:300850	marker/mechanism		NA	300850	
DLG4	1742	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		20952458
DLG4	1742	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
DLG4	1742	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
DLG4	1742	Williams Syndrome	MESH:D018980	marker/mechanism		NA		20952458
DLGAP1	9229	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
DLGAP2	9228	Autistic Disorder	MESH:D001321	marker/mechanism		NA		20531469
DLGAP5	9787	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
DLK1	8788	Fetal Growth Retardation	MESH:D005317	marker/mechanism		NA		27776119
DLK1	8788	Myelodysplastic Syndromes	MESH:D009190	marker/mechanism		NA		18575777
DLL1	28514	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		21127729
DLL1	28514	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21036696
DLL3	10683	Astrocytoma	MESH:D001254	marker/mechanism		NA		21127729
DLL3	10683	Congenital Abnormalities	MESH:D000013	marker/mechanism		NA		17849441
DLL3	10683	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		17849441
DLL3	10683	Osteochondrodysplasias	MESH:D010009	marker/mechanism		NA		11146471
DLL3	10683	Scoliosis	MESH:D012600	marker/mechanism		NA		17849441
DLL3	10683	Spondylocostal dysostosis, autosomal recessive	MESH:C535781	marker/mechanism		NA	277300	
DLL4	54567	Adams Oliver syndrome	MESH:C538225	marker/mechanism		NA	616589	
DLL4	54567	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21036696
DLX1	1745	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		21302352
DLX1	1745	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18728693
DLX1	1745	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		9187081
DLX2	1746	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18728693
DLX2	1746	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		9187081
DLX3	1747	Amelogenesis Imperfecta, Type IV	MESH:C566293	marker/mechanism		NA	104510	
DLX3	1747	TRICHODENTOOSSEOUS SYNDROME	OMIM:190320	marker/mechanism		NA	190320	
DLX4	1748	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		26213588
DLX4	1748	OROFACIAL CLEFT 15	OMIM:616788	marker/mechanism		NA	616788	
DLX5	1749	Birth Weight	MESH:D001724	marker/mechanism		NA		31082282
DLX5	1749	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		10433909
DLX5	1749	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		10433909|10433912|14666512
DLX5	1749	Ectrodactyly	MESH:C574275	marker/mechanism		NA	183600	
DLX5	1749	Split-Hand-Foot Malformation With Sensorineural Hearing Loss	MESH:C565647	marker/mechanism		NA	220600	
DLX6	1750	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		14666512
DMBT1	1755	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
DMD	1756	Calcinosis	MESH:D002114	marker/mechanism		NA		18340010
DMD	1756	Cardiomegaly	MESH:D006332	marker/mechanism		NA		23297412
DMD	1756	Cardiomyopathies	MESH:D009202	marker/mechanism|therapeutic		NA		17440445|18340010|20675662
DMD	1756	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		11496434
DMD	1756	CARDIOMYOPATHY, DILATED, 3B	OMIM:302045	marker/mechanism		NA	302045	
DMD	1756	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		22795790|26930420
DMD	1756	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		24793134
DMD	1756	Leiomyosarcoma	MESH:D007890	marker/mechanism		NA		24793134
DMD	1756	Muscle Weakness	MESH:D018908	marker/mechanism		NA		26930420
DMD	1756	Muscular Dystrophies	MESH:D009136	marker/mechanism|therapeutic		NA		10797403|17440445|20805873|22906800
DMD	1756	Muscular Dystrophy, Animal	MESH:D009137	marker/mechanism		NA		22795790
DMD	1756	Muscular Dystrophy, Duchenne	MESH:D020388	marker/mechanism		NA	300376|310200	10939566|11409421|12966700|14751810|16122626|19309154|21273767|23297412|24349043|26930420|29404407
DMD	1756	Necrosis	MESH:D009336	marker/mechanism		NA		22795790
DMD	1756	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		24793134
DMD	1756	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		24793134
DMD	1756	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
DMD	1756	Rhabdomyosarcoma, Embryonal	MESH:D018233	marker/mechanism		NA		24793134
DMD	1756	Status Epilepticus	MESH:D013226	marker/mechanism		NA		20886625
DMD	1756	Ventricular Dysfunction	MESH:D018754	marker/mechanism		NA		21273767
DMGDH	29958	Dimethylglycine Dehydrogenase Deficiency	MESH:C565278	marker/mechanism		NA	605850	
DMP1	1758	Hypophosphatemic Rickets, Autosomal Recessive, 1	MESH:C562792	marker/mechanism		NA	241520	
DMPK	1760	Myotonia	MESH:D009222	marker/mechanism		NA		24039817
DMPK	1760	Myotonic Dystrophy	MESH:D009223	marker/mechanism		NA	160900	24039817
DMRT1	1761	Neoplasms, Germ Cell and Embryonal	MESH:D009373	marker/mechanism		NA		20543847
DMRT1	1761	Testicular Neoplasms	MESH:D013736	marker/mechanism		NA		20543847
DMXL1	1657	Glioma	MESH:D005910	marker/mechanism		NA		16865689
DNA2	1763	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 6	OMIM:615156	marker/mechanism		NA	615156	
DNAAF1	123872	Ciliary Dyskinesia, Primary, 13	MESH:C567713	marker/mechanism		NA	613193	
DNAAF2	55172	Ciliary Dyskinesia, Primary, 10	MESH:C567287	marker/mechanism		NA	612518	
DNAAF3	352909	Kartagener Syndrome	MESH:D007619	marker/mechanism		NA		22387996
DNAAF3	352909	Primary ciliary dyskinesia, 2	MESH:C535277	marker/mechanism		NA	606763	
DNAAF4	161582	CILIARY DYSKINESIA, PRIMARY, 25	OMIM:615482	marker/mechanism		NA	615482	
DNAAF4	161582	Dyslexia	MESH:D004410	marker/mechanism		NA	127700	
DNAAF4	161582	Infertility, Male	MESH:D007248	marker/mechanism		NA		23872636
DNAAF4	161582	Kartagener Syndrome	MESH:D007619	marker/mechanism		NA		23872636
DNAAF5	54919	CILIARY DYSKINESIA, PRIMARY, 18	OMIM:614874	marker/mechanism		NA	614874	
DNAAF6	139212	CILIARY DYSKINESIA, PRIMARY, 36, X-LINKED	OMIM:300991	marker/mechanism		NA	300991	
DNAH10	196385	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
DNAH11	8701	Ciliary Dyskinesia, Primary, 7	MESH:C567504	marker/mechanism		NA	611884	
DNAH11	8701	Coronary Disease	MESH:D003327	marker/mechanism		NA		19060911
DNAH11	8701	Dyslipidemias	MESH:D050171	marker/mechanism		NA		19060911
DNAH11	8701	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
DNAH5	1767	Asthma	MESH:D001249	marker/mechanism		NA		21912604
DNAH5	1767	Primary ciliary dyskinesia, 3	MESH:C535278	marker/mechanism		NA	608644	
DNAH8	1769	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		18438686
DNAH8	1769	Paranoid Disorders	MESH:D010259	marker/mechanism		NA		18438686
DNAH8	1769	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
DNAI1	27019	Kartagener Syndrome	MESH:D007619	marker/mechanism		NA	244400	19675306
DNAI2	64446	Ciliary Dyskinesia, Primary, 9	MESH:C567310	marker/mechanism		NA	612444	
DNAJA1	3301	Mouth Diseases	MESH:D009059	marker/mechanism		NA		17682004
DNAJB13	374407	CILIARY DYSKINESIA, PRIMARY, 34	OMIM:617091	marker/mechanism		NA	617091	
DNAJB2	3300	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	OMIM:614881	marker/mechanism		NA	614881	
DNAJB6	10049	Muscular Dystrophies, Limb-Girdle	MESH:D049288	marker/mechanism		NA		22366786
DNAJB6	10049	Muscular Dystrophy, Limb-Girdle, Type 1E	MESH:C566589	marker/mechanism		NA	603511	
DNAJB9	4189	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		26881866
DNAJB9	4189	Cholestasis	MESH:D002779	marker/mechanism		NA		26881866
DNAJC1	64215	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
DNAJC10	54431	Neoplasms	MESH:D009369	therapeutic		NA		17353921
DNAJC10	54431	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
DNAJC12	56521	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		26881866
DNAJC12	56521	Cholestasis	MESH:D002779	marker/mechanism		NA		26881866
DNAJC12	56521	HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT	OMIM:617384	marker/mechanism		NA	617384	
DNAJC15	29103	Melanoma	MESH:D008545	marker/mechanism		NA		17145863
DNAJC19	131118	3-Methylglutaconic Aciduria, Type V	MESH:C565706	marker/mechanism		NA	610198	
DNAJC21	134218	Congenital Bone Marrow Failure Syndromes	MESH:D000080984	marker/mechanism		NA	617052	
DNAJC21	134218	Shwachman-Diamond Syndrome	MESH:D000081003	marker/mechanism		NA	260400	
DNAJC3	5611	ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS	OMIM:616192	marker/mechanism		NA	616192	
DNAJC3	5611	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
DNAJC6	9829	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
DNAJC6	9829	PARKINSON DISEASE 19A, JUVENILE-ONSET	OMIM:615528	marker/mechanism		NA	615528	
DNAJC7	7266	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
DNAL1	83544	CILIARY DYSKINESIA, PRIMARY, 16	OMIM:614017	marker/mechanism		NA	614017	
DNAL4	10126	MIRROR MOVEMENTS 3	OMIM:616059	marker/mechanism		NA	616059	
DNASE1	1773	Airway Obstruction	MESH:D000402	therapeutic		NA		28780505
DNASE1	1773	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA	152700	
DNASE1	1773	Proteinuria	MESH:D011507	marker/mechanism		NA		22479529
DNASE1	1773	Respiratory Syncytial Virus Infections	MESH:D018357	therapeutic		NA		28780505
DNASE1L2	1775	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
DNASE1L3	1776	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		23143596|30224649
DNASE1L3	1776	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
DNASE1L3	1776	Lung Neoplasms	MESH:D008175	therapeutic		NA		21720004
DNASE1L3	1776	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA	614420	22019780
DNASE2A	13423	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		20974942
DNASE2A	13423	Splenomegaly	MESH:D013163	marker/mechanism		NA		20974942
DNHD1	144132	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		23797736
DNM1	1759	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 31	OMIM:616346	marker/mechanism		NA	616346	
DNM1	1759	Dog Diseases	MESH:D004283	marker/mechanism		NA		18806795
DNM1	1759	Epilepsy	MESH:D004827	marker/mechanism		NA		29942082
DNM1	1759	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		29942082
DNM1L	10059	Acidosis, Lactic	MESH:D000140	marker/mechanism		NA		17460227
DNM1L	10059	ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	OMIM:614388	marker/mechanism		NA	614388	
DNM1L	10059	Microcephaly	MESH:D008831	marker/mechanism		NA		17460227
DNM1L	10059	Mitochondrial Encephalomyopathies	MESH:D017237	marker/mechanism		NA		17460227
DNM1L	10059	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
DNM1L	10059	Optic Atrophy	MESH:D009896	marker/mechanism		NA		17460227
DNM1L	10059	Optic atrophy 5	MESH:C537126	marker/mechanism		NA	610708	
DNM1L	10059	Parkinson Disease	MESH:D010300	marker/mechanism		NA		28215578
DNM2	1785	Charcot-Marie-Tooth Disease, Dominant Intermediate B	MESH:C564703	marker/mechanism		NA	606482	
DNM2	1785	LETHAL CONGENITAL CONTRACTURE SYNDROME 5	OMIM:615368	marker/mechanism		NA	615368	
DNM2	1785	Myopathies, Structural, Congenital	MESH:D020914	marker/mechanism		NA	160150	17376685
DNM3	26052	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		28321044
DNMT1	1786	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		17571247
DNMT1	1786	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		23791455
DNMT1	1786	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		25194984
DNMT1	1786	Asthma	MESH:D001249	marker/mechanism		NA		23423710
DNMT1	1786	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		22520950|28544374
DNMT1	1786	Carcinoma	MESH:D002277	marker/mechanism		NA		21458988
DNMT1	1786	Carcinoma, Pancreatic Ductal	MESH:D021441	marker/mechanism		NA		29844410
DNMT1	1786	Cerebellar Ataxia, Deafness, and Narcolepsy	MESH:C565825	marker/mechanism		NA	604121	
DNMT1	1786	Clear-cell metastatic renal cell carcinoma	MESH:C538445	marker/mechanism		NA		27292127
DNMT1	1786	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		19723570
DNMT1	1786	Dementia	MESH:D003704	marker/mechanism		NA		21532572
DNMT1	1786	Hearing Loss	MESH:D034381	marker/mechanism		NA		21532572
DNMT1	1786	Hereditary Sensory and Autonomic Neuropathies	MESH:D009477	marker/mechanism		NA		21532572
DNMT1	1786	Medulloblastoma	MESH:D008527	marker/mechanism		NA		19155313
DNMT1	1786	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		28544374
DNMT1	1786	NEUROPATHY, HEREDITARY SENSORY, TYPE IE	OMIM:614116	marker/mechanism		NA	614116	
DNMT1	1786	Prostatic Intraepithelial Neoplasia	MESH:D019048	marker/mechanism		NA		22581815
DNMT1	1786	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		22581815
DNMT1	1786	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		17571247|21458988
DNMT3A	1788	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		25290267
DNMT3A	1788	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		22520950
DNMT3A	1788	Clear-cell metastatic renal cell carcinoma	MESH:C538445	marker/mechanism		NA		27292127
DNMT3A	1788	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		24614070
DNMT3A	1788	Crohn Disease	MESH:D003424	marker/mechanism		NA		21102463
DNMT3A	1788	Dwarfism	MESH:D004392	marker/mechanism		NA		30478443
DNMT3A	1788	Facies	MESH:D019066	marker/mechanism		NA		24614070
DNMT3A	1788	Growth Disorders	MESH:D006130	marker/mechanism		NA		24614070|30478443
DNMT3A	1788	Immunoblastic Lymphadenopathy	MESH:D007119	marker/mechanism		NA		24413737
DNMT3A	1788	Intellectual Disability	MESH:D008607	marker/mechanism		NA		24614070
DNMT3A	1788	Leukemia, Monocytic, Acute	MESH:D007948	marker/mechanism		NA		21399634
DNMT3A	1788	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA	601626	
DNMT3A	1788	Leukemia, Myelomonocytic, Juvenile	MESH:D054429	marker/mechanism		NA		26457647
DNMT3A	1788	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		26285909
DNMT3A	1788	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		26192916
DNMT3A	1788	Lymphoma, T-Cell, Cutaneous	MESH:D016410	marker/mechanism		NA		26192916
DNMT3A	1788	Lymphoma, T-Cell, Peripheral	MESH:D016411	marker/mechanism		NA		24413734|24413737
DNMT3A	1788	Microcephaly	MESH:D008831	marker/mechanism		NA		30478443
DNMT3A	1788	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		26285909
DNMT3A	1788	Sezary Syndrome	MESH:D012751	marker/mechanism		NA		26551667
DNMT3A	1788	TATTON-BROWN-RAHMAN SYNDROME	OMIM:615879	marker/mechanism		NA	615879	
DNMT3B	1789	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		25290267
DNMT3B	1789	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18221536|22520950
DNMT3B	1789	Carcinoma	MESH:D002277	marker/mechanism		NA		21458988
DNMT3B	1789	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		17908720
DNMT3B	1789	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1	OMIM:242860	marker/mechanism		NA	242860	15580563|15952214|17893117|18029387|18762900
DNMT3B	1789	Immunologic Deficiency Syndromes	MESH:D007153	marker/mechanism		NA		17908720
DNMT3B	1789	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
DNMT3B	1789	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16012746
DNMT3B	1789	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21458988
DOCK1	1793	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
DOCK10	55619	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
DOCK2	1794	Adenocarcinoma Of Esophagus	MESH:C562730	marker/mechanism		NA		23525077
DOCK2	1794	IMMUNODEFICIENCY 40	OMIM:616433	marker/mechanism		NA	616433	
DOCK2	1794	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
DOCK4	9732	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19401682
DOCK6	57572	Adams Oliver syndrome	MESH:C538225	marker/mechanism		NA	614219	
DOCK7	85440	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 23	OMIM:615859	marker/mechanism		NA	615859	
DOCK7	85440	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
DOCK8	81704	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		18060736
DOCK8	81704	Intellectual Disability	MESH:D008607	marker/mechanism		NA		18060736
DOCK8	81704	Job Syndrome	MESH:D007589	marker/mechanism		NA	243700	
DOCK8	81704	Neuroblastoma	MESH:D009447	marker/mechanism		NA		26121086
DOCK8	81704	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
DOCK8	81704	Recurrence	MESH:D012008	marker/mechanism		NA		26121086
DOK1	1796	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		20139980
DOK1	1796	Ovarian Neoplasms	MESH:D010051	therapeutic		NA		21856257
DOK2	9046	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		20139980
DOK3	79930	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		20139980
DOK7	285489	Congenital myasthenic syndrome ib	MESH:C536089	marker/mechanism		NA	254300	
DOLK	22845	Congenital Disorder Of Glycosylation, Type Im	MESH:C563666	marker/mechanism		NA	610768	
DONSON	29980	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		25944804
DONSON	29980	Dwarfism	MESH:D004392	marker/mechanism		NA		28191891
DONSON	29980	Microcephaly	MESH:D008831	marker/mechanism		NA		28191891
DOP1R2	43484	Parkinsonian Disorders	MESH:D020734	marker/mechanism		NA		25158689
DOT1L	84444	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27158780
DPAGT1	1798	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		25944804
DPAGT1	1798	Congenital disorder of glycosylation type 1J	MESH:C535748	marker/mechanism		NA	608093	
DPAGT1	1798	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
DPAGT1	1798	Myasthenic Syndromes, Congenital	MESH:D020294	marker/mechanism		NA	614750	
DPAGT1	1798	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
DPEP1	1800	Osteoarthritis	MESH:D010003	marker/mechanism		NA		30664745
DPF3	8110	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
DPH1	1801	DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FACIAL FEATURES, AND SPARSE HAIR	OMIM:616901	marker/mechanism		NA	616901	
DPM1	8813	Congenital disorder of glycosylation type 1E	MESH:C535743	marker/mechanism		NA	608799	
DPM2	8818	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu	OMIM:615042	marker/mechanism		NA	615042	
DPM3	54344	Congenital Disorder of Glycosylation, Type Io	MESH:C567857	marker/mechanism		NA	612937	
DPP	33432	Juvenile polyposis syndrome	MESH:C537702	marker/mechanism		NA		23733344
DPP10	57628	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		18252227
DPP10	57628	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
DPP10	57628	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		19233941
DPP4	1803	Coronavirus Infections	MESH:D018352	marker/mechanism		NA		30626688
DPP4	1803	Proteinuria	MESH:D011507	marker/mechanism		NA		2880436
DPP6	1804	Amyotrophic Lateral Sclerosis	MESH:D000690	marker/mechanism		NA		18084291
DPP6	1804	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		18252227|20844286
DPP6	1804	MENTAL RETARDATION, AUTOSOMAL DOMINANT 33	OMIM:616311	marker/mechanism		NA	616311	
DPP6	1804	Paroxysmal ventricular fibrillation	MESH:C537182	marker/mechanism		NA	612956	
DPP7	29952	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
DPP7	29952	Necrosis	MESH:D009336	marker/mechanism		NA		16725115
DPP9	91039	Idiopathic Pulmonary Fibrosis	MESH:D054990	marker/mechanism		NA		23583980
DPPA3	359787	Neoplasms, Germ Cell and Embryonal	MESH:D009373	marker/mechanism		NA		16168501
DPT	1805	Varicose Veins	MESH:D014648	marker/mechanism		NA		17643059
DPY19L2	283417	SPERMATOGENIC FAILURE 9	OMIM:613958	marker/mechanism		NA	613958	
DPYD	1806	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		18252227|20844286
DPYD	1806	Autistic Disorder	MESH:D001321	marker/mechanism		NA		21114665
DPYD	1806	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19020767
DPYD	1806	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		18019677
DPYD	1806	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		18652704
DPYD	1806	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		15222106|15814641|17047489|17611699|19020767
DPYD	1806	Dihydropyrimidine Dehydrogenase Deficiency	MESH:D054067	marker/mechanism		NA	274270	16151913|9816193
DPYD	1806	Head and Neck Neoplasms	MESH:D006258	marker/mechanism		NA		19020767
DPYD	1806	Language Development Disorders	MESH:D007805	marker/mechanism		NA		21114665
DPYD	1806	Leukoencephalopathies	MESH:D056784	marker/mechanism		NA		11148247
DPYD	1806	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		19020767
DPYD	1806	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17611699
DPYD	1806	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		16435204
DPYD	1806	Neutropenia	MESH:D009503	marker/mechanism		NA		12562666
DPYD	1806	Obesity	MESH:D009765	marker/mechanism		NA		20882379
DPYD	1806	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		17443278|19020767
DPYD	1806	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		20864405
DPYD	1806	Purine-Pyrimidine Metabolism, Inborn Errors	MESH:D011686	marker/mechanism		NA		15571261|3335642
DPYD	1806	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266|23042115
DPYD	1806	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		15837757|17089033|18652704
DPYS	1807	Dihydropyrimidinase Deficiency	MESH:C562815	marker/mechanism		NA	222748	
DPYS	1807	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
DPYSL2	1808	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		19374891
DPYSL2	1808	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
DPYSL2	1808	Schizophrenia, Paranoid	MESH:D012563	marker/mechanism		NA		17105906
DRAM1	55332	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
DRAM2	128338	CONE-ROD DYSTROPHY 21	OMIM:616502	marker/mechanism		NA	616502	
DRAP1	10589	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
DRAXIN	374946	Parkinson Disease	MESH:D010300	marker/mechanism		NA		25475535
DRC1	92749	CILIARY DYSKINESIA, PRIMARY, 21	OMIM:615294	marker/mechanism		NA	615294	
DRC1	92749	Kartagener Syndrome	MESH:D007619	marker/mechanism		NA		23354437
DRD1	1812	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18363855|19444617
DRD1	1812	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18205172
DRD1	1812	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		19153942
DRD1	1812	Catalepsy	MESH:D002375	marker/mechanism		NA		1365866|3283778|7845605
DRD1	1812	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		15295029|16014726|16541082|20456009
DRD1	1812	Dyskinesia, Drug-Induced	MESH:D004409	marker/mechanism		NA		10858612|16982285|19520364|7845605
DRD1	1812	Hyperkinesis	MESH:D006948	marker/mechanism		NA		24418703
DRD1	1812	Hypotension	MESH:D007022	marker/mechanism		NA		12946566|1724532
DRD1	1812	Movement Disorders	MESH:D009069	marker/mechanism		NA		6858777
DRD1	1812	Parkinson Disease	MESH:D010300	therapeutic		NA		8558425
DRD1	1812	Schizophrenia	MESH:D012559	marker/mechanism		NA		18583979
DRD1	1812	Seizures	MESH:D012640	marker/mechanism		NA		1451735|1829682
DRD2	1813	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18363855|18555060|19940168
DRD2	1813	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		18305461|20532872
DRD2	1813	Attention Deficit Disorder with Hyperactivity	MESH:D001289	marker/mechanism		NA		17671965
DRD2	1813	Basal Ganglia Diseases	MESH:D001480	marker/mechanism		NA		11198054|12211096|18480698|19225277|19506579
DRD2	1813	Bradycardia	MESH:D001919	marker/mechanism		NA		10626749|1724532
DRD2	1813	Catalepsy	MESH:D002375	marker/mechanism		NA		1365866|3283778|7845605|9618422
DRD2	1813	Cocaine-Related Disorders	MESH:D019970	marker/mechanism|therapeutic		NA		10900248|11751029|11923462|15010698|15042275|16541082|16971900|17332411|18418874|20494958
DRD2	1813	Cognition Disorders	MESH:D003072	marker/mechanism		NA		19910723
DRD2	1813	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		21592505
DRD2	1813	Disruptive, Impulse Control, and Conduct Disorders	MESH:D007174	marker/mechanism		NA		17332411|19940168|20671181
DRD2	1813	Dyskinesia, Drug-Induced	MESH:D004409	marker/mechanism		NA		10534246|14629710|7845605
DRD2	1813	Dyskinesias	MESH:D020820	marker/mechanism		NA		16435402
DRD2	1813	Heroin Dependence	MESH:D006556	marker/mechanism		NA		11751029
DRD2	1813	Hyperkinesis	MESH:D006948	marker/mechanism		NA		1975278|24418703
DRD2	1813	Hyperprolactinemia	MESH:D006966	marker/mechanism		NA		15286066|19339912
DRD2	1813	Hypertension	MESH:D006973	marker/mechanism		NA		11566895
DRD2	1813	Hypotension	MESH:D007022	marker/mechanism		NA		10626749|12946566|1724532|9917201
DRD2	1813	Language Disorders	MESH:D007806	marker/mechanism		NA		23691092
DRD2	1813	Memory Disorders	MESH:D008569	marker/mechanism		NA		21592505
DRD2	1813	Movement Disorders	MESH:D009069	marker/mechanism		NA		6858777
DRD2	1813	Pain	MESH:D010146	marker/mechanism		NA		15996639
DRD2	1813	Parkinson Disease	MESH:D010300	therapeutic		NA		8558425
DRD2	1813	Parkinsonian Disorders	MESH:D020734	marker/mechanism|therapeutic		NA		12476322|15469457|9171869
DRD2	1813	Pituitary Neoplasms	MESH:D010911	marker/mechanism		NA		12727942
DRD2	1813	Schizophrenia	MESH:D012559	marker/mechanism		NA		10831489|11245917|18583979|21187413
DRD2	1813	Seizures	MESH:D012640	marker/mechanism|therapeutic		NA		11860278|1829682|7936204
DRD2	1813	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		16901644
DRD2	1813	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		17189962
DRD2	1813	Tachycardia	MESH:D013610	marker/mechanism		NA		10721819|9777039
DRD2	1813	Tobacco Use Disorder	MESH:D014029	marker/mechanism		NA		18579413
DRD2	1813	Weight Gain	MESH:D015430	marker/mechanism		NA		20375926
DRD3	1814	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		19940168
DRD3	1814	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19058789
DRD3	1814	Basal Ganglia Diseases	MESH:D001480	marker/mechanism		NA		19506579
DRD3	1814	Cocaine-Related Disorders	MESH:D019970	marker/mechanism|therapeutic		NA		10523822|15100700|17332411|18566292|20494958
DRD3	1814	Cognition Disorders	MESH:D003072	marker/mechanism		NA		15619116
DRD3	1814	Disruptive, Impulse Control, and Conduct Disorders	MESH:D007174	marker/mechanism		NA		17332411|19940168|20671181
DRD3	1814	Dyskinesia, Drug-Induced	MESH:D004409	marker/mechanism		NA		20945430
DRD3	1814	Gambling	MESH:D005715	marker/mechanism		NA		10523822
DRD3	1814	Hyperalgesia	MESH:D006930	marker/mechanism		NA		20433900
DRD3	1814	Hyperkinesis	MESH:D006948	therapeutic		NA		16026479
DRD3	1814	Movement Disorders	MESH:D009069	therapeutic		NA		12535962
DRD3	1814	Schizophrenia	MESH:D012559	marker/mechanism		NA	181500	10523822
DRD3	1814	Seizures	MESH:D012640	therapeutic		NA		18566292
DRD3	1814	Tourette Syndrome	MESH:D005879	marker/mechanism		NA		10523822
DRD3	1814	Tremor hereditary essential, 1	MESH:C536545	marker/mechanism		NA	190300	
DRD4	1815	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		15274053
DRD4	1815	Anxiety, Separation	MESH:D001010	marker/mechanism		NA		20731709
DRD4	1815	Attention Deficit and Disruptive Behavior Disorders	MESH:D019958	marker/mechanism		NA		20731709
DRD4	1815	Attention Deficit Disorder with Hyperactivity	MESH:D001289	marker/mechanism		NA	143465	14699430|14699433|17671965|29054088
DRD4	1815	Child Development Disorders, Pervasive	MESH:D002659	marker/mechanism		NA		20731709
DRD4	1815	Schizophrenia	MESH:D012559	marker/mechanism		NA		18583979
DRD4	1815	Tic Disorders	MESH:D013981	marker/mechanism		NA		20731709
DRD5	1816	Attention Deficit Disorder with Hyperactivity	MESH:D001289	marker/mechanism		NA	143465	14699430|14732906
DRD5	1816	Benign essential blepharospasm	MESH:C535428	marker/mechanism		NA	606798	
DRD5	1816	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		14708030
DRD5	1816	Blepharospasm	MESH:D001764	marker/mechanism		NA		11781417
DRD5	1816	Depressive Disorder	MESH:D003866	marker/mechanism		NA		14708030
DRD5	1816	Psychotic Disorders	MESH:D011618	marker/mechanism		NA		14708030
DRD5	1816	Torticollis	MESH:D014103	marker/mechanism		NA		11459908
DROSHA	29102	Infertility, Male	MESH:D007248	marker/mechanism		NA		22381205
DROSHA	29102	Wilms Tumor	MESH:D009396	marker/mechanism		NA		28825729
DSC1	1823	Melanoma	MESH:D008545	marker/mechanism		NA		22197931
DSC2	1824	Arrhythmogenic Right Ventricular Dysplasia, Familial, 11	MESH:C566471	marker/mechanism		NA	610476	
DSC2	1824	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
DSC3	1825	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16799634
DSC3	1825	Hypotrichosis And Recurrent Skin Vesicles	MESH:C567751	marker/mechanism		NA	613102	
DSCAM	1826	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
DSCAM	1826	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
DSCAM	1826	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
DSE	29940	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2	OMIM:615539	marker/mechanism		NA	615539	
DSG1	1828	Dermatitis	MESH:D003872	marker/mechanism		NA		23974871
DSG1	1828	ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IgE	OMIM:615508	marker/mechanism		NA	615508	
DSG1	1828	Hypersensitivity	MESH:D006967	marker/mechanism		NA		23974871
DSG1	1828	Keratosis palmoplantaris striata 1	MESH:C536162	marker/mechanism		NA	148700	
DSG1	1828	Metabolic Diseases	MESH:D008659	marker/mechanism		NA		23974871
DSG2	1829	Arrhythmogenic Right Ventricular Dysplasia, Familial, 10	MESH:C565707	marker/mechanism		NA	610193	
DSG2	1829	Cardiomyopathy, Dilated, 1BB	MESH:C567877	marker/mechanism		NA	612877	
DSG4	147409	Hypotrichosis, Localized, Autosomal Recessive 1	MESH:C564312	marker/mechanism		NA	607903	
DSP	1832	Arrhythmogenic Right Ventricular Dysplasia, Familial, 8	MESH:C564400	marker/mechanism		NA	607450	
DSP	1832	Cardiomyopathy dilated with Woolly hair and keratoderma	MESH:C535581	marker/mechanism		NA	605676	21193976
DSP	1832	CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR, KERATODERMA, AND TOOTH AGENESIS	OMIM:615821	marker/mechanism		NA	615821	
DSP	1832	Death, Sudden, Cardiac	MESH:D016757	marker/mechanism		NA		20435227
DSP	1832	Epidermolysis bullosa, lethal acantholytic	MESH:C535493	marker/mechanism		NA	609638	
DSP	1832	Idiopathic Pulmonary Fibrosis	MESH:D054990	marker/mechanism		NA		23583980
DSP	1832	Keratosis Palmoplantaris Striata II	MESH:C565102	marker/mechanism		NA	612908	
DSP	1832	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		28166215
DSP	1832	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		28166215
DSP	1832	Skin Fragility-Woolly Hair Syndrome	MESH:C564359	marker/mechanism		NA	607655	
DSPP	1834	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		21103065
DSPP	1834	Deafness, Autosomal Dominant 39, with Dentinogenesis Imperfecta 1	MESH:C565316	marker/mechanism		NA	605594	
DSPP	1834	DENTIN DYSPLASIA, TYPE II	OMIM:125420	marker/mechanism		NA	125420	
DSPP	1834	Dentinogenesis Imperfecta	MESH:D003811	marker/mechanism		NA	125490	
DSPP	1834	Dentinogenesis imperfecta, shields type 3	MESH:C538216	marker/mechanism		NA	125500	
DSPP	1834	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		21103065
DST	667	Epidermolysis Bullosa Simplex, Autosomal Recessive	MESH:C563408	marker/mechanism		NA	615425	
DST	667	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI	OMIM:614653	marker/mechanism		NA	614653	
DSTN	11034	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		29394407
DSTN	11034	Heart Failure	MESH:D006333	marker/mechanism		NA		29394407
DSTN	11034	Ventricular Remodeling	MESH:D020257	marker/mechanism		NA		29394407
DSTYK	25778	Renal Hypodysplasia, Nonsyndromic, 1	MESH:C563661	marker/mechanism		NA	610805	
DSTYK	25778	Spastic paraplegia 23	MESH:C536859	marker/mechanism		NA	270750	
DTL	51514	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
DTL	51514	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
DTL	51514	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
DTNA	1837	LEFT VENTRICULAR NONCOMPACTION 1	OMIM:604169	marker/mechanism		NA	604169	
DTNBP1	84062	Hermanski-Pudlak Syndrome	MESH:D022861	marker/mechanism		NA	614076	
DTNBP1	84062	Mental Disorders	MESH:D001523	marker/mechanism		NA		25298178
DTNBP1	84062	Schizophrenia	MESH:D012559	marker/mechanism		NA		18583979
DTX1	1840	Carcinoma, Pancreatic Ductal	MESH:D021441	marker/mechanism		NA		19208345
DTX1	1840	Oligodendroglioma	MESH:D009837	marker/mechanism		NA		21127729
DTX2	113878	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		21127729
DTX3	196403	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25151356
DTX4	23220	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
DTX4	23220	Carcinoma, Pancreatic Ductal	MESH:D021441	marker/mechanism		NA		19208345
DUBR	344595	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
DUOX2	50506	Congenital Hypothyroidism	MESH:D003409	marker/mechanism		NA		16134168|16322276
DUOX2	50506	Thyroid Dyshormonogenesis 6	MESH:C564608	marker/mechanism		NA	607200	
DUOXA2	405753	Thyroid Dyshormonogenesis 5	MESH:C562771	marker/mechanism		NA	274900	
DUS1L	64118	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
DUSP1	1843	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
DUSP1	1843	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
DUSP1	1843	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
DUSP1	1843	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
DUSP10	11221	Inflammation	MESH:D007249	therapeutic		NA		17151092
DUSP16	80824	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
DUSP2	1844	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
DUSP3	1845	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		15496427
DUSP4	1846	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
DUSP5	1847	Hypertension	MESH:D006973	marker/mechanism		NA		25397684
DUSP6	1848	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
DUSP6	1848	Glioblastoma	MESH:D005909	marker/mechanism		NA		21499306
DUSP6	1848	HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA	OMIM:615269	marker/mechanism		NA	615269	
DUSP6	1848	Idiopathic Hypogonadotropic Hypogonadism	MESH:C562785	marker/mechanism		NA	146110	
DUSP6	1848	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
DUSP6	1848	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
DUSP6	1848	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
DUSP6	1848	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
DUX4	100288687	Muscular Dystrophy, Facioscapulohumeral	MESH:D020391	marker/mechanism		NA		22796148
DUX4	100288687	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D015452	marker/mechanism		NA		27019113
DUX4	100288687	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		27776115
DUX4L5	653545	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
DVL1	1855	Robinow Syndrome	MESH:C562492	marker/mechanism		NA	180700|616331	
DVL3	1857	Robinow Syndrome	MESH:C562492	marker/mechanism		NA	616894	
DYM	54808	Dyggve-Melchior-Clausen syndrome	MESH:C535726	marker/mechanism		NA	223800	
DYM	54808	Smith-McCort Dysplasia	MESH:C564589	marker/mechanism		NA	607326	
DYNC1H1	1778	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O	OMIM:614228	marker/mechanism		NA	614228	
DYNC1H1	1778	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21076407
DYNC1H1	1778	Malformations of Cortical Development	MESH:D054220	marker/mechanism		NA		23603762
DYNC1H1	1778	MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	OMIM:614563	marker/mechanism		NA	614563	
DYNC1H1	1778	Microcephaly	MESH:D008831	marker/mechanism		NA		23603762
DYNC1H1	1778	Spinal Muscular Atrophies of Childhood	MESH:D014897	marker/mechanism		NA	158600	
DYNC1H1	1778	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
DYNC1I1	1780	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		21228734
DYNC1LI2	1783	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
DYNC2H1	79659	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25330770
DYNC2H1	79659	Short Rib-Polydactyly Syndrome	MESH:D012779	marker/mechanism		NA		22499340
DYNC2H1	79659	Short rib-polydactyly syndrome, Verma-Naumoff type	MESH:C537602	marker/mechanism		NA	613091	
DYNC2I1	55112	Short Rib-Polydactyly Syndrome	MESH:D012779	marker/mechanism		NA	615503	
DYNC2I2	89891	Short Rib-Polydactyly Syndrome	MESH:D012779	marker/mechanism		NA	615633	
DYNC2LI1	51626	Short Rib-Polydactyly Syndrome	MESH:D012779	marker/mechanism		NA	617088	
DYNLL1	8655	Brain Ischemia	MESH:D002545	marker/mechanism		NA		9522364
DYNLT2B	255758	Short Rib-Polydactyly Syndrome	MESH:D012779	marker/mechanism		NA	617405	
DYRK1A	1859	Epilepsy	MESH:D004827	marker/mechanism		NA		29942082
DYRK1A	1859	MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	OMIM:614104	marker/mechanism		NA	614104	
DYRK1A	1859	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889|29942082
DYRK1A	1859	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		31838052
DYRK1B	9149	ABDOMINAL OBESITY-METABOLIC SYNDROME 3	OMIM:615812	marker/mechanism		NA	615812	
DYRK1B	9149	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		20857490
DYRK2	8445	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
DYSF	8291	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
DYSF	8291	Limb-girdle muscular dystrophy, type 2B	MESH:C535899	marker/mechanism		NA	253601	15535137
DYSF	8291	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
DYSF	8291	Miyoshi myopathy	MESH:C537480	marker/mechanism		NA	254130	15535137|17868276
DYSF	8291	Myopathy, Distal, with Anterior Tibial Onset	MESH:C564664	marker/mechanism		NA	606768	15535137
DZIP1L	199221	Polycystic Kidney, Autosomal Recessive	MESH:D017044	marker/mechanism		NA		28530676
E2F1	1869	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		14672398
E2F1	1869	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		12029619|15565109|28284560
E2F1	1869	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		29754146
E2F1	1869	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		30515189
E2F1	1869	Clinical Deterioration	MESH:D000075902	marker/mechanism		NA		29464002
E2F1	1869	Melanoma	MESH:D008545	marker/mechanism|therapeutic		NA		15574415|16827129
E2F1	1869	Neoplasms	MESH:D009369	marker/mechanism		NA		29464002
E2F2	1870	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		29754146
E2F2	1870	Disease Progression	MESH:D018450	marker/mechanism		NA		29754146
E2F3	1871	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		29754146
E2F4	1874	Disease Progression	MESH:D018450	marker/mechanism		NA		29754146
E2F5	1875	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		29754146
E2F5	1875	Disease Progression	MESH:D018450	marker/mechanism		NA		29754146
E2F6	1876	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		29754146
E2F7	144455	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		29754146
E2F7	144455	Disease Progression	MESH:D018450	marker/mechanism		NA		29754146
E2F8	79733	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
E2F8	79733	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		29754146
E2F8	79733	Disease Progression	MESH:D018450	marker/mechanism		NA		29754146
E2F8	79733	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		27683099
E4F1	1877	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		30506647
EAF2	55840	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		20564326
EAF2	55840	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		20564326
EAF2	55840	Lymphoma, B-Cell	MESH:D016393	marker/mechanism		NA		20564326
EAF2	55840	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		20564326
EARS2	124454	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12	OMIM:614924	marker/mechanism		NA	614924	
EAS	32585	Paralysis	MESH:D010243	marker/mechanism		NA		14978727
EAS	32585	Seizures	MESH:D012640	marker/mechanism		NA		14978727
EBF1	1879	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		24362818
EBF1	1879	Lymphoma, Follicular	MESH:D008224	marker/mechanism		NA		24362818
EBF1	1879	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
EBF3	253738	HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME	OMIM:617330	marker/mechanism		NA	617330	
EBI3	10148	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
EBP	10682	Chondrodysplasia Punctata	MESH:D002806	marker/mechanism		NA	302960	18176751
EBP	10682	MEND SYNDROME	OMIM:300960	marker/mechanism		NA	300960	
EBVS1	1888	EPSTEIN-BARR VIRUS INSERTION SITE 1	OMIM:132850	marker/mechanism		NA	132850	
ECE1	1889	Autonomic Nervous System Diseases	MESH:D001342	marker/mechanism		NA		9915973
ECE1	1889	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		9449665
ECE1	1889	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		16387788
ECE1	1889	Essential Hypertension	MESH:D000075222	marker/mechanism		NA	145500	
ECE1	1889	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		9449665|9915973
ECE1	1889	Hirschsprung Disease	MESH:D006627	marker/mechanism		NA		9915973
ECE1	1889	Hirschsprung Disease, Cardiac Defects, and Autonomic Dysfunction	MESH:C563939	marker/mechanism		NA	613870	
ECE1	1889	Hypertension	MESH:D006973	marker/mechanism		NA		12566389
ECEL1	9427	ARTHROGRYPOSIS, DISTAL, TYPE 5D	OMIM:615065	marker/mechanism		NA	615065	
ECHDC1	55862	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
ECHDC1	55862	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
ECHS1	1892	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
ECHS1	1892	Leigh Disease	MESH:D007888	marker/mechanism		NA		25125611|26099313
ECHS1	1892	MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY	OMIM:616277	marker/mechanism		NA	616277	
ECHS1	1892	Obesity	MESH:D009765	marker/mechanism		NA		20882379
ECHS1	1892	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		19424620
ECM1	1893	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
ECM1	1893	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
ECM1	1893	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		18438406
ECM1	1893	Lipoid Proteinosis of Urbach and Wiethe	MESH:D008065	marker/mechanism		NA	247100	
ECM1	1893	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		31472228
ECM2	1842	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
ECT2	1894	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
ECT2	1894	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
EDA	1896	Craniofrontonasal dysplasia	MESH:C536456	marker/mechanism		NA		17941886
EDA	1896	Ectodermal Dysplasia 1, Anhidrotic	MESH:D053358	marker/mechanism		NA	305100	
EDA	1896	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
EDA	1896	Tooth Agenesis, Selective, X-Linked, 1	MESH:C567060	marker/mechanism		NA	313500	
EDAR	10913	Ectodermal Dysplasia 3, Anhidrotic	MESH:D053359	marker/mechanism		NA	129490	
EDAR	10913	Ectodermal Dysplasia, Hypohidrotic, Autosomal Recessive	MESH:D053360	marker/mechanism		NA	224900	
EDARADD	128178	ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT	OMIM:614940	marker/mechanism		NA	614940	
EDARADD	128178	Ectodermal Dysplasia 3, Anhidrotic	MESH:D053359	marker/mechanism		NA	129490	
EDARADD	128178	Ectodermal Dysplasia, Hypohidrotic, Autosomal Recessive	MESH:D053360	marker/mechanism		NA	224900|614941	
EDC3	80153	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50	OMIM:616460	marker/mechanism		NA	616460	
EDEM1	9695	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
EDEM2	55741	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
EDIL3	10085	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
EDN1	1906	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		9788586
EDN1	1906	Acute Lung Injury	MESH:D055371	marker/mechanism		NA		16625121
EDN1	1906	Arrhythmias, Cardiac	MESH:D001145	marker/mechanism		NA		12011762|15838369
EDN1	1906	Asthma	MESH:D001249	marker/mechanism		NA		16981460
EDN1	1906	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		16762801
EDN1	1906	Auriculo-condylar syndrome	MESH:C538270	marker/mechanism		NA	612798|615706	
EDN1	1906	Bradycardia	MESH:D001919	therapeutic		NA		1309933|8440307
EDN1	1906	Cardiomegaly	MESH:D006332	marker/mechanism		NA		22198280
EDN1	1906	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		11589785
EDN1	1906	Cardiovascular Abnormalities	MESH:D018376	marker/mechanism		NA		20707411
EDN1	1906	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		16332659
EDN1	1906	Cartilage Diseases	MESH:D002357	marker/mechanism		NA		20707411
EDN1	1906	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		25194819
EDN1	1906	Cerebrovascular Disorders	MESH:D002561	marker/mechanism		NA		17578707
EDN1	1906	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		10100047|20707411|8152482|9671575
EDN1	1906	Depressive Disorder, Major	MESH:D003865	marker/mechanism		NA		29175309
EDN1	1906	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		12458661|12967931
EDN1	1906	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		16387788
EDN1	1906	Erectile Dysfunction	MESH:D007172	marker/mechanism		NA		12002441
EDN1	1906	Gastrointestinal Diseases	MESH:D005767	marker/mechanism		NA		16324314
EDN1	1906	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA		16191423
EDN1	1906	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		9671575
EDN1	1906	Heart Failure	MESH:D006333	marker/mechanism		NA		11136700|11707688|16360360|16762801|7967349|7969316|9861300
EDN1	1906	Hepatorenal Syndrome	MESH:D006530	marker/mechanism		NA		7967349
EDN1	1906	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		10693666|9473106
EDN1	1906	Hyperalgesia	MESH:D006930	marker/mechanism		NA		19429182
EDN1	1906	Hypercholesterolemia	MESH:D006937	marker/mechanism		NA		15486036
EDN1	1906	Hypertension	MESH:D006973	marker/mechanism		NA		10474778|10669576|11847185|12149661|12425201|12600921|15188945|15302986|15314687|15834289|17130675|7721406|8152482|8440307
EDN1	1906	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		12391278|20929026|20967148|7549228|9918753
EDN1	1906	Hypertrophy	MESH:D006984	marker/mechanism		NA		12791704|20177073
EDN1	1906	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		10601118|15486036
EDN1	1906	Hypotension	MESH:D007022	therapeutic		NA		10399635|1309933
EDN1	1906	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		17197033
EDN1	1906	Inflammation	MESH:D007249	marker/mechanism		NA		23451061
EDN1	1906	Kidney Diseases	MESH:D007674	marker/mechanism		NA		10399635|15106802|8604712
EDN1	1906	Lewy Body Disease	MESH:D020961	marker/mechanism		NA		19276553
EDN1	1906	Liver Cirrhosis, Experimental	MESH:D008106	therapeutic		NA		12609069
EDN1	1906	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		10462014|11707688|16306806
EDN1	1906	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		15642760|16700825
EDN1	1906	Nephrosis	MESH:D009401	marker/mechanism		NA		7756592
EDN1	1906	Oral Ulcer	MESH:D019226	therapeutic		NA		16391412
EDN1	1906	Pain	MESH:D010146	marker/mechanism		NA		19429182|20042899
EDN1	1906	Parkinson Disease	MESH:D010300	marker/mechanism		NA		19276553
EDN1	1906	Peptic Ulcer	MESH:D010437	therapeutic		NA		16384872
EDN1	1906	Pre-Eclampsia	MESH:D011225	marker/mechanism		NA		25230003
EDN1	1906	Premature Birth	MESH:D047928	marker/mechanism		NA		25230003
EDN1	1906	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		17235729
EDN1	1906	Renal Insufficiency	MESH:D051437	marker/mechanism		NA		7967349
EDN1	1906	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		17470888
EDN1	1906	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		16625121
EDN1	1906	Stroke	MESH:D020521	marker/mechanism		NA		20083630
EDN1	1906	Subarachnoid Hemorrhage	MESH:D013345	marker/mechanism		NA		8587695
EDN1	1906	Ureteral Obstruction	MESH:D014517	marker/mechanism		NA		26207612
EDN1	1906	Urinary Bladder, Overactive	MESH:D053201	marker/mechanism		NA		15371886
EDN1	1906	Urinary Retention	MESH:D016055	marker/mechanism		NA		15371886
EDN2	1907	Bradycardia	MESH:D001919	therapeutic		NA		1309933
EDN2	1907	Hypotension	MESH:D007022	therapeutic		NA		1309933
EDN3	1908	Bradycardia	MESH:D001919	therapeutic		NA		1309933
EDN3	1908	Congenital central hypoventilation syndrome	MESH:C536209	marker/mechanism		NA	209880	8696331
EDN3	1908	Hirschsprung Disease	MESH:D006627	marker/mechanism		NA	613712	8630502|8630503|8896568|9359047
EDN3	1908	Hypertension	MESH:D006973	marker/mechanism		NA		2059916
EDN3	1908	Hypotension	MESH:D007022	marker/mechanism|therapeutic		NA		1309933|7982458
EDN3	1908	Waardenburg syndrome, type 4	MESH:C536467	marker/mechanism		NA		17516928|8630502|8630503
EDN3	1908	Waardenburg Syndrome, Type 4b	MESH:C567680	marker/mechanism		NA	613265	
EDNRA	1909	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		17294360|9811577
EDNRA	1909	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		16387788
EDNRA	1909	Disease Progression	MESH:D018450	marker/mechanism		NA		25194819
EDNRA	1909	Erectile Dysfunction	MESH:D007172	marker/mechanism		NA		18823320
EDNRA	1909	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		9811577
EDNRA	1909	Heart Failure	MESH:D006333	marker/mechanism		NA		28095452
EDNRA	1909	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		10693666|9473106
EDNRA	1909	Hypertension	MESH:D006973	marker/mechanism		NA		12600921
EDNRA	1909	MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA	OMIM:616367	marker/mechanism		NA	616367	
EDNRA	1909	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	OMIM:157300	marker/mechanism		NA	157300	
EDNRA	1909	Nasopharyngeal Neoplasms	MESH:D009303	marker/mechanism		NA		17032313
EDNRA	1909	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		25194819
EDNRA	1909	Sleep Apnea, Obstructive	MESH:D020181	marker/mechanism		NA		20083432
EDNRA	1909	Stroke	MESH:D020521	marker/mechanism		NA		29531354
EDNRB	1910	ABCD syndrome	MESH:C535334	marker/mechanism		NA	600501	
EDNRB	1910	Breast Neoplasms	MESH:D001943	therapeutic		NA		16244791
EDNRB	1910	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		16387788
EDNRB	1910	Heart Failure	MESH:D006333	marker/mechanism		NA		28095452
EDNRB	1910	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		10693666
EDNRB	1910	Hirschsprung Disease	MESH:D006627	marker/mechanism		NA	600155	8896568
EDNRB	1910	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		15927975
EDNRB	1910	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		26213588
EDNRB	1910	Nephrosis	MESH:D009401	marker/mechanism		NA		7756592
EDNRB	1910	Subarachnoid Hemorrhage	MESH:D013345	marker/mechanism		NA		8587695
EDNRB	1910	WAARDENBURG SYNDROME, TYPE 4A	OMIM:277580	marker/mechanism		NA	277580	
EED	8726	Nerve Sheath Neoplasms	MESH:D018317	marker/mechanism		NA		25240281
EED	8726	Neurilemmoma	MESH:D009442	marker/mechanism		NA		25119042
EEF1A1	1915	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
EEF1A1	1915	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
EEF1A1	1915	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
EEF1A1	1915	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		19424620
EEF1A2	1917	Epilepsy	MESH:D004827	marker/mechanism		NA		29942082
EEF1A2	1917	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33	OMIM:616409	marker/mechanism		NA	616409	
EEF1A2	1917	MENTAL RETARDATION, AUTOSOMAL DOMINANT 38	OMIM:616393	marker/mechanism		NA	616393	
EEF1A2	1917	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		29942082
EEF1A2	1917	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
EEF1AKNMT	51603	DEAFNESS, AUTOSOMAL RECESSIVE 26, MODIFIER OF	OMIM:605429	marker/mechanism		NA	605429	
EEF1B2	1933	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20562527
EEF1B2	1933	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
EEF1B2	1933	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17085005|20562527
EEF2	1938	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		21554491
EEF2	1938	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20562527
EEF2	1938	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		15108329
EEF2	1938	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		21554491
EEF2	1938	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		21554491
EEF2	1938	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		20562527
EEF2	1938	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
EEF2	1938	Recurrence	MESH:D012008	marker/mechanism		NA		21554491
EEF2	1938	Spinocerebellar ataxia 26	MESH:C537203	marker/mechanism		NA	609306	
EEFSEC	60678	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		28166215
EFEMP1	2202	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		17671114
EFEMP1	2202	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19115204
EFEMP1	2202	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
EFEMP1	2202	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17892325
EFEMP1	2202	Doyne honeycomb retinal dystrophy	MESH:C535602	marker/mechanism		NA	126600	
EFEMP1	2202	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17671114
EFEMP1	2202	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
EFEMP1	2202	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
EFEMP1	2202	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		27032653
EFEMP1	2202	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		19208748
EFEMP2	30008	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	OMIM:614437	marker/mechanism		NA	614437	
EFEMP2	30008	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17929269
EFHC1	114327	Epilepsy, Absence	MESH:D004832	marker/mechanism		NA	607631	
EFHC1	114327	Myoclonic Epilepsy, Juvenile	MESH:D020190	marker/mechanism		NA	254770	
EFHD1	80303	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
EFHD1	80303	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
EFHD2	79180	Binge Drinking	MESH:D063425	marker/mechanism		NA		28397836
EFL1	79631	Glioma	MESH:D005910	marker/mechanism		NA		25015090
EFNA1	1942	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20154726
EFNA5	1946	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		16526316
EFNB1	1947	Craniofrontonasal dysplasia	MESH:C536456	marker/mechanism		NA	304110	15124102|15166289|16639408|16685650|17941886|18043713
EFNB1	1947	Craniosynostoses	MESH:D003398	marker/mechanism		NA		15166289
EFNB1	1947	Frontonasal dysplasia	MESH:C538065	marker/mechanism		NA		15166289
EFNB1	1947	Hypertelorism	MESH:D006972	marker/mechanism		NA		15166289
EFNB1	1947	Inflammation	MESH:D007249	marker/mechanism		NA		24098442
EFNB1	1947	Obesity	MESH:D009765	marker/mechanism		NA		24098442
EFNB2	1948	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
EFNB2	1948	Lung agenesis	MESH:C562992	therapeutic		NA		30106123
EFNB2	1948	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
EFNB2	1948	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		19233941
EFNB2	1948	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		16526316
EFTUD2	9343	MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE	OMIM:610536	marker/mechanism		NA	610536	
EGF	1950	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		23064031
EGF	1950	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
EGF	1950	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17626784
EGF	1950	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16175315|21942447|23064031
EGF	1950	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		9029167
EGF	1950	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		12687016|18245498|18995957
EGF	1950	Cleft Palate	MESH:D002972	marker/mechanism		NA		11399798
EGF	1950	Dermatitis	MESH:D003872	marker/mechanism		NA		27206134
EGF	1950	Disease Progression	MESH:D018450	marker/mechanism		NA		21794976
EGF	1950	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		14514962
EGF	1950	Glioblastoma	MESH:D005909	marker/mechanism		NA		16598420
EGF	1950	Hypomagnesemia 4, Renal	MESH:C567127	marker/mechanism		NA	611718	
EGF	1950	Kidney Diseases	MESH:D007674	marker/mechanism		NA		21865292
EGF	1950	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
EGF	1950	Metaplasia	MESH:D008679	marker/mechanism		NA		26390243
EGF	1950	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		15802018|22869556|23064031|24587105|27634460
EGF	1950	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		21942447|23064031
EGF	1950	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		26390243
EGF	1950	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16340751
EGF	1950	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		17266442
EGF	1950	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		16526316
EGF	1950	Stomach Ulcer	MESH:D013276	therapeutic		NA		9324159|9479624
EGF	1950	Wounds and Injuries	MESH:D014947	therapeutic		NA		21967610
EGFR	1956	Acute Kidney Injury	MESH:D058186	therapeutic		NA		14638913
EGFR	1956	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		20934974|21541241|22042947|2523869|27720938
EGFR	1956	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		22071784|22135231
EGFR	1956	Adenomatous Polyposis Coli	MESH:D011125	marker/mechanism		NA		25200834
EGFR	1956	Adrenocortical Carcinoma	MESH:D018268	marker/mechanism		NA		23585556
EGFR	1956	Arthritis, Experimental	MESH:D001169	therapeutic		NA		7589090
EGFR	1956	Bile Duct Neoplasms	MESH:D001650	therapeutic		NA		17341899
EGFR	1956	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16950593|18768436|19075277|20135347|20941507|23867902
EGFR	1956	Carcinoma	MESH:D002277	marker/mechanism		NA		15302576
EGFR	1956	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		9029167
EGFR	1956	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		21336183|21440325|21478906|21777763|21782507|21791641|21904575|21933749|22286583|22617245|22751098|22787409|22787412|22948846|23435014|24467950
EGFR	1956	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		12942316|22042947|22948846
EGFR	1956	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		18599591
EGFR	1956	Chloracne	MESH:D054506	marker/mechanism		NA		21237254
EGFR	1956	Cholangiocarcinoma	MESH:D018281	therapeutic		NA		17341899
EGFR	1956	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		14569062|25200834
EGFR	1956	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17575224|18998757
EGFR	1956	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		10319864
EGFR	1956	Dermatitis	MESH:D003872	marker/mechanism		NA		27206134
EGFR	1956	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		22238402
EGFR	1956	Disease Progression	MESH:D018450	marker/mechanism		NA		20859196
EGFR	1956	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
EGFR	1956	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		21298351|21468131|22042947
EGFR	1956	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21947696
EGFR	1956	Gallbladder Neoplasms	MESH:D005706	marker/mechanism		NA		24997986
EGFR	1956	Glioblastoma	MESH:D005909	marker/mechanism		NA		19204207|23917401|26455392
EGFR	1956	Head and Neck Neoplasms	MESH:D006258	marker/mechanism		NA		12942316|15342401|23917044
EGFR	1956	INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2	OMIM:616069	marker/mechanism		NA	616069	
EGFR	1956	Insulin Resistance	MESH:D007333	marker/mechanism		NA		22238402
EGFR	1956	Leiomyoma	MESH:D007889	marker/mechanism		NA		31468104
EGFR	1956	Lung Neoplasms	MESH:D008175	marker/mechanism		NA	211980	18927287|19336973|20934974|21541241|23523951|27935865|29106415
EGFR	1956	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		8603490
EGFR	1956	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		2523869|8603490
EGFR	1956	Mesothelioma	MESH:D008654	marker/mechanism		NA		21787763
EGFR	1956	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		27032653
EGFR	1956	Nasopharyngeal Neoplasms	MESH:D009303	marker/mechanism		NA		21786012
EGFR	1956	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		18844224|23867902
EGFR	1956	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17369752|17575224|23867902
EGFR	1956	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		21786012|22277784
EGFR	1956	Osteosarcoma	MESH:D012516	marker/mechanism		NA		22235915
EGFR	1956	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		16211241|21909139
EGFR	1956	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		27720938
EGFR	1956	Papilloma	MESH:D010212	marker/mechanism		NA		8603490
EGFR	1956	Polycystic Kidney, Autosomal Recessive	MESH:D017044	marker/mechanism		NA		9486961
EGFR	1956	Prostatic Neoplasms	MESH:D011471	marker/mechanism|therapeutic		NA		15302576|17136230|17914592
EGFR	1956	Rectal Neoplasms	MESH:D012004	marker/mechanism		NA		16839708
EGFR	1956	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		20837450
EGFR	1956	Stomach Neoplasms	MESH:D013274	marker/mechanism|therapeutic		NA		15723263|21173787|22042947
EGFR	1956	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		11723127|23523951
EGFR	1956	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		18703609|20859196|21329967
EGLN1	54583	Erythrocytosis, Familial, 3	MESH:C565221	marker/mechanism		NA	609820	
EGLN1	54583	Neurotoxicity Syndromes	MESH:D020258	marker/mechanism		NA		29471019
EGLN2	112398	TOBACCO ADDICTION, SUSCEPTIBILITY TO	OMIM:188890	marker/mechanism		NA		20418890
EGLN3	112399	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		28108177
EGR1	1958	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
EGR1	1958	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		25055964
EGR1	1958	Brain Ischemia	MESH:D002545	marker/mechanism		NA		17394460
EGR1	1958	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
EGR1	1958	Cholangitis	MESH:D002761	marker/mechanism		NA		25055964
EGR1	1958	Cholestasis	MESH:D002779	marker/mechanism		NA		21224055
EGR1	1958	Cholestasis, Intrahepatic	MESH:D002780	marker/mechanism		NA		18364083|22094456
EGR1	1958	Cocaine-Related Disorders	MESH:D019970	marker/mechanism|therapeutic		NA		16157275|16738229|18311559
EGR1	1958	Hydronephrosis	MESH:D006869	marker/mechanism		NA		25015655
EGR1	1958	Hypoxia	MESH:D000860	marker/mechanism		NA		12468449
EGR1	1958	Inflammation	MESH:D007249	marker/mechanism		NA		22094456
EGR1	1958	Ischemia	MESH:D007511	marker/mechanism		NA		12468449
EGR1	1958	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
EGR1	1958	Mesothelioma	MESH:D008654	marker/mechanism		NA		15878867
EGR1	1958	Pneumonia	MESH:D011014	therapeutic		NA		29787794
EGR1	1958	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16552752
EGR1	1958	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		12468449
EGR2	1959	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19000991
EGR2	1959	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
EGR2	1959	Charcot-Marie-Tooth disease, Type 1D	MESH:C537985	marker/mechanism		NA	607678	
EGR2	1959	Charcot-Marie-Tooth disease, Type 4E	MESH:C535301	marker/mechanism		NA	605253	
EGR2	1959	Hereditary Sensory and Motor Neuropathy	MESH:D015417	marker/mechanism		NA	145900	
EGR2	1959	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
EGR2	1959	Rett Syndrome	MESH:D015518	marker/mechanism		NA		19000991
EGR2	1959	Sarcoma, Ewing	MESH:D012512	marker/mechanism		NA		26214589
EGR3	1960	Ataxia	MESH:D001259	marker/mechanism		NA		16091474
EHBP1	23301	Prostate Cancer, Hereditary, 12	MESH:C567510	marker/mechanism		NA	611868	
EHBP1	23301	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		23593118
EHD3	30845	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
EHD3	30845	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
EHF	26298	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
EHHADH	1962	Fanconi Syndrome	MESH:D005198	marker/mechanism		NA	615605	
EHHADH	1962	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
EHHADH	1962	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
EHMT1	79813	Kleefstra Syndrome	MESH:C563043	marker/mechanism		NA	610253	
EHMT1	79813	Medulloblastoma	MESH:D008527	marker/mechanism		NA		19270706
EHMT2	10919	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		25115793
EHMT2	10919	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		29391238
EHMT2	10919	Chromosome Breakage	MESH:D019457	marker/mechanism		NA		29391238
EHMT2	10919	Cocaine-Related Disorders	MESH:D019970	therapeutic		NA		20056891
EHMT2	10919	Infertility	MESH:D007246	marker/mechanism		NA		25975992
EHMT2	10919	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		24532712
EHMT2	10919	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		20940408
EHMT2	10919	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		20940408|25115793
EHMT2	10919	Vesicular Stomatitis	MESH:D054243	therapeutic		NA		26418342
EI24	9538	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
EID1	23741	Mesothelioma	MESH:D008654	marker/mechanism		NA		15920167
EIF1AD	84285	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
EIF1AX	1964	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17085005
EIF1AX	1964	Uveal melanoma	MESH:C536494	marker/mechanism		NA		23793026
EIF2A	83939	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		19041636
EIF2A	83939	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		19041636
EIF2AK1	27102	Anemia, Hemolytic	MESH:D000743	marker/mechanism		NA		25411909
EIF2AK1	27102	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25411909
EIF2AK1	27102	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		29289645
EIF2AK1	27102	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
EIF2AK1	27102	Splenomegaly	MESH:D013163	marker/mechanism		NA		25411909
EIF2AK2	5610	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
EIF2AK2	5610	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
EIF2AK2	5610	Status Epilepticus	MESH:D013226	marker/mechanism		NA		16492139
EIF2AK3	9451	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		19041636
EIF2AK3	9451	Status Epilepticus	MESH:D013226	marker/mechanism		NA		16492139
EIF2AK3	9451	Supranuclear Palsy, Progressive	MESH:D013494	marker/mechanism		NA		21685912
EIF2AK3	9451	Wolcott-Rallison syndrome	MESH:C536739	marker/mechanism		NA	226980	
EIF2AK4	440275	Amino Acid Metabolism, Inborn Errors	MESH:D000592	marker/mechanism		NA		21239484
EIF2AK4	440275	Hair Diseases	MESH:D006201	marker/mechanism		NA		21239484
EIF2AK4	440275	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		24292273
EIF2AK4	440275	Immune System Diseases	MESH:D007154	marker/mechanism		NA		21239484
EIF2AK4	440275	Muscular Diseases	MESH:D009135	marker/mechanism		NA		21239484
EIF2AK4	440275	Pulmonary Veno-Occlusive Disease	MESH:D011668	marker/mechanism		NA	234810	24292273
EIF2B1	1967	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
EIF2B1	1967	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
EIF2B1	1967	Vanishing White Matter Leukodystrophy with Ovarian Failure	MESH:C565836	marker/mechanism		NA	603896	
EIF2B2	8892	Vanishing White Matter Leukodystrophy with Ovarian Failure	MESH:C565836	marker/mechanism		NA	603896	12707859
EIF2B3	8891	Vanishing White Matter Leukodystrophy with Ovarian Failure	MESH:C565836	marker/mechanism		NA	603896	
EIF2B4	8890	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		24366584
EIF2B4	8890	Vanishing White Matter Leukodystrophy with Ovarian Failure	MESH:C565836	marker/mechanism		NA	603896	12707859
EIF2B5	8893	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		24366584
EIF2B5	8893	Vanishing White Matter Leukodystrophy with Ovarian Failure	MESH:C565836	marker/mechanism		NA	603896	12707859
EIF2S1	1965	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		17406652
EIF2S1	1965	Cognition Disorders	MESH:D003072	marker/mechanism		NA		17406652
EIF2S1	1965	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		16492139
EIF2S1	1965	Osteosarcoma	MESH:D012516	marker/mechanism		NA		14767549
EIF2S1	1965	Status Epilepticus	MESH:D013226	marker/mechanism		NA		15003282
EIF2S2	8894	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25151356
EIF2S3	1968	MEHMO syndrome	MESH:C537451	marker/mechanism		NA	300148	
EIF3A	8661	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
EIF3B	8662	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
EIF3E	3646	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
EIF3E	3646	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
EIF3EA	325102	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		17895999
EIF3H	8667	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		14578863
EIF3H	8667	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18372905
EIF3H	8667	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		14997205
EIF3I	8668	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		11830523|24056964
EIF3I	8668	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		24056964
EIF4A1	1973	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
EIF4A2	1974	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17085005
EIF4A3	9775	Richieri Costa Pereira syndrome	MESH:C535677	marker/mechanism		NA	268305	
EIF4E	1977	Autistic Disorder	MESH:D001321	marker/mechanism		NA	615091	
EIF4E	1977	Lymphoma, Mantle-Cell	MESH:D020522	marker/mechanism		NA		17148679
EIF4E	1977	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		20388789
EIF4E3	317649	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
EIF4EBP1	1978	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
EIF4EBP1	1978	Inflammation	MESH:D007249	marker/mechanism		NA		26297436
EIF4EBP1	1978	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		21813464
EIF4EBP1	1978	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		19458359
EIF4EBP1	1978	Lymphoma, Mantle-Cell	MESH:D020522	marker/mechanism		NA		17148679
EIF4EBP1	1978	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		26297436
EIF4EBP2	1979	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
EIF4G1	1981	Autistic Disorder	MESH:D001321	marker/mechanism		NA		20957522
EIF4G1	1981	PARKINSON DISEASE 18, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO	OMIM:614251	marker/mechanism		NA	614251	
EIF5	1983	Schizophrenia	MESH:D012559	marker/mechanism		NA		21743468
EIF5A	1984	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
EIF5A	1984	Keloid	MESH:D007627	marker/mechanism		NA		20128793
EIF5A	1984	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
EIF5A	1984	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
EIF6	3692	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25151356
EIF6	3692	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
EIPR1	7260	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
ELAC2	60528	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	OMIM:615440	marker/mechanism		NA	615440	
ELAC2	60528	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16114055
ELANE	1991	Cyclic neutropenia	MESH:C536227	marker/mechanism		NA	162800	
ELANE	1991	Neutropenia	MESH:D009503	marker/mechanism		NA		17436313
ELANE	1991	Neutropenia, Severe Congenital, Autosomal Dominant 1	MESH:C565969	marker/mechanism		NA	202700	
ELAVL1	1994	Endometriosis	MESH:D004715	marker/mechanism		NA		20889954
ELAVL2	1993	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941189
ELAVL3	1995	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
ELF2	1998	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
ELF3	1999	Biliary Tract Neoplasms	MESH:D001661	marker/mechanism		NA		26258846
ELF3	1999	Lung Injury	MESH:D055370	therapeutic		NA		21709667
ELK3	2004	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16583263
ELK3	2004	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
ELMO1	9844	Adenocarcinoma Of Esophagus	MESH:C562730	marker/mechanism		NA		23525077
ELMO1	9844	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		17942768
ELMO1	9844	Stevens-Johnson Syndrome	MESH:D013262	marker/mechanism		NA		25811541
ELMO2	63916	Vascular Malformation, Primary Intraosseous	MESH:C564648	marker/mechanism		NA	606893	
ELMOD3	84173	DEAFNESS, AUTOSOMAL RECESSIVE 88	OMIM:615429	marker/mechanism		NA	615429	
ELN	2006	Aortic Stenosis, Supravalvular	MESH:D021921	marker/mechanism		NA	185500	20007321|8096434
ELN	2006	Cutis Laxa	MESH:D003483	marker/mechanism		NA		12189163
ELN	2006	Cutis Laxa, Autosomal Dominant	MESH:C562627	marker/mechanism		NA	123700	
ELN	2006	Diverticular Diseases	MESH:D000076385	marker/mechanism		NA		30177863
ELN	2006	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		10359170
ELN	2006	Hypertension	MESH:D006973	marker/mechanism		NA		17039479
ELN	2006	Muscular Dystrophy, Facioscapulohumeral	MESH:D020391	marker/mechanism		NA		12868502
ELN	2006	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
ELN	2006	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		25106431
ELN	2006	Pulmonary Emphysema	MESH:D011656	marker/mechanism		NA		25106431
ELN	2006	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		10761639|26817844
ELN	2006	Williams Syndrome	MESH:D018980	marker/mechanism		NA	194050	
ELOC	6921	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		23797736
ELOVL2	54898	Infertility, Male	MESH:D007248	marker/mechanism		NA		21106902
ELOVL4	6785	Stargardt disease 3	MESH:C535805	marker/mechanism		NA	600110	
ELOVL5	60481	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ELOVL5	60481	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA	615957	
ELOVL6	79071	Heart Failure	MESH:D006333	marker/mechanism		NA		26670611
ELP1	8518	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		27811057
ELP1	8518	Dysautonomia, Familial	MESH:D004402	marker/mechanism		NA	223900	
ELP1	8518	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		27811057
ELP2	55250	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
ELP2	55250	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58	OMIM:617270	marker/mechanism		NA	617270	
ELP3	55140	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		27811057
ELP3	55140	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27811057
ELP3	55140	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		27811057
ELP3	55140	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		27811057
ELP4	26610	Aniridia	MESH:D015783	marker/mechanism		NA	617141	
ELP4	26610	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
EMB	133418	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17374397
EMB	133418	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
EMC1	23065	CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION	OMIM:616875	marker/mechanism		NA	616875	
EMD	2010	Muscular Dystrophy, Emery-Dreifuss	MESH:D020389	marker/mechanism		NA	310300	
EMG1	10436	Bowen-Conradi syndrome	MESH:C537081	marker/mechanism		NA	211180	
EMG1	10436	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
EML1	2009	Band Heterotopia of Brain	MESH:C563950	marker/mechanism		NA	600348	
EML4	27436	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		22980554|22999080
EML4	27436	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		22986231
EML4	27436	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		17625570|21757253|21767331|22568572|22617245|22986231
EML4	27436	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		22986231|22999080
EMP1	2012	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
EMP1	2012	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
EMP1	2012	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
EMP2	2013	NEPHROTIC SYNDROME, TYPE 10	OMIM:615861	marker/mechanism		NA	615861	
EMP3	2014	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		15583422
EMSY	56946	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19636701
EMSY	56946	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		23042114
EMSY	56946	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
EMSY	56946	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
EMX2	2018	Familial schizencephaly	MESH:C538514	marker/mechanism		NA	269160	
EMX2	2018	Female Urogenital Diseases	MESH:D052776	marker/mechanism		NA		16002989
EMX2	2018	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		20697358
EN1	2019	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
EN1	2019	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		26213588
EN1	2019	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		21892157
EN1	2019	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
EN2	2020	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		25290267
EN2	2020	Autistic Disorder	MESH:D001321	marker/mechanism		NA		15024396|16935268|19186208|20523082
EN2	2020	Taste Disorders	MESH:D013651	marker/mechanism		NA		29953887
ENAH	55740	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		26237430
ENAM	10117	Amelogenesis Imperfecta	MESH:D000567	marker/mechanism		NA		15649948|17652207
ENAM	10117	Amelogenesis Imperfecta, Type IB	MESH:C562879	marker/mechanism		NA	104500	
ENAM	10117	Amelogenesis Imperfecta, Type Ic	MESH:C567147	marker/mechanism		NA	204650	
ENC1	8507	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ENG	2022	Cystic Fibrosis	MESH:D003550	marker/mechanism		NA		30806029
ENG	2022	Telangiectasia, Hereditary Hemorrhagic	MESH:D013683	marker/mechanism		NA	187300	15115879|20135064
ENO1	2023	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		21751358
ENO1	2023	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		15378696
ENO1	2023	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		19381893|27602772
ENO1	2023	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		19374891
ENO1	2023	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		19898480
ENO1	2023	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19655245
ENO1	2023	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
ENO1	2023	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
ENO1	2023	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		17094902
ENO1	2023	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		15274141
ENO1	2023	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		16099942|25231249
ENO1	2023	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
ENO1	2023	Enterocolitis, Necrotizing	MESH:D020345	marker/mechanism		NA		18806098
ENO1	2023	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		15986332
ENO1	2023	Infertility, Male	MESH:D007248	marker/mechanism		NA		27460355
ENO1	2023	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
ENO1	2023	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
ENO1	2023	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		15274141
ENO1	2023	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		15654357
ENO1	2023	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
ENO1	2023	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
ENO1	2023	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		15378696
ENO2	2026	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		21595568
ENO2	2026	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22613180
ENO2	2026	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
ENO2	2026	Lewy Body Disease	MESH:D020961	marker/mechanism		NA		30236862
ENO2	2026	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		2910524
ENO2	2026	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		22613180
ENO2	2026	Parkinson Disease	MESH:D010300	marker/mechanism		NA		30236862
ENO2	2026	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		22613180
ENO3	2027	Glycogen Storage Disease XIII	MESH:C567861	marker/mechanism		NA	612932	
ENO3	2027	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
ENO4	387712	Infertility, Male	MESH:D007248	marker/mechanism		NA		23446454
ENOX2	10495	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		26807072
ENOX2	10495	Neoplasms	MESH:D009369	marker/mechanism		NA		20518072
ENPEP	2028	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ENPP1	5167	Arterial calcification of infancy	MESH:C537440	marker/mechanism		NA	208000	
ENPP1	5167	COLE DISEASE	OMIM:615522	marker/mechanism		NA	615522	
ENPP1	5167	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA	125853	
ENPP1	5167	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
ENPP1	5167	Hypophosphatemic Rickets, Autosomal Recessive, 2	MESH:C567647	marker/mechanism		NA	613312	
ENPP1	5167	Obesity	MESH:D009765	marker/mechanism		NA	601665	
ENPP2	5168	Birth Weight	MESH:D001724	marker/mechanism		NA		23866971
ENPP2	5168	Hepatitis	MESH:D006505	marker/mechanism		NA		17850827
ENPP2	5168	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
ENPP2	5168	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		26037280
ENPP2	5168	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		26037280
ENPP5	59084	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
ENSA	2029	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
ENTPD1	953	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
ENTPD1	953	SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE	OMIM:615683	marker/mechanism		NA	615683	
ENTPD2	954	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		15651265
ENTPD6	955	Obesity	MESH:D009765	marker/mechanism		NA		29273807
ENTPD6	955	Seminoma	MESH:D018239	marker/mechanism		NA		21519793
EOGT	285203	Adams Oliver syndrome	MESH:C538225	marker/mechanism		NA	615297	
EOMES	8320	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		26415720
EOMES	8320	Autoimmune Diseases of the Nervous System	MESH:D020274	marker/mechanism		NA		27742544
EOMES	8320	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		27539959
EOMES	8320	Gastro-enteropancreatic neuroendocrine tumor	MESH:C535650	marker/mechanism		NA		29915428
EOMES	8320	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		26039340
EP300	2033	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27158780
EP300	2033	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		26229107
EP300	2033	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
EP300	2033	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		27158780
EP300	2033	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		21822268
EP300	2033	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	114500	
EP300	2033	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		26921506
EP300	2033	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		23104009
EP300	2033	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		17965222|25151357
EP300	2033	Lymphoma, T-Cell	MESH:D016399	marker/mechanism		NA		26192917
EP300	2033	Melanoma	MESH:D008545	marker/mechanism		NA		23698071
EP300	2033	Obesity	MESH:D009765	marker/mechanism		NA		26441656
EP300	2033	Rubinstein-Taybi Syndrome	MESH:D012415	marker/mechanism		NA	180849|613684	
EP300	2033	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941188
EP300	2033	Stevens-Johnson Syndrome	MESH:D013262	marker/mechanism		NA		25811541
EP300	2033	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		21822268
EPAS1	2034	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		21131975
EPAS1	2034	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		23333640
EPAS1	2034	Chromosome Aberrations	MESH:D002869	marker/mechanism		NA		23333640
EPAS1	2034	Erythrocytosis, Familial, 4	MESH:C567086	marker/mechanism		NA	611783	
EPB41	2035	Elliptocytosis 1	MESH:C567520	marker/mechanism		NA	611804	
EPB41	2035	Melanoma	MESH:D008545	marker/mechanism		NA		17145863
EPB41L1	2036	MENTAL RETARDATION, AUTOSOMAL DOMINANT 11	OMIM:614257	marker/mechanism		NA	614257	
EPB41L2	2037	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
EPB41L3	23136	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17260099
EPB42	2038	Spherocytosis, Type 5	MESH:C567202	marker/mechanism		NA	612690	
EPC2	26122	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		30718926
EPCAM	4072	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
EPCAM	4072	Colorectal Cancer, Hereditary Nonpolyposis, Type 8	MESH:C567685	marker/mechanism		NA	613244	
EPCAM	4072	Colorectal Neoplasms, Hereditary Nonpolyposis	MESH:D003123	marker/mechanism		NA		25701956
EPCAM	4072	Diarrhea 5, With Tufting Enteropathy, Congenital	MESH:C567703	marker/mechanism		NA	613217	
EPCAM	4072	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
EPCAM	4072	Lynch syndrome I (site-specific colonic cancer)	MESH:C537261	marker/mechanism		NA		19098912
EPCAM	4072	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
EPCAM	4072	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
EPCAM	4072	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		20870202
EPCAM	4072	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		17446842
EPCAM	4072	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
EPDR1	54749	Glaucoma, Angle-Closure	MESH:D015812	marker/mechanism		NA		27064256
EPG5	57724	Absent corpus callosum cataract immunodeficiency	MESH:C535566	marker/mechanism		NA	242840	23222957
EPG5	57724	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		23222957
EPG5	57724	Hypopigmentation	MESH:D017496	marker/mechanism		NA		23222957
EPG5	57724	Immunologic Deficiency Syndromes	MESH:D007153	marker/mechanism		NA		23222957
EPHA1	2041	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		21460840|21460841
EPHA1	2041	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		19277044
EPHA2	1969	CATARACT 6, MULTIPLE TYPES	OMIM:116600	marker/mechanism		NA	116600	
EPHA2	1969	Disease Progression	MESH:D018450	marker/mechanism		NA		21479221
EPHA2	1969	LEOPARD Syndrome	MESH:D044542	marker/mechanism		NA		22845314
EPHA2	1969	Neoplasms	MESH:D009369	marker/mechanism		NA		21479221
EPHA2	1969	Noonan Syndrome	MESH:D009634	marker/mechanism		NA		22845314
EPHA3	2042	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
EPHA7	2045	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		30357299
EPHA7	2045	Hemorrhage	MESH:D006470	marker/mechanism		NA		30357299
EPHA7	2045	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941188
EPHB2	2048	Ependymoma	MESH:D004806	marker/mechanism		NA		26075792
EPHB2	2048	PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY	OMIM:603688	marker/mechanism		NA	603688	
EPHB4	2050	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		23063927
EPHB4	2050	LYMPHATIC MALFORMATION 7	OMIM:617300	marker/mechanism		NA	617300	
EPHX1	2052	Abnormalities, Drug-Induced	MESH:D000014	marker/mechanism		NA		2336087
EPHX1	2052	Acute Lung Injury	MESH:D055371	marker/mechanism		NA		26840748
EPHX1	2052	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		19598248
EPHX1	2052	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
EPHX1	2052	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		7892276
EPHX1	2052	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
EPHX1	2052	Fever	MESH:D005334	therapeutic		NA		31422080
EPHX1	2052	Hypercholanemia, Familial	MESH:C564336	marker/mechanism		NA	607748	12878321
EPHX1	2052	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		29605894
EPHX1	2052	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17114358|17311802
EPHX1	2052	Lymphoma	MESH:D008223	marker/mechanism		NA		11406608
EPHX1	2052	Lymphoma, Non-Hodgkin	MESH:D008228	marker/mechanism		NA		11406608
EPHX1	2052	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
EPHX1	2052	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
EPHX1	2052	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		16697254
EPHX1	2052	Micronuclei, Chromosome-Defective	MESH:D048629	marker/mechanism		NA		22156006
EPHX1	2052	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		16949155
EPHX1	2052	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		29298899
EPHX1	2052	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		21983886
EPHX1	2052	Pre-Eclampsia	MESH:D011225	marker/mechanism		NA		11283205|12173035
EPHX1	2052	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17919073|21716162|24763052
EPHX1	2052	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		9288046
EPHX1	2052	Pulmonary Emphysema	MESH:D011656	marker/mechanism		NA		9288046
EPHX1	2052	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		26295053
EPHX2	2053	Acute Kidney Injury	MESH:D058186	therapeutic		NA		26165641
EPHX2	2053	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		30890645
EPHX2	2053	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	therapeutic		NA		26165641
EPHX2	2053	Heart Failure	MESH:D006333	marker/mechanism		NA		18443590
EPHX2	2053	HYPERCHOLESTEROLEMIA, FAMILIAL, 1	OMIM:143890	marker/mechanism		NA	143890	
EPHX2	2053	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		29298899
EPHX2	2053	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		19834332
EPHX2	2053	Schizophrenia	MESH:D012559	marker/mechanism		NA		30890645
EPHX2	2053	Ventricular Dysfunction, Left	MESH:D018487	marker/mechanism		NA		19834332
EPHX3	79852	Melanoma	MESH:D008545	marker/mechanism		NA		16778180
EPHX3	79852	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
EPM2A	7957	Lafora Disease	MESH:D020192	marker/mechanism		NA	254780	
EPM2A	7957	Myoclonic Epilepsies, Progressive	MESH:D020191	marker/mechanism		NA		25401298
EPN3	55040	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
EPO	2056	Acute Kidney Injury	MESH:D058186	therapeutic		NA		21847101|24561306
EPO	2056	Anemia	MESH:D000740	marker/mechanism|therapeutic		NA		10506726|10713657|11245434|11273875|11454181|11569724|11828949|11981781|12670280|12713065|12820454|12897097|12899718|14568602|14706663|15160343|1516988|15232364|15660393|1574960|16434484|16511603|16637862|16707910|16798232|16949463|16970215|16970600|17058596|17168855|17180133|17288690|17397412|17409018|17559739|18265628|18403296|18611800|18695134|1893952|19015056|19212639|19787831|1982298|20189893|20303990|21860424|2186273|2206997|22174104|23077460|7529132|7602351|7631396|7732690|8202718|8250662|8260696|8418619|8504984|9118049|9616293|9617462|9743294
EPO	2056	Anemia, Hemolytic	MESH:D000743	therapeutic		NA		10733367|16629641|20446436
EPO	2056	beta-Thalassemia	MESH:D017086	therapeutic		NA		16225658
EPO	2056	Brain Injuries	MESH:D001930	therapeutic		NA		20833152
EPO	2056	Calcinosis	MESH:D002114	marker/mechanism		NA		12148126
EPO	2056	Cardiomyopathies	MESH:D009202	therapeutic		NA		16449733|16731534|17924179|17928571
EPO	2056	Central Nervous System Diseases	MESH:D002493	therapeutic		NA		15816862
EPO	2056	Cognition Disorders	MESH:D003072	therapeutic		NA		20833152
EPO	2056	Coronary Artery Disease	MESH:D003324	therapeutic		NA		25245553
EPO	2056	Encephalomyelitis, Autoimmune, Experimental	MESH:D004681	therapeutic		NA		18382691
EPO	2056	Fatigue	MESH:D005221	therapeutic		NA		18695134
EPO	2056	Heart Diseases	MESH:D006331	therapeutic		NA		16707910
EPO	2056	Heart Septal Defects, Ventricular	MESH:D006345	marker/mechanism		NA		19337937
EPO	2056	Hemolytic-Uremic Syndrome	MESH:D006463	therapeutic		NA		12053072
EPO	2056	Hernias, Diaphragmatic, Congenital	MESH:D065630	marker/mechanism		NA		27880037
EPO	2056	Hypertension	MESH:D006973	marker/mechanism		NA		10694834|1516988
EPO	2056	Inflammation	MESH:D007249	therapeutic		NA		21497595
EPO	2056	Kidney Diseases	MESH:D007674	therapeutic		NA		20606417
EPO	2056	Kidney Failure, Chronic	MESH:D007676	therapeutic		NA		16707910
EPO	2056	Melanoma	MESH:D008545	marker/mechanism		NA		15743794
EPO	2056	Micronuclei, Chromosome-Defective	MESH:D048629	marker/mechanism		NA		30944280
EPO	2056	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 2	OMIM:612623	marker/mechanism		NA	612623	
EPO	2056	Myelodysplastic Syndromes	MESH:D009190	therapeutic		NA		12670338|16076383
EPO	2056	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		19337937
EPO	2056	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		16699298
EPO	2056	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		16699298
EPO	2056	Nerve Degeneration	MESH:D009410	therapeutic		NA		17010629|17166730|19497871|30837834
EPO	2056	Neurodegenerative Diseases	MESH:D019636	therapeutic		NA		15816862
EPO	2056	Pancytopenia	MESH:D010198	therapeutic		NA		9051142
EPO	2056	Paraneoplastic Syndromes	MESH:D010257	marker/mechanism		NA		10713657
EPO	2056	Poisoning	MESH:D011041	therapeutic		NA		15727166
EPO	2056	Polyneuropathies	MESH:D011115	therapeutic		NA		17010629
EPO	2056	Pulmonary Embolism	MESH:D011655	marker/mechanism		NA		12670338
EPO	2056	Renal Insufficiency	MESH:D051437	therapeutic		NA		22013135
EPO	2056	Sarcoma, Experimental	MESH:D012513	therapeutic		NA		9743294
EPO	2056	Shock, Cardiogenic	MESH:D012770	marker/mechanism		NA		19337937
EPO	2056	Status Epilepticus	MESH:D013226	therapeutic		NA		16679645|17166730
EPO	2056	Stomach Ulcer	MESH:D013276	therapeutic		NA		20723003
EPO	2056	Tachycardia, Ventricular	MESH:D017180	therapeutic		NA		18156309
EPO	2056	Thrombocytopenia	MESH:D013921	therapeutic		NA		8260696
EPO	2056	Thrombosis	MESH:D013927	marker/mechanism		NA		14979412|25013951
EPO	2056	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		16699298
EPO	2056	Uremia	MESH:D014511	therapeutic		NA		12675867
EPO	2056	Vascular Diseases	MESH:D014652	therapeutic		NA		25013951
EPO	2056	Venous Thrombosis	MESH:D020246	marker/mechanism		NA		12670338|17547733
EPO	2056	Ventricular Fibrillation	MESH:D014693	therapeutic		NA		18156309
EPO	2056	Weight Loss	MESH:D015431	therapeutic		NA		8260696
EPOR	2057	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19706814
EPOR	2057	Melanoma	MESH:D008545	marker/mechanism		NA		21860424
EPOR	2057	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		16699298
EPOR	2057	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		16699298
EPOR	2057	Nerve Degeneration	MESH:D009410	therapeutic		NA		19497871
EPOR	2057	Polycythemia	MESH:D011086	marker/mechanism		NA		16484586
EPOR	2057	Polycythemia, primary familial and congenital	MESH:C536842	marker/mechanism		NA	133100	
EPOR	2057	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		16699298
EPPK1	83481	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
EPS8	2059	DEAFNESS, AUTOSOMAL RECESSIVE 102	OMIM:615974	marker/mechanism		NA	615974	
EPS8	2059	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		19799886
EPS8L3	79574	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
EPS8L3	79574	Hypotrichosis 5	MESH:C567554	marker/mechanism		NA	612841	
EPS8L3	79574	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		19223546
EPX	8288	Presentey Anomaly	MESH:C564893	marker/mechanism		NA	261500	
ERAP1	51752	Behcet Syndrome	MESH:D001528	marker/mechanism		NA		23291587
ERAP1	51752	Hypertension	MESH:D006973	marker/mechanism		NA		13678427
ERAP1	51752	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ERAP1	51752	Psoriasis	MESH:D011565	marker/mechanism		NA		20953187|20953190|23291587|24212883
ERAP1	51752	Spondylitis, Ankylosing	MESH:D013167	marker/mechanism		NA		17952073|20062062|21743469|23291587
ERAP2	64167	Crohn Disease	MESH:D003424	marker/mechanism		NA		21102463
ERBB2	2064	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		21673877|22042947
ERBB2	2064	Breast Neoplasms	MESH:D001943	marker/mechanism|therapeutic		NA		10897039|11222871|11248153|11583189|11970740|12006526|12655533|12839951|15581045|15970926|15994142|16091755|16137437|16234514|16446318|16495393|16596621|16682728|16865596|16950593|16978400|17614302|18086299|18768436|18819904|18840765|19075277|19436038|19617202|19801490|19896266|20197467|20332317|20941507|21501481|21638049|22302033|25221644|25358515|26124351
ERBB2	2064	Carcinogenesis	MESH:D063646	marker/mechanism		NA		25221644
ERBB2	2064	Carcinoma, Basal Cell	MESH:D002280	marker/mechanism		NA		26950094
ERBB2	2064	Carcinoma, Ductal, Breast	MESH:D018270	marker/mechanism		NA		28235801
ERBB2	2064	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		28811376
ERBB2	2064	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		10897039
ERBB2	2064	Cholangiocarcinoma	MESH:D018281	marker/mechanism		NA		16818635
ERBB2	2064	Clinical Deterioration	MESH:D000075902	marker/mechanism		NA		29044505
ERBB2	2064	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		11222871
ERBB2	2064	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		22302033
ERBB2	2064	Disease Progression	MESH:D018450	marker/mechanism		NA		10897039|21638049|21750559
ERBB2	2064	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		22042947
ERBB2	2064	Gallbladder Neoplasms	MESH:D005706	marker/mechanism		NA		24997986
ERBB2	2064	Gastrointestinal Neoplasms	MESH:D005770	marker/mechanism		NA		21673877
ERBB2	2064	Glioma	MESH:D005910	marker/mechanism		NA	137800	
ERBB2	2064	Lung Neoplasms	MESH:D008175	marker/mechanism		NA	211980	12483526
ERBB2	2064	Lymphatic Metastasis	MESH:D008207	marker/mechanism		NA		21532492
ERBB2	2064	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		8603490
ERBB2	2064	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		25221644|8603490
ERBB2	2064	Medulloblastoma	MESH:D008527	marker/mechanism		NA		20168248
ERBB2	2064	Nasopharyngeal Carcinoma	MESH:D000077274	marker/mechanism		NA		24952746
ERBB2	2064	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		16984552
ERBB2	2064	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		16984552
ERBB2	2064	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		14612517
ERBB2	2064	Neoplastic Cells, Circulating	MESH:D009360	marker/mechanism		NA		29044505
ERBB2	2064	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		10897039|19896266
ERBB2	2064	Papilloma	MESH:D010212	marker/mechanism		NA		8603490
ERBB2	2064	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		11222871|16984552|17363613
ERBB2	2064	Recurrence	MESH:D012008	marker/mechanism		NA		20079691|21638049|26124351
ERBB2	2064	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA	613659	15640503|21532492|22042947
ERBB3	2065	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21638049|28114269
ERBB3	2065	Disease Progression	MESH:D018450	marker/mechanism		NA		21638049
ERBB3	2065	Gallbladder Neoplasms	MESH:D005706	marker/mechanism		NA		24997986
ERBB3	2065	Lethal Congenital Contracture Syndrome 2	MESH:C564369	marker/mechanism		NA	607598	
ERBB3	2065	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		12483526
ERBB3	2065	Nasopharyngeal Carcinoma	MESH:D000077274	marker/mechanism		NA		24952746
ERBB3	2065	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		28114269
ERBB3	2065	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17634423
ERBB3	2065	Recurrence	MESH:D012008	marker/mechanism		NA		21638049
ERBB4	2066	AMYOTROPHIC LATERAL SCLEROSIS 19	OMIM:615515	marker/mechanism		NA	615515	
ERBB4	2066	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
ERBB4	2066	Gallbladder Neoplasms	MESH:D005706	marker/mechanism		NA		24997986
ERBB4	2066	Melanoma	MESH:D008545	marker/mechanism		NA		19718025
ERBB4	2066	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		19718025
ERBIN	55914	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
ERCC1	2067	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		21327329
ERCC1	2067	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		12569548
ERCC1	2067	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		21553054|23912706
ERCC1	2067	Cerebrooculofacioskeletal Syndrome 4	MESH:C565184	marker/mechanism		NA	610758	
ERCC1	2067	Chromosome Aberrations	MESH:D002869	marker/mechanism		NA		24036326
ERCC1	2067	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		24036326
ERCC1	2067	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		30453383
ERCC1	2067	Melanoma	MESH:D008545	marker/mechanism		NA		21722328
ERCC1	2067	Nasopharyngeal Carcinoma	MESH:D000077274	marker/mechanism		NA		20605357
ERCC1	2067	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		20801905
ERCC1	2067	Neoplasms	MESH:D009369	marker/mechanism		NA		23203453
ERCC1	2067	Neoplasms, Germ Cell and Embryonal	MESH:D009373	marker/mechanism		NA		19956886
ERCC1	2067	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		20979931
ERCC1	2067	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21133646
ERCC1	2067	Testicular Neoplasms	MESH:D013736	marker/mechanism		NA		19956886
ERCC1	2067	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		20934765
ERCC2	2068	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		17687452
ERCC2	2068	Cerebrooculofacioskeletal Syndrome 2	MESH:C565185	marker/mechanism		NA	610756	
ERCC2	2068	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18267032
ERCC2	2068	Hyperkeratosis, Epidermolytic	MESH:D017488	marker/mechanism		NA		17050553
ERCC2	2068	Occupational Diseases	MESH:D009784	marker/mechanism		NA		16889696
ERCC2	2068	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17695467
ERCC2	2068	Skin Abnormalities	MESH:D012868	marker/mechanism		NA		17470448
ERCC2	2068	Skin Diseases	MESH:D012871	marker/mechanism		NA		17050553
ERCC2	2068	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		17050553
ERCC2	2068	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		17009404
ERCC2	2068	Sunburn	MESH:D013471	marker/mechanism		NA		17470448
ERCC2	2068	TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE	OMIM:601675	marker/mechanism		NA	601675	
ERCC2	2068	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		24121791|27111033
ERCC2	2068	Xeroderma Pigmentosum, Complementation Group D	MESH:C562591	marker/mechanism		NA	278730	
ERCC3	2071	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		12569548
ERCC3	2071	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		20864405
ERCC3	2071	TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	OMIM:616390	marker/mechanism		NA	616390	
ERCC3	2071	Xeroderma Pigmentosum, Complementation Group B	MESH:C562590	marker/mechanism		NA	610651	
ERCC4	2072	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		12569548
ERCC4	2072	FANCONI ANEMIA, COMPLEMENTATION GROUP Q	OMIM:615272	marker/mechanism		NA	615272	
ERCC4	2072	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		24036326
ERCC4	2072	Micronuclei, Chromosome-Defective	MESH:D048629	marker/mechanism		NA		21216194|24036326
ERCC4	2072	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		20372803
ERCC4	2072	Neoplasms, Germ Cell and Embryonal	MESH:D009373	marker/mechanism		NA		19956886
ERCC4	2072	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		20864405
ERCC4	2072	Recurrence	MESH:D012008	marker/mechanism		NA		20062074
ERCC4	2072	Testicular Neoplasms	MESH:D013736	marker/mechanism		NA		19956886
ERCC4	2072	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		20062074
ERCC4	2072	Xeroderma Pigmentosum, Complementation Group F	MESH:C562592	marker/mechanism		NA	278760	
ERCC4	2072	XFE Progeroid Syndrome	MESH:C567043	marker/mechanism		NA	610965	
ERCC5	2073	Cerebrooculofacioskeletal Syndrome 3	MESH:C565035	marker/mechanism		NA	616570	
ERCC5	2073	Xeroderma Pigmentosum, Complementation Group G	MESH:C562593	marker/mechanism		NA	278780	
ERCC6	2074	Aging, Premature	MESH:D019588	marker/mechanism		NA		25440059
ERCC6	2074	Arthrogryposis	MESH:D001176	marker/mechanism		NA		18628313
ERCC6	2074	Cataract	MESH:D002386	marker/mechanism		NA		18628313
ERCC6	2074	Cerebrooculofacioskeletal Syndrome 1	MESH:C562434	marker/mechanism		NA	214150	10739753
ERCC6	2074	Cockayne Syndrome	MESH:D003057	marker/mechanism		NA	133540	10739753|10767341|22466610|22466612|25440059|26972010|9443879
ERCC6	2074	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		18628313
ERCC6	2074	De Sanctis-Cacchione syndrome	MESH:C535992	marker/mechanism		NA	278800	10767341
ERCC6	2074	Growth Disorders	MESH:D006130	marker/mechanism		NA		18628313
ERCC6	2074	Hearing Loss	MESH:D034381	marker/mechanism		NA		25440059
ERCC6	2074	Lung Neoplasms	MESH:D008175	marker/mechanism		NA	211980	17854076
ERCC6	2074	Macular Degeneration	MESH:D008268	marker/mechanism		NA		16754848
ERCC6	2074	MACULAR DEGENERATION, AGE-RELATED, 5	OMIM:613761	marker/mechanism		NA	613761	
ERCC6	2074	Microcephaly	MESH:D008831	marker/mechanism		NA		10739753|18628313
ERCC6	2074	Microphthalmos	MESH:D008850	marker/mechanism		NA		10739753
ERCC6	2074	PREMATURE OVARIAN FAILURE 11	OMIM:616946	marker/mechanism		NA	616946	
ERCC6	2074	Psychomotor Disorders	MESH:D011596	marker/mechanism		NA		18628313
ERCC6	2074	UV-Sensitive Syndrome	MESH:C563466	marker/mechanism		NA	600630	26972010
ERCC6L2	375748	Congenital Bone Marrow Failure Syndromes	MESH:D000080984	marker/mechanism		NA	615715	
ERCC8	1161	Cockayne Syndrome	MESH:D003057	marker/mechanism		NA	216400	22466610|22466612
ERCC8	1161	UV-Sensitive Syndrome	MESH:C563466	marker/mechanism		NA	614621	
EREG	2069	Ovarian Neoplasms	MESH:D010051	therapeutic		NA		15313392
EREG	2069	Protoporphyria, Erythropoietic	MESH:D046351	marker/mechanism		NA		19267999
ERF	2077	Arnold-Chiari Malformation	MESH:D001139	marker/mechanism		NA		23354439
ERF	2077	CHITAYAT SYNDROME	OMIM:617180	marker/mechanism		NA	617180	
ERF	2077	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		23354439
ERF	2077	Craniosynostoses	MESH:D003398	marker/mechanism		NA	600775	23354439
ERF	2077	Language Development Disorders	MESH:D007805	marker/mechanism		NA		23354439
ERF	2077	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
ERG	2078	Leukemia	MESH:D007938	marker/mechanism		NA		19108891
ERG	2078	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		19822134
ERG	2078	Neoplastic Processes	MESH:D009385	marker/mechanism		NA		27783944
ERG	2078	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		27776115
ERG	2078	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17173048|18798265|19396168|25735316|27223260|27783944|28783165
ERGIC1	57222	Arthrogryposis multiplex congenita neurogenic type	MESH:C536614	marker/mechanism		NA	208100	
ERGIC3	51614	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		27588471
ERGIC3	51614	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27588471
ERGIC3	51614	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		27588471
ERGIC3	51614	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		27588471
ERLEC1	27248	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		26881866
ERLEC1	27248	Cholestasis	MESH:D002779	marker/mechanism		NA		26881866
ERLIN1	10613	SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE	OMIM:615681	marker/mechanism		NA	615681	
ERLIN2	11160	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
ERLIN2	11160	Spastic Paraplegia 18, Autosomal Recessive	MESH:C567628	marker/mechanism		NA	611225	
ERMARD	55780	Periventricular Nodular Heterotopia	MESH:D054091	marker/mechanism		NA	615544	
ERN1	2081	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		30538632
ERN1	2081	Epilepsy	MESH:D004827	marker/mechanism		NA		19558813
ERN1	2081	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		30538632
ERP29	10961	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		19381893
ERP29	10961	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
ERP29	10961	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17085005
ERP29	10961	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
ERP44	23071	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
ERRFI1	54206	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		28688920
ERRFI1	54206	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
ERRFI1	54206	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
ES2	109579	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
ESAM	90952	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
ESCO2	157570	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		28321044
ESCO2	157570	Roberts Syndrome	MESH:C535687	marker/mechanism		NA	268300|269000	16380922|18186147|20101700
ESD	2098	Hypoxia	MESH:D000860	marker/mechanism		NA		19579223
ESD	2098	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
ESM1	11082	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
ESM1	11082	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		28108177
ESPL1	9700	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
ESPL1	9700	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		24121792
ESPL1	9700	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
ESPL1	9700	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		24121792
ESPN	83715	Deafness	MESH:D003638	marker/mechanism		NA		15286153|15930085
ESPN	83715	DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH OR WITHOUT VESTIBULAR INVOLVEMENT;DFNB36 DEAFNESS, AUTOSOMAL DOMINANT, WITHOUT VESTIBULAR INVOLVEMENT,	OMIM:609006	marker/mechanism		NA	609006	
ESPN	83715	Vestibular Diseases	MESH:D015837	marker/mechanism		NA		15286153
ESR1	2099	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		15639718|20458558
ESR1	2099	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		17192785
ESR1	2099	Astrocytoma	MESH:D001254	marker/mechanism		NA		24680642
ESR1	2099	Atherosclerosis	MESH:D050197	marker/mechanism		NA		11894143
ESR1	2099	Bone Diseases	MESH:D001847	marker/mechanism		NA		28505433
ESR1	2099	Bone Diseases, Metabolic	MESH:D001851	marker/mechanism		NA		18505767
ESR1	2099	Breast Neoplasms	MESH:D001943	marker/mechanism		NA	114480	17417639|20104649|20458558|20966540|21501481|21541733|22038807|22174584|23001124|24014025|24185510|24185512|25330770|27580430
ESR1	2099	Carcinoma	MESH:D002277	marker/mechanism		NA		15637090|17173897
ESR1	2099	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		19363144|28284560
ESR1	2099	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		24014025|27366082
ESR1	2099	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		20559769|9396482
ESR1	2099	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		20962747
ESR1	2099	Disease Progression	MESH:D018450	marker/mechanism		NA		20104649
ESR1	2099	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		24185510
ESR1	2099	Female Urogenital Diseases	MESH:D052776	marker/mechanism		NA		16002989
ESR1	2099	Feminization	MESH:D005262	marker/mechanism		NA		22275727
ESR1	2099	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		20962747
ESR1	2099	Idiopathic Pulmonary Fibrosis	MESH:D054990	marker/mechanism		NA		30165855
ESR1	2099	Infertility, Female	MESH:D007247	marker/mechanism		NA		23710174
ESR1	2099	Infertility, Male	MESH:D007248	marker/mechanism		NA		20833731|23213263
ESR1	2099	Leiomyoma	MESH:D007889	marker/mechanism		NA		18701604|31468104
ESR1	2099	Leukemia	MESH:D007938	marker/mechanism		NA		18808365
ESR1	2099	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		16712894
ESR1	2099	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		11872642|17077188
ESR1	2099	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		15637090|17173897
ESR1	2099	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		15637090
ESR1	2099	Mesothelioma	MESH:D008654	marker/mechanism		NA		15639718|17659810
ESR1	2099	Migraine Disorders	MESH:D008881	marker/mechanism		NA		15133719
ESR1	2099	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	OMIM:157300	marker/mechanism		NA	157300	
ESR1	2099	Musculoskeletal Pain	MESH:D059352	marker/mechanism		NA		25218601
ESR1	2099	Myocardial Infarction	MESH:D009203	marker/mechanism		NA	608446	14600184
ESR1	2099	Neoplasm Invasiveness	MESH:D009361	marker/mechanism|therapeutic		NA		26990689|27366082
ESR1	2099	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		20104649
ESR1	2099	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		20556506
ESR1	2099	Neuroblastoma	MESH:D009447	marker/mechanism		NA		27366082
ESR1	2099	Obesity	MESH:D009765	marker/mechanism		NA		20667977
ESR1	2099	Oligospermia	MESH:D009845	marker/mechanism		NA		20833731
ESR1	2099	Prostatic Intraepithelial Neoplasia	MESH:D019048	marker/mechanism		NA		16220300
ESR1	2099	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16220300|17176215
ESR1	2099	Psychoses, Substance-Induced	MESH:D011605	marker/mechanism		NA		19386276
ESR1	2099	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		16712894
ESR2	2100	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		17639508
ESR2	2100	Arrhythmias, Cardiac	MESH:D001145	marker/mechanism		NA		22166976
ESR2	2100	Astrocytoma	MESH:D001254	marker/mechanism		NA		24680642
ESR2	2100	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
ESR2	2100	Breast Neoplasms	MESH:D001943	marker/mechanism|therapeutic		NA		17132221|19434490|19548127
ESR2	2100	Carcinoma	MESH:D002277	marker/mechanism		NA		15637090
ESR2	2100	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		16700038
ESR2	2100	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		17133264
ESR2	2100	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		15954165
ESR2	2100	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		20559769
ESR2	2100	Coronary Disease	MESH:D003327	marker/mechanism		NA		17367797
ESR2	2100	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		25437045
ESR2	2100	Endometriosis	MESH:D004715	marker/mechanism		NA		17625110
ESR2	2100	Infertility, Female	MESH:D007247	marker/mechanism		NA		23710174
ESR2	2100	Lithiasis	MESH:D020347	marker/mechanism		NA		21670126
ESR2	2100	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		15637090
ESR2	2100	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		15637090
ESR2	2100	Medulloblastoma	MESH:D008527	therapeutic		NA		21351254
ESR2	2100	Prostatic Intraepithelial Neoplasia	MESH:D019048	marker/mechanism		NA		16220300
ESR2	2100	Prostatic Neoplasms	MESH:D011471	marker/mechanism|therapeutic		NA		15046698|16220300|16921512|17132221|17639508|26443449
ESR2	2100	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		16700038
ESRRA	2101	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20961995
ESRRA	2101	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		23090186
ESRRA	2101	Metabolic Diseases	MESH:D008659	therapeutic		NA		16515477
ESRRA	2101	Osteosarcoma	MESH:D012516	marker/mechanism		NA		24967384
ESRRB	2103	Deafness, Autosomal Recessive 35	MESH:C563908	marker/mechanism		NA	608565	
ESS2	8220	DiGeorge Syndrome	MESH:D004062	marker/mechanism		NA	192430	
ETAA1	54465	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		26098869
ETFA	2108	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
ETFA	2108	Diverticular Diseases	MESH:D000076385	marker/mechanism		NA		30177863
ETFA	2108	Multiple Acyl Coenzyme A Dehydrogenase Deficiency	MESH:D054069	marker/mechanism		NA	231680	
ETFA	2108	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
ETFB	2109	Multiple Acyl Coenzyme A Dehydrogenase Deficiency	MESH:D054069	marker/mechanism		NA	231680	
ETFDH	2110	Metabolic Diseases	MESH:D008659	marker/mechanism		NA		17050691
ETFDH	2110	Multiple Acyl Coenzyme A Dehydrogenase Deficiency	MESH:D054069	marker/mechanism		NA	231680	
ETFDH	2110	Obesity	MESH:D009765	marker/mechanism		NA		20882379
ETHE1	23474	Ethylmalonic encephalopathy	MESH:C535737	marker/mechanism		NA	602473	
ETNK1	55500	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
ETS1	2113	Celiac Disease	MESH:D002446	marker/mechanism		NA		20190752
ETS1	2113	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		30718926
ETS1	2113	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		19838193
ETS1	2113	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		16526316
ETS2	2114	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037
ETS2	2114	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		19764029
ETS2	2114	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		16033404
ETS2	2114	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		19522546
ETV1	2115	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		30224643
ETV1	2115	Neoplastic Processes	MESH:D009385	marker/mechanism		NA		27783944
ETV1	2115	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17173048|17671502|27783944
ETV3	2117	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
ETV4	2118	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21679465
ETV4	2118	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		27869830
ETV4	2118	Neoplastic Processes	MESH:D009385	marker/mechanism		NA		27783944
ETV4	2118	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17173048|27783944
ETV5	2119	Neoplastic Processes	MESH:D009385	marker/mechanism		NA		27783944
ETV5	2119	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		27783944
ETV6	2120	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
ETV6	2120	Hematologic Neoplasms	MESH:D019337	marker/mechanism		NA		25581430
ETV6	2120	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA	601626	
ETV6	2120	Macrocytosis, Familial	MESH:C564004	marker/mechanism		NA		25807284
ETV6	2120	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D015452	marker/mechanism		NA		15217836|24413735|25807284
ETV6	2120	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		17255265
ETV6	2120	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
ETV6	2120	Thrombocytopenia	MESH:D013921	marker/mechanism		NA		25581430|25807284
ETV6	2120	THROMBOCYTOPENIA 5	OMIM:616216	marker/mechanism		NA	616216	
EVC	2121	Ellis-Van Creveld Syndrome	MESH:D004613	marker/mechanism		NA	225500	
EVC	2121	Weyers acrofacial dysostosis	MESH:C536695	marker/mechanism		NA	193530	
EVC2	132884	Ellis-Van Creveld Syndrome	MESH:D004613	marker/mechanism		NA	225500	
EVC2	132884	Weyers acrofacial dysostosis	MESH:C536695	marker/mechanism		NA	193530	
EVL	51466	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18507500
EVL	51466	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18507500|21278247
EWSR1	2130	Neoplastic Processes	MESH:D009385	marker/mechanism		NA		27783944
EWSR1	2130	Neuroectodermal Tumors, Primitive	MESH:D018242	marker/mechanism		NA		12162413
EWSR1	2130	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		27783944
EWSR1	2130	Sarcoma, Ewing	MESH:D012512	marker/mechanism		NA	612219	16646077|26214589|27006472
EXO1	9156	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25751625
EXO1	9156	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
EXO1	9156	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17656264
EXOSC2	23404	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
EXOSC2	23404	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		19233941
EXOSC3	51010	Pontocerebellar Hypoplasia Type 1	MESH:C548069	marker/mechanism		NA		22544365
EXOSC3	51010	PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	OMIM:614678	marker/mechanism		NA	614678	
EXOSC5	56915	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
EXOSC5	56915	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
EXOSC8	11340	PONTOCEREBELLAR HYPOPLASIA, TYPE 1C	OMIM:616081	marker/mechanism		NA	616081	
EXPH5	23086	Epidermolysis Bullosa	MESH:D004820	marker/mechanism		NA	615028	
EXT1	2131	Autistic Disorder	MESH:D001321	marker/mechanism		NA		12032595
EXT1	2131	Chondrosarcoma	MESH:D002813	marker/mechanism		NA	215300	
EXT1	2131	Exostoses, Multiple Hereditary	MESH:D005097	marker/mechanism		NA		20080592|23439489
EXT1	2131	EXOSTOSES, MULTIPLE, TYPE I	OMIM:133700	marker/mechanism		NA	133700	
EXT2	2132	Exostoses, Multiple Hereditary	MESH:D005097	marker/mechanism		NA		23439489
EXT2	2132	EXOSTOSES, MULTIPLE, TYPE II	OMIM:133701	marker/mechanism		NA	133701	
EXTL1	2134	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
EXTL3	2137	IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES	OMIM:617425	marker/mechanism		NA	617425	
EY	43812	Eye Abnormalities	MESH:D005124	marker/mechanism		NA		29045453
EYA1	2138	Branchiootic syndrome	MESH:C537104	marker/mechanism		NA	602588	
EYA1	2138	Branchio-Oto-Renal Syndrome	MESH:D019280	marker/mechanism		NA	113650	12834866
EYA1	2138	Cayler cardiofacial syndrome	MESH:C535349	marker/mechanism		NA		15493068
EYA1	2138	Congenital Abnormalities	MESH:D000013	marker/mechanism		NA		10471511
EYA1	2138	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		10471511
EYA1	2138	Hearing Loss, Conductive	MESH:D006314	marker/mechanism		NA		10471511
EYA1	2138	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		15493068
EYA1	2138	Otofaciocervical Syndrome	MESH:C563481	marker/mechanism		NA	166780	
EYA4	2070	Cardiomyopathy, Dilated, 1J	MESH:C565337	marker/mechanism		NA	605362	
EYA4	2070	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		21278247
EYA4	2070	Deafness, Autosomal Dominant 10	MESH:C563354	marker/mechanism		NA	601316	
EYS	346007	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA		18836446
EYS	346007	Retinitis Pigmentosa 25	MESH:C566425	marker/mechanism		NA	602772	
EZH2	2146	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21903722
EZH2	2146	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
EZH2	2146	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		29391238
EZH2	2146	Chromosome Breakage	MESH:D019457	marker/mechanism		NA		29391238
EZH2	2146	Craniosynostoses	MESH:D003398	marker/mechanism		NA		26424790
EZH2	2146	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		21903722
EZH2	2146	Leukemia, Megakaryoblastic, of Down Syndrome	MESH:C566025	marker/mechanism		NA		24056718
EZH2	2146	Leukemia, Myelomonocytic, Juvenile	MESH:D054429	marker/mechanism		NA		26457647
EZH2	2146	Lymphoma, Follicular	MESH:D008224	marker/mechanism		NA		24362818
EZH2	2146	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		20081860
EZH2	2146	Myelodysplastic-Myeloproliferative Diseases	MESH:D054437	marker/mechanism		NA		20601953
EZH2	2146	Myelodysplastic Syndromes	MESH:D009190	marker/mechanism		NA		20601954
EZH2	2146	Osteosarcoma	MESH:D012516	marker/mechanism		NA		14767549
EZH2	2146	Primary Myelofibrosis	MESH:D055728	marker/mechanism		NA		20601953
EZH2	2146	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17003774|17173048|21903722
EZH2	2146	Upper Extremity Deformities, Congenital	MESH:D038062	marker/mechanism		NA		26424790
EZH2	2146	Weaver syndrome	MESH:C536687	marker/mechanism		NA	277590	
EZH2	2146	Weight Gain	MESH:D015430	marker/mechanism		NA		30971429
EZR	7430	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
EZR	7430	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
EZR	7430	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
EZR	7430	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
EZR	7430	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		27137931
EZR	7430	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
EZR	7430	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881|17566973|24763052
F10	2159	Blood Coagulation Disorders	MESH:D001778	marker/mechanism		NA		62897
F10	2159	Factor X Deficiency	MESH:D005171	marker/mechanism		NA	227600	
F10	2159	Thrombosis	MESH:D013927	marker/mechanism		NA		1279834
F11	2160	Factor XI Deficiency	MESH:D005173	marker/mechanism		NA	612416	
F11	2160	Hypertension	MESH:D006973	marker/mechanism		NA		6383834
F12	2161	Angioedemas, Hereditary	MESH:D054179	marker/mechanism		NA		19477491
F12	2161	Factor XII Deficiency	MESH:D005175	marker/mechanism		NA	234000	
F12	2161	Hereditary Angioedema Type III	MESH:D056828	marker/mechanism		NA	610618	
F12	2161	Hypertension	MESH:D006973	marker/mechanism		NA		6383834
F12	2161	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		11420682
F12	2161	Thromboembolism	MESH:D013923	marker/mechanism		NA		16009717
F13A1	2162	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17374397
F13A1	2162	Factor Xiii, A Subunit, Deficiency Of	MESH:C567691	marker/mechanism		NA	613225	
F13A1	2162	Factor XIII Deficiency	MESH:D005177	marker/mechanism		NA		1644910
F13A1	2162	Myocardial Infarction	MESH:D009203	marker/mechanism		NA	608446	17393027
F13A1	2162	Thrombophilia	MESH:D019851	marker/mechanism		NA	188050	
F13A1	2162	Venous Thrombosis	MESH:D020246	marker/mechanism		NA		10365735
F13B	2165	Factor XIII, B Subunit, Deficiency Of	MESH:C567688	marker/mechanism		NA	613235	
F13B	2165	Factor XIII Deficiency	MESH:D005177	marker/mechanism		NA		2334637
F13B	2165	Venous Thrombosis	MESH:D020246	marker/mechanism		NA		16241947
F2	2147	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		8333868
F2	2147	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		26001728
F2	2147	Blood Coagulation Disorders	MESH:D001778	marker/mechanism		NA		17721328
F2	2147	Brain Ischemia	MESH:D002545	marker/mechanism		NA		14753426|15534175
F2	2147	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		2821104
F2	2147	Cerebral Infarction	MESH:D002544	marker/mechanism		NA	601367	
F2	2147	Disseminated Intravascular Coagulation	MESH:D004211	marker/mechanism		NA		1894189
F2	2147	Fatty Liver	MESH:D005234	marker/mechanism		NA		20008134
F2	2147	Hemorrhage	MESH:D006470	marker/mechanism		NA		7740448
F2	2147	Hypertrophy	MESH:D006984	marker/mechanism		NA		26385185
F2	2147	Hypoprothrombinemias	MESH:D007020	marker/mechanism		NA		3567158|7740448
F2	2147	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		29651748
F2	2147	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		10216089
F2	2147	Liver Failure	MESH:D017093	marker/mechanism		NA		18618250
F2	2147	Mesenteric Ischemia	MESH:D065666	marker/mechanism		NA		24282370
F2	2147	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		10027711|9292507|9531249
F2	2147	Nephrosis	MESH:D009401	marker/mechanism		NA		18541230
F2	2147	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		19969022
F2	2147	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		22841818
F2	2147	Obesity	MESH:D009765	marker/mechanism		NA		22841818
F2	2147	Paratuberculosis	MESH:D010283	marker/mechanism		NA		22633222
F2	2147	PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 2	OMIM:614390	marker/mechanism		NA	614390	
F2	2147	PROTHROMBIN DEFICIENCY, CONGENITAL	OMIM:613679	marker/mechanism		NA	613679	
F2	2147	Schizophrenia	MESH:D012559	marker/mechanism		NA		25821032
F2	2147	Sinus Thrombosis, Intracranial	MESH:D012851	marker/mechanism		NA		12269725
F2	2147	Skin Diseases, Vascular	MESH:D017445	marker/mechanism		NA		17535202
F2	2147	Stroke	MESH:D020521	marker/mechanism		NA		15534175
F2	2147	Thromboembolism	MESH:D013923	marker/mechanism		NA		14693181
F2	2147	Thrombophilia	MESH:D019851	marker/mechanism		NA	188050	16628723
F2	2147	Thrombosis	MESH:D013927	marker/mechanism		NA		10064001|11132655|1279834|17245631
F2	2147	Venous Thromboembolism	MESH:D054556	marker/mechanism		NA		12411922
F2	2147	Venous Thrombosis	MESH:D020246	marker/mechanism		NA		12296757|19920886|9869612
F2R	2149	Fatty Liver	MESH:D005234	marker/mechanism		NA		20008134|21907177|22841818
F2R	2149	Hepatitis	MESH:D006505	marker/mechanism		NA		21907177
F2R	2149	Inflammation	MESH:D007249	marker/mechanism		NA		20008134
F2R	2149	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		21037076
F2R	2149	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
F2R	2149	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		17374729
F2R	2149	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
F2RL1	2150	Gastroenteritis	MESH:D005759	marker/mechanism		NA		12682265
F2RL1	2150	Inflammation	MESH:D007249	marker/mechanism		NA		12682265|24795235
F2RL1	2150	Melanoma	MESH:D008545	marker/mechanism		NA		17145863
F2RL1	2150	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
F2RL1	2150	Pruritus	MESH:D011537	marker/mechanism		NA		19712758
F2RL3	9002	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		20974703
F2RL3	9002	Cholestasis	MESH:D002779	marker/mechanism		NA		20974703
F2RL3	9002	Peliosis Hepatis	MESH:D010382	marker/mechanism		NA		20974703
F3	2152	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		15562024
F3	2152	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22407844
F3	2152	Disseminated Intravascular Coagulation	MESH:D004211	marker/mechanism		NA		20642682|7740478|9134660
F3	2152	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		16206674
F3	2152	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		10216089
F3	2152	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16286589
F3	2152	Nephrotic Syndrome	MESH:D009404	marker/mechanism		NA		17513194
F3	2152	Purpura, Thrombotic Thrombocytopenic	MESH:D011697	marker/mechanism		NA		7740478
F3	2152	Thrombosis	MESH:D013927	marker/mechanism		NA		11858183|25339356
F3	2152	Venous Thrombosis	MESH:D020246	marker/mechanism		NA		14967414
F5	2153	Adenomatous Polyposis Coli	MESH:D011125	marker/mechanism		NA		25200834
F5	2153	Blood Coagulation Disorders	MESH:D001778	marker/mechanism		NA		17721328
F5	2153	Brain Ischemia	MESH:D002545	marker/mechanism		NA		15534175
F5	2153	Budd-Chiari Syndrome	MESH:D006502	marker/mechanism		NA	600880	
F5	2153	Cerebral Infarction	MESH:D002544	marker/mechanism		NA	601367	
F5	2153	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		25200834
F5	2153	Factor V Deficiency	MESH:D005166	marker/mechanism		NA	227400	
F5	2153	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		18485088
F5	2153	Mesenteric Ischemia	MESH:D065666	marker/mechanism		NA		24282370
F5	2153	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		9531249
F5	2153	PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 1	OMIM:614389	marker/mechanism		NA	614389	
F5	2153	Retinal Vein Occlusion	MESH:D012170	marker/mechanism		NA		12022286
F5	2153	Sagittal Sinus Thrombosis	MESH:D020225	marker/mechanism		NA		18382986
F5	2153	Stroke	MESH:D020521	marker/mechanism		NA		15534175
F5	2153	Thromboembolism	MESH:D013923	marker/mechanism		NA		14693181|20554945
F5	2153	Thrombophilia due to Activated Protein C Resistance	MESH:C566056	marker/mechanism		NA	188055	
F5	2153	Thrombophilia, hereditary	MESH:C540694	marker/mechanism		NA		9136971
F5	2153	Thrombosis	MESH:D013927	marker/mechanism		NA		11132655|9164807
F5	2153	Venous Thromboembolism	MESH:D054556	marker/mechanism		NA		7500743|9149031
F5	2153	Venous Thrombosis	MESH:D020246	marker/mechanism		NA		12296757|12827938|12865888|15033664|16875063
F54D11.3	186237	Hypoxia	MESH:D000860	therapeutic		NA		19936206
F54G2.1	180562	Hypoxia	MESH:D000860	therapeutic		NA		19936206
F7	2155	Cerebral Hemorrhage	MESH:D002543	therapeutic		NA		16671457|21127298
F7	2155	Disease Models, Animal	MESH:D004195	therapeutic		NA		21127298
F7	2155	Disseminated Intravascular Coagulation	MESH:D004211	marker/mechanism		NA		16159073
F7	2155	Factor VII Deficiency	MESH:D005168	marker/mechanism		NA	227500	20885134
F7	2155	Hematoma, Subdural, Acute	MESH:D020199	therapeutic		NA		12503044
F7	2155	Hematuria	MESH:D006417	therapeutic		NA		17133240
F7	2155	Hemorrhage	MESH:D006470	therapeutic		NA		12707733|12851533|16553518
F7	2155	Hemorrhagic Disorders	MESH:D006474	marker/mechanism		NA		16706976
F7	2155	Intracranial Hemorrhages	MESH:D020300	therapeutic		NA		15595332|16159073|18617125|20172985|20522813
F7	2155	Intracranial Hemorrhage, Traumatic	MESH:D020198	therapeutic		NA		20370756
F7	2155	Myocardial Infarction	MESH:D009203	marker/mechanism		NA	608446	
F7	2155	Postoperative Complications	MESH:D011183	therapeutic		NA		12707733
F7	2155	Thromboembolism	MESH:D013923	marker/mechanism		NA		20172985
F7	2155	Venous Thrombosis	MESH:D020246	marker/mechanism		NA		14967414
F8	2157	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		11886462
F8	2157	Factor 8 deficiency, acquired	MESH:C536392	therapeutic		NA		11886462
F8	2157	Hemophilia A	MESH:D006467	marker/mechanism		NA	306700	11918545|16051741
F8	2157	Thrombophilia	MESH:D019851	marker/mechanism		NA		16628723
F8	2157	Venous Thrombosis	MESH:D020246	marker/mechanism		NA		16875063
F9	2158	Hemophilia A	MESH:D006467	marker/mechanism		NA		16051741
F9	2158	Hemophilia B	MESH:D002836	marker/mechanism		NA	306900	2388855|7062952
F9	2158	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		23056237
F9	2158	Thrombophilia, X-Linked, Due To Factor Ix Defect	MESH:C567581	marker/mechanism		NA	300807	
F9	2158	Thrombosis	MESH:D013927	marker/mechanism		NA		1279834
FA2H	79152	SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	OMIM:612319	marker/mechanism		NA	612319	
FAAH	2166	Huntington Disease	MESH:D006816	marker/mechanism		NA		20929960
FAAH	2166	Obesity	MESH:D009765	marker/mechanism		NA		19103437|20716455
FAAH	2166	Pregnancy Complications	MESH:D011248	marker/mechanism		NA		16886060
FAAH	2166	Seizures	MESH:D012640	therapeutic		NA		25933444
FAAH	2166	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA	606581	12060782|19103437
FAAH	2166	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		18705688|19002671
FAAH2	158584	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		25401301
FABP1	2168	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19878707
FABP1	2168	Kidney Tubular Necrosis, Acute	MESH:D007683	therapeutic		NA		18368030
FABP1	2168	Lipidoses	MESH:D008064	marker/mechanism		NA		15342952|16919414
FABP2	2169	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FABP3	2170	Muscular Diseases	MESH:D009135	marker/mechanism		NA		18308699
FABP3	2170	Necrosis	MESH:D009336	marker/mechanism		NA		18308699
FABP4	2167	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
FABP4	2167	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
FABP4	2167	Kidney Diseases	MESH:D007674	marker/mechanism		NA		30215792
FABP4	2167	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
FABP4	2167	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
FABP5	2171	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
FABP5	2171	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
FABP7	2173	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		22322885
FABP7	2173	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980|25380136
FADD	8772	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		17656375
FADD	8772	Diverticular Diseases	MESH:D000076385	marker/mechanism		NA		30177863
FADD	8772	Hearing Loss, Sensorineural	MESH:D006319	marker/mechanism		NA		17656375
FADD	8772	INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	OMIM:613759	marker/mechanism		NA	613759	
FADD	8772	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		16450001
FADD	8772	Oculoauricular Syndrome	MESH:C567416	marker/mechanism		NA		17656375
FADD	8772	Stomatognathic Diseases	MESH:D009057	marker/mechanism		NA		17656375
FADS1	3992	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
FADS1	3992	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		24836286
FADS1	3992	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
FADS2	9415	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		31043756
FADS2	9415	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
FADS2	9415	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		24836286
FADS2	9415	Lipidoses	MESH:D008064	marker/mechanism		NA		21123845
FAF2	23197	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
FAH	2184	Tyrosinemias	MESH:D020176	marker/mechanism		NA	276700	12899938|23895425
FAHD1	81889	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FAM102B	284611	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FAM107A	11170	Glioma	MESH:D005910	marker/mechanism		NA		16865689
FAM111A	63901	Gracile bone dysplasia	MESH:C537291	marker/mechanism		NA	602361	
FAM111A	63901	Kenny-Caffey syndrome, type 2	MESH:C537020	marker/mechanism		NA	127000	
FAM111B	374393	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
FAM111B	374393	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		22138691
FAM126A	84668	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
FAM126A	84668	Leukodystrophy, Hypomyelinating, 5	MESH:C567166	marker/mechanism		NA	610532	
FAM126A	84668	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
FAM126B	285172	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
FAM134B	100859798	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
FAM13A	10144	Idiopathic Pulmonary Fibrosis	MESH:D054990	marker/mechanism		NA		23583980
FAM13A	10144	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		20173748|28166215
FAM13A	10144	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		28166215
FAM155A	728215	Diverticular Diseases	MESH:D000076385	marker/mechanism		NA		30177863
FAM155A	728215	Diverticulitis	MESH:D004238	marker/mechanism		NA		28585551
FAM160B1	57700	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
FAM161A	84140	RETINITIS PIGMENTOSA 28	OMIM:606068	marker/mechanism		NA	606068	
FAM167B	84734	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FAM168A	23201	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
FAM168A	23201	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
FAM180A	389558	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
FAM180A	389558	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
FAM184A	79632	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
FAM184B	27146	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
FAM20A	54757	AMELOGENESIS IMPERFECTA, TYPE IG	OMIM:204690	marker/mechanism		NA	204690	
FAM20A	54757	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
FAM20C	56975	Raine syndrome	MESH:C535282	marker/mechanism		NA	259775	
FAM210A	125228	Fractures, Bone	MESH:D050723	marker/mechanism		NA		22504420
FAM234A	83986	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28869590
FAM3D	131177	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
FAM43A	131583	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FAM50A	9130	Armfield X-Linked Mental Retardation Syndrome	MESH:C564551	marker/mechanism		NA	300261	
FAM65C	428169	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
FAM72B	653820	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
FAM83D	81610	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
FAM83H	286077	Amelogenesis Imperfecta	MESH:D000567	marker/mechanism		NA		18484629|19407157
FAM83H	286077	Amelogenesis Imperfecta, Type III	MESH:C562880	marker/mechanism		NA	130900	
FAM83H	286077	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		19407157
FAM89A	375061	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FAN1	22909	INTERSTITIAL NEPHRITIS, KARYOMEGALIC	OMIM:614817	marker/mechanism		NA	614817	
FAN1	22909	Megalocytic interstitial nephritis	MESH:C536144	marker/mechanism		NA		22772369
FANCA	2175	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
FANCA	2175	Fanconi Anemia	MESH:D005199	marker/mechanism		NA	227650	22482891
FANCA	2175	Hyperinsulinism	MESH:D006946	marker/mechanism		NA		22482891
FANCA	2175	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
FANCA	2175	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		24121791
FANCB	2187	Fanconi Anemia, Complementation Group B	MESH:C564497	marker/mechanism		NA	300514	
FANCB	2187	VACTERL Association With Hydrocephalus	MESH:C564751	marker/mechanism		NA	314390	
FANCC	2176	Fanconi Anemia	MESH:D005199	marker/mechanism		NA		22482891
FANCC	2176	FANCONI ANEMIA, COMPLEMENTATION GROUP C	OMIM:227645	marker/mechanism		NA	227645	
FANCC	2176	Hyperinsulinism	MESH:D006946	marker/mechanism		NA		22482891
FANCD2	2177	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
FANCD2	2177	Fanconi Anemia	MESH:D005199	marker/mechanism		NA		14667412
FANCD2	2177	FANCONI ANEMIA, COMPLEMENTATION GROUP D2	OMIM:227646	marker/mechanism		NA	227646	
FANCE	2178	FANCONI ANEMIA, COMPLEMENTATION GROUP E	OMIM:600901	marker/mechanism		NA	600901	
FANCF	2188	FANCONI ANEMIA, COMPLEMENTATION GROUP F	OMIM:603467	marker/mechanism		NA	603467	
FANCG	2189	Fanconi Anemia	MESH:D005199	marker/mechanism		NA		10807541|11093276
FANCG	2189	FANCONI ANEMIA, COMPLEMENTATION GROUP G	OMIM:614082	marker/mechanism		NA	614082	
FANCG	2189	Mouth Diseases	MESH:D009059	marker/mechanism		NA		17682004
FANCI	55215	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
FANCI	55215	Fanconi Anemia, Complementation Group I	MESH:C563802	marker/mechanism		NA	609053	
FANCL	55120	Fanconi Anemia	MESH:D005199	marker/mechanism		NA		12973351|19405097
FANCL	55120	FANCONI ANEMIA, COMPLEMENTATION GROUP L	OMIM:614083	marker/mechanism		NA	614083	
FANCM	57697	Fanconi Anemia	MESH:D005199	marker/mechanism		NA		16116422
FARP1	10160	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
FARP2	9855	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19365831
FARP2	9855	Chromosome 2q37 deletion syndrome	MESH:C538317	marker/mechanism		NA		19365831
FARP2	9855	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		20062064
FARS2	10667	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	OMIM:614946	marker/mechanism		NA	614946	
FARS2	10667	SPASTIC PARAPLEGIA 77, AUTOSOMAL RECESSIVE	OMIM:617046	marker/mechanism		NA	617046	
FARSB	10056	RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS 1	OMIM:613658	marker/mechanism		NA	613658	
FAS	355	Acute Lung Injury	MESH:D055371	marker/mechanism		NA		11778176
FAS	355	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		22536412|2545777|26590112
FAS	355	Autoimmune Lymphoproliferative Syndrome	MESH:D056735	marker/mechanism		NA	601859	15877736|17674358
FAS	355	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		10716473|10920071|17943461
FAS	355	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		17943461
FAS	355	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		16123366
FAS	355	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		16123366
FAS	355	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		22536412|26590112
FAS	355	Disease Progression	MESH:D018450	marker/mechanism		NA		11594583
FAS	355	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		21880982
FAS	355	Hematologic Diseases	MESH:D006402	marker/mechanism		NA		15877736
FAS	355	Hypersplenism	MESH:D006971	marker/mechanism		NA		15877736
FAS	355	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		7579353
FAS	355	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		30737368
FAS	355	Liver Failure, Acute	MESH:D017114	marker/mechanism		NA		12828076
FAS	355	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		30737368
FAS	355	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		26192916
FAS	355	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		26192916
FAS	355	Lymphoma, T-Cell, Cutaneous	MESH:D016410	marker/mechanism		NA		26192916
FAS	355	Lymphomatoid Papulosis	MESH:D017731	marker/mechanism		NA		11594583
FAS	355	Malaria, Falciparum	MESH:D016778	marker/mechanism		NA		21625619
FAS	355	Myasthenia Gravis	MESH:D009157	marker/mechanism		NA		15169653
FAS	355	Necrosis	MESH:D009336	marker/mechanism		NA		15664267
FAS	355	Nephritis	MESH:D009393	marker/mechanism		NA		26590112
FAS	355	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		23127599
FAS	355	Pregnancy Complications, Cardiovascular	MESH:D011249	marker/mechanism		NA		10716473
FAS	355	Proteinuria	MESH:D011507	marker/mechanism		NA		26590112
FAS	355	Splenomegaly	MESH:D013163	marker/mechanism		NA		21880982
FAS	355	Taste Disorders	MESH:D013651	marker/mechanism		NA		22536412
FAS	355	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		9070496
FAS	355	Ventricular Dysfunction, Left	MESH:D018487	marker/mechanism		NA		11809923
FASL	14103	Necrosis	MESH:D009336	marker/mechanism		NA		15664267
FASLG	356	Acute Lung Injury	MESH:D055371	marker/mechanism		NA		11778176
FASLG	356	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		20008919
FASLG	356	Atherosclerosis	MESH:D050197	marker/mechanism		NA		15063428
FASLG	356	Autoimmune Lymphoproliferative Syndrome	MESH:D056735	marker/mechanism		NA	601859	
FASLG	356	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		21807637
FASLG	356	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		16324756|17943461
FASLG	356	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		17943461
FASLG	356	Carotid Artery Diseases	MESH:D002340	marker/mechanism		NA		15063428
FASLG	356	Diabetic Angiopathies	MESH:D003925	marker/mechanism		NA		25381014
FASLG	356	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		19706026
FASLG	356	Hepatitis	MESH:D006505	marker/mechanism		NA		19706026
FASLG	356	Hyperlipidemia, Familial Combined	MESH:D006950	marker/mechanism		NA		15063428
FASLG	356	Liver Failure, Acute	MESH:D017114	marker/mechanism		NA		19505222
FASLG	356	Lung Neoplasms	MESH:D008175	marker/mechanism		NA	211980	
FASLG	356	Melanoma	MESH:D008545	therapeutic		NA		16487513
FASLG	356	Prostatic Neoplasms	MESH:D011471	therapeutic		NA		17875776
FASLG	356	Testicular Diseases	MESH:D013733	marker/mechanism		NA		19429229
FASN	2194	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		23305094
FASN	2194	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
FASN	2194	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17089011|18281512
FASN	2194	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		14563831|15543204|21147110
FASN	2194	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		26670611
FASN	2194	Cardiomyopathy, Hypertrophic	MESH:D002312	marker/mechanism		NA		26670611
FASN	2194	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
FASN	2194	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
FASN	2194	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		29379198
FASN	2194	Heart Failure	MESH:D006333	marker/mechanism		NA		26670611
FASN	2194	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
FASN	2194	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19878707
FASN	2194	Liposarcoma	MESH:D008080	therapeutic		NA		20372807
FASN	2194	Melanoma	MESH:D008545	marker/mechanism		NA		18770866|20805790|21213365
FASN	2194	Neoplasms	MESH:D009369	marker/mechanism		NA		20373869
FASN	2194	Obesity	MESH:D009765	marker/mechanism		NA		20882379
FASN	2194	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		21442130
FASTKD5	60493	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
FAT1	2195	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
FAT1	2195	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		23354438
FAT1	2195	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		25151357
FAT1	2195	Glioblastoma	MESH:D005909	marker/mechanism		NA		23354438
FAT1	2195	Head and Neck Neoplasms	MESH:D006258	marker/mechanism		NA		23354438
FAT1	2195	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FAT1	2195	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
FAT2	2196	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		25151357
FAT3	120114	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		25151357
FAT4	79633	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		22484628
FAT4	79633	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		25151357
FAT4	79633	Hennekam lymphangiectasia lymphedema syndrome	MESH:C537255	marker/mechanism		NA	616006	
FAT4	79633	Heterotopia, Periventricular, Autosomal Recessive	MESH:C564292	marker/mechanism		NA		24056717
FAT4	79633	Kidney Diseases, Cystic	MESH:D052177	marker/mechanism		NA		18604206
FAT4	79633	Melanoma	MESH:D008545	marker/mechanism		NA		22197931
FAT4	79633	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		22484628
FAT4	79633	Van Maldergem Wetzburger Verloes syndrome	MESH:C536530	marker/mechanism		NA	615546	24056717
FATE1	89885	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		15580283
FAX	39826	Parkinson Disease	MESH:D010300	marker/mechanism		NA		18353766
FAXDC2	10826	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
FBL	2091	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
FBL	2091	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		19077085|8738957|9693280
FBL	2091	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21466612
FBL	2091	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
FBLN1	2192	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
FBLN1	2192	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17929269
FBLN1	2192	Synpolydactyly 2	MESH:C564278	marker/mechanism		NA	608180	
FBLN2	2199	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17892325
FBLN2	2199	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
FBLN5	10516	Cutis Laxa, Autosomal Dominant	MESH:C562627	marker/mechanism		NA	614434	
FBLN5	10516	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA	OMIM:219100	marker/mechanism		NA	219100	
FBLN5	10516	Cutis laxa, recessive	MESH:C536225	marker/mechanism		NA		12189163
FBLN5	10516	Emphysema	MESH:D004646	marker/mechanism		NA		12189163
FBLN5	10516	Heart Failure	MESH:D006333	marker/mechanism		NA		12189163
FBLN5	10516	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		12189163
FBLN5	10516	Macular Degeneration, Age-Related, 3	MESH:C563838	marker/mechanism		NA	608895	
FBLN5	10516	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17929269
FBLN5	10516	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
FBLN5	10516	Respiratory Insufficiency	MESH:D012131	marker/mechanism		NA		12189163
FBLN5	10516	Respiratory Tract Infections	MESH:D012141	marker/mechanism		NA		12189163
FBLN5	10516	Vascular Diseases	MESH:D014652	marker/mechanism		NA		12189163
FBN1	2200	Acromicric dysplasia	MESH:C535662	marker/mechanism		NA	102370|614185	
FBN1	2200	Aortic Aneurysm, Thoracic	MESH:D017545	marker/mechanism		NA		21909107
FBN1	2200	Aortic Rupture	MESH:D001019	marker/mechanism		NA		18178469
FBN1	2200	Arachnodactyly	MESH:D054119	marker/mechanism		NA		22772368
FBN1	2200	Ectopia Lentis	MESH:D004479	marker/mechanism		NA		22772368
FBN1	2200	ECTOPIA LENTIS 1, ISOLATED, AUTOSOMAL DOMINANT	OMIM:129600	marker/mechanism		NA	129600	
FBN1	2200	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
FBN1	2200	Hyperglycemia	MESH:D006943	marker/mechanism		NA		20836762
FBN1	2200	Hyperinsulinism	MESH:D006946	marker/mechanism		NA		20836762
FBN1	2200	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		26396155
FBN1	2200	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FBN1	2200	MARFANOID-PROGEROID-LIPODYSTROPHY SYNDROME	OMIM:616914	marker/mechanism		NA	616914	
FBN1	2200	Marfan Syndrome	MESH:D008382	marker/mechanism		NA	154700	15235604|17657824|18178469|18212506|19430350|21909107|22772368
FBN1	2200	MASS syndrome	MESH:C536030	marker/mechanism		NA	604308	
FBN1	2200	Stiff Skin Syndrome	MESH:C566112	marker/mechanism		NA	184900	
FBN1	2200	Weill-Marchesani Syndrome	MESH:D056846	marker/mechanism		NA	608328	
FBN2	2201	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		21278247
FBN2	2201	Congenital contractural arachnodactyly	MESH:C536211	marker/mechanism		NA	121050	
FBN2	2201	MACULAR DEGENERATION, EARLY-ONSET	OMIM:616118	marker/mechanism		NA	616118	
FBP1	2203	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		22039417
FBP1	2203	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		22039417
FBP1	2203	Fructose-1,6-Diphosphatase Deficiency	MESH:D015319	marker/mechanism		NA	229700	9382095
FBP1	2203	Parkinson Disease	MESH:D010300	marker/mechanism		NA		18353766
FBP1	2203	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		22039417
FBRSL1	57666	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
FBRSL1	57666	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
FBXL18	80028	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
FBXL19	54620	Arthritis, Psoriatic	MESH:D015535	marker/mechanism		NA		20953189
FBXL19	54620	Psoriasis	MESH:D011565	marker/mechanism		NA		20953189
FBXL4	26235	MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE)	OMIM:615471	marker/mechanism		NA	615471	
FBXO21	23014	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
FBXO31	79791	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45	OMIM:615979	marker/mechanism		NA	615979	
FBXO32	114907	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
FBXO32	114907	Muscular Atrophy	MESH:D009133	marker/mechanism		NA		21139329
FBXO38	81545	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IID	OMIM:615575	marker/mechanism		NA	615575	
FBXO40	51725	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19404257
FBXO44	93611	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
FBXO44	93611	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
FBXO6	26270	Stevens-Johnson Syndrome	MESH:D013262	marker/mechanism		NA		25811541
FBXO7	25793	Pallidopyramidal syndrome	MESH:C538104	marker/mechanism		NA	260300	25029497
FBXO9	26268	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FBXW7	55294	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17588203
FBXW7	55294	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
FBXW7	55294	Carcinoma, Basal Cell	MESH:D002280	marker/mechanism		NA		26950094
FBXW7	55294	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		23104009
FBXW7	55294	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		25151357
FBXW7	55294	Genomic Instability	MESH:D042822	marker/mechanism		NA		17588203
FBXW7	55294	Glioma	MESH:D005910	marker/mechanism		NA		18931460
FBXW7	55294	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054218	marker/mechanism		NA		19246562|24394663
FBXW8	26259	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		26039340
FCER1A	2205	Drug Eruptions	MESH:D003875	marker/mechanism		NA		16502481
FCER1A	2205	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		17125826|20485159
FCER1A	2205	Urticaria	MESH:D014581	marker/mechanism		NA		16502481|20485159
FCER1G	2207	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		18534082|18595682
FCER1G	2207	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		18595682
FCER1G	2207	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FCER2	2208	Encephalitis	MESH:D004660	marker/mechanism		NA		11500085
FCER2	2208	HIV Infections	MESH:D015658	marker/mechanism		NA		11500085
FCER2	2208	Hypersensitivity, Immediate	MESH:D006969	marker/mechanism		NA		22967010
FCER2	2208	Parkinson Disease	MESH:D010300	marker/mechanism		NA		25475535
FCGBP	8857	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
FCGR1	14129	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		12875993
FCGR1A	2209	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
FCGR1A	2209	Calcinosis	MESH:D002114	marker/mechanism		NA		21335463
FCGR1A	2209	Heart Valve Diseases	MESH:D006349	marker/mechanism		NA		21335463
FCGR1A	2209	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FCGR2A	2212	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		20453842|23143596
FCGR2A	2212	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		19915573|20228799
FCGR2A	2212	Cystic Fibrosis	MESH:D003550	marker/mechanism		NA	219700	
FCGR2A	2212	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA	152700	18204446
FCGR2A	2212	Malaria	MESH:D008288	marker/mechanism		NA	611162	
FCGR2A	2212	Mucocutaneous Lymph Node Syndrome	MESH:D009080	marker/mechanism		NA		22081228|22446962
FCGR2A	2212	Sjogren's Syndrome	MESH:D012859	marker/mechanism		NA		24097067
FCGR2A	2212	Thrombocytopenia	MESH:D013921	marker/mechanism		NA		11588041
FCGR2A	2212	Thrombosis	MESH:D013927	marker/mechanism		NA		11588041
FCGR2B	2213	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		10848805
FCGR2B	2213	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA	152700	
FCGR2B	2213	Malaria	MESH:D008288	marker/mechanism		NA	611162	
FCGR2B	2213	Neutropenia	MESH:D009503	marker/mechanism		NA		10848805
FCGR3A	2214	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
FCGR3A	2214	IMMUNODEFICIENCY 20	OMIM:615707	marker/mechanism		NA	615707	
FCGR3A	2214	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FCGR3A	2214	Lupus Vasculitis, Central Nervous System	MESH:D020945	marker/mechanism		NA		26773105
FCGR3B	2215	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		16033404
FCGR3B	2215	Granulomatosis with Polyangiitis	MESH:D014890	marker/mechanism		NA		16482158
FCGR3B	2215	Hyperglycemia	MESH:D006943	marker/mechanism		NA		29035695
FCGR3B	2215	Hyperinsulinism	MESH:D006946	marker/mechanism		NA		29035695
FCGR3B	2215	Lupus Nephritis	MESH:D008181	marker/mechanism		NA		16482158
FCGR3B	2215	Lupus Vasculitis, Central Nervous System	MESH:D020945	marker/mechanism		NA		26773105
FCGR3B	2215	Obesity	MESH:D009765	marker/mechanism		NA		29035695
FCHSD2	9873	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
FCMR	9214	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
FCN1	2219	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FCN2	2220	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
FCN2	2220	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		23056237
FCN3	8547	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
FCN3	8547	FICOLIN 3 DEFICIENCY	OMIM:613860	marker/mechanism		NA	613860	
FCN3	8547	Immunologic Deficiency Syndromes	MESH:D007153	marker/mechanism		NA		19535802
FCRL3	115352	Graves Disease	MESH:D006111	marker/mechanism		NA		21841780
FCRL3	115352	Thyroiditis, Autoimmune	MESH:D013967	marker/mechanism		NA		17952073
FDFT1	2222	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21147110
FDFT1	2222	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		17205118
FDFT1	2222	Marijuana Abuse	MESH:D002189	marker/mechanism		NA		17205118
FDFT1	2222	Phencyclidine Abuse	MESH:D010623	marker/mechanism		NA		17205118
FDPS	2224	Osteoporosis, Postmenopausal	MESH:D015663	marker/mechanism		NA		31774873
FDPS	2224	POROKERATOSIS 9, MULTIPLE TYPES	OMIM:616631	marker/mechanism		NA	616631	
FDX2	112812	Mitochondrial Myopathies	MESH:D017240	marker/mechanism		NA	251900	
FECH	2235	Bile Duct Diseases	MESH:D001649	marker/mechanism		NA		10464147
FECH	2235	Fibrosis	MESH:D005355	marker/mechanism		NA		10464147
FECH	2235	Protoporphyria, Erythropoietic	MESH:D046351	marker/mechanism|therapeutic		NA	177000	10464147|12950064|15284838|15793285|17600043|29906468
FEN1	2237	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		24836286
FEN1	2237	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		28371273
FERMT1	55612	Poikiloderma of Kindler	MESH:C536321	marker/mechanism		NA	173650	
FERMT2	10979	Glaucoma, Angle-Closure	MESH:D015812	marker/mechanism		NA		27064256
FERMT2	10979	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		21624607
FERMT3	83706	Blood Platelet Disorders	MESH:D001791	marker/mechanism		NA		18278053
FERMT3	83706	Hemorrhage	MESH:D006470	marker/mechanism		NA		18278053
FERMT3	83706	Leukocyte Adhesion Deficiency, Type III	MESH:C567555	marker/mechanism		NA	612840	
FERMT3	83706	Osteopetrosis	MESH:D010022	marker/mechanism		NA		18278053
FETUB	26998	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
FEV	54738	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		31209396
FEV	54738	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
FEZ2	9637	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
FEZ2	9637	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
FEZF1	389549	HYPOGONADOTROPIC HYPOGONADISM 22 WITH OR WITHOUT ANOSMIA	OMIM:616030	marker/mechanism		NA	616030	
FEZF1	389549	Idiopathic Hypogonadotropic Hypogonadism	MESH:C562785	marker/mechanism		NA	146110	
FFAR4	338557	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 10	OMIM:607514	marker/mechanism		NA	607514	
FGA	2243	Afibrinogenemia	MESH:D000347	marker/mechanism		NA	202400	10602365|10891444|12358944|1391954
FGA	2243	Amyloidosis, Familial	MESH:D028226	marker/mechanism		NA		8097946|8639778
FGA	2243	Amyloidosis, familial visceral	MESH:C538249	marker/mechanism		NA	105200	
FGA	2243	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		20974703
FGA	2243	Cholestasis	MESH:D002779	marker/mechanism		NA		20974703
FGA	2243	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		15805072
FGA	2243	Dysfibrinogenemia, Congenital	MESH:C562727	marker/mechanism		NA	616004	
FGA	2243	Kidney Diseases	MESH:D007674	marker/mechanism		NA		8097946|8639778
FGA	2243	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		16239339
FGA	2243	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
FGA	2243	Pulmonary Embolism	MESH:D011655	marker/mechanism		NA		10910940
FGA	2243	Stroke	MESH:D020521	marker/mechanism		NA		29531354
FGA	2243	Thrombophilia	MESH:D019851	marker/mechanism		NA		8473507
FGA	2243	Thrombosis	MESH:D013927	marker/mechanism		NA		8473507
FGA	2243	Venous Thromboembolism	MESH:D054556	marker/mechanism		NA		16362348
FGB	2244	Afibrinogenemia	MESH:D000347	marker/mechanism		NA	202400	
FGB	2244	Dysfibrinogenemia, Congenital	MESH:C562727	marker/mechanism		NA	616004	
FGB	2244	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
FGB	2244	Parkinson Disease	MESH:D010300	marker/mechanism		NA		23233872
FGD1	2245	Aarskog Syndrome	MESH:C535331	marker/mechanism		NA	305400	10930571|11093277|14560308|15327482|17152066|7954831
FGD1	2245	Attention Deficit Disorder with Hyperactivity	MESH:D001289	marker/mechanism		NA		15809997
FGD1	2245	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		7954831
FGD1	2245	Foot Deformities, Congenital	MESH:D005532	marker/mechanism		NA		11940089
FGD1	2245	Growth Disorders	MESH:D006130	marker/mechanism		NA		10930571|11093277|11940089|7954831
FGD1	2245	Mental Retardation, X-Linked	MESH:D038901	marker/mechanism		NA		11940089
FGD1	2245	Nervous System Malformations	MESH:D009421	marker/mechanism		NA		11093277
FGD1	2245	Urogenital Abnormalities	MESH:D014564	marker/mechanism		NA		10930571|11093277|7954831
FGD2	221472	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
FGD4	121512	Charcot-Marie-Tooth Disease, Type 4H	MESH:C563740	marker/mechanism		NA	609311	
FGD5	152273	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25151356
FGD6	55785	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
FGD6	55785	Wet Macular Degeneration	MESH:D057135	marker/mechanism		NA		27089177
FGF1	2246	Hypotension	MESH:D007022	marker/mechanism		NA		9233905
FGF1	2246	Leukemia	MESH:D007938	marker/mechanism		NA		17219402
FGF1	2246	Mesothelioma	MESH:D008654	marker/mechanism		NA		15878867
FGF1	2246	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
FGF1	2246	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		25174399
FGF1	2246	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		16324872
FGF1	2246	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
FGF10	2255	Aplasia of Lacrimal and Salivary Glands	MESH:C562407	marker/mechanism		NA	180920	
FGF10	2255	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18438407
FGF10	2255	Cleft Lip	MESH:D002971	marker/mechanism		NA		17963255
FGF10	2255	Cleft Palate	MESH:D002972	marker/mechanism		NA		17963255
FGF10	2255	Lacrimoauriculodentodigital syndrome	MESH:C538132	marker/mechanism		NA	149730	
FGF10	2255	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		21743467
FGF12	2257	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	OMIM:617166	marker/mechanism		NA	617166	
FGF12	2257	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
FGF13	2258	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19917848
FGF13	2258	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		19917848
FGF14	2259	Cartilage Diseases	MESH:D002357	marker/mechanism		NA		11241832
FGF14	2259	Cognition Disorders	MESH:D003072	marker/mechanism		NA		26089778
FGF14	2259	Spinocerebellar ataxia 27	MESH:C537204	marker/mechanism		NA	609307	26089778
FGF15	14170	Colitis	MESH:D003092	marker/mechanism		NA		27580383
FGF15	14170	Hepatic Insufficiency	MESH:D048550	marker/mechanism		NA		28673684
FGF15	14170	Insulin Resistance	MESH:D007333	marker/mechanism		NA		28673684
FGF15	14170	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		28673684
FGF15	14170	Metabolic Syndrome	MESH:D024821	marker/mechanism		NA		28673684
FGF15	14170	Necrosis	MESH:D009336	marker/mechanism		NA		24699334
FGF16	8823	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
FGF16	8823	Metacarpal 4 5 Fusion	MESH:C564100	marker/mechanism		NA	309630	
FGF16	8823	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		24253043
FGF17	8822	HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA	OMIM:615270	marker/mechanism		NA	615270	
FGF17	8822	Idiopathic Hypogonadotropic Hypogonadism	MESH:C562785	marker/mechanism		NA	146110	
FGF18	8817	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		17303798
FGF18	8817	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
FGF18	8817	Osteoarthritis	MESH:D010003	marker/mechanism		NA		30664745
FGF18	8817	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
FGF19	9965	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		25822088
FGF2	2247	Brain Infarction	MESH:D020520	therapeutic		NA		17524524
FGF2	2247	Brain Injuries	MESH:D001930	therapeutic		NA		21269288
FGF2	2247	Cardiomegaly	MESH:D006332	marker/mechanism		NA		10491406
FGF2	2247	Cleft Lip	MESH:D002971	marker/mechanism		NA		17963255
FGF2	2247	Cleft Palate	MESH:D002972	marker/mechanism		NA		17963255
FGF2	2247	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		19014962
FGF2	2247	Corneal Neovascularization	MESH:D016510	marker/mechanism		NA		9301478
FGF2	2247	Depressive Disorder	MESH:D003866	marker/mechanism		NA		16861106
FGF2	2247	Diabetes, Gestational	MESH:D016640	marker/mechanism		NA		20421132
FGF2	2247	Disease Progression	MESH:D018450	marker/mechanism		NA		12644816
FGF2	2247	Epilepsy, Tonic-Clonic	MESH:D004830	marker/mechanism		NA		16023256
FGF2	2247	Glioma	MESH:D005910	therapeutic		NA		10673511
FGF2	2247	Gliosis	MESH:D005911	therapeutic		NA		21087489
FGF2	2247	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		10646786
FGF2	2247	Inflammation	MESH:D007249	therapeutic		NA		21087489
FGF2	2247	Kidney Diseases	MESH:D007674	marker/mechanism		NA		8995747
FGF2	2247	Liver Cirrhosis	MESH:D008103	therapeutic		NA		17093919
FGF2	2247	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		16116963
FGF2	2247	Mesothelioma	MESH:D008654	marker/mechanism		NA		15878867
FGF2	2247	Myocardial Ischemia	MESH:D017202	therapeutic		NA		12173832|14583313
FGF2	2247	Nephrosclerosis	MESH:D009400	marker/mechanism		NA		30818366
FGF2	2247	Nephrotic Syndrome	MESH:D009404	marker/mechanism		NA		21441931
FGF2	2247	Nerve Degeneration	MESH:D009410	therapeutic		NA		10203697
FGF2	2247	Oral Submucous Fibrosis	MESH:D009914	marker/mechanism		NA		16311067
FGF2	2247	Periapical Periodontitis	MESH:D010485	marker/mechanism		NA		16631837
FGF2	2247	Prenatal Exposure Delayed Effects	MESH:D011297	marker/mechanism		NA		19014962
FGF2	2247	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		12644816
FGF2	2247	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		8952537
FGF2	2247	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		16526316
FGF2	2247	Seizures	MESH:D012640	therapeutic		NA		21269288
FGF2	2247	Thrombocythemia, Essential	MESH:D013920	marker/mechanism		NA		15682418
FGF2	2247	Wounds and Injuries	MESH:D014947	therapeutic		NA		11842932
FGF21	26291	Diabetes Mellitus, Experimental	MESH:D003921	therapeutic		NA		23499715
FGF21	26291	Diabetes Mellitus, Type 1	MESH:D003922	therapeutic		NA		23499715
FGF21	26291	Diabetes Mellitus, Type 2	MESH:D003924	therapeutic		NA		26797127
FGF21	26291	Fatty Liver	MESH:D005234	therapeutic		NA		24184811
FGF21	26291	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		25257527
FGF21	26291	Non-alcoholic Fatty Liver Disease	MESH:D065626	therapeutic		NA		26797127|29289645
FGF21	26291	Obesity	MESH:D009765	therapeutic		NA		24184811|26797127
FGF23	8074	Calcinosis	MESH:D002114	marker/mechanism		NA		17710231
FGF23	8074	Hyperphosphatemia	MESH:D054559	marker/mechanism		NA		17710231
FGF23	8074	Hypophosphatemic Rickets, Autosomal Dominant	MESH:C562791	marker/mechanism		NA	193100	
FGF3	2248	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21936542
FGF3	2248	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		25822088
FGF3	2248	Cleft Lip	MESH:D002971	marker/mechanism		NA		17963255
FGF3	2248	Cleft Palate	MESH:D002972	marker/mechanism		NA		17963255
FGF3	2248	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		17656375
FGF3	2248	Deafness, Congenital, with Inner Ear Agenesis, Microtia, and Microdontia	MESH:C565195	marker/mechanism		NA	610706	
FGF3	2248	Hearing Loss, Sensorineural	MESH:D006319	marker/mechanism		NA		17656375
FGF3	2248	Stomatognathic Diseases	MESH:D009057	marker/mechanism		NA		17656375
FGF4	2249	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21936542
FGF4	2249	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		25822088
FGF5	2250	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
FGF6	2251	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
FGF7	2252	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
FGF7	2252	Cleft Lip	MESH:D002971	marker/mechanism		NA		17963255
FGF7	2252	Cleft Palate	MESH:D002972	marker/mechanism		NA		17963255
FGF7	2252	Gingival Hyperplasia	MESH:D005885	marker/mechanism		NA		11023675
FGF7	2252	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		17692400
FGF7	2252	Lung Injury	MESH:D055370	therapeutic		NA		18385170
FGF7	2252	Prostatic Hyperplasia	MESH:D011470	marker/mechanism		NA		14999240
FGF7	2252	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		15677771
FGF7	2252	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		16526316
FGF8	2253	22q11 Deletion Syndrome	MESH:D058165	marker/mechanism		NA		12223415
FGF8	2253	Cardiovascular Abnormalities	MESH:D018376	marker/mechanism		NA		16720880
FGF8	2253	Cleft Lip	MESH:D002971	marker/mechanism		NA		17963255
FGF8	2253	Cleft Palate	MESH:D002972	marker/mechanism		NA		17963255
FGF8	2253	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		16720880
FGF8	2253	DiGeorge Syndrome	MESH:D004062	marker/mechanism		NA		16399080
FGF8	2253	Kallmann Syndrome	MESH:D017436	marker/mechanism		NA	612702	
FGF9	2254	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		20464547
FGF9	2254	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		19358281
FGF9	2254	Cleft Lip	MESH:D002971	marker/mechanism		NA		17963255
FGF9	2254	Cleft Palate	MESH:D002972	marker/mechanism		NA		17963255
FGF9	2254	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		20464547
FGF9	2254	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
FGF9	2254	Multiple Synostoses Syndrome 3	MESH:C567839	marker/mechanism		NA	612961	
FGFR1	2260	Astrocytoma	MESH:D001254	marker/mechanism		NA		23817572
FGFR1	2260	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20179196|21936542
FGFR1	2260	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		22286583|27794399
FGFR1	2260	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		22286583|27794399
FGFR1	2260	Cleft Lip	MESH:D002971	marker/mechanism		NA		17963255
FGFR1	2260	Cleft Palate	MESH:D002972	marker/mechanism		NA		17963255
FGFR1	2260	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		12514106
FGFR1	2260	Craniosynostoses	MESH:D003398	marker/mechanism		NA	190440	
FGFR1	2260	Depressive Disorder	MESH:D003866	marker/mechanism		NA		16861106
FGFR1	2260	Encephalocraniocutaneous lipomatosis	MESH:C535736	marker/mechanism		NA	613001	
FGFR1	2260	Glioma	MESH:D005910	marker/mechanism		NA		23583981
FGFR1	2260	Heart Valve Diseases	MESH:D006349	marker/mechanism		NA		30008375
FGFR1	2260	Jackson-Weiss syndrome	MESH:C537559	marker/mechanism		NA	123150	
FGFR1	2260	Kallmann Syndrome	MESH:D017436	marker/mechanism		NA	147950	
FGFR1	2260	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		21936542
FGFR1	2260	Myeloproliferative Disorders	MESH:D009196	marker/mechanism		NA		21936542|22875613
FGFR1	2260	Osteoglophonic dwarfism	MESH:C536050	marker/mechanism		NA	166250	
FGFR1	2260	Pfeiffer type acrocephalosyndactyly	MESH:C538582	marker/mechanism		NA	101600	
FGFR1	2260	Schizophrenia	MESH:D012559	marker/mechanism		NA		16861106
FGFR1	2260	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941188
FGFR1OP2	26127	Myeloproliferative Disorders	MESH:D009196	marker/mechanism		NA		22875613
FGFR2	2263	Abnormalities, Multiple	MESH:D000015	marker/mechanism		NA		10631169
FGFR2	2263	Acrocephalosyndactylia	MESH:D000168	marker/mechanism		NA	101200|101400	17694057|19186770|9002682|9502772
FGFR2	2263	Ankylosis	MESH:D000844	marker/mechanism		NA		9605588
FGFR2	2263	Antley-Bixler Syndrome Phenotype	MESH:D054882	marker/mechanism		NA		9605588
FGFR2	2263	ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS	OMIM:207410	marker/mechanism		NA	207410	
FGFR2	2263	BENT BONE DYSPLASIA SYNDROME	OMIM:614592	marker/mechanism		NA	614592	
FGFR2	2263	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17529967|17529973|18438407
FGFR2	2263	Burns, Chemical	MESH:D002057	marker/mechanism		NA		22533443
FGFR2	2263	Cholangiocarcinoma	MESH:D018281	marker/mechanism		NA		26258846
FGFR2	2263	Cleft Lip	MESH:D002971	marker/mechanism		NA		17963255
FGFR2	2263	Cleft Palate	MESH:D002972	marker/mechanism		NA		17963255|29526646
FGFR2	2263	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		10631169|16465081|18082115
FGFR2	2263	Craniofacial Dysostosis	MESH:D003394	marker/mechanism		NA	123500	9152842
FGFR2	2263	Craniosynostoses	MESH:D003398	marker/mechanism		NA		16465081|8957519|9605588
FGFR2	2263	Cutis Gyrata Syndrome of Beare And Stevenson	MESH:C565129	marker/mechanism		NA	123790	17449949
FGFR2	2263	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		21936542
FGFR2	2263	Hamartoma Syndrome, Multiple	MESH:D006223	marker/mechanism		NA		9002682
FGFR2	2263	Intellectual Disability	MESH:D008607	marker/mechanism		NA		16465081
FGFR2	2263	Jackson-Weiss syndrome	MESH:C537559	marker/mechanism		NA	123150	
FGFR2	2263	Lacrimoauriculodentodigital syndrome	MESH:C538132	marker/mechanism		NA	149730	
FGFR2	2263	Limb Deformities, Congenital	MESH:D017880	marker/mechanism		NA		10631169
FGFR2	2263	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		17692400
FGFR2	2263	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17311802
FGFR2	2263	Motor Skills Disorders	MESH:D019957	marker/mechanism		NA		16465081
FGFR2	2263	Pfeiffer type acrocephalosyndactyly	MESH:C538582	marker/mechanism		NA	101600	
FGFR2	2263	Plagiocephaly, Nonsynostotic	MESH:D049068	marker/mechanism		NA		9152842
FGFR2	2263	Scaphocephaly, Maxillary Retrusion, And Mental Retardation	MESH:C566511	marker/mechanism		NA	609579	
FGFR2	2263	Skin Abnormalities	MESH:D012868	marker/mechanism		NA		10631169
FGFR2	2263	Skin Diseases	MESH:D012871	marker/mechanism		NA		22533443
FGFR2	2263	Spinal Dysraphism	MESH:D016135	marker/mechanism		NA		9605588
FGFR2	2263	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA	613659	21173787|21936542
FGFR2	2263	Tooth Abnormalities	MESH:D014071	marker/mechanism		NA		10631169
FGFR3	2261	Achondroplasia	MESH:D000130	marker/mechanism		NA	100800|616482	
FGFR3	2261	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		24121792
FGFR3	2261	CATSHL syndrome	MESH:C537975	marker/mechanism		NA	610474	
FGFR3	2261	Cleft Lip	MESH:D002971	marker/mechanism		NA		17963255
FGFR3	2261	Cleft Palate	MESH:D002972	marker/mechanism		NA		17963255
FGFR3	2261	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	114500	
FGFR3	2261	Crouzon Syndrome With Acanthosis Nigricans	MESH:C567382	marker/mechanism		NA	612247	23437153
FGFR3	2261	Epidermal Nevus	MESH:C580062	marker/mechanism		NA	162900	
FGFR3	2261	Hypochondroplasia	MESH:C562937	marker/mechanism		NA	146000	
FGFR3	2261	Lacrimoauriculodentodigital syndrome	MESH:C538132	marker/mechanism		NA	149730	
FGFR3	2261	Muenke Syndrome	MESH:C537369	marker/mechanism		NA	602849	
FGFR3	2261	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		21936542
FGFR3	2261	Seminoma	MESH:D018239	marker/mechanism		NA		19855393
FGFR3	2261	Testicular Germ Cell Tumor	MESH:C563236	marker/mechanism		NA	273300	
FGFR3	2261	Thanatophoric Dysplasia	MESH:D013796	marker/mechanism		NA		19855393
FGFR3	2261	Thanatophoric dysplasia, type 2	MESH:C536508	marker/mechanism		NA	187601	
FGFR3	2261	Thanatophoric Dysplasia, Type I	MESH:C566844	marker/mechanism		NA	187600	
FGFR3	2261	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA	109800	19855393|20348956|21936542|24121792|26853465
FGFR3	2261	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA	603956	
FGFR4	2264	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
FGFR4	2264	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		15448004
FGFR4	2264	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
FGFRL1	53834	Hernias, Diaphragmatic, Congenital	MESH:D065630	marker/mechanism		NA		20938900
FGFRL1	53834	Wolf-Hirschhorn Syndrome	MESH:D054877	marker/mechanism		NA	194190	
FGG	2266	Afibrinogenemia	MESH:D000347	marker/mechanism		NA	202400	
FGG	2266	Dysfibrinogenemia, Congenital	MESH:C562727	marker/mechanism		NA	616004	
FGG	2266	Keloid	MESH:D007627	marker/mechanism		NA		20128793
FGG	2266	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		19424620
FGGY	55277	Obesity	MESH:D009765	marker/mechanism		NA		29220483
FGGY	55277	Weight Gain	MESH:D015430	marker/mechanism		NA		29220483
FGL2	10875	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17374397
FGL2	10875	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FGR	2268	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FH	2271	Fumaric aciduria	MESH:C538191	marker/mechanism		NA	606812	
FH	2271	Hereditary leiomyomatosis and renal cell cancer	MESH:C535516	marker/mechanism		NA	150800	16403393|28289076|30013182
FHIT	2272	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
FHIT	2272	Carcinoma	MESH:D002277	marker/mechanism		NA		16061637
FHIT	2272	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		11788890
FHIT	2272	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		12112319
FHIT	2272	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		10959838|16061637
FHIT	2272	Mesothelioma	MESH:D008654	marker/mechanism		NA		14569398|18038314
FHIT	2272	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17548701
FHIT	2272	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		12958204
FHIT	2272	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
FHIT	2272	Urologic Neoplasms	MESH:D014571	marker/mechanism		NA		23618899
FHL1	2273	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
FHL1	2273	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FHL1	2273	Myopathy, Reducing Body, X-Linked, Childhood-Onset	MESH:C567468	marker/mechanism		NA	300718	
FHL1	2273	Myopathy, Reducing Body, X-Linked, Early-Onset, Severe	MESH:C567469	marker/mechanism		NA	300717	
FHL1	2273	Myopathy, X-Linked, With Postural Muscle Atrophy	MESH:C567480	marker/mechanism		NA	300696	
FHL1	2273	Scapuloperoneal Myopathy, X-Linked Dominant	MESH:C567481	marker/mechanism		NA	300695	
FHL2	2274	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17682292
FHL2	2274	Cardiomegaly	MESH:D006332	marker/mechanism		NA		25358972
FHL2	2274	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
FHL2	2274	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FHL3	2275	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		30510241
FHL5	9457	Migraine Disorders	MESH:D008881	marker/mechanism		NA		23793025
FHOD3	80206	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
FIBIN	387758	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
FIBP	9158	THAUVIN-ROBINET-FAIVRE SYNDROME	OMIM:617107	marker/mechanism		NA	617107	
FIG4	9896	Amyotrophic Lateral Sclerosis 11	MESH:C567244	marker/mechanism		NA	612577	
FIG4	9896	Charcot-Marie-Tooth Disease	MESH:D002607	marker/mechanism		NA		17572665
FIG4	9896	Charcot-Marie-Tooth Disease, Type 4j	MESH:C566984	marker/mechanism		NA	611228	
FIG4	9896	Polymicrogyria, Bilateral Occipital	MESH:C567201	marker/mechanism		NA	612691	
FIG4	9896	Yunis Varon syndrome	MESH:C536719	marker/mechanism		NA	216340	
FIGLA	344018	Premature Ovarian Failure 6	MESH:C567351	marker/mechanism		NA	612310	
FIGNL1	63979	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		28321044
FILIP1	27145	Osteoarthritis, Hip	MESH:D015207	marker/mechanism		NA		30374069
FILIP1	27145	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
FIP1L1	81608	Heart Failure	MESH:D006333	marker/mechanism		NA		28347583
FIP1L1	81608	Hypereosinophilic Syndrome	MESH:D017681	marker/mechanism		NA		16778211|28347583
FIS1	51024	Ceroid lipofuscinosis, neuronal 1, infantile	MESH:C537948	marker/mechanism		NA		21224254
FIS1	51024	Ventricular Remodeling	MESH:D020257	marker/mechanism		NA		20886221
FJX1	24147	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		27935819
FKBP10	60681	Bruck syndrome 1	MESH:C537406	marker/mechanism		NA	259450	
FKBP10	60681	OSTEOGENESIS IMPERFECTA, TYPE XI	OMIM:610968	marker/mechanism		NA	610968	
FKBP11	51303	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
FKBP11	51303	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
FKBP14	55033	EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2	OMIM:614557	marker/mechanism		NA	614557	
FKBP15	23307	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
FKBP15	23307	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
FKBP1A	2280	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
FKBP1A	2280	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FKBP2	2286	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
FKBP2	2286	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
FKBP5	2289	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		12833524
FKBP5	2289	Depressive Disorder, Major	MESH:D003865	marker/mechanism		NA	608516	
FKBP5	2289	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
FKBP5	2289	Infant, Newborn, Diseases	MESH:D007232	marker/mechanism		NA		25115650
FKBP5	2289	Neurobehavioral Manifestations	MESH:D019954	marker/mechanism		NA		25115650
FKBPL	63943	Breast Neoplasms	MESH:D001943	therapeutic		NA		20103631
FKRP	79147	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 5	OMIM:606612	marker/mechanism		NA	606612	
FKRP	79147	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5	OMIM:607155	marker/mechanism		NA	607155	
FKRP	79147	Walker-Warburg Syndrome	MESH:D058494	marker/mechanism		NA	236670|613153	
FKTN	2218	Cardiomyopathy, Dilated, 1x	MESH:C566907	marker/mechanism		NA	611615	
FKTN	2218	Muscular Dystrophies	MESH:D009136	marker/mechanism		NA		16531417
FKTN	2218	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 4	OMIM:613152	marker/mechanism		NA	613152	
FKTN	2218	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4	OMIM:611588	marker/mechanism		NA	611588	
FKTN	2218	Walker-Warburg Syndrome	MESH:D058494	marker/mechanism		NA	236670|253800	
FLACC1	130540	Anthracosis	MESH:D055008	marker/mechanism		NA		29394417
FLACC1	130540	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
FLAD1	80308	Myopathy with Abnormal Lipid Metabolism	MESH:C562935	marker/mechanism		NA	255100	
FLCN	201163	Birt-Hogg-Dube Syndrome	MESH:D058249	marker/mechanism		NA	135150	12204536|24726356|27072130
FLCN	201163	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA	144700	12204536
FLCN	201163	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	114500	
FLCN	201163	Cysts	MESH:D003560	marker/mechanism		NA		27072130
FLCN	201163	Hamartoma	MESH:D006222	marker/mechanism		NA		12204536|27072130
FLCN	201163	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
FLCN	201163	Oncocytoma, renal	MESH:C537750	marker/mechanism		NA		12204536
FLCN	201163	Pneumothorax	MESH:D011030	marker/mechanism		NA	173600	12204536
FLCN	201163	Potocki-Lupski syndrome	MESH:C538355	marker/mechanism		NA	610883	
FLG	2312	Dermatitis	MESH:D003872	marker/mechanism		NA		31330126
FLG	2312	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		19349982|23042114|23348739|24061166
FLG	2312	Dermatitis, Atopic, 2	MESH:C565293	marker/mechanism		NA	605803	
FLG	2312	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
FLG	2312	Eczema	MESH:D004485	marker/mechanism		NA		17417636
FLG	2312	Ichthyosis Vulgaris	MESH:D016112	marker/mechanism		NA	146700	17417636|24061166
FLI1	2313	BLEEDING DISORDER, PLATELET-TYPE, 21	OMIM:617443	marker/mechanism		NA	617443	
FLI1	2313	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FLI1	2313	Medulloblastoma	MESH:D008527	marker/mechanism		NA		19270706
FLI1	2313	Sarcoma, Ewing	MESH:D012512	marker/mechanism		NA		11772151|16646077|26214589
FLNA	2316	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		26437033
FLNA	2316	Cardiac valvular dysplasia, X-linked	MESH:C535576	marker/mechanism		NA	314400	
FLNA	2316	Congenital idiopathic intestinal pseudoobstruction	MESH:C535532	marker/mechanism		NA	300048	
FLNA	2316	Epilepsy	MESH:D004827	marker/mechanism		NA		11914408
FLNA	2316	Frontometaphyseal dysplasia	MESH:C538064	marker/mechanism		NA	305620	12612583|16596676
FLNA	2316	Heterotopia, Periventricular, Ehlers-Danlos Variant	MESH:C564492	marker/mechanism		NA		15668422
FLNA	2316	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FLNA	2316	Opitz-Kaveggia syndrome	MESH:C537923	marker/mechanism		NA	300321	17632775
FLNA	2316	Osteochondrodysplasias	MESH:D010009	marker/mechanism		NA	309350	12612583
FLNA	2316	Oto-Palato-digital syndrome type 1	MESH:C536065	marker/mechanism		NA	311300	12612583|15940695|16596676
FLNA	2316	Oto-palato-digital syndrome, type 2	MESH:C538089	marker/mechanism		NA	304120	12612583|15378534
FLNA	2316	Periventricular Nodular Heterotopia	MESH:D054091	marker/mechanism		NA	300049	11914408|9883725
FLNA	2316	Phyllodes Tumor	MESH:D003557	marker/mechanism		NA		26437033
FLNA	2316	TERMINAL OSSEOUS DYSPLASIA	OMIM:300244	marker/mechanism		NA	300244	
FLNB	2317	Atelosteogenesis, type 1	MESH:C535396	marker/mechanism		NA	108720	14991055
FLNB	2317	ATELOSTEOGENESIS, TYPE III	OMIM:108721	marker/mechanism		NA	108721	14991055
FLNB	2317	Boomerang dysplasia	MESH:C536573	marker/mechanism		NA	112310	
FLNB	2317	Larsen syndrome, dominant type	MESH:C537873	marker/mechanism		NA	150250	14991055
FLNB	2317	Spondylocarpotarsal synostosis	MESH:C535780	marker/mechanism		NA	272460	14991055
FLNC	2318	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 26	OMIM:617047	marker/mechanism		NA	617047	
FLNC	2318	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		21278247
FLNC	2318	Filaminopathy, autosomal dominant	MESH:C537932	marker/mechanism		NA	609524	
FLNC	2318	MYOPATHY, DISTAL, 4	OMIM:614065	marker/mechanism		NA	614065	
FLOT1	10211	Q Fever	MESH:D011778	marker/mechanism		NA		16469060
FLRT3	23767	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
FLRT3	23767	HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA	OMIM:615271	marker/mechanism		NA	615271	
FLT1	2321	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		23146280|26124351
FLT1	2321	Carcinoma, Renal Cell	MESH:D002292	therapeutic		NA		16596207
FLT1	2321	Cerebral Hemorrhage	MESH:D002543	marker/mechanism		NA		17888890
FLT1	2321	Chemical and Drug Induced Liver Injury	MESH:D056486	therapeutic		NA		21135413
FLT1	2321	Disease Progression	MESH:D018450	marker/mechanism		NA		23146280
FLT1	2321	Hemangiosarcoma	MESH:D006394	marker/mechanism		NA		17569031
FLT1	2321	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		11981751
FLT1	2321	Melanoma	MESH:D008545	marker/mechanism		NA		19718025
FLT1	2321	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		21975929
FLT1	2321	Osteochondrodysplasias	MESH:D010009	marker/mechanism		NA		17954590
FLT1	2321	Pre-Eclampsia	MESH:D011225	marker/mechanism		NA		18679377|28628106
FLT1	2321	Recurrence	MESH:D012008	marker/mechanism		NA		23146280|26124351
FLT1	2321	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		19718025
FLT1	2321	Uremia	MESH:D014511	marker/mechanism		NA		19092814
FLT3	2322	Acute erythroleukemia	MESH:C535673	marker/mechanism		NA		30926971
FLT3	2322	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA	601626	17050201|17184839|19822134|21441929|21482694|21928377|22409268|23036488|23906301|24526162|25053825|27099147|27992414
FLT3	2322	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		17454189|24160850|26285909
FLT3	2322	Leukocytosis	MESH:D007964	marker/mechanism		NA		27099147|27725143
FLT3	2322	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA	613065	
FLT3	2322	Splenomegaly	MESH:D013163	marker/mechanism		NA		27725143
FLT3	2322	Thrombosis	MESH:D013927	marker/mechanism		NA		16932337
FLT4	2324	Clear-cell metastatic renal cell carcinoma	MESH:C538445	marker/mechanism		NA		25239121
FLT4	2324	Hemangioma, capillary infantile	MESH:C535860	marker/mechanism		NA	602089	
FLT4	2324	Lymphedema	MESH:D008209	marker/mechanism		NA	153100	
FLT4	2324	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
FLT4	2324	Tetralogy of Fallot	MESH:D013771	marker/mechanism		NA		28991257
FLVCR1	28982	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
FLVCR1	28982	Posterior column ataxia with retinitis pigmentosa	MESH:C536343	marker/mechanism		NA	609033	
FLVCR2	55640	Encephaloclastic Proliferative Vasculopathy	MESH:C565593	marker/mechanism		NA	225790	
FMC1	154791	Parkinson Disease, Mitochondrial	MESH:C564015	marker/mechanism		NA		29371327
FMC1	154791	Parkinson Disease, Secondary	MESH:D010302	marker/mechanism		NA		29371327
FMN2	56776	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		22138691
FMN2	56776	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	OMIM:616193	marker/mechanism		NA	616193	
FMNL1	752	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FMNL2	114793	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FMO1	2326	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		17127561
FMO1	2326	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980|25380136
FMO2	2327	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
FMO3	2328	Adenomatous Polyposis Coli	MESH:D011125	therapeutic		NA		17559352
FMO3	2328	Chemical and Drug Induced Liver Injury	MESH:D056486	therapeutic		NA		24973094
FMO3	2328	Trimethylaminuria	MESH:C536561	marker/mechanism		NA	602079	12214664|16601883
FMR1	2332	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		28616095
FMR1	2332	Autistic Disorder	MESH:D001321	marker/mechanism		NA		14755444|15000256|18621663|20425835|9806479
FMR1	2332	Cognition Disorders	MESH:D003072	marker/mechanism		NA		22043169
FMR1	2332	Congenital Abnormalities	MESH:D000013	marker/mechanism		NA		20425835
FMR1	2332	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		17065172|22043169
FMR1	2332	Facies	MESH:D019066	marker/mechanism		NA		22043169
FMR1	2332	Fragile X Syndrome	MESH:D005600	marker/mechanism		NA	300624	15028757|16043816|16510718|17065172|18835858|20300527|22043169|28616095
FMR1	2332	Fragile X Tremor Ataxia Syndrome	MESH:C564105	marker/mechanism		NA	300623	27385396
FMR1	2332	Gonadal Dysgenesis	MESH:D006059	marker/mechanism		NA		22043169
FMR1	2332	Intellectual Disability	MESH:D008607	marker/mechanism		NA		15000256|20425835
FMR1	2332	Primary Ovarian Insufficiency	MESH:D016649	marker/mechanism		NA	311360	12548733
FN1	2335	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
FN1	2335	Aortic Valve Insufficiency	MESH:D001022	marker/mechanism		NA		21216836
FN1	2335	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		24014025
FN1	2335	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
FN1	2335	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		24014025
FN1	2335	Crohn Disease	MESH:D003424	marker/mechanism		NA		19751734
FN1	2335	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		20551625
FN1	2335	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		24413998
FN1	2335	Glioblastoma	MESH:D005909	marker/mechanism		NA		17099729
FN1	2335	Glomerulopathy with fibronectin deposits	MESH:C536826	marker/mechanism		NA	601894	
FN1	2335	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA		16191423
FN1	2335	Hypertension	MESH:D006973	marker/mechanism		NA		11682445|17324946
FN1	2335	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		11181017
FN1	2335	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
FN1	2335	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
FN1	2335	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		23056237
FN1	2335	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		24014025
FN1	2335	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		26817844
FN1	2335	Ureteral Obstruction	MESH:D014517	marker/mechanism		NA		28318631
FNBP1P1	100533642	Anthracosis	MESH:D055008	marker/mechanism		NA		29394417
FNDC3B	64778	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		31557154
FNDC3B	64778	Glaucoma, Open-Angle	MESH:D005902	marker/mechanism		NA		23291589
FNDC3B	64778	Keratoconus	MESH:D007640	marker/mechanism		NA		23291589
FNDC3B	64778	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		28314734
FNDC4	64838	Lipidoses	MESH:D008064	marker/mechanism		NA		15342952|16919414|17175557
FNDC5	252995	Cardiomegaly	MESH:D006332	therapeutic		NA		30703374
FNDC5	252995	Endomyocardial Fibrosis	MESH:D004719	therapeutic		NA		30703374
FNDC5	252995	Hypertension	MESH:D006973	therapeutic		NA		32165127
FNDC5	252995	Inflammation	MESH:D007249	therapeutic		NA		32165127
FNDC5	252995	Ventricular Dysfunction, Left	MESH:D018487	therapeutic		NA		30703374
FOLH1	2346	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		18247401|21923190
FOLR1	2348	Brain Diseases, Metabolic, Inborn	MESH:D020739	marker/mechanism		NA		19732866
FOLR1	2348	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15705887|18926688
FOLR1	2348	Congenital Abnormalities	MESH:D000013	marker/mechanism		NA		20235221
FOLR1	2348	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		15800851
FOLR1	2348	Epilepsy	MESH:D004827	marker/mechanism		NA		19732866
FOLR1	2348	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		17286298
FOLR1	2348	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
FOLR1	2348	Movement Disorders	MESH:D009069	marker/mechanism		NA		19732866
FOLR1	2348	Neural Tube Defects	MESH:D009436	marker/mechanism		NA		15800851
FOLR1	2348	Neurodegeneration Due To Cerebral Folate Transport Deficiency	MESH:C567791	marker/mechanism		NA	613068	
FOLR1	2348	Osteosarcoma	MESH:D012516	marker/mechanism		NA		17473184
FOLR1	2348	Ovarian Neoplasms	MESH:D010051	therapeutic		NA		17466904
FOLR1	2348	Psychomotor Disorders	MESH:D011596	marker/mechanism		NA		19732866
FOLR2	2350	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FOLR2	2350	Neural Tube Defects	MESH:D009436	marker/mechanism		NA		11749123
FOLR2	2350	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		30794826
FOS	2353	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		19689456
FOS	2353	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
FOS	2353	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		16488545
FOS	2353	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
FOS	2353	Brain Injuries	MESH:D001930	marker/mechanism		NA		9630518
FOS	2353	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037
FOS	2353	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560|9029167
FOS	2353	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		28811376
FOS	2353	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		8777434
FOS	2353	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		28789951
FOS	2353	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		17276011|18311559|19533625
FOS	2353	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27093858
FOS	2353	Endometriosis	MESH:D004715	marker/mechanism		NA		23284138
FOS	2353	Epilepsy	MESH:D004827	marker/mechanism		NA		15973680
FOS	2353	Fibrous Dysplasia of Bone	MESH:D005357	marker/mechanism		NA		7739708
FOS	2353	Heat Stroke	MESH:D018883	marker/mechanism		NA		24039931
FOS	2353	Hemorrhage	MESH:D006470	marker/mechanism		NA		7844257
FOS	2353	Hyperalgesia	MESH:D006930	marker/mechanism		NA		27093858
FOS	2353	Hyperkinesis	MESH:D006948	marker/mechanism		NA		18355967
FOS	2353	Hypertension	MESH:D006973	marker/mechanism		NA		12044476|24039778
FOS	2353	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		12374626
FOS	2353	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FOS	2353	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		16289808
FOS	2353	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		12890883
FOS	2353	Neurotoxicity Syndromes	MESH:D020258	therapeutic		NA		19220411
FOS	2353	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		7922267
FOS	2353	Seizures	MESH:D012640	marker/mechanism		NA		11955713|12946577|8923670|9630518
FOS	2353	Status Epilepticus	MESH:D013226	marker/mechanism		NA		16696126|18587450|18988310|7984056
FOS	2353	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		15196791|15196794|18485423
FOS	2353	Trigeminal Neuralgia	MESH:D014277	marker/mechanism		NA		27093858
FOSB	2354	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
FOSB	2354	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
FOSB	2354	Cocaine-Related Disorders	MESH:D019970	marker/mechanism|therapeutic		NA		12657709|17898221|18539927|19331462
FOSB	2354	Cognition Disorders	MESH:D003072	marker/mechanism		NA		24067299
FOSB	2354	Disruptive, Impulse Control, and Conduct Disorders	MESH:D007174	marker/mechanism		NA		18539927
FOSB	2354	Dyskinesia, Drug-Induced	MESH:D004409	marker/mechanism		NA		17219962
FOSB	2354	Epilepsy	MESH:D004827	marker/mechanism		NA		16391389
FOSB	2354	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		26411935
FOSB	2354	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
FOSB	2354	Movement Disorders	MESH:D009069	marker/mechanism		NA		10600402
FOSB	2354	Prenatal Exposure Delayed Effects	MESH:D011297	marker/mechanism		NA		26411935
FOSL2	2355	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
FOSL2	2355	Glioblastoma	MESH:D005909	marker/mechanism		NA		23582323
FOSL2	2355	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
FOXA1	3169	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		23001124
FOXA1	3169	Carcinoma, Ductal	MESH:D044584	marker/mechanism		NA		29295717
FOXA1	3169	Fatty Liver	MESH:D005234	marker/mechanism		NA		24469900
FOXA1	3169	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		22610119|26457646|29295717|29610475|32690948
FOXA2	3170	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		16863852
FOXA2	3170	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FOXA2	3170	Lung Diseases	MESH:D008171	marker/mechanism		NA		16863852
FOXA3	3171	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		22919386
FOXC1	2296	AXENFELD-RIEGER SYNDROME, TYPE 1	OMIM:180500	marker/mechanism		NA		14630904
FOXC1	2296	AXENFELD-RIEGER SYNDROME, TYPE 3	OMIM:602482	marker/mechanism		NA	602482	
FOXC1	2296	Dandy-Walker Syndrome	MESH:D003616	marker/mechanism		NA		19668217
FOXC1	2296	Glaucoma, Open-Angle	MESH:D005902	marker/mechanism		NA		26752265
FOXC1	2296	Iridogoniodysgenesis type1	MESH:C535535	marker/mechanism		NA	601631	
FOXC1	2296	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
FOXC1	2296	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA		19668217
FOXC1	2296	Tetralogy of Fallot	MESH:D013771	marker/mechanism		NA		25093829
FOXC2	2303	Cardiovascular Abnormalities	MESH:D018376	marker/mechanism		NA		9409679
FOXC2	2303	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		9106663|9409679
FOXC2	2303	Hernias, Diaphragmatic, Congenital	MESH:D065630	marker/mechanism		NA		27663689
FOXC2	2303	Lymphedema distichiasis syndrome	MESH:C537710	marker/mechanism		NA	153400	11078474
FOXC2	2303	Musculoskeletal Abnormalities	MESH:D009139	marker/mechanism		NA		9106663
FOXC2	2303	Tetralogy of Fallot	MESH:D013771	marker/mechanism		NA		25093829
FOXD3	27022	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 1	OMIM:607836	marker/mechanism		NA	607836	
FOXD4L3	286380	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		29054765
FOXD4L5	653427	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		29054765
FOXE1	2304	Bamforth syndrome	MESH:C537901	marker/mechanism		NA	241850	16884476
FOXE1	2304	THYROID CANCER, NONMEDULLARY, 4	OMIM:616534	marker/mechanism		NA	616534	
FOXE3	2301	AORTIC ANEURYSM, FAMILIAL THORACIC 11, SUSCEPTIBILITY TO	OMIM:617349	marker/mechanism		NA	617349	
FOXE3	2301	Aphakia, congenital primary	MESH:C537786	marker/mechanism		NA	610256	
FOXE3	2301	Cataract, Autosomal Recessive Congenital 3	MESH:C567835	marker/mechanism		NA	612968	
FOXF1	2294	Alveolar capillary dysplasia	MESH:C536590	marker/mechanism		NA	265380	
FOXF1	2294	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
FOXF1	2294	Hernias, Diaphragmatic, Congenital	MESH:D065630	marker/mechanism		NA		27663689
FOXF1	2294	Lung Diseases, Obstructive	MESH:D008173	marker/mechanism		NA		18421012
FOXF1	2294	Mastocytosis	MESH:D008415	marker/mechanism		NA		18421012
FOXF2	2295	Stroke	MESH:D020521	marker/mechanism		NA		29531354
FOXF2A	407681	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		20055451
FOXG1	2290	Acrocallosal Syndrome	MESH:D055673	marker/mechanism		NA		18627055
FOXG1	2290	Epilepsy	MESH:D004827	marker/mechanism		NA		29942082
FOXG1	2290	Intellectual Disability	MESH:D008607	marker/mechanism		NA		18627055
FOXG1	2290	Microcephaly	MESH:D008831	marker/mechanism		NA		18627055
FOXG1	2290	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		23203475
FOXG1	2290	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		29942082
FOXG1	2290	RETT SYNDROME, CONGENITAL VARIANT	OMIM:613454	marker/mechanism		NA	613454	
FOXG1	2290	Seizures	MESH:D012640	marker/mechanism		NA		18627055
FOXH1	8928	Tetralogy of Fallot	MESH:D013771	marker/mechanism		NA		25093829
FOXI1	2299	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		16759393
FOXI1	2299	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT	OMIM:600791	marker/mechanism		NA	600791	
FOXI1	2299	Pendred syndrome	MESH:C536648	marker/mechanism		NA	274600	
FOXK2	3607	Infertility, Male	MESH:D007248	marker/mechanism		NA		32522586
FOXL2	668	Blepharophimosis, Ptosis, and Epicanthus Inversus	MESH:C562419	marker/mechanism		NA	110100	
FOXL2	668	Blepharophimosis syndrome type 1	MESH:C536233	marker/mechanism		NA		16219626|20429427|21889601
FOXL2	668	Bpes With Duane Retraction Syndrome	MESH:C566222	marker/mechanism		NA		16283882
FOXL2	668	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17892325
FOXL2	668	Keloid	MESH:D007627	marker/mechanism		NA		20711176
FOXL2	668	Premature Ovarian Failure 3	MESH:C563816	marker/mechanism		NA	608996	
FOXM1	2305	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20208560
FOXM1	2305	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		15082532|17173139|28284560
FOXM1	2305	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		18345025|19672312
FOXM1	2305	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		25133636
FOXM1	2305	Leukemia	MESH:D007938	marker/mechanism		NA		19436953
FOXM1	2305	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		15082532
FOXM1	2305	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		16489016|23255470
FOXM1	2305	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		13679865
FOXN1	8456	T-cell immunodeficiency, congenital alopecia and nail dystrophy	MESH:C536781	marker/mechanism		NA	601705	
FOXO1	2308	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		27663689
FOXO1	2308	Keratoconus	MESH:D007640	marker/mechanism		NA		23291589
FOXO1	2308	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
FOXO1	2308	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29662167
FOXO1	2308	Rhabdomyosarcoma, Alveolar	MESH:D018232	marker/mechanism		NA	268220	
FOXO1A	768121	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
FOXO1A	768121	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
FOXO3	2309	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		19380174
FOXO3	2309	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
FOXO3	2309	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		19380174
FOXO3	2309	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		23090186|23792339
FOXO3	2309	Encephalomyelitis, Autoimmune, Experimental	MESH:D004681	marker/mechanism		NA		27742544
FOXO3	2309	Obesity	MESH:D009765	marker/mechanism		NA		23954404
FOXO3	2309	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		23099361
FOXO3A	494532	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
FOXP1	27086	Adenocarcinoma Of Esophagus	MESH:C562730	marker/mechanism		NA		24121790
FOXP1	27086	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
FOXP1	27086	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		21572417
FOXP1	27086	Lymphatic Metastasis	MESH:D008207	marker/mechanism		NA		25485836
FOXP1	27086	MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	OMIM:613670	marker/mechanism		NA	613670	
FOXP1	27086	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		25485836
FOXP1	27086	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
FOXP1	27086	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		25485836
FOXP1	27086	Vitiligo	MESH:D014820	marker/mechanism		NA		20526340
FOXP2	93986	Apraxias	MESH:D001072	marker/mechanism		NA	602081	17033973|27120335
FOXP2	93986	Autistic Disorder	MESH:D001321	marker/mechanism		NA		15108192|17033973
FOXP2	93986	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
FOXP2	93986	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		17033973
FOXP2	93986	Language Development Disorders	MESH:D007805	marker/mechanism		NA		27120335
FOXP2	93986	Silver-Russell Syndrome	MESH:D056730	marker/mechanism		NA		17033973
FOXP3	50943	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		20476861
FOXP3	50943	Asthma	MESH:D001249	marker/mechanism		NA		27965764|29317916
FOXP3	50943	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17570480
FOXP3	50943	Dermatitis, Occupational	MESH:D009783	marker/mechanism		NA		29477354
FOXP3	50943	Hypersensitivity	MESH:D006967	marker/mechanism		NA		27965764
FOXP3	50943	Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome	MESH:C580192	marker/mechanism		NA	304790	27783946
FOXP3	50943	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		23962110
FOXP3	50943	Lung Injury	MESH:D055370	marker/mechanism		NA		28630656
FOXP3	50943	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
FOXP4	116113	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		20676098
FOXQ1	94234	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		27129776
FOXR2	139628	Nerve Sheath Neoplasms	MESH:D018317	marker/mechanism		NA		23685747
FOXRED1	55572	Mitochondrial Diseases	MESH:D028361	marker/mechanism		NA		20818383
FOXRED1	55572	Mitochondrial Encephalomyopathies	MESH:D017237	marker/mechanism		NA		20858599
FPGS	2356	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		23897011
FPGS	2356	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		15814641
FPGS	2356	Lymphoma, Non-Hodgkin	MESH:D008228	marker/mechanism		NA		17119116
FPGS	2356	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		25013492
FPGT	8790	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		23797736
FPR2	2358	Crohn Disease	MESH:D003424	marker/mechanism		NA		21659618
FRA16E	2464	CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KB	OMIM:136570	marker/mechanism		NA	136570	
FRAS1	80144	Fraser Syndrome	MESH:D058497	marker/mechanism		NA	219000	17163535
FRAS1	80144	Macrostomia	MESH:D008265	marker/mechanism		NA		17163535
FREM1	158326	Bifid nose	MESH:C535441	marker/mechanism		NA		23221805
FREM1	158326	Bifid Nose With Or Without Anorectal And Renal Anomalies	MESH:C567672	marker/mechanism		NA	608980	23221805
FREM1	158326	Craniosynostoses	MESH:D003398	marker/mechanism		NA	614485	
FREM1	158326	Eye Abnormalities	MESH:D005124	marker/mechanism		NA		23221805
FREM1	158326	Hereditary renal agenesis	MESH:C536482	marker/mechanism		NA		23221805
FREM1	158326	Hernias, Diaphragmatic, Congenital	MESH:D065630	marker/mechanism		NA		23221805|26382659
FREM1	158326	Marles Greenberg Persaud syndrome	MESH:C536022	marker/mechanism		NA	248450	23221805
FREM2	341640	Fraser Syndrome	MESH:D058497	marker/mechanism		NA		17163535
FREM3	166752	Depressive Disorder, Major	MESH:D003865	marker/mechanism		NA		26441752
FRG1	2483	Facioscapulohumeral muscular dystrophy 1a	MESH:C536391	marker/mechanism		NA	158900	
FRK	2444	Glucose Intolerance	MESH:D018149	marker/mechanism		NA		17179392
FRMD3	257019	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
FRMD4A	55691	CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA	OMIM:616819	marker/mechanism		NA	616819	
FRMD4A	55691	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
FRMD4B	23150	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
FRMD7	90167	Nystagmus 1, congenital, X- linked	MESH:C537853	marker/mechanism		NA	310700	19892780
FRMPD4	9758	MENTAL RETARDATION, X-LINKED 104	OMIM:300983	marker/mechanism		NA	300983	
FRRS1L	23732	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 37	OMIM:616981	marker/mechanism		NA	616981	
FRY	10129	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
FRY	10129	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FRZB	2487	Osteoarthritis	MESH:D010003	marker/mechanism		NA	165720	
FSCN2	25794	Retinitis Pigmentosa 30	MESH:C564310	marker/mechanism		NA	607921	
FSD1	79187	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
FSHB	2488	Alcoholism	MESH:D000437	marker/mechanism		NA		8590623
FSHB	2488	Amenorrhea	MESH:D000568	marker/mechanism		NA		8220432
FSHB	2488	Fever	MESH:D005334	marker/mechanism		NA		6350720
FSHB	2488	Follicle-stimulating hormone deficiency, isolated	MESH:C537070	marker/mechanism		NA	229070	
FSHB	2488	Hypogonadism	MESH:D007006	marker/mechanism|therapeutic		NA		18449926|24739304|8263139
FSHB	2488	Infertility, Female	MESH:D007247	marker/mechanism		NA		8220432
FSHB	2488	Infertility, Male	MESH:D007248	marker/mechanism		NA		387166
FSHB	2488	Lateral Medullary Syndrome	MESH:D014854	marker/mechanism		NA		17344003
FSHB	2488	Oligospermia	MESH:D009845	marker/mechanism		NA		4607150
FSHR	2492	OVARIAN DYSGENESIS 1	OMIM:233300	marker/mechanism		NA	233300	
FSHR	2492	Ovarian Hyperstimulation Syndrome	MESH:D016471	marker/mechanism		NA	608115	
FSHR	2492	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		22885925
FST	10468	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
FST	10468	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037
FST	10468	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		12203361|19363144
FST	10468	Liver Failure, Acute	MESH:D017114	marker/mechanism		NA		12560755
FST	10468	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		12203361
FST	10468	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
FSTL1	11167	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		20861081
FSTL1	11167	Aortic Valve Insufficiency	MESH:D001022	marker/mechanism		NA		21216836
FSTL1	11167	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FSTL1	11167	Scleroderma, Systemic	MESH:D012595	marker/mechanism		NA		27482699
FSTL1	11167	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
FSTL5	56884	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		31043756
FTCD	10841	Burkitt Lymphoma	MESH:D002051	marker/mechanism		NA		23143597
FTCD	10841	Glutamate formiminotransferase deficiency	MESH:C537425	marker/mechanism		NA	229100	
FTCD	10841	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FTH1	2495	Depressive Disorder	MESH:D003866	marker/mechanism		NA		17063146
FTH1	2495	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
FTH1	2495	Glioma	MESH:D005910	marker/mechanism		NA		21385903
FTH1	2495	HEMOCHROMATOSIS, TYPE 5	OMIM:615517	marker/mechanism		NA	615517	
FTH1	2495	Iron Overload	MESH:D019190	marker/mechanism		NA		11389486
FTH1	2495	Keloid	MESH:D007627	marker/mechanism		NA		20128793
FTH1	2495	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		26818092
FTH1	2495	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		20390345
FTH1	2495	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		15964507
FTH1	2495	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21785164
FTL	2512	Depressive Disorder	MESH:D003866	marker/mechanism		NA		17063146
FTL	2512	Heredodegenerative Disorders, Nervous System	MESH:D020271	marker/mechanism		NA		16825958
FTL	2512	Hyperferritinemia, hereditary, with congenital cataracts	MESH:C538137	marker/mechanism		NA	600886	
FTL	2512	Iron Metabolism Disorders	MESH:D019189	marker/mechanism		NA		16822677
FTL	2512	Keloid	MESH:D007627	marker/mechanism		NA		20128793
FTL	2512	L-FERRITIN DEFICIENCY	OMIM:615604	marker/mechanism		NA	615604	
FTL	2512	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		20390345
FTL	2512	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17085005
FTL	2512	Neuroferritinopathy	MESH:C548080	marker/mechanism		NA	606159	
FTL	2512	Obesity	MESH:D009765	marker/mechanism		NA		20882379
FTL	2512	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
FTL1	14325	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
FTL1	14325	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		15964507
FTO	79068	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 14	OMIM:612460	marker/mechanism		NA	612460	
FTO	79068	Body Weight	MESH:D001835	marker/mechanism		NA		22344219|22344221
FTO	79068	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		23535733
FTO	79068	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		23104008
FTO	79068	Growth Retardation, Developmental Delay, Coarse Facies, And Early Death	MESH:C567856	marker/mechanism		NA	612938	
FTO	79068	Melanoma	MESH:D008545	marker/mechanism		NA		23455637
FTO	79068	Obesity	MESH:D009765	marker/mechanism		NA		17496892|19079260|19079261|19151714|19918250|21076408
FTO	79068	Pediatric Obesity	MESH:D063766	marker/mechanism		NA		25137265
FTO	79068	Weight Gain	MESH:D015430	marker/mechanism		NA		25322899
FTSJ1	24140	Mental Retardation, X-Linked 9	MESH:C563137	marker/mechanism		NA	309549	
FUCA1	2517	Fucosidosis	MESH:D005645	marker/mechanism		NA	230000	
FURIN	5045	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462|16316942
FURIN	5045	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462|16316942
FURIN	5045	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462|16316942
FUS	2521	Amyotrophic Lateral Sclerosis	MESH:D000690	marker/mechanism		NA		30455313
FUS	2521	Amyotrophic Lateral Sclerosis 6, Autosomal Recessive	MESH:C567699	marker/mechanism		NA	608030	
FUS	2521	Liposarcoma, Myxoid	MESH:D018208	marker/mechanism		NA		7503811|8510758
FUS	2521	TREMOR, HEREDITARY ESSENTIAL, 4	OMIM:614782	marker/mechanism		NA	614782	
FUT2	2524	Caliciviridae Infections	MESH:D017250	marker/mechanism		NA		12692541
FUT2	2524	Crohn Disease	MESH:D003424	marker/mechanism		NA		21102463
FUT2	2524	VITAMIN B12 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1	OMIM:612542	marker/mechanism		NA	612542	
FUT4	2526	Thrombosis	MESH:D013927	marker/mechanism		NA		16932337
FUT7	2529	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
FUZ	80199	Neural Tube Defects	MESH:D009436	marker/mechanism		NA	182940	
FXN	2395	Friedreich Ataxia	MESH:D005621	marker/mechanism		NA		12923074|16120311|16239244|16911956|17101455|20098685|22016819|23418481|26954031|29272104|30451920
FXN	2395	Friedreich Ataxia 1	MESH:C565561	marker/mechanism		NA	229300	
FXN	2395	Neurobehavioral Manifestations	MESH:D019954	marker/mechanism		NA		26954031
FXYD2	486	Hypertension	MESH:D006973	marker/mechanism		NA		22228705
FXYD2	486	Hypomagnesemia 2, renal	MESH:C537152	marker/mechanism		NA	154020	
FXYD2	486	Hypomagnesemia primary	MESH:C537153	marker/mechanism		NA		11062458
FXYD2	486	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FXYD2	486	Magnesium Deficiency	MESH:D008275	marker/mechanism		NA		11062458
FXYD3	5349	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
FXYD3	5349	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		16003754
FXYD5	53827	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FXYD6	53826	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
FXYD6	53826	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FYB1	2533	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		16033404
FYB1	2533	Thrombocytopenia 3	MESH:C567487	marker/mechanism		NA	273900	
FYCO1	79443	Cataract, autosomal recessive congenital 2	MESH:C535337	marker/mechanism		NA	610019	
FYN	2534	Catalepsy	MESH:D002375	marker/mechanism		NA		16407246
FYN	2534	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		26437031
FYN	2534	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FYN	2534	Lymphoma, T-Cell, Peripheral	MESH:D016411	marker/mechanism		NA		24413734
FYN	2534	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		30658076
FYN	2534	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
FZD2	2535	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		21188121
FZD4	8322	Arachnodactyly	MESH:D054119	marker/mechanism		NA		17103440
FZD4	8322	Cleft Palate	MESH:D002972	marker/mechanism		NA		17103440
FZD4	8322	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		17103440
FZD4	8322	Exudative vitreoretinopathy 1	MESH:C536382	marker/mechanism		NA	133780	
FZD4	8322	Retinal Diseases	MESH:D012164	marker/mechanism		NA		17103440
FZD4	8322	Syndactyly	MESH:D013576	marker/mechanism		NA		17103440
FZD6	8323	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 1	OMIM:161050	marker/mechanism		NA	161050	
FZD8	8325	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
FZR1	51343	Polyploidy	MESH:D011123	marker/mechanism		NA		25123929
G0S2	50486	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
G0S2	50486	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
G0S2	50486	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
G0S2	50486	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
G6PC	2538	Glycogen Storage Disease Type I	MESH:D005953	marker/mechanism		NA		7573034|8211187
G6PC	2538	Hepatorenal form of glycogen storage disease	MESH:C538655	marker/mechanism		NA	232200	
G6PC	2538	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
G6PC3	92579	Neutropenia, Severe Congenital, Autosomal Recessive 4	MESH:C567260	marker/mechanism		NA	612541	
G6PD	2539	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		4794122|602954|734759
G6PD	2539	Anemia, Hemolytic	MESH:D000743	marker/mechanism		NA		2502894|4794122|8562390
G6PD	2539	Anemia, Hemolytic, Congenital Nonspherocytic	MESH:D000746	marker/mechanism		NA		10666231|4125296
G6PD	2539	ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	OMIM:300908	marker/mechanism		NA	300908	
G6PD	2539	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
G6PD	2539	Favism	MESH:D005236	marker/mechanism		NA		12028056|16143877
G6PD	2539	Glucosephosphate Dehydrogenase Deficiency	MESH:D005955	marker/mechanism		NA		10666231|4125296|4728291
G6PD	2539	Granulomatous Disease, Chronic	MESH:D006105	marker/mechanism		NA		4125296
G6PD	2539	Hemolysis	MESH:D006461	marker/mechanism		NA		5432368|734759
G6PD	2539	Malaria	MESH:D008288	marker/mechanism		NA	611162	
G6PD	2539	Phagocyte Bactericidal Dysfunction	MESH:D010585	marker/mechanism		NA		4125296
G8	54253	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
GAA	2548	Cardiomyopathy, Hypertrophic	MESH:D002312	marker/mechanism		NA		11328962
GAA	2548	Glomerulonephritis, Membranous	MESH:D015433	marker/mechanism		NA		15466083
GAA	2548	Glycogen Storage Disease Type II	MESH:D006009	marker/mechanism|therapeutic		NA	232300	11328962|15466083|18176891|21644219|21963784
GAA	2548	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		11328962
GAA	2548	Ventricular Dysfunction	MESH:D018754	marker/mechanism		NA		11328962
GAB1	2549	Deafness, Autosomal Recessive 26	MESH:C565329	marker/mechanism		NA	605428	
GAB1	2549	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
GAB2	9846	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
GAB2	9846	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		21996746
GAB2	9846	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		21996746
GABBR1	2550	Alcoholism	MESH:D000437	marker/mechanism		NA		22253714
GABBR1	2550	Autistic Disorder	MESH:D001321	marker/mechanism		NA		16770606|19002745
GABBR1	2550	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		22253714
GABBR1	2550	Hyperkinesis	MESH:D006948	marker/mechanism		NA		16990508
GABBR2	9568	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19002745
GABBR2	9568	TOBACCO ADDICTION, SUSCEPTIBILITY TO	OMIM:188890	marker/mechanism		NA	188890	
GABRA1	2554	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
GABRA1	2554	Ataxia	MESH:D001259	marker/mechanism		NA		12404077
GABRA1	2554	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18821008
GABRA1	2554	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 19	OMIM:615744	marker/mechanism		NA	615744	
GABRA1	2554	Essential Tremor	MESH:D020329	marker/mechanism		NA		15765150
GABRA1	2554	Hepatic Encephalopathy	MESH:D006501	marker/mechanism		NA		15929193
GABRA1	2554	Myoclonic Epilepsy, Juvenile	MESH:D020190	marker/mechanism		NA	611136	
GABRA1	2554	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
GABRA2	2555	Alcoholism	MESH:D000437	marker/mechanism		NA	103780	22253714
GABRA2	2555	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		18313124
GABRA2	2555	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18821008
GABRA2	2555	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		19833324|20133874
GABRA2	2555	Heroin Dependence	MESH:D006556	marker/mechanism		NA		19833324
GABRA3	2556	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18821008
GABRA4	2557	Ataxia	MESH:D001259	marker/mechanism		NA		16091474
GABRA4	2557	Autistic Disorder	MESH:D001321	marker/mechanism		NA		16080114|16770606
GABRA5	2558	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		27231709
GABRA5	2558	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17353214
GABRA5	2558	Isodicentric Chromosome 15 Syndrome	MESH:C580205	marker/mechanism		NA		23663378
GABRA5	2558	Memory Disorders	MESH:D008569	marker/mechanism		NA		20180861
GABRA5	2558	Seizures	MESH:D012640	marker/mechanism		NA		8985701
GABRA5	2558	Social Communication Disorder	MESH:D000067404	marker/mechanism		NA		27231709
GABRA6	2559	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		25257527
GABRA6	2559	Schizophrenia	MESH:D012559	marker/mechanism		NA		18923069
GABRB1	2560	Autistic Disorder	MESH:D001321	marker/mechanism		NA		16080114|16770606
GABRB1	2560	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	OMIM:617153	marker/mechanism		NA	617153	
GABRB1	2560	Hepatic Encephalopathy	MESH:D006501	marker/mechanism		NA		15929193
GABRB1	2560	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
GABRB2	2561	Epilepsy	MESH:D004827	marker/mechanism		NA		29942082
GABRB2	2561	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		29942082
GABRB2	2561	Schizophrenia	MESH:D012559	marker/mechanism		NA		18583979
GABRB3	2562	Angelman Syndrome	MESH:D017204	marker/mechanism		NA		15878204
GABRB3	2562	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		22037176
GABRB3	2562	Autistic Disorder	MESH:D001321	marker/mechanism		NA		11920158|9545402
GABRB3	2562	Brain Injuries	MESH:D001930	marker/mechanism		NA		23159883
GABRB3	2562	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		15878204
GABRB3	2562	Epilepsy	MESH:D004827	marker/mechanism		NA		15878204|29942082
GABRB3	2562	Epilepsy, Absence	MESH:D004832	marker/mechanism		NA	612269	18514161
GABRB3	2562	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	OMIM:617113	marker/mechanism		NA	617113	
GABRB3	2562	Isodicentric Chromosome 15 Syndrome	MESH:C580205	marker/mechanism		NA		23663378
GABRB3	2562	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		29942082
GABRB3	2562	Sleep Initiation and Maintenance Disorders	MESH:D007319	marker/mechanism		NA		12189488
GABRD	2563	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
GABRD	2563	Epilepsy, Idiopathic Generalized	MESH:C562694	marker/mechanism		NA	613060	
GABRD	2563	Schizophrenia	MESH:D012559	marker/mechanism		NA		18923069
GABRG2	2566	Alcoholism	MESH:D000437	marker/mechanism		NA		22253714
GABRG2	2566	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		15772696
GABRG2	2566	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		22253714
GABRG2	2566	FEBRILE SEIZURES, FAMILIAL, 8	OMIM:607681	marker/mechanism		NA	607681	
GABRG2	2566	Hepatic Encephalopathy	MESH:D006501	marker/mechanism		NA		15929193
GABRG2	2566	Seizures, Febrile	MESH:D003294	marker/mechanism		NA		25362483
GABRG3	2567	Brain Injuries	MESH:D001930	marker/mechanism		NA		23159883
GABRG3	2567	Isodicentric Chromosome 15 Syndrome	MESH:C580205	marker/mechanism		NA		23663378
GABRR2	2570	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
GABRR2	2570	Neurotoxicity Syndromes	MESH:D020258	marker/mechanism		NA		19784758
GAD1	2571	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17918742
GAD1	2571	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		15560956
GAD1	2571	Cerebral Palsy, Spastic Quadriplegic, 1	MESH:C567853	marker/mechanism		NA	603513	
GAD1	2571	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		22253714
GAD1	2571	Depressive Disorder, Major	MESH:D003865	marker/mechanism		NA		15560956
GAD1	2571	Dyskinesia, Drug-Induced	MESH:D004409	marker/mechanism		NA		9767399
GAD1	2571	Hyperprolactinemia	MESH:D006966	marker/mechanism		NA		7138674
GAD1	2571	Hypertension	MESH:D006973	marker/mechanism		NA		32165127
GAD1	2571	Schizophrenia	MESH:D012559	marker/mechanism		NA		15560956|17942719|18923069|19110320
GAD2	2572	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		15560956
GAD2	2572	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		22253714
GAD2	2572	Depressive Disorder, Major	MESH:D003865	marker/mechanism		NA		15560956
GAD2	2572	Diabetic Retinopathy	MESH:D003930	marker/mechanism		NA		21412422
GAD2	2572	Schizophrenia	MESH:D012559	marker/mechanism		NA		15560956|18923069
GAD2	2572	Seizures	MESH:D012640	marker/mechanism		NA		8954991|8985701
GADD45A	1647	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
GADD45A	1647	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		20623750
GADD45A	1647	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
GADD45A	1647	HIV Infections	MESH:D015658	marker/mechanism		NA		12878215
GADD45A	1647	Ovarian Neoplasms	MESH:D010051	therapeutic		NA		17474084
GADD45A	1647	Pancreatic Neoplasms	MESH:D010190	therapeutic		NA		19003803
GADD45A	1647	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		19190346
GADD45A	1647	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		15837757
GADD45B	4616	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
GADD45B	4616	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
GADL1	339896	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
GADR-1	186498	Hypoxia	MESH:D000860	therapeutic		NA		19936206
GAGE1	2543	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		14991579
GAGE1	2543	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		14991579
GAK	2580	Parkinson Disease	MESH:D010300	marker/mechanism		NA		20711177
GAL	51083	Depressive Disorder, Major	MESH:D003865	marker/mechanism		NA		27940914
GAL	51083	EPILEPSY, FAMILIAL TEMPORAL LOBE, 8	OMIM:616461	marker/mechanism		NA	616461	
GAL	51083	Hyperalgesia	MESH:D006930	marker/mechanism		NA		12787826
GAL	51083	Hypertension	MESH:D006973	marker/mechanism		NA		10818254
GAL	51083	Inflammation	MESH:D007249	marker/mechanism		NA		17999197
GAL	51083	Neuralgia	MESH:D009437	marker/mechanism		NA		18400411
GAL	51083	Tachycardia	MESH:D013610	marker/mechanism		NA		10818254
GALC	2581	Leukodystrophy, Globoid Cell	MESH:D007965	marker/mechanism		NA	245200	
GALC	2581	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GALE	2582	Galactosemias	MESH:D005693	marker/mechanism		NA	230350	25526675
GALK1	2584	Cataract	MESH:D002386	marker/mechanism		NA		7670469
GALK1	2584	Galactosemias	MESH:D005693	marker/mechanism		NA	230200	7670469
GALNS	2588	Inflammation	MESH:D007249	therapeutic		NA		7849337
GALNS	2588	Mucopolysaccharidosis IV	MESH:D009085	marker/mechanism		NA	253000	
GALNT12	79695	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	608812	
GALNT13	114805	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
GALNT16	57452	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
GALNT3	2591	Calcinosis	MESH:D002114	marker/mechanism		NA		17710231
GALNT3	2591	Hyperphosphatemia	MESH:D054559	marker/mechanism		NA		17710231
GALNT3	2591	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
GALNT3	2591	Tumoral Calcinosis, Hyperphosphatemic, Familial	MESH:C566870	marker/mechanism		NA	211900	
GALNTL5	168391	Skin Diseases	MESH:D012871	marker/mechanism		NA		28720099
GALR1	2587	Depressive Disorder, Major	MESH:D003865	marker/mechanism		NA		27940914
GALR2	8811	Depressive Disorder, Major	MESH:D003865	marker/mechanism		NA		27940914
GALR3	8484	Depressive Disorder, Major	MESH:D003865	marker/mechanism		NA		27940914
GALT	2592	Galactosemias	MESH:D005693	marker/mechanism		NA	230400	22773758
GAMT	2593	Amino Acid Metabolism, Inborn Errors	MESH:D000592	marker/mechanism		NA		15651030
GAMT	2593	Guanidinoacetate methyltransferase deficiency	MESH:C537622	marker/mechanism		NA	612736	15651030
GAMT	2593	Intellectual Disability	MESH:D008607	marker/mechanism		NA		15651030
GAMT	2593	Seizures	MESH:D012640	marker/mechanism		NA		15651030
GAN	8139	Giant Axonal Neuropathy	MESH:D056768	marker/mechanism		NA	256850	
GAN	8139	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		19398414
GANAB	23193	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
GANAB	23193	Polycystic Kidney, Autosomal Dominant	MESH:D016891	marker/mechanism		NA	600666	
GAP43	2596	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
GAP43	2596	Status Epilepticus	MESH:D013226	marker/mechanism		NA		10366005
GAPDH	2597	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		21751358
GAPDH	2597	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
GAPDH	2597	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		16767786|21472284
GAPDH	2597	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		15274141
GAPDH	2597	Clinical Deterioration	MESH:D000075902	marker/mechanism		NA		27602772
GAPDH	2597	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		25944804
GAPDH	2597	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
GAPDH	2597	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		15986332
GAPDH	2597	Hypoxia	MESH:D000860	marker/mechanism		NA		19579223
GAPDH	2597	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		15274141
GAPDH	2597	Necrosis	MESH:D009336	therapeutic		NA		25725130
GAPDH	2597	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
GAPDH	2597	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
GAPDH	2597	Parkinsonian Disorders	MESH:D020734	marker/mechanism		NA		29886133
GAPDHS	26330	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		17192785
GAR1	54433	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
GAR1	54433	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
GAR1	54433	Dyskeratosis Congenita	MESH:D019871	marker/mechanism		NA		22299032
GAR1	54433	Hematologic Diseases	MESH:D006402	marker/mechanism		NA		22299032
GARS1	2617	Charcot-Marie-Tooth disease, Type 2D	MESH:C537993	marker/mechanism		NA	601472	
GARS1	2617	Neuronopathy, Distal Hereditary Motor, Type V	MESH:C563443	marker/mechanism		NA	600794	
GART	2618	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
GART	2618	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		23897011
GART	2618	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
GAS1	2619	Holoprosencephaly	MESH:D016142	marker/mechanism		NA		17525797
GAS2	2620	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
GAS2	2620	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
GAS2L1	10634	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
GAS5	60674	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
GAS6	2621	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		19564549
GAS6	2621	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
GAS6	2621	Cardiomegaly	MESH:D006332	marker/mechanism		NA		19564549
GAS6	2621	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		12644472
GAS6	2621	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
GAS6	2621	Thromboembolism	MESH:D013923	marker/mechanism		NA		16564713
GAS6	2621	Thrombosis	MESH:D013927	marker/mechanism		NA		11175853|15130911|15733062|16564713
GAS7	8522	Obesity	MESH:D009765	marker/mechanism		NA		19270708
GAS8	2622	CILIARY DYSKINESIA, PRIMARY, 33	OMIM:616726	marker/mechanism		NA	616726	
GASK1B	51313	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GAST	2520	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		3952654
GAST	2520	Barrett Esophagus	MESH:D001471	marker/mechanism		NA		15387324
GAST	2520	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		3952654
GAST	2520	Gastrointestinal Diseases	MESH:D005767	marker/mechanism		NA		12729842
GAST	2520	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		11208460
GAST	2520	Peptic Ulcer	MESH:D010437	marker/mechanism		NA		10700044
GAST	2520	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		10594344
GAST	2520	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		15492468
GATA1	2623	ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES	OMIM:300835	marker/mechanism		NA	300835	
GATA1	2623	Down Syndrome	MESH:D004314	marker/mechanism		NA	190685	
GATA1	2623	Myelodysplastic Syndromes	MESH:D009190	marker/mechanism		NA		28963909
GATA1	2623	Thrombocytopenia	MESH:D013921	marker/mechanism		NA		16966598
GATA1	2623	Thrombocytopenia, Platelet Dysfunction, Hemolysis, and Imbalanced Globin Synthesis	MESH:C564050	marker/mechanism		NA	314050	
GATA1	2623	THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA	OMIM:300367	marker/mechanism		NA	300367	
GATA1	2623	Transient Myeloproliferative Disorder of Down Syndrome	MESH:C566024	marker/mechanism		NA		24056718
GATA2	2624	Arteriosclerosis	MESH:D001161	marker/mechanism		NA		28569748
GATA2	2624	Cardiovascular Abnormalities	MESH:D018376	marker/mechanism		NA		20707411
GATA2	2624	Cartilage Diseases	MESH:D002357	marker/mechanism		NA		20707411
GATA2	2624	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		20707411
GATA2	2624	IMMUNODEFICIENCY 21	OMIM:614172	marker/mechanism		NA	614172	
GATA2	2624	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA	601626	21892158|21892162
GATA2	2624	Leukemia, Myelomonocytic, Juvenile	MESH:D054429	marker/mechanism		NA		26457647
GATA2	2624	Lymphedema	MESH:D008209	marker/mechanism		NA		21892158
GATA2	2624	LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	OMIM:614038	marker/mechanism		NA	614038	
GATA2	2624	Myelodysplastic Syndromes	MESH:D009190	marker/mechanism		NA	614286	21892158|21892162|27992414
GATA2	2624	Neointima	MESH:D058426	marker/mechanism		NA		28569748
GATA2	2624	Primary Graft Dysfunction	MESH:D055031	marker/mechanism		NA		28569748
GATA2	2624	Vascular Remodeling	MESH:D066253	marker/mechanism		NA		28569748
GATA2	2624	Vasculitis	MESH:D014657	marker/mechanism		NA		28569748
GATA3	2625	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		23143596
GATA3	2625	Barakat syndrome	MESH:C537907	marker/mechanism		NA	146255	20006695
GATA3	2625	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
GATA3	2625	Eosinophilia	MESH:D004802	therapeutic		NA		27315767
GATA3	2625	Gastro-enteropancreatic neuroendocrine tumor	MESH:C535650	marker/mechanism		NA		29915428
GATA3	2625	Hodgkin Disease	MESH:D006689	marker/mechanism		NA		21037568
GATA3	2625	Inflammation	MESH:D007249	marker/mechanism		NA		22325453
GATA3	2625	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		26970513
GATA3	2625	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		26437031
GATA3	2625	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
GATA3	2625	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
GATA3	2625	Metaplasia	MESH:D008679	therapeutic		NA		27315767
GATA3	2625	Neuroblastoma	MESH:D009447	marker/mechanism		NA		30127528
GATA3	2625	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D015452	marker/mechanism		NA		24141364
GATA4	2626	Alcoholism	MESH:D000437	marker/mechanism		NA		20585342
GATA4	2626	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
GATA4	2626	Atrial septal defect 2	MESH:C538263	marker/mechanism		NA	607941	
GATA4	2626	Atrioventricular Septal Defect	MESH:C562831	marker/mechanism		NA	614430	
GATA4	2626	Cardiomegaly	MESH:D006332	marker/mechanism		NA		16259952|18252717
GATA4	2626	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		19509152
GATA4	2626	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		29394407
GATA4	2626	Heart Septal Defects, Ventricular	MESH:D006345	marker/mechanism		NA	614429	
GATA4	2626	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		18280291
GATA4	2626	Hernias, Diaphragmatic, Congenital	MESH:D065630	marker/mechanism		NA		23426975
GATA4	2626	Myocardial Infarction	MESH:D009203	therapeutic		NA		20200331
GATA4	2626	TESTICULAR ANOMALIES WITH OR WITHOUT CONGENITAL HEART DISEASE	OMIM:615542	marker/mechanism		NA	615542	
GATA4	2626	Tetralogy of Fallot	MESH:D013771	marker/mechanism		NA	187500	
GATA4	2626	Ventricular Remodeling	MESH:D020257	marker/mechanism		NA		29394407
GATA5	140628	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		19509152
GATA6	2627	ATRIAL SEPTAL DEFECT 9	OMIM:614475	marker/mechanism		NA	614475	
GATA6	2627	Atrioventricular Septal Defect	MESH:C562831	marker/mechanism		NA	614474	
GATA6	2627	CONOTRUNCAL HEART MALFORMATIONS	OMIM:217095	marker/mechanism		NA	217095	
GATA6	2627	HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES	OMIM:600001	marker/mechanism		NA	600001	
GATA6	2627	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		18280291
GATA6	2627	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		16271038
GATA6	2627	Pancreatic Agenesis, Congenital	MESH:C564908	marker/mechanism		NA		22158542
GATA6	2627	Tetralogy of Fallot	MESH:D013771	marker/mechanism		NA	187500	
GATAD1	57798	CARDIOMYOPATHY, DILATED, 2B	OMIM:614672	marker/mechanism		NA	614672	
GATAD2B	57459	GAND SYNDROME	OMIM:615074	marker/mechanism		NA	615074	
GATM	2628	Arginine-Glycine Amidinotransferase Deficiency	MESH:C567192	marker/mechanism		NA	612718	
GATM	2628	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
GATM	2628	Fanconi Syndrome	MESH:D005198	marker/mechanism		NA	134600	
GATM	2628	Heart Failure	MESH:D006333	marker/mechanism		NA		16820567
GATM	2628	Kidney Diseases	MESH:D007674	marker/mechanism		NA		22061828
GATM	2628	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
GATM	2628	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
GATM	2628	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
GATM	2628	Necrosis	MESH:D009336	marker/mechanism		NA		22061828
GBA	2629	Gaucher Disease	MESH:D005776	marker/mechanism		NA	230800|230900|231000	10757640|12359135|21250698|21370884|26027833|9101438
GBA	2629	Gaucher Disease, Perinatal Lethal	MESH:C564306	marker/mechanism		NA	608013	
GBA	2629	Gaucher Disease, Type Iiic	MESH:C565553	marker/mechanism		NA	231005	
GBA	2629	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		12359135
GBA	2629	Lewy Body Disease	MESH:D020961	marker/mechanism		NA	127750	22803570
GBA	2629	Parkinson Disease	MESH:D010300	marker/mechanism		NA		20947659|25064009
GBA	2629	PARKINSON DISEASE, LATE-ONSET	OMIM:168600	marker/mechanism		NA	168600	
GBA	2629	Parkinsonian Disorders	MESH:D020734	marker/mechanism		NA		25881142
GBA2	57704	SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE	OMIM:614409	marker/mechanism		NA	614409	
GBA3	57733	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
GBA3	57733	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
GBE1	2632	Glycogen Storage Disease Type IV	MESH:D006011	marker/mechanism		NA	232500	
GBE1	2632	Polyglucosan Body Disease, Adult Form	MESH:C564878	marker/mechanism		NA	263570	
GBP1	2633	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
GBP2	2634	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GBP2	2634	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
GBP4	115361	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GBP5	115362	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
GBX2	2637	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
GC	2638	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		28885000
GC	2638	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		3874814
GC	2638	Bone Diseases, Metabolic	MESH:D001851	marker/mechanism		NA		24381012
GC	2638	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		16099942
GC	2638	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		28885000
GC	2638	Graves Disease	MESH:D006111	marker/mechanism		NA		12050214
GC	2638	Hepatic Encephalopathy	MESH:D006501	marker/mechanism		NA		11510020
GC	2638	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		24381012
GC	2638	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GC	2638	Liver Failure, Acute	MESH:D017114	marker/mechanism		NA		17852808|8666322
GC	2638	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17902193
GC	2638	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		25590278
GC	2638	Schizophrenia	MESH:D012559	marker/mechanism		NA		25821032
GC	2638	Shock, Septic	MESH:D012772	marker/mechanism		NA		17852808
GC	2638	Wounds and Injuries	MESH:D014947	marker/mechanism		NA		17852808
GCAT	23464	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GCC1	79571	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		17205118
GCC1	79571	Marijuana Abuse	MESH:D002189	marker/mechanism		NA		17205118
GCC1	79571	Phencyclidine Abuse	MESH:D010623	marker/mechanism		NA		17205118
GCDH	2639	Glutaric Acidemia I	MESH:C536833	marker/mechanism		NA	231670	10759157|25204480
GCG	2641	Aberrant Crypt Foci	MESH:D058739	marker/mechanism		NA		22323126
GCG	2641	Anorexia	MESH:D000855	marker/mechanism		NA		21824258|28633506
GCG	2641	Bradycardia	MESH:D001919	therapeutic		NA		3277781|3736332|6542785|7787496|9674488
GCG	2641	Catalepsy	MESH:D002375	marker/mechanism		NA		9798264
GCG	2641	Colitis	MESH:D003092	therapeutic		NA		22323126
GCG	2641	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		22323126
GCG	2641	Coma	MESH:D003128	therapeutic		NA		10464538
GCG	2641	Constipation	MESH:D003248	marker/mechanism		NA		12107204
GCG	2641	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		23466488
GCG	2641	Heart Diseases	MESH:D006331	therapeutic		NA		3277781
GCG	2641	Heart Failure	MESH:D006333	therapeutic		NA		7608802
GCG	2641	Hyperglycemia	MESH:D006943	marker/mechanism|therapeutic		NA		18669601|3019152
GCG	2641	Hyperinsulinism	MESH:D006946	marker/mechanism		NA		3019152
GCG	2641	Hyperkinesis	MESH:D006948	therapeutic		NA		9798264
GCG	2641	Hyperlipidemias	MESH:D006949	therapeutic		NA		69995
GCG	2641	Hypertension	MESH:D006973	marker/mechanism		NA		22228705
GCG	2641	Hypotension	MESH:D007022	therapeutic		NA		3277781|8517581
GCG	2641	Hypothermia	MESH:D007035	therapeutic		NA		10464538
GCG	2641	Obesity	MESH:D009765	therapeutic		NA		20065960
GCG	2641	Poisoning	MESH:D011041	therapeutic		NA		7629900
GCG	2641	Spasm	MESH:D013035	marker/mechanism		NA		7192515
GCG	2641	Stomach Diseases	MESH:D013272	therapeutic		NA		17891687
GCG	2641	Tachycardia	MESH:D013610	marker/mechanism		NA		7629900
GCG	2641	Tachycardia, Sinus	MESH:D013616	marker/mechanism		NA		7359351
GCG	2641	Taste Disorders	MESH:D013651	marker/mechanism		NA		21824258
GCG	2641	Vascular Diseases	MESH:D014652	therapeutic		NA		10464538
GCGR	2642	Acth-Independent Macronodular Adrenal Hyperplasia	MESH:C565662	marker/mechanism		NA		20529775
GCH1	2643	Dyskinesia, Drug-Induced	MESH:D004409	therapeutic		NA		15659429
GCH1	2643	Dystonia	MESH:D004421	marker/mechanism		NA		15389992
GCH1	2643	Dystonia, Dopa-responsive	MESH:C538007	marker/mechanism		NA	128230	10825351
GCH1	2643	Hyperphenylalaninemia, BH4-Deficient, B	MESH:C562656	marker/mechanism		NA	233910	
GCH1	2643	Hypertension	MESH:D006973	marker/mechanism		NA		12855421
GCH1	2643	Hypokinesia	MESH:D018476	marker/mechanism		NA		17368676
GCH1	2643	Muscle Rigidity	MESH:D009127	marker/mechanism		NA		17368676
GCH1	2643	Musculoskeletal Pain	MESH:D059352	marker/mechanism		NA		25218601
GCH1	2643	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
GCH1	2643	Pain	MESH:D010146	marker/mechanism		NA		19081190
GCHFR	2644	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GCK	2645	Congenital Hyperinsulinism	MESH:D044903	marker/mechanism		NA		15277402
GCK	2645	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		16123366
GCK	2645	Diabetes Mellitus, Permanent Neonatal	MESH:C563425	marker/mechanism		NA	606176	
GCK	2645	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA	125853	15102714|15161764|16123366|20081858
GCK	2645	Hyperglycemia	MESH:D006943	marker/mechanism		NA		18056790
GCK	2645	Hyperinsulinemic hypoglycemia, familial, 3	MESH:C538374	marker/mechanism		NA	602485	
GCK	2645	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
GCK	2645	Maturity-Onset Diabetes of the Young, Type 2	MESH:C564219	marker/mechanism		NA	125851	21115832
GCKR	2646	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		20081858
GCKR	2646	Hypertriglyceridemia	MESH:D015228	marker/mechanism		NA		20657596
GCLC	2729	Amino Acid Metabolism, Inborn Errors	MESH:D000592	marker/mechanism		NA		10515893
GCLC	2729	Anemia, Hemolytic	MESH:D000743	marker/mechanism		NA		10515893
GCLC	2729	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		15496427
GCLC	2729	Cell Transformation, Neoplastic	MESH:D002471	therapeutic		NA		30940545
GCLC	2729	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		19481141
GCLC	2729	Coronary Vessel Anomalies	MESH:D003330	marker/mechanism		NA		12598062
GCLC	2729	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
GCLC	2729	Diabetes Mellitus, Type 2	MESH:D003924	therapeutic		NA		32715377
GCLC	2729	Gamma-Glutamylcysteine Synthetase Deficiency, Hemolytic Anemia due to	MESH:C565557	marker/mechanism		NA	230450	
GCLC	2729	Hypertension	MESH:D006973	marker/mechanism		NA		22228705
GCLC	2729	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
GCLC	2729	Myocardial Infarction	MESH:D009203	marker/mechanism		NA	608446	12598062
GCLC	2729	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
GCLM	2730	Berylliosis	MESH:D001607	marker/mechanism		NA		16766924
GCLM	2730	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
GCLM	2730	Diabetes Mellitus, Type 2	MESH:D003924	therapeutic		NA		32715377
GCLM	2730	Myocardial Infarction	MESH:D009203	marker/mechanism		NA	608446	12081989|12975258
GCM2	9247	HYPERPARATHYROIDISM 4	OMIM:617343	marker/mechanism		NA	617343	
GCNT1	2650	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GCNT1	2650	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		15882971
GCNT2	2651	CATARACT 13 WITH ADULT i PHENOTYPE	OMIM:116700	marker/mechanism		NA	116700	
GCOM1	145781	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
GCSH	2653	Hyperglycinemia, Nonketotic	MESH:D020158	marker/mechanism		NA	605899	
GDA	9615	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
GDA	9615	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
GDA	9615	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
GDA	9615	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
GDAP1	54332	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE	OMIM:607706	marker/mechanism		NA	607706	
GDAP1	54332	Charcot-Marie-Tooth Disease, Recessive Intermediate A	MESH:C564256	marker/mechanism		NA	608340	
GDAP1	54332	Charcot-Marie-Tooth disease, Type 2K	MESH:C535418	marker/mechanism		NA	607831	
GDAP1	54332	Charcot-Marie-Tooth disease, Type 4A	MESH:C535419	marker/mechanism		NA	214400	
GDF1	2657	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 6	OMIM:613854	marker/mechanism		NA	613854	
GDF1	2657	Double Outlet Right Ventricle	MESH:D004310	marker/mechanism		NA		17924340
GDF1	2657	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		28991257
GDF1	2657	Heterotaxy Syndrome	MESH:D059446	marker/mechanism		NA	208530	
GDF1	2657	Tetralogy of Fallot	MESH:D013771	marker/mechanism		NA		17924340
GDF1	2657	Transposition of Great Vessels	MESH:D014188	marker/mechanism		NA		17924340
GDF10	2662	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		23180569
GDF10	2662	Mesothelioma	MESH:D008654	marker/mechanism		NA		18949431
GDF15	9518	Anemia, Sideroblastic	MESH:D000756	marker/mechanism		NA		19036111
GDF15	9518	Cachexia	MESH:D002100	marker/mechanism		NA		30782979
GDF15	9518	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		20512989
GDF15	9518	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		20855664
GDF15	9518	Gastrointestinal Neoplasms	MESH:D005770	therapeutic		NA		24440808
GDF15	9518	Heart Failure	MESH:D006333	marker/mechanism		NA		20855664
GDF15	9518	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		19505289
GDF15	9518	Melanoma	MESH:D008545	marker/mechanism		NA		17145863
GDF15	9518	Mouth Diseases	MESH:D009059	marker/mechanism		NA		17682004
GDF15	9518	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
GDF15	9518	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		23996089
GDF15	9518	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16775185|23996089
GDF15	9518	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
GDF2	2658	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		23936038|28284560
GDF2	2658	Fractures, Bone	MESH:D050723	therapeutic		NA		27394662
GDF2	2658	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		26801773
GDF2	2658	Telangiectasia, Hereditary Hemorrhagic	MESH:D013683	marker/mechanism		NA		26801773
GDF2	2658	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5	OMIM:615506	marker/mechanism		NA	615506	
GDF3	9573	KLIPPEL-FEIL SYNDROME 3, AUTOSOMAL DOMINANT	OMIM:613702	marker/mechanism		NA	613702	
GDF3	9573	MICROPHTHALMIA, ISOLATED 7	OMIM:613704	marker/mechanism		NA	613704	
GDF3	9573	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	OMIM:613703	marker/mechanism		NA	613703	
GDF3	9573	Neoplasms, Germ Cell and Embryonal	MESH:D009373	marker/mechanism		NA		16168501
GDF5	8200	ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	OMIM:201250	marker/mechanism		NA	201250	
GDF5	8200	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		18830904
GDF5	8200	BRACHYDACTYLY, TYPE A1, C	OMIM:615072	marker/mechanism		NA	615072	
GDF5	8200	Brachydactyly type A2	MESH:C537089	marker/mechanism		NA	112600	
GDF5	8200	Brachydactyly type C	MESH:C537093	marker/mechanism		NA	113100	
GDF5	8200	Chondrodysplasia, Grebe type	MESH:C537915	marker/mechanism		NA	200700	
GDF5	8200	DEVELOPMENTAL DYSPLASIA OF THE HIP 1	OMIM:142700	marker/mechanism		NA		18947434
GDF5	8200	Fibular hypoplasia and complex brachydactyly	MESH:C537931	marker/mechanism		NA	228900	
GDF5	8200	Multiple synostoses syndrome 2	MESH:C537380	marker/mechanism		NA	610017	
GDF5	8200	Osteoarthritis	MESH:D010003	marker/mechanism		NA	612400	18830904|30664745
GDF5	8200	Osteoarthritis, Knee	MESH:D020370	marker/mechanism		NA		30374069
GDF5	8200	SYMPHALANGISM, PROXIMAL, 1B	OMIM:615298	marker/mechanism		NA	615298	
GDF6	392255	Klippel-Feil Syndrome	MESH:D007714	marker/mechanism		NA		18425797
GDF6	392255	Klippel Feil syndrome dominant type	MESH:C536887	marker/mechanism		NA	118100	
GDF6	392255	LEBER CONGENITAL AMAUROSIS 17	OMIM:615360	marker/mechanism		NA	615360	
GDF6	392255	Microphthalmia, Isolated 4	MESH:C567757	marker/mechanism		NA	613094	
GDF6	392255	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	OMIM:613703	marker/mechanism		NA	613703	
GDF9	2661	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		22825968
GDI1	2664	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
GDI1	2664	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
GDI1	2664	Mental Retardation, X-Linked	MESH:D038901	marker/mechanism		NA		8826463|9668174
GDI1	2664	MENTAL RETARDATION, X-LINKED 41	OMIM:300849	marker/mechanism		NA	300849	
GDI2	2665	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
GDNF	2668	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		17356005
GDNF	2668	Cocaine-Related Disorders	MESH:D019970	therapeutic		NA		14622243|15899247
GDNF	2668	Congenital central hypoventilation syndrome	MESH:C536209	marker/mechanism		NA	209880	9497256
GDNF	2668	Dyskinesia, Drug-Induced	MESH:D004409	therapeutic		NA		11168568
GDNF	2668	Ependymoma	MESH:D004806	marker/mechanism		NA		19138852
GDNF	2668	Glioblastoma	MESH:D005909	marker/mechanism		NA		19138852
GDNF	2668	Glioma	MESH:D005910	marker/mechanism		NA		19138852
GDNF	2668	Hirschsprung Disease	MESH:D006627	marker/mechanism		NA	613711	8896568|8968758
GDNF	2668	Huntington Disease	MESH:D006816	therapeutic		NA		16943855
GDNF	2668	Hyperalgesia	MESH:D006930	marker/mechanism		NA		20457222
GDNF	2668	Neurodegenerative Diseases	MESH:D019636	therapeutic		NA		11592846
GDNF	2668	Neurologic Manifestations	MESH:D009461	therapeutic		NA		19894114
GDNF	2668	Oligodendroglioma	MESH:D009837	marker/mechanism		NA		19138852
GDNF	2668	Parkinson Disease	MESH:D010300	therapeutic		NA		11031079|16324109
GDNF	2668	Parkinson Disease, Secondary	MESH:D010302	therapeutic		NA		19909981
GDNF	2668	Parkinsonian Disorders	MESH:D020734	therapeutic		NA		12213621|9266731
GDNF	2668	Pheochromocytoma	MESH:D010673	marker/mechanism		NA	171300	9215674
GDNF	2668	Retinal Degeneration	MESH:D012162	therapeutic		NA		17935603
GDNF	2668	Status Epilepticus	MESH:D013226	marker/mechanism		NA		12914250|7854063
GDPD3	79153	Lipidoses	MESH:D008064	marker/mechanism		NA		15342952|16919414|17175557
GET1	7485	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GFAP	2670	Alexander Disease	MESH:D038261	marker/mechanism		NA	203450	31484723
GFAP	2670	Amyotrophic Lateral Sclerosis	MESH:D000690	marker/mechanism		NA		11723166
GFAP	2670	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
GFAP	2670	Ceroid lipofuscinosis, neuronal 1, infantile	MESH:C537948	marker/mechanism		NA		21224254
GFAP	2670	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27093858
GFAP	2670	Epilepsy	MESH:D004827	marker/mechanism		NA		21177194
GFAP	2670	Gliosis	MESH:D005911	marker/mechanism		NA		12183020
GFAP	2670	Hyperalgesia	MESH:D006930	marker/mechanism		NA		27093858
GFAP	2670	Lewy Body Disease	MESH:D020961	marker/mechanism		NA		19276553
GFAP	2670	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		10773198|9427479|9634552
GFAP	2670	Neuromyelitis Optica	MESH:D009471	marker/mechanism		NA		18509235
GFAP	2670	Parkinson Disease	MESH:D010300	marker/mechanism		NA		19276553
GFAP	2670	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		10447555
GFAP	2670	Spina Bifida Cystica	MESH:D016137	marker/mechanism		NA		8422324
GFAP	2670	Trigeminal Neuralgia	MESH:D014277	marker/mechanism		NA		27093858
GFER	2671	Acute Kidney Injury	MESH:D058186	therapeutic		NA		20030531
GFER	2671	Carbon Tetrachloride Poisoning	MESH:D002252	therapeutic		NA		15968720
GFER	2671	Liver Failure, Acute	MESH:D017114	therapeutic		NA		15968720
GFER	2671	Myopathy, Mitochondrial Progressive, With Congenital Cataract, Hearing Loss, And Developmental Delay	MESH:C567769	marker/mechanism		NA	613076	
GFI1	2672	Gastro-enteropancreatic neuroendocrine tumor	MESH:C535650	marker/mechanism		NA		29915428
GFI1	2672	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
GFI1	2672	Neutropenia, Nonimmune Chronic Idiopathic, Adult	MESH:C564320	marker/mechanism		NA	607847	
GFI1	2672	Neutropenia, Severe Congenital, Autosomal Dominant 2	MESH:C567748	marker/mechanism		NA	613107	
GFI1	2672	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA		16122429
GFI1B	8328	Thrombasthenia-Thrombocytopenia, Hereditary	MESH:C566060	marker/mechanism		NA	187900	
GFM1	85476	Combined Oxidative Phosphorylation Deficiency 1	MESH:C563797	marker/mechanism		NA	609060	
GFPT1	2673	Muscular Diseases	MESH:D009135	marker/mechanism		NA		29905857
GFPT1	2673	Myasthenic syndrome, congenital, type Id	MESH:C536090	marker/mechanism		NA	608931	
GFPT1	2673	Myasthenic Syndromes, Congenital	MESH:D020294	marker/mechanism		NA	610542	29905857
GFPT1	2673	Obesity	MESH:D009765	marker/mechanism		NA		20882379
GFRA1	2674	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GFRA1	2674	Neuralgia	MESH:D009437	marker/mechanism		NA		18400411
GGCX	2677	Blood Coagulation Disorders	MESH:D001778	marker/mechanism		NA		19141161
GGCX	2677	Pseudoxanthoma Elasticum-Like Disorder with Multiple Coagulation Factor Deficiency	MESH:C563654	marker/mechanism		NA	610842	
GGCX	2677	Urolithiasis	MESH:D052878	marker/mechanism		NA		9471053
GGCX	2677	Vitamin K-Dependent Clotting Factors, Combined Deficiency Of, 1	MESH:C564741	marker/mechanism		NA	277450	
GGH	8836	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		23897011
GGH	8836	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		19815704
GGH	8836	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		21219404
GGH	8836	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		15814641
GGH	8836	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GGH	8836	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		19815704
GGT1	2678	Alcoholism	MESH:D000437	marker/mechanism		NA		12747453
GGT1	2678	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
GGT1	2678	Glutathionuria	MESH:C536836	marker/mechanism		NA	231950	
GGT1	2678	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
GGT1	2678	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
GGT1	2678	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
GGT1	2678	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		19419996
GGT1	2678	Periodontitis	MESH:D010518	marker/mechanism		NA		12747453
GGT1	2678	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
GGTA1	2681	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GH	14599	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		15528971
GH	14599	Weight Gain	MESH:D015430	marker/mechanism		NA		17372281
GH1	2688	Acromegaly	MESH:D000172	marker/mechanism		NA		1682667|18381583|18388193|3059976|6237480|7440347|9186818
GH1	2688	Azotemia	MESH:D053099	marker/mechanism		NA		14728886
GH1	2688	Cardiovascular Diseases	MESH:D002318	therapeutic		NA		17324600
GH1	2688	Growth Disorders	MESH:D006130	therapeutic		NA		15151564
GH1	2688	Growth Hormone-Secreting Pituitary Adenoma	MESH:D049912	marker/mechanism		NA		1611713|2042694
GH1	2688	Insulin Resistance	MESH:D007333	marker/mechanism		NA		21559284
GH1	2688	Isolated Growth Hormone Deficiency, Type IB	MESH:C567564	marker/mechanism		NA	612781	
GH1	2688	Isolated Growth Hormone Deficiency, Type II	MESH:C562704	marker/mechanism		NA	173100	
GH1	2688	Kowarski syndrome	MESH:C537505	marker/mechanism		NA	262650	
GH1	2688	Liver Cirrhosis, Experimental	MESH:D008106	therapeutic		NA		15334695
GH1	2688	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12082019|17584969
GH1	2688	Muscular Atrophy	MESH:D009133	therapeutic		NA		8937196
GH1	2688	Obesity	MESH:D009765	marker/mechanism		NA		8923850
GH1	2688	Pituitary dwarfism 1	MESH:C537404	marker/mechanism		NA	262400	
GH1	2688	Pituitary Neoplasms	MESH:D010911	marker/mechanism		NA		19420816
GH1	2688	Polycythemia	MESH:D011086	marker/mechanism		NA		15161484
GH1	2688	Turner Syndrome	MESH:D014424	therapeutic		NA		15151564
GH1	2688	Weight Gain	MESH:D015430	marker/mechanism		NA		17372281
GH1	2688	Weight Loss	MESH:D015431	therapeutic		NA		7711889
GH2	2689	Silver-Russell Syndrome	MESH:D056730	marker/mechanism		NA		14642004
GHR	2690	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17547689
GHR	2690	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
GHR	2690	HYPERCHOLESTEROLEMIA, FAMILIAL, 1	OMIM:143890	marker/mechanism		NA	143890	
GHR	2690	Laron Syndrome	MESH:D046150	marker/mechanism		NA	262500	
GHR	2690	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980|25380136
GHR	2690	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
GHR	2690	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17220348
GHR	2690	Short Stature, Idiopathic, Autosomal	MESH:C565805	marker/mechanism		NA	604271	
GHRH	2691	Pulmonary Edema	MESH:D011654	therapeutic		NA		22308467
GHRL	51738	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		21472143
GHRL	51738	Bone Resorption	MESH:D001862	therapeutic		NA		29477364
GHRL	51738	Cachexia	MESH:D002100	therapeutic		NA		17347304
GHRL	51738	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		17407494
GHRL	51738	Colitis	MESH:D003092	therapeutic		NA		19617644
GHRL	51738	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		19617644
GHRL	51738	Depressive Disorder	MESH:D003866	marker/mechanism		NA		19272368
GHRL	51738	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		21472143
GHRL	51738	Heart Failure	MESH:D006333	therapeutic		NA		20572026
GHRL	51738	Nerve Degeneration	MESH:D009410	therapeutic		NA		19429016
GHRL	51738	Neural Tube Defects	MESH:D009436	therapeutic		NA		17400914
GHRL	51738	Obesity	MESH:D009765	marker/mechanism		NA	601665	
GHRL	51738	Reperfusion Injury	MESH:D015427	therapeutic		NA		16581065
GHRL	51738	Seizures	MESH:D012640	therapeutic		NA		19429016
GHRL	51738	Stomach Ulcer	MESH:D013276	therapeutic		NA		15177919|16259727
GHRL	51738	Weight Gain	MESH:D015430	marker/mechanism		NA		16493877
GHSR	2693	Alcoholism	MESH:D000437	therapeutic		NA		23977009
GHSR	2693	Digestive System Neoplasms	MESH:D004067	marker/mechanism		NA		18064392
GIGYF2	26058	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
GIGYF2	26058	PARKINSON DISEASE 11, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO	OMIM:607688	marker/mechanism		NA	607688	
GIN1	54826	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		23143596
GINS1	9837	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
GINS2	51659	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
GINS2	51659	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
GIP	2695	Anorexia	MESH:D000855	marker/mechanism		NA		28633506|28666375|29689362
GIPC3	126326	Deafness, Autosomal Recessive 15	MESH:C566611	marker/mechanism		NA	601869	21326233
GIPR	2696	Body Weight	MESH:D001835	marker/mechanism		NA		22344221
GIPR	2696	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		17094902
GIT1	28964	Attention Deficit Disorder with Hyperactivity	MESH:D001289	marker/mechanism		NA		21499268
GIT1	28964	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		28100775
GIT1	28964	Hyperkinesis	MESH:D006948	marker/mechanism		NA		21499268
GIT1	28964	Memory Disorders	MESH:D008569	marker/mechanism		NA		21499268
GJA1	2697	Adenoma	MESH:D000236	marker/mechanism		NA		16926031
GJA1	2697	Arrhythmias, Cardiac	MESH:D001145	marker/mechanism		NA		18003637|18077386
GJA1	2697	Atrioventricular Septal Defect	MESH:C562831	marker/mechanism		NA	600309	
GJA1	2697	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18435417
GJA1	2697	Basaran Yilmaz syndrome	MESH:C537660	marker/mechanism		NA	104100	
GJA1	2697	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29180066
GJA1	2697	Coronary Aneurysm	MESH:D003323	marker/mechanism		NA		15548583
GJA1	2697	Craniometaphyseal dysplasia, autosomal recessive type	MESH:C536570	marker/mechanism		NA	218400	
GJA1	2697	Disease Progression	MESH:D018450	marker/mechanism		NA		29180066
GJA1	2697	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		16292552|16720372
GJA1	2697	Hypertension	MESH:D006973	marker/mechanism		NA		16448880
GJA1	2697	Hypoplastic Left Heart Syndrome	MESH:D018636	marker/mechanism		NA	241550	
GJA1	2697	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GJA1	2697	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		15166089|16926031
GJA1	2697	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		17445419
GJA1	2697	Oculodentodigital Dysplasia	MESH:C563160	marker/mechanism		NA	164200	12457340|15879313|16155213|16211004|16378922|17420259|17509830|17687502|18003637|18077386|18660473|18946008|19725242
GJA1	2697	Oculodentodigital Dysplasia, Autosomal Recessive	MESH:C567605	marker/mechanism		NA	257850	
GJA1	2697	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
GJA1	2697	Renal Insufficiency, Chronic	MESH:D051436	marker/mechanism		NA		32045570
GJA1	2697	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		7586191
GJA1	2697	Syndactyly, type 3	MESH:C538154	marker/mechanism		NA	186100	
GJA3	2700	Cataract, Zonular Pulverulent 3	MESH:C566608	marker/mechanism		NA	601885	
GJA4	2701	Hemangiosarcoma	MESH:D006394	marker/mechanism		NA		17569031
GJA4	2701	Hypertension	MESH:D006973	marker/mechanism		NA		16448880
GJA4	2701	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GJA5	2702	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
GJA5	2702	ATRIAL FIBRILLATION, FAMILIAL, 11	OMIM:614049	marker/mechanism		NA	614049	
GJA5	2702	Atrial Standstill	MESH:C563984	marker/mechanism		NA	108770	
GJA5	2702	Chromosome 1q21.1 Deletion Syndrome, 1.35-Mb	MESH:C567291	marker/mechanism		NA	612474	
GJA5	2702	Hypertension	MESH:D006973	marker/mechanism		NA		19109587
GJA8	2703	Cataract	MESH:D002386	marker/mechanism		NA		9497259
GJA8	2703	Cataract microcornea syndrome	MESH:C538287	marker/mechanism		NA		16604058
GJA8	2703	Cataract, Nuclear Progressive	MESH:C564596	marker/mechanism		NA		14627691
GJA8	2703	Cataract, Zonular Pulverulent 1	MESH:C566158	marker/mechanism		NA	116200	
GJA8	2703	Chromosome 1q21.1 Deletion Syndrome, 1.35-Mb	MESH:C567291	marker/mechanism		NA	612474	
GJB1	2705	Adenoma	MESH:D000236	marker/mechanism		NA		16926031
GJB1	2705	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		17978847
GJB1	2705	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		18264126
GJB1	2705	Charcot-Marie-Tooth disease, X-linked, 1	MESH:C535919	marker/mechanism		NA	302800	
GJB1	2705	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		2559087
GJB1	2705	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		18308698
GJB1	2705	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		15492231|16926031
GJB1	2705	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17978847
GJB1	2705	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		2559087
GJB1	2705	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		25530438
GJB2	2706	Cellulitis	MESH:D002481	marker/mechanism		NA		16172043
GJB2	2706	Deafness	MESH:D003638	marker/mechanism		NA		16172043
GJB2	2706	Deafness, Autosomal Dominant 3A	MESH:C567277	marker/mechanism		NA	601544	
GJB2	2706	Deafness, Autosomal Recessive 1A	MESH:C567134	marker/mechanism		NA	220290	
GJB2	2706	Hearing Loss, Sensorineural	MESH:D006319	marker/mechanism		NA		15091236
GJB2	2706	Hidradenitis Suppurativa	MESH:D017497	marker/mechanism		NA		16172043
GJB2	2706	HID Syndrome	MESH:C566528	marker/mechanism		NA	602540	
GJB2	2706	Ichthyosis	MESH:D007057	marker/mechanism		NA		16172043
GJB2	2706	Keratitis	MESH:D007634	marker/mechanism		NA		16172043
GJB2	2706	Keratitis, Ichthyosis, and Deafness (KID) Syndrome	MESH:C536168	marker/mechanism		NA	148210	
GJB2	2706	Keratoderma, Palmoplantar	MESH:D007645	marker/mechanism		NA		16172043
GJB2	2706	Knuckle pads, leuconychia and sensorineural deafness	MESH:C537210	marker/mechanism		NA	149200	
GJB2	2706	Palmoplantar Keratoderma with Deafness	MESH:C536152	marker/mechanism		NA	148350	
GJB2	2706	Progressive hearing loss stapes fixation	MESH:C536424	marker/mechanism		NA	304400	
GJB2	2706	Psoriasis	MESH:D011565	marker/mechanism		NA		20953187|24212883
GJB2	2706	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		7586191
GJB2	2706	Vohwinkel syndrome	MESH:C536457	marker/mechanism		NA	124500	
GJB3	2707	Deafness	MESH:D003638	marker/mechanism		NA		9843210
GJB3	2707	Deafness, Autosomal Dominant 2B	MESH:C567214	marker/mechanism		NA	612644	
GJB3	2707	Deafness, Autosomal Recessive 1A	MESH:C567134	marker/mechanism		NA	220290	
GJB3	2707	Erythrokeratodermia Variabilis	MESH:D056266	marker/mechanism		NA	133200	9843209
GJB3	2707	Hearing Loss, Sensorineural	MESH:D006319	marker/mechanism		NA		11309368
GJB3	2707	Hyperkeratosis, Epidermolytic	MESH:D017488	marker/mechanism		NA		16297190
GJB3	2707	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		11309368
GJB3	2707	Skin Diseases	MESH:D012871	marker/mechanism		NA		16372802
GJB4	127534	Hyperkeratosis, Epidermolytic	MESH:D017488	marker/mechanism		NA		16297190
GJB5	2709	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		7586191
GJB6	10804	Deafness, Autosomal Dominant 3B	MESH:C567215	marker/mechanism		NA	612643	
GJB6	10804	Deafness, Autosomal Recessive 1A	MESH:C567134	marker/mechanism		NA	220290	
GJB6	10804	Deafness, Autosomal Recessive 1b	MESH:C567213	marker/mechanism		NA	612645	
GJB6	10804	Ectodermal Dysplasia	MESH:D004476	marker/mechanism		NA	129500	
GJB6	10804	Progressive hearing loss stapes fixation	MESH:C536424	marker/mechanism		NA	304400	
GJC1	10052	Hypertension	MESH:D006973	therapeutic		NA		19109587
GJC2	57165	Leukodystrophy, Hypomyelinating, 2	MESH:C563855	marker/mechanism		NA	608804	18571143
GJC2	57165	LYMPHATIC MALFORMATION 3	OMIM:613480	marker/mechanism		NA	613480	
GJC2	57165	Spastic Paraplegia 44, Autosomal Recessive	MESH:C567707	marker/mechanism		NA	613206	
GJD2	57369	Myopia	MESH:D009216	marker/mechanism		NA		23396134
GJD2	57369	Refractive Errors	MESH:D012030	marker/mechanism		NA		20835239
GJE1	100126572	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		21228734
GK	2710	GLYCEROL KINASE DEFICIENCY	OMIM:307030	marker/mechanism		NA	307030	
GK	2710	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GK	2710	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
GKN1	56287	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		15378696
GKN1	56287	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
GKN1	56287	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		15378696
GLA	2717	Angiokeratoma	MESH:D000794	therapeutic		NA		19925601
GLA	2717	Fabry Disease	MESH:D000795	marker/mechanism		NA	301500	18565198|19925601|22773828
GLAZ	36447	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		28182653
GLAZ	36447	Retinal Diseases	MESH:D012164	marker/mechanism		NA		28182653
GLB1	2720	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		7586649
GLB1	2720	Corneal Opacity	MESH:D003318	marker/mechanism		NA		817853
GLB1	2720	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		23042114
GLB1	2720	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
GLB1	2720	Gangliosidosis, GM1	MESH:D016537	marker/mechanism		NA	230500|230600|230650	
GLB1	2720	Mucopolysaccharidosis IV	MESH:D009085	marker/mechanism		NA	253010	1928092|7586649
GLB1	2720	Osteochondrodysplasias	MESH:D010009	marker/mechanism		NA		817853
GLDC	2731	Hyperglycinemia, Nonketotic	MESH:D020158	marker/mechanism		NA	605899	16404748|16450403|17361008
GLDN	342035	LETHAL CONGENITAL CONTRACTURE SYNDROME 11	OMIM:617194	marker/mechanism		NA	617194	
GLE1	2733	Lethal Arthrogryposis With Anterior Horn Cell Disease	MESH:C567502	marker/mechanism		NA	611890	
GLE1	2733	Lethal congenital contracture syndrome 1	MESH:C537194	marker/mechanism		NA	253310	18204449
GLI1	2735	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		26189965
GLI1	2735	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
GLI1	2735	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		23867347
GLI1	2735	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		21625222
GLI1	2735	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		20864405
GLI1	2735	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		20179202
GLI2	2736	Basal Cell Nevus Syndrome	MESH:D001478	marker/mechanism		NA		16936257
GLI2	2736	Carcinoma, Basal Cell	MESH:D002280	marker/mechanism		NA		10700170
GLI2	2736	CULLER-JONES SYNDROME	OMIM:615849	marker/mechanism		NA	615849	
GLI2	2736	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27585885
GLI2	2736	Facial Dysmorphism with Multiple Malformations	MESH:C565579	marker/mechanism		NA		27585885
GLI2	2736	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
GLI2	2736	Holoprosencephaly	MESH:D016142	marker/mechanism		NA		27585885
GLI2	2736	Holoprosencephaly 9	MESH:C563659	marker/mechanism		NA	610829	
GLI2	2736	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		23867347
GLI2	2736	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		10700170
GLI3	2737	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
GLI3	2737	Greig cephalopolysyndactyly syndrome	MESH:C537300	marker/mechanism		NA	175700	10441342|14608643|15739154|18154020|18241058|9302279
GLI3	2737	Hypopigmentation	MESH:D017496	marker/mechanism		NA		18397875
GLI3	2737	Hypothalamic hamartomas	MESH:C537158	marker/mechanism		NA	241800	
GLI3	2737	Neural Tube Defects	MESH:D009436	marker/mechanism		NA		16359493
GLI3	2737	Pallister-Hall Syndrome	MESH:D054975	marker/mechanism		NA	146510	15739154|21532573
GLI3	2737	Polydactyly	MESH:D017689	marker/mechanism		NA		17688467
GLI3	2737	Polydactyly, Postaxial	MESH:C562429	marker/mechanism		NA	174200	
GLI3	2737	Polydactyly, preaxial 4	MESH:C536333	marker/mechanism		NA	174700	
GLI3	2737	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		24816253
GLIPR1	11010	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GLIPR1	11010	Wilms Tumor	MESH:D009396	marker/mechanism		NA		18030365
GLIS2	84662	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
GLIS2	84662	Kidney Diseases	MESH:D007674	marker/mechanism		NA		17618285
GLIS2	84662	Nephronophthisis 7	MESH:C566930	marker/mechanism		NA	611498	
GLIS3	169792	Diabetes Mellitus, Neonatal, with Congenital Hypothyroidism	MESH:C565705	marker/mechanism		NA	610199	
GLIS3	169792	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		19430480
GLIS3	169792	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		22158537
GLIS3	169792	Glaucoma, Angle-Closure	MESH:D015812	marker/mechanism		NA		27064256
GLMN	11146	Glomus vagale tumors	MESH:C536827	marker/mechanism		NA	138000	
GLO1	2739	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		22113448
GLO1	2739	Autistic Disorder	MESH:D001321	marker/mechanism		NA		15386471
GLO1	2739	Depressive Disorder	MESH:D003866	marker/mechanism		NA		22113448
GLO1	2739	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
GLO1	2739	Melanoma	MESH:D008545	marker/mechanism		NA		20093988
GLP1R	2740	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		30718926
GLP1R	2740	Hyperplasia	MESH:D006965	marker/mechanism		NA		23471186
GLP1R	2740	Hypertension	MESH:D006973	marker/mechanism		NA		22228705
GLP1R	2740	Neoplasms	MESH:D009369	marker/mechanism		NA		23471186
GLRA1	2741	Dystonic Disorders	MESH:D020821	marker/mechanism		NA		17114051
GLRA1	2741	Hyperexplexia hereditary	MESH:C538136	marker/mechanism		NA	149400	18175347|9927632
GLRA3	8001	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		28811376
GLRB	2743	Hyperexplexia hereditary	MESH:C538136	marker/mechanism		NA	614619	
GLRX3	10539	Cardiomegaly	MESH:D006332	therapeutic		NA		16809552
GLRX5	51218	Anemia, Sideroblastic	MESH:D000756	marker/mechanism		NA		18637800
GLRX5	51218	Anemia, Sideroblastic, Pyridoxine-Refractory, Autosomal Recessive	MESH:C567145	marker/mechanism		NA	616860	
GLS	2744	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
GLS	2744	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GLS	2744	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
GLS2	27165	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GLT8D1	55830	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GLUD1	2746	Fetal Growth Retardation	MESH:D005317	marker/mechanism		NA		19500843
GLUD1	2746	Hyperammonemia	MESH:D022124	marker/mechanism		NA		9571255
GLUD1	2746	Hyperinsulinemic hypoglycemia, familial, 6	MESH:C538375	marker/mechanism		NA	606762	
GLUD1	2746	Hyperinsulinism	MESH:D006946	marker/mechanism		NA		9571255
GLUD2	2747	PARKINSON DISEASE, LATE-ONSET	OMIM:168600	marker/mechanism		NA	168600	
GLUL	2752	Brain Diseases, Metabolic, Inborn	MESH:D020739	marker/mechanism		NA		16267323
GLUL	2752	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		19363144
GLUL	2752	Glutamine deficiency, congenital	MESH:C536832	marker/mechanism		NA	610015	16267323
GLUL	2752	Hepatic Encephalopathy	MESH:D006501	marker/mechanism		NA		10564534
GLUL	2752	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		20118494|21147764
GLUL	2752	Obesity	MESH:D009765	marker/mechanism		NA		20882379
GLYCAM1	644076	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
GLYCAM1	644076	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
GLYCAM1	644076	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
GLYCAM1	644076	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		26213588
GLYCTK	132158	D-glycericacidemia	MESH:C535767	marker/mechanism		NA	220120	
GM2A	2760	Tay-Sachs Disease, AB Variant	MESH:D049290	marker/mechanism		NA	272750	
GMFG	9535	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GMNN	51053	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
GMNN	51053	Meier-Gorlin syndrome	MESH:C538012	marker/mechanism		NA	616835	
GMPPA	29926	ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	OMIM:615510	marker/mechanism		NA	615510	
GMPPB	29925	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 14	OMIM:615351	marker/mechanism		NA	615351	
GMPPB	29925	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14	OMIM:615352	marker/mechanism		NA	615352	
GMPPB	29925	Walker-Warburg Syndrome	MESH:D058494	marker/mechanism		NA	615350	
GMPR	2766	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
GMPR2	51292	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		15378696
GMPR2	51292	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		15378696
GNA11	2767	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		9687499
GNA11	2767	Hypocalciuric hypercalcemia, familial, type 2	MESH:C537146	marker/mechanism		NA	145981	
GNA11	2767	Melanoma	MESH:D008545	marker/mechanism		NA		23432625
GNA11	2767	Uveal melanoma	MESH:C536494	marker/mechanism		NA		22733540|26397223|27089179
GNA12	2768	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		21297633
GNA12	2768	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
GNA13	10672	Burkitt Lymphoma	MESH:D002051	marker/mechanism		NA		23143597
GNA14	9630	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GNAI1	2770	Amnesia	MESH:D000647	marker/mechanism		NA		11350863
GNAI1	2770	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		12199159
GNAI2	2771	Atrioventricular Block	MESH:D054537	marker/mechanism		NA		17277016
GNAI2	2771	Bradycardia	MESH:D001919	marker/mechanism		NA		17277016
GNAI2	2771	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18925433
GNAI2	2771	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
GNAI2	2771	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GNAI2	2771	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
GNAI2	2771	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
GNAI2	2771	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		18925433
GNAI2	2771	VENTRICULAR TACHYCARDIA, FAMILIAL	OMIM:192605	marker/mechanism		NA	192605	
GNAI3	2773	Amnesia	MESH:D000647	marker/mechanism		NA		11350863
GNAI3	2773	Auriculo-condylar syndrome	MESH:C538270	marker/mechanism		NA	602483	
GNAL	2774	Dystonia	MESH:D004421	marker/mechanism		NA	615073	23222958
GNAL	2774	Dystonic Disorders	MESH:D020821	marker/mechanism		NA		23222958
GNAO1	2775	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
GNAO1	2775	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17	OMIM:615473	marker/mechanism		NA	615473	
GNAO1	2775	Epilepsy	MESH:D004827	marker/mechanism		NA		29942082
GNAO1	2775	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		29942082
GNAO1	2775	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		12199159
GNAQ	2776	Albuminuria	MESH:D000419	marker/mechanism		NA		16267159
GNAQ	2776	Blood Coagulation Disorders	MESH:D001778	marker/mechanism		NA		9296496
GNAQ	2776	CAPILLARY MALFORMATIONS, CONGENITAL	OMIM:163000	marker/mechanism		NA	163000	
GNAQ	2776	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		9687499
GNAQ	2776	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA		16267159
GNAQ	2776	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		9687499
GNAQ	2776	Melanoma	MESH:D008545	marker/mechanism		NA		23432625
GNAQ	2776	Port-Wine Stain	MESH:D019339	marker/mechanism		NA		23656586
GNAQ	2776	Sturge-Weber Syndrome	MESH:D013341	marker/mechanism		NA	185300	23656586
GNAQ	2776	Uveal melanoma	MESH:C536494	marker/mechanism		NA		22733540|26397223|27089179
GNAS	2778	Acromegaly	MESH:D000172	marker/mechanism		NA		11254676
GNAS	2778	Acth-Independent Macronodular Adrenal Hyperplasia	MESH:C565662	marker/mechanism		NA	219080	
GNAS	2778	Adrenal Gland Neoplasms	MESH:D000310	marker/mechanism		NA		24747643
GNAS	2778	Albright's hereditary osteodystrophy	MESH:C537045	marker/mechanism		NA		17299070|2109828|2122458|21823526
GNAS	2778	Brachydactyly	MESH:D059327	marker/mechanism		NA		12719376
GNAS	2778	Cafe-au-Lait Spots	MESH:D019080	marker/mechanism		NA		1594625|1944469
GNAS	2778	Cholangiocarcinoma	MESH:D018281	marker/mechanism		NA		22561520
GNAS	2778	Endocrine System Diseases	MESH:D004700	marker/mechanism		NA		1594625|1944469
GNAS	2778	Fibrous Dysplasia, Polyostotic	MESH:D005359	marker/mechanism		NA	174800	1594625|18345393|1944469
GNAS	2778	Gallstones	MESH:D042882	marker/mechanism		NA		21823526
GNAS	2778	Growth Hormone-Secreting Pituitary Adenoma	MESH:D049912	marker/mechanism		NA		11254676
GNAS	2778	Hemorrhagic Disorders	MESH:D006474	marker/mechanism		NA		11583302
GNAS	2778	Hypertension	MESH:D006973	marker/mechanism		NA		9506701
GNAS	2778	Hypoxia	MESH:D000860	marker/mechanism		NA		20862257
GNAS	2778	Insulin Resistance	MESH:D007333	marker/mechanism		NA		17062894
GNAS	2778	Intellectual Disability	MESH:D008607	marker/mechanism		NA		11583302
GNAS	2778	Liver Diseases, Parasitic	MESH:D008109	marker/mechanism		NA		22561520
GNAS	2778	Neuroblastoma	MESH:D009447	marker/mechanism		NA		20862257
GNAS	2778	Obesity	MESH:D009765	marker/mechanism		NA		17062894
GNAS	2778	Osseous Heteroplasia, Progressive	MESH:C562735	marker/mechanism		NA	166350	
GNAS	2778	Ossification, Heterotopic	MESH:D009999	marker/mechanism		NA		18553568
GNAS	2778	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
GNAS	2778	Pseudohypoaldosteronism	MESH:D011546	marker/mechanism		NA	603233|612462	
GNAS	2778	Pseudohypoparathyroidism	MESH:D011547	marker/mechanism		NA		17299070|21823526|9506752
GNAS	2778	Pseudohypoparathyroidism Type 1B	MESH:C548075	marker/mechanism		NA		21836370
GNAS	2778	PSEUDOHYPOPARATHYROIDISM, TYPE IA	OMIM:103580	marker/mechanism		NA	103580	
GNAS	2778	Pseudopseudohypoparathyroidism	MESH:D011556	marker/mechanism		NA	612463	9506752
GNAS	2778	Puberty, Precocious	MESH:D011629	marker/mechanism		NA		1594625|1944469
GNAS	2778	Respiration Disorders	MESH:D012120	marker/mechanism		NA		9506701
GNAS	2778	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		12199159
GNAS	2778	Tachycardia	MESH:D013610	marker/mechanism		NA		9506701
GNAS-AS1	149775	Pseudohypoaldosteronism	MESH:D011546	marker/mechanism		NA	603233	
GNAT1	2779	Night blindness, congenital stationary	MESH:C536122	marker/mechanism		NA	616389	
GNAT1	2779	Night Blindness, Congenital Stationary, Autosomal Dominant 3	MESH:C566475	marker/mechanism		NA	610444	
GNAT2	2780	Achromatopsia 4	MESH:C564206	marker/mechanism		NA	613856	
GNAT2	2780	Color Vision Defects	MESH:D003117	marker/mechanism		NA		12077706
GNAT3	346562	Infertility, Male	MESH:D007248	marker/mechanism		NA		23818598
GNAZ	2781	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
GNB1	2782	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		22113448
GNB1	2782	Depressive Disorder	MESH:D003866	marker/mechanism		NA		22113448
GNB1	2782	MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	OMIM:616973	marker/mechanism		NA	616973	
GNB1	2782	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA	613065	
GNB3	2784	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		16141801
GNB3	2784	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		12511541
GNB3	2784	Essential Hypertension	MESH:D000075222	marker/mechanism		NA	145500	
GNB3	2784	Hypertension	MESH:D006973	marker/mechanism		NA		15961981|16141801
GNB3	2784	Night blindness, congenital stationary	MESH:C536122	marker/mechanism		NA	617024	
GNB3	2784	Obesity	MESH:D009765	marker/mechanism		NA		15961981|16141801
GNB3	2784	Seizures	MESH:D012640	marker/mechanism		NA		18855531
GNB3	2784	Weight Gain	MESH:D015430	marker/mechanism		NA		16141801
GNB4	59345	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
GNB4	59345	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE F	OMIM:615185	marker/mechanism		NA	615185	
GNB4	59345	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17892325
GNB5	10681	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		25944804
GNB5	10681	INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	OMIM:617173	marker/mechanism		NA	617173	
GNB5	10681	LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA	OMIM:617182	marker/mechanism		NA	617182	
GNE	10020	Distal myopathy, Nonaka type	MESH:C536816	marker/mechanism		NA	605820	11916006
GNE	10020	Inclusion body myopathy autosomal recessive	MESH:C538329	marker/mechanism		NA		12473780
GNE	10020	Myositis, Inclusion Body	MESH:D018979	marker/mechanism		NA		17261181
GNE	10020	Sialic Acid Storage Disease	MESH:D029461	marker/mechanism		NA	269921	
GNG11	2791	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		24366584
GNG11	2791	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
GNG5	2787	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
GNG7	2788	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		18219292
GNG8	94235	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
GNGT2	2793	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GNMT	27232	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		19146867|31086990
GNMT	27232	Hepatitis	MESH:D006505	marker/mechanism		NA		21137059
GNMT	27232	Hepatitis, Chronic	MESH:D006521	marker/mechanism		NA		19146867
GNMT	27232	Hyperhomocysteinemia	MESH:D020138	marker/mechanism		NA		16317120
GNMT	27232	Hypermethioninemia	MESH:C564683	marker/mechanism		NA	606664	11596649|11810299
GNMT	27232	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		21137059
GNMT	27232	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		31086990
GNMT	27232	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17332283
GNPAT	8443	Rhizomelic chondrodysplasia punctata, type 2	MESH:C537607	marker/mechanism		NA	222765	
GNPDA1	10007	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GNPDA2	132789	Body Weight	MESH:D001835	marker/mechanism		NA		22344219
GNPDA2	132789	Obesity	MESH:D009765	marker/mechanism		NA		19079261
GNPNAT1	64841	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
GNPNAT1	64841	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
GNPTAB	79158	MUCOLIPIDOSIS II ALPHA/BETA	OMIM:252500	marker/mechanism		NA	252500	
GNPTAB	79158	MUCOLIPIDOSIS III ALPHA/BETA	OMIM:252600	marker/mechanism		NA	252600	
GNPTG	84572	Mucolipidosis III Gamma	MESH:C565367	marker/mechanism		NA	252605	
GNRH1	2796	Adrenal Gland Neoplasms	MESH:D000310	therapeutic		NA		19261682
GNRH1	2796	Bradycardia	MESH:D001919	therapeutic		NA		6350720
GNRH1	2796	Eunuchoidism, familial hypogonadotropic	MESH:C535764	marker/mechanism		NA	614841	
GNRH1	2796	Headache	MESH:D006261	marker/mechanism		NA		12910066
GNRH1	2796	Hyperprolactinemia	MESH:D006966	marker/mechanism		NA		2204052
GNRH1	2796	Hypertension	MESH:D006973	marker/mechanism		NA		6350720
GNRH1	2796	Hypogonadism	MESH:D007006	therapeutic		NA		20063086
GNRH1	2796	Hypothermia	MESH:D007035	marker/mechanism		NA		6350720
GNRH1	2796	Idiopathic Hypogonadotropic Hypogonadism	MESH:C562785	marker/mechanism		NA	146110	19535795
GNRH1	2796	Infertility, Male	MESH:D007248	therapeutic		NA		20063086
GNRH1	2796	Puberty, Precocious	MESH:D011629	marker/mechanism		NA		18345393
GNRH1	2796	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
GNRH1	2796	Tachycardia	MESH:D013610	marker/mechanism		NA		6350720
GNRH1	2796	Vomiting	MESH:D014839	marker/mechanism		NA		12910066
GNRHR	2798	Adrenal Gland Neoplasms	MESH:D000310	marker/mechanism		NA		19131502
GNRHR	2798	Hypogonadism	MESH:D007006	marker/mechanism		NA		15625238
GNRHR	2798	Idiopathic Hypogonadotropic Hypogonadism	MESH:C562785	marker/mechanism		NA	146110	
GNS	2799	Mucopolysaccharidosis III	MESH:D009084	marker/mechanism		NA	252940	3391615
GOLGA4	2803	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
GOLGA4	2803	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
GOLGA4	2803	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
GOLGA6L7	728310	Skin Diseases	MESH:D012871	marker/mechanism		NA		28720099
GOLM1	51280	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
GOLM1	51280	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
GON4L	54856	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
GOPC	57120	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
GOPC	57120	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
GORAB	92344	Gerodermia osteodysplastica	MESH:C537799	marker/mechanism		NA	231070	18997784
GORAB	92344	Osteoporosis	MESH:D010024	marker/mechanism		NA		18997784
GORAB	92344	Skin Abnormalities	MESH:D012868	marker/mechanism		NA		18997784
GOSR2	9570	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
GOSR2	9570	Myoclonic Epilepsies, Progressive	MESH:D020191	marker/mechanism		NA	614018	
GOT1	2805	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
GOT1	2805	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
GP1BA	2811	Bernard-Soulier Syndrome	MESH:D001606	marker/mechanism		NA	231200	
GP1BA	2811	BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT	OMIM:153670	marker/mechanism		NA	153670	
GP1BA	2811	Hypertension	MESH:D006973	marker/mechanism		NA		22352330
GP1BA	2811	NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY, SUSCEPTIBILITY TO	OMIM:258660	marker/mechanism		NA	258660	
GP1BA	2811	Thrombosis	MESH:D013927	marker/mechanism		NA		17334511
GP1BA	2811	Von Willebrand disease, platelet type	MESH:C536458	marker/mechanism		NA	177820	
GP1BB	2812	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
GP1BB	2812	Bernard-Soulier Syndrome	MESH:D001606	marker/mechanism		NA	231200	
GP1BB	2812	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		15213848
GP1BB	2812	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		15213848
GP1BB	2812	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
GP1BB	2812	Thrombocytopenia	MESH:D013921	marker/mechanism		NA		15213848
GP2	2813	Body Weight	MESH:D001835	marker/mechanism		NA		22344219
GP2	2813	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		30718926
GP6	51206	BLEEDING DISORDER, PLATELET-TYPE, 11	OMIM:614201	marker/mechanism		NA	614201	
GP9	2815	Bernard-Soulier Syndrome	MESH:D001606	marker/mechanism		NA	231200	
GP9	2815	Thrombocytopenia	MESH:D013921	marker/mechanism		NA		15225244
GPAM	57678	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		9452481
GPAM	57678	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GPAM	57678	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
GPBAR1	151306	Constipation	MESH:D003248	marker/mechanism		NA		23041323
GPBAR1	151306	Crohn Disease	MESH:D003424	marker/mechanism		NA		23566200
GPC3	2719	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		16698587|28284560
GPC3	2719	Mesothelioma	MESH:D008654	marker/mechanism		NA		10656689
GPC3	2719	Simpson-Golabi-Behmel syndrome	MESH:C537340	marker/mechanism		NA	312870	
GPC3	2719	Wilms Tumor	MESH:D009396	marker/mechanism		NA	194070	
GPC4	2239	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		16759393
GPC4	2239	Simpson-Golabi-Behmel syndrome	MESH:C537340	marker/mechanism		NA	312870	
GPC4	2239	Wilms Tumor	MESH:D009396	marker/mechanism		NA	194070	
GPC5	2262	Albuminuria	MESH:D000419	therapeutic		NA		21441931
GPC5	2262	Nephrotic Syndrome	MESH:D009404	therapeutic		NA		21441931
GPC6	10082	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		19481194
GPC6	10082	Limb Deformities, Congenital	MESH:D017880	marker/mechanism		NA		19481194
GPC6	10082	Omodysplasia type 1	MESH:C537746	marker/mechanism		NA	258315	19481194
GPC6	10082	Osteoporosis	MESH:D010024	marker/mechanism		NA		28869591
GPCPD1	56261	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		25482527
GPD1	2819	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
GPD1	2819	HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE	OMIM:614480	marker/mechanism		NA	614480	
GPD1L	23171	Brugada Syndrome 2	MESH:C567087	marker/mechanism		NA	611777	
GPD1L	23171	Fatty Liver	MESH:D005234	marker/mechanism		NA		25226513
GPD2	2820	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		16123366
GPD2	2820	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA	125853	16123366
GPD2	2820	Methylmalonic acidemia	MESH:C537358	marker/mechanism		NA		16823967
GPD2	2820	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
GPDH1	33824	Parkinson Disease	MESH:D010300	marker/mechanism		NA		18353766
GPER1	2852	Abnormalities, Multiple	MESH:D000015	marker/mechanism		NA		21984484
GPER1	2852	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		24440569
GPER1	2852	Idiopathic Pulmonary Fibrosis	MESH:D054990	marker/mechanism		NA		30165855
GPER1	2852	Leiomyoma	MESH:D007889	marker/mechanism		NA		31468104
GPHA2	170589	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
GPHN	10243	Alcoholism	MESH:D000437	marker/mechanism		NA		22253714
GPHN	10243	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		22253714
GPHN	10243	Hyperexplexia hereditary	MESH:C538136	marker/mechanism		NA	149400	
GPHN	10243	Molybdenum Cofactor Deficiency, Complementation Group C	MESH:C565374	marker/mechanism		NA	615501	
GPI	2821	Anemia, Hemolytic	MESH:D000743	marker/mechanism		NA		8822954
GPI	2821	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17659439
GPI	2821	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY	OMIM:613470	marker/mechanism		NA	613470	
GPI1	14751	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
GPI1	14751	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
GPIHBP1	338328	HYPERLIPOPROTEINEMIA, TYPE ID	OMIM:615947	marker/mechanism		NA	615947	
GPM6A	2823	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
GPN1	11321	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		27749845
GPNMB	10457	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		23052191
GPNMB	10457	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18507500
GPNMB	10457	Carcinoma, Pancreatic Ductal	MESH:D021441	marker/mechanism		NA		24979617
GPNMB	10457	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18507500|21278247
GPNMB	10457	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GPNMB	10457	Liver Failure, Acute	MESH:D017114	marker/mechanism		NA		15763343
GPR101	83550	Growth Hormone-Secreting Pituitary Adenoma	MESH:D049912	marker/mechanism		NA	300943	
GPR143	4935	NYSTAGMUS 6, CONGENITAL, X-LINKED	OMIM:300814	marker/mechanism		NA	300814	
GPR143	4935	Ocular Albinism type 1	MESH:C537863	marker/mechanism		NA	300500	
GPR150	285601	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		17303177
GPR153	387509	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
GPR155	151556	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17519220
GPR155	151556	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
GPR158	57512	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
GPR158	57512	Diverticular Diseases	MESH:D000076385	marker/mechanism		NA		30177863
GPR17	2840	Brain Infarction	MESH:D020520	therapeutic		NA		18974869
GPR179	440435	Night blindness, congenital stationary	MESH:C536122	marker/mechanism		NA	614565	
GPR179	440435	Polyomavirus Infections	MESH:D027601	marker/mechanism		NA		25463609
GPR182	11318	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
GPR183	1880	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		25133636
GPR183	1880	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		26437031
GPR27	2850	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
GPR34	2857	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
GPR37	2861	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
GPR50	9248	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		20657642
GPR55	9290	Neoplasms	MESH:D009369	marker/mechanism		NA		27423937
GPR65	8477	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		30616622
GPR68	8111	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA6	OMIM:617217	marker/mechanism		NA	617217	
GPR68	8111	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GPR88	54112	CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	OMIM:616939	marker/mechanism		NA	616939	
GPRC5A	9052	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		17379860
GPSM1	26086	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		15091342
GPSM2	29899	Chudley-Mccullough syndrome	MESH:C535459	marker/mechanism		NA	604213	22578326
GPT	2875	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		145039|19481104
GPT	2875	Fatty Liver	MESH:D005234	marker/mechanism		NA		19481104
GPT	2875	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
GPT	2875	Liver Diseases	MESH:D008107	marker/mechanism		NA		25455894
GPT	2875	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		8215636
GPT2	84706	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49	OMIM:616281	marker/mechanism		NA	616281	
GPX1	2876	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19195803
GPX1	2876	Brain Ischemia	MESH:D002545	therapeutic		NA		12531513
GPX1	2876	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		12810669
GPX1	2876	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		15557674
GPX1	2876	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		15247771
GPX1	2876	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		18940188
GPX1	2876	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		14573732
GPX1	2876	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		16123366
GPX1	2876	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		16123366|23795780
GPX1	2876	Epilepsy	MESH:D004827	marker/mechanism		NA		19499324
GPX1	2876	Fatty Liver	MESH:D005234	marker/mechanism		NA		10860543
GPX1	2876	Glutathione Peroxidase Deficiency, Hemolytic Anemia possibly due to	MESH:C564217	marker/mechanism		NA	614164	
GPX1	2876	Head and Neck Neoplasms	MESH:D006258	marker/mechanism		NA		15557674
GPX1	2876	Hepatitis, Chronic	MESH:D006521	marker/mechanism		NA		25053573
GPX1	2876	Hyperglycemia	MESH:D006943	marker/mechanism		NA		15184668
GPX1	2876	Hyperinsulinism	MESH:D006946	marker/mechanism		NA		15184668|18560803
GPX1	2876	Hypertension	MESH:D006973	marker/mechanism		NA		21593737
GPX1	2876	Hyperthyroidism	MESH:D006980	marker/mechanism		NA		19914224
GPX1	2876	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		11103801
GPX1	2876	Obesity	MESH:D009765	marker/mechanism		NA		15184668
GPX1	2876	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
GPX1	2876	Parkinson Disease	MESH:D010300	therapeutic		NA		15824117
GPX1	2876	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		23743330
GPX1	2876	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		15247771
GPX2	2877	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18056462
GPX2	2877	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		28108177
GPX2	2877	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		23867582
GPX3	2878	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		21552421
GPX3	2878	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642|21063030
GPX3	2878	Fanconi Syndrome	MESH:D005198	marker/mechanism		NA		9851889
GPX3	2878	Insulin Resistance	MESH:D007333	marker/mechanism		NA		19270708
GPX3	2878	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		20195826
GPX3	2878	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		19180532|21552421
GPX3	2878	Neoplasms	MESH:D009369	marker/mechanism		NA		21684681
GPX3	2878	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		15964507
GPX3	2878	Obesity	MESH:D009765	marker/mechanism		NA		11328671|19270708
GPX3	2878	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17804715
GPX4	2879	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17634480
GPX4	2879	Cadmium Poisoning	MESH:D002105	marker/mechanism		NA		20643113
GPX4	2879	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18850177
GPX4	2879	Cryptorchidism	MESH:D003456	marker/mechanism		NA		26050606
GPX4	2879	Embryo Loss	MESH:D020964	marker/mechanism		NA		12566075
GPX4	2879	Fatty Liver	MESH:D005234	marker/mechanism		NA		26042203
GPX4	2879	Fibrosis	MESH:D005355	marker/mechanism		NA		26042203
GPX4	2879	Glucose Intolerance	MESH:D018149	marker/mechanism		NA		26042203
GPX4	2879	Heart Failure	MESH:D006333	marker/mechanism		NA		20304815
GPX4	2879	Infertility, Male	MESH:D007248	marker/mechanism		NA		19417079|19744930
GPX4	2879	Spondylometaphyseal dysplasia, Sedaghatian type	MESH:C535798	marker/mechanism		NA	250220	
GPX6	257202	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		25581431
GPX8	493869	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GRB14	2888	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		21874001
GRB14	2888	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
GRB7	2886	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		21552421
GRB7	2886	Breast Neoplasms	MESH:D001943	marker/mechanism|therapeutic		NA		17426702|19075277
GRB7	2886	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		23797736
GRB7	2886	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		21552421
GRB7	2886	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
GREB1	9687	Endometriosis	MESH:D004715	marker/mechanism		NA		23104006
GREB1	9687	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16496412
GREM1	26585	Adenomatous Polyposis Coli	MESH:D011125	marker/mechanism		NA		22561515
GREM1	26585	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18084292|30510241
GREM1	26585	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		17975199
GREM1	26585	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
GREM2	64388	TOOTH AGENESIS, SELECTIVE, 9	OMIM:617275	marker/mechanism		NA	617275	
GRHL2	79977	Deafness, Autosomal Dominant 28	MESH:C563890	marker/mechanism		NA	608641	
GRHL2	79977	ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	OMIM:616029	marker/mechanism		NA	616029	
GRHL3	57822	Fetal Death	MESH:D005313	marker/mechanism		NA		6635991
GRHL3	57822	Neural Tube Defects	MESH:D009436	marker/mechanism		NA		6635991
GRHL3	57822	Van der Woude syndrome 2	MESH:C536529	marker/mechanism		NA	606713	
GRHPR	9380	Primary hyperoxaluria type 2	MESH:C536415	marker/mechanism		NA	260000	
GRHPR	9380	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
GRIA1	2890	Autistic Disorder	MESH:D001321	marker/mechanism		NA		11706102
GRIA1	2890	Cocaine-Related Disorders	MESH:D019970	marker/mechanism|therapeutic		NA		14684464|15764012|16495937|18430032|18486119
GRIA1	2890	Hyperkinesis	MESH:D006948	marker/mechanism		NA		18171924|19036973
GRIA1	2890	Hypotension	MESH:D007022	marker/mechanism		NA		18639534
GRIA1	2890	Learning Disabilities	MESH:D007859	marker/mechanism		NA		16495937
GRIA1	2890	Morphine Dependence	MESH:D009021	marker/mechanism		NA		11404432
GRIA1	2890	Sexual Dysfunctions, Psychological	MESH:D020018	marker/mechanism		NA		19295509
GRIA1	2890	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		11404432|12511956
GRIA2	2891	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		18945913
GRIA2	2891	Hyperkinesis	MESH:D006948	marker/mechanism		NA		18171924
GRIA2	2891	Status Epilepticus	MESH:D013226	marker/mechanism		NA		19222700
GRIA2	2891	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		12511956
GRIA3	2892	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		15264227
GRIA3	2892	Mental Retardation, X-Linked 94	MESH:C567479	marker/mechanism		NA	300699	
GRIA3	2892	Sexual Dysfunctions, Psychological	MESH:D020018	marker/mechanism		NA		19295509
GRIA4	2893	Myopia	MESH:D009216	marker/mechanism		NA		23396134
GRIA4	2893	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
GRID1	2894	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		21278247
GRID2	2895	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA	616204	
GRIK1	2897	Seizures	MESH:D012640	marker/mechanism		NA		12080343
GRIK2	2898	Autistic Disorder	MESH:D001321	marker/mechanism		NA		11920157|20442744
GRIK2	2898	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		18332879
GRIK2	2898	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		30705370
GRIK2	2898	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		30705370
GRIK2	2898	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		30705370
GRIK2	2898	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		30705370
GRIK2	2898	Glioblastoma	MESH:D005909	marker/mechanism		NA		30705370
GRIK2	2898	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		30705370
GRIK2	2898	Lymphatic Metastasis	MESH:D008207	marker/mechanism		NA		30705370
GRIK2	2898	Mental Retardation, Autosomal Recessive 6	MESH:C567017	marker/mechanism		NA	611092	
GRIK2	2898	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		30705370
GRIK2	2898	Schizophrenia	MESH:D012559	marker/mechanism		NA		18923069
GRIK2	2898	Sexual Dysfunctions, Psychological	MESH:D020018	marker/mechanism		NA		19295509
GRIK2	2898	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
GRIK3	2899	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941189
GRIK5	2901	Schizophrenia	MESH:D012559	marker/mechanism		NA		18923069
GRIN1	2902	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		16014726|20149346
GRIN1	2902	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27093858
GRIN1	2902	Hyperalgesia	MESH:D006930	marker/mechanism		NA		27093858
GRIN1	2902	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT	OMIM:614254	marker/mechanism		NA	614254	
GRIN1	2902	Pain	MESH:D010146	therapeutic		NA		18155693
GRIN1	2902	Psychotic Disorders	MESH:D011618	marker/mechanism		NA		14708030
GRIN1	2902	Trigeminal Neuralgia	MESH:D014277	marker/mechanism		NA		27093858
GRIN2A	2903	Autistic Disorder	MESH:D001321	marker/mechanism		NA		15830322
GRIN2A	2903	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		31043756
GRIN2A	2903	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17922030
GRIN2A	2903	Epilepsy	MESH:D004827	marker/mechanism		NA		20890276|23933818
GRIN2A	2903	EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT MENTAL RETARDATION	OMIM:245570	marker/mechanism		NA	245570	
GRIN2A	2903	Epilepsy, Rolandic	MESH:D019305	marker/mechanism		NA		23933819
GRIN2A	2903	Landau-Kleffner Syndrome	MESH:D018887	marker/mechanism		NA		23933820
GRIN2A	2903	Language Development Disorders	MESH:D007805	marker/mechanism		NA		23933820
GRIN2A	2903	Melanoma	MESH:D008545	marker/mechanism		NA		21499247
GRIN2A	2903	Morphine Dependence	MESH:D009021	marker/mechanism		NA		12878694
GRIN2A	2903	Speech Disorders	MESH:D013064	marker/mechanism		NA		23933820
GRIN2A	2903	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		12878694
GRIN2B	2904	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		21572417
GRIN2B	2904	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 27	OMIM:616139	marker/mechanism		NA	616139	
GRIN2B	2904	Epilepsy	MESH:D004827	marker/mechanism		NA		16407536|29942082
GRIN2B	2904	Hyperalgesia	MESH:D006930	marker/mechanism		NA		20042082
GRIN2B	2904	Hypotension	MESH:D007022	marker/mechanism		NA		18639534
GRIN2B	2904	Intellectual Disability	MESH:D008607	marker/mechanism		NA		20890276
GRIN2B	2904	MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES	OMIM:613970	marker/mechanism		NA	613970	
GRIN2B	2904	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889|29942082
GRIN2B	2904	Schizophrenia	MESH:D012559	marker/mechanism		NA		18583979
GRIN2D	2906	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46	OMIM:617162	marker/mechanism		NA	617162	
GRIN2D	2906	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		19911010
GRIN2D	2906	Schizophrenia	MESH:D012559	marker/mechanism		NA		19856012
GRIN3A	116443	Erectile Dysfunction	MESH:D007172	marker/mechanism		NA		19295509
GRK1	6011	Neuralgia	MESH:D009437	marker/mechanism		NA		31432094
GRK1	6011	Oguchi disease	MESH:C537743	marker/mechanism		NA	613411	
GRK2	156	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		10094932
GRK2	156	Cardiomegaly	MESH:D006332	marker/mechanism		NA		11901213
GRK2	156	Cardiomyopathies	MESH:D009202	therapeutic		NA		17008600
GRK2	156	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		26032411
GRK2	156	Congenital Abnormalities	MESH:D000013	marker/mechanism		NA		17008600
GRK2	156	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		16033404
GRK2	156	Embryo Loss	MESH:D020964	marker/mechanism		NA		17008600
GRK2	156	Heart Failure	MESH:D006333	marker/mechanism		NA		26670611
GRK2	156	Hypertension	MESH:D006973	marker/mechanism		NA		11901213
GRK3	157	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		12808434
GRK4	2868	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
GRK5	2869	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		26032411
GRK5	2869	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
GRK6	2870	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		10094932
GRM1	2911	Attention Deficit Disorder with Hyperactivity	MESH:D001289	marker/mechanism		NA		22138692
GRM1	2911	Epilepsy	MESH:D004827	marker/mechanism		NA		19853022
GRM1	2911	Epilepsy, Temporal Lobe	MESH:D004833	marker/mechanism		NA		15694259
GRM1	2911	Fibroma	MESH:D005350	marker/mechanism		NA		24658000
GRM1	2911	Neoplasms, Bone Tissue	MESH:D018213	marker/mechanism		NA		24658000
GRM1	2911	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA	614831	
GRM1	2911	Status Epilepticus	MESH:D013226	marker/mechanism		NA		15058486|17446080
GRM2	2912	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		20211215
GRM2	2912	Epilepsy, Temporal Lobe	MESH:D004833	marker/mechanism		NA		18804094
GRM2	2912	Psychoses, Substance-Induced	MESH:D011605	marker/mechanism		NA		20211215
GRM2	2912	Schizophrenia	MESH:D012559	marker/mechanism		NA		18923069
GRM3	2913	Epilepsy, Temporal Lobe	MESH:D004833	marker/mechanism		NA		18804094
GRM3	2913	Melanoma	MESH:D008545	marker/mechanism		NA		21946352|22842228
GRM3	2913	Schizophrenia	MESH:D012559	marker/mechanism		NA		18256595
GRM4	2914	Epilepsy, Temporal Lobe	MESH:D004833	marker/mechanism		NA		15694259
GRM4	2914	Nerve Degeneration	MESH:D009410	therapeutic		NA		17446080
GRM4	2914	Osteosarcoma	MESH:D012516	marker/mechanism		NA		23727862
GRM5	2915	Attention Deficit Disorder with Hyperactivity	MESH:D001289	marker/mechanism		NA		19546859|22138692
GRM5	2915	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		20826661
GRM5	2915	Diabetic Neuropathies	MESH:D003929	marker/mechanism		NA		19840219
GRM5	2915	Epilepsy, Temporal Lobe	MESH:D004833	marker/mechanism		NA		15694259
GRM5	2915	Neuralgia	MESH:D009437	marker/mechanism		NA		19840219
GRM5	2915	Status Epilepticus	MESH:D013226	marker/mechanism		NA		17634364|18774262
GRM5	2915	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
GRM6	2916	Night blindness, congenital stationary	MESH:C536122	marker/mechanism		NA	257270	
GRM7	2917	Attention Deficit Disorder with Hyperactivity	MESH:D001289	marker/mechanism		NA		22138692
GRM7	2917	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
GRM8	2918	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		17434465
GRM8	2918	Attention Deficit Disorder with Hyperactivity	MESH:D001289	marker/mechanism		NA		22138692
GRM8	2918	Autistic Disorder	MESH:D001321	marker/mechanism		NA		12676915
GRM8	2918	Brain Injuries	MESH:D001930	marker/mechanism		NA		23159883
GRM8	2918	Gliosis	MESH:D005911	marker/mechanism		NA		11226630
GRM8	2918	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941189
GRN	2896	CEROID LIPOFUSCINOSIS, NEURONAL, 11	OMIM:614706	marker/mechanism		NA	614706	
GRN	2896	Dementia	MESH:D003704	marker/mechanism		NA		17436289|18543312
GRN	2896	Frontotemporal Dementia	MESH:D057180	marker/mechanism		NA		21454553|22028881
GRN	2896	Frontotemporal Lobar Degeneration	MESH:D057174	marker/mechanism		NA		20154673
GRN	2896	FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	OMIM:607485	marker/mechanism		NA	607485	
GRN	2896	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GRN	2896	Nerve Degeneration	MESH:D009410	therapeutic		NA		21820214
GRP	2922	Amnesia	MESH:D000647	therapeutic		NA		11564462
GRP	2922	Head and Neck Neoplasms	MESH:D006258	marker/mechanism		NA		15342401
GRP	2922	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		2910524
GRP	2922	Pruritus	MESH:D011537	marker/mechanism		NA		29669290
GRPEL1	80273	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
GRPR	2925	Memory Disorders	MESH:D008569	marker/mechanism		NA		17097693
GRPR	2925	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17204703
GRWD1	83743	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
GRWD1	83743	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
GRXCR1	389207	DEAFNESS, AUTOSOMAL RECESSIVE 25	OMIM:613285	marker/mechanism		NA	613285	
GRXCR2	643226	DEAFNESS, AUTOSOMAL RECESSIVE 101	OMIM:615837	marker/mechanism		NA	615837	
GSC	145258	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		10433910
GSDMB	55876	Asthma	MESH:D001249	marker/mechanism		NA		24241537
GSDME	1687	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		17379860
GSDME	1687	Deafness, Autosomal Dominant 5	MESH:C563410	marker/mechanism		NA	600994	
GSDME	1687	Hearing Loss	MESH:D034381	marker/mechanism		NA		21782914
GSK3A	2931	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		20357757
GSK3A	2931	Depressive Disorder	MESH:D003866	marker/mechanism		NA		20357757
GSK3A	2931	Schizophrenia	MESH:D012559	marker/mechanism		NA		16223876
GSK3B	2932	Abnormalities, Multiple	MESH:D000015	marker/mechanism		NA		22975441
GSK3B	2932	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		22785175
GSK3B	2932	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		17409235|22944069
GSK3B	2932	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		16713974
GSK3B	2932	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		20357757
GSK3B	2932	Brain Injuries	MESH:D001930	marker/mechanism		NA		24675465
GSK3B	2932	Cardiomegaly	MESH:D006332	marker/mechanism		NA		17901358
GSK3B	2932	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		29626521
GSK3B	2932	Ceroid Lipofuscinosis, Neuronal, 6	MESH:C566627	marker/mechanism		NA		23516525
GSK3B	2932	Cognition Disorders	MESH:D003072	marker/mechanism		NA		24634145
GSK3B	2932	Depressive Disorder	MESH:D003866	marker/mechanism		NA		20357757|20534517
GSK3B	2932	Heart Failure	MESH:D006333	marker/mechanism		NA		17901358
GSK3B	2932	Hypertension	MESH:D006973	marker/mechanism		NA		22982863
GSK3B	2932	Lymphoma, Mantle-Cell	MESH:D020522	marker/mechanism		NA		18787224
GSK3B	2932	Muscular Atrophy	MESH:D009133	therapeutic		NA		18467435
GSK3B	2932	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		16716347
GSK3B	2932	Peritonitis	MESH:D010538	marker/mechanism		NA		16713974
GSK3B	2932	Poisoning	MESH:D011041	marker/mechanism		NA		22975441
GSK3B	2932	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16421604|25246272
GSK3B	2932	Schizophrenia	MESH:D012559	marker/mechanism		NA		14745448|31563592
GSK3B	2932	Tauopathies	MESH:D024801	marker/mechanism		NA		26945731
GSKIP	51527	Leukemia, Myeloid	MESH:D007951	marker/mechanism		NA		26280900
GSKIP	51527	Myeloproliferative Disorders	MESH:D009196	marker/mechanism		NA		26280900
GSN	2934	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		21751358
GSN	2934	Cardiomegaly	MESH:D006332	marker/mechanism		NA		30240538
GSN	2934	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		16099942
GSN	2934	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GSN	2934	Meretoja syndrome	MESH:C537459	marker/mechanism		NA	105120	
GSN	2934	Mesothelioma	MESH:D008654	marker/mechanism		NA		15920167
GSN	2934	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
GSN	2934	Paratuberculosis	MESH:D010283	marker/mechanism		NA		22633222
GSN	2934	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
GSR	2936	Amyotrophic Lateral Sclerosis	MESH:D000690	marker/mechanism		NA		16681429
GSR	2936	Anemia	MESH:D000740	marker/mechanism		NA		5984971
GSR	2936	Anemia, Hemolytic	MESH:D000743	marker/mechanism		NA		13931269
GSR	2936	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513|28069987
GSR	2936	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
GSR	2936	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		20620209
GSR	2936	Edema	MESH:D004487	marker/mechanism		NA		19874808
GSR	2936	Hyperthyroidism	MESH:D006980	marker/mechanism		NA		19914224
GSR	2936	Hypoglycemia	MESH:D007003	marker/mechanism		NA		20620209
GSR	2936	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		15964507
GSR	2936	Parkinsonian Disorders	MESH:D020734	therapeutic		NA		22721943
GSR	2936	Protein Deficiency	MESH:D011488	marker/mechanism		NA		15865262
GSR	2936	Ureteral Calculi	MESH:D014514	marker/mechanism		NA		24360074
GSS	2937	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
GSS	2937	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
GSS	2937	Glutathione synthetase deficiency	MESH:C536835	marker/mechanism		NA	266130	
GSS	2937	GLUTATHIONE SYNTHETASE DEFICIENCY OF ERYTHROCYTES, HEMOLYTIC ANEMIA DUE TO	OMIM:231900	marker/mechanism		NA	231900	
GSS	2937	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
GSS	2937	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
GSS	2937	Mouth Diseases	MESH:D009059	marker/mechanism		NA		17682004
GST-1	176281	Nerve Degeneration	MESH:D009410	therapeutic		NA		23721876
GSTA1	2938	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		28885000
GSTA1	2938	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		28885000
GSTA1	2938	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
GSTA1	2938	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		23643483
GSTA1	2938	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		15616829
GSTA2	2939	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
GSTA3	2940	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GSTA4	2941	Arteriosclerosis	MESH:D001161	marker/mechanism|therapeutic		NA		15064094|20177342
GSTA4	2941	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
GSTA4	2941	Parkinson Disease	MESH:D010300	marker/mechanism		NA		16510128
GSTA4	2941	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		20180811
GSTA5	221357	Hypertension	MESH:D006973	marker/mechanism		NA		22228705
GSTCD	79807	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		21716162
GSTK1	373156	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
GSTK1	373156	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
GSTM1	2944	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		19254865
GSTM1	2944	Asthma	MESH:D001249	marker/mechanism		NA		16870661|18988661
GSTM1	2944	Atherosclerosis	MESH:D050197	marker/mechanism		NA		19822795
GSTM1	2944	Autistic Disorder	MESH:D001321	marker/mechanism		NA		16472391
GSTM1	2944	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		7892276
GSTM1	2944	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		31569996
GSTM1	2944	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		18566013|26656529
GSTM1	2944	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		22072123
GSTM1	2944	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		17465707|18666253
GSTM1	2944	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
GSTM1	2944	Chromosome Aberrations	MESH:D002869	marker/mechanism		NA		23159492|24036326
GSTM1	2944	Chromosome Breakage	MESH:D019457	marker/mechanism		NA		27406225
GSTM1	2944	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		20878130
GSTM1	2944	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		22652274
GSTM1	2944	Disease Susceptibility	MESH:D004198	marker/mechanism		NA		16537716|31569996
GSTM1	2944	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		20485159
GSTM1	2944	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		24036326
GSTM1	2944	Leukemia	MESH:D007938	marker/mechanism		NA		14694614|18505952
GSTM1	2944	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		15650968
GSTM1	2944	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		21214675
GSTM1	2944	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17114358|17311802|22072123
GSTM1	2944	Mesothelioma	MESH:D008654	marker/mechanism		NA		17290392
GSTM1	2944	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		16697254
GSTM1	2944	Micronuclei, Chromosome-Defective	MESH:D048629	marker/mechanism		NA		20951227
GSTM1	2944	Neoplasms, Second Primary	MESH:D016609	marker/mechanism		NA		16703596
GSTM1	2944	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		15964507
GSTM1	2944	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		23643483
GSTM1	2944	Parkinson Disease	MESH:D010300	marker/mechanism		NA		17449559
GSTM1	2944	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		11275366|18304461|22564066
GSTM1	2944	Raynaud Disease	MESH:D011928	marker/mechanism		NA		16977343
GSTM1	2944	Skin Diseases	MESH:D012871	marker/mechanism		NA		16353154
GSTM1	2944	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		18505952|20972438
GSTM1	2944	Urticaria	MESH:D014581	marker/mechanism		NA		16433794
GSTM2	2946	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		20623750
GSTM2	2946	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		19900515
GSTM2	2946	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		20623750
GSTM2	2946	Down Syndrome	MESH:D004314	marker/mechanism		NA		11771762
GSTM2	2946	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
GSTM2	2946	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		15964507
GSTM3	2947	Chemical and Drug Induced Liver Injury	MESH:D056486	therapeutic		NA		25743375
GSTM3	2947	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
GSTM3	2947	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17892325
GSTM3	2947	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		14968442
GSTM4	2948	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
GSTM4	2948	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		15964507
GSTM5	2949	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
GSTM5	2949	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		15964507
GSTM6	14867	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		15964507
GSTO1	9446	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
GSTO1	9446	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
GSTO1	9446	Leukemia	MESH:D007938	marker/mechanism		NA		22293942
GSTO1	9446	Lung Diseases	MESH:D008171	marker/mechanism		NA		22293942
GSTO1	9446	Neoplasms	MESH:D009369	marker/mechanism		NA		21899313
GSTO1	9446	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		15964507
GSTO1	9446	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21472284
GSTO1	9446	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
GSTO1	9446	Skin Diseases	MESH:D012871	marker/mechanism		NA		17548696
GSTO2	119391	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		22306368
GSTP1	2950	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		21751358
GSTP1	2950	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		20623750
GSTP1	2950	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		15729709
GSTP1	2950	Amyotrophic Lateral Sclerosis	MESH:D000690	marker/mechanism		NA		16109392
GSTP1	2950	Asthma	MESH:D001249	marker/mechanism		NA		11994713|16870661|18988661|29411558
GSTP1	2950	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17404132
GSTP1	2950	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25322848
GSTP1	2950	Carcinoma	MESH:D002277	marker/mechanism		NA		11196146
GSTP1	2950	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		9029167
GSTP1	2950	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		17094902
GSTP1	2950	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		15108329
GSTP1	2950	Carotid Artery Diseases	MESH:D002340	marker/mechanism		NA		16973168
GSTP1	2950	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		20623750|25226513
GSTP1	2950	Chromosome Aberrations	MESH:D002869	marker/mechanism		NA		16537716
GSTP1	2950	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
GSTP1	2950	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
GSTP1	2950	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		20485159
GSTP1	2950	Essential Tremor	MESH:D020329	marker/mechanism		NA		18215156
GSTP1	2950	Glioma	MESH:D005910	marker/mechanism		NA		16899598
GSTP1	2950	Hodgkin Disease	MESH:D006689	marker/mechanism		NA		11406608
GSTP1	2950	Hypertension	MESH:D006973	marker/mechanism		NA		24915237
GSTP1	2950	Kidney Calculi	MESH:D007669	marker/mechanism		NA		24360074
GSTP1	2950	Kidney Diseases	MESH:D007674	marker/mechanism		NA		12868187
GSTP1	2950	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	MESH:D015464	marker/mechanism		NA		20843134
GSTP1	2950	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		20188851|2563599|3124819|7585603
GSTP1	2950	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17909032
GSTP1	2950	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
GSTP1	2950	Necrosis	MESH:D009336	marker/mechanism		NA		14710442
GSTP1	2950	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		23643483
GSTP1	2950	Osteosarcoma	MESH:D012516	marker/mechanism		NA		17152492
GSTP1	2950	Parkinson Disease	MESH:D010300	marker/mechanism		NA		17190945|23721876
GSTP1	2950	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		20979931
GSTP1	2950	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		15526359|16332721|20188851|21785164|2563599|7585603
GSTP1	2950	Prostatic Intraepithelial Neoplasia	MESH:D019048	marker/mechanism		NA		22581815
GSTP1	2950	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		11196146|15538743|17173048|19223546|22581815
GSTP1	2950	Psychoses, Substance-Induced	MESH:D011605	marker/mechanism		NA		15729709
GSTP1	2950	Respiratory Sounds	MESH:D012135	marker/mechanism		NA		18950799
GSTP1	2950	Sarcoma	MESH:D012509	marker/mechanism		NA		17152492
GSTP1	2950	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21133646|21364753
GSTP1	2950	Ureteral Calculi	MESH:D014514	marker/mechanism		NA		24360074
GSTP1	2950	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		12500666|22306368|7729958
GSTP1	2950	Vestibular Diseases	MESH:D015837	marker/mechanism		NA		18776599
GSTP2	14869	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17909032
GSTT1	2952	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18186040|19254865
GSTT1	2952	Asbestosis	MESH:D001195	marker/mechanism		NA		17563610
GSTT1	2952	Asthenozoospermia	MESH:D053627	marker/mechanism		NA		19303595
GSTT1	2952	Carcinoma	MESH:D002277	marker/mechanism		NA		20663906
GSTT1	2952	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		31569996
GSTT1	2952	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		18566013|26656529
GSTT1	2952	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		18397238|18666253|25226513
GSTT1	2952	Chromosome Aberrations	MESH:D002869	marker/mechanism		NA		16537716|16980312|23159492
GSTT1	2952	Disease Susceptibility	MESH:D004198	marker/mechanism		NA		31569996
GSTT1	2952	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		17173682
GSTT1	2952	Glioblastoma	MESH:D005909	marker/mechanism		NA		16874663
GSTT1	2952	Hypertension	MESH:D006973	marker/mechanism		NA		22228705
GSTT1	2952	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		20663906
GSTT1	2952	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17000715
GSTT1	2952	Micronuclei, Chromosome-Defective	MESH:D048629	marker/mechanism		NA		16702390
GSTT1	2952	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		16949155
GSTT1	2952	Neoplasms	MESH:D009369	marker/mechanism		NA		25325283
GSTT1	2952	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		23643483
GSTT1	2952	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		11275366|16998812|17507624|22564066
GSTT1	2952	Raynaud Disease	MESH:D011928	marker/mechanism		NA		16977343
GSTT1	2952	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		26295053
GSTT1B	393556	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28069987
GSTT2	2953	Hypertension	MESH:D006973	marker/mechanism		NA		22228705
GSTT2	2953	Muscular Dystrophy, Facioscapulohumeral	MESH:D020391	marker/mechanism		NA		12868502
GSTT3	103140	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
GSTZ1	2954	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		22306368
GSTZ1	2954	Vestibular Diseases	MESH:D015837	marker/mechanism		NA		18776599
GSX2	170825	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
GTF2E2	2961	TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE	OMIM:616943	marker/mechanism		NA	616943	
GTF2H5	404672	TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE	OMIM:616395	marker/mechanism		NA	616395	
GTF2I	2969	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
GTF2I	2969	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		22048961
GTF2I	2969	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		18206229
GTF2I	2969	Sjogren's Syndrome	MESH:D012859	marker/mechanism		NA		24097066
GTF2I	2969	Thymic epithelial tumor	MESH:C536905	marker/mechanism		NA		24974848
GTF2I	2969	Williams Syndrome	MESH:D018980	marker/mechanism		NA		20007321|21328569
GTF2IRD1	9569	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		20007321
GTF2IRD1	9569	Williams Syndrome	MESH:D018980	marker/mechanism		NA		20007321
GTF3A	2971	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
GTPBP1	9567	Diverticular Diseases	MESH:D000076385	marker/mechanism		NA		30177863
GTPBP2	54676	Cholestasis	MESH:D002779	marker/mechanism		NA		27989131
GTPBP3	84705	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	OMIM:616198	marker/mechanism		NA	616198	
GTSE1	51512	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
GUCA1A	2978	Cone Dystrophy 3	MESH:C566579	marker/mechanism		NA	602093	
GUCA1B	2979	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA		15452722
GUCA1B	2979	RETINITIS PIGMENTOSA 48	OMIM:613827	marker/mechanism		NA	613827	
GUCA2B	2981	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		15780094
GUCA2B	2981	Nephrotic Syndrome	MESH:D009404	marker/mechanism		NA		15780094
GUCD1	83606	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		24763052
GUCY1A1	2982	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
GUCY1A1	2982	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
GUCY1A1	2982	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		22751097
GUCY1A1	2982	Hypertension	MESH:D006973	marker/mechanism		NA		18339647
GUCY1A1	2982	MOYAMOYA DISEASE 6 WITH OR WITHOUT ACHALASIA	OMIM:615750	marker/mechanism		NA	615750	
GUCY1A1	2982	Pulmonary edema of mountaineers	MESH:C535833	marker/mechanism		NA		25373139
GUCY1A1	2982	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
GUCY1A1	2982	Thrombosis	MESH:D013927	marker/mechanism		NA		24213632
GUCY1A2	2977	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18507500
GUCY1A2	2977	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18507500|21278247
GUCY2C	2984	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17155897
GUCY2C	2984	Diarrhea	MESH:D003967	marker/mechanism		NA	614616	22436048
GUCY2C	2984	Meconium Ileus	MESH:D000074270	marker/mechanism		NA	614665	
GUCY2D	3000	Amaurosis congenita of Leber, type 1	MESH:C536600	marker/mechanism		NA	204000	
GUCY2D	3000	Choroidal sclerosis	MESH:C535358	marker/mechanism		NA	215500	
GUCY2D	3000	Retinal cone dystrophy 2	MESH:C538363	marker/mechanism		NA	601777	
GUCY2D	3000	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA		16272259
GUF1	60558	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	OMIM:617065	marker/mechanism		NA	617065	
GULO	268756	Ascorbic Acid Deficiency	MESH:D001206	marker/mechanism		NA		30606963
GULO	268756	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
GULO	268756	Fatty Liver	MESH:D005234	marker/mechanism		NA		25226513
GULO	268756	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
GULP1	51454	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GULP1	51454	Thyroid Diseases	MESH:D013959	marker/mechanism		NA		23397585
GUSB	2990	Mucopolysaccharidosis VII	MESH:D016538	marker/mechanism		NA	253220	
GUSB	2990	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		7073948|7107415
GUSB	2990	Proteinuria	MESH:D011507	marker/mechanism		NA		2880436
GYG1	2992	Arrhythmias, Cardiac	MESH:D001145	marker/mechanism		NA		20357282
GYG1	2992	Glycogen Storage Disease	MESH:D006008	marker/mechanism		NA		20357282
GYG1	2992	GLYCOGEN STORAGE DISEASE XV	OMIM:613507	marker/mechanism		NA	613507	
GYG1	2992	Muscle Weakness	MESH:D018908	marker/mechanism		NA		20357282
GYG1	2992	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
GYPA	2993	Malaria	MESH:D008288	marker/mechanism		NA	611162	
GYPA	2993	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		17029826
GYPB	2994	Malaria	MESH:D008288	marker/mechanism		NA	611162	
GYPC	2995	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
GYPC	2995	Malaria	MESH:D008288	marker/mechanism		NA	611162	
GYS1	2997	Glycogen Storage Disease 0, Muscle	MESH:C566917	marker/mechanism		NA	611556	
GYS2	2998	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
GYS2	2998	Glycogen Storage Disease 0, Liver	MESH:C565485	marker/mechanism		NA	240600	
GZMA	3001	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
GZMB	3002	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18762240
GZMB	3002	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19446661
GZMB	3002	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		19706026
GZMB	3002	Hepatitis	MESH:D006505	marker/mechanism		NA		19706026
H1-0	3005	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
H1-2	3006	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17659439
H1-2	3006	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
H1-4	3008	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
H19	283120	Birth Weight	MESH:D001724	marker/mechanism		NA		31082282
H19	283120	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		28544374
H19	283120	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		30515189
H19	283120	Hepatitis, Animal	MESH:D006520	marker/mechanism		NA		18559427
H19	283120	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		11420682
H19	283120	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		28544374
H19	283120	Silver-Russell Syndrome	MESH:D056730	marker/mechanism		NA		19066168
H19	283120	Wilms Tumor	MESH:D009396	marker/mechanism		NA	194070	
H19-ICR	105259599	Beckwith-Wiedemann Syndrome	MESH:D001506	marker/mechanism		NA	130650	
H19-ICR	105259599	Familial Wilms tumor 2	MESH:C536853	marker/mechanism		NA	194071	
H19-ICR	105259599	Silver-Russell Syndrome	MESH:D056730	marker/mechanism		NA	180860	
H1F10	243529	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
H1F10	243529	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
H2AC16	8332	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
H2AC8	3012	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
H2AX	3014	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18925433|21463514
H2AX	3014	Chromosome Breakage	MESH:D019457	marker/mechanism		NA		26231820
H2AX	3014	Glioblastoma	MESH:D005909	marker/mechanism		NA		26651356
H2AX	3014	Micronuclei, Chromosome-Defective	MESH:D048629	marker/mechanism		NA		26651356
H2AX	3014	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		18925433
H2AX	3014	Polyploidy	MESH:D011123	marker/mechanism		NA		25123929
H2BC12	85236	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17659439
H2BC14	8342	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
H2BC4	8347	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
H2BC4	8347	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17659439
H2BC4	8347	Clinical Deterioration	MESH:D000075902	marker/mechanism		NA		27602772
H2BC4	8347	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
H2BC8	8339	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
H2BC8	8339	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		19208208
H2-T23	15040	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
H3-3A	3020	Giant Cell Tumor of Bone	MESH:D018212	marker/mechanism		NA		24162739
H3-3A	3020	Glioblastoma	MESH:D005909	marker/mechanism		NA		22286216|23817572
H3-3A	3020	Glioma	MESH:D005910	marker/mechanism		NA		22286216|23583981
H3-3B	3021	Chondroblastoma	MESH:D002804	marker/mechanism		NA		24162739
H3-4	8290	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
H3-4	8290	Pneumoconiosis	MESH:D011009	marker/mechanism		NA		25445010
H3C2	8358	Glioblastoma	MESH:D005909	marker/mechanism		NA		22286216
H3C2	8358	Glioma	MESH:D005910	marker/mechanism		NA		22286216
H3F3B	15081	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
H3F3B	15081	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
H3F3B	15081	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
H4C2	8366	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
H4C3	8364	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		28920961
H4C3	8364	Growth Disorders	MESH:D006130	marker/mechanism		NA		28920961
H4C3	8364	Intellectual Disability	MESH:D008607	marker/mechanism		NA		28920961
H4C3	8364	Microcephaly	MESH:D008831	marker/mechanism		NA		28920961
H4C4	8360	Creutzfeldt-Jakob Syndrome	MESH:D007562	marker/mechanism		NA		23349890
H4C8	8365	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		19208208
H6PD	9563	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29295867
H6PD	9563	Cortisone reductase deficiency	MESH:C536447	marker/mechanism		NA	604931	
HABP2	3026	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
HABP2	3026	Thrombophilia	MESH:D019851	marker/mechanism		NA	188050	
HABP2	3026	THYROID CANCER, NONMEDULLARY, 5	OMIM:616535	marker/mechanism		NA	616535	
HACD1	9200	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
HACE1	57531	Neuroblastoma	MESH:D009447	marker/mechanism		NA		22941191
HACL1	26061	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		26881866
HACL1	26061	Cholestasis	MESH:D002779	marker/mechanism		NA		26881866
HADH	3033	3-Hydroxyacyl-CoA Dehydrogenase Deficiency	MESH:C535310	marker/mechanism		NA	231530	
HADH	3033	Hyperinsulinemic Hypoglycemia, Familial, 4	MESH:C566493	marker/mechanism		NA	609975	
HADH	3033	Obesity	MESH:D009765	marker/mechanism		NA		20882379
HADH	3033	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21472284
HADHA	3030	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
HADHA	3030	LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	OMIM:609016	marker/mechanism		NA	609016	
HADHA	3030	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
HADHA	3030	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
HADHA	3030	Trifunctional Protein Deficiency With Myopathy And Neuropathy	MESH:C566945	marker/mechanism		NA	609015	
HADHB	3032	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21466612
HADHB	3032	Fatty Liver	MESH:D005234	marker/mechanism		NA		17116638
HADHB	3032	Heart Diseases	MESH:D006331	marker/mechanism		NA		17116638
HADHB	3032	Lipid Metabolism Disorders	MESH:D052439	marker/mechanism		NA		17116638
HADHB	3032	Trifunctional Protein Deficiency With Myopathy And Neuropathy	MESH:C566945	marker/mechanism		NA	609015	
HAGH	3029	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
HAL	3034	Histidinemia	MESH:C538320	marker/mechanism		NA	235800	
HAL	3034	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
HAMP	57817	Anemia	MESH:D000740	marker/mechanism		NA		16434484|16627556|24086573
HAMP	57817	beta-Thalassemia	MESH:D017086	marker/mechanism		NA		16755567
HAMP	57817	Biliary Atresia	MESH:D001656	marker/mechanism		NA		16627878
HAMP	57817	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
HAMP	57817	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
HAMP	57817	Hemochromatosis	MESH:D006432	marker/mechanism		NA		16574947|16627556|17255318|19252486|21411349|22383097
HAMP	57817	Hemochromatosis, Type 2B	MESH:C566557	marker/mechanism		NA	613313	
HAMP	57817	Hepatolenticular Degeneration	MESH:D006527	marker/mechanism		NA		23519153
HAMP	57817	Iron Overload	MESH:D019190	marker/mechanism		NA		20801540|22659129
HAMP	57817	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		16929540
HAMP	57817	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		28321044
HAMP2	66438	Iron Overload	MESH:D019190	marker/mechanism		NA		19524651
HAND1	9421	Poisoning	MESH:D011041	marker/mechanism		NA		21964422
HAND2	9464	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		28416822|29892015|30061737
HAND2	9464	Cardiomegaly	MESH:D006332	marker/mechanism		NA		29394407
HAND2	9464	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		29394407
HAND2	9464	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		9671575
HAND2	9464	Heart Failure	MESH:D006333	marker/mechanism		NA		29394407
HAND2	9464	Neuroblastoma	MESH:D009447	marker/mechanism		NA		30127528
HAND2	9464	Tetralogy of Fallot	MESH:D013771	marker/mechanism		NA		25093829
HAND2	9464	Ventricular Remodeling	MESH:D020257	marker/mechanism		NA		29394407
HAO1	54363	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
HAO1	54363	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
HAO2	51179	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
HAO2	51179	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
HAO2	51179	Cholestasis	MESH:D002779	marker/mechanism		NA		27989131
HAO2	51179	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980|25380136
HAPLN1	1404	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		17568789
HAPLN1	1404	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		21278247
HAPLN1	1404	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		9988279
HAPLN1	1404	Dwarfism	MESH:D004392	marker/mechanism		NA		9988279
HAPLN1	1404	Limb Deformities, Congenital	MESH:D017880	marker/mechanism		NA		9988279
HAPLN4	404037	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
HARS	15115	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		23256773
HARS	15115	Lung Diseases	MESH:D008171	marker/mechanism		NA		23256773
HARS1	3035	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		15108329
HARS1	3035	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2W	OMIM:616625	marker/mechanism		NA	616625	
HARS1	3035	USHER SYNDROME, TYPE IIIB	OMIM:614504	marker/mechanism		NA	614504	
HAS3	3038	Fatty Liver	MESH:D005234	marker/mechanism		NA		27042213
HAUS6	54801	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		31043753
HAUS6	54801	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
HAVCR1	26762	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		20118187|21259293|21835770|22005293|23052191|23845967|24189134|24361871|24958931|28885000
HAVCR1	26762	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		20623750
HAVCR1	26762	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		15805072|24361871|28885000
HAVCR1	26762	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA		19225054
HAVCR1	26762	Kidney Diseases	MESH:D007674	marker/mechanism		NA		19349640|20181666|20438795|21888673|23019274|24863737|24880025
HAVCR1	26762	Necrosis	MESH:D009336	marker/mechanism		NA		24880025
HAVCR1	26762	Proteinuria	MESH:D011507	marker/mechanism		NA		19225054
HAVCR2	84868	Lymphohistiocytosis, Hemophagocytic	MESH:D051359	marker/mechanism		NA		30374066
HAVCR2	84868	Subcutaneous panniculitis-like T-cell lymphoma	MESH:C537503	marker/mechanism		NA		30374066
HAX1	10456	Neutropenia, Severe Congenital, Autosomal Recessive 3	MESH:C537592	marker/mechanism		NA	610738	
HBA1	3039	alpha-Thalassemia	MESH:D017085	marker/mechanism		NA	604131|613978	16798638
HBA1	3039	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
HBA1	3039	Cerebral Infarction	MESH:D002544	marker/mechanism		NA		1634355
HBA1	3039	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
HBA1	3039	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		16632892
HBA1	3039	Heinz Body Anemias	MESH:C563030	marker/mechanism		NA	140700	2833478
HBA1	3039	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
HBA1	3039	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
HBA1	3039	Methemoglobinemia	MESH:D008708	marker/mechanism		NA		3026948
HBA1	3039	Polycythemia	MESH:D011086	marker/mechanism		NA		1634355
HBA1	3039	Polycythemia Vera	MESH:D011087	marker/mechanism		NA		1634355
HBA2	3040	alpha-Thalassemia	MESH:D017085	marker/mechanism		NA	604131|613978	15182556|16798638
HBA2	3040	beta-Thalassemia	MESH:D017086	marker/mechanism		NA		17292142
HBA2	3040	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
HBA2	3040	Heinz Body Anemias	MESH:C563030	marker/mechanism		NA	140700	
HBA-A1	15122	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
HBB	3043	alpha-Thalassemia	MESH:D017085	marker/mechanism		NA	604131	
HBB	3043	Anemia, Sickle Cell	MESH:D000755	marker/mechanism		NA	603903	29255069|81926
HBB	3043	beta-Thalassemia	MESH:D017086	marker/mechanism		NA	613985	16755567|23975182|3021607|6270663|6280057|88735
HBB	3043	Beta Thalassemia, Dominant Inclusion Body Type	MESH:C565834	marker/mechanism		NA	603902	
HBB	3043	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
HBB	3043	Cyanosis	MESH:D003490	marker/mechanism		NA		15929117
HBB	3043	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		23975182|29255069
HBB	3043	Echinococcosis	MESH:D004443	marker/mechanism		NA		24270252
HBB	3043	Heinz Body Anemias	MESH:C563030	marker/mechanism		NA	140700	5420592|8704193
HBB	3043	Hemoglobinopathies	MESH:D006453	marker/mechanism		NA		5773089
HBB	3043	Malaria	MESH:D008288	marker/mechanism		NA	611162	
HBB	3043	Malaria, Falciparum	MESH:D016778	marker/mechanism		NA		20305663
HBB	3043	Methemoglobinemia	MESH:D008708	marker/mechanism		NA		15929117
HBB	3043	Polycythemia	MESH:D011086	marker/mechanism		NA		1117598|7161106
HBB	3043	Polycythemia Vera	MESH:D011087	marker/mechanism		NA		5773089
HBB	3043	Splenomegaly	MESH:D013163	marker/mechanism		NA		29255069
HBB-B1	15129	beta-Thalassemia	MESH:D017086	marker/mechanism		NA		17018382
HBB-B2	15130	beta-Thalassemia	MESH:D017086	marker/mechanism		NA		17018382
HBB-LCR	109580095	beta-Thalassemia	MESH:D017086	marker/mechanism		NA	613985	
HBD	3045	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
HBD	3045	Keloid	MESH:D007627	marker/mechanism		NA		20128793
HBEGF	1839	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		7635938
HBEGF	1839	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
HBEGF	1839	Cardiotoxicity	MESH:D066126	therapeutic		NA		29305325
HBEGF	1839	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		21937979
HBEGF	1839	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
HBEGF	1839	Enterocolitis, Necrotizing	MESH:D020345	therapeutic		NA		16567187
HBEGF	1839	Epilepsy, Tonic-Clonic	MESH:D004830	marker/mechanism		NA		16023256
HBEGF	1839	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		9709397
HBEGF	1839	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		21937979
HBEGF	1839	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		7635938
HBEGF	1839	Stomach Neoplasms	MESH:D013274	therapeutic		NA		15723263
HBEGFA	797938	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		27935819
HBEGFB	407664	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		27935819
HBG1	3047	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
HBG1	3047	Parkinson Disease	MESH:D010300	marker/mechanism		NA		25475535
HBG1	3047	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		19208208
HBG2	3048	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		562503|851170
HBG2	3048	CYANOSIS, TRANSIENT NEONATAL	OMIM:613977	marker/mechanism		NA	613977	
HBG2	3048	Oliguria	MESH:D009846	marker/mechanism		NA		851170
HBG2	3048	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		19208208
HCAR2	338442	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		21655214
HCAR2	338442	Flushing	MESH:D005483	marker/mechanism		NA		16322797
HCAR2	338442	Psoriasis	MESH:D011565	marker/mechanism		NA		18722346
HCAR2	338442	Schizophrenia	MESH:D012559	marker/mechanism		NA		18639743
HCAR2	338442	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		21655214
HCAR3	8843	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		21655214
HCAR3	8843	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		21655214
HCCS	3052	Microphthalmia, syndromic 7	MESH:C537466	marker/mechanism		NA	309801	
HCFC1	3054	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19255062
HCFC1	3054	Mental Retardation, X-Linked 3	MESH:C563136	marker/mechanism		NA	309541	
HCK	3055	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
HCK	3055	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		17344919
HCLS1	3059	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		12833524
HCN1	348980	Ataxia	MESH:D001259	marker/mechanism		NA		19747469
HCN1	348980	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 24	OMIM:615871	marker/mechanism		NA	615871	
HCN1	348980	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		19747469
HCN1	348980	Epilepsy	MESH:D004827	marker/mechanism		NA		12890777
HCN1	348980	Infantile Epileptic-Dyskinetic Encephalopathy	MESH:C567924	marker/mechanism		NA		24747641
HCN1	348980	Seizures	MESH:D012640	marker/mechanism		NA		20384728
HCN4	10021	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		22544366|30061737
HCN4	10021	Brugada Syndrome 8	MESH:C567732	marker/mechanism		NA	613123	
HCN4	10021	Sick Sinus Syndrome 2, Autosomal Dominant	MESH:C563513	marker/mechanism		NA	163800	
HCRT	3060	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		16357203
HCRT	3060	Narcolepsy 1	MESH:C563534	marker/mechanism		NA	161400	
HCRT	3060	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		23246865
HCRT	3060	Pain	MESH:D010146	therapeutic		NA		16202530
HCRT	3060	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		20738730
HCRTR1	3061	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		16357203|19591850|19741128
HCRTR1	3061	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		20667500
HCRTR2	3062	Narcolepsy	MESH:D009290	marker/mechanism		NA		17521418
HDAC1	3065	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		32289289
HDAC1	3065	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		21527555
HDAC1	3065	Endometriosis	MESH:D004715	marker/mechanism		NA		22138541
HDAC1	3065	Familial Primary Pulmonary Hypertension	MESH:D065627	marker/mechanism		NA		22711276
HDAC1	3065	Heart Diseases	MESH:D006331	marker/mechanism		NA		18625706
HDAC1	3065	Myelodysplastic Syndromes	MESH:D009190	marker/mechanism		NA		28963909
HDAC2	3066	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		21527555
HDAC2	3066	Cardiomegaly	MESH:D006332	marker/mechanism		NA		18625706
HDAC2	3066	Endometriosis	MESH:D004715	marker/mechanism		NA		22138541
HDAC2	3066	Leukemia, Myeloid	MESH:D007951	marker/mechanism		NA		21535412
HDAC2	3066	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		27396813
HDAC2	3066	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
HDAC2	3066	Microsatellite Instability	MESH:D053842	marker/mechanism		NA		25701956
HDAC2	3066	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		15337792|18421014
HDAC3	8841	Heart Diseases	MESH:D006331	marker/mechanism		NA		18625706
HDAC4	9759	Brachydactyly	MESH:D059327	marker/mechanism		NA		20691407
HDAC4	9759	Brachydactyly, Type E	MESH:C566194	marker/mechanism		NA		24715439
HDAC4	9759	Chromosome 2q37 deletion syndrome	MESH:C538317	marker/mechanism		NA		20691407
HDAC4	9759	Cocaine-Related Disorders	MESH:D019970	therapeutic		NA		17988634
HDAC4	9759	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
HDAC4	9759	Familial Primary Pulmonary Hypertension	MESH:D065627	marker/mechanism		NA		22711276
HDAC4	9759	Intellectual Disability	MESH:D008607	marker/mechanism		NA		20691407
HDAC4	9759	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
HDAC4	9759	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		21507255
HDAC5	10014	Adjustment Disorders	MESH:D000275	marker/mechanism		NA		17988634
HDAC5	10014	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		31043756
HDAC5	10014	Cocaine-Related Disorders	MESH:D019970	therapeutic		NA		17988634
HDAC5	10014	Familial Primary Pulmonary Hypertension	MESH:D065627	marker/mechanism		NA		22711276
HDAC5	10014	Scleroderma, Systemic	MESH:D012595	marker/mechanism		NA		27482699
HDAC6	10013	CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	OMIM:300863	marker/mechanism		NA	300863	
HDAC6	10013	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
HDAC6	10013	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		19010849
HDAC6	10013	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		24763052
HDAC9	9734	Osteoarthritis, Hip	MESH:D015207	marker/mechanism		NA		30374069
HDAC9	9734	Stroke	MESH:D020521	marker/mechanism		NA		22306652
HDC	3067	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
HDC	3067	Tourette Syndrome	MESH:D005879	marker/mechanism		NA	137580	
HDGF	3068	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
HDHD2	84064	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
HDLBP	3069	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19365831
HDLBP	3069	Chromosome 2q37 deletion syndrome	MESH:C538317	marker/mechanism		NA		19365831
HDLBP	3069	Neoplastic Processes	MESH:D009385	marker/mechanism		NA		25129143
HEBP2	23593	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		25058030
HECTD4	283450	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		22751097
HECW2	57520	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE	OMIM:617268	marker/mechanism		NA	617268	
HELLS	3070	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
HELLS	3070	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
HELLS	3070	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4	OMIM:616911	marker/mechanism		NA	616911	
HELLS	3070	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
HELLS	3070	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
HEPACAM	220296	Megalencephalic leukoencephalopathy with subcortical cysts	MESH:C536141	marker/mechanism		NA	604004|613925	
HEPACAM	220296	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION	OMIM:613926	marker/mechanism		NA	613926	
HEPH	9843	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		26818092
HERC1	8925	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
HERC1	8925	MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION	OMIM:617011	marker/mechanism		NA	617011	
HERC2	8924	Asthma, Occupational	MESH:D059366	marker/mechanism		NA		25918132
HERC2	8924	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		18438405
HERC2	8924	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38	OMIM:615516	marker/mechanism		NA	615516	
HERC2	8924	Prader-Willi Syndrome	MESH:D011218	marker/mechanism		NA	176270	
HERC3	8916	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
HERC5	51191	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28919514
HERC5	51191	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
HERC5	51191	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
HERC6	55008	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
HERPUD1	9709	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
HERPUD2	64224	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
HES1	3280	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20197467|21036696
HES1	3280	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		21994468
HES1	3280	Carcinoma, Pancreatic Ductal	MESH:D021441	marker/mechanism		NA		19208345
HES1	3280	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		19147571
HES1	3280	Glioblastoma	MESH:D005909	marker/mechanism		NA		21127729
HES1	3280	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17804716
HES1	3280	Lymphangioleiomyomatosis	MESH:D018192	marker/mechanism		NA		20038814
HES1	3280	Meningioma	MESH:D008579	marker/mechanism		NA		21127729
HES1	3280	Neuroectodermal Tumors, Primitive	MESH:D018242	marker/mechanism		NA		21127729
HES1	3280	Oligodendroglioma	MESH:D009837	marker/mechanism		NA		21127729
HES1	3280	Ureteral Obstruction	MESH:D014517	marker/mechanism		NA		28318631
HES1	3280	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		25061499
HES5	388585	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		21127729
HES5	388585	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		23203475
HES7	84667	Spondylocostal dysostosis, autosomal recessive	MESH:C535781	marker/mechanism		NA	613686	
HESX1	8820	Hypopituitarism and septooptic 'dysplasia'	MESH:C531815	marker/mechanism		NA	182230	
HEXA	3073	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
HEXA	3073	Tay-Sachs Disease	MESH:D013661	marker/mechanism		NA	272800	11392526
HEXB	3074	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		22005293
HEXB	3074	Sandhoff Disease	MESH:D012497	marker/mechanism		NA	268800	
HEXIM1	10614	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
HEY1	23462	Astrocytoma	MESH:D001254	marker/mechanism		NA		21127729
HEY1	23462	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		20868653
HEY1	23462	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21036696
HEY1	23462	Carcinoma, Pancreatic Ductal	MESH:D021441	marker/mechanism		NA		19208345
HEY1	23462	Glioblastoma	MESH:D005909	marker/mechanism		NA		21127729
HEY1	23462	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17804716
HEY1	23462	Neuroectodermal Tumors, Primitive	MESH:D018242	marker/mechanism		NA		21127729
HEY1	23462	Oligodendroglioma	MESH:D009837	marker/mechanism		NA		21127729
HEY1	23462	Ureteral Obstruction	MESH:D014517	marker/mechanism		NA		28318631
HEY2	23493	Astrocytoma	MESH:D001254	marker/mechanism		NA		21127729
HEY2	23493	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21036696
HEY2	23493	Brugada Syndrome	MESH:D053840	marker/mechanism		NA		23872634
HEY2	23493	Carcinoma, Pancreatic Ductal	MESH:D021441	marker/mechanism		NA		19208345
HEY2	23493	Cardiomyopathy, Hypertrophic	MESH:D002312	therapeutic		NA		20001863
HEY2	23493	Ureteral Obstruction	MESH:D014517	marker/mechanism		NA		28318631
HEYL	26508	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21036696
HFE	3077	Alzheimer Disease	MESH:D000544	marker/mechanism		NA	104300	15060098|17047092
HFE	3077	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		20808228
HFE	3077	Birth Weight	MESH:D001724	marker/mechanism		NA		20659343
HFE	3077	Hemochromatosis	MESH:D006432	marker/mechanism		NA	235200	11050162|16793930|17119292|17236123|17255318|17258727|17376729|18317567|20160468|20843714|21411349|22383097|23705020|25874029
HFE	3077	Hepatitis C	MESH:D006526	marker/mechanism		NA		15865084
HFE	3077	Lead Poisoning	MESH:D007855	marker/mechanism		NA		20659343
HFE	3077	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 7	OMIM:612635	marker/mechanism		NA	612635	
HFE	3077	Myelodysplastic Syndromes	MESH:D009190	marker/mechanism		NA		17001480
HFE	3077	Osteoarthritis, Hip	MESH:D015207	marker/mechanism		NA		30374069
HFE	3077	Parkinson Disease	MESH:D010300	marker/mechanism		NA		16824219
HFE	3077	Porphyria Cutanea Tarda	MESH:D017119	marker/mechanism		NA	176100	12622622
HFE	3077	Porphyria, Variegate	MESH:D046350	marker/mechanism		NA	176200	
HFM1	164045	PREMATURE OVARIAN FAILURE 9	OMIM:615724	marker/mechanism		NA	615724	
HGD	3081	Alkaptonuria	MESH:D000474	marker/mechanism		NA	203500	
HGF	3082	Astrocytoma	MESH:D001254	marker/mechanism		NA		11223164
HGF	3082	Barrett Esophagus	MESH:D001471	marker/mechanism		NA		15387324
HGF	3082	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		11896611|9932610
HGF	3082	Carcinoma, Squamous Cell	MESH:D002294	therapeutic		NA		21273587
HGF	3082	Cardiomyopathies	MESH:D009202	therapeutic		NA		16109756|18083897
HGF	3082	Copper-Overload Cirrhosis	MESH:C566858	marker/mechanism		NA		22879914
HGF	3082	Deafness, Autosomal Recessive 39	MESH:C564265	marker/mechanism		NA	608265	
HGF	3082	Diabetic Neuropathies	MESH:D003929	therapeutic		NA		26000320
HGF	3082	Hepatitis, Chronic	MESH:D006521	marker/mechanism		NA		22879914
HGF	3082	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		22683780
HGF	3082	Liver Cirrhosis	MESH:D008103	therapeutic		NA		17097021
HGF	3082	Liver Cirrhosis, Experimental	MESH:D008106	therapeutic		NA		10677585|12918455|15793283|16465399|16627068|17714472|18637143
HGF	3082	Liver Failure, Acute	MESH:D017114	therapeutic		NA		12479984
HGF	3082	Liver Neoplasms	MESH:D008113	therapeutic		NA		8807143
HGF	3082	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		11896611
HGF	3082	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25162674
HGF	3082	Myocardial Ischemia	MESH:D017202	therapeutic		NA		12447174
HGF	3082	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		15654357|9932610
HGF	3082	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		25971889
HGF	3082	Neoplasms, Experimental	MESH:D009374	therapeutic		NA		21273587
HGF	3082	Neuroblastoma	MESH:D009447	marker/mechanism		NA		16051641
HGF	3082	Pain	MESH:D010146	therapeutic		NA		26000320
HGF	3082	Pancreatitis	MESH:D010195	therapeutic		NA		14751415
HGF	3082	Parkinson Disease	MESH:D010300	therapeutic		NA		16791285
HGF	3082	Polyomavirus Infections	MESH:D027601	marker/mechanism		NA		25162674
HGF	3082	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		16324872
HGF	3082	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		16526316
HGF	3082	Thrombosis	MESH:D013927	marker/mechanism		NA		15367830
HGF	3082	Vascular Diseases	MESH:D014652	therapeutic		NA		15071489
HGF	3082	Wounds, Penetrating	MESH:D014950	therapeutic		NA		12890377
HGFAC	3083	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		19363144
HGSNAT	138050	Mucopolysaccharidosis III	MESH:D009084	marker/mechanism		NA	252930	
HGSNAT	138050	RETINITIS PIGMENTOSA 73	OMIM:616544	marker/mechanism		NA	616544	
HHAT	55733	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
HHEX	3087	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16854221
HHEX	3087	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		23104008
HHEX	3087	Fatty Liver	MESH:D005234	marker/mechanism		NA		24469900
HHIP	64399	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		18559595
HHIP	64399	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		30510241
HHIP	64399	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
HHIP	64399	Hypospadias	MESH:D007021	marker/mechanism		NA		31568847
HHIPL1	84439	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		21378990
HIBCH	26275	Beta-Hydroxyisobutyryl CoA Deacylase Deficiency	MESH:C562803	marker/mechanism		NA	250620	
HIBCH	26275	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
HIC1	3090	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20154726
HIC1	3090	Gastrointestinal Neoplasms	MESH:D005770	marker/mechanism		NA		21297660
HIC1	3090	Macular Degeneration	MESH:D008268	marker/mechanism		NA		30742112
HIC1	3090	Medulloblastoma	MESH:D008527	marker/mechanism		NA		18347096
HIC1	3090	Polyps	MESH:D011127	marker/mechanism		NA		21297660
HIF1A	3091	Anaplasia	MESH:D000708	marker/mechanism		NA		19808899
HIF1A	3091	Astrocytoma	MESH:D001254	marker/mechanism		NA		15341671
HIF1A	3091	Brain Ischemia	MESH:D002545	marker/mechanism		NA		19429140
HIF1A	3091	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		24349381
HIF1A	3091	Carcinoma	MESH:D002277	marker/mechanism		NA		19808899
HIF1A	3091	Carcinoma, Ductal	MESH:D044584	marker/mechanism		NA		20526721
HIF1A	3091	Carcinoma, Intraductal, Noninfiltrating	MESH:D002285	marker/mechanism		NA		20526721
HIF1A	3091	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		30381462
HIF1A	3091	Cardiomegaly	MESH:D006332	marker/mechanism		NA		15942707
HIF1A	3091	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		29501572
HIF1A	3091	Cholangitis, Sclerosing	MESH:D015209	marker/mechanism		NA		22271822
HIF1A	3091	Diabetes Complications	MESH:D048909	marker/mechanism		NA		26073000
HIF1A	3091	Disease Progression	MESH:D018450	marker/mechanism		NA		30381462
HIF1A	3091	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		17201171
HIF1A	3091	Glioblastoma	MESH:D005909	marker/mechanism		NA		12811834
HIF1A	3091	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		26073000
HIF1A	3091	Heart Failure	MESH:D006333	marker/mechanism		NA		15732037
HIF1A	3091	Hemangioblastoma	MESH:D018325	marker/mechanism		NA		15341671
HIF1A	3091	Hyperplasia	MESH:D006965	marker/mechanism		NA		20526721
HIF1A	3091	Hypertension	MESH:D006973	therapeutic		NA		22349312
HIF1A	3091	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		20110409
HIF1A	3091	Hypoxia-Ischemia, Brain	MESH:D020925	marker/mechanism		NA		23694759
HIF1A	3091	Idiopathic Pulmonary Fibrosis	MESH:D054990	therapeutic		NA		28434932
HIF1A	3091	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		22271822
HIF1A	3091	Lung Diseases	MESH:D008171	marker/mechanism		NA		20152896
HIF1A	3091	Micronuclei, Chromosome-Defective	MESH:D048629	therapeutic		NA		23065176
HIF1A	3091	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		18549825|22050707
HIF1A	3091	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		12811834|29501572
HIF1A	3091	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		28574600
HIF1A	3091	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		16628086
HIF1A	3091	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16205110
HIF1A	3091	Radiation Injuries, Experimental	MESH:D011833	therapeutic		NA		23065176
HIF1A	3091	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		19276359
HIF1A	3091	Spinal Cord Injuries	MESH:D013119	marker/mechanism		NA		21092735
HIF1A	3091	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		19808899
HIGD2A	192286	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
HIGD2A	192286	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		19233941
HIKESHI	51501	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
HIKESHI	51501	LEUKODYSTROPHY, HYPOMYELINATING, 13	OMIM:616881	marker/mechanism		NA	616881	
HIKESHI	51501	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
HIKESHI	51501	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
HILPDA	29923	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
HIM-6	178201	Hypoxia	MESH:D000860	therapeutic		NA		19936206
HINT1	3094	Inherited Peripheral Neuropathy	MESH:C548028	marker/mechanism		NA		22961002
HINT1	3094	Isaacs Syndrome	MESH:D020386	marker/mechanism		NA	137200	
HINT1	3094	Muscular Diseases	MESH:D009135	marker/mechanism		NA		22961002
HINT1	3094	Schizophrenia	MESH:D012559	marker/mechanism		NA		17203012|20514075
HINT1	3094	TOBACCO ADDICTION, SUSCEPTIBILITY TO	OMIM:188890	marker/mechanism		NA		20514075
HIP1	3092	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
HIP1R	9026	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
HIPK1	204851	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
HIPK2	28996	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
HIPK2	28996	Nephrosclerosis	MESH:D009400	marker/mechanism		NA		28318631
HIPK2	28996	Ureteral Obstruction	MESH:D014517	marker/mechanism		NA		28318631
HIVEP2	3097	MENTAL RETARDATION, AUTOSOMAL DOMINANT 43	OMIM:616977	marker/mechanism		NA	616977	
HIVEP2	3097	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
HIVEP3	59269	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
HJURP	55355	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
HJV	148738	Cholestasis	MESH:D002779	marker/mechanism		NA		27989131
HJV	148738	Hemochromatosis	MESH:D006432	marker/mechanism		NA		16868025|17255318|19252486|21411349
HJV	148738	Hemochromatosis, type 2	MESH:C537247	marker/mechanism		NA	602390	
HJV	148738	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
HK1	3098	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
HK1	3098	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		16123366
HK1	3098	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		16123366
HK1	3098	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
HK1	3098	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY	OMIM:235700	marker/mechanism		NA	235700	
HK1	3098	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
HK1	3098	Neuropathy, hereditary motor and sensory, Russe type	MESH:C535813	marker/mechanism		NA	605285	
HK1	3098	RETINITIS PIGMENTOSA 79	OMIM:617460	marker/mechanism		NA	617460	
HK2	3099	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
HK2	3099	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
HK2	3099	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
HK2	3099	Obesity	MESH:D009765	marker/mechanism		NA		20882379
HK3	3101	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
HLA-A	3105	Autistic Disorder	MESH:D001321	marker/mechanism		NA		16720216
HLA-A	3105	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		21570397|28043905
HLA-A	3105	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		3459889
HLA-A	3105	Glioma	MESH:D005910	marker/mechanism		NA		14511464
HLA-A	3105	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		17283154
HLA-A	3105	Parapsoriasis	MESH:D010267	marker/mechanism		NA		16538176
HLA-A	3105	Stevens-Johnson Syndrome	MESH:D013262	marker/mechanism		NA	608579	
HLA-A	3105	Thrombocytopenia	MESH:D013921	marker/mechanism		NA		3459889
HLA-B	3106	Behcet Syndrome	MESH:D001528	marker/mechanism		NA		20622878|23396137
HLA-B	3106	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		19483685
HLA-B	3106	Dermatitis	MESH:D003872	marker/mechanism		NA		18007983|3084782
HLA-B	3106	Dermatomyositis	MESH:D003882	marker/mechanism		NA		3501473
HLA-B	3106	Drug Eruptions	MESH:D003875	marker/mechanism		NA		19712599|29370880
HLA-B	3106	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		11943262|15024131|17392574|18007983
HLA-B	3106	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		29370880|3084782|3133153|3157529|3437418|6770269
HLA-B	3106	Exanthema	MESH:D005076	marker/mechanism		NA		20485159
HLA-B	3106	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		3459889
HLA-B	3106	Glioma	MESH:D005910	marker/mechanism		NA		14511464
HLA-B	3106	HIV Infections	MESH:D015658	marker/mechanism		NA		17496894
HLA-B	3106	Hypersensitivity	MESH:D006967	marker/mechanism		NA		23541086
HLA-B	3106	Myasthenia Gravis	MESH:D009157	marker/mechanism		NA		6402089|6605118
HLA-B	3106	Nephritis	MESH:D009393	marker/mechanism		NA		3084782
HLA-B	3106	Proteinuria	MESH:D011507	marker/mechanism		NA		3459889|3487119|6376799|6770269
HLA-B	3106	Spondylitis, Ankylosing	MESH:D013167	marker/mechanism		NA	106300	21743469|22138694|8053961
HLA-B	3106	Stevens-Johnson Syndrome	MESH:D013262	marker/mechanism		NA	608579	15057820|15743917|16538176|18855540|19694795|19915237|20235791|20485159|21428768|25099164
HLA-B	3106	Synovitis	MESH:D013585	marker/mechanism		NA		12648975
HLA-C	3107	Arthritis, Psoriatic	MESH:D015535	marker/mechanism		NA		20953186
HLA-C	3107	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		19629158
HLA-C	3107	Glioma	MESH:D005910	marker/mechanism		NA		14511464
HLA-C	3107	Hepatitis B, Chronic	MESH:D019694	marker/mechanism		NA		24162738
HLA-C	3107	HIV Infections	MESH:D015658	marker/mechanism		NA	609423	
HLA-C	3107	Psoriasis	MESH:D011565	marker/mechanism		NA	177900	19169254|20953190
HLA-C	3107	Stevens-Johnson Syndrome	MESH:D013262	marker/mechanism		NA		19629158
HLA-DMA	3108	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		18348411
HLA-DMA	3108	Dermatitis, Occupational	MESH:D009783	marker/mechanism		NA		16737583
HLA-DOA	3111	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
HLA-DPA1	3113	Dermatitis, Irritant	MESH:D017453	marker/mechanism		NA		27258892
HLA-DPA1	3113	Hepatitis B, Chronic	MESH:D019694	marker/mechanism		NA		19349983
HLA-DPB1	3115	Angioedema	MESH:D000799	marker/mechanism		NA		15784113
HLA-DPB1	3115	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		17956852|22286218
HLA-DPB1	3115	Asthma	MESH:D001249	marker/mechanism		NA		16792590|17956852
HLA-DPB1	3115	Asthma, Aspirin-Induced	MESH:D055963	marker/mechanism		NA		16502481
HLA-DPB1	3115	Berylliosis	MESH:D001607	marker/mechanism		NA		11551429|14662898|15273960|17927685|17956852|8105536
HLA-DPB1	3115	Celiac Disease	MESH:D002446	marker/mechanism		NA		17956852
HLA-DPB1	3115	Dermatitis, Irritant	MESH:D017453	marker/mechanism		NA		27258892
HLA-DPB1	3115	Drug Eruptions	MESH:D003875	marker/mechanism		NA		16502481
HLA-DPB1	3115	Endometriosis	MESH:D004715	marker/mechanism		NA		17956852
HLA-DPB1	3115	Hepatitis B, Chronic	MESH:D019694	marker/mechanism		NA		19349983
HLA-DPB1	3115	Memory Disorders	MESH:D008569	marker/mechanism		NA		14975599
HLA-DPB1	3115	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		17956852
HLA-DPB1	3115	Myasthenia Gravis	MESH:D009157	marker/mechanism		NA		17956852
HLA-DPB1	3115	Sarcoidosis	MESH:D012507	marker/mechanism		NA		14508706|17956852|8909942
HLA-DPB1	3115	Urticaria	MESH:D014581	marker/mechanism		NA		16502481
HLA-DPB1	3115	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		23817570
HLA-DPB2	3116	Berylliosis	MESH:D001607	marker/mechanism		NA		16272364
HLA-DPB2	3116	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		23817570
HLA-DQA1	3117	Asthma	MESH:D001249	marker/mechanism		NA		10792356
HLA-DQA1	3117	Dermatitis	MESH:D003872	marker/mechanism		NA		16836882
HLA-DQA1	3117	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		26168013
HLA-DQA1	3117	Eosinophilia-Myalgia Syndrome	MESH:D016603	marker/mechanism		NA		19790128
HLA-DQA1	3117	Esophageal Achalasia	MESH:D004931	marker/mechanism		NA		24997987
HLA-DQA1	3117	Glomerulonephritis, Membranous	MESH:D015433	marker/mechanism		NA		11436868
HLA-DQA1	3117	Hypersensitivity	MESH:D006967	marker/mechanism		NA		8725357
HLA-DQA1	3117	Leishmaniasis, Visceral	MESH:D007898	marker/mechanism		NA		23291585
HLA-DQA1	3117	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		11436868
HLA-DQA1	3117	Mycobacterium tuberculosis, susceptibility to infection by	MESH:C536092	marker/mechanism		NA		26829749
HLA-DQA1	3117	Oropharyngeal Neoplasms	MESH:D009959	marker/mechanism		NA		27749845
HLA-DQA1	3117	Pancreatitis	MESH:D010195	marker/mechanism		NA		25217962
HLA-DQA1	3117	Proteinuria	MESH:D011507	marker/mechanism		NA		11436868
HLA-DQA2	3118	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		17568789
HLA-DQB1	3119	Angioedema	MESH:D000799	marker/mechanism		NA		15784113
HLA-DQB1	3119	Asthma	MESH:D001249	marker/mechanism		NA		10792356
HLA-DQB1	3119	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		21570397
HLA-DQB1	3119	Creutzfeldt-Jakob Syndrome	MESH:D007562	marker/mechanism		NA	123400	
HLA-DQB1	3119	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		26168013
HLA-DQB1	3119	Drug Eruptions	MESH:D003875	marker/mechanism		NA		16502481
HLA-DQB1	3119	Esophageal Achalasia	MESH:D004931	marker/mechanism		NA		24997987
HLA-DQB1	3119	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		25305756
HLA-DQB1	3119	Hypersensitivity	MESH:D006967	marker/mechanism		NA		8725357
HLA-DQB1	3119	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA	126200	
HLA-DQB1	3119	Narcolepsy	MESH:D009290	marker/mechanism		NA		20711174
HLA-DQB1	3119	Oropharyngeal Neoplasms	MESH:D009959	marker/mechanism		NA		27749845
HLA-DQB1	3119	Scleroderma, Systemic	MESH:D012595	marker/mechanism		NA		20383147
HLA-DQB1	3119	Urticaria	MESH:D014581	marker/mechanism		NA		16502481
HLA-DRA	3122	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		17660530
HLA-DRA	3122	Parkinson Disease	MESH:D010300	marker/mechanism		NA		20711177
HLA-DRA	3122	Shock, Septic	MESH:D012772	marker/mechanism		NA		28771573
HLA-DRB1	3123	Angioedema	MESH:D000799	marker/mechanism		NA		15784113
HLA-DRB1	3123	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		19898480|20453842|22286218
HLA-DRB1	3123	Asthma	MESH:D001249	marker/mechanism		NA		16792590
HLA-DRB1	3123	Autistic Disorder	MESH:D001321	marker/mechanism		NA		8765331
HLA-DRB1	3123	Berylliosis	MESH:D001607	marker/mechanism		NA		16272364|17927685
HLA-DRB1	3123	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		21570397
HLA-DRB1	3123	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		25559196
HLA-DRB1	3123	Crohn Disease	MESH:D003424	marker/mechanism		NA		25559196
HLA-DRB1	3123	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		26168013
HLA-DRB1	3123	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		20485159
HLA-DRB1	3123	Eosinophilia-Myalgia Syndrome	MESH:D016603	marker/mechanism		NA		19790128
HLA-DRB1	3123	Glomerulonephritis, Membranous	MESH:D015433	marker/mechanism		NA		11436868
HLA-DRB1	3123	Hypersensitivity	MESH:D006967	marker/mechanism		NA		8725357
HLA-DRB1	3123	Leishmaniasis, Visceral	MESH:D007898	marker/mechanism		NA		23291585
HLA-DRB1	3123	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		11436868
HLA-DRB1	3123	Lymphoma, Non-Hodgkin	MESH:D008228	marker/mechanism		NA		22096508
HLA-DRB1	3123	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA	126200	25911099
HLA-DRB1	3123	Narcolepsy	MESH:D009290	marker/mechanism		NA		20711174
HLA-DRB1	3123	Nephrotic Syndrome	MESH:D009404	marker/mechanism		NA		11095018|6420562
HLA-DRB1	3123	Oropharyngeal Neoplasms	MESH:D009959	marker/mechanism		NA		27749845
HLA-DRB1	3123	Pancreatitis	MESH:D010195	marker/mechanism		NA		25217962
HLA-DRB1	3123	Proteinuria	MESH:D011507	marker/mechanism		NA		11436868|6420562
HLA-DRB1	3123	Sarcoidosis	MESH:D012507	marker/mechanism		NA	181000	14508706
HLA-DRB1	3123	Schizophrenia	MESH:D012559	marker/mechanism		NA		16223876
HLA-DRB1	3123	Typhoid Fever	MESH:D014435	marker/mechanism		NA		25383971
HLA-DRB1	3123	Urticaria	MESH:D014581	marker/mechanism		NA		20485159
HLA-DRB4	3126	Hypersensitivity	MESH:D006967	marker/mechanism		NA		8725357
HLA-DRB5	3127	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		27713094
HLA-DRB5	3127	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28869590
HLA-DRB5	3127	Hypersensitivity	MESH:D006967	marker/mechanism		NA		8725357
HLA-DRB5	3127	Parkinson Disease	MESH:D010300	marker/mechanism		NA		27713094
HLA-E	3133	Parapsoriasis	MESH:D010267	marker/mechanism		NA		16538176
HLA-G	3135	Asthma	MESH:D001249	marker/mechanism		NA	600807	
HLCS	3141	Holocarboxylase Synthetase Deficiency	MESH:D028922	marker/mechanism		NA	253270	
HLF	3131	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		26214592
HLTF	6596	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		16762066
HMBS	3145	Porphyria, Acute Intermittent	MESH:D017118	marker/mechanism		NA	176000	6132132|8772850
HMCN1	83872	Macular Degeneration, Age-Related, 1	MESH:C566411	marker/mechanism		NA	603075	
HMG20A	10363	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		21874001
HMGA1	3159	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA	125853	23512162
HMGA1	3159	Hyperglycemia	MESH:D006943	marker/mechanism		NA		23512162
HMGA1	3159	Insulin Resistance	MESH:D007333	marker/mechanism		NA		23512162
HMGA1	3159	Leiomyosarcoma	MESH:D007890	marker/mechanism		NA		18645019
HMGA1	3159	Metabolic Syndrome	MESH:D024821	marker/mechanism		NA		23512162
HMGA1	3159	Uterine Neoplasms	MESH:D014594	marker/mechanism		NA		18645019
HMGA2	8091	Birth Weight	MESH:D001724	marker/mechanism		NA		23202124
HMGA2	8091	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		28830677
HMGA2	8091	Neoplasms	MESH:D009369	marker/mechanism		NA		18413806
HMGB1	3146	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		19783637
HMGB1	3146	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		28789951
HMGB1	3146	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		27474498
HMGB1	3146	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
HMGB1	3146	Fever	MESH:D005334	marker/mechanism		NA		19265175
HMGB1	3146	Hyperalgesia	MESH:D006930	marker/mechanism		NA		27474498
HMGB1	3146	Hypertension	MESH:D006973	marker/mechanism		NA		32147540
HMGB1	3146	Inflammation	MESH:D007249	marker/mechanism		NA		21617575|22178603|22386814|22429818|23146691
HMGB1	3146	Leukostasis	MESH:D018921	marker/mechanism		NA		28294475
HMGB1	3146	Multiple Organ Failure	MESH:D009102	marker/mechanism		NA		19265175
HMGB1	3146	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		21113057
HMGB1	3146	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
HMGB1	3146	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		21113057
HMGB1	3146	Necrosis	MESH:D009336	marker/mechanism		NA		19783637|22178603
HMGB1	3146	Neuralgia	MESH:D009437	marker/mechanism		NA		25014009
HMGB1	3146	Neuropathy, Painful	MESH:C564945	marker/mechanism		NA		27474498
HMGB1	3146	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		27616297
HMGB1	3146	Sepsis	MESH:D018805	marker/mechanism		NA		19265175|23146691
HMGB1	3146	Systemic Vasculitis	MESH:D056647	marker/mechanism		NA		23146691
HMGB2	3148	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		24366584|27602772
HMGB2	3148	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		20851854
HMGB2	3148	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
HMGB2	3148	Obesity	MESH:D009765	marker/mechanism		NA		20882379
HMGB2	3148	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29877212
HMGB3	3149	MICROPHTHALMIA, SYNDROMIC 13	OMIM:300915	marker/mechanism		NA	300915	
HMGB3	3149	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		30639441
HMGCL	3155	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	MESH:C538324	marker/mechanism		NA	246450	
HMGCR	3156	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		23953224
HMGCR	3156	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21147110|9207284
HMGCR	3156	Gallstones	MESH:D042882	marker/mechanism		NA		7461467
HMGCR	3156	Hypercholesterolemia	MESH:D006937	marker/mechanism		NA		8593127
HMGCR	3156	Hyperlipoproteinemia Type II	MESH:D006938	marker/mechanism		NA		12477733
HMGCR	3156	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19878707
HMGCR	3156	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
HMGCR	3156	Mevalonate Kinase Deficiency	MESH:D054078	marker/mechanism		NA		12477733
HMGCR	3156	Muscular Diseases	MESH:D009135	marker/mechanism		NA		23953224
HMGCR	3156	Q Fever	MESH:D011778	marker/mechanism		NA		16469060
HMGCS2	3158	3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency	MESH:C567784	marker/mechanism		NA	605911	
HMGCS2	3158	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925|27816970
HMGCS2	3158	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		27816970
HMGCS2	3158	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
HMGCS2	3158	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		27816970
HMGCS2	3158	Recurrence	MESH:D012008	marker/mechanism		NA		27816970
HMGN1	3150	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		24747640
HMGN5	79366	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		28914995
HMGN5	79366	Glioma	MESH:D005910	marker/mechanism		NA		22109888
HMGN5	79366	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		22109888
HMGN5	79366	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		22109888
HMGN5B	681284	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
HMMR	3161	Breast Neoplasms	MESH:D001943	marker/mechanism		NA	114480	17922014
HMMR	3161	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
HMMR	3161	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	MESH:D015464	marker/mechanism		NA		17157168
HMMR	3161	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
HMOX1	3162	Acute Kidney Injury	MESH:D058186	therapeutic		NA		21048024
HMOX1	3162	Adrenoleukodystrophy	MESH:D000326	marker/mechanism		NA		16319717
HMOX1	3162	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		11144356
HMOX1	3162	Anemia, Hemolytic	MESH:D000743	marker/mechanism		NA		9884342
HMOX1	3162	Asthma	MESH:D001249	marker/mechanism		NA		18048809
HMOX1	3162	Blood Coagulation Disorders	MESH:D001778	marker/mechanism		NA		9884342
HMOX1	3162	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037
HMOX1	3162	Cardiomegaly	MESH:D006332	therapeutic		NA		15226216
HMOX1	3162	Carotid Artery Diseases	MESH:D002340	marker/mechanism		NA		17095719
HMOX1	3162	Cerebral Hemorrhage	MESH:D002543	marker/mechanism		NA		12401953
HMOX1	3162	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism|therapeutic		NA		18227147|22688006
HMOX1	3162	Colitis	MESH:D003092	therapeutic		NA		16365149|21444764
HMOX1	3162	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		12136229
HMOX1	3162	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
HMOX1	3162	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism|therapeutic		NA		16123366|16959961|18375438|19804535
HMOX1	3162	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism|therapeutic		NA		12136229|16123366|16959961
HMOX1	3162	Diabetic Angiopathies	MESH:D003925	therapeutic		NA		16959961
HMOX1	3162	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		18227147
HMOX1	3162	Fibrosis	MESH:D005355	therapeutic		NA		18784349
HMOX1	3162	Gastroparesis	MESH:D018589	therapeutic		NA		20378827
HMOX1	3162	Growth Disorders	MESH:D006130	marker/mechanism		NA		9884342
HMOX1	3162	Heart Failure	MESH:D006333	marker/mechanism		NA		22352330
HMOX1	3162	Heme Oxygenase 1 Deficiency	MESH:C564200	marker/mechanism		NA	614034	
HMOX1	3162	Hemolysis	MESH:D006461	marker/mechanism		NA		25247420
HMOX1	3162	Hepatitis	MESH:D006505	therapeutic		NA		14512878
HMOX1	3162	Hepatorenal Syndrome	MESH:D006530	marker/mechanism		NA		21253390
HMOX1	3162	Hyperinsulinism	MESH:D006946	therapeutic		NA		19171794
HMOX1	3162	Hyperplasia	MESH:D006965	therapeutic		NA		19234301
HMOX1	3162	Hypertension	MESH:D006973	marker/mechanism|therapeutic		NA		16959961|22349312|22352330
HMOX1	3162	Inflammation	MESH:D007249	marker/mechanism		NA		12649161|16982915|23451061|29086419
HMOX1	3162	Insulin Resistance	MESH:D007333	marker/mechanism|therapeutic		NA		18375438|19171794
HMOX1	3162	Iron Metabolism Disorders	MESH:D019189	marker/mechanism		NA		9884342
HMOX1	3162	Ischemia	MESH:D007511	therapeutic		NA		15036356|19667931
HMOX1	3162	Kidney Failure, Chronic	MESH:D007676	therapeutic		NA		22622455
HMOX1	3162	Learning Disabilities	MESH:D007859	marker/mechanism		NA		11718997
HMOX1	3162	Leishmaniasis, Visceral	MESH:D007898	marker/mechanism		NA		22461696
HMOX1	3162	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism|therapeutic		NA		16025519|16610050|21163135|25380136
HMOX1	3162	Liver Diseases	MESH:D008107	marker/mechanism|therapeutic		NA		16964402|17002867|17275847
HMOX1	3162	Liver Neoplasms	MESH:D008113	therapeutic		NA		17002867
HMOX1	3162	Lung Injury	MESH:D055370	marker/mechanism		NA		17365036
HMOX1	3162	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		15688187|18508827
HMOX1	3162	Mammary Neoplasms, Experimental	MESH:D008325	therapeutic		NA		16319139
HMOX1	3162	Mastocytosis, Systemic	MESH:D034721	marker/mechanism		NA		17420286
HMOX1	3162	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
HMOX1	3162	Neoplasm Invasiveness	MESH:D009361	therapeutic		NA		24211270
HMOX1	3162	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		10942521|12709579|15964507
HMOX1	3162	Obesity	MESH:D009765	marker/mechanism		NA		18334666|18375438|19171794
HMOX1	3162	Pancreatic Diseases	MESH:D010182	therapeutic		NA		18784349
HMOX1	3162	Parkinson Disease	MESH:D010300	marker/mechanism		NA		21318773
HMOX1	3162	Pneumonia	MESH:D011014	marker/mechanism		NA		16582079
HMOX1	3162	Pre-Eclampsia	MESH:D011225	marker/mechanism		NA		22197494
HMOX1	3162	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		25246272
HMOX1	3162	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA	606963	
HMOX1	3162	Pulmonary Emphysema	MESH:D011656	marker/mechanism		NA		10631150
HMOX1	3162	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		15814490
HMOX1	3162	Reperfusion Injury	MESH:D015427	marker/mechanism|therapeutic		NA		12352873|16982915|17660127|17906103|23075401|25780291
HMOX1	3162	Retinal Diseases	MESH:D012164	marker/mechanism		NA		23075401
HMOX1	3162	Spinocerebellar Ataxia 17	MESH:C564616	marker/mechanism		NA		24413982
HMOX1	3162	Status Epilepticus	MESH:D013226	marker/mechanism		NA		20971094
HMOX1	3162	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		14647439|22490514
HMOX1	3162	Thrombosis	MESH:D013927	therapeutic		NA		19168058
HMOX1	3162	Vascular System Injuries	MESH:D057772	therapeutic		NA		19234301
HMOX1	3162	Wounds and Injuries	MESH:D014947	marker/mechanism		NA		12649161
HMOX2	3163	Cerebral Hemorrhage	MESH:D002543	therapeutic		NA		16459095
HMX1	3166	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		19379485
HMX1	3166	Microphthalmos	MESH:D008850	marker/mechanism		NA		19379485
HMX1	3166	Oculoauricular Syndrome	MESH:C567416	marker/mechanism		NA	612109	19379485
HNF1A	6927	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA	144700	
HNF1A	6927	Coronary Disease	MESH:D003327	marker/mechanism		NA		28869590
HNF1A	6927	Diabetes Mellitus, Insulin-Dependent, 20	MESH:C567286	marker/mechanism		NA	612520	
HNF1A	6927	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA	222100	
HNF1A	6927	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA	125853	28869590
HNF1A	6927	Hepatic Adenomas, Familial	MESH:C564190	marker/mechanism		NA	142330	
HNF1A	6927	Hyperglycemia	MESH:D006943	marker/mechanism		NA		29753610
HNF1A	6927	Hypoglycemia	MESH:D007003	marker/mechanism		NA		15787664
HNF1A	6927	Maturity-Onset Diabetes of the Young, Type 3	MESH:C563933	marker/mechanism		NA	600496	29753610
HNF1B	6928	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA	144700	
HNF1B	6928	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism|therapeutic		NA	125853	17603485
HNF1B	6928	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		18264096|18758462
HNF1B	6928	Renal cysts and diabetes syndrome	MESH:C535520	marker/mechanism		NA	137920	
HNF4A	3172	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		19915572
HNF4A	3172	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA	125853	17317762|21874001|22158537
HNF4A	3172	FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG	OMIM:616026	marker/mechanism		NA	616026	
HNF4A	3172	Maturity-Onset Diabetes of the Young, Type 1	MESH:C565101	marker/mechanism		NA	125850	21115832
HNMT	3176	Asthma	MESH:D001249	marker/mechanism		NA	600807	17651147
HNMT	3176	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		20485159
HNMT	3176	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	OMIM:616739	marker/mechanism		NA	616739	
HNMT	3176	Rhinitis	MESH:D012220	marker/mechanism		NA		17651147
HNMT	3176	Urticaria	MESH:D014581	marker/mechanism		NA		20485159
HNRNPA1	3178	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
HNRNPA1	3178	AMYOTROPHIC LATERAL SCLEROSIS 20	OMIM:615426	marker/mechanism		NA	615426	
HNRNPA1	3178	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
HNRNPA1	3178	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
HNRNPA1	3178	Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia	MESH:C563476	marker/mechanism		NA	615424	
HNRNPA1	3178	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
HNRNPA1	3178	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
HNRNPA2B1	3181	Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia	MESH:C563476	marker/mechanism		NA	615422	
HNRNPA2B1	3181	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		26437031
HNRNPA3	220988	Schizophrenia	MESH:D012559	marker/mechanism		NA		16223876
HNRNPAB	3182	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		15538050
HNRNPDL	9987	Limb-Girdle Muscular Dystrophy, Type 1G	MESH:C563794	marker/mechanism		NA	609115	
HNRNPH1	3187	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17566973
HNRNPH2	3188	MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE	OMIM:300986	marker/mechanism		NA	300986	
HNRNPK	3190	AU-KLINE SYNDROME	OMIM:616580	marker/mechanism		NA	616580	
HNRNPK	3190	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21466612
HNRNPL	3191	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21466612
HNRNPL	3191	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
HNRNPL	3191	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
HNRNPR	10236	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21466612
HNRNPU	3192	Epilepsy	MESH:D004827	marker/mechanism		NA		29942082
HNRNPU	3192	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54	OMIM:617391	marker/mechanism		NA	617391	
HNRNPU	3192	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		29942082
HOGA1	112817	Cholestasis	MESH:D002779	marker/mechanism		NA		27989131
HOGA1	112817	HYPEROXALURIA, PRIMARY, TYPE III	OMIM:613616	marker/mechanism		NA	613616	
HOMER1	9456	Cocaine-Related Disorders	MESH:D019970	marker/mechanism|therapeutic		NA		16160706|16314758
HOMER1	9456	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		24126708
HOMER1	9456	Dyskinesia, Drug-Induced	MESH:D004409	marker/mechanism		NA		24126708
HOMER1	9456	Hallucinations	MESH:D006212	marker/mechanism		NA		24126708
HOMER2	9455	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		15545022
HOMER2	9455	DEAFNESS, AUTOSOMAL DOMINANT 68	OMIM:616707	marker/mechanism		NA	616707	
HOMER3	9454	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
HOMER3	9454	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
HOOK3	84376	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
HOPX	84525	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
HOTAIR	100124700	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21327457
HOTAIR	100124700	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		21327457
HOTAIR	100124700	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		26384301
HOTAIR	100124700	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		29572071
HOXA1	3198	Athabaskan brainstem dysgenesis	MESH:C535397	marker/mechanism		NA	601536	24239177
HOXA1	3198	Autistic Disorder	MESH:D001321	marker/mechanism		NA		11091361
HOXA1	3198	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		10529420
HOXA1	3198	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		21940751
HOXA1	3198	Nervous System Malformations	MESH:D009421	marker/mechanism		NA		10529420
HOXA10	3206	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		21670700
HOXA10	3206	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
HOXA10	3206	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		21670700
HOXA10	3206	Female Urogenital Diseases	MESH:D052776	marker/mechanism		NA		16002989
HOXA11	3207	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		16804899
HOXA11	3207	Female Urogenital Diseases	MESH:D052776	marker/mechanism		NA		16002989
HOXA11	3207	Kidney Diseases	MESH:D007674	marker/mechanism		NA		7596412
HOXA11	3207	Limb Deformities, Congenital	MESH:D017880	marker/mechanism		NA		7596412
HOXA11	3207	Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia	MESH:C565328	marker/mechanism		NA	605432	24239177
HOXA13	3209	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
HOXA13	3209	Female Urogenital Diseases	MESH:D052776	marker/mechanism		NA		16002989
HOXA13	3209	Hand foot uterus syndrome	MESH:C535627	marker/mechanism		NA	140000	24239177|9020844
HOXA13	3209	Preaxial deficiency, postaxial polydactyly and hypospadias	MESH:C538278	marker/mechanism		NA	176305	24239177
HOXA2	3199	Microtia, Hearing Impairment, And Cleft Palate	MESH:C567359	marker/mechanism		NA	612290	24239177
HOXA2	3199	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		17786296
HOXA3	3200	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		1673020
HOXA3	3200	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		1673020
HOXA3	3200	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
HOXA3	3200	Lymphatic Abnormalities	MESH:D044148	marker/mechanism		NA		1673020
HOXA5	3202	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		18351244
HOXA5	3202	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		22227861
HOXA5	3202	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		22227861
HOXA9	3205	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		22541086
HOXA9	3205	Melanoma	MESH:D008545	marker/mechanism		NA		16778180
HOXA9	3205	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		26332997
HOXA9	3205	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		26332997
HOXB1	3211	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		10529420
HOXB1	3211	Facial paresis, hereditary, congenital	MESH:C536386	marker/mechanism		NA	614744	24239177
HOXB1	3211	Nervous System Malformations	MESH:D009421	marker/mechanism		NA		10529420
HOXB13	10481	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		24239177
HOXB13	10481	Melanoma	MESH:D008545	marker/mechanism		NA		17145863
HOXB13	10481	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		26213588
HOXB13	10481	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		22236224
HOXB13	10481	Prostate Cancer, Hereditary, 9	MESH:C567031	marker/mechanism		NA	610997	
HOXB13	10481	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		23104005|24239177|24390282|26457646|32690948
HOXB3	3213	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		18351244
HOXB5	3215	Obesity	MESH:D009765	marker/mechanism		NA		22484627
HOXB8	3218	Obsessive-Compulsive Disorder	MESH:D009771	marker/mechanism		NA		11779477
HOXB8	3218	Trichotillomania	MESH:D014256	marker/mechanism		NA		11779477
HOXB9	3219	Acute erythroleukemia	MESH:C535673	marker/mechanism		NA		30926971
HOXB9	3219	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		27182052
HOXB9	3219	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		27182052
HOXB9	3219	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		27182052
HOXB9	3219	Uterine Neoplasms	MESH:D014594	marker/mechanism		NA		27182052
HOXC13	3229	ECTODERMAL DYSPLASIA 4, HAIR/NAIL TYPE	OMIM:602032	marker/mechanism		NA		24239177
HOXC13	3229	ECTODERMAL DYSPLASIA 9, HAIR/NAIL TYPE	OMIM:614931	marker/mechanism		NA	614931	
HOXD1	3231	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17892325
HOXD1	3231	Hyperalgesia	MESH:D006930	marker/mechanism		NA		21151121
HOXD1	3231	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		20852632
HOXD1	3231	Pain	MESH:D010146	marker/mechanism		NA		21151121
HOXD10	3236	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		17568789
HOXD10	3236	Charcot-Marie-Tooth Disease	MESH:D002607	marker/mechanism		NA		15146389
HOXD10	3236	Flatfoot	MESH:D005413	marker/mechanism		NA		15146389|16450407|24239177
HOXD10	3236	Lower Extremity Deformities, Congenital	MESH:D038061	marker/mechanism		NA		9409668
HOXD10	3236	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		22227861
HOXD10	3236	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		22227861
HOXD10	3236	VERTICAL TALUS, CONGENITAL	OMIM:192950	marker/mechanism		NA	192950	
HOXD11	3237	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		17568789
HOXD11	3237	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19540081
HOXD11	3237	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		7925020
HOXD11	3237	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		15818620
HOXD11	3237	Infertility, Male	MESH:D007248	marker/mechanism		NA		7925020
HOXD11	3237	Kidney Diseases	MESH:D007674	marker/mechanism		NA		7596412
HOXD11	3237	Limb Deformities, Congenital	MESH:D017880	marker/mechanism		NA		7596412|7925020|8620844
HOXD11	3237	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		22227861
HOXD11	3237	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		17303177
HOXD11	3237	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		22227861
HOXD12	3238	Limb Deformities, Congenital	MESH:D017880	marker/mechanism		NA		19108020|8620844
HOXD12	3238	Melanoma	MESH:D008545	marker/mechanism		NA		16778180
HOXD13	3239	Anemia	MESH:D000740	marker/mechanism		NA		27725143
HOXD13	3239	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		17568789
HOXD13	3239	Brachydactyly-Syndactyly Syndrome	MESH:C565193	marker/mechanism		NA	610713	24239177
HOXD13	3239	Brachydactyly, Type D	MESH:C562420	marker/mechanism		NA	113200	24239177
HOXD13	3239	BRACHYDACTYLY, TYPE E1	OMIM:113300	marker/mechanism		NA	113300	24239177
HOXD13	3239	Limb Deformities, Congenital	MESH:D017880	marker/mechanism		NA		8620844
HOXD13	3239	Lymphopenia	MESH:D008231	marker/mechanism		NA		27725143
HOXD13	3239	Neutropenia	MESH:D009503	marker/mechanism		NA		27725143
HOXD13	3239	Syndactyly	MESH:D013576	marker/mechanism		NA	186000	
HOXD13	3239	Syndactyly, type 2	MESH:C538153	marker/mechanism		NA		24239177
HOXD13	3239	Syndactyly, type v	MESH:C538155	marker/mechanism		NA	186300	24239177
HOXD13	3239	VATER association	MESH:C536534	marker/mechanism		NA		19006232
HOXD3	3232	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		19283074
HOXD4	3233	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		15776434
HOXD9	3235	Adenocarcinoma, Mucinous	MESH:D002288	marker/mechanism		NA		26075790
HOXD9	3235	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
HOXD9	3235	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		26075790
HOXD9	3235	Neoplastic Processes	MESH:D009385	marker/mechanism		NA		26075790
HOXD9	3235	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		26075790
HP	3240	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		28885000
HP	3240	Anemia	MESH:D000740	marker/mechanism		NA		16637741
HP	3240	Anemia, Sickle Cell	MESH:D000755	marker/mechanism		NA		16597321
HP	3240	Arthritis	MESH:D001168	marker/mechanism		NA		16597321
HP	3240	Atherosclerosis	MESH:D050197	marker/mechanism		NA		16597321
HP	3240	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		16597321
HP	3240	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16597321
HP	3240	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		19769483
HP	3240	Diabetes Complications	MESH:D048909	marker/mechanism		NA		19769483
HP	3240	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		16506275
HP	3240	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		16506275
HP	3240	Diabetic Angiopathies	MESH:D003925	marker/mechanism		NA		16597321
HP	3240	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		28885000
HP	3240	Dyslipidemias	MESH:D050171	marker/mechanism		NA		16597321
HP	3240	Foodborne Diseases	MESH:D005517	marker/mechanism		NA		21075095
HP	3240	Genital Neoplasms, Female	MESH:D005833	marker/mechanism		NA		16597321
HP	3240	Hemochromatosis	MESH:D006432	marker/mechanism		NA		16597321
HP	3240	Hemolysis	MESH:D006461	marker/mechanism		NA		25247420
HP	3240	Hepatitis B	MESH:D006509	marker/mechanism		NA		16597321
HP	3240	Hepatitis B, Chronic	MESH:D019694	marker/mechanism		NA		16597321
HP	3240	Hepatitis C, Chronic	MESH:D019698	marker/mechanism		NA		16597321
HP	3240	HIV Infections	MESH:D015658	marker/mechanism		NA		16597321
HP	3240	Hypersensitivity	MESH:D006967	marker/mechanism		NA		16597321
HP	3240	Hypertension	MESH:D006973	marker/mechanism		NA		16597321
HP	3240	Hypertension, Pregnancy-Induced	MESH:D046110	marker/mechanism		NA		16597321
HP	3240	Leukemia	MESH:D007938	marker/mechanism		NA		16597321
HP	3240	Malaria	MESH:D008288	marker/mechanism		NA		16597321|8730300
HP	3240	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		16597321|17068284|17207726
HP	3240	Pasteurellaceae Infections	MESH:D016871	marker/mechanism		NA		16755360
HP	3240	Retinal Detachment	MESH:D012163	marker/mechanism		NA		16597321
HP	3240	Schizophrenia	MESH:D012559	marker/mechanism		NA		18583979
HP	3240	Tuberculosis	MESH:D014376	marker/mechanism		NA		16597321
HPCA	3208	Dystonia musculorum deformans type 2	MESH:C538006	marker/mechanism		NA	224500	
HPCAL1	3241	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
HPCL2	100302972	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
HPD	3242	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		16099942|22872058
HPD	3242	Hawkinsinuria	MESH:C535845	marker/mechanism		NA	140350	
HPD	3242	Tyrosinemias	MESH:D020176	marker/mechanism		NA	276710	
HPGD	3248	Carcinoma, Medullary	MESH:D018276	therapeutic		NA		11352223
HPGD	3248	Osteoarthropathy, Primary Hypertrophic	MESH:D010004	marker/mechanism		NA	119900|259100	18500342|25526675
HPGD	3248	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
HPGD	3248	Thyroid Neoplasms	MESH:D013964	therapeutic		NA		11352223
HPGDS	27306	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		28321044
HPGDS	27306	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
HPGDS	27306	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
HPGDS	27306	Testicular Germ Cell Tumor	MESH:C563236	marker/mechanism		NA		23666239
HPH1	15447	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		22784235
HPH1	15447	Phenylketonurias	MESH:D010661	marker/mechanism		NA		22784235
HPN	3249	Lipidoses	MESH:D008064	marker/mechanism		NA		15342952|16919414
HPN	3249	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		15583422|16783571
HPRT	15452	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
HPRT1	3251	Gout, HPRT-Related	MESH:C562583	marker/mechanism		NA	300323	23348497
HPRT1	3251	Hyperuricemia	MESH:D033461	marker/mechanism		NA		23348497
HPRT1	3251	Lesch-Nyhan Syndrome	MESH:D007926	marker/mechanism		NA	300322	
HPS1	3257	Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells	MESH:C538539	marker/mechanism		NA	203300	
HPS3	84343	Hermanski-Pudlak Syndrome	MESH:D022861	marker/mechanism		NA	614072	
HPS4	89781	Hermanski-Pudlak Syndrome	MESH:D022861	marker/mechanism		NA	614073	
HPS5	11234	Hermanski-Pudlak Syndrome	MESH:D022861	marker/mechanism		NA	614074	
HPS6	79803	Hermanski-Pudlak Syndrome	MESH:D022861	marker/mechanism		NA	614075	
HPSE	10855	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16391819
HPSE	10855	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		25133636
HPSE	10855	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		15095483|18458672
HPSE	10855	Melanoma	MESH:D008545	marker/mechanism		NA		22240343
HPSE	10855	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		22240343
HPSE	10855	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		22240343
HPSE	10855	Nephrosis	MESH:D009401	marker/mechanism		NA		16899518
HPSE2	60495	Urofacial syndrome	MESH:C536480	marker/mechanism		NA	236730	20560209
HPV18I1	3260	HUMAN PAPILLOMAVIRUS TYPE 18 INTEGRATION SITE 1	OMIM:167959	marker/mechanism		NA	167959	
HPV18I2	3261	HUMAN PAPILLOMAVIRUS TYPE 18 INTEGRATION SITE 2	OMIM:167960	marker/mechanism		NA	167960	
HPX	3263	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		28885000
HPX	3263	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		18641331
HPX	3263	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		16099942
HPX	3263	Compartment Syndromes	MESH:D003161	therapeutic		NA		14500188
HPX	3263	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		16506275
HPX	3263	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		28885000
HR	55806	Alopecia	MESH:D000505	marker/mechanism		NA		16455232
HR	55806	Alopecia universalis	MESH:C537055	marker/mechanism		NA	203655	
HR	55806	Atrichia with Papular Lesions	MESH:C565924	marker/mechanism		NA	209500	
HR	55806	Marie Unna congenital hypotrichosis	MESH:C535912	marker/mechanism		NA	146550	19122663
HRAS	3265	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		26558449
HRAS	3265	Adenoma, Liver Cell	MESH:D018248	marker/mechanism		NA		8200073
HRAS	3265	Autistic Disorder	MESH:D001321	marker/mechanism		NA		8098541
HRAS	3265	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		27935819
HRAS	3265	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		12165863|15958052|17474063|19652463|32621833
HRAS	3265	Carcinoma	MESH:D002277	marker/mechanism		NA		8185828
HRAS	3265	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
HRAS	3265	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		20118494|27517622|28284560|8200073|9311599
HRAS	3265	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		24224046|25125259
HRAS	3265	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		3433577
HRAS	3265	Cardiofaciocutaneous syndrome	MESH:C535579	marker/mechanism		NA		17703371
HRAS	3265	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		12115494|18245498|18829283|22048643|23877152
HRAS	3265	Costello Syndrome	MESH:D056685	marker/mechanism		NA	218040	17468812|17703371|19132118
HRAS	3265	Disease Progression	MESH:D018450	marker/mechanism		NA		12082015|32621833
HRAS	3265	Epidermal Nevus	MESH:C580062	marker/mechanism		NA	162900	
HRAS	3265	Glioma	MESH:D005910	marker/mechanism		NA		30619488
HRAS	3265	Hemangiosarcoma	MESH:D006394	marker/mechanism		NA		10930038
HRAS	3265	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		10874023|12082015|12127263|16410370|17514646
HRAS	3265	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		20118494|21147764|27517622|7955063
HRAS	3265	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		10779650|11307925|11552296|12765245|15902970
HRAS	3265	Lymphoma, T-Cell	MESH:D016399	marker/mechanism		NA		29438700
HRAS	3265	Malformations of Cortical Development	MESH:D054220	marker/mechanism		NA		27935819
HRAS	3265	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		8185828
HRAS	3265	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		11376698|8185828
HRAS	3265	MELANOCYTIC NEVUS SYNDROME, CONGENITAL	OMIM:137550	marker/mechanism		NA	137550	
HRAS	3265	Melanoma	MESH:D008545	marker/mechanism		NA		30619488
HRAS	3265	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		24224046
HRAS	3265	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		23877152
HRAS	3265	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		11552296|26558449|3433577
HRAS	3265	Neoplastic Processes	MESH:D009385	marker/mechanism		NA		12082015
HRAS	3265	Neuroblastoma	MESH:D009447	marker/mechanism		NA		15814359|26121086
HRAS	3265	Nevus, Sebaceous of Jadassohn	MESH:D054000	marker/mechanism		NA	163200	22683711
HRAS	3265	Noonan Syndrome	MESH:D009634	marker/mechanism		NA		17703371
HRAS	3265	Papilloma	MESH:D010212	marker/mechanism		NA		8330346
HRAS	3265	Penile Neoplasms	MESH:D010412	marker/mechanism		NA		18355852
HRAS	3265	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		2675901
HRAS	3265	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
HRAS	3265	Recurrence	MESH:D012008	marker/mechanism		NA		26121086
HRAS	3265	Seminoma	MESH:D018239	marker/mechanism		NA		19855393
HRAS	3265	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		15958052|18758463|24898257|26558449|8330346|8508502|9766437
HRAS	3265	Splenic Neoplasms	MESH:D013160	marker/mechanism		NA		26558449
HRAS	3265	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		11397402|26558449
HRAS	3265	Thyroid cancer, follicular	MESH:C572845	marker/mechanism		NA	188470	
HRAS	3265	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		3078959
HRAS	3265	Tongue Neoplasms	MESH:D014062	marker/mechanism		NA		20043093
HRAS	3265	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA	109800	15958052|2228319|2278634
HRC	3270	Body Weight	MESH:D001835	marker/mechanism		NA		17030629
HRC	3270	Cardiomegaly	MESH:D006332	marker/mechanism		NA		17030629
HRG	3273	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19552798
HRG	3273	Thrombophilia Due To Elevated Histidine-Rich Glycoprotein	MESH:C567737	marker/mechanism		NA	613116	
HRH1	3269	Atherosclerosis	MESH:D050197	marker/mechanism		NA		25020133
HRH1	3269	Extravasation of Diagnostic and Therapeutic Materials	MESH:D005119	therapeutic		NA		32061592
HRH1	3269	Hypotension	MESH:D007022	marker/mechanism		NA		2105067
HRH1	3269	Pain	MESH:D010146	marker/mechanism		NA		12128009|14569158
HRH1	3269	Pruritus	MESH:D011537	marker/mechanism		NA		19652466
HRH1	3269	Respiratory Hypersensitivity	MESH:D012130	marker/mechanism		NA		12095164
HRH1	3269	Rhinitis	MESH:D012220	marker/mechanism		NA		12167471
HRH1	3269	Rhinitis, Allergic	MESH:D065631	marker/mechanism		NA		23333628
HRH1	3269	Schizophrenia	MESH:D012559	marker/mechanism		NA		1912125
HRH1	3269	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		8870037
HRH1	3269	Telangiectasis	MESH:D013684	therapeutic		NA		32061592
HRH2	3274	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		6224980
HRH2	3274	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22926047
HRH2	3274	Coronary Stenosis	MESH:D023921	marker/mechanism		NA		12721106
HRH2	3274	Hypertension	MESH:D006973	marker/mechanism		NA		30310171
HRH2	3274	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		30310171
HRH2	3274	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		6224980
HRH2	3274	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		6224980
HRH2	3274	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		8870037
HRH3	11255	Amnesia	MESH:D000647	marker/mechanism		NA		11125734
HRH3	11255	Hypertension	MESH:D006973	marker/mechanism		NA		9050021
HRH3	11255	Memory Disorders	MESH:D008569	marker/mechanism		NA		16488453
HRH4	59340	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		22363581
HRH4	59340	Pruritus	MESH:D011537	marker/mechanism		NA		19652466
HRH4	59340	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		22363581
HS3ST3B1	9953	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
HS3ST4	9951	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
HS3ST5	222537	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
HS3ST6	64711	Pneumoconiosis	MESH:D011009	marker/mechanism		NA		25445010
HS6ST1	9394	HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA	OMIM:614880	marker/mechanism		NA	614880	
HSC70-3	32133	Parkinson Disease	MESH:D010300	marker/mechanism		NA		18353766
HSD11B1	3290	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		19192274
HSD11B1	3290	Cortisone reductase deficiency	MESH:C536447	marker/mechanism		NA	614662	25526675
HSD11B1	3290	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		16033404
HSD11B1	3290	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		14697232
HSD11B1	3290	Hyperglycemia	MESH:D006943	marker/mechanism		NA		14697232
HSD11B1	3290	Hypertension	MESH:D006973	marker/mechanism		NA		15199296|21786805|9683905
HSD11B1	3290	Insulin Resistance	MESH:D007333	marker/mechanism		NA		21786805
HSD11B1	3290	Obesity	MESH:D009765	marker/mechanism		NA		17628001|21786805
HSD11B1	3290	Obesity, Abdominal	MESH:D056128	marker/mechanism		NA		15199296
HSD11B2	3291	Apparent mineralocorticoid excess	MESH:C537422	marker/mechanism		NA	218030	11085685|19075542|7608290|7670488|9683905|9707624
HSD11B2	3291	Asthma	MESH:D001249	marker/mechanism		NA		11932298
HSD11B2	3291	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		16616286
HSD11B2	3291	Hypertension	MESH:D006973	marker/mechanism		NA		11082157|7670488|9683905|9707624
HSD11B2	3291	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		15199296
HSD11B2	3291	Mineralocorticoid Excess Syndrome, Apparent	MESH:D043204	marker/mechanism		NA		25526675
HSD11B2	3291	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		17587755
HSD11B2	3291	Nephrotic Syndrome	MESH:D009404	marker/mechanism		NA		15199296
HSD11B2	3291	Pregnancy Complications	MESH:D011248	marker/mechanism		NA		11932298
HSD17B1	3292	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
HSD17B1	3292	Endometriosis	MESH:D004715	marker/mechanism		NA		18815356
HSD17B1	3292	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17507624
HSD17B10	3028	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		19381893
HSD17B10	3028	Mental Retardation, X-Linked, Syndromic 10	MESH:C564560	marker/mechanism		NA	300438	25526675
HSD17B2	3294	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		23200943
HSD17B2	3294	Endometriosis	MESH:D004715	marker/mechanism		NA		18815356|21232532
HSD17B2	3294	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980|25380136
HSD17B3	3293	17-Hydroxysteroid Dehydrogenase Deficiency	MESH:C537805	marker/mechanism		NA	264300	25526675
HSD17B3	3293	Disorders of Sex Development	MESH:D012734	marker/mechanism		NA		17071532
HSD17B3	3293	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		12210481
HSD17B4	3295	D-BIFUNCTIONAL PROTEIN DEFICIENCY	OMIM:261515	marker/mechanism		NA	261515	
HSD17B4	3295	Gonadal dysgenesis XX type deafness	MESH:C537286	marker/mechanism		NA	233400	25526675
HSD17B4	3295	Peroxisomal Disorders	MESH:D018901	marker/mechanism		NA		16385454|9345094
HSD17B4	3295	Spasms, Infantile	MESH:D013036	marker/mechanism		NA		16919904
HSD17B4	3295	Zellweger Syndrome	MESH:D015211	marker/mechanism		NA		10343282
HSD17B6	8630	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
HSD3B1	3283	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		22381227
HSD3B1	3283	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17826523
HSD3B2	3284	3b-Hydroxysteroid Dehydrogenase Deficiency	MESH:C579862	marker/mechanism		NA		25526675
HSD3B2	3284	Adrenal hyperplasia 2	MESH:C538236	marker/mechanism		NA	201810	
HSD3B2	3284	Adrenal Hyperplasia, Congenital	MESH:D000312	marker/mechanism		NA		18252794
HSD3B2	3284	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		19363144
HSD3B2	3284	Cryptorchidism	MESH:D003456	marker/mechanism		NA		26050606
HSD3B2	3284	Hypospadias	MESH:D007021	marker/mechanism		NA		14764821
HSD3B2	3284	Paranoid Disorders	MESH:D010259	marker/mechanism		NA		22356824
HSD3B2	3284	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		22381227
HSD3B2	3284	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17823934
HSD3B7	80270	Bile acid synthesis defect, congenital, 1	MESH:C535442	marker/mechanism		NA	607765	
HSD3B7	80270	Cholestasis	MESH:D002779	marker/mechanism		NA		25526675
HSDL2	84263	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		25058030
HSF1	3297	Amyotrophic lateral sclerosis 1	MESH:C531617	therapeutic		NA		24256636
HSF1	3297	Neoplasms	MESH:D009369	marker/mechanism		NA		22885793
HSF2	3298	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
HSF4	3299	Cataract, zonular	MESH:C535342	marker/mechanism		NA	116800	
HSFY1	86614	Spermatogenic Failure, Nonobstructive, Y-Linked	MESH:C564030	marker/mechanism		NA	415000	
HSP27	39078	Myocardial Infarction	MESH:D009203	therapeutic		NA		12160945
HSP70	652971	Hypoxia	MESH:D000860	marker/mechanism		NA		18258771
HSP90AA1	3320	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20562527
HSP90AA1	3320	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
HSP90AA1	3320	HIV Infections	MESH:D015658	marker/mechanism		NA		12878215
HSP90AA1	3320	Lymphoma, Large-Cell, Anaplastic	MESH:D017728	marker/mechanism		NA		17157164
HSP90AA1	3320	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		20562527
HSP90AB1	3326	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
HSP90AB1	3326	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17566973
HSP90B1	7184	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17566973
HSPA12A	259217	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
HSPA14	51182	Mouth Diseases	MESH:D009059	marker/mechanism		NA		17682004
HSPA1A	3303	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		12690470|19546256
HSPA1A	3303	Brain Injuries	MESH:D001930	marker/mechanism		NA		21549006
HSPA1A	3303	Carcinoma, Pancreatic Ductal	MESH:D021441	marker/mechanism		NA		17234771
HSPA1A	3303	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		16538175
HSPA1A	3303	Heat Stress Disorders	MESH:D018882	therapeutic		NA		16627676
HSPA1A	3303	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
HSPA1A	3303	Melanoma	MESH:D008545	marker/mechanism		NA		26984758
HSPA1A	3303	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
HSPA1A	3303	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		26984758
HSPA1A	3303	Parkinson Disease	MESH:D010300	therapeutic		NA		15585408
HSPA1A	3303	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		15764345
HSPA1A	3303	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		7922267
HSPA1B	3304	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
HSPA1B	3304	Atherosclerosis	MESH:D050197	marker/mechanism		NA		16513158
HSPA1B	3304	Breast Neoplasms	MESH:D001943	therapeutic		NA		15665820
HSPA1B	3304	Carcinoma, Pancreatic Ductal	MESH:D021441	marker/mechanism		NA		17234771
HSPA1B	3304	Muscular Dystrophy, Facioscapulohumeral	MESH:D020391	marker/mechanism		NA		12868502
HSPA1B	3304	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
HSPA1L	3305	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		16538175
HSPA2	3306	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
HSPA2	3306	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
HSPA4	3308	Muscular Dystrophy, Facioscapulohumeral	MESH:D020391	marker/mechanism		NA		12868502
HSPA5	3309	Asbestosis	MESH:D001195	marker/mechanism		NA		25324550
HSPA5	3309	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284|29698666
HSPA5	3309	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
HSPA5	3309	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
HSPA5	3309	Hematologic Neoplasms	MESH:D019337	marker/mechanism		NA		23777986
HSPA5	3309	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	MESH:D015464	marker/mechanism		NA		23777986
HSPA5	3309	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		25450231
HSPA5	3309	Obesity	MESH:D009765	marker/mechanism		NA		26655953
HSPA5	3309	Respiratory Hypersensitivity	MESH:D012130	marker/mechanism		NA		24211530
HSPA5	3309	Spinocerebellar Ataxia 17	MESH:C564616	marker/mechanism		NA		24413982
HSPA6	3310	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
HSPA8	3312	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		21751358
HSPA8	3312	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		15378696
HSPA8	3312	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		15274141
HSPA8	3312	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		15274141
HSPA8	3312	Reperfusion Injury	MESH:D015427	therapeutic		NA		10216529
HSPA8	3312	Spinocerebellar Ataxia 17	MESH:C564616	marker/mechanism		NA		24413982
HSPA8	3312	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		15378696
HSPA9	3313	Anemia, Sideroblastic	MESH:D000756	marker/mechanism		NA	182170	
HSPA9	3313	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		21850155
HSPA9	3313	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
HSPA9	3313	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		15108329
HSPA9	3313	Endotoxemia	MESH:D019446	marker/mechanism		NA		16741687
HSPA9	3313	Enterocolitis, Necrotizing	MESH:D020345	marker/mechanism		NA		18806098
HSPA9	3313	EVEN-PLUS SYNDROME	OMIM:616854	marker/mechanism		NA	616854	
HSPA9	3313	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
HSPA9	3313	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
HSPA9	3313	Parkinson Disease	MESH:D010300	marker/mechanism		NA		16565515
HSPA9	3313	Uveitis	MESH:D014605	marker/mechanism		NA		21850155
HSPB1	3315	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		19381893
HSPB1	3315	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
HSPB1	3315	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		15108329
HSPB1	3315	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		15274141
HSPB1	3315	Cardiomyopathy, Hypertrophic	MESH:D002312	marker/mechanism		NA		9527842
HSPB1	3315	Charcot-Marie-Tooth disease, Type 2F	MESH:C535413	marker/mechanism		NA	606595	
HSPB1	3315	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
HSPB1	3315	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
HSPB1	3315	Heart Failure	MESH:D006333	therapeutic		NA		17481944
HSPB1	3315	HIV Infections	MESH:D015658	marker/mechanism		NA		12878215
HSPB1	3315	Hyperplasia	MESH:D006965	marker/mechanism		NA		20864298
HSPB1	3315	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
HSPB1	3315	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		15274141
HSPB1	3315	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		12855565
HSPB1	3315	Neuronopathy, Distal Hereditary Motor, Type IIB	MESH:C567084	marker/mechanism		NA	608634	
HSPB1	3315	Reperfusion Injury	MESH:D015427	therapeutic		NA		19193722
HSPB1	3315	Status Epilepticus	MESH:D013226	marker/mechanism		NA		20971094
HSPB1	3315	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		19424620
HSPB1	3315	Tongue Neoplasms	MESH:D014062	marker/mechanism		NA		19840781
HSPB11	51668	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		31546644
HSPB3	8988	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC	OMIM:613376	marker/mechanism		NA	613376	
HSPB6	126393	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	therapeutic		NA		18948619
HSPB6	126393	Heart Diseases	MESH:D006331	therapeutic		NA		18948619
HSPB8	26353	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L	OMIM:608673	marker/mechanism		NA	608673	
HSPB8	26353	Neuropathy, Distal Hereditary Motor, Type IIA	MESH:C563561	marker/mechanism		NA	158590	
HSPB9	94086	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		31546644
HSPD1	3329	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		21751358
HSPD1	3329	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		15378696
HSPD1	3329	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		15108329
HSPD1	3329	Cardiomyopathies	MESH:D009202	therapeutic		NA		12967636
HSPD1	3329	Cardiomyopathy, Hypertrophic	MESH:D002312	marker/mechanism		NA		9527842
HSPD1	3329	Endotoxemia	MESH:D019446	marker/mechanism		NA		16741687
HSPD1	3329	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
HSPD1	3329	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		12374626
HSPD1	3329	Leukodystrophy, Hypomyelinating, 4	MESH:C567390	marker/mechanism		NA	612233	18571143
HSPD1	3329	Spastic paraplegia 13, autosomal dominant	MESH:C537485	marker/mechanism		NA	605280	18571143
HSPD1	3329	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		15378696|19424620
HSPE1	3336	Cardiomyopathies	MESH:D009202	therapeutic		NA		12967636
HSPG2	3339	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
HSPG2	3339	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		10545953
HSPG2	3339	Dyssegmental dysplasia	MESH:C537998	marker/mechanism		NA	224410	11279527
HSPG2	3339	Osteochondrodysplasias	MESH:D010009	marker/mechanism		NA	255800	10545953|11279527
HSPH1	10808	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
HTATIP2	10553	Carcinoma, Hepatocellular	MESH:D006528	therapeutic		NA		16799960
HTN1	3346	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19367726
HTOR	3349	5-HYDROXYTRYPTAMINE OXYGENASE REGULATOR	OMIM:143460	marker/mechanism		NA	143460	
HTR1A	3350	Apnea	MESH:D001049	therapeutic		NA		10640309
HTR1A	3350	Bradycardia	MESH:D001919	marker/mechanism		NA		2207497
HTR1A	3350	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		11853856
HTR1A	3350	Fever	MESH:D005334	marker/mechanism		NA		21990073
HTR1A	3350	Learning Disabilities	MESH:D007859	marker/mechanism		NA		12591222
HTR1A	3350	Memory Disorders	MESH:D008569	marker/mechanism		NA		12591222
HTR1A	3350	Pain	MESH:D010146	therapeutic		NA		12595749
HTR1A	3350	PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	OMIM:614674	marker/mechanism		NA	614674	
HTR1A	3350	Psychoses, Substance-Induced	MESH:D011605	marker/mechanism		NA		19747927
HTR1A	3350	Seizures	MESH:D012640	marker/mechanism|therapeutic		NA		12646302|16313900|2533336
HTR1A	3350	Stomach Neoplasms	MESH:D013274	therapeutic		NA		21447133
HTR1A	3350	Tremor	MESH:D014202	marker/mechanism		NA		11070179
HTR1B	3351	Amphetamine-Related Disorders	MESH:D019969	therapeutic		NA		10780831
HTR1B	3351	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19038234
HTR1B	3351	Cocaine-Related Disorders	MESH:D019970	marker/mechanism|therapeutic		NA		17509084|9603521
HTR1B	3351	Hypotension	MESH:D007022	marker/mechanism		NA		9109356
HTR1B	3351	Psychotic Disorders	MESH:D011618	marker/mechanism		NA		14708030
HTR1B	3351	Seizures	MESH:D012640	marker/mechanism		NA		2533336
HTR1D	3352	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19038234
HTR1D	3352	Hypotension	MESH:D007022	marker/mechanism		NA		9109356
HTR1D	3352	Obsessive-Compulsive Disorder	MESH:D009771	marker/mechanism		NA		10621951
HTR2A	3356	Alcoholism	MESH:D000437	marker/mechanism		NA	103780	
HTR2A	3356	Anorexia Nervosa	MESH:D000856	marker/mechanism		NA	606788	
HTR2A	3356	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17280648
HTR2A	3356	Basal Ganglia Diseases	MESH:D001480	marker/mechanism		NA		18480698
HTR2A	3356	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		14708030
HTR2A	3356	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		11259563|16300424|19212317
HTR2A	3356	Depressive Disorder, Major	MESH:D003865	marker/mechanism		NA	608516	
HTR2A	3356	Dyskinesias	MESH:D020820	marker/mechanism		NA		11526996
HTR2A	3356	Fever	MESH:D005334	marker/mechanism		NA		19879056
HTR2A	3356	Hyperalgesia	MESH:D006930	marker/mechanism		NA		17888573|18930597
HTR2A	3356	Hyperkinesis	MESH:D006948	marker/mechanism		NA		16300424|19347958
HTR2A	3356	Metabolic Diseases	MESH:D008659	marker/mechanism		NA		19142110
HTR2A	3356	Migraine Disorders	MESH:D008881	marker/mechanism		NA		12482207
HTR2A	3356	Obesity	MESH:D009765	marker/mechanism		NA		17097612
HTR2A	3356	Obsessive-Compulsive Disorder	MESH:D009771	marker/mechanism		NA	164230	19644229
HTR2A	3356	Psychotic Disorders	MESH:D011618	marker/mechanism		NA		14708030
HTR2A	3356	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		22048642
HTR2A	3356	Schizophrenia	MESH:D012559	marker/mechanism		NA	181500	14708030|18513383
HTR2B	3357	Cardiomegaly	MESH:D006332	marker/mechanism		NA		15302781|19023134|20374255
HTR2B	3357	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		16863450
HTR2B	3357	Heart Failure	MESH:D006333	marker/mechanism		NA		19023134
HTR2B	3357	Heart Valve Diseases	MESH:D006349	marker/mechanism		NA		10617681|11104741|16141947|19505264
HTR2B	3357	Hypertension	MESH:D006973	marker/mechanism		NA		8627522
HTR2B	3357	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		14659797
HTR2C	3358	Hyperkinesis	MESH:D006948	therapeutic		NA		19347958
HTR2C	3358	Metabolic Syndrome	MESH:D024821	marker/mechanism		NA		17632216|18515891|19142101
HTR2C	3358	Neuralgia	MESH:D009437	marker/mechanism		NA		28011743
HTR2C	3358	Obesity	MESH:D009765	marker/mechanism		NA		17702092|19142110
HTR2C	3358	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		17105947
HTR2C	3358	Weight Gain	MESH:D015430	marker/mechanism		NA		19434072|19997080
HTR3A	3359	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		19689456
HTR3A	3359	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19184136
HTR3B	9177	Muscular Diseases	MESH:D009135	marker/mechanism		NA		17600820
HTR3B	9177	Pain	MESH:D010146	marker/mechanism		NA		17600820
HTR3C	170572	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19035560
HTR4	3360	Adrenal Hyperplasia, Congenital	MESH:D000312	marker/mechanism		NA		17218722
HTR4	3360	Anorexia	MESH:D000855	marker/mechanism		NA		15146954
HTR4	3360	Arrhythmias, Cardiac	MESH:D001145	marker/mechanism		NA		9806222
HTR4	3360	Atrial Fibrillation	MESH:D001281	therapeutic		NA		7886817
HTR4	3360	Stroke	MESH:D020521	therapeutic		NA		7886817
HTR4	3360	Tachycardia	MESH:D013610	marker/mechanism		NA		7886817
HTR5A	3361	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17203304
HTR6	3362	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		20705401
HTR6	3362	Memory Disorders	MESH:D008569	marker/mechanism		NA		19733250
HTR6	3362	Psychoses, Substance-Induced	MESH:D011605	marker/mechanism		NA		20705401
HTR6	3362	Schizophrenia	MESH:D012559	marker/mechanism		NA		12165372
HTR7	3363	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		21859099
HTR7	3363	Depressive Disorder	MESH:D003866	marker/mechanism		NA		21859099
HTR7	3363	Learning Disabilities	MESH:D007859	marker/mechanism		NA		21859099
HTR7	3363	Memory Disorders	MESH:D008569	marker/mechanism		NA		21859099
HTR7	3363	Muscular Diseases	MESH:D009135	marker/mechanism		NA		17600820
HTR7	3363	Pain	MESH:D010146	marker/mechanism		NA		17600820
HTR7	3363	Schizophrenia	MESH:D012559	marker/mechanism		NA		12165372
HTR7	3363	Sleep Wake Disorders	MESH:D012893	marker/mechanism		NA		21859099
HTRA1	5654	CADASIL	MESH:D046589	marker/mechanism		NA	616779	
HTRA1	5654	CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY	OMIM:600142	marker/mechanism		NA	600142	
HTRA1	5654	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
HTRA1	5654	Macular Degeneration, Age-Related, 7	MESH:C565718	marker/mechanism		NA	610149	
HTRA2	27429	3-METHYLGLUTACONIC ACIDURIA, TYPE VIII	OMIM:617248	marker/mechanism		NA	617248	
HTRA2	27429	Ischemic Attack, Transient	MESH:D002546	marker/mechanism		NA		15306124
HTRA2	27429	PARKINSON DISEASE 13, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO	OMIM:610297	marker/mechanism		NA	610297	
HTRA2	27429	Parkinsonian Disorders	MESH:D020734	marker/mechanism		NA		26558463
HTT	3064	Cadmium Poisoning	MESH:D002105	marker/mechanism		NA		19845833
HTT	3064	Huntington Disease	MESH:D006816	marker/mechanism		NA	143100	15218539|15312898|16137562|17018277|17925440|18831068|19094060|19476553|20929960|21867705|28111121
HTT	3064	Manganese Poisoning	MESH:D020149	therapeutic		NA		19845833
HTT	3064	Movement Disorders	MESH:D009069	marker/mechanism		NA		20929960
HULC	728655	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		28765279
HULC	728655	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		26317792
HUWE1	10075	Mental Retardation, X-Linked, Syndromic, Turner Type	MESH:C567476	marker/mechanism		NA	309590	
HYAL1	3373	Hyaluronidase Deficiency	MESH:C563209	marker/mechanism		NA	601492	
HYDIN	54768	Ciliary Dyskinesia, Primary, 5	MESH:C563886	marker/mechanism		NA	608647	
HYDIN	54768	Hydrocephalus	MESH:D006849	marker/mechanism		NA		12719380|19029900
HYDIN2	100288805	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		19029900
HYKK	123688	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
HYLS1	219844	Hydrolethalus Syndrome 1	MESH:C565504	marker/mechanism		NA	236680	
HYMAI	57061	Diabetes Mellitus, Transient Neonatal, 1	MESH:C563322	marker/mechanism		NA	601410	
HYOU1	10525	Spinocerebellar Ataxia 17	MESH:C564616	marker/mechanism		NA		24413982
IAPP	3375	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		16123366
IAPP	3375	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		16123366|23793354
IAPP	3375	Stomach Ulcer	MESH:D013276	therapeutic		NA		9286623
IARS1	3376	GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY	OMIM:617093	marker/mechanism		NA	617093	
IARS2	55699	CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA	OMIM:616007	marker/mechanism		NA	616007	
IARS2	55699	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
IBA57	200205	Multiple Mitochondrial Dysfunctions Syndrome	MESH:C565304	marker/mechanism		NA	615330	
IBA57	200205	SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE	OMIM:616451	marker/mechanism		NA	616451	
IBSP	3381	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		24980816
IBSP	3381	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		22407340|24980816
IBSP	3381	Osteolysis	MESH:D010014	marker/mechanism		NA		22407340
ICAM1	3383	Acute Lung Injury	MESH:D055371	marker/mechanism		NA		17973899|27525872
ICAM1	3383	Arteriosclerosis	MESH:D001161	marker/mechanism		NA		28569748
ICAM1	3383	Asthma	MESH:D001249	marker/mechanism		NA		17014439|25003170
ICAM1	3383	Atherosclerosis	MESH:D050197	marker/mechanism		NA		12677255
ICAM1	3383	Behcet Syndrome	MESH:D001528	marker/mechanism		NA		12074830|8712863
ICAM1	3383	Brain Injuries, Traumatic	MESH:D000070642	marker/mechanism		NA		28642177
ICAM1	3383	Brain Ischemia	MESH:D002545	marker/mechanism		NA		17394460|19417757
ICAM1	3383	Bronchial Hyperreactivity	MESH:D016535	marker/mechanism		NA		17014439
ICAM1	3383	Bronchiectasis	MESH:D001987	marker/mechanism		NA		17931847
ICAM1	3383	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		16332659|25575156
ICAM1	3383	Cholestasis	MESH:D002779	marker/mechanism		NA		21224055
ICAM1	3383	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		15553846
ICAM1	3383	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		16497620|7902311
ICAM1	3383	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		14871415|20388520|24513509
ICAM1	3383	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		24513509
ICAM1	3383	Diabetic Retinopathy	MESH:D003930	therapeutic		NA		10485912
ICAM1	3383	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		12759764|17245593
ICAM1	3383	Hodgkin Disease	MESH:D006689	marker/mechanism		NA		7621881|8656679
ICAM1	3383	Hypercholesterolemia	MESH:D006937	marker/mechanism		NA		14602771
ICAM1	3383	Hypertension	MESH:D006973	marker/mechanism		NA		12149661|12425201
ICAM1	3383	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		12374626
ICAM1	3383	Inflammation	MESH:D007249	marker/mechanism		NA		19324842|23371441
ICAM1	3383	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA		28067908
ICAM1	3383	Leukostasis	MESH:D018921	marker/mechanism		NA		10485912
ICAM1	3383	Malaria	MESH:D008288	marker/mechanism		NA	611162	
ICAM1	3383	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		24069166
ICAM1	3383	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		20175758
ICAM1	3383	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		10070497
ICAM1	3383	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
ICAM1	3383	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		12087064
ICAM1	3383	Nephrosis	MESH:D009401	marker/mechanism		NA		12845231
ICAM1	3383	Obesity	MESH:D009765	marker/mechanism		NA		11782876
ICAM1	3383	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		21245421
ICAM1	3383	Pleurisy	MESH:D010998	marker/mechanism		NA		11181422
ICAM1	3383	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16606632
ICAM1	3383	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		29329563
ICAM1	3383	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		11557319|23743330
ICAM1	3383	Respiratory Syncytial Virus Infections	MESH:D018357	marker/mechanism		NA		17425601
ICAM1	3383	Retinal Diseases	MESH:D012164	marker/mechanism		NA		19324842
ICAM1	3383	Shock, Hemorrhagic	MESH:D012771	marker/mechanism		NA		21192278
ICAM1	3383	Stroke	MESH:D020521	marker/mechanism		NA		20083630
ICAM1	3383	Uremia	MESH:D014511	marker/mechanism		NA		17347482
ICAM1	3383	Urticaria	MESH:D014581	marker/mechanism		NA		12121561
ICAM1	3383	Wounds and Injuries	MESH:D014947	marker/mechanism		NA		21192278
ICAM2	3384	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ICAM2	3384	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		23056237
ICAM2	3384	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
ICAM3	3385	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		18422935
ICAM5	7087	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18507500
ICAM5	7087	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18507500|21278247
ICE2	79664	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		18438686
ICE2	79664	Paranoid Disorders	MESH:D010259	marker/mechanism		NA		18438686
ICOS	29851	Common Variable Immunodeficiency	MESH:D017074	marker/mechanism		NA	240500|607594	
ICOS	29851	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		26437031
ICOSLG	23308	Celiac Disease	MESH:D002446	marker/mechanism		NA		20190752
ICOSLG	23308	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		20228799
ID1	3397	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		16123366
ID1	3397	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		16123366
ID1	3397	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		21283680
ID1	3397	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
ID1	3397	Neoplasm Metastasis	MESH:D009362	therapeutic		NA		24910342
ID1	3397	Neoplasms	MESH:D009369	marker/mechanism		NA		16966095
ID2	3398	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
ID2	3398	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
ID2	3398	Liver Cirrhosis, Experimental	MESH:D008106	therapeutic		NA		17127702
ID2	3398	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
ID2	3398	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		23582323
ID2	3398	Thyroid Diseases	MESH:D013959	marker/mechanism		NA		23397585
ID3	3399	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		21552421
ID3	3399	Burkitt Lymphoma	MESH:D002051	marker/mechanism		NA		23143595|23143597
ID3	3399	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
ID3	3399	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
ID3	3399	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		21552421
ID3	3399	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
ID3	3399	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
ID3	3399	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
ID3	3399	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		21245421
ID3	3399	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
ID3	3399	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		16526316
ID3	3399	Thyroid Diseases	MESH:D013959	marker/mechanism		NA		23397585
ID4	3400	Carcinoma	MESH:D002277	marker/mechanism		NA		14633621
ID4	3400	Cholestasis	MESH:D002779	marker/mechanism		NA		27989131
ID4	3400	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ID4	3400	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		14633621
ID4	3400	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		14633621
ID4	3400	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		14633621
ID4	3400	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
IDE	3416	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		17192785
IDH1	3417	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
IDH1	3417	Cholangiocarcinoma	MESH:D018281	marker/mechanism		NA		24185509
IDH1	3417	Chondroma	MESH:D002812	marker/mechanism		NA		22057234|25895133
IDH1	3417	Enchondromatosis	MESH:D004687	marker/mechanism		NA		22057234|22057236
IDH1	3417	Glioma	MESH:D005910	marker/mechanism		NA	137800	19901110|25391653|25848751|26618343|28122345
IDH1	3417	Hemangioma	MESH:D006391	marker/mechanism		NA		22057234
IDH1	3417	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		25324972|27992414
IDH1	3417	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		26285909
IDH1	3417	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		26285909
IDH1	3417	Oligodendroglioma	MESH:D009837	marker/mechanism		NA		20160062
IDH1	3417	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		22674224
IDH1	3417	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
IDH2	3418	2-Hydroxyglutaricaciduria	MESH:C535306	marker/mechanism		NA	613657	27469509
IDH2	3418	Cardiomegaly	MESH:D006332	marker/mechanism		NA		27469509
IDH2	3418	Cardiomyopathy, Hypertrophic	MESH:D002312	marker/mechanism		NA		27469509
IDH2	3418	Central Nervous System Diseases	MESH:D002493	marker/mechanism		NA		27469509
IDH2	3418	Cholangiocarcinoma	MESH:D018281	marker/mechanism		NA		24185509
IDH2	3418	Chondroma	MESH:D002812	marker/mechanism		NA		22057234|25895133
IDH2	3418	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		27469509
IDH2	3418	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27469509
IDH2	3418	Enchondromatosis	MESH:D004687	marker/mechanism		NA		22057234|22057236
IDH2	3418	Growth Disorders	MESH:D006130	marker/mechanism		NA		27469509
IDH2	3418	Hemangioma	MESH:D006391	marker/mechanism		NA		22057234
IDH2	3418	Hydronephrosis	MESH:D006869	marker/mechanism		NA		27469509
IDH2	3418	Immunoblastic Lymphadenopathy	MESH:D007119	marker/mechanism		NA		24413737
IDH2	3418	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		25324972|27992414
IDH2	3418	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		26285909
IDH2	3418	Lymphoma, T-Cell, Peripheral	MESH:D016411	marker/mechanism		NA		24413734|24413737
IDH2	3418	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		26285909
IDH2	3418	Oligodendroglioma	MESH:D009837	marker/mechanism		NA		20160062
IDH2	3418	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
IDH2	3418	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
IDH2	3418	Renal Insufficiency	MESH:D051437	marker/mechanism		NA		27469509
IDH2	3418	Seizures	MESH:D012640	marker/mechanism		NA		27469509
IDH2	3418	Ventricular Dysfunction, Left	MESH:D018487	marker/mechanism		NA		27469509
IDH3A	3419	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
IDH3B	3420	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
IDH3B	3420	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA		18806796
IDH3B	3420	Retinitis Pigmentosa 46	MESH:C567249	marker/mechanism		NA	612572	
IDH3B	3420	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
IDO1	3620	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18925433
IDO1	3620	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
IDO1	3620	Inflammation	MESH:D007249	marker/mechanism		NA		16365156
IDO1	3620	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		18925433
IDO1	3620	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		16365156
IDO1	3620	Obesity	MESH:D009765	marker/mechanism		NA		27020609
IDO1	3620	Weight Gain	MESH:D015430	marker/mechanism		NA		27020609
IDO2	169355	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		32289347
IDO2	169355	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		32289347
IDS	3423	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
IDS	3423	Mucopolysaccharidosis II	MESH:D016532	marker/mechanism		NA	309900	
IDUA	3425	Mucopolysaccharidosis I	MESH:D008059	marker/mechanism|therapeutic		NA	607014|607015|607016	11159948|15081804|15194053|19309154|22822036
IER2	9592	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
IER3	8870	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
IER3	8870	Dermatitis, Irritant	MESH:D017453	marker/mechanism		NA		27258892
IER3	8870	Hypertension	MESH:D006973	marker/mechanism		NA		20713914
IER3	8870	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
IER3IP1	51124	MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	OMIM:614231	marker/mechanism		NA	614231	
IFI204	15951	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
IFI27	3429	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
IFI27	3429	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
IFI27L2B	217845	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
IFI30	10437	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17597826
IFI30	10437	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
IFI35	3430	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
IFI35	3430	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
IFI35	3430	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
IFI44	10561	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
IFI44	10561	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
IFI44L	10964	Depressive Disorder, Major	MESH:D003865	marker/mechanism		NA		29175309
IFI44L	10964	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
IFI6	2537	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
IFI6	2537	Depressive Disorder, Major	MESH:D003865	marker/mechanism		NA		29175309
IFI6	2537	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
IFIH1	64135	Aicardi-Goutieres syndrome	MESH:C535607	marker/mechanism		NA	615846	24686847
IFIH1	64135	Graves Disease	MESH:D006111	marker/mechanism		NA		17535987
IFIH1	64135	IgA Deficiency	MESH:D017098	marker/mechanism		NA		20694011|27723758
IFIH1	64135	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
IFIH1	64135	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		19838195|24686847
IFIH1	64135	Psoriasis	MESH:D011565	marker/mechanism		NA		20953190
IFIH1	64135	Singleton Merten syndrome	MESH:C537343	marker/mechanism		NA	182250	
IFIH1	64135	Vitiligo	MESH:D014820	marker/mechanism		NA		22561518
IFIT1	3434	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
IFIT1	3434	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
IFIT2	3433	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
IFIT3	3437	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
IFIT5	24138	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
IFITM1	8519	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
IFITM3	10410	Influenza, Human	MESH:D007251	marker/mechanism		NA	614680	23326326
IFITM5	387733	Osteogenesis Imperfecta, Type V	MESH:C567042	marker/mechanism		NA	610967	
IFNA	111654	Carcinoma, Transitional Cell	MESH:D002295	therapeutic		NA		2297754
IFNA	111654	Hepatitis C, Chronic	MESH:D019698	therapeutic		NA		9058296
IFNA	111654	Hypertriglyceridemia	MESH:D015228	marker/mechanism		NA		15304625
IFNA	111654	Melanoma	MESH:D008545	therapeutic		NA		15304625
IFNA	111654	Neoplasms, Experimental	MESH:D009374	therapeutic		NA		1674182|2297754
IFNA	111654	Urinary Bladder Neoplasms	MESH:D001749	therapeutic		NA		1674182|2297754
IFNA1	3439	Acquired Immunodeficiency Syndrome	MESH:D000163	marker/mechanism		NA		9612607
IFNA1	3439	Adenocarcinoma	MESH:D000230	therapeutic		NA		17198089
IFNA1	3439	Carcinoma, Hepatocellular	MESH:D006528	therapeutic		NA		17088986|17971768|18665156
IFNA1	3439	Colorectal Neoplasms	MESH:D015179	therapeutic		NA		15289873
IFNA1	3439	Hepatitis B	MESH:D006509	therapeutic		NA		15504288
IFNA1	3439	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	therapeutic		NA		20370541
IFNA1	3439	Liver Cirrhosis	MESH:D008103	therapeutic		NA		18665156
IFNA1	3439	Liver Cirrhosis, Experimental	MESH:D008106	therapeutic		NA		12898905|14512876|16027843
IFNA1	3439	Liver Neoplasms	MESH:D008113	therapeutic		NA		14633663
IFNA1	3439	Melanoma	MESH:D008545	therapeutic		NA		15176220|15577320|15577323|16034308|16260693|16260697|16432458
IFNA1	3439	Pancreatic Neoplasms	MESH:D010190	therapeutic		NA		17198089|17961653
IFNA1	3439	Severe Acute Respiratory Syndrome	MESH:D045169	therapeutic		NA		15200845
IFNA1	3439	Vaginal Neoplasms	MESH:D014625	therapeutic		NA		15577323
IFNA1	3439	Vipoma	MESH:D003969	therapeutic		NA		17961653
IFNA10	3446	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
IFNA2	3440	Abdominal Pain	MESH:D015746	marker/mechanism		NA		9234591
IFNA2	3440	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		12810204
IFNA2	3440	Anemia	MESH:D000740	marker/mechanism		NA		11981781|12620292|16557544|1670585|8886046
IFNA2	3440	Anemia, Hemolytic	MESH:D000743	marker/mechanism		NA		11010742|15293138|16633111
IFNA2	3440	Anorexia	MESH:D000855	marker/mechanism		NA		8759893
IFNA2	3440	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		12297606
IFNA2	3440	Carcinoma, Renal Cell	MESH:D002292	therapeutic		NA		8886046
IFNA2	3440	Carcinoma, Squamous Cell	MESH:D002294	therapeutic		NA		17172406
IFNA2	3440	Carcinoma, Transitional Cell	MESH:D002295	therapeutic		NA		17172406
IFNA2	3440	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		1670585
IFNA2	3440	Chills	MESH:D023341	marker/mechanism		NA		8759893
IFNA2	3440	Colorectal Neoplasms	MESH:D015179	therapeutic		NA		8026229
IFNA2	3440	Depressive Disorder	MESH:D003866	marker/mechanism		NA		12297606|17292481|17451562|19691667
IFNA2	3440	Diarrhea	MESH:D003967	marker/mechanism		NA		12620292
IFNA2	3440	Fatigue	MESH:D005221	marker/mechanism		NA		8759893
IFNA2	3440	Fatty Liver	MESH:D005234	marker/mechanism|therapeutic		NA		31299271|7736406
IFNA2	3440	Fever	MESH:D005334	marker/mechanism		NA		8026229|8759893
IFNA2	3440	Flavivirus Infections	MESH:D018177	therapeutic		NA		16902856
IFNA2	3440	Glioblastoma	MESH:D005909	therapeutic		NA		18679580
IFNA2	3440	Headache	MESH:D006261	marker/mechanism		NA		15951019
IFNA2	3440	Hemangioendothelioma, Epithelioid	MESH:D018323	therapeutic		NA		15982392
IFNA2	3440	Hepatitis B	MESH:D006509	therapeutic		NA		10836394|11112032|9339942
IFNA2	3440	Hepatitis B, Chronic	MESH:D019694	therapeutic		NA		12802750|15340535|15751770|16246192|16476009|16557544|16944240
IFNA2	3440	Hepatitis C	MESH:D006526	therapeutic		NA		11010742|11132533|11981781|15980766|19302339|19691667|9722937
IFNA2	3440	Hepatitis C, Chronic	MESH:D019698	therapeutic		NA		11454181|15293138|15751770|15951019|15996025|16476009|16633111|18294165|9563925|9860407
IFNA2	3440	Hepatitis, Chronic	MESH:D006521	therapeutic		NA		15516819
IFNA2	3440	Hepatomegaly	MESH:D006529	therapeutic		NA		31299271
IFNA2	3440	Hodgkin Disease	MESH:D006689	therapeutic		NA		16170182
IFNA2	3440	Hypertriglyceridemia	MESH:D015228	marker/mechanism		NA		12643008
IFNA2	3440	Intestinal Perforation	MESH:D007416	marker/mechanism		NA		12810204
IFNA2	3440	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	therapeutic		NA		12560223|17077332
IFNA2	3440	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	MESH:D015464	therapeutic		NA		10520005|10715301|12620292
IFNA2	3440	Leukopenia	MESH:D007970	marker/mechanism		NA		10520005|12620292|3298131|3597002|8886046
IFNA2	3440	Liver Cirrhosis, Experimental	MESH:D008106	therapeutic		NA		12649538
IFNA2	3440	Lymphoma, Follicular	MESH:D008224	therapeutic		NA		12855623
IFNA2	3440	Lymphoma, Non-Hodgkin	MESH:D008228	therapeutic		NA		7515650
IFNA2	3440	Melanoma	MESH:D008545	therapeutic		NA		11135225|12374674|12393984|12439608|12829675|12883367|15917704|16034308|16248763|16939954|17023156|17576461|17709802|17761969|17973783|18176117|18281266|18332650
IFNA2	3440	Meningism	MESH:D008580	marker/mechanism		NA		15951019
IFNA2	3440	Mental Disorders	MESH:D001523	marker/mechanism		NA		10715301
IFNA2	3440	Multiple Myeloma	MESH:D009101	therapeutic		NA		3597002|8833401|9234591
IFNA2	3440	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		3597002
IFNA2	3440	Nausea	MESH:D009325	marker/mechanism		NA		8759893|8886046|9234591
IFNA2	3440	Neutropenia	MESH:D009503	marker/mechanism		NA		1670585
IFNA2	3440	Optic Neuropathy, Ischemic	MESH:D018917	marker/mechanism		NA		15980766
IFNA2	3440	Pain	MESH:D010146	marker/mechanism		NA		8759893
IFNA2	3440	Pancreatic Neoplasms	MESH:D010190	therapeutic		NA		12738744
IFNA2	3440	Polycythemia Vera	MESH:D011087	therapeutic		NA		20160369
IFNA2	3440	Polyomavirus Infections	MESH:D027601	marker/mechanism		NA		25162674
IFNA2	3440	Pterygium	MESH:D011625	therapeutic		NA		16723453
IFNA2	3440	Raynaud Disease	MESH:D011928	marker/mechanism		NA		12620292
IFNA2	3440	Renal Insufficiency	MESH:D051437	marker/mechanism		NA		3597002
IFNA2	3440	Retinal Detachment	MESH:D012163	marker/mechanism		NA		15951019|20177954
IFNA2	3440	Retinal Diseases	MESH:D012164	marker/mechanism		NA		12578794
IFNA2	3440	Sepsis	MESH:D018805	marker/mechanism		NA		3597002
IFNA2	3440	Skin Diseases	MESH:D012871	marker/mechanism		NA		12620292
IFNA2	3440	Somatoform Disorders	MESH:D013001	marker/mechanism		NA		12297606
IFNA2	3440	Stevens-Johnson Syndrome	MESH:D013262	marker/mechanism		NA		25811541
IFNA2	3440	Stomatitis	MESH:D013280	marker/mechanism		NA		9234591
IFNA2	3440	Substance Withdrawal Syndrome	MESH:D013375	therapeutic		NA		2449543
IFNA2	3440	Thrombocythemia, Essential	MESH:D013920	therapeutic		NA		12924084
IFNA2	3440	Thrombocytopenia	MESH:D013921	marker/mechanism		NA		10520005|12620292|15274073|8886046
IFNA2	3440	Thyroid Neoplasms	MESH:D013964	therapeutic		NA		17909728
IFNA2	3440	Tinnitus	MESH:D014012	marker/mechanism		NA		15951019
IFNA2	3440	Urinary Bladder Neoplasms	MESH:D001749	therapeutic		NA		17172406
IFNA2	3440	Uveomeningoencephalitic Syndrome	MESH:D014607	marker/mechanism		NA		14633182|15951019|20172621|20177954
IFNA2	3440	Viremia	MESH:D014766	therapeutic		NA		11132533
IFNA2	3440	Vomiting	MESH:D014839	marker/mechanism		NA		8759893|8886046
IFNA2	3440	Weight Gain	MESH:D015430	therapeutic		NA		31299271
IFNA2	3440	Weight Loss	MESH:D015431	marker/mechanism		NA		1670585
IFNA5	3442	Melanoma	MESH:D008545	therapeutic		NA		16809738
IFNA5	3442	Pancreatic Neoplasms	MESH:D010190	therapeutic		NA		15320962
IFNAR1	3454	Virus Diseases	MESH:D014777	marker/mechanism		NA		18722370
IFNAR2	3455	Hepatitis B	MESH:D006509	marker/mechanism		NA	610424	
IFNAR2	3455	IMMUNODEFICIENCY 45	OMIM:616669	marker/mechanism		NA	616669	
IFNB1	3456	Anus Neoplasms	MESH:D001005	therapeutic		NA		12170190|12397731
IFNB1	3456	Brain Diseases	MESH:D001927	marker/mechanism		NA		8615598
IFNB1	3456	Breast Neoplasms	MESH:D001943	therapeutic		NA		18608205
IFNB1	3456	Carcinoma, Transitional Cell	MESH:D002295	therapeutic		NA		2297754
IFNB1	3456	Coronavirus Infections	MESH:D018352	therapeutic		NA		24323636
IFNB1	3456	Hepatitis B	MESH:D006509	therapeutic		NA		15994231
IFNB1	3456	Melanoma	MESH:D008545	therapeutic		NA		16928243|21846298
IFNB1	3456	Melanoma, Amelanotic	MESH:D018328	therapeutic		NA		15990972
IFNB1	3456	Melanoma, Experimental	MESH:D008546	therapeutic		NA		16417267
IFNB1	3456	Multiple Sclerosis	MESH:D009103	therapeutic		NA		10520943|12424511|12432978|23517930|27806875
IFNB1	3456	Neoplasms, Experimental	MESH:D009374	therapeutic		NA		2297754
IFNB1	3456	Neuroblastoma	MESH:D009447	therapeutic		NA		16115947
IFNB1	3456	Seizures	MESH:D012640	marker/mechanism		NA		12432978
IFNB1	3456	Severe Acute Respiratory Syndrome	MESH:D045169	marker/mechanism|therapeutic		NA		15200845|26861016
IFNB1	3456	Urinary Bladder Neoplasms	MESH:D001749	therapeutic		NA		2297754
IFNG	3458	Acquired Immunodeficiency Syndrome	MESH:D000163	marker/mechanism		NA		9612607
IFNG	3458	Adrenoleukodystrophy	MESH:D000326	marker/mechanism		NA		16319717
IFNG	3458	Anemia, Aplastic	MESH:D000741	marker/mechanism		NA	609135	
IFNG	3458	Appendicitis	MESH:D001064	marker/mechanism		NA		16367942
IFNG	3458	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		19203382|22450443
IFNG	3458	Arthritis, Infectious	MESH:D001170	marker/mechanism		NA		19203382
IFNG	3458	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		22450443
IFNG	3458	Atherosclerosis	MESH:D050197	marker/mechanism		NA		9169506
IFNG	3458	Autistic Disorder	MESH:D001321	marker/mechanism		NA		16360218
IFNG	3458	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		19077085|9647229
IFNG	3458	Brain Diseases	MESH:D001927	therapeutic		NA		18282668
IFNG	3458	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19446661
IFNG	3458	Bronchiolitis Obliterans	MESH:D001989	therapeutic		NA		16137903
IFNG	3458	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
IFNG	3458	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		12153990|21245496
IFNG	3458	Chills	MESH:D023341	marker/mechanism		NA		3091246
IFNG	3458	Chlamydia Infections	MESH:D002690	marker/mechanism		NA		19203382
IFNG	3458	Colitis	MESH:D003092	marker/mechanism		NA		24548422
IFNG	3458	Colonic Neoplasms	MESH:D003110	therapeutic		NA		10866311
IFNG	3458	Crohn Disease	MESH:D003424	marker/mechanism		NA		21829567
IFNG	3458	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		11312644|12484431|15347381
IFNG	3458	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		18249437
IFNG	3458	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		21340626
IFNG	3458	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		21340626
IFNG	3458	Disease Models, Animal	MESH:D004195	therapeutic		NA		16845661
IFNG	3458	Drug Eruptions	MESH:D003875	marker/mechanism		NA		31150805
IFNG	3458	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		31557154
IFNG	3458	Entamoebiasis	MESH:D004749	marker/mechanism		NA		16374615
IFNG	3458	Eyelid Diseases	MESH:D005141	therapeutic		NA		17075842
IFNG	3458	Fever	MESH:D005334	marker/mechanism|therapeutic		NA		18282668|3091246
IFNG	3458	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		1825860
IFNG	3458	Graft vs Host Disease	MESH:D006086	marker/mechanism		NA		22077062
IFNG	3458	Heart Arrest	MESH:D006323	marker/mechanism		NA		9806674
IFNG	3458	Heart Failure	MESH:D006333	marker/mechanism		NA		20938210|3091246
IFNG	3458	Hepatitis	MESH:D006505	marker/mechanism		NA		3091246
IFNG	3458	Hepatitis, Autoimmune	MESH:D019693	marker/mechanism		NA		21227906
IFNG	3458	Hepatitis B	MESH:D006509	therapeutic		NA		15994231|20610715
IFNG	3458	Hepatitis C	MESH:D006526	marker/mechanism		NA	609532	
IFNG	3458	HIV Infections	MESH:D015658	marker/mechanism		NA	609423	10202824
IFNG	3458	Hypersensitivity	MESH:D006967	marker/mechanism|therapeutic		NA		10886234|21625544
IFNG	3458	Hyponatremia	MESH:D007010	marker/mechanism		NA		3091246
IFNG	3458	Hypotension	MESH:D007022	marker/mechanism		NA		3091246
IFNG	3458	Immune Complex Diseases	MESH:D007105	marker/mechanism		NA		1825860
IFNG	3458	Inflammation	MESH:D007249	marker/mechanism|therapeutic		NA		21937650|22617429|23164921
IFNG	3458	Job Syndrome	MESH:D007589	marker/mechanism		NA		16112032
IFNG	3458	Legionnaires' Disease	MESH:D007877	therapeutic		NA		11349020
IFNG	3458	Leishmaniasis	MESH:D007896	marker/mechanism		NA		16540374|17218153
IFNG	3458	Leishmaniasis, Cutaneous	MESH:D016773	marker/mechanism|therapeutic		NA		20102417|8154019|9234779
IFNG	3458	Leishmaniasis, Mucocutaneous	MESH:D007897	therapeutic		NA		7854095
IFNG	3458	Leishmaniasis, Visceral	MESH:D007898	therapeutic		NA		1901333|7854095
IFNG	3458	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		23962110
IFNG	3458	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		22617429
IFNG	3458	Liver Cirrhosis, Experimental	MESH:D008106	therapeutic		NA		12389079|15996030|16953842|17347453
IFNG	3458	Lung Neoplasms	MESH:D008175	therapeutic		NA		7614408
IFNG	3458	Lymphoproliferative Disorders	MESH:D008232	marker/mechanism		NA		22617429
IFNG	3458	Manganese Poisoning	MESH:D020149	marker/mechanism		NA		18041089
IFNG	3458	Melanoma	MESH:D008545	therapeutic		NA		9794839
IFNG	3458	Mesothelioma	MESH:D008654	therapeutic		NA		12768194
IFNG	3458	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25162674
IFNG	3458	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		23517930
IFNG	3458	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO	OMIM:607948	marker/mechanism		NA	607948	
IFNG	3458	Nausea	MESH:D009325	marker/mechanism		NA		3091246
IFNG	3458	Necrosis	MESH:D009336	marker/mechanism		NA		10903806|10909967
IFNG	3458	Neoplasms, Experimental	MESH:D009374	therapeutic		NA		15711825
IFNG	3458	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		15153526|16307444|19457078
IFNG	3458	Neural Tube Defects	MESH:D009436	therapeutic		NA		17075842
IFNG	3458	Oral Submucous Fibrosis	MESH:D009914	marker/mechanism		NA		16311067
IFNG	3458	Peritonitis	MESH:D010538	marker/mechanism		NA		19804847
IFNG	3458	Pleural Diseases	MESH:D010995	marker/mechanism		NA		21357438
IFNG	3458	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
IFNG	3458	Proteinuria	MESH:D011507	marker/mechanism		NA		3091246|8289579
IFNG	3458	Radiation Injuries, Experimental	MESH:D011833	marker/mechanism		NA		11121210
IFNG	3458	Renal Insufficiency	MESH:D051437	marker/mechanism		NA		3091246|8289579
IFNG	3458	Respiratory Syncytial Virus Infections	MESH:D018357	marker/mechanism		NA		21937650
IFNG	3458	Respiratory Tract Diseases	MESH:D012140	marker/mechanism		NA		21937650
IFNG	3458	Salmonella Infections, Animal	MESH:D012481	marker/mechanism		NA		16002714
IFNG	3458	Sarcoma	MESH:D012509	therapeutic		NA		9794839
IFNG	3458	Sepsis	MESH:D018805	marker/mechanism		NA		9806674
IFNG	3458	Stevens-Johnson Syndrome	MESH:D013262	marker/mechanism		NA		25811541
IFNG	3458	Trichuriasis	MESH:D014257	marker/mechanism		NA		20864659
IFNG	3458	Tuberous Sclerosis	MESH:D014402	therapeutic		NA		16845661
IFNG	3458	Tuberous Sclerosis 2	MESH:C566021	marker/mechanism		NA	613254	
IFNG	3458	Vomiting	MESH:D014839	marker/mechanism		NA		3091246
IFNGR1	3459	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
IFNGR1	3459	Helicobacter Infections	MESH:D016481	marker/mechanism		NA	600263	
IFNGR1	3459	Hepatitis B	MESH:D006509	marker/mechanism		NA	610424	
IFNGR1	3459	IMMUNODEFICIENCY 27B	OMIM:615978	marker/mechanism		NA	615978	
IFNGR1	3459	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
IFNGR1	3459	Mycobacterium Infections, Nontuberculous	MESH:D009165	marker/mechanism		NA	209950	
IFNGR1	3459	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO	OMIM:607948	marker/mechanism		NA	607948	
IFNGR1	3459	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
IFNGR2	3460	IMMUNODEFICIENCY 28	OMIM:614889	marker/mechanism		NA	614889	
IFNL3	282617	Asthma	MESH:D001249	marker/mechanism		NA		22295096
IFNL3	282617	Brain Injuries	MESH:D001930	marker/mechanism		NA		23159883
IFNL3	282617	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		22295096
IFNL3	282617	Food Hypersensitivity	MESH:D005512	marker/mechanism		NA		22295096
IFNL3	282617	Hepatic Fibrosis, Congenital	MESH:C562378	marker/mechanism		NA		28394349
IFNL3	282617	Hepatitis C	MESH:D006526	marker/mechanism		NA	609532	
IFNL3	282617	Inflammation	MESH:D007249	marker/mechanism		NA		28394349
IFNL3	282617	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	therapeutic		NA		21304406
IFNLR1	163702	Psoriasis	MESH:D011565	marker/mechanism		NA		20953190
IFRD1	3475	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
IFRD1	3475	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
IFT122	55764	Ciliary Motility Disorders	MESH:D002925	marker/mechanism		NA		20493458
IFT122	55764	Cranioectodermal Dysplasia	MESH:C562966	marker/mechanism		NA	218330	
IFT122	55764	Craniosynostoses	MESH:D003398	marker/mechanism		NA		20493458
IFT122	55764	Edema, Cardiac	MESH:D004489	marker/mechanism		NA		20493458
IFT122	55764	Eye Abnormalities	MESH:D005124	marker/mechanism		NA		20493458
IFT122	55764	Hydrocephalus	MESH:D006849	marker/mechanism		NA		20493458
IFT122	55764	Kidney Diseases	MESH:D007674	marker/mechanism		NA		20493458
IFT122	55764	Spinal Curvatures	MESH:D013121	marker/mechanism		NA		20493458
IFT140	9742	Short Rib-Polydactyly Syndrome	MESH:D012779	marker/mechanism		NA	266920	
IFT172	26160	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
IFT172	26160	RETINITIS PIGMENTOSA 71	OMIM:616394	marker/mechanism		NA	616394	
IFT172	26160	Short Rib-Polydactyly Syndrome	MESH:D012779	marker/mechanism		NA	615630	
IFT27	11020	BARDET-BIEDL SYNDROME 19	OMIM:615996	marker/mechanism		NA	615996	
IFT43	112752	Cranioectodermal Dysplasia	MESH:C562966	marker/mechanism		NA	614099	
IFT52	51098	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
IFT52	51098	Short Rib-Polydactyly Syndrome	MESH:D012779	marker/mechanism		NA	617102	
IFT74	80173	BARDET-BIEDL SYNDROME 20	OMIM:617119	marker/mechanism		NA	617119	
IFT80	57560	Asphyxia	MESH:D001237	marker/mechanism		NA		17468754
IFT80	57560	Asphyxiating Thoracic Dystrophy 2	MESH:C566982	marker/mechanism		NA	611263	
IFT80	57560	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		17468754
IFT80	57560	Kidney Diseases, Cystic	MESH:D052177	marker/mechanism		NA		17468754
IFT80	57560	Polydactyly	MESH:D017689	marker/mechanism		NA		17468754
IFT80	57560	Respiratory Insufficiency	MESH:D012131	marker/mechanism		NA		17468754
IFT80	57560	Retinal Degeneration	MESH:D012162	marker/mechanism		NA		17468754
IFT80	57560	Thoracic Diseases	MESH:D013896	marker/mechanism		NA		17468754
IFT88	8100	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
IFT88	8100	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		9362446
IFT88	8100	Polycystic Kidney, Autosomal Recessive	MESH:D017044	marker/mechanism		NA		8191288|8608416
IFT88	8100	Polydactyly	MESH:D017689	marker/mechanism		NA		12701101
IFT88	8100	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		9362446
IGBP1	3476	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21339737
IGBP1	3476	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21339737
IGBP1	3476	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		21339737
IGBP1	3476	Corpus Callosum, Agenesis of, with Mental Retardation, Ocular Coloboma, and Micrognathia	MESH:C564509	marker/mechanism		NA	300472	
IGBP1	3476	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		21339737
IGF1	3479	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
IGF1	3479	Acromegaly	MESH:D000172	marker/mechanism		NA		1682667|18381583|18388193|9186818
IGF1	3479	Acute Kidney Injury	MESH:D058186	therapeutic		NA		7540432
IGF1	3479	Adenoma	MESH:D000236	marker/mechanism		NA		1611713
IGF1	3479	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		15750215
IGF1	3479	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17547689
IGF1	3479	Bone Diseases, Metabolic	MESH:D001851	therapeutic		NA		11014614
IGF1	3479	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17520698|18398872
IGF1	3479	Cachexia	MESH:D002100	marker/mechanism		NA		30782979
IGF1	3479	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
IGF1	3479	Cardiomegaly	MESH:D006332	marker/mechanism		NA		10547078
IGF1	3479	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		23639586|25226513
IGF1	3479	Cholestasis	MESH:D002779	therapeutic		NA		12826230
IGF1	3479	Colitis	MESH:D003092	marker/mechanism		NA		24782617
IGF1	3479	Corneal Diseases	MESH:D003316	therapeutic		NA		12824234
IGF1	3479	Crohn Disease	MESH:D003424	marker/mechanism		NA		19751734
IGF1	3479	Demyelinating Diseases	MESH:D003711	therapeutic		NA		9452187
IGF1	3479	Diabetes Mellitus, Experimental	MESH:D003921	therapeutic		NA		24632065
IGF1	3479	Diabetes Mellitus, Type 1	MESH:D003922	therapeutic		NA		24632065
IGF1	3479	Diabetic Cardiomyopathies	MESH:D058065	therapeutic		NA		11375343
IGF1	3479	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	therapeutic		NA		20064577
IGF1	3479	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
IGF1	3479	Female Urogenital Diseases	MESH:D052776	marker/mechanism		NA		16002989
IGF1	3479	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		10370016
IGF1	3479	Hyperalgesia	MESH:D006930	therapeutic		NA		9452187
IGF1	3479	Hypertension	MESH:D006973	marker/mechanism|therapeutic		NA		19502719|22228705
IGF1	3479	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		25257527
IGF1	3479	Insulin-Like Growth Factor I Deficiency	MESH:C563867	marker/mechanism		NA	608747	
IGF1	3479	Kidney Diseases	MESH:D007674	therapeutic		NA		8825380
IGF1	3479	Kidney Failure, Chronic	MESH:D007676	therapeutic		NA		10198369
IGF1	3479	Liver Cirrhosis, Experimental	MESH:D008106	therapeutic		NA		15591519|15745444
IGF1	3479	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		15217511|15528971|17584969
IGF1	3479	Muscular Atrophy	MESH:D009133	therapeutic		NA		18467435
IGF1	3479	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
IGF1	3479	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		18398872
IGF1	3479	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		18398872
IGF1	3479	Nerve Degeneration	MESH:D009410	therapeutic		NA		10203697|9452187
IGF1	3479	Peripheral Nervous System Diseases	MESH:D010523	therapeutic		NA		8866126|9452187
IGF1	3479	Pituitary Neoplasms	MESH:D010911	marker/mechanism		NA		1611713
IGF1	3479	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16465378|19208208|24586243
IGF1	3479	Puberty, Precocious	MESH:D011629	marker/mechanism		NA		21402727
IGF1	3479	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		15286697
IGF1	3479	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		24353828
IGF1	3479	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		30594912
IGF1	3479	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		19415693
IGF1R	3480	Adrenocortical Carcinoma	MESH:D018268	marker/mechanism		NA		22407999
IGF1R	3480	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		15750215
IGF1R	3480	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
IGF1R	3480	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
IGF1R	3480	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21057462
IGF1R	3480	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		17441810|23958494
IGF1R	3480	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		23748240
IGF1R	3480	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		21442237
IGF1R	3480	Fetal Growth Retardation	MESH:D005317	marker/mechanism		NA		14657428
IGF1R	3480	Growth Disorders	MESH:D006130	marker/mechanism		NA		14657428
IGF1R	3480	Hernias, Diaphragmatic, Congenital	MESH:D065630	marker/mechanism		NA		20620343|21433279
IGF1R	3480	Insulin-Like Growth Factor I, Resistance To	MESH:C564816	marker/mechanism		NA	270450	
IGF1R	3480	Lewy Body Disease	MESH:D020961	marker/mechanism		NA		19276553
IGF1R	3480	Lung Diseases	MESH:D008171	marker/mechanism		NA		20620343|21433279
IGF1R	3480	Parkinson Disease	MESH:D010300	marker/mechanism		NA		19276553
IGF1R	3480	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		20864405
IGF1R	3480	Respiratory Insufficiency	MESH:D012131	marker/mechanism		NA		20620343
IGF1R	3480	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		10365914
IGF2	3481	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
IGF2	3481	Adrenocortical Carcinoma	MESH:D018268	marker/mechanism		NA		21521927|23417626
IGF2	3481	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		15750215
IGF2	3481	Anemia	MESH:D000740	therapeutic		NA		12090760
IGF2	3481	Atherosclerosis	MESH:D050197	marker/mechanism		NA		11726660
IGF2	3481	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17547689
IGF2	3481	Beckwith-Wiedemann Syndrome	MESH:D001506	marker/mechanism		NA	130650	8252039|9349812
IGF2	3481	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		9349812
IGF2	3481	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		12532445|16092956
IGF2	3481	Cognition Disorders	MESH:D003072	therapeutic		NA		21270887
IGF2	3481	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15057734
IGF2	3481	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		12637750
IGF2	3481	Fetal Growth Retardation	MESH:D005317	marker/mechanism		NA		12087403|16040806
IGF2	3481	Growth Disorders	MESH:D006130	marker/mechanism		NA		9349812
IGF2	3481	Hepatoblastoma	MESH:D018197	marker/mechanism		NA		23958494
IGF2	3481	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		10370016
IGF2	3481	Hypoglycemia	MESH:D007003	marker/mechanism		NA		3185662
IGF2	3481	Lewy Body Disease	MESH:D020961	marker/mechanism		NA		19276553
IGF2	3481	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		12127304
IGF2	3481	Memory Disorders	MESH:D008569	therapeutic		NA		21270887
IGF2	3481	Nerve Degeneration	MESH:D009410	therapeutic		NA		24667322
IGF2	3481	Obesity	MESH:D009765	marker/mechanism		NA		11528401
IGF2	3481	Parkinson Disease	MESH:D010300	marker/mechanism		NA		19276553
IGF2	3481	Placenta Diseases	MESH:D010922	marker/mechanism		NA		12087403
IGF2	3481	Polyhydramnios	MESH:D006831	marker/mechanism		NA		9349812
IGF2	3481	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		16092956
IGF2	3481	Rhabdomyosarcoma	MESH:D012208	marker/mechanism		NA		7981680
IGF2	3481	Silver-Russell Syndrome	MESH:D056730	marker/mechanism		NA	180860|616489	19066168
IGF2	3481	Wilms Tumor	MESH:D009396	marker/mechanism		NA	194070	8252039
IGF2BP1	10642	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
IGF2BP2	10644	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA	125853	
IGF2BP3	10643	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
IGF2BP3	10643	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
IGF2BP3	10643	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		23621518
IGF2BP3	10643	Peritoneal Neoplasms	MESH:D010534	marker/mechanism		NA		23621518
IGF2R	3482	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		15750215
IGF2R	3482	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA	114550	15057872
IGF2R	3482	Endomyocardial Fibrosis	MESH:D004719	marker/mechanism		NA		30450786
IGF2R	3482	Hernias, Diaphragmatic, Congenital	MESH:D065630	marker/mechanism		NA		20620343|21433279
IGF2R	3482	Lewy Body Disease	MESH:D020961	marker/mechanism		NA		19276553
IGF2R	3482	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
IGF2R	3482	Lung Diseases	MESH:D008171	marker/mechanism		NA		20620343|21433279
IGF2R	3482	Parkinson Disease	MESH:D010300	marker/mechanism		NA		19276553
IGF2R	3482	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
IGF2R	3482	Ventricular Dysfunction	MESH:D018754	marker/mechanism		NA		30450786
IGFALS	3483	ACID-LABILE SUBUNIT DEFICIENCY	OMIM:615961	marker/mechanism		NA	615961	
IGFALS	3483	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
IGFALS	3483	Growth Disorders	MESH:D006130	marker/mechanism		NA		14762184|17726072
IGFALS	3483	Insulin Resistance	MESH:D007333	marker/mechanism		NA		17726072
IGFALS	3483	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
IGFALS	3483	Puberty, Delayed	MESH:D011628	marker/mechanism		NA		14762184|17726072
IGFBP1	3484	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
IGFBP1	3484	Acute Kidney Injury	MESH:D058186	therapeutic		NA		7540432
IGFBP1	3484	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
IGFBP1	3484	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		15805072
IGFBP1	3484	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
IGFBP1	3484	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		26396155
IGFBP1	3484	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		18422935
IGFBP1	3484	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980|25380136
IGFBP1	3484	Precancerous Conditions	MESH:D011230	therapeutic		NA		12619036
IGFBP2	3485	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
IGFBP2	3485	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
IGFBP2	3485	Insulin Resistance	MESH:D007333	marker/mechanism		NA		22537059
IGFBP2	3485	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		26396155
IGFBP2	3485	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980|25380136
IGFBP2	3485	Obesity	MESH:D009765	marker/mechanism		NA		22537059
IGFBP2	3485	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
IGFBP3	3486	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
IGFBP3	3486	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		17379860
IGFBP3	3486	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17547689
IGFBP3	3486	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		21347663
IGFBP3	3486	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		21278247
IGFBP3	3486	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
IGFBP3	3486	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
IGFBP3	3486	Prostatic Neoplasms	MESH:D011471	marker/mechanism|therapeutic		NA		15318950|16000583|24586243
IGFBP3	3486	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
IGFBP3	3486	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		21347663
IGFBP5	3488	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20354179
IGFBP5	3488	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		26039340
IGFBP5	3488	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
IGFBP6	3489	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
IGFBP6	3489	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
IGFBP6	3489	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
IGFBP6	3489	Prostatic Neoplasms	MESH:D011471	therapeutic		NA		15846301
IGFBP6	3489	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
IGFBP7	3490	Breast Neoplasms	MESH:D001943	therapeutic		NA		12592389
IGFBP7	3490	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
IGFBP7	3490	Prostatic Neoplasms	MESH:D011471	therapeutic		NA		12592389
IGFBP7	3490	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
IGG1C	404060	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
IGG-2A	367586	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		28885000
IGG-2A	367586	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		28885000
IGG-2A	367586	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
IGH-6	299357	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
IGHG1	3500	Myositis	MESH:D009220	marker/mechanism		NA		18821675
IGHG1	3500	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
IGHG2	3501	Myositis	MESH:D009220	marker/mechanism		NA		18821675
IGHM	3507	Agammaglobulinemia	MESH:D000361	marker/mechanism		NA	601495	
IGHMBP2	3508	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S	OMIM:616155	marker/mechanism		NA	616155	
IGHMBP2	3508	Spinal muscular atrophy with respiratory distress 1	MESH:C536880	marker/mechanism		NA	604320	
IGHV3-21	28444	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		15817677
IGKC	3514	Dysgammaglobulinemia	MESH:D004406	marker/mechanism		NA		3931219
IGKC	3514	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
IGKC	3514	IMMUNOGLOBULIN KAPPA LIGHT CHAIN DEFICIENCY	OMIM:614102	marker/mechanism		NA	614102	
IGKC	3514	Myositis	MESH:D009220	marker/mechanism		NA		18821675
IGLL1	3543	Agammaglobulinemia	MESH:D000361	marker/mechanism		NA	613500	
IGSF1	3547	Congenital Hypothyroidism	MESH:D003409	marker/mechanism		NA		23143598
IGSF1	3547	HYPOTHYROIDISM, CENTRAL, WITH TESTICULAR ENLARGEMENT	OMIM:300888	marker/mechanism		NA	300888	
IGSF1	3547	Testicular Diseases	MESH:D013733	marker/mechanism		NA		23143598
IGSF21	84966	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		26039340
IGSF3	3321	Lacrimal Duct Obstruction	MESH:D007767	marker/mechanism		NA	149700	
IGSF5	150084	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
IGSF6	10261	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		16033404
IGSF6	10261	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
IHH	3549	Acrocapitofemoral Dysplasia	MESH:C564334	marker/mechanism		NA	607778	
IHH	3549	Brachydactyly type A1	MESH:C537088	marker/mechanism		NA	112500	
IHH	3549	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
IHH	3549	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
IHH	3549	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
IKBKB	3551	Glucose Intolerance	MESH:D018149	therapeutic		NA		31095431
IKBKB	3551	Hyperbilirubinemia, Neonatal	MESH:D051556	marker/mechanism		NA		28167773
IKBKB	3551	Hypertension	MESH:D006973	marker/mechanism		NA		27659729|32147540
IKBKB	3551	IMMUNODEFICIENCY 15B	OMIM:615592	marker/mechanism		NA	615592	
IKBKB	3551	Inflammation	MESH:D007249	marker/mechanism		NA		29036520
IKBKB	3551	Insulin Resistance	MESH:D007333	marker/mechanism		NA		29036520
IKBKB	3551	Pneumonia	MESH:D011014	marker/mechanism		NA		31095431
IKBKB	3551	Vascular Diseases	MESH:D014652	marker/mechanism		NA		29036520
IKBKG	8517	Ectodermal dysplasia, hypohidrotic, with immune deficiency	MESH:C536181	marker/mechanism		NA	300291	
IKBKG	8517	Incontinentia Pigmenti	MESH:D007184	marker/mechanism		NA	308300	
IKBKG	8517	Invasive Pneumococcal Disease, Recurrent Isolated, 2	MESH:C564468	marker/mechanism		NA	300636	
IKBKG	8517	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		30737368
IKBKG	8517	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		30737368
IKBKG	8517	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17114358
IKBKG	8517	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		21115542
IKZF1	10320	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		20228799
IKZF1	10320	Common Variable Immunodeficiency	MESH:D017074	marker/mechanism		NA	616873	
IKZF1	10320	Gastro-enteropancreatic neuroendocrine tumor	MESH:C535650	marker/mechanism		NA		29915428
IKZF1	10320	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		19838193
IKZF1	10320	Lymphoma	MESH:D008223	marker/mechanism		NA		11980663
IKZF1	10320	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D015452	marker/mechanism		NA		24141364
IKZF1	10320	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		19684604
IKZF2	22807	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		26437031
IKZF2	22807	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		23334668
IKZF3	22806	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		23143596
IKZF3	22806	Asthma	MESH:D001249	marker/mechanism		NA		25256354
IKZF3	22806	Gastro-enteropancreatic neuroendocrine tumor	MESH:C535650	marker/mechanism		NA		29915428
IKZF3	22806	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		23334668
IKZF4	64375	Alopecia Areata	MESH:D000506	marker/mechanism		NA		20596022
IKZF4	64375	Vitiligo	MESH:D014820	marker/mechanism		NA		22561518
IL10	3586	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		18460982
IL10	3586	Appendicitis	MESH:D001064	marker/mechanism		NA		16367942
IL10	3586	Arthritis, Experimental	MESH:D001169	marker/mechanism|therapeutic		NA		20974942|22450443
IL10	3586	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA	180300	22450443
IL10	3586	Asthma	MESH:D001249	marker/mechanism		NA		29317916
IL10	3586	Autistic Disorder	MESH:D001321	marker/mechanism		NA		16360218
IL10	3586	Behcet Syndrome	MESH:D001528	marker/mechanism		NA		20622878|20622879
IL10	3586	Brain Injuries	MESH:D001930	marker/mechanism		NA		21549006
IL10	3586	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29582634
IL10	3586	Burns	MESH:D002056	marker/mechanism		NA		18277951
IL10	3586	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		20471133
IL10	3586	Colitis	MESH:D003092	marker/mechanism|therapeutic		NA		19238344|21807089|22119709|24314293
IL10	3586	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		18836448|20228799
IL10	3586	COVID-19	MESH:C000657245	marker/mechanism		NA		31986264|32161940
IL10	3586	Crohn Disease	MESH:D003424	marker/mechanism		NA		21102463
IL10	3586	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		15347381
IL10	3586	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		18249437
IL10	3586	Dermatitis, Occupational	MESH:D009783	marker/mechanism		NA		29477354
IL10	3586	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		19430480
IL10	3586	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27580383|28411859
IL10	3586	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		19222424|20485159
IL10	3586	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		31557154
IL10	3586	Endometriosis	MESH:D004715	marker/mechanism		NA		30579999
IL10	3586	Entamoebiasis	MESH:D004749	marker/mechanism		NA		16374615
IL10	3586	Enterocolitis	MESH:D004760	marker/mechanism		NA		17574631
IL10	3586	Gastro-enteropancreatic neuroendocrine tumor	MESH:C535650	marker/mechanism		NA		29915428
IL10	3586	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		19222424
IL10	3586	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		10910440
IL10	3586	Graft vs Host Disease	MESH:D006086	marker/mechanism		NA	614395	
IL10	3586	Heat Stroke	MESH:D018883	marker/mechanism		NA		24039931
IL10	3586	Hepatitis, Autoimmune	MESH:D019693	marker/mechanism		NA		21227906
IL10	3586	Hepatolenticular Degeneration	MESH:D006527	marker/mechanism		NA		25002079
IL10	3586	HIV Infections	MESH:D015658	marker/mechanism		NA	609423	10202824
IL10	3586	Hyperalgesia	MESH:D006930	marker/mechanism|therapeutic		NA		17174526|7582491
IL10	3586	Hypersensitivity, Immediate	MESH:D006969	marker/mechanism		NA		20485159
IL10	3586	Ileitis	MESH:D007079	marker/mechanism		NA		27580383
IL10	3586	Inflammation	MESH:D007249	marker/mechanism		NA		11181422
IL10	3586	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA		23291587|27783946|28411859
IL10	3586	Irritable Bowel Syndrome	MESH:D043183	marker/mechanism		NA		12404228
IL10	3586	Leishmaniasis	MESH:D007896	marker/mechanism		NA		16540374|20404924
IL10	3586	Leishmaniasis, Cutaneous	MESH:D016773	marker/mechanism		NA		20102417
IL10	3586	Leishmaniasis, Visceral	MESH:D007898	marker/mechanism		NA		15716043|17404324|22461696
IL10	3586	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		23962110
IL10	3586	Liver Cirrhosis, Experimental	MESH:D008106	therapeutic		NA		12632514|15362042|16097045|16126171|16539848|16552806|16609999|16688825|18251166
IL10	3586	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		14587096
IL10	3586	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		19838195|20728533
IL10	3586	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		14999141
IL10	3586	Mucositis	MESH:D052016	marker/mechanism		NA		20881642
IL10	3586	Multiple Organ Failure	MESH:D009102	therapeutic		NA		10479408
IL10	3586	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		23517930
IL10	3586	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		15883752|16310260
IL10	3586	Pleurisy	MESH:D010998	marker/mechanism		NA		11181422
IL10	3586	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16284379|17999153|18174250
IL10	3586	Prostatitis	MESH:D011472	marker/mechanism		NA		12050565
IL10	3586	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		18460982
IL10	3586	Sepsis	MESH:D018805	therapeutic		NA		11441115
IL10	3586	Weight Loss	MESH:D015431	marker/mechanism|therapeutic		NA		24314293|27580383
IL10RA	3587	Inflammatory Bowel Disease 28, Autosomal Recessive	MESH:C567728	marker/mechanism		NA	613148	
IL10RA	3587	Leishmaniasis, Visceral	MESH:D007898	therapeutic		NA		15716043
IL10RB	3588	Brain Ischemia	MESH:D002545	marker/mechanism		NA		15829914
IL10RB	3588	Hepatitis B	MESH:D006509	marker/mechanism		NA	610424	
IL10RB	3588	Inflammatory Bowel Disease 25, Autosomal Recessive	MESH:C567251	marker/mechanism		NA	612567	
IL11	3589	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
IL11	3589	Chemical and Drug Induced Liver Injury	MESH:D056486	therapeutic		NA		11421492
IL11	3589	Cystitis	MESH:D003556	therapeutic		NA		17980069
IL11	3589	Edema	MESH:D004487	therapeutic		NA		17980069
IL11	3589	Hemorrhage	MESH:D006470	therapeutic		NA		17980069
IL11	3589	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		25257527
IL11	3589	Liver Diseases	MESH:D008107	therapeutic		NA		16964402
IL11	3589	Osteoarthritis, Hip	MESH:D015207	marker/mechanism		NA		30374069|30664745
IL11RA	3590	CRANIOSYNOSTOSIS AND DENTAL ANOMALIES	OMIM:614188	marker/mechanism		NA	614188	
IL11RA	3590	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		11161848
IL11RA1	16157	Heat Stroke	MESH:D018883	marker/mechanism		NA		24039931
IL12A	3592	Glioma	MESH:D005910	therapeutic		NA		18176109
IL12A	3592	Hypothermia	MESH:D007035	marker/mechanism		NA		16369138
IL12A	3592	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		20639880
IL12A	3592	Liver Neoplasms	MESH:D008113	therapeutic		NA		17326190
IL12A	3592	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		24076602
IL12A	3592	Neoplasms, Experimental	MESH:D009374	therapeutic		NA		17332360
IL12A	3592	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		16526316
IL12A	3592	Sjogren's Syndrome	MESH:D012859	marker/mechanism		NA		24097067
IL12A-AS1	101928376	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		29059373
IL12B	3593	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
IL12B	3593	Arthritis, Psoriatic	MESH:D015535	marker/mechanism		NA		20953186
IL12B	3593	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		18438406|20228799|21297633
IL12B	3593	Crohn Disease	MESH:D003424	marker/mechanism		NA		18438406
IL12B	3593	Glioma	MESH:D005910	therapeutic		NA		18176109
IL12B	3593	Hypothermia	MESH:D007035	marker/mechanism		NA		16369138
IL12B	3593	IMMUNODEFICIENCY 29	OMIM:614890	marker/mechanism		NA	614890	
IL12B	3593	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		20639880
IL12B	3593	Liver Neoplasms	MESH:D008113	therapeutic		NA		17326190
IL12B	3593	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		19838195|26808113
IL12B	3593	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25162674
IL12B	3593	Neoplasms, Experimental	MESH:D009374	therapeutic		NA		17332360
IL12B	3593	Neuralgia	MESH:D009437	marker/mechanism		NA		31432094
IL12B	3593	Psoriasis	MESH:D011565	marker/mechanism		NA		19169254|19169255|20953190
IL12B	3593	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		12193738
IL12B	3593	Spondylitis, Ankylosing	MESH:D013167	marker/mechanism		NA		21743469
IL12RB1	3594	Brain Ischemia	MESH:D002545	marker/mechanism		NA		15829914
IL12RB1	3594	IMMUNODEFICIENCY 30	OMIM:614891	marker/mechanism		NA	614891	
IL12RB2	3595	Brain Injuries	MESH:D001930	marker/mechanism		NA		23159883
IL13	3596	Arthritis, Experimental	MESH:D001169	therapeutic		NA		10444273
IL13	3596	Asthma	MESH:D001249	marker/mechanism		NA	600807	22867017
IL13	3596	Autistic Disorder	MESH:D001321	marker/mechanism		NA		16360218
IL13	3596	Bronchial Hyperreactivity	MESH:D016535	marker/mechanism		NA		12654629|23434795
IL13	3596	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		22317767
IL13	3596	Dermatitis	MESH:D003872	marker/mechanism		NA		31330126
IL13	3596	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		18249437|22355542
IL13	3596	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		20485159
IL13	3596	Hepatitis, Autoimmune	MESH:D019693	marker/mechanism		NA		21227906
IL13	3596	Hyperplasia	MESH:D006965	marker/mechanism		NA		19342650
IL13	3596	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
IL13	3596	Hypersensitivity, Immediate	MESH:D006969	marker/mechanism		NA		20485159|22967010
IL13	3596	Inflammation	MESH:D007249	marker/mechanism		NA		22867017
IL13	3596	Lung Diseases	MESH:D008171	marker/mechanism		NA		22355542
IL13	3596	Metaplasia	MESH:D008679	marker/mechanism		NA		21203431
IL13	3596	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
IL13	3596	Psoriasis	MESH:D011565	marker/mechanism		NA		19169254|20953190
IL13	3596	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		15322207
IL13	3596	Rhinitis, Allergic	MESH:D065631	marker/mechanism		NA	607154	
IL13	3596	Sinusitis	MESH:D012852	marker/mechanism		NA		20358028
IL13RA1	3597	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		30718926
IL13RA2	3598	Brain Injuries	MESH:D001930	marker/mechanism		NA		23159883
IL15	3600	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18929414
IL15	3600	Celiac Disease	MESH:D002446	marker/mechanism		NA		23269601
IL15	3600	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
IL15	3600	Polyomavirus Infections	MESH:D027601	marker/mechanism		NA		25162674
IL15	3600	Respiratory Hypersensitivity	MESH:D012130	marker/mechanism		NA		18394133
IL16	3603	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
IL16	3603	Hypersensitivity	MESH:D006967	marker/mechanism		NA		23624239
IL16	3603	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		18264096
IL17A	3605	Acute Lung Injury	MESH:D055371	marker/mechanism		NA		28600744
IL17A	3605	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		20974942
IL17A	3605	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		21227906
IL17A	3605	Brain Ischemia	MESH:D002545	marker/mechanism		NA		15829914
IL17A	3605	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		29114965
IL17A	3605	Central Nervous System Diseases	MESH:D002493	marker/mechanism		NA		19940258
IL17A	3605	Cerebrovascular Disorders	MESH:D002561	marker/mechanism		NA		29114965
IL17A	3605	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		19633216|24949944
IL17A	3605	Colitis	MESH:D003092	marker/mechanism		NA		24548422
IL17A	3605	Drug Eruptions	MESH:D003875	marker/mechanism		NA		31150805
IL17A	3605	Graft vs Host Disease	MESH:D006086	marker/mechanism		NA		22077062
IL17A	3605	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
IL17A	3605	Inflammation	MESH:D007249	marker/mechanism		NA		22617429
IL17A	3605	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		22617429
IL17A	3605	Lymphoproliferative Disorders	MESH:D008232	marker/mechanism		NA		22617429
IL17A	3605	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		23517930
IL17A	3605	Necrosis	MESH:D009336	marker/mechanism		NA		24949944
IL17A	3605	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
IL17A	3605	Pulmonary Edema	MESH:D011654	marker/mechanism		NA		28600744
IL17F	112744	CANDIDIASIS, FAMILIAL, 6	OMIM:613956	marker/mechanism		NA	613956	
IL17RA	23765	Brain Ischemia	MESH:D002545	marker/mechanism		NA		15829914
IL17RA	23765	IMMUNODEFICIENCY 51	OMIM:613953	marker/mechanism		NA	613953	
IL17RA	23765	Inflammation	MESH:D007249	marker/mechanism		NA		29724254
IL17RC	84818	CANDIDIASIS, FAMILIAL, 9	OMIM:616445	marker/mechanism		NA	616445	
IL17RC	84818	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17603628
IL17RD	54756	Brain Injuries	MESH:D001930	marker/mechanism		NA		23159883
IL17RD	54756	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
IL17RD	54756	HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA	OMIM:615267	marker/mechanism		NA	615267	
IL17RD	54756	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16474841
IL17REL	400935	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		20228798
IL18	3606	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		16368150
IL18	3606	Brain Ischemia	MESH:D002545	marker/mechanism		NA		15829914
IL18	3606	Calcinosis	MESH:D002114	marker/mechanism		NA		21335463
IL18	3606	Cardiomegaly	MESH:D006332	marker/mechanism		NA		18660453
IL18	3606	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		19164858
IL18	3606	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		27585668
IL18	3606	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
IL18	3606	Drug Eruptions	MESH:D003875	marker/mechanism		NA		18204966
IL18	3606	Glomerulonephritis	MESH:D005921	therapeutic		NA		18462998
IL18	3606	Heart Valve Diseases	MESH:D006349	marker/mechanism		NA		21335463
IL18	3606	Hepatitis, Autoimmune	MESH:D019693	marker/mechanism		NA		21227906
IL18	3606	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
IL18	3606	Hypersensitivity, Immediate	MESH:D006969	marker/mechanism		NA		22967010
IL18	3606	Leishmaniasis	MESH:D007896	marker/mechanism		NA		16879623
IL18	3606	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
IL18	3606	Metabolic Syndrome	MESH:D024821	marker/mechanism		NA		16644639
IL18	3606	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		24349532
IL18	3606	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		12748951
IL18	3606	Neoplasms	MESH:D009369	therapeutic		NA		21273262
IL18	3606	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
IL18	3606	Polyomavirus Infections	MESH:D027601	marker/mechanism		NA		25162674
IL18	3606	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17688413
IL18	3606	Radiation Injuries, Experimental	MESH:D011833	marker/mechanism		NA		11121210
IL18	3606	Sarcoidosis	MESH:D012507	marker/mechanism		NA		16100009
IL18	3606	Urticaria	MESH:D014581	marker/mechanism		NA		18204966
IL18BP	10068	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
IL18R1	8809	Brain Injuries	MESH:D001930	marker/mechanism		NA		23159883
IL18RAP	8807	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		20228799
IL18RAP	8807	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA		21983784
IL19	29949	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		19430480
IL19	29949	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		18006695
IL19	29949	Renal Insufficiency, Chronic	MESH:D051436	marker/mechanism		NA		24714768
IL1A	3552	Amnesia	MESH:D000647	therapeutic		NA		8003924
IL1A	3552	Anthracosis	MESH:D055008	marker/mechanism		NA		20005085
IL1A	3552	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
IL1A	3552	Brain Injuries	MESH:D001930	marker/mechanism		NA		21549006
IL1A	3552	Brain Ischemia	MESH:D002545	marker/mechanism		NA		15829914
IL1A	3552	Burns	MESH:D002056	marker/mechanism		NA		10431976
IL1A	3552	Burns, Chemical	MESH:D002057	marker/mechanism		NA		22533443
IL1A	3552	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		7979221
IL1A	3552	Chemical and Drug Induced Liver Injury	MESH:D056486	therapeutic		NA		8218930
IL1A	3552	Chondrosarcoma, Mesenchymal	MESH:D018211	marker/mechanism		NA		12817616
IL1A	3552	Chorioamnionitis	MESH:D002821	marker/mechanism		NA		21493953
IL1A	3552	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		23178550
IL1A	3552	Dermatomyositis	MESH:D003882	marker/mechanism		NA		19035492
IL1A	3552	Diarrhea	MESH:D003967	marker/mechanism		NA		9278552
IL1A	3552	Disease Progression	MESH:D018450	marker/mechanism		NA		27738319
IL1A	3552	Fever	MESH:D005334	marker/mechanism		NA		15384034
IL1A	3552	Heat Stroke	MESH:D018883	marker/mechanism		NA		24039931
IL1A	3552	Hemolytic-Uremic Syndrome	MESH:D006463	marker/mechanism		NA		15384034
IL1A	3552	HIV Wasting Syndrome	MESH:D019247	marker/mechanism		NA		7979221
IL1A	3552	Hyperalgesia	MESH:D006930	marker/mechanism		NA		12727271
IL1A	3552	Hypotension	MESH:D007022	marker/mechanism		NA		15384034
IL1A	3552	Inflammation	MESH:D007249	marker/mechanism		NA		21467745|22163019
IL1A	3552	Kearns-Sayre Syndrome	MESH:D007625	marker/mechanism		NA		7979221
IL1A	3552	MELAS Syndrome	MESH:D017241	marker/mechanism		NA		7979221
IL1A	3552	MERRF Syndrome	MESH:D017243	marker/mechanism		NA		7979221
IL1A	3552	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25162674
IL1A	3552	Mitochondrial Myopathies	MESH:D017240	marker/mechanism		NA		7979221
IL1A	3552	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
IL1A	3552	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		21664615
IL1A	3552	Ophthalmoplegia, Chronic Progressive External	MESH:D017246	marker/mechanism		NA		7979221
IL1A	3552	Optic Atrophy, Hereditary, Leber	MESH:D029242	marker/mechanism		NA		7979221
IL1A	3552	Polymyositis	MESH:D017285	marker/mechanism		NA		7979221
IL1A	3552	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		23875703
IL1A	3552	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338|22533443
IL1A	3552	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		8435107
IL1A	3552	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		27738319
IL1A	3552	Vitiligo	MESH:D014820	marker/mechanism		NA		28836394
IL1B	3553	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
IL1B	3553	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		19028472
IL1B	3553	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		18675847
IL1B	3553	Anorexia	MESH:D000855	marker/mechanism		NA		12077204|25392278
IL1B	3553	Anthracosis	MESH:D055008	marker/mechanism		NA		20005085
IL1B	3553	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
IL1B	3553	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		19330884|20131233|20974942|22450443
IL1B	3553	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		12566094|17379860|22450443
IL1B	3553	Asthma	MESH:D001249	marker/mechanism		NA		9176529
IL1B	3553	Brain Injuries	MESH:D001930	marker/mechanism		NA		19800810|21549006
IL1B	3553	Brain Injuries, Traumatic	MESH:D000070642	marker/mechanism		NA		28642177
IL1B	3553	Brain Ischemia	MESH:D002545	marker/mechanism		NA		15737438|15756928|17394460|9236716
IL1B	3553	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037|17516992|28212736
IL1B	3553	Bronchopulmonary Dysplasia	MESH:D001997	marker/mechanism		NA		16813970
IL1B	3553	Burns	MESH:D002056	marker/mechanism		NA		18277951
IL1B	3553	Burns, Chemical	MESH:D002057	marker/mechanism		NA		22533443
IL1B	3553	Calcinosis	MESH:D002114	marker/mechanism		NA		21335463
IL1B	3553	Cardiomegaly	MESH:D006332	marker/mechanism		NA		15302781
IL1B	3553	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		7979221
IL1B	3553	Cardiotoxicity	MESH:D066126	marker/mechanism		NA		32068018
IL1B	3553	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism|therapeutic		NA		19164858|28138970
IL1B	3553	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		28789951
IL1B	3553	Colitis	MESH:D003092	marker/mechanism		NA		23810507|24548422
IL1B	3553	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		12133438|15955209|20452301|22119283
IL1B	3553	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925|18987561|19028472
IL1B	3553	COVID-19	MESH:C000657245	marker/mechanism		NA		32171193
IL1B	3553	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		18249437
IL1B	3553	Dermatomyositis	MESH:D003882	marker/mechanism		NA		19035492
IL1B	3553	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		12123627
IL1B	3553	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27093858
IL1B	3553	Entamoebiasis	MESH:D004749	marker/mechanism		NA		16374615
IL1B	3553	Fever	MESH:D005334	marker/mechanism		NA		11852909|15384034|22143887|25164664|9952427
IL1B	3553	Fibrosis	MESH:D005355	therapeutic		NA		25388157
IL1B	3553	Gastritis, Atrophic	MESH:D005757	marker/mechanism		NA		19448967
IL1B	3553	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		22467534
IL1B	3553	Glioblastoma	MESH:D005909	marker/mechanism		NA		16356833
IL1B	3553	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		10910440|9403216
IL1B	3553	Gout	MESH:D006073	marker/mechanism		NA		26462562
IL1B	3553	Heart Failure	MESH:D006333	marker/mechanism		NA		15135663
IL1B	3553	Heart Valve Diseases	MESH:D006349	marker/mechanism		NA		21335463
IL1B	3553	Heat Stroke	MESH:D018883	marker/mechanism		NA		24039931
IL1B	3553	Hemolytic-Uremic Syndrome	MESH:D006463	marker/mechanism		NA		15384034
IL1B	3553	HIV Wasting Syndrome	MESH:D019247	marker/mechanism		NA		7979221
IL1B	3553	Hyperalgesia	MESH:D006930	marker/mechanism		NA		10401557|12727271|17320857|20937348|27093858|7582491
IL1B	3553	Hyperemia	MESH:D006940	marker/mechanism		NA		8846404
IL1B	3553	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
IL1B	3553	Hypertension	MESH:D006973	marker/mechanism		NA		27292124|27659729|27847271|32147540|32165127
IL1B	3553	Hypoglycemia	MESH:D007003	marker/mechanism		NA		1884014
IL1B	3553	Hypotension	MESH:D007022	marker/mechanism		NA		15384034|1884014
IL1B	3553	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		25257527
IL1B	3553	Inflammation	MESH:D007249	marker/mechanism		NA		11181422|16227999|21437948|21467745|22001142|23640035|24609059|28212736|9952427
IL1B	3553	Kearns-Sayre Syndrome	MESH:D007625	marker/mechanism		NA		7979221
IL1B	3553	Learning Disabilities	MESH:D007859	marker/mechanism		NA		21290410
IL1B	3553	Leishmaniasis, Cutaneous	MESH:D016773	marker/mechanism		NA		20102417
IL1B	3553	Leishmaniasis, Visceral	MESH:D007898	marker/mechanism		NA		17404324
IL1B	3553	Lethargy	MESH:D053609	marker/mechanism		NA		22143887
IL1B	3553	Leukocytosis	MESH:D007964	marker/mechanism		NA		1884014
IL1B	3553	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		16085334
IL1B	3553	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		22369883|28212736
IL1B	3553	Lymphopenia	MESH:D008231	marker/mechanism		NA		1884014
IL1B	3553	Manganese Poisoning	MESH:D020149	marker/mechanism		NA		18041089
IL1B	3553	MELAS Syndrome	MESH:D017241	marker/mechanism		NA		7979221
IL1B	3553	Memory Disorders	MESH:D008569	marker/mechanism		NA		21290410
IL1B	3553	MERRF Syndrome	MESH:D017243	marker/mechanism		NA		7979221
IL1B	3553	Mitochondrial Myopathies	MESH:D017240	marker/mechanism		NA		7979221
IL1B	3553	Mucositis	MESH:D052016	marker/mechanism		NA		20844880
IL1B	3553	Multiple Sclerosis	MESH:D009103	marker/mechanism|therapeutic		NA		15210533|25458313
IL1B	3553	Muscular Diseases	MESH:D009135	marker/mechanism		NA		9184656
IL1B	3553	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		11743230|15883752|16310260
IL1B	3553	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
IL1B	3553	Necrosis	MESH:D009336	marker/mechanism		NA		10631206|10903806|10909967
IL1B	3553	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		27567548
IL1B	3553	Neoplasms	MESH:D009369	marker/mechanism		NA		22467534
IL1B	3553	Neutropenia	MESH:D009503	marker/mechanism		NA		1884014
IL1B	3553	Ophthalmoplegia, Chronic Progressive External	MESH:D017246	marker/mechanism		NA		7979221
IL1B	3553	Optic Atrophy, Hereditary, Leber	MESH:D029242	marker/mechanism		NA		7979221
IL1B	3553	Osteoarthritis	MESH:D010003	marker/mechanism		NA		21954917
IL1B	3553	Osteoporosis, Postmenopausal	MESH:D015663	marker/mechanism		NA		9032749
IL1B	3553	Peptic Ulcer	MESH:D010437	marker/mechanism		NA		19448967
IL1B	3553	Pleurisy	MESH:D010998	marker/mechanism		NA		11181422
IL1B	3553	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
IL1B	3553	Polymyositis	MESH:D017285	marker/mechanism		NA		7979221
IL1B	3553	Psoriasis	MESH:D011565	marker/mechanism		NA		7744320
IL1B	3553	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		17266442|23640035
IL1B	3553	Pyogenic arthritis, pyoderma gangrenosum, and acne	MESH:C536253	marker/mechanism		NA		27106250
IL1B	3553	Radiation Injuries, Experimental	MESH:D011833	marker/mechanism		NA		11121210
IL1B	3553	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		10594344|12468449|15829914|19058328|19673871
IL1B	3553	Schizophrenia	MESH:D012559	marker/mechanism		NA		18583979
IL1B	3553	Seizures	MESH:D012640	marker/mechanism		NA		16824509
IL1B	3553	Silicosis	MESH:D012829	marker/mechanism		NA		23640035
IL1B	3553	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338|22533443
IL1B	3553	Sleep Wake Disorders	MESH:D012893	marker/mechanism		NA		17520785
IL1B	3553	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA	137215	15492468|19584167|22414649
IL1B	3553	Stomach Ulcer	MESH:D013276	marker/mechanism		NA		11376495
IL1B	3553	Stroke	MESH:D020521	marker/mechanism		NA		10950380
IL1B	3553	Subarachnoid Hemorrhage	MESH:D013345	marker/mechanism		NA		27157545
IL1B	3553	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		26037280
IL1B	3553	Trigeminal Neuralgia	MESH:D014277	marker/mechanism		NA		27093858
IL1B	3553	Urticaria	MESH:D014581	marker/mechanism		NA		12121561
IL1R1	3554	Brain Injuries	MESH:D001930	marker/mechanism		NA		21549006
IL1R1	3554	Burns, Chemical	MESH:D002057	marker/mechanism		NA		22533443
IL1R1	3554	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642|21063030
IL1R1	3554	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
IL1R1	3554	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
IL1R1	3554	Skin Diseases	MESH:D012871	marker/mechanism		NA		22533443
IL1R2	7850	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		17984051
IL1R2	7850	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		21297633
IL1R2	7850	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
IL1R2	7850	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
IL1R2	7850	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
IL1R2	7850	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
IL1R2	7850	Spondylitis, Ankylosing	MESH:D013167	marker/mechanism		NA		20062062
IL1RAP	3556	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
IL1RAP	3556	Disease Progression	MESH:D018450	marker/mechanism		NA		27738319
IL1RAP	3556	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
IL1RAP	3556	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		27738319
IL1RAPL1	11141	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		20479760
IL1RAPL1	11141	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18801879|20437600
IL1RAPL1	11141	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
IL1RAPL1	11141	Mental Retardation, X-Linked	MESH:D038901	marker/mechanism		NA		18801879
IL1RAPL1	11141	MENTAL RETARDATION, X-LINKED 21	OMIM:300143	marker/mechanism		NA	300143	
IL1RL1	9173	Acute Lung Injury	MESH:D055371	therapeutic		NA		21352201
IL1RL1	9173	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		20472598
IL1RL1	9173	Asthma	MESH:D001249	marker/mechanism		NA		19198610|21150878|21804549|24241537|27472835
IL1RN	3557	Anorexia	MESH:D000855	therapeutic		NA		25392278
IL1RN	3557	Anthracosis	MESH:D055008	marker/mechanism		NA		20005085
IL1RN	3557	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
IL1RN	3557	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
IL1RN	3557	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism|therapeutic		NA		19192274|7706905
IL1RN	3557	Asthma	MESH:D001249	marker/mechanism		NA		9176529
IL1RN	3557	Atrophy	MESH:D001284	therapeutic		NA		7637259
IL1RN	3557	Autistic Disorder	MESH:D001321	marker/mechanism		NA		11803234
IL1RN	3557	Brain Injuries	MESH:D001930	therapeutic		NA		25665855
IL1RN	3557	Brain Ischemia	MESH:D002545	therapeutic		NA		9236716
IL1RN	3557	Bronchial Hyperreactivity	MESH:D016535	therapeutic		NA		14754758
IL1RN	3557	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
IL1RN	3557	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		29114965
IL1RN	3557	Cerebrovascular Disorders	MESH:D002561	marker/mechanism		NA		29114965
IL1RN	3557	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		18987561
IL1RN	3557	Diarrhea	MESH:D003967	therapeutic		NA		20844880
IL1RN	3557	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		31557154
IL1RN	3557	Exanthema	MESH:D005076	therapeutic		NA		16096327
IL1RN	3557	Extravasation of Diagnostic and Therapeutic Materials	MESH:D005119	marker/mechanism		NA		7706905
IL1RN	3557	Fever	MESH:D005334	therapeutic		NA		16096327
IL1RN	3557	Fibrosis	MESH:D005355	therapeutic		NA		7637259
IL1RN	3557	Gout	MESH:D006073	therapeutic		NA		18403674
IL1RN	3557	Hyperalgesia	MESH:D006930	marker/mechanism|therapeutic		NA		15317861|17174526|20937348|8864563
IL1RN	3557	Inflammation	MESH:D007249	therapeutic		NA		25665855
IL1RN	3557	Kidney Diseases	MESH:D007674	therapeutic		NA		9370186
IL1RN	3557	Learning Disabilities	MESH:D007859	therapeutic		NA		25665855
IL1RN	3557	Liver Failure, Acute	MESH:D017114	therapeutic		NA		20644519
IL1RN	3557	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 4	OMIM:612628	marker/mechanism		NA	612628	
IL1RN	3557	Mucositis	MESH:D052016	therapeutic		NA		20844880
IL1RN	3557	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		25458313
IL1RN	3557	Myocardial Infarction	MESH:D009203	therapeutic		NA		18474815|19005744
IL1RN	3557	Myositis	MESH:D009220	marker/mechanism		NA		10886238
IL1RN	3557	Necrosis	MESH:D009336	therapeutic		NA		1838896|20644519
IL1RN	3557	Neoplasm Invasiveness	MESH:D009361	therapeutic		NA		27567548
IL1RN	3557	OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS	OMIM:612852	marker/mechanism		NA	612852	
IL1RN	3557	Pain	MESH:D010146	therapeutic		NA		15317861
IL1RN	3557	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16106254|16284379
IL1RN	3557	Proteinuria	MESH:D011507	therapeutic		NA		9370186
IL1RN	3557	Pulmonary Fibrosis	MESH:D011658	therapeutic		NA		18403674
IL1RN	3557	Schnitzler Syndrome	MESH:D019873	therapeutic		NA		16096327
IL1RN	3557	Sclerosis	MESH:D012598	therapeutic		NA		7637259
IL1RN	3557	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338|7706905
IL1RN	3557	Status Epilepticus	MESH:D013226	therapeutic		NA		19010416
IL1RN	3557	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA	137215	
IL1RN	3557	Stroke	MESH:D020521	marker/mechanism		NA		12374626
IL2	3558	Acquired Immunodeficiency Syndrome	MESH:D000163	therapeutic		NA		9861562
IL2	3558	Amnesia	MESH:D000647	marker/mechanism		NA		8241462
IL2	3558	Anemia	MESH:D000740	therapeutic		NA		7678812
IL2	3558	Anorexia	MESH:D000855	marker/mechanism		NA		8635092
IL2	3558	Asthenia	MESH:D001247	marker/mechanism		NA		8635092
IL2	3558	Autistic Disorder	MESH:D001321	marker/mechanism		NA		16360218|18929414
IL2	3558	Brain Injuries	MESH:D001930	marker/mechanism		NA		23159883
IL2	3558	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		6319491
IL2	3558	COVID-19	MESH:C000657245	marker/mechanism		NA		31986264
IL2	3558	Depressive Disorder, Major	MESH:D003865	marker/mechanism		NA		12635532
IL2	3558	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		11312644|22245253
IL2	3558	Drug Eruptions	MESH:D003875	marker/mechanism		NA		31150805
IL2	3558	Entamoebiasis	MESH:D004749	marker/mechanism		NA		16374615
IL2	3558	Fever	MESH:D005334	marker/mechanism		NA		8635092
IL2	3558	Glioblastoma	MESH:D005909	therapeutic		NA		7719933
IL2	3558	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		10910440|9403216
IL2	3558	Hepatitis, Autoimmune	MESH:D019693	marker/mechanism		NA		21227906
IL2	3558	HIV Infections	MESH:D015658	marker/mechanism		NA		12878215
IL2	3558	Hyperkinesis	MESH:D006948	marker/mechanism		NA		8241462
IL2	3558	Hypotension	MESH:D007022	marker/mechanism		NA		8635092
IL2	3558	Kidney Neoplasms	MESH:D007680	therapeutic		NA		17105418|18298334|18625569|19409039
IL2	3558	Leukemia	MESH:D007938	therapeutic		NA		17500047
IL2	3558	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		23962110
IL2	3558	Leukopenia	MESH:D007970	therapeutic		NA		7678812
IL2	3558	Liver Neoplasms	MESH:D008113	therapeutic		NA		18298334
IL2	3558	Lung Neoplasms	MESH:D008175	therapeutic		NA		18298334|18625569|7614408
IL2	3558	Melanoma	MESH:D008545	therapeutic		NA		12374674|12439608|15577323|15917704|16131448|16248763|16260693|16432458|16809738|16939954|17023156|17105418|17576460|17709802|17761969|18176117|18281670|18298334|18332650|18999936|19243244|20423231
IL2	3558	Neoplasm Metastasis	MESH:D009362	therapeutic		NA		17105418
IL2	3558	Neoplasm, Residual	MESH:D018365	therapeutic		NA		14654953
IL2	3558	Neoplasms	MESH:D009369	therapeutic		NA		12579325
IL2	3558	Neoplasms, Experimental	MESH:D009374	therapeutic		NA		1949363|22306178|3495671
IL2	3558	Nephrotic Syndrome	MESH:D009404	marker/mechanism		NA		19242727
IL2	3558	Pain	MESH:D010146	therapeutic		NA		12421473
IL2	3558	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17115417
IL2	3558	Urinary Bladder Neoplasms	MESH:D001749	therapeutic		NA		1949363|3495671
IL2	3558	Vaginal Neoplasms	MESH:D014625	therapeutic		NA		15577323
IL20	50604	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		18496552
IL20	50604	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		19430480
IL20RA	53832	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
IL21	59067	Celiac Disease	MESH:D002446	marker/mechanism		NA		17558408
IL21	59067	Common Variable Immunodeficiency	MESH:D017074	marker/mechanism		NA	615767	
IL21	59067	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		17911475
IL21R	50615	Ige Responsiveness, Atopic	MESH:C564133	marker/mechanism		NA	147050	
IL21R	50615	IMMUNODEFICIENCY 56	OMIM:615207	marker/mechanism		NA	615207	
IL21R	50615	Lupus Erythematosus, Systemic	MESH:D008180	therapeutic		NA		17911475
IL22	50616	Chemical and Drug Induced Liver Injury	MESH:D056486	therapeutic		NA		15122762|16212920|23375450
IL22	50616	Hepatitis, Autoimmune	MESH:D019693	marker/mechanism		NA		21227906
IL22	50616	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		25257527
IL23A	51561	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		19192274
IL23A	51561	Psoriasis	MESH:D011565	marker/mechanism		NA		19169254|20953190
IL23R	149233	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		18438406|19122664|20228799
IL23R	149233	Crohn Disease	MESH:D003424	marker/mechanism		NA		17435756|18438406
IL23R	149233	Inflammatory Bowel Disease 17	MESH:C567378	marker/mechanism		NA	612261	
IL23R	149233	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA		21983784|23291587|26192919
IL23R	149233	Leprosy	MESH:D007918	marker/mechanism		NA		22019778
IL23R	149233	Psoriasis	MESH:D011565	marker/mechanism		NA	605606	19169254|20953190|24212883
IL23R	149233	Spondylitis, Ankylosing	MESH:D013167	marker/mechanism		NA		17952073|20062062
IL24	11009	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
IL24	11009	Breast Neoplasms	MESH:D001943	marker/mechanism|therapeutic		NA		16298037|21671747
IL24	11009	Lung Neoplasms	MESH:D008175	therapeutic		NA		12830052|15713900
IL24	11009	Pancreatic Neoplasms	MESH:D010190	therapeutic		NA		15580305
IL24	11009	Prostatic Neoplasms	MESH:D011471	therapeutic		NA		14678967|21671747
IL27	246778	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		19430480
IL27	246778	Prostatic Neoplasms	MESH:D011471	therapeutic		NA		21801027|24028178
IL27RA	9466	Pneumoconiosis	MESH:D011009	marker/mechanism		NA		25445010
IL2RA	3559	Alopecia Areata	MESH:D000506	marker/mechanism		NA		20596022
IL2RA	3559	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		20453842|20476861|23143596
IL2RA	3559	Berylliosis	MESH:D001607	marker/mechanism		NA		8977230
IL2RA	3559	COVID-19	MESH:C000657245	marker/mechanism		NA		32026671|32161940
IL2RA	3559	Crohn Disease	MESH:D003424	marker/mechanism		NA		21102463
IL2RA	3559	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		16033404
IL2RA	3559	Diabetes Mellitus, Insulin-Dependent, 10	MESH:C566602	marker/mechanism		NA	601942	
IL2RA	3559	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		17676041|19119414|19701192|30224649
IL2RA	3559	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		10910440
IL2RA	3559	HIV Infections	MESH:D015658	marker/mechanism		NA		12878215
IL2RA	3559	Interleukin 2 Receptor, Alpha, Deficiency of	MESH:C565232	marker/mechanism		NA	606367	
IL2RA	3559	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25162674
IL2RA	3559	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		17660530|19119414|19525955|24076602
IL2RA	3559	Schizophrenia	MESH:D012559	marker/mechanism		NA		8067274
IL2RB	3560	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		20453842|23143596
IL2RB	3560	Gastro-enteropancreatic neuroendocrine tumor	MESH:C535650	marker/mechanism		NA		29915428
IL2RB	3560	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
IL2RB	3560	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
IL2RB	3560	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
IL2RG	3561	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
IL2RG	3561	Sezary Syndrome	MESH:D012751	marker/mechanism		NA		26551670
IL2RG	3561	X-Linked Combined Immunodeficiency Diseases	MESH:D053632	marker/mechanism		NA	300400|312863	
IL3	3562	Anemia	MESH:D000740	therapeutic		NA		12090760|8202718
IL3	3562	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	therapeutic		NA		8202718
IL3	3562	Leukopenia	MESH:D007970	therapeutic		NA		8202718
IL3	3562	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25162674
IL3	3562	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		21664615
IL3	3562	Thrombocytopenia	MESH:D013921	therapeutic		NA		8202718
IL31	386653	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		18249437
IL31RA	133396	Amyloidosis, Primary Cutaneous	MESH:C562642	marker/mechanism		NA	613955	
IL31RA	133396	Brain Injuries	MESH:D001930	marker/mechanism		NA		23159883
IL32	9235	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		25279216
IL32	9235	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17597826
IL32	9235	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		25279216
IL32	9235	Sezary Syndrome	MESH:D012751	marker/mechanism		NA		26551670
IL32	9235	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		25279216
IL33	90865	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		20472598
IL33	90865	Asthma	MESH:D001249	marker/mechanism		NA		19198610|21804549|24241537|27472835|29067999
IL33	90865	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		18249437
IL33	90865	Hypersensitivity, Immediate	MESH:D006969	marker/mechanism		NA		22967010
IL33	90865	Kidney Diseases	MESH:D007674	marker/mechanism		NA		21949094
IL33	90865	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
IL33	90865	Pneumonia	MESH:D011014	marker/mechanism		NA		24453940
IL34	146433	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
IL36RN	26525	Psoriasis	MESH:D011565	marker/mechanism		NA	614204	
IL4	3565	Arthritis, Experimental	MESH:D001169	therapeutic		NA		10444273
IL4	3565	Asthma	MESH:D001249	marker/mechanism		NA		18357729
IL4	3565	Autistic Disorder	MESH:D001321	marker/mechanism		NA		16360218
IL4	3565	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		19077085|7871386|8898950
IL4	3565	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		7578376
IL4	3565	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism|therapeutic		NA		21094227|21735453|22107450
IL4	3565	Chromosome Breakage	MESH:D019457	marker/mechanism		NA		27634759
IL4	3565	Colitis	MESH:D003092	therapeutic		NA		24314293
IL4	3565	Dermatitis	MESH:D003872	marker/mechanism		NA		31330126
IL4	3565	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		12484431|21804303
IL4	3565	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		11886533|12230500|18249437
IL4	3565	Drug Eruptions	MESH:D003875	marker/mechanism		NA		19351467
IL4	3565	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		15867870|20485159
IL4	3565	Fibrosis	MESH:D005355	marker/mechanism		NA		24286936
IL4	3565	Hepatitis, Autoimmune	MESH:D019693	marker/mechanism		NA		21227906
IL4	3565	Hypersensitivity	MESH:D006967	marker/mechanism		NA		16095146|21625544
IL4	3565	Hypersensitivity, Immediate	MESH:D006969	marker/mechanism		NA		12755381|20485159|22967010
IL4	3565	Leishmaniasis, Cutaneous	MESH:D016773	marker/mechanism		NA		20102417
IL4	3565	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		23962110
IL4	3565	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		18158872
IL4	3565	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25162674
IL4	3565	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		21664615
IL4	3565	Pleural Diseases	MESH:D010995	marker/mechanism		NA		21357438
IL4	3565	Pneumoconiosis	MESH:D011009	marker/mechanism		NA		21857939
IL4	3565	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
IL4	3565	Premature Birth	MESH:D047928	marker/mechanism		NA		26055944
IL4	3565	Psoriasis	MESH:D011565	marker/mechanism		NA		19169254
IL4	3565	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		12574379|15322207
IL4	3565	Respiratory Hypersensitivity	MESH:D012130	marker/mechanism		NA		18394133
IL4	3565	Respiratory Sounds	MESH:D012135	marker/mechanism		NA		18410779
IL4	3565	Rhinitis	MESH:D012220	marker/mechanism		NA		19672097
IL4	3565	Tuberculosis, Bovine	MESH:D014380	therapeutic		NA		17387165
IL4	3565	Weight Loss	MESH:D015431	therapeutic		NA		24314293
IL4R	3566	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		22317767|30472377
IL4R	3566	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		30472377
IL4R	3566	HIV Infections	MESH:D015658	marker/mechanism		NA	609423	
IL4R	3566	Ige Responsiveness, Atopic	MESH:C564133	marker/mechanism		NA	147050	
IL4R	3566	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		11918534
IL4RA	16190	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		20485159
IL4RA	16190	Eczema	MESH:D004485	marker/mechanism		NA		19759553
IL4RA	16190	Hypersensitivity, Immediate	MESH:D006969	marker/mechanism		NA		20485159
IL5	3567	Asthma	MESH:D001249	marker/mechanism		NA		23266719|7540862
IL5	3567	Autistic Disorder	MESH:D001321	marker/mechanism		NA		16360218
IL5	3567	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		15347381
IL5	3567	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		11886533|18249437
IL5	3567	Entamoebiasis	MESH:D004749	marker/mechanism		NA		16374615
IL5	3567	Eosinophilia	MESH:D004802	marker/mechanism		NA		11006010|1988543
IL5	3567	Hepatitis, Autoimmune	MESH:D019693	marker/mechanism		NA		21227906
IL5	3567	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		17620002
IL5RA	3568	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
IL5RA	3568	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
IL5RA	3568	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
IL6	3569	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
IL6	3569	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		23305094
IL6	3569	Acute Kidney Injury	MESH:D058186	therapeutic		NA		21570986
IL6	3569	Albuminuria	MESH:D000419	marker/mechanism		NA		17167242
IL6	3569	Amnesia	MESH:D000647	therapeutic		NA		9189931
IL6	3569	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		20131233|20974942|22450443
IL6	3569	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		19192274|22450443
IL6	3569	Asthma	MESH:D001249	marker/mechanism		NA		29902480
IL6	3569	Atherosclerosis	MESH:D050197	marker/mechanism		NA		19330073
IL6	3569	Autistic Disorder	MESH:D001321	marker/mechanism		NA		8964908
IL6	3569	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		19077085
IL6	3569	Berylliosis	MESH:D001607	marker/mechanism		NA		8428540
IL6	3569	Brain Injuries	MESH:D001930	marker/mechanism		NA		19800810|21549006|23159883
IL6	3569	Brain Ischemia	MESH:D002545	marker/mechanism		NA		15829914|17394460
IL6	3569	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037|17516992|19435922|19446661
IL6	3569	Burns	MESH:D002056	marker/mechanism		NA		10431976|18277951
IL6	3569	Burns, Chemical	MESH:D002057	marker/mechanism		NA		22533443
IL6	3569	Cachexia	MESH:D002100	marker/mechanism		NA		17878525
IL6	3569	Carcinoma, Basal Cell	MESH:D002280	marker/mechanism		NA		22108589
IL6	3569	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		17615358|20818158|26297436|27022031
IL6	3569	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		7834629
IL6	3569	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		26372664
IL6	3569	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		10716473
IL6	3569	Castleman Disease	MESH:D005871	marker/mechanism		NA		15182131
IL6	3569	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		23593346
IL6	3569	Chemical and Drug Induced Liver Injury	MESH:D056486	therapeutic		NA		15763341|7532385
IL6	3569	Cholangiocarcinoma	MESH:D018281	marker/mechanism		NA		17621267
IL6	3569	Cholestasis	MESH:D002779	marker/mechanism		NA		22461449
IL6	3569	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		28789951
IL6	3569	Colitis	MESH:D003092	marker/mechanism		NA		22410118|24548422
IL6	3569	COVID-19	MESH:C000657245	marker/mechanism		NA		32026671|32161940|32171193|32534021
IL6	3569	Coxsackievirus Infections	MESH:D003384	marker/mechanism		NA		25396421
IL6	3569	Crohn Disease	MESH:D003424	marker/mechanism		NA		10700533|21829567
IL6	3569	Depressive Disorder	MESH:D003866	marker/mechanism		NA		18458677
IL6	3569	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		18249437
IL6	3569	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		22138235
IL6	3569	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA	222100	
IL6	3569	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		31557154
IL6	3569	Edema	MESH:D004487	marker/mechanism		NA		19874808
IL6	3569	Entamoebiasis	MESH:D004749	marker/mechanism		NA		16374615
IL6	3569	Fever	MESH:D005334	marker/mechanism		NA		11852909|15384034|7537110
IL6	3569	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		9403216
IL6	3569	Goiter, Nodular	MESH:D006044	marker/mechanism		NA		16372246
IL6	3569	Graves Disease	MESH:D006111	marker/mechanism		NA		16372246
IL6	3569	Hashimoto Disease	MESH:D050031	marker/mechanism		NA		16372246
IL6	3569	Headache	MESH:D006261	marker/mechanism		NA		7537110
IL6	3569	Heart Failure	MESH:D006333	marker/mechanism		NA		15135663|16360360
IL6	3569	Heat Stroke	MESH:D018883	marker/mechanism		NA		24039931
IL6	3569	Hemolytic-Uremic Syndrome	MESH:D006463	marker/mechanism		NA		15384034
IL6	3569	Hepatitis, Autoimmune	MESH:D019693	marker/mechanism		NA		21227906
IL6	3569	Hepatolenticular Degeneration	MESH:D006527	marker/mechanism		NA		25002079
IL6	3569	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		18500730
IL6	3569	HIV Wasting Syndrome	MESH:D019247	marker/mechanism		NA		7979221
IL6	3569	Hyperalgesia	MESH:D006930	marker/mechanism		NA		10401557|18652822|7582491
IL6	3569	Hypercalcemia	MESH:D006934	marker/mechanism		NA		10638776
IL6	3569	Hyperglycemia	MESH:D006943	marker/mechanism		NA		29035695
IL6	3569	Hyperoxaluria	MESH:D006959	marker/mechanism		NA		16284884
IL6	3569	Hyperparathyroidism, Secondary	MESH:D006962	marker/mechanism		NA		21350317
IL6	3569	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
IL6	3569	Hypertension	MESH:D006973	marker/mechanism		NA		27292124|27659729|27847271|32147540|32165127
IL6	3569	Hypoalbuminemia	MESH:D034141	marker/mechanism		NA		15044820
IL6	3569	Hypotension	MESH:D007022	marker/mechanism		NA		15217654|15384034
IL6	3569	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		12374626|21940958|25257527
IL6	3569	Inflammation	MESH:D007249	marker/mechanism		NA		11181422|16227999|19762220|19803787|20056584|20578705|20816778|21467745|23159501|23371441|26297436
IL6	3569	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA	266600	
IL6	3569	Intracranial Arteriovenous Malformations	MESH:D002538	marker/mechanism		NA	108010	
IL6	3569	Ischemia	MESH:D007511	marker/mechanism		NA		18091701
IL6	3569	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19539174
IL6	3569	Leishmaniasis	MESH:D007896	marker/mechanism		NA		16540374
IL6	3569	Leishmaniasis, Visceral	MESH:D007898	marker/mechanism		NA		17404324|22461696|7554475
IL6	3569	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		18006695
IL6	3569	Lichenoid Eruptions	MESH:D017512	marker/mechanism		NA		18393961
IL6	3569	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		12830005
IL6	3569	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		23274713
IL6	3569	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		26297436
IL6	3569	Lung Injury	MESH:D055370	marker/mechanism		NA		19762220
IL6	3569	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		26372664
IL6	3569	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		18158872
IL6	3569	Meningitis, Aseptic	MESH:D008582	marker/mechanism		NA		10888991
IL6	3569	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25162674
IL6	3569	Metabolic Syndrome	MESH:D024821	marker/mechanism		NA		16644639
IL6	3569	Mitochondrial Myopathies	MESH:D017240	marker/mechanism		NA		7979221
IL6	3569	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		12855565|19330649|8520508
IL6	3569	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		15883752|16310260
IL6	3569	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16286589
IL6	3569	Myocarditis	MESH:D009205	marker/mechanism		NA		25396421
IL6	3569	Necrosis	MESH:D009336	marker/mechanism		NA		7608651
IL6	3569	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		26284488
IL6	3569	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		21937440
IL6	3569	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		12836160
IL6	3569	Obesity	MESH:D009765	marker/mechanism		NA		20141834|24042701
IL6	3569	Obstetric Labor, Premature	MESH:D007752	marker/mechanism		NA		20610570|22122352
IL6	3569	Oral Submucous Fibrosis	MESH:D009914	marker/mechanism		NA		28984080
IL6	3569	Osteoporosis	MESH:D010024	marker/mechanism		NA		15995586
IL6	3569	Osteoporosis, Postmenopausal	MESH:D015663	marker/mechanism		NA		9032749
IL6	3569	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		19401270
IL6	3569	Parkinson Disease	MESH:D010300	marker/mechanism		NA		21318773
IL6	3569	Peripheral Nervous System Diseases	MESH:D010523	therapeutic		NA		18270703
IL6	3569	Pleural Diseases	MESH:D010995	marker/mechanism		NA		21357438
IL6	3569	Pleurisy	MESH:D010998	marker/mechanism		NA		11181422
IL6	3569	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
IL6	3569	Polymyositis	MESH:D017285	marker/mechanism		NA		7979221
IL6	3569	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		26297436
IL6	3569	Pregnancy Complications, Cardiovascular	MESH:D011249	marker/mechanism		NA		10716473
IL6	3569	Premature Birth	MESH:D047928	marker/mechanism		NA		26055944
IL6	3569	Prostatic Neoplasms	MESH:D011471	marker/mechanism|therapeutic		NA		15672864|17196171|19011039|19240160|25970160
IL6	3569	Psoriasis	MESH:D011565	marker/mechanism		NA		16844318
IL6	3569	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		28864214|29329563|31349846
IL6	3569	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		17266442|25216247
IL6	3569	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		15829914|17032661|18258783|19673871|21940958
IL6	3569	Respiratory Hypersensitivity	MESH:D012130	marker/mechanism		NA		18394133
IL6	3569	Rheumatoid Arthritis, Systemic Juvenile	MESH:C565798	marker/mechanism		NA	604302	
IL6	3569	Sarcoma, Kaposi	MESH:D012514	marker/mechanism		NA	148000	
IL6	3569	Schizophrenia	MESH:D012559	marker/mechanism		NA		8067274
IL6	3569	Seizures	MESH:D012640	marker/mechanism		NA		12836160
IL6	3569	Shock, Hemorrhagic	MESH:D012771	marker/mechanism		NA		21192278
IL6	3569	Skin Diseases	MESH:D012871	marker/mechanism		NA		22533443
IL6	3569	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		23593346
IL6	3569	Stroke	MESH:D020521	marker/mechanism		NA		18319729
IL6	3569	Subarachnoid Hemorrhage	MESH:D013345	marker/mechanism		NA		27157545
IL6	3569	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		26037280
IL6	3569	Tobacco Use Disorder	MESH:D014029	marker/mechanism		NA		28864214
IL6	3569	Ventricular Dysfunction, Left	MESH:D018487	marker/mechanism		NA		16286589
IL6	3569	Wounds and Injuries	MESH:D014947	marker/mechanism		NA		21192278
IL6R	3570	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism|therapeutic		NA		16729287|23143596
IL6R	3570	Asthma	MESH:D001249	marker/mechanism		NA		29902480
IL6R	3570	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		22552503
IL6R	3570	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		7834629
IL6R	3570	Graves Disease	MESH:D006111	marker/mechanism		NA		16372246
IL6R	3570	Hashimoto Disease	MESH:D050031	marker/mechanism		NA		16372246
IL6R	3570	Osteoporosis	MESH:D010024	marker/mechanism		NA		15995586
IL6R	3570	Schizophrenia	MESH:D012559	marker/mechanism		NA		8067274
IL6R	3570	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
IL6RA	16194	Fever	MESH:D005334	marker/mechanism		NA		25429137
IL6RA	16194	Heat Stroke	MESH:D018883	marker/mechanism		NA		24039931
IL6RA	16194	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		21940958
IL6RA	16194	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		21940958
IL6ST	3572	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		20453842
IL6ST	3572	Carcinoma	MESH:D002277	marker/mechanism		NA		12606953
IL6ST	3572	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		19223499
IL6ST	3572	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
IL6ST	3572	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		21940958
IL6ST	3572	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12606953
IL6ST	3572	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12606953
IL6ST	3572	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
IL6ST	3572	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		11161848
IL6ST	3572	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
IL6ST	3572	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475|29662167
IL6ST	3572	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		21940958
IL7	3574	Brain Injuries	MESH:D001930	marker/mechanism		NA		23159883
IL7	3574	COVID-19	MESH:C000657245	marker/mechanism		NA		31986264
IL7	3574	Glucose Intolerance	MESH:D018149	therapeutic		NA		20376352
IL7	3574	Hyperglycemia	MESH:D006943	therapeutic		NA		20376352
IL7	3574	Insulin Resistance	MESH:D007333	therapeutic		NA		20376352
IL7	3574	Lymphopenia	MESH:D008231	marker/mechanism		NA		17151827
IL7	3574	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		17660816
IL7	3574	Obesity	MESH:D009765	therapeutic		NA		20376352
IL7	3574	Weight Gain	MESH:D015430	therapeutic		NA		20376352
IL7R	3575	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		21892159
IL7R	3575	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		21297633
IL7R	3575	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
IL7R	3575	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		21399635
IL7R	3575	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
IL7R	3575	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		17660530|17660816|17660817|19525955
IL7R	3575	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054218	marker/mechanism		NA		21892159
IL7R	3575	Severe Combined Immunodeficiency, Autosomal Recessive, T Cell Negative, B Cell Positive, NK Cell Positive	MESH:C563822	marker/mechanism		NA	608971	
IL9	3578	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
IL9	3578	Hepatitis, Autoimmune	MESH:D019693	marker/mechanism		NA		21227906
IL9	3578	Hyperplasia	MESH:D006965	marker/mechanism		NA		19342650
IL9R	3581	Brain Injuries	MESH:D001930	marker/mechanism		NA		23159883
IL9R	3581	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
ILDR1	286676	Deafness, Autosomal Recessive 42	MESH:C566460	marker/mechanism		NA	609646	
ILF2	3608	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
ILF2	3608	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
ILK	3611	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		18702665|19629758
ILK	3611	Colonic Polyps	MESH:D003111	marker/mechanism		NA		11593435
ILK	3611	Epilepsy	MESH:D004827	therapeutic		NA		20064661
ILK	3611	Ischemic Attack, Transient	MESH:D002546	marker/mechanism		NA		15472100
ILK	3611	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		16941698
ILK	3611	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		23045294
ILK	3611	Thoracic Diseases	MESH:D013896	marker/mechanism		NA		23045294
IMMP2L	83943	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19401682
IMMP2L	83943	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		27356265
IMMT	10989	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
IMMT	10989	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
IMPA1	3612	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 59	OMIM:617323	marker/mechanism		NA	617323	
IMPA1	3612	Seizures	MESH:D012640	marker/mechanism		NA		17460611
IMPA2	3613	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
IMPA2	3613	Seizures, Febrile	MESH:D003294	marker/mechanism		NA		15557493
IMPDH1	3614	Leber Congenital Amaurosis	MESH:D057130	marker/mechanism		NA		16384941
IMPDH1	3614	Leber Congenital Amaurosis 11	MESH:C564140	marker/mechanism		NA	613837	
IMPDH1	3614	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA		11875050|16384941
IMPDH1	3614	Retinitis Pigmentosa 10	MESH:C566715	marker/mechanism		NA	180105	
IMPDH2	3615	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
IMPDH2	3615	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
IMPG1	3617	Vitelliform Macular Dystrophy	MESH:D057826	marker/mechanism		NA	616151	
IMPG2	50939	RETINITIS PIGMENTOSA 56	OMIM:613581	marker/mechanism		NA	613581	
IMPG2	50939	Vitelliform Macular Dystrophy	MESH:D057826	marker/mechanism		NA	616152	
INA	9118	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
INA	9118	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		22430071
INAVA	55765	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA		21983784
INCENP	3619	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
INCENP	3619	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
INF2	64423	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E	OMIM:614455	marker/mechanism		NA	614455	
INF2	64423	Focal Segmental Glomerulosclerosis 5	MESH:C567687	marker/mechanism		NA	613237	
INF2	64423	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA		20023659
ING1	3621	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
ING1	3621	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
ING1	3621	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA	275355	
ING1	3621	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
ING4	51147	Colorectal Neoplasms	MESH:D015179	therapeutic		NA		27806345
ING4	51147	Lymphatic Metastasis	MESH:D008207	therapeutic		NA		27806345
INHA	3623	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
INHA	3623	Familial Testotoxicosis	MESH:C536961	marker/mechanism		NA		16684832
INHBA	3624	Leiomyoma	MESH:D007889	marker/mechanism		NA		22228119
INHBA	3624	Liver Failure, Acute	MESH:D017114	marker/mechanism		NA		12560755
INHBA	3624	Pre-Eclampsia	MESH:D011225	marker/mechanism		NA		17332518
INHBA	3624	Uterine Neoplasms	MESH:D014594	marker/mechanism		NA		22228119
INHBB	3625	Familial Testotoxicosis	MESH:C536961	marker/mechanism		NA		16684832
INHBC	3626	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
INHBE	83729	Lipidoses	MESH:D008064	marker/mechanism		NA		17175557
INHBE	83729	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980|25380136
INMT	11185	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
INMT	11185	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
INPP1	3628	Autistic Disorder	MESH:D001321	marker/mechanism		NA		14627686
INPP4A	3631	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
INPP4B	8821	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		29415082
INPP4B	8821	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		29415082
INPP4B	8821	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		29415082
INPP4B	8821	Pancreatic Carcinoma	MESH:C562463	marker/mechanism		NA		29415082
INPP4B	8821	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		29415082
INPP5A	3632	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		25759212
INPP5A	3632	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		25759212
INPP5A	3632	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
INPP5A	3632	Skin Diseases	MESH:D012871	marker/mechanism		NA		25759212
INPP5D	3635	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		30320580
INPP5D	3635	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
INPP5D	3635	Reperfusion Injury	MESH:D015427	therapeutic		NA		25780291
INPP5E	56623	Agenesis of Cerebellar Vermis	MESH:C536293	marker/mechanism		NA	213300	19668216
INPP5E	56623	Ciliary Motility Disorders	MESH:D002925	marker/mechanism		NA		19668215|19668216
INPP5E	56623	Eye Diseases, Hereditary	MESH:D015785	marker/mechanism		NA		19668215
INPP5E	56623	Intellectual Disability	MESH:D008607	marker/mechanism		NA		19668215
INPP5E	56623	MORM syndrome	MESH:C536984	marker/mechanism		NA	610156	
INPP5E	56623	Obesity	MESH:D009765	marker/mechanism		NA		19668215
INPP5E	56623	Penile Diseases	MESH:D010409	marker/mechanism		NA		19668215
INPP5K	51763	MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	OMIM:617404	marker/mechanism		NA	617404	
INPPL1	3636	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		12086927|25635986
INPPL1	3636	Hypertension	MESH:D006973	marker/mechanism		NA		15220217
INPPL1	3636	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
INPPL1	3636	Metabolic Syndrome	MESH:D024821	marker/mechanism		NA		15220217
INPPL1	3636	Opsismodysplasia	MESH:C537122	marker/mechanism		NA	258480	
INS	3630	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		12243603
INS	3630	Albuminuria	MESH:D000419	marker/mechanism		NA		9861226
INS	3630	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		15750215|9443474
INS	3630	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		5506046
INS	3630	Cardiomyopathy, Hypertrophic	MESH:D002312	marker/mechanism		NA		8660453
INS	3630	Diabetes Mellitus	MESH:D003920	marker/mechanism|therapeutic		NA		11446671|15628829|17855560|18162506|2055425|7294224|7624867|8400068
INS	3630	Diabetes Mellitus, Insulin-Dependent, 2	MESH:C565100	marker/mechanism		NA	125852	
INS	3630	Diabetes Mellitus, Permanent Neonatal	MESH:C563425	marker/mechanism		NA	606176	
INS	3630	Diabetes Mellitus, Type 1	MESH:D003922	therapeutic		NA		20620209
INS	3630	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism|therapeutic		NA		11522680|11978674|15531508|16259526|16519038|21680998|21779873|23349674|3511099|7573102
INS	3630	Diabetic Cardiomyopathies	MESH:D058065	therapeutic		NA		20828608
INS	3630	Diabetic Ketoacidosis	MESH:D016883	therapeutic		NA		11430560
INS	3630	Diabetic Nephropathies	MESH:D003928	marker/mechanism|therapeutic		NA		2143390|7713310|7987072
INS	3630	Edema	MESH:D004487	marker/mechanism		NA		15628829
INS	3630	Fatty Liver	MESH:D005234	marker/mechanism		NA		9048448
INS	3630	Glucose Intolerance	MESH:D018149	marker/mechanism		NA		21779873
INS	3630	Heart Arrest	MESH:D006323	therapeutic		NA		17449947
INS	3630	Heart Failure	MESH:D006333	marker/mechanism		NA		15628829
INS	3630	Hepatitis	MESH:D006505	marker/mechanism		NA		12243603
INS	3630	Hyperglycemia	MESH:D006943	marker/mechanism|therapeutic		NA		8660453|9861226
INS	3630	Hyperinsulinism	MESH:D006946	marker/mechanism		NA		2991050|3511099|4019786|6382002
INS	3630	Hyperkalemia	MESH:D006947	marker/mechanism|therapeutic		NA		20466255|8606734
INS	3630	Hyperproinsulinemia	MESH:C562776	marker/mechanism		NA	616214	
INS	3630	Hypertension	MESH:D006973	marker/mechanism|therapeutic		NA		18360027|9719048
INS	3630	Hypertriglyceridemia	MESH:D015228	marker/mechanism		NA		12754275
INS	3630	Hypoglycemia	MESH:D007003	marker/mechanism		NA		1324617|1646414|1890151|20620209|22940631|2554359|48835
INS	3630	Hypokalemia	MESH:D007008	marker/mechanism		NA		496411
INS	3630	Hypotension	MESH:D007022	marker/mechanism|therapeutic		NA		1324617|48835|7418494
INS	3630	Insulin Resistance	MESH:D007333	marker/mechanism		NA		11522680|24648896|25796170
INS	3630	Kidney Diseases, Cystic	MESH:D052177	therapeutic		NA		9879822
INS	3630	Lewy Body Disease	MESH:D020961	marker/mechanism		NA		19276553
INS	3630	Liver Cirrhosis, Experimental	MESH:D008106	therapeutic		NA		26806094
INS	3630	Liver Diseases	MESH:D008107	marker/mechanism		NA		29684222
INS	3630	Liver Failure, Acute	MESH:D017114	marker/mechanism		NA		12639207
INS	3630	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10	OMIM:613370	marker/mechanism		NA	613370	
INS	3630	Memory Disorders	MESH:D008569	therapeutic		NA		9264093
INS	3630	Metabolic Diseases	MESH:D008659	marker/mechanism		NA		19131468
INS	3630	Metabolic Syndrome	MESH:D024821	marker/mechanism		NA		11274935|16259526
INS	3630	Micronuclei, Chromosome-Defective	MESH:D048629	marker/mechanism		NA		27884723|30266311
INS	3630	MPTP Poisoning	MESH:D020267	therapeutic		NA		26364587
INS	3630	Muscular Diseases	MESH:D009135	marker/mechanism		NA		496411
INS	3630	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		24587105
INS	3630	Neural Tube Defects	MESH:D009436	therapeutic		NA		19446573
INS	3630	Neurocognitive Disorders	MESH:D019965	therapeutic		NA		21911655
INS	3630	Obesity	MESH:D009765	marker/mechanism		NA		11528401|2777199|29035695|8923850
INS	3630	Pancreatitis	MESH:D010195	marker/mechanism		NA		17163263
INS	3630	Panic Disorder	MESH:D016584	marker/mechanism		NA		12073167
INS	3630	Paralysis	MESH:D010243	therapeutic		NA		7433326
INS	3630	Paresthesia	MESH:D010292	marker/mechanism		NA		9861226
INS	3630	Parkinson Disease	MESH:D010300	marker/mechanism		NA		19276553
INS	3630	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		11889176|16123091|2777199
INS	3630	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		12610512
INS	3630	Renal Insufficiency	MESH:D051437	marker/mechanism		NA		8606734|9861226
INS	3630	Rhabdomyolysis	MESH:D012206	marker/mechanism		NA		12243603
INS	3630	Seizures	MESH:D012640	marker/mechanism		NA		14714756|4115818
INS	3630	Tachycardia	MESH:D013610	marker/mechanism		NA		1324617
INS	3630	Telomeric 22q13 Monosomy Syndrome	MESH:C536801	therapeutic		NA		18948358
INS	3630	Urinary Bladder Diseases	MESH:D001745	therapeutic		NA		2055425
INS	3630	Ventricular Dysfunction, Left	MESH:D018487	therapeutic		NA		11872684
INS	3630	Ventricular Fibrillation	MESH:D014693	therapeutic		NA		5348156
INS	3630	Ventricular Outflow Obstruction	MESH:D014694	marker/mechanism		NA		8660453
INS	3630	Weight Loss	MESH:D015431	marker/mechanism		NA		22940631
INS1	16333	Bradycardia	MESH:D001919	therapeutic		NA		3525850
INS1	16333	Diabetes Mellitus, Experimental	MESH:D003921	therapeutic		NA		2975197|3044883
INS1	16333	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		19586609
INS1	16333	Diabetic Cardiomyopathies	MESH:D058065	therapeutic		NA		6225876
INS1	16333	Hyperglycemia	MESH:D006943	therapeutic		NA		26887929|28422052|32554039
INS1	16333	Hypoglycemia	MESH:D007003	marker/mechanism		NA		18545258|222008|3084764|6797439
INS1	16333	Insulin Resistance	MESH:D007333	marker/mechanism		NA		19586609
INS1	16333	Ketosis	MESH:D007662	therapeutic		NA		29420703
INS1	16333	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		21558470
INS1	16333	Necrosis	MESH:D009336	therapeutic		NA		9826672
INS1	16333	Reflex, Abnormal	MESH:D012021	therapeutic		NA		3525850
INS1	16333	Seizures	MESH:D012640	marker/mechanism		NA		3084764|3928877|6797439
INS2	16334	Albuminuria	MESH:D000419	marker/mechanism		NA		29420703
INS2	16334	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		19775285
INS2	16334	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		17151334|29420703
INS2	16334	Diabetic Retinopathy	MESH:D003930	marker/mechanism		NA		30463601
INS2	16334	Hyperglycemia	MESH:D006943	marker/mechanism		NA		18056790
INSIG1	3638	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
INSIG1	3638	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
INSIG1	3638	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
INSIG2	51141	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
INSIG2	51141	Weight Gain	MESH:D015430	marker/mechanism		NA		18195716|20373477
INS-IGF2	723961	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
INSL3	3640	Cryptorchidism	MESH:D003456	marker/mechanism		NA	219050	14687758|16102138
INSM1	3642	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		23582323
INSR	3643	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		24055495
INSR	3643	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		22138235|9243097
INSR	3643	Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans	MESH:C562710	marker/mechanism		NA	610549	
INSR	3643	Diabetic Neuropathies	MESH:D003929	marker/mechanism		NA		18331706
INSR	3643	Donohue Syndrome	MESH:D056731	marker/mechanism		NA	246200|262190	18411068
INSR	3643	Glucose Intolerance	MESH:D018149	marker/mechanism		NA		10949030
INSR	3643	Hernias, Diaphragmatic, Congenital	MESH:D065630	marker/mechanism		NA		21433279
INSR	3643	Hyperalgesia	MESH:D006930	marker/mechanism		NA		18331706
INSR	3643	Hyperglycemia	MESH:D006943	marker/mechanism		NA		18056790
INSR	3643	Hyperinsulinemic Hypoglycemia, Familial, 5	MESH:C566494	marker/mechanism		NA	609968	
INSR	3643	Hyperinsulinism	MESH:D006946	marker/mechanism		NA		10949030|18411068
INSR	3643	Insulin Resistance	MESH:D007333	marker/mechanism		NA		10949030|11887975
INSR	3643	Lewy Body Disease	MESH:D020961	marker/mechanism		NA		19276553
INSR	3643	Lung Diseases	MESH:D008171	marker/mechanism		NA		20438933|21433279
INSR	3643	Parkinson Disease	MESH:D010300	marker/mechanism		NA		19276553
INSR	3643	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
INSRR	3645	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
INTS13	55726	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
INTS4	92105	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		24763052
INVS	27130	Nephronophthisis 2	MESH:C566582	marker/mechanism		NA	602088	
IP6K2	51447	Huntington Disease	MESH:D006816	marker/mechanism		NA		21652713
IPCEF1	26034	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17374397
IPCEF1	26034	Leukemia, Lymphoid	MESH:D007945	marker/mechanism		NA		24292274
IPO11	51194	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
IPO4	79711	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
IPO4	79711	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
IPO5	3843	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
IPO5	3843	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
IPO7	10527	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
IPP	3652	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		25944804
IPW	3653	Prader-Willi Syndrome	MESH:D011218	marker/mechanism		NA	176270	
IQCB1	9657	Senior-Loken Syndrome 5	MESH:C563763	marker/mechanism		NA	609254	
IQCC	55721	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
IQCH	64799	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
IQCK	124152	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		30820047
IQGAP1	8826	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		27935819
IQGAP1	8826	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		20977743
IQGAP1	8826	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
IQGAP1	8826	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
IQGAP2	10788	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		27935819
IQGAP2	10788	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		20977743
IQGAP3	128239	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		28191889
IQGAP3	128239	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
IQSEC1	9922	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
IQSEC2	23096	Epilepsy	MESH:D004827	marker/mechanism		NA		29942082
IQSEC2	23096	Mental Retardation, X-Linked	MESH:D038901	marker/mechanism		NA		20473311
IQSEC2	23096	Mental Retardation, X-Linked 1	MESH:C567906	marker/mechanism		NA	309530	26793055
IQSEC2	23096	Mental Retardation, X-Linked 78	MESH:C564489	marker/mechanism		NA		26793055
IQSEC2	23096	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		29942082
IRAK1	3654	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		23143596
IRAK1	3654	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
IRAK1	3654	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		20524934
IRAK1	3654	Hypoxia-Ischemia, Brain	MESH:D020925	marker/mechanism		NA		21925238
IRAK1BP1	134728	Sjogren's Syndrome	MESH:D012859	marker/mechanism		NA		24097067
IRAK3	11213	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 5	OMIM:611064	marker/mechanism		NA	611064	
IRAK3	11213	Reperfusion Injury	MESH:D015427	therapeutic		NA		25780291
IRAK4	51135	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		28003376
IRAK4	51135	Hypoxia-Ischemia, Brain	MESH:D020925	marker/mechanism		NA		21925238
IRAK4	51135	IRAK4 Deficiency	MESH:C564352	marker/mechanism		NA	607676	
IRAK4	51135	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		28003376
IRAK4	51135	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16537705
IREB2	3658	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		20390345
IRF1	3659	Brain Injuries	MESH:D001930	marker/mechanism		NA		21549006
IRF1	3659	Lung Neoplasms	MESH:D008175	marker/mechanism		NA	211980	
IRF1	3659	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
IRF1	3659	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA	613659	
IRF1	3659	Stroke	MESH:D020521	marker/mechanism		NA		12374626
IRF2	3660	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		22561517
IRF2BP2	359948	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		25583766
IRF2BPL	64207	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
IRF3	3661	Encephalitis, Herpes Simplex	MESH:D020803	marker/mechanism		NA	616532	
IRF3	3661	Severe Acute Respiratory Syndrome	MESH:D045169	marker/mechanism		NA		26861016
IRF4	3662	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		18758461
IRF4	3662	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		26437031
IRF4	3662	Lymphoma, T-Cell, Cutaneous	MESH:D016410	marker/mechanism		NA		26192916
IRF4	3662	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		18568025
IRF5	3663	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		20453842|23143596
IRF5	3663	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		21297633
IRF5	3663	Inflammatory Bowel Disease 14	MESH:C567383	marker/mechanism		NA	612245	
IRF5	3663	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA	612251	18204446|19838193
IRF5	3663	Scleroderma, Systemic	MESH:D012595	marker/mechanism		NA		20383147
IRF6	3664	Cleft Lip	MESH:D002971	marker/mechanism		NA		17041601|18836445|20436469
IRF6	3664	Cleft Palate	MESH:D002972	marker/mechanism		NA		17041601
IRF6	3664	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		17041601
IRF6	3664	Limb Deformities, Congenital	MESH:D017880	marker/mechanism		NA		17041601
IRF6	3664	OROFACIAL CLEFT 6, SUSCEPTIBILITY TO	OMIM:608864	marker/mechanism		NA	608864	
IRF6	3664	Popliteal Pterygium Syndrome	MESH:C562509	marker/mechanism		NA	119500	
IRF6	3664	Skin Abnormalities	MESH:D012868	marker/mechanism		NA		17041601
IRF6	3664	Van der Woude syndrome	MESH:C536528	marker/mechanism		NA	119300	16211254|16998136|18813858
IRF7	3665	IMMUNODEFICIENCY 39	OMIM:616345	marker/mechanism		NA	616345	
IRF7	3665	Inflammation	MESH:D007249	marker/mechanism		NA		20513754
IRF7	3665	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
IRF8	3394	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		23143596
IRF8	3394	IMMUNODEFICIENCY 32A	OMIM:614893	marker/mechanism		NA	614893	
IRF8	3394	IMMUNODEFICIENCY 32B	OMIM:226990	marker/mechanism		NA	226990	21524210|27893462
IRF8	3394	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
IRF8	3394	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		19525953
IRGM	345611	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		20228799
IRGM	345611	Crohn Disease	MESH:D003424	marker/mechanism		NA		17554261|18438406|19165925|21278745
IRGM	345611	Inflammatory Bowel Disease 19	MESH:C567372	marker/mechanism		NA	612278	
IRGM	345611	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA		26192919
IRGM	345611	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO	OMIM:607948	marker/mechanism		NA	607948	
IRS1	3667	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		1311924|23958494
IRS1	3667	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		23748240
IRS1	3667	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		10591678
IRS1	3667	Coronary Disease	MESH:D003327	marker/mechanism		NA		28869590
IRS1	3667	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		10591678
IRS1	3667	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		22138235
IRS1	3667	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA	125853	10430617|12679424|15688983|19734900|28869590|8104271|8723689
IRS1	3667	Hyperinsulinism	MESH:D006946	marker/mechanism		NA		19734900
IRS1	3667	Hyperlipidemias	MESH:D006949	marker/mechanism		NA		10591678
IRS1	3667	Insulin Resistance	MESH:D007333	marker/mechanism		NA		19734900
IRS1	3667	Obesity	MESH:D009765	marker/mechanism		NA		23954404
IRS1	3667	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		9466558
IRS1	3667	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		15678496
IRS1	3667	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		30594912
IRS2	8660	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		16127164
IRS2	8660	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		25808216
IRS2	8660	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA	125853	
IRS2	8660	Hyperglycemia	MESH:D006943	marker/mechanism		NA		20028942|25808216
IRS2	8660	Insulin Resistance	MESH:D007333	marker/mechanism		NA		25808216
IRS2	8660	Medulloblastoma	MESH:D008527	marker/mechanism		NA		19270706
IRS2	8660	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
IRX1	79192	Lung Diseases	MESH:D008171	marker/mechanism		NA		21238641
IRX2	153572	Lung Diseases	MESH:D008171	marker/mechanism		NA		21238641
IRX3	79191	Lung Diseases	MESH:D008171	marker/mechanism		NA		21238641
IRX4	50805	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
IRX4	50805	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
IRX5	10265	Anemia, hypochromic microcytic	MESH:C536357	marker/mechanism		NA		22581230
IRX5	10265	Anodontia	MESH:D000848	marker/mechanism		NA		22581230
IRX5	10265	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		22581230
IRX5	10265	Fractures, Bone	MESH:D050723	marker/mechanism		NA		22581230
IRX5	10265	Frontonasal dysplasia	MESH:C538065	marker/mechanism		NA		22581230
IRX5	10265	Hearing Loss, Sensorineural	MESH:D006319	marker/mechanism		NA		22581230
IRX5	10265	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		22581230
IRX5	10265	Hypertelorism, Severe, With Midface Prominence, Myopia, Mental Retardation, And Bone Fragility	MESH:C566988	marker/mechanism		NA	611174	
IRX5	10265	Lacrimal Apparatus Diseases	MESH:D007766	marker/mechanism		NA		22581230
IRX5	10265	Lung Diseases	MESH:D008171	marker/mechanism		NA		21238641
IRX5	10265	Myopia	MESH:D009216	marker/mechanism		NA		22581230
ISCA2	122961	Multiple Mitochondrial Dysfunctions Syndrome	MESH:C565304	marker/mechanism		NA	616370	
ISCU	23479	Myopathy with Lactic Acidosis, Hereditary	MESH:C564972	marker/mechanism		NA	255125	
ISG15	9636	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28919514
ISG15	9636	Depressive Disorder, Major	MESH:D003865	marker/mechanism		NA		29175309
ISG15	9636	IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION	OMIM:616126	marker/mechanism		NA	616126	
ISG15	9636	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
ISG20	3669	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ISL1	3670	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		26332997
ISL1	3670	Neuroblastoma	MESH:D009447	marker/mechanism		NA		30127528
ISL1	3670	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		26332997
ISL2	64843	Diverticular Diseases	MESH:D000076385	marker/mechanism		NA		30177863
ISOC2	79763	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
ISYNA1	51477	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
ISYNA1	51477	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ISYNA1	51477	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
ISYNA1	51477	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
ITCH	83737	AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM	OMIM:613385	marker/mechanism		NA	613385	
ITGA1	3672	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		30718926
ITGA1	3672	Gliosis	MESH:D005911	marker/mechanism		NA		12851778
ITGA2	3673	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
ITGA2	3673	Gliosis	MESH:D005911	marker/mechanism		NA		12851778
ITGA2	3673	Hyperalgesia	MESH:D006930	marker/mechanism		NA		18234883
ITGA2	3673	Retinal Vein Occlusion	MESH:D012170	marker/mechanism		NA		12928694
ITGA2B	3674	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
ITGA2B	3674	Carotid Artery Thrombosis	MESH:D002341	marker/mechanism		NA		1605806
ITGA2B	3674	Cerebral Hemorrhage	MESH:D002543	marker/mechanism		NA		9445356
ITGA2B	3674	Glanzmann Thrombasthenia, Autosomal Dominant	MESH:C566061	marker/mechanism		NA	187800	
ITGA2B	3674	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ITGA2B	3674	Stroke	MESH:D020521	marker/mechanism		NA		9445356
ITGA2B	3674	Thrombasthenia	MESH:D013915	marker/mechanism		NA	273800	
ITGA2B	3674	Thrombocytopenia	MESH:D013921	marker/mechanism		NA		15225244
ITGA3	3675	INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL	OMIM:614748	marker/mechanism		NA	614748	
ITGA4	3676	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18348195
ITGA4	3676	Gliosis	MESH:D005911	marker/mechanism		NA		12851778
ITGA4	3676	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA		28067908
ITGA4	3676	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		21093051
ITGA5	3678	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		21401805
ITGA5	3678	Gliosis	MESH:D005911	marker/mechanism		NA		12851778
ITGA5	3678	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		21224397
ITGA5	3678	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		16526316
ITGA5	3678	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		17786296
ITGA6	3655	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		17379860
ITGA6	3655	Epidermolysis bullosa with pyloric atresia	MESH:C535377	marker/mechanism		NA	226730	
ITGA7	3679	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
ITGA7	3679	Muscular Dystrophy, Congenital, Due To Integrin Alpha-7 Deficiency	MESH:C567709	marker/mechanism		NA	613204	
ITGA8	8516	Hereditary renal agenesis	MESH:C536482	marker/mechanism		NA	191830	
ITGA8	8516	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		17303177
ITGA8	8516	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		17786296
ITGAL	3683	Behcet Syndrome	MESH:D001528	marker/mechanism		NA		8712863
ITGAL	3683	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA		28067908
ITGAL	3683	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		16764927
ITGAL	3683	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ITGAM	3684	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		16033404
ITGAM	3684	Hyperglycemia	MESH:D006943	marker/mechanism		NA		29035695
ITGAM	3684	Hyperinsulinism	MESH:D006946	marker/mechanism		NA		29035695
ITGAM	3684	Ileitis	MESH:D007079	marker/mechanism		NA		10647630
ITGAM	3684	Insulin Resistance	MESH:D007333	marker/mechanism		NA		29035695
ITGAM	3684	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		16764927
ITGAM	3684	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		18204446|18204448
ITGAM	3684	Lupus Vasculitis, Central Nervous System	MESH:D020945	marker/mechanism		NA		26773105
ITGAM	3684	Nerve Degeneration	MESH:D009410	therapeutic		NA		32375810
ITGAM	3684	Obesity	MESH:D009765	marker/mechanism		NA		29035695
ITGAV	3685	Cerebral Hemorrhage	MESH:D002543	marker/mechanism		NA		9445356
ITGAV	3685	Stroke	MESH:D020521	marker/mechanism		NA		9445356
ITGAX	3687	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		16764927
ITGB1	3688	Brain Injuries, Traumatic	MESH:D000070642	marker/mechanism		NA		25668593
ITGB1	3688	Calcinosis	MESH:D002114	marker/mechanism		NA		18340010
ITGB1	3688	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		21478906
ITGB1	3688	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		21401805
ITGB1	3688	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		18340010
ITGB1	3688	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		11884376
ITGB1	3688	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
ITGB1	3688	Gliosis	MESH:D005911	marker/mechanism		NA		12851778
ITGB1	3688	Heart Failure	MESH:D006333	marker/mechanism		NA		11884376
ITGB1	3688	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ITGB1	3688	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		21224397
ITGB1	3688	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		23562787
ITGB1BP1	9270	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		17567669
ITGB1BP1	9270	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		17567669
ITGB2	3689	Behcet Syndrome	MESH:D001528	marker/mechanism		NA		8712863
ITGB2	3689	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		27935819
ITGB2	3689	Calcinosis	MESH:D002114	marker/mechanism		NA		21335463
ITGB2	3689	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
ITGB2	3689	Dermatitis	MESH:D003872	marker/mechanism		NA		9653089
ITGB2	3689	Heart Valve Diseases	MESH:D006349	marker/mechanism		NA		21335463
ITGB2	3689	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
ITGB2	3689	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		16764927
ITGB2	3689	Leukocyte-Adhesion Deficiency Syndrome	MESH:D018370	marker/mechanism		NA		9653089
ITGB2	3689	Leukocyte adhesion deficiency type 1	MESH:C535887	marker/mechanism		NA	116920	
ITGB2	3689	Leukocyte Disorders	MESH:D007960	marker/mechanism		NA		2880869|9653089
ITGB2	3689	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ITGB2	3689	Nephrosis	MESH:D009401	marker/mechanism		NA		12845231
ITGB2	3689	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
ITGB2	3689	Skin Ulcer	MESH:D012883	marker/mechanism		NA		9653089
ITGB3	3690	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		15840736
ITGB3	3690	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		21254450
ITGB3	3690	Autistic Disorder	MESH:D001321	marker/mechanism		NA		16721604|16724005|17203304
ITGB3	3690	Carotid Artery Thrombosis	MESH:D002341	marker/mechanism		NA		1605806
ITGB3	3690	Cerebral Hemorrhage	MESH:D002543	marker/mechanism		NA		9445356
ITGB3	3690	Coronary Thrombosis	MESH:D003328	marker/mechanism		NA		8598867
ITGB3	3690	Glanzmann Thrombasthenia, Autosomal Dominant	MESH:C566061	marker/mechanism		NA	187800	
ITGB3	3690	Gliosis	MESH:D005911	marker/mechanism		NA		12851778
ITGB3	3690	Hemorrhage	MESH:D006470	marker/mechanism		NA		16153930
ITGB3	3690	Hip Fractures	MESH:D006620	marker/mechanism		NA		17264806
ITGB3	3690	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ITGB3	3690	Myocardial Infarction	MESH:D009203	marker/mechanism		NA	608446	8598867
ITGB3	3690	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16158739
ITGB3	3690	Stroke	MESH:D020521	marker/mechanism		NA		9445356
ITGB3	3690	Thrombasthenia	MESH:D013915	marker/mechanism		NA	273800	1371279|1602006
ITGB3	3690	Thrombocytopenia	MESH:D013921	marker/mechanism		NA		15225244
ITGB3	3690	Thrombocytopenia, Neonatal Alloimmune	MESH:D054098	marker/mechanism		NA		2257303|7694683
ITGB3BP	23421	Endometriosis	MESH:D004715	marker/mechanism		NA		22138541
ITGB4	3691	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
ITGB4	3691	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
ITGB4	3691	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		27107458
ITGB4	3691	Ectodermal Dysplasia	MESH:D004476	marker/mechanism		NA		18348258
ITGB4	3691	Epidermolysis Bullosa	MESH:D004820	marker/mechanism		NA		18348258
ITGB4	3691	Epidermolysis Bullosa, Junctional	MESH:D016109	marker/mechanism		NA		7545057
ITGB4	3691	Epidermolysis Bullosa, Junctional, Non-Herlitz Type	MESH:C562639	marker/mechanism		NA	226650	
ITGB4	3691	Epidermolysis Bullosa Simplex	MESH:D016110	marker/mechanism		NA	131800	
ITGB4	3691	Epidermolysis bullosa with pyloric atresia	MESH:C535377	marker/mechanism		NA	226730	18348258|7545057
ITGB4	3691	Gliosis	MESH:D005911	marker/mechanism		NA		12851778
ITGB4	3691	Pyloric Atresia	MESH:C562561	marker/mechanism		NA		18348258|7545057
ITGB4	3691	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
ITGB5	3693	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
ITGB5	3693	Thyroid Diseases	MESH:D013959	marker/mechanism		NA		23397585
ITGB6	3694	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
ITGB6	3694	AMELOGENESIS IMPERFECTA, TYPE IH	OMIM:616221	marker/mechanism		NA	616221	
ITGB6	3694	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		25055964
ITGB6	3694	Cholangitis	MESH:D002761	marker/mechanism		NA		25055964
ITGB6	3694	Hepatitis C, Chronic	MESH:D019698	marker/mechanism		NA		18221819
ITGB6	3694	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		18221819
ITGB6	3694	Liver Diseases	MESH:D008107	marker/mechanism		NA		18221819
ITGB6	3694	Pulmonary Emphysema	MESH:D011656	marker/mechanism		NA		12634787
ITGB8	3696	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
ITGB8	3696	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA		28067908
ITGB8	3696	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
ITIH1	3697	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		31043756
ITIH1	3697	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		17114358
ITIH1	3697	Osteoarthritis, Hip	MESH:D015207	marker/mechanism		NA		30374069
ITIH3	3699	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		19363144
ITIH4	3700	Adenomatous Polyposis Coli	MESH:D011125	marker/mechanism		NA		25200834
ITIH4	3700	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		25200834
ITK	3702	Lymphoproliferative Syndrome, Ebv-Associated, Autosomal, 1	MESH:C567815	marker/mechanism		NA	613011	
ITLN1	55600	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		23555749
ITLN1	55600	Mesothelioma	MESH:D008654	marker/mechanism		NA		15777968
ITLN1	55600	Ventricular Dysfunction, Left	MESH:D018487	therapeutic		NA		23555749
ITM2B	9445	CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 1	OMIM:176500	marker/mechanism		NA	176500	
ITM2B	9445	Dementia, familial Danish	MESH:C538209	marker/mechanism		NA	117300	
ITM2B	9445	Hypertension	MESH:D006973	marker/mechanism		NA		22228705
ITM2B	9445	RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES	OMIM:616079	marker/mechanism		NA	616079	
ITPA	3704	Anemia, Hemolytic	MESH:D000743	therapeutic		NA		20547162
ITPA	3704	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 35	OMIM:616647	marker/mechanism		NA	616647	
ITPA	3704	Inosine Triphosphatase Deficiency	MESH:C564127	marker/mechanism		NA	613850	
ITPA	3704	Metabolism, Inborn Errors	MESH:D008661	marker/mechanism		NA		12384777|20547162
ITPA	3704	Recurrence	MESH:D012008	marker/mechanism		NA		23029095
ITPA	3704	Thrombocytopenia	MESH:D013921	marker/mechanism		NA		18662289
ITPK1	3705	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		26213588
ITPKC	80271	Coronary Aneurysm	MESH:D003323	marker/mechanism		NA		18084290
ITPKC	80271	Mucocutaneous Lymph Node Syndrome	MESH:D009080	marker/mechanism		NA		18084290
ITPR1	3708	Aniridia cerebellar ataxia mental deficiency	MESH:C536370	marker/mechanism		NA	206700	
ITPR1	3708	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
ITPR1	3708	Hypoxia, Brain	MESH:D002534	marker/mechanism		NA		17285299
ITPR1	3708	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
ITPR1	3708	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
ITPR1	3708	Spinocerebellar Ataxia 15	MESH:C564685	marker/mechanism		NA	606658	22986007
ITPR1	3708	Spinocerebellar Ataxia 29	MESH:C537206	marker/mechanism		NA	117360	22986007
ITPR2	3709	ANHIDROSIS, ISOLATED, WITH NORMAL SWEAT GLANDS	OMIM:106190	marker/mechanism		NA	106190	
ITPR2	3709	Cardiomegaly	MESH:D006332	marker/mechanism		NA		20616315
ITPR2	3709	Hypoxia, Brain	MESH:D002534	marker/mechanism		NA		17285299
ITPR3	3710	Acrodermatitis	MESH:D000169	marker/mechanism		NA		27258892
ITPR3	3710	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA	222100	
ITSN1	6453	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
ITSN2	50618	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18925433
ITSN2	50618	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		18925433
ITSN2	50618	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
ITSN2	50618	Sjogren's Syndrome	MESH:D012859	marker/mechanism		NA		24097067
IVD	3712	Acidemia, isovaleric	MESH:C538167	marker/mechanism		NA	243500	
IVD	3712	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
IVL	3713	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		18572023
IVL	3713	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		18572023
IVNS1ABP	10625	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		19208208
IYD	389434	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
IYD	389434	Thyroid Dyshormonogenesis 4	MESH:C562770	marker/mechanism		NA	274800	
JADE2	23338	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28869590
JADE2	23338	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
JAG1	182	Alagille Syndrome	MESH:D016738	marker/mechanism		NA	118450	21532573|9207787|9207788
JAG1	182	Bone Diseases	MESH:D001847	marker/mechanism		NA		9207788
JAG1	182	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21036696
JAG1	182	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
JAG1	182	Carcinoma, Pancreatic Ductal	MESH:D021441	marker/mechanism		NA		19208345
JAG1	182	Corneal Opacity	MESH:D003318	marker/mechanism		NA		12022040
JAG1	182	Deafness	MESH:D003638	marker/mechanism		NA		12022040
JAG1	182	Eye Abnormalities	MESH:D005124	marker/mechanism		NA		12022040|9207787|9207788
JAG1	182	Facies	MESH:D019066	marker/mechanism		NA		9207787|9207788
JAG1	182	Glioblastoma	MESH:D005909	marker/mechanism		NA		21127729
JAG1	182	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		12022040
JAG1	182	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17804716
JAG1	182	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
JAG1	182	Tetralogy of Fallot	MESH:D013771	marker/mechanism		NA	187500	11152664
JAG2	3714	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21036696
JAG2	3714	Carcinoma, Pancreatic Ductal	MESH:D021441	marker/mechanism		NA		19208345
JAG2	3714	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		9531541
JAG2	3714	Glioblastoma	MESH:D005909	marker/mechanism		NA		21127729
JAG2	3714	Lymphangioleiomyomatosis	MESH:D018192	marker/mechanism		NA		20038814
JAG2	3714	Syndactyly	MESH:D013576	marker/mechanism		NA		9531541
JAGN1	84522	Neutropenia	MESH:D009503	marker/mechanism		NA		25129144|25129145
JAGN1	84522	NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE	OMIM:616022	marker/mechanism		NA	616022	
JAK1	3716	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
JAK2	3717	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		17989398
JAK2	3717	Budd-Chiari Syndrome	MESH:D006502	marker/mechanism		NA	600880	16762626|19293426
JAK2	3717	Calcinosis	MESH:D002114	marker/mechanism		NA		21335463
JAK2	3717	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		20228799|21297633
JAK2	3717	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		29047144
JAK2	3717	Heart Valve Diseases	MESH:D006349	marker/mechanism		NA		21335463
JAK2	3717	Inflammation	MESH:D007249	therapeutic		NA		20943775
JAK2	3717	Leukemia	MESH:D007938	marker/mechanism		NA		19636672
JAK2	3717	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA	601626	16247455
JAK2	3717	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
JAK2	3717	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		28100771
JAK2	3717	Mesenteric Vascular Occlusion	MESH:D008641	marker/mechanism		NA		20434300
JAK2	3717	Myeloproliferative Disorders	MESH:D009196	marker/mechanism		NA		22087750|29047144
JAK2	3717	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		15746188|16214533
JAK2	3717	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		28100771
JAK2	3717	Polycythemia	MESH:D011086	marker/mechanism		NA		17267906
JAK2	3717	Polycythemia, primary familial and congenital	MESH:C536842	marker/mechanism		NA	133100	
JAK2	3717	Polycythemia Vera	MESH:D011087	marker/mechanism		NA	263300	15781101|15793561|15858187|16484586|17267906|18717827|19154659|19287382|19287384|20160369|21942426
JAK2	3717	Pregnancy Complications	MESH:D011248	marker/mechanism		NA		19636672
JAK2	3717	Primary Myelofibrosis	MESH:D055728	marker/mechanism		NA	254450	15781101|15858187|16951397|19154659|19287382|19287384|19287385|19636672|21942426
JAK2	3717	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
JAK2	3717	Thrombocythemia, Essential	MESH:D013920	marker/mechanism		NA		15781101|15858187|16484586|16896569|19154659|19636672|20434300|21942426
JAK2	3717	Thrombocytosis	MESH:D013922	marker/mechanism		NA	614521	19287382|19287384
JAK2	3717	Thromboembolism	MESH:D013923	marker/mechanism		NA		19636672
JAK2	3717	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		27470402
JAK2	3717	Venous Thrombosis	MESH:D020246	marker/mechanism		NA		20434300
JAK3	3718	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
JAK3	3718	Leukemia, Myelomonocytic, Juvenile	MESH:D054429	marker/mechanism		NA		23832011
JAK3	3718	Lymphoma, B-Cell	MESH:D016393	marker/mechanism		NA		24837469
JAK3	3718	Lymphoma, Extranodal NK-T-Cell	MESH:D054391	marker/mechanism		NA		22705984|23689514
JAK3	3718	Mediastinal Neoplasms	MESH:D008479	marker/mechanism		NA		24837469
JAK3	3718	Severe Combined Immunodeficiency	MESH:D016511	marker/mechanism		NA		15220007|15661026
JAK3	3718	Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Positive, NK Cell-Negative	MESH:C563440	marker/mechanism		NA	600802	
JAKMIP1	152789	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17519220
JAKMIP2	9832	Melanoma	MESH:D008545	marker/mechanism		NA		22842228
JAM3	83700	HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION, AND CATARACTS	OMIM:613730	marker/mechanism		NA	613730	
JARID2	3720	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		21308764
JAZF1	221895	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		18372903
JAZF1	221895	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		18264096
JAZF1	221895	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		19838195
JAZF1	221895	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		18264096
JCAD	57608	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		21378988
JDP2	122953	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		20214788
JDP2	122953	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
JMJD1C	221037	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
JMJD1C	221037	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17290275
JMJD1C	221037	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
JMJD2C	100329036	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
JMJD6	23210	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		30619488
JMJD6	23210	Melanoma	MESH:D008545	marker/mechanism		NA		30619488
JMJD6	23210	Melanoma, Cutaneous Malignant	MESH:C562393	marker/mechanism		NA		30619488
JMJD6	23210	Mesothelioma	MESH:D008654	marker/mechanism		NA		30619488
JMJD6	23210	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		30619488
JMJD6	23210	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		30619488
JMJD6	23210	Uveal melanoma	MESH:C536494	marker/mechanism		NA		30619488
JPH1	56704	Charcot-Marie-Tooth disease, Type 2K	MESH:C535418	marker/mechanism		NA	607831	
JPH2	57158	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 17	OMIM:613873	marker/mechanism		NA	613873	
JPH3	57338	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17892325
JPH3	57338	Huntington Disease-Like 2	MESH:C564708	marker/mechanism		NA	606438	
JRK	8629	Epilepsy, Absence	MESH:D004832	marker/mechanism		NA		11463517
JRK	8629	Epilepsy, Generalized	MESH:D004829	marker/mechanism		NA		11463517
JRK	8629	Myoclonic Epilepsy, Juvenile	MESH:D020190	marker/mechanism		NA		11463517
JSRP1	126306	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
JUN	3725	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
JUN	3725	Brain Injuries	MESH:D001930	marker/mechanism		NA		21549006
JUN	3725	Brain Ischemia	MESH:D002545	marker/mechanism		NA		17901229
JUN	3725	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037
JUN	3725	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		20214788
JUN	3725	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		21726611|8777434
JUN	3725	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		28789951
JUN	3725	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		12628520|18283038
JUN	3725	Heat Stroke	MESH:D018883	marker/mechanism		NA		24039931
JUN	3725	Hemangiosarcoma	MESH:D006394	marker/mechanism		NA		17569031
JUN	3725	Hypertension	MESH:D006973	marker/mechanism		NA		24039778
JUN	3725	Intestinal Polyps	MESH:D007417	marker/mechanism		NA		12584176
JUN	3725	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		12127263|24183702
JUN	3725	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		20716630
JUN	3725	Mercury Poisoning, Nervous System	MESH:D020262	marker/mechanism		NA		15515958
JUN	3725	Osteosarcoma	MESH:D012516	marker/mechanism		NA		18645001
JUN	3725	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		17686523
JUN	3725	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		7922267
JUN	3725	Silicosis	MESH:D012829	marker/mechanism		NA		27621875
JUN	3725	Status Epilepticus	MESH:D013226	marker/mechanism		NA		7984056
JUN	3725	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		17355264
JUNB	3726	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		24366584
JUNB	3726	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		12374626
JUNB	3726	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		16289808|27935865
JUNB	3726	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
JUNB	3726	Status Epilepticus	MESH:D013226	marker/mechanism		NA		7984056
JUND	3727	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
JUND	3727	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		30515189
JUND	3727	Cocaine-Related Disorders	MESH:D019970	therapeutic		NA		17898221
JUND	3727	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		18443593
JUND	3727	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		17133482
JUND	3727	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
JUND	3727	Status Epilepticus	MESH:D013226	marker/mechanism		NA		7984056
JUP	3728	Arrhythmogenic Right Ventricular Dysplasia, Familial, 12	MESH:C566925	marker/mechanism		NA	611528	
JUP	3728	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
JUP	3728	Naxos disease	MESH:C538346	marker/mechanism		NA	601214	
JUP	3728	No-Reflow Phenomenon	MESH:D054318	therapeutic		NA		16824628
JUP	3728	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
JUS	43453	Paralysis	MESH:D010243	marker/mechanism		NA		14978727
JUS	43453	Seizures	MESH:D012640	marker/mechanism		NA		14978727
KANK1	23189	Cerebral Palsy, Spastic Quadriplegic, 2	MESH:C567867	marker/mechanism		NA	612900	
KANK1	23189	Cholestasis	MESH:D002779	marker/mechanism		NA		27989131
KANK1	23189	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
KANK2	25959	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
KANK2	25959	PALMOPLANTAR KERATODERMA AND WOOLLY HAIR	OMIM:616099	marker/mechanism		NA	616099	
KANSL1	284058	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
KANSL1	284058	Chromosome 17 deletion	MESH:C538045	marker/mechanism		NA		22544363|22544367
KANSL1	284058	Chromosome 17q21.31 Deletion Syndrome	MESH:C566476	marker/mechanism		NA	610443	
KANSL1	284058	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		22544363|22544367
KANSL1	284058	Intellectual Disability	MESH:D008607	marker/mechanism		NA		22544363|22544367
KANSL1	284058	Leukemia, Megakaryoblastic, of Down Syndrome	MESH:C566025	marker/mechanism		NA		24056718
KANSL1	284058	Muscle Hypotonia	MESH:D009123	marker/mechanism		NA		22544363|22544367
KANSL1	284058	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		31043753
KANSL1-AS1	644246	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
KARS1	3735	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B	OMIM:613641	marker/mechanism		NA	613641	
KARS1	3735	DEAFNESS, AUTOSOMAL RECESSIVE 89	OMIM:613916	marker/mechanism		NA	613916	
KAT6A	7994	ARBOLEDA-THAM SYNDROME	OMIM:616268	marker/mechanism		NA	616268	
KAT6A	7994	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
KAT6A	7994	Medulloblastoma	MESH:D008527	marker/mechanism		NA		19270706
KAT6A	7994	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29662167
KAT6B	23522	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
KAT6B	23522	Genitopatellar Syndrome	MESH:C565255	marker/mechanism		NA	606170	
KAT6B	23522	Young Simpson syndrome	MESH:C536717	marker/mechanism		NA	603736	
KAT8	84148	Cardiomyopathy, Hypertrophic	MESH:D002312	marker/mechanism		NA		27768893
KAT8	84148	Heart Failure	MESH:D006333	marker/mechanism		NA		27768893
KATNAL2	83473	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
KATNB1	10300	LISSENCEPHALY 6 WITH MICROCEPHALY	OMIM:616212	marker/mechanism		NA	616212	
KB15	366992	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
KBTBD11	9920	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
KBTBD13	390594	Nemaline myopathy 6	MESH:C538398	marker/mechanism		NA	609273	
KCNA1	3736	Episodic Ataxia, Type 1	MESH:C563278	marker/mechanism		NA	160120	
KCNA2	3737	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32	OMIM:616366	marker/mechanism		NA	616366	
KCNA2	3737	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		15088113
KCNA2	3737	Intellectual Disability	MESH:D008607	marker/mechanism		NA		25751627
KCNA2	3737	Language Development Disorders	MESH:D007805	marker/mechanism		NA		25751627
KCNA2	3737	Seizures	MESH:D012640	marker/mechanism		NA		25751627
KCNA5	3741	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		19698954
KCNA5	3741	Atrial Fibrillation, Familial, 7	MESH:C567389	marker/mechanism		NA	612240	
KCNA5	3741	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		27522126
KCNAB2	8514	Epilepsy	MESH:D004827	marker/mechanism		NA		11580756
KCNB1	3745	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 26	OMIM:616056	marker/mechanism		NA	616056	
KCNB1	3745	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		15088113
KCNB1	3745	Schizophrenia	MESH:D012559	marker/mechanism		NA		26240432
KCNC1	3746	Myoclonic Epilepsies, Progressive	MESH:D020191	marker/mechanism		NA	616187	25401298
KCNC3	3748	Spinocerebellar ataxia 13	MESH:C537195	marker/mechanism		NA	605259	
KCNC4	3749	Epilepsy, Temporal Lobe	MESH:D004833	marker/mechanism		NA		20971086
KCND3	3752	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		28416822|29892015|30061737
KCND3	3752	BRUGADA SYNDROME 9	OMIM:616399	marker/mechanism		NA	616399	
KCND3	3752	Spinocerebellar ataxia 19	MESH:C537198	marker/mechanism		NA	607346	
KCNE1	3753	Hearing Loss, Noise-Induced	MESH:D006317	marker/mechanism		NA		16823764
KCNE1	3753	Jervell And Lange-Nielsen Syndrome 2	MESH:C567343	marker/mechanism		NA	612347	
KCNE1	3753	Jervell-Lange Nielsen Syndrome	MESH:D029593	marker/mechanism		NA		9354783
KCNE1	3753	Long QT Syndrome	MESH:D008133	marker/mechanism		NA		14510655|18329740|9354802
KCNE1	3753	Long Qt Syndrome 5	MESH:C566766	marker/mechanism		NA	613695	
KCNE2	9992	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		15368194
KCNE2	9992	Atrial Fibrillation, Familial, 4	MESH:C566244	marker/mechanism		NA	611493	
KCNE2	9992	Long QT Syndrome	MESH:D008133	marker/mechanism		NA		10219239|10984545|14510655
KCNE2	9992	Long Qt Syndrome 6	MESH:C566333	marker/mechanism		NA	613693	
KCNE2	9992	Ventricular Fibrillation	MESH:D014693	marker/mechanism		NA		10219239
KCNE3	10008	Brugada Syndrome 6	MESH:C567735	marker/mechanism		NA	613119	
KCNH1	3756	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17520698
KCNH1	3756	Epilepsy	MESH:D004827	marker/mechanism		NA		25420144|29942082
KCNH1	3756	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		29942082
KCNH1	3756	Osteosarcoma	MESH:D012516	marker/mechanism		NA		22248279
KCNH1	3756	Temple-Baraitser Syndrome	MESH:C567516	marker/mechanism		NA	611816	25420144
KCNH1	3756	Zimmerman Laband syndrome	MESH:C536725	marker/mechanism		NA	135500	25915598
KCNH2	3757	Arrhythmias, Cardiac	MESH:D001145	marker/mechanism		NA		14678746|15673388|18250272
KCNH2	3757	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
KCNH2	3757	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		24830940
KCNH2	3757	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		16086867
KCNH2	3757	Long QT Syndrome	MESH:D008133	marker/mechanism		NA		11741928|12070109|14510655|15043509|15213294|17467628|18329740|18848812|19057127|19583963|20211602|20513597|21650221|22396785|23103450|25107562|28768059|7889573|8635257
KCNH2	3757	Long Qt Syndrome 2	MESH:C563614	marker/mechanism		NA	613688	
KCNH2	3757	Muscular Atrophy	MESH:D009133	marker/mechanism		NA		16723379
KCNH2	3757	Neoplasms	MESH:D009369	marker/mechanism		NA		24830940
KCNH2	3757	Short QT Syndrome 1	MESH:C566506	marker/mechanism		NA	609620	18724381|29574456
KCNH2	3757	Torsades de Pointes	MESH:D016171	marker/mechanism		NA		15043509|15213294|20034863
KCNJ1	3758	Bartter Syndrome	MESH:D001477	marker/mechanism		NA		10561751|12911542|22275899
KCNJ1	3758	Bartter syndrome, antenatal , type 2	MESH:C537651	marker/mechanism		NA	241200	
KCNJ1	3758	Hypertension	MESH:D006973	marker/mechanism		NA		22228705
KCNJ10	3766	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT	OMIM:600791	marker/mechanism		NA	600791	
KCNJ10	3766	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		24070676
KCNJ10	3766	Pendred syndrome	MESH:C536648	marker/mechanism		NA	274600	
KCNJ10	3766	SeSAME syndrome	MESH:C557674	marker/mechanism		NA	612780	
KCNJ11	3767	Congenital Hyperinsulinism	MESH:D044903	marker/mechanism		NA	601820	15579781
KCNJ11	3767	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		16123366
KCNJ11	3767	Diabetes Mellitus, Permanent Neonatal	MESH:C563425	marker/mechanism		NA	606176	
KCNJ11	3767	Diabetes Mellitus, Transient Neonatal, 3	MESH:C566432	marker/mechanism		NA	610582	
KCNJ11	3767	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		18025464
KCNJ11	3767	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA	125853	16123366|22209866
KCNJ11	3767	Insulin Resistance	MESH:D007333	marker/mechanism		NA		9032110
KCNJ11	3767	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13	OMIM:616329	marker/mechanism		NA	616329	
KCNJ11	3767	Seizures	MESH:D012640	marker/mechanism		NA		18021373
KCNJ13	3769	LEBER CONGENITAL AMAUROSIS 16	OMIM:614186	marker/mechanism		NA	614186	
KCNJ13	3769	Snowflake vitreoretinal degeneration	MESH:C536677	marker/mechanism		NA	193230	
KCNJ15	3772	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
KCNJ18	100134444	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2	OMIM:613239	marker/mechanism		NA	613239	
KCNJ2	3759	Andersen Syndrome	MESH:D050030	marker/mechanism		NA	170390	17399643|19931173
KCNJ2	3759	Arrhythmias, Cardiac	MESH:D001145	marker/mechanism		NA		17399643|17546530
KCNJ2	3759	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
KCNJ2	3759	ATRIAL FIBRILLATION, FAMILIAL, 9	OMIM:613980	marker/mechanism		NA	613980	
KCNJ2	3759	Short QT Syndrome 3	MESH:C566504	marker/mechanism		NA	609622	
KCNJ2	3759	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
KCNJ2	3759	Tachycardia, Ventricular	MESH:D017180	marker/mechanism		NA		17546530
KCNJ4	3761	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		30512237
KCNJ4	3761	Nerve Degeneration	MESH:D009410	therapeutic		NA		18619942
KCNJ4	3761	Parkinson Disease	MESH:D010300	therapeutic		NA		18619942
KCNJ5	3762	Adenoma	MESH:D000236	marker/mechanism		NA		23913001|23913004
KCNJ5	3762	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
KCNJ5	3762	Heart Block	MESH:D006327	therapeutic		NA		26831068
KCNJ5	3762	HYPERALDOSTERONISM, FAMILIAL, TYPE III	OMIM:613677	marker/mechanism		NA	613677	
KCNJ5	3762	LONG QT SYNDROME 13	OMIM:613485	marker/mechanism		NA	613485	
KCNJ5	3762	Sick Sinus Syndrome	MESH:D012804	therapeutic		NA		26831068
KCNJ6	3763	KEPPEN-LUBINSKY SYNDROME	OMIM:614098	marker/mechanism		NA	614098	
KCNJ6	3763	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		15256069
KCNJ8	3764	Cantu syndrome	MESH:C535572	marker/mechanism		NA		28842488
KCNJ8	3764	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		19120683
KCNJ8	3764	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
KCNJ8	3764	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
KCNJ8	3764	Ventricular Fibrillation	MESH:D014693	marker/mechanism		NA		19120683
KCNK1	3775	Hyperplasia	MESH:D006965	therapeutic		NA		23291559
KCNK16	83795	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		22158537
KCNK18	338567	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 13	OMIM:613656	marker/mechanism		NA	613656	
KCNK2	3776	Depressive Disorder	MESH:D003866	marker/mechanism		NA		21871532
KCNK3	3777	Familial Primary Pulmonary Hypertension	MESH:D065627	marker/mechanism		NA	615344	
KCNK3	3777	Gliosis	MESH:D005911	marker/mechanism		NA		18671295
KCNK3	3777	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		30365877
KCNK3	3777	Stroke	MESH:D020521	marker/mechanism		NA		29531354
KCNK5	8645	Status Epilepticus	MESH:D013226	marker/mechanism		NA		19220408
KCNK9	51305	Birk-Barel Mental Retardation Dysmorphism Syndrome	MESH:C567357	marker/mechanism		NA	612292	
KCNK9	51305	Epilepsy, Absence	MESH:D004832	marker/mechanism		NA		15781965
KCNMA1	3778	Autistic Disorder	MESH:D001321	marker/mechanism		NA		16946189
KCNMA1	3778	Bone Diseases, Metabolic	MESH:D001851	marker/mechanism		NA		21695131
KCNMA1	3778	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		23797736
KCNMA1	3778	Generalized Epilepsy and Paroxysmal Dyskinesia	MESH:C563719	marker/mechanism		NA	609446	
KCNMA1	3778	Growth Disorders	MESH:D006130	marker/mechanism		NA		28242822
KCNMA1	3778	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		15088113
KCNMA1	3778	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		28090300
KCNMA1	3778	Obesity	MESH:D009765	marker/mechanism		NA		27605626
KCNMA1	3778	Obesity, Morbid	MESH:D009767	marker/mechanism		NA		21708048
KCNMA1	3778	Perinatal Death	MESH:D066087	marker/mechanism		NA		28242822
KCNMA1	3778	Status Epilepticus	MESH:D013226	marker/mechanism		NA		18695509
KCNMA1	3778	Weight Gain	MESH:D015430	marker/mechanism		NA		27605626
KCNMB1	3779	Hypertension	MESH:D006973	marker/mechanism		NA		17700361
KCNMB1	3779	Hypertension, Diastolic, Resistance to	MESH:C563897	marker/mechanism		NA	608622	
KCNMB1	3779	Weight Gain	MESH:D015430	marker/mechanism		NA		27288421
KCNN2	3781	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
KCNN2	3781	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
KCNN3	3782	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		20173747|30061737
KCNN4	3783	Xerocytosis, hereditary	MESH:C536764	marker/mechanism		NA	616689	
KCNQ1	3784	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		23975432
KCNQ1	3784	Atrial Fibrillation, Familial, 3	MESH:C563817	marker/mechanism		NA	607554	
KCNQ1	3784	Beckwith-Wiedemann Syndrome	MESH:D001506	marker/mechanism		NA	130650	
KCNQ1	3784	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		18711366|18711367|26551672
KCNQ1	3784	Hearing Loss, Noise-Induced	MESH:D006317	marker/mechanism		NA		16823764
KCNQ1	3784	Intestinal Neoplasms	MESH:D007414	marker/mechanism		NA		23975432
KCNQ1	3784	Jervell-Lange Nielsen Syndrome	MESH:D029593	marker/mechanism		NA	220400	
KCNQ1	3784	Long QT Syndrome	MESH:D008133	marker/mechanism		NA		10868744|14510655|15028050|17467628|18329740|20513597|22910039
KCNQ1	3784	Romano-Ward Syndrome	MESH:D029597	marker/mechanism		NA	192500	15004216
KCNQ1	3784	Short QT Syndrome 2	MESH:C566505	marker/mechanism		NA	609621	
KCNQ1OT1	10984	Beckwith-Wiedemann Syndrome	MESH:D001506	marker/mechanism		NA	130650	
KCNQ2	3785	Brain Diseases	MESH:D001927	marker/mechanism		NA		27602407
KCNQ2	3785	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 7	OMIM:613720	marker/mechanism		NA	613720	
KCNQ2	3785	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		20805988|27602407
KCNQ2	3785	Epilepsy	MESH:D004827	marker/mechanism		NA		16464983|29942082
KCNQ2	3785	Epilepsy, Benign Neonatal	MESH:D020936	marker/mechanism		NA		19380078|26910900
KCNQ2	3785	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		20805988
KCNQ2	3785	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		29942082
KCNQ2	3785	Seizures	MESH:D012640	marker/mechanism		NA		27602407
KCNQ2	3785	SEIZURES, BENIGN FAMILIAL NEONATAL, 1	OMIM:121200	marker/mechanism		NA	121200	
KCNQ3	3786	SEIZURES, BENIGN FAMILIAL NEONATAL, 2	OMIM:121201	marker/mechanism		NA	121201	
KCNQ4	9132	Deafness, Autosomal Dominant 2A	MESH:C567441	marker/mechanism		NA	600101	
KCNQ4	9132	Hearing Loss, Noise-Induced	MESH:D006317	marker/mechanism		NA		16823764
KCNQ5	56479	Hernias, Diaphragmatic, Congenital	MESH:D065630	marker/mechanism		NA		28189443
KCNQ5	56479	Myopia	MESH:D009216	marker/mechanism		NA		23396134
KCNT1	57582	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 14	OMIM:614959	marker/mechanism		NA	614959	
KCNT1	57582	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		23086397
KCNT1	57582	Epilepsies, Partial	MESH:D004828	marker/mechanism		NA		23086397
KCNT1	57582	Epilepsy, Frontal Lobe	MESH:D017034	marker/mechanism		NA		23086396
KCNT1	57582	EPILEPSY, NOCTURNAL FRONTAL LOBE, 5	OMIM:615005	marker/mechanism		NA	615005	
KCNU1	157855	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28869590
KCNV2	169522	Retinal Cone Dystrophy 3B	MESH:C563678	marker/mechanism		NA	610356	
KCTD1	284252	Scalp ear nipple syndrome	MESH:C536623	marker/mechanism		NA	181270	
KCTD15	79047	Obesity	MESH:D009765	marker/mechanism		NA		19079261
KCTD17	79734	Myoclonic dystonia	MESH:C536096	marker/mechanism		NA	616398	
KCTD7	154881	EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	OMIM:611726	marker/mechanism		NA	611726	
KDELR1	10945	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
KDF1	126695	ECTODERMAL DYSPLASIA 12, HYPOHIDROTIC/HAIR/TOOTH/NAIL TYPE	OMIM:617337	marker/mechanism		NA	617337	
KDM1A	23028	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		22493729
KDM1A	23028	CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	OMIM:616728	marker/mechanism		NA	616728	
KDM1A	23028	Clinical Deterioration	MESH:D000075902	marker/mechanism		NA		29438700
KDM1A	23028	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		25043185
KDM1A	23028	Critical Illness	MESH:D016638	marker/mechanism		NA		22493729
KDM1A	23028	Disease Progression	MESH:D018450	marker/mechanism		NA		22493729
KDM1A	23028	Hyperplasia	MESH:D006965	marker/mechanism		NA		22493729
KDM1A	23028	Lymphoma, T-Cell	MESH:D016399	marker/mechanism		NA		29438700
KDM1A	23028	Melanoma	MESH:D008545	marker/mechanism		NA		29438700
KDM1A	23028	Melanoma, Experimental	MESH:D008546	marker/mechanism		NA		29438700
KDM1A	23028	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		22493729
KDM1A	23028	Prostatic Neoplasms, Castration-Resistant	MESH:D064129	marker/mechanism		NA		29581250
KDM1B	221656	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
KDM2A	22992	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		25944804
KDM2A	22992	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
KDM2B	84678	Schizophrenia	MESH:D012559	marker/mechanism		NA		21743468
KDM3B	51780	Heavy Metal Poisoning	MESH:D000075322	therapeutic		NA		21262293
KDM4A	9682	Melanoma	MESH:D008545	marker/mechanism		NA		29438700
KDM4B	23030	Medulloblastoma	MESH:D008527	marker/mechanism		NA		19270706
KDM4B	23030	Melanoma	MESH:D008545	marker/mechanism		NA		29438700
KDM4C	23081	Lymphoma, T-Cell	MESH:D016399	marker/mechanism		NA		29438700
KDM4C	23081	Medulloblastoma	MESH:D008527	marker/mechanism		NA		19270706
KDM4C	23081	Melanoma	MESH:D008545	marker/mechanism		NA		29438700
KDM4C	23081	Melanoma, Experimental	MESH:D008546	marker/mechanism		NA		29438700
KDM5A	5927	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
KDM5B	10765	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		25043185
KDM5C	8242	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18203167
KDM5C	8242	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		22138691
KDM5C	8242	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21076407
KDM5C	8242	Mental Retardation, X-Linked, Syndromic, Jarid1c-Related	MESH:C564494	marker/mechanism		NA	300534	
KDM5D	8284	Spermatogenic Failure, Nonobstructive, Y-Linked	MESH:C564030	marker/mechanism		NA	415000	
KDM6A	7403	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
KDM6A	7403	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		21822268
KDM6A	7403	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		25151357
KDM6A	7403	Kabuki syndrome	MESH:C537705	marker/mechanism		NA	147920|300867	
KDM6A	7403	Neoplasms	MESH:D009369	marker/mechanism		NA		19330029
KDM6A	7403	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
KDM6A	7403	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		21822268
KDM6B	23135	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
KDM6B	23135	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
KDM8	79831	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
KDR	3791	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		21472143
KDR	3791	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20135347
KDR	3791	Cerebral Hemorrhage	MESH:D002543	marker/mechanism		NA		17888890
KDR	3791	Colorectal Neoplasms	MESH:D015179	therapeutic		NA		20346928
KDR	3791	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		18630688
KDR	3791	Epilepsy, Temporal Lobe	MESH:D004833	marker/mechanism		NA		17533168
KDR	3791	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		21472143
KDR	3791	Hemangioma, capillary infantile	MESH:C535860	marker/mechanism		NA	602089	
KDR	3791	Hemangiosarcoma	MESH:D006394	marker/mechanism		NA		17569031
KDR	3791	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		11956651
KDR	3791	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
KDR	3791	Neovascularization, Pathologic	MESH:D009389	marker/mechanism		NA		17533168
KDR	3791	Osteochondrodysplasias	MESH:D010009	marker/mechanism		NA		17954590
KDR	3791	Pancreatic Neoplasms	MESH:D010190	therapeutic		NA		12385004
KDR	3791	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		16526316
KDR	3791	Schizophrenia	MESH:D012559	marker/mechanism		NA		21647420
KDR	3791	Uremia	MESH:D014511	marker/mechanism		NA		19092814
KDR	3791	Venous Thrombosis	MESH:D020246	marker/mechanism		NA		26600200
KDSR	2531	Lymphoma, Follicular	MESH:D008224	marker/mechanism		NA		25526675
KEAP1	9817	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		22684020
KEAP1	9817	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		23797736
KEAP1	9817	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		30026087
KEAP1	9817	Disease Progression	MESH:D018450	marker/mechanism		NA		20124447
KEAP1	9817	Gallbladder Neoplasms	MESH:D005706	marker/mechanism		NA		18692501
KEAP1	9817	Gastrointestinal Diseases	MESH:D005767	marker/mechanism		NA		20404090
KEAP1	9817	Hepatic Insufficiency	MESH:D048550	marker/mechanism		NA		30026087
KEAP1	9817	Hepatitis	MESH:D006505	marker/mechanism		NA		20404090
KEAP1	9817	Hepatomegaly	MESH:D006529	marker/mechanism		NA		30026087
KEAP1	9817	Keratosis	MESH:D007642	marker/mechanism		NA		20404090
KEAP1	9817	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		30026087
KEAP1	9817	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		24763052|29610475
KERA	11081	Cornea Plana 2	MESH:C565677	marker/mechanism		NA	217300	
KHDC3L	154288	Hydatidiform Mole	MESH:D006828	marker/mechanism		NA	614293	
KHDRBS2	202559	Melanoma	MESH:D008545	marker/mechanism		NA		21499247
KHK	3795	Fructosuria	MESH:C538068	marker/mechanism		NA	229800	18035330|7833921
KHSRP	8570	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941189
KIAA0586	9786	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		15554946
KIAA0586	9786	Polydactyly	MESH:D017689	marker/mechanism		NA		15554946
KIAA0586	9786	Short Rib-Polydactyly Syndrome	MESH:D012779	marker/mechanism		NA	616546	
KIAA0753	9851	OROFACIODIGITAL SYNDROME XV	OMIM:617127	marker/mechanism		NA	617127	
KIAA1549	57670	Astrocytoma	MESH:D001254	marker/mechanism		NA		23817572
KIF11	3832	Aneuploidy	MESH:D000782	marker/mechanism		NA		17974955
KIF11	3832	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
KIF11	3832	Chromosomal Instability	MESH:D043171	marker/mechanism		NA		17974955
KIF11	3832	MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION	OMIM:152950	marker/mechanism		NA	152950	
KIF11	3832	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		17974955
KIF14	9928	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
KIF15	56992	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
KIF15	56992	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		25133636
KIF18A	81930	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
KIF18B	146909	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
KIF18B	146909	Melanoma	MESH:D008545	marker/mechanism		NA		31617652
KIF1A	547	Autistic Disorder	MESH:D001321	marker/mechanism		NA		30559488
KIF1A	547	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		30559488
KIF1A	547	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		23776493
KIF1A	547	NESCAV SYNDROME	OMIM:614255	marker/mechanism		NA	614255	
KIF1A	547	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA	OMIM:201300	marker/mechanism		NA	201300	
KIF1A	547	NEUROPATHY, HEREDITARY SENSORY, TYPE IIC	OMIM:614213	marker/mechanism		NA	614213	
KIF1A	547	Spastic Paraplegia 30, Autosomal Recessive	MESH:C563677	marker/mechanism		NA	610357	
KIF1B	23095	Charcot-Marie-Tooth Disease, Axonal, Type 2a1	MESH:C566138	marker/mechanism		NA	118210	
KIF1B	23095	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		18997785
KIF1B	23095	Neuroblastoma	MESH:D009447	marker/mechanism		NA	256700	
KIF1B	23095	Pheochromocytoma	MESH:D010673	marker/mechanism		NA	171300	
KIF1C	10749	Ataxia, Spastic, 2, Autosomal Recessive	MESH:C566969	marker/mechanism		NA	611302	
KIF20A	10112	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
KIF21A	55605	Fibrosis of Extraocular Muscles, Congenital, 3B	MESH:C567739	marker/mechanism		NA	135700	
KIF21A	55605	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941189
KIF21B	23046	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		20228799
KIF23	9493	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
KIF2A	3796	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3	OMIM:615411	marker/mechanism		NA	615411	
KIF2A	3796	Malformations of Cortical Development	MESH:D054220	marker/mechanism		NA		23603762
KIF2A	3796	Microcephaly	MESH:D008831	marker/mechanism		NA		23603762
KIF2C	11004	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
KIF2C	11004	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
KIF3A	11127	Asthma	MESH:D001249	marker/mechanism		NA		21912604
KIF3A	11127	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		17698054
KIF3A	11127	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		17698054
KIF3A	11127	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
KIF3A	11127	Polydactyly	MESH:D017689	marker/mechanism		NA		17698054
KIF3C	3797	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
KIF3C	3797	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
KIF4A	24137	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
KIF4A	24137	MENTAL RETARDATION, X-LINKED 100	OMIM:300923	marker/mechanism		NA	300923	
KIF5A	3798	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		23143596
KIF5A	3798	MYOCLONUS, INTRACTABLE, NEONATAL	OMIM:617235	marker/mechanism		NA	617235	
KIF5A	3798	Spastic paraplegia 10, autosomal dominant	MESH:C537482	marker/mechanism		NA	604187	
KIF5B	3799	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		21757253
KIF5B	3799	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		23776493
KIF5C	3800	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2	OMIM:615282	marker/mechanism		NA	615282	
KIF5C	3800	Malformations of Cortical Development	MESH:D054220	marker/mechanism		NA		23603762
KIF5C	3800	Microcephaly	MESH:D008831	marker/mechanism		NA		23603762
KIF6	221458	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		21943003
KIF7	374654	Acrocallosal Syndrome	MESH:D055673	marker/mechanism		NA	200990	21552264
KIF7	374654	Cleft Palate	MESH:D002972	marker/mechanism		NA		21552264
KIF7	374654	Hydrolethalus syndrome	MESH:C536079	marker/mechanism		NA		21552264
KIF7	374654	Hydrolethalus Syndrome 1	MESH:C565504	marker/mechanism		NA	614120	
KIF7	374654	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
KIF7	374654	Macrocephaly with Multiple Epiphyseal Dysplasia and Distinctive Facies	MESH:C564621	marker/mechanism		NA	607131	
KIFBP	26128	Goldberg-Shprintzen megacolon syndrome	MESH:C537279	marker/mechanism		NA	609460	15883926
KIFBP	26128	Intellectual Disability	MESH:D008607	marker/mechanism		NA		15883926
KIFBP	26128	Malformations of Cortical Development	MESH:D054220	marker/mechanism		NA		15883926
KIFBP	26128	Microcephaly	MESH:D008831	marker/mechanism		NA		15883926
KIFC1	3833	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
KIFC1	3833	Triple Negative Breast Neoplasms	MESH:D064726	marker/mechanism		NA		26177331
KIR3DL1	3811	HIV Infections	MESH:D015658	marker/mechanism		NA	609423	17496894
KISS1	3814	HYPOGONADOTROPIC HYPOGONADISM 13 WITH OR WITHOUT ANOSMIA	OMIM:614842	marker/mechanism		NA	614842	
KISS1	3814	Lymphatic Metastasis	MESH:D008207	therapeutic		NA		21383688
KISS1	3814	Puberty, Delayed	MESH:D011628	marker/mechanism		NA		21527035
KISS1	3814	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	therapeutic		NA		21383688
KISS1	3814	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
KISS1R	84634	HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA	OMIM:614837	marker/mechanism		NA	614837	
KISS1R	84634	Puberty, Delayed	MESH:D011628	marker/mechanism		NA		21527035
KISS1R	84634	Puberty, Precocious	MESH:D011629	marker/mechanism		NA	176400	
KISS1R	84634	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
KIT	3815	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20941507
KIT	3815	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		24688052
KIT	3815	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA	606764	16740725|20028860|27793025
KIT	3815	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA	601626	
KIT	3815	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		26285909
KIT	3815	Lung Diseases	MESH:D008171	marker/mechanism		NA		21471107
KIT	3815	Mastocytosis	MESH:D008415	marker/mechanism		NA	154800	
KIT	3815	Mastocytosis, Systemic	MESH:D034721	marker/mechanism		NA		16597595
KIT	3815	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		23056237
KIT	3815	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		22277784
KIT	3815	Neuroectodermal Tumors, Primitive, Peripheral	MESH:D018241	marker/mechanism		NA		15618851
KIT	3815	Piebaldism	MESH:D016116	marker/mechanism		NA	172800	
KIT	3815	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		15499612
KIT	3815	Testicular Germ Cell Tumor	MESH:C563236	marker/mechanism		NA	273300	
KITL	17311	Chemical and Drug Induced Liver Injury	MESH:D056486	therapeutic		NA		12594235
KITL	17311	Mastocytosis, Cutaneous	MESH:D034701	marker/mechanism		NA		20559008
KITL	17311	Obesity	MESH:D009765	marker/mechanism		NA		23954404
KITLG	4254	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
KITLG	4254	Carcinoma, Pancreatic Ductal	MESH:D021441	marker/mechanism		NA		24979617
KITLG	4254	DEAFNESS, AUTOSOMAL DOMINANT 69	OMIM:616697	marker/mechanism		NA	616697	
KITLG	4254	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	therapeutic		NA		1720698
KITLG	4254	HYPERPIGMENTATION WITH OR WITHOUT HYPOPIGMENTATION, FAMILIAL PROGRESSIVE	OMIM:145250	marker/mechanism		NA	145250	
KITLG	4254	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
KITLG	4254	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
KITLG	4254	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
KITLG	4254	Nasal Polyps	MESH:D009298	marker/mechanism		NA		15813808
KITLG	4254	Neoplasms, Germ Cell and Embryonal	MESH:D009373	marker/mechanism		NA		19483681|19483682
KITLG	4254	Testicular Neoplasms	MESH:D013736	marker/mechanism		NA		19483681|19483682
KIZ	55857	RETINITIS PIGMENTOSA 69	OMIM:615780	marker/mechanism		NA	615780	
KL	9365	Aging, Premature	MESH:D019588	marker/mechanism		NA		25550330|9363890
KL	9365	Arteriosclerosis	MESH:D001161	marker/mechanism		NA		9363890
KL	9365	Calcinosis	MESH:D002114	marker/mechanism		NA		17710231
KL	9365	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		12669274
KL	9365	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28869590
KL	9365	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		25550330
KL	9365	Emphysema	MESH:D004646	marker/mechanism		NA		9363890
KL	9365	Hypercalcemia	MESH:D006934	marker/mechanism		NA		17710231
KL	9365	Hypercalcemia, Idiopathic, of Infancy	MESH:C562581	marker/mechanism		NA		20394945
KL	9365	Hypercalciuria, childhood idiopathic	MESH:C536082	marker/mechanism		NA		20394945
KL	9365	Hyperphosphatemia	MESH:D054559	marker/mechanism		NA		17710231
KL	9365	Infertility	MESH:D007246	marker/mechanism		NA		9363890
KL	9365	Kidney Diseases	MESH:D007674	marker/mechanism		NA		23665422
KL	9365	Learning Disabilities	MESH:D007859	marker/mechanism		NA		25309793
KL	9365	Memory Disorders	MESH:D008569	marker/mechanism		NA		25309793|25550330
KL	9365	Osteoporosis	MESH:D010024	marker/mechanism		NA		9363890
KL	9365	Skin Diseases	MESH:D012871	marker/mechanism		NA		9363890
KLB	152831	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		29289645
KLC2	64837	Spastic Paraplegia, Optic Atrophy, and Neuropathy	MESH:C563702	marker/mechanism		NA	609541	
KLF1	10661	Anemia, Dyserythropoietic, Congenital	MESH:D000742	marker/mechanism		NA	613673	
KLF1	10661	Hematologic Diseases	MESH:D006402	marker/mechanism		NA		20676099
KLF11	8462	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
KLF11	8462	Maturity-Onset Diabetes of the Young, Type 7	MESH:C566466	marker/mechanism		NA	610508	
KLF12	11278	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
KLF12	11278	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
KLF13	51621	Chromosome 15q13.3 Microdeletion Syndrome	MESH:C567439	marker/mechanism		NA	612001	
KLF13	51621	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
KLF13	51621	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		29122578
KLF14	136259	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		29632379
KLF14	136259	Dyslipidemias	MESH:D050171	marker/mechanism		NA		29632379
KLF14	136259	Insulin Resistance	MESH:D007333	marker/mechanism		NA		29632379
KLF15	28999	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
KLF2	10365	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		30510241
KLF2	10365	Lung Diseases	MESH:D008171	marker/mechanism		NA		21053160
KLF4	9314	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
KLF4	9314	Congenital Abnormalities	MESH:D000013	marker/mechanism		NA		20439457
KLF4	9314	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		20439457
KLF4	9314	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
KLF4	9314	Thrombosis	MESH:D013927	therapeutic		NA		25339356
KLF5	688	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27158780
KLF5	688	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		27158780
KLF5	688	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		30510241
KLF5	688	Neointima	MESH:D058426	marker/mechanism		NA		16224062
KLF5	688	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		26098869
KLF5	688	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		30639269
KLF5	688	Thyroid Neoplasms	MESH:D013964	therapeutic		NA		32173973
KLF5	688	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		27514407
KLF6	1316	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
KLF6	1316	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA	176807	
KLF6	1316	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA	613659	
KLF9	687	Body Weight	MESH:D001835	marker/mechanism		NA		22344221
KLF9	687	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
KLF9	687	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
KLF9	687	Thyroid Diseases	MESH:D013959	marker/mechanism		NA		23397585
KLHDC10	23008	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
KLHDC7A	127707	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
KLHDC8B	200942	Hodgkin Disease	MESH:D006689	marker/mechanism		NA	236000	
KLHL10	317719	SPERMATOGENIC FAILURE 11	OMIM:615081	marker/mechanism		NA	615081	
KLHL15	80311	MENTAL RETARDATION, X-LINKED 103	OMIM:300982	marker/mechanism		NA	300982	
KLHL24	54800	EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED, WITH SCARRING AND HAIR LOSS	OMIM:617294	marker/mechanism		NA	617294	
KLHL3	26249	Pseudohypoaldosteronism	MESH:D011546	marker/mechanism		NA		22406640
KLHL3	26249	PSEUDOHYPOALDOSTERONISM, TYPE IID	OMIM:614495	marker/mechanism		NA	614495	
KLHL40	131377	NEMALINE MYOPATHY 8	OMIM:615348	marker/mechanism		NA	615348	
KLHL41	10324	NEMALINE MYOPATHY 9	OMIM:615731	marker/mechanism		NA	615731	
KLHL5	51088	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		18438686
KLHL7	55975	Crisponi syndrome	MESH:C536214	marker/mechanism		NA	617055	
KLHL7	55975	Retinitis Pigmentosa 42	MESH:C567854	marker/mechanism		NA	612943	
KLK1	3816	Acute Kidney Injury	MESH:D058186	therapeutic		NA		18227104
KLK1	3816	Diabetic Cardiomyopathies	MESH:D058065	therapeutic		NA		16129698
KLK1	3816	Diabetic Nephropathies	MESH:D003928	therapeutic		NA		19516248
KLK1	3816	Fibrosis	MESH:D005355	therapeutic		NA		18227104
KLK1	3816	Hypertension	MESH:D006973	therapeutic		NA		14568997
KLK1	3816	Kallikrein, Decreased Urinary Activity of	MESH:C563653	marker/mechanism		NA	615953	
KLK1	3816	Myocardial Infarction	MESH:D009203	therapeutic		NA		12411458
KLK10	5655	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
KLK10	5655	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16800735
KLK10	5655	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		20686372
KLK10	5655	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		17182177
KLK2	3817	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		15643194|17085659
KLK3	354	Disease Progression	MESH:D018450	marker/mechanism		NA		12644816
KLK3	354	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		16984552
KLK3	354	Phyllodes Tumor of the Prostate	MESH:C549759	marker/mechanism		NA		22360509
KLK3	354	Prostatic Hyperplasia	MESH:D011470	marker/mechanism		NA		21128595
KLK3	354	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		12644816|15790600|16424004|16442593|16984552|17003774|17148459|18264097|18500220|18676866|27318894
KLK4	9622	Amelogenesis imperfecta pigmented hypomaturation type	MESH:C538242	marker/mechanism		NA	204700	
KLK5	25818	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16517595
KLKB1	3818	Carotid Artery Thrombosis	MESH:D002341	marker/mechanism		NA		25339356
KLKB1	3818	Prekallikrein Deficiency	MESH:C562725	marker/mechanism		NA	612423	
KLKB1	3818	Pulmonary Embolism	MESH:D011655	marker/mechanism		NA		25339356
KLKB1	3818	Thrombosis	MESH:D013927	marker/mechanism		NA		25339356
KLKP1	606293	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16541416
KLLN	100144748	COWDEN SYNDROME 4	OMIM:615107	marker/mechanism		NA	615107	
KLRB1	3820	Melanoma	MESH:D008545	marker/mechanism		NA		17295095
KLRC2	3822	Creutzfeldt-Jakob Syndrome	MESH:D007562	marker/mechanism		NA		23349890
KLRC4	8302	Behcet Syndrome	MESH:D001528	marker/mechanism		NA		23291587
KLRC4	8302	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		18006695
KLRK1	22914	Melanoma	MESH:D008545	marker/mechanism		NA		17295095
KMO	8564	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		16033404
KMO	8564	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
KMT2A	4297	Acute erythroleukemia	MESH:C535673	marker/mechanism		NA		30926971
KMT2A	4297	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		22484628
KMT2A	4297	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		22634756
KMT2A	4297	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		21822268
KMT2A	4297	Chromosome Aberrations	MESH:D002869	marker/mechanism		NA		24736461
KMT2A	4297	Leukemia	MESH:D007938	marker/mechanism		NA		11731795|12937054
KMT2A	4297	Leukemia, Lymphoid	MESH:D007945	marker/mechanism		NA		17463288
KMT2A	4297	Leukemia, Monocytic, Acute	MESH:D007948	marker/mechanism		NA		8282816
KMT2A	4297	Leukemia, Myeloid	MESH:D007951	marker/mechanism		NA		17463288|8282816
KMT2A	4297	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		10339604|26237430
KMT2A	4297	Leukemia, Myelomonocytic, Acute	MESH:D015479	marker/mechanism		NA		8282816
KMT2A	4297	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
KMT2A	4297	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		24736461|25730765
KMT2A	4297	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
KMT2A	4297	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941188
KMT2A	4297	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		22484628
KMT2A	4297	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		21822268
KMT2A	4297	WIEDEMANN-STEINER SYNDROME	OMIM:605130	marker/mechanism		NA	605130	
KMT2B	9757	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		22634754
KMT2B	9757	Dystonia	MESH:D004421	marker/mechanism		NA		27992417
KMT2B	9757	Dystonic Disorders	MESH:D020821	marker/mechanism		NA	617284	
KMT2C	58508	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		22484628
KMT2C	58508	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
KMT2C	58508	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		22634756
KMT2C	58508	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		21822268
KMT2C	58508	Cholangiocarcinoma	MESH:D018281	marker/mechanism		NA		22561520
KMT2C	58508	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		25151357
KMT2C	58508	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		24794707
KMT2C	58508	Liver Diseases, Parasitic	MESH:D008109	marker/mechanism		NA		22561520
KMT2C	58508	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
KMT2C	58508	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
KMT2C	58508	Sezary Syndrome	MESH:D012751	marker/mechanism		NA		26551667
KMT2C	58508	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		22484628
KMT2C	58508	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		21822268
KMT2D	8085	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		26437033
KMT2D	8085	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		25151357
KMT2D	8085	Infertility, Male	MESH:D007248	marker/mechanism		NA		19348672
KMT2D	8085	Kabuki syndrome	MESH:C537705	marker/mechanism		NA	147920	20711175
KMT2D	8085	Lymphoma, Follicular	MESH:D008224	marker/mechanism		NA		24362818
KMT2D	8085	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		21804550
KMT2D	8085	Lymphoma, T-Cell	MESH:D016399	marker/mechanism		NA		26192917
KMT2D	8085	Phyllodes Tumor	MESH:D003557	marker/mechanism		NA		26437033
KMT2D	8085	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
KMT2D	8085	Sezary Syndrome	MESH:D012751	marker/mechanism		NA		26551667
KMT2D	8085	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		24121791
KMT2E	55904	Leukemia	MESH:D007938	marker/mechanism		NA		18818388
KMT2E	55904	Leukemia, Myeloid	MESH:D007951	marker/mechanism		NA		18854576
KMT2E	55904	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
KMT5B	51111	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
KNG1	3827	Acquired angioedema	MESH:C538173	marker/mechanism		NA		9734886
KNG1	3827	Acute Kidney Injury	MESH:D058186	therapeutic		NA		3015452|513486
KNG1	3827	Anaphylaxis	MESH:D000707	marker/mechanism		NA		7623993
KNG1	3827	Angioedemas, Hereditary	MESH:D054179	marker/mechanism		NA		9734886
KNG1	3827	Arrhythmias, Cardiac	MESH:D001145	therapeutic		NA		2535056
KNG1	3827	Bradycardia	MESH:D001919	marker/mechanism		NA		1281941
KNG1	3827	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		20362651|30685357
KNG1	3827	Cough	MESH:D003371	marker/mechanism		NA		22693178
KNG1	3827	Dermatitis, Occupational	MESH:D009783	marker/mechanism		NA		30685357
KNG1	3827	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		30685357
KNG1	3827	Drug Eruptions	MESH:D003875	marker/mechanism|therapeutic		NA		1371395|3034372
KNG1	3827	Edema	MESH:D004487	marker/mechanism		NA		9719496
KNG1	3827	Extravasation of Diagnostic and Therapeutic Materials	MESH:D005119	marker/mechanism		NA		9622145
KNG1	3827	Flaujeac factor deficiency	MESH:C537060	marker/mechanism		NA	228960	
KNG1	3827	Hyperalgesia	MESH:D006930	marker/mechanism		NA		10401557|10499367|10543429|15626726|16259764|16793879|18234883|2010815|2128375|21521205|3061568|7493622|7582491|7881729|9714424|9720808
KNG1	3827	Hyperemia	MESH:D006940	marker/mechanism		NA		11837250
KNG1	3827	Hyperesthesia	MESH:D006941	marker/mechanism		NA		8190269
KNG1	3827	Hypersensitivity	MESH:D006967	marker/mechanism		NA		11160071
KNG1	3827	Hypertension	MESH:D006973	marker/mechanism		NA		7027322
KNG1	3827	Hypotension	MESH:D007022	marker/mechanism		NA		10805402|1334354|14744816|16321614|18084312|21420289|2404862|6675575|9249246
KNG1	3827	Liver Cirrhosis, Experimental	MESH:D008106	therapeutic		NA		18054572
KNG1	3827	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		22248470
KNG1	3827	Myocardial Reperfusion Injury	MESH:D015428	therapeutic		NA		2535056|7856280
KNG1	3827	Pain	MESH:D010146	marker/mechanism		NA		10445233|10543429|1281941|16076651|20018876|29655911|3951883
KNG1	3827	Tachycardia	MESH:D013610	marker/mechanism		NA		7027322
KNL1	57082	Microcephaly, Primary Autosomal Recessive, 4	MESH:C565792	marker/mechanism		NA	604321	
KNL1	57082	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
KNSTRN	90417	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		25194279
KPNA1	3836	Schizophrenia	MESH:D012559	marker/mechanism		NA		21743468
KPNA2	3838	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
KPNA2	3838	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
KPNB1	3837	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		28811376
KPNB1	3837	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
KPTN	11133	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41	OMIM:615637	marker/mechanism		NA	615637	
KRAS	3845	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		11745231|16247444|20101149
KRAS	3845	Adenocarcinoma, Follicular	MESH:D018263	marker/mechanism		NA		27440272
KRAS	3845	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		22071784|22135231|24045185|25184679|26463840
KRAS	3845	Adenoma	MESH:D000236	marker/mechanism		NA		10545420|10813127|25851810|8761429
KRAS	3845	Anemia	MESH:D000740	marker/mechanism		NA		27725143
KRAS	3845	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
KRAS	3845	Astrocytoma	MESH:D001254	marker/mechanism		NA		23817572
KRAS	3845	Breast Neoplasms	MESH:D001943	marker/mechanism		NA	114480	
KRAS	3845	Carcinogenesis	MESH:D063646	marker/mechanism		NA		26595770|29247004
KRAS	3845	Carcinoma	MESH:D002277	marker/mechanism		NA		10545420|20565773
KRAS	3845	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		11286481|11563603
KRAS	3845	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		21336183|22617245|22787409|22887466|23435014|24688052|27588471
KRAS	3845	Carcinoma, Pancreatic Ductal	MESH:D021441	marker/mechanism		NA		25347530|30654191
KRAS	3845	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		19435901|25125259
KRAS	3845	Cardiofaciocutaneous syndrome	MESH:C535579	marker/mechanism		NA	615278	17703371
KRAS	3845	Cecal Neoplasms	MESH:D002430	marker/mechanism		NA		14688030
KRAS	3845	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		27510461
KRAS	3845	Cholangiocarcinoma	MESH:D018281	marker/mechanism		NA		22561520|8968066
KRAS	3845	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		10813127|12800193|12839936|17192441|18372904|19424582
KRAS	3845	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		20565773|21369707|25280562
KRAS	3845	Costello Syndrome	MESH:D056685	marker/mechanism		NA		17468812|17703371
KRAS	3845	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		26390243|27588471
KRAS	3845	Disease Progression	MESH:D018450	marker/mechanism		NA		30654191
KRAS	3845	Endometriosis	MESH:D004715	marker/mechanism		NA		23284138
KRAS	3845	Gallbladder Neoplasms	MESH:D005706	marker/mechanism		NA		24997986
KRAS	3845	Hemangiosarcoma	MESH:D006394	marker/mechanism		NA		10930038|12211074|13678655|20737008
KRAS	3845	Intracranial Arteriovenous Malformations	MESH:D002538	marker/mechanism		NA	108010	
KRAS	3845	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA	601626	
KRAS	3845	Leukemia, Myelomonocytic, Juvenile	MESH:D054429	marker/mechanism		NA		26457647
KRAS	3845	Leukocytosis	MESH:D007964	marker/mechanism		NA		27725143
KRAS	3845	Liver Diseases, Parasitic	MESH:D008109	marker/mechanism		NA		22561520
KRAS	3845	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		10629081|12211074
KRAS	3845	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		8603461
KRAS	3845	Lung Neoplasms	MESH:D008175	marker/mechanism		NA	211980	10223196|10545420|10874023|11641043|11745231|11884234|12376484|12725029|16247444|16271038|16289808|16410370|16823377|17233834|17290066|17325976|18062963|18758463|18927287|19336973|19424582|19555203|20101149|21519798|22028818|25851810|26390243|29247004|7614698|7750092|8508514|8597069|8761429
KRAS	3845	Lymphoma	MESH:D008223	marker/mechanism		NA		9205081
KRAS	3845	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		19435901
KRAS	3845	Myelodysplastic Syndromes	MESH:D009190	marker/mechanism		NA		27992414
KRAS	3845	Nasopharyngeal Carcinoma	MESH:D000077274	marker/mechanism		NA		24952746
KRAS	3845	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		8635384
KRAS	3845	Neoplasms	MESH:D009369	marker/mechanism		NA		10673434|26595770
KRAS	3845	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		10813127|21311774|25851810|26390243|9205081
KRAS	3845	Neuroblastoma	MESH:D009447	marker/mechanism		NA		26121086
KRAS	3845	Nevus, Sebaceous of Jadassohn	MESH:D054000	marker/mechanism		NA	163200	22683711
KRAS	3845	Noonan Syndrome	MESH:D009634	marker/mechanism		NA		17468812|17603482|17603483|17703371
KRAS	3845	Noonan syndrome 3	MESH:C537847	marker/mechanism		NA	609942	
KRAS	3845	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		21372221
KRAS	3845	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA	260350	14520703|19424582|21699781|24694877|25961927|26390243
KRAS	3845	Penile Neoplasms	MESH:D010412	marker/mechanism		NA		18355852
KRAS	3845	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
KRAS	3845	Recurrence	MESH:D012008	marker/mechanism		NA		26121086
KRAS	3845	Splenomegaly	MESH:D013163	marker/mechanism		NA		27725143
KRAS	3845	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA	137215	10874023|11397402
KRAS	3845	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		3078959
KRAS	3845	Triple Negative Breast Neoplasms	MESH:D064726	marker/mechanism		NA		30654191
KRAS	3845	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA	109800	29644616
KRAS	3845	Uterine Neoplasms	MESH:D014594	marker/mechanism		NA		17325976
KREMEN1	83999	ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE	OMIM:617392	marker/mechanism		NA	617392	
KRIT1	889	Hemangioma, Cavernous, Central Nervous System	MESH:D020786	marker/mechanism		NA	116860	
KRT1	3848	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		18572023
KRT1	3848	Hyperkeratosis, Epidermolytic	MESH:D017488	marker/mechanism		NA	113800	
KRT1	3848	Ichthyosis, Cyclic, with Epidermolytic Hyperkeratosis	MESH:C564367	marker/mechanism		NA	607602	
KRT1	3848	Ichthyosis hystrix, Curth Macklin type	MESH:C536088	marker/mechanism		NA	146590	
KRT1	3848	Keratoderma, Palmoplantar, Epidermolytic	MESH:D053546	marker/mechanism		NA	144200	
KRT1	3848	Keratosis palmoplantaris striata 3	MESH:C536163	marker/mechanism		NA	607654	
KRT1	3848	Palmoplantar Keratoderma, Nonepidermolytic	MESH:C563422	marker/mechanism		NA	600962	
KRT1	3848	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		18572023
KRT10	3858	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		19953893
KRT10	3858	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		18572023
KRT10	3858	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
KRT10	3858	ERYTHRODERMA, ICHTHYOSIFORM, CONGENITAL RETICULAR	OMIM:609165	marker/mechanism		NA	609165	
KRT10	3858	Hyperkeratosis, Epidermolytic	MESH:D017488	marker/mechanism		NA	113800	
KRT10	3858	Ichthyosis, Cyclic, with Epidermolytic Hyperkeratosis	MESH:C564367	marker/mechanism		NA	607602	
KRT10	3858	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		18572023
KRT12	3859	Corneal Dystrophy, Juvenile Epithelial of Meesmann	MESH:D053559	marker/mechanism		NA	122100	
KRT13	3860	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
KRT13	3860	Leukokeratosis, Hereditary Mucosal	MESH:D053529	marker/mechanism		NA	615785	
KRT14	3861	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25330770
KRT14	3861	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		16543248
KRT14	3861	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22011395
KRT14	3861	Dermatopathia pigmentosa reticularis	MESH:C535374	marker/mechanism		NA	125595	
KRT14	3861	Epidermolysis Bullosa Simplex	MESH:D016110	marker/mechanism		NA	131760|131800|131900	
KRT14	3861	Epidermolysis Bullosa Simplex, Autosomal Recessive	MESH:C563408	marker/mechanism		NA	601001	
KRT14	3861	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		16543248
KRT14	3861	Naegeli syndrome	MESH:C538331	marker/mechanism		NA	161000	16960809
KRT14	3861	Pigmentation Disorders	MESH:D010859	marker/mechanism		NA		16960809
KRT14	3861	Tongue Neoplasms	MESH:D014062	marker/mechanism		NA		16543248
KRT15	3866	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
KRT15	3866	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22011395
KRT15	3866	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
KRT16	3868	Pachyonychia Congenita	MESH:D053549	marker/mechanism		NA	167200	
KRT16	3868	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL 1	OMIM:613000	marker/mechanism		NA	613000	
KRT16	3868	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		20186695
KRT17	3872	Carcinoma, Basal Cell	MESH:D002280	marker/mechanism		NA		20871598
KRT17	3872	Chloracne	MESH:D054506	marker/mechanism		NA		21237254
KRT17	3872	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
KRT17	3872	Pachyonychia Congenita	MESH:D053549	marker/mechanism		NA	167210	
KRT17	3872	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		26168014
KRT17	3872	Steatocystoma Multiplex	MESH:D062685	marker/mechanism		NA	184500	
KRT18	3875	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20061804|25330770
KRT18	3875	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		19783637
KRT18	3875	Cirrhosis, Familial	MESH:C566123	marker/mechanism		NA	215600	
KRT18	3875	Liver Cirrhosis	MESH:D008103	therapeutic		NA		20538000
KRT18	3875	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		15999547|17072980|18395095|25380136
KRT18	3875	Liver Failure, Acute	MESH:D017114	marker/mechanism		NA		20538000
KRT18	3875	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19409407|19796649
KRT18	3875	Necrosis	MESH:D009336	marker/mechanism		NA		19783637
KRT19	3880	Asthma	MESH:D001249	marker/mechanism		NA		15478392
KRT19	3880	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		25055964
KRT19	3880	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22011395
KRT19	3880	Cholangitis	MESH:D002761	marker/mechanism		NA		25055964
KRT19	3880	Copper-Overload Cirrhosis	MESH:C566858	marker/mechanism		NA		22879914
KRT19	3880	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
KRT19	3880	Hepatitis, Chronic	MESH:D006521	marker/mechanism		NA		22879914
KRT19	3880	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
KRT19	3880	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		15048980
KRT2	3849	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
KRT2	3849	Ichthyosis Bullosa of Siemens	MESH:D053560	marker/mechanism		NA	146800	
KRT20	54474	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		15378696
KRT20	54474	Cecal Neoplasms	MESH:D002430	marker/mechanism		NA		14688030
KRT20	54474	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		15378696
KRT25	147183	Woolly Hair, Autosomal Recessive	MESH:C564735	marker/mechanism		NA	616760	
KRT3	3850	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
KRT32	3882	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		23797736
KRT4	3851	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
KRT4	3851	Leukokeratosis, Hereditary Mucosal	MESH:D053529	marker/mechanism		NA	193900	
KRT5	3852	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25330770
KRT5	3852	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
KRT5	3852	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
KRT5	3852	Carcinoma, Basal Cell	MESH:D002280	marker/mechanism		NA		19578363|20871598
KRT5	3852	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22011395
KRT5	3852	Dowling-Degos Disease	MESH:C562924	marker/mechanism		NA	179850	
KRT5	3852	Epidermolysis Bullosa Simplex	MESH:D016110	marker/mechanism		NA	131760|131800|131900	
KRT5	3852	Epidermolysis Bullosa Simplex, Autosomal Recessive	MESH:C563408	marker/mechanism		NA	601001	
KRT5	3852	Epidermolysis Bullosa Simplex with Migratory Circinate Erythema	MESH:C563730	marker/mechanism		NA	609352	
KRT5	3852	Epidermolysis bullosa simplex with mottled pigmentation	MESH:C535959	marker/mechanism		NA	131960	
KRT5	3852	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
KRT5	3852	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
KRT5	3852	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
KRT6	110309	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25330770
KRT6	110309	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		20186695
KRT6A	3853	Pachyonychia Congenita	MESH:D053549	marker/mechanism		NA	615726	
KRT6B	3854	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		15274141
KRT6B	3854	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		15274141
KRT6B	3854	Pachyonychia Congenita	MESH:D053549	marker/mechanism		NA	615728	
KRT6C	286887	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL OR DIFFUSE	OMIM:615735	marker/mechanism		NA	615735	
KRT7	3855	Adenoma, Oxyphilic	MESH:D018249	marker/mechanism		NA		16927643
KRT7	3855	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		15108329|16927643
KRT7	3855	Copper-Overload Cirrhosis	MESH:C566858	marker/mechanism		NA		22879914
KRT7	3855	Hepatitis, Chronic	MESH:D006521	marker/mechanism		NA		22879914
KRT7	3855	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		21681009
KRT7	3855	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		19921857
KRT71	112802	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
KRT71	112802	Hypotrichosis	MESH:D007039	marker/mechanism		NA	615896	
KRT71	112802	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
KRT71	112802	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
KRT73	319101	Creutzfeldt-Jakob Syndrome	MESH:D007562	marker/mechanism		NA		23349890
KRT74	121391	ECTODERMAL DYSPLASIA 7, HAIR/NAIL TYPE	OMIM:614929	marker/mechanism		NA	614929	
KRT74	121391	Hypotrichosis	MESH:D007039	marker/mechanism		NA	613981	
KRT74	121391	WOOLLY HAIR, AUTOSOMAL DOMINANT	OMIM:194300	marker/mechanism		NA	194300	
KRT75	9119	Pseudofolliculitis Barbae	MESH:C563016	marker/mechanism		NA	612318	
KRT8	3856	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		15378696
KRT8	3856	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20061804
KRT8	3856	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		15108329
KRT8	3856	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
KRT8	3856	Cirrhosis, Familial	MESH:C566123	marker/mechanism		NA	215600	
KRT8	3856	Liver Cirrhosis	MESH:D008103	therapeutic		NA		20538000
KRT8	3856	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980|25380136
KRT8	3856	Liver Failure, Acute	MESH:D017114	marker/mechanism		NA		20538000
KRT8	3856	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19409407|19796649
KRT8	3856	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21472284
KRT8	3856	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		15378696
KRT81	3887	Monilethrix	MESH:D056734	marker/mechanism		NA	158000	
KRT83	3889	Monilethrix	MESH:D056734	marker/mechanism		NA	158000	
KRT85	3891	ECTODERMAL DYSPLASIA 4, HAIR/NAIL TYPE	OMIM:602032	marker/mechanism		NA	602032	
KRT86	3892	Monilethrix	MESH:D056734	marker/mechanism		NA	158000	
KRT9	3857	Keratoderma, Palmoplantar, Epidermolytic	MESH:D053546	marker/mechanism		NA	144200	
KSR2	283455	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		30718926
KSR2	283455	Obesity, Morbid	MESH:D009767	marker/mechanism		NA		29273807
KST	38418	Parkinson Disease	MESH:D010300	marker/mechanism		NA		18353766
KTN1	3895	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
KY	339855	Myofibrillar Myopathy	MESH:C580316	marker/mechanism		NA	617114	
KYAT1	883	Carcinoma	MESH:D002277	marker/mechanism		NA		20663906
KYAT1	883	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		20663906
KYNU	8942	Hydroxykynureninuria	MESH:C536081	marker/mechanism		NA	236800	17334708
KYNU	8942	Inflammation	MESH:D007249	marker/mechanism		NA		16365156
KYNU	8942	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
KYNU	8942	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		16365156
L1CAM	3897	Aphasia	MESH:D001037	marker/mechanism		NA		7920660
L1CAM	3897	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		21097529
L1CAM	3897	Corpus Callosum, Partial Agenesis of, X-Linked	MESH:C564115	marker/mechanism		NA	304100	
L1CAM	3897	Gait Disorders, Neurologic	MESH:D020233	marker/mechanism		NA		7920660
L1CAM	3897	Hand Deformities, Congenital	MESH:D006228	marker/mechanism		NA		7920660
L1CAM	3897	Hydrocephalus, X-linked	MESH:C536078	marker/mechanism		NA	307000	7920659|7920660
L1CAM	3897	MASA (Mental Retardation, Aphasia, Shuffling Gait, Adducted Thumbs) Syndrome	MESH:C536029	marker/mechanism		NA	303350	7920659|7920660
L2HGDH	79944	2-Hydroxyglutaricaciduria	MESH:C535306	marker/mechanism		NA	236792	15385440|15548604|21937992
L2HGDH	79944	Epilepsy	MESH:D004827	marker/mechanism		NA		15385440
L2HGDH	79944	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
L2HGDH	79944	Nervous System Malformations	MESH:D009421	marker/mechanism		NA		15385440
L3HYPDH	112849	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
L3MBTL2	83746	Medulloblastoma	MESH:D008527	marker/mechanism		NA		19270706
L3MBTL3	84456	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
L3MBTL3	84456	Medulloblastoma	MESH:D008527	marker/mechanism		NA		19270706
LACTB	114294	Obesity	MESH:D009765	marker/mechanism		NA		18344982
LAGE3	8270	Galloway Mowat syndrome	MESH:C537548	marker/mechanism		NA		28805828
LAIR1	3903	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		25133636
LAMA1	284217	Brain Injuries, Traumatic	MESH:D000070642	marker/mechanism		NA		25668593
LAMA1	284217	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		21278247
LAMA1	284217	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
LAMA1	284217	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		21664615
LAMA1	284217	Schizophrenia	MESH:D012559	marker/mechanism		NA		21743468
LAMA2	3908	Muscular Dystrophies	MESH:D009136	marker/mechanism		NA		18074402|22906800
LAMA2	3908	Muscular dystrophy congenital, merosin negative	MESH:C537384	marker/mechanism		NA	607855	
LAMA2	3908	Myopia	MESH:D009216	marker/mechanism		NA		23396134
LAMA2	3908	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266|23042115
LAMA2	3908	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		26039340
LAMA3	3909	Epidermolysis Bullosa, Junctional	MESH:D016109	marker/mechanism		NA	226700	12915477
LAMA3	3909	Epidermolysis Bullosa, Junctional, Non-Herlitz Type	MESH:C562639	marker/mechanism		NA	226650	
LAMA3	3909	Laryngo onycho cutaneous syndrome	MESH:C537032	marker/mechanism		NA	245660	12915477
LAMA3	3909	Nail Diseases	MESH:D009260	marker/mechanism		NA		12915477
LAMA3	3909	Skin Ulcer	MESH:D012883	marker/mechanism		NA		12915477
LAMA3	3909	Wounds and Injuries	MESH:D014947	therapeutic		NA		15541073
LAMA4	3910	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
LAMA4	3910	CARDIOMYOPATHY, DILATED, 1JJ	OMIM:615235	marker/mechanism		NA	615235	
LAMB1	3912	Autistic Disorder	MESH:D001321	marker/mechanism		NA		15523497
LAMB1	3912	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		19915572
LAMB1	3912	Coloboma	MESH:D003103	marker/mechanism		NA		18809619
LAMB1	3912	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
LAMB1	3912	Lissencephaly	MESH:D054082	marker/mechanism		NA	615191	
LAMB1	3912	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		28444932
LAMB2	3913	Cognition Disorders	MESH:D003072	marker/mechanism		NA		30226399
LAMB2	3913	Mesangial sclerosis, diffuse	MESH:C537346	marker/mechanism		NA		15367484
LAMB2	3913	NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES	OMIM:614199	marker/mechanism		NA	614199	
LAMB2	3913	Pierson syndrome	MESH:C537185	marker/mechanism		NA	609049	15367484
LAMB2	3913	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
LAMB3	3914	Amelogenesis imperfecta local hypoplastic form	MESH:C538240	marker/mechanism		NA	104530	
LAMB3	3914	Epidermolysis Bullosa, Junctional	MESH:D016109	marker/mechanism		NA	226700	
LAMB3	3914	Epidermolysis Bullosa, Junctional, Non-Herlitz Type	MESH:C562639	marker/mechanism		NA	226650	
LAMB3	3914	Wounds and Injuries	MESH:D014947	therapeutic		NA		15541073
LAMC1	3915	Aortic Diseases	MESH:D001018	marker/mechanism		NA		25101153
LAMC1	3915	Marfan Syndrome	MESH:D008382	marker/mechanism		NA		25101153
LAMC1	3915	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
LAMC2	3918	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		30381462
LAMC2	3918	Disease Progression	MESH:D018450	marker/mechanism		NA		30381462
LAMC2	3918	Epidermolysis Bullosa, Junctional	MESH:D016109	marker/mechanism		NA	226700	
LAMC2	3918	Epidermolysis Bullosa, Junctional, Non-Herlitz Type	MESH:C562639	marker/mechanism		NA	226650	24550734
LAMC2	3918	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		26396155
LAMC2	3918	Wounds and Injuries	MESH:D014947	therapeutic		NA		15541073
LAMC3	10319	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		21572417|28191889
LAMC3	10319	Brain Diseases	MESH:D001927	marker/mechanism		NA		21572413
LAMC3	10319	CORTICAL MALFORMATIONS, OCCIPITAL	OMIM:614115	marker/mechanism		NA	614115	
LAMC3	10319	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		27749845
LAMP2	3920	Glycogen Storage Disease Type IIb	MESH:D052120	marker/mechanism		NA	300257	
LAMP2	3920	Status Epilepticus	MESH:D013226	marker/mechanism		NA		19272430
LAMP3	27074	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
LAMTOR2	28956	Immunodeficiency due to Defect in MAPBP-Interacting Protein	MESH:C563663	marker/mechanism		NA	610798	
LAMTOR5	10542	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		26229107
LAMTOR5	10542	Glucose Intolerance	MESH:D018149	therapeutic		NA		29259128
LAP3	51056	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
LAPTM5	7805	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		25133636
LAPTM5	7805	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
LARGE1	9215	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
LARGE1	9215	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
LARGE1	9215	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 6	OMIM:608840	marker/mechanism		NA	608840	
LARGE1	9215	Walker-Warburg Syndrome	MESH:D058494	marker/mechanism		NA	236670|613154	
LARGE1	9215	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
LARP4	113251	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
LARP4B	23185	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
LARP7	51574	ALAZAMI SYNDROME	OMIM:615071	marker/mechanism		NA	615071	
LARP7	51574	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
LARS1	51520	INFANTILE LIVER FAILURE SYNDROME 1	OMIM:615438	marker/mechanism		NA	615438	
LARS2	23395	HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA	OMIM:617021	marker/mechanism		NA	617021	
LAS1L	81887	Wilson-Turner X-linked mental retardation syndrome	MESH:C536708	marker/mechanism		NA	309585	
LASP1	3927	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17376794
LASP1	3927	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		28232485
LAT	27040	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
LAT	27040	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
LAT	27040	Neurotoxicity Syndromes	MESH:D020258	marker/mechanism		NA		19784758
LATS1	9113	Astrocytoma	MESH:D001254	marker/mechanism		NA		17049657
LATS1	9113	Carcinoma, Basal Cell	MESH:D002280	marker/mechanism		NA		26950094
LATS1	9113	Neoplasms, Glandular and Epithelial	MESH:D009375	marker/mechanism		NA		21447609
LATS2	26524	Astrocytoma	MESH:D001254	marker/mechanism		NA		17049657
LBH	81606	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
LBP	3929	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
LBP	3929	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980|25380136
LBP	3929	Metabolic Syndrome	MESH:D024821	marker/mechanism		NA		23349936
LBP	3929	Multiple Organ Failure	MESH:D009102	marker/mechanism		NA		22167001
LBP	3929	Obesity	MESH:D009765	marker/mechanism		NA		23349936
LBP	3929	Sepsis	MESH:D018805	marker/mechanism		NA		22167001
LBP	3929	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
LBR	3930	GREENBERG DYSPLASIA	OMIM:215140	marker/mechanism		NA	215140	
LBR	3930	Pelger-Huet Anomaly	MESH:D010381	marker/mechanism		NA	169400	
LBR	3930	REYNOLDS SYNDROME	OMIM:613471	marker/mechanism		NA	613471	
LBX1	10660	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19651985
LCA5	167691	Amaurosis congenita of Leber, type 5	MESH:C536602	marker/mechanism		NA	604537	
LCA5	167691	Blindness	MESH:D001766	marker/mechanism		NA		17546029
LCAT	3931	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
LCAT	3931	Lecithin Cholesterol Acyltransferase Deficiency	MESH:D007863	marker/mechanism		NA	136120|245900	
LCE2B	26239	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29662167
LCE3B	353143	Psoriasis	MESH:D011565	marker/mechanism		NA		19169253
LCE3C	353144	Psoriasis	MESH:D011565	marker/mechanism		NA		19169253
LCE3D	84648	Psoriasis	MESH:D011565	marker/mechanism		NA		20953190|24212883
LCK	3932	IMMUNODEFICIENCY 22	OMIM:615758	marker/mechanism		NA	615758	
LCMT1	51451	Embryo Loss	MESH:D020964	marker/mechanism		NA		17724024
LCN2	3934	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		20623750|22005293|23052191|27888128|28885000
LCN2	3934	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		7554268
LCN2	3934	beta-Thalassemia	MESH:D017086	marker/mechanism		NA		16755567
LCN2	3934	Calcinosis	MESH:D002114	marker/mechanism		NA		21335463
LCN2	3934	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
LCN2	3934	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		20362651|20623750
LCN2	3934	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
LCN2	3934	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		28885000
LCN2	3934	Heart Valve Diseases	MESH:D006349	marker/mechanism		NA		21335463
LCN2	3934	Hepatitis, Animal	MESH:D006520	marker/mechanism		NA		18559427
LCN2	3934	Inflammation	MESH:D007249	marker/mechanism		NA		20118187
LCN2	3934	Kidney Diseases	MESH:D007674	marker/mechanism		NA		19349640|20181666|20438795|27026710
LCN2	3934	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980|25380136
LCN2	3934	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		24570342
LCN2	3934	Neoplasms	MESH:D009369	therapeutic		NA		17114340
LCN2	3934	Renal Insufficiency, Chronic	MESH:D051436	marker/mechanism		NA		24714768
LCN2	3934	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
LCORL	254251	Birth Weight	MESH:D001724	marker/mechanism		NA		23202124
LCP1	3936	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
LCP1	3936	Tobacco Use Disorder	MESH:D014029	marker/mechanism		NA		18438686
LCP2	3937	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
LCT	3938	Lactase Deficiency, Congenital	MESH:C562600	marker/mechanism		NA	223000	
LCT	3938	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
LCT-AS1	100507600	Hirschsprung Disease	MESH:D006627	marker/mechanism		NA		29429387
LDAH	60526	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		20676098
LDB3	11155	Cardiomyopathy, Dilated, 1C	MESH:C563307	marker/mechanism		NA	601493	
LDB3	11155	Myofibrillar Myopathy	MESH:C580316	marker/mechanism		NA	609452	
LDHA	3939	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
LDHA	3939	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		15231041
LDHA	3939	Clinical Deterioration	MESH:D000075902	marker/mechanism		NA		29384525
LDHA	3939	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
LDHA	3939	Lactate dehydrogenase deficiency type A	MESH:C538133	marker/mechanism		NA	612933	
LDHA	3939	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		3279722
LDHA	3939	Myoglobinuria	MESH:D009212	marker/mechanism		NA		21332213
LDHA	3939	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		29384525
LDHAL6B	92483	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20562527
LDHB	3945	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		21751358
LDHB	3945	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		23437403
LDHB	3945	Carcinoma, Intraductal, Noninfiltrating	MESH:D002285	marker/mechanism		NA		23437403
LDHB	3945	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		15108329
LDHB	3945	Lactate Dehydrogenase B Deficiency	MESH:C563641	marker/mechanism		NA	614128	
LDHB	3945	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
LDHB	3945	Metabolism, Inborn Errors	MESH:D008661	marker/mechanism		NA		2334429
LDHB	3945	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		15048980
LDHB	3945	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17566973
LDHC	3948	Infertility, Male	MESH:D007248	marker/mechanism		NA		21565994|23486916
LDHC	3948	Lung Diseases	MESH:D008171	marker/mechanism		NA		21602193
LDLR	3949	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
LDLR	3949	Atherosclerosis	MESH:D050197	marker/mechanism|therapeutic		NA		11947894|18450471|22153697|25619500|28899902
LDLR	3949	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		21378990|27135400
LDLR	3949	Coronary Disease	MESH:D003327	marker/mechanism		NA		9430375
LDLR	3949	Dyslipidemias	MESH:D050171	marker/mechanism		NA		20530721
LDLR	3949	Fatty Liver	MESH:D005234	marker/mechanism		NA		25554529
LDLR	3949	Hypercholesterolemia	MESH:D006937	marker/mechanism		NA		18450471|20530721|22884763|26875785
LDLR	3949	HYPERCHOLESTEROLEMIA, FAMILIAL, 1	OMIM:143890	marker/mechanism		NA	143890	
LDLR	3949	Hyperlipidemias	MESH:D006949	marker/mechanism		NA		11947894|25619500
LDLR	3949	Hyperlipoproteinemia Type II	MESH:D006938	marker/mechanism		NA		10952765|11600564|12009418|12477733|12522687|12673584|9430375
LDLR	3949	Hyperplasia	MESH:D006965	marker/mechanism		NA		9207284
LDLR	3949	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		20938947|23127599|23285030
LDLR	3949	Obesity	MESH:D009765	marker/mechanism		NA		25554529
LDLR	3949	Q Fever	MESH:D011778	marker/mechanism		NA		16469060
LDLRAD3	143458	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
LDLRAP1	26119	Hypercholesterolemia, Autosomal Recessive	MESH:C566331	marker/mechanism		NA	603813	
LECT2	3950	Carcinoma, Lewis Lung	MESH:D018827	therapeutic		NA		30453282
LECT2	3950	Lung Neoplasms	MESH:D008175	therapeutic		NA		30453282
LECT2	3950	Neoplasm Metastasis	MESH:D009362	therapeutic		NA		30453282
LECT2	3950	Neoplasms, Experimental	MESH:D009374	therapeutic		NA		30453282
LEF1	51176	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		27811057
LEF1	51176	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		21188121
LEF1	51176	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27811057
LEF1	51176	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		23770605
LEF1	51176	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		27811057
LEF1	51176	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		27811057
LEF1	51176	Sebaceous Gland Neoplasms	MESH:D012626	marker/mechanism		NA		16565724
LEFTY2	7044	Abnormalities, Multiple	MESH:D000015	marker/mechanism		NA		10053005
LEFTY2	7044	Heterotaxy Syndrome	MESH:D059446	marker/mechanism		NA		10053005
LEMD2	221496	CATARACT 46, JUVENILE-ONSET, WITH OR WITHOUT ARRHYTHMIC CARDIOMYOPATHY	OMIM:212500	marker/mechanism		NA	212500	
LEMD3	23592	Buschke-Ollendorff syndrome	MESH:C537415	marker/mechanism		NA	166700	
LEP	3952	Alzheimer Disease	MESH:D000544	therapeutic		NA		20157255
LEP	3952	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		15142272
LEP	3952	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17347881
LEP	3952	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21353530
LEP	3952	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		17354198
LEP	3952	Crohn Disease	MESH:D003424	marker/mechanism		NA		21829567
LEP	3952	Diabetes, Gestational	MESH:D016640	marker/mechanism		NA		20421132
LEP	3952	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		28242381|31313498|31483951
LEP	3952	Diabetes Mellitus, Type 2	MESH:D003924	therapeutic		NA		15070752
LEP	3952	Fatty Liver	MESH:D005234	marker/mechanism		NA		12661780|19716478|23839791|24525044|25554529|27712037
LEP	3952	Glucose Intolerance	MESH:D018149	marker/mechanism		NA		21315688|24150608
LEP	3952	Hepatitis, Autoimmune	MESH:D019693	marker/mechanism		NA		21227906
LEP	3952	Hepatomegaly	MESH:D006529	marker/mechanism		NA		19716478
LEP	3952	Heroin Dependence	MESH:D006556	marker/mechanism		NA		15717844
LEP	3952	Hypercholesterolemia	MESH:D006937	marker/mechanism		NA		25086370
LEP	3952	Hyperglycemia	MESH:D006943	marker/mechanism		NA		19716478|21561152|31313498|31483951
LEP	3952	Hyperinsulinism	MESH:D006946	marker/mechanism		NA		9826672
LEP	3952	Hyperphagia	MESH:D006963	marker/mechanism|therapeutic		NA		12177191|25086370|26186301
LEP	3952	Hyperplasia	MESH:D006965	marker/mechanism		NA		27712037
LEP	3952	Hypertension	MESH:D006973	marker/mechanism		NA		12050272|16827954|25205467|27226618
LEP	3952	Hypogonadism	MESH:D007006	marker/mechanism|therapeutic		NA		15070752|9500540
LEP	3952	Infertility, Female	MESH:D007247	marker/mechanism		NA		22265003
LEP	3952	Inflammation	MESH:D007249	marker/mechanism|therapeutic		NA		14599722|27712037
LEP	3952	Insulin Resistance	MESH:D007333	marker/mechanism|therapeutic		NA		10753628|11342529|24150608
LEP	3952	LEPTIN DEFICIENCY OR DYSFUNCTION	OMIM:614962	marker/mechanism		NA	614962	
LEP	3952	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		12586293|16097051|29248466
LEP	3952	Metabolic Syndrome	MESH:D024821	marker/mechanism		NA		16793964|18515891
LEP	3952	Nerve Degeneration	MESH:D009410	therapeutic		NA		17993459
LEP	3952	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		24211274
LEP	3952	Obesity	MESH:D009765	marker/mechanism|therapeutic		NA		17517446|18515891|19913045|20122948|23839791|24042701|25086370|25551525|25554529|26186301|28698385|31313498|9202122|9502777|9826672
LEP	3952	Obesity, Morbid	MESH:D009767	marker/mechanism|therapeutic		NA		15070752|9500540
LEP	3952	Oral Ulcer	MESH:D019226	therapeutic		NA		16391412
LEP	3952	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		22381227
LEP	3952	Polydipsia	MESH:D059606	marker/mechanism		NA		25086370
LEP	3952	Polyuria	MESH:D011141	marker/mechanism		NA		25086370
LEP	3952	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		15042602
LEP	3952	Proteinuria	MESH:D011507	marker/mechanism		NA		25205467
LEP	3952	Seizures	MESH:D012640	therapeutic		NA		17993459
LEP	3952	Stomach Ulcer	MESH:D013276	therapeutic		NA		10422768|11025360|11787760|15024038|16015682|18181030
LEP	3952	Tachycardia	MESH:D013610	marker/mechanism		NA		16827954
LEP	3952	Weight Gain	MESH:D015430	marker/mechanism|therapeutic		NA		15070752|15809509|17502770|19716478|21561152|23839791|25086370|27472835|29967158
LEP	3952	Weight Loss	MESH:D015431	marker/mechanism		NA		27417254
LEPR	3953	Albuminuria	MESH:D000419	marker/mechanism		NA		17065336|20175764|23159718|28130181|29988851
LEPR	3953	Bone Diseases	MESH:D001847	marker/mechanism		NA		28130181
LEPR	3953	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21353530
LEPR	3953	Diabetes, Gestational	MESH:D016640	marker/mechanism		NA		20421132
LEPR	3953	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		15028607
LEPR	3953	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		15093691|16427799|17065336|19452630|19478208|20567778|22933112|24263156|26939912|27151219|30635400
LEPR	3953	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		20175764|22933112|24263156|26939912
LEPR	3953	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		28130181|29988851
LEPR	3953	Diabetic Neuropathies	MESH:D003929	marker/mechanism		NA		24263156
LEPR	3953	Dyslipidemias	MESH:D050171	marker/mechanism		NA		20567778|29988851
LEPR	3953	Fatty Liver	MESH:D005234	marker/mechanism		NA		25367288|29743445
LEPR	3953	Fibrosis	MESH:D005355	marker/mechanism		NA		20567778|29988851
LEPR	3953	Gliosis	MESH:D005911	marker/mechanism		NA		29191728
LEPR	3953	Glucose Intolerance	MESH:D018149	marker/mechanism		NA		19452630|25367288|28611668|29988851
LEPR	3953	Granulosa Cell Tumor	MESH:D006106	marker/mechanism		NA		28861689
LEPR	3953	Hepatomegaly	MESH:D006529	marker/mechanism		NA		23038009|29743445
LEPR	3953	Hyperglycemia	MESH:D006943	marker/mechanism		NA		15093691|17065336|19682441|20567778|24384915|28130181|29743445|29988851|29991592|30635400|3519326
LEPR	3953	Hyperinsulinism	MESH:D006946	marker/mechanism		NA		15093691|22949526|24384915|25222487|29988851|30689673|3519326
LEPR	3953	Hyperlipidemias	MESH:D006949	marker/mechanism		NA		25222487
LEPR	3953	Hyperphagia	MESH:D006963	marker/mechanism		NA		15093691|17229951|3519326
LEPR	3953	Hypertension	MESH:D006973	marker/mechanism		NA		22949526
LEPR	3953	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		30689673
LEPR	3953	Hypertrophy, Right Ventricular	MESH:D017380	marker/mechanism		NA		30689673
LEPR	3953	Hypogonadism	MESH:D007006	marker/mechanism		NA		17229951
LEPR	3953	Immunologic Deficiency Syndromes	MESH:D007153	marker/mechanism		NA		17229951
LEPR	3953	Infertility	MESH:D007246	marker/mechanism		NA		15093691
LEPR	3953	Infertility, Female	MESH:D007247	marker/mechanism		NA		22265003
LEPR	3953	Insulin Resistance	MESH:D007333	marker/mechanism		NA		19452630|20567778|25367288|28611668|29988851|30689673
LEPR	3953	Kidney Diseases	MESH:D007674	marker/mechanism		NA		20567778
LEPR	3953	LEPTIN RECEPTOR DEFICIENCY	OMIM:614963	marker/mechanism		NA	614963	
LEPR	3953	Metabolism, Inborn Errors	MESH:D008661	marker/mechanism		NA		17229951
LEPR	3953	Nephritis	MESH:D009393	marker/mechanism		NA		29988851
LEPR	3953	Obesity	MESH:D009765	marker/mechanism		NA		17065336|17229951|19913045|20567778|22276206|23563609|24263156|25222487|29743445|30689673|30993381|3519326
LEPR	3953	Obesity, Morbid	MESH:D009767	marker/mechanism		NA		9537324
LEPR	3953	Overweight	MESH:D050177	marker/mechanism		NA		23038009
LEPR	3953	Pancreatic Diseases	MESH:D010182	marker/mechanism		NA		3519326
LEPR	3953	Pituitary Diseases	MESH:D010900	marker/mechanism		NA		9537324
LEPR	3953	Puberty, Delayed	MESH:D011628	marker/mechanism		NA		17229951
LEPR	3953	Renal Insufficiency	MESH:D051437	marker/mechanism		NA		29988851
LEPR	3953	Respiratory Tract Infections	MESH:D012141	marker/mechanism		NA		17229951
LEPR	3953	Weight Gain	MESH:D015430	marker/mechanism		NA		15809509|29988851
LETM1	3954	Carcinoma, Hepatocellular	MESH:D006528	therapeutic		NA		23392203
LETM1	3954	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		14706454
LETM1	3954	Intellectual Disability	MESH:D008607	marker/mechanism		NA		14706454
LETM1	3954	Muscle Hypotonia	MESH:D009123	marker/mechanism		NA		14706454
LETM1	3954	Seizures	MESH:D012640	marker/mechanism		NA		14706454
LETM1	3954	Wolf-Hirschhorn Syndrome	MESH:D054877	marker/mechanism		NA	194190	14706454
LFNG	3955	Spondylocostal dysostosis, autosomal recessive	MESH:C535781	marker/mechanism		NA	609813	
LGALS1	3956	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		17094902
LGALS1	3956	Keloid	MESH:D007627	marker/mechanism		NA		20128793
LGALS1	3956	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		26396155
LGALS1	3956	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
LGALS1	3956	Nephritis	MESH:D009393	therapeutic		NA		11044214
LGALS14	56891	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
LGALS2	3957	Enterocolitis, Necrotizing	MESH:D020345	marker/mechanism		NA		18806098
LGALS2	3957	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
LGALS2	3957	Myocardial Infarction	MESH:D009203	marker/mechanism		NA	608446	15129282
LGALS3	3958	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
LGALS3	3958	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		16322222
LGALS3	3958	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22461450
LGALS3	3958	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		17634542
LGALS3	3958	Fibrosis	MESH:D005355	marker/mechanism		NA		27870162
LGALS3	3958	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		16549783|25380136
LGALS3	3958	Melanoma	MESH:D008545	marker/mechanism		NA		23994248
LGALS3	3958	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		29769800
LGALS3	3958	Necrosis	MESH:D009336	marker/mechanism		NA		22461450
LGALS3	3958	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		25882088
LGALS3	3958	Nephritis	MESH:D009393	therapeutic		NA		11044214
LGALS3	3958	ST Elevation Myocardial Infarction	MESH:D000072657	marker/mechanism		NA		29769800
LGALS3	3958	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21750908
LGALS3	3958	Vascular Diseases	MESH:D014652	marker/mechanism		NA		27870162
LGALS3BP	3959	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		26396155
LGALS7	3963	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
LGALS7	3963	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		15274141
LGALS7	3963	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
LGALS7	3963	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
LGALS7	3963	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		15274141
LGALS9	3965	Nephritis	MESH:D009393	therapeutic		NA		11044214
LGALSL	29094	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
LGI1	9211	EPILEPSY, FAMILIAL TEMPORAL LOBE, 1	OMIM:600512	marker/mechanism		NA	600512	
LGI4	163175	ARTHROGRYPOSIS MULTIPLEX CONGENITA 1, NEUROGENIC, WITH MYELIN DEFECT	OMIM:617468	marker/mechanism		NA	617468	
LGMN	5641	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
LGMN	5641	Orthomyxoviridae Infections	MESH:D009976	marker/mechanism		NA		22916010
LGR4	55366	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 17	OMIM:615311	marker/mechanism		NA	615311	
LGR5	8549	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		21188121
LGR5	8549	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		25280562
LGR6	59352	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18507500|23535733
LGR6	59352	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		28945253
LGR6	59352	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18507500|21278247
LHB	3972	Alcoholism	MESH:D000437	marker/mechanism		NA		8590623
LHB	3972	Bradycardia	MESH:D001919	therapeutic		NA		6350720
LHB	3972	Fertile eunuch syndrome	MESH:C537919	marker/mechanism		NA	228300	
LHB	3972	Hyperprolactinemia	MESH:D006966	marker/mechanism		NA		6770916
LHB	3972	Hypertension	MESH:D006973	marker/mechanism		NA		6350720
LHB	3972	Hypogonadism	MESH:D007006	marker/mechanism|therapeutic		NA		15602022|1727547|18449926|8263139
LHB	3972	Hypothermia	MESH:D007035	marker/mechanism		NA		6350720
LHB	3972	Infertility, Female	MESH:D007247	marker/mechanism		NA		9457942
LHB	3972	Infertility, Male	MESH:D007248	marker/mechanism		NA		10739843|15602022|387166
LHB	3972	Leydig Cell Tumor	MESH:D007984	marker/mechanism		NA		25289773
LHB	3972	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		11889176|20378617
LHB	3972	Puberty, Delayed	MESH:D011628	marker/mechanism		NA		15602022
LHB	3972	Puberty, Precocious	MESH:D011629	marker/mechanism		NA		18345393
LHB	3972	Tachycardia	MESH:D013610	marker/mechanism		NA		6350720
LHCGR	3973	Disorder of Sex Development, 46,XY	MESH:D058490	marker/mechanism		NA		19887492|7719343
LHCGR	3973	Disorders of Sex Development	MESH:D012734	marker/mechanism		NA		22615892
LHCGR	3973	Familial Testotoxicosis	MESH:C536961	marker/mechanism		NA	176410	16684832|18345393|19209621|26831561|7692306
LHCGR	3973	Infertility, Male	MESH:D007248	marker/mechanism		NA		20164437
LHCGR	3973	Leydig Cell Hypoplasia	MESH:C562567	marker/mechanism		NA	238320	7719343
LHCGR	3973	Leydig Cell Tumor	MESH:D007984	marker/mechanism		NA		10580072|11857565
LHFPL2	10184	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		25133636
LHFPL5	222662	Deafness, Autosomal Recessive 67	MESH:C565207	marker/mechanism		NA	610265	30177809
LHFPL6	10186	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
LHX1	3975	Female Urogenital Diseases	MESH:D052776	marker/mechanism		NA		16002989
LHX2	9355	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		17568789
LHX3	8022	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
LHX3	8022	Winkelman Bethge Pfeiffer syndrome	MESH:C536710	marker/mechanism		NA	221750	
LHX4	89884	Pituitary Hormone Deficiency, Combined, 4	MESH:C567492	marker/mechanism		NA	262700	
LIAS	11019	HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	OMIM:614462	marker/mechanism		NA	614462	
LIAS	11019	Pneumonia	MESH:D011014	therapeutic		NA		32017981
LIAS	11019	Pulmonary Fibrosis	MESH:D011658	therapeutic		NA		32017981
LIF	3976	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
LIF	3976	Cardiomegaly	MESH:D006332	marker/mechanism		NA		15226216
LIF	3976	Embryo Loss	MESH:D020964	marker/mechanism		NA		23409146
LIF	3976	Female Urogenital Diseases	MESH:D052776	marker/mechanism		NA		16002989
LIF	3976	Infertility, Female	MESH:D007247	marker/mechanism		NA		23407384
LIF	3976	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		21664615
LIF	3976	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
LIF	3976	Weight Loss	MESH:D015431	marker/mechanism		NA		23291613
LIFR	3977	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
LIFR	3977	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
LIFR	3977	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		19208208
LIFR	3977	Stuve-Wiedemann syndrome	MESH:C537502	marker/mechanism		NA	601559	19603067
LIG1	3978	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		8631603
LIG4	3981	LIG4 Syndrome	MESH:C564694	marker/mechanism		NA	606593	
LIG4	3981	Multiple Myeloma	MESH:D009101	marker/mechanism		NA	254500	
LILRA4	23547	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		18006695
LILRA5	353514	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
LILRB5	10990	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
LIM2	3982	Cataract	MESH:D002386	marker/mechanism		NA		11917274
LIM2	3982	CATARACT 19, MULTIPLE TYPES	OMIM:615277	marker/mechanism		NA	615277	
LIM2	3982	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
LIMCH1	22998	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
LIMCH1	22998	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
LIMD2	80774	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18925433
LIMD2	80774	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		18925433
LIMK2	3985	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
LIMS2	55679	MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE, WITH CARDIOMYOPATHY AND TRIANGULAR TONGUE	OMIM:616827	marker/mechanism		NA	616827	
LIN28A	79727	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		19483683
LIN28A	79727	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		26910839
LIN28A	79727	Neoplasms	MESH:D009369	marker/mechanism		NA		19483683
LIN28B	389421	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		19483683
LIN28B	389421	Neoplasms	MESH:D009369	marker/mechanism		NA		19483683
LIN28B	389421	Neuroblastoma	MESH:D009447	marker/mechanism		NA		22941191|23042116
LIN7A	8825	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
LIN7A	8825	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
LIN7A	8825	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
LIN7A	8825	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
LINC00221	338005	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
LINC00475	158314	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
LINC00477	144360	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
LINC00671	388387	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
LINC00673	100499467	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		30510241
LINC00673	100499467	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		27213290
LINC00880	339894	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		27322209
LINC00908	284276	Birth Weight	MESH:D001724	marker/mechanism		NA		25982381
LINC00908	284276	Fetal Growth Retardation	MESH:D005317	marker/mechanism		NA		25982381
LINC00977	728724	Leukemia	MESH:D007938	marker/mechanism		NA		26752646
LINC01142	284688	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
LINC01426	100506385	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
LINGO1	84894	Essential Tremor	MESH:D020329	marker/mechanism		NA		19182806
LINGO2	158038	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
LINGO2	158038	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
LINS1	55180	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
LINS1	55180	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	OMIM:614340	marker/mechanism		NA	614340	
LIPA	3988	Cholesterol Ester Storage Disease	MESH:D015217	marker/mechanism		NA		24295952
LIPA	3988	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		21378988
LIPA	3988	Lysosomal acid lipase deficiency	MESH:C531854	marker/mechanism		NA	278000	
LIPA	3988	Niemann-Pick Disease, Type C	MESH:D052556	therapeutic		NA		20557099
LIPC	3990	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA	125853	15126514|15656877
LIPC	3990	HEPATIC LIPASE DEFICIENCY	OMIM:614025	marker/mechanism		NA	614025	
LIPC	3990	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12	OMIM:612797	marker/mechanism		NA	612797	
LIPC	3990	Hyperemia	MESH:D006940	marker/mechanism		NA		16330034
LIPC	3990	Hyperlipidemias	MESH:D006949	marker/mechanism		NA		1883393
LIPC	3990	Hyperlipoproteinemias	MESH:D006951	marker/mechanism		NA		18160998
LIPC	3990	Hyperlipoproteinemia Type II	MESH:D006938	marker/mechanism		NA		16030523
LIPC	3990	Insulin Resistance	MESH:D007333	marker/mechanism		NA		15504970
LIPC	3990	Lipid Metabolism, Inborn Errors	MESH:D008052	marker/mechanism		NA		15292318|1671786|1883393
LIPE	3991	Lipodystrophy, Familial Partial	MESH:D052496	marker/mechanism		NA	615980	
LIPH	200879	Hypotrichosis	MESH:D007039	marker/mechanism		NA	604379	23066499
LIPH	200879	Woolly hair, congenital	MESH:C536745	marker/mechanism		NA		23066499
LIPN	643418	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8	OMIM:613943	marker/mechanism		NA	613943	
LIPT1	51601	LIPOYLTRANSFERASE 1 DEFICIENCY	OMIM:616299	marker/mechanism		NA	616299	
LITAF	9516	Charcot-Marie-Tooth disease, Type 1C	MESH:C537984	marker/mechanism		NA	601098	
LITAF	9516	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29845714
LKB1	41673	Huntington Disease	MESH:D006816	therapeutic		NA		21909362
LLGL1	3996	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037
LLGL2	3993	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		28114269
LLGL2	3993	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		28114269
LMAN1	3998	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 1	OMIM:227300	marker/mechanism		NA	227300	
LMAN2L	81562	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		31043756
LMAN2L	81562	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		23797736
LMAN2L	81562	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	OMIM:616887	marker/mechanism		NA	616887	
LMBR1	64327	Absence of tibia with polydactyly	MESH:C535564	marker/mechanism		NA	188740	
LMBR1	64327	Acheiropodia	MESH:C536014	marker/mechanism		NA	200500	
LMBR1	64327	Laurin-Sandrow syndrome	MESH:C535689	marker/mechanism		NA	135750	
LMBR1	64327	POLYDACTYLY, PREAXIAL II	OMIM:174500	marker/mechanism		NA	174500	
LMBR1	64327	Syndactyly, Type IV	MESH:C566092	marker/mechanism		NA	186200	
LMBRD1	55788	Methylmalonic Aciduria and Homocystinuria, CblF Type	MESH:C564747	marker/mechanism		NA	277380	22922874
LMCD1	29995	Mitral Valve Insufficiency	MESH:D008944	marker/mechanism		NA		26301497
LMCD1	29995	Mitral Valve Prolapse	MESH:D008945	marker/mechanism		NA		26301497
LMF1	64788	Hypertriglyceridemia	MESH:D015228	marker/mechanism		NA		17994020
LMF1	64788	Lipase deficiency combined	MESH:C535904	marker/mechanism		NA	246650	
LMNA	4000	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		19381893
LMNA	4000	Atrioventricular Block	MESH:D054537	marker/mechanism		NA		10580070
LMNA	4000	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA	115200	10580070|15996213|20019332|21689390
LMNA	4000	CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	OMIM:212112	marker/mechanism		NA	212112	
LMNA	4000	Charcot-Marie-Tooth disease, Type 2B1	MESH:C537990	marker/mechanism		NA	605588	
LMNA	4000	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		15726408
LMNA	4000	Death, Sudden, Cardiac	MESH:D016757	marker/mechanism		NA		15996213
LMNA	4000	Foot Deformities, Congenital	MESH:D005532	marker/mechanism		NA		15996213
LMNA	4000	Hand Deformities, Congenital	MESH:D006228	marker/mechanism		NA		15996213
LMNA	4000	Heart Block	MESH:D006327	marker/mechanism		NA		15996213
LMNA	4000	Heart-hand syndrome, Slovenian type	MESH:C535852	marker/mechanism		NA	610140	
LMNA	4000	HIV-Associated Lipodystrophy Syndrome	MESH:D039682	marker/mechanism		NA		18230615
LMNA	4000	Lipodystrophy, Familial Partial	MESH:D052496	marker/mechanism		NA	151660	12844477|14510863|16241930|19793595
LMNA	4000	Mandibuloacral dysplasia with type A lipodystrophy	MESH:C535705	marker/mechanism		NA	248370	12788894|17848409|19764019
LMNA	4000	Muscular Dystrophies, Limb-Girdle	MESH:D049288	marker/mechanism		NA		10814726|12032588|30055862
LMNA	4000	Muscular Dystrophy, Congenital, Lmna-Related	MESH:C567708	marker/mechanism		NA	613205	
LMNA	4000	Muscular Dystrophy, Emery-Dreifuss	MESH:D020389	marker/mechanism		NA	181350|616516	10814726|12032588|30055862
LMNA	4000	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
LMNA	4000	Progeria	MESH:D011371	marker/mechanism		NA	176670	15726408|17469202|23217256|28229933
LMNA	4000	Scleroderma, Localized	MESH:D012594	marker/mechanism		NA		15726408
LMNA	4000	Sinoatrial Block	MESH:D012848	marker/mechanism		NA		15996213
LMNA	4000	Tachycardia, Ventricular	MESH:D017180	marker/mechanism		NA		15996213
LMNA	4000	Tight skin contracture syndrome, lethal	MESH:C536920	marker/mechanism		NA	275210	
LMNB1	4001	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
LMNB1	4001	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
LMNB1	4001	Pelizaeus-Merzbacher Disease	MESH:D020371	marker/mechanism		NA	169500	
LMNB2	84823	Lipodystrophy, Partial, Acquired	MESH:C562448	marker/mechanism		NA	608709	
LMNB2	84823	Myoclonic Epilepsies, Progressive	MESH:D020191	marker/mechanism		NA	616540	
LMNTD1	160492	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		15064703
LMO1	4004	Leukemia, T-Cell	MESH:D015458	marker/mechanism		NA		2034676|3259177
LMO1	4004	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054218	marker/mechanism		NA		19246562
LMO2	4005	Leukemia, T-Cell	MESH:D015458	marker/mechanism		NA		2034676
LMO2	4005	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
LMO2	4005	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054218	marker/mechanism		NA		19246562|24394663
LMOD1	25802	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		28530674
LMOD1	25802	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
LMOD3	56203	NEMALINE MYOPATHY 10	OMIM:616165	marker/mechanism		NA	616165	
LMTK2	22853	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		18264097
LMX1A	4009	Deafness, Autosomal Dominant 7	MESH:C563321	marker/mechanism		NA	601412	
LMX1A	4009	Hearing Loss	MESH:D034381	marker/mechanism		NA		29971487
LMX1B	4010	Clubfoot	MESH:D003025	marker/mechanism		NA		19147669
LMX1B	4010	Hematuria	MESH:D006417	marker/mechanism		NA		19147669
LMX1B	4010	Hyperlipidemias	MESH:D006949	marker/mechanism		NA		20199424
LMX1B	4010	Mental Disorders	MESH:D001523	marker/mechanism		NA		20199424
LMX1B	4010	Nail-Patella Syndrome	MESH:D009261	marker/mechanism		NA	161200	19147669|20199424
LMX1B	4010	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		20199424
LMX1B	4010	Osteoarthritis, Hip	MESH:D015207	marker/mechanism		NA		30374069
LMX1B	4010	Proteinuria	MESH:D011507	marker/mechanism		NA		19147669|20199424
LMX1B	4010	Sleep Initiation and Maintenance Disorders	MESH:D007319	marker/mechanism		NA		20199424
LNCRI	401296	Micronuclei, Chromosome-Defective	MESH:D048629	marker/mechanism		NA		29216366
LNPEP	4012	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16619500
LNPEP	4012	Memory Disorders	MESH:D008569	marker/mechanism		NA		11730987
LONP1	9361	CODAS syndrome	MESH:C536434	marker/mechanism		NA	600373	
LORICRIN	4014	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		18572023
LORICRIN	4014	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		18572023
LORICRIN	4014	Vohwinkel Syndrome, Variant Form	MESH:C565826	marker/mechanism		NA	604117	
LOX	4015	AORTIC ANEURYSM, FAMILIAL THORACIC 10	OMIM:617168	marker/mechanism		NA	617168	
LOX	4015	Aortic Valve Insufficiency	MESH:D001022	marker/mechanism		NA		21216836
LOX	4015	Hepatitis B	MESH:D006509	marker/mechanism		NA		16023247
LOX	4015	Hepatitis C	MESH:D006526	marker/mechanism		NA		16023247
LOX	4015	Hepatolenticular Degeneration	MESH:D006527	marker/mechanism		NA		16023247
LOX	4015	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		24614111
LOX	4015	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		26396155
LOX	4015	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		16023247
LOX	4015	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
LOX	4015	Oral Submucous Fibrosis	MESH:D009914	marker/mechanism		NA		16311067
LOX	4015	Osteosarcoma	MESH:D012516	marker/mechanism		NA		23886186
LOX	4015	Prenatal Injuries	MESH:D049188	marker/mechanism		NA		20045017
LOXHD1	125336	Deafness, Autosomal Recessive 77	MESH:C567543	marker/mechanism		NA	613079	
LOXL1	4016	Exfoliation Syndrome	MESH:D017889	marker/mechanism		NA	177650	25706626|28553957
LOXL1	4016	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		30097701
LOXL1	4016	Prenatal Injuries	MESH:D049188	marker/mechanism		NA		20045017
LOXL1	4016	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		17456585
LOXL2	4017	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19330836|24014025
LOXL2	4017	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		24014025
LOXL2	4017	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		24716982
LOXL2	4017	Hepatitis B	MESH:D006509	marker/mechanism		NA		16023247
LOXL2	4017	Hepatitis C	MESH:D006526	marker/mechanism		NA		16023247
LOXL2	4017	Hepatolenticular Degeneration	MESH:D006527	marker/mechanism		NA		16023247
LOXL2	4017	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		16023247
LOXL2	4017	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
LOXL2	4017	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		24014025
LOXL4	84171	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		17456585
LOXL5B	100124531	Prenatal Injuries	MESH:D049188	marker/mechanism		NA		20045017
LPA	4018	Atherosclerosis	MESH:D050197	marker/mechanism		NA		1465128|17845920|9770530
LPA	4018	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
LPA	4018	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		18775538
LPA	4018	Cerebral Infarction	MESH:D002544	marker/mechanism		NA		17845920
LPA	4018	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		20435227|21378990
LPA	4018	Coronary Disease	MESH:D003327	marker/mechanism		NA		10484779
LPA	4018	Hypercholesterolemia	MESH:D006937	marker/mechanism		NA		12697372
LPA	4018	Hypolipoproteinemias	MESH:D007009	marker/mechanism		NA		10484779
LPA	4018	Stroke	MESH:D020521	marker/mechanism		NA		10484779
LPA	4018	Thromboembolism	MESH:D013923	marker/mechanism		NA		9164807
LPA	4018	Venous Thrombosis	MESH:D020246	marker/mechanism		NA		9164807
LPAR1	1902	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037
LPAR1	1902	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		30510241
LPAR1	1902	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		11087877
LPAR1	1902	Fetal Death	MESH:D005313	marker/mechanism		NA		11087877
LPAR1	1902	Growth Disorders	MESH:D006130	marker/mechanism		NA		11087877
LPAR1	1902	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
LPAR1	1902	Olfaction Disorders	MESH:D000857	marker/mechanism		NA		11087877
LPAR1	1902	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16809448
LPAR6	10161	Hypotrichosis	MESH:D007039	marker/mechanism		NA	278150	18297072
LPAR6	10161	Hypotrichosis simplex	MESH:C537160	marker/mechanism		NA		18297070
LPCAT2	54947	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
LPGAT1	9926	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
LPIN1	23175	Myoglobinuria, Acute Recurrent, Autosomal Recessive	MESH:C564832	marker/mechanism		NA	268200	
LPIN2	9663	Majeed syndrome	MESH:C537839	marker/mechanism		NA	609628	
LPL	4023	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
LPL	4023	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		10533957
LPL	4023	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		16544732
LPL	4023	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
LPL	4023	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
LPL	4023	Dyslipidemias	MESH:D050171	marker/mechanism		NA		17952847
LPL	4023	Hepatitis C	MESH:D006526	therapeutic		NA		17517063
LPL	4023	Hypercholesterolemia	MESH:D006937	marker/mechanism		NA		21852083
LPL	4023	Hyperlipidemia, Familial Combined	MESH:D006950	marker/mechanism		NA	144250	
LPL	4023	Hyperlipidemias	MESH:D006949	marker/mechanism		NA		17658632
LPL	4023	Hyperlipoproteinemia Type I	MESH:D008072	marker/mechanism		NA	238600	
LPL	4023	Hyperlipoproteinemia Type II	MESH:D006938	marker/mechanism		NA		16030523
LPL	4023	Hypertension	MESH:D006973	marker/mechanism		NA		22228705
LPL	4023	Hypertriglyceridemia	MESH:D015228	marker/mechanism|therapeutic		NA		20657596|8147947
LPL	4023	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
LPL	4023	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
LPL	4023	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
LPL	4023	Necrosis	MESH:D009336	marker/mechanism		NA		10533957
LPL	4023	Obesity	MESH:D009765	marker/mechanism		NA		18344982
LPL	4023	Pancreatitis	MESH:D010195	marker/mechanism		NA		18936103
LPL	4023	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		15386377
LPP	4026	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
LPP	4026	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA	601626	
LPXN	9404	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
LRAT	9227	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
LRAT	9227	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
LRAT	9227	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
LRAT	9227	Eye Diseases, Hereditary	MESH:D015785	marker/mechanism		NA		16968212
LRAT	9227	Leber Congenital Amaurosis	MESH:D057130	marker/mechanism		NA		19339306
LRAT	9227	Leber Congenital Amaurosis 14	MESH:C567636	marker/mechanism		NA	613341	
LRAT	9227	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
LRAT	9227	Optic Atrophy, Hereditary, Leber	MESH:D029242	marker/mechanism		NA		16250670|17011878
LRAT	9227	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA	268000	
LRAT	9227	Vitamin A Deficiency	MESH:D014802	marker/mechanism		NA		16174770
LRATD1	151354	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
LRBA	987	IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY	OMIM:614700	marker/mechanism		NA	614700	
LRCH1	23143	Stroke	MESH:D020521	marker/mechanism		NA		29531354
LRG1	116844	Adenomatous Polyposis Coli	MESH:D011125	marker/mechanism		NA		25200834
LRG1	116844	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		25200834
LRIG1	26018	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
LRIG2	9860	Urofacial syndrome	MESH:C536480	marker/mechanism		NA	615112	
LRIT3	345193	Night blindness, congenital stationary	MESH:C536122	marker/mechanism		NA	615058	
LRMDA	83938	ALBINISM, OCULOCUTANEOUS, TYPE VII	OMIM:615179	marker/mechanism		NA	615179	
LRMDA	83938	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
LRMDA	83938	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
LRP1	4035	KERATOSIS PILARIS ATROPHICANS	OMIM:604093	marker/mechanism		NA	604093	
LRP1	4035	Migraine Disorders	MESH:D008881	marker/mechanism		NA		21666692
LRP1	4035	Migraine without Aura	MESH:D020326	marker/mechanism		NA		22683712
LRP1	4035	Schizophrenia	MESH:D012559	marker/mechanism		NA		21743468
LRP12	29967	Muscular Dystrophy, Oculopharyngeal	MESH:D039141	marker/mechanism		NA		31332380
LRP1B	53353	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		22138691
LRP1B	53353	Melanoma	MESH:D008545	marker/mechanism		NA		22197931
LRP1B	53353	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29662167
LRP2	4036	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		29286200
LRP2	4036	Bone Diseases, Metabolic	MESH:D001851	marker/mechanism		NA		10052453
LRP2	4036	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		17632512
LRP2	4036	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		17632512
LRP2	4036	Donnai-Barrow syndrome	MESH:C536390	marker/mechanism		NA	222448	
LRP2	4036	Eye Diseases, Hereditary	MESH:D015785	marker/mechanism		NA		17632512
LRP2	4036	Hearing Loss, Sensorineural	MESH:D006319	marker/mechanism		NA		17632512
LRP2	4036	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		17632512
LRP2	4036	Kidney Diseases	MESH:D007674	marker/mechanism		NA		17632512
LRP2	4036	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		22919386
LRP2	4036	Vitamin D Deficiency	MESH:D014808	marker/mechanism		NA		10052453
LRP4	4038	Myasthenic Syndromes, Congenital	MESH:D020294	marker/mechanism		NA	616304	
LRP4	4038	Sclerosteosis	MESH:C537525	marker/mechanism		NA	614305	
LRP4	4038	Syndactyly	MESH:D013576	marker/mechanism		NA		16207730
LRP4	4038	Syndactyly Cenani Lenz type	MESH:C538150	marker/mechanism		NA	212780	
LRP4	4038	Tooth Abnormalities	MESH:D014071	marker/mechanism		NA		16207730
LRP5	4041	Exudative vitreoretinopathy 1	MESH:C536382	marker/mechanism		NA	133780	
LRP5	4041	Exudative Vitreoretinopathy 4	MESH:C566619	marker/mechanism		NA	601813	
LRP5	4041	Familial Exudative Vitreoretinopathies	MESH:D000080345	marker/mechanism		NA		29207047
LRP5	4041	Fractures, Bone	MESH:D050723	marker/mechanism		NA		22504420
LRP5	4041	Osteopetrosis autosomal dominant type 1	MESH:C536056	marker/mechanism		NA	607634	
LRP5	4041	Osteoporosis	MESH:D010024	marker/mechanism		NA	166710|601884	
LRP5	4041	Osteoporosis-pseudoglioma syndrome	MESH:C536063	marker/mechanism		NA	259770	18825883
LRP5	4041	Van Buchem disease type 2	MESH:C536527	marker/mechanism		NA	607636	
LRP5	4041	Vitreoretinopathy, Proliferative	MESH:D018630	marker/mechanism		NA		18263894
LRP5	4041	Worth syndrome	MESH:C536748	marker/mechanism		NA	144750	
LRP6	4040	Coronary Artery Disease, Autosomal Dominant 2	MESH:C567045	marker/mechanism		NA	610947	
LRP6	4040	TOOTH AGENESIS, SELECTIVE, 7	OMIM:616724	marker/mechanism		NA	616724	
LRP6	4040	Triple Negative Breast Neoplasms	MESH:D064726	marker/mechanism		NA		24552774
LRP8	7804	Myocardial Infarction	MESH:D009203	marker/mechanism		NA	608446	
LRP8	7804	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		18172410
LRPAP1	4043	MYOPIA 23, AUTOSOMAL RECESSIVE	OMIM:615431	marker/mechanism		NA	615431	
LRPPRC	10128	Leigh syndrome , French Canadian type	MESH:C537004	marker/mechanism		NA	220111	12529507
LRRC1	55227	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
LRRC10	376132	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
LRRC28	123355	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
LRRC37A	9884	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
LRRC37A2	474170	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
LRRC3B	116135	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
LRRC3B	116135	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18815942
LRRC3B	116135	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		18757430
LRRC46	90506	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		31043753
LRRC51	69358	Deafness	MESH:D003638	marker/mechanism		NA		18953341
LRRC59	55379	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		30705370
LRRC59	55379	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		30705370
LRRC59	55379	Glioblastoma	MESH:D005909	marker/mechanism		NA		30705370
LRRC59	55379	Lymphatic Metastasis	MESH:D008207	marker/mechanism		NA		30705370
LRRC59	55379	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		30705370
LRRC6	23639	CILIARY DYSKINESIA, PRIMARY, 19	OMIM:614935	marker/mechanism		NA	614935	
LRRC7	57554	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		18438686
LRRC8A	56262	Agammaglobulinemia	MESH:D000361	marker/mechanism		NA	613506	
LRRFIP1	9208	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
LRRK2	120892	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		22138691
LRRK2	120892	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
LRRK2	120892	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		19741132
LRRK2	120892	Parkinson Disease	MESH:D010300	marker/mechanism		NA		17388990|19915575|19915576|20205471|22043175|23017109|23472874|23628791|25149416|25475535|25631236
LRRK2	120892	PARKINSON DISEASE 8, AUTOSOMAL DOMINANT	OMIM:607060	marker/mechanism		NA	607060	
LRRK2	120892	Parkinsonian Disorders	MESH:D020734	marker/mechanism		NA		23046578|25017139|26558463
LRRN3	54674	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		20678249
LRRTM3	347731	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		20678249
LRSAM1	90678	Charcot-Marie-Tooth Disease	MESH:D002607	marker/mechanism		NA		20865121
LRSAM1	90678	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P	OMIM:614436	marker/mechanism		NA	614436	
LRSAM1	90678	Charcot-Marie-Tooth disease, Type 4A, axonal form	MESH:C539595	marker/mechanism		NA		22781092|27686364
LRTOMT	220074	Deafness, Autosomal Recessive 63	MESH:C566951	marker/mechanism		NA	611451	
LSG1	55341	Brain Injuries	MESH:D001930	marker/mechanism		NA		14499481
LSM5	23658	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
LSP1	4046	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17529967|20453838
LSP1	4046	Calcinosis	MESH:D002114	marker/mechanism		NA		21335463
LSP1	4046	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		21297633
LSP1	4046	Heart Valve Diseases	MESH:D006349	marker/mechanism		NA		21335463
LSR	51599	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462|16316942
LSR	51599	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462|16316942
LSR	51599	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462|16316942
LSS	4047	CATARACT 44	OMIM:616509	marker/mechanism		NA	616509	
LSS	4047	Lipidoses	MESH:D008064	marker/mechanism		NA		15342952|16919414
LSS	4047	Q Fever	MESH:D011778	marker/mechanism		NA		16469060
LTA	4049	Arthritis, Psoriatic	MESH:D015535	marker/mechanism		NA	607507	12746914
LTA	4049	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		15266304
LTA	4049	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		29379198
LTA	4049	Hepatic Encephalopathy	MESH:D006501	marker/mechanism		NA		9696492
LTA	4049	Leprosy	MESH:D007918	marker/mechanism		NA	610988	17353895
LTA	4049	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25162674
LTA	4049	Myocardial Infarction	MESH:D009203	marker/mechanism		NA	608446	12426569|15129282
LTA	4049	Sepsis	MESH:D018805	marker/mechanism		NA		22977509
LTA4H	4048	Atherosclerosis	MESH:D050197	marker/mechanism		NA		16698924
LTA4H	4048	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
LTB	4050	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
LTB4R	1241	Anaphylaxis	MESH:D000707	marker/mechanism		NA		10934231
LTB4R	1241	Inflammation	MESH:D007249	marker/mechanism		NA		10934231
LTB4R	1241	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
LTB4R1	16995	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28487374
LTB4R1	16995	Nephrosclerosis	MESH:D009400	marker/mechanism		NA		30818366
LTBP1	4052	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
LTBP1	4052	Osteoarthritis, Knee	MESH:D020370	marker/mechanism		NA		30374069
LTBP2	4053	Glaucoma	MESH:D005901	marker/mechanism		NA		19361779|27149523
LTBP2	4053	Glaucoma 3, Primary Congenital, D	MESH:C567765	marker/mechanism		NA	613086	
LTBP2	4053	Glaucoma 3, primary infantile, B	MESH:C536824	marker/mechanism		NA	600975	
LTBP2	4053	MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA	OMIM:251750	marker/mechanism		NA	251750	
LTBP2	4053	Weill-Marchesani Syndrome	MESH:D056846	marker/mechanism		NA	614819	
LTBP3	4054	Amelogenesis Imperfecta	MESH:D000567	marker/mechanism		NA		25669657
LTBP3	4054	Anodontia	MESH:D000848	marker/mechanism		NA		19344874|25899461
LTBP3	4054	Bone Diseases	MESH:D001847	marker/mechanism		NA		19344874
LTBP3	4054	Brachyolmia	MESH:C537098	marker/mechanism		NA		25669657
LTBP3	4054	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		11790802|12379497
LTBP3	4054	Growth Disorders	MESH:D006130	marker/mechanism		NA		19344874|25899461
LTBP3	4054	Kyphosis	MESH:D007738	marker/mechanism		NA		11790802
LTBP3	4054	Mitral Valve Prolapse	MESH:D008945	marker/mechanism		NA		25899461
LTBP3	4054	Osteoarthritis	MESH:D010003	marker/mechanism		NA		11790802|12379497
LTBP3	4054	Osteoarthritis, Hip	MESH:D015207	marker/mechanism		NA		30374069
LTBP3	4054	Osteosclerosis	MESH:D010026	marker/mechanism		NA		11790802|12379497
LTBP3	4054	Tooth Agenesis, Selective, 6	MESH:C567755	marker/mechanism		NA	601216	
LTBP4	8425	Cutis Laxa With Severe Pulmonary, Gastrointestinal, And Urinary Abnormalities	MESH:C567716	marker/mechanism		NA	613177	
LTBP4	8425	Glioblastoma	MESH:D005909	marker/mechanism		NA		27270107
LTBP4	8425	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		27270107
LTBR	4055	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		31557154
LTBR	4055	Malaria	MESH:D008288	marker/mechanism		NA		15788153
LTC4S	4056	Asthma, Aspirin-Induced	MESH:D055963	marker/mechanism		NA		10970818|20485159|9393345|9466979
LTC4S	4056	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		16433794
LTC4S	4056	Leukotriene C4 Synthase Deficiency	MESH:C565439	marker/mechanism		NA	614037	
LTF	4057	Candidiasis, Oral	MESH:D002180	therapeutic		NA		16640825
LTF	4057	Candidiasis, Vulvovaginal	MESH:D002181	therapeutic		NA		16640825
LTF	4057	Carbon Tetrachloride Poisoning	MESH:D002252	therapeutic		NA		16141546
LTF	4057	Chemical and Drug Induced Liver Injury	MESH:D056486	therapeutic		NA		16141546
LTF	4057	Colitis, Ulcerative	MESH:D003093	therapeutic		NA		16640825
LTF	4057	Colonic Neoplasms	MESH:D003110	therapeutic		NA		12079509
LTF	4057	Diarrhea	MESH:D003967	therapeutic		NA		16640825
LTF	4057	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
LTF	4057	Enterocolitis, Necrotizing	MESH:D020345	therapeutic		NA		16640825
LTF	4057	Gastrointestinal Hemorrhage	MESH:D006471	therapeutic		NA		15651117
LTF	4057	Hypertension	MESH:D006973	therapeutic		NA		24587916
LTF	4057	Hypotension	MESH:D007022	marker/mechanism		NA		14563657
LTF	4057	Inflammation	MESH:D007249	therapeutic		NA		16141546
LTF	4057	Joint Diseases	MESH:D007592	therapeutic		NA		16640825
LTF	4057	Liver Neoplasms	MESH:D008113	therapeutic		NA		12079509
LTF	4057	Neoplasms	MESH:D009369	therapeutic		NA		16640825
LTF	4057	Osteoporosis	MESH:D010024	therapeutic		NA		16648989|16936800
LTF	4057	Premature Birth	MESH:D047928	therapeutic		NA		16640825
LTF	4057	Weight Loss	MESH:D015431	therapeutic		NA		24587916
LTF	4057	Wounds and Injuries	MESH:D014947	therapeutic		NA		16640825
LTK	4058	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
LUM	4060	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		26396155
LUM	4060	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
LUM	4060	Muscular Dystrophy, Facioscapulohumeral	MESH:D020391	marker/mechanism		NA		12868502
LUM	4060	Wounds and Injuries	MESH:D014947	therapeutic		NA		24367547
LURAP1L	286343	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
LXN	56925	Chromosomal Instability	MESH:D043171	marker/mechanism		NA		25341047
LXN	56925	Melanoma	MESH:D008545	marker/mechanism		NA		17145863
LY6	17062	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		8305641
LY6	17062	Nephritis	MESH:D009393	marker/mechanism		NA		8305641
LY6E	4061	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
LY6E	4061	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		17446842
LY6G	546644	Kidney Diseases	MESH:D007674	marker/mechanism		NA		19913069
LY86	9450	Brain Injuries	MESH:D001930	marker/mechanism		NA		21549006
LY86	9450	Calcinosis	MESH:D002114	marker/mechanism		NA		21335463
LY86	9450	Heart Valve Diseases	MESH:D006349	marker/mechanism		NA		21335463
LY86	9450	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
LY96	23643	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		17379860
LY96	23643	Carcinoma	MESH:D002277	marker/mechanism		NA		22180778
LY96	23643	Cholestasis	MESH:D002779	marker/mechanism		NA		27989131
LY96	23643	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22180778
LY96	23643	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
LY96	23643	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		22180778
LYL1	4066	Leukemia, Lymphoid	MESH:D007945	marker/mechanism		NA		3162254
LYL1	4066	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		16094422
LYL1	4066	Myelodysplastic Syndromes	MESH:D009190	marker/mechanism		NA		16094422
LYN	4067	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
LYRM4	57128	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19	OMIM:615595	marker/mechanism		NA	615595	
LYRM7	90624	Mitochondrial Complex III Deficiency	MESH:C565128	marker/mechanism		NA	615838	
LYRM9	201229	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941189
LYSMD3	116068	Tobacco Use Disorder	MESH:D014029	marker/mechanism		NA		18438686
LYST	1130	Chediak-Higashi Syndrome	MESH:D002609	marker/mechanism		NA	214500	
LYST	1130	Influenza, Human	MESH:D007251	marker/mechanism		NA		26597256
LYVE1	10894	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
LYZ	4069	Amyloidosis, familial visceral	MESH:C538249	marker/mechanism		NA	105200	
LZTFL1	54585	BARDET-BIEDL SYNDROME 17	OMIM:615994	marker/mechanism		NA	615994	
LZTFL1	54585	COVID-19	MESH:C000657245	marker/mechanism		NA		32558485|32998156
LZTFL1	54585	Critical Illness	MESH:D016638	marker/mechanism		NA		32558485|32998156
LZTFL1	54585	Respiratory Insufficiency	MESH:D012131	marker/mechanism		NA		32558485
LZTR1	8216	Autistic Disorder	MESH:D001321	marker/mechanism		NA		25961944
LZTR1	8216	Glioblastoma	MESH:D005909	marker/mechanism		NA		23917401
LZTR1	8216	NOONAN SYNDROME 10	OMIM:616564	marker/mechanism		NA	616564	
LZTR1	8216	Schwannomatosis	MESH:C536641	marker/mechanism		NA	615670	24362817
LZTS1	11178	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA	133239	
LZTS1	11178	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		12377406
M6PR	4074	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		23797736
M6PR	4074	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
M6PR	4074	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
M6PR	4074	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
MAB21L2	10586	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		17568789
MAB21L2	10586	MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME	OMIM:615877	marker/mechanism		NA	615877	
MACIR	90355	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		30705370
MACIR	90355	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		30705370
MACIR	90355	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		30705370
MACIR	90355	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		30705370
MACIR	90355	Glioblastoma	MESH:D005909	marker/mechanism		NA		30705370
MACIR	90355	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		30705370
MACIR	90355	Lymphatic Metastasis	MESH:D008207	marker/mechanism		NA		30705370
MACIR	90355	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		30705370
MACIR	90355	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		30705370
MACO1	55219	Coronary Disease	MESH:D003327	marker/mechanism		NA		19060911
MACO1	55219	Dyslipidemias	MESH:D050171	marker/mechanism		NA		19060911
MACROD2	140733	Autistic Disorder	MESH:D001321	marker/mechanism		NA		20663923
MACROD2	140733	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		27064257
MACROD2	140733	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
MAD1L1	8379	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
MAD1L1	8379	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
MAD1L1	8379	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA	176807	
MAD1L1	8379	Testicular Germ Cell Tumor	MESH:C563236	marker/mechanism		NA		23666239
MAD2L1	4085	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
MAD2L1	4085	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		18691855
MAD2L1	4085	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
MAD2L2	10459	FANCONI ANEMIA, COMPLEMENTATION GROUP V	OMIM:617243	marker/mechanism		NA	617243	
MADCAM1	8174	Colitis	MESH:D003092	therapeutic		NA		16917232
MADCAM1	8174	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
MAEA	10296	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		22158537
MAF	4094	Cataract, Pulverulent, Juvenile-Onset	MESH:C565703	marker/mechanism		NA	610202	
MAF	4094	Cataracts, Congenital, with Sensorineural Deafness, Down Syndrome-Like Facial Appearance, Short Stature, and Mental Retardation	MESH:C563390	marker/mechanism		NA	601088	
MAF	4094	Cholestasis, Intrahepatic	MESH:D002780	marker/mechanism		NA		20146260
MAF	4094	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		30510241
MAFB	9935	Cleft Lip	MESH:D002971	marker/mechanism		NA		20436469
MAFB	9935	Duane Retraction Syndrome	MESH:D004370	marker/mechanism		NA	617041	
MAFB	9935	MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME	OMIM:166300	marker/mechanism		NA	166300	
MAFF	23764	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
MAFG	4097	Cholestasis, Intrahepatic	MESH:D002780	marker/mechanism		NA		20146260
MAG	4099	Lewy Body Disease	MESH:D020961	marker/mechanism		NA		19276553
MAG	4099	Parkinson Disease	MESH:D010300	marker/mechanism		NA		19276553
MAG	4099	SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	OMIM:616680	marker/mechanism		NA	616680	
MAGEA1	4100	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
MAGEA1	4100	Melanoma	MESH:D008545	marker/mechanism		NA		26640592
MAGEA3	4102	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
MAGEA6	4105	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
MAGEA9	4108	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		17290406
MAGEC1	9947	Melanoma	MESH:D008545	marker/mechanism		NA		22842228
MAGEC1	9947	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
MAGEC2	51438	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
MAGED2	10916	BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	OMIM:300971	marker/mechanism		NA	300971	
MAGED4	728239	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21472284
MAGEE1	57692	Bile Duct Diseases	MESH:D001649	marker/mechanism		NA		30515189
MAGEE1	57692	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
MAGEL2	54551	Autistic Disorder	MESH:D001321	marker/mechanism		NA		24076603
MAGEL2	54551	Prader-Willi Syndrome	MESH:D011218	marker/mechanism		NA	176270	24076603
MAGI1	9223	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
MAGI2	9863	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		25653350
MAGI2	9863	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
MAGI2	9863	Memory Disorders	MESH:D008569	marker/mechanism		NA		25653350
MAGI2	9863	Neurobehavioral Manifestations	MESH:D019954	marker/mechanism		NA		25653350
MAGI2	9863	Schizophrenia	MESH:D012559	marker/mechanism		NA		25653350
MAGOHB	55110	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
MAGT1	84061	IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA	OMIM:300853	marker/mechanism		NA	300853	
MAK	4117	RETINITIS PIGMENTOSA 62	OMIM:614181	marker/mechanism		NA	614181	
MAL	4118	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19208741
MAL	4118	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		19445022
MAL	4118	Head and Neck Neoplasms	MESH:D006258	marker/mechanism		NA		19445022
MALAT1	378938	Breast Neoplasms	MESH:D001943	marker/mechanism|therapeutic		NA		29912916|30349115
MALAT1	378938	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		30515189
MALAT1	378938	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		25538231
MALAT1	378938	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		29119387
MALAT1	378938	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		26435214
MALAT1	378938	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		27064257
MALAT1	378938	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		25538231
MALAT1	378938	Neoplasm Metastasis	MESH:D009362	marker/mechanism|therapeutic		NA		24244343|30349115
MALAT1	378938	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
MALT1	10892	IMMUNODEFICIENCY 12	OMIM:615468	marker/mechanism		NA	615468	
MALT1	10892	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		21173233
MAML2	84441	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
MAML3	55534	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
MAML3	55534	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		23708190
MAML3	55534	Sarcoma	MESH:D012509	marker/mechanism		NA		24859338
MAML3	55534	Sinonasal undifferentiated carcinoma	MESH:C537344	marker/mechanism		NA		24859338
MAMLD1	10046	Hypospadias	MESH:D007021	marker/mechanism		NA		21559465
MAMLD1	10046	Hypospadias 2, X-Linked	MESH:C567462	marker/mechanism		NA	300758	
MAN1B1	11253	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
MAN1B1	11253	RAFIQ SYNDROME	OMIM:614202	marker/mechanism		NA	614202	
MAN2B1	4125	alpha-Mannosidosis	MESH:D008363	marker/mechanism		NA	248500	
MAN2B1	4125	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		25133636
MAN2C1	4123	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
MANBA	4126	beta-Mannosidosis	MESH:D044905	marker/mechanism		NA	248510	
MANEA	79694	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		18438686|19255376
MANEA	79694	Paranoid Disorders	MESH:D010259	marker/mechanism		NA		18438686
MANEA	79694	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
MAOA	4128	Antisocial Personality Disorder	MESH:D000987	marker/mechanism		NA		12161658|18212819|8503438
MAOA	4128	Autistic Disorder	MESH:D001321	marker/mechanism		NA		12919132|18361446|20573161
MAOA	4128	Brunner Syndrome	MESH:C563156	marker/mechanism		NA	300615	8211186
MAOA	4128	Cognition Disorders	MESH:D003072	marker/mechanism		NA		24402517
MAOA	4128	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
MAOA	4128	End Stage Liver Disease	MESH:D058625	marker/mechanism		NA		15025246
MAOA	4128	Fetal Nutrition Disorders	MESH:D048070	marker/mechanism		NA		22340208
MAOA	4128	Hepatic Encephalopathy	MESH:D006501	marker/mechanism		NA		10206825|10564534|9048767
MAOA	4128	Huntington Disease	MESH:D006816	marker/mechanism		NA		21075085
MAOA	4128	Hypotension	MESH:D007022	marker/mechanism		NA		11834493
MAOA	4128	Mental Disorders	MESH:D001523	marker/mechanism		NA		22340208
MAOA	4128	Mental Retardation, X-Linked	MESH:D038901	marker/mechanism		NA		8503438
MAOA	4128	Muscular Diseases	MESH:D009135	marker/mechanism		NA		15946989
MAOA	4128	Parkinson Disease	MESH:D010300	marker/mechanism		NA		17449559
MAOA	4128	Pheochromocytoma	MESH:D010673	marker/mechanism		NA		22569243
MAOA	4128	Prenatal Exposure Delayed Effects	MESH:D011297	marker/mechanism		NA		22340208
MAOB	4129	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		21075085|7816197
MAOB	4129	Anemia, Megaloblastic	MESH:D000749	marker/mechanism		NA		7430361
MAOB	4129	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19221690
MAOB	4129	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
MAOB	4129	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
MAOB	4129	Hepatic Encephalopathy	MESH:D006501	marker/mechanism		NA		10564534
MAOB	4129	Huntington Disease	MESH:D006816	marker/mechanism		NA		21075085
MAOB	4129	Hypotension	MESH:D007022	marker/mechanism		NA		11834493
MAOB	4129	Parkinson Disease	MESH:D010300	marker/mechanism		NA		21318773
MAOB	4129	Pheochromocytoma	MESH:D010673	marker/mechanism		NA		22569243
MAOB	4129	Plaque, Amyloid	MESH:D058225	marker/mechanism		NA		7816197
MAOB	4129	Schizophrenia	MESH:D012559	marker/mechanism		NA		20479760
MAP1	109953	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		28885000
MAP1	109953	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		28885000
MAP1LC3A	84557	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
MAP1LC3B	81631	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
MAP1LC3B	81631	Spinal Cord Injuries	MESH:D013119	marker/mechanism		NA		29793971
MAP2	4133	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
MAP2	4133	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
MAP2	4133	Lewy Body Disease	MESH:D020961	marker/mechanism		NA		30236862
MAP2	4133	Parkinson Disease	MESH:D010300	marker/mechanism		NA		30236862
MAP2K1	5604	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		22135231
MAP2K1	5604	Brain Ischemia	MESH:D002545	marker/mechanism		NA		17901229
MAP2K1	5604	Cardiofaciocutaneous syndrome	MESH:C535579	marker/mechanism		NA	615279	16439621|17703371
MAP2K1	5604	Costello Syndrome	MESH:D056685	marker/mechanism		NA		17703371
MAP2K1	5604	Leukemia, Hairy Cell	MESH:D007943	marker/mechanism		NA		24241536
MAP2K1	5604	Melanoma	MESH:D008545	marker/mechanism		NA		22197931
MAP2K1	5604	Melorheostosis	MESH:D008557	marker/mechanism		NA	155950	
MAP2K1	5604	Noonan Syndrome	MESH:D009634	marker/mechanism		NA	163950	17703371
MAP2K1	5604	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
MAP2K1	5604	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		32512071
MAP2K2	5605	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
MAP2K2	5605	Cardiofaciocutaneous syndrome	MESH:C535579	marker/mechanism		NA	615280	16439621|17703371
MAP2K2	5605	Costello Syndrome	MESH:D056685	marker/mechanism		NA		17703371
MAP2K2	5605	Melanoma	MESH:D008545	marker/mechanism		NA		22197931
MAP2K2	5605	Noonan Syndrome	MESH:D009634	marker/mechanism		NA		17703371
MAP2K2	5605	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		32512071
MAP2K3	5606	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		32512071
MAP2K5	5607	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
MAP2K5	5607	Body Weight	MESH:D001835	marker/mechanism		NA		22344219
MAP2K5	5607	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		32512071
MAP2K6	5608	Colonic Neoplasms	MESH:D003110	therapeutic		NA		15037631
MAP2K6	5608	Edema	MESH:D004487	therapeutic		NA		21544193
MAP2K6	5608	Hypersensitivity	MESH:D006967	therapeutic		NA		21544193
MAP2K6	5608	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		32512071
MAP2K7	5609	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21317887
MAP2K7	5609	Fibrosis	MESH:D005355	marker/mechanism		NA		21284947
MAP2K7	5609	Heart Failure	MESH:D006333	marker/mechanism		NA		21284947
MAP2K7	5609	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		21317887
MAP2K7	5609	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		21317887
MAP2K7	5609	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21317887
MAP3K1	4214	46,XY SEX REVERSAL 6	OMIM:613762	marker/mechanism		NA	613762	
MAP3K1	4214	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17529967
MAP3K1	4214	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29662167
MAP3K20	51776	SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY	OMIM:616890	marker/mechanism		NA	616890	
MAP3K3	4215	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		17068819
MAP3K4	4216	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		23104009
MAP3K4	4216	Wilms Tumor	MESH:D009396	marker/mechanism		NA		28825729
MAP3K5	4217	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		18342293
MAP3K5	4217	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		18700144
MAP3K5	4217	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		16731828
MAP3K5	4217	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		18342293
MAP3K5	4217	Melanoma	MESH:D008545	marker/mechanism		NA		22197930
MAP3K5	4217	Parkinson Disease	MESH:D010300	marker/mechanism		NA		21815648
MAP3K7	6885	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		28789951
MAP3K7	6885	Forney Robinson Pascoe syndrome	MESH:C537269	marker/mechanism		NA	157800	
MAP3K7	6885	Frontometaphyseal dysplasia	MESH:C538064	marker/mechanism		NA	617137	
MAP3K7	6885	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
MAP3K8	1326	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
MAP3K8	1326	Lung Neoplasms	MESH:D008175	marker/mechanism		NA	211980	
MAP3K8	1326	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
MAP3K9	4293	Melanoma	MESH:D008545	marker/mechanism		NA		22197930
MAP4	4134	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
MAP4K4	9448	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
MAP6	4135	Hyperkinesis	MESH:D006948	marker/mechanism		NA		16046005
MAPK1	5594	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
MAPK1	5594	Brain Ischemia	MESH:D002545	marker/mechanism		NA		17901229
MAPK1	5594	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		21401805
MAPK1	5594	Cardiomyopathies	MESH:D009202	therapeutic		NA		10620750
MAPK1	5594	Ceroid Lipofuscinosis, Neuronal, 6	MESH:C566627	marker/mechanism		NA		23516525
MAPK1	5594	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		28789951
MAPK1	5594	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		16407894|20692647
MAPK1	5594	Coronavirus Infections	MESH:D018352	marker/mechanism		NA		20484496
MAPK1	5594	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27093858
MAPK1	5594	Gliosis	MESH:D005911	marker/mechanism		NA		19402951
MAPK1	5594	Head and Neck Neoplasms	MESH:D006258	marker/mechanism		NA		15342401
MAPK1	5594	Hodgkin Disease	MESH:D006689	marker/mechanism		NA		7545087
MAPK1	5594	Hyperalgesia	MESH:D006930	marker/mechanism		NA		12941468|27093858
MAPK1	5594	Hypertrophy	MESH:D006984	marker/mechanism		NA		12237323
MAPK1	5594	Infertility, Female	MESH:D007247	marker/mechanism		NA		21177758
MAPK1	5594	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		21813464
MAPK1	5594	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		28100771
MAPK1	5594	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		11884234|12376484
MAPK1	5594	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		22580338
MAPK1	5594	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		22580338
MAPK1	5594	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		19911010
MAPK1	5594	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		16211241
MAPK1	5594	Pneumonia, Pneumococcal	MESH:D011018	marker/mechanism		NA		24894820
MAPK1	5594	Radiation Injuries, Experimental	MESH:D011833	therapeutic		NA		22247605
MAPK1	5594	Sepsis	MESH:D018805	marker/mechanism		NA		15489642
MAPK1	5594	Severe Acute Respiratory Syndrome	MESH:D045169	marker/mechanism		NA		20484496
MAPK1	5594	Sezary Syndrome	MESH:D012751	marker/mechanism		NA		26551667
MAPK1	5594	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		17003101
MAPK1	5594	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		17549049
MAPK1	5594	Trigeminal Neuralgia	MESH:D014277	marker/mechanism		NA		27093858
MAPK11	5600	Cardiomyopathies	MESH:D009202	therapeutic		NA		10620750
MAPK13	5603	Cholestasis	MESH:D002779	marker/mechanism		NA		20626112
MAPK14	1432	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		10620750
MAPK14	1432	Cholestasis	MESH:D002779	marker/mechanism		NA		20626112
MAPK14	1432	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		30026087
MAPK14	1432	Hepatic Insufficiency	MESH:D048550	marker/mechanism		NA		30026087
MAPK14	1432	Hepatomegaly	MESH:D006529	marker/mechanism		NA		30026087
MAPK14	1432	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	MESH:D015464	therapeutic		NA		16818652
MAPK14	1432	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		30026087
MAPK14	1432	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		17468757
MAPK14	1432	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17468755
MAPK14	1432	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
MAPK15	225689	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		26039340
MAPK3	5595	Atrophy	MESH:D001284	marker/mechanism		NA		16391472
MAPK3	5595	Autistic Disorder	MESH:D001321	marker/mechanism		NA		30559488
MAPK3	5595	Brain Ischemia	MESH:D002545	marker/mechanism		NA		17901229
MAPK3	5595	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		21401805
MAPK3	5595	Cardiomyopathies	MESH:D009202	therapeutic		NA		10620750
MAPK3	5595	Ceroid Lipofuscinosis, Neuronal, 6	MESH:C566627	marker/mechanism		NA		23516525
MAPK3	5595	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		28789951
MAPK3	5595	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		20692647
MAPK3	5595	Coronavirus Infections	MESH:D018352	marker/mechanism		NA		20484496
MAPK3	5595	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		30559488
MAPK3	5595	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27093858
MAPK3	5595	Gliosis	MESH:D005911	marker/mechanism		NA		19402951
MAPK3	5595	Head and Neck Neoplasms	MESH:D006258	marker/mechanism		NA		15342401
MAPK3	5595	Hyperalgesia	MESH:D006930	marker/mechanism		NA		12941468|27093858
MAPK3	5595	Hypertrophy	MESH:D006984	marker/mechanism		NA		12237323
MAPK3	5595	Infertility, Female	MESH:D007247	marker/mechanism		NA		21177758
MAPK3	5595	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		21813464
MAPK3	5595	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		28100771
MAPK3	5595	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		11884234|12083368
MAPK3	5595	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		22580338
MAPK3	5595	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		22580338
MAPK3	5595	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		19911010
MAPK3	5595	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		16211241
MAPK3	5595	Pneumonia, Pneumococcal	MESH:D011018	marker/mechanism		NA		24894820
MAPK3	5595	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		24763052
MAPK3	5595	Radiation Injuries, Experimental	MESH:D011833	therapeutic		NA		22247605
MAPK3	5595	Sepsis	MESH:D018805	marker/mechanism		NA		15489642
MAPK3	5595	Severe Acute Respiratory Syndrome	MESH:D045169	marker/mechanism		NA		20484496
MAPK3	5595	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		17003101
MAPK3	5595	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		17549049
MAPK3	5595	Trigeminal Neuralgia	MESH:D014277	marker/mechanism		NA		27093858
MAPK6	5597	Hyperplasia	MESH:D006965	marker/mechanism		NA		22561872
MAPK7	5598	Hyperalgesia	MESH:D006930	marker/mechanism		NA		17237256
MAPK7	5598	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		29507229
MAPK8	5599	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		21726611
MAPK8	5599	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		28789951
MAPK8	5599	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		24046278
MAPK8	5599	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27093858
MAPK8	5599	Hyperalgesia	MESH:D006930	marker/mechanism		NA		27093858
MAPK8	5599	Liver Failure, Acute	MESH:D017114	marker/mechanism		NA		17185352
MAPK8	5599	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21317887
MAPK8	5599	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		20302854
MAPK8	5599	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		18593901
MAPK8	5599	Trigeminal Neuralgia	MESH:D014277	marker/mechanism		NA		27093858
MAPK8IP1	9479	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA	125853	
MAPK8IP3	23162	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
MAPK9	5601	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		28789951
MAPK9	5601	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27093858
MAPK9	5601	Hyperalgesia	MESH:D006930	marker/mechanism		NA		27093858
MAPK9	5601	Ischemia	MESH:D007511	marker/mechanism		NA		19667931
MAPK9	5601	Neoplasm Metastasis	MESH:D009362	therapeutic		NA		21779479
MAPK9	5601	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21317887
MAPK9	5601	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		32512071
MAPK9	5601	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		19667931|20302854
MAPK9	5601	Trigeminal Neuralgia	MESH:D014277	marker/mechanism		NA		27093858
MAPKAPK3	7867	Patterned dystrophy of retinal pigment epithelium	MESH:C536309	marker/mechanism		NA	617111	
MAPKBP1	23005	NEPHRONOPHTHISIS 20	OMIM:617271	marker/mechanism		NA	617271	
MAPRE1	22919	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
MAPRE1	22919	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
MAPRE3	22924	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
MAPRE3	22924	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
MAPT	4137	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		12852432|14517953|15750215|20157255|21715663|25352456|27117003
MAPT	4137	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		29860433
MAPT	4137	Ataxia	MESH:D001259	therapeutic		NA		31783120
MAPT	4137	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
MAPT	4137	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
MAPT	4137	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		29068127
MAPT	4137	Cognition Disorders	MESH:D003072	marker/mechanism		NA		24556215|26945731
MAPT	4137	Dementia	MESH:D003704	marker/mechanism		NA		11889249|22300406
MAPT	4137	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		24556215
MAPT	4137	Frontotemporal Dementia	MESH:D057180	marker/mechanism		NA	600274	10802785|11117542|11912108|16495328|9641683|9789048
MAPT	4137	Learning Disabilities	MESH:D007859	marker/mechanism		NA		22430071|24556215
MAPT	4137	Memory Disorders	MESH:D008569	marker/mechanism		NA		12368474|22430071|24556215|29203278|29860433
MAPT	4137	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		22430071|9789048
MAPT	4137	Osteoarthritis, Hip	MESH:D015207	marker/mechanism		NA		30664745
MAPT	4137	Parkinson Disease	MESH:D010300	marker/mechanism		NA		19915575|20711177
MAPT	4137	PARKINSON DISEASE, LATE-ONSET	OMIM:168600	marker/mechanism		NA	168600	
MAPT	4137	Parkinsonian Disorders	MESH:D020734	marker/mechanism		NA		10802785|19458322
MAPT	4137	Pick Disease of the Brain	MESH:D020774	marker/mechanism		NA	172700	10604746|11117542|11601501|9641683
MAPT	4137	Progressive supranuclear palsy atypical	MESH:C537240	marker/mechanism		NA	260540	
MAPT	4137	Psychomotor Agitation	MESH:D011595	marker/mechanism		NA		24556215
MAPT	4137	Respiratory Insufficiency	MESH:D012131	marker/mechanism		NA		14595660
MAPT	4137	Splenomegaly	MESH:D013163	marker/mechanism		NA		27117003
MAPT	4137	Supranuclear Palsy, Progressive	MESH:D013494	marker/mechanism		NA	601104	12325083|19458322|21685912|25402454
MAPT	4137	Tauopathies	MESH:D024801	marker/mechanism		NA		10604746|11889249|14595660|24556215|27569447
MAPT	4137	Weight Gain	MESH:D015430	marker/mechanism		NA		29203278
MAPT	4137	Weight Loss	MESH:D015431	marker/mechanism		NA		24556215
MARCHF6	10299	Epilepsy, Familial Adult Myoclonic, 3	MESH:C567098	marker/mechanism		NA	613608	
MARCHF8	220972	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		17068819
MARCKS	4082	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		19192274
MARCKS	4082	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
MARCKS	4082	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
MARCKS	4082	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
MARCO	8685	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
MARK1	4139	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18492799
MARK1	4139	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
MARK2	2011	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
MARK2	2011	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
MARS1	4141	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2U	OMIM:616280	marker/mechanism		NA	616280	
MARS1	4141	INTERSTITIAL LUNG AND LIVER DISEASE	OMIM:615486	marker/mechanism		NA	615486	
MARS2	92935	Ataxia, Spastic, 3, Autosomal Recessive	MESH:C566956	marker/mechanism		NA	611390	
MARS2	92935	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25	OMIM:616430	marker/mechanism		NA	616430	
MARVELD2	153562	Deafness, Autosomal Recessive 49	MESH:C565717	marker/mechanism		NA	610153	
MAS1	4142	Thrombosis	MESH:D013927	therapeutic		NA		25339356
MASP1	5648	Carnevale syndrome	MESH:C535586	marker/mechanism		NA		21258343
MASP1	5648	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		21258343
MASP1	5648	Malpuech facial clefting syndrome	MESH:C535704	marker/mechanism		NA		21258343
MASP1	5648	Oculopalatoskeletal syndrome	MESH:C537738	marker/mechanism		NA	257920	21258343
MASP1	5648	Pigmentation Disorders	MESH:D010859	marker/mechanism		NA		21258343
MASP2	10747	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		12904520
MASP2	10747	Erythema Multiforme	MESH:D004892	marker/mechanism		NA		12904520
MASP2	10747	Immune Complex Diseases	MESH:D007105	marker/mechanism		NA		12904520
MASP2	10747	Inflammation	MESH:D007249	marker/mechanism		NA		12904520
MASP2	10747	MASP2 Deficiency	MESH:C565360	marker/mechanism		NA	613791	
MASP2	10747	Pneumonia, Pneumococcal	MESH:D011018	marker/mechanism		NA		12904520
MAT1A	4143	Amino Acid Metabolism, Inborn Errors	MESH:D000592	marker/mechanism		NA		7560086|8770875
MAT1A	4143	Brain Diseases	MESH:D001927	marker/mechanism		NA		8770875
MAT1A	4143	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		12060674
MAT1A	4143	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
MAT1A	4143	Demyelinating Diseases	MESH:D003711	marker/mechanism		NA		8770875
MAT1A	4143	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		23665415
MAT1A	4143	Fatty Liver	MESH:D005234	marker/mechanism		NA		12060674
MAT1A	4143	Hypermethioninemia	MESH:C564683	marker/mechanism		NA	250850	
MAT1A	4143	Hyperplasia	MESH:D006965	marker/mechanism		NA		12060674
MATN3	4148	Epiphyseal dysplasia, multiple, 5	MESH:C535505	marker/mechanism		NA	607078	
MATN3	4148	Osteoarthritis	MESH:D010003	marker/mechanism		NA	140600	
MATN3	4148	Spondyloepimetaphyseal Dysplasia, Matrilin-3 Related	MESH:C563869	marker/mechanism		NA	608728	
MATN4	8785	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
MATR3	9782	Myopathy, Distal 2	MESH:C565262	marker/mechanism		NA	606070	
MAX	4149	Pheochromocytoma	MESH:D010673	marker/mechanism		NA	171300	21685915
MAX	4149	Wilms Tumor	MESH:D009396	marker/mechanism		NA		28825729
MAZ	4150	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
MBD1	4152	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
MBD2	8932	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
MBD2	8932	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
MBD3	53615	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19921286
MBD3L2	125997	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
MBD4	8930	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19921286
MBD5	55777	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
MBD5	55777	Mental Retardation, Autosomal Dominant 1	MESH:C566947	marker/mechanism		NA	156200	
MBL2	4153	Birth Weight	MESH:D001724	marker/mechanism		NA		20923744
MBL2	4153	Diabetes, Gestational	MESH:D016640	marker/mechanism		NA		15472209
MBL2	4153	HIV Infections	MESH:D015658	marker/mechanism		NA		16960176
MBL2	4153	Infections	MESH:D007239	marker/mechanism		NA		7707811
MBL2	4153	Mannose-Binding Protein Deficiency	MESH:C563602	marker/mechanism		NA	614372	
MBL2	4153	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		20864405
MBL2	4153	Premature Birth	MESH:D047928	marker/mechanism		NA		16912583
MBNL1	4154	Myotonia	MESH:D009222	therapeutic		NA		24039817
MBNL1	4154	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
MBOAT1	154141	Cholestasis	MESH:D002779	marker/mechanism		NA		27989131
MBOAT2	129642	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
MBOAT7	79143	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		26482880
MBOAT7	79143	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57	OMIM:617188	marker/mechanism		NA	617188	
MBP	4155	Cerebrovascular Disorders	MESH:D002561	marker/mechanism		NA		15159442
MBP	4155	Demyelinating Diseases	MESH:D003711	marker/mechanism		NA		2580064
MBP	4155	Encephalomyelitis, Autoimmune, Experimental	MESH:D004681	marker/mechanism		NA		11501064|15159442|17884951|24070732
MBP	4155	Inflammation	MESH:D007249	marker/mechanism		NA		15159442
MBP	4155	Neuromyelitis Optica	MESH:D009471	marker/mechanism		NA		18509235
MBTPS1	8720	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		14563831
MBTPS1	8720	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		16759393
MBTPS1	8720	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
MBTPS2	51360	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		14563831
MBTPS2	51360	Ichthyosis follicularis atrichia photophobia syndrome	MESH:C536085	marker/mechanism		NA	308205	
MBTPS2	51360	Keratosis Follicularis Spinulosa Decalvans, X-Linked	MESH:C536159	marker/mechanism		NA	308800	
MBTPS2	51360	PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTIC PLAQUES, X-LINKED	OMIM:300918	marker/mechanism		NA	300918	
MC1R	4157	Carcinoma, Basal Cell	MESH:D002280	marker/mechanism		NA		18539553
MC1R	4157	Hyperalgesia	MESH:D006930	marker/mechanism		NA		19996949
MC1R	4157	Melanoma	MESH:D008545	marker/mechanism		NA		19578364|21559390|21983785
MC1R	4157	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 5	OMIM:613099	marker/mechanism		NA	613099	
MC1R	4157	Oculocutaneous albinism type 2	MESH:C537730	marker/mechanism		NA	203200	
MC1R	4157	Vitiligo	MESH:D014820	marker/mechanism		NA		22561518
MC2R	4158	Familial Glucocorticoid Deficiency 1	MESH:C565974	marker/mechanism		NA	202200	
MC2R	4158	Hypertension	MESH:D006973	marker/mechanism		NA		11082157
MC2R	4158	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
MC3R	4159	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 9	OMIM:602025	marker/mechanism		NA	602025	
MC4R	4160	Body Weight	MESH:D001835	marker/mechanism		NA		22344219|22344221
MC4R	4160	Hyperinsulinism	MESH:D006946	marker/mechanism		NA		23251400
MC4R	4160	Hyperphagia	MESH:D006963	marker/mechanism		NA		23251400
MC4R	4160	Insulin Resistance	MESH:D007333	marker/mechanism		NA		18454146
MC4R	4160	Obesity	MESH:D009765	marker/mechanism		NA		17143585|18454148|19079260|19079261|19151714|23251400
MC4R	4160	Obesity, Morbid	MESH:D009767	marker/mechanism		NA		29273807|29311635
MCAM	4162	Autoimmune Diseases of the Nervous System	MESH:D020274	therapeutic		NA		23595028
MCAM	4162	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		22784439|23621518
MCAM	4162	Multiple Sclerosis	MESH:D009103	therapeutic		NA		23595028
MCAM	4162	Neurogenic Inflammation	MESH:D020078	therapeutic		NA		23595028
MCAM	4162	Peritoneal Neoplasms	MESH:D010534	marker/mechanism		NA		22784439|23621518
MCC	4163	Adenomatous Polyposis Coli	MESH:D011125	marker/mechanism		NA		8071957
MCC	4163	Autistic Disorder	MESH:D001321	marker/mechanism		NA		8071957
MCC	4163	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	114500	
MCC	4163	Intellectual Disability	MESH:D008607	marker/mechanism		NA		8071957
MCC	4163	Rectal Neoplasms	MESH:D012004	marker/mechanism		NA		8071957
MCCC1	56922	3-methylcrotonyl CoA carboxylase 1 deficiency	MESH:C535308	marker/mechanism		NA	210200	
MCCC1	56922	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
MCCC2	64087	3-methylcrotonyl CoA carboxylase 2 deficiency	MESH:C535309	marker/mechanism		NA	210210	
MCEE	84693	Methylmalonyl-CoA Epimerase Deficiency	MESH:C565386	marker/mechanism		NA	251120	
MCFD2	90411	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2	OMIM:613625	marker/mechanism		NA	613625	
MCL1	4170	Barrett Esophagus	MESH:D001471	marker/mechanism		NA		21127259
MCL1	4170	Leishmaniasis	MESH:D007896	marker/mechanism		NA		26670606
MCL1	4170	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		19903766|27935865
MCL1	4170	Lymphoma, T-Cell, Cutaneous	MESH:D016410	marker/mechanism		NA		12754746
MCL1	4170	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		12429644
MCL1	4170	Sarcoma	MESH:D012509	marker/mechanism		NA		15217956
MCM10	55388	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
MCM2	4171	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
MCM2	4171	Colonic Neoplasms	MESH:D003110	therapeutic		NA		23770000
MCM2	4171	DEAFNESS, AUTOSOMAL DOMINANT 70	OMIM:616968	marker/mechanism		NA	616968	
MCM4	4173	IMMUNODEFICIENCY 54	OMIM:609981	marker/mechanism		NA	609981	
MCM6	4175	Lactose Intolerance, Adult Type	MESH:C562601	marker/mechanism		NA	223100	
MCM8	84515	PREMATURE OVARIAN FAILURE 10	OMIM:612885	marker/mechanism		NA	612885	
MCM9	254394	OVARIAN DYSGENESIS 4	OMIM:616185	marker/mechanism		NA	616185	
MCOLN1	57192	Mucolipidoses	MESH:D009081	marker/mechanism		NA	252650	20864526|21613607
MCPH1	79648	Microcephaly, Primary Autosomal Recessive, 1	MESH:C565384	marker/mechanism		NA	251200	
MCPT1	17224	Depressive Disorder	MESH:D003866	marker/mechanism		NA		19058337
MCPT1	17224	Hypertension	MESH:D006973	marker/mechanism		NA		11416217
MDH1	4190	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		16099942
MDH1	4190	Hypertension	MESH:D006973	marker/mechanism		NA		22228705
MDH1	4190	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
MDH1	4190	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
MDH2	4191	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
MDH2	4191	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		28811376
MDH2	4191	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51	OMIM:617339	marker/mechanism		NA	617339	
MDH2	4191	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
MDH2	4191	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
MDK	4192	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		19217924
MDK	4192	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		17607302
MDK	4192	Glioma	MESH:D005910	marker/mechanism		NA		21233844
MDK	4192	Memory Disorders	MESH:D008569	marker/mechanism		NA		19217924
MDK	4192	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		23056237
MDM2	4193	Acquired Hyperostosis Syndrome	MESH:D020083	marker/mechanism		NA		19779722
MDM2	4193	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		26229107
MDM2	4193	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		19941079|21268124
MDM2	4193	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA	614401	15550242
MDM2	4193	HIV Infections	MESH:D015658	marker/mechanism		NA		12878215
MDM2	4193	Infertility, Male	MESH:D007248	marker/mechanism		NA		22773013
MDM2	4193	Melanoma	MESH:D008545	marker/mechanism		NA		17210701
MDM2	4193	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		14555611
MDM2	4193	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		20875869
MDM2	4193	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		31945315
MDM4	4194	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		23535733
MDM4	4194	Glioblastoma	MESH:D005909	marker/mechanism		NA		20472715
MDM4	4194	Pneumoconiosis	MESH:D011009	marker/mechanism		NA		25445010
ME1	4199	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21147110
ME1	4199	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
ME1	4199	Obesity	MESH:D009765	marker/mechanism		NA		19270708
ME1	4199	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
MECOM	2122	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		23770046
MECOM	2122	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		23770046
MECOM	2122	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		29047144
MECOM	2122	Leukemia, Lymphoid	MESH:D007945	marker/mechanism		NA		23770046
MECOM	2122	Leukemia, Myeloid	MESH:D007951	marker/mechanism		NA		23770046
MECOM	2122	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		30472098
MECOM	2122	Myeloproliferative Disorders	MESH:D009196	marker/mechanism		NA		29047144
MECOM	2122	Nasopharyngeal Neoplasms	MESH:D009303	marker/mechanism		NA		20512145
MECOM	2122	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		23770046
MECOM	2122	Pancytopenia	MESH:D010198	marker/mechanism		NA		27725143
MECOM	2122	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
MECOM	2122	Splenomegaly	MESH:D013163	marker/mechanism		NA		27725143
MECP2	4204	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		22231481
MECP2	4204	Autistic Disorder	MESH:D001321	marker/mechanism		NA	300496	15211631|18621663|19921286
MECP2	4204	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		26189965
MECP2	4204	Child Development Disorders, Pervasive	MESH:D002659	marker/mechanism		NA		22231481
MECP2	4204	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		20711185
MECP2	4204	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		19559301
MECP2	4204	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		19559301
MECP2	4204	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		28592917
MECP2	4204	Encephalopathy, Neonatal Severe, Due To Mecp2 Mutations	MESH:C566878	marker/mechanism		NA	300673	20098342
MECP2	4204	Epilepsy	MESH:D004827	marker/mechanism		NA		29942082
MECP2	4204	Intellectual Disability	MESH:D008607	marker/mechanism		NA		19921286|20098342
MECP2	4204	Learning Disabilities	MESH:D007859	marker/mechanism		NA		19921286
MECP2	4204	Lubs X-linked mental retardation syndrome	MESH:C537723	marker/mechanism		NA	300260	
MECP2	4204	Mental Retardation, X-Linked, Syndromic 13	MESH:C566875	marker/mechanism		NA	300055	
MECP2	4204	Muscle Hypotonia	MESH:D009123	marker/mechanism		NA		19559301
MECP2	4204	Myoclonus	MESH:D009207	marker/mechanism		NA		19559301
MECP2	4204	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889|29942082
MECP2	4204	Psychomotor Disorders	MESH:D011596	marker/mechanism		NA		20098342
MECP2	4204	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		21435439
MECP2	4204	Respiratory Insufficiency	MESH:D012131	marker/mechanism		NA		19559301
MECP2	4204	Rett Syndrome	MESH:D015518	marker/mechanism		NA	312750	14593183|16670375|17433737|19000991|19190538|19559301|19921286|20098342|21316312|21966470|22343140|22532851|23892605|26214522|28498846|28592917
MECP2	4204	Seizures	MESH:D012640	marker/mechanism		NA		19921286
MECR	51102	DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES	OMIM:617282	marker/mechanism		NA	617282	
MED1	5469	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		20007298
MED1	5469	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		16109766
MED1	5469	Endometriosis	MESH:D004715	marker/mechanism		NA		22138541
MED12	9968	Adrenocortical Carcinoma	MESH:D018268	marker/mechanism		NA		24747642
MED12	9968	Blepharophimosis syndrome Ohdo type	MESH:C536232	marker/mechanism		NA	300895	
MED12	9968	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25038752|26437033
MED12	9968	Fibroadenoma	MESH:D018226	marker/mechanism		NA		25038752|26437033
MED12	9968	Lujan Fryns syndrome	MESH:C537724	marker/mechanism		NA	309520	
MED12	9968	Opitz-Kaveggia syndrome	MESH:C537923	marker/mechanism		NA	305450	17334363
MED12	9968	Phyllodes Tumor	MESH:D003557	marker/mechanism		NA		26437033
MED12	9968	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		22610119|29610475
MED13L	23389	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
MED13L	23389	MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	OMIM:616789	marker/mechanism		NA	616789	
MED13L	23389	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
MED13L	23389	Transposition of the Great Arteries, Dextro-Looped 1	MESH:C563853	marker/mechanism		NA	608808	
MED14	9282	Endometriosis	MESH:D004715	marker/mechanism		NA		22138541
MED16	10025	Endometriosis	MESH:D004715	marker/mechanism		NA		22138541
MED17	9440	Endometriosis	MESH:D004715	marker/mechanism		NA		22138541
MED17	9440	MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	OMIM:613668	marker/mechanism		NA	613668	
MED23	9439	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 18	OMIM:614249	marker/mechanism		NA	614249	
MED25	81857	BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME	OMIM:616449	marker/mechanism		NA	616449	
MED25	81857	Charcot-Marie-Tooth disease, Type 2B2	MESH:C537991	marker/mechanism		NA	605589	
MED28	80306	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21942447
MED28	80306	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		21942447
MED4	29079	Endometriosis	MESH:D004715	marker/mechanism		NA		22138541
MEF2A	4205	Coronary Artery Disease, Autosomal Dominant, 1	MESH:C564258	marker/mechanism		NA	608320	
MEF2C	4208	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		20412115
MEF2C	4208	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19131610
MEF2C	4208	Epilepsy	MESH:D004827	marker/mechanism		NA		20412115|29942082
MEF2C	4208	Intellectual Disability	MESH:D008607	marker/mechanism		NA		20412115
MEF2C	4208	MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	OMIM:613443	marker/mechanism		NA	613443	
MEF2C	4208	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		29942082
MEF2C	4208	Status Epilepticus	MESH:D013226	marker/mechanism		NA		18949272
MEF2C	4208	Stereotypic Movement Disorder	MESH:D019956	marker/mechanism		NA		20412115
MEF2D	4209	Migraine without Aura	MESH:D020326	marker/mechanism		NA		22683712
MEFV	4210	Acne Vulgaris	MESH:D000152	marker/mechanism		NA		27106250
MEFV	4210	Arthritis, Psoriatic	MESH:D015535	marker/mechanism		NA		17408446
MEFV	4210	Familial Mediterranean Fever	MESH:D010505	marker/mechanism		NA	249100	15805719|21329287
MEFV	4210	Familial Mediterranean Fever, Autosomal Dominant	MESH:C565021	marker/mechanism		NA	134610	
MEFV	4210	Hidradenitis Suppurativa	MESH:D017497	marker/mechanism		NA		27106250
MEFV	4210	Pyoderma Gangrenosum	MESH:D017511	marker/mechanism		NA		27106250
MEGF10	84466	Deglutition Disorders	MESH:D003680	marker/mechanism		NA		22101682
MEGF10	84466	Muscular Diseases	MESH:D009135	marker/mechanism		NA		22101682
MEGF10	84466	Respiratory Distress Syndrome, Newborn	MESH:D012127	marker/mechanism		NA		22101682
MEGF8	1954	Acrocephalopolysyndactyly Type II	MESH:C563187	marker/mechanism		NA	614976	
MEIS1	4211	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19776672
MEIS1	4211	Restless Legs Syndrome	MESH:D012148	marker/mechanism		NA		17637780|28604731
MEIS1	4211	Sleep Initiation and Maintenance Disorders	MESH:D007319	marker/mechanism		NA		28604731
MEIS1-AS3	730198	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
MEIS2	4212	Cardiac Malformation, Cleft Lip-Palate, Microcephaly and Digital Anomalies	MESH:C563414	marker/mechanism		NA	600987	
MELK	9833	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
MELTF	4241	Melanoma	MESH:D008545	marker/mechanism		NA		16704991
MEN1	4221	Adrenocortical Carcinoma	MESH:D018268	marker/mechanism		NA		24747642
MEN1	4221	Gastrinoma	MESH:D015408	marker/mechanism		NA		17961653
MEN1	4221	Glucagonoma	MESH:D005935	marker/mechanism		NA		17961653
MEN1	4221	Insulinoma	MESH:D007340	marker/mechanism		NA		17961653
MEN1	4221	Multiple Endocrine Neoplasia Type 1	MESH:D018761	marker/mechanism		NA	131100	19847644
MEN1	4221	Neuroendocrine Tumors	MESH:D018358	marker/mechanism		NA		21252315
MEN1	4221	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		17961653|21252315
MEN1	4221	Vipoma	MESH:D003969	marker/mechanism		NA		17961653
MEOX1	4222	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		16033404
MEOX1	4222	Klippel Feil syndrome recessive type	MESH:C536888	marker/mechanism		NA	214300	
MEOX2	4223	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
MEOX2	4223	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
MEP1A	4224	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
MEPE	56955	Fractures, Bone	MESH:D050723	marker/mechanism		NA		22504420
MEPE	56955	Osteomalacia	MESH:D010018	marker/mechanism		NA		11414762
MERTK	10461	Carcinoma	MESH:D002277	marker/mechanism		NA		19028587
MERTK	10461	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		25133636
MERTK	10461	Pulmonary Embolism	MESH:D011655	therapeutic		NA		19028587
MERTK	10461	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA		11062461
MERTK	10461	RETINITIS PIGMENTOSA 38	OMIM:613862	marker/mechanism		NA	613862	
MERTK	10461	Thromboembolism	MESH:D013923	therapeutic		NA		17047157
MERTK	10461	Thrombosis	MESH:D013927	marker/mechanism		NA		15130911
MESP2	145873	Spondylocostal dysostosis, autosomal recessive	MESH:C535781	marker/mechanism		NA	277300|608681	
MEST	4232	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
MET	4233	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		20934974|22042947
MET	4233	Astrocytoma	MESH:D001254	marker/mechanism		NA		11223164
MET	4233	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17053076|21328570
MET	4233	Carcinoma	MESH:D002277	marker/mechanism		NA		20661229
MET	4233	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA	114550	
MET	4233	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		21623265|21815704|22787409|24688052
MET	4233	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA	605074	25401301
MET	4233	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		22948846
MET	4233	Cognition Disorders	MESH:D003072	marker/mechanism		NA		20080979
MET	4233	Copper-Overload Cirrhosis	MESH:C566858	marker/mechanism		NA		22879914
MET	4233	DEAFNESS, AUTOSOMAL RECESSIVE 97	OMIM:616705	marker/mechanism		NA	616705	
MET	4233	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		22042947
MET	4233	Glioblastoma	MESH:D005909	marker/mechanism		NA		22162573
MET	4233	Hepatitis, Chronic	MESH:D006521	marker/mechanism		NA		22879914
MET	4233	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		22683780
MET	4233	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		11956651
MET	4233	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		20934974
MET	4233	Lymphatic Metastasis	MESH:D008207	marker/mechanism		NA		29426936
MET	4233	Melanoma	MESH:D008545	marker/mechanism		NA		29426936
MET	4233	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
MET	4233	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		15654357
MET	4233	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		20080979|21225626
MET	4233	Neuroblastoma	MESH:D009447	marker/mechanism		NA		16051641
MET	4233	Osteofibrous Dysplasia	MESH:C563276	marker/mechanism		NA	607278	
MET	4233	Osteosarcoma	MESH:D012516	marker/mechanism		NA		22235915
MET	4233	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		20661229
MET	4233	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
MET	4233	Schizophrenia	MESH:D012559	marker/mechanism		NA		20080979
MET	4233	Sinusitis	MESH:D012852	marker/mechanism		NA		18391768
MET	4233	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		22042947|22729845
METRNL	284207	Glucose Intolerance	MESH:D018149	therapeutic		NA		30213948
METRNL	284207	Insulin Resistance	MESH:D007333	therapeutic		NA		30213948
METRNL	284207	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
METRNL	284207	Weight Gain	MESH:D015430	therapeutic		NA		30213948
METTL23	124512	Intellectual Disability	MESH:D008607	marker/mechanism		NA		24626631
METTL23	124512	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	OMIM:615942	marker/mechanism		NA	615942	
METTL6	131965	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25151356
METTL7A	25840	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
METTL7B	196410	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		28811376
MEX3C	51320	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
MEX3C	51320	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
MFAP2	4237	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
MFAP4	4239	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
MFAP5	8076	AORTIC ANEURYSM, FAMILIAL THORACIC 9	OMIM:616166	marker/mechanism		NA	616166	
MFF	56947	ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	OMIM:617086	marker/mechanism		NA	617086	
MFF	56947	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		23867156
MFF	56947	Ventricular Dysfunction, Left	MESH:D018487	marker/mechanism		NA		23867156
MFGE8	4240	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21127199
MFGE8	4240	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		21505870
MFGE8	4240	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		11420682
MFN1	55669	Ceroid lipofuscinosis, neuronal 1, infantile	MESH:C537948	marker/mechanism		NA		21224254
MFN2	9927	Cardiomegaly	MESH:D006332	marker/mechanism		NA		17499311
MFN2	9927	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B	OMIM:617087	marker/mechanism		NA	617087	
MFN2	9927	Charcot-Marie-Tooth Disease, Axonal, Type 2A2	MESH:C563757	marker/mechanism		NA	609260	
MFN2	9927	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		27997345
MFN2	9927	Hereditary Motor And Sensory Neuropathy VI	MESH:C562851	marker/mechanism		NA	601152	
MFN2	9927	Hyperalgesia	MESH:D006930	marker/mechanism		NA		28587902
MFN2	9927	Ventricular Remodeling	MESH:D020257	marker/mechanism		NA		20886221
MFRP	83552	MICROPHTHALMIA, ISOLATED 5	OMIM:611040	marker/mechanism		NA	611040	
MFRP	83552	Nanophthalmos 2	MESH:C563700	marker/mechanism		NA	609549	
MFSD2A	84879	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
MFSD2A	84879	Intellectual Disability	MESH:D008607	marker/mechanism		NA		26005865
MFSD2A	84879	Microcephaly	MESH:D008831	marker/mechanism		NA		26005865|26005868
MFSD2A	84879	NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN IMAGING ABNORMALITIES	OMIM:616486	marker/mechanism		NA	616486	
MFSD2A	84879	Speech Disorders	MESH:D013064	marker/mechanism		NA		26005865
MFSD8	256471	Ceroid Lipofuscinosis, Neuronal, 7	MESH:C563989	marker/mechanism		NA	610951	
MFSD8	256471	MACULAR DYSTROPHY WITH CENTRAL CONE INVOLVEMENT	OMIM:616170	marker/mechanism		NA	616170	
MGA	23269	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
MGA	23269	Lymphoma, T-Cell	MESH:D016399	marker/mechanism		NA		26192917
MGA	23269	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D015452	marker/mechanism		NA		24413735
MGA	23269	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
MGARP	84709	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		17568789
MGAT2	4247	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
MGAT2	4247	Congenital disorder of glycosylation type 2A	MESH:C535752	marker/mechanism		NA	212066	
MGAT5	4249	Enterovirus Infections	MESH:D004769	marker/mechanism		NA		28446605
MGAT5	4249	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		23798564
MGAT5B	146664	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
MGLL	11343	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
MGME1	92667	Emaciation	MESH:D004614	marker/mechanism		NA		23313956
MGME1	92667	Mitochondrial Diseases	MESH:D028361	marker/mechanism		NA		23313956
MGME1	92667	MITOCHONDRIAL DNA DEPLETION SYNDROME 11	OMIM:615084	marker/mechanism		NA	615084	
MGME1	92667	Ophthalmoplegia	MESH:D009886	marker/mechanism		NA		23313956
MGME1	92667	Respiratory Insufficiency	MESH:D012131	marker/mechanism		NA		23313956
MGMT	4255	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		20131314
MGMT	4255	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		25520135
MGMT	4255	Glioblastoma	MESH:D005909	marker/mechanism		NA		20131314|22162573
MGMT	4255	Glioma	MESH:D005910	marker/mechanism		NA		16033832|16899598|19901110
MGMT	4255	Leukemia	MESH:D007938	marker/mechanism		NA		16412662
MGMT	4255	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
MGMT	4255	Micronuclei, Chromosome-Defective	MESH:D048629	marker/mechanism		NA		26410583
MGMT	4255	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		24991542
MGMT	4255	Necrosis	MESH:D009336	therapeutic		NA		21619552
MGMT	4255	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		24991542
MGMT	4255	Recurrence	MESH:D012008	marker/mechanism		NA		20131314
MGMT	4255	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		24991542
MGP	4256	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
MGP	4256	Aortic Valve Disease 1	MESH:C563178	marker/mechanism		NA		19350115
MGP	4256	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462|16316942
MGP	4256	Keutel syndrome	MESH:C536167	marker/mechanism		NA	245150	21705322
MGP	4256	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
MGP	4256	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462|16316942
MGP	4256	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462|16316942
MGP	4256	Uremia	MESH:D014511	marker/mechanism		NA		19092814
MGP	4256	Varicose Veins	MESH:D014648	marker/mechanism		NA		17643059
MGP	4256	Vascular Calcification	MESH:D061205	marker/mechanism		NA		21705322
MGST1	4257	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		15964507
MIA	8190	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
MIA3	375056	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		21378990
MIA3	375056	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		19198609
MIAT	440823	Myocardial Infarction	MESH:D009203	marker/mechanism		NA	608446	17066261
MIB1	57534	LEFT VENTRICULAR NONCOMPACTION 7	OMIM:615092	marker/mechanism		NA	615092	
MIB1	57534	Seizures	MESH:D012640	marker/mechanism		NA		20943912
MICA	100507436	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21499248
MICA	100507436	Coronary Aneurysm	MESH:D003323	marker/mechanism		NA		10899738
MICA	100507436	Oral Submucous Fibrosis	MESH:D009914	marker/mechanism		NA		16311067
MICAL1	64780	EPILEPSY, FAMILIAL TEMPORAL LOBE, 1	OMIM:600512	marker/mechanism		NA	600512	
MICAL2	9645	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		32659284
MICB	4277	Severe Dengue	MESH:D019595	marker/mechanism		NA		22001756
MICU1	10367	Basal Ganglia Diseases	MESH:D001480	marker/mechanism		NA		24336167
MICU1	10367	Learning Disabilities	MESH:D007859	marker/mechanism		NA		24336167
MICU1	10367	Movement Disorders	MESH:D009069	marker/mechanism		NA		24336167
MICU1	10367	Muscular Diseases	MESH:D009135	marker/mechanism		NA		24336167
MICU1	10367	MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	OMIM:615673	marker/mechanism		NA	615673	
MID1	4281	Opitz GBBB Syndrome, X-Linked	MESH:C567932	marker/mechanism		NA	300000	
MID1IP1	58526	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
MID2	11043	MENTAL RETARDATION, X-LINKED 101	OMIM:300928	marker/mechanism		NA	300928	
MIER2	54531	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
MIER2	54531	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
MIF	4282	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		20177408
MIF	4282	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		16872482
MIF	4282	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		30503813
MIF	4282	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18676531
MIF	4282	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19602265
MIF	4282	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
MIF	4282	Colitis	MESH:D003092	therapeutic		NA		12105854
MIF	4282	Depressive Disorder	MESH:D003866	marker/mechanism		NA		20177408
MIF	4282	Inflammation	MESH:D007249	marker/mechanism		NA		20127836
MIF	4282	Keloid	MESH:D007627	marker/mechanism		NA		20128793
MIF	4282	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
MIF	4282	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
MIF	4282	Memory Disorders	MESH:D008569	marker/mechanism		NA		20177408
MIF	4282	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25162674
MIF	4282	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17728788
MIF	4282	Rheumatoid Arthritis, Systemic Juvenile	MESH:C565798	marker/mechanism		NA	604302	
MIF	4282	Sepsis	MESH:D018805	therapeutic		NA		9892616
MIF	4282	Stevens-Johnson Syndrome	MESH:D013262	marker/mechanism		NA		9372356
MINDY3	80013	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
MINPP1	9562	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
MINPP1	9562	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
MINPP1	9562	Thyroid cancer, follicular	MESH:C572845	marker/mechanism		NA	188470	
MIP	4284	Cataract	MESH:D002386	marker/mechanism		NA		10802646
MIP	4284	CATARACT 15, MULTIPLE TYPES	OMIM:615274	marker/mechanism		NA	615274	
MIPEP	4285	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	OMIM:617228	marker/mechanism		NA	617228	
MIPOL1	145282	Polydactyly	MESH:D017689	marker/mechanism		NA		11954550
MIR100	406892	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		25992776
MIR100	406892	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		30026881
MIR100	406892	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR100	406892	Disease Progression	MESH:D018450	marker/mechanism		NA		30026881
MIR100	406892	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		25758243
MIR100	406892	Hepatitis B	MESH:D006509	marker/mechanism		NA		28545106
MIR100	406892	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		24447120
MIR100	406892	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR100	406892	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR100	406892	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		30026881
MIR101-1	406893	Pulmonary Fibrosis	MESH:D011658	therapeutic		NA		28726637
MIR101-2	406894	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		24475105
MIR103-1	723824	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22363424
MIR106A	406899	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		20889678
MIR106A	406899	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR106A	406899	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29845714
MIR106B	406900	Autistic Disorder	MESH:D001321	marker/mechanism		NA		20374639
MIR106B	406900	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22510560
MIR106B	406900	Osteosarcoma	MESH:D012516	marker/mechanism		NA		22510560
MIR107	406901	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25359176|28545106
MIR107	406901	Hearing Loss, Noise-Induced	MESH:D006317	marker/mechanism		NA		23472202
MIR10A	406902	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		30682439
MIR10A	406902	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20099276
MIR10A	406902	Carcinoid Tumor	MESH:D002276	marker/mechanism		NA		25105010
MIR10A	406902	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22363424
MIR10A	406902	Hearing Loss, Noise-Induced	MESH:D006317	marker/mechanism		NA		23472202
MIR10A	406902	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR10A	406902	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		25105010
MIR10A	406902	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		24447120
MIR10A	406902	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR10A	406902	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		25926378
MIR10B	406903	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20099276
MIR10B	406903	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22363424
MIR10B	406903	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR10B	406903	Fatty Liver	MESH:D005234	marker/mechanism		NA		22363424
MIR10B	406903	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		25758243
MIR10B	406903	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		24447120
MIR10B	406903	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR1-1	406904	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		30125006
MIR1179	100302235	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		29859832
MIR1193	100422837	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		28030816
MIR1193	100422837	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR1197	100302250	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR1-1HG	128826	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
MIR122	406906	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		30682439
MIR122	406906	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		16924677
MIR122	406906	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22045675|22363424|25359176|25527335|26489516|28545106|28844483
MIR122	406906	Hepatitis B	MESH:D006509	marker/mechanism		NA		28545106
MIR122	406906	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		25926378
MIR122	406906	Radiation Injuries	MESH:D011832	marker/mechanism		NA		32422326
MIR122	406906	Radiation Injuries, Experimental	MESH:D011833	marker/mechanism		NA		32422326
MIR1226	100302232	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR1228	100302201	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR124	100631041	Eye Injuries	MESH:D005131	marker/mechanism		NA		27208084
MIR124	100631041	Retinal Diseases	MESH:D012164	marker/mechanism		NA		27208084
MIR1246	100302142	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		22048643
MIR1246	100302142	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22048643
MIR1246	100302142	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR1247	100302145	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR1247	100302145	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR1249	100302149	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR1249	100302149	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR124A-3	723951	Alzheimer Disease	MESH:D000544	therapeutic		NA		28867212
MIR124A-3	723951	Learning Disabilities	MESH:D007859	therapeutic		NA		28867212
MIR125A	406910	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR125A	406910	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
MIR125A	406910	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR125A	406910	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21035526
MIR125A	406910	Pulmonary Fibrosis	MESH:D011658	therapeutic		NA		30658076
MIR125B1	406911	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR125B1	406911	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		24478399
MIR125B2	406912	Cardiomegaly	MESH:D006332	therapeutic		NA		29122578
MIR125B2	406912	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR125B2	406912	Down Syndrome	MESH:D004314	marker/mechanism		NA		29403643
MIR125B2	406912	Endomyocardial Fibrosis	MESH:D004719	therapeutic		NA		29122578
MIR125B2	406912	Hepatitis B	MESH:D006509	marker/mechanism		NA		28545106
MIR125B2	406912	Myocardial Infarction	MESH:D009203	therapeutic		NA		29122578
MIR125B2	406912	Ventricular Dysfunction, Left	MESH:D018487	therapeutic		NA		29122578
MIR126	406913	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20099276
MIR126	406913	Carcinoma, Non-Small-Cell Lung	MESH:D002289	therapeutic		NA		20097187
MIR126	406913	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		24478399
MIR126	406913	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		21483773
MIR126	406913	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR126	406913	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
MIR1260A	100302236	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR1260A	100302236	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR1260B	100422991	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR1260B	100422991	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR127	406914	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20099276
MIR127	406914	Carcinoid Tumor	MESH:D002276	marker/mechanism		NA		25105010
MIR127	406914	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR127	406914	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		25105010
MIR127	406914	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
MIR127	406914	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR1271	100302203	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		29315995
MIR1271	100302203	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		29315995
MIR1273C	100422821	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		25701956
MIR1273C	100422821	Microsatellite Instability	MESH:D053842	marker/mechanism		NA		25701956
MIR1273H	102466247	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR1275	100302123	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22048643
MIR128-1	406915	Hirschsprung Disease	MESH:D006627	marker/mechanism		NA		29429387
MIR128-2	406916	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
MIR1285-1	100302218	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR1290	100302276	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR1291	100302221	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR129-2	406918	Neoplasms	MESH:D009369	marker/mechanism		NA		29212414
MIR1296	100302150	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR1301	100302246	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR1303	100302284	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR1304	100302240	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR1306	100302197	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR1306	100302197	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR1307	100302174	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR1307	100302174	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR130A	406919	Adenocarcinoma, Bronchiolo-Alveolar	MESH:D002282	marker/mechanism		NA		25926378
MIR130A	406919	Albuminuria	MESH:D000419	marker/mechanism		NA		24223694
MIR130A	406919	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25359176|28545106
MIR130A	406919	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		20643829
MIR130A	406919	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR130A	406919	Obesity	MESH:D009765	marker/mechanism		NA		28242765
MIR130A	406919	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR130B	406920	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR130B	406920	Cholestasis	MESH:D002779	marker/mechanism		NA		22363424
MIR130B	406920	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22510560
MIR130B	406920	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		24478399
MIR130B	406920	Hearing Loss, Noise-Induced	MESH:D006317	marker/mechanism		NA		23472202
MIR130B	406920	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR130B	406920	Obesity	MESH:D009765	marker/mechanism		NA		28242765
MIR130B	406920	Osteosarcoma	MESH:D012516	marker/mechanism		NA		22510560
MIR130B	406920	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR132	406921	Brain Injuries	MESH:D001930	marker/mechanism		NA		23159883
MIR132	406921	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20099276
MIR132	406921	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22363424
MIR133	100314349	Long QT Syndrome	MESH:D008133	marker/mechanism		NA		22889704
MIR133A1	406922	Fibrosis	MESH:D005355	therapeutic		NA		19893015
MIR133A2	406923	Heart Failure	MESH:D006333	marker/mechanism		NA		28751527
MIR133A-2	723954	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		28751527
MIR134	406924	Fatty Liver	MESH:D005234	marker/mechanism		NA		22363424
MIR134	406924	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR134	406924	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR1343	100616437	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR135A-2	723955	Neuralgia	MESH:D009437	marker/mechanism		NA		31432094
MIR135B	442891	Neuralgia	MESH:D009437	marker/mechanism		NA		31432094
MIR135B	442891	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
MIR136	406927	Carcinoid Tumor	MESH:D002276	marker/mechanism		NA		25105010
MIR136	406927	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		20643829
MIR136	406927	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		25105010
MIR136	406927	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR137	406928	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		20643829
MIR137	406928	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR137	406928	Schizophrenia	MESH:D012559	marker/mechanism		NA		21926974
MIR138-1	406929	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		20643829
MIR139	406931	Fatty Liver	MESH:D005234	marker/mechanism		NA		22363424
MIR140	406932	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		30682439
MIR140	406932	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		24478399
MIR140	406932	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		25926378
MIR141	406933	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20099276
MIR141	406933	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22363424|28545106
MIR141	406933	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR141	406933	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		28545106
MIR141	406933	Neoplasm Invasiveness	MESH:D009361	therapeutic		NA		27616325
MIR141	406933	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR142	406934	Carcinoma, Pancreatic Ductal	MESH:D021441	marker/mechanism		NA		29844410
MIR142	406934	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR142	406934	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		24478399
MIR142	406934	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR143	406935	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		30682439
MIR143	406935	Carcinogenesis	MESH:D063646	therapeutic		NA		28736328
MIR143	406935	Cell Transformation, Neoplastic	MESH:D002471	therapeutic		NA		26721309
MIR143	406935	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		30125006
MIR143	406935	Cholestasis	MESH:D002779	marker/mechanism		NA		30125006
MIR143	406935	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		17892514
MIR143	406935	Lymphoma	MESH:D008223	therapeutic		NA		28736328
MIR143	406935	Lymphoma, B-Cell	MESH:D016393	marker/mechanism		NA		17892514
MIR143	406935	Neoplasms, Experimental	MESH:D009374	therapeutic		NA		28736328|31152816
MIR144	406936	Adenocarcinoma, Bronchiolo-Alveolar	MESH:D002282	marker/mechanism		NA		25926378
MIR144	406936	Adenoma	MESH:D000236	marker/mechanism		NA		25926378
MIR144	406936	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR145	406937	Albuminuria	MESH:D000419	marker/mechanism		NA		24223694
MIR145	406937	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		29705342
MIR145	406937	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21463514
MIR145	406937	Carcinoma, Non-Small-Cell Lung	MESH:D002289	therapeutic		NA		20097187
MIR145	406937	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		30365097
MIR145	406937	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		30026881
MIR145	406937	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		24223694
MIR145	406937	Disease Progression	MESH:D018450	marker/mechanism		NA		30026881
MIR145	406937	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		21248297
MIR145	406937	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		17892514
MIR145	406937	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR145	406937	Lymphoma, B-Cell	MESH:D016393	marker/mechanism		NA		17892514
MIR145	406937	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		24447120
MIR145	406937	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		29956747
MIR145	406937	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21035526
MIR145	406937	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		30026881
MIR145A	387163	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		25926378
MIR1468	100302115	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR1468	100302115	Hepatitis B	MESH:D006509	marker/mechanism		NA		28545106
MIR1469	100302258	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22048643
MIR146A	406938	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		22099153|25992776
MIR146A	406938	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20099276
MIR146A	406938	Carcinoid Tumor	MESH:D002276	marker/mechanism		NA		25105010
MIR146A	406938	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22048643
MIR146A	406938	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		20524934
MIR146A	406938	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		25105010
MIR146B	574447	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		30682439
MIR146B	574447	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		20524934
MIR146B	574447	Hearing Loss, Noise-Induced	MESH:D006317	marker/mechanism		NA		23472202
MIR146B	574447	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		21789255
MIR148A	406940	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		30682439
MIR148A	406940	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25359176|28545106
MIR148A	406940	Hepatitis B	MESH:D006509	marker/mechanism		NA		28545106
MIR148A	406940	Liver Neoplasms	MESH:D008113	therapeutic		NA		32268151
MIR148A	406940	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR148B	442892	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		20643829
MIR148B	442892	Fatty Liver	MESH:D005234	marker/mechanism		NA		22363424
MIR148B	442892	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR148B	442892	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		30308185
MIR149	406941	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22363424
MIR150	406942	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR150	406942	Fatty Liver	MESH:D005234	marker/mechanism		NA		22363424
MIR150	406942	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR151	387169	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		30682439
MIR151	387169	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR151	387169	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21035526
MIR151A	442893	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR151B	100616247	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR152	406943	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		32583487
MIR152	406943	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		25194984
MIR152	406943	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		28544374
MIR152	406943	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR153	387171	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		22363424
MIR153C	100033678	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		22253472
MIR153C	100033678	Neurobehavioral Manifestations	MESH:D019954	marker/mechanism		NA		22253472
MIR154	406946	Carcinoid Tumor	MESH:D002276	marker/mechanism		NA		25105010
MIR154	406946	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		20643829
MIR154	406946	Fatty Liver	MESH:D005234	marker/mechanism		NA		22363424
MIR154	406946	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		25105010
MIR154	406946	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR155	406947	Albuminuria	MESH:D000419	marker/mechanism		NA		24223694
MIR155	406947	Carcinoid Tumor	MESH:D002276	marker/mechanism		NA		25105010
MIR155	406947	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		28688901
MIR155	406947	Down Syndrome	MESH:D004314	marker/mechanism		NA		29403643
MIR155	406947	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		25105010|27692344
MIR155	406947	Microsatellite Instability	MESH:D053842	marker/mechanism		NA		25701956
MIR155	406947	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		28315615
MIR155	406947	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542|27692344
MIR155	406947	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR15A	406948	Leukemia, Promyelocytic, Acute	MESH:D015473	therapeutic		NA		21056550
MIR15A	406948	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR15A	406948	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR15B	406949	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22048643
MIR16-1	406950	Leukemia, Promyelocytic, Acute	MESH:D015473	therapeutic		NA		21056550
MIR17	406952	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		30365097
MIR17	406952	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR17	406952	Fatty Liver	MESH:D005234	marker/mechanism		NA		22363424
MIR17	406952	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		28545106
MIR17HG	407975	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		21892160
MIR17HG	407975	Coronary Disease	MESH:D003327	marker/mechanism		NA		28869590
MIR17HG	407975	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28869590
MIR17HG	407975	Growth Disorders	MESH:D006130	marker/mechanism		NA		21892160
MIR17HG	407975	Limb Deformities, Congenital	MESH:D017880	marker/mechanism		NA		21892160
MIR17HG	407975	Microcephaly	MESH:D008831	marker/mechanism		NA		21892160
MIR17HG	407975	Oculodigitoesophagoduodenal syndrome	MESH:C537734	marker/mechanism		NA	614326	
MIR181A1	406995	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		20643829
MIR181B-1	723890	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		20868653
MIR181C	406957	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22363424
MIR181C	406957	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR181C	406957	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR181C	406957	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR181C	406957	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR181C	406957	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR181C	406957	Parkinson Disease	MESH:D010300	marker/mechanism		NA		28770951
MIR181D	574457	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR181D	574457	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR181D	574457	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR182	406958	Eye Injuries	MESH:D005131	marker/mechanism		NA		27208084
MIR182	406958	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR182	406958	Retinal Diseases	MESH:D012164	marker/mechanism		NA		27208084
MIR183	406959	Brain Injuries	MESH:D001930	marker/mechanism		NA		23159883
MIR183	406959	Eye Injuries	MESH:D005131	marker/mechanism		NA		27208084
MIR183	406959	Fatty Liver	MESH:D005234	marker/mechanism		NA		22363424
MIR183	406959	Hearing Loss, Noise-Induced	MESH:D006317	marker/mechanism		NA		23472202
MIR183	406959	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR183	406959	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR183	406959	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR183	406959	Retinal Diseases	MESH:D012164	marker/mechanism		NA		27208084
MIR184	406960	EDICT SYNDROME	OMIM:614303	marker/mechanism		NA	614303	
MIR184	406960	Obesity	MESH:D009765	marker/mechanism		NA		23954404
MIR185	406961	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22048643
MIR185	406961	Cholestasis	MESH:D002779	marker/mechanism		NA		22363424
MIR186	406962	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		20643829
MIR186	406962	Hearing Loss, Noise-Induced	MESH:D006317	marker/mechanism		NA		23472202
MIR186	406962	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR186	406962	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR188	406964	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR188	406964	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR18A	406953	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR18A	406953	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR18A	406953	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
MIR18B	574033	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR1908	100302263	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR190A	406965	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		21750348
MIR190A	406965	Cholestasis	MESH:D002779	marker/mechanism		NA		22363424
MIR190A	406965	Hepatitis B	MESH:D006509	marker/mechanism		NA		28545106
MIR190B	100126346	Hearing Loss, Noise-Induced	MESH:D006317	marker/mechanism		NA		23472202
MIR191	406966	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22048643|29277653
MIR191	406966	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR191	406966	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		29277653
MIR1915	100302129	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22048643
MIR192	406967	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		30682439
MIR192	406967	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22045675|25359176|28483554|28545106
MIR192	406967	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		24478399
MIR192	406967	Hepatitis B	MESH:D006509	marker/mechanism		NA		28545106
MIR192	406967	Hepatomegaly	MESH:D006529	therapeutic		NA		28483554
MIR192	406967	Kidney Diseases	MESH:D007674	marker/mechanism		NA		24880025
MIR192	406967	Necrosis	MESH:D009336	marker/mechanism		NA		24880025
MIR192	406967	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR193A	406968	Carcinoid Tumor	MESH:D002276	marker/mechanism		NA		25105010
MIR193A	406968	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR193A	406968	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		25105010
MIR193A	406968	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR193B	574455	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR193B	574455	Hepatitis B	MESH:D006509	marker/mechanism		NA		28545106
MIR193B	574455	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		28545106
MIR194-1	406969	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28844483
MIR194-2	406970	Hepatitis B	MESH:D006509	marker/mechanism		NA		28545106
MIR195	406971	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		24478399
MIR195	406971	Hirschsprung Disease	MESH:D006627	marker/mechanism		NA		25007945
MIR195	406971	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR196A	100314048	Disease Progression	MESH:D018450	marker/mechanism		NA		27816459
MIR196A	100314048	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		27816459
MIR196B	442920	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR196B	442920	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR196B	442920	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21035526
MIR197	406974	Fatty Liver	MESH:D005234	marker/mechanism		NA		22363424
MIR197	406974	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR197	406974	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR199A	100886814	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		24447120
MIR19A	406979	Adenocarcinoma, Bronchiolo-Alveolar	MESH:D002282	marker/mechanism		NA		25926378
MIR19A	406979	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22363424
MIR19A	406979	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		29687521
MIR19A	406979	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR19A	406979	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
MIR1A-1	387136	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		23761296
MIR200A	406983	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR200A	406983	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR200B	406984	Breast Neoplasms	MESH:D001943	marker/mechanism|therapeutic		NA		19839049|20099276
MIR200B	406984	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		21292642
MIR200B	406984	Disease Progression	MESH:D018450	marker/mechanism		NA		19839049
MIR200B	406984	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR200B	406984	Neoplasm Invasiveness	MESH:D009361	therapeutic		NA		19839049
MIR200B	406984	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR200B	406984	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21035526
MIR200C	406985	Breast Neoplasms	MESH:D001943	marker/mechanism|therapeutic		NA		19839049|20099276
MIR200C	406985	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22363424
MIR200C	406985	Disease Progression	MESH:D018450	marker/mechanism		NA		19839049
MIR200C	406985	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		22569286
MIR200C	406985	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		21248297
MIR200C	406985	Hearing Loss, Noise-Induced	MESH:D006317	marker/mechanism		NA		23472202
MIR200C	406985	Neoplasm Invasiveness	MESH:D009361	therapeutic		NA		19839049
MIR200C	406985	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR200C	406985	Pulmonary Fibrosis	MESH:D011658	marker/mechanism|therapeutic		NA		25926378|29113749
MIR201	387197	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR203	387199	Chemical and Drug Induced Liver Injury	MESH:D056486	therapeutic		NA		32659284
MIR203	387199	Liver Cirrhosis	MESH:D008103	therapeutic		NA		32659284
MIR203A	406986	Carcinogenesis	MESH:D063646	therapeutic		NA		23968727
MIR203A	406986	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR203A	406986	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR204	406987	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR204	406987	Hepatitis B	MESH:D006509	marker/mechanism		NA		28545106
MIR204	406987	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		26224795
MIR204	406987	RETINAL DYSTROPHY AND IRIS COLOBOMA WITH OR WITHOUT CONGENITAL CATARACT	OMIM:616722	marker/mechanism		NA	616722	
MIR205	406988	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20099276
MIR205	406988	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		21563230
MIR205	406988	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		21563230
MIR205	406988	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		25586904
MIR205	406988	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22048643
MIR205	406988	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR205	406988	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		24447120
MIR205	406988	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR206	406989	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20099276
MIR206	406989	Hirschsprung Disease	MESH:D006627	marker/mechanism		NA		25792468
MIR206	406989	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR206	406989	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR207	387203	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR207	387203	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR207	387203	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
MIR208A	406990	Cardiotoxicity	MESH:D066126	marker/mechanism		NA		26454886
MIR208A	406990	Neuralgia	MESH:D009437	marker/mechanism		NA		31432094
MIR20B	574032	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR20B	574032	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR20B	574032	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR21	406991	Cardiomegaly	MESH:D006332	marker/mechanism		NA		17525252
MIR21	406991	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism|therapeutic		NA		27323401|27344173|28881718|29501572
MIR21	406991	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR21	406991	Disease Progression	MESH:D018450	marker/mechanism		NA		27816459
MIR21	406991	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
MIR21	406991	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		21248297
MIR21	406991	Fibrosis	MESH:D005355	marker/mechanism		NA		23469132
MIR21	406991	Heart Diseases	MESH:D006331	marker/mechanism		NA		29355689
MIR21	406991	Inflammation	MESH:D007249	marker/mechanism		NA		29355689
MIR21	406991	Kidney Diseases	MESH:D007674	marker/mechanism		NA		23469132
MIR21	406991	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27323401
MIR21	406991	Microsatellite Instability	MESH:D053842	marker/mechanism		NA		25701956
MIR21	406991	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR21	406991	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		29501572
MIR21	406991	Obesity	MESH:D009765	marker/mechanism		NA		23954404
MIR21	406991	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		23272133
MIR210	406992	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR210	406992	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
MIR211	406993	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21035526
MIR2116	100313886	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR212	406994	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		20613834|20711185
MIR212	406994	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR212	406994	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21035526
MIR214	406996	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20099276
MIR214	406996	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR214	406996	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR215	406997	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		30682439
MIR215	406997	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR215	406997	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		22363424
MIR215	406997	Neoplasm Invasiveness	MESH:D009361	therapeutic		NA		28887306
MIR215	406997	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR215	406997	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
MIR216A	406998	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR216B	100126319	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR217	406999	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22363424
MIR217	406999	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		25538231
MIR217	406999	Fibrosis	MESH:D005355	marker/mechanism		NA		26891083
MIR217	406999	Inflammation	MESH:D007249	marker/mechanism		NA		26891083
MIR217	406999	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		25538231
MIR217	406999	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR218-1	407000	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22363424|30125006
MIR218-1	407000	Cholestasis	MESH:D002779	marker/mechanism		NA		22363424|30125006
MIR218-1	407000	Hirschsprung Disease	MESH:D006627	marker/mechanism		NA		25786906
MIR218-2	407001	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		28864214
MIR218-2	407001	Tobacco Use Disorder	MESH:D014029	marker/mechanism		NA		28864214
MIR219A1	407002	Fatty Liver	MESH:D005234	marker/mechanism		NA		22363424
MIR21A	387140	Weight Gain	MESH:D015430	therapeutic		NA		26996129
MIR22	407004	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25359176|28545106
MIR22	407004	Inflammation	MESH:D007249	marker/mechanism		NA		28161397
MIR22	407004	Lymphoma, T-Cell, Cutaneous	MESH:D016410	marker/mechanism		NA		26244872
MIR22	407004	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR221	407006	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20099276
MIR221	407006	Cataract	MESH:D002386	marker/mechanism		NA		30926320
MIR221	407006	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22048643
MIR221	407006	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR221	407006	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR221	407006	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR221	407006	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR222	407007	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20099276
MIR222	407007	Carcinoid Tumor	MESH:D002276	marker/mechanism		NA		25105010
MIR222	407007	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR222	407007	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		24478399|28545106
MIR222	407007	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		25105010
MIR222	407007	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR222	407007	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		19487542
MIR222	407007	Tongue Neoplasms	MESH:D014062	marker/mechanism		NA		19487542
MIR223	407008	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		29660302
MIR224	407009	Carcinoid Tumor	MESH:D002276	marker/mechanism		NA		25105010
MIR224	407009	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		25105010
MIR224	407009	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR22HG	84981	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
MIR22HG	84981	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		30670679
MIR23A	407010	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		30682439
MIR23A	407010	Autistic Disorder	MESH:D001321	marker/mechanism		NA		20374639
MIR23A	407010	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR23B	407011	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR23B	407011	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR24-1	407012	Cholestasis	MESH:D002779	marker/mechanism		NA		22363424
MIR24-2	407013	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21463514
MIR25	407014	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		30682439
MIR25	407014	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22048643
MIR26A	100314290	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		30682439
MIR26A	100314290	Arthritis, Experimental	MESH:D001169	therapeutic		NA		24423102
MIR26A	100314290	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR26A	100314290	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
MIR26B	407017	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		23922874
MIR26B	407017	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR26B	407017	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21035526
MIR26B	407017	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		25926378
MIR27A	407018	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR27A	407018	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR27A	407018	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR27B	407019	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25359176|28545106
MIR27B	407019	Cholestasis	MESH:D002779	marker/mechanism		NA		22363424
MIR27B	407019	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR27B	407019	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR28	407020	Hepatitis B	MESH:D006509	marker/mechanism		NA		28545106
MIR28	407020	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR2861	100422910	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 15	OMIM:613418	marker/mechanism		NA	613418	
MIR290	100314249	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR290	100314249	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21035526
MIR291A	100049715	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21035526
MIR292	100049711	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR292	100049711	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21035526
MIR296	407022	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		25992776
MIR296	407022	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR299	407023	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR29A	407021	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20099276
MIR29A	407021	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		22048643
MIR29A	407021	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22048643
MIR29A	407021	Liver Neoplasms	MESH:D008113	therapeutic		NA		21175813
MIR29A	407021	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR29B2	407025	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22363424
MIR29C	407026	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		30026881
MIR29C	407026	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106|30515189
MIR29C	407026	Disease Progression	MESH:D018450	marker/mechanism		NA		30026881
MIR29C	407026	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		22363424
MIR29C	407026	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR29C	407026	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		25926378
MIR29C	407026	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		30026881
MIR300	100126297	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR300	100126297	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		28030816
MIR300	100126297	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR301A	407027	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29763890
MIR301A	407027	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR301A	407027	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR301B	100126318	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		20643829
MIR301B	100126318	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR302B	442894	Osteosarcoma	MESH:D012516	therapeutic		NA		23845851
MIR302C	442895	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		22363424
MIR302D	442896	Carcinoid Tumor	MESH:D002276	marker/mechanism		NA		25105010
MIR302D	442896	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		25105010
MIR30A	407029	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		30682439
MIR30A	407029	Carcinoid Tumor	MESH:D002276	marker/mechanism		NA		25105010
MIR30A	407029	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22363424|25359176|28545106
MIR30A	407029	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR30A	407029	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR30A	407029	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		25105010
MIR30A	407029	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR30A	407029	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR30A	407029	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21035526
MIR30A	407029	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		25926378
MIR30A	407029	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
MIR30B	407030	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
MIR30B	407030	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR30B	407030	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		22363424
MIR30B	407030	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR30B	407030	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR30B	407030	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
MIR30C1	407031	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		20889907
MIR30C-1	387227	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22363424
MIR30C-1	387227	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		22363424
MIR30C2	407032	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		22363424
MIR30D	407033	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		30682439
MIR30D	407033	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22048643
MIR30D	407033	Fibrosis	MESH:D005355	marker/mechanism		NA		31697999
MIR30D	407033	Hearing Loss, Noise-Induced	MESH:D006317	marker/mechanism		NA		23472202
MIR30D	407033	Kidney Diseases	MESH:D007674	marker/mechanism		NA		31697999
MIR30D	407033	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR30D	407033	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21035526
MIR30E	407034	Fibrosis	MESH:D005355	marker/mechanism		NA		31697999
MIR30E	407034	Hearing Loss, Noise-Induced	MESH:D006317	marker/mechanism		NA		23472202
MIR30E	407034	Kidney Diseases	MESH:D007674	marker/mechanism		NA		31697999
MIR30E	407034	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR30E	407034	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR31	407035	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		20237410
MIR31	407035	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR31	407035	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR3173	100422981	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR31HG	554202	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
MIR320A	407037	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22048643
MIR320A	407037	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106|30125006
MIR320A	407037	Fatty Liver	MESH:D005234	marker/mechanism		NA		30125006
MIR323	723839	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		28030816
MIR323	723839	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR323A	442897	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR323B	574410	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR324	442898	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		20643829
MIR324	442898	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR324	442898	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21035526
MIR325	442899	Hearing Loss, Noise-Induced	MESH:D006317	marker/mechanism		NA		23472202
MIR326	442900	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		25926378
MIR327	100124437	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22363424
MIR327	100124437	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR328	442901	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR328	442901	Osteosarcoma	MESH:D012516	marker/mechanism		NA		25605016
MIR329-1	574408	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR330	442902	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR331	442903	Hearing Loss, Noise-Induced	MESH:D006317	marker/mechanism		NA		23472202
MIR331	442903	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR331	442903	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR331	442903	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21035526
MIR335	442904	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR335	442904	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR335	442904	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR335	442904	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR335	442904	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR336	100314219	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR337	442905	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22363424
MIR337	442905	Cholestasis	MESH:D002779	marker/mechanism		NA		22363424
MIR337	442905	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		20643829
MIR337	442905	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR337	442905	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		28030816
MIR337	442905	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
MIR337	442905	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR338	442906	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR338	442906	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		28545106
MIR338	442906	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR338	442906	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21035526
MIR339	442907	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR339	442907	Hearing Loss, Noise-Induced	MESH:D006317	marker/mechanism		NA		23472202
MIR339	442907	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR33B	693120	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		30026881
MIR33B	693120	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR33B	693120	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR33B	693120	Disease Progression	MESH:D018450	marker/mechanism		NA		30026881
MIR33B	693120	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		30026881
MIR340	442908	Hyperplasia	MESH:D006965	marker/mechanism		NA		25926378
MIR340	442908	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR340	442908	Melanoma	MESH:D008545	marker/mechanism		NA		25043973
MIR340	442908	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21035526
MIR341	723846	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
MIR342	442909	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20099276
MIR342	442909	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR342	442909	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR344-1	100313981	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
MIR344F	100526527	Neuralgia	MESH:D009437	marker/mechanism		NA		31432094
MIR345	442910	Adenocarcinoma, Bronchiolo-Alveolar	MESH:D002282	marker/mechanism		NA		25926378
MIR345	442910	Adenoma	MESH:D000236	marker/mechanism		NA		25926378
MIR345	442910	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20099276
MIR345	442910	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR345	442910	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		25926378
MIR346	442911	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		27777383
MIR346	442911	Disease Progression	MESH:D018450	marker/mechanism		NA		27777383
MIR346	442911	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR346	442911	Nasopharyngeal Carcinoma	MESH:D000077274	marker/mechanism		NA		27501413
MIR346	442911	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		27501413|27777383
MIR346	442911	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		27501413|27777383
MIR346	442911	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
MIR347	100313982	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR347	100313982	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21035526
MIR3473	102466618	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		30682439
MIR349	100313983	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR349	100313983	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21035526
MIR349	100313983	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
MIR34A	407040	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		27424985
MIR34A	407040	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR34A	407040	Fatty Liver	MESH:D005234	marker/mechanism		NA		23834033
MIR34A	407040	Glucose Intolerance	MESH:D018149	marker/mechanism		NA		23834033
MIR34A	407040	Heart Diseases	MESH:D006331	marker/mechanism		NA		25448438
MIR34A	407040	Inflammation	MESH:D007249	marker/mechanism		NA		23834033
MIR34A	407040	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR34A	407040	Obesity	MESH:D009765	marker/mechanism		NA		23834033
MIR34B	407041	Carcinoid Tumor	MESH:D002276	marker/mechanism		NA		25105010
MIR34B	407041	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		30026881
MIR34B	407041	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		21339737
MIR34B	407041	Disease Progression	MESH:D018450	marker/mechanism		NA		30026881
MIR34B	407041	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		21339737|25105010
MIR34B	407041	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR34B	407041	Neoplasms, Experimental	MESH:D009374	therapeutic		NA		22113133
MIR34B	407041	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		30026881
MIR34C	407042	Carcinoid Tumor	MESH:D002276	marker/mechanism		NA		25105010
MIR34C	407042	Cell Transformation, Neoplastic	MESH:D002471	therapeutic		NA		24362009
MIR34C	407042	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22363424
MIR34C	407042	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		25105010
MIR34C	407042	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR34C	407042	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR350	723921	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR351	723910	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22363424
MIR351	723910	Cholestasis	MESH:D002779	marker/mechanism		NA		22363424
MIR351	723910	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR352	100313986	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR3591	100616357	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR361	494323	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR361	494323	Cholestasis	MESH:D002779	marker/mechanism		NA		22363424
MIR361	494323	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR361	494323	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR3615	100500847	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR3615	100500847	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		28545106
MIR362	574030	Adenocarcinoma, Bronchiolo-Alveolar	MESH:D002282	marker/mechanism		NA		25926378
MIR362	574030	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR362	574030	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR3622B	100500871	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		25992776
MIR365A	100126355	Hepatitis B	MESH:D006509	marker/mechanism		NA		28545106
MIR365B	100126356	Hepatitis B	MESH:D006509	marker/mechanism		NA		28545106
MIR367	442912	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22363424
MIR369	442914	Carcinoid Tumor	MESH:D002276	marker/mechanism		NA		25105010
MIR369	442914	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		20643829
MIR369	442914	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		25105010
MIR369	442914	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR369	442914	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		28030816
MIR369	442914	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR370	442915	Carcinoid Tumor	MESH:D002276	marker/mechanism		NA		25105010
MIR370	442915	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		25105010
MIR370	442915	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR370	442915	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		28030816
MIR370	442915	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR374B	100126317	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22048643
MIR375	494324	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		25992776
MIR375	494324	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR375	494324	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR375	494324	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR376A	723855	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		20643829
MIR376A	723855	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR376A	723855	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		28030816
MIR376A	723855	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR376A1	494325	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR376A2	664615	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR376B	574435	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR376B	574435	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		28030816
MIR376B	574435	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR376C	442913	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		21224400
MIR376C	442913	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		20643829
MIR376C	442913	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		22363424
MIR376C	442913	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR376C	442913	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR377	494326	Cholestasis	MESH:D002779	marker/mechanism		NA		22363424
MIR377	494326	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR377	494326	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR378A	494327	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR378A	494327	Hepatitis B	MESH:D006509	marker/mechanism		NA		28545106
MIR378A	494327	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		25926378
MIR378C	100422867	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR378I	100616259	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR378I	100616259	Hepatitis B	MESH:D006509	marker/mechanism		NA		28545106
MIR379	494328	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		28030816
MIR379	494328	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR379	494328	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR380	494329	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		20643829
MIR380	494329	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
MIR380	494329	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR381	494330	Hearing Loss, Noise-Induced	MESH:D006317	marker/mechanism		NA		23472202
MIR381	494330	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		28030816
MIR381	494330	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR382	494331	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		28030816
MIR382	494331	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR383	494332	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR384	494333	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		20643829
MIR384	494333	Fatty Liver	MESH:D005234	marker/mechanism		NA		22363424
MIR409	574413	Carcinoid Tumor	MESH:D002276	marker/mechanism		NA		25105010
MIR409	574413	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR409	574413	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR409	574413	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		25105010
MIR409	574413	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21035526
MIR409	574413	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR410	574434	Carcinoid Tumor	MESH:D002276	marker/mechanism		NA		25105010
MIR410	574434	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22363424
MIR410	574434	Fatty Liver	MESH:D005234	marker/mechanism		NA		22363424
MIR410	574434	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		25105010
MIR410	574434	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR411	693121	Cholestasis	MESH:D002779	marker/mechanism		NA		22363424
MIR411	693121	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR411	693121	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR412	574433	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR421	693122	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR421	693122	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		28545106
MIR423	494335	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR423	494335	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		24478399
MIR423	494335	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		24205249
MIR423	494335	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		28545106
MIR423	494335	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		24253456
MIR424	494336	Albuminuria	MESH:D000419	marker/mechanism		NA		24223694
MIR425	494337	Adenoma	MESH:D000236	marker/mechanism		NA		25926378
MIR425	494337	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		25926378
MIR429	554210	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20099276
MIR429	554210	Hearing Loss, Noise-Induced	MESH:D006317	marker/mechanism		NA		23472202
MIR429	554210	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR429	554210	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR429	554210	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR431	574038	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		28030816
MIR431	574038	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR432	574451	Carcinoid Tumor	MESH:D002276	marker/mechanism		NA		25105010
MIR432	574451	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR432	574451	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		25105010
MIR432	574451	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR4324	100422979	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		30026881
MIR4324	100422979	Disease Progression	MESH:D018450	marker/mechanism		NA		30026881
MIR4324	100422979	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		30026881
MIR433	574034	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR433	574034	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		28030816
MIR433	574034	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR4433B	102465833	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR4435-2HG	541471	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		25888808
MIR4448	100616127	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR4467	100616367	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		25992776
MIR4482	100616323	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR4492	100616376	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR449C	100313923	Fatty Liver	MESH:D005234	marker/mechanism		NA		22363424
MIR4507	100616135	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR4516	100616258	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR4516	100616258	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR451A	574411	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR452	574412	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR452	574412	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR455	619556	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR455	619556	Hepatitis B	MESH:D006509	marker/mechanism		NA		28545106
MIR463	723887	Fatty Liver	MESH:D005234	marker/mechanism		NA		22363424
MIR467B	735257	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		20643829
MIR483	619552	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR483	619552	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR483	619552	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		28545106
MIR483	619552	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR483	619552	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21035526
MIR484	619553	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR484	619553	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		28545106
MIR484	619553	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
MIR485	574436	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR485	574436	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		28030816
MIR485	574436	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR486	723876	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		30682439
MIR486-1	619554	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		20868653
MIR487A	619555	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR487B	664616	Carcinoid Tumor	MESH:D002276	marker/mechanism		NA		25105010
MIR487B	664616	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR487B	664616	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		25105010
MIR487B	664616	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		28030816
MIR487B	664616	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR488	574441	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		20643829
MIR489	574442	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20099276
MIR493	574450	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR493	574450	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR494	574452	Carcinoid Tumor	MESH:D002276	marker/mechanism		NA		25105010
MIR494	574452	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		25105010
MIR494	574452	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR495	574453	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		28030816
MIR495	574453	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR496	574454	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR497	574456	Adenocarcinoma, Bronchiolo-Alveolar	MESH:D002282	marker/mechanism		NA		25926378
MIR497	574456	Adenoma	MESH:D000236	marker/mechanism		NA		25926378
MIR497	574456	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR499A	574501	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR500	723974	Adenoma	MESH:D000236	marker/mechanism		NA		25926378
MIR500	723974	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		20643829
MIR500	723974	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR501	574503	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		29477382
MIR503	574506	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22363424
MIR503	574506	Fatty Liver	MESH:D005234	marker/mechanism		NA		22363424
MIR503	574506	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		22363424
MIR503	574506	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR503	574506	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR505	574508	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		25992776
MIR505	574508	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR505	574508	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR506	574511	Azoospermia	MESH:D053713	marker/mechanism		NA		27107421
MIR506	574511	Neoplasms, Experimental	MESH:D009374	therapeutic		NA		21726609
MIR5099	100628578	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28844483
MIR511	574445	Carcinoid Tumor	MESH:D002276	marker/mechanism		NA		25105010
MIR511	574445	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		25105010
MIR5112	100628586	Adenoma	MESH:D000236	marker/mechanism		NA		25926378
MIR5196	100847070	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR519C	574466	Neoplasm Metastasis	MESH:D009362	therapeutic		NA		20233879
MIR520B	574473	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		29191453
MIR532	693124	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		30639441
MIR532	693124	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR532	693124	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		24478399
MIR532	693124	Hearing Loss, Noise-Induced	MESH:D006317	marker/mechanism		NA		23472202
MIR532	693124	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		28545106
MIR532	693124	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR532	693124	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		30639441
MIR532	693124	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR532	693124	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR532	693124	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		30639441
MIR539	664612	Carcinoma, Hepatocellular	MESH:D006528	therapeutic		NA		27717846
MIR539	664612	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR539	664612	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR542	664617	Fatty Liver	MESH:D005234	marker/mechanism		NA		22363424
MIR542	664617	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR543	100126335	Neoplasm Invasiveness	MESH:D009361	therapeutic		NA		30710498
MIR543	100126335	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR543	100126335	Uterine Cervical Neoplasms	MESH:D002583	therapeutic		NA		30710498
MIR544	100124450	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		20643829
MIR548B	693128	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR5588	100847054	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR564	693149	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR574	693159	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR582	693167	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR589	693174	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR589	693174	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		28545106
MIR592	693177	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22363424|28545106
MIR595	693180	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR598	693183	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR598	693183	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR609	693194	Pancreatitis	MESH:D010195	marker/mechanism		NA		27840954
MIR615	693200	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		22819824
MIR6240	102466620	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		25926378
MIR625	693210	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR627	693212	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR628	693213	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR629	693214	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR629	693214	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		28545106
MIR638	693223	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		22048643
MIR638	693223	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22048643
MIR638	693223	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR6500	102466656	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
MIR651	723779	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR652	724022	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR652	724022	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21035526
MIR654	724024	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		28030816
MIR654	724024	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		28030816
MIR654	724024	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR655	724025	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR656	724026	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR660	724030	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR665	100126315	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		20643829
MIR666	751521	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR671	768213	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR672	751535	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR674	732489	Hearing Loss, Noise-Induced	MESH:D006317	marker/mechanism		NA		23472202
MIR6741	102466270	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR6741	102466270	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR6803	102466739	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR6815	102465489	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR6852	102465513	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR687	751541	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22363424
MIR6881	102465530	Hepatitis B	MESH:D006509	marker/mechanism		NA		28545106
MIR690	751543	Adenoma	MESH:D000236	marker/mechanism		NA		25926378
MIR697	735277	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22363424
MIR702	735283	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		25926378
MIR704	735289	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22363424
MIR704	735289	Cholestasis	MESH:D002779	marker/mechanism		NA		22363424
MIR706	735290	Fatty Liver	MESH:D005234	marker/mechanism		NA		22363424
MIR708	100126333	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		25992776
MIR708	100126333	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR741	100049545	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR743A	100314117	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR743B	100124496	Cholestasis	MESH:D002779	marker/mechanism		NA		22363424
MIR743B	100124496	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR744	100126313	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22363424|28545106
MIR744	100126313	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR744	100126313	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR758	768212	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIR758	768212	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		28030816
MIR758	768212	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR760	100126348	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR761	100313892	Myocardial Infarction	MESH:D009203	therapeutic		NA		23867156
MIR761	100313892	Ventricular Dysfunction, Left	MESH:D018487	therapeutic		NA		23867156
MIR764	100313838	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22363424
MIR764	100313838	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		22363424
MIR766	768218	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		25992776
MIR766	768218	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR7688	102465791	Neuralgia	MESH:D009437	marker/mechanism		NA		31432094
MIR770	768222	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		28030816
MIR770	768222	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR7704	102465802	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR7704	102465802	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR7977	102465858	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR802	768219	Down Syndrome	MESH:D004314	marker/mechanism		NA		29403643
MIR8061	102466251	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR872	100124456	Cholestasis	MESH:D002779	marker/mechanism		NA		22363424
MIR872	100124456	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR872	100124456	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21035526
MIR873	100126316	Carcinoma, Pancreatic Ductal	MESH:D021441	therapeutic		NA		30654191
MIR873	100126316	Triple Negative Breast Neoplasms	MESH:D064726	therapeutic		NA		30654191
MIR874	100126343	Neoplasm Invasiveness	MESH:D009361	therapeutic		NA		30004169
MIR875	100126309	Cholestasis	MESH:D002779	marker/mechanism		NA		22363424
MIR877	100126314	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22048643
MIR877	100126314	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		27713024
MIR879	100124492	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22363424
MIR885	100126334	Carcinoma, Hepatocellular	MESH:D006528	therapeutic		NA		27738331
MIR885	100126334	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR885	100126334	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR885	100126334	Disease Progression	MESH:D018450	therapeutic		NA		27738331
MIR885	100126334	Hepatitis B	MESH:D006509	marker/mechanism		NA		28545106
MIR885	100126334	Hepatitis B, Chronic	MESH:D019694	marker/mechanism		NA		27738331
MIR885	100126334	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		27738331
MIR885	100126334	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		28545106
MIR885	100126334	Neoplasm Metastasis	MESH:D009362	therapeutic		NA		27738331
MIR889	100126345	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
MIR9-1	407046	Neurobehavioral Manifestations	MESH:D019954	marker/mechanism		NA		22253472
MIR92A1	407048	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		29687521
MIR92B	693235	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22048643
MIR92B	693235	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR92B	693235	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR92B	693235	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21035526
MIR93	407050	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR93	407050	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22510560
MIR93	407050	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		28545106
MIR93	407050	Osteosarcoma	MESH:D012516	marker/mechanism		NA		22510560
MIR938	100126327	Carcinoid Tumor	MESH:D002276	marker/mechanism		NA		25105010
MIR938	100126327	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		25105010
MIR939	100126351	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR940	100126328	Neoplasm Invasiveness	MESH:D009361	therapeutic		NA		28423620
MIR942	100126331	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		30097701
MIR96	407053	DEAFNESS, AUTOSOMAL DOMINANT 50	OMIM:613074	marker/mechanism		NA	613074	
MIR96	407053	Eye Injuries	MESH:D005131	marker/mechanism		NA		27208084
MIR96	407053	Hearing Loss	MESH:D034381	marker/mechanism		NA		19363478|19363479
MIR96	407053	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR96	407053	Retinal Diseases	MESH:D012164	marker/mechanism		NA		27208084
MIR98	407054	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		30365097
MIR98	407054	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		27270317
MIR98	407054	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIR98	407054	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		27270317
MIR98	407054	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR98	407054	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27270317
MIR98	407054	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21035526
MIR99A	407055	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		30682439
MIR99A	407055	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		30026881
MIR99A	407055	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIR99A	407055	Cholestasis	MESH:D002779	marker/mechanism		NA		22363424
MIR99A	407055	Disease Progression	MESH:D018450	marker/mechanism		NA		30026881
MIR99A	407055	Down Syndrome	MESH:D004314	marker/mechanism		NA		29403643
MIR99A	407055	Hepatitis B	MESH:D006509	marker/mechanism		NA		28545106
MIR99A	407055	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR99A	407055	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
MIR99A	407055	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		30026881
MIR99B	407056	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22048643
MIR99B	407056	Hearing Loss, Noise-Induced	MESH:D006317	marker/mechanism		NA		23472202
MIR99B	407056	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIR99B	407056	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19487542
MIR99B	407056	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21035526
MIRLET7B	406884	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106|30125006
MIRLET7B	406884	Cholestasis	MESH:D002779	marker/mechanism		NA		22363424
MIRLET7B	406884	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIRLET7B	406884	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21035526
MIRLET7B	406884	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
MIRLET7BHG	400931	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		26199339
MIRLET7C	406885	Cell Transformation, Neoplastic	MESH:D002471	therapeutic		NA		24704393
MIRLET7C	406885	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIRLET7C	406885	Down Syndrome	MESH:D004314	marker/mechanism		NA		29403643
MIRLET7C	406885	Hepatitis B	MESH:D006509	marker/mechanism		NA		28545106
MIRLET7D	406886	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIRLET7D	406886	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28545106
MIRLET7D	406886	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIRLET7D	406886	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21035526
MIRLET7D	406886	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
MIRLET7E	406887	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIRLET7F-2	387253	Fibrosis	MESH:D005355	marker/mechanism		NA		31570982
MIRLET7F-2	387253	Heart Injuries	MESH:D006335	marker/mechanism		NA		31570982
MIRLET7G	406890	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIRLET7I	406891	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		30682439
MIRLET7I	406891	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28545106
MIRLET7I	406891	Cholestasis	MESH:D002779	marker/mechanism		NA		22363424
MIRLET7I	406891	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21035526
MIRLET7I	406891	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
MIS12	79003	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
MITF	4286	Albinism, Oculocutaneous	MESH:D016115	marker/mechanism		NA		9158138
MITF	4286	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		22012259
MITF	4286	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		25401301
MITF	4286	COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS	OMIM:617306	marker/mechanism		NA	617306	
MITF	4286	Deafness	MESH:D003638	marker/mechanism		NA		9158138
MITF	4286	Melanoma	MESH:D008545	marker/mechanism		NA		25043973
MITF	4286	Melanoma, Cutaneous Malignant	MESH:C562393	marker/mechanism		NA		22080950
MITF	4286	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8	OMIM:614456	marker/mechanism		NA	614456	22012259
MITF	4286	Pigmentation Disorders	MESH:D010859	marker/mechanism		NA		9158138
MITF	4286	Tietz syndrome	MESH:C536919	marker/mechanism		NA	103500	
MITF	4286	Waardenburg syndrome type 2	MESH:C536463	marker/mechanism		NA		9158138
MITF	4286	Waardenburg syndrome type 2A	MESH:C536464	marker/mechanism		NA	193510	
MKI67	4288	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		19028472
MKI67	4288	Adenoma, Liver Cell	MESH:D018248	marker/mechanism		NA		31939706
MKI67	4288	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		15706428|18768436|19436038
MKI67	4288	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
MKI67	4288	Chondrosarcoma, Mesenchymal	MESH:D018211	marker/mechanism		NA		12817616
MKI67	4288	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		19028472
MKI67	4288	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		12645814
MKI67	4288	Copper-Overload Cirrhosis	MESH:C566858	marker/mechanism		NA		22879914
MKI67	4288	Disease Progression	MESH:D018450	marker/mechanism		NA		29179997
MKI67	4288	Hepatitis, Chronic	MESH:D006521	marker/mechanism		NA		22879914
MKI67	4288	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
MKI67	4288	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		21442130
MKI67	4288	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		20864405
MKI67	4288	Psoriasis	MESH:D011565	marker/mechanism		NA		10384915
MKI67IP	476111	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
MKI67IP	476111	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
MKKS	8195	Bardet-Biedl Syndrome 6	MESH:C565738	marker/mechanism		NA	605231	
MKKS	8195	McKusick Kaufman syndrome	MESH:C538159	marker/mechanism		NA	236700	
MKNK1	8569	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
MKRN3	7681	Prader-Willi Syndrome	MESH:D011218	marker/mechanism		NA	176270	
MKRN3	7681	Puberty, Precocious	MESH:D011629	marker/mechanism		NA	615346	23738509
MKRN3-AS1	10108	Prader-Willi Syndrome	MESH:D011218	marker/mechanism		NA	176270	
MKS1	54903	Bardet-Biedl Syndrome	MESH:D020788	marker/mechanism		NA		18327255
MKS1	54903	Bardet-Biedl Syndrome 13	MESH:C567140	marker/mechanism		NA	615990	
MKS1	54903	Meckel syndrome type 1	MESH:C536133	marker/mechanism		NA	249000	
MLANA	2315	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
MLANA	2315	Melanoma	MESH:D008545	marker/mechanism		NA		26640592
MLANA	2315	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		22784439
MLANA	2315	Peritoneal Neoplasms	MESH:D010534	marker/mechanism		NA		22784439
MLC1	23209	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
MLC1	23209	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
MLC1	23209	Megalencephalic leukoencephalopathy with subcortical cysts	MESH:C536141	marker/mechanism		NA	604004	11254442
MLC1	23209	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
MLF1	4291	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
MLH1	4292	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		25043185
MLH1	4292	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18497967|18718023|18949393
MLH1	4292	Colorectal Neoplasms, Hereditary Nonpolyposis	MESH:D003123	marker/mechanism		NA		14756672|20020535|21064154|22102614|25701956
MLH1	4292	Lymphoma	MESH:D008223	marker/mechanism		NA		15700306
MLH1	4292	Lynch Syndrome II	MESH:D055847	marker/mechanism		NA	609310	25077178
MLH1	4292	Muir-Torre Syndrome	MESH:D055653	marker/mechanism		NA	158320	
MLH1	4292	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17717427
MLH1	4292	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		19032668
MLH1	4292	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		15583422
MLH1	4292	Turcot syndrome	MESH:C536928	marker/mechanism		NA	276300	
MLH3	27030	Colorectal Cancer, Hereditary Nonpolyposis, Type 7	MESH:C565777	marker/mechanism		NA	614385	
MLH3	27030	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	114500	17656264
MLH3	27030	Colorectal Neoplasms, Hereditary Nonpolyposis	MESH:D003123	marker/mechanism		NA		12702580
MLH3	27030	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA	608089	
MLH3	27030	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		16981255
MLLT1	4298	Wilms Tumor	MESH:D009396	marker/mechanism		NA		28825729
MLLT10	8028	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		23797736
MLLT10	8028	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA	601626	
MLLT10	8028	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
MLLT10	8028	Meningioma	MESH:D008579	marker/mechanism		NA		21804547
MLN	4295	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		16538176
MLP60A	37853	Parkinson Disease	MESH:D010300	marker/mechanism		NA		18353766
MLPH	79083	Griscelli syndrome type 3	MESH:C537303	marker/mechanism		NA	609227	
MLXIPL	51085	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21147110
MLXIPL	51085	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19878707
MLXIPL	51085	Williams Syndrome	MESH:D018980	marker/mechanism		NA	194050	
MLYCD	23417	Malonic aciduria	MESH:C535702	marker/mechanism		NA	248360	
MMAA	166785	Methylmalonic aciduria cblA type	MESH:C537360	marker/mechanism		NA	251100	
MMAB	326625	Methylmalonic aciduria cblB type	MESH:C537361	marker/mechanism		NA	251110	
MMACHC	25974	Methylmalonic acidemia with homocystinuria	MESH:C537359	marker/mechanism		NA	277400	19700356
MMADHC	27249	Methylmalonic Aciduria and Homocystinuria, CblD Type	MESH:C564743	marker/mechanism		NA	277410	
MME	4311	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		23063927
MME	4311	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T	OMIM:617017	marker/mechanism		NA	617017	
MME	4311	Cryopyrin-Associated Periodic Syndromes	MESH:D056587	marker/mechanism		NA		12928894
MME	4311	Diabetic Neuropathies	MESH:D003929	marker/mechanism		NA		20148083
MME	4311	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		16085334
MME	4311	Lung Injury	MESH:D055370	marker/mechanism		NA		21114838
MME	4311	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17173048
MME	4311	Renal Insufficiency	MESH:D051437	marker/mechanism		NA		10485324
MME	4311	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA	617018	
MMEL1	79258	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		23143596
MMEL1	79258	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		20639879
MMP1	4312	Aneurysm	MESH:D000783	marker/mechanism		NA		21742783
MMP1	4312	Asthma	MESH:D001249	marker/mechanism		NA		24469321
MMP1	4312	Atherosclerosis	MESH:D050197	marker/mechanism		NA		21742783
MMP1	4312	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		23548910
MMP1	4312	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		20471133
MMP1	4312	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		23548910
MMP1	4312	Epidermolysis Bullosa Dystrophica	MESH:D016108	marker/mechanism		NA	226600	
MMP1	4312	Liver Cirrhosis, Experimental	MESH:D008106	therapeutic		NA		12557150
MMP1	4312	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		23548910
MMP1	4312	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		22580338
MMP1	4312	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		12538496|19487542|22580338|23548910
MMP1	4312	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		21664615
MMP1	4312	Ocular Hypertension	MESH:D009798	therapeutic		NA		20089869
MMP1	4312	Oral Submucous Fibrosis	MESH:D009914	marker/mechanism		NA		16311067
MMP1	4312	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA	606963	
MMP10	4319	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		19192274
MMP10	4319	Asthma	MESH:D001249	marker/mechanism		NA		16926187
MMP10	4319	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
MMP10	4319	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		22022614
MMP10	4319	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		22022614
MMP10	4319	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		22285823
MMP11	4320	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
MMP11	4320	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		10741738
MMP12	4321	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
MMP12	4321	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		19192274
MMP12	4321	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
MMP12	4321	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
MMP12	4321	Pulmonary Emphysema	MESH:D011656	marker/mechanism		NA		12634787|25106431
MMP12	4321	Stroke	MESH:D020521	marker/mechanism		NA		29531354
MMP12	4321	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
MMP13	4322	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		17728286
MMP13	4322	Liver Cirrhosis, Experimental	MESH:D008106	therapeutic		NA		17404313
MMP13	4322	Metaphyseal chondrodysplasia Spahr type	MESH:C537353	marker/mechanism		NA	250400	
MMP13	4322	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		15138554
MMP13	4322	Spondyloepimetaphyseal Dysplasia, Missouri Type	MESH:C566574	marker/mechanism		NA	602111	
MMP14	4323	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		21472143
MMP14	4323	Aortic Aneurysm, Abdominal	MESH:D017544	marker/mechanism		NA		19010778
MMP14	4323	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		24014025
MMP14	4323	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		23804419
MMP14	4323	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		21472143
MMP14	4323	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		24014025
MMP14	4323	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
MMP14	4323	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		19661247
MMP14	4323	Winchester syndrome	MESH:C536709	marker/mechanism		NA	277950	
MMP15	4324	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
MMP15	4324	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
MMP19	4327	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
MMP19	4327	Cavitary Optic Disc Anomalies	MESH:C566924	marker/mechanism		NA	611543	
MMP1A	83995	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25330770
MMP1A	83995	Nephrotic Syndrome	MESH:D009404	marker/mechanism		NA		1281619
MMP2	4313	Aortic Aneurysm, Thoracic	MESH:D017545	marker/mechanism		NA		16159824
MMP2	4313	Aortic Diseases	MESH:D001018	marker/mechanism		NA		15545515
MMP2	4313	Aortic Rupture	MESH:D001019	marker/mechanism		NA		18178469
MMP2	4313	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		16872482
MMP2	4313	Bone Diseases	MESH:D001847	marker/mechanism		NA		17440987
MMP2	4313	Bone Diseases, Metabolic	MESH:D001851	marker/mechanism		NA		17440987
MMP2	4313	Bone Neoplasms	MESH:D001859	marker/mechanism		NA		16475674
MMP2	4313	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18398872|18507500
MMP2	4313	Calcinosis	MESH:D002114	marker/mechanism		NA		15545515|21193197
MMP2	4313	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		20084675
MMP2	4313	Cerebral Hemorrhage	MESH:D002543	marker/mechanism		NA		10698078
MMP2	4313	Cerebral Infarction	MESH:D002544	marker/mechanism		NA		16846501
MMP2	4313	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		15763341
MMP2	4313	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		28789951
MMP2	4313	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18507500|21278247
MMP2	4313	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		17400654|17440987
MMP2	4313	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		21963884
MMP2	4313	Diabetic Neuropathies	MESH:D003929	marker/mechanism		NA		20213226
MMP2	4313	Disease Progression	MESH:D018450	marker/mechanism		NA		22321834
MMP2	4313	Fetal Growth Retardation	MESH:D005317	marker/mechanism		NA		28157488
MMP2	4313	Glioblastoma	MESH:D005909	marker/mechanism		NA		16598420
MMP2	4313	Hypertension	MESH:D006973	marker/mechanism		NA		18836702
MMP2	4313	Inflammation	MESH:D007249	marker/mechanism		NA		24795235
MMP2	4313	Leishmaniasis, Cutaneous	MESH:D016773	marker/mechanism		NA		21091666
MMP2	4313	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		15763341|26396155
MMP2	4313	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		23274713
MMP2	4313	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		15095483|25380136
MMP2	4313	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		30603057
MMP2	4313	Lupus Nephritis	MESH:D008181	marker/mechanism		NA		22479529
MMP2	4313	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		28574600
MMP2	4313	Mandibular Diseases	MESH:D008336	marker/mechanism		NA		19070762
MMP2	4313	Marfan Syndrome	MESH:D008382	marker/mechanism		NA		18178469
MMP2	4313	Maxillary Diseases	MESH:D008439	marker/mechanism		NA		19070762
MMP2	4313	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		16310260|24358288
MMP2	4313	Nasopharyngeal Carcinoma	MESH:D000077274	marker/mechanism		NA		20461718
MMP2	4313	Nasopharyngeal Neoplasms	MESH:D009303	marker/mechanism		NA		17607721
MMP2	4313	Neointima	MESH:D058426	marker/mechanism		NA		17964422
MMP2	4313	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		18398872|19770485|22321834|23707804
MMP2	4313	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		16475674|18398872|21209944|22321834|23707804|30603057
MMP2	4313	Nose Neoplasms	MESH:D009669	marker/mechanism		NA		16178123
MMP2	4313	Oral Submucous Fibrosis	MESH:D009914	marker/mechanism		NA		16311067
MMP2	4313	Osteolysis hereditary multicentric	MESH:C536051	marker/mechanism		NA	259600	17400654
MMP2	4313	Osteonecrosis	MESH:D010020	marker/mechanism		NA		19070762
MMP2	4313	Osteosarcoma	MESH:D012516	marker/mechanism		NA		25605016
MMP2	4313	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		30603057
MMP2	4313	Pulmonary Emphysema	MESH:D011656	marker/mechanism		NA		25106431
MMP2	4313	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		21468558
MMP2	4313	Testicular Germ Cell Tumor	MESH:C563236	marker/mechanism		NA		22321834
MMP2	4313	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		30548095
MMP2	4313	Weight Gain	MESH:D015430	marker/mechanism		NA		25322899
MMP20	9313	Amelogenesis Imperfecta, Hypomaturation Type, Iia2	MESH:C567279	marker/mechanism		NA	612529	
MMP21	118856	Heterotaxy Syndrome	MESH:D059446	marker/mechanism		NA		26437028
MMP21	118856	HETEROTAXY, VISCERAL, 7, AUTOSOMAL	OMIM:616749	marker/mechanism		NA	616749	
MMP21	118856	Histiocytoma, Benign Fibrous	MESH:D018219	marker/mechanism		NA		16984259
MMP21	118856	Skin Diseases	MESH:D012871	marker/mechanism		NA		16984259
MMP24	10893	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		27869830
MMP26	56547	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
MMP26	56547	Skin Diseases	MESH:D012871	marker/mechanism		NA		16984259
MMP3	4314	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		20974942
MMP3	4314	Astrocytoma	MESH:D001254	marker/mechanism		NA		20188714
MMP3	4314	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037
MMP3	4314	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
MMP3	4314	Cerebral Hemorrhage	MESH:D002543	marker/mechanism		NA		17971790
MMP3	4314	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		8662692
MMP3	4314	Coronary Disease	MESH:D003327	marker/mechanism		NA	614466	
MMP3	4314	Coronary Restenosis	MESH:D023903	marker/mechanism		NA		8662692
MMP3	4314	Hyperalgesia	MESH:D006930	marker/mechanism		NA		18754875
MMP3	4314	Idiopathic Pulmonary Fibrosis	MESH:D054990	therapeutic		NA		28434932
MMP3	4314	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		20188714|26284488
MMP3	4314	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		18754875
MMP3	4314	Tuberculosis, Pulmonary	MESH:D014397	marker/mechanism		NA		24890593
MMP7	4316	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
MMP7	4316	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
MMP7	4316	Recurrence	MESH:D012008	marker/mechanism		NA		25596746
MMP7	4316	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		25847246
MMP7	4316	Tuberculosis, Pulmonary	MESH:D014397	marker/mechanism		NA		24890593
MMP7	4316	Ureteral Obstruction	MESH:D014517	marker/mechanism		NA		28318631
MMP8	4317	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
MMP8	4317	Liver Cirrhosis, Experimental	MESH:D008106	therapeutic		NA		15057751
MMP8	4317	Lung Diseases	MESH:D008171	marker/mechanism		NA		21602193
MMP8	4317	Melanoma	MESH:D008545	therapeutic		NA		19330028
MMP8	4317	Tuberculosis, Pulmonary	MESH:D014397	marker/mechanism		NA		24890593
MMP8	4317	Wounds and Injuries	MESH:D014947	marker/mechanism		NA		11172683
MMP9	4318	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		20981132
MMP9	4318	Angina, Stable	MESH:D060050	marker/mechanism		NA		20981132
MMP9	4318	Aortic Aneurysm	MESH:D001014	marker/mechanism		NA		10231640
MMP9	4318	Aortic Aneurysm, Abdominal	MESH:D017544	marker/mechanism		NA		17196988
MMP9	4318	Aortic Aneurysm, Thoracic	MESH:D017545	marker/mechanism		NA		16159824
MMP9	4318	Aortic Diseases	MESH:D001018	marker/mechanism		NA		15545515
MMP9	4318	Aortic Rupture	MESH:D001019	marker/mechanism		NA		18178469
MMP9	4318	Asthma	MESH:D001249	marker/mechanism		NA		11742282|15131573
MMP9	4318	Astrocytoma	MESH:D001254	marker/mechanism		NA		20188714
MMP9	4318	Bone Neoplasms	MESH:D001859	marker/mechanism		NA		16475674
MMP9	4318	Brain Edema	MESH:D001929	therapeutic		NA		15529013
MMP9	4318	Brain Injuries	MESH:D001930	marker/mechanism		NA		19631748
MMP9	4318	Brain Injuries, Traumatic	MESH:D000070642	marker/mechanism		NA		25668593
MMP9	4318	Brain Ischemia	MESH:D002545	marker/mechanism		NA		15060315
MMP9	4318	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19617202
MMP9	4318	Calcinosis	MESH:D002114	marker/mechanism		NA		15545515|21193197
MMP9	4318	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		20084675
MMP9	4318	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		21789004
MMP9	4318	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		18572023
MMP9	4318	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		14700523|19617202|22011395
MMP9	4318	Cerebral Hemorrhage	MESH:D002543	marker/mechanism|therapeutic		NA		14630814|15488484|15529013|16190367|19095969
MMP9	4318	Cerebral Infarction	MESH:D002544	marker/mechanism		NA		16846501
MMP9	4318	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22507835
MMP9	4318	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		28789951
MMP9	4318	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		22119283
MMP9	4318	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15725655
MMP9	4318	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		21963884|22191573
MMP9	4318	Diabetic Neuropathies	MESH:D003929	marker/mechanism		NA		20213226
MMP9	4318	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		21051829
MMP9	4318	Glioblastoma	MESH:D005909	marker/mechanism		NA		16598420
MMP9	4318	Hyperplasia	MESH:D006965	marker/mechanism		NA		15728660
MMP9	4318	Hypertension	MESH:D006973	marker/mechanism		NA		21051829
MMP9	4318	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		19309543
MMP9	4318	Inflammation	MESH:D007249	marker/mechanism		NA		24429678|24795235
MMP9	4318	Lead Poisoning	MESH:D007855	marker/mechanism		NA		16700817
MMP9	4318	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		15095483
MMP9	4318	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
MMP9	4318	Lupus Nephritis	MESH:D008181	marker/mechanism		NA		22479529
MMP9	4318	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		21283680
MMP9	4318	Mandibuloacral dysplasia with type A lipodystrophy	MESH:C535705	marker/mechanism		NA		18554282
MMP9	4318	Marfan Syndrome	MESH:D008382	marker/mechanism		NA		18178469
MMP9	4318	Metaphyseal Anadysplasia 2	MESH:C567771	marker/mechanism		NA	613073	
MMP9	4318	Morphine Dependence	MESH:D009021	marker/mechanism		NA		20519536
MMP9	4318	Multiple Organ Failure	MESH:D009102	marker/mechanism		NA		15259001
MMP9	4318	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		16310260|24358288
MMP9	4318	Neointima	MESH:D058426	marker/mechanism		NA		17964422
MMP9	4318	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		19617202|19700239|20188714|21187089|22503731|23867902|24333868
MMP9	4318	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		15659795|16475674|18930813|21209944|21942447
MMP9	4318	Obesity	MESH:D009765	marker/mechanism		NA		21156398
MMP9	4318	Oral Submucous Fibrosis	MESH:D009914	marker/mechanism		NA		16311067
MMP9	4318	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		22952646
MMP9	4318	Periodontitis	MESH:D010518	marker/mechanism		NA		22808498|24640096
MMP9	4318	Premature Birth	MESH:D047928	marker/mechanism		NA		24429678
MMP9	4318	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16606632
MMP9	4318	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		19299917
MMP9	4318	Pulmonary Emphysema	MESH:D011656	marker/mechanism		NA		25106431
MMP9	4318	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		21468558
MMP9	4318	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		23075401
MMP9	4318	Retinal Diseases	MESH:D012164	marker/mechanism		NA		23075401
MMP9	4318	Sepsis	MESH:D018805	marker/mechanism		NA		16003065
MMP9	4318	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		18572023
MMP9	4318	Stomach Ulcer	MESH:D013276	marker/mechanism		NA		17603938
MMP9	4318	Subarachnoid Hemorrhage	MESH:D013345	marker/mechanism		NA		27157545
MMP9	4318	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		20519536
MMP9	4318	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		30548095
MMUT	4594	Metabolism, Inborn Errors	MESH:D008661	marker/mechanism		NA		19427250
MMUT	4594	Methylmalonic acidemia	MESH:C537358	marker/mechanism		NA		16823967
MMUT	4594	Methylmalonic Aciduria due to Methylmalonyl-CoA Mutase Deficiency	MESH:C565390	marker/mechanism		NA	251000	
MMUT	4594	Obesity	MESH:D009765	marker/mechanism		NA		20882379
MN1	4330	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		19822134
MN1	4330	Meningioma, familial	MESH:C537443	marker/mechanism		NA	607174	
MNT	4335	Classical Lissencephalies and Subcortical Band Heterotopias	MESH:D054221	marker/mechanism		NA		15028671
MNT	4335	Cleft Palate	MESH:D002972	marker/mechanism		NA		15028671
MNT	4335	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		15028671
MNX1	3110	Currarino triad	MESH:C536221	marker/mechanism		NA	176450	
MNX1-AS1	645249	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		28114269
MNX1-AS1	645249	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		28114269
MNX1-AS1	645249	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		28114269
MOB2	81532	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
MOB3A	126308	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
MOBP	4336	Amyotrophic Lateral Sclerosis	MESH:D000690	marker/mechanism		NA		27455348
MOBP	4336	Supranuclear Palsy, Progressive	MESH:D013494	marker/mechanism		NA		21685912
MOCOS	55034	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		29935280
MOCOS	55034	Pancytopenia	MESH:D010198	marker/mechanism		NA		29935280
MOCOS	55034	Vasculitis	MESH:D014657	marker/mechanism		NA		29935280
MOCOS	55034	Xanthinuria, Type II	MESH:C566358	marker/mechanism		NA	603592	29935280
MOCS1	4337	Molybdenum cofactor deficiency	MESH:C535811	marker/mechanism		NA	252150	
MOCS2	4338	Molybdenum Cofactor Deficiency, Complementation Group B	MESH:C565373	marker/mechanism		NA	252160	
MOG	4340	Demyelinating Diseases	MESH:D003711	marker/mechanism		NA		23360710|23547115
MOG	4340	Encephalomyelitis, Autoimmune, Experimental	MESH:D004681	marker/mechanism		NA		12904460|16931536|17654737|17728465|18566399|18667803|21068375|21317386|21341682|23360710|23547115|23639249
MOG	4340	Narcolepsy	MESH:D009290	marker/mechanism		NA	614250	
MOG	4340	Paralysis	MESH:D010243	marker/mechanism		NA		23547115
MOGAT2	80168	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
MOGS	7841	Congenital Disorder Of Glycosylation, Type IIB	MESH:C565264	marker/mechanism		NA	606056	
MOK	5891	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		23500658
MON1A	84315	Iron Metabolism Disorders	MESH:D019189	marker/mechanism		NA		17632513
MORC2	22880	Charcot-Marie-Tooth Disease	MESH:D002607	marker/mechanism		NA		28581500
MORC2	22880	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z	OMIM:616688	marker/mechanism		NA	616688	
MORF4L1	10933	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
MORN1	79906	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
MOXD2	194357	Hypertension	MESH:D006973	marker/mechanism		NA		3814904
MPC1	51660	MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	OMIM:614741	marker/mechanism		NA	614741	
MPC1	51660	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
MPDU1	9526	Congenital disorder of glycosylation type 1F	MESH:C535744	marker/mechanism		NA	609180	
MPDZ	8777	HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES	OMIM:615219	marker/mechanism		NA	615219	
MPDZ	8777	Seizures	MESH:D012640	marker/mechanism		NA		14960011
MPEG1	219972	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		11420682
MPI	4351	Congenital disorder of glycosylation type 1B	MESH:C535740	marker/mechanism		NA	602579	
MPIG6B	80739	THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS	OMIM:617441	marker/mechanism		NA	617441	
MPL	4352	Congenital amegakaryocytic thrombocytopenia	MESH:C535982	marker/mechanism		NA	604498	
MPL	4352	Medulloblastoma	MESH:D008527	marker/mechanism		NA		19270706
MPL	4352	Myeloproliferative Disorders	MESH:D009196	marker/mechanism		NA		29047144
MPL	4352	Primary Myelofibrosis	MESH:D055728	marker/mechanism		NA	254450	
MPL	4352	Thrombocytosis	MESH:D013922	marker/mechanism		NA	601977	15813844|16484586
MPLKIP	136647	Trichothiodystrophy Syndromes	MESH:D054463	marker/mechanism		NA	234050	
MPO	4353	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		20623750
MPO	4353	Alzheimer Disease	MESH:D000544	marker/mechanism		NA	104300	15023809
MPO	4353	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		22450443
MPO	4353	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		22450443|26001728
MPO	4353	Brain Diseases	MESH:D001927	marker/mechanism		NA		23593274
MPO	4353	Brain Injuries	MESH:D001930	marker/mechanism		NA		23159883
MPO	4353	Brain Injuries, Traumatic	MESH:D000070642	marker/mechanism		NA		25668593
MPO	4353	Brain Ischemia	MESH:D002545	marker/mechanism		NA		19417757
MPO	4353	Burns	MESH:D002056	marker/mechanism		NA		11996850
MPO	4353	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		19731237
MPO	4353	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		19326902
MPO	4353	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		28789951
MPO	4353	Colitis	MESH:D003092	marker/mechanism		NA		23810507
MPO	4353	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		20380826|22119283|24055189
MPO	4353	Depressive Disorder, Major	MESH:D003865	marker/mechanism		NA		20471444
MPO	4353	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		20388520
MPO	4353	Drug Eruptions	MESH:D003875	marker/mechanism		NA		18204966
MPO	4353	Hypoxia	MESH:D000860	marker/mechanism		NA		8552434
MPO	4353	Inflammation	MESH:D007249	marker/mechanism		NA		10407471|19066340|19326902|23371441|23451061
MPO	4353	Keratosis	MESH:D007642	marker/mechanism		NA		14580687
MPO	4353	Kidney Diseases	MESH:D007674	marker/mechanism		NA		19913069
MPO	4353	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		19731237|23274713
MPO	4353	Lung Diseases	MESH:D008171	marker/mechanism		NA		23451061
MPO	4353	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		12111688
MPO	4353	Myeloperoxidase Deficiency	MESH:C562864	marker/mechanism		NA	254600	
MPO	4353	Occupational Diseases	MESH:D009784	marker/mechanism		NA		15576619
MPO	4353	Pancreatitis	MESH:D010195	marker/mechanism		NA		16440434
MPO	4353	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		14580687
MPO	4353	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		21716162
MPO	4353	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		10706834|12024109|16971220|19058328|20863214|8869312
MPO	4353	Shock, Hemorrhagic	MESH:D012771	marker/mechanism		NA		21192278
MPO	4353	Trichuriasis	MESH:D014257	marker/mechanism		NA		20864659
MPO	4353	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		14729580
MPO	4353	Urticaria	MESH:D014581	marker/mechanism		NA		18204966
MPO	4353	Wounds and Injuries	MESH:D014947	marker/mechanism		NA		21192278
MPP1	4354	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		21552421
MPP1	4354	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		21552421
MPP7	143098	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
MPRIP	23164	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
MPST	4357	Melanoma	MESH:D008545	marker/mechanism		NA		25205294
MPV17	4358	Cochlear Diseases	MESH:D015834	marker/mechanism		NA		18818194
MPV17	4358	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA		18818194
MPV17	4358	Mitochondrial Diseases	MESH:D028361	marker/mechanism		NA		18818194
MPV17	4358	Navajo neurohepatopathy	MESH:C538344	marker/mechanism		NA	256810	
MPV17	4358	Pigmentation Disorders	MESH:D010859	marker/mechanism		NA		18818194
MPV17	4358	Proteinuria	MESH:D011507	marker/mechanism		NA		18818194
MPZ	4359	Charcot-Marie-Tooth Disease	MESH:D002607	marker/mechanism		NA	118200|180800	
MPZ	4359	Charcot-Marie-Tooth Disease, Dominant Intermediate D	MESH:C564333	marker/mechanism		NA	607791	
MPZ	4359	Charcot-Marie-Tooth disease, Type 2I	MESH:C535416	marker/mechanism		NA	607677	
MPZ	4359	Charcot-Marie-Tooth disease, Type 2J	MESH:C535417	marker/mechanism		NA	607736	
MPZ	4359	Hereditary Sensory and Motor Neuropathy	MESH:D015417	marker/mechanism		NA	145900	
MPZ	4359	Hyperalgesia	MESH:D006930	marker/mechanism		NA		16676325
MPZ	4359	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		16676325
MPZL1	9019	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
MPZL1	9019	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
MPZL1	9019	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
MRAP	56246	Glucocorticoid Deficiency 2	MESH:C564577	marker/mechanism		NA	607398	
MRAP2	112609	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 18	OMIM:615457	marker/mechanism		NA	615457	
MRAS	22808	Carotid Artery Diseases	MESH:D002340	marker/mechanism		NA		19198612
MRAS	22808	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		21378990
MRAS	22808	Coronary Disease	MESH:D003327	marker/mechanism		NA		28869590
MRAS	22808	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28869590
MRC1	4360	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		16033404
MRC1	4360	Hyperinsulinism	MESH:D006946	marker/mechanism		NA		29035695
MRC1	4360	Insulin Resistance	MESH:D007333	marker/mechanism		NA		29035695
MRC1	4360	Obesity	MESH:D009765	marker/mechanism		NA		29035695
MRC2	9902	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
MRC2	9902	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
MRC2	9902	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
MRE11	4361	Ataxia Telangiectasia Like Disorder	MESH:C565779	marker/mechanism		NA	604391	
MRE11A	17535	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
MRE11A	17535	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
MRE11A	17535	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
MRLC2	414399	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
MRO	83876	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
MRO	83876	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
MRPL12	6182	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
MRPL12	6182	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
MRPL13	28998	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21466612
MRPL13	28998	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		15274141
MRPL13	28998	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
MRPL13	28998	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		15274141
MRPL13	28998	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
MRPL19	9801	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21466612
MRPL3	11222	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9	OMIM:614582	marker/mechanism		NA	614582	
MRPL44	65080	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16	OMIM:615395	marker/mechanism		NA	615395	
MRPL49	740	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
MRPL9	65005	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21466612
MRPS11	64963	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
MRPS11	64963	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
MRPS16	51021	Combined Oxidative Phosphorylation Deficiency 2	MESH:C566468	marker/mechanism		NA	610498	
MRPS18B	28973	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
MRPS18B	28973	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
MRPS22	56945	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21466612
MRPS22	56945	Combined Oxidative Phosphorylation Deficiency 5	MESH:C567126	marker/mechanism		NA	611719	
MRPS23	51649	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25151356
MRPS28	28957	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21466612
MRPS33	51650	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		31043756
MRPS5	64969	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
MRPS5	64969	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
MRPS6	64968	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		21378990
MRPS7	51081	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21466612
MRTFB	57496	Child Development Disorders, Pervasive	MESH:D002659	marker/mechanism		NA		20442744
MS4A1	931	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		22514692
MS4A1	931	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		22514692
MS4A1	931	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		22514692
MS4A1	931	Common Variable Immunodeficiency	MESH:D017074	marker/mechanism		NA	613495	
MS4A1	931	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
MS4A2	2206	Asthma, Aspirin-Induced	MESH:D055963	marker/mechanism		NA		16502481
MS4A2	2206	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		16839402|18534082|20485159
MS4A2	2206	Hypersensitivity, Immediate	MESH:D006969	marker/mechanism		NA		20485159
MS4A2	2206	Ige Responsiveness, Atopic	MESH:C564133	marker/mechanism		NA	147050	
MS4A4A	51338	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		21460841
MS4A4A	51338	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
MS4A6A	64231	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		25133636
MS4A6A	64231	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
MSGN1	343930	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		23797736
MSH2	4436	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18949393
MSH2	4436	Colorectal Neoplasms, Hereditary Nonpolyposis	MESH:D003123	marker/mechanism		NA		12702580|14756672|22102614|25701956
MSH2	4436	Lynch syndrome I (site-specific colonic cancer)	MESH:C537261	marker/mechanism		NA	120435	19098912
MSH2	4436	Muir-Torre Syndrome	MESH:D055653	marker/mechanism		NA	158320	
MSH2	4436	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		19032668
MSH2	4436	Turcot syndrome	MESH:C536928	marker/mechanism		NA	276300	
MSH3	4437	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		21327329
MSH3	4437	Adenomatous Polyposis Coli	MESH:D011125	marker/mechanism		NA	617100	
MSH3	4437	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA	608089	
MSH3	4437	Microsatellite Instability	MESH:D053842	marker/mechanism		NA		25701956
MSH3	4437	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		18355840
MSH5	4439	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
MSH5	4439	PREMATURE OVARIAN FAILURE 13	OMIM:617442	marker/mechanism		NA	617442	
MSH6	2956	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		21327329
MSH6	2956	Colorectal Cancer, Hereditary Nonpolyposis, Type 5	MESH:C563456	marker/mechanism		NA	614350	
MSH6	2956	Colorectal Neoplasms, Hereditary Nonpolyposis	MESH:D003123	marker/mechanism		NA		11586295|18417481|22102614|25701956|9354786
MSH6	2956	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA	608089	10508506
MSH6	2956	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		29616133
MSH6	2956	Microsatellite Instability	MESH:D053842	marker/mechanism		NA		25701956
MSH6	2956	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		29616133
MSH6	2956	Turcot syndrome	MESH:C536928	marker/mechanism		NA	276300	
MSL3	10943	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		30224647
MSL3	10943	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		30224647
MSL3	10943	Facies	MESH:D019066	marker/mechanism		NA		30224647
MSL3	10943	Gait Disorders, Neurologic	MESH:D020233	marker/mechanism		NA		30224647
MSL3	10943	Genetic Diseases, X-Linked	MESH:D040181	marker/mechanism		NA		30224647
MSL3P1	151507	Creutzfeldt-Jakob Syndrome	MESH:D007562	marker/mechanism		NA		23349890
MSLN	10232	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		11751476
MSLN	10232	Carcinoma, Endometrioid	MESH:D018269	marker/mechanism		NA		14576474
MSLN	10232	Carcinoma, Pancreatic Ductal	MESH:D021441	marker/mechanism		NA		14576474|21775916|25347530
MSLN	10232	Cholangiocarcinoma	MESH:D018281	marker/mechanism		NA		14576474
MSLN	10232	Lymphatic Metastasis	MESH:D008207	marker/mechanism		NA		22644300
MSLN	10232	Mesothelioma	MESH:D008654	marker/mechanism		NA		11751476|18394747|20933535
MSLN	10232	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		19190155|27032653
MSLN	10232	Neoplasms	MESH:D009369	marker/mechanism		NA		23277285
MSLN	10232	Neoplasms, Mesothelial	MESH:D018301	marker/mechanism		NA		20371980|21984916
MSLN	10232	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		11751476
MSLN	10232	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		11751476
MSLN	10232	Pleural Diseases	MESH:D010995	marker/mechanism		NA		23277285
MSLN	10232	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		22644300
MSMB	4477	Prostate Cancer, Hereditary, 13	MESH:C567456	marker/mechanism		NA	611928	
MSMB	4477	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881|18264096|18264097
MSMO1	6307	MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	OMIM:616834	marker/mechanism		NA	616834	
MSN	4478	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
MSN	4478	IMMUNODEFICIENCY 50	OMIM:300988	marker/mechanism		NA	300988	
MSN	4478	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
MSN	4478	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
MSN	4478	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
MSR1	4481	Barrett Esophagus	MESH:D001471	marker/mechanism		NA	614266	
MSR1	4481	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19878707
MSR1	4481	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16998812
MSRA	4482	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
MSRB3	253827	DEAFNESS, AUTOSOMAL RECESSIVE 74	OMIM:613718	marker/mechanism		NA	613718	
MSRB3	253827	Hearing Loss	MESH:D034381	marker/mechanism		NA		21782914
MST1	4485	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		28114269
MST1	4485	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
MST1	4485	Cholangitis, Sclerosing	MESH:D015209	marker/mechanism		NA		21151127
MST1	4485	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		18438406|20228799
MST1	4485	Crohn Disease	MESH:D003424	marker/mechanism		NA		18438406
MST1	4485	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		28114269
MST1R	4486	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22575169
MST1R	4486	Nasopharyngeal Carcinoma	MESH:D000077274	marker/mechanism		NA	617075	
MST1R	4486	Osteosarcoma	MESH:D012516	marker/mechanism		NA		22235915
MSTN	2660	Heart Failure	MESH:D006333	marker/mechanism		NA		16968467
MSTN	2660	MUSCLE HYPERTROPHY	OMIM:614160	marker/mechanism		NA	614160	
MSTN	2660	Myostatin-related muscle hypertrophy	MESH:C536106	marker/mechanism		NA		15215484|19248183
MSX1	4487	Anodontia	MESH:D000848	marker/mechanism		NA	106600	
MSX1	4487	Cleft Palate	MESH:D002972	marker/mechanism		NA		12163415|12701100|15301380
MSX1	4487	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		12163415|14630905|14654219|15301380
MSX1	4487	Nonsyndromic Deafness	MESH:C580334	marker/mechanism		NA		27356075
MSX1	4487	Orofacial Cleft 5	MESH:C563843	marker/mechanism		NA	608874	
MSX1	4487	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
MSX1	4487	Tooth Abnormalities	MESH:D014071	marker/mechanism		NA		14630905
MSX1	4487	Witkop syndrome	MESH:C536736	marker/mechanism		NA	189500	
MSX1	4487	Wolf-Hirschhorn Syndrome	MESH:D054877	marker/mechanism		NA		14630905
MSX2	4488	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		9147639
MSX2	4488	Craniosynostosis, Type 2	MESH:C565753	marker/mechanism		NA	604757	
MSX2	4488	Female Urogenital Diseases	MESH:D052776	marker/mechanism		NA		16513791
MSX2	4488	Parietal Foramina	MESH:C566826	marker/mechanism		NA	168500	11137991
MSX2	4488	Parietal Foramina With Cleidocranial Dysplasia	MESH:C566825	marker/mechanism		NA	168550	
MT1	17748	Acute Lung Injury	MESH:D055371	marker/mechanism		NA		16166738
MT1	17748	Amyotrophic lateral sclerosis 1	MESH:C531617	therapeutic		NA		24163136
MT1	17748	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		16543248
MT1	17748	Cardiac Output, Low	MESH:D002303	marker/mechanism		NA		30096613
MT1	17748	Cognition Disorders	MESH:D003072	marker/mechanism		NA		18226494
MT1	17748	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		16543248
MT1	17748	Learning Disabilities	MESH:D007859	marker/mechanism		NA		16216453
MT1	17748	Listeriosis	MESH:D008088	marker/mechanism		NA		19576872
MT1	17748	Movement Disorders	MESH:D009069	marker/mechanism		NA		16216453
MT1	17748	Muscular Atrophy	MESH:D009133	therapeutic		NA		24163136
MT1	17748	Nerve Degeneration	MESH:D009410	therapeutic		NA		11835189
MT1	17748	Prenatal Injuries	MESH:D049188	therapeutic		NA		12514265
MT1	17748	Respiratory Hypersensitivity	MESH:D012130	marker/mechanism		NA		17085522
MT1	17748	Sepsis	MESH:D018805	marker/mechanism		NA		17374846
MT1	17748	Tongue Neoplasms	MESH:D014062	marker/mechanism		NA		16543248
MT1	17748	Weight Loss	MESH:D015431	therapeutic		NA		24163136
MT1A	4489	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		19953893
MT1A	4489	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		17363595|19363144
MT1A	4489	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		17418620
MT1A	4489	Hepatitis, Chronic	MESH:D006521	marker/mechanism		NA		25053573
MT1A	4489	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980|25380136
MT1A	4489	Lymphatic Metastasis	MESH:D008207	marker/mechanism		NA		17418620
MT1A	4489	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		17418620
MT1A	4489	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		16565513
MT1E	4493	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
MT1F	4494	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
MT1G	4495	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		17068819
MT2	17750	Acute Lung Injury	MESH:D055371	marker/mechanism		NA		16166738
MT2	17750	Cardiac Output, Low	MESH:D002303	marker/mechanism		NA		30096613
MT2	17750	Cognition Disorders	MESH:D003072	marker/mechanism		NA		18226494
MT2	17750	Learning Disabilities	MESH:D007859	marker/mechanism		NA		16216453
MT2	17750	Listeriosis	MESH:D008088	marker/mechanism		NA		19576872
MT2	17750	Lung Injury	MESH:D055370	therapeutic		NA		18528683
MT2	17750	Movement Disorders	MESH:D009069	marker/mechanism		NA		16216453
MT2	17750	Nerve Degeneration	MESH:D009410	therapeutic		NA		11835189
MT2	17750	Pulmonary Fibrosis	MESH:D011658	therapeutic		NA		18528683
MT2	17750	Respiratory Hypersensitivity	MESH:D012130	marker/mechanism		NA		17085522
MT2	17750	Sepsis	MESH:D018805	marker/mechanism		NA		17374846
MT2A	4502	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		17363595|28284560
MT2A	4502	Cardiomegaly	MESH:D006332	therapeutic		NA		11309296
MT2A	4502	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		27122239
MT2A	4502	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		27122239
MT2A	4502	Heart Diseases	MESH:D006331	therapeutic		NA		16144979
MT2A	4502	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
MT2A	4502	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		21187089
MT2A	4502	Prostatic Intraepithelial Neoplasia	MESH:D019048	marker/mechanism		NA		16574721
MT2A	4502	Prostatic Neoplasms	MESH:D011471	marker/mechanism|therapeutic		NA		16574721|17914565
MT2A	4502	Renal Insufficiency, Chronic	MESH:D051436	marker/mechanism		NA		27122239
MT2A	4502	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
MT2A	4502	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		14503839
MT2A	4502	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		16565513|7729958
MT3	4504	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21170156
MT3	4504	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		17043644
MT3	4504	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		23794209
MT3	4504	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
MT3	4504	Seizures	MESH:D012640	marker/mechanism		NA		23266720
MT3	4504	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		16854967
MT4	84560	Kidney Diseases	MESH:D007674	marker/mechanism		NA		19921116
MT4	84560	Lead Poisoning	MESH:D007855	marker/mechanism		NA		19921116
MTA1	9112	Endometriosis	MESH:D004715	marker/mechanism		NA		22138541
MTA1	9112	Parkinson Disease	MESH:D010300	marker/mechanism		NA		27044752
MTA2	9219	Endometriosis	MESH:D004715	marker/mechanism		NA		22138541
MTAP	4507	Diaphyseal medullary stenosis with malignant fibrous histiocytoma	MESH:C536169	marker/mechanism		NA	112250	
MTAP	4507	Melanoma	MESH:D008545	marker/mechanism		NA		19578364
MTAP	4507	Nevus	MESH:D009506	marker/mechanism		NA		19578365
MTAP	4507	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		21716162
MTARC1	64757	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
MTARC2	54996	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
MTBP	27085	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		29765550
MTCH2	23788	Obesity	MESH:D009765	marker/mechanism		NA		19079261
MTCL1	23255	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		28166215
MTDH	92140	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19111877
MTDH	92140	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		29315995
MTDH	92140	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		29315995
MTDH	92140	Neoplasm Metastasis	MESH:D009362	therapeutic		NA		19111877
MTF1	4520	Autistic Disorder	MESH:D001321	marker/mechanism		NA		15446388
MTFMT	123263	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15	OMIM:614947	marker/mechanism		NA	614947	
MTH	38058	Organophosphate Poisoning	MESH:D062025	marker/mechanism		NA		25746179
MTHFD1	4522	Abruptio Placentae	MESH:D000037	marker/mechanism		NA		15633187
MTHFD1	4522	Neural tube defect, folate-sensitive	MESH:C536409	marker/mechanism		NA	601634	
MTHFD1	4522	Neural Tube Defects	MESH:D009436	marker/mechanism		NA		12384833|16552426
MTHFD2	10797	Hodgkin Disease	MESH:D006689	marker/mechanism		NA		24688052
MTHFR	4524	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		17387702
MTHFR	4524	Alopecia	MESH:D000505	marker/mechanism		NA		18381794
MTHFR	4524	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		17192785
MTHFR	4524	Anemia	MESH:D000740	marker/mechanism		NA		19391036|25007187
MTHFR	4524	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		24384392
MTHFR	4524	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		22104130
MTHFR	4524	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19267885
MTHFR	4524	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		17074966
MTHFR	4524	Blood Coagulation Disorders, Inherited	MESH:D025861	marker/mechanism		NA		17493413
MTHFR	4524	Brain Ischemia	MESH:D002545	marker/mechanism		NA		15534175
MTHFR	4524	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16777985|17595805|28114181
MTHFR	4524	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		16958597|25050994
MTHFR	4524	Cervical Intraepithelial Neoplasia	MESH:D018290	marker/mechanism		NA		17303386
MTHFR	4524	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		18551038|19648163
MTHFR	4524	Cleft Lip	MESH:D002971	marker/mechanism		NA		16470725
MTHFR	4524	Clubfoot	MESH:D003025	marker/mechanism		NA		16936070
MTHFR	4524	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		16284371
MTHFR	4524	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		15608557|16512993|16985020|17047490|17087956|17245555|17350979|18676755|26858257
MTHFR	4524	Coronary Disease	MESH:D003327	marker/mechanism		NA		16792904
MTHFR	4524	Coronary Restenosis	MESH:D023903	marker/mechanism		NA		16489563
MTHFR	4524	Crohn Disease	MESH:D003424	marker/mechanism		NA		28002332
MTHFR	4524	Depressive Disorder	MESH:D003866	marker/mechanism		NA		17074966
MTHFR	4524	Diabetic Angiopathies	MESH:D003925	marker/mechanism		NA		16681562
MTHFR	4524	Down Syndrome	MESH:D004314	marker/mechanism		NA		16353284|16489479|16845273|17431899
MTHFR	4524	Drug Eruptions	MESH:D003875	marker/mechanism		NA		14723717
MTHFR	4524	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		15753437|16166815|17387702|17502830|18551038|19159907|19391036|19821069|21064136|25007187|26077125
MTHFR	4524	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		17301261
MTHFR	4524	Gastrointestinal Diseases	MESH:D005767	marker/mechanism		NA		19648163
MTHFR	4524	Graft vs Host Disease	MESH:D006086	marker/mechanism		NA		16518429
MTHFR	4524	Hearing Loss, Sudden	MESH:D003639	marker/mechanism		NA		16275406
MTHFR	4524	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		16524890
MTHFR	4524	Hematologic Diseases	MESH:D006402	marker/mechanism		NA		19159907
MTHFR	4524	Hyperhomocysteinemia	MESH:D020138	marker/mechanism|therapeutic		NA		10459572|15226090|16317120|16397167|16411416|16575899|17387702|18234410|18551038|19204075|19646848
MTHFR	4524	Hypersensitivity	MESH:D006967	marker/mechanism		NA		16766537
MTHFR	4524	Infertility, Female	MESH:D007247	marker/mechanism		NA		16679164
MTHFR	4524	Infertility, Male	MESH:D007248	marker/mechanism		NA		16861746
MTHFR	4524	Kidney Diseases	MESH:D007674	marker/mechanism		NA		18551038
MTHFR	4524	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		16706930
MTHFR	4524	Leukoencephalopathies	MESH:D056784	marker/mechanism		NA		15753437
MTHFR	4524	Leukopenia	MESH:D007970	marker/mechanism		NA		19648163
MTHFR	4524	Liver Diseases	MESH:D008107	marker/mechanism		NA		16877991
MTHFR	4524	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17389614
MTHFR	4524	Lymphoma	MESH:D008223	marker/mechanism		NA		16799656
MTHFR	4524	Lymphoma, Follicular	MESH:D008224	marker/mechanism		NA		16410450
MTHFR	4524	Lymphoma, Non-Hodgkin	MESH:D008228	marker/mechanism		NA		17488658
MTHFR	4524	Malnutrition	MESH:D044342	marker/mechanism		NA		16709328
MTHFR	4524	Maxillofacial Abnormalities	MESH:D019767	marker/mechanism		NA		16832597
MTHFR	4524	Meningomyelocele	MESH:D008591	marker/mechanism		NA		16602021
MTHFR	4524	Methylenetetrahydrofolate reductase deficiency	MESH:C537357	marker/mechanism		NA	236250	
MTHFR	4524	Microsatellite Instability	MESH:D053842	marker/mechanism		NA		17350979
MTHFR	4524	Microvascular Angina	MESH:D017566	marker/mechanism		NA		17491230
MTHFR	4524	Mucositis	MESH:D052016	marker/mechanism		NA		17488658
MTHFR	4524	Necrosis	MESH:D009336	marker/mechanism		NA		14723717
MTHFR	4524	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17704422
MTHFR	4524	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		21064136
MTHFR	4524	Neural tube defect, folate-sensitive	MESH:C536409	marker/mechanism		NA	601634	
MTHFR	4524	Neural Tube Defects	MESH:D009436	marker/mechanism		NA		23056169
MTHFR	4524	Neutropenia	MESH:D009503	marker/mechanism		NA		19391036
MTHFR	4524	Parkinson Disease	MESH:D010300	marker/mechanism		NA		30726997
MTHFR	4524	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		16706930
MTHFR	4524	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17967524
MTHFR	4524	Pulmonary Embolism	MESH:D011655	marker/mechanism		NA		19123085
MTHFR	4524	Schizophrenia	MESH:D012559	marker/mechanism		NA	181500	16641680|17074966|18583979
MTHFR	4524	Sinus Thrombosis, Intracranial	MESH:D012851	marker/mechanism		NA		18941937
MTHFR	4524	Skin Diseases	MESH:D012871	marker/mechanism		NA		17548696
MTHFR	4524	Spinal Cord Diseases	MESH:D013118	marker/mechanism		NA		16361298
MTHFR	4524	Spinal Dysraphism	MESH:D016135	marker/mechanism		NA		27713094
MTHFR	4524	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		18505952|21347786
MTHFR	4524	Stroke	MESH:D020521	marker/mechanism		NA		15534175|16681562|19646848
MTHFR	4524	Thrombocytopenia	MESH:D013921	marker/mechanism		NA		19391036
MTHFR	4524	Thrombophilia	MESH:D019851	marker/mechanism		NA	188050	17493413
MTHFR	4524	Thyrotoxicosis	MESH:D013971	marker/mechanism		NA		18941937
MTHFR	4524	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		22747749
MTHFR	4524	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		17303386
MTHFR	4524	Vascular Diseases	MESH:D014652	marker/mechanism		NA		19646848
MTHFR	4524	Venous Thrombosis	MESH:D020246	marker/mechanism		NA		19123085
MTHFS	10588	Cleft Lip	MESH:D002971	marker/mechanism		NA		21254359
MTHFS	10588	Cleft Palate	MESH:D002972	marker/mechanism		NA		21254359
MTM1	4534	Myopathies, Structural, Congenital	MESH:D020914	marker/mechanism		NA	310400	17376685
MTMR14	64419	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		30365097
MTMR14	64419	Myopathies, Structural, Congenital	MESH:D020914	marker/mechanism		NA	160150	
MTMR2	8898	Charcot-Marie-Tooth disease, Type 4B1	MESH:C535420	marker/mechanism		NA	601382	
MTMR4	9110	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
MTMR7	9108	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
MTNR1A	4543	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		20657642
MTNR1A	4543	Retinal Diseases	MESH:D012164	marker/mechanism		NA		21915336
MTNR1B	4544	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		20657642
MTNR1B	4544	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA	125853	19060907|19060908|19060909|22286214|26551672
MTNR1B	4544	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		20207350
MTO1	25821	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	OMIM:614702	marker/mechanism		NA	614702	
MTOR	2475	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		18058806
MTOR	2475	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		30705370
MTOR	2475	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21147110
MTOR	2475	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		30705370
MTOR	2475	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		23797736
MTOR	2475	Carcinoma, Small Cell	MESH:D018288	marker/mechanism		NA		20946520
MTOR	2475	Clinical Deterioration	MESH:D000075902	marker/mechanism		NA		29384525
MTOR	2475	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		30705370
MTOR	2475	Endocrine System Diseases	MESH:D004700	marker/mechanism		NA		29384525
MTOR	2475	Exocrine Pancreatic Insufficiency	MESH:D010188	marker/mechanism		NA		29384525
MTOR	2475	Focal cortical dysplasia of Taylor	MESH:C537067	marker/mechanism		NA	607341	
MTOR	2475	Glioblastoma	MESH:D005909	marker/mechanism		NA		30705370
MTOR	2475	Hypertension	MESH:D006973	marker/mechanism		NA		19289642
MTOR	2475	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		19289642
MTOR	2475	Lymphatic Metastasis	MESH:D008207	marker/mechanism		NA		30705370
MTOR	2475	Lymphoma, Mantle-Cell	MESH:D020522	marker/mechanism		NA		17148679
MTOR	2475	Malformations of Cortical Development	MESH:D054220	marker/mechanism		NA		22729223
MTOR	2475	Mesothelioma	MESH:D008654	marker/mechanism		NA		21358348
MTOR	2475	Neurotoxicity Syndromes	MESH:D020258	marker/mechanism		NA		16955484
MTOR	2475	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		20138251|30705370
MTOR	2475	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054218	marker/mechanism		NA		19246562
MTOR	2475	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		28936961
MTOR	2475	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
MTOR	2475	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		18058806
MTPAP	55149	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
MTPAP	55149	SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE	OMIM:613672	marker/mechanism		NA	613672	
MTPN	136319	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
MTR	4548	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17595805
MTR	4548	Cleft Lip	MESH:D002971	marker/mechanism		NA		21254359
MTR	4548	Cleft Palate	MESH:D002972	marker/mechanism		NA		21254359
MTR	4548	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		15753437|19159907
MTR	4548	Gastrointestinal Diseases	MESH:D005767	marker/mechanism		NA		19159907
MTR	4548	Hematologic Diseases	MESH:D006402	marker/mechanism		NA		19159907
MTR	4548	Infertility, Male	MESH:D007248	marker/mechanism		NA		16861746
MTR	4548	Leukoencephalopathies	MESH:D056784	marker/mechanism		NA		15753437
MTR	4548	Lymphoma	MESH:D008223	marker/mechanism		NA		16799656
MTR	4548	Lymphoma, Follicular	MESH:D008224	marker/mechanism		NA		16410450
MTR	4548	Malnutrition	MESH:D044342	marker/mechanism		NA		16709328
MTR	4548	Methylcobalamin Deficiency, CblG Type	MESH:C565394	marker/mechanism		NA	250940	
MTR	4548	Neural tube defect, folate-sensitive	MESH:C536409	marker/mechanism		NA	601634	
MTRR	4552	Adenoma	MESH:D000236	marker/mechanism		NA		17389618
MTRR	4552	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		16985020|17389618
MTRR	4552	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		21064136
MTRR	4552	Homocystinuria	MESH:D006712	marker/mechanism		NA		12555939|15714522
MTRR	4552	Homocystinuria-Megaloblastic Anemia due to Defect in Cobalamin Metabolism, CblE Complementation Type	MESH:C565510	marker/mechanism		NA	236270	
MTRR	4552	Hyperhomocysteinemia	MESH:D020138	marker/mechanism		NA		16575899|17369066
MTRR	4552	Infertility, Male	MESH:D007248	marker/mechanism		NA		16861746
MTRR	4552	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		21064136
MTRR	4552	Neural tube defect, folate-sensitive	MESH:C536409	marker/mechanism		NA	601634	
MTRR	4552	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		17136115
MTSS1	9788	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
MTSS1	9788	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
MTTP	4547	ABDOMINAL OBESITY-METABOLIC SYNDROME 1	OMIM:605552	marker/mechanism		NA	605552	
MTTP	4547	Abetalipoproteinemia	MESH:D000012	marker/mechanism		NA	200100	
MTTP	4547	Fatty Liver	MESH:D005234	marker/mechanism		NA		17303181
MUC1	4582	Cell Transformation, Neoplastic	MESH:D002471	therapeutic		NA		22457794
MUC1	4582	Medullary cystic kidney disease 1	MESH:C536137	marker/mechanism		NA	174000	23396133
MUC1	4582	Mesothelioma	MESH:D008654	marker/mechanism		NA		18454162
MUC1	4582	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		22784439
MUC1	4582	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		9949172
MUC1	4582	Peritoneal Neoplasms	MESH:D010534	marker/mechanism		NA		22784439
MUC1	4582	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		28220687
MUC1	4582	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		26098866
MUC12	10071	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		29054765
MUC16	94025	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		29552305
MUC16	94025	Ovarian Neoplasms	MESH:D010051	therapeutic		NA		11706781
MUC16	94025	Proteinuria	MESH:D011507	marker/mechanism		NA		12169874
MUC19	283463	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA		21983784
MUC2	4583	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		12468628
MUC2	4583	Adenoma	MESH:D000236	marker/mechanism		NA		12468628
MUC2	4583	Intestinal Neoplasms	MESH:D007414	marker/mechanism		NA		12468628
MUC2	4583	Rectal Neoplasms	MESH:D012004	marker/mechanism		NA		12468628
MUC4	4585	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
MUC4	4585	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		23797736
MUC4	4585	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
MUC5B	727897	Idiopathic Pulmonary Fibrosis	MESH:D054990	marker/mechanism		NA	178500	23583980
MUC6	4588	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		24816253
MUC7	4589	Asthma	MESH:D001249	marker/mechanism		NA	600807	
MUCL3	135656	Diffuse panbronchiolitis	MESH:C536174	marker/mechanism		NA		22152429
MUG1	17836	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		28885000
MUG1	17836	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		28885000
MUSK	4593	Myasthenia Gravis	MESH:D009157	marker/mechanism		NA		22981737|27119269
MUSK	4593	Myasthenic Syndrome, Congenital, with Facial Dysmorphism, associated with Acetylcholine Receptor Deficiency	MESH:C563829	marker/mechanism		NA	616325	
MUSK	4593	Pena Shokeir syndrome, type 1	MESH:C536647	marker/mechanism		NA	208150	
MUTYH	4595	Adenomatous Polyposis Coli	MESH:D011125	marker/mechanism		NA		15987719
MUTYH	4595	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		25030372
MUTYH	4595	Colorectal Adenomatous Polyposis, Autosomal Recessive	MESH:C563924	marker/mechanism		NA	608456	
MUTYH	4595	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA	613659	
MVD	4597	POROKERATOSIS 7, MULTIPLE TYPES	OMIM:614714	marker/mechanism		NA	614714	
MVK	4598	Arthralgia	MESH:D018771	marker/mechanism		NA		10369261
MVK	4598	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21147110
MVK	4598	Exanthema	MESH:D005076	marker/mechanism		NA		10369261
MVK	4598	Fever	MESH:D005334	marker/mechanism		NA		10369261
MVK	4598	Inflammation	MESH:D007249	marker/mechanism		NA		24073415
MVK	4598	Mevalonate Kinase Deficiency	MESH:D054078	marker/mechanism		NA	260920|610377	10369261|12477733|17596604|18008182|24073415|27377765
MVK	4598	Porokeratosis, disseminated superficial actinic 1	MESH:C536339	marker/mechanism		NA	175900	22983302
MVP	9961	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
MVP	9961	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
MX1	4599	Fanconi Anemia	MESH:D005199	marker/mechanism		NA		9389754
MX1	4599	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
MX1	4599	Influenza in Birds	MESH:D005585	therapeutic		NA		178595
MX1	4599	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
MX1	4599	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
MX1	4599	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
MX2	4600	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
MX2	4600	Melanoma	MESH:D008545	marker/mechanism		NA		21983787
MXD1	4084	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17374397
MXI1	4601	Kidney Diseases	MESH:D007674	marker/mechanism		NA		23316056
MXI1	4601	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA	176807	
MXRA5	25878	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		22696596
MYADM	91663	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
MYB	4602	Asthma	MESH:D001249	marker/mechanism		NA		19198610
MYB	4602	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749|26829750
MYB	4602	Glioma	MESH:D005910	marker/mechanism		NA		23583981|26829751
MYB	4602	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054218	marker/mechanism		NA		17435759|28671688
MYBBP1A	10514	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
MYBL1	4603	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
MYBL1	4603	Glioma	MESH:D005910	marker/mechanism		NA		23583981
MYBL1	4603	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
MYBL2	4605	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
MYBPC1	4604	ARTHROGRYPOSIS, DISTAL, TYPE 1B	OMIM:614335	marker/mechanism		NA	614335	
MYBPC1	4604	LETHAL CONGENITAL CONTRACTURE SYNDROME 4	OMIM:614915	marker/mechanism		NA	614915	
MYBPC3	4607	Cardiomegaly	MESH:D006332	marker/mechanism		NA		22189562
MYBPC3	4607	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		19151713
MYBPC3	4607	Cardiomyopathy, Familial Hypertrophic, 4	MESH:C566169	marker/mechanism		NA	115197	
MYBPC3	4607	Cardiomyopathy, Hypertrophic	MESH:D002312	marker/mechanism		NA		22076249|23816408|25566086|27994558
MYBPC3	4607	Cardiomyopathy, Hypertrophic, Familial	MESH:D024741	marker/mechanism		NA		11815426|23896226|9241277
MYBPC3	4607	Death, Sudden, Cardiac	MESH:D016757	marker/mechanism		NA		20435227
MYBPC3	4607	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		25566086
MYBPC3	4607	LEFT VENTRICULAR NONCOMPACTION 10	OMIM:615396	marker/mechanism		NA	615396	
MYC	4609	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		26432044
MYC	4609	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		26656844|27602772
MYC	4609	Burkitt Lymphoma	MESH:D002051	marker/mechanism		NA	113970	
MYC	4609	Carcinoma	MESH:D002277	marker/mechanism		NA		2228319
MYC	4609	Carcinoma, Ductal	MESH:D044584	marker/mechanism		NA		29295717
MYC	4609	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		12029619|15565109|29698666|9029167
MYC	4609	Carcinoma, Merkel Cell	MESH:D015266	marker/mechanism		NA		25277525
MYC	4609	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		24688052
MYC	4609	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		26432044
MYC	4609	Cardiomyopathy, Hypertrophic	MESH:D002312	marker/mechanism		NA		22000973
MYC	4609	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		12115494|2543982|29626521|31504995
MYC	4609	Chromosome Breakage	MESH:D019457	marker/mechanism		NA		25933419
MYC	4609	Cleft Lip	MESH:D002971	marker/mechanism		NA		24859337
MYC	4609	Cleft Palate	MESH:D002972	marker/mechanism		NA		24859337
MYC	4609	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		12189186|15059925|18283038|21081470
MYC	4609	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		30510241
MYC	4609	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
MYC	4609	Disease Progression	MESH:D018450	marker/mechanism		NA		22321834|28191284
MYC	4609	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		26656844
MYC	4609	Fatty Liver	MESH:D005234	therapeutic		NA		24210820
MYC	4609	Glioblastoma	MESH:D005909	marker/mechanism		NA		21127729
MYC	4609	Hemangiosarcoma	MESH:D006394	marker/mechanism		NA		17569031
MYC	4609	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		21472269
MYC	4609	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		25956709
MYC	4609	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
MYC	4609	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		11532874|8807143
MYC	4609	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		11280770|18560566|9079223
MYC	4609	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		16289808|28191284
MYC	4609	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		27356265
MYC	4609	Medulloblastoma	MESH:D008527	marker/mechanism		NA		19270706
MYC	4609	Myelodysplastic Syndromes	MESH:D009190	marker/mechanism		NA		10914558
MYC	4609	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		22321834
MYC	4609	Neoplasms	MESH:D009369	marker/mechanism		NA		11559025
MYC	4609	Neuroblastoma	MESH:D009447	marker/mechanism		NA		8761367
MYC	4609	Neuroectodermal Tumors	MESH:D017599	marker/mechanism		NA		8761367
MYC	4609	Osteosarcoma	MESH:D012516	marker/mechanism		NA		24646477
MYC	4609	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		20852632
MYC	4609	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		25961927
MYC	4609	Polycystic Kidney, Autosomal Dominant	MESH:D016891	marker/mechanism		NA		25877301
MYC	4609	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17173048|23704919|29295717|32512071
MYC	4609	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		17171786|21173787
MYC	4609	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		2228319
MYC	4609	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		26432044
MYCBP	26292	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
MYCL	4610	Medulloblastoma	MESH:D008527	marker/mechanism		NA		19270706
MYCL	4610	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		26005866
MYCL	4610	Small Cell Lung Carcinoma	MESH:D055752	therapeutic		NA		22941189
MYCN	4613	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
MYCN	4613	Carcinoma, Basal Cell	MESH:D002280	marker/mechanism		NA		26950094
MYCN	4613	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22286764
MYCN	4613	Chromosome Aberrations	MESH:D002869	marker/mechanism		NA		25174395
MYCN	4613	Hyperplasia	MESH:D006965	marker/mechanism		NA		25174395
MYCN	4613	Medulloblastoma	MESH:D008527	marker/mechanism		NA		19270706
MYCN	4613	Necrosis	MESH:D009336	marker/mechanism		NA		21214410
MYCN	4613	Neuroblastoma	MESH:D009447	marker/mechanism		NA		16051641|16989911|17283129|18353067|22286764|22789543|23042116|23334666|23500671|25174395|26523776|26733615|29379199|30127528
MYCN	4613	Oculodigitoesophagoduodenal syndrome	MESH:C537734	marker/mechanism		NA	164280	19852433|21532573
MYCN	4613	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054218	marker/mechanism		NA		28671688
MYCN	4613	Wilms Tumor	MESH:D009396	marker/mechanism		NA		28825729
MYD88	4615	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		24362818
MYD88	4615	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		28789951
MYD88	4615	Eosinophilia	MESH:D004802	marker/mechanism		NA		26882889
MYD88	4615	Hypertension	MESH:D006973	marker/mechanism		NA		27292124
MYD88	4615	Inflammation	MESH:D007249	marker/mechanism		NA		22053092
MYD88	4615	Lymphoma, Follicular	MESH:D008224	marker/mechanism		NA		24362818
MYD88	4615	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		25049379
MYD88	4615	MYD88 Deficiency	MESH:C567379	marker/mechanism		NA	612260	
MYD88	4615	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		21473897
MYD88	4615	Pneumonia	MESH:D011014	marker/mechanism		NA		26882889
MYD88	4615	Pulmonary Eosinophilia	MESH:D011657	marker/mechanism		NA		29067999
MYD88	4615	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		25780291
MYD88	4615	Severe Acute Respiratory Syndrome	MESH:D045169	marker/mechanism		NA		26861016
MYD88	4615	Waldenstrom Macroglobulinemia	MESH:D008258	marker/mechanism		NA	153600	30126942
MYDGF	56005	Keloid	MESH:D007627	marker/mechanism		NA		20128793
MYH10	4628	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA		9678433
MYH11	4629	Aortic aneurysm, familial thoracic 4	MESH:C537784	marker/mechanism		NA	132900	
MYH11	4629	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		18206229|27798625
MYH11	4629	Leukemia, Myelomonocytic, Acute	MESH:D015479	marker/mechanism		NA		10958941
MYH13	8735	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
MYH14	79784	DEAFNESS, AUTOSOMAL DOMINANT 4A	OMIM:600652	marker/mechanism		NA	600652	
MYH14	79784	PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS	OMIM:614369	marker/mechanism		NA	614369	
MYH14	79784	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
MYH2	4620	Inclusion Body Myopathy 3, Autosomal Dominant	MESH:C565311	marker/mechanism		NA	605637	
MYH3	4621	Freeman-Sheldon syndrome	MESH:C535483	marker/mechanism		NA	193700	
MYH3	4621	Multiple Pterygium Syndrome, Autosomal Dominant	MESH:C566739	marker/mechanism		NA	178110	
MYH6	4624	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
MYH6	4624	Atrial Septal Defect 3	MESH:C563540	marker/mechanism		NA	614089	
MYH6	4624	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		15998695
MYH6	4624	Cardiomyopathy, Dilated, 1EE	MESH:C567683	marker/mechanism		NA	613252	
MYH6	4624	Cardiomyopathy, Familial Hypertrophic, 1	MESH:C566005	marker/mechanism		NA	192600	
MYH6	4624	Cardiomyopathy, Familial Hypertrophic, 14	MESH:C567684	marker/mechanism		NA	613251	
MYH6	4624	Cardiomyopathy, Hypertrophic	MESH:D002312	marker/mechanism		NA		15998695|29741611
MYH6	4624	Cardiomyopathy, Hypertrophic, Familial	MESH:D024741	marker/mechanism		NA		11815426
MYH6	4624	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		28991257
MYH6	4624	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
MYH6	4624	Heart Septal Defects, Atrial	MESH:D006344	marker/mechanism		NA		15735645
MYH6	4624	Sick Sinus Syndrome	MESH:D012804	marker/mechanism		NA		21378987
MYH7	4625	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
MYH7	4625	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		11986409
MYH7	4625	Cardiomyopathy, Dilated, 1s	MESH:C563538	marker/mechanism		NA	613426	
MYH7	4625	Cardiomyopathy, Familial Hypertrophic, 1	MESH:C566005	marker/mechanism		NA	192600	
MYH7	4625	Cardiomyopathy, Hypertrophic	MESH:D002312	marker/mechanism		NA		29686627|29741611
MYH7	4625	Cardiomyopathy, Hypertrophic, Familial	MESH:D024741	marker/mechanism		NA		23896226
MYH7	4625	Coronary Stenosis	MESH:D023921	marker/mechanism		NA		12721106
MYH7	4625	Distal Myopathies	MESH:D049310	marker/mechanism		NA	160500	
MYH7	4625	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
MYH7	4625	Hypertension	MESH:D006973	marker/mechanism		NA		32147540
MYH7	4625	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		11743230
MYH7	4625	Myopathies, Structural, Congenital	MESH:D020914	marker/mechanism		NA	255310	
MYH7	4625	Myopathy, Hyaline Body, Autosomal Recessive	MESH:C564970	marker/mechanism		NA	255160	
MYH7	4625	Myopathy, Myosin Storage	MESH:C564253	marker/mechanism		NA	608358	
MYH7	4625	SCAPULOPERONEAL MYOPATHY, MYH7-RELATED	OMIM:181430	marker/mechanism		NA	181430	
MYH8	4626	Carney Complex Variant	MESH:C563845	marker/mechanism		NA	608837	
MYH8	4626	Hecht syndrome	MESH:C535857	marker/mechanism		NA	158300	
MYH9	4627	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		28650484
MYH9	4627	Carcinoma, Lobular	MESH:D018275	marker/mechanism		NA		28650484
MYH9	4627	Deafness, autosomal dominant nonsyndromic sensorineural 17	MESH:C538050	marker/mechanism		NA	603622	
MYH9	4627	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA		18794856
MYH9	4627	Hypertension, Renal	MESH:D006977	marker/mechanism		NA		18794856
MYH9	4627	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		18794854|18794856
MYH9	4627	Macrothrombocytopenia progressive deafness	MESH:C537831	marker/mechanism		NA		12621333
MYH9	4627	MYH9-Related Disorders	MESH:C535507	marker/mechanism		NA	155100	10973259|11590545|12621333
MYH9	4627	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		28650484
MYH9	4627	Nephritis, Hereditary	MESH:D009394	marker/mechanism		NA		10973259
MYL1	4632	Heart Injuries	MESH:D006335	marker/mechanism		NA		19854236
MYL2	4633	Cardiomyopathy, Familial Hypertrophic, 10	MESH:C563865	marker/mechanism		NA	608758	
MYL2	4633	Cardiomyopathy, Hypertrophic	MESH:D002312	marker/mechanism		NA		9527842
MYL2	4633	Cardiomyopathy, Hypertrophic, Familial	MESH:D024741	marker/mechanism		NA		9241277
MYL3	4634	Cardiomyopathy, Familial Hypertrophic, 8	MESH:C563866	marker/mechanism		NA	608751	
MYL4	4635	ATRIAL FIBRILLATION, FAMILIAL, 18	OMIM:617280	marker/mechanism		NA	617280	
MYL4	4635	Cardiomyopathy, Hypertrophic	MESH:D002312	marker/mechanism		NA		9527842
MYL6B	140465	Keloid	MESH:D007627	marker/mechanism		NA		20128793
MYL7	58498	Cardiomyopathy, Hypertrophic	MESH:D002312	marker/mechanism		NA		9527842
MYL9	10398	Brain Edema	MESH:D001929	marker/mechanism		NA		17419808
MYL9	10398	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
MYL9	10398	Vascular Diseases	MESH:D014652	marker/mechanism		NA		18511912
MYLIP	29116	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
MYLK	4638	Acute Lung Injury	MESH:D055371	marker/mechanism		NA		19374788
MYLK	4638	AORTIC ANEURYSM, FAMILIAL THORACIC 7	OMIM:613780	marker/mechanism		NA	613780	
MYLK	4638	Brain Edema	MESH:D001929	marker/mechanism		NA		19943851
MYLK	4638	Gastrointestinal Diseases	MESH:D005767	marker/mechanism		NA		15621374
MYLK	4638	Glaucoma	MESH:D005901	marker/mechanism		NA		20375339
MYLK	4638	Glioma	MESH:D005910	marker/mechanism		NA		10232591
MYLK	4638	Hypercholesterolemia	MESH:D006937	marker/mechanism		NA		21052790
MYLK	4638	Hypersensitivity	MESH:D006967	marker/mechanism		NA		15621374
MYLK	4638	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		10232591|12970723
MYLK	4638	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		12970723|18710790
MYLK	4638	Pneumonia	MESH:D011014	marker/mechanism		NA		15863634
MYLK	4638	Vascular Diseases	MESH:D014652	marker/mechanism		NA		18511912
MYLK2	85366	Cardiomyopathy, Familial Hypertrophic, 1	MESH:C566005	marker/mechanism		NA	192600	
MYO10	4651	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
MYO15A	51168	Deafness, Autosomal Recessive 3	MESH:C563961	marker/mechanism		NA	600316	
MYO18B	84700	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
MYO18B	84700	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		29054765
MYO18B	84700	KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM	OMIM:616549	marker/mechanism		NA	616549	
MYO18B	84700	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		29054765
MYO18B	84700	Mesothelioma	MESH:D008654	therapeutic		NA		17294804
MYO1B	4430	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
MYO1B	4430	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
MYO1C	4641	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
MYO1C	4641	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
MYO1D	4642	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17376794
MYO1E	4643	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA	614131	
MYO1F	4542	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
MYO3A	53904	Deafness, Autosomal Recessive 30	MESH:C564624	marker/mechanism		NA	607101	
MYO5A	4644	Griscelli syndrome type 1	MESH:C537301	marker/mechanism		NA	214450	
MYO5A	4644	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
MYO5A	4644	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		20864405
MYO5B	4645	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
MYO5B	4645	Diarrhea	MESH:D003967	marker/mechanism		NA		18724368
MYO5B	4645	Intestinal Diseases	MESH:D007410	marker/mechanism		NA		18724368
MYO5B	4645	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		25058030
MYO5B	4645	Metabolism, Inborn Errors	MESH:D008661	marker/mechanism		NA		18724368
MYO5B	4645	Microvillus inclusion disease	MESH:C537470	marker/mechanism		NA	251850	
MYO5C	55930	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
MYO6	4646	DEAFNESS, AUTOSOMAL DOMINANT 22;DFNA22 DEAFNESS, AUTOSOMAL DOMINANT 22, WITH HYPERTROPHIC CARDIOMYOPATHY,	OMIM:606346	marker/mechanism		NA	606346	
MYO6	4646	Deafness, Autosomal Recessive 37	MESH:C564331	marker/mechanism		NA	607821	
MYO6	4646	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
MYO7A	4647	Deafness, Autosomal Dominant 11	MESH:C563353	marker/mechanism		NA	601317	
MYO7A	4647	Deafness, Autosomal Recessive 2	MESH:C564007	marker/mechanism		NA	600060	
MYO7A	4647	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
MYO7A	4647	Usher Syndromes	MESH:D052245	marker/mechanism		NA		15965244
MYO7A	4647	Usher syndrome, type 1B	MESH:C536485	marker/mechanism		NA	276900	
MYO9B	4650	Celiac Disease	MESH:D002446	marker/mechanism		NA	609753	
MYO9B	4650	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
MYOC	4653	Glaucoma	MESH:D005901	marker/mechanism		NA		30389787|31959993
MYOC	4653	Glaucoma 1, Open Angle, A	MESH:C564234	marker/mechanism		NA	137750	
MYOC	4653	Glaucoma, Open-Angle	MESH:D005902	marker/mechanism		NA		21059646
MYOC	4653	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
MYOCD	93649	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
MYOCD	93649	Cardiomegaly	MESH:D006332	marker/mechanism		NA		16556869
MYOD1	4654	Hernias, Diaphragmatic, Congenital	MESH:D065630	marker/mechanism		NA		21258934
MYOD1	4654	Prenatal Exposure Delayed Effects	MESH:D011297	marker/mechanism		NA		21258934
MYOD1	4654	Rhabdomyosarcoma, Embryonal	MESH:D018233	marker/mechanism		NA		24793135
MYOT	9499	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
MYOT	9499	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		15111675
MYOT	9499	Muscle Weakness	MESH:D018908	marker/mechanism		NA		15111675
MYOT	9499	Muscular Dystrophies, Limb-Girdle	MESH:D049288	marker/mechanism		NA		21336781
MYOT	9499	MYOPATHY, SPHEROID BODY	OMIM:182920	marker/mechanism		NA	182920	
MYOT	9499	Myotilinopathy	MESH:C563775	marker/mechanism		NA	609200	15111675
MYOT	9499	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		15111675
MYOZ1	58529	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
MYOZ2	51778	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 16	OMIM:613838	marker/mechanism		NA	613838	
MYPN	84665	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
MYPN	84665	CARDIOMYOPATHY, DILATED, 1KK	OMIM:615248	marker/mechanism		NA	615248	
MYPN	84665	NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE	OMIM:617336	marker/mechanism		NA	617336	
MYT1L	23040	MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	OMIM:616521	marker/mechanism		NA	616521	
MYT1L	23040	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
MYZAP	100820829	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
N4BP2L2	10443	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
N4BP2L2	10443	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
NAA10	8260	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
NAA10	8260	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
NAA10	8260	Microphthalmia, syndromic 1	MESH:C537464	marker/mechanism		NA	309800	
NAA10	8260	OGDEN SYNDROME	OMIM:300855	marker/mechanism		NA	300855	
NAA15	80155	Intellectual Disability	MESH:D008607	marker/mechanism		NA		28191889
NAB2	4665	Solitary Fibrous Tumors	MESH:D054364	marker/mechanism		NA		23313952|23313954
NACA	4666	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
NACC1	112939	Neoplasms	MESH:D009369	marker/mechanism		NA		31101655
NACC1	112939	NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	OMIM:617393	marker/mechanism		NA	617393	
NADK2	133686	2,4-Dienoyl-CoA Reductase Deficiency	MESH:C565624	marker/mechanism		NA	616034	
NAGA	4668	Neuroaxonal Dystrophies	MESH:D019150	marker/mechanism		NA		2243144
NAGA	4668	Schindler Disease, Type I	MESH:C536631	marker/mechanism		NA	609241|609242	19683538|2243144
NAGK	55577	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
NAGK	55577	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17085005
NAGK	55577	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
NAGLU	4669	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2V	OMIM:616491	marker/mechanism		NA	616491	
NAGLU	4669	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
NAGLU	4669	Mucopolysaccharidosis III	MESH:D009084	marker/mechanism		NA	252920	
NAGLU	4669	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
NAGS	162417	Hyperammonemia	MESH:D022124	marker/mechanism		NA		12594532|12754705|17703373
NAGS	162417	N-acetyl glutamate synthetase deficiency	MESH:C536109	marker/mechanism		NA	237310	12594532|12754705
NALCN	259232	CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	OMIM:616266	marker/mechanism		NA	616266	
NALCN	259232	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1	OMIM:615419	marker/mechanism		NA	615419	
NAMPT	10135	Colitis	MESH:D003092	marker/mechanism		NA		23810507
NAMPT	10135	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		23922874
NAMPT	10135	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17374397
NAMPT	10135	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		28501332
NAMPT	10135	Obesity	MESH:D009765	marker/mechanism		NA		23834033
NAMPT	10135	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		28501332
NANOG	79923	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		29626521
NANOG	79923	Neoplasms, Germ Cell and Embryonal	MESH:D009373	marker/mechanism		NA		16168501
NANOS1	340719	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
NANOS1	340719	SPERMATOGENIC FAILURE 12	OMIM:615413	marker/mechanism		NA	615413	
NANOS2	339345	Infertility, Male	MESH:D007248	marker/mechanism		NA		22190708
NANS	54187	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		27213289
NANS	54187	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		27213289
NANS	54187	Spondyloepimetaphyseal dysplasia, Genevieve type	MESH:C535785	marker/mechanism		NA	610442	
NANSA	322780	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		27213289
NAP1L5	266812	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
NARS2	79731	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24	OMIM:616239	marker/mechanism		NA	616239	
NAT1	9	Chromosome Aberrations	MESH:D002869	marker/mechanism		NA		16537716
NAT1	9	Dermatitis, Occupational	MESH:D009783	marker/mechanism		NA		19834256
NAT1	9	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		11505221
NAT1	9	Neoplasms	MESH:D009369	marker/mechanism		NA		11505221
NAT1	9	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		12618593
NAT1	9	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		16003747
NAT2	10	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19692670
NAT2	10	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
NAT2	10	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		11915035|16799928|17950035|25693865
NAT2	10	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		21572414
NAT2	10	Dermatitis, Occupational	MESH:D009783	marker/mechanism		NA		19834256
NAT2	10	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		20485159|20602614|21572414
NAT2	10	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		17377643|17502830
NAT2	10	Leukopenia	MESH:D007970	marker/mechanism		NA		12795783
NAT2	10	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19666988
NAT2	10	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		16697254
NAT2	10	Neural Tube Defects	MESH:D009436	marker/mechanism		NA		20641098
NAT2	10	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		22200898
NAT2	10	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		12618593|12622714|15717312|16083506
NAT2	10	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		10022756|15717312|18505952|20972438|24221535
NAT8	9027	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
NAV2	89797	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
NAV3	89795	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		22138691
NAV3	89795	Opioid-Related Disorders	MESH:D009293	marker/mechanism		NA		18438686
NAXD	55739	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
NAXD	55739	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
NAXE	128240	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1	OMIM:617186	marker/mechanism		NA	617186	
NBAS	51594	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
NBAS	51594	INFANTILE LIVER FAILURE SYNDROME 2	OMIM:616483	marker/mechanism		NA	616483	
NBAS	51594	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
NBEA	26960	Autistic Disorder	MESH:D001321	marker/mechanism		NA		12746398|20071347
NBEA	26960	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
NBEAL2	23218	Gray Platelet Syndrome	MESH:D055652	marker/mechanism		NA	139090	21765411|21765412|21765413
NBN	4683	Anemia, Aplastic	MESH:D000741	marker/mechanism		NA	609135	
NBN	4683	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		25415046
NBN	4683	Nijmegen Breakage Syndrome	MESH:D049932	marker/mechanism		NA	251260	16521404|17395558|18186968
NBN	4683	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA	613065	
NBN	4683	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		14973119|25415046
NBN	4683	Stomatitis	MESH:D013280	marker/mechanism		NA		24594932
NCAM1	4684	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
NCAM1	4684	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		19700239
NCAN	1463	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		31043756
NCAN	1463	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		26039340
NCAPG	64151	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
NCAPG2	54892	Parkinson Disease	MESH:D010300	marker/mechanism		NA		25475535
NCAPH	23397	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
NCF1	653361	Aortic Aneurysm, Abdominal	MESH:D017544	marker/mechanism		NA		16864727
NCF1	653361	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		12833524|28135245
NCF1	653361	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		21742780
NCF1	653361	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		23723366
NCF1	653361	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		14871415|16380483
NCF1	653361	Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Positive, Type I	MESH:C565532	marker/mechanism		NA	233700	
NCF1	653361	Hypercholesterolemia	MESH:D006937	marker/mechanism		NA		14871415
NCF1	653361	Hypertension	MESH:D006973	marker/mechanism		NA		16331104|17324946|19018797|32165127
NCF1	653361	Hypothermia	MESH:D007035	therapeutic		NA		30366073
NCF1	653361	Intracranial Aneurysm	MESH:D002532	marker/mechanism		NA		19381132
NCF1	653361	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19420110
NCF1	653361	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		28135245
NCF1	653361	Sjogren's Syndrome	MESH:D012859	marker/mechanism		NA		28135245
NCF2	4688	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		12833524
NCF2	4688	Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Positive, Type II	MESH:C565531	marker/mechanism		NA	233710	
NCF4	4689	Crohn Disease	MESH:D003424	marker/mechanism		NA		17435756
NCF4	4689	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 3	OMIM:613960	marker/mechanism		NA	613960	
NCF4	4689	Heart Diseases	MESH:D006331	marker/mechanism		NA		16330681
NCK1	4690	Albuminuria	MESH:D000419	marker/mechanism		NA		19443634
NCK1	4690	Nephrotic Syndrome	MESH:D009404	marker/mechanism		NA		19443634
NCK1	4690	Proteinuria	MESH:D011507	marker/mechanism		NA		19443634
NCK2	8440	Albuminuria	MESH:D000419	marker/mechanism		NA		19443634
NCK2	8440	Nephrotic Syndrome	MESH:D009404	marker/mechanism		NA		19443634
NCK2	8440	Proteinuria	MESH:D011507	marker/mechanism		NA		19443634
NCKAP1	10787	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
NCKAP1L	3071	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
NCL	4691	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
NCL	4691	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
NCL	4691	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
NCOA1	8648	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20332317
NCOA1	8648	Endometriosis	MESH:D004715	marker/mechanism		NA		22138541
NCOA1	8648	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		21080969
NCOA1	8648	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		21080969
NCOA1	8648	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		12237244
NCOA2	10499	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20332317
NCOA2	10499	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		12237244
NCOA3	8202	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		20852035
NCOA3	8202	Astrocytoma	MESH:D001254	marker/mechanism		NA		24680642
NCOA3	8202	Bone Neoplasms	MESH:D001859	marker/mechanism		NA		24134957
NCOA3	8202	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20332317
NCOA3	8202	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		20852035
NCOA3	8202	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		20852035
NCOA3	8202	Leukemia	MESH:D007938	marker/mechanism		NA		19365708|19433130
NCOA3	8202	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		11927493|12237244
NCOA4	8031	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		23811263
NCOA6	23054	Endometriosis	MESH:D004715	marker/mechanism		NA		22138541
NCOA7	135112	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29662167
NCOR1	9611	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19781322
NCOR1	9611	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		21822268
NCOR1	9611	Endometriosis	MESH:D004715	marker/mechanism		NA		22138541
NCOR1	9611	Glioblastoma	MESH:D005909	marker/mechanism		NA		17312396
NCOR1	9611	Hyperbilirubinemia, Neonatal	MESH:D051556	marker/mechanism		NA		28167773
NCOR1	9611	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		27064257
NCOR1	9611	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
NCOR1	9611	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		21822268
NCOR2	9612	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
NCR3	259197	Malaria	MESH:D008288	marker/mechanism		NA	609148	
NCSTN	23385	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		17192785
NCSTN	23385	Hidradenitis suppurativa, familial	MESH:C538118	marker/mechanism		NA	142690	20929727
ND1	4535	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		14563825
ND1	4535	MELAS Syndrome	MESH:D017241	marker/mechanism		NA	540000	
ND1	4535	Optic Atrophy, Hereditary, Leber	MESH:D029242	marker/mechanism		NA	535000	15342361|15505787|24569607|27449621|29991444
ND2	4536	Optic Atrophy, Hereditary, Leber	MESH:D029242	marker/mechanism		NA	535000	
ND4	4538	Optic Atrophies, Hereditary	MESH:D015418	marker/mechanism		NA		11695835|8662757
ND4	4538	Optic Atrophy, Hereditary, Leber	MESH:D029242	marker/mechanism		NA	535000	15342361|24569607
ND4	4538	Schizophrenia	MESH:D012559	marker/mechanism		NA		14623372
ND4L	4539	Optic Atrophy, Hereditary, Leber	MESH:D029242	marker/mechanism		NA	535000	
ND5	4540	MELAS Syndrome	MESH:D017241	marker/mechanism		NA	540000	
ND5	4540	Optic Atrophy, Hereditary, Leber	MESH:D029242	marker/mechanism		NA	535000	
ND6	4541	Disease Susceptibility	MESH:D004198	marker/mechanism		NA		20130021
ND6	4541	MELAS Syndrome	MESH:D017241	marker/mechanism		NA	540000	
ND6	4541	Optic Atrophies, Hereditary	MESH:D015418	marker/mechanism		NA		10072046
ND6	4541	Optic Atrophy, Hereditary, Leber	MESH:D029242	marker/mechanism		NA	535000	15342361|24569607
NDC1	55706	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
NDC80	10403	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
NDE1	54820	Lissencephaly	MESH:D054082	marker/mechanism		NA	614019	
NDE1	54820	Microhydranencephaly	MESH:C537555	marker/mechanism		NA	605013	
NDEL1	81565	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
NDN	4692	Birth Weight	MESH:D001724	marker/mechanism		NA		31082282
NDN	4692	Carcinoma	MESH:D002277	marker/mechanism		NA		21489049
NDN	4692	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		21489049
NDN	4692	Prader-Willi Syndrome	MESH:D011218	marker/mechanism		NA	176270	
NDNF	79625	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
NDP	4693	EXUDATIVE VITREORETINOPATHY 2, X-LINKED	OMIM:305390	marker/mechanism		NA	305390	
NDP	4693	Macular Edema	MESH:D008269	marker/mechanism		NA		29654250
NDP	4693	Norrie disease	MESH:C537849	marker/mechanism		NA	310600	
NDP	4693	Retinal Neovascularization	MESH:D015861	marker/mechanism		NA		29654250
NDP	4693	Retinitis	MESH:D012173	marker/mechanism		NA		29654250
NDRG1	10397	Astrocytoma	MESH:D001254	marker/mechanism		NA		15341671
NDRG1	10397	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		15341671
NDRG1	10397	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		15341671
NDRG1	10397	Carcinoma, Pancreatic Ductal	MESH:D021441	marker/mechanism		NA		16778198
NDRG1	10397	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		15108329
NDRG1	10397	Glioblastoma	MESH:D005909	marker/mechanism		NA		15341671
NDRG1	10397	Hemangioblastoma	MESH:D018325	marker/mechanism		NA		15341671
NDRG1	10397	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		15341671
NDRG1	10397	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
NDRG1	10397	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		15341671
NDRG1	10397	Melanoma	MESH:D008545	marker/mechanism		NA		15341671
NDRG1	10397	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		22972152
NDRG1	10397	Neoplasm Metastasis	MESH:D009362	marker/mechanism|therapeutic		NA		15867226|22972152
NDRG1	10397	Neuropathy, hereditary motor and sensory, LOM type	MESH:C535716	marker/mechanism		NA	601455	
NDRG1	10397	Oropharyngeal Neoplasms	MESH:D009959	marker/mechanism		NA		22972152
NDRG1	10397	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		15341671
NDRG1	10397	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		15341671
NDRG1	10397	Smooth Muscle Tumor	MESH:D018235	marker/mechanism		NA		15341671
NDRG1	10397	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		22972152
NDRG2	57447	Cataract	MESH:D002386	marker/mechanism		NA		22043305
NDRG2	57447	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
NDRG2	57447	Ischemic Attack, Transient	MESH:D002546	marker/mechanism		NA		23451161
NDRG2	57447	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
NDST1	3340	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		16020517
NDST1	3340	Eye Abnormalities	MESH:D005124	marker/mechanism		NA		16020517
NDST1	3340	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
NDST1	3340	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
NDST1	3340	Malformations of Cortical Development	MESH:D054220	marker/mechanism		NA		16020517
NDST1	3340	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	OMIM:616116	marker/mechanism		NA	616116	
NDST2	8509	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
NDST4	64579	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29662167
NDUFA13	51079	Thyroid cancer, Hurthle cell	MESH:C536913	marker/mechanism		NA	607464	
NDUFA2	4695	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
NDUFA2	4695	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
NDUFA4L2	56901	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		19192274
NDUFAF2	91942	Brain Diseases, Metabolic, Inborn	MESH:D020739	marker/mechanism		NA		16200211
NDUFB11	54539	LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3	OMIM:300952	marker/mechanism		NA	300952	
NDUFB11	54539	Microphthalmia, syndromic 7	MESH:C537466	marker/mechanism		NA	309801	
NDUFB7	4713	Hepatolenticular Degeneration	MESH:D006527	marker/mechanism		NA		23519153
NDUFB8	4714	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
NDUFB8	4714	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
NDUFB9	4715	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
NDUFS1	4719	Cardiomyopathy, Hypertrophic	MESH:D002312	marker/mechanism		NA		9527842
NDUFS1	4719	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
NDUFS1	4719	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
NDUFS2	4720	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		14729820
NDUFS2	4720	Mitochondrial Encephalomyopathies	MESH:D017237	marker/mechanism		NA		14729820
NDUFS3	4722	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21466612
NDUFS3	4722	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
NDUFS3	4722	Leigh Disease	MESH:D007888	marker/mechanism		NA		14729820
NDUFS3	4722	Optic Atrophy	MESH:D009896	marker/mechanism		NA		14729820
NDUFS4	4724	Brain Diseases	MESH:D001927	marker/mechanism		NA		24935635
NDUFS4	4724	Leigh Disease	MESH:D007888	marker/mechanism		NA		11181577
NDUFS4	4724	Mitochondrial complex I deficiency	MESH:C537475	marker/mechanism		NA	252010	
NDUFS4	4724	Motor Skills Disorders	MESH:D019957	marker/mechanism		NA		24935635
NDUFS8	4728	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
NDUFV1	4723	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
NDUFV1	4723	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
NDUFV1	4723	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
NDUFV2	4729	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		19135101
NDUFV2	4729	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		14729820
NDUFV2	4729	Mitochondrial Encephalomyopathies	MESH:D017237	marker/mechanism		NA		14729820
NDUFV2	4729	Schizophrenia	MESH:D012559	marker/mechanism		NA		19135101
NEAT1	283131	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
NEAT1	283131	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		27064257
NEAT1	283131	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29662167
NEB	4703	Nemaline Myopathy 2	MESH:C538349	marker/mechanism		NA	256030	
NEBL	10529	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		28416822
NECAP1	25977	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 21	OMIM:615833	marker/mechanism		NA	615833	
NECTIN1	5818	Herpes Simplex	MESH:D006561	marker/mechanism		NA		10729168
NECTIN1	5818	Herpesviridae Infections	MESH:D006566	marker/mechanism		NA		10932188
NECTIN1	5818	Zlotogora-Ogur syndrome	MESH:C536726	marker/mechanism		NA	225060	10932188
NECTIN2	5819	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		29107063|30319691|30320580
NECTIN2	5819	Atherosclerosis	MESH:D050197	marker/mechanism		NA		28062492
NECTIN2	5819	Breast Neoplasms	MESH:D001943	therapeutic		NA		23758976
NECTIN2	5819	Cognitive Dysfunction	MESH:D060825	marker/mechanism		NA		30503753
NECTIN2	5819	Dyslipidemias	MESH:D050171	marker/mechanism		NA		29670124
NECTIN2	5819	Herpes Simplex	MESH:D006561	marker/mechanism		NA		10729168|11602758|30319691
NECTIN2	5819	Leukemia, Myeloid, Acute	MESH:D015470	therapeutic		NA		29855615
NECTIN2	5819	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
NECTIN2	5819	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		27356265
NECTIN2	5819	Lymphoma, T-Cell, Peripheral	MESH:D016411	marker/mechanism		NA		28659334
NECTIN2	5819	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		16738668
NECTIN2	5819	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		29321541
NECTIN2	5819	Orofacial Cleft 1	MESH:C566121	marker/mechanism		NA		21637507
NECTIN2	5819	Ovarian Neoplasms	MESH:D010051	therapeutic		NA		23758976
NECTIN2	5819	Parkinson Disease	MESH:D010300	marker/mechanism		NA		25475535
NECTIN2	5819	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		30614027
NECTIN2	5819	Scleroderma, Systemic	MESH:D012595	marker/mechanism		NA		27482699
NECTIN2	5819	Teratozoospermia	MESH:D000072660	marker/mechanism		NA		28689229
NECTIN2	5819	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		29321541
NECTIN3	25945	Teratozoospermia	MESH:D000072660	marker/mechanism		NA		28689229
NECTIN4	81607	ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1	OMIM:613573	marker/mechanism		NA	613573	
NEDD4	4734	Keloid	MESH:D007627	marker/mechanism		NA		20711176
NEDD4	4734	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
NEDD4	4734	Stevens-Johnson Syndrome	MESH:D013262	marker/mechanism		NA		25811541
NEDD4L	23327	Cleft Palate	MESH:D002972	marker/mechanism		NA		27694961
NEDD4L	23327	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
NEDD4L	23327	Hypertension	MESH:D006973	marker/mechanism		NA		18524855|23348737
NEDD4L	23327	Periventricular Nodular Heterotopia	MESH:D054091	marker/mechanism		NA	617201	27694961
NEDD4L	23327	Syndactyly	MESH:D013576	marker/mechanism		NA		27694961
NEFH	4744	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA	105400	
NEFH	4744	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC	OMIM:616924	marker/mechanism		NA	616924	
NEFH	4744	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		10447555
NEFL	4747	Charcot-Marie-Tooth disease, Type 1F	MESH:C537987	marker/mechanism		NA	607734	
NEFL	4747	Charcot-Marie-Tooth disease, Type 2E	MESH:C537994	marker/mechanism		NA	607684	
NEFM	4741	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
NEGR1	257194	Obesity	MESH:D009765	marker/mechanism		NA		19079261
NEIL1	79661	Dyslipidemias	MESH:D050171	marker/mechanism		NA		16446448
NEIL1	79661	Fatty Liver	MESH:D005234	marker/mechanism		NA		16446448|21285402
NEIL1	79661	Glucose Intolerance	MESH:D018149	marker/mechanism		NA		21285402
NEIL1	79661	Hyperinsulinism	MESH:D006946	marker/mechanism		NA		16446448
NEIL1	79661	Hyperlipidemias	MESH:D006949	marker/mechanism		NA		21285402
NEIL1	79661	Insulin Resistance	MESH:D007333	marker/mechanism		NA		21285402
NEIL1	79661	Metabolic Syndrome	MESH:D024821	marker/mechanism		NA		16446448|17389588
NEIL1	79661	Obesity	MESH:D009765	marker/mechanism		NA		16446448|21285402
NEIL3	55247	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
NEK1	4750	Amyotrophic Lateral Sclerosis	MESH:D000690	marker/mechanism		NA		26945885|27455347
NEK1	4750	Short Rib-Polydactyly Syndrome	MESH:D012779	marker/mechanism		NA	263520	21211617|22482978|22499340
NEK2	4751	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
NEK2	4751	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		28509438
NEK2	4751	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		28509438
NEK2	4751	RETINITIS PIGMENTOSA 67	OMIM:615565	marker/mechanism		NA	615565	
NEK6	10783	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
NEK7	140609	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
NEK8	284086	Kidney Diseases	MESH:D007674	marker/mechanism		NA		18199800
NEK8	284086	NEPHRONOPHTHISIS 9	OMIM:613824	marker/mechanism		NA	613824	
NEK9	91754	ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY	OMIM:614262	marker/mechanism		NA	614262	
NEK9	91754	LETHAL CONGENITAL CONTRACTURE SYNDROME 10	OMIM:617022	marker/mechanism		NA	617022	
NEK9	91754	NEVUS COMEDONICUS	OMIM:617025	marker/mechanism		NA	617025	
NELL1	4745	Adenocarcinoma Of Esophagus	MESH:C562730	marker/mechanism		NA		17452981
NELL1	4745	Craniosynostoses	MESH:D003398	marker/mechanism		NA		14672347
NEMF	9147	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		28191889
NES	10763	Epilepsy, Tonic-Clonic	MESH:D004830	marker/mechanism		NA		16137769
NES	10763	Nephrosis	MESH:D009401	marker/mechanism		NA		16418842
NETO2	81831	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
NETO2	81831	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
NEU1	4758	Myoclonic Epilepsies, Progressive	MESH:D020191	marker/mechanism		NA		25401298
NEU1	4758	Neuraminidase 1 deficiency	MESH:C537366	marker/mechanism		NA	256550	
NEURL1	9148	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
NEURL1	9148	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17892325
NEUROD1	4760	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		16123366
NEUROD1	4760	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA	125853	16123366
NEUROD1	4760	MODY, Type 6	MESH:C565231	marker/mechanism		NA	606394	
NEUROD1	4760	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		23203475
NEUROG3	50674	Diarrhea 4, Malabsorptive, Congenital	MESH:C563673	marker/mechanism		NA	610370	
NEXMIF	340533	Epilepsy	MESH:D004827	marker/mechanism		NA		29942082
NEXMIF	340533	MENTAL RETARDATION, X-LINKED 98	OMIM:300912	marker/mechanism		NA	300912	
NEXMIF	340533	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		29942082
NEXN	91624	Cardiomyopathy, Dilated, 1CC	MESH:C567733	marker/mechanism		NA	613122	
NEXN	91624	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 20	OMIM:613876	marker/mechanism		NA	613876	
NF1	4763	Adenoma	MESH:D000236	marker/mechanism		NA		25119042
NF1	4763	Astrocytoma	MESH:D001254	marker/mechanism		NA		20176786|23817572
NF1	4763	Autistic Disorder	MESH:D001321	marker/mechanism		NA		15389774
NF1	4763	Fibrosarcoma	MESH:D005354	marker/mechanism		NA		20601955
NF1	4763	Glioblastoma	MESH:D005909	marker/mechanism		NA		25119042
NF1	4763	Glioma	MESH:D005910	marker/mechanism		NA		25119042
NF1	4763	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21236316
NF1	4763	Learning Disabilities	MESH:D007859	marker/mechanism		NA		21949590
NF1	4763	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		21441929|25822087
NF1	4763	Leukemia, Myelomonocytic, Juvenile	MESH:D054429	marker/mechanism		NA	607785	22315502|26457647|26457648
NF1	4763	Liposarcoma	MESH:D008080	marker/mechanism		NA		20601955
NF1	4763	Melanoma	MESH:D008545	marker/mechanism		NA		25119042|26214590
NF1	4763	Nerve Sheath Neoplasms	MESH:D018317	marker/mechanism		NA		20176786|25240281
NF1	4763	Neurilemmoma	MESH:D009442	marker/mechanism		NA		25119042
NF1	4763	Neurofibroma	MESH:D009455	marker/mechanism		NA		25119042
NF1	4763	Neurofibromatoses	MESH:D017253	marker/mechanism		NA		21949590
NF1	4763	Neurofibromatosis 1	MESH:D009456	marker/mechanism		NA	162200	21501659
NF1	4763	Neurofibromatosis, Familial Spinal	MESH:C563523	marker/mechanism		NA	162210	
NF1	4763	Neurofibromatosis-Noonan syndrome	MESH:C537393	marker/mechanism		NA	601321	
NF1	4763	Nevus, Pigmented	MESH:D009508	marker/mechanism		NA		25119042
NF1	4763	Pheochromocytoma	MESH:D010673	marker/mechanism		NA		11151443
NF1	4763	Retinal Neovascularization	MESH:D015861	marker/mechanism		NA		29847659
NF1	4763	Sarcoma	MESH:D012509	marker/mechanism		NA		20601955
NF1	4763	WATSON SYNDROME	OMIM:193520	marker/mechanism		NA	193520	
NF2	4771	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		25401301
NF2	4771	Meningioma	MESH:D008579	marker/mechanism		NA		23334667
NF2	4771	Meningioma, familial	MESH:C537443	marker/mechanism		NA	607174	
NF2	4771	Mesothelioma	MESH:D008654	marker/mechanism		NA		12136076|12168054|12802287|16166281|16319530|18835652
NF2	4771	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		23435014|26463840|26678224|26928227|29112861
NF2	4771	Neurofibromatosis 2	MESH:D016518	marker/mechanism		NA	101000	12136076
NF2	4771	Pleural Neoplasms	MESH:D010997	marker/mechanism		NA		23435014
NF2	4771	Schwannomatosis	MESH:C536641	marker/mechanism		NA	162091	
NFATC2	4773	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		30718926
NFATC2	4773	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		27522126
NFATC2	4773	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		21245421
NFE2L2	4780	Acidosis	MESH:D000138	marker/mechanism		NA		29618784
NFE2L2	4780	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		24958931
NFE2L2	4780	Acute Lung Injury	MESH:D055371	therapeutic		NA		24812154
NFE2L2	4780	Anemia, Sickle Cell	MESH:D000755	marker/mechanism		NA		29255069
NFE2L2	4780	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		32621833
NFE2L2	4780	Carcinogenesis	MESH:D063646	marker/mechanism		NA		29228771
NFE2L2	4780	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		22561517
NFE2L2	4780	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		22684020|26482881
NFE2L2	4780	Carcinoma, Pancreatic Ductal	MESH:D021441	marker/mechanism		NA		21489257
NFE2L2	4780	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		18572023
NFE2L2	4780	Cardiac Output, Low	MESH:D002303	marker/mechanism		NA		30096613
NFE2L2	4780	Chemical and Drug Induced Liver Injury	MESH:D056486	therapeutic		NA		22491424|22627062|24813929|26958860|30215777
NFE2L2	4780	Cholestasis	MESH:D002779	therapeutic		NA		20977460
NFE2L2	4780	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		30026087
NFE2L2	4780	Chromosome Breakage	MESH:D019457	therapeutic		NA		27774770
NFE2L2	4780	Clinical Deterioration	MESH:D000075902	marker/mechanism		NA		29255069
NFE2L2	4780	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		23564646
NFE2L2	4780	Diabetic Nephropathies	MESH:D003928	therapeutic		NA		20103708
NFE2L2	4780	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		29255069
NFE2L2	4780	Disease Progression	MESH:D018450	marker/mechanism		NA		32621833
NFE2L2	4780	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	therapeutic		NA		20605904
NFE2L2	4780	Emphysema	MESH:D004646	therapeutic		NA		20133372
NFE2L2	4780	Encephalomyelitis, Autoimmune, Experimental	MESH:D004681	marker/mechanism		NA		19910389
NFE2L2	4780	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		20530669
NFE2L2	4780	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		25151357
NFE2L2	4780	Fatty Liver	MESH:D005234	marker/mechanism		NA		28555106
NFE2L2	4780	Fetal Death	MESH:D005313	marker/mechanism		NA		29255069
NFE2L2	4780	Gastrointestinal Diseases	MESH:D005767	marker/mechanism		NA		20404090
NFE2L2	4780	Heart Failure	MESH:D006333	therapeutic		NA		28373008
NFE2L2	4780	Hepatic Insufficiency	MESH:D048550	marker/mechanism		NA		30026087
NFE2L2	4780	Hepatomegaly	MESH:D006529	marker/mechanism		NA		30026087
NFE2L2	4780	Hyperglycemia	MESH:D006943	marker/mechanism		NA		20086057
NFE2L2	4780	Hyperplasia	MESH:D006965	therapeutic		NA		19234301
NFE2L2	4780	Hypertension	MESH:D006973	marker/mechanism		NA		32165127
NFE2L2	4780	Keratosis	MESH:D007642	marker/mechanism		NA		20404090
NFE2L2	4780	Kidney Diseases	MESH:D007674	therapeutic		NA		20605904
NFE2L2	4780	Liver Cirrhosis	MESH:D008103	therapeutic		NA		23793039
NFE2L2	4780	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		30026087
NFE2L2	4780	Liver Cirrhosis, Experimental	MESH:D008106	therapeutic		NA		23341968
NFE2L2	4780	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		20722399
NFE2L2	4780	Micronuclei, Chromosome-Defective	MESH:D048629	therapeutic		NA		27774770
NFE2L2	4780	Necrosis	MESH:D009336	therapeutic		NA		24813929
NFE2L2	4780	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		32682831
NFE2L2	4780	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		32682831
NFE2L2	4780	Neurotoxicity Syndromes	MESH:D020258	therapeutic		NA		20211941
NFE2L2	4780	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		25294219
NFE2L2	4780	Primary Ovarian Insufficiency	MESH:D016649	marker/mechanism		NA		26247513
NFE2L2	4780	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		20124447|23441843
NFE2L2	4780	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		23570914
NFE2L2	4780	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		18572023
NFE2L2	4780	Splenomegaly	MESH:D013163	marker/mechanism		NA		29255069
NFE2L2	4780	Vascular System Injuries	MESH:D057772	therapeutic		NA		19234301
NFE2L2	4780	Ventricular Dysfunction, Left	MESH:D018487	therapeutic		NA		29353218
NFE2L2	4780	Ventricular Remodeling	MESH:D020257	therapeutic		NA		29353218
NFE2L2	4780	Vitiligo	MESH:D014820	marker/mechanism		NA		28836394
NFIA	4774	BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS	OMIM:613735	marker/mechanism		NA	613735	
NFIB	4781	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
NFIC	4782	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
NFIL3	4783	Sleep Disorders, Circadian Rhythm	MESH:D020178	marker/mechanism		NA		25395965
NFIX	4784	Marshall-Smith syndrome	MESH:C536026	marker/mechanism		NA	602535	
NFKB1	4790	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		29286200
NFKB1	4790	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		19028472
NFKB1	4790	Brain Ischemia	MESH:D002545	therapeutic		NA		18628779
NFKB1	4790	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism|therapeutic		NA		20516118|28823542
NFKB1	4790	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		19028472|20715105
NFKB1	4790	Common Variable Immunodeficiency	MESH:D017074	marker/mechanism		NA	616576	
NFKB1	4790	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		17107852
NFKB1	4790	Heat Stroke	MESH:D018883	marker/mechanism		NA		24039931
NFKB1	4790	Hyperoxaluria	MESH:D006959	marker/mechanism		NA		16284884
NFKB1	4790	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19420110
NFKB1	4790	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		21399635
NFKB1	4790	Liver Diseases	MESH:D008107	therapeutic		NA		15743782
NFKB1	4790	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
NFKB2	4791	Common Variable Immunodeficiency	MESH:D017074	marker/mechanism		NA	615577	
NFKB2	4791	Heat Stroke	MESH:D018883	marker/mechanism		NA		24039931
NFKB2	4791	Lymphoma, T-Cell, Cutaneous	MESH:D016410	marker/mechanism		NA		26192916
NFKBIA	4792	Arteriosclerosis	MESH:D001161	marker/mechanism		NA		28569748
NFKBIA	4792	Brain Ischemia	MESH:D002545	marker/mechanism		NA		18628779
NFKBIA	4792	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037
NFKBIA	4792	Carcinoma, Hepatocellular	MESH:D006528	therapeutic		NA		22022477
NFKBIA	4792	Ectodermal Dysplasia, Anhidrotic, With T-Cell Immunodeficiency, Autosomal Dominant	MESH:C567411	marker/mechanism		NA	612132	
NFKBIA	4792	Hodgkin Disease	MESH:D006689	marker/mechanism		NA		19223558
NFKBIA	4792	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		26806094
NFKBIA	4792	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
NFKBIA	4792	Pancreatic Neoplasms	MESH:D010190	therapeutic		NA		15861417
NFKBIA	4792	Psoriasis	MESH:D011565	marker/mechanism		NA		20953190
NFKBIA	4792	Vasculitis	MESH:D014657	marker/mechanism		NA		28569748
NFKBIE	4794	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		22446963
NFKBIE	4794	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
NFKBIE	4794	Melanoma	MESH:D008545	marker/mechanism		NA		26343386
NFKBIL1	4795	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA	180300	
NFKBIZ	64332	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
NFU1	27247	Multiple Mitochondrial Dysfunctions Syndrome	MESH:C565304	marker/mechanism		NA	605711	
NFXL1	152518	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		26881866
NFXL1	152518	Cholestasis	MESH:D002779	marker/mechanism		NA		26881866
NFYA	4800	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		16271038
NGB	58157	Heredodegenerative Disorders, Nervous System	MESH:D020271	marker/mechanism		NA		16825958
NGF	4803	Amnesia	MESH:D000647	therapeutic		NA		16405025|19694610
NGF	4803	Bronchial Hyperreactivity	MESH:D016535	marker/mechanism		NA		22871964
NGF	4803	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		17715210
NGF	4803	Corneal Ulcer	MESH:D003320	therapeutic		NA		24244623
NGF	4803	Cystitis	MESH:D003556	marker/mechanism		NA		16889433
NGF	4803	Epilepsy, Tonic-Clonic	MESH:D004830	marker/mechanism		NA		16023256
NGF	4803	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		24244623
NGF	4803	Hereditary Sensory and Autonomic Neuropathies	MESH:D009477	marker/mechanism		NA	608654	
NGF	4803	Heroin Dependence	MESH:D006556	marker/mechanism		NA		17715210
NGF	4803	Hyperalgesia	MESH:D006930	marker/mechanism		NA		20457222
NGF	4803	Hyperkinesis	MESH:D006948	marker/mechanism		NA		1661212
NGF	4803	Infarction, Middle Cerebral Artery	MESH:D020244	therapeutic		NA		10408807
NGF	4803	Inflammation	MESH:D007249	marker/mechanism		NA		10653021
NGF	4803	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		24244623
NGF	4803	Lewy Body Disease	MESH:D020961	marker/mechanism		NA		19276553
NGF	4803	Lung Injury	MESH:D055370	therapeutic		NA		20075049
NGF	4803	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25162674
NGF	4803	Nephritis, Interstitial	MESH:D009395	marker/mechanism		NA		16889433
NGF	4803	Nerve Degeneration	MESH:D009410	therapeutic		NA		22666365
NGF	4803	Nervous System Diseases	MESH:D009422	therapeutic		NA		15093677
NGF	4803	Neurobehavioral Manifestations	MESH:D019954	therapeutic		NA		22666365
NGF	4803	Neurodegenerative Diseases	MESH:D019636	therapeutic		NA		24244623
NGF	4803	Neurogenic Inflammation	MESH:D020078	marker/mechanism		NA		21570423
NGF	4803	Parkinson Disease	MESH:D010300	marker/mechanism		NA		19276553
NGF	4803	Parkinsonian Disorders	MESH:D020734	therapeutic		NA		19694610
NGF	4803	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		15319252
NGF	4803	Renal Insufficiency, Chronic	MESH:D051436	marker/mechanism		NA		24244623
NGF	4803	Seizures	MESH:D012640	marker/mechanism		NA		18815271
NGF	4803	Skin Ulcer	MESH:D012883	therapeutic		NA		24244623
NGF	4803	Status Epilepticus	MESH:D013226	marker/mechanism		NA		8635431|8821376
NGF	4803	Urinary Bladder, Overactive	MESH:D053201	marker/mechanism		NA		16600756
NGFR	4804	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		10436046
NGFR	4804	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		12097334
NGFR	4804	Prostatic Neoplasms	MESH:D011471	marker/mechanism|therapeutic		NA		17409433|18056468
NGFR	4804	Seizures	MESH:D012640	marker/mechanism		NA		10436046
NGLY1	55768	CONGENITAL DISORDER OF DEGLYCOSYLATION	OMIM:615273	marker/mechanism		NA	615273	
NHEJ1	79840	Severe Combined Immunodeficiency with Microcephaly, Growth Retardation, and Sensitivity to Ionizing Radiation	MESH:C566970	marker/mechanism		NA	611291	
NHLH2	4808	Obesity	MESH:D009765	marker/mechanism		NA		20808804
NHLRC1	378884	Lafora Disease	MESH:D020192	marker/mechanism		NA	254780	
NHLRC1	378884	Myoclonic Epilepsies, Progressive	MESH:D020191	marker/mechanism		NA		25401298
NHP2	55651	Dyskeratosis Congenita, Autosomal Recessive	MESH:C565611	marker/mechanism		NA	224230	
NHP2	55651	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 2	OMIM:613987	marker/mechanism		NA	613987	
NHS	4810	Cataract, congenital, with microcornea or slight microphthalmia	MESH:C535338	marker/mechanism		NA	302200	
NHS	4810	Nance-Horan syndrome	MESH:C538336	marker/mechanism		NA	302350	
NIBAN1	116496	Cholestasis	MESH:D002779	marker/mechanism		NA		27989131
NID1	4811	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
NID1	4811	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
NID2	22795	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
NINJ1	4814	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17374397
NIPA1	123606	Spastic paraplegia 6, autosomal dominant	MESH:C536866	marker/mechanism		NA	600363	
NIPAL2	79815	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
NIPAL3	57185	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17173048
NIPAL4	348938	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 6	OMIM:612281	marker/mechanism		NA	612281	
NIPBL	25836	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		19763162
NIPBL	25836	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		19763162
NIPBL	25836	De Lange Syndrome	MESH:D003635	marker/mechanism		NA	122470	19763162|19886366|29379197
NIPBL	25836	Hearing Disorders	MESH:D006311	marker/mechanism		NA		19763162
NIPBL	25836	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		19763162
NISCH	11188	Bradycardia	MESH:D001919	marker/mechanism		NA		11486246
NISCH	11188	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29912916
NISCH	11188	Hypotension	MESH:D007022	marker/mechanism		NA		11486246|22613216
NKAPL	222698	Schizophrenia	MESH:D012559	marker/mechanism		NA		22037552
NKILA	105416157	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		29481769
NKX2-1	7080	Chorea	MESH:D002819	marker/mechanism		NA	118700	
NKX2-1	7080	Choreoathetosis, Hypothyroidism, And Neonatal Respiratory Distress	MESH:C567034	marker/mechanism		NA	610978	
NKX2-1	7080	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		10830305|16863852
NKX2-1	7080	Lung Diseases	MESH:D008171	marker/mechanism		NA		16863852
NKX2-1	7080	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA	188550	
NKX2-3	159296	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		18438405|18438406|20228799
NKX2-3	159296	Crohn Disease	MESH:D003424	marker/mechanism		NA		17554261|18438405|18438406
NKX2-5	1482	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		20062060|29892015|30061737
NKX2-5	1482	ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS	OMIM:108900	marker/mechanism		NA	108900	
NKX2-5	1482	Cardiomegaly	MESH:D006332	marker/mechanism		NA		28973413
NKX2-5	1482	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		28973413
NKX2-5	1482	CONOTRUNCAL HEART MALFORMATIONS	OMIM:217095	marker/mechanism		NA	217095	
NKX2-5	1482	Heart Septal Defects, Ventricular	MESH:D006345	marker/mechanism		NA	614432	
NKX2-5	1482	Hypoplastic Left Heart Syndrome	MESH:D018636	marker/mechanism		NA	614435	
NKX2-5	1482	Hypothyroidism, Congenital, Nongoitrous, 5	MESH:C567123	marker/mechanism		NA	225250	
NKX2-5	1482	Myotonic Dystrophy	MESH:D009223	marker/mechanism		NA		18084293
NKX2-5	1482	Stroke	MESH:D020521	marker/mechanism		NA		29531354
NKX2-5	1482	Tetralogy of Fallot	MESH:D013771	marker/mechanism		NA	187500	
NKX2-6	137814	CONOTRUNCAL HEART MALFORMATIONS	OMIM:217095	marker/mechanism		NA	217095	
NKX3-1	4824	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16817226|17173048|17202838|22610119|32690948
NKX3-2	579	Spondylo-Megaepiphyseal-Metaphyseal Dysplasia	MESH:C567639	marker/mechanism		NA	613330	
NKX6-1	4825	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		16123366
NKX6-1	4825	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		16123366
NLG-1	181484	Sensation Disorders	MESH:D012678	marker/mechanism		NA		20083577
NLGN1	22871	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19404257
NLGN3	54413	ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1	OMIM:300494	marker/mechanism		NA	300494	
NLGN3	54413	Autistic Disorder	MESH:D001321	marker/mechanism		NA	300425	12669065|18621663
NLGN4X	57502	ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2	OMIM:300497	marker/mechanism		NA	300497	
NLGN4X	57502	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		18252227
NLGN4X	57502	Autistic Disorder	MESH:D001321	marker/mechanism		NA	300495	12669065
NLRC3	197358	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		30081150
NLRC4	58484	AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS	OMIM:616050	marker/mechanism		NA	616050	
NLRC4	58484	Cryopyrin-Associated Periodic Syndromes	MESH:D056587	marker/mechanism		NA	616115	
NLRC4	58484	Enterocolitis	MESH:D004760	marker/mechanism		NA		25217960
NLRC4	58484	Hereditary Autoinflammatory Diseases	MESH:D056660	marker/mechanism		NA		25217959|25217960
NLRC4	58484	Macrophage Activation Syndrome	MESH:D055501	marker/mechanism		NA		25217959
NLRC5	84166	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		26806094
NLRP1	22861	AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS	OMIM:617388	marker/mechanism		NA	617388	
NLRP1	22861	PALMOPLANTAR CARCINOMA, MULTIPLE SELF-HEALING	OMIM:615225	marker/mechanism		NA	615225	
NLRP1	22861	VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1	OMIM:606579	marker/mechanism		NA	606579	
NLRP12	91662	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		23797736
NLRP12	91662	Familial Cold Autoinflammatory Syndrome 2	MESH:C567090	marker/mechanism		NA	611762	
NLRP3	114548	Acne Vulgaris	MESH:D000152	marker/mechanism		NA		27106250
NLRP3	114548	Anaphylaxis	MESH:D000707	marker/mechanism		NA		19767079
NLRP3	114548	Asbestosis	MESH:D001195	marker/mechanism		NA		24142982
NLRP3	114548	Ataxia	MESH:D001259	marker/mechanism		NA		32014472
NLRP3	114548	Crohn Disease	MESH:D003424	marker/mechanism		NA		19098911
NLRP3	114548	Cryopyrin-Associated Periodic Syndromes	MESH:D056587	marker/mechanism		NA	120100|607115	11687797|12032915|12928894|25217959
NLRP3	114548	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		19767079
NLRP3	114548	Food Hypersensitivity	MESH:D005512	marker/mechanism		NA		19767079
NLRP3	114548	Hidradenitis Suppurativa	MESH:D017497	marker/mechanism		NA		27106250
NLRP3	114548	Inflammation	MESH:D007249	marker/mechanism		NA		12032915|22325453
NLRP3	114548	MUCKLE-WELLS SYNDROME	OMIM:191900	marker/mechanism		NA	191900	11687797
NLRP3	114548	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		25458313
NLRP3	114548	Neurotoxicity Syndromes	MESH:D020258	marker/mechanism		NA		32014472
NLRP3	114548	Pyoderma Gangrenosum	MESH:D017511	marker/mechanism		NA		27106250
NLRP7	199713	Hydatidiform Mole	MESH:D006828	marker/mechanism		NA	231090	
NMB	4828	Pruritus	MESH:D011537	marker/mechanism		NA		29669290
NMBR	4829	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		24349381
NME1	4830	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
NME1	4830	Cardiomyopathy, Hypertrophic	MESH:D002312	marker/mechanism		NA		9527842
NME1	4830	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		15814641
NME1	4830	Hypoxia	MESH:D000860	marker/mechanism		NA		19579223
NME1	4830	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		15048980
NME1	4830	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		15928304
NME2	4831	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
NME2	4831	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		15814641
NME2	4831	Mesothelioma	MESH:D008654	marker/mechanism		NA		15920167
NME2	4831	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
NME2	4831	Ovarian Neoplasms	MESH:D010051	therapeutic		NA		15674352
NME7	29922	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
NME7	29922	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
NME8	51314	Ciliary Dyskinesia, Primary, 6	MESH:C567057	marker/mechanism		NA	610852	
NMI	9111	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
NMNAT1	64802	Amaurosis congenita of Leber, type 9	MESH:C536603	marker/mechanism		NA	608553	
NMNAT1	64802	Brain Injuries, Traumatic	MESH:D000070642	therapeutic		NA		27822499
NMNAT1	64802	Hereditary macular coloboma	MESH:C535968	marker/mechanism		NA		22842230
NMNAT1	64802	Leber Congenital Amaurosis	MESH:D057130	marker/mechanism		NA		22842227|22842229|22842230|22842231
NMNAT1	64802	Macular Degeneration	MESH:D008268	marker/mechanism		NA		22842229
NMNAT1	64802	Neurobehavioral Manifestations	MESH:D019954	therapeutic		NA		27822499
NMNAT1	64802	Optic Atrophy	MESH:D009896	marker/mechanism		NA		22842229
NMNAT1	64802	Retinal Degeneration	MESH:D012162	marker/mechanism		NA		22842230
NMNAT1	64802	Wallerian Degeneration	MESH:D014855	therapeutic		NA		27822499
NMNAT3	349565	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
NMT2	9397	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
NNAT	4826	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		17043644
NNAT	4826	Neuroblastoma	MESH:D009447	marker/mechanism		NA		17762496
NNMT	4837	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
NNT	23530	Familial Glucocorticoid Deficiency 1	MESH:C565974	marker/mechanism		NA		22634753
NNT	23530	GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY	OMIM:614736	marker/mechanism		NA	614736	
NOBOX	135935	Premature Ovarian Failure 5	MESH:C566921	marker/mechanism		NA	611548	
NOCT	25819	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
NOD1	10392	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		11158245
NOD2	64127	Acne Vulgaris	MESH:D000152	marker/mechanism		NA		27106250
NOD2	64127	Blau syndrome	MESH:C538157	marker/mechanism		NA	186580	11528384|15086578|15459013|19467619
NOD2	64127	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		20452301
NOD2	64127	Crohn Disease	MESH:D003424	marker/mechanism		NA		11385576|11385577|11528384|17435756|17568627|18371140|18438406|19467619
NOD2	64127	Dermatitis	MESH:D003872	marker/mechanism		NA		19467619
NOD2	64127	Hidradenitis Suppurativa	MESH:D017497	marker/mechanism		NA		27106250
NOD2	64127	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA	266600	21983784|26192919|28450277
NOD2	64127	Pyoderma Gangrenosum	MESH:D017511	marker/mechanism		NA		27106250
NOD2	64127	Sarcoidosis, Early-Onset	MESH:C563714	marker/mechanism		NA		15459013|19467619
NOD2	64127	YAO SYNDROME	OMIM:617321	marker/mechanism		NA	617321	
NODAL	4838	HETEROTAXY, VISCERAL, 5, AUTOSOMAL	OMIM:270100	marker/mechanism		NA	270100	
NODAL	4838	Holoprosencephaly	MESH:D016142	marker/mechanism		NA		23264560
NOG	9241	BRACHYDACTYLY, TYPE B2	OMIM:611377	marker/mechanism		NA	611377	
NOG	9241	Cushing's symphalangism	MESH:C536223	marker/mechanism		NA	185800	
NOG	9241	MULTIPLE SYNOSTOSES SYNDROME 1	OMIM:186500	marker/mechanism		NA	186500	
NOG	9241	NOG-Related-Symphalangism Spectrum Disorder	MESH:C536943	marker/mechanism		NA	184460|186570	
NOL3	8996	Mitochondrial Diseases	MESH:D028361	therapeutic		NA		19139834
NOL3	8996	MYOCLONUS, FAMILIAL, 1	OMIM:614937	marker/mechanism		NA	614937	
NOL8	55035	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		30125550
NOM1	64434	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		22474449
NONO	4841	Glucose Intolerance	MESH:D018149	marker/mechanism		NA		29358041
NONO	4841	MENTAL RETARDATION, X-LINKED, SYNDROMIC 34	OMIM:300967	marker/mechanism		NA	300967	
NONO	4841	Wilms Tumor	MESH:D009396	marker/mechanism		NA		28825729
NOP10	55505	Dyskeratosis Congenita, Autosomal Recessive	MESH:C565611	marker/mechanism		NA	224230	
NOP16	51491	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
NOP16	51491	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		19233941
NOP53	29997	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
NOP56	10528	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
NOP56	10528	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
NOP56	10528	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
NOP56	10528	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA	614153	
NOP56	10528	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
NOP58	51602	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
NOP58	51602	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
NOP9	161424	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18507500
NORAD	647979	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		26942882
NOS1	4842	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		15542708
NOS1	4842	Cerebellar Diseases	MESH:D002526	marker/mechanism		NA		25511929
NOS1	4842	Depressive Disorder	MESH:D003866	marker/mechanism		NA		17854383
NOS1	4842	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		21666113
NOS1	4842	End Stage Liver Disease	MESH:D058625	marker/mechanism		NA		15025246
NOS1	4842	Fetal Alcohol Spectrum Disorders	MESH:D063647	marker/mechanism		NA		25511929
NOS1	4842	Fever	MESH:D005334	marker/mechanism		NA		9495865
NOS1	4842	Hepatic Encephalopathy	MESH:D006501	marker/mechanism		NA		10206825|10564534
NOS1	4842	Hyperalgesia	MESH:D006930	marker/mechanism		NA		19300402
NOS1	4842	Hypoxia	MESH:D000860	marker/mechanism		NA		10956627
NOS1	4842	Intestinal Perforation	MESH:D007416	marker/mechanism		NA		18030227
NOS1	4842	Mental Disorders	MESH:D001523	marker/mechanism		NA		17426488
NOS1	4842	Morphine Dependence	MESH:D009021	marker/mechanism		NA		17989510
NOS1	4842	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		10791088|9436549
NOS1	4842	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		9495865
NOS1	4842	Neurobehavioral Manifestations	MESH:D019954	marker/mechanism		NA		25511929
NOS1	4842	Parkinson Disease	MESH:D010300	marker/mechanism		NA		26383258
NOS1	4842	Radiation Injuries, Experimental	MESH:D011833	marker/mechanism		NA		20726721
NOS1	4842	Schizophrenia	MESH:D012559	marker/mechanism		NA		18923069
NOS1	4842	Seizures	MESH:D012640	marker/mechanism		NA		8749039
NOS1	4842	Status Epilepticus	MESH:D013226	marker/mechanism		NA		20149694
NOS1	4842	Trauma, Nervous System	MESH:D020196	marker/mechanism		NA		10531423
NOS1	4842	Urination Disorders	MESH:D014555	marker/mechanism		NA		9142130
NOS1	4842	Ventricular Remodeling	MESH:D020257	marker/mechanism		NA		16344403
NOS2	4843	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		9810145
NOS2	4843	Arthritis, Psoriatic	MESH:D015535	marker/mechanism		NA		20953189
NOS2	4843	Asbestosis	MESH:D001195	marker/mechanism		NA		12160931
NOS2	4843	Asthma	MESH:D001249	marker/mechanism		NA		19800904
NOS2	4843	Atherosclerosis	MESH:D050197	marker/mechanism		NA		20720404
NOS2	4843	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18563708
NOS2	4843	Brain Edema	MESH:D001929	marker/mechanism		NA		19374494
NOS2	4843	Brain Injuries, Traumatic	MESH:D000070642	marker/mechanism		NA		28642177
NOS2	4843	Brain Ischemia	MESH:D002545	marker/mechanism		NA		17394460|9778187
NOS2	4843	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		15631943
NOS2	4843	Bronchial Diseases	MESH:D001982	marker/mechanism		NA		15774269
NOS2	4843	Burns	MESH:D002056	marker/mechanism		NA		15650120
NOS2	4843	Cardiovascular Abnormalities	MESH:D018376	marker/mechanism		NA		19587355
NOS2	4843	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		14700523
NOS2	4843	Cholangiocarcinoma	MESH:D018281	marker/mechanism		NA		16818635
NOS2	4843	Cholangitis, Sclerosing	MESH:D015209	marker/mechanism		NA		12612912
NOS2	4843	Cholestasis	MESH:D002779	marker/mechanism		NA		12612912|20626112
NOS2	4843	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		30026087
NOS2	4843	Colitis	MESH:D003092	marker/mechanism		NA		17449036|8698225
NOS2	4843	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		16105666|21081470
NOS2	4843	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		16380483|16959961
NOS2	4843	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		16959961
NOS2	4843	Duodenal Ulcer	MESH:D004381	marker/mechanism		NA		12481160|17045617
NOS2	4843	Emphysema	MESH:D004646	marker/mechanism		NA		24465666
NOS2	4843	Endotoxemia	MESH:D019446	marker/mechanism		NA		12620498
NOS2	4843	Enterocolitis, Necrotizing	MESH:D020345	marker/mechanism		NA		17923197
NOS2	4843	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		15264214
NOS2	4843	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA		16191423
NOS2	4843	Heart Failure	MESH:D006333	marker/mechanism		NA		19168511
NOS2	4843	Hepatic Insufficiency	MESH:D048550	marker/mechanism		NA		30026087
NOS2	4843	Hepatomegaly	MESH:D006529	marker/mechanism		NA		30026087
NOS2	4843	Hyperalgesia	MESH:D006930	marker/mechanism		NA		17989504|19300402
NOS2	4843	Hyperemia	MESH:D006940	marker/mechanism		NA		12646421
NOS2	4843	Hypertension	MESH:D006973	marker/mechanism		NA		18605955|25101153|27292124
NOS2	4843	Hypothermia	MESH:D007035	therapeutic		NA		24675228
NOS2	4843	Hypoxia-Ischemia, Brain	MESH:D020925	marker/mechanism		NA		23694759
NOS2	4843	Inflammation	MESH:D007249	marker/mechanism		NA		11289658|24465666
NOS2	4843	Intestinal Diseases	MESH:D007410	marker/mechanism		NA		11713966
NOS2	4843	Kidney Diseases	MESH:D007674	marker/mechanism		NA		18441258
NOS2	4843	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		30026087
NOS2	4843	Liver Cirrhosis, Experimental	MESH:D008106	therapeutic		NA		18380797
NOS2	4843	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
NOS2	4843	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		12460898|22369883
NOS2	4843	Malaria	MESH:D008288	marker/mechanism		NA	611162	
NOS2	4843	Manganese Poisoning	MESH:D020149	marker/mechanism		NA		15010209|22174044
NOS2	4843	Marfan Syndrome	MESH:D008382	marker/mechanism		NA		25101153
NOS2	4843	Mitochondrial Diseases	MESH:D028361	therapeutic		NA		16157314
NOS2	4843	Mycoplasma Infections	MESH:D009175	marker/mechanism		NA		20179380
NOS2	4843	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		10090345|11489778
NOS2	4843	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism|therapeutic		NA		12003803|12087064|14990356|19207477|20828608
NOS2	4843	Myocardial Stunning	MESH:D017682	marker/mechanism		NA		11927517
NOS2	4843	Necrosis	MESH:D009336	marker/mechanism		NA		10620138|10909967
NOS2	4843	Parkinson Disease, Secondary	MESH:D010302	marker/mechanism		NA		25634431
NOS2	4843	Pneumonia, Aspiration	MESH:D011015	marker/mechanism		NA		15607125
NOS2	4843	Psoriasis	MESH:D011565	marker/mechanism		NA		20953189
NOS2	4843	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		21843929
NOS2	4843	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		10383581|19673871|23061969|23075401
NOS2	4843	Retinal Diseases	MESH:D012164	marker/mechanism		NA		23075401
NOS2	4843	Schistosomiasis mansoni	MESH:D012555	therapeutic		NA		9673227
NOS2	4843	Seizures	MESH:D012640	marker/mechanism		NA		19559095
NOS2	4843	Sepsis	MESH:D018805	marker/mechanism		NA		17138957|20035746
NOS2	4843	Shock, Septic	MESH:D012772	marker/mechanism		NA		8745224
NOS2	4843	Silicosis	MESH:D012829	marker/mechanism		NA		15292275
NOS2	4843	Status Epilepticus	MESH:D013226	marker/mechanism		NA		20149694
NOS2	4843	Stevens-Johnson Syndrome	MESH:D013262	marker/mechanism		NA		10620138
NOS2	4843	Stomach Ulcer	MESH:D013276	marker/mechanism		NA		12481160|15138204|19066340
NOS2	4843	Stroke	MESH:D020521	marker/mechanism		NA		20083630
NOS2	4843	Subarachnoid Hemorrhage	MESH:D013345	marker/mechanism		NA		17053178
NOS2	4843	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		19751225
NOS2	4843	Takayasu Arteritis	MESH:D013625	marker/mechanism		NA		25101153
NOS2	4843	Turner Syndrome	MESH:D014424	marker/mechanism		NA		25101153
NOS2	4843	Ureteral Obstruction	MESH:D014517	marker/mechanism		NA		26207612
NOS2	4843	Urinary Tract Infections	MESH:D014552	marker/mechanism		NA		9011564
NOS3	4846	Abruptio Placentae	MESH:D000037	marker/mechanism		NA		11354626
NOS3	4846	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		9788586
NOS3	4846	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		21472143
NOS3	4846	Alzheimer Disease	MESH:D000544	marker/mechanism		NA	104300	10514107|16813604
NOS3	4846	Arteriosclerosis	MESH:D001161	therapeutic		NA		14736551
NOS3	4846	Atherosclerosis	MESH:D050197	marker/mechanism|therapeutic		NA		12677255|20720404
NOS3	4846	Atrial Fibrillation	MESH:D001281	therapeutic		NA		11761419
NOS3	4846	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		15375496|19671875
NOS3	4846	Cardiomegaly	MESH:D006332	marker/mechanism|therapeutic		NA		11504159|12224825|16844920|17487232
NOS3	4846	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		12947532|20610621
NOS3	4846	Cerebral Infarction	MESH:D002544	marker/mechanism		NA	601367	
NOS3	4846	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		30026087
NOS3	4846	Cleft Lip	MESH:D002971	marker/mechanism		NA		21254359
NOS3	4846	Cleft Palate	MESH:D002972	marker/mechanism		NA		21254359
NOS3	4846	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		10510054|14989558|17267746|19696404
NOS3	4846	Coronary Vasospasm	MESH:D003329	marker/mechanism		NA		10359729|9737779
NOS3	4846	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		11696579|14871415|15490108|16959961|18266981|19478208|22191573|22933112
NOS3	4846	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		21666113
NOS3	4846	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		12716763|16959961
NOS3	4846	Diabetic Angiopathies	MESH:D003925	marker/mechanism		NA		12124201
NOS3	4846	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		20042665
NOS3	4846	Enterocolitis, Necrotizing	MESH:D020345	marker/mechanism		NA		23650378
NOS3	4846	Erectile Dysfunction	MESH:D007172	marker/mechanism|therapeutic		NA		12002441|17071732
NOS3	4846	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		21472143
NOS3	4846	Essential Hypertension	MESH:D000075222	marker/mechanism		NA	145500	
NOS3	4846	Fetal Growth Retardation	MESH:D005317	marker/mechanism		NA		22421449|23667712
NOS3	4846	Heart Failure	MESH:D006333	marker/mechanism		NA		19168511|20304815
NOS3	4846	Hepatic Insufficiency	MESH:D048550	marker/mechanism		NA		30026087
NOS3	4846	Hepatomegaly	MESH:D006529	marker/mechanism		NA		30026087
NOS3	4846	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		7576705|8863223
NOS3	4846	Hyperglycemia	MESH:D006943	marker/mechanism		NA		11696579
NOS3	4846	Hyperinsulinism	MESH:D006946	therapeutic		NA		19008412
NOS3	4846	Hyperlipidemias	MESH:D006949	marker/mechanism		NA		11457755
NOS3	4846	Hypertension	MESH:D006973	marker/mechanism|therapeutic		NA		11457755|12947532|16331104|19008412|19407804
NOS3	4846	Hypertension, Portal	MESH:D006975	therapeutic		NA		18070013
NOS3	4846	Hypertension, Pregnancy-Induced	MESH:D046110	marker/mechanism		NA		11745998
NOS3	4846	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		21144100
NOS3	4846	Hypertension, Renovascular	MESH:D006978	therapeutic		NA		18641695
NOS3	4846	Hypoxia	MESH:D000860	marker/mechanism		NA		10956627
NOS3	4846	Infertility, Male	MESH:D007248	marker/mechanism		NA		25517965
NOS3	4846	Insulin Resistance	MESH:D007333	marker/mechanism|therapeutic		NA		11457755|12716763|12947532|19008412
NOS3	4846	Intestinal Perforation	MESH:D007416	marker/mechanism		NA		18030227
NOS3	4846	Ischemia	MESH:D007511	therapeutic		NA		15036356
NOS3	4846	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		30026087
NOS3	4846	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		18555214
NOS3	4846	Metabolic Syndrome	MESH:D024821	marker/mechanism		NA		12947532|15269839|20876122
NOS3	4846	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		10510054|16337503
NOS3	4846	Myocardial Ischemia	MESH:D017202	therapeutic		NA		12354446
NOS3	4846	Myocardial Reperfusion Injury	MESH:D015428	therapeutic		NA		12354446
NOS3	4846	Neoplasms	MESH:D009369	marker/mechanism		NA		18344980
NOS3	4846	Oligospermia	MESH:D009845	marker/mechanism		NA		29983398
NOS3	4846	Pre-Eclampsia	MESH:D011225	marker/mechanism		NA	189800	
NOS3	4846	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		12429631|12445681|16458450
NOS3	4846	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		21843929
NOS3	4846	Pulmonary Edema	MESH:D011654	therapeutic		NA		16844920
NOS3	4846	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		21968084
NOS3	4846	Sepsis	MESH:D018805	marker/mechanism		NA		20035746
NOS3	4846	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
NOS3	4846	Stomach Ulcer	MESH:D013276	marker/mechanism		NA		19066340
NOS3	4846	Tachycardia, Ventricular	MESH:D017180	therapeutic		NA		11761419
NOS3	4846	Teratozoospermia	MESH:D000072660	marker/mechanism		NA		29983398
NOS3	4846	Uremia	MESH:D014511	marker/mechanism		NA		19092814
NOS3	4846	Ureteral Obstruction	MESH:D014517	marker/mechanism		NA		26207612
NOS3	4846	Ventricular Premature Complexes	MESH:D018879	therapeutic		NA		11761419
NOS3	4846	Vestibular Diseases	MESH:D015837	marker/mechanism		NA		18776599
NOTCH1	4851	Adams Oliver syndrome	MESH:C538225	marker/mechanism		NA	616028	
NOTCH1	4851	Aortic Valve, Calcification of	MESH:C562942	marker/mechanism		NA		16025100
NOTCH1	4851	AORTIC VALVE DISEASE 1	OMIM:109730	marker/mechanism		NA	109730	
NOTCH1	4851	Astrocytoma	MESH:D001254	marker/mechanism		NA		21127729
NOTCH1	4851	Bicuspid Aortic Valve	MESH:C562388	marker/mechanism		NA		30455415
NOTCH1	4851	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21036696|21679465
NOTCH1	4851	Calcinosis	MESH:D002114	marker/mechanism		NA		22110751
NOTCH1	4851	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
NOTCH1	4851	Carcinoma, Pancreatic Ductal	MESH:D021441	marker/mechanism		NA		19208345
NOTCH1	4851	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		27923803
NOTCH1	4851	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22011395
NOTCH1	4851	Chemical and Drug Induced Liver Injury	MESH:D056486	therapeutic		NA		30394310
NOTCH1	4851	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		19147571
NOTCH1	4851	Congenital Abnormalities	MESH:D000013	marker/mechanism		NA		17849441
NOTCH1	4851	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		17849441
NOTCH1	4851	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		25151357
NOTCH1	4851	Glioblastoma	MESH:D005909	marker/mechanism		NA		21127729
NOTCH1	4851	Heart Valve Diseases	MESH:D006349	marker/mechanism		NA		22110751
NOTCH1	4851	Leukemia, T-Cell	MESH:D015458	marker/mechanism		NA		25585350
NOTCH1	4851	Lymphoma	MESH:D008223	marker/mechanism		NA		18798262
NOTCH1	4851	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		23203475
NOTCH1	4851	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054218	marker/mechanism		NA		19246562|19318552|21498710|24394663|28671688
NOTCH1	4851	Scoliosis	MESH:D012600	marker/mechanism		NA		17849441
NOTCH1	4851	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		27923803
NOTCH1	4851	Splenomegaly	MESH:D013163	marker/mechanism		NA		25585350
NOTCH1	4851	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		25061499
NOTCH2	4853	Alagille Syndrome	MESH:D016738	marker/mechanism		NA	610205	
NOTCH2	4853	Astrocytoma	MESH:D001254	marker/mechanism		NA		21127729
NOTCH2	4853	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21036696
NOTCH2	4853	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		27923803
NOTCH2	4853	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		18372903
NOTCH2	4853	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		25151357
NOTCH2	4853	Gastro-enteropancreatic neuroendocrine tumor	MESH:C535650	marker/mechanism		NA		29915428
NOTCH2	4853	Glioblastoma	MESH:D005909	marker/mechanism		NA		21127729
NOTCH2	4853	Hajdu-Cheney Syndrome	MESH:D031845	marker/mechanism		NA	102500	21378985|21378989
NOTCH2	4853	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17804716
NOTCH2	4853	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		30670679
NOTCH2	4853	Neuroectodermal Tumors, Primitive	MESH:D018242	marker/mechanism		NA		21127729
NOTCH2	4853	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		27923803
NOTCH2	4853	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		30670679
NOTCH2	4853	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		25061499
NOTCH2NLC	100996717	Neuronal intranuclear inclusion disease	MESH:C537395	marker/mechanism		NA		31332380|31332381
NOTCH3	4854	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21036696
NOTCH3	4854	CADASIL	MESH:D046589	marker/mechanism		NA	125310	
NOTCH3	4854	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
NOTCH3	4854	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		21994468
NOTCH3	4854	Carcinoma, Pancreatic Ductal	MESH:D021441	marker/mechanism		NA		19208345
NOTCH3	4854	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		27923803
NOTCH3	4854	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		25151357
NOTCH3	4854	Fibromatosis, Congenital Generalized	MESH:C562978	marker/mechanism		NA	615293	
NOTCH3	4854	Glioblastoma	MESH:D005909	marker/mechanism		NA		21127729
NOTCH3	4854	Lateral meningocele syndrome	MESH:C537878	marker/mechanism		NA	130720	
NOTCH3	4854	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17804716
NOTCH3	4854	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		27923803
NOTCH4	4855	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21036696|21679465
NOTCH4	4855	Carcinoma, Pancreatic Ductal	MESH:D021441	marker/mechanism		NA		19208345
NOTCH4	4855	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		27923803
NOTCH4	4855	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		27923803
NOX1	27035	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		20715105
NOX1	27035	Heart Failure	MESH:D006333	marker/mechanism		NA		20304815
NOX1	27035	Hypercholesterolemia	MESH:D006937	marker/mechanism		NA		20832062
NOX2	100169685	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		24313545
NOX3	50508	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
NOX4	50507	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
NOX4	50507	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		20715105
NOX4	50507	Heart Failure	MESH:D006333	marker/mechanism		NA		20304815
NOX4	50507	Hypertension	MESH:D006973	marker/mechanism		NA		27659729|27847271|32147540
NOX4	50507	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19420110
NOX4	50507	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
NOX4	50507	Renal Insufficiency	MESH:D051437	marker/mechanism		NA		23325087
NPAP1	23742	Melanoma	MESH:D008545	marker/mechanism		NA		22842228
NPAP1	23742	Prader-Willi Syndrome	MESH:D011218	marker/mechanism		NA	176270	
NPAS2	4862	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17264841
NPAS2	4862	Chronobiology Disorders	MESH:D021081	marker/mechanism		NA		31284022
NPAS2	4862	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
NPB	256933	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
NPC1	4864	Ataxia	MESH:D001259	marker/mechanism		NA		21273508
NPC1	4864	Atherosclerosis	MESH:D050197	therapeutic		NA		18483620
NPC1	4864	Brucellosis	MESH:D002006	marker/mechanism		NA		12183525
NPC1	4864	Dysarthria	MESH:D004401	marker/mechanism		NA		21273508
NPC1	4864	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
NPC1	4864	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		22216111
NPC1	4864	Liver Diseases	MESH:D008107	marker/mechanism		NA		24901380
NPC1	4864	Niemann-Pick Disease, Type C	MESH:D052556	marker/mechanism		NA	257220	22216111|9802331
NPC1	4864	Obesity	MESH:D009765	marker/mechanism		NA		19151714
NPC1	4864	Ophthalmoplegia	MESH:D009886	marker/mechanism		NA		21273508
NPC2	10577	Niemann-Pick disease, type C2	MESH:C536119	marker/mechanism		NA	607625	
NPDC1	56654	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
NPHP1	4867	Joubert syndrome 4	MESH:C536296	marker/mechanism		NA	609583	
NPHP1	4867	Nephronophthisis, familial juvenile	MESH:C537699	marker/mechanism		NA	256100	
NPHP1	4867	Senior Loken Syndrome	MESH:C537580	marker/mechanism		NA	266900	
NPHP3	27031	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		12089381
NPHP3	27031	Nephronophthisis 3	MESH:C565780	marker/mechanism		NA	604387	
NPHP3	27031	Polycystic Kidney, Autosomal Recessive	MESH:D017044	marker/mechanism		NA		12089381
NPHP3	27031	RENAL-HEPATIC-PANCREATIC DYSPLASIA 1	OMIM:208540	marker/mechanism		NA	208540	
NPHP3	27031	Renal hepatic pancreatic dysplasia Dandy Walker cyst	MESH:C537756	marker/mechanism		NA	267010	
NPHP4	261734	Nephronophthisis 4	MESH:C564640	marker/mechanism		NA	606966	
NPHP4	261734	Senior-Loken syndrome 4	MESH:C537581	marker/mechanism		NA	606996	
NPHS1	4868	Albuminuria	MESH:D000419	marker/mechanism		NA		15684566
NPHS1	4868	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		11337370|20962747
NPHS1	4868	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA		15942677
NPHS1	4868	Hyperhomocysteinemia	MESH:D020138	marker/mechanism		NA		20116427
NPHS1	4868	Kidney Diseases	MESH:D007674	marker/mechanism		NA		12012391|16382022
NPHS1	4868	Nephrosis, congenital	MESH:C535761	marker/mechanism		NA	256300	10792613|11012881
NPHS1	4868	Nephrosis, Lipoid	MESH:D009402	marker/mechanism		NA		18256598
NPHS1	4868	Proteinuria	MESH:D011507	marker/mechanism|therapeutic		NA		12012391|16687628|20071462
NPHS2	7827	Albuminuria	MESH:D000419	marker/mechanism		NA		15684566
NPHS2	7827	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA		15942677
NPHS2	7827	Nephrosis	MESH:D009401	marker/mechanism		NA		15684566
NPHS2	7827	Nephrotic Syndrome	MESH:D009404	marker/mechanism		NA		16898497
NPHS2	7827	Nephrotic syndrome, idiopathic, steroid-resistant	MESH:C536404	marker/mechanism		NA	600995	21171529|24509478
NPL	80896	Cholestasis	MESH:D002779	marker/mechanism		NA		27989131
NPM	100195119	Lymphoma, Large-Cell, Anaplastic	MESH:D017728	marker/mechanism		NA		19503098
NPM1	4869	Acute erythroleukemia	MESH:C535673	marker/mechanism		NA		30926971
NPM1	4869	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
NPM1	4869	Clinical Deterioration	MESH:D000075902	marker/mechanism		NA		27602772
NPM1	4869	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
NPM1	4869	Dyskeratosis Congenita	MESH:D019871	marker/mechanism		NA		31570891
NPM1	4869	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA	601626	19822134|21441929|23877794|27992414|30420649
NPM1	4869	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		14508522|26285909
NPM1	4869	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		10619186
NPM3	10360	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
NPM3	10360	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
NPPA	4878	Acute Kidney Injury	MESH:D058186	marker/mechanism|therapeutic		NA		1825077|19298916|2948068
NPPA	4878	Adenocarcinoma	MESH:D000230	therapeutic		NA		18225537
NPPA	4878	Aortic Valve Insufficiency	MESH:D001022	marker/mechanism		NA		21216836
NPPA	4878	Atrial Fibrillation, Familial, 6	MESH:C567400	marker/mechanism		NA	612201	
NPPA	4878	Atrial Standstill	MESH:C563984	marker/mechanism		NA	615745	
NPPA	4878	Carcinoma, Small Cell	MESH:D018288	therapeutic		NA		18717826
NPPA	4878	Cardiomegaly	MESH:D006332	marker/mechanism		NA		12224825|18056528|20886221|21242511|21297083|22083722
NPPA	4878	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		11986409|16762803
NPPA	4878	Coronary Stenosis	MESH:D023921	marker/mechanism		NA		12721106
NPPA	4878	Ductus Arteriosus, Patent	MESH:D004374	marker/mechanism		NA		1421905
NPPA	4878	Heart Failure	MESH:D006333	marker/mechanism		NA		11136700|16101196|1647690|8112904
NPPA	4878	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
NPPA	4878	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		11584395
NPPA	4878	Hypercapnia	MESH:D006935	marker/mechanism		NA		11311734
NPPA	4878	Hypertension	MESH:D006973	marker/mechanism|therapeutic		NA		12940879|19219041|24039778|2526952|32147540|7839143|8188982|9869009
NPPA	4878	Hypertension, Renal	MESH:D006977	marker/mechanism		NA		8763405
NPPA	4878	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		10755198|9455993
NPPA	4878	Hypotension	MESH:D007022	marker/mechanism		NA		2951327|2961279
NPPA	4878	Hypoxia	MESH:D000860	marker/mechanism		NA		11311734
NPPA	4878	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		15613622
NPPA	4878	Lung Neoplasms	MESH:D008175	therapeutic		NA		18717826
NPPA	4878	Melanoma	MESH:D008545	therapeutic		NA		18004088
NPPA	4878	Myocardial Infarction	MESH:D009203	marker/mechanism|therapeutic		NA		11743230|9527094
NPPA	4878	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		1830552
NPPA	4878	Neoplasm Metastasis	MESH:D009362	therapeutic		NA		18717826
NPPA	4878	Pain	MESH:D010146	therapeutic		NA		13679232
NPPA	4878	Prostatic Neoplasms	MESH:D011471	therapeutic		NA		18225537
NPPA	4878	Skin Neoplasms	MESH:D012878	therapeutic		NA		18004088
NPPA	4878	Ureteral Obstruction	MESH:D014517	marker/mechanism		NA		26207612
NPPA	4878	Urination Disorders	MESH:D014555	marker/mechanism		NA		8318687
NPPA	4878	Ventricular Remodeling	MESH:D020257	marker/mechanism		NA		20886221
NPPB	4879	Anemia, Sickle Cell	MESH:D000755	marker/mechanism		NA		20408845
NPPB	4879	Aortic Valve Insufficiency	MESH:D001022	marker/mechanism		NA		21216836
NPPB	4879	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		15864246
NPPB	4879	Brain Injuries	MESH:D001930	therapeutic		NA		19803787
NPPB	4879	Cardiac Output, High	MESH:D016534	marker/mechanism		NA		20339970
NPPB	4879	Cardiomegaly	MESH:D006332	marker/mechanism		NA		15942707|15969258|18056528|21565836
NPPB	4879	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		14745153|16127512
NPPB	4879	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism|therapeutic		NA		16762803|18628775
NPPB	4879	Cardiotoxicity	MESH:D066126	marker/mechanism		NA		29959987
NPPB	4879	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		19220183
NPPB	4879	Cerebral Hemorrhage	MESH:D002543	therapeutic		NA		19803787
NPPB	4879	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		18022110
NPPB	4879	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		29394407
NPPB	4879	Dyspnea	MESH:D004417	therapeutic		NA		20339970
NPPB	4879	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		16014188
NPPB	4879	Heart Diseases	MESH:D006331	marker/mechanism		NA		18004637
NPPB	4879	Heart Failure	MESH:D006333	marker/mechanism|therapeutic		NA		11136700|11279304|12628948|15732037|15860969|16101196|16333235|16360360|16762801|16777915|19650993|24535859|29959987
NPPB	4879	Hypertension	MESH:D006973	marker/mechanism|therapeutic		NA		19219041|24039778|30310171|32147540|9194512
NPPB	4879	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		20408845|21351102
NPPB	4879	Hypokalemia	MESH:D007008	marker/mechanism		NA		20339970
NPPB	4879	Hypotension	MESH:D007022	marker/mechanism		NA		20339970|9194512
NPPB	4879	Inflammation	MESH:D007249	therapeutic		NA		19803787
NPPB	4879	Pain	MESH:D010146	therapeutic		NA		27687165
NPPB	4879	Postoperative Complications	MESH:D011183	marker/mechanism		NA		23019395
NPPB	4879	Tachycardia, Ventricular	MESH:D017180	marker/mechanism		NA		20339970
NPPB	4879	Ureteral Obstruction	MESH:D014517	marker/mechanism		NA		26207612
NPPB	4879	Ventricular Dysfunction, Left	MESH:D018487	marker/mechanism		NA		16689991
NPPB	4879	Ventricular Dysfunction, Right	MESH:D018497	marker/mechanism		NA		16014188|19650993
NPPB	4879	Ventricular Remodeling	MESH:D020257	marker/mechanism		NA		29394407
NPPC	4880	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		17676597
NPPC	4880	Cartilage Diseases	MESH:D002357	marker/mechanism		NA		17676597
NPPC	4880	Growth Disorders	MESH:D006130	marker/mechanism		NA		17676597
NPPC	4880	Hyperkinesis	MESH:D006948	therapeutic		NA		11860464
NPPC	4880	Ureteral Obstruction	MESH:D014517	marker/mechanism		NA		26207612
NPR1	4881	Cardiomegaly	MESH:D006332	marker/mechanism		NA		20881240
NPR1	4881	Fibrosis	MESH:D005355	marker/mechanism		NA		20881240
NPR1	4881	Heart Failure	MESH:D006333	marker/mechanism		NA		20881240
NPR1	4881	Hypertension	MESH:D006973	marker/mechanism		NA		20881240
NPR1	4881	Kidney Diseases	MESH:D007674	marker/mechanism		NA		20881240
NPR1	4881	Pain	MESH:D010146	therapeutic		NA		27687165
NPR2	4882	Acromesomelic dysplasia, Maroteaux type	MESH:C535661	marker/mechanism		NA	602875	
NPR2	4882	EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE	OMIM:615923	marker/mechanism		NA	615923	
NPR3	4883	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		19208208
NPR3	4883	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
NPRL2	10641	Epilepsy, Partial, with Variable Foci	MESH:C565785	marker/mechanism		NA	617116	
NPRL2	10641	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
NPRL3	8131	Epilepsy, Partial, with Variable Foci	MESH:C565785	marker/mechanism		NA	617118	
NPS	594857	Anxiety Disorders	MESH:D001008	marker/mechanism|therapeutic		NA		19339610|21466221
NPS	594857	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		19339610|20974945|21466221
NPS	594857	Hyperkinesis	MESH:D006948	marker/mechanism		NA		19339610
NPSR1	387129	Asthma	MESH:D001249	marker/mechanism		NA		15710598|15764725|16926187
NPSR1	387129	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 2	OMIM:608584	marker/mechanism		NA	608584	
NPTN	27020	Hypertension	MESH:D006973	marker/mechanism		NA		22228705
NPTN	27020	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
NPTX2	4885	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		19084905
NPY	4852	Alcoholism	MESH:D000437	marker/mechanism		NA		17572454
NPY	4852	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		11709213
NPY	4852	Anorexia	MESH:D000855	marker/mechanism		NA		16084549|16101753|25825358
NPY	4852	Anxiety Disorders	MESH:D001008	therapeutic		NA		11440811
NPY	4852	Asthma	MESH:D001249	marker/mechanism		NA		9731035
NPY	4852	Bronchitis, Chronic	MESH:D029481	marker/mechanism		NA		9731035
NPY	4852	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		9812770
NPY	4852	Cerebral Infarction	MESH:D002544	marker/mechanism		NA		11821007
NPY	4852	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		19063928
NPY	4852	Depressive Disorder	MESH:D003866	marker/mechanism|therapeutic		NA		17572454|9729278
NPY	4852	Epilepsy	MESH:D004827	therapeutic		NA		20064661|8868293
NPY	4852	Epilepsy, Temporal Lobe	MESH:D004833	therapeutic		NA		15716408
NPY	4852	Hyperkinesis	MESH:D006948	marker/mechanism		NA		19063928
NPY	4852	Hypertrophy	MESH:D006984	marker/mechanism		NA		9812770
NPY	4852	Memory Disorders	MESH:D008569	marker/mechanism		NA		2611661
NPY	4852	Muscle Rigidity	MESH:D009127	therapeutic		NA		10675796
NPY	4852	Nasal Obstruction	MESH:D015508	therapeutic		NA		9288221
NPY	4852	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		17686523
NPY	4852	Rhinitis	MESH:D012220	marker/mechanism		NA		12746121
NPY	4852	Seizures	MESH:D012640	marker/mechanism|therapeutic		NA		15451008|16194568|18005069
NPY	4852	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		19063928
NPY	4852	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		16952158
NPY	4852	Weight Loss	MESH:D015431	marker/mechanism		NA		25825358
NPY1R	4886	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		19566775
NPY1R	4886	Anxiety Disorders	MESH:D001008	therapeutic		NA		11440811
NPY1R	4886	Depressive Disorder	MESH:D003866	marker/mechanism		NA		9729278
NPY1R	4886	Neural Tube Defects	MESH:D009436	marker/mechanism		NA		17400914
NPY1R	4886	Obesity	MESH:D009765	marker/mechanism		NA		20975297
NPY1R	4886	Psychoses, Substance-Induced	MESH:D011605	marker/mechanism		NA		19566775
NPY1R	4886	Toothache	MESH:D014098	therapeutic		NA		18809749
NPY2R	4887	Alcoholism	MESH:D000437	marker/mechanism		NA		18828811
NPY2R	4887	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		18828811
NPY2R	4887	Epilepsy	MESH:D004827	therapeutic		NA		8868293
NPY2R	4887	Epilepsy, Temporal Lobe	MESH:D004833	therapeutic		NA		15716408
NPY2R	4887	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		18828811
NPY5R	4889	Obesity	MESH:D009765	marker/mechanism		NA		10849579
NQO1	1728	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		26723870
NQO1	1728	Asthma	MESH:D001249	marker/mechanism		NA		20049212
NQO1	1728	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18511948
NQO1	1728	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		21479364|9865924
NQO1	1728	Cholestasis	MESH:D002779	marker/mechanism		NA		22461449
NQO1	1728	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		20593958
NQO1	1728	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
NQO1	1728	Diabetes Mellitus, Experimental	MESH:D003921	therapeutic		NA		23458895
NQO1	1728	Hemolytic-Uremic Syndrome	MESH:D006463	marker/mechanism		NA		12588957
NQO1	1728	Hemorrhage	MESH:D006470	marker/mechanism		NA		27581200
NQO1	1728	Hyperglycemia	MESH:D006943	therapeutic		NA		23458895
NQO1	1728	Kidney Diseases	MESH:D007674	therapeutic		NA		21613233
NQO1	1728	Leukemia, Myeloid	MESH:D007951	marker/mechanism		NA		11882782
NQO1	1728	Liver Diseases	MESH:D008107	marker/mechanism		NA		16610002|17405841
NQO1	1728	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		16949155
NQO1	1728	Neoplasms	MESH:D009369	marker/mechanism		NA		8375015
NQO1	1728	Neoplasms, Experimental	MESH:D009374	marker/mechanism|therapeutic		NA		21034357|9496914
NQO1	1728	Neurotoxicity Syndromes	MESH:D020258	therapeutic		NA		20849151
NQO1	1728	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		29289645
NQO1	1728	Obesity	MESH:D009765	marker/mechanism		NA		17405841
NQO1	1728	Occupational Diseases	MESH:D009784	marker/mechanism		NA		15576619|15727169|17178637|9230185
NQO1	1728	Papilloma	MESH:D010212	marker/mechanism		NA		9496914
NQO1	1728	Parkinson Disease	MESH:D010300	marker/mechanism		NA		17188257
NQO1	1728	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		11774269|17332311
NQO1	1728	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17507624
NQO1	1728	Spinocerebellar Ataxia 17	MESH:C564616	marker/mechanism		NA		24413982
NQO1	1728	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		8631603
NQO1	1728	Warfarin Sensitivity	MESH:C567080	marker/mechanism		NA		27581200
NQO2	4835	Agranulocytosis	MESH:D000380	marker/mechanism		NA		14617031
NQO2	4835	Bone Marrow Diseases	MESH:D001855	marker/mechanism		NA		12351651
NQO2	4835	Breast Neoplasms	MESH:D001943	marker/mechanism		NA	114480	
NQO2	4835	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
NQO2	4835	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
NQO2	4835	Memory Disorders	MESH:D008569	marker/mechanism		NA		20861374
NR0B1	190	Dosage-sensitive sex reversal	MESH:C535601	marker/mechanism		NA	300018	
NR0B1	190	Hypoadrenocorticism, Familial	MESH:D000075262	marker/mechanism		NA	300200	12519885|7990958
NR0B1	190	Hypogonadism	MESH:D007006	marker/mechanism		NA		7990958
NR0B1	190	Oligospermia	MESH:D009845	marker/mechanism		NA		23384712
NR0B2	8431	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		23811326
NR0B2	8431	Chemical and Drug Induced Liver Injury	MESH:D056486	therapeutic		NA		29943110
NR0B2	8431	Cognition Disorders	MESH:D003072	marker/mechanism		NA		29382564
NR0B2	8431	Diabetes Complications	MESH:D048909	marker/mechanism		NA		29382564
NR0B2	8431	Fatty Liver	MESH:D005234	marker/mechanism		NA		27664470
NR0B2	8431	Lipidoses	MESH:D008064	marker/mechanism		NA		15342952|16919414|17175557
NR0B2	8431	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
NR0B2	8431	Obesity	MESH:D009765	marker/mechanism		NA	601665	
NR1D1	9572	Fatty Liver	MESH:D005234	marker/mechanism		NA		27664470
NR1D2	9975	Endometriosis	MESH:D004715	marker/mechanism		NA		22138541
NR1H2	7376	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21147110
NR1H2	7376	Cholestasis	MESH:D002779	therapeutic		NA		17256725
NR1H2	7376	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
NR1H3	10062	Chemical and Drug Induced Liver Injury	MESH:D056486	therapeutic		NA		17256725
NR1H3	10062	Cholestasis	MESH:D002779	therapeutic		NA		17256725
NR1H3	10062	Fatty Liver	MESH:D005234	marker/mechanism		NA		23651738
NR1H4	9971	Atherosclerosis	MESH:D050197	therapeutic		NA		30996006
NR1H4	9971	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		23811326|25496033
NR1H4	9971	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		12875239
NR1H4	9971	Cholestasis	MESH:D002779	marker/mechanism		NA		22461449|23178280
NR1H4	9971	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	OMIM:617049	marker/mechanism		NA	617049	
NR1H4	9971	Crohn Disease	MESH:D003424	marker/mechanism		NA		21829567
NR1H4	9971	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		29142166|32062620
NR1H4	9971	Extravasation of Diagnostic and Therapeutic Materials	MESH:D005119	marker/mechanism		NA		22135065
NR1H4	9971	Fatty Liver	MESH:D005234	marker/mechanism		NA		29142166
NR1H4	9971	Hepatomegaly	MESH:D006529	marker/mechanism		NA		29142166
NR1H4	9971	Infertility, Male	MESH:D007248	marker/mechanism		NA		30245210
NR1H4	9971	Inflammation	MESH:D007249	marker/mechanism		NA		29142166
NR1H4	9971	Intestinal Neoplasms	MESH:D007414	marker/mechanism		NA		23178280
NR1H4	9971	Liver Diseases	MESH:D008107	marker/mechanism		NA		22130247
NR1H4	9971	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		23178280|24091600|24189133|29142166|30556042
NR1H4	9971	Necrosis	MESH:D009336	therapeutic		NA		30996006
NR1H4	9971	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		29142166|32062620
NR1H4	9971	Plaque, Atherosclerotic	MESH:D058226	therapeutic		NA		30996006
NR1I2	8856	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		21977915
NR1I2	8856	Barrett Esophagus	MESH:D001471	marker/mechanism		NA		21977915
NR1I2	8856	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism|therapeutic		NA		19797606|28058446
NR1I2	8856	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		20869355
NR1I2	8856	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		21977915
NR1I2	8856	Fatty Liver	MESH:D005234	marker/mechanism		NA		25182422
NR1I2	8856	Hepatomegaly	MESH:D006529	marker/mechanism		NA		23607986|32320717
NR1I2	8856	Hypophosphatemia	MESH:D017674	marker/mechanism		NA		19898264
NR1I2	8856	Infertility, Female	MESH:D007247	marker/mechanism		NA		23710174
NR1I2	8856	Jaundice, Neonatal	MESH:D007567	marker/mechanism		NA		22371261
NR1I2	8856	Metabolic Syndrome	MESH:D024821	marker/mechanism		NA		20869355
NR1I2	8856	Obesity	MESH:D009765	marker/mechanism		NA		20869355
NR1I2	8856	Osteosarcoma	MESH:D012516	marker/mechanism		NA		17279585
NR1I2	8856	Plaque, Atherosclerotic	MESH:D058226	marker/mechanism		NA		29425287
NR1I3	9970	Adenoma, Liver Cell	MESH:D018248	marker/mechanism		NA		25656644
NR1I3	9970	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism|therapeutic		NA		14742670|25656644|28058446
NR1I3	9970	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		20869355
NR1I3	9970	Hepatomegaly	MESH:D006529	marker/mechanism|therapeutic		NA		23607986|23721867|25656644|32320717|32435917
NR1I3	9970	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941|19482888|22293087|24449422|28218408
NR1I3	9970	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		17172636|24769335|25656644
NR1I3	9970	Metabolic Syndrome	MESH:D024821	marker/mechanism		NA		20869355
NR1I3	9970	Obesity	MESH:D009765	marker/mechanism		NA		20869355
NR1I3	9970	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		19233941|25656644
NR2C1	7181	Endometriosis	MESH:D004715	marker/mechanism		NA		22138541
NR2C2	7182	Endometriosis	MESH:D004715	marker/mechanism		NA		22138541
NR2E3	10002	Enhanced S-Cone Syndrome	MESH:C564835	marker/mechanism		NA	268100	
NR2E3	10002	Retinitis Pigmentosa 37	MESH:C567005	marker/mechanism		NA	611131	
NR2F1	7025	BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME	OMIM:615722	marker/mechanism		NA	615722	
NR2F1	7025	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		11850205
NR2F1	7025	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
NR2F2	7026	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
NR2F2	7026	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 4	OMIM:615779	marker/mechanism		NA	615779	
NR2F2	7026	Endometriosis	MESH:D004715	marker/mechanism		NA		22138541
NR2F2	7026	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		17436238
NR2F2	7026	Infertility, Female	MESH:D007247	marker/mechanism		NA		17590085
NR2F6	2063	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		11850205
NR2F6	2063	Endometriosis	MESH:D004715	marker/mechanism		NA		22138541
NR3C1	2908	46, XX Disorders of Sex Development	MESH:D058489	marker/mechanism		NA		11932321
NR3C1	2908	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
NR3C1	2908	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		14708030
NR3C1	2908	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		12805318|19234455
NR3C1	2908	Depressive Disorder	MESH:D003866	marker/mechanism		NA		14708030
NR3C1	2908	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		29802709
NR3C1	2908	Endometriosis	MESH:D004715	marker/mechanism		NA		22138541
NR3C1	2908	Glucocorticoid Receptor Deficiency	MESH:C564221	marker/mechanism		NA	615962	
NR3C1	2908	Glucose Metabolism Disorders	MESH:D044882	marker/mechanism		NA		29802709
NR3C1	2908	Hypertension	MESH:D006973	marker/mechanism		NA		18434569|20659135
NR3C1	2908	Hypokalemia	MESH:D007008	marker/mechanism		NA		11932321
NR3C1	2908	Lung Diseases, Obstructive	MESH:D008173	marker/mechanism		NA		9926163
NR3C1	2908	Mood Disorders	MESH:D019964	marker/mechanism		NA		29921868
NR3C1	2908	Ocular Hypertension	MESH:D009798	marker/mechanism		NA		17563720
NR3C1	2908	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
NR3C1	2908	Psychotic Disorders	MESH:D011618	marker/mechanism		NA		14708030
NR3C1	2908	Schizophrenia	MESH:D012559	marker/mechanism		NA		14708030|21647420
NR3C2	4306	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		21321305
NR3C2	4306	Endometriosis	MESH:D004715	marker/mechanism		NA		22138541
NR3C2	4306	Heart Failure	MESH:D006333	marker/mechanism		NA		15722665|21321305
NR3C2	4306	Hypertension, Early-Onset, Autosomal Dominant, with Severe Exacerbation in Pregnancy	MESH:C565359	marker/mechanism		NA	605115	
NR3C2	4306	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		16413583|17587755
NR3C2	4306	Pseudohypoaldosteronism	MESH:D011546	marker/mechanism		NA	177735	
NR3C2	4306	Ventricular Dysfunction, Left	MESH:D018487	marker/mechanism		NA		21321305
NR4A1	3164	Depressive Disorder, Major	MESH:D003865	marker/mechanism		NA		29175309
NR4A1	3164	Endometriosis	MESH:D004715	marker/mechanism		NA		22138541
NR4A1	3164	Insulin Resistance	MESH:D007333	marker/mechanism		NA		17785466
NR4A1	3164	Kidney Diseases	MESH:D007674	marker/mechanism		NA		24722447
NR4A1	3164	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
NR4A1	3164	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		20660371
NR4A1	3164	Proteinuria	MESH:D011507	marker/mechanism		NA		24722447
NR4A2	4929	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
NR4A2	4929	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
NR4A2	4929	Arthritis, Psoriatic	MESH:D015535	marker/mechanism		NA		19732956
NR4A2	4929	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		16293616
NR4A2	4929	PARKINSON DISEASE, LATE-ONSET	OMIM:168600	marker/mechanism		NA	168600	
NR4A2	4929	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
NR4A3	8013	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
NR4A3	8013	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		19192274
NR4A3	8013	Chondrosarcoma, Extraskeletal Myxoid	MESH:C563195	marker/mechanism		NA	612237	
NR4A3	8013	Hypercholesterolemia	MESH:D006937	marker/mechanism		NA		16005304
NR4A3	8013	Insulin Resistance	MESH:D007333	marker/mechanism		NA		17785466
NR5A1	2516	Adrenal Insufficiency	MESH:D000309	marker/mechanism		NA		10369247
NR5A1	2516	Disorder of Sex Development, 46,XY	MESH:D058490	marker/mechanism		NA	612965	
NR5A1	2516	Endometriosis	MESH:D004715	marker/mechanism		NA		17519303
NR5A1	2516	Gonadal Dysgenesis, 46,XX	MESH:D023961	marker/mechanism		NA		19246354
NR5A1	2516	Gonadal Dysgenesis, 46,XY	MESH:D006061	marker/mechanism		NA		10369247|11932325|15070943
NR5A1	2516	Infertility, Male	MESH:D007248	marker/mechanism		NA		20887963
NR5A1	2516	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		23291911
NR5A1	2516	Premature Ovarian Failure 7	MESH:C567838	marker/mechanism		NA	612964	
NR5A1	2516	Primary Ovarian Insufficiency	MESH:D016649	marker/mechanism		NA		19246354
NR5A1	2516	SPERMATOGENIC FAILURE 8	OMIM:613957	marker/mechanism		NA	613957	
NR5A2	2494	Anovulation	MESH:D000858	marker/mechanism		NA		18628394
NR5A2	2494	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		29515023
NR5A2	2494	Dyslipidemias	MESH:D050171	marker/mechanism		NA		29515023
NR5A2	2494	Glucose Intolerance	MESH:D018149	marker/mechanism		NA		29515023
NR5A2	2494	Hepatomegaly	MESH:D006529	marker/mechanism		NA		29515023
NR5A2	2494	Infertility, Female	MESH:D007247	marker/mechanism		NA		17409375
NR5A2	2494	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		29515023
NR5A2	2494	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		20101243|26098869
NRARP	441478	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		21127729
NRAS	4893	Autoimmune Lymphoproliferative Syndrome	MESH:D056735	marker/mechanism		NA		17517660
NRAS	4893	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	114500	
NRAS	4893	Epidermal Nevus	MESH:C580062	marker/mechanism		NA	162900	
NRAS	4893	Leukemia, Megakaryoblastic, of Down Syndrome	MESH:C566025	marker/mechanism		NA		24056718
NRAS	4893	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		27992414
NRAS	4893	Leukemia, Myelomonocytic, Juvenile	MESH:D054429	marker/mechanism		NA		19775298|26457647
NRAS	4893	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		26285909
NRAS	4893	Leukocytosis	MESH:D007964	marker/mechanism		NA		27725143
NRAS	4893	Lymphoma	MESH:D008223	marker/mechanism		NA		9205081
NRAS	4893	Lymphoma, B-Cell	MESH:D016393	marker/mechanism		NA		14633661
NRAS	4893	MELANOCYTIC NEVUS SYNDROME, CONGENITAL	OMIM:137550	marker/mechanism		NA	137550	
NRAS	4893	Melanoma	MESH:D008545	marker/mechanism		NA		22535842|22842228|23432625|25043973|26214590|29574239
NRAS	4893	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		9205081
NRAS	4893	Neuroblastoma	MESH:D009447	marker/mechanism		NA		23334666
NRAS	4893	Neurocutaneous melanosis	MESH:C537387	marker/mechanism		NA	249400	
NRAS	4893	Neurofibrosarcoma	MESH:D018319	marker/mechanism		NA		16239399
NRAS	4893	Nevus, Sebaceous of Jadassohn	MESH:D054000	marker/mechanism		NA	163200	
NRAS	4893	Noonan Syndrome	MESH:D009634	marker/mechanism		NA		19966803
NRAS	4893	Noonan Syndrome 6	MESH:C548084	marker/mechanism		NA	613224	
NRAS	4893	Rectal Neoplasms	MESH:D012004	marker/mechanism		NA		3102434
NRAS	4893	Splenomegaly	MESH:D013163	marker/mechanism		NA		27725143
NRAS	4893	Thyroid cancer, follicular	MESH:C572845	marker/mechanism		NA	188470	12727991
NRCAM	4897	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17106428|18664314
NRCAM	4897	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18507500
NRCAM	4897	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18507500|21278247
NRCAM	4897	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		16123759
NREP	9315	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
NREP	9315	Fatty Liver	MESH:D005234	marker/mechanism		NA		25226513
NREP	9315	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
NRF1	4899	Bowen's Disease	MESH:D001913	marker/mechanism		NA		21514422
NRG1	3084	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
NRG1	3084	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
NRG1	3084	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19617202
NRG1	3084	Cardiotoxicity	MESH:D066126	therapeutic		NA		29305325
NRG1	3084	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		19617202
NRG1	3084	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
NRG1	3084	Heart Failure	MESH:D006333	therapeutic		NA		19801490
NRG1	3084	Hirschsprung Disease	MESH:D006627	marker/mechanism		NA		22974608
NRG1	3084	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
NRG1	3084	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		28604730
NRG1	3084	Movement Disorders	MESH:D009069	marker/mechanism		NA		22226049
NRG1	3084	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		19617202
NRG1	3084	Pain	MESH:D010146	marker/mechanism		NA		20561508
NRG1	3084	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
NRG1	3084	Schizophrenia	MESH:D012559	marker/mechanism		NA	603013	12145742|17333138|17460065|17905522|20561508|20582876|20701826
NRG1	3084	Stomach Ulcer	MESH:D013276	marker/mechanism		NA		16357062
NRG3	10718	Schizophrenia	MESH:D012559	marker/mechanism		NA		20713722
NRGN	4900	Schizophrenia	MESH:D012559	marker/mechanism		NA		17140601
NRIP1	8204	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		22267197
NRIP1	8204	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		27348297
NRIP1	8204	Heart Failure	MESH:D006333	marker/mechanism		NA		22503866
NRIP1	8204	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		22503866
NRIP1	8204	Schizophrenia	MESH:D012559	marker/mechanism		NA		21743468
NRL	4901	Night Blindness	MESH:D009755	marker/mechanism		NA		12796249|15591106
NRL	4901	Retinal Degeneration	MESH:D012162	marker/mechanism		NA		15591106
NRL	4901	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA		10192380|12796249
NRL	4901	Retinitis Pigmentosa 27	MESH:C563526	marker/mechanism		NA	613750	
NRP1	8829	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
NRP1	8829	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
NRP1	8829	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		15956974
NRP1	8829	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
NRP2	8828	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17427189
NRP2	8828	Seizures	MESH:D012640	marker/mechanism		NA		18657176
NRROS	375387	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
NRSN1	140767	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		26039340
NRXN1	9378	Abnormalities, Multiple	MESH:D000015	marker/mechanism		NA		18057082
NRXN1	9378	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		18252227
NRXN1	9378	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17322880|18057082|18621663|20157312
NRXN1	9378	CHROMOSOME 2p16.3 DELETION SYNDROME	OMIM:614332	marker/mechanism		NA	614332	
NRXN1	9378	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		18057082
NRXN1	9378	Intellectual Disability	MESH:D008607	marker/mechanism		NA		18057082|28191889
NRXN1	9378	Language Development Disorders	MESH:D007805	marker/mechanism		NA		20157312
NRXN1	9378	PITT-HOPKINS-LIKE SYNDROME 2	OMIM:614325	marker/mechanism		NA	614325	
NRXN1	9378	Pitt-Hopkins syndrome	MESH:C537403	marker/mechanism		NA		19896112
NRXN1	9378	Schizophrenia	MESH:D012559	marker/mechanism		NA		20157312|21285140|21424692
NRXN2	9379	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		21424692
NRXN3	9369	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
NSA2	10412	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		18422935
NSD1	64324	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18001468
NSD1	64324	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
NSD1	64324	Intellectual Disability	MESH:D008607	marker/mechanism		NA		12807965
NSD1	64324	Sotos Syndrome	MESH:D058495	marker/mechanism		NA	117550	12807965|14517949|14571271|15452385|15580547|15640245|16188863|16232326|17561922|18001468|18505455|20101679|21972110
NSD1	64324	Weaver syndrome	MESH:C536687	marker/mechanism		NA		12807965
NSD2	7468	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		24874954
NSD2	7468	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		24076604
NSD2	7468	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	therapeutic		NA		24076604
NSD2	7468	Wolf-Hirschhorn Syndrome	MESH:D054877	marker/mechanism		NA	194190	24874954
NSDHL	50814	CK SYNDROME	OMIM:300831	marker/mechanism		NA	300831	
NSDHL	50814	Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects	MESH:C562515	marker/mechanism		NA	308050	25526675
NSDHL	50814	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		23125191
NSMCE3	56160	LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME	OMIM:617241	marker/mechanism		NA	617241	
NSMF	26012	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
NSMF	26012	HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA	OMIM:614838	marker/mechanism		NA	614838	
NSMF	26012	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
NSMF	26012	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
NSMF	26012	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
NSUN2	54888	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		31209396
NSUN2	54888	Mental Retardation, Autosomal Recessive 5	MESH:C567018	marker/mechanism		NA	611091	
NSUN6	221078	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		28114269
NSUN6	221078	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		28114269
NSUN7	79730	Infertility, Male	MESH:D007248	marker/mechanism		NA		17442852
NT5C	30833	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		15814641
NT5C2	22978	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		31557154
NT5C2	22978	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		23377183
NT5C2	22978	Recurrence	MESH:D012008	marker/mechanism		NA		23377183
NT5C2	22978	SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE	OMIM:613162	marker/mechanism		NA	613162	
NT5C3A	51251	Anemia, Hemolytic, Congenital Nonspherocytic	MESH:D000746	marker/mechanism		NA		16672222
NT5C3A	51251	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
NT5C3A	51251	Uridine 5-Prime Monophosphate Hydrolase Deficiency, Hemolytic Anemia due to	MESH:C564859	marker/mechanism		NA	266120	
NT5DC1	221294	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
NT5E	4907	Calcification of Joints and Arteries	MESH:C565891	marker/mechanism		NA	211800	
NT5E	4907	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		18263696
NT5E	4907	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
NTF3	4908	Autistic Disorder	MESH:D001321	marker/mechanism		NA		16289943
NTF3	4908	Diabetic Neuropathies	MESH:D003929	therapeutic		NA		11779407
NTF3	4908	Down Syndrome	MESH:D004314	marker/mechanism		NA		16289943
NTF3	4908	Epilepsy, Tonic-Clonic	MESH:D004830	marker/mechanism		NA		16023256
NTF3	4908	Hearing Loss	MESH:D034381	therapeutic		NA		18024279
NTF3	4908	Hyperalgesia	MESH:D006930	therapeutic		NA		15659614
NTF3	4908	Nerve Degeneration	MESH:D009410	therapeutic		NA		8921280|8978711
NTF3	4908	Schizophrenia	MESH:D012559	marker/mechanism		NA		18572319
NTF3	4908	Status Epilepticus	MESH:D013226	marker/mechanism		NA		8635431
NTF4	4909	Autistic Disorder	MESH:D001321	marker/mechanism		NA		11357950|16289943
NTF4	4909	Glaucoma 1, Open Angle, O	MESH:C567753	marker/mechanism		NA	613100	
NTF4	4909	Intellectual Disability	MESH:D008607	marker/mechanism		NA		11357950
NTF4	4909	Nerve Degeneration	MESH:D009410	therapeutic		NA		8921280
NTF5	78405	Nerve Degeneration	MESH:D009410	therapeutic		NA		8921280
NTHL1	4913	Adenomatous Polyposis Coli	MESH:D011125	marker/mechanism		NA	616415	25938944
NTN1	9423	Brain Edema	MESH:D001929	therapeutic		NA		29162556
NTN1	9423	Neurobehavioral Manifestations	MESH:D019954	therapeutic		NA		29162556
NTN1	9423	Subarachnoid Hemorrhage	MESH:D013345	marker/mechanism		NA		29162556
NTNG1	22854	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		17507910
NTNG1	22854	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		21278247
NTNG1	22854	Schizophrenia	MESH:D012559	marker/mechanism		NA		17507910
NTNG2	84628	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		17507910
NTNG2	84628	Schizophrenia	MESH:D012559	marker/mechanism		NA		17507910
NTRK1	4914	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		14708030
NTRK1	4914	Glioma	MESH:D005910	marker/mechanism		NA		24705251
NTRK1	4914	Hereditary Sensory and Autonomic Neuropathies	MESH:D009477	marker/mechanism		NA	256800	
NTRK1	4914	Lewy Body Disease	MESH:D020961	marker/mechanism		NA		19276553
NTRK1	4914	Lung Injury	MESH:D055370	therapeutic		NA		20075049
NTRK1	4914	Neuralgia	MESH:D009437	marker/mechanism		NA		18400411
NTRK1	4914	Neuroblastoma	MESH:D009447	marker/mechanism		NA		16989911
NTRK1	4914	Psychotic Disorders	MESH:D011618	marker/mechanism		NA		14708030
NTRK1	4914	Schizophrenia	MESH:D012559	marker/mechanism		NA		14708030
NTRK2	4915	Astrocytoma	MESH:D001254	marker/mechanism		NA		23817572
NTRK2	4915	Autistic Disorder	MESH:D001321	marker/mechanism		NA		20662941
NTRK2	4915	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		19018715
NTRK2	4915	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		20826313|20947769
NTRK2	4915	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		15494731
NTRK2	4915	Glioma	MESH:D005910	marker/mechanism		NA		24705251
NTRK2	4915	Hyperkinesis	MESH:D006948	marker/mechanism		NA		20826313|20947769
NTRK2	4915	Hyperphagia	MESH:D006963	marker/mechanism		NA		15494731
NTRK2	4915	Lewy Body Disease	MESH:D020961	marker/mechanism		NA		19276553
NTRK2	4915	Neuroblastoma	MESH:D009447	marker/mechanism		NA		16051641
NTRK2	4915	Obesity	MESH:D009765	marker/mechanism		NA		15494731
NTRK2	4915	Obesity, Hyperphagia, and Developmental Delay	MESH:C563938	marker/mechanism		NA	613886	
NTRK2	4915	Status Epilepticus	MESH:D013226	marker/mechanism		NA		8635431|8821376
NTRK3	4916	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
NTRK3	4916	Glioma	MESH:D005910	marker/mechanism		NA		24705251
NTRK3	4916	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		29119387
NTRK3	4916	Status Epilepticus	MESH:D013226	marker/mechanism		NA		8635431
NTS	4922	Bradycardia	MESH:D001919	therapeutic		NA		2326505
NTS	4922	Catalepsy	MESH:D002375	therapeutic		NA		20882060
NTS	4922	Hyperkinesis	MESH:D006948	therapeutic		NA		3748325|6682440
NTS	4922	Muscle Rigidity	MESH:D009127	therapeutic		NA		8036282
NTSR1	4923	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		24781735
NTSR1	4923	Pain	MESH:D010146	therapeutic		NA		20727387
NTSR1	4923	Schizophrenia	MESH:D012559	marker/mechanism		NA		20659557
N-TUTCA2	22069	Insulin Resistance	MESH:D007333	marker/mechanism		NA		28228267
N-TUTCA2	22069	Myocarditis	MESH:D009205	marker/mechanism		NA		17142041
NUAK1	9891	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		26873845
NUAK1	9891	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		26213588|26873845
NUBPL	80224	Mitochondrial Diseases	MESH:D028361	marker/mechanism		NA		20818383
NUCB1	4924	Stevens-Johnson Syndrome	MESH:D013262	marker/mechanism		NA		25811541
NUCB2	4925	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
NUCKS1	64710	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
NUDCD3	23386	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
NUDT15	55270	THIOPURINES, POOR METABOLISM OF, 2	OMIM:616903	marker/mechanism		NA	616903	
NUDT16	131870	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
NUDT17	200035	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
NUDT2	318	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20533549
NUDT21	11051	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
NUDT21	11051	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
NUDT7	283927	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		25058030
NUF2	83540	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
NUMA1	4926	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		16033404
NUMA1	4926	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA	612376	
NUP107	57122	NEPHROTIC SYNDROME, TYPE 11	OMIM:616730	marker/mechanism		NA	616730	
NUP155	9631	ATRIAL FIBRILLATION, FAMILIAL, 15	OMIM:615770	marker/mechanism		NA	615770	
NUP205	23165	Nephrotic syndrome, idiopathic, steroid-resistant	MESH:C536404	marker/mechanism		NA		26878725
NUP205	23165	NEPHROTIC SYNDROME, TYPE 13	OMIM:616893	marker/mechanism		NA	616893	
NUP205	23165	Osteitis Deformans	MESH:D010001	marker/mechanism		NA		21623375
NUP214	8021	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA	601626	
NUP214	8021	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA	613065	
NUP62	23636	Striatonigral degeneration infantile	MESH:C537500	marker/mechanism		NA	271930	
NUP88	4927	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
NUP93	9688	Nephrotic syndrome, idiopathic, steroid-resistant	MESH:C536404	marker/mechanism		NA		26878725
NUP93	9688	NEPHROTIC SYNDROME, TYPE 12	OMIM:616892	marker/mechanism		NA	616892	
NUP98	4928	Acute erythroleukemia	MESH:C535673	marker/mechanism		NA		30926971
NUP98	4928	Anemia	MESH:D000740	marker/mechanism		NA		27725143
NUP98	4928	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		21441929
NUP98	4928	Lymphopenia	MESH:D008231	marker/mechanism		NA		27725143
NUP98	4928	Neutropenia	MESH:D009503	marker/mechanism		NA		27725143
NUPR1	26471	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
NUPR1	26471	Lipidoses	MESH:D008064	marker/mechanism		NA		17175557
NUPR1	26471	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
NUPR1	26471	Pancreatitis	MESH:D010195	marker/mechanism		NA		16822955
NUS1	116150	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iaa	OMIM:617082	marker/mechanism		NA	617082	
NUS1	116150	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		30718926
NUS1	116150	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
NUSAP1	51203	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
NUSAP1	51203	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		25944804
NUTF2	10204	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
NUTM2B-AS1	101060691	Muscular Dystrophy, Oculopharyngeal	MESH:D039141	marker/mechanism		NA		31332380
NXN	64359	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		24836286
NXPH2	11249	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
NYX	60506	Night blindness, congenital stationary	MESH:C536122	marker/mechanism		NA	310500	
OACYLP	390858	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
OAS1	4938	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
OAS1	4938	Virus Diseases	MESH:D014777	marker/mechanism		NA		15732009
OAS1A	246730	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		17984051
OAS2	4939	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
OAS3	4940	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
OASL	8638	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
OAT	4942	Enterocolitis, Necrotizing	MESH:D020345	marker/mechanism		NA		18806098
OAT	4942	Gyrate Atrophy	MESH:D015799	marker/mechanism		NA	258870	
OAT	4942	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
OAT	4942	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		28108177
OBP3	259247	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
OBP3	259247	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		25226513
OBP3	259247	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
OBP3	259247	Liver Diseases	MESH:D008107	marker/mechanism		NA		1715830
OBP99B	43497	Parkinson Disease	MESH:D010300	marker/mechanism		NA		18353766
OBSL1	23363	Three M Syndrome 2	MESH:C567862	marker/mechanism		NA	612921	
OC90	729330	Vestibular Diseases	MESH:D015837	marker/mechanism		NA		21269433
OCA2	4948	Oculocutaneous albinism type 2	MESH:C537730	marker/mechanism		NA	203200	
OCIAD1	54940	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
OCLN	100506658	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		19766176
OCLN	100506658	Brain Injuries, Traumatic	MESH:D000070642	marker/mechanism		NA		25668593
OCLN	100506658	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17459053|24014025
OCLN	100506658	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		24014025
OCLN	100506658	Hepatic Veno-Occlusive Disease	MESH:D006504	marker/mechanism		NA		17015055
OCLN	100506658	Neoplasms	MESH:D009369	marker/mechanism		NA		16982755
OCLN	100506658	PSEUDO-TORCH SYNDROME 1	OMIM:251290	marker/mechanism		NA	251290	
OCLN	100506658	Retinal Diseases	MESH:D012164	marker/mechanism		NA		19324842
OCLN	100506658	Splenomegaly	MESH:D013163	marker/mechanism		NA		17015055
OCRL	4952	Dent Disease 2	MESH:C564487	marker/mechanism		NA	300555	
OCRL	4952	Oculocerebrorenal Syndrome	MESH:D009800	marker/mechanism		NA	309000	9430698
ODAD1	93233	CILIARY DYSKINESIA, PRIMARY, 20	OMIM:615067	marker/mechanism		NA	615067	
ODAD2	55130	CILIARY DYSKINESIA, PRIMARY, 23	OMIM:615451	marker/mechanism		NA	615451	
ODAD3	115948	CILIARY DYSKINESIA, PRIMARY, 30	OMIM:616037	marker/mechanism		NA	616037	
ODAD4	83538	CILIARY DYSKINESIA, PRIMARY, 35	OMIM:617092	marker/mechanism		NA	617092	
ODAPH	152816	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA4	OMIM:614832	marker/mechanism		NA	614832	
ODC1	4953	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		12810952
ODC1	4953	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		21930798
ODC1	4953	HIV Infections	MESH:D015658	marker/mechanism		NA		12878215
ODC1	4953	Papilloma	MESH:D010212	marker/mechanism		NA		17928125
ODC1	4953	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		2591024|7653998
ODF3B	440836	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
OFD1	8481	Joubert Syndrome 10	MESH:C567582	marker/mechanism		NA	300804	
OFD1	8481	Orofaciodigital syndrome type1	MESH:C537134	marker/mechanism		NA	311200	
OFD1	8481	Oto-Palato-digital syndrome type 1	MESH:C536065	marker/mechanism		NA		16783569
OFD1	8481	RETINITIS PIGMENTOSA 23	OMIM:300424	marker/mechanism		NA	300424	
OFD1	8481	Simpson-Golabi-Behmel Syndrome, Type 2	MESH:C564567	marker/mechanism		NA	300209	
OGDH	4967	Alpha-ketoglutarate dehydrogenase deficiency	MESH:C536582	marker/mechanism		NA	203740	
OGDH	4967	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
OGG1	4968	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		19336973
OGG1	4968	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		23951099
OGG1	4968	Brain Diseases	MESH:D001927	marker/mechanism		NA		24075420
OGG1	4968	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA	144700	
OGG1	4968	Chromosome Aberrations	MESH:D002869	marker/mechanism		NA		24036326
OGG1	4968	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		22652274
OGG1	4968	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		24036326
OGG1	4968	Hearing Loss, Noise-Induced	MESH:D006317	marker/mechanism		NA		24599382
OGG1	4968	Heart Diseases	MESH:D006331	therapeutic		NA		21873502
OGG1	4968	HIV Infections	MESH:D015658	marker/mechanism		NA		29709520
OGG1	4968	Huntington Disease	MESH:D006816	marker/mechanism		NA		19857538
OGG1	4968	Hyperplasia	MESH:D006965	marker/mechanism		NA		19336973
OGG1	4968	Infertility, Male	MESH:D007248	marker/mechanism		NA		23376476
OGG1	4968	Lung Neoplasms	MESH:D008175	marker/mechanism|therapeutic		NA		17441966|19336973
OGG1	4968	Lymphoma	MESH:D008223	therapeutic		NA		17441966
OGG1	4968	Motor Skills Disorders	MESH:D019957	marker/mechanism		NA		18768699
OGG1	4968	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		26629949
OGG1	4968	Obesity	MESH:D009765	marker/mechanism		NA		29709520
OGG1	4968	Premature Birth	MESH:D047928	marker/mechanism		NA		29709520
OGG1	4968	Prenatal Exposure Delayed Effects	MESH:D011297	marker/mechanism		NA		18768699
OGG1	4968	Prenatal Injuries	MESH:D049188	marker/mechanism		NA		24075420
OGG1	4968	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		11956079|14634453
OGG1	4968	Skin Diseases	MESH:D012871	marker/mechanism		NA		16759981
OGG1	4968	Urologic Neoplasms	MESH:D014571	marker/mechanism		NA		26359225
OGN	4969	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17085005
OIT3	170392	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
OLFM1	10439	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		19208208
OLFM4	10562	Endometriosis	MESH:D004715	marker/mechanism		NA		21048224
OLFML2A	169611	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
OLFML2B	25903	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
OLFML2B	25903	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
OLFML3	56944	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
OLR1	4973	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
OLR1	4973	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		16055083
OLR1	4973	Heart Failure	MESH:D006333	marker/mechanism		NA		22352330
OLR1	4973	Hypertension	MESH:D006973	marker/mechanism		NA		22352330
OLR1	4973	Myocardial Infarction	MESH:D009203	marker/mechanism		NA	608446	12646194|14684693
OLR59	170816	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
OLR59	170816	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ONECUT2	9480	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29581250
OPA1	4976	Behr syndrome	MESH:C537669	marker/mechanism		NA	210000	
OPA1	4976	GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO	OMIM:606657	marker/mechanism		NA	606657	
OPA1	4976	MITOCHONDRIAL DNA DEPLETION SYNDROME 14 (CARDIOENCEPHALOMYOPATHIC TYPE)	OMIM:616896	marker/mechanism		NA	616896	
OPA1	4976	Optic atrophy 1 and deafness	MESH:C537124	marker/mechanism		NA	125250	
OPA1	4976	Optic Atrophy, Autosomal Dominant	MESH:D029241	marker/mechanism		NA	165500	19900585|23409176
OPA1	4976	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
OPA1	4976	Ventricular Remodeling	MESH:D020257	marker/mechanism		NA		20886221
OPA3	80207	Costeff optic atrophy syndrome	MESH:C535311	marker/mechanism		NA	258501	
OPA3	80207	Optic atrophy and cataract, autosomal dominant	MESH:C537128	marker/mechanism		NA	165300	
OPCML	4978	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA	167000	
OPHN1	4983	Craniofrontonasal dysplasia	MESH:C536456	marker/mechanism		NA		17941886
OPHN1	4983	Mental Retardation, X-Linked	MESH:D038901	marker/mechanism		NA		17941886
OPHN1	4983	Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance	MESH:C537456	marker/mechanism		NA	300486	
OPLAH	26873	5-oxoprolinase deficiency	MESH:C535322	marker/mechanism		NA	260005	
OPN1LW	5956	Blue cone monochromatism	MESH:C536238	marker/mechanism		NA	303700	
OPN1LW	5956	COLORBLINDNESS, PARTIAL, PROTAN SERIES	OMIM:303900	marker/mechanism		NA	303900	
OPN1MW	2652	Blue cone monochromatism	MESH:C536238	marker/mechanism		NA	303700	
OPN1MW	2652	COLORBLINDNESS, PARTIAL, DEUTAN SERIES	OMIM:303800	marker/mechanism		NA	303800	
OPN1SW	611	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
OPN1SW	611	TRITANOPIA	OMIM:190900	marker/mechanism		NA	190900	
OPRD1	4985	Epilepsy	MESH:D004827	marker/mechanism		NA		2415332
OPRD1	4985	Hypotension, Orthostatic	MESH:D007024	marker/mechanism		NA		2981652
OPRD1	4985	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		17622222|20098672
OPRD1	4985	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		2415332
OPRK1	4986	Arrhythmias, Cardiac	MESH:D001145	therapeutic		NA		16995444
OPRK1	4986	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		18575850|20232055
OPRK1	4986	Pain	MESH:D010146	marker/mechanism		NA		9463367
OPRK1	4986	Seizures	MESH:D012640	marker/mechanism|therapeutic		NA		1675896|18042875
OPRK1	4986	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		20232057|9463367
OPRL1	4987	Arrhythmias, Cardiac	MESH:D001145	therapeutic		NA		16995444
OPRL1	4987	Hypokinesia	MESH:D018476	marker/mechanism		NA		20950413
OPRL1	4987	Morphine Dependence	MESH:D009021	marker/mechanism		NA		11027224
OPRL1	4987	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		11027224
OPRM1	4988	AIDS Dementia Complex	MESH:D015526	marker/mechanism		NA		27400929
OPRM1	4988	Alcoholism	MESH:D000437	marker/mechanism		NA		12815747
OPRM1	4988	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		16402083
OPRM1	4988	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		12815747|16893609|18762918
OPRM1	4988	Constipation	MESH:D003248	marker/mechanism		NA		27192616
OPRM1	4988	Dyskinesias	MESH:D020820	marker/mechanism		NA		16435402
OPRM1	4988	Encephalitis, Viral	MESH:D018792	marker/mechanism		NA		27400929
OPRM1	4988	Epilepsy	MESH:D004827	marker/mechanism		NA		2415332
OPRM1	4988	Hepatic Encephalopathy	MESH:D006501	marker/mechanism		NA		11991257
OPRM1	4988	Hepatitis C	MESH:D006526	marker/mechanism		NA		12937158|17299060
OPRM1	4988	Heroin Dependence	MESH:D006556	marker/mechanism		NA		20201854
OPRM1	4988	Hyperalgesia	MESH:D006930	marker/mechanism		NA		17996026
OPRM1	4988	Hypotension, Orthostatic	MESH:D007024	marker/mechanism		NA		2981652
OPRM1	4988	Morphine Dependence	MESH:D009021	marker/mechanism		NA		3720824
OPRM1	4988	Movement Disorders	MESH:D009069	marker/mechanism		NA		20298714
OPRM1	4988	Nausea	MESH:D009325	marker/mechanism		NA		27192616
OPRM1	4988	Neuralgia	MESH:D009437	marker/mechanism		NA		14718584|18400411
OPRM1	4988	Pruritus	MESH:D011537	marker/mechanism		NA		27192616
OPRM1	4988	Psychoses, Substance-Induced	MESH:D011605	marker/mechanism		NA		16402083
OPRM1	4988	Respiratory Insufficiency	MESH:D012131	marker/mechanism		NA		27192616
OPRM1	4988	Seizures	MESH:D012640	marker/mechanism		NA		1675896|18042875
OPRM1	4988	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		27192616
OPTN	10133	Amyotrophic Lateral Sclerosis	MESH:D000690	marker/mechanism		NA		21059646|25096716
OPTN	10133	AMYOTROPHIC LATERAL SCLEROSIS 12	OMIM:613435	marker/mechanism		NA	613435	
OPTN	10133	GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO	OMIM:606657	marker/mechanism		NA	606657	
OPTN	10133	Glaucoma, Open-Angle	MESH:D005902	marker/mechanism		NA	137760	21059646|25096716
OPTN	10133	Osteitis Deformans	MESH:D010001	marker/mechanism		NA		20436471|21059646
OR2B3	442184	Dermatitis, Irritant	MESH:D017453	marker/mechanism		NA		27258892
OR4C13	283092	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		23797736
OR4C46	119749	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
OR51E1	143503	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
OR5J2	282775	Skin Diseases	MESH:D012871	marker/mechanism		NA		28720099
OR8S1	341568	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		26039340
ORAI1	84876	Hypertension	MESH:D006973	marker/mechanism		NA		19897708
ORAI1	84876	Immune dysfunction with T-cell inactivation due to calcium entry defect 1	MESH:C557826	marker/mechanism		NA	612782	
ORAI1	84876	Myopathies, Structural, Congenital	MESH:D020914	marker/mechanism		NA	615883	
ORC1	4998	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
ORC1	4998	Dwarfism	MESH:D004392	marker/mechanism		NA		21358633
ORC1	4998	Fetal Growth Retardation	MESH:D005317	marker/mechanism		NA		21358633
ORC1	4998	Meier-Gorlin syndrome	MESH:C538012	marker/mechanism		NA	224690	21358632
ORC1	4998	Microcephaly	MESH:D008831	marker/mechanism		NA		21358633
ORC4	5000	Meier-Gorlin syndrome	MESH:C538012	marker/mechanism		NA	613800	21358631|21358632
ORC6	23594	Meier-Gorlin syndrome	MESH:C538012	marker/mechanism		NA	613803	21358632
ORM1	5004	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		28885000
ORM1	5004	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		28885000
ORM1	5004	Liver Failure	MESH:D017093	therapeutic		NA		18256743
ORMDL3	94103	Asthma	MESH:D001249	marker/mechanism		NA		21150878|25256354
ORMDL3	94103	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		20228799
OSBPL2	9885	DEAFNESS, AUTOSOMAL DOMINANT 67	OMIM:616340	marker/mechanism		NA	616340	
OSBPL8	114882	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
OSGEP	55644	Galloway Mowat syndrome	MESH:C537548	marker/mechanism		NA		28805828
OSGIN1	29948	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
OSM	5008	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
OSM	5008	Carcinoma, Pancreatic Ductal	MESH:D021441	marker/mechanism		NA		24979617
OSM	5008	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
OSM	5008	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
OSM	5008	Liver Cirrhosis, Experimental	MESH:D008106	therapeutic		NA		17640959
OSM	5008	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		21937440
OSMR	9180	Amyloidosis IX	MESH:C562643	marker/mechanism		NA	105250	
OSMR	9180	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		15496427
OSMR	9180	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
OSR2	116039	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
OSTM1	28962	Osteopetrosis, Autosomal Recessive 5	MESH:C566883	marker/mechanism		NA	259720	
OTC	5009	Brain Diseases	MESH:D001927	marker/mechanism		NA		8778603
OTC	5009	Cognition Disorders	MESH:D003072	marker/mechanism		NA		8778603
OTC	5009	Endotoxemia	MESH:D019446	marker/mechanism		NA		16741687
OTC	5009	Hyperammonemia	MESH:D022124	marker/mechanism		NA		10227223|11286510|19669271|20406775|6825366|8424807|8562862|8581365|8778603|9598692
OTC	5009	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
OTC	5009	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		24161480
OTC	5009	Ornithine Carbamoyltransferase Deficiency Disease	MESH:D020163	marker/mechanism|therapeutic		NA		16677864|19669271|8778603
OTC	5009	ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO	OMIM:311250	marker/mechanism		NA	311250	
OTOA	146183	Deafness, Autosomal Recessive 22	MESH:C564633	marker/mechanism		NA	607039	
OTOF	9381	Deafness	MESH:D003638	marker/mechanism		NA		17967520
OTOF	9381	Deafness, Autosomal Recessive 9	MESH:C563396	marker/mechanism		NA	601071	
OTOG	340990	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
OTOG	340990	DEAFNESS, AUTOSOMAL RECESSIVE 18B	OMIM:614945	marker/mechanism		NA	614945	
OTOGL	283310	DEAFNESS, AUTOSOMAL RECESSIVE 84B	OMIM:614944	marker/mechanism		NA	614944	
OTUB2	78990	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
OTUD6B	51633	INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	OMIM:617452	marker/mechanism		NA	617452	
OTULIN	90268	AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME	OMIM:617099	marker/mechanism		NA	617099	
OTULINL	54491	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
OTX2	5015	Combined Pituitary Hormone Deficiency	MESH:C580003	marker/mechanism		NA	613986	
OTX2	5015	Jaw Abnormalities	MESH:D007569	marker/mechanism		NA		12183386
OTX2	5015	Medulloblastoma	MESH:D008527	marker/mechanism		NA		19270706
OTX2	5015	Microphthalmia, Syndromic 5	MESH:C566441	marker/mechanism		NA	610125	
OTX2	5015	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		20573704
OVAL	101801591	Airway Obstruction	MESH:D000402	marker/mechanism		NA		29986831
OVAL	101801591	Airway Remodeling	MESH:D056151	marker/mechanism		NA		28935613
OVAL	101801591	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		30713661
OVAL	101801591	Asthma	MESH:D001249	marker/mechanism		NA		22733167|23062010|24950052|25739523|26549244|28529457
OVAL	101801591	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		22733167|24950052|26549244|30148989
OVAL	101801591	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		24950052
OVAL	101801591	Hyperplasia	MESH:D006965	marker/mechanism		NA		25127755|28529457
OVAL	101801591	Hypersensitivity	MESH:D006967	marker/mechanism		NA		16979384|25127755|28529457
OVAL	101801591	Hypothermia	MESH:D007035	marker/mechanism		NA		27682001
OVAL	101801591	Inflammation	MESH:D007249	marker/mechanism		NA		29986831
OVAL	101801591	Pneumonia	MESH:D011014	marker/mechanism		NA		23642096
OVAL	101801591	Pulmonary Edema	MESH:D011654	marker/mechanism		NA		30713661
OVAL	101801591	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		29758289
OVAL	101801591	Respiratory Hypersensitivity	MESH:D012130	marker/mechanism		NA		28935613|29758289
OVAL	101801591	Rhinitis, Allergic	MESH:D065631	marker/mechanism		NA		24131540|30148989
OVAL	101801591	Splenomegaly	MESH:D013163	marker/mechanism		NA		24051191|24131540
OVGP1	5016	Pneumoconiosis	MESH:D011009	marker/mechanism		NA		25445010
OVOL1	5017	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		23042114
OVOL1	5017	Pilomatrixoma	MESH:D018296	marker/mechanism		NA		26873447
OVOL2	58495	Corneal Dystrophy, Posterior Polymorphous, 1	MESH:C562745	marker/mechanism		NA	122000	26749309
OVOL2	58495	Pilomatrixoma	MESH:D018296	marker/mechanism		NA		26873447
OXCT1	5019	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
OXCT1	5019	Succinyl-CoA:3-oxoacid CoA transferase deficiency	MESH:C537527	marker/mechanism		NA	245050	
OXSR1	9943	Hypertension	MESH:D006973	therapeutic		NA		22949526
OXT	5020	Anxiety Disorders	MESH:D001008	therapeutic		NA		19228979
OXT	5020	Autistic Disorder	MESH:D001321	marker/mechanism|therapeutic		NA		15288368|18775368
OXT	5020	Carcinoma	MESH:D002277	therapeutic		NA		8647655
OXT	5020	Colonic Neoplasms	MESH:D003110	therapeutic		NA		8647655
OXT	5020	Coma	MESH:D003128	marker/mechanism		NA		19397503|292422|5067144
OXT	5020	Disseminated Intravascular Coagulation	MESH:D004211	marker/mechanism		NA		15547535
OXT	5020	Dysmenorrhea	MESH:D004412	marker/mechanism		NA		10440088
OXT	5020	Edema	MESH:D004487	marker/mechanism		NA		5067144|5538905
OXT	5020	Epilepsy, Tonic-Clonic	MESH:D004830	marker/mechanism		NA		4988877|6407273
OXT	5020	Fetal Death	MESH:D005313	marker/mechanism		NA		5067144
OXT	5020	Fetal Distress	MESH:D005316	marker/mechanism		NA		2862618
OXT	5020	Flushing	MESH:D005483	marker/mechanism		NA		7080326
OXT	5020	Headache	MESH:D006261	marker/mechanism		NA		7080326
OXT	5020	Hyperkinesis	MESH:D006948	therapeutic		NA		18092152
OXT	5020	Hypertension	MESH:D006973	therapeutic		NA		18562099|9334988
OXT	5020	Hyponatremia	MESH:D007010	marker/mechanism		NA		19397503|3923190|6407273
OXT	5020	Hypotension	MESH:D007022	marker/mechanism		NA		11171655
OXT	5020	Inflammation	MESH:D007249	therapeutic		NA		18940936
OXT	5020	Ischemia	MESH:D007511	marker/mechanism		NA		10440088
OXT	5020	Mammary Neoplasms, Experimental	MESH:D008325	therapeutic		NA		15089975|8647655
OXT	5020	Muscle Hypertonia	MESH:D009122	marker/mechanism		NA		2862618
OXT	5020	Pain	MESH:D010146	therapeutic		NA		17420069|6094376
OXT	5020	Polyuria	MESH:D011141	marker/mechanism		NA		20649851
OXT	5020	Prostatic Diseases	MESH:D011469	marker/mechanism		NA		17492653
OXT	5020	Seizures	MESH:D012640	marker/mechanism		NA		19397503|292422|3923190|5067144|5493616|644406
OXT	5020	Spasm	MESH:D013035	marker/mechanism		NA		2444298|3567346|5784655|8680739
OXT	5020	Taste Disorders	MESH:D013651	marker/mechanism		NA		7080326
OXT	5020	Water Intoxication	MESH:D014869	marker/mechanism		NA		292422|3923190|4988877|5067144|5493616|5528113|7360068|803783
OXT	5020	Weight Gain	MESH:D015430	marker/mechanism		NA		18562099
OXT	5020	Weight Loss	MESH:D015431	marker/mechanism		NA		18562099
OXTR	5021	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		20832055
OXTR	5021	Autistic Disorder	MESH:D001321	marker/mechanism		NA		15288368|15992526|17383819|17893705|18207134|21082655
OXTR	5021	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		17043644
OXTR	5021	Chromosome 3, monosomy 3p25	MESH:C536807	marker/mechanism		NA		21082655
OXTR	5021	Cognition Disorders	MESH:D003072	marker/mechanism		NA		20347913
OXTR	5021	Schizophrenia	MESH:D012559	marker/mechanism		NA		20196918
P2RX1	5023	Neurotoxicity Syndromes	MESH:D020258	marker/mechanism		NA		19784758
P2RX2	22953	Deafness, Autosomal Dominant 41	MESH:C564272	marker/mechanism		NA	608224	
P2RX2	22953	Epilepsy	MESH:D004827	marker/mechanism		NA		12941474
P2RX2	22953	Hyperalgesia	MESH:D006930	marker/mechanism		NA		19383439
P2RX3	5024	Hyperalgesia	MESH:D006930	marker/mechanism		NA		19383439
P2RX3	5024	Trauma, Nervous System	MESH:D020196	marker/mechanism		NA		24136739
P2RX4	5025	Epilepsy	MESH:D004827	marker/mechanism		NA		12941474
P2RX4	5025	Epilepsy, Temporal Lobe	MESH:D004833	marker/mechanism		NA		19084381
P2RX7	5027	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27466191
P2RX7	5027	Epilepsy, Temporal Lobe	MESH:D004833	marker/mechanism		NA		12121326|19084381
P2RX7	5027	Hypophosphatasia	MESH:D007014	marker/mechanism		NA		27466191
P2RX7	5027	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		11003599
P2RX7	5027	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		17728465
P2RX7	5027	Spinal Cord Injuries	MESH:D013119	therapeutic		NA		15258577
P2RY1	5028	Thrombosis	MESH:D013927	marker/mechanism		NA		17334511
P2RY11	5032	Narcolepsy	MESH:D009290	marker/mechanism		NA		21170044
P2RY12	64805	BLEEDING DISORDER, PLATELET-TYPE, 8	OMIM:609821	marker/mechanism		NA	609821	
P2RY12	64805	Hemorrhage	MESH:D006470	marker/mechanism		NA		11196645
P2RY12	64805	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		15304052
P2RY12	64805	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		19334620
P2RY12	64805	Thrombosis	MESH:D013927	marker/mechanism		NA		17334511
P2RY8	286530	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		19838194
P3H1	64175	Osteogenesis Imperfecta	MESH:D010013	marker/mechanism		NA		18566967
P3H1	64175	Osteogenesis imperfecta, type VIII	MESH:C536049	marker/mechanism		NA	610915	
P3H2	55214	MYOPIA, HIGH, WITH CATARACT AND VITREORETINAL DEGENERATION	OMIM:614292	marker/mechanism		NA	614292	
P3H3	10536	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
P4HA2	8974	MYOPIA 25, AUTOSOMAL DOMINANT	OMIM:617238	marker/mechanism		NA	617238	
P4HB	5034	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
P4HB	5034	Cole Carpenter syndrome	MESH:C535963	marker/mechanism		NA	112240	
P4HB	5034	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
P4HB	5034	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
P4HB	5034	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
P4HB	5034	Spinocerebellar Ataxia 17	MESH:C564616	marker/mechanism		NA		24413982
PA2G4	5036	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
PA2G4	5036	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
PABPC1	26986	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21466612
PABPC1	26986	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		25783786
PABPC1	26986	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		25783786
PABPC4	8761	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
PABPC4	8761	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
PABPN1	8106	Muscular Dystrophy, Oculopharyngeal	MESH:D039141	marker/mechanism		NA	164300	12823221|16239242|25728001
PACS1	55690	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		31043756
PACS1	55690	Obesity	MESH:D009765	marker/mechanism		NA		23563609
PACS1	55690	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
PACSIN2	11252	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
PADI3	51702	Uncombable hair syndrome	MESH:C536939	marker/mechanism		NA	191480	
PADI4	23569	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA	180300	23143596
PADI4	23569	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
PADI4	23569	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
PADI4	23569	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
PADI6	353238	PREIMPLANTATION EMBRYONIC LETHALITY 2	OMIM:617234	marker/mechanism		NA	617234	
PAEP	5047	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
PAEP	5047	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		22296396
PAFAH1B1	5048	Carcinogenesis	MESH:D063646	marker/mechanism		NA		24487275
PAFAH1B1	5048	Lissencephaly	MESH:D054082	marker/mechanism		NA	607432	
PAG1	55824	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		23334668
PAG1	55824	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
PAGE4	9506	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		26213588
PAH	5053	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		31209396
PAH	5053	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
PAH	5053	Phenylketonurias	MESH:D010661	marker/mechanism		NA	261600	
PAIP2	51247	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		25944804
PAK1	5058	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20179234
PAK1	5058	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		17621631
PAK1	5058	Proteinuria	MESH:D011507	marker/mechanism		NA		20071462
PAK2	5062	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
PAK2	5062	Proteinuria	MESH:D011507	marker/mechanism		NA		20071462
PAK2	5062	Schizophrenia	MESH:D012559	marker/mechanism		NA		20691406
PAK3	5063	Mental Retardation, X-Linked 30	MESH:C563146	marker/mechanism		NA	300558	
PAK4	10298	Neuroblastoma	MESH:D009447	marker/mechanism		NA		29048629
PAK6	56924	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		18642328
PAKAP	677884	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
PALB2	79728	Breast Neoplasms	MESH:D001943	marker/mechanism		NA	114480	28825726
PALB2	79728	Fanconi Anemia, Complementation Group N	MESH:C563657	marker/mechanism		NA	610832	
PALB2	79728	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA	613348	26098869
PALB2	79728	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
PALLD	23022	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA	606856	
PALLD	23022	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
PALMD	54873	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PAM	5066	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		19815072
PAM	5066	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		24464100|30054598
PAM	5066	Seizures	MESH:D012640	marker/mechanism		NA		19815072
PAMR1	25891	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
PAMR1	25891	Heart Failure	MESH:D006333	marker/mechanism		NA		28751527
PAMR1	25891	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		28751527
PAMR1	25891	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PAN2	9924	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		26881866
PAN2	9924	Cholestasis	MESH:D002779	marker/mechanism		NA		26881866
PANK2	80025	Hypoprebetalipoproteinemia, Acanthocytosis, Retinitis Pigmentosa, And Pallidal Degeneration	MESH:C564603	marker/mechanism		NA	607236	
PANK2	80025	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		20493851
PANK2	80025	Neurodegeneration with brain iron accumulation (NBIA)	MESH:C538421	marker/mechanism		NA		20629144
PANK2	80025	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		16450344|17296847
PANK2	80025	Pantothenate Kinase-Associated Neurodegeneration	MESH:D006211	marker/mechanism		NA	234200	14580665
PANX1	24145	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		29246445
PANX1	24145	Liver Failure, Acute	MESH:D017114	marker/mechanism		NA		29246445
PANX1	24145	Massive Hepatic Necrosis	MESH:D047508	marker/mechanism		NA		29246445
PAOX	196743	Stroke	MESH:D020521	marker/mechanism		NA		16269634
PAPPA	5069	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		11586954
PAPPA	5069	Angina, Unstable	MESH:D000789	marker/mechanism		NA		11586954
PAPPA	5069	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		11586954
PAPPA	5069	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
PAPPA	5069	Infertility, Female	MESH:D007247	marker/mechanism		NA		20130263
PAPPA	5069	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		11586954
PAPSS2	9060	Spondyloepimetaphyseal Dysplasia, Pakistani Type	MESH:C567551	marker/mechanism		NA	612847	
PAQR4	124222	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		27415467
PAQR4	124222	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		27415467
PAQR9	344838	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PARA	32619	Paralysis	MESH:D010243	marker/mechanism		NA		14978727
PARA	32619	Seizures	MESH:D012640	marker/mechanism		NA		14978727
PARD3	56288	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		28319090
PARD3B	117583	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
PARG	8505	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism|therapeutic		NA		25628927|27003318
PARG	8505	Embryo Loss	MESH:D020964	marker/mechanism		NA		15591342
PARK16	100359403	Parkinson Disease	MESH:D010300	marker/mechanism		NA		19915575|19915576
PARK7	11315	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
PARK7	11315	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
PARK7	11315	Enterocolitis, Necrotizing	MESH:D020345	marker/mechanism		NA		18806098
PARK7	11315	Nerve Degeneration	MESH:D009410	therapeutic		NA		29649621
PARK7	11315	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
PARK7	11315	Parkinson Disease	MESH:D010300	marker/mechanism		NA		15784737|17010972|20423725|20800516|22043175|22898350|23037695|23792957|25149416
PARK7	11315	Parkinson Disease 7, Autosomal Recessive Early-Onset	MESH:C565238	marker/mechanism		NA	606324	28348719
PARK7	11315	Parkinsonian Disorders	MESH:D020734	marker/mechanism		NA		23046578|26558463
PARK7	11315	Reticulocytosis	MESH:D045262	marker/mechanism		NA		20800516
PARN	5073	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	OMIM:616353	marker/mechanism		NA	616353	
PARN	5073	Idiopathic Pulmonary Fibrosis	MESH:D054990	marker/mechanism		NA		25848748
PARN	5073	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 4	OMIM:616371	marker/mechanism		NA	616371	
PARP1	142	Alopecia	MESH:D000505	marker/mechanism		NA		20561897
PARP1	142	Anemia	MESH:D000740	marker/mechanism		NA		20561897
PARP1	142	Aortic Aneurysm, Abdominal	MESH:D017544	marker/mechanism		NA		30354818
PARP1	142	Asthma	MESH:D001249	marker/mechanism		NA		18261157
PARP1	142	Atherosclerosis	MESH:D050197	marker/mechanism		NA		18093987|19124646
PARP1	142	Brain Injuries	MESH:D001930	marker/mechanism		NA		17640816
PARP1	142	Brain Injuries, Traumatic	MESH:D000070642	marker/mechanism		NA		15829224|28642177
PARP1	142	Brain Ischemia	MESH:D002545	marker/mechanism		NA		17640816
PARP1	142	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20941507
PARP1	142	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		18695907
PARP1	142	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		20561897
PARP1	142	Ceroid lipofuscinosis, neuronal 1, infantile	MESH:C537948	marker/mechanism		NA		21224254
PARP1	142	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		27694308
PARP1	142	Dermatitis	MESH:D003872	marker/mechanism		NA		20561897
PARP1	142	Hepatitis	MESH:D006505	marker/mechanism		NA		20561897
PARP1	142	Inflammation	MESH:D007249	marker/mechanism		NA		18261157
PARP1	142	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
PARP1	142	Kidney Diseases	MESH:D007674	marker/mechanism		NA		20561897|21884784
PARP1	142	Kyphosis	MESH:D007738	marker/mechanism		NA		20561897
PARP1	142	Lung Injury	MESH:D055370	marker/mechanism		NA		16127429
PARP1	142	Melanoma	MESH:D008545	marker/mechanism		NA		28759004
PARP1	142	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		21543585
PARP1	142	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		21917757
PARP1	142	Obesity	MESH:D009765	marker/mechanism		NA		20561897
PARP1	142	Pancreatitis	MESH:D010195	marker/mechanism		NA		16127429
PARP1	142	Paralysis	MESH:D010243	marker/mechanism		NA		15696051
PARP1	142	Parkinsonian Disorders	MESH:D020734	marker/mechanism		NA		17640816
PARP1	142	Plaque, Atherosclerotic	MESH:D058226	marker/mechanism		NA		18093987|19124646
PARP1	142	Pneumonia	MESH:D011014	marker/mechanism		NA		20561897
PARP1	142	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		15342424
PARP1	142	Pulmonary Edema	MESH:D011654	therapeutic		NA		11818323
PARP1	142	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		27704718
PARP1	142	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		15696051|16798486
PARP1	142	Spinal Cord Injuries	MESH:D013119	marker/mechanism		NA		15696051
PARP1	142	Spinal Cord Ischemia	MESH:D020760	marker/mechanism		NA		15696051
PARP1	142	Stevens-Johnson Syndrome	MESH:D013262	marker/mechanism		NA		25811541
PARP1	142	Vitamin A Deficiency	MESH:D014802	marker/mechanism		NA		18676402
PARP12	64761	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
PARP12	64761	Macular Degeneration	MESH:D008268	marker/mechanism		NA		30742112
PARP2	10038	Lipodystrophy	MESH:D008060	marker/mechanism		NA		21417348
PARP4	143	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		16204055
PARVA	55742	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
PAS1	112278	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		11992545|12807761
PASK	23178	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19365831
PASK	23178	Chromosome 2q37 deletion syndrome	MESH:C538317	marker/mechanism		NA		19365831
PATJ	10207	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
PATJ	10207	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
PAWR	5074	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		15877079
PAWR	5074	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		15877079
PAWR	5074	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		15877079
PAX1	5075	Otofaciocervical Syndrome	MESH:C563481	marker/mechanism		NA	615560	
PAX2	5076	Endometriosis	MESH:D004715	marker/mechanism		NA		22473392
PAX2	5076	Female Urogenital Diseases	MESH:D052776	marker/mechanism		NA		16002989
PAX2	5076	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA	616002	
PAX2	5076	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		16631587
PAX2	5076	Papillorenal syndrome	MESH:C537168	marker/mechanism		NA	120330	
PAX3	5077	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		14556253
PAX3	5077	Craniofacial deafness hand syndrome	MESH:C536453	marker/mechanism		NA	122880	18553554
PAX3	5077	Deafness	MESH:D003638	marker/mechanism		NA		14556253
PAX3	5077	Hand Deformities, Congenital	MESH:D006228	marker/mechanism		NA		14556253
PAX3	5077	Nervous System Malformations	MESH:D009421	marker/mechanism		NA		7556916
PAX3	5077	Neural Tube Defects	MESH:D009436	marker/mechanism|therapeutic		NA		12739027|12854658|3293260
PAX3	5077	Rhabdomyosarcoma, Alveolar	MESH:D018232	marker/mechanism		NA	268220	
PAX3	5077	Sarcoma	MESH:D012509	marker/mechanism		NA		24859338
PAX3	5077	Sinonasal undifferentiated carcinoma	MESH:C537344	marker/mechanism		NA		24859338
PAX3	5077	Spinal Dysraphism	MESH:D016135	marker/mechanism		NA		12854658|17149730|3902948|6385329
PAX3	5077	Waardenburg Syndrome	MESH:D014849	marker/mechanism		NA	148820|193500	18553554
PAX4	5078	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA	612227	
PAX4	5078	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA	125853	
PAX4	5078	Maturity-Onset Diabetes Of The Young, Type 9	MESH:C567393	marker/mechanism		NA	612225	
PAX4	5078	Melanoma	MESH:D008545	marker/mechanism		NA		18949370
PAX5	5079	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
PAX5	5079	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D015452	marker/mechanism		NA		24013638|30643249
PAX5	5079	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA	615545	26214592
PAX6	5080	Aniridia	MESH:D015783	marker/mechanism		NA	106210	18322702|30221735
PAX6	5080	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18322702
PAX6	5080	AXENFELD-RIEGER SYNDROME, TYPE 1	OMIM:180500	marker/mechanism		NA		14630904
PAX6	5080	Cataract	MESH:D002386	marker/mechanism		NA		30221735
PAX6	5080	Coloboma	MESH:D003103	marker/mechanism		NA	120200	
PAX6	5080	Coloboma of optic nerve	MESH:C535970	marker/mechanism		NA	120430	
PAX6	5080	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		7559133|9079035|9363853
PAX6	5080	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		16123366
PAX6	5080	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		16123366
PAX6	5080	Intellectual Disability	MESH:D008607	marker/mechanism		NA		18322702
PAX6	5080	Keratitis, hereditary	MESH:C537022	marker/mechanism		NA	148190	
PAX6	5080	Melanoma	MESH:D008545	marker/mechanism		NA		16778180
PAX6	5080	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		26213588
PAX6	5080	Nervous System Malformations	MESH:D009421	marker/mechanism		NA		19329571
PAX6	5080	O'Donnell Pappas syndrome	MESH:C537858	marker/mechanism		NA	136520	
PAX6	5080	Optic Nerve Diseases	MESH:D009901	marker/mechanism		NA		12721955
PAX6	5080	Optic Nerve Hypoplasia, Bilateral	MESH:C563492	marker/mechanism		NA	165550	
PAX6	5080	Peters anomaly	MESH:C537884	marker/mechanism		NA	604229	
PAX6	5080	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
PAX6	5080	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
PAX6	5080	Tooth Abnormalities	MESH:D014071	marker/mechanism		NA		7559133|9363853
PAX6	5080	WAGR Syndrome	MESH:D017624	marker/mechanism		NA	194072	
PAX7	5081	Rhabdomyosarcoma, Alveolar	MESH:D018232	marker/mechanism		NA	268220	
PAX8	7849	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		26075790
PAX8	7849	Hypothyroidism, Congenital, Nongoitrous, 2	MESH:C566852	marker/mechanism		NA	218700	
PAX8	7849	Thyroid cancer, follicular	MESH:C572845	marker/mechanism		NA		15785241
PAX9	5083	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
PAX9	5083	Tooth Agenesis, Selective, 3	MESH:C567036	marker/mechanism		NA	604625	
PBK	55872	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
PBK	55872	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
PBLD	64081	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21472284
PBRM1	55193	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		22138691|23797736
PBRM1	55193	Cholangiocarcinoma	MESH:D018281	marker/mechanism		NA		24185509
PBRM1	55193	Thymoma	MESH:D013945	marker/mechanism		NA		24974848
PBSN	54192	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
PBW1	112230	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		11529278
PBX1	5087	Burkitt Lymphoma	MESH:D002051	marker/mechanism		NA		17244677|1967982
PBX1	5087	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
PBX4	80714	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		16759393
PC	5091	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		31043756
PC	5091	Burkitt Lymphoma	MESH:D002051	marker/mechanism		NA		23143597
PC	5091	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
PC	5091	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
PC	5091	Pyruvate Carboxylase Deficiency Disease	MESH:D015324	marker/mechanism		NA	266150	
PCARE	388939	RETINITIS PIGMENTOSA 54	OMIM:613428	marker/mechanism		NA	613428	
PCAT1	100750225	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		26752646
PCBD1	5092	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
PCBD1	5092	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
PCBD1	5092	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	OMIM:264070	marker/mechanism		NA	264070	
PCCA	5095	Propionic Acidemia	MESH:D056693	marker/mechanism		NA	606054	
PCCB	5096	Propionic Acidemia	MESH:D056693	marker/mechanism		NA	606054	
PCDH10	57575	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18621663
PCDH11X	27328	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		19136949
PCDH11Y	83259	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16637074
PCDH15	65217	Cochlear Diseases	MESH:D015834	marker/mechanism		NA		10978835
PCDH15	65217	Deafness	MESH:D003638	marker/mechanism		NA		10978835
PCDH15	65217	Deafness, Autosomal Recessive 23	MESH:C563705	marker/mechanism		NA	609533	
PCDH15	65217	Hearing Loss	MESH:D034381	marker/mechanism		NA		30029624
PCDH15	65217	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
PCDH15	65217	Usher Syndromes	MESH:D052245	marker/mechanism		NA		19309154
PCDH15	65217	Usher syndrome, type 1D	MESH:C536487	marker/mechanism		NA	601067	
PCDH15	65217	Usher syndrome, type 1F	MESH:C536489	marker/mechanism		NA	602083	
PCDH19	57526	Epilepsy	MESH:D004827	marker/mechanism		NA		18469813
PCDH19	57526	Epilepsy, Female-Restricted, with Mental Retardation	MESH:C564715	marker/mechanism		NA	300088	
PCDH19	57526	Mental Retardation, X-Linked	MESH:D038901	marker/mechanism		NA		18469813
PCDH8	5100	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		19208208
PCDH9	5101	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		18252227
PCDHA13	56136	Hypoplastic Left Heart Syndrome	MESH:D018636	marker/mechanism		NA		28530678
PCDHA3	56145	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
PCDHA9	9752	Heart Valve Diseases	MESH:D006349	marker/mechanism		NA		28530678
PCDHA9	9752	Hypoplastic Left Heart Syndrome	MESH:D018636	marker/mechanism		NA		28530678
PCDHB8	56128	Melanoma	MESH:D008545	marker/mechanism		NA		21499247
PCDHGB6	56100	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		15818620
PCK1	5105	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		19363144|28284560
PCK1	5105	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
PCK1	5105	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		20363216
PCK1	5105	Heart Failure	MESH:D006333	marker/mechanism		NA		26670611
PCK1	5105	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
PCK1	5105	Obesity	MESH:D009765	marker/mechanism		NA		20882379
PCK1	5105	Phosphoenolpyruvate carboxykinase deficiency	MESH:C536654	marker/mechanism		NA	261680	
PCK2	5106	Hypoxia	MESH:D000860	marker/mechanism		NA		18258771
PCK2	5106	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PCK2	5106	Phosphoenolpyruvate carboxykinase 2 deficiency	MESH:C536655	marker/mechanism		NA	261650	
PCLAF	9768	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
PCLO	27445	Pontocerebellar Hypoplasia Type 3	MESH:C548072	marker/mechanism		NA	608027	
PCM1	5108	Schizophrenia	MESH:D012559	marker/mechanism		NA		19048012
PCMT1	5110	Spinal Dysraphism	MESH:D016135	marker/mechanism		NA		16256389
PCNA	5111	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		19028472
PCNA	5111	Ataxia Telangiectasia Like Disorder	MESH:C565779	marker/mechanism		NA	615919	
PCNA	5111	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		20932960
PCNA	5111	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		19028472|19723570
PCNA	5111	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA		17121042
PCNA	5111	Hepatoblastoma	MESH:D018197	marker/mechanism		NA		11560253
PCNA	5111	Ischemia	MESH:D007511	marker/mechanism		NA		19458120
PCNA	5111	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		11884234
PCNA	5111	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		20932960
PCNA	5111	Psoriasis	MESH:D011565	marker/mechanism		NA		10384915
PCNA	5111	Radiation Injuries, Experimental	MESH:D011833	marker/mechanism		NA		21931560
PCNT	5116	Microcephalic Osteodysplastic Primordial Dwarfism, Type II	MESH:C565898	marker/mechanism		NA	210720	
PCNT	5116	Seckel syndrome 1	MESH:C537533	marker/mechanism		NA		18157127
PCNT	5116	Seckel syndrome 2	MESH:C537534	marker/mechanism		NA		18174396
PCNX3	399909	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		26808113
PCOLCE	5118	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
PCOLCE	5118	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		26396155
PCOLCE2	26577	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
PCP4	5121	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
PCSK1	5122	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 12	OMIM:612362	marker/mechanism		NA	612362	
PCSK1	5122	Body Weight	MESH:D001835	marker/mechanism		NA		22344219
PCSK1	5122	Obesity	MESH:D009765	marker/mechanism		NA		18604207
PCSK1	5122	Proprotein Convertase 1 3 Deficiency	MESH:C563423	marker/mechanism		NA	600955	
PCSK1N	27344	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
PCSK1N	27344	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
PCSK2	5126	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		16123366
PCSK2	5126	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		16123366
PCSK5	5125	Anus, Imperforate	MESH:D001006	marker/mechanism		NA		18519639
PCSK5	5125	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		18519639
PCSK5	5125	Currarino triad	MESH:C536221	marker/mechanism		NA		18519639
PCSK5	5125	Heart Septal Defects	MESH:D006343	marker/mechanism		NA		18519639
PCSK5	5125	Heart Septal Defects, Ventricular	MESH:D006345	marker/mechanism		NA		18519639
PCSK5	5125	Hernia, Umbilical	MESH:D006554	marker/mechanism		NA		18519639
PCSK5	5125	Jaw Abnormalities	MESH:D007569	marker/mechanism		NA		18519639
PCSK5	5125	Kidney Diseases	MESH:D007674	marker/mechanism		NA		18519639
PCSK5	5125	Lower Extremity Deformities, Congenital	MESH:D038061	marker/mechanism		NA		18519639
PCSK5	5125	Lung Diseases	MESH:D008171	marker/mechanism		NA		18519639
PCSK5	5125	Mouth Abnormalities	MESH:D009056	marker/mechanism		NA		18519639
PCSK5	5125	Sacral defect and anterior sacral meningocele	MESH:C537221	marker/mechanism		NA		18519639
PCSK5	5125	Tracheoesophageal Fistula	MESH:D014138	marker/mechanism		NA		18519639
PCSK5	5125	VATER association	MESH:C536534	marker/mechanism		NA		18519639
PCSK9	255738	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		21378990|27135400
PCSK9	255738	Hypercholesterolemia	MESH:D006937	marker/mechanism		NA		12730697
PCSK9	255738	Hypercholesterolemia, Autosomal Dominant, 3	MESH:C566337	marker/mechanism		NA	603776	
PCX	18563	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		16123366
PCX	18563	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		16123366
PCYOX1	51449	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
PCYT1A	5130	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
PCYT1A	5130	Spinal Dysraphism	MESH:D016135	marker/mechanism		NA		17184542
PCYT1A	5130	Spondylometaphyseal Dysplasia with Cone-Rod Dystrophy	MESH:C563825	marker/mechanism		NA	608940	
PCYT1B	9468	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
PDCD1	5133	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA	605218	
PDCD1	5133	Melanoma	MESH:D008545	therapeutic		NA		21802280
PDCD1	5133	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA	126200	
PDCD10	11235	Cerebral Cavernous Malformations 3	MESH:C566393	marker/mechanism		NA	603285	
PDCD4	27250	Cell Transformation, Neoplastic	MESH:D002471	therapeutic		NA		27323401|27344173|28881718
PDCD4	27250	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27323401
PDCD4	27250	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		23272133
PDCD6IP	10015	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
PDE10A	10846	DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET	OMIM:616921	marker/mechanism		NA	616921	
PDE10A	10846	STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2	OMIM:616922	marker/mechanism		NA	616922	
PDE11A	50940	Pigmented Nodular Adrenocortical Disease, Primary, 2	MESH:C566472	marker/mechanism		NA	610475	
PDE12	201626	Cardiovirus Infections	MESH:D018188	marker/mechanism		NA		26055709
PDE12	201626	Respiratory Syncytial Virus Infections	MESH:D018357	marker/mechanism		NA		26055709
PDE1B	5153	Learning Disabilities	MESH:D007859	marker/mechanism		NA		12077213
PDE1C	5137	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
PDE2A	5138	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		12972520
PDE3A	5139	Brachydactyly with hypertension	MESH:C537095	marker/mechanism		NA	112410	25961942
PDE3A	5139	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		19027736
PDE3A	5139	Stroke	MESH:D020521	marker/mechanism		NA		29531354
PDE3A	5139	Thrombosis	MESH:D013927	marker/mechanism		NA		17482796
PDE3B	5140	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
PDE4A	5141	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18090323
PDE4B	5142	Alcoholism	MESH:D000437	marker/mechanism		NA		18438686
PDE4B	5142	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
PDE4B	5142	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
PDE4B	5142	Asthma	MESH:D001249	marker/mechanism		NA		21912604
PDE4B	5142	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18090323
PDE4B	5142	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		18394866
PDE4B	5142	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
PDE4B	5142	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
PDE4B	5142	Schizophrenia	MESH:D012559	marker/mechanism		NA		16293762|18394866
PDE4B	5142	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
PDE4D	5144	Acrodysostosis	MESH:C538179	marker/mechanism		NA	614613	
PDE4D	5144	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
PDE4D	5144	Asthma	MESH:D001249	marker/mechanism		NA		19426955|21611147
PDE4D	5144	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16740699|29662167
PDE5A	8654	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		12972520
PDE6A	5145	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA		21039428|27551530|7493036
PDE6A	5145	RETINITIS PIGMENTOSA 43	OMIM:613810	marker/mechanism		NA	613810	
PDE6B	5158	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		17213800
PDE6B	5158	Night blindness, congenital stationary	MESH:C536122	marker/mechanism		NA		8075643
PDE6B	5158	Night Blindness, Congenital Stationary, Autosomal Dominant 2	MESH:C566869	marker/mechanism		NA	163500	
PDE6B	5158	Retinal Degeneration	MESH:D012162	marker/mechanism		NA		16123450|17213800|24586289|8692941
PDE6B	5158	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA		8394174
PDE6B	5158	RETINITIS PIGMENTOSA 40	OMIM:613801	marker/mechanism		NA	613801	
PDE6C	5146	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
PDE6C	5146	Cone Dystrophy 4	MESH:C567758	marker/mechanism		NA	613093	
PDE6G	5148	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA	268000	
PDE6G	5148	RETINITIS PIGMENTOSA 57	OMIM:613582	marker/mechanism		NA	613582	
PDE6H	5149	Color Vision Defects	MESH:D003117	marker/mechanism		NA		25739440
PDE6H	5149	Retinal Cone Dystrophy 3A	MESH:C566483	marker/mechanism		NA	610024	
PDE8B	8622	Adrenal Hyperplasia, Congenital	MESH:D000312	marker/mechanism		NA		18272904
PDE8B	8622	Basal Ganglia Diseases	MESH:D001480	marker/mechanism		NA		20085714
PDE8B	8622	Dysarthria	MESH:D004401	marker/mechanism		NA		20085714
PDE8B	8622	Muscle Rigidity	MESH:D009127	marker/mechanism		NA		20085714
PDE8B	8622	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		20085714
PDE8B	8622	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 3	OMIM:614190	marker/mechanism		NA	614190	
PDE8B	8622	Striatal Degeneration, Autosomal Dominant	MESH:C563783	marker/mechanism		NA	609161	
PDGFA	5154	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
PDGFA	5154	Bone Diseases, Endocrine	MESH:D001849	marker/mechanism		NA		18635661
PDGFA	5154	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037
PDGFA	5154	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462|16316942
PDGFA	5154	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PDGFA	5154	Lung Diseases	MESH:D008171	marker/mechanism		NA		20920717
PDGFA	5154	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462|16316942
PDGFA	5154	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462|16316942
PDGFA	5154	Mesothelioma	MESH:D008654	marker/mechanism		NA		11415934
PDGFA	5154	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		16324872
PDGFA	5154	Thrombocythemia, Essential	MESH:D013920	marker/mechanism		NA		15682418
PDGFA	5154	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		26037280
PDGFB	5155	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5	OMIM:615483	marker/mechanism		NA	615483	
PDGFB	5155	Basal Ganglia Diseases	MESH:D001480	marker/mechanism		NA		25938945
PDGFB	5155	Calcinosis	MESH:D002114	marker/mechanism		NA		25938945
PDGFB	5155	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		20506153
PDGFB	5155	Dermatofibrosarcoma	MESH:D018223	marker/mechanism		NA	607907	
PDGFB	5155	Fahr's disease	MESH:C536275	marker/mechanism		NA	213600	23913003
PDGFB	5155	Fibrosis	MESH:D005355	marker/mechanism		NA		22004089
PDGFB	5155	Gingival Hyperplasia	MESH:D005885	marker/mechanism		NA		8708960
PDGFB	5155	Meningioma, familial	MESH:C537443	marker/mechanism		NA	607174	
PDGFB	5155	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		15286697
PDGFB	5155	Retinal Diseases	MESH:D012164	therapeutic		NA		11840346
PDGFB	5155	Thrombocythemia, Essential	MESH:D013920	marker/mechanism		NA		15682418
PDGFC	56034	Mesothelioma	MESH:D008654	marker/mechanism		NA		15920167
PDGFD	80310	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		21378988
PDGFD	80310	Fibrosis	MESH:D005355	marker/mechanism		NA		25280005
PDGFD	80310	Lung Injury	MESH:D055370	marker/mechanism		NA		25280005
PDGFRA	5156	Chondrosarcoma, Mesenchymal	MESH:D018211	marker/mechanism		NA		12817616
PDGFRA	5156	Cleft Palate	MESH:D002972	marker/mechanism		NA		18264099
PDGFRA	5156	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		11023856
PDGFRA	5156	Fetal Death	MESH:D005313	marker/mechanism		NA		11023856
PDGFRA	5156	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		20028860
PDGFRA	5156	Heart Failure	MESH:D006333	marker/mechanism		NA		28347583
PDGFRA	5156	Hypereosinophilic Syndrome	MESH:D017681	marker/mechanism		NA	607685	16778211|28347583
PDGFRA	5156	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PDGFRA	5156	Lung Diseases	MESH:D008171	marker/mechanism		NA		20920717
PDGFRA	5156	Medulloblastoma	MESH:D008527	marker/mechanism		NA		19270706
PDGFRA	5156	Respiratory System Abnormalities	MESH:D015619	marker/mechanism		NA		11023856
PDGFRA	5156	Spinal Dysraphism	MESH:D016135	marker/mechanism		NA		11023856
PDGFRB	5159	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4	OMIM:615007	marker/mechanism		NA	615007	
PDGFRB	5159	Basal Ganglia Diseases	MESH:D001480	marker/mechanism		NA		25938945
PDGFRB	5159	Calcinosis	MESH:D002114	marker/mechanism		NA		25938945
PDGFRB	5159	Fahr's disease	MESH:C536275	marker/mechanism		NA	213600	
PDGFRB	5159	Fibromatosis, Congenital Generalized	MESH:C562978	marker/mechanism		NA	228550	
PDGFRB	5159	KOSAKI OVERGROWTH SYNDROME	OMIM:616592	marker/mechanism		NA	616592	
PDGFRB	5159	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		15623374|18466260
PDGFRB	5159	Myeloproliferative Disorder, Chronic, with Eosinophilia	MESH:C565054	marker/mechanism		NA	131440	
PDGFRB	5159	Penttinen-Aula syndrome	MESH:C536653	marker/mechanism		NA	601812	
PDGFRL	5157	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA	114550	
PDGFRL	5157	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	114500	
PDHA1	5160	Acidosis, Lactic	MESH:D000140	marker/mechanism		NA		2537010
PDHA1	5160	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
PDHA1	5160	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
PDHA1	5160	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
PDHA1	5160	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881|29335542
PDHA1	5160	Pyruvate Dehydrogenase Complex Deficiency Disease	MESH:D015325	marker/mechanism		NA	312170	2378353
PDHA1	5160	Pyruvate Metabolism, Inborn Errors	MESH:D015323	marker/mechanism		NA		2378353
PDHA1	5160	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
PDHB	5162	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		25401301
PDHB	5162	Pyruvate Dehydrogenase Complex Deficiency Disease	MESH:D015325	marker/mechanism		NA		15138885
PDHB	5162	Pyruvate Dehydrogenase E1-Beta Deficiency	MESH:C566729	marker/mechanism		NA	614111	
PDHX	8050	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
PDHX	8050	Pyruvate Dehydrogenase E3-Binding Protein Deficiency	MESH:C565447	marker/mechanism		NA	245349	
PDIA3	2923	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		21751358
PDIA3	2923	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
PDIA3	2923	Neoplasms	MESH:D009369	therapeutic		NA		17353921
PDIA3	2923	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17566973
PDIA3	2923	Spinocerebellar Ataxia 17	MESH:C564616	marker/mechanism		NA		24413982
PDK2	5164	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		21037199
PDK4	5166	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28003426
PDK4	5166	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism|therapeutic		NA		21182459|31809757
PDK4	5166	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		14563825
PDK4	5166	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
PDK4	5166	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		29289645
PDLIM4	8572	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
PDLIM4	8572	Osteoporosis	MESH:D010024	marker/mechanism		NA	166710	
PDLIM4	8572	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
PDLIM5	10611	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
PDLIM5	10611	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
PDP1	54704	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29335542
PDP1	54704	Pyruvate dehydrogenase phosphatase deficiency	MESH:C536258	marker/mechanism		NA	608782	
PDPK1	5170	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		24739482
PDPK1	5170	Heart Failure	MESH:D006333	marker/mechanism		NA		19429709
PDPK1	5170	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		21173233
PDPN	10630	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		22784439
PDPN	10630	Peritoneal Neoplasms	MESH:D010534	marker/mechanism		NA		22784439
PDRG1	81572	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
PDS5A	23244	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
PDSS1	23590	COENZYME Q10 DEFICIENCY, PRIMARY, 2	OMIM:614651	marker/mechanism		NA	614651	
PDSS2	57107	COENZYME Q10 DEFICIENCY, PRIMARY, 3	OMIM:614652	marker/mechanism		NA	614652	
PDX1	3651	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		16123366
PDX1	3651	Diabetes Mellitus, Permanent Neonatal	MESH:C563425	marker/mechanism		NA	606176	
PDX1	3651	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA	125853	16123366|24464100
PDX1	3651	Maturity-Onset Diabetes of the Young, Type 4	MESH:C563451	marker/mechanism		NA	606392	21115832
PDX1	3651	Pancreatic Agenesis, Congenital	MESH:C564908	marker/mechanism		NA	260370	22158542
PDX1	3651	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		19077462|25086665|26098869
PDXDC1	23042	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		25401301
PDXK	8566	Status Epilepticus	MESH:D013226	marker/mechanism		NA		19356691
PDYN	5173	Alcoholism	MESH:D000437	marker/mechanism		NA		17559549|18923396
PDYN	5173	Amnesia	MESH:D000647	therapeutic		NA		7768285
PDYN	5173	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		16529859
PDYN	5173	Bradycardia	MESH:D001919	marker/mechanism		NA		1676337|6131355|6716269
PDYN	5173	Cholestasis	MESH:D002779	marker/mechanism		NA		16919318
PDYN	5173	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		16184603|17559549|18575850|18923396
PDYN	5173	Dyskinesia, Drug-Induced	MESH:D004409	marker/mechanism		NA		21737418|9767399
PDYN	5173	Dyskinesias	MESH:D020820	marker/mechanism		NA		21984936
PDYN	5173	Hyperalgesia	MESH:D006930	marker/mechanism		NA		17670969
PDYN	5173	Hypercapnia	MESH:D006935	marker/mechanism		NA		11311734
PDYN	5173	Hypotension	MESH:D007022	marker/mechanism		NA		1676337|2536002|2566129|6131355
PDYN	5173	Hypoxia	MESH:D000860	marker/mechanism		NA		11311734
PDYN	5173	Movement Disorders	MESH:D009069	marker/mechanism		NA		20298714
PDYN	5173	Pain	MESH:D010146	marker/mechanism		NA		17670969|20068450
PDYN	5173	Parkinsonian Disorders	MESH:D020734	marker/mechanism		NA		9930741
PDYN	5173	Pruritus	MESH:D011537	marker/mechanism		NA		29669290
PDYN	5173	Respiration Disorders	MESH:D012120	marker/mechanism		NA		6131355
PDYN	5173	Respiratory Insufficiency	MESH:D012131	therapeutic		NA		6662192
PDYN	5173	Seizures	MESH:D012640	therapeutic		NA		1675896
PDYN	5173	Sensation Disorders	MESH:D012678	marker/mechanism		NA		19200067
PDYN	5173	Spinocerebellar ataxia 23	MESH:C537201	marker/mechanism		NA	610245	
PDZD7	79955	Usher syndrome, type 2A	MESH:C536490	marker/mechanism		NA	276901	
PDZD7	79955	Usher syndrome, type 2C	MESH:C536492	marker/mechanism		NA	605472	
PDZK1	5174	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25751625
PDZK1	5174	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
PDZK1	5174	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
PDZK1	5174	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
PDZK1IP1	10158	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
PDZRN3	23024	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PDZRN4	29951	Silicosis	MESH:D012829	marker/mechanism		NA		24986923
PEA15A	18611	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PEBP1	5037	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
PEBP1	5037	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		25329396
PEBP1	5037	Heart Failure	MESH:D006333	marker/mechanism		NA		26670611
PEBP1	5037	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
PEBP1	5037	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
PEBP1	5037	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
PEBP1	5037	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21472284
PECAM1	5175	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17509538
PECAM1	5175	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		10848805
PECAM1	5175	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		28530674
PECAM1	5175	Thrombocytopenia	MESH:D013921	marker/mechanism		NA		10848805
PECR	55825	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
PEG3	5178	Cholangiocarcinoma	MESH:D018281	marker/mechanism		NA		22561520
PEG3	5178	Liver Diseases, Parasitic	MESH:D008109	marker/mechanism		NA		22561520
PELI1	57162	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
PELI1	57162	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		31557154
PELI1	57162	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
PEMT	10400	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		29416063
PEMT	10400	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		29416063
PENK	5179	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
PENK	5179	Dyskinesia, Drug-Induced	MESH:D004409	marker/mechanism		NA		9767399
PENK	5179	Narcolepsy	MESH:D009290	marker/mechanism		NA		17521418
PENK	5179	Nervous System Diseases	MESH:D009422	therapeutic		NA		12030189
PENK	5179	Opioid-Related Disorders	MESH:D009293	marker/mechanism		NA		10321497
PENK	5179	Pain	MESH:D010146	therapeutic		NA		15833551
PENK	5179	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
PEPD	5184	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		22158537
PEPD	5184	Hepatomegaly	MESH:D006529	marker/mechanism		NA		16470701
PEPD	5184	Infections	MESH:D007239	marker/mechanism		NA		16470701
PEPD	5184	Organophosphate Poisoning	MESH:D062025	therapeutic		NA		22982776
PEPD	5184	Prolidase Deficiency	MESH:D056732	marker/mechanism		NA	170100	16470701|1972707
PEPD	5184	Respiratory Tract Diseases	MESH:D012140	marker/mechanism		NA		16470701
PEPD	5184	Skin Ulcer	MESH:D012883	marker/mechanism		NA		16470701
PEPD	5184	Splenomegaly	MESH:D013163	marker/mechanism		NA		16470701
PER1	5187	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
PER1	5187	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17264841
PER1	5187	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	MESH:D015464	marker/mechanism		NA		16999817
PER1	5187	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		20738730
PER2	8864	Advanced Sleep-Phase Syndrome, Familial	MESH:C565789	marker/mechanism		NA	604348	
PER2	8864	Alcoholic Intoxication	MESH:D000435	marker/mechanism		NA		15608650
PER2	8864	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	MESH:D015464	marker/mechanism		NA		16999817
PER2	8864	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		20434889|20738730
PER3	8863	Advanced Sleep-Phase Syndrome, Familial	MESH:C565789	marker/mechanism		NA	616882	
PER3	8863	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20625127
PER3	8863	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	MESH:D015464	marker/mechanism		NA		16999817
PER3	8863	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		20738730
PEX1	5189	Deafness enamel hypoplasia nail defects	MESH:C535994	marker/mechanism		NA	234580	
PEX1	5189	Peroxisome biogenesis disorders	MESH:C536664	marker/mechanism		NA		9398847|9398848|9539740
PEX1	5189	Refsum Disease, Infantile	MESH:D052919	marker/mechanism		NA	601539	
PEX1	5189	Zellweger Syndrome	MESH:D015211	marker/mechanism		NA	214100	10447258|26319495|9539740
PEX10	5192	PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER)	OMIM:614870	marker/mechanism		NA	614870	
PEX10	5192	PEROXISOME BIOGENESIS DISORDER 6B	OMIM:614871	marker/mechanism		NA	614871	
PEX10	5192	Peroxisome biogenesis disorders	MESH:C536664	marker/mechanism		NA		10862081|9683594|9700193
PEX10	5192	Zellweger Syndrome	MESH:D015211	marker/mechanism		NA		10862081|26319495|9683594|9700193
PEX11A	8800	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
PEX11A	8800	Dyslipidemias	MESH:D050171	marker/mechanism		NA		30585412
PEX11A	8800	Obesity	MESH:D009765	marker/mechanism		NA		30585412
PEX11B	8799	PEROXISOME BIOGENESIS DISORDER 14B	OMIM:614920	marker/mechanism		NA	614920	
PEX12	5193	PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER)	OMIM:614859	marker/mechanism		NA	614859	
PEX12	5193	Peroxisome biogenesis disorders	MESH:C536664	marker/mechanism		NA	266510	9090384
PEX12	5193	Zellweger Syndrome	MESH:D015211	marker/mechanism		NA		26319495|9090384
PEX13	5194	Adrenoleukodystrophy	MESH:D000326	marker/mechanism		NA		10441568
PEX13	5194	PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	OMIM:614883	marker/mechanism		NA	614883	
PEX13	5194	PEROXISOME BIOGENESIS DISORDER 11B	OMIM:614885	marker/mechanism		NA	614885	
PEX13	5194	Peroxisome biogenesis disorders	MESH:C536664	marker/mechanism		NA		10332040|10441568|19449432
PEX13	5194	Zellweger Syndrome	MESH:D015211	marker/mechanism		NA		10332040|19449432
PEX14	5195	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
PEX14	5195	PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	OMIM:614887	marker/mechanism		NA	614887	
PEX14	5195	Peroxisome biogenesis disorders	MESH:C536664	marker/mechanism		NA		15146459|18285423|20647552
PEX14	5195	Zellweger Syndrome	MESH:D015211	marker/mechanism		NA		15146459|18285423
PEX16	9409	PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER)	OMIM:614876	marker/mechanism		NA	614876	
PEX16	9409	PEROXISOME BIOGENESIS DISORDER 8B	OMIM:614877	marker/mechanism		NA	614877	
PEX16	9409	Peroxisome biogenesis disorders	MESH:C536664	marker/mechanism		NA		11890679|12223482
PEX16	9409	Zellweger Syndrome	MESH:D015211	marker/mechanism		NA		11890679
PEX19	5824	PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	OMIM:614886	marker/mechanism		NA	614886	
PEX19	5824	Peroxisome biogenesis disorders	MESH:C536664	marker/mechanism		NA		20683989
PEX19	5824	Zellweger Syndrome	MESH:D015211	marker/mechanism		NA		10051604
PEX2	5828	PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	OMIM:614866	marker/mechanism		NA	614866	
PEX2	5828	PEROXISOME BIOGENESIS DISORDER 5B	OMIM:614867	marker/mechanism		NA	614867	
PEX2	5828	Peroxisome biogenesis disorders	MESH:C536664	marker/mechanism		NA		10528859|1546315
PEX2	5828	Refsum Disease, Infantile	MESH:D052919	marker/mechanism		NA		10528859
PEX2	5828	Zellweger Syndrome	MESH:D015211	marker/mechanism		NA		1546315
PEX26	55670	Adrenoleukodystrophy	MESH:D000326	marker/mechanism		NA		12851857
PEX26	55670	PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER)	OMIM:614872	marker/mechanism		NA	614872	
PEX26	55670	PEROXISOME BIOGENESIS DISORDER 7B	OMIM:614873	marker/mechanism		NA	614873	
PEX26	55670	Peroxisome biogenesis disorders	MESH:C536664	marker/mechanism		NA		12851857
PEX26	55670	Refsum Disease, Infantile	MESH:D052919	marker/mechanism		NA		12851857
PEX26	55670	Zellweger Syndrome	MESH:D015211	marker/mechanism		NA		12851857|26319495
PEX3	8504	PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER)	OMIM:614882	marker/mechanism		NA	614882	
PEX3	8504	PEROXISOME BIOGENESIS DISORDER 10B	OMIM:617370	marker/mechanism		NA	617370	
PEX3	8504	Peroxisome biogenesis disorders	MESH:C536664	marker/mechanism		NA		10942428
PEX3	8504	Zellweger Syndrome	MESH:D015211	marker/mechanism		NA		10942428
PEX5	5830	PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER)	OMIM:214110	marker/mechanism		NA	214110	
PEX5	5830	PEROXISOME BIOGENESIS DISORDER 2B	OMIM:202370	marker/mechanism		NA	202370	
PEX5	5830	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5	OMIM:616716	marker/mechanism		NA	616716	
PEX6	5190	Deafness enamel hypoplasia nail defects	MESH:C535994	marker/mechanism		NA	616617	
PEX6	5190	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
PEX6	5190	PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	OMIM:614862	marker/mechanism		NA	614862	
PEX6	5190	PEROXISOME BIOGENESIS DISORDER 4B	OMIM:614863	marker/mechanism		NA	614863	
PEX6	5190	Peroxisome biogenesis disorders	MESH:C536664	marker/mechanism		NA		10408779|8940266
PEX6	5190	Zellweger Syndrome	MESH:D015211	marker/mechanism		NA		10408779|8940266
PEX7	5191	Chondrodysplasia Punctata, Rhizomelic	MESH:D018902	marker/mechanism		NA		9090381
PEX7	5191	PEROXISOME BIOGENESIS DISORDER 9B	OMIM:614879	marker/mechanism		NA	614879	
PEX7	5191	Refsum Disease	MESH:D012035	marker/mechanism		NA	266500	12522768
PEX7	5191	Rhizomelic chondrodysplasia punctata, type 1	MESH:C531651	marker/mechanism		NA	215100	11781871|12522768
PF4	5196	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		20162249
PF4	5196	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
PF4	5196	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
PF4	5196	Thrombocytopenia	MESH:D013921	marker/mechanism		NA		10381515|11588041|15795722|20162249|8282825|9158107|9446652
PF4	5196	Thrombosis	MESH:D013927	marker/mechanism		NA		11588041|15795722|8282825|9446652
PFKFB3	5209	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
PFKFB3	5209	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
PFKFB3	5209	Obesity	MESH:D009765	marker/mechanism		NA		20882379
PFKFB3	5209	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
PFKM	5213	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		14563825
PFKM	5213	Glycogen Storage Disease Type VII	MESH:D006014	marker/mechanism		NA	232800	2140573|8444874
PFKM	5213	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
PFKP	5214	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PFN1	5216	AMYOTROPHIC LATERAL SCLEROSIS 18	OMIM:614808	marker/mechanism		NA	614808	
PFN1	5216	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
PFN1	5216	Keloid	MESH:D007627	marker/mechanism		NA		20128793
PFN1	5216	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PGA5	5222	Esophagitis	MESH:D004941	marker/mechanism		NA		12928072
PGAM1	5223	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		15378696
PGAM1	5223	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
PGAM1	5223	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		17094902
PGAM1	5223	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		15274141
PGAM1	5223	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
PGAM1	5223	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
PGAM1	5223	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		15274141
PGAM1	5223	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		15378696
PGAM2	5224	Dimauro disease	MESH:C536176	marker/mechanism		NA	261670	
PGAM2	5224	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
PGAP1	80055	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42	OMIM:615802	marker/mechanism		NA	615802	
PGAP2	27315	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3	OMIM:614207	marker/mechanism		NA	614207	
PGAP3	93210	Hyperphosphatasia with Mental Retardation	MESH:C565495	marker/mechanism		NA	615716	
PGBD1	84547	Schizophrenia	MESH:D012559	marker/mechanism		NA		22037552
PGBD5	79605	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		28504702
PGBD5	79605	Rhabdoid Tumor	MESH:D018335	marker/mechanism		NA		28504702
PGD	5226	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		19363144
PGF	5228	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
PGGT1B	5229	Lung Neoplasms	MESH:D008175	therapeutic		NA		22028818
PGK1	5230	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
PGK1	5230	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		15108329
PGK1	5230	Phosphoglycerate Kinase 1 Deficiency	MESH:C567067	marker/mechanism		NA	300653	
PGLS	25796	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
PGLYRP1	8993	Brain Injuries	MESH:D001930	marker/mechanism		NA		21549006
PGM1	5236	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
PGM1	5236	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		25944804
PGM1	5236	Glycogen Storage Disease XIV	MESH:C567859	marker/mechanism		NA	614921	
PGM1	5236	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
PGM3	5238	IMMUNODEFICIENCY 23	OMIM:615816	marker/mechanism		NA	615816	
PGM5	5239	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
PGR	5241	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		15639718
PGR	5241	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19436038|21501481
PGR	5241	Carcinoma	MESH:D002277	marker/mechanism		NA		15637090
PGR	5241	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		23200943
PGR	5241	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642|21232532
PGR	5241	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		15637090
PGR	5241	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		15637090
PGR	5241	Meningioma	MESH:D008579	marker/mechanism		NA		19731987|19747051|8008172
PGR	5241	Mesothelioma	MESH:D008654	marker/mechanism		NA		15639718
PGR	5241	Progesterone Resistance	MESH:C564871	marker/mechanism		NA	264080	
PGR	5241	Recurrence	MESH:D012008	marker/mechanism		NA		19747051
PGRMC1	10857	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		25390692
PGRMC1	10857	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
PHACTR1	221692	Cerebrovascular Trauma	MESH:D020214	marker/mechanism		NA		25420145
PHACTR1	221692	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		21378990|22751097|26098115
PHACTR1	221692	Migraine without Aura	MESH:D020326	marker/mechanism		NA		22683712
PHACTR1	221692	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		19198609|26098115
PHB	5245	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		15378696
PHB	5245	Breast Neoplasms	MESH:D001943	marker/mechanism		NA	114480	
PHB	5245	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
PHB	5245	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
PHB	5245	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
PHB	5245	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		15986332
PHB	5245	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
PHB	5245	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
PHB	5245	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		15986332
PHB	5245	Psychoses, Substance-Induced	MESH:D011605	marker/mechanism		NA		18504422
PHB	5245	Schizophrenia	MESH:D012559	marker/mechanism		NA		18504422
PHB	5245	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		15378696|21364753
PHC1	1911	MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE	OMIM:615414	marker/mechanism		NA	615414	
PHC1	1911	Neoplasms, Germ Cell and Embryonal	MESH:D009373	marker/mechanism		NA		16168501
PHETA1	144717	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		25944804
PHEX	5251	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		1962291
PHEX	5251	Familial Hypophosphatemic Rickets	MESH:D053098	marker/mechanism		NA	307800	11414762|18775977|3414685|9430241
PHEX	5251	Nephrocalcinosis	MESH:D009397	marker/mechanism		NA		9430241
PHF2	5253	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
PHF21A	51317	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		28811376
PHF6	84295	Borjeson-Forssman-Lehmann syndrome	MESH:C536575	marker/mechanism		NA	301900	
PHF6	84295	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054218	marker/mechanism		NA		20228800
PHF8	23133	Siderius X-linked mental retardation syndrome	MESH:C537333	marker/mechanism		NA	300263	
PHGDH	26227	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21804546
PHGDH	26227	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		26482881
PHGDH	26227	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		21804546
PHGDH	26227	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		28108177
PHGDH	26227	Melanoma	MESH:D008545	marker/mechanism		NA		21804546
PHGDH	26227	Neu Laxova syndrome	MESH:C536405	marker/mechanism		NA	256520	
PHGDH	26227	Phosphoglycerate Dehydrogenase Deficiency	MESH:C566618	marker/mechanism		NA	601815	
PHGDH	26227	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
PHIP	55023	Intellectual Disability	MESH:D008607	marker/mechanism		NA		28191889
PHIP	55023	Sjogren's Syndrome	MESH:D012859	marker/mechanism		NA		24097067
PHKA1	5255	Glycogen Storage Disease, Type IXD	MESH:C564485	marker/mechanism		NA	300559	
PHKA2	5256	Glycogen Storage Disease	MESH:D006008	marker/mechanism		NA		7711737
PHKA2	5256	GLYCOGEN STORAGE DISEASE IXa1	OMIM:306000	marker/mechanism		NA	306000	
PHKB	5257	Glycogen Storage Disease IXB	MESH:C563008	marker/mechanism		NA	261750	
PHKG1P2	644032	Skin Diseases	MESH:D012871	marker/mechanism		NA		28720099
PHKG2	5261	Glycogen Storage Disease IXC	MESH:C567809	marker/mechanism		NA	613027	
PHLDA1	22822	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
PHLDA1	22822	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
PHLDA1	22822	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17374397
PHLDA2	7262	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		15496427
PHLDA2	7262	Osteosarcoma	MESH:D012516	therapeutic		NA		22021909
PHLDB1	23187	Glioma	MESH:D005910	marker/mechanism		NA		19578367
PHLDB2	90102	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
PHLPP	35178	Tobacco Use Disorder	MESH:D014029	marker/mechanism		NA		18438686
PHLPP1	23239	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		21750348
PHOSPHO1	162466	Bone Diseases, Metabolic	MESH:D001851	marker/mechanism		NA		26773408
PHOX2A	401	Fibrosis Of Extraocular Muscles, Congenital, 2	MESH:C566587	marker/mechanism		NA	602078	
PHOX2B	8929	Congenital central hypoventilation syndrome	MESH:C536209	marker/mechanism		NA	209880	12640453|14608649
PHOX2B	8929	Crohn Disease	MESH:D003424	marker/mechanism		NA		17435756
PHOX2B	8929	Neuroblastoma	MESH:D009447	marker/mechanism		NA	613013	25174395|30127528
PHRF1	57661	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		18204446
PHYH	5264	Refsum Disease	MESH:D012035	marker/mechanism		NA	266500	12522768
PI3	5266	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
PI4KB	5298	Coronavirus Infections	MESH:D018352	marker/mechanism		NA		22253445
PI4KB	5298	Severe Acute Respiratory Syndrome	MESH:D045169	marker/mechanism		NA		22253445
PIAS1	8554	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
PIAS1	8554	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
PIAS3	10401	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		25061499
PIBF1	10464	Abortion, Threatened	MESH:D000033	marker/mechanism		NA		15760377
PICALM	8301	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		19734902|21460841
PICALM	8301	Cognitive Dysfunction	MESH:D060825	marker/mechanism		NA		30503753
PICALM	8301	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA	601626	
PICK1	9463	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		17606663
PICK1	9463	Psychoses, Substance-Induced	MESH:D011605	marker/mechanism		NA		17606663
PIDD1	55367	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		20208132
PIEZO1	9780	Dehydrated Hereditary Stomatocytosis, Pseudohyperkalemia, and Perinatal Edema	MESH:C566369	marker/mechanism		NA	194380	
PIEZO1	9780	LYMPHATIC MALFORMATION 6	OMIM:616843	marker/mechanism		NA	616843	
PIEZO2	63895	ARTHROGRYPOSIS, DISTAL, TYPE 3	OMIM:114300	marker/mechanism		NA	114300	
PIEZO2	63895	ARTHROGRYPOSIS, DISTAL, TYPE 5	OMIM:108145	marker/mechanism		NA	108145	
PIEZO2	63895	ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH	OMIM:617146	marker/mechanism		NA	617146	
PIEZO2	63895	Marden-Walker syndrome	MESH:C535910	marker/mechanism		NA	248700	
PIGA	5277	Hemoglobinuria, Paroxysmal	MESH:D006457	marker/mechanism		NA	300818	15720958|16767100
PIGA	5277	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2	OMIM:300868	marker/mechanism		NA	300868	
PIGG	54872	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53	OMIM:616917	marker/mechanism		NA	616917	
PIGL	9487	Zunich neuroectodermal syndrome	MESH:C536729	marker/mechanism		NA	280000	
PIGM	93183	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 1	OMIM:610293	marker/mechanism		NA	610293	
PIGM	93183	Seizures	MESH:D012640	marker/mechanism		NA		16767100
PIGM	93183	Venous Thrombosis	MESH:D020246	marker/mechanism		NA		16767100
PIGN	23556	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
PIGN	23556	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
PIGN	23556	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1	OMIM:614080	marker/mechanism		NA	614080	
PIGO	84720	Hyperphosphatasia with Mental Retardation	MESH:C565495	marker/mechanism		NA	614749	
PIGP	51227	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		24763052
PIGT	51604	Hemoglobinuria, Paroxysmal	MESH:D006457	marker/mechanism		NA	615399	25417052
PIGT	51604	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3	OMIM:615398	marker/mechanism		NA	615398	
PIGV	55650	Hyperphosphatasia with Mental Retardation	MESH:C565495	marker/mechanism		NA	239300	20802478
PIGW	284098	Hyperphosphatasia with Mental Retardation	MESH:C565495	marker/mechanism		NA	616025	
PIGY	84992	Hyperphosphatasia with Mental Retardation	MESH:C565495	marker/mechanism		NA	616809	
PIK3C2B	5287	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		21986133
PIK3CA	5290	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		22484628
PIK3CA	5290	Adenocarcinoma Of Esophagus	MESH:C562730	marker/mechanism		NA		23525077
PIK3CA	5290	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		22135231
PIK3CA	5290	Breast Neoplasms	MESH:D001943	marker/mechanism		NA	114480	19196980|19685490|20479250|21633166|22370636|25267515|25358515|26587011
PIK3CA	5290	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
PIK3CA	5290	Carcinoma, Basal Cell	MESH:D002280	marker/mechanism		NA		26950094
PIK3CA	5290	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA	114550	
PIK3CA	5290	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		23797736
PIK3CA	5290	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		24224046
PIK3CA	5290	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	114500	
PIK3CA	5290	Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi	MESH:C567863	marker/mechanism		NA	612918	
PIK3CA	5290	COWDEN SYNDROME 5	OMIM:615108	marker/mechanism		NA	615108	
PIK3CA	5290	Disease Progression	MESH:D018450	marker/mechanism		NA		29106415
PIK3CA	5290	Epidermal Nevus	MESH:C580062	marker/mechanism		NA	162900	
PIK3CA	5290	Growth Disorders	MESH:D006130	marker/mechanism		NA		22729222
PIK3CA	5290	Hyperplasia	MESH:D006965	marker/mechanism		NA		22729222
PIK3CA	5290	Keratosis, Seborrheic	MESH:D017492	marker/mechanism		NA	182000	
PIK3CA	5290	Lung Neoplasms	MESH:D008175	marker/mechanism		NA	211980	
PIK3CA	5290	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		21173233
PIK3CA	5290	Malformations of Cortical Development	MESH:D054220	marker/mechanism		NA		22729223
PIK3CA	5290	Megalancephaly Polymicrogyria-Polydactyly Hydrocephalus Syndrome	MESH:C566381	marker/mechanism		NA		22729224
PIK3CA	5290	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		24224046
PIK3CA	5290	Nasopharyngeal Carcinoma	MESH:D000077274	marker/mechanism		NA		24952746
PIK3CA	5290	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		29106415
PIK3CA	5290	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA	167000	
PIK3CA	5290	Penile Neoplasms	MESH:D010412	marker/mechanism		NA		18355852
PIK3CA	5290	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881|29610475
PIK3CA	5290	Sarcoma	MESH:D012509	marker/mechanism		NA		20601955
PIK3CA	5290	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		23873848
PIK3CA	5290	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA	613659	22484628
PIK3CA	5290	Ventricular Dysfunction, Left	MESH:D018487	therapeutic		NA		31025080
PIK3CA	5290	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
PIK3CB	5291	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		21173233
PIK3CB	5291	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
PIK3CB	5291	Schizophrenia	MESH:D012559	marker/mechanism		NA		21743468
PIK3CD	5293	IMMUNODEFICIENCY 14	OMIM:615513	marker/mechanism		NA	615513	
PIK3CD	5293	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		21173233
PIK3CD	5293	Lymphoma, Mantle-Cell	MESH:D020522	marker/mechanism		NA		23676220
PIK3CD	5293	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
PIK3CG	5294	Autistic Disorder	MESH:D001321	marker/mechanism		NA		14627686
PIK3CG	5294	Cardiomegaly	MESH:D006332	marker/mechanism		NA		12963636
PIK3CG	5294	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		31626838
PIK3CG	5294	Fibrosis	MESH:D005355	marker/mechanism		NA		12963636
PIK3CG	5294	Heart Failure	MESH:D006333	marker/mechanism		NA		12963636
PIK3CG	5294	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		21173233
PIK3CG	5294	Medulloblastoma	MESH:D008527	marker/mechanism		NA		21652733
PIK3IP1	113791	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
PIK3R1	5295	AGAMMAGLOBULINEMIA 7, AUTOSOMAL RECESSIVE	OMIM:615214	marker/mechanism		NA	615214	
PIK3R1	5295	Burkitt Lymphoma	MESH:D002051	marker/mechanism		NA		23143597
PIK3R1	5295	Carcinoma	MESH:D002277	marker/mechanism		NA		12606953
PIK3R1	5295	IMMUNODEFICIENCY 36	OMIM:616005	marker/mechanism		NA	616005	
PIK3R1	5295	Insulin Resistance	MESH:D007333	marker/mechanism		NA		14714311
PIK3R1	5295	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12606953
PIK3R1	5295	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12606953
PIK3R1	5295	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475|29662167
PIK3R1	5295	SHORT syndrome	MESH:C537327	marker/mechanism		NA	269880	
PIK3R1	5295	Vitiligo	MESH:D014820	marker/mechanism		NA		28836394
PIK3R2	5296	Megalancephaly Polymicrogyria-Polydactyly Hydrocephalus Syndrome	MESH:C566381	marker/mechanism		NA	603387	22729224
PIK3R2	5296	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
PIK3R5	23533	ATAXIA-OCULOMOTOR APRAXIA 3	OMIM:615217	marker/mechanism		NA	615217	
PIKFYVE	200576	Corneal Dystrophy, Fleck	MESH:C563256	marker/mechanism		NA	121850	
PIM1	5292	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037
PIM1	5292	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		23565217
PIM1	5292	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		16033404
PIM1	5292	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		25812446
PIM1	5292	Glioblastoma	MESH:D005909	marker/mechanism		NA		23724780
PIM1	5292	Hernias, Diaphragmatic, Congenital	MESH:D065630	marker/mechanism		NA		25812446
PIM1	5292	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		26297436
PIM1	5292	Prostatic Intraepithelial Neoplasia	MESH:D019048	marker/mechanism		NA		23565217
PIM1	5292	Pyelonephritis	MESH:D011704	marker/mechanism		NA		23565217
PIM2	11040	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		19458359
PIN	47190	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		32621833
PIN1	5300	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19671742|19681904
PIN1	5300	Disease Progression	MESH:D018450	marker/mechanism		NA		32621833
PINK1	65018	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		24161480
PINK1	65018	Neuroblastoma	MESH:D009447	marker/mechanism		NA		23334666
PINK1	65018	Parkinson Disease	MESH:D010300	marker/mechanism		NA		17010972|21366594|22043175|24374061|25149416
PINK1	65018	Parkinson Disease 6, Autosomal Recessive Early-Onset	MESH:C565276	marker/mechanism		NA	605909	19048950|21421046|24475098|27003823
PINK1	65018	Parkinsonian Disorders	MESH:D020734	marker/mechanism		NA		11254447|15349871|23046578|24441527|24792327|26558463
PIP	5304	Sinusitis	MESH:D012852	marker/mechanism		NA		18391768
PIP4K2A	5305	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
PIP5K1C	23396	Lethal Congenital Contractural Syndrome 3	MESH:C566961	marker/mechanism		NA	611369	
PIPOX	51268	Peroxisomal Disorders	MESH:D018901	marker/mechanism		NA		10642506
PIR	8544	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
PIRA2	18725	Lung Diseases	MESH:D008171	marker/mechanism		NA		21602193
PITPNM1	9600	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
PITPNM3	83394	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
PITPNM3	83394	Cone-Rod Dystrophy 5	MESH:C563415	marker/mechanism		NA	600977	
PITRM1	10531	Tobacco Use Disorder	MESH:D014029	marker/mechanism		NA		29216386
PITX1	5307	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18053270
PITX1	5307	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
PITX1	5307	Clubfoot	MESH:D003025	marker/mechanism		NA	119800	
PITX1	5307	Synostosis, Carpal, with Dysplastic Elbow Joints and Brachydactyly	MESH:C566090	marker/mechanism		NA	186550	
PITX1	5307	Testicular Germ Cell Tumor	MESH:C563236	marker/mechanism		NA		23666240
PITX2	5308	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
PITX2	5308	AXENFELD-RIEGER SYNDROME, TYPE 1	OMIM:180500	marker/mechanism		NA	180500	10502778|10644443|14623826|14630904|15378534
PITX2	5308	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		10499585|14623826
PITX2	5308	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		10499585
PITX2	5308	Iridogoniodysgenesis, dominant type	MESH:C535536	marker/mechanism		NA	137600	10502778
PITX2	5308	Ring dermoid of cornea	MESH:C535684	marker/mechanism		NA	180550	
PITX2	5308	Stroke	MESH:D020521	marker/mechanism		NA		29531354
PITX2	5308	Tooth Abnormalities	MESH:D014071	marker/mechanism		NA		10499585
PITX3	5309	Anterior segment mesenchymal dysgenesis	MESH:C537775	marker/mechanism		NA	107250	18989383|9620774
PITX3	5309	Cataract	MESH:D002386	marker/mechanism		NA		16565358|9620774
PITX3	5309	Cataract, posterior polar, 4	MESH:C535344	marker/mechanism		NA	610623	15286169
PITX3	5309	Microphthalmos	MESH:D008850	marker/mechanism		NA		16565358
PITX3	5309	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		27415467
PITX3	5309	Neurologic Manifestations	MESH:D009461	marker/mechanism		NA		16565358
PITX3	5309	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		27415467
PIWIL1	9271	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
PIWIL2	55124	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
PIWIL3	440822	Oligospermia	MESH:D009845	marker/mechanism		NA		20940137
PIWIL4	143689	Oligospermia	MESH:D009845	marker/mechanism		NA		20940137
PJA1	64219	Craniofrontonasal dysplasia	MESH:C536456	marker/mechanism		NA		17941886
PJVK	494513	Deafness	MESH:D003638	marker/mechanism		NA		17329413
PJVK	494513	Deafness, Autosomal Recessive 59	MESH:C565698	marker/mechanism		NA	610220	
PKD1	5310	Cysts	MESH:D003560	marker/mechanism		NA		21685914
PKD1	5310	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		25877301
PKD1	5310	Polycystic Kidney, Autosomal Dominant	MESH:D016891	marker/mechanism		NA		12089381|19401297|25877301|28887310|7581371|8004675
PKD1	5310	Polycystic Kidney Diseases	MESH:D007690	marker/mechanism		NA	173900	17932118|25877301|28887310
PKD1L1	168507	HETEROTAXY, VISCERAL, 8, AUTOSOMAL	OMIM:617205	marker/mechanism		NA	617205	
PKD2	5311	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PKD2	5311	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		25013951
PKD2	5311	Polycystic Kidney, Autosomal Dominant	MESH:D016891	marker/mechanism		NA	613095	12089381|15001556|24719335|25877301|28887310|30883612
PKD2	5311	Retinal Diseases	MESH:D012164	marker/mechanism		NA		25013951
PKD2	5311	Vascular Diseases	MESH:D014652	marker/mechanism		NA		25013951
PKHD1	5314	Choledochal Cyst	MESH:D015529	marker/mechanism		NA		18988797
PKHD1	5314	Polycystic Kidney, Autosomal Recessive	MESH:D017044	marker/mechanism		NA	263200	16133180|18988797|19524688|21685914
PKLR	5313	Adenosine Triphosphate, Elevated, Of Erythrocytes	MESH:C566310	marker/mechanism		NA	102900	
PKLR	5313	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		20363216
PKLR	5313	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PKLR	5313	Pyruvate Kinase Deficiency of Red Cells	MESH:C564858	marker/mechanism		NA	266200	
PKM	5315	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
PKM	5315	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		19363144
PKM	5315	Lymphangioleiomyomatosis	MESH:D018192	marker/mechanism		NA		32078667
PKM	5315	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
PKM	5315	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
PKM	5315	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		15048980|15654357
PKM	5315	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
PKMYT1	9088	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
PKMYT1	9088	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
PKNOX2	63876	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
PKP1	5317	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
PKP1	5317	Ectodermal Dysplasia-Skin Fragility Syndrome	MESH:C536183	marker/mechanism		NA	604536	
PKP2	5318	Arrhythmogenic Right Ventricular Dysplasia, Familial, 9	MESH:C563808	marker/mechanism		NA	609040	
PKP2	5318	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
PKP3	11187	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
PLA2	406141	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		10533957
PLA2	406141	Necrosis	MESH:D009336	marker/mechanism		NA		10533957
PLA2G12A	81579	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PLA2G2A	5320	Atherosclerosis	MESH:D050197	marker/mechanism		NA		19237014
PLA2G2A	5320	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	114500	
PLA2G2A	5320	Endometriosis	MESH:D004715	marker/mechanism		NA		25446850
PLA2G2A	5320	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
PLA2G2A	5320	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		12967936
PLA2G2D1	494318	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
PLA2G4A	5321	Amyotrophic Lateral Sclerosis	MESH:D000690	marker/mechanism		NA		15816863
PLA2G4A	5321	Asthma, Occupational	MESH:D059366	marker/mechanism		NA		27504716
PLA2G4A	5321	Autistic Disorder	MESH:D001321	marker/mechanism		NA		15301788
PLA2G4A	5321	Blood Platelet Disorders	MESH:D001791	marker/mechanism		NA		18451993
PLA2G4A	5321	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21119660
PLA2G4A	5321	Dermatitis	MESH:D003872	marker/mechanism		NA		18287786
PLA2G4A	5321	Duodenal Ulcer	MESH:D004381	marker/mechanism		NA		18451993
PLA2G4A	5321	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PLA2G4A	5321	Metabolism, Inborn Errors	MESH:D008661	marker/mechanism		NA		18451993
PLA2G4A	5321	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		10881173
PLA2G5	5322	Fleck Retina, Familial Benign	MESH:C565564	marker/mechanism		NA	228980	
PLA2G6	8398	NBIA2B	MESH:C565699	marker/mechanism		NA	610217	
PLA2G6	8398	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	OMIM:256600	marker/mechanism		NA	256600	
PLA2G6	8398	Nevus	MESH:D009506	marker/mechanism		NA		19578365
PLA2G6	8398	PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE	OMIM:612953	marker/mechanism		NA	612953	
PLA2G7	7941	Asthma	MESH:D001249	marker/mechanism		NA	600807	10733466
PLA2G7	7941	Coronary Disease	MESH:D003327	marker/mechanism		NA		21356620
PLA2G7	7941	Hypersensitivity, Immediate	MESH:D006969	marker/mechanism		NA		10733466
PLA2G7	7941	Ige Responsiveness, Atopic	MESH:C564133	marker/mechanism		NA	147050	
PLA2G7	7941	Metabolism, Inborn Errors	MESH:D008661	marker/mechanism		NA		8675689
PLA2G7	7941	Platelet-Activating Factor Acetylhydrolase Deficiency	MESH:C566640	marker/mechanism		NA	614278	
PLA2G7	7941	Stroke	MESH:D020521	marker/mechanism		NA		21356620
PLA2R1	22925	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
PLAA	9373	Inflammation	MESH:D007249	marker/mechanism		NA		11094054
PLAC8	51316	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
PLAC8	51316	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PLAG1	5324	Lipoblastoma	MESH:D062689	marker/mechanism		NA		16308870
PLAG1	5324	Salivary Gland Adenoma, Pleomorphic	MESH:C563250	marker/mechanism		NA	181030	
PLAGL1	5325	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
PLAT	5327	Acidosis, Lactic	MESH:D000140	therapeutic		NA		25331496
PLAT	5327	Airway Obstruction	MESH:D000402	therapeutic		NA		25331496
PLAT	5327	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		15659235
PLAT	5327	Angioedema	MESH:D000799	marker/mechanism		NA		16184341|18453163|20547619
PLAT	5327	Aphasia	MESH:D001037	therapeutic		NA		12690208
PLAT	5327	Arterial Occlusive Diseases	MESH:D001157	therapeutic		NA		15557913
PLAT	5327	Atherosclerosis	MESH:D050197	therapeutic		NA		12677255
PLAT	5327	Back Pain	MESH:D001416	marker/mechanism		NA		12227717
PLAT	5327	Bacteremia	MESH:D016470	therapeutic		NA		1430592
PLAT	5327	Brain Edema	MESH:D001929	therapeutic		NA		29651748
PLAT	5327	Brain Infarction	MESH:D020520	therapeutic		NA		16190367
PLAT	5327	Brain Ischemia	MESH:D002545	therapeutic		NA		10572812|11108748|11940547|12221155|12511774|14986460|15017018|15087567|16126134|16763187|16809570|17086147|17525387|17903870|20123226|20212195|20488584|20536612|21037505|23876515|7477192|9259745|9400355|9479658|9566367|9633741
PLAT	5327	Cardiac Tamponade	MESH:D002305	marker/mechanism		NA		9633741
PLAT	5327	Cerebral Hemorrhage	MESH:D002543	marker/mechanism		NA		10501537|11113218|11940547|1430592|14630814|1579960|16126134|16190367|16908730|17690543|18346647|18369171|18753474|1899364|19095969|20212195|21088392|22436003|23876515|29651748|7477192|7723950|8969996|9836764
PLAT	5327	Cerebral Infarction	MESH:D002544	marker/mechanism|therapeutic		NA		12865603|15502123|1579960|16148626|18195371|18544249|1899364|19473668|19907167|9183334
PLAT	5327	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22507835
PLAT	5327	Coronary Thrombosis	MESH:D003328	therapeutic		NA		1452937|15301905|8172379
PLAT	5327	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17374397
PLAT	5327	Embolism	MESH:D004617	therapeutic		NA		16148626
PLAT	5327	Embolism and Thrombosis	MESH:D016769	therapeutic		NA		9684808
PLAT	5327	Embolism, Cholesterol	MESH:D017700	marker/mechanism		NA		7939511
PLAT	5327	Heart Failure	MESH:D006333	marker/mechanism		NA		22352330
PLAT	5327	Hematoma, Epidural, Spinal	MESH:D046748	marker/mechanism		NA		10914357|12227717
PLAT	5327	Hematoma, Subdural	MESH:D006408	marker/mechanism		NA		1899364
PLAT	5327	Hemorrhage	MESH:D006470	marker/mechanism		NA		15016487|15502123|22507835|2514002|8082347|8427107|9199818|9266785
PLAT	5327	Hypertension	MESH:D006973	marker/mechanism		NA		22352330
PLAT	5327	Hypotension	MESH:D007022	marker/mechanism		NA		1492007
PLAT	5327	Hypoxia	MESH:D000860	therapeutic		NA		25331496
PLAT	5327	Infarction, Middle Cerebral Artery	MESH:D020244	therapeutic		NA		12297567|17690543|18453163|20547619|29651748
PLAT	5327	Intracranial Embolism and Thrombosis	MESH:D002542	therapeutic		NA		7482654|8427107
PLAT	5327	Intracranial Hemorrhages	MESH:D020300	marker/mechanism		NA		11320361|12230423|15017018|15215796|15557913|17612434|17687131|17903947|20123226|20536612|2104561|3168586|7902905|8961984
PLAT	5327	Intracranial Thrombosis	MESH:D020767	therapeutic		NA		8678742
PLAT	5327	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PLAT	5327	Low Back Pain	MESH:D017116	therapeutic		NA		7888893
PLAT	5327	Meningoencephalitis	MESH:D008590	therapeutic		NA		1430592
PLAT	5327	Myocardial Infarction	MESH:D009203	therapeutic		NA		10171637|10505926|10645301|10914357|11382373|11489769|12074692|12227717|12848087|1430592|1492007|15215796|15301905|18195371|1898952|1899364|1900011|19341228|20122609|2104561|2105625|2494454|2505604|2521976|3089627|3121335|7488445|7723950|7775709|7902905|8328192|8554022|8598594|9183334
PLAT	5327	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		19911010
PLAT	5327	Neurologic Manifestations	MESH:D009461	marker/mechanism|therapeutic		NA		22436003|23876515|29651748
PLAT	5327	Neurotoxicity Syndromes	MESH:D020258	marker/mechanism		NA		19442825
PLAT	5327	Paresis	MESH:D010291	therapeutic		NA		12690208
PLAT	5327	Pericardial Effusion	MESH:D010490	marker/mechanism		NA		9633741
PLAT	5327	Pulmonary Embolism	MESH:D011655	marker/mechanism|therapeutic		NA		1899825|19415734|2123154|3105914|3122266|8082347|8451030|9199818|9266785
PLAT	5327	Reperfusion Injury	MESH:D015427	therapeutic		NA		9472885
PLAT	5327	Respiratory Insufficiency	MESH:D012131	therapeutic		NA		25331496
PLAT	5327	Shock, Cardiogenic	MESH:D012770	therapeutic		NA		1430592
PLAT	5327	Spinal Cord Compression	MESH:D013117	marker/mechanism		NA		12227717
PLAT	5327	Stroke	MESH:D020521	marker/mechanism|therapeutic		NA		10171637|10346413|10436095|10572812|11061250|11108748|11113218|11239184|11739841|11940547|12221155|12230423|12384244|12511774|14581697|14657446|14986460|15016487|15017018|15087567|1598096|16126134|16184341|16763187|16809570|16908730|17086147|17525387|17612434|17903870|17903947|18346647|18369171|18560214|18753472|18753474|19286598|20123226|20212195|20488584|20536612|20705933|2124386|23876515|2514002|25245553|7477192|8427107|8598594|9056608|9259745|9400355|9472885|9479657|9479658|9566367|9633741|9707184|9836764|9933289
PLAT	5327	Thromboembolism	MESH:D013923	therapeutic		NA		8451030
PLAT	5327	THROMBOPHILIA, FAMILIAL, DUE TO DECREASED RELEASE OF TISSUE PLASMINOGEN ACTIVATOR;THPH9 HYPERFIBRINOLYSIS, FAMILIAL, DUE TO INCREASED RELEASE OF TISSUE PLASMINOGEN	OMIM:612348	marker/mechanism		NA	612348	
PLAT	5327	Thrombosis	MESH:D013927	marker/mechanism|therapeutic		NA		12677255|19348381|2123154|22352330
PLAT	5327	Vasospasm, Intracranial	MESH:D020301	therapeutic		NA		19057314|29651748
PLAT	5327	Venous Thromboembolism	MESH:D054556	marker/mechanism		NA		16167916
PLAT	5327	Venous Thrombosis	MESH:D020246	therapeutic		NA		11144008|15557913|19415734
PLAT	5327	Ventricular Dysfunction, Left	MESH:D018487	therapeutic		NA		8763515
PLAU	5328	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		10467400
PLAU	5328	Alzheimer Disease	MESH:D000544	marker/mechanism		NA	104300	
PLAU	5328	Angina Pectoris	MESH:D000787	therapeutic		NA		1730212
PLAU	5328	Angina, Unstable	MESH:D000789	therapeutic		NA		2382605
PLAU	5328	Anuria	MESH:D001002	marker/mechanism		NA		8225663
PLAU	5328	Arterial Occlusive Diseases	MESH:D001157	therapeutic		NA		15557913|1713745|9181759|9731615
PLAU	5328	Asthenozoospermia	MESH:D053627	marker/mechanism		NA		18998460
PLAU	5328	Asthma	MESH:D001249	marker/mechanism		NA		21912604
PLAU	5328	Bone Neoplasms	MESH:D001859	marker/mechanism		NA		16475674
PLAU	5328	Brain Edema	MESH:D001929	marker/mechanism		NA		11677890
PLAU	5328	Brain Ischemia	MESH:D002545	therapeutic		NA		10472989|10512912|17927297|9731615
PLAU	5328	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		14644129
PLAU	5328	Carotid Artery Diseases	MESH:D002340	therapeutic		NA		10512912
PLAU	5328	Cerebral Hemorrhage	MESH:D002543	marker/mechanism		NA		1265806|15181847|17702958|8025938|9731615
PLAU	5328	Cerebral Infarction	MESH:D002544	therapeutic		NA		12133459|15502123|16773802
PLAU	5328	Cerebrovascular Disorders	MESH:D002561	therapeutic		NA		1265806|17308290
PLAU	5328	Coronary Disease	MESH:D003327	therapeutic		NA		1730212|9181759
PLAU	5328	Embolism, Cholesterol	MESH:D017700	marker/mechanism		NA		16773802
PLAU	5328	Glomerulonephritis, IGA	MESH:D005922	therapeutic		NA		9002298
PLAU	5328	Graft Occlusion, Vascular	MESH:D006083	therapeutic		NA		10392865|11041470|8025938|8416330
PLAU	5328	Heart Rupture, Post-Infarction	MESH:D006342	marker/mechanism		NA		9403446
PLAU	5328	Hematuria	MESH:D006417	marker/mechanism		NA		8225663
PLAU	5328	Hemorrhage	MESH:D006470	marker/mechanism		NA		15502123|15557913|8225663|9266785
PLAU	5328	Hypotension	MESH:D007022	marker/mechanism		NA		10392865
PLAU	5328	Idiopathic Pulmonary Fibrosis	MESH:D054990	therapeutic		NA		18491991
PLAU	5328	Infarction, Middle Cerebral Artery	MESH:D020244	therapeutic		NA		11677890|15181847|17702958
PLAU	5328	Intracranial Embolism and Thrombosis	MESH:D002542	therapeutic		NA		9403446
PLAU	5328	Intracranial Hemorrhages	MESH:D020300	marker/mechanism		NA		10392865|10472989|10512912|17308290
PLAU	5328	Ischemia	MESH:D007511	therapeutic		NA		15557913|8662173
PLAU	5328	Liver Cirrhosis	MESH:D008103	marker/mechanism|therapeutic		NA		18481824|26396155
PLAU	5328	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PLAU	5328	Myocardial Infarction	MESH:D009203	marker/mechanism|therapeutic		NA		1908371|2174952|2382605|3068399|3984876|8416330
PLAU	5328	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		14644129|26284488
PLAU	5328	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		16475674
PLAU	5328	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		16430655
PLAU	5328	Nephritis	MESH:D009393	therapeutic		NA		12671112
PLAU	5328	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		10467400
PLAU	5328	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		11454671|16430655|17192053
PLAU	5328	Pulmonary Embolism	MESH:D011655	marker/mechanism|therapeutic		NA		1098216|11041470|4430106|4884574|9038699|9266785
PLAU	5328	Purpura, Schoenlein-Henoch	MESH:D011695	therapeutic		NA		12671112|9002298
PLAU	5328	Quebec platelet disorder	MESH:C536260	marker/mechanism		NA	601709	
PLAU	5328	Reperfusion Injury	MESH:D015427	therapeutic		NA		15181847
PLAU	5328	Sagittal Sinus Thrombosis	MESH:D020225	therapeutic		NA		10668740
PLAU	5328	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
PLAU	5328	Stroke	MESH:D020521	marker/mechanism		NA		12742636
PLAU	5328	Thromboembolism	MESH:D013923	therapeutic		NA		3718210
PLAU	5328	Thrombosis	MESH:D013927	therapeutic		NA		12830724|2106299|2133253|2795766|4884574|8657906
PLAU	5328	Venous Thrombosis	MESH:D020246	therapeutic		NA		15557913|3161212|3488869|6359570
PLAU	5328	Ventricular Fibrillation	MESH:D014693	marker/mechanism		NA		9083243
PLAUR	5329	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
PLAUR	5329	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19360663|21328570
PLAUR	5329	Carcinoma	MESH:D002277	marker/mechanism		NA		15302576
PLAUR	5329	Inflammation	MESH:D007249	marker/mechanism		NA		22261521
PLAUR	5329	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		22261521
PLAUR	5329	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		15659795
PLAUR	5329	Neoplasms	MESH:D009369	marker/mechanism		NA		22261521
PLAUR	5329	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		15302576
PLB1	151056	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		24520335
PLBD1	79887	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		15496427
PLCB1	23236	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
PLCB1	23236	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 12	OMIM:613722	marker/mechanism		NA	613722	
PLCB1	23236	Myelodysplastic Syndromes	MESH:D009190	marker/mechanism		NA		19805378
PLCB1	23236	Pain	MESH:D010146	marker/mechanism		NA		16405873
PLCB1	23236	Schizophrenia	MESH:D012559	marker/mechanism		NA		17667964
PLCB4	5332	Auriculo-condylar syndrome	MESH:C538270	marker/mechanism		NA	614669	
PLCB4	5332	Melanoma	MESH:D008545	marker/mechanism		NA		21499247
PLCB4	5332	Uveal melanoma	MESH:C536494	marker/mechanism		NA		27089179
PLCD1	5333	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3	OMIM:151600	marker/mechanism		NA	151600	
PLCD1	5333	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
PLCE1	51196	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		20729852
PLCE1	51196	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		20729852|20729853
PLCE1	51196	NEPHROTIC SYNDROME, TYPE 3	OMIM:610725	marker/mechanism		NA	610725	
PLCE1	51196	Severe Dengue	MESH:D019595	marker/mechanism		NA		22001756
PLCE1	51196	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		20729852
PLCG1	5335	Hemangiosarcoma	MESH:D006394	marker/mechanism		NA		24633157
PLCG1	5335	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		26437031
PLCG1	5335	Lymphoma, T-Cell, Cutaneous	MESH:D016410	marker/mechanism		NA		26192916
PLCG1	5335	Sezary Syndrome	MESH:D012751	marker/mechanism		NA		26551670
PLCG2	5336	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		28714976
PLCG2	5336	AUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION	OMIM:614878	marker/mechanism		NA	614878	
PLCG2	5336	Cryopyrin-Associated Periodic Syndromes	MESH:D056587	marker/mechanism		NA	614468	
PLCG2	5336	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA		28067908
PLCG2	5336	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		27542411
PLCL2	23228	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
PLCZ1	89869	SPERMATOGENIC FAILURE 17	OMIM:617214	marker/mechanism		NA	617214	
PLD1	5337	Cardiomegaly	MESH:D006332	marker/mechanism		NA		15988127
PLD1	5337	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		12374626
PLD2	5338	Cardiomegaly	MESH:D006332	marker/mechanism		NA		15988127
PLD2	5338	Orthomyxoviridae Infections	MESH:D009976	marker/mechanism		NA		25065577
PLD4	122618	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		22446963
PLD4	122618	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PLD5	200150	Autistic Disorder	MESH:D001321	marker/mechanism		NA		20663923
PLEC	5339	Epidermolysa bullosa simplex and limb girdle muscular dystrophy	MESH:C535955	marker/mechanism		NA	226670	
PLEC	5339	Epidermolysis bullosa simplex, Ogna type	MESH:C535962	marker/mechanism		NA	131950	
PLEC	5339	EPIDERMOLYSIS BULLOSA SIMPLEX WITH NAIL DYSTROPHY	OMIM:616487	marker/mechanism		NA	616487	
PLEC	5339	Epidermolysis Bullosa Simplex With Pyloric Atresia	MESH:C567408	marker/mechanism		NA	612138	
PLEC	5339	Epidermolysis bullosa with pyloric atresia	MESH:C535377	marker/mechanism		NA	226730	
PLEC	5339	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 17	OMIM:613723	marker/mechanism		NA	613723	
PLEK	5341	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		12833524
PLEK	5341	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PLEK	5341	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
PLEK2	26499	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
PLEKHA1	59338	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28869590
PLEKHA7	144100	Glaucoma, Angle-Closure	MESH:D015812	marker/mechanism		NA		22922875|27064256
PLEKHB1	58473	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PLEKHD1	400224	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
PLEKHF1	79156	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		21397856
PLEKHG1	57480	Tobacco Use Disorder	MESH:D014029	marker/mechanism		NA		18438686
PLEKHG2	64857	LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA	OMIM:616763	marker/mechanism		NA	616763	
PLEKHG5	57449	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE C	OMIM:615376	marker/mechanism		NA	615376	
PLEKHG5	57449	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
PLEKHG5	57449	Spinal Muscular Atrophy, Distal, Autosomal Recessive, 4	MESH:C567023	marker/mechanism		NA	611067	
PLEKHH1	57475	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PLEKHM1	9842	Osteopetrosis, Autosomal Recessive 6	MESH:C566931	marker/mechanism		NA	611497	
PLEKHO1	51177	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		31043756
PLEKHS1	79949	Neoplasms	MESH:D009369	marker/mechanism		NA		25261935
PLG	5340	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		28885000
PLG	5340	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22507835
PLG	5340	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		28885000
PLG	5340	Hypertension	MESH:D006973	marker/mechanism		NA		6383834
PLG	5340	Leukocyte Disorders	MESH:D007960	marker/mechanism		NA		30213540
PLG	5340	Liver Cirrhosis, Experimental	MESH:D008106	therapeutic		NA		14716496
PLG	5340	Plasminogen Deficiency, Type I	MESH:C566897	marker/mechanism		NA	217090	
PLG	5340	Venous Thrombosis	MESH:D020246	therapeutic		NA		7215189
PLIN1	5346	Lipodystrophy, Familial Partial	MESH:D052496	marker/mechanism		NA	613877	
PLIN1	5346	Obesity	MESH:D009765	marker/mechanism		NA		15001633
PLIN2	123	Fatty Liver	MESH:D005234	marker/mechanism		NA		16439473
PLIN2	123	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PLIN2	123	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
PLIN3	10226	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PLK1	5347	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
PLK1	5347	Glioma	MESH:D005910	marker/mechanism		NA		22000864
PLK1	5347	Leukemia	MESH:D007938	marker/mechanism		NA		26008977
PLK2	10769	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
PLK2	10769	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
PLK2	10769	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		12897130
PLK2	10769	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
PLK2	10769	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
PLK4	10733	Dwarfism	MESH:D004392	marker/mechanism		NA		25344692
PLK4	10733	Eye Diseases, Hereditary	MESH:D015785	marker/mechanism		NA		25344692
PLK4	10733	Microcephaly	MESH:D008831	marker/mechanism		NA		25344692
PLK4	10733	Microcephaly with Chorioretinopathy, Autosomal Recessive	MESH:C565379	marker/mechanism		NA	616171	
PLLP	51090	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
PLN	5350	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
PLN	5350	Cardiomyopathy, Dilated, 1p	MESH:C563690	marker/mechanism		NA	609909	
PLN	5350	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 18	OMIM:613874	marker/mechanism		NA	613874	
PLN	5350	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		16026515|16162791
PLN	5350	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		10734148
PLN	5350	Myocardial Stunning	MESH:D017682	marker/mechanism		NA		16317512
PLN	5350	Ventricular Dysfunction, Left	MESH:D018487	marker/mechanism		NA		14991071
PLOD1	5351	Ehlers-Danlos syndrome type 6	MESH:C536198	marker/mechanism		NA	225400	15666309
PLOD1	5351	Kyphosis	MESH:D007738	marker/mechanism		NA		15666309
PLOD1	5351	Nevo syndrome	MESH:C536113	marker/mechanism		NA		15666309
PLOD2	5352	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
PLOD2	5352	Bone Neoplasms	MESH:D001859	marker/mechanism		NA		15865105
PLOD2	5352	Bruck syndrome 2	MESH:C537407	marker/mechanism		NA	609220	
PLOD2	5352	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		26396155
PLOD2	5352	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PLOD2	5352	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
PLOD3	8985	Bone Fragility with Contractures, Arterial Rupture, and Deafness	MESH:C567320	marker/mechanism		NA	612394	
PLP1	5354	Encephalomyelitis, Autoimmune, Experimental	MESH:D004681	marker/mechanism		NA		21068375
PLP1	5354	Pelizaeus-Merzbacher Disease	MESH:D020371	marker/mechanism		NA	312080	18571143
PLP1	5354	Spastic paraplegia 2, X-linked	MESH:C536857	marker/mechanism		NA	312920	
PLPBP	11212	Pyridoxine-dependent epilepsy	MESH:C536254	marker/mechanism		NA	617290	
PLPP1	8611	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
PLPP1	8611	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
PLPP2	8612	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PLPP3	8613	Cardiomegaly	MESH:D006332	marker/mechanism		NA		28982073
PLPP3	8613	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		21378990
PLPP3	8613	Ventricular Dysfunction, Left	MESH:D018487	marker/mechanism		NA		28982073
PLPPR1	54886	Seizures	MESH:D012640	marker/mechanism		NA		23266720
PLS1	5357	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		17114358
PLS3	5358	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 18	OMIM:300910	marker/mechanism		NA	300910	
PLS3	5358	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
PLS3	5358	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
PLSCR1	5359	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
PLSCR1	5359	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PLSCR2	57047	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PLSCR4	57088	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941189
PLTP	5360	Dyslipidemias	MESH:D050171	marker/mechanism		NA		17952847
PLTP	5360	Hypertriglyceridemia	MESH:D015228	marker/mechanism		NA		12754275
PLTP	5360	Insulin Resistance	MESH:D007333	marker/mechanism		NA		12754275
PLTP	5360	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PLVAP	83483	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
PLXDC1	57125	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
PLXNA2	5362	Schizophrenia	MESH:D012559	marker/mechanism		NA		18583979
PLXNA3	55558	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		21933904
PLXNB1	5364	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
PLXNC1	10154	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
PLXND1	23129	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
PMAIP1	5366	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		23770605
PMAIP1	5366	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
PMCH	5367	Obesity	MESH:D009765	marker/mechanism		NA		12355323
PMEL	6490	Melanoma	MESH:D008545	marker/mechanism		NA		26640592
PMEPA1	56937	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PML	5371	Glioblastoma	MESH:D005909	marker/mechanism		NA		23440206
PML	5371	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		10742073|14706140|16788101|16835227|16891316|16935935|17294898|17649720|19029980|19035177|19884644|19887701|21345080|21613260|22213200|23208507|23734343|26285909|26728337|8616088
PML	5371	Liver Neoplasms, Experimental	MESH:D008114	therapeutic		NA		20377131
PML	5371	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		29335545
PML	5371	Neoplasms, Second Primary	MESH:D016609	marker/mechanism		NA		19884644
PML	5371	Osteitis Deformans	MESH:D010001	marker/mechanism		NA		21623375
PML	5371	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29335545
PML	5371	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
PML	5371	Stevens-Johnson Syndrome	MESH:D013262	marker/mechanism		NA		25811541
PMM2	5373	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		25944804
PMM2	5373	Congenital disorder of glycosylation type 1A	MESH:C535739	marker/mechanism		NA	212065	21539312
PMM2	5373	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
PMP22	5376	Charcot-Marie-Tooth Disease	MESH:D002607	marker/mechanism		NA	118220|180800	17275665|17303424|19427269
PMP22	5376	Charcot-Marie-Tooth Disease, Demyelinating, Type 1e	MESH:C566136	marker/mechanism		NA	118300	
PMP22	5376	Demyelinating Diseases	MESH:D003711	marker/mechanism		NA		20739560
PMP22	5376	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		17275665
PMP22	5376	Epilepsies, Myoclonic	MESH:D004831	marker/mechanism		NA		17275665
PMP22	5376	Guillain-Barre Syndrome	MESH:D020275	marker/mechanism		NA	139393	
PMP22	5376	Hereditary Sensory and Motor Neuropathy	MESH:D015417	marker/mechanism		NA	145900	17701891
PMP22	5376	Muscle Weakness	MESH:D018908	marker/mechanism		NA		12427913
PMP22	5376	Paresthesia	MESH:D010292	marker/mechanism		NA		12427913
PMP22	5376	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		12427913|20739560
PMP22	5376	Quadriplegia	MESH:D011782	marker/mechanism		NA		12427913
PMP22	5376	Reflex, Abnormal	MESH:D012021	marker/mechanism		NA		12427913
PMP22	5376	Tomaculous neuropathy	MESH:C536965	marker/mechanism		NA	162500	
PMPCA	23203	Spinocerebellar Ataxia, Autosomal Recessive 2	MESH:C565865	marker/mechanism		NA	213200	
PMS1	5378	Lynch syndrome I (site-specific colonic cancer)	MESH:C537261	marker/mechanism		NA	120435	
PMS1	5378	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
PMS2	5395	Cafe-au-Lait Spots	MESH:D019080	marker/mechanism		NA		15077197
PMS2	5395	Colorectal Cancer, Hereditary Nonpolyposis, Type 4	MESH:C563971	marker/mechanism		NA	614337	
PMS2	5395	Colorectal Neoplasms, Hereditary Nonpolyposis	MESH:D003123	marker/mechanism		NA		14756672|15887124|25701956
PMS2	5395	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17717427
PMS2	5395	Neuroectodermal Tumors, Primitive	MESH:D018242	marker/mechanism		NA		15077197
PMS2	5395	Rhabdomyosarcoma	MESH:D012208	marker/mechanism		NA		19293170
PMS2	5395	Supratentorial Neoplasms	MESH:D015173	marker/mechanism		NA		15077197
PMS2	5395	Turcot syndrome	MESH:C536928	marker/mechanism		NA	276300	10763829|15077197
PMVK	10654	POROKERATOSIS 1, MULTIPLE TYPES	OMIM:175800	marker/mechanism		NA	175800	
PNKD	25953	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		25401301
PNKD	25953	Paroxysmal nonkinesigenic dyskinesia	MESH:C537181	marker/mechanism		NA	118800	21487022
PNKP	11284	ATAXIA-OCULOMOTOR APRAXIA 4	OMIM:616267	marker/mechanism		NA	616267	
PNKP	11284	Charcot-Marie-Tooth disease, Type 2B2	MESH:C537991	marker/mechanism		NA	605589	
PNKP	11284	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		20118933
PNKP	11284	DNA Repair-Deficiency Disorders	MESH:D049914	marker/mechanism		NA		20118933
PNKP	11284	Microcephaly	MESH:D008831	marker/mechanism		NA		20118933
PNKP	11284	MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	OMIM:613402	marker/mechanism		NA	613402	
PNKP	11284	Seizures	MESH:D012640	marker/mechanism		NA		20118933
PNLIP	5406	PANCREATIC LIPASE DEFICIENCY	OMIM:614338	marker/mechanism		NA	614338	
PNOC	5368	Hyperalgesia	MESH:D006930	marker/mechanism		NA		12665541|19231294
PNOC	5368	Hypotension	MESH:D007022	marker/mechanism		NA		10794074
PNOC	5368	Learning Disabilities	MESH:D007859	marker/mechanism		NA		10401555
PNOC	5368	Memory Disorders	MESH:D008569	marker/mechanism		NA		10401555
PNOC	5368	Neurogenic Inflammation	MESH:D020078	therapeutic		NA		11973003
PNOC	5368	Pain	MESH:D010146	therapeutic		NA		19231294
PNOC	5368	Parkinsonian Disorders	MESH:D020734	marker/mechanism		NA		26687234
PNOC	5368	Substance Withdrawal Syndrome	MESH:D013375	therapeutic		NA		10680585
PNP	4860	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		18414634
PNP	4860	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		16099942
PNP	4860	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
PNP	4860	Purine Nucleoside Phosphorylase Deficiency	MESH:C562587	marker/mechanism		NA	613179	9403342
PNPLA1	285848	Ichthyosis	MESH:D007057	marker/mechanism		NA		22246504
PNPLA1	285848	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 10	OMIM:615024	marker/mechanism		NA	615024	
PNPLA2	57104	Heart Diseases	MESH:D006331	marker/mechanism		NA		21585347|23867907
PNPLA2	57104	Neutral Lipid Storage Disease with Myopathy	MESH:C565192	marker/mechanism		NA	610717	
PNPLA2	57104	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
PNPLA3	80339	Fatty Liver	MESH:D005234	marker/mechanism		NA		25678388
PNPLA3	80339	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		19946271|26482880
PNPLA3	80339	Liver Diseases, Alcoholic	MESH:D008108	marker/mechanism		NA		19946271
PNPLA3	80339	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		18820647|24531328|27180240
PNPLA6	10908	Chorioretinal Dystrophy, Spinocerebellar Ataxia, and Hypogonadotropic Hypogonadism	MESH:C565850	marker/mechanism		NA	215470	
PNPLA6	10908	Laurence-Moon Syndrome	MESH:D007849	marker/mechanism		NA	245800	
PNPLA6	10908	Motor Neuron Disease	MESH:D016472	marker/mechanism		NA		18313024|20603202
PNPLA6	10908	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		8211998
PNPLA6	10908	Oliver-McFarlane syndrome	MESH:C536554	marker/mechanism		NA	275400	
PNPLA6	10908	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		20188121
PNPLA6	10908	Polyneuropathies	MESH:D011115	marker/mechanism		NA		22819951
PNPLA6	10908	Sick Building Syndrome	MESH:D018877	marker/mechanism		NA		23418070
PNPLA6	10908	Spastic Paraplegia 39, Autosomal Recessive	MESH:C567433	marker/mechanism		NA	612020	
PNPLA6	10908	Spastic Paraplegia, Hereditary	MESH:D015419	marker/mechanism		NA		20382209
PNPLA8	50640	Mitochondrial myopathy with lactic acidosis	MESH:C537476	marker/mechanism		NA	251950	
PNPO	55163	Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency	MESH:C566449	marker/mechanism		NA	610090	
PNPO	55163	Status Epilepticus	MESH:D013226	marker/mechanism		NA		19356691
PNPT1	87178	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
PNPT1	87178	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13	OMIM:614932	marker/mechanism		NA	614932	
PNPT1	87178	DEAFNESS, AUTOSOMAL RECESSIVE 70	OMIM:614934	marker/mechanism		NA	614934	
PNRC1	10957	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
POC1B	282809	CONE-ROD DYSTROPHY 20	OMIM:615973	marker/mechanism		NA	615973	
PODXL	5420	Carotid Artery Diseases	MESH:D002340	marker/mechanism		NA		22016802
PODXL	5420	Hemorrhage	MESH:D006470	marker/mechanism		NA		22016802
PODXL	5420	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16434482
PODXL	5420	Thrombosis	MESH:D013927	marker/mechanism		NA		22016802
POF1B	79983	Premature Ovarian Failure 2b	MESH:C564476	marker/mechanism		NA	300604	
POFUT1	23509	Dowling-Degos Disease	MESH:C562924	marker/mechanism		NA	615327	
POGLUT1	56983	Dowling-Degos Disease	MESH:C562924	marker/mechanism		NA	615696	
POGLUT1	56983	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 21	OMIM:617232	marker/mechanism		NA	617232	
POGZ	23126	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
POGZ	23126	WHITE-SUTTON SYNDROME	OMIM:616364	marker/mechanism		NA	616364	
POLA1	5422	Pigmentary Disorder, Reticulate, with Systemic Manifestations	MESH:C564461	marker/mechanism		NA	301220	
POLB	5423	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		25030372
POLB	5423	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		18006695
POLB	5423	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		8631603
POLD1	5424	Abnormalities, Multiple	MESH:D000015	marker/mechanism		NA		23770608
POLD1	5424	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	612591	23263490
POLD1	5424	Deafness	MESH:D003638	marker/mechanism		NA		23770608
POLD1	5424	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		23263490
POLD1	5424	Hypogonadism	MESH:D007006	marker/mechanism		NA		23770608
POLD1	5424	Jaw Abnormalities	MESH:D007569	marker/mechanism		NA		23770608
POLD1	5424	Lipodystrophy	MESH:D008060	marker/mechanism		NA		23770608
POLD1	5424	MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME	OMIM:615381	marker/mechanism		NA	615381	
POLD3	10714	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		22634755|30510241
POLE	5426	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	615083	23263490|26053496
POLE	5426	FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE	OMIM:615139	marker/mechanism		NA	615139	
POLG	5428	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		18208989|20138553
POLG	5428	Diffuse Cerebral Sclerosis of Schilder	MESH:D002549	marker/mechanism		NA		17923349|18716558|20138553
POLG	5428	Epilepsy	MESH:D004827	marker/mechanism		NA		18716558
POLG	5428	Infertility, Male	MESH:D007248	marker/mechanism		NA		17923349
POLG	5428	Mitochondrial Diseases	MESH:D028361	marker/mechanism		NA		18716558
POLG	5428	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE)	OMIM:603041	marker/mechanism		NA	603041	
POLG	5428	MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	OMIM:203700	marker/mechanism		NA	203700	
POLG	5428	MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE)	OMIM:613662	marker/mechanism		NA	613662	
POLG	5428	Ophthalmoplegia, Chronic Progressive External	MESH:D017246	marker/mechanism		NA		17923349
POLG	5428	Parkinsonian Disorders	MESH:D020734	marker/mechanism		NA		17923349
POLG	5428	Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 1	MESH:C563575	marker/mechanism		NA	157640	
POLG	5428	Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Recessive	MESH:C564926	marker/mechanism		NA	258450	
POLG	5428	Seizures	MESH:D012640	marker/mechanism		NA		20138553|20446108
POLG	5428	Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis	MESH:C537583	marker/mechanism		NA	607459	17923349
POLG2	11232	Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 4	MESH:C566437	marker/mechanism		NA	610131	
POLH	5429	Xeroderma Pigmentosum	MESH:D014983	marker/mechanism		NA		22745795
POLH	5429	Xeroderma pigmentosum, variant type	MESH:C536766	marker/mechanism		NA	278750	
POLK	51426	Glioblastoma	MESH:D005909	marker/mechanism		NA		26651356
POLK	51426	Micronuclei, Chromosome-Defective	MESH:D048629	marker/mechanism		NA		26651356
POLK	51426	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		26046662
POLR1A	25885	ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE	OMIM:616462	marker/mechanism		NA	616462	
POLR1C	9533	LEUKODYSTROPHY, HYPOMYELINATING, 11	OMIM:616494	marker/mechanism		NA	616494	
POLR1C	9533	Mandibulofacial Dysostosis	MESH:D008342	marker/mechanism		NA		21131976
POLR1C	9533	Mandibulofacial dysostosis, Treacher Collins type, autosomal recessive	MESH:C535707	marker/mechanism		NA	248390	
POLR1D	51082	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
POLR1D	51082	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
POLR1D	51082	Mandibulofacial Dysostosis	MESH:D008342	marker/mechanism		NA		21131976
POLR1D	51082	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
POLR1D	51082	TREACHER COLLINS SYNDROME 2	OMIM:613717	marker/mechanism		NA	613717	
POLR1H	30834	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		16609701
POLR1H	30834	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16609701
POLR2G	5436	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
POLR3A	11128	Leukodystrophy, Hypomyelinating, with Hypodontia and Hypogonadotropic Hypogonadism	MESH:C567313	marker/mechanism		NA	607694	
POLR3B	55703	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
POLR3B	55703	Leukodystrophy, Hypomyelinating, with Hypodontia and Hypogonadotropic Hypogonadism	MESH:C567313	marker/mechanism		NA	607694|614381	
POLR3K	51728	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
POLR3K	51728	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
POMC	5443	ACTH Syndrome, Ectopic	MESH:D000182	marker/mechanism		NA		1459535|2844640|4367732|8562174
POMC	5443	Acute Kidney Injury	MESH:D058186	therapeutic		NA		17216604
POMC	5443	Adrenal Cortex Diseases	MESH:D000303	therapeutic		NA		11370731
POMC	5443	Amnesia	MESH:D000647	marker/mechanism		NA		2841920
POMC	5443	Aortic Stenosis, Subvalvular	MESH:D001020	marker/mechanism		NA		1965992
POMC	5443	Arthritis, Gouty	MESH:D015210	therapeutic		NA		8035395
POMC	5443	Autistic Disorder	MESH:D001321	marker/mechanism		NA		8570775
POMC	5443	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		2843795|9664777
POMC	5443	Body Weight	MESH:D001835	marker/mechanism		NA		1316127
POMC	5443	Bradycardia	MESH:D001919	marker/mechanism		NA		1676337|19039989|2636709
POMC	5443	Burns	MESH:D002056	marker/mechanism		NA		2968671
POMC	5443	Calcinosis	MESH:D002114	marker/mechanism		NA		6143199
POMC	5443	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		2844640
POMC	5443	Cardiomegaly	MESH:D006332	marker/mechanism		NA		19039989|1965992|2821097|6088243|8279378|8381257
POMC	5443	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		6143199
POMC	5443	Cardiomyopathy, Hypertrophic	MESH:D002312	marker/mechanism		NA		2536513|2831920|2853496|8381257|8928979
POMC	5443	Catalepsy	MESH:D002375	marker/mechanism|therapeutic		NA		2999739|6329457
POMC	5443	Cerebral Hemorrhage	MESH:D002543	marker/mechanism		NA		6254450
POMC	5443	Cerebral Palsy	MESH:D002547	therapeutic		NA		8980841
POMC	5443	Cholestasis	MESH:D002779	therapeutic		NA		3421781
POMC	5443	Chondrocalcinosis	MESH:D002805	therapeutic		NA		8035395
POMC	5443	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		11750770|16520439|18201294|19279569
POMC	5443	Constipation	MESH:D003248	therapeutic		NA		3421781
POMC	5443	Cushing Syndrome	MESH:D003480	marker/mechanism		NA		19153526|6088243
POMC	5443	Cystitis	MESH:D003556	marker/mechanism		NA		1267567
POMC	5443	Depressive Disorder	MESH:D003866	marker/mechanism		NA		18201294
POMC	5443	Diabetes Insipidus	MESH:D003919	therapeutic		NA		6258694
POMC	5443	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		19153526
POMC	5443	Edema	MESH:D004487	marker/mechanism		NA		1459535|4327920|8562174
POMC	5443	Epilepsies, Myoclonic	MESH:D004831	therapeutic		NA		6088243
POMC	5443	Epilepsy	MESH:D004827	therapeutic		NA		20708863
POMC	5443	Epilepsy, Tonic-Clonic	MESH:D004830	marker/mechanism		NA		4371370
POMC	5443	Eye Diseases	MESH:D005128	marker/mechanism		NA		4340068
POMC	5443	Eye Pain	MESH:D058447	marker/mechanism		NA		4327920
POMC	5443	Facial Paralysis	MESH:D005158	therapeutic		NA		4327920
POMC	5443	Fatty Liver	MESH:D005234	marker/mechanism		NA		167377
POMC	5443	Femur Head Necrosis	MESH:D005271	marker/mechanism		NA		4326745
POMC	5443	Fever	MESH:D005334	marker/mechanism		NA		6350720
POMC	5443	Gastrointestinal Diseases	MESH:D005767	marker/mechanism		NA		6254450
POMC	5443	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		4368615|6300362
POMC	5443	Heart Failure	MESH:D006333	marker/mechanism		NA		3026683|8277081
POMC	5443	Hematuria	MESH:D006417	marker/mechanism		NA		1267567|1324751
POMC	5443	Hemorrhage	MESH:D006470	marker/mechanism		NA		1267567|3014908
POMC	5443	Heroin Dependence	MESH:D006556	marker/mechanism		NA		18201294
POMC	5443	Hirsutism	MESH:D006628	marker/mechanism		NA		1324751
POMC	5443	Hypercalciuria	MESH:D053565	marker/mechanism		NA		1324751|3017235
POMC	5443	Hypernatremia	MESH:D006955	marker/mechanism		NA		10100081|6279499
POMC	5443	Hypertension	MESH:D006973	marker/mechanism|therapeutic		NA		10100081|10474778|10513829|10658937|11071300|11071304|11132610|11193135|11518849|11560123|11703388|12872045|12887135|1316127|1321011|1321309|1327015|1330390|1334993|15110907|15132301|15554453|16053986|16243970|1649024|16546835|16620303|1664305|17324744|17954371|17994356|18067589|18487447|187612|19153526|19458537|20186125|20659135|2157753|216942|2455169|2551692|2821097|2822310|2849322|2992854|3001556|3015460|323586|4367732|6088243|6089027|6097376|6100240|6135010|6143199|6254450|6274577|6279500|6283272|76749|8136112|8261660|8279378|8713685|8800598|9056691|9535146
POMC	5443	Hypocalcemia	MESH:D006996	marker/mechanism		NA		3017235
POMC	5443	Hypokalemia	MESH:D007008	marker/mechanism		NA		10100081|1327015|323586|4323972|6254450|6258369|6279499|8035395|8562174
POMC	5443	Hypotension	MESH:D007022	marker/mechanism		NA		1676337|2536002|2566129|2636709
POMC	5443	Hypoxia	MESH:D000860	marker/mechanism		NA		11311734|24412703
POMC	5443	Immune System Diseases	MESH:D007154	marker/mechanism		NA		6107850
POMC	5443	Infections	MESH:D007239	marker/mechanism		NA		6088243|6254450
POMC	5443	Kidney Calculi	MESH:D007669	marker/mechanism		NA		1324751
POMC	5443	Kidney Diseases	MESH:D007674	marker/mechanism		NA		6143199
POMC	5443	Kidney Tubular Necrosis, Acute	MESH:D007683	marker/mechanism		NA		4358912|6254450
POMC	5443	Liver Cirrhosis, Experimental	MESH:D008106	therapeutic		NA		16508911|16511523
POMC	5443	Liver Failure, Acute	MESH:D017114	therapeutic		NA		15313186
POMC	5443	Long QT Syndrome	MESH:D008133	marker/mechanism		NA		19931775
POMC	5443	Melanoma	MESH:D008545	therapeutic		NA		24412703
POMC	5443	Mental Disorders	MESH:D001523	marker/mechanism		NA		18056188
POMC	5443	Multiple Sclerosis	MESH:D009103	therapeutic		NA		2843795|9664777
POMC	5443	Myasthenia Gravis	MESH:D009157	therapeutic		NA		4323972
POMC	5443	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		10908253
POMC	5443	Nausea	MESH:D009325	marker/mechanism		NA		11141589
POMC	5443	Necrosis	MESH:D009336	marker/mechanism		NA		7608651
POMC	5443	Nephrocalcinosis	MESH:D009397	marker/mechanism		NA		3017235
POMC	5443	Neurogenic Inflammation	MESH:D020078	therapeutic		NA		19333140
POMC	5443	Obesity	MESH:D009765	marker/mechanism		NA	601665	16289378|19153526
POMC	5443	Oliguria	MESH:D009846	marker/mechanism		NA		6254450
POMC	5443	Opsoclonus-Myoclonus Syndrome	MESH:D053578	therapeutic		NA		1318289
POMC	5443	Osteoporosis	MESH:D010024	marker/mechanism		NA		19153526|3017235|4367732|6143199|6254450
POMC	5443	Pain	MESH:D010146	marker/mechanism|therapeutic		NA		20084599|4345333|6094376
POMC	5443	Pancreatic Diseases	MESH:D010182	marker/mechanism		NA		6143199
POMC	5443	Penile Diseases	MESH:D010409	marker/mechanism		NA		1358647|2825910|3033702
POMC	5443	Pituitary ACTH Hypersecretion	MESH:D047748	marker/mechanism		NA		16809932
POMC	5443	Pneumonia	MESH:D011014	marker/mechanism		NA		6254450
POMC	5443	Postoperative Complications	MESH:D011183	marker/mechanism		NA		4371370
POMC	5443	Proopiomelanocortin Deficiency	MESH:C565726	marker/mechanism		NA	609734	
POMC	5443	Proteinuria	MESH:D011507	marker/mechanism		NA		4368615
POMC	5443	Recurrence	MESH:D012008	marker/mechanism		NA		20078871
POMC	5443	Restless Legs Syndrome	MESH:D012148	marker/mechanism		NA		18464280
POMC	5443	Rhabdomyoma	MESH:D012207	marker/mechanism		NA		10908253
POMC	5443	Sacroiliitis	MESH:D058566	therapeutic		NA		19533139
POMC	5443	Seizures	MESH:D012640	marker/mechanism|therapeutic		NA		1656808|2169275|2554740|2821097|6324019|7127082
POMC	5443	Sick Sinus Syndrome	MESH:D012804	marker/mechanism		NA		19039989
POMC	5443	Sleep Wake Disorders	MESH:D012893	marker/mechanism		NA		18464280
POMC	5443	Spasms, Infantile	MESH:D013036	marker/mechanism|therapeutic		NA		10908253|11341487|1324751|1327015|1656808|17287597|19039989|1965992|20078871|2551692|2554740|2853496|2983143|6107850|6143199|6254450|6259007|8381257|8928979|8980841
POMC	5443	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism|therapeutic		NA		15689546|15714323|20738730|225122
POMC	5443	Synovitis	MESH:D013585	therapeutic		NA		8035395
POMC	5443	Urinary Tract Infections	MESH:D014552	marker/mechanism		NA		6254450
POMC	5443	Weight Gain	MESH:D015430	marker/mechanism		NA		4367732|6143199
POMC	5443	Weight Loss	MESH:D015431	marker/mechanism		NA		11193135|1459535
POMGNT1	55624	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 3	OMIM:613151	marker/mechanism		NA	613151	
POMGNT1	55624	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3	OMIM:613157	marker/mechanism		NA	613157	
POMGNT1	55624	RETINITIS PIGMENTOSA 76	OMIM:617123	marker/mechanism		NA	617123	
POMGNT1	55624	Walker-Warburg Syndrome	MESH:D058494	marker/mechanism		NA	253280	
POMGNT2	84892	Walker-Warburg Syndrome	MESH:D058494	marker/mechanism		NA	614830	
POMK	84197	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12	OMIM:616094	marker/mechanism		NA	616094	
POMK	84197	Walker-Warburg Syndrome	MESH:D058494	marker/mechanism		NA	615249	
POMP	51371	Exfoliation Syndrome	MESH:D017889	marker/mechanism		NA		28553957
POMP	51371	Keratosis Linearis with Ichthyosis Congenita and Sclerosing Keratoderma	MESH:C566600	marker/mechanism		NA	601952	
POMT1	10585	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL IMPAIRMENT), TYPE B, 1	OMIM:613155	marker/mechanism		NA	613155	
POMT1	10585	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1	OMIM:609308	marker/mechanism		NA	609308	
POMT1	10585	Walker-Warburg Syndrome	MESH:D058494	marker/mechanism		NA	236670	
POMT2	29954	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 2	OMIM:613156	marker/mechanism		NA	613156	
POMT2	29954	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2	OMIM:613158	marker/mechanism		NA	613158	
POMT2	29954	Walker-Warburg Syndrome	MESH:D058494	marker/mechanism		NA	236670|613150	
PON1	5444	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		26241956
PON1	5444	Agricultural Workers' Diseases	MESH:D000382	marker/mechanism		NA		15982977|18430447
PON1	5444	Amyotrophic Lateral Sclerosis	MESH:D000690	marker/mechanism		NA		28070599
PON1	5444	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		17204329
PON1	5444	Arteritis	MESH:D001167	marker/mechanism		NA		19022366
PON1	5444	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		16055108
PON1	5444	Atherosclerosis	MESH:D050197	marker/mechanism|therapeutic		NA		16216721|16229851|16331452|19371607|21629682|26241956
PON1	5444	Autistic Disorder	MESH:D001321	marker/mechanism		NA		16027737|16297937|22490277
PON1	5444	Birth Weight	MESH:D001724	marker/mechanism		NA		17237730
PON1	5444	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		16002382
PON1	5444	Cardiovascular Diseases	MESH:D002318	marker/mechanism|therapeutic		NA		15169886|19152805
PON1	5444	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		16099942
PON1	5444	Cholestasis	MESH:D002779	marker/mechanism		NA		27989131
PON1	5444	Constipation	MESH:D003248	marker/mechanism		NA		19022366
PON1	5444	Coronary Artery Disease	MESH:D003324	marker/mechanism|therapeutic		NA		21629682|8675673|9215303
PON1	5444	Coronary Disease	MESH:D003327	marker/mechanism		NA		16353344|16882531
PON1	5444	Coronary Vasospasm	MESH:D003329	marker/mechanism		NA		11810302
PON1	5444	Depressive Disorder	MESH:D003866	marker/mechanism		NA		19272368
PON1	5444	Diabetes Complications	MESH:D048909	marker/mechanism		NA		19003935
PON1	5444	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		16229851|19022366
PON1	5444	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		26884296
PON1	5444	Diabetic Retinopathy	MESH:D003930	marker/mechanism		NA		20012460|9661650
PON1	5444	Fatty Liver	MESH:D005234	marker/mechanism		NA		26945512
PON1	5444	Glomerulonephritis, Membranoproliferative	MESH:D015432	marker/mechanism		NA		16175651
PON1	5444	Heart Diseases	MESH:D006331	marker/mechanism		NA		28396702
PON1	5444	Heart Failure	MESH:D006333	marker/mechanism		NA		26670611
PON1	5444	Hematologic Neoplasms	MESH:D019337	marker/mechanism		NA		22800774
PON1	5444	Hemorrhoids	MESH:D006484	marker/mechanism		NA		19022366
PON1	5444	Hypercholesterolemia	MESH:D006937	marker/mechanism		NA		16229851
PON1	5444	Hyperhomocysteinemia	MESH:D020138	marker/mechanism		NA		17292331|19028542
PON1	5444	Hyperlipoproteinemias	MESH:D006951	marker/mechanism		NA		15324535
PON1	5444	Hyperlipoproteinemia Type II	MESH:D006938	marker/mechanism		NA		16030523|16238680
PON1	5444	Hyperthyroidism	MESH:D006980	marker/mechanism		NA		14678291
PON1	5444	Infertility, Male	MESH:D007248	marker/mechanism		NA		21561808|22206979
PON1	5444	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		16323636
PON1	5444	Lymphoma	MESH:D008223	marker/mechanism		NA		22800774
PON1	5444	Metabolic Diseases	MESH:D008659	marker/mechanism		NA		28396702
PON1	5444	Metabolic Syndrome	MESH:D024821	marker/mechanism		NA		21573798
PON1	5444	Micronuclei, Chromosome-Defective	MESH:D048629	marker/mechanism		NA		26839999
PON1	5444	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 5	OMIM:612633	marker/mechanism		NA	612633	
PON1	5444	Neuroectodermal Tumors, Primitive	MESH:D018242	marker/mechanism		NA		16002382
PON1	5444	Neurotoxicity Syndromes	MESH:D020258	therapeutic		NA		21329748
PON1	5444	Occupational Diseases	MESH:D009784	marker/mechanism		NA		22800774
PON1	5444	Organophosphate Poisoning	MESH:D062025	marker/mechanism|therapeutic		NA		11022865|20581384|20981111|23123254|24326413|26340881|28070599
PON1	5444	Parkinson Disease, Secondary	MESH:D010302	marker/mechanism		NA		26457621
PON1	5444	Periodontal Diseases	MESH:D010510	marker/mechanism		NA		19003935
PON1	5444	Persian Gulf Syndrome	MESH:D018923	marker/mechanism		NA		10373407
PON1	5444	Prenatal Exposure Delayed Effects	MESH:D011297	marker/mechanism		NA		25463530|28396702
PON1	5444	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		12783936|15538743|21716162
PON1	5444	Spinal Dysraphism	MESH:D016135	marker/mechanism		NA		21031563
PON2	5445	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		19152805
PON2	5445	Hyperlipoproteinemia Type II	MESH:D006938	marker/mechanism		NA		16030523
POP1	10940	Anauxetic dysplasia	MESH:C538256	marker/mechanism		NA	617396	
POP4	10775	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		21397856
POR	5447	Adrenal Hyperplasia, Congenital	MESH:D000312	marker/mechanism		NA		18559916
POR	5447	Amenorrhea	MESH:D000568	marker/mechanism		NA		14758361
POR	5447	Antley-Bixler Syndrome Phenotype	MESH:D054882	marker/mechanism		NA	613571	14758361|15220035|16906539|27496950
POR	5447	ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS	OMIM:201750	marker/mechanism		NA	201750	
POR	5447	ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS	OMIM:207410	marker/mechanism		NA	207410	
POR	5447	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		15089088
POR	5447	Gliosarcoma	MESH:D018316	therapeutic		NA		9766669
POR	5447	Learning Disabilities	MESH:D007859	marker/mechanism		NA		21987461
POR	5447	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		8631603
PORCN	64840	Focal Dermal Hypoplasia	MESH:D005489	marker/mechanism		NA	305600	17546030|17546031
POSTN	10631	Asthma, Aspirin-Induced	MESH:D055963	marker/mechanism		NA		18391768
POSTN	10631	Bronchopulmonary Dysplasia	MESH:D001997	marker/mechanism		NA		22363622
POSTN	10631	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		15731169
POSTN	10631	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		18391768
POSTN	10631	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		32344006
POSTN	10631	Muscular Dystrophy, Duchenne	MESH:D020388	marker/mechanism		NA		21641384
POT1	25913	Chromosome Aberrations	MESH:D002869	marker/mechanism		NA		23502782
POT1	25913	Chromosome Disorders	MESH:D025063	marker/mechanism		NA		23502782
POT1	25913	Glioma	MESH:D005910	marker/mechanism		NA	616568	
POT1	25913	Leukemia, Lymphoid	MESH:D007945	marker/mechanism		NA		23502782|24292274
POT1	25913	Melanoma	MESH:D008545	marker/mechanism		NA		24686849
POT1	25913	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 10	OMIM:615848	marker/mechanism		NA	615848	
POT1	25913	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		24686849
POU1F1	5449	Dwarfism, Pituitary	MESH:D004393	marker/mechanism		NA		9392392
POU1F1	5449	Pituitary Hormone Deficiency, Combined, 1	MESH:C567803	marker/mechanism		NA	613038	
POU2F2	5452	Gastro-enteropancreatic neuroendocrine tumor	MESH:C535650	marker/mechanism		NA		29915428
POU2F2	5452	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
POU3F1	5453	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		23143596
POU3F2	5454	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		31043756
POU3F3	5455	Osteoarthritis	MESH:D010003	marker/mechanism		NA		17568789
POU3F4	5456	Progressive hearing loss stapes fixation	MESH:C536424	marker/mechanism		NA	304400	
POU4F1	5457	Cervical Intraepithelial Neoplasia	MESH:D018290	marker/mechanism		NA		20190800
POU4F1	5457	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		18206229
POU4F1	5457	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		21928122
POU4F3	5459	Deafness, Autosomal Dominant 15	MESH:C566545	marker/mechanism		NA	602459	
POU5F1	5460	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
POU5F1	5460	Gestational Trophoblastic Disease	MESH:D031901	marker/mechanism		NA		18440631
POU5F1	5460	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		26507003
POU5F1	5460	Neoplasms, Germ Cell and Embryonal	MESH:D009373	marker/mechanism		NA		16168501
POU6F2	11281	Autistic Disorder	MESH:D001321	marker/mechanism		NA		20663923
POU6F2	11281	WILMS TUMOR 5	OMIM:601583	marker/mechanism		NA	601583	
PPA2	27068	SUDDEN CARDIAC FAILURE, ALCOHOL-INDUCED	OMIM:617223	marker/mechanism		NA	617223	
PPA2	27068	SUDDEN CARDIAC FAILURE, INFANTILE	OMIM:617222	marker/mechanism		NA	617222	
PPAN	56342	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
PPAN	56342	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
PPAP2A	100164616	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PPAP2A	100164616	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29662167
PPARA	5465	Abdominal obesity metabolic syndrome	MESH:C535554	marker/mechanism		NA		15309680
PPARA	5465	Carcinoma	MESH:D002277	marker/mechanism		NA		11137312
PPARA	5465	Cardiomegaly	MESH:D006332	therapeutic		NA		22198280
PPARA	5465	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		24385052
PPARA	5465	Crohn Disease	MESH:D003424	marker/mechanism		NA		21829567
PPARA	5465	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		18249437
PPARA	5465	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		12967931|14563825|23090186
PPARA	5465	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		17317762|31626838
PPARA	5465	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		19683050
PPARA	5465	Dyslipidemias	MESH:D050171	therapeutic		NA		16168052
PPARA	5465	Encephalomyelitis, Autoimmune, Experimental	MESH:D004681	marker/mechanism		NA		17261635
PPARA	5465	Fatty Liver	MESH:D005234	therapeutic		NA		19124612
PPARA	5465	Fatty Liver, Alcoholic	MESH:D005235	marker/mechanism		NA		18703563
PPARA	5465	Hepatomegaly	MESH:D006529	marker/mechanism		NA		14982965
PPARA	5465	Hyperlipidemias	MESH:D006949	therapeutic		NA		21640707
PPARA	5465	Hyperlipoproteinemias	MESH:D006951	marker/mechanism		NA		10828087
PPARA	5465	Hypertension	MESH:D006973	marker/mechanism|therapeutic		NA		16054168|19834340
PPARA	5465	Hypertriglyceridemia	MESH:D015228	marker/mechanism		NA		15309680
PPARA	5465	Hypoglycemia	MESH:D007003	marker/mechanism		NA		16777972
PPARA	5465	Inflammation	MESH:D007249	therapeutic		NA		21300114
PPARA	5465	Insulin Resistance	MESH:D007333	therapeutic		NA		16168052|21324916
PPARA	5465	Kidney Diseases	MESH:D007674	marker/mechanism		NA		16316343
PPARA	5465	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19878707
PPARA	5465	Kidney Tubular Necrosis, Acute	MESH:D007683	marker/mechanism		NA		19834340
PPARA	5465	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		20143881|29134746
PPARA	5465	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		11137312
PPARA	5465	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		11137312
PPARA	5465	Muscular Diseases	MESH:D009135	marker/mechanism		NA		19683050
PPARA	5465	Myocardial Reperfusion Injury	MESH:D015428	therapeutic		NA		16411023
PPARA	5465	Neoplasms	MESH:D009369	marker/mechanism		NA		17405874
PPARA	5465	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		23603006
PPARA	5465	Obesity	MESH:D009765	marker/mechanism		NA		11089532|30738174
PPARA	5465	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		22919386
PPARA	5465	Proteinuria	MESH:D011507	marker/mechanism		NA		16054168
PPARA	5465	Reperfusion Injury	MESH:D015427	therapeutic		NA		19151258
PPARD	5467	Cardiomegaly	MESH:D006332	marker/mechanism		NA		20075336
PPARD	5467	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		20075336
PPARD	5467	Fatty Liver	MESH:D005234	marker/mechanism		NA		23851158
PPARD	5467	Liver Diseases, Alcoholic	MESH:D008108	marker/mechanism		NA		27765815
PPARD	5467	Melanoma	MESH:D008545	therapeutic		NA		28962521
PPARD	5467	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism|therapeutic		NA		16574099|29289645
PPARD	5467	Obesity	MESH:D009765	therapeutic		NA		16168052|20176998
PPARD	5467	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		20864405|21245421
PPARD	5467	Skin Neoplasms	MESH:D012878	marker/mechanism|therapeutic		NA		19748995|21159610
PPARD	5467	Weight Gain	MESH:D015430	therapeutic		NA		20176998
PPARG	5468	Acute Kidney Injury	MESH:D058186	marker/mechanism|therapeutic		NA		20623750|24011919|24433871
PPARG	5468	Acute Lung Injury	MESH:D055371	therapeutic		NA		21153920
PPARG	5468	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		11034103
PPARG	5468	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		15993441|16407166|30328325
PPARG	5468	Antiphospholipid Syndrome	MESH:D016736	marker/mechanism		NA		28182703
PPARG	5468	Atherosclerosis	MESH:D050197	therapeutic		NA		18269830
PPARG	5468	Barrett Esophagus	MESH:D001471	marker/mechanism		NA		15387324
PPARG	5468	Carcinoma, Hepatocellular	MESH:D006528	therapeutic		NA		16374840
PPARG	5468	Carotid Intimal Medial Thickness 1	MESH:C563733	marker/mechanism		NA	609338	
PPARG	5468	Chronobiology Disorders	MESH:D021081	marker/mechanism		NA		22899986
PPARG	5468	Colonic Neoplasms	MESH:D003110	therapeutic		NA		20540935
PPARG	5468	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		16489531
PPARG	5468	Crohn Disease	MESH:D003424	marker/mechanism		NA		21829567
PPARG	5468	Diabetes Mellitus	MESH:D003920	therapeutic		NA		16168052
PPARG	5468	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		12967931|16123366|21757225
PPARG	5468	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism|therapeutic		NA	125853	15592662|16123366|16249460|17317762|21484566|28182703|31626838
PPARG	5468	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		28182703
PPARG	5468	Dyslipidemias	MESH:D050171	therapeutic		NA		16168052
PPARG	5468	Glomerulonephritis	MESH:D005921	therapeutic		NA		11318962
PPARG	5468	Heart Failure	MESH:D006333	marker/mechanism		NA		26670611
PPARG	5468	Hypertension	MESH:D006973	marker/mechanism|therapeutic		NA		15199296|19666838|27292124
PPARG	5468	Inflammation	MESH:D007249	marker/mechanism|therapeutic		NA		19926821|21354099
PPARG	5468	Insulin Resistance	MESH:D007333	therapeutic		NA		16168052|21354099|21484566
PPARG	5468	Ischemia	MESH:D007511	therapeutic		NA		12468449|24433871
PPARG	5468	Leukostasis	MESH:D018921	therapeutic		NA		12468449
PPARG	5468	Lipidoses	MESH:D008064	marker/mechanism		NA		21123845
PPARG	5468	Lipodystrophy, Familial Partial	MESH:D052496	marker/mechanism		NA	604367	19793595
PPARG	5468	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		20143881
PPARG	5468	Lymphoma, T-Cell	MESH:D016399	marker/mechanism		NA		17255338
PPARG	5468	Melanoma	MESH:D008545	marker/mechanism|therapeutic		NA		14512786|28962521
PPARG	5468	Metabolic Diseases	MESH:D008659	marker/mechanism		NA		19589179
PPARG	5468	Nerve Degeneration	MESH:D009410	therapeutic		NA		18289512
PPARG	5468	Obesity	MESH:D009765	marker/mechanism		NA	601665	11089532|28242765
PPARG	5468	Osteoarthritis	MESH:D010003	marker/mechanism		NA		17568789
PPARG	5468	Pancreatic Neoplasms	MESH:D010190	marker/mechanism|therapeutic		NA		11034103|11741176
PPARG	5468	Pituitary ACTH Hypersecretion	MESH:D047748	therapeutic		NA		16809932
PPARG	5468	Polycystic Kidney, Autosomal Dominant	MESH:D016891	marker/mechanism		NA		20210794
PPARG	5468	Psoriasis	MESH:D011565	therapeutic		NA		10815854
PPARG	5468	Renal Insufficiency	MESH:D051437	marker/mechanism		NA		28182703
PPARG	5468	Reperfusion Injury	MESH:D015427	therapeutic		NA		12468449|24011919|24433871
PPARG	5468	Stomach Neoplasms	MESH:D013274	marker/mechanism|therapeutic		NA		15492468|19140230
PPARG	5468	Subarachnoid Hemorrhage	MESH:D013345	marker/mechanism		NA		29162556
PPARG	5468	Thyroid cancer, follicular	MESH:C572845	marker/mechanism		NA		15785241
PPARG	5468	Thyroid Neoplasms	MESH:D013964	therapeutic		NA		15785241
PPARGC1A	10891	Bowen's Disease	MESH:D001913	marker/mechanism		NA		21514422
PPARGC1A	10891	Ceroid lipofuscinosis, neuronal 1, infantile	MESH:C537948	marker/mechanism		NA		21224254
PPARGC1A	10891	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		14563825
PPARGC1A	10891	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		15592662|17317762
PPARGC1A	10891	Heart Failure	MESH:D006333	marker/mechanism		NA		19808358|22503866
PPARGC1A	10891	Lewy Body Disease	MESH:D020961	marker/mechanism		NA		30236862
PPARGC1A	10891	Muscular Dystrophy, Animal	MESH:D009137	therapeutic		NA		22795790
PPARGC1A	10891	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		22503866
PPARGC1A	10891	Parkinson Disease	MESH:D010300	marker/mechanism		NA		30236862
PPARGC1B	133522	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20961995
PPARGC1B	133522	Hyperlipidemias	MESH:D006949	marker/mechanism		NA		17932310
PPARGC1B	133522	Obesity	MESH:D009765	marker/mechanism		NA		30738174
PPAT	5471	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		761203
PPAT	5471	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
PPBP	5473	Hypersensitivity	MESH:D006967	marker/mechanism		NA		23624239
PPBP	5473	Hypertension	MESH:D006973	marker/mechanism		NA		15513305|6192689
PPBP	5473	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
PPFIA4	8497	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		28416822|29892015|30061737
PPFIBP1	8496	Plasma Cell Granuloma, Pulmonary	MESH:D016726	marker/mechanism		NA		21430068
PPFIBP2	8495	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
PPFIBP2	8495	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		26443449
PPIA	5478	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		17094902
PPIA	5478	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		15274141
PPIA	5478	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		15274141
PPIA	5478	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		21956400
PPIA	5478	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		19424620
PPIB	5479	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
PPIB	5479	Osteogenesis Imperfecta, Type IX	MESH:C564921	marker/mechanism		NA	259440	
PPIC	5480	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
PPIF	10105	Intestinal Diseases	MESH:D007410	marker/mechanism		NA		20668000
PPIF	10105	Ulcer	MESH:D014456	marker/mechanism		NA		20668000
PPL	5493	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
PPM1B	5495	Hypotonia-Cystinuria Syndrome	MESH:C564710	marker/mechanism		NA		26247364
PPM1B	5495	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
PPM1D	8493	Brain Stem Neoplasms	MESH:D020295	marker/mechanism		NA		24880341
PPM1D	8493	Breast Neoplasms	MESH:D001943	marker/mechanism		NA	114480	
PPM1D	8493	Glioma	MESH:D005910	marker/mechanism		NA		24880341
PPM1D	8493	JANSEN-DE VRIES SYNDROME	OMIM:617450	marker/mechanism		NA	617450	
PPM1D	8493	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
PPM1E	22843	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		21278247
PPM1K	152926	Maple Syrup Urine Disease	MESH:D008375	marker/mechanism		NA	615135	
PPM1L	151742	Obesity	MESH:D009765	marker/mechanism		NA		18344982
PPOX	5498	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		25944804
PPOX	5498	Porphyria, Variegate	MESH:D046350	marker/mechanism		NA	176200	
PPP1CC	5501	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		21397856
PPP1R12B	4660	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		28650484
PPP1R12B	4660	Carcinoma, Lobular	MESH:D018275	marker/mechanism		NA		28650484
PPP1R12B	4660	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		28650484
PPP1R13L	10848	Leukemia	MESH:D007938	marker/mechanism		NA		19299014
PPP1R14A	94274	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17892325
PPP1R14A	94274	Mesothelioma	MESH:D008654	marker/mechanism		NA		18835652
PPP1R14B	26472	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
PPP1R15A	23645	Spinal Cord Injuries	MESH:D013119	marker/mechanism		NA		29793971
PPP1R15B	84919	MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	OMIM:616817	marker/mechanism		NA	616817	
PPP1R17	10842	HYPERCHOLESTEROLEMIA, FAMILIAL, 1	OMIM:143890	marker/mechanism		NA	143890	
PPP1R18	170954	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PPP1R1A	5502	Arrhythmias, Cardiac	MESH:D001145	marker/mechanism		NA		20071777
PPP1R1A	5502	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		15010824
PPP1R1A	5502	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		20071777
PPP1R1A	5502	Heart Failure	MESH:D006333	therapeutic		NA		20071777
PPP1R1B	84152	Catalepsy	MESH:D002375	therapeutic		NA		20682746
PPP1R1B	84152	Dyskinesias	MESH:D020820	therapeutic		NA		20682746
PPP1R3A	5506	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA	125853	
PPP1R3B	79660	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PPP1R3C	5507	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PPP1R9B	84687	Sinusitis	MESH:D012852	marker/mechanism		NA		18391768
PPP2CA	5515	Asthma	MESH:D001249	marker/mechanism		NA		22205926
PPP2CA	5515	Heart Diseases	MESH:D006331	marker/mechanism		NA		15247211
PPP2CA	5515	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
PPP2R1A	5518	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
PPP2R1A	5518	MENTAL RETARDATION, AUTOSOMAL DOMINANT 36	OMIM:616362	marker/mechanism		NA	616362	
PPP2R1A	5518	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
PPP2R1A	5518	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
PPP2R1B	5519	Lung Neoplasms	MESH:D008175	marker/mechanism		NA	211980	
PPP2R2A	5520	Chromosomal Instability	MESH:D043171	therapeutic		NA		25772433
PPP2R2A	5520	Emphysema	MESH:D004646	marker/mechanism		NA		22223484
PPP2R2A	5520	Micronuclei, Chromosome-Defective	MESH:D048629	therapeutic		NA		25772433
PPP2R2A	5520	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29662167
PPP2R2B	5521	Spinocerebellar Ataxia 12	MESH:C565790	marker/mechanism		NA	604326	
PPP2R2B	5521	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA		18940801
PPP2R2C	5522	Emphysema	MESH:D004646	marker/mechanism		NA		22223484
PPP2R3A	5523	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
PPP2R5A	5525	Emphysema	MESH:D004646	marker/mechanism		NA		22223484
PPP2R5C	5527	Chromosomal Instability	MESH:D043171	marker/mechanism		NA		25772433
PPP2R5C	5527	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		16038780
PPP2R5C	5527	Micronuclei, Chromosome-Defective	MESH:D048629	marker/mechanism		NA		25772433
PPP2R5C	5527	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
PPP2R5D	5528	MENTAL RETARDATION, AUTOSOMAL DOMINANT 35	OMIM:616355	marker/mechanism		NA	616355	
PPP2R5D	5528	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
PPP2R5E	5529	Chromosomal Instability	MESH:D043171	therapeutic		NA		25772433
PPP2R5E	5529	Micronuclei, Chromosome-Defective	MESH:D048629	therapeutic		NA		25772433
PPP3CA	5530	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27158780
PPP3CA	5530	Brain Injuries	MESH:D001930	marker/mechanism		NA		14499481
PPP3CA	5530	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		30365097
PPP3CA	5530	Hepatolenticular Degeneration	MESH:D006527	marker/mechanism		NA		23519153
PPP3CA	5530	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		18344631
PPP3CA	5530	Pancreatitis	MESH:D010195	marker/mechanism		NA		22952646
PPP3CA	5530	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
PPP3CA	5530	Testicular Diseases	MESH:D013733	marker/mechanism		NA		17785681
PPP3CB	5532	Hepatolenticular Degeneration	MESH:D006527	marker/mechanism		NA		23519153
PPP3CC	5533	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		29275364
PPP3CC	5533	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		29275364
PPP3R1	5534	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		18344631
PPP3R1	5534	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
PPP4R3C	139420	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
PPP6C	5537	Carcinoma, Basal Cell	MESH:D002280	marker/mechanism		NA		26950094
PPP6C	5537	Melanoma	MESH:D008545	marker/mechanism		NA		22842228
PPT1	5538	Ceroid Lipofuscinosis, Neuronal, 1	MESH:C564953	marker/mechanism		NA	256730	9425237
PPT1	5538	Ceroid lipofuscinosis, neuronal 1, infantile	MESH:C537948	marker/mechanism		NA		21224254|27722792|7637805
PPT1	5538	Neoplasms	MESH:D009369	marker/mechanism		NA		30442709
PPTC7	160760	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
PQBP1	10084	Growth Disorders	MESH:D006130	marker/mechanism		NA		14634649|16740914
PQBP1	10084	Heart Septal Defects, Atrial	MESH:D006344	marker/mechanism		NA		16740914
PQBP1	10084	Mental Retardation, X-Linked	MESH:D038901	marker/mechanism		NA		14634649|15024694
PQBP1	10084	Microcephaly	MESH:D008831	marker/mechanism		NA		14634649|15024694|16740914
PQBP1	10084	Renpenning syndrome 1	MESH:C537761	marker/mechanism		NA	309500	15024694|15782410|16740914
PQBP1	10084	Spastic Paraplegia, Hereditary	MESH:D015419	marker/mechanism		NA		14634649
PQLC3	217430	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PQLC3	217430	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		25058030
PRAF2	11230	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PRAME	23532	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		16179254
PRAME	23532	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		16179254
PRAME	23532	Head and Neck Neoplasms	MESH:D006258	marker/mechanism		NA		16179254
PRAME	23532	Leukemia	MESH:D007938	marker/mechanism		NA		16179254
PRAME	23532	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	MESH:D015464	marker/mechanism		NA		17157168
PRAME	23532	Medulloblastoma	MESH:D008527	marker/mechanism		NA		16179254
PRAME	23532	Melanoma	MESH:D008545	marker/mechanism		NA		16179254
PRAME	23532	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		16179254
PRAME	23532	Sarcoma	MESH:D012509	marker/mechanism		NA		16179254
PRC1	9055	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25038754
PRC1	9055	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
PRC1	9055	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		25133636
PRC1	9055	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		31043753
PRCC	5546	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA	605074	
PRCD	768206	Retinitis Pigmentosa 36	MESH:C566431	marker/mechanism		NA	610599	
PRDM1	639	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		19898481|20453842|23143596
PRDM1	639	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		21297633
PRDM1	639	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		19838195
PRDM1	639	Sjogren's Syndrome	MESH:D012859	marker/mechanism		NA		24097067
PRDM12	59335	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VIII	OMIM:616488	marker/mechanism		NA	616488	
PRDM12	59335	Pain Insensitivity, Congenital	MESH:D000699	marker/mechanism		NA		26005867
PRDM14	63978	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		19043588
PRDM14	63978	Testicular Germ Cell Tumor	MESH:C563236	marker/mechanism		NA		23666240
PRDM16	63976	LEFT VENTRICULAR NONCOMPACTION 8	OMIM:615373	marker/mechanism		NA	615373	
PRDM16	63976	Migraine Disorders	MESH:D008881	marker/mechanism		NA		21666692
PRDM2	7799	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
PRDM2	7799	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		17103461
PRDM2	7799	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		26039340
PRDM5	11107	BRITTLE CORNEA SYNDROME 2	OMIM:614170	marker/mechanism		NA	614170	
PRDM6	93166	Ductus Arteriosus, Patent	MESH:D004374	marker/mechanism		NA	617039	
PRDM8	56978	Myoclonic Epilepsies, Progressive	MESH:D020191	marker/mechanism		NA	616640	
PRDX1	5052	Asbestosis	MESH:D001195	marker/mechanism		NA		22537621
PRDX1	5052	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		27517622
PRDX1	5052	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		17094902
PRDX1	5052	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		15986332
PRDX1	5052	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
PRDX1	5052	Keloid	MESH:D007627	marker/mechanism		NA		20128793
PRDX1	5052	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		27517622
PRDX1	5052	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		22537621
PRDX1	5052	Methylmalonic acidemia with homocystinuria	MESH:C537359	marker/mechanism		NA	277400	
PRDX1	5052	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		15986332
PRDX1	5052	Schistosomiasis	MESH:D012552	therapeutic		NA		19041905
PRDX2	7001	Asbestosis	MESH:D001195	marker/mechanism		NA		22537621
PRDX2	7001	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
PRDX2	7001	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
PRDX2	7001	Down Syndrome	MESH:D004314	marker/mechanism		NA		11771762
PRDX2	7001	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		15986332
PRDX2	7001	Keloid	MESH:D007627	marker/mechanism		NA		20128793
PRDX2	7001	Leukemia, Myeloid	MESH:D007951	therapeutic		NA		16932348
PRDX2	7001	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
PRDX2	7001	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
PRDX2	7001	Melanoma	MESH:D008545	marker/mechanism		NA		16778180
PRDX2	7001	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		23911960
PRDX2	7001	Osteosarcoma	MESH:D012516	marker/mechanism		NA		23911960
PRDX2	7001	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17566973
PRDX3	10935	Disease Progression	MESH:D018450	marker/mechanism		NA		16081686
PRDX3	10935	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		16081686
PRDX3	10935	Motor Neuron Disease	MESH:D016472	marker/mechanism		NA		16702190
PRDX3	10935	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
PRDX4	10549	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		16033404
PRDX4	10549	Disease Progression	MESH:D018450	marker/mechanism		NA		16081686
PRDX4	10549	Glucose Intolerance	MESH:D018149	therapeutic		NA		20446767
PRDX4	10549	Hyperglycemia	MESH:D006943	therapeutic		NA		20446767
PRDX4	10549	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		16081686
PRDX5	25824	Alopecia Areata	MESH:D000506	marker/mechanism		NA		20596022
PRDX5	25824	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		19424620
PRDX6	9588	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
PRDX6	9588	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
PRDX6	9588	Down Syndrome	MESH:D004314	marker/mechanism		NA		11771762
PRDX6	9588	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		23692979
PRDX6	9588	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
PRDX6	9588	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
PREP	5550	Amnesia	MESH:D000647	marker/mechanism		NA		8691432
PREP	5550	Amnesia, Retrograde	MESH:D000648	marker/mechanism		NA		18318186
PREP	5550	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
PREP	5550	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
PREPL	9581	Hypotonia-Cystinuria Syndrome	MESH:C564710	marker/mechanism		NA		26247364
PREPL	9581	Myasthenic Syndromes, Congenital	MESH:D020294	marker/mechanism		NA	616224	
PRF1	5551	Anemia, Aplastic	MESH:D000741	marker/mechanism		NA	609135	
PRF1	5551	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18762240
PRF1	5551	Hemophagocytic lymphohistiocytosis, familial, 2	MESH:C537250	marker/mechanism		NA	603553	
PRF1	5551	Influenza, Human	MESH:D007251	marker/mechanism		NA		26597256
PRF1	5551	Lymphoma, Non-Hodgkin	MESH:D008228	marker/mechanism		NA	605027	
PRF1	5551	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		24211274
PRG4	10216	Contracture	MESH:D003286	marker/mechanism		NA		10545950
PRG4	10216	Hyperplasia	MESH:D006965	marker/mechanism		NA		10545950
PRG4	10216	Jacobs syndrome	MESH:C537560	marker/mechanism		NA	208250	10545950
PRG4	10216	Pericarditis	MESH:D010493	marker/mechanism		NA		10545950
PRICKLE1	144165	Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia	MESH:C580388	marker/mechanism		NA	612437	
PRICKLE2	166336	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
PRICKLE2	166336	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		19233941
PRIMA1	145270	Muscular Dystrophies	MESH:D009136	marker/mechanism		NA		22906800
PRIMPOL	201973	MYOPIA 22, AUTOSOMAL DOMINANT	OMIM:615420	marker/mechanism		NA	615420	
PRKAA1	5562	Glucose Intolerance	MESH:D018149	marker/mechanism		NA		19934007
PRKAA1	5562	Helicobacter Infections	MESH:D016481	marker/mechanism		NA		28220687
PRKAA1	5562	Insulin Resistance	MESH:D007333	marker/mechanism		NA		19934007
PRKAA1	5562	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		28220687
PRKAA1	5562	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		26098866
PRKAA2	5563	Cardiomegaly	MESH:D006332	therapeutic		NA		18812163
PRKAA2	5563	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		21037199
PRKAA2	5563	Glucose Intolerance	MESH:D018149	marker/mechanism		NA		19934007
PRKAA2	5563	Insulin Resistance	MESH:D007333	marker/mechanism		NA		19934007
PRKAA2	5563	Stroke	MESH:D020521	therapeutic		NA		20847317
PRKAA2	5563	Ventricular Dysfunction, Left	MESH:D018487	marker/mechanism		NA		29753072
PRKAB1	5564	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
PRKAB1	5564	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
PRKACA	5566	Adrenal Gland Neoplasms	MESH:D000310	marker/mechanism		NA		24747643
PRKACA	5566	Cholangiocarcinoma	MESH:D018281	marker/mechanism		NA		26258846
PRKACA	5566	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		29341352
PRKACA	5566	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	OMIM:615830	marker/mechanism		NA	615830	
PRKACB	5567	Adrenocortical Adenoma	MESH:D018246	marker/mechanism		NA		29669941
PRKACB	5567	Biliary Tract Neoplasms	MESH:D001661	marker/mechanism		NA		26258846
PRKACB	5567	Cholangiocarcinoma	MESH:D018281	marker/mechanism		NA		26258846
PRKACB	5567	Cushing Syndrome	MESH:D003480	marker/mechanism		NA		29669941
PRKACB	5567	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16949795
PRKACG	5568	BLEEDING DISORDER, PLATELET-TYPE, 19	OMIM:616176	marker/mechanism		NA	616176	
PRKAG2	51422	Cardiomyopathy, Familial Hypertrophic, 6	MESH:C563436	marker/mechanism		NA	600858	
PRKAG2	51422	Glycogen Storage Disease of Heart, Lethal Congenital	MESH:C564888	marker/mechanism		NA	261740	
PRKAG2	51422	Wolff-Parkinson-White Syndrome	MESH:D014927	marker/mechanism		NA	194200	
PRKAG3	53632	Carbohydrate Metabolism, Inborn Errors	MESH:D002239	marker/mechanism		NA		10818001|17878938
PRKAG3	53632	Lipid Metabolism, Inborn Errors	MESH:D008052	marker/mechanism		NA		17878938
PRKAR1A	5573	Acrodysostosis	MESH:C538179	marker/mechanism		NA	101800	27825928
PRKAR1A	5573	Adrenal Hyperplasia, Congenital	MESH:D000312	marker/mechanism		NA		15521956
PRKAR1A	5573	Alopecia	MESH:D000505	marker/mechanism		NA		29367455
PRKAR1A	5573	Apparent mineralocorticoid excess	MESH:C537422	marker/mechanism		NA		15521956
PRKAR1A	5573	Atrial myxoma, familial	MESH:C538262	marker/mechanism		NA	255960	
PRKAR1A	5573	Carney Complex	MESH:D056733	marker/mechanism		NA	160980	27825928
PRKAR1A	5573	Cushing Syndrome	MESH:D003480	marker/mechanism		NA		15521956|29367455
PRKAR1A	5573	Hyperglycemia	MESH:D006943	marker/mechanism		NA		29367455
PRKAR1A	5573	Insulin Resistance	MESH:D007333	marker/mechanism		NA		29367455
PRKAR1A	5573	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		17712046
PRKAR1A	5573	Muscular Atrophy	MESH:D009133	marker/mechanism		NA		29367455
PRKAR1A	5573	Obesity	MESH:D009765	marker/mechanism		NA		29367455
PRKAR1A	5573	Pigmented Nodular Adrenocortical Disease, Primary, 1	MESH:C566469	marker/mechanism		NA	610489	
PRKAR2B	5577	Heart Failure	MESH:D006333	marker/mechanism		NA		26670611
PRKAR2B	5577	Obesity	MESH:D009765	marker/mechanism		NA		20975297
PRKCA	5578	Asthma, Occupational	MESH:D059366	marker/mechanism		NA		27504716
PRKCA	5578	Cardiomegaly	MESH:D006332	marker/mechanism		NA		21565836
PRKCA	5578	Diabetes Insipidus, Nephrogenic	MESH:D018500	marker/mechanism		NA		25006961
PRKCA	5578	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		12198386
PRKCA	5578	Intestinal Neoplasms	MESH:D007414	marker/mechanism		NA		11983831
PRKCA	5578	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		29341352
PRKCA	5578	Polyuria	MESH:D011141	marker/mechanism		NA		25006961
PRKCB	5579	Autistic Disorder	MESH:D001321	marker/mechanism		NA		16027742
PRKCB	5579	Cardiomegaly	MESH:D006332	marker/mechanism		NA		17121852
PRKCB	5579	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		7705931
PRKCB	5579	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		15531508
PRKCB	5579	Hyperglycemia	MESH:D006943	marker/mechanism		NA		17443133
PRKCB	5579	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		26437031
PRKCB	5579	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PRKCB	5579	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		17003101
PRKCD	5580	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III	OMIM:615559	marker/mechanism		NA	615559	
PRKCD	5580	Chemical and Drug Induced Liver Injury	MESH:D056486	therapeutic		NA		30393195
PRKCD	5580	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		12198386
PRKCD	5580	Fever	MESH:D005334	therapeutic		NA		31422080|32437895
PRKCD	5580	Hypertension	MESH:D006973	marker/mechanism		NA		23973649
PRKCD	5580	Hypothermia	MESH:D007035	therapeutic		NA		30366073
PRKCD	5580	Intestinal Neoplasms	MESH:D007414	marker/mechanism		NA		11983831
PRKCD	5580	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PRKCD	5580	Neurotoxicity Syndromes	MESH:D020258	marker/mechanism		NA		22512859
PRKCD	5580	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		29341352
PRKCD	5580	Parkinsonian Disorders	MESH:D020734	therapeutic		NA		15681813
PRKCD	5580	Seizures	MESH:D012640	marker/mechanism		NA		25895139
PRKCE	5581	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		15242976
PRKCE	5581	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		7705931
PRKCE	5581	Coronary Stenosis	MESH:D023921	marker/mechanism		NA		16782078
PRKCE	5581	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		12198386
PRKCE	5581	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		20665664
PRKCE	5581	Hyperalgesia	MESH:D006930	marker/mechanism		NA		11738263|12582831|20457222
PRKCE	5581	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
PRKCE	5581	Myocardial Infarction	MESH:D009203	therapeutic		NA		16782078
PRKCE	5581	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
PRKCE	5581	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		29341352
PRKCE	5581	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		20726883
PRKCE	5581	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
PRKCG	5582	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27093858
PRKCG	5582	Hyperalgesia	MESH:D006930	marker/mechanism		NA		19955894|27093858
PRKCG	5582	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
PRKCG	5582	Spinocerebellar ataxia 14	MESH:C537196	marker/mechanism		NA	605361	
PRKCG	5582	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA		20398063
PRKCG	5582	Trigeminal Neuralgia	MESH:D014277	marker/mechanism		NA		27093858
PRKCH	5583	Cerebral Infarction	MESH:D002544	marker/mechanism		NA	601367	
PRKCH	5583	Obesity	MESH:D009765	marker/mechanism		NA		23563609
PRKCH	5583	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
PRKCI	5584	Autistic Disorder	MESH:D001321	marker/mechanism		NA		20957522
PRKCQ	5588	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		18794853|20453842|23143596
PRKCQ	5588	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		18978792
PRKCQ	5588	Lymphoma, T-Cell, Cutaneous	MESH:D016410	marker/mechanism		NA		26192916
PRKCQ	5588	Retinal Detachment	MESH:D012163	marker/mechanism		NA		26978024
PRKCSH	5589	Polycystic Kidney Diseases	MESH:D007690	marker/mechanism		NA		21685914
PRKCSH	5589	Polycystic liver disease	MESH:C536330	marker/mechanism		NA	174050	21685914|24719335
PRKCZ	5590	Cardiomegaly	MESH:D006332	therapeutic		NA		27094369
PRKCZ	5590	Hyperalgesia	MESH:D006930	marker/mechanism		NA		27899695
PRKCZ	5590	Leukemia	MESH:D007938	marker/mechanism		NA		12970779
PRKCZ	5590	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16931574
PRKD1	5587	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		25240283
PRKD1	5587	Asthma, Occupational	MESH:D059366	marker/mechanism		NA		27504716
PRKD1	5587	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		21278247
PRKD1	5587	CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	OMIM:617364	marker/mechanism		NA	617364	
PRKD1	5587	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		25240283
PRKD2	25865	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		18758461
PRKD2	25865	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
PRKD3	23683	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
PRKDC	5591	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
PRKDC	5591	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		25125259
PRKDC	5591	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		21224054
PRKDC	5591	Hepatic Encephalopathy	MESH:D006501	marker/mechanism		NA		21224054
PRKDC	5591	IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES	OMIM:615966	marker/mechanism		NA	615966	
PRKDC	5591	Lung Diseases	MESH:D008171	marker/mechanism		NA		17200189
PRKDC	5591	Massive Hepatic Necrosis	MESH:D047508	marker/mechanism		NA		21224054
PRKDC	5591	Poisoning	MESH:D011041	marker/mechanism		NA		20036648
PRKDC	5591	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17196815|25415046
PRKG1	5592	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
PRKG1	5592	AORTIC ANEURYSM, FAMILIAL THORACIC 8	OMIM:615436	marker/mechanism		NA	615436	
PRKG1	5592	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		21351102
PRKG1	5592	Neuralgia	MESH:D009437	marker/mechanism		NA		30152261
PRKG1	5592	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21472284
PRKG1	5592	Sezary Syndrome	MESH:D012751	marker/mechanism		NA		26551667
PRKN	5071	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19404257
PRKN	5071	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		19946270
PRKN	5071	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		15882845
PRKN	5071	Glioblastoma	MESH:D005909	marker/mechanism		NA		19946270
PRKN	5071	Learning Disabilities	MESH:D007859	marker/mechanism		NA		12915482
PRKN	5071	Lung Neoplasms	MESH:D008175	marker/mechanism		NA	211980	19946270|25640678
PRKN	5071	Manganese Poisoning	MESH:D020149	therapeutic		NA		20089134
PRKN	5071	Memory Disorders	MESH:D008569	marker/mechanism		NA		12915482
PRKN	5071	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		17687034
PRKN	5071	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
PRKN	5071	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA	167000	
PRKN	5071	Parkinson Disease	MESH:D010300	marker/mechanism		NA		12588799|15198987|15882845|16573651|17010972|19946270|22043175|22841634|23628791|24582596|25149416|25631236|28284907
PRKN	5071	Parkinson Disease, Secondary	MESH:D010302	marker/mechanism		NA		15993444
PRKN	5071	Parkinsonian Disorders	MESH:D020734	marker/mechanism|therapeutic		NA	600116	10072423|10894217|11254447|12764051|16914382|23046578|25640678|26558463
PRKRA	8575	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		22194846
PRKRA	8575	Dystonia	MESH:D004421	marker/mechanism		NA	612067	
PRKRA	8575	Dystonic Disorders	MESH:D020821	marker/mechanism		NA		18243799
PRKRA	8575	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
PRKRA	8575	Parkinsonian Disorders	MESH:D020734	marker/mechanism		NA		18243799
PRL	5617	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		6280079
PRL	5617	Adenoma	MESH:D000236	marker/mechanism		NA		12058109|2274009
PRL	5617	Amenorrhea	MESH:D000568	marker/mechanism		NA		6777091
PRL	5617	Anemia	MESH:D000740	therapeutic		NA		10340396
PRL	5617	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18207134
PRL	5617	Basal Ganglia Diseases	MESH:D001480	marker/mechanism		NA		7214106
PRL	5617	Bradycardia	MESH:D001919	marker/mechanism		NA		6350720
PRL	5617	Catalepsy	MESH:D002375	marker/mechanism		NA		7197982
PRL	5617	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		15064918
PRL	5617	Endometriosis	MESH:D004715	marker/mechanism		NA		11925390
PRL	5617	Erectile Dysfunction	MESH:D007172	marker/mechanism		NA		15829128|387166|4001434|7878608|8845563
PRL	5617	Fetal Resorption	MESH:D005327	therapeutic		NA		3816235
PRL	5617	Fever	MESH:D005334	marker/mechanism		NA		6350720
PRL	5617	Galactorrhea	MESH:D005687	marker/mechanism		NA		20083845
PRL	5617	Growth Hormone-Secreting Pituitary Adenoma	MESH:D049912	marker/mechanism		NA		2042694
PRL	5617	Gynecomastia	MESH:D006177	marker/mechanism		NA		7878608|9334596
PRL	5617	Heart Failure	MESH:D006333	marker/mechanism		NA		18926768
PRL	5617	Hyperprolactinemia	MESH:D006966	marker/mechanism		NA		17303669|2880862|2948424|4001434
PRL	5617	Hypogonadism	MESH:D007006	marker/mechanism		NA		15829128
PRL	5617	Hypopituitarism	MESH:D007018	marker/mechanism		NA		1304515
PRL	5617	Hypotension	MESH:D007022	marker/mechanism		NA		6350720|71628
PRL	5617	Infarction	MESH:D007238	marker/mechanism		NA		718334
PRL	5617	Infertility, Female	MESH:D007247	marker/mechanism		NA		19531635
PRL	5617	Leydig Cell Tumor	MESH:D007984	therapeutic		NA		4092719
PRL	5617	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		14870917
PRL	5617	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942|6280079
PRL	5617	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
PRL	5617	Parkinsonian Disorders	MESH:D020734	marker/mechanism		NA		240179
PRL	5617	Phobic Disorders	MESH:D010698	marker/mechanism		NA		2554359
PRL	5617	Pituitary Neoplasms	MESH:D010911	marker/mechanism|therapeutic		NA		2274009|3498743|6156259
PRL	5617	Pregnancy Complications, Cardiovascular	MESH:D011249	marker/mechanism		NA		18926768
PRL	5617	Prolactinoma	MESH:D015175	marker/mechanism		NA		1407345|3776530|718334|9617019
PRL	5617	Prostatic Hyperplasia	MESH:D011470	marker/mechanism		NA		2208075
PRL	5617	Puerperal Disorders	MESH:D011644	marker/mechanism		NA		18926768
PRL	5617	Sexual Dysfunction, Physiological	MESH:D012735	marker/mechanism		NA		10084644|15677431
PRL	5617	Sexual Dysfunctions, Psychological	MESH:D020018	marker/mechanism		NA		15829128|9334596
PRL	5617	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		9037573
PRLR	5618	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
PRLR	5618	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18207134
PRLR	5618	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942|17173897
PRLR	5618	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
PRLR	5618	Hyperprolactinemia	MESH:D006966	marker/mechanism		NA	615555	
PRLR	5618	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PRLR	5618	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942|17173897
PRLR	5618	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
PRLR	5618	MULTIPLE FIBROADENOMAS OF THE BREAST	OMIM:615554	marker/mechanism		NA	615554	
PRM	39002	Parkinson Disease	MESH:D010300	marker/mechanism		NA		18353766
PRMT6	55170	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		27506785
PRNP	5621	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		17192785
PRNP	5621	Creutzfeldt-Jakob Syndrome	MESH:D007562	marker/mechanism		NA	123400	12572668|23349890
PRNP	5621	Gerstmann-Straussler-Scheinker Disease	MESH:D016098	marker/mechanism		NA	137440	10203975
PRNP	5621	Hepatolenticular Degeneration	MESH:D006527	marker/mechanism		NA		16831968
PRNP	5621	Huntington Disease-Like 1	MESH:C566398	marker/mechanism		NA	603218	
PRNP	5621	Insomnia, Fatal Familial	MESH:D034062	marker/mechanism		NA	600072	
PRNP	5621	Kuru	MESH:D007729	marker/mechanism		NA	245300	
PRNP	5621	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PRNP	5621	Myoclonic Epilepsies, Progressive	MESH:D020191	marker/mechanism		NA		25401298
PRNP	5621	Necrosis	MESH:D009336	marker/mechanism		NA		18547651
PRNP	5621	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17387271
PRNP	5621	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		21265952
PRNP	5621	Prion Diseases	MESH:D017096	marker/mechanism		NA		11701772|11994310|17257012|17274528
PRNP	5621	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
PRNP	5621	Scrapie	MESH:D012608	marker/mechanism		NA		11701772|18717736|19486493|21533749
PRNP	5621	Spongiform Encephalopathy with Neuropsychiatric Features	MESH:C564678	marker/mechanism		NA	606688	
PRNP	5621	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		17387271
PROC	5624	Arteritis	MESH:D001167	marker/mechanism		NA		17139375
PROC	5624	Congenital thrombotic disease, due to Protein C deficiency	MESH:C535424	marker/mechanism		NA	176860	25748729
PROC	5624	Disseminated Intravascular Coagulation	MESH:D004211	marker/mechanism		NA		18376272
PROC	5624	Hypertension	MESH:D006973	marker/mechanism		NA		22352330
PROC	5624	Protein C Deficiency	MESH:D020151	marker/mechanism|therapeutic		NA		14707701|18376272|21445774
PROC	5624	Purpura Fulminans	MESH:D055665	marker/mechanism		NA		18376272
PROC	5624	Sepsis	MESH:D018805	therapeutic		NA		11820775|17556722
PROC	5624	Thromboembolism	MESH:D013923	marker/mechanism		NA		8052960
PROC	5624	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE	OMIM:612304	marker/mechanism		NA	612304	
PROC	5624	Thrombosis	MESH:D013927	marker/mechanism		NA		11132655|18376272|8967151|9164807
PROC	5624	Venous Thromboembolism	MESH:D054556	marker/mechanism|therapeutic		NA		21445774|9149031
PROC	5624	Venous Thrombosis	MESH:D020246	marker/mechanism		NA		12730085|25748729
PROCR	10544	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		28530674
PROCR	10544	Inflammation	MESH:D007249	marker/mechanism		NA		23774263
PROCR	10544	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PRODH	5625	Amino Acid Metabolism, Inborn Errors	MESH:D000592	marker/mechanism		NA		17412540
PRODH	5625	HYPERPROLINEMIA, TYPE I	OMIM:239500	marker/mechanism		NA	239500	
PRODH	5625	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PRODH	5625	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		17412540
PRODH	5625	Schizophrenia	MESH:D012559	marker/mechanism		NA	600850	16234811
PRODH2	58510	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PROK2	60675	Hyperalgesia	MESH:D006930	marker/mechanism		NA		16793879
PROK2	60675	Kallmann Syndrome	MESH:D017436	marker/mechanism		NA	610628	
PROKR1	10887	Hyperalgesia	MESH:D006930	marker/mechanism		NA		16793879
PROKR1	10887	Pain	MESH:D010146	marker/mechanism		NA		16793879
PROKR2	128674	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		20576534
PROKR2	128674	Kallmann Syndrome	MESH:D017436	marker/mechanism		NA	244200	
PROM1	8842	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		32673656
PROM1	8842	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		29626521
PROM1	8842	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		21188121
PROM1	8842	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18829568
PROM1	8842	Cone-Rod Dystrophy 12	MESH:C567206	marker/mechanism		NA	612657	
PROM1	8842	Glioblastoma	MESH:D005909	marker/mechanism		NA		18679414|18829568|19718438
PROM1	8842	Macular Dystrophy, Retinal, 2	MESH:C562746	marker/mechanism		NA	608051	
PROM1	8842	Mixed Tumor, Mullerian	MESH:D018200	marker/mechanism		NA		21919130
PROM1	8842	Retinitis Pigmentosa 41	MESH:C567422	marker/mechanism		NA	612095	
PROM1	8842	Stargardt disease 4	MESH:C535521	marker/mechanism		NA	603786	
PROM1	8842	Uterine Neoplasms	MESH:D014594	marker/mechanism		NA		21919130
PROP1	5626	Pituitary Hormone Deficiency, Combined, 2	MESH:C563172	marker/mechanism		NA	262600	
PROS1	5627	Activated Protein C Resistance	MESH:D020016	marker/mechanism		NA		11703344
PROS1	5627	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
PROS1	5627	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
PROS1	5627	Sagittal Sinus Thrombosis	MESH:D020225	marker/mechanism		NA		18382986
PROS1	5627	Thromboembolism	MESH:D013923	marker/mechanism		NA		8052960
PROS1	5627	Thrombophilia, Hereditary, Due To Protein S Deficiency, Autosomal Dominant	MESH:C567347	marker/mechanism		NA	612336	
PROS1	5627	Thrombophilia, Hereditary, Due To Protein S Deficiency, Autosomal Recessive	MESH:C567348	marker/mechanism		NA	614514	
PROS1	5627	Thrombosis	MESH:D013927	marker/mechanism		NA		10706858|11132655
PROX1	5629	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		20081858
PROX1	5629	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17415710
PRPF19	27339	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
PRPF19	27339	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
PRPF3	9129	Retinitis Pigmentosa 18	MESH:C563320	marker/mechanism		NA	601414	
PRPF31	26121	Retinitis Pigmentosa 11	MESH:C563991	marker/mechanism		NA	600138	
PRPF4	9128	RETINITIS PIGMENTOSA 70	OMIM:615922	marker/mechanism		NA	615922	
PRPF4	9128	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
PRPF6	24148	RETINITIS PIGMENTOSA 60	OMIM:613983	marker/mechanism		NA	613983	
PRPF8	10594	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
PRPF8	10594	Retinitis Pigmentosa 13	MESH:C564008	marker/mechanism		NA	600059	
PRPF8	10594	Stroke	MESH:D020521	marker/mechanism		NA		29531354
PRPH	5630	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA	105400	
PRPH2	5961	Choroidal Dystrophy, Central Areolar 2	MESH:C567750	marker/mechanism		NA	613105	
PRPH2	5961	Fundus Albipunctatus	MESH:C562733	marker/mechanism		NA	136880	
PRPH2	5961	Patterned dystrophy of retinal pigment epithelium	MESH:C536309	marker/mechanism		NA	169150	
PRPH2	5961	Retinal Dystrophies	MESH:D058499	marker/mechanism		NA		28723922
PRPH2	5961	Retinitis Pigmentosa 7	MESH:C564284	marker/mechanism		NA	608133	
PRPH2	5961	Vitelliform Macular Dystrophy	MESH:D057826	marker/mechanism		NA	608161	
PRPS1	5631	Arts syndrome	MESH:C535388	marker/mechanism		NA	301835	
PRPS1	5631	Deafness, X-Linked 1	MESH:C564433	marker/mechanism		NA	304500	
PRPS1	5631	Optic atrophy polyneuropathy deafness	MESH:C537129	marker/mechanism		NA	311070	
PRPS1	5631	Phosphoribosylpyrophosphate Synthetase Superactivity	MESH:C567064	marker/mechanism		NA	300661	
PRPS1	5631	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
PRR13	54458	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		21157449
PRR13	54458	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PRR5-ARHGAP8	553158	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		25279216
PRR5-ARHGAP8	553158	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		25279216
PRRT2	112476	Familial paroxysmal dystonia	MESH:C537180	marker/mechanism		NA	128200	22101681
PRRT2	112476	Infantile convulsions and paroxysmal choreoathetosis, familial	MESH:C535522	marker/mechanism		NA	602066	
PRRT2	112476	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
PRRT2	112476	SEIZURES, BENIGN FAMILIAL INFANTILE, 2	OMIM:605751	marker/mechanism		NA	605751	
PRRX1	5396	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		22544366
PRRX1	5396	Demyelinating Diseases	MESH:D003711	marker/mechanism		NA		30566868
PRRX1	5396	Dysgnathia complex	MESH:C537996	marker/mechanism		NA	202650	23444262
PRRX1	5396	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		19208208
PRRX1	5396	Retrognathia	MESH:D063173	marker/mechanism		NA		23444262
PRSS1	5644	Hereditary pancreatitis	MESH:C537262	marker/mechanism		NA	167800	8841182
PRSS1	5644	Pancreatitis	MESH:D010195	marker/mechanism		NA		23143602
PRSS1	5644	Pancreatitis, Chronic	MESH:D050500	marker/mechanism		NA		18206817
PRSS12	8492	Mental Retardation, Autosomal Recessive 1	MESH:C565406	marker/mechanism		NA	249500	
PRSS2	5645	Hereditary pancreatitis	MESH:C537262	marker/mechanism		NA	167800	
PRSS2	5645	Pancreatitis, Chronic	MESH:D050500	marker/mechanism		NA		16699518|18206817
PRSS23	11098	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
PRSS3	5646	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		15987713
PRSS35	167681	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
PRSS46	74306	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
PRSS56	646960	Glaucoma, Angle-Closure	MESH:D015812	marker/mechanism		NA		21532570
PRSS56	646960	MICROPHTHALMIA, ISOLATED 6	OMIM:613517	marker/mechanism		NA	613517	
PRSS56	646960	Microphthalmos	MESH:D008850	marker/mechanism		NA		21532570
PRSS56	646960	Myopia	MESH:D009216	marker/mechanism		NA		23396134
PRSS8	5652	Fetal Diseases	MESH:D005315	marker/mechanism		NA		22705055
PRSS8	5652	Neural Tube Defects	MESH:D009436	therapeutic		NA		24722141
PRSS8	5652	Placenta Diseases	MESH:D010922	therapeutic		NA		24722141
PRSS8	5652	Prenatal Injuries	MESH:D049188	therapeutic		NA		24722141
PRSS8	5652	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16541421
PRSS8	5652	Skin Diseases	MESH:D012871	marker/mechanism		NA		22705055
PRTFDC1	56952	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		17599052
PRTFDC1	56952	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PRTFDC1	56952	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		17599052
PRTFDC1	56952	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		17303177
PRTG	283659	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PRTN3	5657	Granulomatosis with Polyangiitis	MESH:D014890	marker/mechanism		NA		25288799
PRTN3	5657	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	MESH:D015464	marker/mechanism		NA		17157168
PRUNE2	158471	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PRX	57716	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4F	OMIM:614895	marker/mechanism		NA	614895	
PRX	57716	Hereditary Sensory and Motor Neuropathy	MESH:D015417	marker/mechanism		NA	145900	
PRY	9081	Spermatogenic Failure, Nonobstructive, Y-Linked	MESH:C564030	marker/mechanism		NA	415000	
PRY2	442862	Spermatogenic Failure, Nonobstructive, Y-Linked	MESH:C564030	marker/mechanism		NA	415000	
PSAP	5660	Combined Saposin Deficiency	MESH:C567125	marker/mechanism		NA	611721	
PSAP	5660	Gaucher Disease, Atypical, Due To Saposin C Deficiency	MESH:C566435	marker/mechanism		NA	610539	
PSAP	5660	Krabbe Disease, Atypical, due to Saposin A Deficiency	MESH:C567097	marker/mechanism		NA	611722	
PSAP	5660	Metachromatic Leukodystrophy due to Saposin B Deficiency	MESH:C562609	marker/mechanism		NA	249900	
PSAT1	29968	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
PSAT1	29968	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		26482881
PSAT1	29968	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
PSAT1	29968	Neu Laxova syndrome	MESH:C536405	marker/mechanism		NA	616038	
PSAT1	29968	Phosphoserine Aminotransferase Deficiency	MESH:C567032	marker/mechanism		NA	610992	
PSCA	8000	Duodenal Ulcer	MESH:D004381	marker/mechanism		NA		22387998
PSCA	8000	Helicobacter Infections	MESH:D016481	marker/mechanism		NA		28220687
PSCA	8000	Linitis Plastica	MESH:D008039	marker/mechanism		NA		18488030
PSCA	8000	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		28220687
PSCA	8000	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16015594
PSCA	8000	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		18488030|26098866
PSCA	8000	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		19648920|20083643
PSD2	84249	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21472284
PSD3	23362	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
PSD3	23362	Glioma	MESH:D005910	marker/mechanism		NA		16865689
PSEN1	5663	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		15622541|16449385|16651627|17192785|17573346|17962197|18227305|22507317|25352456|25714973|27117003|28448946|7596406
PSEN1	5663	Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia	MESH:C564330	marker/mechanism		NA	607822	
PSEN1	5663	Amyloidosis	MESH:D000686	marker/mechanism		NA		23541064
PSEN1	5663	Asphyxia Neonatorum	MESH:D001238	marker/mechanism		NA		17963755
PSEN1	5663	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		29068127
PSEN1	5663	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		17186461
PSEN1	5663	Cardiomyopathy, Dilated, 1u	MESH:C566296	marker/mechanism		NA	613694	
PSEN1	5663	Cognition Disorders	MESH:D003072	marker/mechanism		NA		26945731
PSEN1	5663	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		16651627
PSEN1	5663	Frontotemporal Dementia	MESH:D057180	marker/mechanism		NA	600274	11094121
PSEN1	5663	Hidradenitis suppurativa, familial	MESH:C538118	marker/mechanism		NA	613737	20929727
PSEN1	5663	Learning Disabilities	MESH:D007859	marker/mechanism		NA		25213453
PSEN1	5663	Memory Disorders	MESH:D008569	marker/mechanism		NA		25213453|28448946
PSEN1	5663	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		19522546
PSEN1	5663	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		23541064
PSEN1	5663	Pick Disease of the Brain	MESH:D020774	marker/mechanism		NA	172700	15122701|15622541
PSEN1	5663	Splenomegaly	MESH:D013163	marker/mechanism		NA		27117003
PSEN2	5664	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		12925374|16651627|9050898
PSEN2	5664	Alzheimer disease type 4	MESH:C536596	marker/mechanism		NA	606889	
PSEN2	5664	Asphyxia Neonatorum	MESH:D001238	marker/mechanism		NA		17963755
PSEN2	5664	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		17186461
PSEN2	5664	Cardiomyopathy, Dilated, 1V	MESH:C566856	marker/mechanism		NA	613697	
PSENEN	55851	Hidradenitis suppurativa, familial	MESH:C538118	marker/mechanism		NA	613736	20929727
PSG5	5673	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		17379860
PSIP1	11168	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
PSMA2	5683	Heart Diseases	MESH:D006331	marker/mechanism		NA		16844662
PSMA2	5683	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
PSMA4	5685	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
PSMA4	5685	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
PSMA4	5685	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		20195826
PSMA4	5685	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
PSMA4	5685	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
PSMA4	5685	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
PSMA5	5686	Fatty Liver	MESH:D005234	marker/mechanism		NA		25226513
PSMA5	5686	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
PSMA5	5686	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
PSMA6	5687	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
PSMA6	5687	Myocardial Infarction	MESH:D009203	marker/mechanism		NA	608446	16845397
PSMB1	5689	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		21751358
PSMB1	5689	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
PSMB1	5689	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		21228734
PSMB10	5699	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
PSMB10	5699	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PSMB2	5690	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		26039340
PSMB4	5692	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
PSMB5	5693	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
PSMB7	5695	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
PSMB8	5696	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PSMB8	5696	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1	OMIM:256040	marker/mechanism		NA	256040	
PSMB9	5698	Acrodermatitis	MESH:D000169	marker/mechanism		NA		27258892
PSMB9	5698	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PSMC3	5702	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
PSMC3IP	29893	OVARIAN DYSGENESIS 3	OMIM:614324	marker/mechanism		NA	614324	
PSMC3IP	29893	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
PSMC5	5705	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
PSMC5	5705	Stevens-Johnson Syndrome	MESH:D013262	marker/mechanism		NA		25811541
PSMD12	5718	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
PSMD13	5719	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
PSMD14	10213	Disease Progression	MESH:D018450	marker/mechanism		NA		30871063
PSMD14	10213	Neuroblastoma	MESH:D009447	marker/mechanism		NA		30871063
PSMD3	5709	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
PSMD6	9861	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		22158537
PSMD6	9861	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
PSMD8	5714	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
PSME1	5720	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
PSME1	5720	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
PSME1	5720	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
PSME1	5720	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
PSME1	5720	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
PSME2	5721	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
PSME2	5721	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
PSME2	5721	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PSME3	10197	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
PSME4	23198	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
PSMG1	8624	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		20228799
PSORS1C1	170679	Behcet Syndrome	MESH:D001528	marker/mechanism		NA		23396137
PSORS1C1	170679	Scleroderma, Systemic	MESH:D012595	marker/mechanism		NA		21750679
PSORS1C2	170680	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		23955597
PSPH	5723	Amino Acid Metabolism, Inborn Errors	MESH:D000592	marker/mechanism		NA		14673469
PSPH	5723	PHOSPHOSERINE PHOSPHATASE DEFICIENCY	OMIM:614023	marker/mechanism		NA	614023	
PSTPIP1	9051	Acne Vulgaris	MESH:D000152	marker/mechanism		NA		27106250
PSTPIP1	9051	Hidradenitis Suppurativa	MESH:D017497	marker/mechanism		NA		27106250
PSTPIP1	9051	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PSTPIP1	9051	Pyoderma Gangrenosum	MESH:D017511	marker/mechanism		NA		27106250
PSTPIP1	9051	Pyogenic arthritis, pyoderma gangrenosum, and acne	MESH:C536253	marker/mechanism		NA	604416	27106250
PSTPIP2	9050	Acquired Hyperostosis Syndrome	MESH:D020083	marker/mechanism		NA		27106250
PTAFR	5724	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PTAFR	5724	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
PTBP1	5725	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
PTBP1	5725	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
PTBP1	5725	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
PTCH1	5727	Basal Cell Nevus Syndrome	MESH:D001478	marker/mechanism		NA	109400	16405370|16936257|18539553|19287498|25559776|25876211
PTCH1	5727	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		9581815
PTCH1	5727	Carcinoma, Basal Cell	MESH:D002280	marker/mechanism		NA	605462	18854826|26950094|9581815
PTCH1	5727	Cleft Lip	MESH:D002971	marker/mechanism		NA		16405370
PTCH1	5727	Cleft Palate	MESH:D002972	marker/mechanism		NA		16405370
PTCH1	5727	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		16405370|18539553
PTCH1	5727	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
PTCH1	5727	HIV Infections	MESH:D015658	marker/mechanism		NA		12878215
PTCH1	5727	Holoprosencephaly 7	MESH:C563660	marker/mechanism		NA	610828	
PTCH1	5727	Medulloblastoma	MESH:D008527	marker/mechanism		NA		18347096|19155313|19213072
PTCH1	5727	Neuroectodermal Tumors, Primitive	MESH:D018242	marker/mechanism		NA		9581815
PTCH1	5727	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		19077462
PTCH1	5727	Rhabdomyosarcoma	MESH:D012208	marker/mechanism		NA		19155313
PTCH1	5727	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		9581815
PTCH2	8643	Basal Cell Nevus Syndrome	MESH:D001478	marker/mechanism		NA	109400	
PTCH2	8643	Carcinoma, Basal Cell	MESH:D002280	marker/mechanism		NA	605462	
PTCH2	8643	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
PTCH2	8643	Medulloblastoma	MESH:D008527	marker/mechanism		NA	155255	
PTCHD1	139411	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		18252227|20844286
PTCHD1	139411	Autistic Disorder	MESH:D001321	marker/mechanism		NA	300830	21091464
PTCHD1	139411	Intellectual Disability	MESH:D008607	marker/mechanism		NA		20844286
PTCHD1	139411	Mental Retardation, X-Linked	MESH:D038901	marker/mechanism		NA		21091464
PTCRA	171558	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
PTDSS1	9791	Lenz Majewski hyperostotic dwarfism	MESH:C537115	marker/mechanism		NA	151050	24241535
PTEN	5728	Abnormalities, Multiple	MESH:D000015	marker/mechanism		NA		18759867
PTEN	5728	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		17909629
PTEN	5728	Adenoma, Liver Cell	MESH:D018248	marker/mechanism		NA		27022031
PTEN	5728	Anisometropia	MESH:D015858	marker/mechanism		NA		9286463
PTEN	5728	Asthma	MESH:D001249	therapeutic		NA		17982072
PTEN	5728	Autistic Disorder	MESH:D001321	marker/mechanism		NA		11496368|18759867|19211884|19265751
PTEN	5728	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18066063|19685490|19968660|20400965
PTEN	5728	Carcinoma	MESH:D002277	marker/mechanism		NA		9326929
PTEN	5728	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
PTEN	5728	Carcinoma, Ductal	MESH:D044584	marker/mechanism		NA		29295717
PTEN	5728	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		27022031
PTEN	5728	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		25401301
PTEN	5728	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		28823542
PTEN	5728	Cholangiocarcinoma	MESH:D018281	marker/mechanism		NA		27022031
PTEN	5728	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		14574156|17427195|18759867|19265751|19321504|9286463
PTEN	5728	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		18759867|19265751|19321504
PTEN	5728	Disease Progression	MESH:D018450	marker/mechanism		NA		20729295
PTEN	5728	Endometrial Hyperplasia	MESH:D004714	marker/mechanism		NA		16402032
PTEN	5728	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		12888921|16402032|16804899|9326929
PTEN	5728	Fatty Liver	MESH:D005234	marker/mechanism		NA		27022031
PTEN	5728	Glioma	MESH:D005910	marker/mechanism		NA	613028	12085208
PTEN	5728	Hamartoma Syndrome, Multiple	MESH:D006223	marker/mechanism		NA	158350|601728	10353779|10400993|11496368|11685670|11748304|14574156|17427195|17526800|19321504|19968660|9140396|9241266|9259288|9286463
PTEN	5728	Hemangioma	MESH:D006391	marker/mechanism		NA		9286463
PTEN	5728	Hypertension	MESH:D006973	marker/mechanism		NA		15646324
PTEN	5728	Hypertrophy	MESH:D006984	marker/mechanism		NA		19211884
PTEN	5728	Insulin Resistance	MESH:D007333	marker/mechanism		NA		18303120
PTEN	5728	Intellectual Disability	MESH:D008607	marker/mechanism		NA		11496368|14574156|17427195|18759867|19265751
PTEN	5728	Language Development Disorders	MESH:D007805	marker/mechanism		NA		9286463
PTEN	5728	LEOPARD Syndrome	MESH:D044542	marker/mechanism		NA		11685670
PTEN	5728	Leukemia	MESH:D007938	marker/mechanism		NA		12970779
PTEN	5728	Lipoma	MESH:D008067	marker/mechanism		NA		9286463
PTEN	5728	Lipomatosis	MESH:D008068	marker/mechanism		NA		11748304
PTEN	5728	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		26023714
PTEN	5728	Long QT Syndrome	MESH:D008133	marker/mechanism		NA		21097842
PTEN	5728	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17909629|27980214
PTEN	5728	Lymphoma	MESH:D008223	marker/mechanism		NA		22287727
PTEN	5728	Macrocephaly Autism Syndrome	MESH:C565342	marker/mechanism		NA	605309	15805158|17286265|17427195
PTEN	5728	Melanoma	MESH:D008545	marker/mechanism		NA		10978354|19282848|22535842
PTEN	5728	Melanoma, Experimental	MESH:D008546	marker/mechanism		NA		29179997
PTEN	5728	Meningioma	MESH:D008579	marker/mechanism		NA		12085208
PTEN	5728	Meningioma, familial	MESH:C537443	marker/mechanism		NA	607174	
PTEN	5728	Motor Skills Disorders	MESH:D019957	marker/mechanism		NA		9286463
PTEN	5728	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		19038262
PTEN	5728	Nasopharyngeal Carcinoma	MESH:D000077274	marker/mechanism		NA		24952746
PTEN	5728	Neoplasm Invasiveness	MESH:D009361	therapeutic		NA		21994956
PTEN	5728	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		10978354
PTEN	5728	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
PTEN	5728	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		26023714
PTEN	5728	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		21372221
PTEN	5728	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		19917848
PTEN	5728	Polydactyly	MESH:D017689	marker/mechanism		NA		17427195
PTEN	5728	Prostatic Intraepithelial Neoplasia	MESH:D019048	marker/mechanism		NA		19081794|22581815
PTEN	5728	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA	176807	16421604|17173048|19081794|19396168|20729295|21456062|21714127|22581815|22610119|23248098|28319090|29295717|29335545|29610475|32525019|9371490
PTEN	5728	Proteus Syndrome	MESH:D016715	marker/mechanism		NA		11748304|12471211|17427195
PTEN	5728	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		19038262
PTEN	5728	Sezary Syndrome	MESH:D012751	marker/mechanism		NA		26551667
PTEN	5728	Silicosis	MESH:D012829	marker/mechanism		NA		27621875
PTEN	5728	Skin Diseases	MESH:D012871	marker/mechanism		NA		19321504
PTEN	5728	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941188
PTEN	5728	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		11801303|23873848
PTEN	5728	VACTERL Association With Hydrocephalus	MESH:C564751	marker/mechanism		NA		11748304
PTER	9317	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PTER	9317	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		25058030
PTER	9317	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
PTF1A	256297	Cerebellar Diseases	MESH:D002526	marker/mechanism		NA		15543146|19650412
PTF1A	256297	Chemical and Drug Induced Liver Injury	MESH:D056486	therapeutic		NA		21182459
PTF1A	256297	Diabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis	MESH:C563796	marker/mechanism		NA	609069	15543146|19650412
PTF1A	256297	Pancreatic Agenesis, Congenital	MESH:C564908	marker/mechanism		NA	615935	15543146|22158542|24212882
PTGDR	5729	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 1	OMIM:607277	marker/mechanism		NA	607277	
PTGDR2	11251	Asthma	MESH:D001249	therapeutic		NA		27103662
PTGDR2	11251	Asthma, Aspirin-Induced	MESH:D055963	marker/mechanism		NA		20485159
PTGER1	5731	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		11751431
PTGER1	5731	Carcinoma, Ductal, Breast	MESH:D018270	marker/mechanism		NA		11751431
PTGER1	5731	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		21739481
PTGER1	5731	Hydronephrosis	MESH:D006869	marker/mechanism		NA		30641090
PTGER1	5731	Hyperalgesia	MESH:D006930	marker/mechanism		NA		11375261
PTGER1	5731	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		11751431
PTGER1	5731	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		11751431
PTGER1	5731	Sexual Dysfunction, Physiological	MESH:D012735	therapeutic		NA		18726914
PTGER2	5732	Asthma, Aspirin-Induced	MESH:D055963	marker/mechanism		NA		16502481
PTGER2	5732	Asthma, Nasal Polyps, And Aspirin Intolerance	MESH:C565935	marker/mechanism		NA	208550	
PTGER2	5732	Endometriosis	MESH:D004715	marker/mechanism		NA		19407222
PTGER2	5732	Infertility	MESH:D007246	marker/mechanism		NA		10359563
PTGER2	5732	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PTGER2	5732	Sexual Dysfunction, Physiological	MESH:D012735	therapeutic		NA		18726914
PTGER3	5733	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		20587336
PTGER3	5733	Pemphigoid, Benign Mucous Membrane	MESH:D010390	marker/mechanism		NA		21966456
PTGER3	5733	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
PTGER3	5733	Stevens-Johnson Syndrome	MESH:D013262	marker/mechanism		NA		21966456
PTGER3	5733	Thrombosis	MESH:D013927	marker/mechanism		NA		17242161
PTGER4	5734	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		18287210
PTGER4	5734	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
PTGER4	5734	Endometriosis	MESH:D004715	marker/mechanism		NA		19407222
PTGER4	5734	Inflammation	MESH:D007249	marker/mechanism		NA		18287210
PTGER4	5734	Lymphoma	MESH:D008223	therapeutic		NA		19075289
PTGER4	5734	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
PTGER4	5734	Sexual Dysfunction, Physiological	MESH:D012735	therapeutic		NA		18726914
PTGER4	5734	Spondylitis, Ankylosing	MESH:D013167	marker/mechanism		NA		21743469
PTGES	9536	Fever	MESH:D005334	marker/mechanism		NA		25164664
PTGES	9536	Hydronephrosis	MESH:D006869	marker/mechanism		NA		22430074|25015655
PTGES	9536	Inflammation	MESH:D007249	marker/mechanism		NA		25314295
PTGES	9536	Polyuria	MESH:D011141	marker/mechanism		NA		19692487
PTGES2	80142	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		31444509
PTGES2	80142	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		22387750
PTGES3	10728	Neurotoxicity Syndromes	MESH:D020258	marker/mechanism		NA		29471019
PTGFR	5737	Airway Obstruction	MESH:D000402	marker/mechanism		NA		1219628
PTGFR	5737	Endometriosis	MESH:D004715	marker/mechanism		NA		25446850
PTGIR	5739	Asthma, Aspirin-Induced	MESH:D055963	marker/mechanism		NA		20485159
PTGIR	5739	Heart Diseases	MESH:D006331	marker/mechanism		NA		16154102
PTGIS	5740	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
PTGIS	5740	Ductus Arteriosus, Patent	MESH:D004374	marker/mechanism		NA		19336370
PTGIS	5740	Essential Hypertension	MESH:D000075222	marker/mechanism		NA	145500	
PTGIS	5740	Lung Neoplasms	MESH:D008175	therapeutic		NA		11830527
PTGIS	5740	Stevens-Johnson Syndrome	MESH:D013262	marker/mechanism		NA		25811541
PTGS1	5742	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		15167967
PTGS1	5742	Asthma, Occupational	MESH:D059366	marker/mechanism		NA		25721048
PTGS1	5742	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18488158
PTGS1	5742	Bronchial Hyperreactivity	MESH:D016535	marker/mechanism		NA		17508966
PTGS1	5742	Carcinoma	MESH:D002277	marker/mechanism		NA		12189197
PTGS1	5742	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		17508966
PTGS1	5742	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		12189197
PTGS1	5742	Flushing	MESH:D005483	marker/mechanism		NA		16322797
PTGS1	5742	Heart Failure	MESH:D006333	marker/mechanism		NA		20304815
PTGS1	5742	Hyperalgesia	MESH:D006930	marker/mechanism		NA		17989504
PTGS1	5742	Intestinal Polyps	MESH:D007417	marker/mechanism		NA		10753194|12189188
PTGS1	5742	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19420110
PTGS1	5742	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PTGS1	5742	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
PTGS1	5742	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		10594344
PTGS1	5742	Sleep Deprivation	MESH:D012892	marker/mechanism		NA		16343605
PTGS1	5742	Stomach Ulcer	MESH:D013276	marker/mechanism		NA		10594344|19066340
PTGS2	5743	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		10485483|16820089
PTGS2	5743	Adenocarcinoma Of Esophagus	MESH:C562730	marker/mechanism		NA		12507933
PTGS2	5743	Adenomatous Polyposis Coli	MESH:D011125	marker/mechanism		NA		17942926
PTGS2	5743	Adrenal Gland Neoplasms	MESH:D000310	marker/mechanism		NA		15492235
PTGS2	5743	Albuminuria	MESH:D000419	marker/mechanism		NA		17890881
PTGS2	5743	Amyotrophic Lateral Sclerosis	MESH:D000690	marker/mechanism		NA		11220737|15816863
PTGS2	5743	Aortic Aneurysm, Abdominal	MESH:D017544	marker/mechanism		NA		16514081
PTGS2	5743	Arrhythmias, Cardiac	MESH:D001145	marker/mechanism		NA		19376970
PTGS2	5743	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		11978490|19192274
PTGS2	5743	Asphyxia Neonatorum	MESH:D001238	marker/mechanism		NA		17963755
PTGS2	5743	Asthma, Aspirin-Induced	MESH:D055963	marker/mechanism		NA		16502481|20485159
PTGS2	5743	Asthma, Occupational	MESH:D059366	marker/mechanism		NA		25721048
PTGS2	5743	Atherosclerosis	MESH:D050197	marker/mechanism		NA		20720404
PTGS2	5743	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18579107
PTGS2	5743	Barrett Esophagus	MESH:D001471	marker/mechanism		NA		11059772|15387324|17244951
PTGS2	5743	Bone Neoplasms	MESH:D001859	marker/mechanism		NA		16489006
PTGS2	5743	Brain Injuries	MESH:D001930	marker/mechanism		NA		12410334|20810888|21549006
PTGS2	5743	Brain Injuries, Traumatic	MESH:D000070642	marker/mechanism		NA		28642177
PTGS2	5743	Brain Ischemia	MESH:D002545	marker/mechanism		NA		15737438|17394460|17564305|19417757
PTGS2	5743	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16127422|16870006|17285134|18498876|18509974
PTGS2	5743	Burns	MESH:D002056	marker/mechanism		NA		15650120
PTGS2	5743	Cachexia	MESH:D002100	marker/mechanism		NA		17878525
PTGS2	5743	Carcinoma	MESH:D002277	marker/mechanism		NA		10485483
PTGS2	5743	Carcinoma, Ductal, Breast	MESH:D018270	marker/mechanism		NA		21153458
PTGS2	5743	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		11872629|12024111|14563831|16374840|17510421
PTGS2	5743	Carcinoma in Situ	MESH:D002278	marker/mechanism		NA		10582676|10873095
PTGS2	5743	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		12664575
PTGS2	5743	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		16543248|18202791
PTGS2	5743	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		10582676|10873095|12151359|12664575
PTGS2	5743	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		11978490
PTGS2	5743	Cardiovascular Diseases	MESH:D002318	therapeutic		NA		17518513
PTGS2	5743	Chemical and Drug Induced Liver Injury	MESH:D056486	therapeutic		NA		11743745
PTGS2	5743	Cholangiocarcinoma	MESH:D018281	marker/mechanism		NA		16818635
PTGS2	5743	Cognition Disorders	MESH:D003072	marker/mechanism		NA		12410334
PTGS2	5743	Colitis	MESH:D003092	marker/mechanism		NA		11820457
PTGS2	5743	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		12189188|17667525|21081470
PTGS2	5743	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		10485483|11375891|12837940|15753380|19671906|20427397
PTGS2	5743	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		14642682
PTGS2	5743	Depressive Disorder	MESH:D003866	marker/mechanism		NA		19356723
PTGS2	5743	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		15885672
PTGS2	5743	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		14514642|21414306
PTGS2	5743	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		10698006
PTGS2	5743	Duodenal Ulcer	MESH:D004381	marker/mechanism		NA		12481160
PTGS2	5743	Edema	MESH:D004487	marker/mechanism		NA		11820457
PTGS2	5743	Endometriosis	MESH:D004715	marker/mechanism		NA		25446850
PTGS2	5743	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		11059772|16322294|17707579
PTGS2	5743	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		15756444|16543248|18197933
PTGS2	5743	Fever	MESH:D005334	marker/mechanism		NA		25164664
PTGS2	5743	Fibrosis	MESH:D005355	marker/mechanism		NA		11872629
PTGS2	5743	Gastroesophageal Reflux	MESH:D005764	marker/mechanism		NA		21451212
PTGS2	5743	Glaucoma, Open-Angle	MESH:D005902	marker/mechanism		NA		16330497
PTGS2	5743	Glioma	MESH:D005910	marker/mechanism		NA		15561105
PTGS2	5743	Graves Ophthalmopathy	MESH:D049970	marker/mechanism		NA		17614770
PTGS2	5743	Heart Failure	MESH:D006333	marker/mechanism		NA		20304815
PTGS2	5743	Hydronephrosis	MESH:D006869	marker/mechanism		NA		22430074
PTGS2	5743	Hyperalgesia	MESH:D006930	marker/mechanism		NA		17112505|17989504
PTGS2	5743	Hyperemia	MESH:D006940	marker/mechanism		NA		11820457
PTGS2	5743	Hyperglycemia	MESH:D006943	marker/mechanism		NA		14514642
PTGS2	5743	Hyperplasia	MESH:D006965	marker/mechanism		NA		12151359|17093206|22561872
PTGS2	5743	Hypertension	MESH:D006973	marker/mechanism|therapeutic		NA		14757778|15834289|20667508|22349312
PTGS2	5743	Inflammation	MESH:D007249	marker/mechanism		NA		11094054|11321505|19084589
PTGS2	5743	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA		11820457
PTGS2	5743	Intestinal Polyps	MESH:D007417	marker/mechanism		NA		10753194|11245490|11507063
PTGS2	5743	Kidney Diseases	MESH:D007674	marker/mechanism		NA		19643929
PTGS2	5743	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19420110
PTGS2	5743	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		12664575
PTGS2	5743	Leiomyosarcoma	MESH:D007890	marker/mechanism		NA		18645019
PTGS2	5743	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		16314473
PTGS2	5743	Leukoplakia, Oral	MESH:D007972	marker/mechanism		NA		18202791
PTGS2	5743	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17565644|18555214
PTGS2	5743	Lung Diseases	MESH:D008171	marker/mechanism		NA		19084589
PTGS2	5743	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		17761345
PTGS2	5743	Lymphoma, B-Cell	MESH:D016393	marker/mechanism		NA		14654083
PTGS2	5743	Melanoma	MESH:D008545	marker/mechanism		NA		17145863|17499752|18454317
PTGS2	5743	Mouth Diseases	MESH:D009059	marker/mechanism		NA		17682004
PTGS2	5743	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		12969226
PTGS2	5743	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		16489006|18509974
PTGS2	5743	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		14566678
PTGS2	5743	Neoplasms	MESH:D009369	marker/mechanism		NA		20155627
PTGS2	5743	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		10698006
PTGS2	5743	Neurogenic Inflammation	MESH:D020078	marker/mechanism		NA		17539917
PTGS2	5743	Obesity	MESH:D009765	marker/mechanism		NA		21156398
PTGS2	5743	Oral Submucous Fibrosis	MESH:D009914	marker/mechanism		NA		16311067
PTGS2	5743	Osteoarthritis	MESH:D010003	marker/mechanism		NA		32004530
PTGS2	5743	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		10485483|10657949|15705899|16820089
PTGS2	5743	Pancreatitis	MESH:D010195	marker/mechanism		NA		19820421
PTGS2	5743	Papilloma	MESH:D010212	marker/mechanism		NA		12151359|16144915
PTGS2	5743	Pericardial Effusion	MESH:D010490	marker/mechanism		NA		20801906
PTGS2	5743	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		12151359|19522023
PTGS2	5743	Premature Birth	MESH:D047928	marker/mechanism		NA		26055944|27748297
PTGS2	5743	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		10753955|14754878|15126378|16506214|17609663
PTGS2	5743	Proteinuria	MESH:D011507	marker/mechanism		NA		19643929
PTGS2	5743	Puberty, Precocious	MESH:D011629	marker/mechanism		NA		21402727
PTGS2	5743	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		10588920|10594344|11567657|16386242|18258783|19673871
PTGS2	5743	Rhinitis, Allergic	MESH:D065631	marker/mechanism		NA		16979129
PTGS2	5743	Seizures	MESH:D012640	marker/mechanism		NA		14518562
PTGS2	5743	Skin Diseases	MESH:D012871	marker/mechanism		NA		15451306
PTGS2	5743	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		17499752|19748995|21159610
PTGS2	5743	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		12969226
PTGS2	5743	Status Epilepticus	MESH:D013226	marker/mechanism		NA		18988310
PTGS2	5743	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		10404093|17003101|17224647|22385256
PTGS2	5743	Stomach Ulcer	MESH:D013276	marker/mechanism		NA		10594344|11376495|12481160|19066340|9024292
PTGS2	5743	Stroke	MESH:D020521	marker/mechanism		NA		20083630
PTGS2	5743	Thrombosis	MESH:D013927	marker/mechanism		NA		20350286
PTGS2	5743	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		22387750
PTGS2	5743	Tongue Neoplasms	MESH:D014062	marker/mechanism		NA		16543248|22561872
PTGS2	5743	Urinary Bladder Neck Obstruction	MESH:D001748	marker/mechanism		NA		15311063
PTGS2	5743	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		10582676|10873095|12442003|12664575|16098373|17093206|29396848
PTH	5741	Anemia	MESH:D000740	marker/mechanism		NA		15354979|19578808
PTH	5741	Basal Cell Nevus Syndrome	MESH:D001478	marker/mechanism		NA		24803734
PTH	5741	Bone Diseases, Endocrine	MESH:D001849	marker/mechanism		NA		18635661
PTH	5741	Bone Resorption	MESH:D001862	marker/mechanism		NA		9881647
PTH	5741	Disease Models, Animal	MESH:D004195	therapeutic		NA		30639440
PTH	5741	Fractures, Bone	MESH:D050723	therapeutic		NA		16094769
PTH	5741	Heart Failure	MESH:D006333	marker/mechanism		NA		17162251
PTH	5741	Hypercalcemia	MESH:D006934	marker/mechanism		NA		10638776|12399635|17164314|4004906|7891547|9382671
PTH	5741	Hypercalciuria	MESH:D053565	marker/mechanism		NA		17164314
PTH	5741	Hyperostosis	MESH:D015576	marker/mechanism		NA		25289773
PTH	5741	Hyperparathyroidism, Secondary	MESH:D006962	marker/mechanism		NA		21350317|22118402|22373954
PTH	5741	Hyperphosphatemia	MESH:D054559	marker/mechanism		NA		12399635
PTH	5741	Hypertension	MESH:D006973	marker/mechanism		NA		1930854
PTH	5741	Hypocalcemia	MESH:D006996	marker/mechanism		NA		11701698|11770836
PTH	5741	Hypoparathyroidism familial isolated	MESH:C537156	marker/mechanism		NA	146200	
PTH	5741	Osteoporosis	MESH:D010024	therapeutic		NA		15710971|17317460|17882678|19578808|21306167|30639440
PTH	5741	Osteoporosis, Postmenopausal	MESH:D015663	therapeutic		NA		20567999
PTH	5741	Rickets	MESH:D012279	marker/mechanism		NA		10375030
PTH	5741	Uremia	MESH:D014511	marker/mechanism		NA		2051637
PTH1R	5745	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
PTH1R	5745	Chondrodysplasia, blomstrand type	MESH:C537914	marker/mechanism		NA	215045	
PTH1R	5745	Eiken Skeletal Dysplasia	MESH:C564010	marker/mechanism		NA	600002	
PTH1R	5745	Failure of Tooth Eruption, Primary	MESH:C565114	marker/mechanism		NA	125350	
PTH1R	5745	Hyperparathyroidism	MESH:D006961	marker/mechanism		NA		11014383
PTH1R	5745	Jansen type metaphyseal chondrodysplasia	MESH:C537564	marker/mechanism		NA	156400	
PTH1R	5745	Lung Diseases	MESH:D008171	marker/mechanism		NA		20857298
PTH1R	5745	Rickets	MESH:D012279	marker/mechanism		NA		10375030
PTHLH	5744	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
PTHLH	5744	Bone Resorption	MESH:D001862	marker/mechanism		NA		16769263
PTHLH	5744	BRACHYDACTYLY, TYPE E2	OMIM:613382	marker/mechanism		NA	613382	
PTHLH	5744	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		22267197
PTHLH	5744	Cachexia	MESH:D002100	marker/mechanism		NA		17878525
PTHLH	5744	Carcinoma, Non-Small-Cell Lung	MESH:D002289	therapeutic		NA		17676588
PTHLH	5744	Edema	MESH:D004487	marker/mechanism		NA		25035110
PTHLH	5744	Foot Deformities, Congenital	MESH:D005532	marker/mechanism		NA		20170896
PTHLH	5744	Growth Disorders	MESH:D006130	marker/mechanism		NA		20170896
PTHLH	5744	Hand Deformities, Congenital	MESH:D006228	marker/mechanism		NA		20170896
PTHLH	5744	Hyperalgesia	MESH:D006930	marker/mechanism		NA		16769263
PTHLH	5744	Hypercalcemia	MESH:D006934	marker/mechanism		NA		10638776|11054717|12358896|3616618
PTHLH	5744	Lung Diseases	MESH:D008171	marker/mechanism		NA		20857298
PTHLH	5744	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		11054717
PTHLH	5744	Neuroendocrine Tumors	MESH:D018358	marker/mechanism		NA		17625444
PTHLH	5744	Osteolysis	MESH:D010014	marker/mechanism		NA		11054717
PTHLH	5744	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		17625444
PTHLH	5744	Pancreatitis, Acute Necrotizing	MESH:D019283	marker/mechanism		NA		25035110
PTHLH	5744	Pancreatitis, Alcoholic	MESH:D019512	marker/mechanism		NA		22280800
PTHLH	5744	Pancreatitis, Chronic	MESH:D050500	marker/mechanism		NA		25035110
PTHLH	5744	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16243370
PTHLH	5744	Superior Vena Cava Syndrome	MESH:D013479	marker/mechanism		NA		12358896
PTI	100156830	Anaphylaxis	MESH:D000707	marker/mechanism		NA		20693069
PTI	100156830	Blood Loss, Surgical	MESH:D016063	therapeutic		NA		9806378
PTI	100156830	Graft Occlusion, Vascular	MESH:D006083	marker/mechanism		NA		9806378
PTI	100156830	Heart Failure	MESH:D006333	marker/mechanism		NA		16436767
PTI	100156830	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		16436767
PTI	100156830	Renal Insufficiency	MESH:D051437	marker/mechanism		NA		16436767
PTI	100156830	Shock	MESH:D012769	therapeutic		NA		18263716
PTI	100156830	Stroke	MESH:D020521	marker/mechanism		NA		16436767
PTI	100156830	Thromboembolism	MESH:D013923	marker/mechanism		NA		9118606
PTK2	5747	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		12833524
PTK2	5747	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
PTK2	5747	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		14578863
PTK2	5747	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism|therapeutic		NA		21401805|25199511
PTK2	5747	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		23804419
PTK2	5747	Glioblastoma	MESH:D005909	marker/mechanism		NA		12811834
PTK2	5747	Mammary Neoplasms, Experimental	MESH:D008325	therapeutic		NA		24809783
PTK2	5747	Mouth Neoplasms	MESH:D009062	therapeutic		NA		25199511
PTK2	5747	Neoplasm Invasiveness	MESH:D009361	marker/mechanism|therapeutic		NA		12811834|25199511
PTK2B	2185	Melanoma	MESH:D008545	marker/mechanism		NA		19718025
PTK2B	2185	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		19718025
PTK2B	2185	Status Epilepticus	MESH:D013226	marker/mechanism		NA		16600505
PTK7	5754	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
PTMA	5757	Adenoma	MESH:D000236	therapeutic		NA		10822126
PTMA	5757	Fatty Liver	MESH:D005234	therapeutic		NA		15885234
PTMA	5757	Lung Neoplasms	MESH:D008175	therapeutic		NA		10822126
PTMA	5757	Rhabdomyosarcoma	MESH:D012208	marker/mechanism		NA		16669873
PTN	5764	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
PTN	5764	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PTN	5764	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
PTN	5764	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
PTOV1	53635	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
PTOV1	53635	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
PTP4A2	8073	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
PTP4A3	11156	Colonic Neoplasms	MESH:D003110	therapeutic		NA		23555575
PTPA	5524	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
PTPA	5524	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
PTPN1	5770	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA	125853	
PTPN1	5770	Hodgkin Disease	MESH:D006689	marker/mechanism		NA		24531327
PTPN1	5770	Hyperinsulinism	MESH:D006946	therapeutic		NA		28899902
PTPN1	5770	Hypertension	MESH:D006973	therapeutic		NA		28899902
PTPN1	5770	Inflammation	MESH:D007249	therapeutic		NA		28899902
PTPN1	5770	Insulin Resistance	MESH:D007333	marker/mechanism		NA		10744717
PTPN1	5770	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		26739621
PTPN1	5770	Lymphoma, B-Cell	MESH:D016393	marker/mechanism		NA		24531327
PTPN1	5770	Mediastinal Neoplasms	MESH:D008479	marker/mechanism		NA		24531327
PTPN1	5770	Obesity	MESH:D009765	marker/mechanism		NA		10744717|20075852
PTPN1	5770	Rett Syndrome	MESH:D015518	marker/mechanism		NA		26214522
PTPN11	5781	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		26432044
PTPN11	5781	Astrocytoma	MESH:D001254	marker/mechanism		NA		23817572
PTPN11	5781	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		26432044
PTPN11	5781	Cardiofaciocutaneous syndrome	MESH:C535579	marker/mechanism		NA		17703371
PTPN11	5781	Costello Syndrome	MESH:D056685	marker/mechanism		NA		17703371
PTPN11	5781	Enchondromatosis	MESH:D004687	marker/mechanism		NA		20577567|21533187
PTPN11	5781	Exostoses, Multiple Hereditary	MESH:D005097	marker/mechanism		NA		21533187
PTPN11	5781	LEOPARD Syndrome	MESH:D044542	marker/mechanism		NA	151100	17603483
PTPN11	5781	Leukemia	MESH:D007938	marker/mechanism		NA		15273746
PTPN11	5781	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		27992414
PTPN11	5781	Leukemia, Myelomonocytic, Juvenile	MESH:D054429	marker/mechanism		NA	607785	22315502|26457647
PTPN11	5781	Metachondromatosis	MESH:C562938	marker/mechanism		NA	156250	
PTPN11	5781	Neuroblastoma	MESH:D009447	marker/mechanism		NA		23334666
PTPN11	5781	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
PTPN11	5781	Noonan Syndrome	MESH:D009634	marker/mechanism		NA	163950	15273746|17603482|17603483|17703371
PTPN11	5781	Osteochondroma	MESH:D015831	marker/mechanism		NA		20577567
PTPN12	5782	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	114500	
PTPN14	5784	Carcinoma, Basal Cell	MESH:D002280	marker/mechanism		NA		26950094
PTPN14	5784	CHOANAL ATRESIA AND LYMPHEDEMA	OMIM:613611	marker/mechanism		NA	613611	
PTPN14	5784	Neuroblastoma	MESH:D009447	marker/mechanism		NA		26121086
PTPN14	5784	Recurrence	MESH:D012008	marker/mechanism		NA		26121086
PTPN18	26469	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PTPN2	5771	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		22446963
PTPN2	5771	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		18438405
PTPN2	5771	Crohn Disease	MESH:D003424	marker/mechanism		NA		17554261
PTPN2	5771	Leukemia, T-Cell	MESH:D015458	marker/mechanism		NA		20473312
PTPN2	5771	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054218	marker/mechanism		NA		20473312
PTPN22	26191	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA	180300	19898480|20453842|21190368|23143596|30224649
PTPN22	26191	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		21341673
PTPN22	26191	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA	222100	21190368|30224649
PTPN22	26191	Graves Disease	MESH:D006111	marker/mechanism		NA		21190368
PTPN22	26191	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA		21983784
PTPN22	26191	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA	152700	18204446|21190368
PTPN3	5774	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
PTPN5	84867	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		17360923
PTPN6	5777	Calcinosis	MESH:D002114	marker/mechanism		NA		21335463
PTPN6	5777	Heart Valve Diseases	MESH:D006349	marker/mechanism		NA		21335463
PTPN6	5777	Respiratory Hypersensitivity	MESH:D012130	marker/mechanism		NA		18441283
PTPRA	5786	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
PTPRB	5787	Hemangiosarcoma	MESH:D006394	marker/mechanism		NA		24633157
PTPRC	5788	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		20453842|23143596
PTPRC	5788	Gastro-enteropancreatic neuroendocrine tumor	MESH:C535650	marker/mechanism		NA		29915428
PTPRC	5788	Hepatitis C	MESH:D006526	marker/mechanism		NA	609532	
PTPRC	5788	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PTPRC	5788	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
PTPRC	5788	Retinal Diseases	MESH:D012164	marker/mechanism		NA		19324842
PTPRC	5788	Severe Combined Immunodeficiency, Autosomal Recessive, T Cell Negative, B Cell Positive, NK Cell Positive	MESH:C563822	marker/mechanism		NA	608971	
PTPRD	5789	Attention Deficit Disorder with Hyperactivity	MESH:D001289	marker/mechanism		NA		19546859
PTPRD	5789	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18507500
PTPRD	5789	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18507500|21278247
PTPRD	5789	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PTPRD	5789	Restless Legs Syndrome	MESH:D012148	marker/mechanism		NA		18660810
PTPRF	5792	BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 2	OMIM:616001	marker/mechanism		NA	616001	
PTPRF	5792	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
PTPRF	5792	Heart Failure	MESH:D006333	marker/mechanism		NA		28751527
PTPRF	5792	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		28751527
PTPRF	5792	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
PTPRF	5792	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
PTPRG	5793	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		17963294
PTPRJ	5795	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	114500	
PTPRK	5796	Melanoma	MESH:D008545	marker/mechanism		NA		22535842|22842228
PTPRK	5796	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
PTPRO	5800	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PTPRO	5800	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941|20163174
PTPRO	5800	Melanoma	MESH:D008545	marker/mechanism		NA		21499247
PTPRO	5800	NEPHROTIC SYNDROME, TYPE 6	OMIM:614196	marker/mechanism		NA	614196	
PTPRQ	374462	DEAFNESS, AUTOSOMAL RECESSIVE 84A	OMIM:613391	marker/mechanism		NA	613391	
PTPRZ1	5803	Helicobacter Infections	MESH:D016481	marker/mechanism		NA		17030583
PTPRZ1	5803	Pneumoconiosis	MESH:D011009	marker/mechanism		NA		25445010
PTRH1	138428	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PTRH2	51651	NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET	OMIM:616263	marker/mechanism		NA	616263	
PTRH2	51651	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
PTRHD1	391356	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PTS	5805	6-pyruvoyl-tetrahydropterin synthase deficiency	MESH:C535325	marker/mechanism		NA	261640	
PTTG1	9232	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
PTTG1	9232	Psoriasis	MESH:D011565	marker/mechanism		NA		20953187
PTTG1	9232	Sjogren's Syndrome	MESH:D012859	marker/mechanism		NA		24097067
PTX3	5806	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
PTX3	5806	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		22210019
PTX3	5806	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
PUF60	22827	Mesothelioma	MESH:D008654	therapeutic		NA		21435101
PUF60	22827	Necrosis	MESH:D009336	marker/mechanism		NA		21435101
PUF60	22827	Neoplasms, Experimental	MESH:D009374	therapeutic		NA		21435101
PUF60	22827	VERHEIJ SYNDROME	OMIM:615583	marker/mechanism		NA	615583	
PUM1	9698	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
PURA	5813	Epilepsy	MESH:D004827	marker/mechanism		NA		29942082
PURA	5813	MENTAL RETARDATION, AUTOSOMAL DOMINANT 31	OMIM:616158	marker/mechanism		NA	616158	
PURA	5813	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		29942082
PUS1	80324	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
PUS1	80324	Myopathy with lactic acidosis and sideroblastic anemia	MESH:C536101	marker/mechanism		NA	600462	
PUS1	80324	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
PUS3	83480	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	OMIM:617051	marker/mechanism		NA	617051	
PVALB	5816	Adenoma, Oxyphilic	MESH:D018249	marker/mechanism		NA		16927643
PVALB	5816	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		14708030
PVALB	5816	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		16927643
PVALB	5816	Psychotic Disorders	MESH:D011618	marker/mechanism		NA		14708030
PVALB	5816	Schizophrenia	MESH:D012559	marker/mechanism		NA		14708030
PVALB	5816	Seizures	MESH:D012640	marker/mechanism		NA		18495095
PVR	5817	Leukemia, Myeloid, Acute	MESH:D015470	therapeutic		NA		29855615
PVR	5817	Orofacial Cleft 1	MESH:C566121	marker/mechanism		NA		21637507
PVR	5817	Poliomyelitis	MESH:D011051	marker/mechanism		NA		28446605|3020560
PVR	5817	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		30614027
PVT1	5820	Hodgkin Disease	MESH:D006689	marker/mechanism		NA		21037568
PVT1	5820	IgA Deficiency	MESH:D017098	marker/mechanism		NA		27723758
PWAR1	145624	Prader-Willi Syndrome	MESH:D011218	marker/mechanism		NA	176270	
PWAR6	100506965	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
PWRN1	791114	Prader-Willi Syndrome	MESH:D011218	marker/mechanism		NA	176270	
PWWP2B	170394	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
PXDN	7837	Anterior segment mesenchymal dysgenesis	MESH:C537775	marker/mechanism		NA	269400	
PXDN	7837	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
PXDN	7837	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PXK	54899	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		20453842
PXK	54899	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		18204446
PXN	5829	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		21159652
PXN	5829	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		28100775
PXN	5829	Melanoma, Experimental	MESH:D008546	marker/mechanism		NA		18492274
PXN	5829	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		18492274
PYCARD	29108	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		16778195
PYCARD	29108	Albuminuria	MESH:D000419	marker/mechanism		NA		22647887
PYCARD	29108	Calcinosis	MESH:D002114	marker/mechanism		NA		21335463
PYCARD	29108	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		17471463
PYCARD	29108	Carcinoma, Large Cell	MESH:D018287	marker/mechanism		NA		16778195
PYCARD	29108	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		16778195
PYCARD	29108	Carcinoma, Small Cell	MESH:D018288	marker/mechanism		NA		16778195
PYCARD	29108	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		16778195
PYCARD	29108	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17986858
PYCARD	29108	Heart Valve Diseases	MESH:D006349	marker/mechanism		NA		21335463
PYCARD	29108	Hyperhomocysteinemia	MESH:D020138	marker/mechanism		NA		22647887
PYCARD	29108	Kidney Diseases	MESH:D007674	marker/mechanism|therapeutic		NA		22647887|24508291
PYCARD	29108	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PYCARD	29108	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		16778195
PYCARD	29108	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		26935421
PYCARD	29108	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
PYCARD	29108	Weight Gain	MESH:D015430	therapeutic		NA		24508291
PYCR1	5831	Cutis Laxa	MESH:D003483	marker/mechanism		NA		19648921
PYCR1	5831	Cutis Laxa, Autosomal Recessive, Type IIB	MESH:C567855	marker/mechanism		NA	612940	
PYCR1	5831	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB	OMIM:614438	marker/mechanism		NA	614438	
PYCR1	5831	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
PYCR1	5831	Progeria	MESH:D011371	marker/mechanism		NA		19648921
PYCR2	29920	LEUKODYSTROPHY, HYPOMYELINATING, 10	OMIM:616420	marker/mechanism		NA	616420	
PYD3	40916	Purine-Pyrimidine Metabolism, Inborn Errors	MESH:D011686	marker/mechanism		NA		16361227
PYGB	5834	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
PYGB	5834	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
PYGB	5834	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
PYGL	5836	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		2885971
PYGL	5836	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
PYGL	5836	Glycogen Storage Disease Type VI	MESH:D006013	marker/mechanism		NA	232700	9529348|9536091
PYGM	5837	Glycogen Storage Disease Type V	MESH:D006012	marker/mechanism		NA	232600	12666117|18380285
PYGM	5837	Muscular Diseases	MESH:D009135	marker/mechanism		NA		18380285
PYHIN1	149628	Asthma	MESH:D001249	marker/mechanism		NA		21804549
PYHIN1	149628	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
PYROXD1	79912	Myofibrillar Myopathy	MESH:C580316	marker/mechanism		NA	617258	
PYY	5697	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		11709213
PYY	5697	Anorexia	MESH:D000855	marker/mechanism		NA		22903826|29689362
PYY	5697	Diarrhea	MESH:D003967	therapeutic		NA		19925840
PYY	5697	Neural Tube Defects	MESH:D009436	marker/mechanism		NA		17400914
PYY	5697	Obesity	MESH:D009765	marker/mechanism		NA		16368708
PZP	5858	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
PZP	5858	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		16099942
QARS	97541	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
QARS1	5859	MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	OMIM:615760	marker/mechanism		NA	615760	
QDPR	5860	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C	OMIM:261630	marker/mechanism		NA	261630	
QDPR	5860	Phenylketonurias	MESH:D010661	marker/mechanism		NA		25526675
QK	19317	Demyelinating Diseases	MESH:D003711	marker/mechanism		NA		16245024
QKI	9444	Glioma	MESH:D005910	marker/mechanism		NA		26829751
QPCT	25797	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		16033404
QPCT	25797	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		23770605
QPCT	25797	Melanoma	MESH:D008545	marker/mechanism		NA		17145863
QSOX1	5768	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
R3HDM2	22864	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
R3HDM2	22864	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RAB11A	8766	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
RAB11B	9230	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
RAB11FIP5	26056	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18384058
RAB12	201475	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
RAB18	22931	Warburg Sjo Fledelius syndrome	MESH:C536681	marker/mechanism		NA	614222	
RAB1B	81876	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
RAB21	23011	Obesity	MESH:D009765	marker/mechanism		NA		29273807
RAB23	51715	Acrocephalopolysyndactyly Type II	MESH:C563187	marker/mechanism		NA	201000	
RAB23	51715	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
RAB27A	5873	Griscelli syndrome type 2	MESH:C537302	marker/mechanism		NA	607624	
RAB28	9364	CONE-ROD DYSTROPHY 18	OMIM:615374	marker/mechanism		NA	615374	
RAB2A	5862	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
RAB30	27314	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RAB31	11031	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RAB32	10981	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17374397
RAB32	10981	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
RAB32	10981	Leprosy	MESH:D007918	marker/mechanism		NA		22019778
RAB32	10981	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RAB39B	116442	Autistic Disorder	MESH:D001321	marker/mechanism		NA		20159109
RAB39B	116442	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		20159109
RAB39B	116442	Epilepsy	MESH:D004827	marker/mechanism		NA		20159109
RAB39B	116442	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21076407
RAB39B	116442	Mental Retardation, X-Linked	MESH:D038901	marker/mechanism		NA		20159109
RAB39B	116442	Mental Retardation, X-Linked 72	MESH:C564547	marker/mechanism		NA	300271	
RAB39B	116442	Parkinsonism, early onset with mental retardation	MESH:C537179	marker/mechanism		NA	311510	
RAB3A	5864	Ependymoma	MESH:D004806	marker/mechanism		NA		26075792
RAB3GAP1	22930	Warburg Sjo Fledelius syndrome	MESH:C536681	marker/mechanism		NA	600118	
RAB3GAP2	25782	Martsolf syndrome	MESH:C536028	marker/mechanism		NA	212720	
RAB3GAP2	25782	Warburg Sjo Fledelius syndrome	MESH:C536681	marker/mechanism		NA	614225	
RAB40AL	282808	Cognition Disorders	MESH:D003072	marker/mechanism		NA		22581972
RAB40AL	282808	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		22581972
RAB40AL	282808	Facies	MESH:D019066	marker/mechanism		NA		22581972
RAB40AL	282808	Growth Disorders	MESH:D006130	marker/mechanism		NA		22581972
RAB40AL	282808	Martin-Probst Deafness-Mental Retardation Syndrome	MESH:C564495	marker/mechanism		NA		22581972
RAB40AL	282808	Mental Retardation, X-Linked	MESH:D038901	marker/mechanism		NA		22581972
RAB40B	10966	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RAB4B	53916	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
RAB5A	5868	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
RAB7A	7879	Charcot-Marie-Tooth disease, Type 2B	MESH:C537989	marker/mechanism		NA	600882	
RAB7A	7879	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
RAB7B	338382	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		21751358
RAB7B	338382	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
RAB8A	4218	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		12833524
RAB8B	51762	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RABGAP1L	9910	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RABL3	285282	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		31406347
RABL6	55684	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
RAC1	5879	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		18506888
RAC1	5879	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		16155095
RAC1	5879	Cardiotoxicity	MESH:D066126	marker/mechanism		NA		28710503
RAC1	5879	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22011395
RAC1	5879	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		23723366
RAC1	5879	Heart Failure	MESH:D006333	marker/mechanism		NA		16155095
RAC1	5879	Liver Diseases	MESH:D008107	marker/mechanism		NA		17058265
RAC1	5879	Melanoma	MESH:D008545	marker/mechanism		NA		22842228
RAC1	5879	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		18506888
RAC1	5879	Ventricular Dysfunction, Left	MESH:D018487	marker/mechanism		NA		28710503
RAC2	5880	Heart Diseases	MESH:D006331	marker/mechanism		NA		16330681
RAC2	5880	Leukemia, Myelomonocytic, Juvenile	MESH:D054429	marker/mechanism		NA		26457648
RAC2	5880	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RAC2	5880	Lymphoma	MESH:D008223	marker/mechanism		NA		19783987
RAC2	5880	Melanoma	MESH:D008545	marker/mechanism		NA		17145863
RAC2	5880	Neutrophil Immunodeficiency Syndrome	MESH:C564275	marker/mechanism		NA	608203	
RACGAP1	29127	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
RACGAP1	29127	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
RACK1	10399	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		15274141
RACK1	10399	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		15274141
RAD21	5885	De Lange Syndrome	MESH:D003635	marker/mechanism		NA	614701	
RAD21	5885	Leukemia, Megakaryoblastic, of Down Syndrome	MESH:C566025	marker/mechanism		NA		24056718
RAD21	5885	Leukemia, Myeloid	MESH:D007951	marker/mechanism		NA		23955599
RAD21	5885	Mungan Syndrome	MESH:C548078	marker/mechanism		NA	611376	
RAD23A	5886	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
RAD23A	5886	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
RAD23B	5887	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		11809813
RAD23B	5887	Infertility, Male	MESH:D007248	marker/mechanism		NA		11809813
RAD23B	5887	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		19208208
RAD50	10111	Asthma	MESH:D001249	marker/mechanism		NA		24241537
RAD50	10111	Nijmegen Breakage Syndrome-Like Disorder	MESH:C567767	marker/mechanism		NA	613078	
RAD51	5888	Breast Neoplasms	MESH:D001943	marker/mechanism		NA	114480	
RAD51	5888	FANCONI ANEMIA, COMPLEMENTATION GROUP R	OMIM:617244	marker/mechanism		NA	617244	
RAD51	5888	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		22613844
RAD51	5888	Head and Neck Neoplasms	MESH:D006258	marker/mechanism		NA		22613844
RAD51	5888	Micronuclei, Chromosome-Defective	MESH:D048629	marker/mechanism		NA		9885240
RAD51	5888	MIRROR MOVEMENTS 2	OMIM:614508	marker/mechanism		NA	614508	
RAD51B	5890	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19330030
RAD51B	5890	Breast Neoplasms, Male	MESH:D018567	marker/mechanism		NA		23001122
RAD51B	5890	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
RAD51C	5889	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20400964|28825726
RAD51C	5889	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3	OMIM:613399	marker/mechanism		NA	613399	
RAD51C	5889	Fanconi Anemia	MESH:D005199	marker/mechanism		NA		20400963
RAD51C	5889	FANCONI ANEMIA, COMPLEMENTATION GROUP O	OMIM:613390	marker/mechanism		NA	613390	
RAD51C	5889	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		20400964
RAD51D	5892	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	OMIM:614291	marker/mechanism		NA	614291	
RAD51D	5892	Chromosome Deletion	MESH:D002872	marker/mechanism		NA		27924006
RAD51D	5892	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		21822267
RAD52	5893	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		26013599
RAD52	5893	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		26013599
RAD54B	25788	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	114500	
RAD54B	25788	Lymphoma, Non-Hodgkin	MESH:D008228	marker/mechanism		NA	605027	
RAD54L	8438	Breast Neoplasms	MESH:D001943	marker/mechanism		NA	114480	
RAD54L	8438	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
RAD54L	8438	Lymphoma, Non-Hodgkin	MESH:D008228	marker/mechanism		NA	605027	
RAD9A	5883	Neoplasms, Second Primary	MESH:D016609	marker/mechanism		NA		21991345
RAET1L	154064	Alopecia Areata	MESH:D000506	marker/mechanism		NA		20596022
RAF	31221	Coronavirus Infections	MESH:D018352	marker/mechanism		NA		20484496
RAF	31221	Severe Acute Respiratory Syndrome	MESH:D045169	marker/mechanism		NA		20484496
RAF1	5894	Breast Neoplasms	MESH:D001943	therapeutic		NA		12432273
RAF1	5894	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		16862215
RAF1	5894	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		28811376
RAF1	5894	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		24777450
RAF1	5894	CARDIOMYOPATHY, DILATED, 1NN	OMIM:615916	marker/mechanism		NA	615916	
RAF1	5894	Cardiomyopathy, Hypertrophic	MESH:D002312	marker/mechanism		NA		17603482|17603483
RAF1	5894	Glioma	MESH:D005910	marker/mechanism		NA		23583981
RAF1	5894	Hyperalgesia	MESH:D006930	marker/mechanism		NA		18976650
RAF1	5894	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		21813464
RAF1	5894	LEOPARD Syndrome	MESH:D044542	marker/mechanism		NA		17603483
RAF1	5894	LEOPARD syndrome, 2	MESH:C537117	marker/mechanism		NA	611554	
RAF1	5894	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19499222
RAF1	5894	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		11884234
RAF1	5894	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
RAF1	5894	Noonan Syndrome	MESH:D009634	marker/mechanism		NA		17603482|17603483
RAF1	5894	Noonan Syndrome 5	MESH:C548083	marker/mechanism		NA	611553	
RAF1	5894	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		32512071
RAG1	5896	Alpha-Beta T-Cell Lymphopenia with Gamma-Delta T-Cell Expansion, Severe Cytomegalovirus Infection, and Autoimmunity	MESH:C563691	marker/mechanism		NA	609889	
RAG1	5896	Combined Cellular And Humoral Immune Defects With Granulomas	MESH:C567115	marker/mechanism		NA	233650	
RAG1	5896	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
RAG1	5896	Reticuloendotheliosis, familial, with eosinophilia	MESH:C538564	marker/mechanism		NA	603554	
RAG1	5896	Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Negative, NK Cell-Positive	MESH:C563311	marker/mechanism		NA	601457	
RAG2	5897	Arthritis, Experimental	MESH:D001169	therapeutic		NA		20974942
RAG2	5897	Combined Cellular And Humoral Immune Defects With Granulomas	MESH:C567115	marker/mechanism		NA	233650	
RAG2	5897	Eosinophilia	MESH:D004802	therapeutic		NA		27315767
RAG2	5897	Metaplasia	MESH:D008679	therapeutic		NA		27315767
RAG2	5897	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		24211274
RAG2	5897	Reticuloendotheliosis, familial, with eosinophilia	MESH:C538564	marker/mechanism		NA	603554	
RAG2	5897	Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Negative, NK Cell-Positive	MESH:C563311	marker/mechanism		NA	601457	
RAI1	10743	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		18285828
RAI1	10743	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		20981775
RAI1	10743	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		19116176
RAI1	10743	Dyssomnias	MESH:D020920	marker/mechanism		NA		19752160
RAI1	10743	Growth Disorders	MESH:D006130	marker/mechanism		NA		18285828
RAI1	10743	Intellectual Disability	MESH:D008607	marker/mechanism		NA		19752160
RAI1	10743	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
RAI1	10743	Neurobehavioral Manifestations	MESH:D019954	marker/mechanism		NA		19116176
RAI1	10743	Obesity	MESH:D009765	marker/mechanism		NA		15459175|19116176
RAI1	10743	Potocki-Lupski syndrome	MESH:C538355	marker/mechanism		NA		17517686
RAI1	10743	Psychomotor Agitation	MESH:D011595	marker/mechanism		NA		18285828
RAI1	10743	Smith-Magenis Syndrome	MESH:D058496	marker/mechanism		NA	182290	15459175|15746153|15788730|16845274|17273973|17517686|18285828|19116176|19236431|19752160|20691407|20981775
RALBP1	10928	Hypertension	MESH:D006973	marker/mechanism		NA		23821548
RALBP1	10928	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
RALBP1	10928	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
RALGDS	5900	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
RALGPS1	9649	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		26039340
RALY	22913	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
RALYL	138046	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21466612
RAMP1	10267	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RAMP2	10266	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		17671114
RAMP2	10266	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17671114
RAMP2	10266	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
RAMP2	10266	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
RAN	5901	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462|16316942
RAN	5901	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
RAN	5901	Keloid	MESH:D007627	marker/mechanism		NA		20128793
RAN	5901	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462|16316942
RAN	5901	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462|16316942
RAN	5901	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
RANBP1	5902	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
RANBP1	5902	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		28321044
RANBP10	57610	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
RANBP10	57610	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
RANBP2	5903	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3	OMIM:608033	marker/mechanism		NA	608033	
RANBP2	5903	Granuloma, Plasma Cell	MESH:D006104	marker/mechanism		NA		21030459
RANGAP1	5905	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		27150054
RANGRF	29098	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
RANGRF	29098	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
RAP1GAP	5909	Disease Progression	MESH:D018450	marker/mechanism		NA		22614916
RAP1GAP	5909	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		22614916
RAP1GAP	5909	Melanoma	MESH:D008545	marker/mechanism		NA		19147557|22614916
RAP1GAP	5909	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		22614916
RAP1GAP	5909	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		22614916
RAP2A	5911	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		12833524
RAPGEF2	9693	Epilepsies, Myoclonic	MESH:D004831	marker/mechanism		NA		29507423
RAPGEF3	10411	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		21745194
RAPGEF3	10411	Glucose Intolerance	MESH:D018149	marker/mechanism		NA		27381457
RAPGEF3	10411	Obesity	MESH:D009765	marker/mechanism		NA		29273807
RAPGEF3	10411	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		22363678
RAPGEF3	10411	Rickettsia Infections	MESH:D012282	marker/mechanism		NA		24218580
RAPGEF3	10411	Tick-Borne Diseases	MESH:D017282	marker/mechanism		NA		24218580
RAPGEF5	9771	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
RAPSN	5913	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		9668287
RAPSN	5913	Muscular Diseases	MESH:D009135	marker/mechanism		NA		9668287
RAPSN	5913	Myasthenic Syndrome, Congenital, with Facial Dysmorphism, associated with Acetylcholine Receptor Deficiency	MESH:C563829	marker/mechanism		NA	616326	
RARA	5914	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		26437033
RARA	5914	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		18026104
RARA	5914	Fibroadenoma	MESH:D018226	marker/mechanism		NA		26437033
RARA	5914	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA	612376	10742073|14508522|14706140|16239915|16788101|16835227|16891316|16935935|17294898|17649720|17712046|19029980|19035177|19884644|19887701|21613260|22213200|23208507|25583766|26285909|26728337|28314734|8616088
RARA	5914	Neoplasms, Second Primary	MESH:D016609	marker/mechanism		NA		19884644
RARA	5914	Phyllodes Tumor	MESH:D003557	marker/mechanism		NA		26437033
RARA	5914	Sciatic Neuropathy	MESH:D020426	marker/mechanism		NA		16782282
RARB	5915	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		14656941
RARB	5915	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		31209396
RARB	5915	Breast Neoplasms	MESH:D001943	therapeutic		NA		16255778
RARB	5915	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		17549354
RARB	5915	Endometriosis	MESH:D004715	marker/mechanism		NA		22138541
RARB	5915	Head and Neck Neoplasms	MESH:D006258	marker/mechanism		NA		17549354
RARB	5915	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		14656941
RARB	5915	MICROPHTHALMIA, SYNDROMIC 12	OMIM:615524	marker/mechanism		NA	615524	
RARB	5915	Sciatic Neuropathy	MESH:D020426	marker/mechanism		NA		16782282
RARB	5915	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16134180
RARB	5915	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		17961338
RARG	5916	Cardiotoxicity	MESH:D066126	marker/mechanism		NA		26237429
RARG	5916	Cleft Palate	MESH:D002972	marker/mechanism		NA		21807577
RARG	5916	Heart Diseases	MESH:D006331	marker/mechanism		NA		26237429
RARG	5916	Musculoskeletal Abnormalities	MESH:D009139	marker/mechanism		NA		9142499
RARRES1	5918	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RARRES1	5918	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16134180
RARRES2	5919	Glucose Intolerance	MESH:D018149	marker/mechanism		NA		22355640
RARRES2	5919	Granulosa Cell Tumor	MESH:D006106	marker/mechanism		NA		29653259
RARS1	5917	LEUKODYSTROPHY, HYPOMYELINATING, 9	OMIM:616140	marker/mechanism		NA	616140	
RARS2	57038	Pontocerebellar Hypoplasia Type 6	MESH:C548074	marker/mechanism		NA	611523	
RAS	19412	Coronavirus Infections	MESH:D018352	marker/mechanism		NA		20484496
RAS	19412	Severe Acute Respiratory Syndrome	MESH:D045169	marker/mechanism		NA		20484496
RASA1	5921	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27158780
RASA1	5921	Arteriovenous Malformations	MESH:D001165	marker/mechanism		NA		14639529
RASA1	5921	Capillary Malformation-Arteriovenous Malformation	MESH:C564254	marker/mechanism		NA	608354	
RASA1	5921	Carcinoma	MESH:D002277	marker/mechanism		NA		12606953
RASA1	5921	Carcinoma, Basal Cell	MESH:D002280	marker/mechanism		NA	605462	
RASA1	5921	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		27158780
RASA1	5921	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
RASA1	5921	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12606953
RASA1	5921	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12606953
RASA1	5921	Port-Wine Stain	MESH:D019339	marker/mechanism		NA		14639529
RASA2	5922	Melanoma	MESH:D008545	marker/mechanism		NA		26214590|26502337
RASAL1	8437	Kidney Diseases	MESH:D007674	marker/mechanism		NA		23665422
RASD1	51655	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
RASGEF1B	153020	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
RASGRF1	5923	Dyskinesia, Drug-Induced	MESH:D004409	therapeutic		NA		21115823
RASGRF1	5923	Myopia	MESH:D009216	marker/mechanism		NA		23396134
RASGRF1	5923	Refractive Errors	MESH:D012030	marker/mechanism		NA		20835236
RASGRF2	5924	Carcinoma	MESH:D002277	marker/mechanism		NA		12606953
RASGRF2	5924	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12606953
RASGRF2	5924	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12606953
RASGRP1	10125	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		23143596
RASGRP1	10125	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
RASGRP1	10125	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		21441929
RASGRP1	10125	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		26808113
RASGRP2	10235	BLEEDING DISORDER, PLATELET-TYPE, 18	OMIM:615888	marker/mechanism		NA	615888	
RASGRP3	25780	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		19838193
RASL10B	91608	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
RASL11A	387496	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		30224643
RASL11A	387496	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
RASSF1	11186	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		15639718
RASSF1	11186	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		18337602
RASSF1	11186	Cardiomyopathy, Hypertrophic	MESH:D002312	therapeutic		NA		19652091
RASSF1	11186	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA		24146755
RASSF1	11186	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		18337602
RASSF1	11186	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		20008439
RASSF1	11186	Medulloblastoma	MESH:D008527	marker/mechanism		NA		21880625
RASSF1	11186	Mesothelioma	MESH:D008654	marker/mechanism		NA		12082623|15639718
RASSF1	11186	Micronuclei, Chromosome-Defective	MESH:D048629	marker/mechanism		NA		26410583
RASSF1	11186	Schistosomiasis	MESH:D012552	marker/mechanism		NA		23527093
RASSF1	11186	Urinary Bladder Diseases	MESH:D001745	marker/mechanism		NA		23527093
RASSF1	11186	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		15987713
RASSF2	9770	Lymphatic Metastasis	MESH:D008207	marker/mechanism		NA		17013896
RASSF2	9770	Nasopharyngeal Neoplasms	MESH:D009303	marker/mechanism		NA		17013896
RASSF3	283349	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
RASSF4	83937	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RASSF5	83593	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		25217643
RASSF5	83593	Neuroblastoma	MESH:D009447	marker/mechanism		NA		18452173
RASSF8	11228	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941189
RATNP-3B	498659	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
RAX	30062	Anophthalmos	MESH:D000853	marker/mechanism		NA		15789424
RAX	30062	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		15789424
RAX	30062	Melanoma	MESH:D008545	marker/mechanism		NA		16778180
RAX	30062	Microphthalmia, Isolated 3	MESH:C567025	marker/mechanism		NA	611038	
RAX2	84839	Cone-Rod Dystrophy 11	MESH:C563671	marker/mechanism		NA	610381	
RAX2	84839	Macular Degeneration, Age-Related, 6	MESH:C563674	marker/mechanism		NA	613757	
RAX2	84839	Retinal Degeneration	MESH:D012162	marker/mechanism		NA		15028672
RB1	5925	Acute erythroleukemia	MESH:C535673	marker/mechanism		NA		30926971
RB1	5925	Adrenal Gland Neoplasms	MESH:D000310	marker/mechanism		NA		24747643
RB1	5925	Adrenocortical Carcinoma	MESH:D018268	marker/mechanism		NA		24747642
RB1	5925	Brain Ischemia	MESH:D002545	marker/mechanism		NA		17901229
RB1	5925	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		14672398|19234134|20948315
RB1	5925	Carcinoma	MESH:D002277	marker/mechanism		NA		14522882
RB1	5925	Carcinoma, Basal Cell	MESH:D002280	marker/mechanism		NA		26950094
RB1	5925	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		12029619|14961299
RB1	5925	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		16862215
RB1	5925	Carcinoma, Small Cell	MESH:D018288	marker/mechanism		NA	182280	
RB1	5925	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		25151357
RB1	5925	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
RB1	5925	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		17854601
RB1	5925	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		14522882
RB1	5925	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		14522882
RB1	5925	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		27137931
RB1	5925	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		27137931
RB1	5925	Osteosarcoma	MESH:D012516	marker/mechanism		NA	259500	27137931
RB1	5925	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		21699781
RB1	5925	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		23334668
RB1	5925	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
RB1	5925	Retinoblastoma	MESH:D012175	marker/mechanism		NA	180200	
RB1	5925	Sezary Syndrome	MESH:D012751	marker/mechanism		NA		26551667
RB1	5925	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941188|22941189
RB1	5925	Stevens-Johnson Syndrome	MESH:D013262	marker/mechanism		NA		25811541
RB1	5925	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA	109800	
RB1CC1	9821	Breast Neoplasms	MESH:D001943	marker/mechanism		NA	114480	21466612
RB1CC1	9821	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
RBBP8	5932	Microcephaly with Mental Retardation and Digital Anomalies	MESH:C567101	marker/mechanism		NA	251255	
RBBP8	5932	Seckel syndrome 2	MESH:C537534	marker/mechanism		NA	606744	
RBCK1	10616	Cardiomegaly	MESH:D006332	marker/mechanism		NA		17121852
RBFOX1	54715	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17503474|18621663
RBFOX1	54715	Seizures	MESH:D012640	marker/mechanism		NA		21623373
RBFOX2	23543	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
RBFOX2	23543	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
RBL2	5934	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		16038780
RBL2	5934	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RBL2	5934	Ovarian Neoplasms	MESH:D010051	therapeutic		NA		16936753
RBM10	8241	TARP syndrome	MESH:C536942	marker/mechanism		NA	311900	
RBM12	10137	Psychotic Disorders	MESH:D011618	marker/mechanism		NA		28628109
RBM17	84991	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA		18337722
RBM20	282996	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
RBM20	282996	Cardiomyopathy, Dilated, 1DD	MESH:C567725	marker/mechanism		NA	613172	
RBM26	64062	Anthracosis	MESH:D055008	marker/mechanism		NA		29394417
RBM28	55131	Alopecia, Neurologic Defects, and Endocrinopathy Syndrome	MESH:C567425	marker/mechanism		NA	612079	
RBM3	5935	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19734850
RBM3	5935	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RBM47	54502	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
RBM7	10179	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		15496427
RBM8A	9939	Absent radii and thrombocytopenia	MESH:C536940	marker/mechanism		NA	274000	22366785
RBMS3	27303	Exfoliation Syndrome	MESH:D017889	marker/mechanism		NA		28553957
RBMX	27316	Orofaciodigital syndrome, Shashi type	MESH:C537135	marker/mechanism		NA	300238	
RBMY	19657	Adenoma	MESH:D000236	marker/mechanism		NA		22073224
RBMY	19657	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		22073224
RBMY	19657	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		22073224
RBMY1A1	5940	Spermatogenic Failure, Nonobstructive, Y-Linked	MESH:C564030	marker/mechanism		NA	415000	
RBP1	5947	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
RBP1	5947	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		16099942
RBP1	5947	Fetal Growth Retardation	MESH:D005317	marker/mechanism		NA		28157488
RBP1	5947	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
RBP1	5947	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
RBP1	5947	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16134180|16367923
RBP3	5949	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		20007828|21850155
RBP3	5949	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA	268000	23486466
RBP3	5949	RETINITIS PIGMENTOSA 66	OMIM:615233	marker/mechanism		NA	615233	
RBP3	5949	Uveitis	MESH:D014605	marker/mechanism		NA		21850155
RBP4	5950	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
RBP4	5950	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
RBP4	5950	Heart Failure	MESH:D006333	marker/mechanism		NA		26670611
RBP4	5950	Keratomalacia	MESH:C536156	marker/mechanism		NA		9888420
RBP4	5950	Kidney Diseases	MESH:D007674	marker/mechanism		NA		22061828
RBP4	5950	Liver Diseases, Alcoholic	MESH:D008108	marker/mechanism		NA		16762690
RBP4	5950	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
RBP4	5950	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
RBP4	5950	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 10	OMIM:616428	marker/mechanism		NA	616428	
RBP4	5950	Necrosis	MESH:D009336	marker/mechanism		NA		22061828
RBP4	5950	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		17456573
RBP4	5950	RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME	OMIM:615147	marker/mechanism		NA	615147	
RBP4	5950	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
RBP4	5950	Vitamin A Deficiency	MESH:D014802	marker/mechanism		NA		16157297
RBPJ	3516	Adams Oliver syndrome	MESH:C538225	marker/mechanism		NA	614814	
RBPJ	3516	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		20453842|23143596
RBPJ	3516	Endometriosis	MESH:D004715	marker/mechanism		NA		22138541
RBPJ	3516	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		25853421
RBX1	9978	Stevens-Johnson Syndrome	MESH:D013262	marker/mechanism		NA		25811541
RCAN1	1827	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		23143596
RCAN1	1827	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
RCAN1	1827	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		15906378
RCAN1	1827	Down Syndrome	MESH:D004314	marker/mechanism		NA		15906378
RCAN1	1827	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		15906378
RCAN1	1827	Huntington Disease	MESH:D006816	marker/mechanism		NA		19270310
RCBTB1	55213	RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES	OMIM:617175	marker/mechanism		NA	617175	
RCCD1	91433	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
RCHY1	25898	Disease Progression	MESH:D018450	marker/mechanism		NA		28191284
RCHY1	25898	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		28191284
RCL1	10171	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
RCL1	10171	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
RCN1	5954	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
RCN1	5954	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RCN1	5954	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
RCN1	5954	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
RCN2	5955	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RCN3	57333	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
RCOR1	23186	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		25043185
RCSD1	92241	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RD3	343035	Leber Congenital Amaurosis 12	MESH:C565697	marker/mechanism		NA	610612	
RDGA	31826	Parkinson Disease	MESH:D010300	marker/mechanism		NA		18353766
RDH10	157506	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		27793605
RDH10	157506	Fetal Death	MESH:D005313	marker/mechanism		NA		27793605
RDH10	157506	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RDH11	51109	RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME	OMIM:616108	marker/mechanism		NA	616108	
RDH12	145226	Leber Congenital Amaurosis 13	MESH:C567197	marker/mechanism		NA	612712	25526675
RDH12	145226	Retinal Degeneration	MESH:D012162	marker/mechanism		NA		16269441
RDH12	145226	Retinal Dystrophies	MESH:D058499	marker/mechanism		NA		18048336
RDH12	145226	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA		16968212
RDH13	112724	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		27865848
RDH13	112724	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		27865848
RDH13	112724	Necrosis	MESH:D009336	marker/mechanism		NA		27865848
RDH2	107460	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
RDH3	100305177	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
RDH5	5959	Fundus Albipunctatus	MESH:C562733	marker/mechanism		NA	136880	18048336|25526675
RDH5	5959	Myopia	MESH:D009216	marker/mechanism		NA		23396134
RDL	39054	Seizures	MESH:D012640	marker/mechanism		NA		17074045
RDX	5962	Cholestasis	MESH:D002779	marker/mechanism		NA		17681005
RDX	5962	Deafness, Autosomal Recessive, 24	MESH:C567027	marker/mechanism		NA	611022	
RDX	5962	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		29341352
REC8	9985	Melanoma	MESH:D008545	marker/mechanism		NA		16778180
REC8	9985	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
RECK	8434	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		17233834
RECK	8434	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		17443689
RECK	8434	Glioblastoma	MESH:D005909	therapeutic		NA		20127710
RECK	8434	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RECK	8434	Neoplasm Invasiveness	MESH:D009361	therapeutic		NA		20127710
RECK	8434	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17233834
RECQL	5965	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25915596
RECQL4	9401	Craniosynostosis radial aplasia syndrome	MESH:C536788	marker/mechanism		NA	218600	
RECQL4	9401	Rapadilino syndrome	MESH:C535288	marker/mechanism		NA	266280	
RECQL4	9401	Rothmund-Thomson Syndrome	MESH:D011038	marker/mechanism		NA	268400	18616953
REEP1	65055	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
REEP1	65055	Neuronopathy, Distal Hereditary Motor, Type V	MESH:C563443	marker/mechanism		NA	614751	
REEP1	65055	Spastic Paraplegia 31, Autosomal Dominant	MESH:C565210	marker/mechanism		NA	610250	
REEP2	51308	SPASTIC PARAPLEGIA 72, AUTOSOMAL RECESSIVE	OMIM:615625	marker/mechanism		NA	615625	
REEP3	221035	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
REEP3	221035	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17290275
REEP5	7905	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		26881866
REEP5	7905	Cholestasis	MESH:D002779	marker/mechanism		NA		26881866
REEP5	7905	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
REEP6	92840	RETINITIS PIGMENTOSA 77	OMIM:617304	marker/mechanism		NA	617304	
REG1	19692	Stomach Neoplasms	MESH:D013274	therapeutic		NA		15940630
REG3G	130120	Hypertension	MESH:D006973	marker/mechanism		NA		27798352
REG4	83998	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		17237819
REL	5966	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		19503088|20453842|23143596
REL	5966	Heat Stroke	MESH:D018883	marker/mechanism		NA		24039931
REL	5966	Hodgkin Disease	MESH:D006689	marker/mechanism		NA		21037568
REL	5966	Memory Disorders	MESH:D008569	marker/mechanism		NA		20477932
REL	5966	Psoriasis	MESH:D011565	marker/mechanism		NA		20953190
RELA	5970	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		19689456
RELA	5970	Barrett Esophagus	MESH:D001471	marker/mechanism		NA		15387324
RELA	5970	Brain Injuries, Traumatic	MESH:D000070642	marker/mechanism		NA		25668593|28642177
RELA	5970	Brain Ischemia	MESH:D002545	therapeutic		NA		18628779
RELA	5970	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		20932960
RELA	5970	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20154269
RELA	5970	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		18089796
RELA	5970	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		23069812|29501572
RELA	5970	Cholestasis	MESH:D002779	marker/mechanism		NA		20626112
RELA	5970	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		28789951|30026087
RELA	5970	Colitis	MESH:D003092	marker/mechanism		NA		23810507
RELA	5970	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		15955209
RELA	5970	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		20715105
RELA	5970	Cystitis	MESH:D003556	marker/mechanism		NA		22099998
RELA	5970	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		22138235
RELA	5970	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		23500658
RELA	5970	Diabetic Angiopathies	MESH:D003925	marker/mechanism		NA		25381014
RELA	5970	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		17900838
RELA	5970	Drug Eruptions	MESH:D003875	marker/mechanism		NA		31150805
RELA	5970	Heat Stroke	MESH:D018883	marker/mechanism		NA		24039931
RELA	5970	Hepatic Insufficiency	MESH:D048550	marker/mechanism		NA		30026087
RELA	5970	Hepatomegaly	MESH:D006529	marker/mechanism		NA		30026087
RELA	5970	Hypertension	MESH:D006973	marker/mechanism		NA		19018797|27659729|32147540
RELA	5970	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19420110
RELA	5970	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		23274713
RELA	5970	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		30026087
RELA	5970	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		26806094
RELA	5970	Lymphoma, Large-Cell, Anaplastic	MESH:D017728	marker/mechanism		NA		17261581
RELA	5970	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		19896475|29501572
RELA	5970	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		20932960
RELA	5970	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		20302854|23743330
RELA	5970	Severe Acute Respiratory Syndrome	MESH:D045169	marker/mechanism		NA		26861016
RELA	5970	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		23069812
RELA	5970	Subarachnoid Hemorrhage	MESH:D013345	marker/mechanism		NA		27157545
RELA	5970	Ureteral Obstruction	MESH:D014517	marker/mechanism		NA		28318631
RELB	5971	Heat Stroke	MESH:D018883	marker/mechanism		NA		24039931
RELL1	768211	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RELN	5649	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		20610758
RELN	5649	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		24781735|28191889
RELN	5649	Autistic Disorder	MESH:D001321	marker/mechanism		NA		11317216|11814262|20442744
RELN	5649	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		11126396|14708030|15560956
RELN	5649	Depressive Disorder	MESH:D003866	marker/mechanism		NA		14708030
RELN	5649	Depressive Disorder, Major	MESH:D003865	marker/mechanism		NA		11126396
RELN	5649	EPILEPSY, FAMILIAL TEMPORAL LOBE, 1	OMIM:600512	marker/mechanism		NA	600512	
RELN	5649	EPILEPSY, FAMILIAL TEMPORAL LOBE, 7	OMIM:616436	marker/mechanism		NA	616436	
RELN	5649	Norman Roberts lissencephaly syndrome	MESH:C537848	marker/mechanism		NA	257320	
RELN	5649	Schizophrenia	MESH:D012559	marker/mechanism		NA		11126396|14708030|15560956|19110320
REN	5972	Albuminuria	MESH:D000419	marker/mechanism		NA		12414515|18679781
REN	5972	Allanson Pantzar McLeod syndrome	MESH:C537048	marker/mechanism		NA		16116425
REN	5972	Anemia	MESH:D000740	marker/mechanism		NA		3524928
REN	5972	Azotemia	MESH:D053099	marker/mechanism		NA		6338847
REN	5972	Bartter Syndrome	MESH:D001477	marker/mechanism		NA		15976003|3519017|929154
REN	5972	Cardiomegaly	MESH:D006332	marker/mechanism		NA		20429690|20811386
REN	5972	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		18829990
REN	5972	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		8723173
REN	5972	Fetal Growth Retardation	MESH:D005317	marker/mechanism		NA		17537837
REN	5972	Fibrosis	MESH:D005355	marker/mechanism		NA		12414515
REN	5972	Heart Failure	MESH:D006333	marker/mechanism		NA		1647690|20811386|7034517
REN	5972	Hemorrhage	MESH:D006470	marker/mechanism		NA		6991409
REN	5972	Hypertension	MESH:D006973	marker/mechanism		NA		1071603|1149188|11501062|12414515|12600921|17537837|18679781|18847324|19770776|20429690|20811386|21393355|45830|62162|6381767|7721401|998518
REN	5972	Hypertension, Malignant	MESH:D006974	marker/mechanism		NA		2493837
REN	5972	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		18679781|8349331
REN	5972	Hyperuricemic Nephropathy, Familial Juvenile 2	MESH:C567760	marker/mechanism		NA	613092	
REN	5972	Hypotension	MESH:D007022	marker/mechanism|therapeutic		NA		11171655|3536153|6251761
REN	5972	Ischemia	MESH:D007511	marker/mechanism		NA		3915608
REN	5972	Kidney Diseases	MESH:D007674	marker/mechanism		NA		12414515|6156352|8723173
REN	5972	Liddle Syndrome	MESH:D056929	marker/mechanism		NA		12185466
REN	5972	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		15613622
REN	5972	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		1668233
REN	5972	Nephrosis	MESH:D009401	marker/mechanism		NA		2046802|6358456
REN	5972	Osteoporosis	MESH:D010024	marker/mechanism		NA		18847324
REN	5972	Proteinuria	MESH:D011507	marker/mechanism		NA		2046802|464098
REN	5972	Psoriasis	MESH:D011565	marker/mechanism		NA		3540694
REN	5972	RENAL TUBULAR DYSGENESIS	OMIM:267430	marker/mechanism		NA	267430	
REN	5972	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		28415
REN2	19702	Albuminuria	MESH:D000419	marker/mechanism		NA		12586211|27428043
REN2	19702	Cardiomegaly	MESH:D006332	marker/mechanism		NA		12586211|9869009
REN2	19702	Cardiomyopathy, Hypertrophic	MESH:D002312	marker/mechanism		NA		27428043
REN2	19702	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA		27428043
REN2	19702	Hypertension	MESH:D006973	marker/mechanism		NA		12512695|12586211|9595497|9869009
REN2	19702	Hypertension, Malignant	MESH:D006974	marker/mechanism		NA		27428043
REN2	19702	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		9595497
REN2	19702	Inflammation	MESH:D007249	marker/mechanism		NA		12586211
REN2	19702	Nephritis, Interstitial	MESH:D009395	marker/mechanism		NA		27428043
REN2	19702	Weight Loss	MESH:D015431	marker/mechanism		NA		27428043
RENBP	5973	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		12612874
REPS2	9185	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19776672
RERE	473	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
RERE	473	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART	OMIM:616975	marker/mechanism		NA	616975	
REST	5978	DEAFNESS, AUTOSOMAL DOMINANT 27	OMIM:612431	marker/mechanism		NA	612431	
REST	5978	Seizures	MESH:D012640	therapeutic		NA		21905079
REST	5978	Wilms Tumor	MESH:D009396	marker/mechanism		NA		26551668
REST	5978	WILMS TUMOR 6	OMIM:616806	marker/mechanism		NA	616806	
RET	5979	Amyloidosis, Familial	MESH:D028226	marker/mechanism		NA		12864791
RET	5979	Burkitt Lymphoma	MESH:D002051	marker/mechanism		NA		23143597
RET	5979	Carcinoma, Medullary	MESH:D018276	marker/mechanism		NA		7915165
RET	5979	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18507500|21278247
RET	5979	Congenital central hypoventilation syndrome	MESH:C536209	marker/mechanism		NA	209880	12086152|9497256
RET	5979	Familial medullary thyroid carcinoma	MESH:C536911	marker/mechanism		NA	155240	12864791|7915165
RET	5979	Hereditary renal agenesis	MESH:C536482	marker/mechanism		NA		18252215
RET	5979	Hirschsprung Disease	MESH:D006627	marker/mechanism		NA	142623	8114938|8896568
RET	5979	Multiple Endocrine Neoplasia	MESH:D009377	marker/mechanism		NA		17664273
RET	5979	Multiple Endocrine Neoplasia Type 2a	MESH:D018813	marker/mechanism		NA	171400	12864791|7915165|8099202
RET	5979	Multiple Endocrine Neoplasia Type 2b	MESH:D018814	marker/mechanism		NA	162300	
RET	5979	Pheochromocytoma	MESH:D010673	marker/mechanism		NA	171300	12000816
RET	5979	Status Epilepticus	MESH:D013226	marker/mechanism		NA		12914250
RET	5979	Thyroid cancer, medullary	MESH:C536914	marker/mechanism		NA		7915165
RET	5979	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
RET	5979	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		16940797
RETININ	53564	Parkinson Disease	MESH:D010300	marker/mechanism		NA		18353766
RETN	56729	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA	125853	
RETN	56729	Heart Failure	MESH:D006333	marker/mechanism		NA		26670611
RETN	56729	Heroin Dependence	MESH:D006556	marker/mechanism		NA		15717844
RETN	56729	Insulin Resistance	MESH:D007333	marker/mechanism		NA		16493877
RETN	56729	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19539174
RETN	56729	Metabolic Syndrome	MESH:D024821	marker/mechanism		NA		18328350
RETN	56729	Renal Insufficiency, Chronic	MESH:D051436	marker/mechanism		NA		22421264
RETNLA	57262	Asbestosis	MESH:D001195	marker/mechanism		NA		26699812
RETNLA	57262	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		20582166
RETNLA	57262	Silicosis	MESH:D012829	marker/mechanism		NA		15292275
RETREG1	54463	Hereditary Sensory and Autonomic Neuropathies	MESH:D009477	marker/mechanism		NA		19838196
RETREG1	54463	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA	OMIM:201300	marker/mechanism		NA	201300	
RETREG1	54463	Neuropathy, Hereditary Sensory And Autonomic, Type IIB	MESH:C567738	marker/mechanism		NA	613115	
RETSAT	54884	Simpson-Golabi-Behmel syndrome	MESH:C537340	marker/mechanism		NA		19139408
REXO1	57455	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
RFC1	5981	Bilateral Vestibulopathy	MESH:D000071699	marker/mechanism		NA		30926972
RFC1	5981	Cerebellar Ataxia	MESH:D002524	marker/mechanism		NA		30926972
RFC1	5981	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		18926688
RFC1	5981	Hereditary Sensory and Motor Neuropathy	MESH:D015417	marker/mechanism		NA		30926972
RFC1	5981	Osteosarcoma	MESH:D012516	marker/mechanism		NA		19159907
RFC4	5984	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
RFC4	5984	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
RFK	55312	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		21308351
RFLNB	359845	Cholestasis	MESH:D002779	marker/mechanism		NA		27989131
RFNG	5986	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
RFT1	91869	Congenital Disorder Of Glycosylation, Type In	MESH:C567437	marker/mechanism		NA	612015	
RFWD3	55159	Testicular Germ Cell Tumor	MESH:C563236	marker/mechanism		NA		23666239
RFX3	5991	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
RFX3	5991	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
RFX5	5993	Bare lymphocyte syndrome 2	MESH:C537079	marker/mechanism		NA	209920	
RFX6	222546	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
RFX6	222546	Mitchell-Riley Syndrome	MESH:C567570	marker/mechanism		NA	615710	
RFX6	222546	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		24390282
RFX7	64864	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
RFXANK	8625	Bare lymphocyte syndrome 2	MESH:C537079	marker/mechanism		NA	209920	
RFXAP	5994	Bare lymphocyte syndrome 2	MESH:C537079	marker/mechanism		NA	209920	
RGCC	28984	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
RGD1305347	362576	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RGD1307603	293656	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RGD1309104	289084	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RGD1309534	363016	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RGD1561149	500552	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RGD1562339	498107	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RGD1563818	296356	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RGD1564865	498789	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980|25380136
RGD1565959	301230	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
RGD1566227	500042	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RGMB	285704	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		17568789
RGMB	285704	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29662167
RGN	9104	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
RGN	9104	Kidney Diseases	MESH:D007674	marker/mechanism		NA		18805471
RGN	9104	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		25226513
RGN	9104	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980|25380136
RGN	9104	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		11420682
RGR	5995	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA		10581022|16968212
RGR	5995	RETINITIS PIGMENTOSA 44	OMIM:613769	marker/mechanism		NA	613769	
RGS1	5996	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
RGS1	5996	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17374397
RGS1	5996	Osteosarcoma	MESH:D012516	marker/mechanism		NA		14767549
RGS1	5996	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
RGS10	6001	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RGS12	6002	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
RGS17	26575	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
RGS2	5997	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037
RGS2	5997	Hypertension	MESH:D006973	therapeutic		NA		1798635
RGS2	5997	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
RGS2	5997	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RGS2	5997	Parkinson Disease, Secondary	MESH:D010302	marker/mechanism		NA		18347610
RGS2	5997	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
RGS3	5998	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RGS4	5999	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
RGS5	8490	Essential Hypertension	MESH:D000075222	marker/mechanism		NA	145500	
RGS5	8490	Hypertension	MESH:D006973	therapeutic		NA		1798635
RGS5	8490	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RGS7	6000	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
RGS7	6000	Stroke	MESH:D020521	marker/mechanism		NA		29531354
RGS9	8787	Dyskinesia, Drug-Induced	MESH:D004409	marker/mechanism|therapeutic		NA		18160641|24663062
RGS9	8787	Prolonged Electroretinal Response Suppression	MESH:C564243	marker/mechanism		NA	608415	
RGS9	8787	Psychoses, Substance-Induced	MESH:D011605	marker/mechanism		NA		17318883
RGS9	8787	Schizophrenia	MESH:D012559	marker/mechanism		NA		17318883
RGS9BP	388531	Prolonged Electroretinal Response Suppression	MESH:C564243	marker/mechanism		NA	608415	
RHAG	6005	Rh-Null, Regulator Type	MESH:C564833	marker/mechanism		NA	268150	
RHAG	6005	Stomatocytosis I	MESH:C566111	marker/mechanism		NA	185000	
RHBDD3	25807	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
RHBDF2	79651	Keratosis palmoplantaris with esophageal cancer	MESH:C536164	marker/mechanism		NA	148500	
RHCE	6006	Anemia, Hemolytic, Congenital	MESH:D000745	marker/mechanism		NA		9657769
RHD	6007	Anemia, Hemolytic, Congenital	MESH:D000745	marker/mechanism		NA		9657769
RHEB	6009	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		20554106
RHO	6010	Fundus Albipunctatus	MESH:C562733	marker/mechanism		NA	136880	8554077
RHO	6010	Night blindness, congenital stationary	MESH:C536122	marker/mechanism		NA		8358437
RHO	6010	Night Blindness, Congenital Stationary, Autosomal Dominant 1	MESH:C566474	marker/mechanism		NA	610445	
RHO	6010	Retinal Degeneration	MESH:D012162	marker/mechanism		NA		27233447|8692941
RHO	6010	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA		16737970|18273801|19206210|2137202|2215617|28715844|9020854|9391065
RHO	6010	Retinitis Pigmentosa 4	MESH:C566706	marker/mechanism		NA	613731	
RHOA	387	Abnormalities, Drug-Induced	MESH:D000014	marker/mechanism		NA		25783350
RHOA	387	Alopecia	MESH:D000505	marker/mechanism		NA		31570889
RHOA	387	Carcinoma	MESH:D002277	marker/mechanism		NA		24816255
RHOA	387	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		30158054
RHOA	387	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		31570889
RHOA	387	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		25783350
RHOA	387	Ectodermal Dysplasia	MESH:D004476	marker/mechanism		NA		31570889
RHOA	387	Facial ectodermal dysplasia	MESH:C536385	marker/mechanism		NA		31570889
RHOA	387	Hernias, Diaphragmatic, Congenital	MESH:D065630	marker/mechanism		NA		25783350
RHOA	387	Hypopigmentation	MESH:D017496	marker/mechanism		NA		31570889
RHOA	387	Immunoblastic Lymphadenopathy	MESH:D007119	marker/mechanism		NA		24413737|24584070
RHOA	387	Leukoencephalopathies	MESH:D056784	marker/mechanism		NA		31570889
RHOA	387	Lymphoma, T-Cell	MESH:D016399	marker/mechanism		NA		24584070
RHOA	387	Lymphoma, T-Cell, Cutaneous	MESH:D016410	marker/mechanism		NA		26192916
RHOA	387	Lymphoma, T-Cell, Peripheral	MESH:D016411	marker/mechanism		NA		24413734|24413737
RHOA	387	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		19896475
RHOA	387	Neurocutaneous Syndromes	MESH:D020752	marker/mechanism		NA		31570889
RHOA	387	Proteinuria	MESH:D011507	marker/mechanism		NA		19955829
RHOA	387	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		15448013|24816253|24816255
RHOA	387	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		30158054
RHOA	387	Tooth Diseases	MESH:D014076	marker/mechanism		NA		31570889
RHOA	387	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		19896475
RHOB	388	Scleroderma, Systemic	MESH:D012595	marker/mechanism		NA		21750679
RHOBTB1	9886	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
RHOBTB2	23221	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		20864405
RHOC	389	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
RHOC	389	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		18230616
RHOJ	57381	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		21037199
RHOJ	57381	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
RHOQ	23433	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RHOX3H	434758	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		25926378
RHPN1	114822	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
RHPN2	85415	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		19011631
RIBC2	26150	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21466612
RIC8A	60626	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
RIMS1	22999	Autistic Disorder	MESH:D001321	marker/mechanism		NA		25961944
RIMS1	22999	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		31043756
RIMS1	22999	Cone-Rod Dystrophy 7	MESH:C566350	marker/mechanism		NA	603649	
RIMS1	22999	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
RIMS2	9699	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941189
RIN1	9610	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
RIN2	54453	Macrocephaly, Alopecia, Cutis Laxa, and Scoliosis	MESH:C567770	marker/mechanism		NA	613075	
RIN3	79890	Osteitis Deformans	MESH:D010001	marker/mechanism		NA		21623375
RIOX2	84864	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		15897898
RIPK2	8767	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		20452301
RIPK3	11035	Calcinosis	MESH:D002114	marker/mechanism		NA		21335463
RIPK3	11035	Chemical and Drug Induced Liver Injury	MESH:D056486	therapeutic		NA		26769846
RIPK3	11035	Fatty Liver	MESH:D005234	therapeutic		NA		26769846
RIPK3	11035	Heart Valve Diseases	MESH:D006349	marker/mechanism		NA		21335463
RIPK4	54101	Popliteal Pterygium Syndrome, Lethal Type	MESH:C564874	marker/mechanism		NA	263650	
RIPOR2	9750	DEAFNESS, AUTOSOMAL RECESSIVE 104	OMIM:616515	marker/mechanism		NA	616515	
RIPPLY2	134701	Spondylocostal dysostosis, autosomal recessive	MESH:C535781	marker/mechanism		NA	616566	
RIT1	6016	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RIT1	6016	NOONAN SYNDROME 8	OMIM:615355	marker/mechanism		NA	615355	
RLBP1	6017	Bothnia Retinal Dystrophy	MESH:C564392	marker/mechanism		NA	607475	
RLBP1	6017	Eye Diseases, Hereditary	MESH:D015785	marker/mechanism		NA		16968212
RLBP1	6017	Fundus Albipunctatus	MESH:C562733	marker/mechanism		NA	136880	
RLBP1	6017	Macular Degeneration	MESH:D008268	marker/mechanism		NA		30742112
RLBP1	6017	Newfoundland Rod-Cone Dystrophy	MESH:C564391	marker/mechanism		NA	607476	
RLIM	51132	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		19208208
RLIM	51132	TONNE-KALSCHEUER SYNDROME	OMIM:300978	marker/mechanism		NA	300978	
RLN1	6013	Hypertrophy	MESH:D006984	marker/mechanism		NA		22028442
RLN2	6019	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16434975
RLN3	117579	Hyperplasia	MESH:D006965	therapeutic		NA		16112403
RLN3	117579	Myocardial Ischemia	MESH:D017202	therapeutic		NA		16112403
RMDN2	151393	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RMND1	55005	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
RMND1	55005	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11	OMIM:614922	marker/mechanism		NA	614922	
RMND5B	64777	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RMRP	6023	Anauxetic dysplasia	MESH:C538256	marker/mechanism		NA	607095	
RMRP	6023	Cartilage-hair hypoplasia	MESH:C535916	marker/mechanism		NA	250250	
RMRP	6023	Metaphyseal Dysplasia without Hypotrichosis	MESH:C563574	marker/mechanism		NA	250460	
RMST	196475	Obesity	MESH:D009765	marker/mechanism		NA		23563609
RN7SKP114	106480868	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
RNASE3	6037	Asthma	MESH:D001249	marker/mechanism		NA		12153692|12587966|8874658
RNASE3	6037	Gram-Negative Bacterial Infections	MESH:D016905	therapeutic		NA		21696142
RNASE3	6037	Gram-Positive Bacterial Infections	MESH:D016908	therapeutic		NA		21696142
RNASE4	6038	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
RNASE4	6038	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
RNASE6	6039	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
RNASE6	6039	Neurotoxicity Syndromes	MESH:D020258	marker/mechanism		NA		19784758
RNASEH1	246243	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2	OMIM:616479	marker/mechanism		NA	616479	
RNASEH2A	10535	Aicardi-Goutieres Syndrome 4	MESH:C563681	marker/mechanism		NA	610333	
RNASEH2B	79621	Aicardi-Goutieres syndrome	MESH:C535607	marker/mechanism		NA	610181	
RNASEH2C	84153	Aicardi-Goutieres Syndrome 3	MESH:C563683	marker/mechanism		NA	610329	
RNASEL	6041	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RNASEL	6041	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA	601518	
RNASEL	6041	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16114055|17020975|27318894
RNASET2	8635	Brain Diseases	MESH:D001927	marker/mechanism		NA		19525954
RNASET2	8635	Graves Disease	MESH:D006111	marker/mechanism		NA		21841780
RNASET2	8635	Leukoencephalopathy, Cystic, Without Megalencephaly	MESH:C567845	marker/mechanism		NA	612951	
RNASET2	8635	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		28604730
RND3	390	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
RNF103	7844	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
RNF113A	7737	TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	OMIM:300953	marker/mechanism		NA	300953	
RNF114	55905	Psoriasis	MESH:D011565	marker/mechanism		NA		20953190
RNF115	27246	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25751625
RNF125	54941	TENORIO SYNDROME	OMIM:616260	marker/mechanism		NA	616260	
RNF130	55819	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
RNF135	84282	Growth Disorders	MESH:D006130	marker/mechanism		NA		17632510
RNF135	84282	NF1 Microdeletion Syndrome	MESH:C563524	marker/mechanism		NA		17632510
RNF139	11236	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA	144700	
RNF144B	255488	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		29724995
RNF157	114804	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
RNF168	165918	Riddle Syndrome	MESH:C567453	marker/mechanism		NA	611943	
RNF170	81790	ATAXIA, SENSORY, 1, AUTOSOMAL DOMINANT	OMIM:608984	marker/mechanism		NA	608984	
RNF182	221687	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18507500
RNF182	221687	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18507500
RNF207	388591	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		26213588
RNF213	57674	Moyamoya disease 2	MESH:C536992	marker/mechanism		NA	607151	
RNF216	54476	Cerebellar Ataxia and Hypogonadotropic Hypogonadism	MESH:C565870	marker/mechanism		NA	212840	
RNF31	55072	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
RNF34	80196	Colonic Neoplasms	MESH:D003110	therapeutic		NA		16270526
RNF39	80352	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RNF43	54894	Cholangiocarcinoma	MESH:D018281	marker/mechanism		NA		22561520
RNF43	54894	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		25344691
RNF43	54894	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		25344691
RNF43	54894	Liver Diseases, Parasitic	MESH:D008109	marker/mechanism		NA		22561520
RNF43	54894	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
RNF43	54894	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
RNF43	54894	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		24816253
RNF6	6049	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28869590
RNF6	6049	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA	133239	
RNF8	9025	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18621663
RNLS	55328	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
RNPEP	6051	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16619500
RNR1	4549	Deafness	MESH:D003638	marker/mechanism		NA		12031626|12037390|15722487|9391883
RNR1	4549	Deafness, Sensorineural, Autosomal-Mitochondrial Type	MESH:C565637	marker/mechanism		NA	500008	
RNR1	4549	Muscular Diseases	MESH:D009135	marker/mechanism		NA		12031626
RNR1	4549	Tinnitus	MESH:D014012	marker/mechanism		NA		15141753
RNU4ATAC	100151683	Microcephalic osteodysplastic primordial dwarfism, type 1	MESH:C537577	marker/mechanism		NA	210710	26522830
RNU4ATAC	100151683	Roifman syndrome	MESH:C535866	marker/mechanism		NA	616651	26522830
RNU6-148P	106479631	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
RNU6-456P	106481323	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
RNU6-491P	106479784	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
ROBO1	6091	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		17671114
ROBO1	6091	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18270976
ROBO1	6091	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
ROBO1	6091	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17671114
ROBO1	6091	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29662167
ROBO2	6092	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18270976
ROBO2	6092	Cholangiocarcinoma	MESH:D018281	marker/mechanism		NA		22561520
ROBO2	6092	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ROBO2	6092	Liver Diseases, Parasitic	MESH:D008109	marker/mechanism		NA		22561520
ROBO2	6092	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29662167
ROBO2	6092	Vesicoureteral Reflux 2	MESH:C567053	marker/mechanism		NA	610878	
ROBO3	64221	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18270976
ROBO3	64221	Gaze Palsy, Familial Horizontal, with Progressive Scoliosis	MESH:C564593	marker/mechanism		NA	607313	
ROBO4	54538	Aortic Aneurysm, Thoracic	MESH:D017545	marker/mechanism		NA		30455415
ROBO4	54538	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18270976
ROBO4	54538	Bicuspid Aortic Valve	MESH:C562388	marker/mechanism		NA		30455415
ROCK1	6093	Prenatal Injuries	MESH:D049188	marker/mechanism		NA		18956198
ROCK2	9475	Cardiomegaly	MESH:D006332	marker/mechanism		NA		29394407
ROCK2	9475	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		29394407
ROCK2	9475	Heart Failure	MESH:D006333	marker/mechanism		NA		29394407
ROCK2	9475	Prenatal Injuries	MESH:D049188	marker/mechanism		NA		18956198
ROCK2	9475	Ventricular Remodeling	MESH:D020257	marker/mechanism		NA		29394407
ROGDI	79641	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		31209396
ROGDI	79641	Kohlschutter Tonz syndrome	MESH:C537213	marker/mechanism		NA	226750	
ROM1	6094	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA	268000	
ROM1	6094	Retinitis Pigmentosa 7	MESH:C564284	marker/mechanism		NA	608133	
ROR1	4919	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		28114269
ROR1	4919	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		28114269
ROR2	4920	Brachydactyly, Type B1	MESH:C566196	marker/mechanism		NA	113000	12815588
ROR2	4920	Robinow syndrome, autosomal recessive	MESH:C535863	marker/mechanism		NA	268310	12815588|15952209
RORA	6095	Autistic Disorder	MESH:D001321	marker/mechanism		NA		20375269|21359227
RORA	6095	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
RORB	6096	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
RORC	6097	IMMUNODEFICIENCY 42	OMIM:616622	marker/mechanism		NA	616622	
RORC	6097	Inflammation	MESH:D007249	marker/mechanism		NA		22325453
RORC	6097	Sleep Disorders, Circadian Rhythm	MESH:D020178	marker/mechanism		NA		25395965
ROS1	6098	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		22215748
ROS1	6098	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		22215748|22585869|22617245|22919003
ROS1	6098	Glioma	MESH:D005910	marker/mechanism		NA		19276365
ROS1	6098	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
RP1	6101	Retinitis pigmentosa 1	MESH:C538365	marker/mechanism		NA	180100	
RP1L1	94137	OCCULT MACULAR DYSTROPHY	OMIM:613587	marker/mechanism		NA	613587	
RP2	6102	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
RP2	6102	Retinitis Pigmentosa 2	MESH:C567523	marker/mechanism		NA	312600	
RP9	6100	Retinitis Pigmentosa 9	MESH:C566716	marker/mechanism		NA	180104	
RPA1	6117	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
RPE65	6121	Amaurosis congenita of Leber, type 2	MESH:C536601	marker/mechanism		NA	204100	
RPE65	6121	Blindness	MESH:D001766	marker/mechanism|therapeutic		NA		16150724|16226919
RPE65	6121	Eye Diseases, Hereditary	MESH:D015785	therapeutic		NA		16968212
RPE65	6121	Leber Congenital Amaurosis	MESH:D057130	marker/mechanism		NA		19339306|9326927|9501220
RPE65	6121	Optic Atrophy, Hereditary, Leber	MESH:D029242	marker/mechanism		NA		16828753|17011878
RPE65	6121	Retinal Degeneration	MESH:D012162	marker/mechanism		NA		24849605
RPE65	6121	Retinal Dystrophies	MESH:D058499	marker/mechanism		NA		9326941
RPE65	6121	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA		16272259|16968212|9501220
RPE65	6121	Retinitis Pigmentosa 20	MESH:C566718	marker/mechanism		NA	613794	
RPGR	6103	CONE-ROD DYSTROPHY, X-LINKED, 1	OMIM:304020	marker/mechanism		NA	304020	
RPGR	6103	Hearing Loss	MESH:D034381	marker/mechanism		NA		12920075
RPGR	6103	Macular Degeneration	MESH:D008268	marker/mechanism		NA		12160730
RPGR	6103	MACULAR DEGENERATION, X-LINKED ATROPHIC	OMIM:300834	marker/mechanism		NA	300834	
RPGR	6103	Respiratory Tract Infections	MESH:D012141	marker/mechanism		NA		12920075
RPGR	6103	Retinal Degeneration	MESH:D012162	marker/mechanism		NA		19430481
RPGR	6103	Retinal Dystrophies	MESH:D058499	marker/mechanism		NA		11857109
RPGR	6103	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA		10094550|12920075|17480003
RPGR	6103	Retinitis Pigmentosa 3	MESH:C564520	marker/mechanism		NA	300029	
RPGR	6103	Retinitis Pigmentosa, X-Linked, And Sinorespiratory Infections, With Or Without Deafness	MESH:C567595	marker/mechanism		NA	300455	
RPGRIP1	57096	Cone-Rod Dystrophy 13	MESH:C567698	marker/mechanism		NA	608194	
RPGRIP1	57096	Leber Congenital Amaurosis	MESH:D057130	marker/mechanism		NA		11283794|11528500
RPGRIP1	57096	Leber Congenital Amaurosis 6	MESH:C565327	marker/mechanism		NA	613826	
RPGRIP1	57096	Nystagmus, Pathologic	MESH:D009759	marker/mechanism		NA		11283794
RPGRIP1	57096	Retinal Dystrophies	MESH:D058499	marker/mechanism		NA		12920076
RPGRIP1	57096	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA		16272259
RPGRIP1L	23322	Cerebellar Diseases	MESH:D002526	marker/mechanism		NA		17558407|17558409
RPGRIP1L	23322	Ciliary Motility Disorders	MESH:D002925	marker/mechanism		NA		17558407|17558409
RPGRIP1L	23322	COACH syndrome	MESH:C536430	marker/mechanism		NA	216360	
RPGRIP1L	23322	Eye Diseases	MESH:D005128	marker/mechanism		NA		17558407|17558409
RPGRIP1L	23322	Joubert Syndrome 7	MESH:C566916	marker/mechanism		NA	611560	
RPGRIP1L	23322	Kidney Diseases	MESH:D007674	marker/mechanism		NA		17558407|17558409
RPGRIP1L	23322	Meckel Syndrome, Type 5	MESH:C566915	marker/mechanism		NA	611561	
RPGRIP1L	23322	Retinal Degeneration	MESH:D012162	marker/mechanism		NA		19430481
RPH3AL	9501	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
RPIA	22934	Ribose 5-Phosphate Isomerase Deficiency	MESH:C563212	marker/mechanism		NA	608611	
RPL10	6134	Autistic Disorder	MESH:D001321	marker/mechanism		NA	300847	16940977
RPL10	6134	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054218	marker/mechanism		NA		23263491
RPL10	6134	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
RPL10A	4736	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
RPL10A	4736	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
RPL11	6135	Diamond-Blackfan Anemia 7	MESH:C567254	marker/mechanism		NA	612562	
RPL11	6135	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29662167
RPL12	6136	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
RPL13	6137	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
RPL13	6137	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
RPL13A	23521	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
RPL13A	23521	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
RPL14	9045	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		23797736
RPL14	9045	Parkinson Disease	MESH:D010300	marker/mechanism		NA		18353766
RPL15	6138	DIAMOND-BLACKFAN ANEMIA 12	OMIM:615550	marker/mechanism		NA	615550	
RPL15	6138	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
RPL15	6138	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
RPL17	6139	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
RPL18	6141	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
RPL18	6141	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
RPL21	6144	Hypotrichosis	MESH:D007039	marker/mechanism		NA	615885	
RPL23A	6147	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21466612
RPL23A	6147	Parkinson Disease	MESH:D010300	marker/mechanism		NA		18353766
RPL24	6152	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
RPL26	6154	DIAMOND-BLACKFAN ANEMIA 11	OMIM:614900	marker/mechanism		NA	614900	
RPL27	6155	DIAMOND-BLACKFAN ANEMIA 16	OMIM:617408	marker/mechanism		NA	617408	
RPL27A	6157	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
RPL27A	6157	Cerebellar Ataxia	MESH:D002524	marker/mechanism		NA		21674502
RPL27A	6157	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
RPL27A	6157	Hyperpigmentation	MESH:D017495	marker/mechanism		NA		21674502
RPL27A	6157	Pancytopenia	MESH:D010198	marker/mechanism		NA		21674502
RPL28	6158	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
RPL3	6122	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
RPL3	6122	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
RPL3	6122	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
RPL31	6160	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21466612
RPL35A	6165	Diamond-Blackfan Anemia 5	MESH:C567280	marker/mechanism		NA	612528	
RPL36A	6173	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
RPL36A	6173	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
RPL37A	6168	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
RPL3L	6123	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
RPL3L	6123	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		26213588
RPL4	6124	Sepsis	MESH:D018805	marker/mechanism		NA		27978524
RPL5	6125	DIAMOND-BLACKFAN ANEMIA 6	OMIM:612561	marker/mechanism		NA	612561	
RPL5	6125	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
RPL5	6125	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054218	marker/mechanism		NA		23263491
RPL6	6128	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
RPL6	6128	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
RPL6	6128	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
RPL6	6128	Parkinson Disease	MESH:D010300	marker/mechanism		NA		18353766
RPL9	6133	Sepsis	MESH:D018805	marker/mechanism		NA		27978524
RPLP2	6181	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
RPN2	6185	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
RPP38	10557	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
RPRD2	23248	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
RPRM	56475	Barrett Esophagus	MESH:D001471	marker/mechanism		NA		17121882
RPRM	56475	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		17121882
RPS10	6204	Diamond-Blackfan Anemia 9	MESH:C567650	marker/mechanism		NA	613308	
RPS14	6208	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
RPS14	6208	Chromosome 5q Deletion Syndrome	MESH:C535323	marker/mechanism		NA	153550	
RPS14	6208	Hypoxia	MESH:D000860	marker/mechanism		NA		18258771
RPS14	6208	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
RPS14	6208	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
RPS14	6208	Neutropenia	MESH:D009503	marker/mechanism		NA		27725143
RPS15	6209	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
RPS15	6209	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
RPS17	6218	Anemia, Diamond-Blackfan	MESH:D029503	marker/mechanism		NA		17647292
RPS17	6218	Diamond-Blackfan Anemia 4	MESH:C567281	marker/mechanism		NA	612527	
RPS19	6223	Anemia, Diamond-Blackfan	MESH:D029503	marker/mechanism		NA	105650	
RPS19	6223	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
RPS19	6223	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
RPS19	6223	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
RPS2	6187	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
RPS2	6187	Hypoxia	MESH:D000860	marker/mechanism		NA		18258771
RPS21	6227	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
RPS21	6227	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
RPS23	6228	BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY	OMIM:617412	marker/mechanism		NA	617412	
RPS24	6229	Anemia, Diamond-Blackfan, 3	MESH:C536355	marker/mechanism		NA	610629	
RPS26	6231	Diamond-Blackfan Anemia 10	MESH:C567649	marker/mechanism		NA	613309	
RPS26	6231	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
RPS26	6231	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
RPS27	6232	DIAMOND-BLACKFAN ANEMIA 17	OMIM:617409	marker/mechanism		NA	617409	
RPS28	6234	DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS	OMIM:606164	marker/mechanism		NA	606164	
RPS28	6234	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
RPS29	6235	DIAMOND-BLACKFAN ANEMIA 13	OMIM:615909	marker/mechanism		NA	615909	
RPS3	6188	Chromosomal Instability	MESH:D043171	marker/mechanism		NA		25341047
RPS3	6188	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
RPS4X	6191	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21466612
RPS4Y2	140032	Spermatogenic Failure, Nonobstructive, Y-Linked	MESH:C564030	marker/mechanism		NA	415000	
RPS6	6194	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20197467
RPS6	6194	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21147110
RPS6	6194	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
RPS6	6194	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
RPS6KA1	6195	Fetal Alcohol Spectrum Disorders	MESH:D063647	marker/mechanism		NA		29109170
RPS6KA1	6195	Sezary Syndrome	MESH:D012751	marker/mechanism		NA		26551670
RPS6KA2	6196	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		31043756
RPS6KA3	6197	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		8955270
RPS6KA3	6197	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		22561517
RPS6KA3	6197	Coffin-Lowry Syndrome	MESH:D038921	marker/mechanism		NA	303600	21488662|8955270
RPS6KA3	6197	MENTAL RETARDATION, X-LINKED 19	OMIM:300844	marker/mechanism		NA	300844	
RPS6KA3	6197	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		21488662
RPS6KA3	6197	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		21488662
RPS6KA3	6197	Psychomotor Disorders	MESH:D011596	marker/mechanism		NA		8955270
RPS6KA5	9252	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		16339038
RPS6KB1	6198	Atrophy	MESH:D001284	marker/mechanism		NA		16391472
RPS6KB1	6198	Ceroid lipofuscinosis, neuronal 1, infantile	MESH:C537948	marker/mechanism		NA		21224254
RPS6KB1	6198	Hypertension	MESH:D006973	marker/mechanism		NA		19289642
RPS6KB1	6198	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		19289642
RPS6KB1	6198	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		19223503
RPS6KB2	6199	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20953835
RPS7	6201	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21466612
RPS7	6201	Diamond-Blackfan Anemia 8	MESH:C567253	marker/mechanism		NA	612563	
RPS8	6202	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21466612
RPS8	6202	Parkinson Disease	MESH:D010300	marker/mechanism		NA		18353766
RPS8	6202	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
RPSA	3921	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
RPSA	3921	ASPLENIA, ISOLATED CONGENITAL	OMIM:271400	marker/mechanism		NA	271400	
RPSA	3921	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
RPSA	3921	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		15048980
RPTOR	57521	Tobacco Use Disorder	MESH:D014029	marker/mechanism		NA		18438686
RRAD	6236	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17195088
RRAD	6236	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		17195088
RRAD	6236	Cardiomegaly	MESH:D006332	marker/mechanism		NA		18056528
RRAGC	64121	Lymphoma, Follicular	MESH:D008224	marker/mechanism		NA		26691987
RRAS	6237	Leukemia, Myelomonocytic, Juvenile	MESH:D054429	marker/mechanism		NA		26457647
RRAS	6237	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
RRAS2	22800	Leukemia, Myelomonocytic, Juvenile	MESH:D054429	marker/mechanism		NA		26457647
RRAS2	22800	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21147764
RRM1	6240	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
RRM1	6240	Adrenocortical Carcinoma	MESH:D018268	marker/mechanism		NA		22547773
RRM1	6240	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		18230555
RRM1	6240	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		21496433
RRM1	6240	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
RRM1	6240	Disease Progression	MESH:D018450	marker/mechanism		NA		21496433
RRM1	6240	Neural Tube Defects	MESH:D009436	marker/mechanism		NA		10716750
RRM2	6241	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
RRM2	6241	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		18230555|28284560
RRM2	6241	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		15814641
RRM2	6241	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
RRM2	6241	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
RRM2B	50484	Acidosis, Lactic	MESH:D000140	marker/mechanism		NA		19138848
RRM2B	50484	Kidney Diseases	MESH:D007674	marker/mechanism		NA		19138848
RRM2B	50484	MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	OMIM:612075	marker/mechanism		NA	612075	
RRM2B	50484	Mitochondrial Myopathies	MESH:D017240	marker/mechanism		NA		17486094|19138848
RRM2B	50484	Muscle Hypotonia	MESH:D009123	marker/mechanism		NA		19138848
RRM2B	50484	Progressive External Ophthalmoplegia With Mitochondrial Dna Deletions, Autosomal Dominant, 5	MESH:C567768	marker/mechanism		NA	613077	
RRM2B	50484	Visceral myopathy familial external ophthalmoplegia	MESH:C536350	marker/mechanism		NA		19667227
RRP9	9136	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
RRP9	9136	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
RRS1	23212	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
RRS1	23212	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
RS1	6247	Retinoschisis	MESH:D041441	marker/mechanism		NA	312700	16088326|21738583
RSAD2	91543	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
RSAD2	91543	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
RSPH1	89765	CILIARY DYSKINESIA, PRIMARY, 24	OMIM:615481	marker/mechanism		NA	615481	
RSPH3	83861	CILIARY DYSKINESIA, PRIMARY, 32	OMIM:616481	marker/mechanism		NA	616481	
RSPH4A	345895	Ciliary Dyskinesia, Primary, 11	MESH:C567212	marker/mechanism		NA	612649	
RSPH9	221421	Ciliary Dyskinesia, Primary, 12	MESH:C567211	marker/mechanism		NA	612650	
RSPO1	284654	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		25581431
RSPO1	284654	Palmoplantar Hyperkeratosis with Squamous Cell Carcinoma of Skin and Sex Reversal	MESH:C565693	marker/mechanism		NA	610644	
RSPO3	84870	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17468756
RSPO3	84870	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
RSPO4	343637	Anonychia congenita	MESH:C536377	marker/mechanism		NA	206800	
RSRP1	57035	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RSU1	6251	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
RSU1	6251	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
RT1-BA	309621	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RT1-CE5	309607	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RT1-DA	294269	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RT1-DB1	294270	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RT1-DMA	294274	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RT1-DMB	294273	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RT1-DOA	24984	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
RT1-M3-1	24747	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RT1-N3	24750	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
RTBDN	83546	Ependymoma	MESH:D004806	marker/mechanism		NA		26075792
RTEL1	51750	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5	OMIM:615190	marker/mechanism		NA	615190	
RTEL1	51750	Glioma	MESH:D005910	marker/mechanism		NA		19578366|19578367
RTEL1	51750	Idiopathic Pulmonary Fibrosis	MESH:D054990	marker/mechanism		NA		25848748
RTEL1	51750	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		28604730
RTEL1	51750	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 3	OMIM:616373	marker/mechanism		NA	616373	
RTL6	84247	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
RTN1	6252	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
RTN2	6253	Spastic paraplegia 12, autosomal dominant	MESH:C537484	marker/mechanism		NA	604805	
RTN4	57142	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RTN4	57142	Schizophrenia	MESH:D012559	marker/mechanism		NA		20071518
RTN4IP1	84816	OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	OMIM:616732	marker/mechanism		NA	616732	
RTN4R	65078	Schizophrenia	MESH:D012559	marker/mechanism		NA	181500	
RTNL1	33721	Parkinson Disease	MESH:D010300	marker/mechanism		NA		18353766
RTP3	83597	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		17693185
RTP3	83597	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
RTP3	83597	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		17693185
RTP4	64108	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
RTTN	25914	MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES	OMIM:614833	marker/mechanism		NA	614833	
RUBCN	9711	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA	615705	
RUFY3	22902	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
RUFY3	22902	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
RUNX1	861	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		23143596
RUNX1	861	Glioblastoma	MESH:D005909	marker/mechanism		NA		23582323
RUNX1	861	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA	601626	18206229|27798625|30420649
RUNX1	861	Leukemia, Myelomonocytic, Juvenile	MESH:D054429	marker/mechanism		NA		26457647
RUNX1	861	Myelodysplastic Syndromes	MESH:D009190	marker/mechanism		NA		27992414
RUNX1	861	Platelet Disorder, Familial, with Associated Myeloid Malignancy	MESH:C563324	marker/mechanism		NA	601399	
RUNX1	861	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D015452	marker/mechanism		NA		15217836|24413735
RUNX1	861	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		17255265
RUNX1	861	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17909013
RUNX1T1	862	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		18206229|27798625
RUNX1T1	862	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941189
RUNX2	860	Arthritis, Psoriatic	MESH:D015535	marker/mechanism		NA		20008919
RUNX2	860	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		20008919
RUNX2	860	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		32198086
RUNX2	860	Cleidocranial Dysplasia	MESH:D002973	marker/mechanism		NA	119600	14688224|17022082|20357738
RUNX2	860	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		30158054
RUNX2	860	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		14688224
RUNX2	860	Metaphyseal Dysplasia with Maxillary Hypoplasia and Brachydactyly	MESH:C563586	marker/mechanism		NA	156510	
RUNX2	860	Osteoarthritis	MESH:D010003	marker/mechanism		NA		20008919
RUNX2	860	Osteoarthritis, Hip	MESH:D015207	marker/mechanism		NA		30374069
RUNX2	860	Osteosarcoma	MESH:D012516	marker/mechanism		NA		24646477|25307878
RUNX2	860	Spondylarthritis	MESH:D025241	marker/mechanism		NA		20008919
RUNX2	860	Stomatognathic System Abnormalities	MESH:D018640	marker/mechanism		NA		20357738
RUNX2	860	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		30158054
RUNX2	860	Tooth Abnormalities	MESH:D014071	marker/mechanism		NA		14688224
RUNX2	860	Uremia	MESH:D014511	marker/mechanism		NA		19092814
RUNX3	864	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		21552421
RUNX3	864	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28458013
RUNX3	864	Celiac Disease	MESH:D002446	marker/mechanism		NA		20190752
RUNX3	864	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		18058463
RUNX3	864	Gastro-enteropancreatic neuroendocrine tumor	MESH:C535650	marker/mechanism		NA		29915428
RUNX3	864	Glioblastoma	MESH:D005909	marker/mechanism		NA		16909125
RUNX3	864	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		18206229
RUNX3	864	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		21552421
RUNX3	864	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
RUNX3	864	Psoriasis	MESH:D011565	marker/mechanism		NA		23143594
RUNX3	864	Spondylitis, Ankylosing	MESH:D013167	marker/mechanism		NA		21743469
RUNX3	864	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
RUP2	619560	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		28885000
RUP2	619560	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		28885000
RX3	30474	Adrenal Insufficiency	MESH:D000309	marker/mechanism		NA		27941970
RX3	30474	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27941970
RX3	30474	Eye Abnormalities	MESH:D005124	marker/mechanism		NA		27941970
RXFP1	59350	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
RXRA	6256	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
RXRA	6256	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
RXRA	6256	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		15318950
RXRA	6256	Sciatic Neuropathy	MESH:D020426	marker/mechanism		NA		16782282
RXRA	6256	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		23811263
RXRB	6257	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		22322885
RXRB	6257	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
RXRB	6257	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
RXRG	6258	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
RXYLT1	10329	Walker-Warburg Syndrome	MESH:D058494	marker/mechanism		NA	615041	
RYK	6259	Cleft Palate	MESH:D002972	marker/mechanism		NA		10932185
RYK	6259	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		10932185
RYK	6259	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
RYR1	6261	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		22138691
RYR1	6261	Malignant Hyperthermia	MESH:D008305	marker/mechanism		NA		11695996|14570802|14708096|16917943|17707769|19191329|19191333|21485675|30329129
RYR1	6261	Malignant hyperthermia susceptibility type 1	MESH:C535694	marker/mechanism		NA	145600	
RYR1	6261	Minicore Myopathy with External Ophthalmoplegia	MESH:C564969	marker/mechanism		NA	255320	
RYR1	6261	Myopathies, Structural, Congenital	MESH:D020914	marker/mechanism		NA	255310	17376685
RYR1	6261	Myopathy, Central Core	MESH:D020512	marker/mechanism		NA	117000	14570802|14708096|16917943
RYR2	6262	Arrhythmogenic Right Ventricular Dysplasia, Familial, 2	MESH:C563409	marker/mechanism		NA	600996	
RYR2	6262	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		21151189
RYR2	6262	Death, Sudden, Cardiac	MESH:D016757	marker/mechanism		NA		31913406
RYR2	6262	Diabetic Cardiomyopathies	MESH:D058065	marker/mechanism		NA		16685413
RYR2	6262	Familial Sudden Death	MESH:C566172	marker/mechanism		NA		31913406
RYR2	6262	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		26928227
RYR2	6262	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
RYR2	6262	Polymorphic catecholergic ventricular tachycardia	MESH:C536334	marker/mechanism		NA		20080988|20513597
RYR2	6262	Tachycardia	MESH:D013610	marker/mechanism		NA		15749201
RYR2	6262	Tachycardia, Ventricular	MESH:D017180	marker/mechanism		NA		18052993|20944434
RYR2	6262	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY	OMIM:604772	marker/mechanism		NA	604772	
S100A1	6271	Vasospasm, Intracranial	MESH:D020301	marker/mechanism		NA		12186470
S100A10	6281	Depressive Disorder	MESH:D003866	marker/mechanism		NA		21682946
S100A10	6281	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		21682946
S100A10	6281	Keloid	MESH:D007627	marker/mechanism		NA		20128793
S100A10	6281	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
S100A10	6281	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
S100A10	6281	Medulloblastoma	MESH:D008527	marker/mechanism		NA		17579622
S100A11	6282	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
S100A11	6282	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
S100A11	6282	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		20388789
S100A12	6283	Mouth Diseases	MESH:D009059	marker/mechanism		NA		17682004
S100A4	6275	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		21685359
S100A4	6275	Ischemia	MESH:D007511	marker/mechanism		NA		19458120
S100A4	6275	Keloid	MESH:D007627	marker/mechanism		NA		20128793
S100A4	6275	Medulloblastoma	MESH:D008527	marker/mechanism		NA		17579622
S100A4	6275	Melanoma	MESH:D008545	marker/mechanism		NA		29179997
S100A4	6275	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		15048980
S100A4	6275	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		21636539|21685359
S100A4	6275	Nephrosclerosis	MESH:D009400	marker/mechanism		NA		30818366
S100A4	6275	Osteoarthritis	MESH:D010003	marker/mechanism		NA		16948116
S100A4	6275	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
S100A4	6275	Vasospasm, Intracranial	MESH:D020301	marker/mechanism		NA		12186470
S100A5	6276	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		25257527
S100A6	6277	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
S100A6	6277	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		16123366
S100A6	6277	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		16123366
S100A6	6277	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
S100A6	6277	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
S100A6	6277	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
S100A6	6277	Medulloblastoma	MESH:D008527	marker/mechanism		NA		17579622
S100A6	6277	Vasospasm, Intracranial	MESH:D020301	marker/mechanism		NA		12186470
S100A7	6278	Psoriasis	MESH:D011565	marker/mechanism		NA		18194266
S100A7A	338324	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
S100A8	6279	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		18336422
S100A8	6279	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
S100A8	6279	Keloid	MESH:D007627	marker/mechanism		NA		20128793
S100A8	6279	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		21971985
S100A8	6279	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		22248470
S100A9	6280	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
S100A9	6280	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
S100A9	6280	Keloid	MESH:D007627	marker/mechanism		NA		20128793
S100A9	6280	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
S100A9	6280	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
S100B	6285	Attention Deficit and Disruptive Behavior Disorders	MESH:D019958	marker/mechanism		NA		25451971
S100B	6285	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		15581912|16476148
S100B	6285	Brain Edema	MESH:D001929	marker/mechanism		NA		19027832
S100B	6285	Brain Injuries	MESH:D001930	marker/mechanism|therapeutic		NA		11520488|21783483
S100B	6285	Brain Injuries, Diffuse	MESH:D000070625	marker/mechanism		NA		30076900
S100B	6285	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		27935819
S100B	6285	Cerebral Hemorrhage	MESH:D002543	marker/mechanism		NA		19027832
S100B	6285	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		12888777
S100B	6285	Down Syndrome	MESH:D004314	marker/mechanism		NA		12888777
S100B	6285	Hematoma	MESH:D006406	marker/mechanism		NA		19027832
S100B	6285	Mercury Poisoning, Nervous System	MESH:D020262	marker/mechanism		NA		30076900
S100B	6285	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		9788975
S100B	6285	Vasospasm, Intracranial	MESH:D020301	marker/mechanism		NA		12186470
S100P	6286	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
S1PR1	1901	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
S1PR1	1901	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
S1PR1	1901	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
S1PR1	1901	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
S1PR1	1901	Neointima	MESH:D058426	marker/mechanism		NA		29609002
S1PR1	1901	Vascular System Injuries	MESH:D057772	marker/mechanism		NA		29609002
S1PR2	9294	Deafness, Autosomal Recessive 68	MESH:C563669	marker/mechanism		NA	610419	
S1PR2	9294	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		22406263
S1PR2	9294	Heart Diseases	MESH:D006331	marker/mechanism		NA		16844662
S1PR2	9294	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		26518876
S1PR4	8698	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		22406263
S1PR5	53637	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		22406263
S1PR5	53637	Scleroderma, Systemic	MESH:D012595	marker/mechanism		NA		29033951
SAA1	6288	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		15944321
SAA1	6288	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		15944321
SAC3D1	29901	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
SACS	26278	Myoclonic Epilepsies, Progressive	MESH:D020191	marker/mechanism		NA		25401298
SACS	26278	Spastic ataxia Charlevoix-Saguenay type	MESH:C536787	marker/mechanism		NA	270550	
SAG	6295	Night blindness, congenital stationary	MESH:C536122	marker/mechanism		NA		7670478
SAG	6295	Oguchi disease	MESH:C537743	marker/mechanism		NA	258100	7670478|9565049
SAG	6295	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA		9565049
SAG	6295	RETINITIS PIGMENTOSA 47	OMIM:613758	marker/mechanism		NA	613758	
SAG	6295	Uveitis	MESH:D014605	marker/mechanism		NA		8407215
SAGG	103917	Cutis Laxa	MESH:D003483	marker/mechanism		NA		16424879
SAGG	103917	Ehlers-Danlos Syndrome	MESH:D004535	marker/mechanism		NA		16424879
SALL1	6299	Congenital Abnormalities	MESH:D000013	marker/mechanism		NA		20127799
SALL1	6299	Limb Deformities, Congenital	MESH:D017880	marker/mechanism		NA		16088922|9425907
SALL1	6299	Townes-Brocks syndrome	MESH:C536974	marker/mechanism		NA	107480	16088922|9425907
SALL2	6297	Coloboma	MESH:D003103	marker/mechanism		NA	216820	
SALL3	27164	Burkitt Lymphoma	MESH:D002051	marker/mechanism		NA		23143597
SALL3	27164	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		15282310
SALL3	27164	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
SALL4	57167	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		16402211
SALL4	57167	Duane Retraction Syndrome	MESH:D004370	marker/mechanism		NA	607323	16402211|30067223
SALL4	57167	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		30431698
SALL4	57167	Heart Septal Defects, Ventricular	MESH:D006345	marker/mechanism		NA		30067223
SALL4	57167	Holt-Oram syndrome	MESH:C535326	marker/mechanism		NA		30067223
SALL4	57167	Limb Deformities, Congenital	MESH:D017880	marker/mechanism		NA		30067223
SALL4	57167	Oculootoradial syndrome	MESH:C535544	marker/mechanism		NA	147750	
SAMD11	148398	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SAMD12	401474	Epilepsies, Myoclonic	MESH:D004831	marker/mechanism		NA		29507423
SAMD12	401474	Epilepsy, Myoclonic, Benign Adult Familial, Type 1	MESH:C563399	marker/mechanism		NA	601068	
SAMD4A	23034	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
SAMD9	54809	Fetal Growth Retardation	MESH:D005317	marker/mechanism		NA		27182967
SAMD9	54809	Hypoadrenocorticism, Familial	MESH:D000075262	marker/mechanism		NA		27182967
SAMD9	54809	Infections	MESH:D007239	marker/mechanism		NA		27182967
SAMD9	54809	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
SAMD9	54809	Intestinal Diseases	MESH:D007410	marker/mechanism		NA		27182967
SAMD9	54809	MIRAGE SYNDROME	OMIM:617053	marker/mechanism		NA	617053	
SAMD9	54809	Myelodysplastic Syndromes	MESH:D009190	marker/mechanism		NA		27182967
SAMD9	54809	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
SAMD9	54809	Tumoral Calcinosis, Normophosphatemic, Familial	MESH:C566473	marker/mechanism		NA	610455	
SAMD9	54809	Urogenital Abnormalities	MESH:D014564	marker/mechanism		NA		27182967
SAMD9L	219285	Myelocerebellar Disorder	MESH:C563233	marker/mechanism		NA	159550	
SAMHD1	25939	Aicardi-Goutieres syndrome	MESH:C535607	marker/mechanism		NA		23364794
SAMHD1	25939	Aicardi-Goutieres syndrome 5	MESH:C535608	marker/mechanism		NA	612952	19525956
SAMHD1	25939	Chilblain lupus 1	MESH:C535924	marker/mechanism		NA		27566796
SAMHD1	25939	CHILBLAIN LUPUS 2	OMIM:614415	marker/mechanism		NA	614415	
SAMHD1	25939	Deoxyguanosine Kinase Deficiency	MESH:C580039	marker/mechanism		NA		26342080
SAO	789307	Necrosis	MESH:D009336	marker/mechanism		NA		10942576
SAP130	79595	Hypoplastic Left Heart Syndrome	MESH:D018636	marker/mechanism		NA		28530678
SAP130A	100073341	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		28530678
SAP30BP	29115	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
SAP30L	79685	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
SAR1B	51128	Chylomicron retention disease	MESH:C535460	marker/mechanism		NA	246700	
SARDH	1757	Hypoxia	MESH:D000860	marker/mechanism		NA		19579223
SARDH	1757	Sarcosinemia	MESH:C537236	marker/mechanism		NA	268900	
SARM1	23098	Respiratory Syncytial Virus Infections	MESH:D018357	marker/mechanism		NA		24478430
SARS2	54938	HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	OMIM:613845	marker/mechanism		NA	613845	
SASH1	23328	Dyschromatosis Universalis Hereditaria 1	MESH:C567273	marker/mechanism		NA	127500	
SASH3	54440	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SASS6	163786	MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE	OMIM:616402	marker/mechanism		NA	616402	
SAT1	6303	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17374397
SAT1	6303	Obesity	MESH:D009765	marker/mechanism		NA		20882379
SATB1	6304	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
SATB1	6304	Clinical Deterioration	MESH:D000075902	marker/mechanism		NA		27602772
SATB1	6304	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
SATB2	23314	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		26780400
SATB2	23314	Chromosome 2q32-Q33 Deletion Syndrome	MESH:C567350	marker/mechanism		NA	612313	
SATB2	23314	Cleft Palate	MESH:D002972	marker/mechanism		NA		16960803|19170718
SATB2	23314	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		30510241
SATB2	23314	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		16960803
SATB2	23314	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941189
SBDS	51119	Anemia, Aplastic	MESH:D000741	marker/mechanism		NA	609135	
SBDS	51119	Shwachman-Diamond Syndrome	MESH:D000081003	marker/mechanism		NA	260400	
SBF1	6305	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3	OMIM:615284	marker/mechanism		NA	615284	
SBF2	81846	Charcot-Marie-Tooth disease, Type 4B2	MESH:C535421	marker/mechanism		NA	604563	
SBNO1	55206	Osteoarthritis, Knee	MESH:D020370	marker/mechanism		NA		30374069
SBNO1	55206	Schizophrenia	MESH:D012559	marker/mechanism		NA		21743468
SBP	20234	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
SBSPON	157869	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
SC5D	6309	Intellectual Disability	MESH:D008607	marker/mechanism		NA		12189593
SC5D	6309	Lathosterolosis	MESH:C537880	marker/mechanism		NA	607330	12189593
SC5D	6309	Liver Diseases	MESH:D008107	marker/mechanism		NA		12189593
SCAMP5	192683	Autistic Disorder	MESH:D001321	marker/mechanism		NA		20071347
SCAP	22937	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		14563831
SCAPER	49855	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
SCARB1	949	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
SCARB1	949	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		21131975
SCARB1	949	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		17205118
SCARB1	949	Follicular Cyst	MESH:D005497	marker/mechanism		NA		20404351
SCARB1	949	Hepatitis C	MESH:D006526	marker/mechanism		NA		17517063
SCARB1	949	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6	OMIM:610762	marker/mechanism		NA	610762	
SCARB1	949	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19878707
SCARB1	949	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
SCARB1	949	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
SCARB1	949	Marijuana Abuse	MESH:D002189	marker/mechanism		NA		17205118
SCARB1	949	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		23127599
SCARB1	949	Phencyclidine Abuse	MESH:D010623	marker/mechanism		NA		17205118
SCARB2	950	EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE	OMIM:254900	marker/mechanism		NA	254900	
SCARF2	91179	Marden Walker like syndrome	MESH:C535909	marker/mechanism		NA	600920	
SCD	6319	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462|16316942
SCD	6319	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21147110
SCD	6319	Graves Ophthalmopathy	MESH:D049970	marker/mechanism		NA		17614770
SCD	6319	Lipidoses	MESH:D008064	marker/mechanism		NA		21123845
SCD	6319	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		12419843
SCD	6319	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462|16316942
SCD	6319	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462|16316942
SCD1	20249	Eye Diseases	MESH:D005128	marker/mechanism		NA		21661758
SCD1	20249	Fatty Liver	MESH:D005234	therapeutic		NA		21661758
SCD1	20249	Glucose Intolerance	MESH:D018149	marker/mechanism		NA		21661758
SCD1	20249	Heart Failure	MESH:D006333	marker/mechanism		NA		26670611
SCD1	20249	Insulin Resistance	MESH:D007333	therapeutic		NA		21661758
SCD1	20249	Obesity	MESH:D009765	marker/mechanism		NA		20882379
SCD1	20249	Skin Diseases	MESH:D012871	marker/mechanism		NA		21661758
SCD1	20249	Weight Gain	MESH:D015430	therapeutic		NA		21661758
SCD2	20250	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SCD2	20250	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
SCFD1	23256	Amyotrophic Lateral Sclerosis	MESH:D000690	marker/mechanism		NA		27455348
SCG5	6447	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18084292
SCG5	6447	Medulloblastoma	MESH:D008527	marker/mechanism		NA		17334394
SCGB1A1	7356	Inflammation	MESH:D007249	marker/mechanism		NA		16052892
SCGB1A1	7356	Lung Diseases	MESH:D008171	marker/mechanism		NA		16052892
SCGB1A1	7356	Respiration Disorders	MESH:D012120	marker/mechanism		NA		18288317
SCGB3A1	92304	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
SCGB3A2	117156	Asthma	MESH:D001249	marker/mechanism		NA	600807	
SCHLAP1	101669767	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		24076601
SCHLAP1	101669767	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		24076601
SCMH1	22955	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
SCML2	10389	Medulloblastoma	MESH:D008527	marker/mechanism		NA		19270706
SCN10A	6336	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		20062060|29892015|30061737
SCN10A	6336	Brugada Syndrome	MESH:D053840	marker/mechanism		NA		23872634
SCN10A	6336	EPISODIC PAIN SYNDROME, FAMILIAL, 2	OMIM:615551	marker/mechanism		NA	615551	
SCN10A	6336	Heart Block	MESH:D006327	marker/mechanism		NA		20062061
SCN10A	6336	Hyperalgesia	MESH:D006930	marker/mechanism		NA		16545521
SCN10A	6336	Neuralgia	MESH:D009437	marker/mechanism		NA		18400411
SCN10A	6336	Ventricular Fibrillation	MESH:D014693	marker/mechanism		NA		20062061
SCN11A	11280	EPISODIC PAIN SYNDROME, FAMILIAL, 3	OMIM:615552	marker/mechanism		NA	615552	
SCN11A	11280	Hyperalgesia	MESH:D006930	marker/mechanism		NA		23264124
SCN11A	11280	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII	OMIM:615548	marker/mechanism		NA	615548	
SCN11A	11280	Pain Insensitivity, Congenital	MESH:D000699	marker/mechanism		NA		24036948
SCN1A	6323	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		21572417
SCN1A	6323	Epilepsies, Myoclonic	MESH:D004831	marker/mechanism		NA	607208	12907273|19099883|21480876
SCN1A	6323	Epilepsy	MESH:D004827	marker/mechanism		NA		15805193|19694741|23708187|29942082
SCN1A	6323	Epilepsy, Generalized	MESH:D004829	marker/mechanism		NA		21480876
SCN1A	6323	Generalized Epilepsy With Febrile Seizures Plus, Type 2	MESH:C565810	marker/mechanism		NA	604403	
SCN1A	6323	Intellectual Disability	MESH:D008607	marker/mechanism		NA		28191889
SCN1A	6323	Migraine, Familial Hemiplegic, 3	MESH:C566500	marker/mechanism		NA	609634	
SCN1A	6323	Movement Disorders	MESH:D009069	marker/mechanism		NA		12907273
SCN1A	6323	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		29942082
SCN1A	6323	Seizures, Febrile	MESH:D003294	marker/mechanism		NA		21480876|25344690|25362483
SCN1B	6324	ATRIAL FIBRILLATION, FAMILIAL, 13	OMIM:615377	marker/mechanism		NA	615377	
SCN1B	6324	Brugada Syndrome	MESH:D053840	marker/mechanism		NA		22155597
SCN1B	6324	Brugada Syndrome 5	MESH:C567556	marker/mechanism		NA	612838	
SCN1B	6324	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 52	OMIM:617350	marker/mechanism		NA	617350	
SCN1B	6324	Generalized Epilepsy With Febrile Seizures Plus, Type 1	MESH:C565809	marker/mechanism		NA	604233	
SCN1B	6324	Seizures, Febrile	MESH:D003294	marker/mechanism		NA		25362483
SCN1B	6324	Sudden Infant Death	MESH:D013398	marker/mechanism		NA		22155597
SCN2A	6326	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		31043756
SCN2A	6326	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 11	OMIM:613721	marker/mechanism		NA	613721	
SCN2A	6326	Epilepsy	MESH:D004827	marker/mechanism		NA		16464983|23708187|29942082
SCN2A	6326	Epilepsy, Benign Neonatal, 3	MESH:C564274	marker/mechanism		NA	607745	
SCN2A	6326	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889|29942082
SCN2A	6326	Seizures, Febrile	MESH:D003294	marker/mechanism		NA		25344690
SCN2B	6327	ATRIAL FIBRILLATION, FAMILIAL, 14	OMIM:615378	marker/mechanism		NA	615378	
SCN3A	6328	Epilepsy, Complex Partial	MESH:D017029	marker/mechanism		NA		18242854
SCN3B	55800	Brugada Syndrome 7	MESH:C567734	marker/mechanism		NA	613120	
SCN4A	6329	Hypokalemic Periodic Paralysis	MESH:D020514	marker/mechanism		NA		11912116
SCN4A	6329	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1	OMIM:170400	marker/mechanism		NA	170400	
SCN4A	6329	Hypokalemic Periodic Paralysis, Type 2	MESH:C567635	marker/mechanism		NA	613345	
SCN4A	6329	Myasthenic Syndromes, Congenital	MESH:D020294	marker/mechanism		NA	614198	12766226
SCN4A	6329	Myotonia	MESH:D009222	marker/mechanism		NA		8308722
SCN4A	6329	Myotonia Congenita	MESH:D009224	marker/mechanism		NA		1316765
SCN4A	6329	Myotonic Disorders	MESH:D020967	marker/mechanism		NA	168300	
SCN4A	6329	Paralysis, Hyperkalemic Periodic	MESH:D020513	marker/mechanism		NA	170500	1659948
SCN4A	6329	Potassium aggravated myotonia	MESH:C538353	marker/mechanism		NA	608390	16832098
SCN4B	6330	Long Qt Syndrome 10	MESH:C567514	marker/mechanism		NA	611819	
SCN5A	6331	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		20062060|30061737
SCN5A	6331	ATRIAL FIBRILLATION, FAMILIAL, 10	OMIM:614022	marker/mechanism		NA	614022	
SCN5A	6331	Brugada Syndrome	MESH:D053840	marker/mechanism		NA	601144	10662748|12687841|15520322|16144991|16239976|16945804|17728436|17805561|18507554|18599870|19140927|19875396|20174578|20513597|23872634|30232268
SCN5A	6331	Cardiomyopathy, Dilated, 1E	MESH:C563384	marker/mechanism		NA	601154	
SCN5A	6331	Long QT Syndrome	MESH:D008133	marker/mechanism		NA		10627139|12208804|12796143|14510655|16301357|17110414|19140927|20513597
SCN5A	6331	Long Qt Syndrome 3	MESH:C565840	marker/mechanism		NA	603830	
SCN5A	6331	Long QT syndrome type 3	MESH:C537034	marker/mechanism		NA		17805561
SCN5A	6331	Paroxysmal ventricular fibrillation	MESH:C537182	marker/mechanism		NA	603829	
SCN5A	6331	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA	OMIM:113900	marker/mechanism		NA	113900	
SCN5A	6331	Sick Sinus Syndrome 1, Autosomal Recessive	MESH:C563907	marker/mechanism		NA	608567	
SCN5A	6331	Sudden Infant Death	MESH:D013398	marker/mechanism		NA	272120	
SCN5A	6331	Tachycardia, Ventricular	MESH:D017180	marker/mechanism		NA		18848812
SCN5A	6331	Torsades de Pointes	MESH:D016171	marker/mechanism		NA		12208804|16301357
SCN7A	6332	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18621663
SCN8A	6334	Ataxia	MESH:D001259	marker/mechanism		NA		19261867
SCN8A	6334	Cerebellar Ataxia	MESH:D002524	marker/mechanism		NA		16236810
SCN8A	6334	COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA	OMIM:614306	marker/mechanism		NA	614306	
SCN8A	6334	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 13	OMIM:614558	marker/mechanism		NA	614558	
SCN8A	6334	Epilepsy	MESH:D004827	marker/mechanism		NA		23708187|29942082
SCN8A	6334	Herpesviridae Infections	MESH:D006566	marker/mechanism		NA		23382806
SCN8A	6334	Intellectual Disability	MESH:D008607	marker/mechanism		NA		16236810
SCN8A	6334	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		15170223
SCN8A	6334	Neuralgia, Postherpetic	MESH:D051474	marker/mechanism		NA		23382806
SCN8A	6334	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		29942082
SCN8A	6334	SEIZURES, BENIGN FAMILIAL INFANTILE, 5	OMIM:617080	marker/mechanism		NA	617080	
SCN8A	6334	Status Epilepticus	MESH:D013226	marker/mechanism		NA		19306853
SCN8A	6334	Tremor	MESH:D014202	marker/mechanism		NA		19261867
SCN9A	6335	Chronic Pain	MESH:D059350	marker/mechanism		NA		21634377
SCN9A	6335	Erythromelalgia	MESH:D004916	marker/mechanism		NA	133020	17145499|19549232|19557861
SCN9A	6335	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7	OMIM:613863	marker/mechanism		NA	613863	
SCN9A	6335	Herpesviridae Infections	MESH:D006566	marker/mechanism		NA		23382806
SCN9A	6335	Indifference to Pain, Congenital, Autosomal Recessive	MESH:C565467	marker/mechanism		NA	243000	
SCN9A	6335	Neuralgia	MESH:D009437	marker/mechanism		NA		19557861
SCN9A	6335	Neuralgia, Postherpetic	MESH:D051474	marker/mechanism		NA		23382806
SCN9A	6335	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA	OMIM:201300	marker/mechanism		NA	201300	
SCN9A	6335	Paroxysmal Extreme Pain Disorder	MESH:C563475	marker/mechanism		NA	167400	17145499|17679678
SCN9A	6335	Pruritus	MESH:D011537	marker/mechanism		NA		24820863
SCNN1A	6337	Bronchiectasis With Or Without Elevated Sweat Chloride 2	MESH:C567813	marker/mechanism		NA	613021	
SCNN1A	6337	Cystic Fibrosis	MESH:D003550	marker/mechanism		NA		15077107|19462466
SCNN1A	6337	Hypertension	MESH:D006973	marker/mechanism		NA		11752024|23348737
SCNN1A	6337	Liddle Syndrome	MESH:D056929	marker/mechanism		NA		23348737
SCNN1A	6337	Lung Diseases	MESH:D008171	marker/mechanism		NA		15077107|19462466
SCNN1A	6337	Neoplasms, Germ Cell and Embryonal	MESH:D009373	marker/mechanism		NA		16168501
SCNN1A	6337	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
SCNN1A	6337	Pre-Eclampsia	MESH:D011225	marker/mechanism		NA		16555725
SCNN1A	6337	Proteinuria	MESH:D011507	marker/mechanism		NA		11752024
SCNN1A	6337	Pseudohypoaldosteronism	MESH:D011546	marker/mechanism		NA	264350	11752024
SCNN1B	6338	Bronchiectasis With Or Without Elevated Sweat Chloride 1	MESH:C567618	marker/mechanism		NA	211400	
SCNN1B	6338	Cystic Fibrosis	MESH:D003550	marker/mechanism		NA		16207733|16463024
SCNN1B	6338	Hypertension	MESH:D006973	marker/mechanism		NA		15174897|15198480|19344079
SCNN1B	6338	Liddle Syndrome	MESH:D056929	marker/mechanism		NA	177200	18398334|19344079
SCNN1B	6338	Lung Diseases	MESH:D008171	marker/mechanism		NA		16207733
SCNN1B	6338	Lung Diseases, Obstructive	MESH:D008173	marker/mechanism		NA		27982104
SCNN1B	6338	Pseudohypoaldosteronism	MESH:D011546	marker/mechanism		NA	264350	
SCNN1B	6338	Pulmonary Emphysema	MESH:D011656	marker/mechanism		NA		27982104
SCNN1G	6340	Bronchiectasis With Or Without Elevated Sweat Chloride 3	MESH:C567772	marker/mechanism		NA	613071	
SCNN1G	6340	Cystic Fibrosis	MESH:D003550	marker/mechanism		NA		16463024
SCNN1G	6340	Hypertension	MESH:D006973	marker/mechanism		NA		15198480
SCNN1G	6340	Hypotension	MESH:D007022	marker/mechanism		NA		11463765
SCNN1G	6340	Pseudohypoaldosteronism	MESH:D011546	marker/mechanism		NA	264350	8640238
SCO1	6341	Brain Diseases	MESH:D001927	marker/mechanism		NA		23345593
SCO1	6341	Heart Diseases	MESH:D006331	marker/mechanism		NA		23345593
SCO1	6341	Liver Diseases	MESH:D008107	marker/mechanism		NA		23345593
SCO1	6341	Liver Failure, Acute	MESH:D017114	marker/mechanism		NA		20864674
SCO1	6341	Mitochondrial Diseases	MESH:D028361	marker/mechanism		NA		17182746
SCO2	9997	Brain Diseases, Metabolic, Inborn	MESH:D020739	marker/mechanism		NA		23345593
SCO2	9997	Cardioencephalomyopathy, Fatal Infantile, due to Cytochrome C Oxidase Deficiency	MESH:C565784	marker/mechanism		NA	604377	20864674|22515166
SCO2	9997	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		16326995
SCO2	9997	Cardiomyopathy, Hypertrophic	MESH:D002312	marker/mechanism		NA		11027508|14970747
SCO2	9997	Cytochrome-c Oxidase Deficiency	MESH:D030401	marker/mechanism		NA		11027508|16326995
SCO2	9997	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
SCO2	9997	Mitochondrial Encephalomyopathies	MESH:D017237	marker/mechanism		NA		16326995|23345593
SCO2	9997	Myopia 6	MESH:C536105	marker/mechanism		NA	608908	
SCP2	6342	Dystonia	MESH:D004421	marker/mechanism		NA		16685654
SCP2	6342	Leukoencephalopathies	MESH:D056784	marker/mechanism		NA		16685654
SCP2	6342	LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	OMIM:613724	marker/mechanism		NA	613724	
SCP2	6342	Polyneuropathies	MESH:D011115	marker/mechanism		NA		16685654
SCRN1	9805	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
SCRN1	9805	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
SCT	6343	Autistic Disorder	MESH:D001321	therapeutic		NA		12732234|15206007|15272612|16168596
SCT	6343	Choledochal Cyst	MESH:D015529	marker/mechanism		NA		18988797
SCT	6343	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
SCT	6343	Tachycardia	MESH:D013610	marker/mechanism		NA		2103752
SCTR	6344	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		30718926
SCYL1	57410	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA	616719	
SDC1	6382	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		27032653
SDC3	9672	Obesity	MESH:D009765	marker/mechanism		NA	601665	
SDC4	6385	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		22919003
SDCBP	6386	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
SDCCAG8	10806	BARDET-BIEDL SYNDROME 16	OMIM:615993	marker/mechanism		NA	615993	
SDCCAG8	10806	Kidney Diseases, Cystic	MESH:D052177	marker/mechanism		NA		20835237
SDCCAG8	10806	Retinal Diseases	MESH:D012164	marker/mechanism		NA		20835237
SDF2L1	23753	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
SDF2L1	23753	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
SDF4	51150	Schizophrenia	MESH:D012559	marker/mechanism		NA		21743468
SDHA	6389	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA	613642	
SDHA	6389	Leigh Disease	MESH:D007888	marker/mechanism		NA	256000	
SDHA	6389	Mitochondrial Complex II Deficiency	MESH:C565375	marker/mechanism		NA	252011	
SDHA	6389	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
SDHA	6389	PARAGANGLIOMAS 5	OMIM:614165	marker/mechanism		NA	614165	
SDHAF1	644096	Dementia, Vascular	MESH:D015140	marker/mechanism		NA		19465911
SDHAF1	644096	Mitochondrial Complex II Deficiency	MESH:C565375	marker/mechanism		NA	252011	
SDHAF2	54949	Hepatolenticular Degeneration	MESH:D006527	marker/mechanism		NA		23519153
SDHAF2	54949	Paragangliomas 2	MESH:C566646	marker/mechanism		NA	601650	
SDHB	6390	Carney-Stratakis Syndrome	MESH:C564650	marker/mechanism		NA	606864	
SDHB	6390	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA	606764	
SDHB	6390	Paraganglioma	MESH:D010235	marker/mechanism		NA		19927285|30013182
SDHB	6390	PARAGANGLIOMAS 4	OMIM:115310	marker/mechanism		NA	115310	
SDHB	6390	Pheochromocytoma	MESH:D010673	marker/mechanism		NA	171300	
SDHB-1	174482	Embryo Loss	MESH:D020964	marker/mechanism		NA		19233206
SDHC	6391	Carney-Stratakis Syndrome	MESH:C564650	marker/mechanism		NA	606864	
SDHC	6391	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA	606764	
SDHC	6391	Paragangliomas 3	MESH:C565335	marker/mechanism		NA	605373	
SDHD	6392	Carney-Stratakis Syndrome	MESH:C564650	marker/mechanism		NA	606864	
SDHD	6392	Melanoma	MESH:D008545	marker/mechanism		NA		25261935
SDHD	6392	Mitochondrial Complex II Deficiency	MESH:C565375	marker/mechanism		NA	252011	
SDHD	6392	Paraganglioma	MESH:D010235	marker/mechanism		NA	168000	21318381
SDHD	6392	Pheochromocytoma	MESH:D010673	marker/mechanism		NA	171300	
SDR42E1	93517	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SDS	10993	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SEC16B	89866	Body Weight	MESH:D001835	marker/mechanism		NA		22344219|22344221
SEC23A	10484	Craniolenticulosutural Dysplasia	MESH:C564332	marker/mechanism		NA	607812	17981132
SEC23A	10484	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
SEC23B	10483	Anemia, Dyserythropoietic, Congenital	MESH:D000742	marker/mechanism		NA	224100	19561605
SEC23B	10483	COWDEN SYNDROME 7	OMIM:616858	marker/mechanism		NA	616858	
SEC24D	9871	Cole Carpenter syndrome	MESH:C535963	marker/mechanism		NA	616294	
SEC31A	22872	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		22474449
SEC61A1	29927	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		16759393
SEC61A1	29927	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4	OMIM:617056	marker/mechanism		NA	617056	
SEC63	11231	Polycystic Kidney Diseases	MESH:D007690	marker/mechanism		NA		21685914
SEC63	11231	Polycystic liver disease	MESH:C536330	marker/mechanism		NA	617004	21685914
SECISBP2	79048	Amino Acid Metabolism, Inborn Errors	MESH:D000592	marker/mechanism		NA		16228000
SECISBP2	79048	Growth Disorders	MESH:D006130	marker/mechanism		NA		19602558
SECISBP2	79048	Thyroid Hormone Metabolism, Abnormal	MESH:C566454	marker/mechanism		NA	609698	19602558
SECISBP2L	9728	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		28604730
SECTM1B	58210	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SELE	6401	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		17890461
SELE	6401	Brain Ischemia	MESH:D002545	marker/mechanism		NA		17394460
SELE	6401	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		16332659|16544732
SELE	6401	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17597826
SELE	6401	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		12410700
SELE	6401	Hypercholesterolemia	MESH:D006937	marker/mechanism		NA		14602771
SELE	6401	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		20175758
SELE	6401	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
SELE	6401	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		17112405|23743330
SELE	6401	Urticaria	MESH:D014581	marker/mechanism		NA		12121561
SELENBP1	8991	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		14991897|15378696
SELENBP1	8991	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		20623750
SELENBP1	8991	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18435490
SELENBP1	8991	Halitosis	MESH:D006209	marker/mechanism		NA		29255262
SELENBP1	8991	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		14991897
SELENBP1	8991	Metabolism, Inborn Errors	MESH:D008661	marker/mechanism		NA		29255262
SELENBP1	8991	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		16380993|18272210
SELENBP1	8991	Psychotic Disorders	MESH:D011618	marker/mechanism		NA		18163446
SELENBP1	8991	Schizophrenia	MESH:D012559	marker/mechanism		NA		16223876|18163446
SELENBP1	8991	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		15378696|19424620
SELENBP2	20342	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		15650968
SELENOM	140606	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SELENON	57190	Muscular Dystrophies	MESH:D009136	marker/mechanism		NA		17123513
SELENON	57190	Myopathies, Structural, Congenital	MESH:D020914	marker/mechanism		NA	255310	
SELENON	57190	Rigid spine syndrome	MESH:C535683	marker/mechanism		NA	602771	
SELENOP	6414	Adenoma	MESH:D000236	marker/mechanism		NA		18483336
SELENOP	6414	Cadmium Poisoning	MESH:D002105	marker/mechanism		NA		20643113
SELENOP	6414	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462|16316942
SELENOP	6414	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18483336
SELENOP	6414	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
SELENOP	6414	Infertility, Male	MESH:D007248	marker/mechanism		NA		17961124
SELENOP	6414	Insulin Resistance	MESH:D007333	marker/mechanism		NA		14714311
SELENOP	6414	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SELENOP	6414	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		19058871
SELENOP	6414	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462|16316942
SELENOP	6414	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462|16316942
SELENOP	6414	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		18172410
SELENOP	6414	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		14704310|17961124
SELENOP	6414	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		15964507
SELENOP	6414	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		12235003
SELENOS	55829	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		20471133
SELENOS	55829	Inflammation	MESH:D007249	marker/mechanism		NA		16227999
SELENOS	55829	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
SELENOW	6415	Epilepsy	MESH:D004827	marker/mechanism		NA		19499324
SELENOW	6415	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SELL	6402	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		10070497
SELP	6403	Depressive Disorder	MESH:D003866	marker/mechanism		NA		25451969
SELP	6403	Hypersensitivity	MESH:D006967	marker/mechanism		NA		12929084
SELP	6403	Hypertension	MESH:D006973	marker/mechanism		NA		15513305
SELP	6403	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
SELP	6403	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		12087064
SELP	6403	Neurobehavioral Manifestations	MESH:D019954	marker/mechanism		NA		25451969
SELP	6403	Pleurisy	MESH:D010998	marker/mechanism		NA		11181422
SELP	6403	Primary Graft Dysfunction	MESH:D055031	marker/mechanism		NA		28569748
SELP	6403	Thrombosis	MESH:D013927	marker/mechanism		NA		10544909
SELPLG	6404	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
SELS	100186840	Stevens-Johnson Syndrome	MESH:D013262	marker/mechanism		NA		25811541
SEM1	7979	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		18922899
SEM1	7979	Diverticular Diseases	MESH:D000076385	marker/mechanism		NA		30177863
SEMA3A	10371	HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA	OMIM:614897	marker/mechanism		NA	614897	
SEMA3B	7869	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		21933904
SEMA3B	7869	Neuroblastoma	MESH:D009447	marker/mechanism		NA		17452250
SEMA3C	10512	Truncus Arteriosus, Persistent	MESH:D014339	marker/mechanism		NA		15548583
SEMA3E	9723	CHARGE Syndrome	MESH:D058747	marker/mechanism		NA	214800	
SEMA3E	9723	Idiopathic Hypogonadotropic Hypogonadism	MESH:C562785	marker/mechanism		NA	146110	
SEMA3F	6405	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		21933904
SEMA4A	64218	Cone-Rod Dystrophy 10	MESH:C564597	marker/mechanism		NA	610283	
SEMA4A	64218	Retinitis Pigmentosa 35	MESH:C565206	marker/mechanism		NA	610282	
SEMA4F	10505	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
SEMA5A	9037	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17028446
SEMA6D	80031	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SEMA6D	80031	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
SENP1	29843	Arteriosclerosis	MESH:D001161	marker/mechanism		NA		28569748
SENP1	29843	Neointima	MESH:D058426	marker/mechanism		NA		28569748
SENP1	29843	Primary Graft Dysfunction	MESH:D055031	marker/mechanism		NA		28569748
SENP1	29843	Vascular Remodeling	MESH:D066253	marker/mechanism		NA		28569748
SENP1	29843	Vasculitis	MESH:D014657	marker/mechanism		NA		28569748
SENP2	59343	Chemical and Drug Induced Liver Injury	MESH:D056486	therapeutic		NA		29535048
SENP2	59343	Liver Cirrhosis, Experimental	MESH:D008106	therapeutic		NA		29535048
SENP6	26054	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29662167
SEPSECS	51091	PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	OMIM:613811	marker/mechanism		NA	613811	
SEPSECS	51091	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
SEPTIN11	55752	Methylmalonic acidemia	MESH:C537358	marker/mechanism		NA		16823967
SEPTIN12	124404	SPERMATOGENIC FAILURE 10	OMIM:614822	marker/mechanism		NA	614822	
SEPTIN14	346288	Glioblastoma	MESH:D005909	marker/mechanism		NA		23917401
SEPTIN2	4735	Methylmalonic acidemia	MESH:C537358	marker/mechanism		NA		16823967
SEPTIN5	5413	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		22430071
SEPTIN5	5413	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
SEPTIN9	10801	Brachial Plexus Neuritis	MESH:D020968	marker/mechanism		NA	162100	17546647
SEPTIN9	10801	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		10339604
SEPTIN9	10801	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		20388789
SERAC1	84947	3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME	OMIM:614739	marker/mechanism		NA	614739	
SERAC1	84947	Deafness	MESH:D003638	marker/mechanism		NA		22683713
SERAC1	84947	Dystonia	MESH:D004421	marker/mechanism		NA		22683713
SERAC1	84947	Lipid Metabolism, Inborn Errors	MESH:D008052	marker/mechanism		NA		22683713
SERBP1	26135	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
SERBP1	26135	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
SERINC3	10955	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
SERPINA1	5265	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		28885000
SERPINA1	5265	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		15378696
SERPINA1	5265	alpha 1-Antitrypsin Deficiency	MESH:D019896	marker/mechanism		NA	613490	17559149|3485249
SERPINA1	5265	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		17659342
SERPINA1	5265	Arteriosclerosis	MESH:D001161	marker/mechanism		NA		12692006
SERPINA1	5265	Asbestosis	MESH:D001195	marker/mechanism		NA		12368052
SERPINA1	5265	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		17659342
SERPINA1	5265	Bronchiectasis	MESH:D001987	marker/mechanism		NA		7785020
SERPINA1	5265	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284|6258829
SERPINA1	5265	Cholestasis	MESH:D002779	marker/mechanism		NA		4117022
SERPINA1	5265	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		28885000
SERPINA1	5265	Emphysema	MESH:D004646	marker/mechanism		NA		25579632
SERPINA1	5265	Gastro-enteropancreatic neuroendocrine tumor	MESH:C535650	marker/mechanism		NA		29915428
SERPINA1	5265	Hemorrhage	MESH:D006470	marker/mechanism		NA		412531
SERPINA1	5265	HIV Infections	MESH:D015658	therapeutic		NA		17448989
SERPINA1	5265	Hypoglycemia	MESH:D007003	marker/mechanism		NA		17659342
SERPINA1	5265	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		20511674|25579632|3485248
SERPINA1	5265	Liver Diseases	MESH:D008107	marker/mechanism		NA		17006946|17659342|3485248|4117996|5095241|6600583
SERPINA1	5265	Lung Diseases	MESH:D008171	marker/mechanism		NA		17659342
SERPINA1	5265	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17902193
SERPINA1	5265	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17085005
SERPINA1	5265	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		17659342
SERPINA1	5265	Panniculitis, Nodular Nonsuppurative	MESH:D010201	marker/mechanism		NA		3259592|6982619
SERPINA1	5265	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		16278826|25579632
SERPINA1	5265	Pulmonary Emphysema	MESH:D011656	marker/mechanism		NA		3485249
SERPINA1	5265	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		72955
SERPINA1	5265	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		15378696
SERPINA1	5265	Thiamine Deficiency	MESH:D013832	marker/mechanism		NA		17659342
SERPINA1	5265	Vasculitis	MESH:D014657	marker/mechanism		NA		1684994
SERPINA10	51156	Thrombophilia	MESH:D019851	marker/mechanism		NA		15461625
SERPINA10	51156	Venous Thrombosis	MESH:D020246	marker/mechanism		NA		15461625
SERPINA3	12	Lipidoses	MESH:D008064	marker/mechanism		NA		15342952|16919414|17175557
SERPINA3	12	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		18383875
SERPINA3K	20714	Diabetic Retinopathy	MESH:D003930	marker/mechanism		NA		19324842
SERPINA3K	20714	Inflammation	MESH:D007249	therapeutic		NA		19324842
SERPINA3K	20714	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		15650968
SERPINA3K	20714	Retinal Diseases	MESH:D012164	therapeutic		NA		19324842
SERPINA3M	20717	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
SERPINA3M	20717	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SERPINA3N	20716	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
SERPINA4	5267	Carcinoma, Hepatocellular	MESH:D006528	therapeutic		NA		19709125
SERPINA4	5267	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SERPINA4	5267	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		23056237
SERPINA5	5104	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
SERPINA5	5104	Cholestasis	MESH:D002779	marker/mechanism		NA		27989131
SERPINA6	866	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
SERPINA6	866	Corticosteroid-Binding Globulin Deficiency	MESH:C565152	marker/mechanism		NA	611489	
SERPINA6	866	Fatty Liver	MESH:D005234	marker/mechanism		NA		25226513
SERPINA6	866	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		25226513
SERPINA6	866	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SERPINA7	6906	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SERPINA7	6906	Metabolism, Inborn Errors	MESH:D008661	marker/mechanism		NA		2155256
SERPINB10	5273	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16172807
SERPINB2	5055	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037
SERPINB2	5055	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		21664615
SERPINB2	5055	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		21245421
SERPINB2	5055	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
SERPINB3	6317	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
SERPINB3	6317	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		15274141
SERPINB3	6317	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
SERPINB3	6317	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		15986332
SERPINB3	6317	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
SERPINB3	6317	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		15274141
SERPINB3	6317	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		15986332
SERPINB4	6318	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
SERPINB4	6318	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
SERPINB5	5268	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16799634
SERPINB5	5268	Carcinoma, Ductal, Breast	MESH:D018270	marker/mechanism		NA		19944674
SERPINB5	5268	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
SERPINB5	5268	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		16331619
SERPINB5	5268	Keloid	MESH:D007627	marker/mechanism		NA		20128793
SERPINB5	5268	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19514085
SERPINB6	5269	DEAFNESS, AUTOSOMAL RECESSIVE 91	OMIM:613453	marker/mechanism		NA	613453	
SERPINB6A	20719	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
SERPINB7	8710	PALMOPLANTAR KERATODERMA, NAGASHIMA TYPE	OMIM:615598	marker/mechanism		NA	615598	
SERPINB8	5271	Peeling Skin Syndrome	MESH:C564818	marker/mechanism		NA	617115	
SERPINB8	5271	Psoriasis	MESH:D011565	marker/mechanism		NA		20953187
SERPINB9	5272	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
SERPINB9	5272	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SERPINC1	462	Acute Coronary Syndrome	MESH:D054058	therapeutic		NA		7923645
SERPINC1	462	Antithrombin III Deficiency	MESH:D020152	marker/mechanism		NA	613118	6435583
SERPINC1	462	Blood Coagulation Disorders	MESH:D001778	marker/mechanism		NA		62897
SERPINC1	462	Brain Injuries	MESH:D001930	therapeutic		NA		21534203
SERPINC1	462	Cerebral Hemorrhage	MESH:D002543	marker/mechanism		NA		6636041
SERPINC1	462	Craniocerebral Trauma	MESH:D006259	marker/mechanism		NA		8810955
SERPINC1	462	Disseminated Intravascular Coagulation	MESH:D004211	marker/mechanism|therapeutic		NA		6233579|8810955|9637888
SERPINC1	462	Intracranial Thrombosis	MESH:D020767	marker/mechanism		NA		6636041
SERPINC1	462	Liver Failure, Acute	MESH:D017114	marker/mechanism		NA		4089794
SERPINC1	462	Nephrotic Syndrome	MESH:D009404	marker/mechanism		NA		11304663
SERPINC1	462	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		8810955
SERPINC1	462	Thrombosis	MESH:D013927	marker/mechanism|therapeutic		NA		11132655|2133253|6889048|8967151
SERPINC1	462	Venous Thromboembolism	MESH:D054556	marker/mechanism		NA		453287
SERPINC1	462	Venous Thrombosis	MESH:D020246	marker/mechanism		NA		55783|6435583|8810955
SERPIND1	3053	Carotid Artery Thrombosis	MESH:D002341	therapeutic		NA		11805133
SERPIND1	3053	Heparin Cofactor II Deficiency	MESH:C562865	marker/mechanism		NA	612356	
SERPIND1	3053	Mesenteric Vascular Occlusion	MESH:D008641	marker/mechanism		NA		1831893
SERPIND1	3053	Thrombophilia	MESH:D019851	marker/mechanism		NA		2214444
SERPIND1	3053	Venous Thromboembolism	MESH:D054556	marker/mechanism		NA		1831893
SERPINE1	5054	Atherosclerosis	MESH:D050197	marker/mechanism		NA		12677255
SERPINE1	5054	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19360663
SERPINE1	5054	Behcet Syndrome	MESH:D001528	marker/mechanism		NA		12074830
SERPINE1	5054	Cholestasis	MESH:D002779	marker/mechanism		NA		21224055
SERPINE1	5054	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		21757225
SERPINE1	5054	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		18682491
SERPINE1	5054	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		21051829
SERPINE1	5054	Fatty Liver	MESH:D005234	marker/mechanism		NA		18641190|29684222
SERPINE1	5054	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA		18682491
SERPINE1	5054	Heart Failure	MESH:D006333	marker/mechanism		NA		22352330
SERPINE1	5054	Hypertension	MESH:D006973	marker/mechanism		NA		21051829|22352330
SERPINE1	5054	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19420110
SERPINE1	5054	Liver Diseases	MESH:D008107	marker/mechanism		NA		29684222
SERPINE1	5054	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		21159647
SERPINE1	5054	Nephrotic Syndrome	MESH:D009404	marker/mechanism		NA		17513194
SERPINE1	5054	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		21245421
SERPINE1	5054	Obesity	MESH:D009765	marker/mechanism		NA		23819014
SERPINE1	5054	Plasminogen Activator Inhibitor-1 Deficiency	MESH:C567640	marker/mechanism		NA	613329	
SERPINE1	5054	Pre-Eclampsia	MESH:D011225	marker/mechanism		NA		18679377
SERPINE1	5054	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16172807
SERPINE1	5054	Respiratory Hypersensitivity	MESH:D012130	marker/mechanism		NA		24211530
SERPINE1	5054	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
SERPINE1	5054	Thrombosis	MESH:D013927	marker/mechanism		NA		12677255|22352330
SERPINE1	5054	Ureteral Obstruction	MESH:D014517	marker/mechanism		NA		28318631
SERPINF1	5176	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
SERPINF1	5176	Corneal Ulcer	MESH:D003320	therapeutic		NA		19553628
SERPINF1	5176	Diabetic Angiopathies	MESH:D003925	marker/mechanism		NA		25381014
SERPINF1	5176	Keloid	MESH:D007627	marker/mechanism		NA		20128793
SERPINF1	5176	Osteogenesis imperfecta, type 6	MESH:C536047	marker/mechanism		NA	613982	
SERPINF1	5176	Prostatic Neoplasms	MESH:D011471	therapeutic		NA		21671747
SERPINF1	5176	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
SERPINF1	5176	Uveitis	MESH:D014605	therapeutic		NA		19553628
SERPINF2	5345	Anti-plasmin deficiency, congenital	MESH:C537777	marker/mechanism		NA	262850	
SERPING1	710	Acquired angioedema	MESH:C538173	marker/mechanism|therapeutic		NA		23406939|9734886
SERPING1	710	Angioedemas, Hereditary	MESH:D054179	marker/mechanism|therapeutic		NA	106100	19477491|23406939|23634741|23844784|23866957|9734886
SERPING1	710	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
SERPING1	710	Complement Component 4, Partial Deficiency Of	MESH:C565168	marker/mechanism		NA	120790	
SERPING1	710	Hereditary Angioedema Types I and II	MESH:D056829	marker/mechanism		NA		15806011|1644161|18387221
SERPING1	710	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
SERPING1	710	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		26396155
SERPING1	710	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
SERPING1	710	Lupus Nephritis	MESH:D008181	marker/mechanism		NA		4014294
SERPINH1	871	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		12374626
SERPINH1	871	Ischemia	MESH:D007511	marker/mechanism		NA		19458120
SERPINH1	871	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		24321339
SERPINH1	871	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		18376398|25380136
SERPINH1	871	OSTEOGENESIS IMPERFECTA, TYPE X	OMIM:613848	marker/mechanism		NA	613848	
SERPINH1	871	Preterm Premature Rupture of the Membranes	MESH:C563032	marker/mechanism		NA	610504	
SERPINH1	871	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
SERPINI1	5274	Familial encephalopathy with neuroserpin inclusion bodies	MESH:C536841	marker/mechanism		NA	604218	
SERPINI1	5274	Myoclonic Epilepsies, Progressive	MESH:D020191	marker/mechanism		NA		25401298
SERTAD1	29950	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		18097604
SESN2	83667	Chemical and Drug Induced Liver Injury	MESH:D056486	therapeutic		NA		28209544
SESN2	83667	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		31054940
SESN2	83667	Hepatomegaly	MESH:D006529	therapeutic		NA		28209544
SESN3	143686	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		24763052
SESTD1	91404	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
SET	6418	Necrosis	MESH:D009336	marker/mechanism		NA		24555657
SET	6418	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		24555657
SETBP1	26040	Abnormalities, Multiple	MESH:D000015	marker/mechanism		NA		20436468
SETBP1	26040	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25751625
SETBP1	26040	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		20436468
SETBP1	26040	Intellectual Disability	MESH:D008607	marker/mechanism		NA		20436468|25217958
SETBP1	26040	Language Development Disorders	MESH:D007805	marker/mechanism		NA		25217958
SETBP1	26040	Leukemia, Myeloid	MESH:D007951	marker/mechanism		NA		23832012
SETBP1	26040	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	MESH:D054438	marker/mechanism		NA		23222956
SETBP1	26040	Leukemia, Myelomonocytic, Juvenile	MESH:D054429	marker/mechanism		NA		23832011|26457647
SETBP1	26040	MENTAL RETARDATION, AUTOSOMAL DOMINANT 29	OMIM:616078	marker/mechanism		NA	616078	
SETBP1	26040	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
SETBP1	26040	Schinzel-Giedion syndrome	MESH:C536632	marker/mechanism		NA	269150	23222956|23832012
SETBP1	26040	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
SETD2	29072	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		26437033
SETD2	29072	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
SETD2	29072	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		22138691|23797736
SETD2	29072	Leukemia	MESH:D007938	marker/mechanism		NA		24509477
SETD2	29072	LUSCAN-LUMISH SYNDROME	OMIM:616831	marker/mechanism		NA	616831	
SETD2	29072	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		26928227
SETD2	29072	Microsatellite Instability	MESH:D053842	marker/mechanism		NA		25701956
SETD2	29072	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
SETD2	29072	Phyllodes Tumor	MESH:D003557	marker/mechanism		NA		26437033
SETD2	29072	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
SETD2	29072	Rhabdomyosarcoma, Embryonal	MESH:D018233	marker/mechanism		NA		29376028
SETD5	55209	MENTAL RETARDATION, AUTOSOMAL DOMINANT 23	OMIM:615761	marker/mechanism		NA	615761	
SETD5	55209	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
SETDB1	9869	Melanoma	MESH:D008545	marker/mechanism		NA		21983785
SETDB1	9869	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		26928227
SETDB1	9869	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
SETX	23064	Amyotrophic Lateral Sclerosis 4, Juvenile	MESH:C566550	marker/mechanism		NA	602433	
SETX	23064	Spinocerebellar ataxia, autosomal recessive 1	MESH:C537308	marker/mechanism		NA	606002	
SEZ6	124925	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SEZ6L2	26470	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19242545
SF1	7536	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
SF3A3	10946	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
SF3B1	23451	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		22158541
SF3B1	23451	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		26928227
SF3B1	23451	Myelodysplastic Syndromes	MESH:D009190	marker/mechanism		NA	614286	
SF3B1	23451	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
SF3B1	23451	Uveal melanoma	MESH:C536494	marker/mechanism		NA		23313955|23793026
SF3B4	10262	Acrofacial dysostosis, Nager type	MESH:C538184	marker/mechanism		NA	154400	
SFN	2810	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		19381893
SFN	2810	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
SFN	2810	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		15274141
SFN	2810	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		15986332
SFN	2810	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
SFN	2810	Keloid	MESH:D007627	marker/mechanism		NA		20128793
SFN	2810	Lymphatic Metastasis	MESH:D008207	marker/mechanism		NA		19381893
SFN	2810	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		15274141
SFPQ	6421	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
SFPQ	6421	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
SFPQ	6421	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
SFRP1	6422	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18283316
SFRP1	6422	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
SFRP1	6422	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17923031|18716850
SFRP1	6422	Fibrosis	MESH:D005355	marker/mechanism		NA		30377735
SFRP1	6422	Heart Diseases	MESH:D006331	marker/mechanism		NA		30377735
SFRP1	6422	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
SFRP1	6422	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA		18716850
SFRP1	6422	Leiomyoma	MESH:D007889	marker/mechanism		NA		15972578
SFRP2	6423	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18283316
SFRP2	6423	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		18404682
SFRP2	6423	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17923031|18716850
SFRP2	6423	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA		18716850
SFRP4	6424	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		25194984
SFRP4	6424	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17923031
SFRP4	6424	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		23140642
SFRP4	6424	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
SFRP4	6424	Pyle disease	MESH:C536252	marker/mechanism		NA	265900	
SFRP5	6425	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18283316
SFRP5	6425	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17923031
SFSWAP	6433	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		24781735
SFTPA2	729238	Idiopathic Pulmonary Fibrosis	MESH:D054990	marker/mechanism		NA	178500	
SFTPB	6439	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		10830305|16863852
SFTPB	6439	Lung Diseases	MESH:D008171	marker/mechanism		NA		16863852
SFTPB	6439	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		16570259
SFTPB	6439	Surfactant Metabolism Dysfunction, Pulmonary, 1	MESH:C566882	marker/mechanism		NA	265120	
SFTPC	6440	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		25851810
SFTPC	6440	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		10751355
SFTPC	6440	Idiopathic Pulmonary Fibrosis	MESH:D054990	marker/mechanism		NA	178500	
SFTPC	6440	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
SFTPC	6440	Surfactant Metabolism Dysfunction, Pulmonary, 2	MESH:C567048	marker/mechanism		NA	610913	
SFTPD	6441	Acute Lung Injury	MESH:D055371	therapeutic		NA		30060251
SFTPD	6441	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		14522914|15136449
SFTPD	6441	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		28166215
SFXN1	94081	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
SFXN1	94081	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		25944804
SFXN1	94081	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
SFXN4	119559	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	OMIM:615578	marker/mechanism		NA	615578	
SGCA	6442	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
SGCA	6442	Sarcoglycanopathies	MESH:D058088	marker/mechanism		NA	608099	
SGCB	6443	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		21037199
SGCB	6443	Limb-girdle muscular dystrophy, type 2E	MESH:C535902	marker/mechanism		NA	604286	
SGCB	6443	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SGCD	6444	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		20675662|25281567
SGCD	6444	Cardiomyopathy, Dilated, 1l	MESH:C564679	marker/mechanism		NA	606685	
SGCD	6444	Limb-girdle muscular dystrophy type 2F	MESH:C535896	marker/mechanism		NA	601287	20675662
SGCE	8910	Myoclonic dystonia	MESH:C536096	marker/mechanism		NA	159900	
SGCG	6445	Limb-girdle muscular dystrophy, type 2C	MESH:C535900	marker/mechanism		NA	253700	
SGCG	6445	Osteoarthritis	MESH:D010003	marker/mechanism		NA		17568789
SGCZ	137868	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
SGCZ	137868	Skin Diseases	MESH:D012871	marker/mechanism		NA		28720099
SGF29	112869	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
SGK1	6446	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
SGK1	6446	Diabetic Neuropathies	MESH:D003929	marker/mechanism		NA		16696316
SGK1	6446	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
SGK1	6446	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
SGK1	6446	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
SGK1	6446	Uremia	MESH:D014511	marker/mechanism		NA		18768591
SGK2	10110	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SGO1	151648	Arrhythmias, Cardiac	MESH:D001145	marker/mechanism		NA		25282101
SGO1	151648	CHRONIC ATRIAL AND INTESTINAL DYSRHYTHMIA	OMIM:616201	marker/mechanism		NA	616201	
SGO1	151648	Chronobiology Disorders	MESH:D021081	marker/mechanism		NA		25282101
SGO1	151648	Intestinal Diseases	MESH:D007410	marker/mechanism		NA		25282101
SGSH	6448	Mucopolysaccharidosis III	MESH:D009084	marker/mechanism		NA	252900	
SH2B1	25970	Obesity	MESH:D009765	marker/mechanism		NA		19079261
SH2B3	10019	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		21378990
SH2B3	10019	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		30224649
SH2B3	10019	Inflammation	MESH:D007249	therapeutic		NA		21496118
SH2B3	10019	Leukemia, Myelomonocytic, Juvenile	MESH:D054429	marker/mechanism		NA		26457647
SH2B3	10019	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		19838195
SH2B3	10019	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		19198610
SH2B3	10019	Polycythemia, primary familial and congenital	MESH:C536842	marker/mechanism		NA	133100	
SH2B3	10019	Primary Myelofibrosis	MESH:D055728	marker/mechanism		NA	254450	
SH2B3	10019	Stroke	MESH:D020521	marker/mechanism		NA		29531354
SH2B3	10019	Thrombocytosis	MESH:D013922	marker/mechanism		NA	187950	
SH2B3	10019	Vitiligo	MESH:D014820	marker/mechanism		NA		22561518
SH2D1A	4068	Lymphoproliferative Disorders	MESH:D008232	marker/mechanism		NA	308240	10229804
SH3BGRL2	83699	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
SH3BGRL3	83442	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SH3BP2	6452	Cherubism	MESH:D002636	marker/mechanism		NA	118400	
SH3GL1	6455	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA	601626	
SH3KBP1	30011	Agammaglobulinemia, X-linked, type 2	MESH:C538057	marker/mechanism		NA	300310	
SH3KBP1	30011	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
SH3PXD2A	9644	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		28416822
SH3PXD2A	9644	Stroke	MESH:D020521	marker/mechanism		NA		29531354
SH3PXD2B	285590	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		19669234
SH3PXD2B	285590	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		19669234
SH3PXD2B	285590	Eye Abnormalities	MESH:D005124	marker/mechanism		NA		19669234
SH3PXD2B	285590	Growth Disorders	MESH:D006130	marker/mechanism		NA		19669234
SH3PXD2B	285590	Hearing Loss	MESH:D034381	marker/mechanism		NA		19669234
SH3PXD2B	285590	Ter Haar syndrome	MESH:C537274	marker/mechanism		NA	249420	
SH3RF3	344558	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
SH3TC1	54436	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		21278247
SH3TC2	79628	Charcot-Marie-Tooth disease, Type 4C	MESH:C535423	marker/mechanism		NA	601596	
SH3TC2	79628	MONONEUROPATHY OF THE MEDIAN NERVE, MILD	OMIM:613353	marker/mechanism		NA	613353	
SHANK1	50944	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		18272690
SHANK1	50944	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18272690
SHANK1	50944	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		22138691
SHANK1	50944	Motor Skills Disorders	MESH:D019957	marker/mechanism		NA		20868654
SHANK2	22941	Autistic Disorder	MESH:D001321	marker/mechanism		NA	613436	20473310|20531469
SHANK2	22941	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		31043756
SHANK2	22941	Intellectual Disability	MESH:D008607	marker/mechanism		NA		20473310
SHANK3	85358	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		17173049|18252227
SHANK3	85358	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18621663|26027926
SHANK3	85358	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		16284256
SHANK3	85358	Intellectual Disability	MESH:D008607	marker/mechanism		NA		16284256
SHANK3	85358	Language Development Disorders	MESH:D007805	marker/mechanism		NA		16284256|17173049
SHANK3	85358	Schizophrenia	MESH:D012559	marker/mechanism		NA	613950	
SHANK3	85358	Telomeric 22q13 Monosomy Syndrome	MESH:C536801	marker/mechanism		NA	606232	16284256
SHARPIN	81858	Dermatitis	MESH:D003872	marker/mechanism		NA		19650867
SHARPIN	81858	Eosinophilia	MESH:D004802	marker/mechanism		NA		19650867
SHBG	6462	Alcoholism	MESH:D000437	marker/mechanism		NA		8590623
SHBG	6462	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		25996886
SHBG	6462	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		21982312
SHBG	6462	Erectile Dysfunction	MESH:D007172	marker/mechanism		NA		17961146
SHBG	6462	Metabolic Syndrome	MESH:D024821	marker/mechanism		NA		16968811|17992261
SHBG	6462	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17220347
SHC1	6464	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
SHC1	6464	Cardiomegaly	MESH:D006332	marker/mechanism		NA		19168439
SHC1	6464	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249|32659284
SHC1	6464	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		32659284
SHCBP1	79801	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SHCBP1	79801	Sarcoma, Synovial	MESH:D013584	marker/mechanism		NA		27572315
SHFM1	772237	Disease Progression	MESH:D018450	marker/mechanism		NA		30871063
SHFM1	772237	Neuroblastoma	MESH:D009447	marker/mechanism		NA		30871063
SHH	6469	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		26189965
SHH	6469	Eye Abnormalities	MESH:D005124	marker/mechanism		NA		24973920
SHH	6469	Facial Dysmorphism with Multiple Malformations	MESH:C565579	marker/mechanism		NA		27585885
SHH	6469	Familial schizencephaly	MESH:C538514	marker/mechanism		NA	269160	
SHH	6469	Holoprosencephaly	MESH:D016142	marker/mechanism		NA		15107988|17525797|23264560|27585885|31642701
SHH	6469	Holoprosencephaly 3	MESH:C564181	marker/mechanism		NA	142945	
SHH	6469	Microphthalmia, Isolated, with Coloboma 5	MESH:C566899	marker/mechanism		NA	611638	
SHH	6469	Parkinson Disease, Secondary	MESH:D010302	therapeutic		NA		11771942
SHH	6469	Single upper central incisor	MESH:C537342	marker/mechanism		NA	147250	
SHHA	30269	Jaw Abnormalities	MESH:D007569	marker/mechanism		NA		16580747
SHISA3	152573	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SHMT1	6470	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
SHMT1	6470	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17595805
SHMT1	6470	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
SHMT1	6470	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		21064136
SHMT1	6470	Lymphoma, Non-Hodgkin	MESH:D008228	marker/mechanism		NA		17119116
SHMT1	6470	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		21064136
SHMT2	6472	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		26482881
SHOC2	8036	Hair Diseases	MESH:D006201	marker/mechanism		NA		19684605
SHOC2	8036	Noonan Syndrome	MESH:D009634	marker/mechanism		NA		19684605
SHOC2	8036	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1	OMIM:607721	marker/mechanism		NA	607721	
SHOX	6473	Langer mesomelic dysplasia	MESH:C537267	marker/mechanism		NA	249700	
SHOX	6473	Leri-Weil syndrome	MESH:C537119	marker/mechanism		NA	127300	
SHOX	6473	Short Stature, Idiopathic, X-Linked	MESH:C564479	marker/mechanism		NA	300582	
SHROOM4	57477	Stocco dos Santos syndrome	MESH:C537495	marker/mechanism		NA	300434	
SI	6476	Sucrase-isomaltase deficiency, congenital	MESH:C538139	marker/mechanism		NA	222900	
SIAE	54414	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA	613551	
SIAH2	6478	Lens Diseases	MESH:D007905	marker/mechanism		NA		24282676
SIDT2	51092	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
SIGLEC1	6614	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
SIGLEC5	8778	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SIGLEC6	946	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		26808113
SIGMAR1	10280	Amnesia	MESH:D000647	therapeutic		NA		12028363
SIGMAR1	10280	Amyotrophic Lateral Sclerosis	MESH:D000690	marker/mechanism		NA		24885036
SIGMAR1	10280	AMYOTROPHIC LATERAL SCLEROSIS 16, JUVENILE	OMIM:614373	marker/mechanism		NA	614373	
SIGMAR1	10280	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		12736327|16132061
SIGMAR1	10280	Frontotemporal Lobar Degeneration	MESH:D057174	marker/mechanism		NA		24885036
SIGMAR1	10280	HIV Infections	MESH:D015658	marker/mechanism		NA		16204638
SIGMAR1	10280	Learning Disabilities	MESH:D007859	therapeutic		NA		15451042
SIGMAR1	10280	Memory Disorders	MESH:D008569	therapeutic		NA		15451042
SIGMAR1	10280	Prenatal Exposure Delayed Effects	MESH:D011297	therapeutic		NA		15451042
SIGMAR1	10280	Seizures	MESH:D012640	marker/mechanism		NA		11684152
SIGMAR1	10280	Spinal muscular atrophy, Jerash type	MESH:C535715	marker/mechanism		NA	605726	
SIK1	150094	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
SIK1	150094	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		16243910
SIK1	150094	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 30	OMIM:616341	marker/mechanism		NA	616341	
SIL1	64374	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
SIL1	64374	Spinocerebellar Degenerations	MESH:D013132	marker/mechanism		NA	248800	
SIM1	6492	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		15818620
SIM1	6492	Hyperglycemia	MESH:D006943	marker/mechanism		NA		18056790
SIM2	6493	Cleft Palate	MESH:D002972	marker/mechanism		NA		12203729
SIM2	6493	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		12203729
SIN3A	25942	Agenesis of Corpus Callosum	MESH:D061085	marker/mechanism		NA		27399968
SIN3A	25942	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		27399968
SIN3A	25942	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		27399968
SIN3A	25942	Dwarfism	MESH:D004392	marker/mechanism		NA		27399968
SIN3A	25942	Hydrocephalus	MESH:D006849	marker/mechanism		NA		27399968
SIN3A	25942	Intellectual Disability	MESH:D008607	marker/mechanism		NA		27399968
SIN3A	25942	Microcephaly	MESH:D008831	marker/mechanism		NA		27399968
SIN3A	25942	WITTEVEEN-KOLK SYNDROME	OMIM:613406	marker/mechanism		NA	613406	
SIPA1	6494	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
SIPA1L1	26037	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
SIPA1L1	26037	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
SIPA1L1	26037	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
SIPA1L3	23094	CATARACT 45	OMIM:616851	marker/mechanism		NA	616851	
SIRPA	140885	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21472284
SIRT1	23411	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		21416250
SIRT1	23411	Atherosclerosis	MESH:D050197	marker/mechanism		NA		20068143
SIRT1	23411	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
SIRT1	23411	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		23993977
SIRT1	23411	Brain Infarction	MESH:D020520	marker/mechanism		NA		22878646
SIRT1	23411	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		22523472
SIRT1	23411	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19839049
SIRT1	23411	Ceroid lipofuscinosis, neuronal 1, infantile	MESH:C537948	marker/mechanism		NA		21224254
SIRT1	23411	Colitis	MESH:D003092	marker/mechanism		NA		19940103|24548422|24782617
SIRT1	23411	Demyelinating Diseases	MESH:D003711	therapeutic		NA		23547115
SIRT1	23411	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		24894401
SIRT1	23411	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		23090186|23792339
SIRT1	23411	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		23834033
SIRT1	23411	Diabetic Retinopathy	MESH:D003930	marker/mechanism		NA		24894401
SIRT1	23411	Encephalomyelitis, Autoimmune, Experimental	MESH:D004681	therapeutic		NA		23547115
SIRT1	23411	Fatty Liver	MESH:D005234	marker/mechanism|therapeutic		NA		21321189|23834033|24184811|24210820|24442997
SIRT1	23411	Fibrosis	MESH:D005355	marker/mechanism		NA		20651248
SIRT1	23411	Genomic Instability	MESH:D042822	marker/mechanism		NA		23217256
SIRT1	23411	Glucose Intolerance	MESH:D018149	therapeutic		NA		21321189
SIRT1	23411	Heart Diseases	MESH:D006331	marker/mechanism		NA		23217256
SIRT1	23411	Heart Failure	MESH:D006333	therapeutic		NA		24535859
SIRT1	23411	HIV Infections	MESH:D015658	marker/mechanism		NA		19720090
SIRT1	23411	Hypertrophy	MESH:D006984	therapeutic		NA		23297412
SIRT1	23411	Insulin Resistance	MESH:D007333	marker/mechanism|therapeutic		NA		20068143|21321189|24442997|25849131|26026874
SIRT1	23411	Liver Cirrhosis, Experimental	MESH:D008106	therapeutic		NA		26435214
SIRT1	23411	Lung Injury	MESH:D055370	therapeutic		NA		24633890
SIRT1	23411	Metabolic Syndrome	MESH:D024821	marker/mechanism		NA		20068143
SIRT1	23411	Myocardial Reperfusion Injury	MESH:D015428	therapeutic		NA		21060073
SIRT1	23411	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		27793039
SIRT1	23411	Nerve Degeneration	MESH:D009410	therapeutic		NA		17581637
SIRT1	23411	Neurodegenerative Diseases	MESH:D019636	therapeutic		NA		17581637|17652729
SIRT1	23411	Non-alcoholic Fatty Liver Disease	MESH:D065626	therapeutic		NA		26026874
SIRT1	23411	Obesity	MESH:D009765	therapeutic		NA		24184811
SIRT1	23411	Osteosarcoma	MESH:D012516	marker/mechanism		NA		27793039
SIRT1	23411	Paralysis	MESH:D010243	therapeutic		NA		23547115
SIRT1	23411	Pneumonia	MESH:D011014	therapeutic		NA		24633890
SIRT1	23411	Pneumonia, Pneumococcal	MESH:D011018	marker/mechanism		NA		24894820
SIRT1	23411	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		21062352
SIRT1	23411	Retinal Diseases	MESH:D012164	marker/mechanism		NA		23217256
SIRT1	23411	Scleroderma, Systemic	MESH:D012595	therapeutic		NA		25707573
SIRT1	23411	Thrombosis	MESH:D013927	therapeutic		NA		25339356
SIRT1	23411	Wallerian Degeneration	MESH:D014855	marker/mechanism		NA		24252177
SIRT3	23410	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		21472714
SIRT3	23410	Diabetes, Gestational	MESH:D016640	marker/mechanism		NA		23956348
SIRT3	23410	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		21472714
SIRT3	23410	Obesity	MESH:D009765	marker/mechanism		NA		23956348
SIRT4	23409	Cardiomegaly	MESH:D006332	marker/mechanism		NA		27099261
SIRT4	23409	Endomyocardial Fibrosis	MESH:D004719	marker/mechanism		NA		27099261
SIRT6	51548	Cardiomegaly	MESH:D006332	therapeutic		NA		22335191
SIRT6	51548	Fatty Liver	MESH:D005234	therapeutic		NA		28536482
SIRT7	51547	Fatty Liver	MESH:D005234	marker/mechanism		NA		24210820
SIRT7	51547	Reperfusion Injury	MESH:D015427	therapeutic		NA		28675767
SIRT7	51547	Scleroderma, Systemic	MESH:D012595	marker/mechanism		NA		25707573
SIVA1	10572	Coxsackievirus Infections	MESH:D003384	marker/mechanism		NA		16683188
SIX1	6495	Branchiootic Syndrome 3	MESH:C564248	marker/mechanism		NA	608389	
SIX1	6495	Branchio-Oto-Renal Syndrome	MESH:D019280	marker/mechanism		NA	113650	
SIX1	6495	Congenital Abnormalities	MESH:D000013	marker/mechanism		NA		12834866
SIX1	6495	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		12834866
SIX1	6495	Deafness, Autosomal Dominant 23	MESH:C565357	marker/mechanism		NA	605192	
SIX1	6495	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		27259717
SIX1	6495	Wilms Tumor	MESH:D009396	marker/mechanism		NA		28825729
SIX2	10736	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
SIX2	10736	Frontonasal dysplasia	MESH:C538065	marker/mechanism		NA		18570229
SIX2	10736	Kidney Diseases	MESH:D007674	marker/mechanism		NA		18570229
SIX2	10736	Wilms Tumor	MESH:D009396	marker/mechanism		NA		28825729
SIX3	6496	Familial schizencephaly	MESH:C538514	marker/mechanism		NA	269160	
SIX3	6496	Holoprosencephaly	MESH:D016142	marker/mechanism		NA		10369266
SIX3	6496	Holoprosencephaly 2	MESH:C563579	marker/mechanism		NA	157170	
SIX3	6496	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
SIX3	6496	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		19233941
SIX5	147912	Branchio-Oto-Renal Syndrome	MESH:D019280	marker/mechanism		NA	610896	
SIX6	4990	Microphthalmia, Isolated, with Cataract 2	MESH:C565876	marker/mechanism		NA	212550	
SIX6	4990	Microphthalmia, Syndromic 3	MESH:C565948	marker/mechanism		NA	206900	
SIX6	4990	Myopia	MESH:D009216	marker/mechanism		NA		23396134
SKA1	220134	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
SKA3	221150	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
SKAP1	8631	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		20852632
SKAP2	8935	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SKI	6497	Aortic Aneurysm	MESH:D001014	marker/mechanism		NA		23023332
SKI	6497	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		9284043
SKI	6497	Musculoskeletal Abnormalities	MESH:D009139	marker/mechanism		NA		9284043
SKI	6497	Neural Tube Defects	MESH:D009436	marker/mechanism		NA		9284043
SKI	6497	Shprintzen Golberg craniosynostosis	MESH:C537328	marker/mechanism		NA	182212	23023332
SKIL	6498	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
SKIL	6498	Paraquat lung	MESH:C537171	therapeutic		NA		23590892
SKIL	6498	Pulmonary Fibrosis	MESH:D011658	therapeutic		NA		23590892
SKIL	6498	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
SKIV2L	6499	Trichohepatoenteric Syndrome	MESH:C565627	marker/mechanism		NA	614602	
SKN-1	177343	Gait Disorders, Neurologic	MESH:D020233	marker/mechanism		NA		23555279
SKN-1	177343	Manganese Poisoning	MESH:D020149	therapeutic		NA		20865164
SKN-1	177343	Nerve Degeneration	MESH:D009410	therapeutic		NA		20865164|23106139
SKN-1	177343	Neuromuscular Manifestations	MESH:D020879	marker/mechanism		NA		23555279
SKP2	6502	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		12717389
SKP2	6502	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		18850583
SKP2	6502	Medulloblastoma	MESH:D008527	marker/mechanism		NA		19270706
SKP2	6502	Neoplasms	MESH:D009369	marker/mechanism		NA		18451165
SKP2	6502	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		19636294
SLA	6503	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SLA	6503	Vitiligo	MESH:D014820	marker/mechanism		NA		22561518
SLAMF8	56833	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA		28067908
SLAMF9	89886	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SLBP	7884	Coloboma	MESH:D003103	marker/mechanism		NA		30695021
SLBP	7884	Optic Atrophy	MESH:D009896	marker/mechanism		NA		30695021
SLBP	7884	Retinal Dysplasia	MESH:D015792	marker/mechanism		NA		30695021
SLC10A1	6554	Hepatitis B	MESH:D006509	marker/mechanism		NA		25550158
SLC10A1	6554	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
SLC10A2	6555	Bile Acid Malabsorption, Primary	MESH:C567652	marker/mechanism		NA	613291	
SLC10A2	6555	Cognition Disorders	MESH:D003072	marker/mechanism		NA		29382564
SLC10A2	6555	Diabetes Complications	MESH:D048909	marker/mechanism		NA		29382564
SLC10A2	6555	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		21245421
SLC10A2	6555	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
SLC10A6	345274	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		30186172
SLC10A7	84068	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		26881866
SLC10A7	84068	Cholestasis	MESH:D002779	marker/mechanism		NA		26881866
SLC11A1	6556	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		20623750
SLC11A1	6556	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		16597321
SLC11A1	6556	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		16597321
SLC11A1	6556	Buruli Ulcer	MESH:D054312	marker/mechanism		NA	610446	
SLC11A1	6556	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		16059695
SLC11A1	6556	Crohn Disease	MESH:D003424	marker/mechanism		NA		16059695
SLC11A1	6556	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		16597321
SLC11A1	6556	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		16597321
SLC11A1	6556	Food Hypersensitivity	MESH:D005512	marker/mechanism		NA		16597321
SLC11A1	6556	HIV Infections	MESH:D015658	marker/mechanism		NA		16597321
SLC11A1	6556	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA		16597321
SLC11A1	6556	Leishmaniasis, Visceral	MESH:D007898	marker/mechanism		NA		16597321
SLC11A1	6556	Leprosy	MESH:D007918	marker/mechanism		NA		16597321
SLC11A1	6556	Meningitis, Meningococcal	MESH:D008585	marker/mechanism		NA		16597321
SLC11A1	6556	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		16597321
SLC11A1	6556	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO	OMIM:607948	marker/mechanism		NA	607948	
SLC11A1	6556	Sarcoidosis	MESH:D012507	marker/mechanism		NA		16597321
SLC11A1	6556	Tuberculosis	MESH:D014376	marker/mechanism		NA		16597321
SLC11A2	4891	Anemia, Hypochromic Microcytic, With Iron Overload	MESH:C567144	marker/mechanism		NA	206100	
SLC11A2	4891	Anemia, Iron-Deficiency	MESH:D018798	marker/mechanism		NA		17116712
SLC11A2	4891	Hemochromatosis	MESH:D006432	marker/mechanism		NA		11439223
SLC11A2	4891	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
SLC12A1	6557	Bartter Syndrome	MESH:D001477	marker/mechanism		NA		10561751
SLC12A1	6557	Bartter syndrome, antenatal type 1	MESH:C537652	marker/mechanism		NA	601678	
SLC12A2	6558	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
SLC12A2	6558	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		15135928
SLC12A2	6558	Epilepsy	MESH:D004827	marker/mechanism		NA		18550034
SLC12A2	6558	Epilepsy, Temporal Lobe	MESH:D004833	marker/mechanism		NA		19674083
SLC12A2	6558	Glucose Intolerance	MESH:D018149	marker/mechanism		NA		22872759
SLC12A2	6558	Hypertension	MESH:D006973	marker/mechanism		NA		17259435
SLC12A2	6558	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
SLC12A2	6558	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
SLC12A2	6558	Movement Disorders	MESH:D009069	marker/mechanism		NA		15135928
SLC12A2	6558	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
SLC12A3	6559	Gitelman Syndrome	MESH:D053579	marker/mechanism		NA	263800	10561751
SLC12A3	6559	Hypertension	MESH:D006973	marker/mechanism		NA		18480177
SLC12A3	6559	Kidney Diseases	MESH:D007674	marker/mechanism		NA		21865292
SLC12A3	6559	Vascular Diseases	MESH:D014652	marker/mechanism		NA		23348737
SLC12A5	57468	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 34	OMIM:616645	marker/mechanism		NA	616645	
SLC12A5	57468	Epilepsy	MESH:D004827	marker/mechanism		NA		12000122|18550034
SLC12A5	57468	Epilepsy, Idiopathic Generalized	MESH:C562694	marker/mechanism		NA	616685	
SLC12A5	57468	Epilepsy, Temporal Lobe	MESH:D004833	marker/mechanism		NA		19674083
SLC12A5	57468	Hyperalgesia	MESH:D006930	marker/mechanism		NA		20086212
SLC12A5	57468	Seizures	MESH:D012640	marker/mechanism		NA		20086212
SLC12A5	57468	Status Epilepticus	MESH:D013226	marker/mechanism		NA		20600929
SLC12A6	9990	Corpus callosum agenesis neuronopathy	MESH:C536446	marker/mechanism		NA	218000	
SLC12A6	9990	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		21245421
SLC12A7	10723	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		26039340
SLC13A4	26266	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
SLC13A4	26266	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		25226513
SLC13A5	284111	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 25, WITH AMELOGENESIS IMPERFECTA	OMIM:615905	marker/mechanism		NA	615905	
SLC13A5	284111	Fatty Liver	MESH:D005234	marker/mechanism		NA		26303333
SLC14A1	6563	Anemia, Hemolytic, Autoimmune	MESH:D000744	marker/mechanism		NA		6427987
SLC15A2	6565	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
SLC15A2	6565	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
SLC15A2	6565	Melanoma	MESH:D008545	marker/mechanism		NA		22842228
SLC15A3	51296	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SLC15A4	121260	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		19838193
SLC16A1	6566	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		11953883
SLC16A1	6566	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		11953883
SLC16A1	6566	Erythrocyte Lactate Transporter Defect	MESH:C565449	marker/mechanism		NA	245340	
SLC16A1	6566	Hyperinsulinemic hypoglycemia, familial, 7	MESH:C538376	marker/mechanism		NA	610021	
SLC16A1	6566	MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY	OMIM:616095	marker/mechanism		NA	616095	
SLC16A12	387700	Cataract, Juvenile, With Microcornea And Glucosuria	MESH:C567434	marker/mechanism		NA	612018	
SLC16A2	6567	Allan-Herndon-Dudley syndrome	MESH:C537047	marker/mechanism		NA	300523	
SLC16A2	6567	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		24781735
SLC16A2	6567	Cholestasis	MESH:D002779	marker/mechanism		NA		27989131
SLC16A2	6567	Hypothyroidism	MESH:D007037	marker/mechanism		NA		31121238
SLC16A3	9123	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		22313602
SLC16A3	9123	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		27224918
SLC16A6	9120	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
SLC16A7	9194	Obesity	MESH:D009765	marker/mechanism		NA		20882379
SLC16A8	23539	Macular Degeneration	MESH:D008268	marker/mechanism		NA		26691988
SLC17A1	6568	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980|25380136
SLC17A2	10246	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		25226513
SLC17A2	10246	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SLC17A3	10786	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4	OMIM:612671	marker/mechanism		NA	612671	
SLC17A5	26503	Melanoma	MESH:D008545	marker/mechanism		NA		21499247
SLC17A5	26503	Sialic Acid Storage Disease	MESH:D029461	marker/mechanism		NA	269920|604369	
SLC17A6	57084	Learning Disabilities	MESH:D007859	marker/mechanism		NA		21295146
SLC17A6	57084	Memory Disorders	MESH:D008569	marker/mechanism		NA		21295146
SLC17A7	57030	Learning Disabilities	MESH:D007859	marker/mechanism		NA		21295146
SLC17A7	57030	Memory Disorders	MESH:D008569	marker/mechanism		NA		21295146
SLC17A7	57030	Seizures	MESH:D012640	marker/mechanism		NA		18495095
SLC17A8	246213	Deafness, Autosomal Dominant 25	MESH:C565319	marker/mechanism		NA	605583	
SLC17A9	63910	POROKERATOSIS 8, DISSEMINATED SUPERFICIAL ACTINIC TYPE	OMIM:616063	marker/mechanism		NA	616063	
SLC18A2	6571	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		18643795
SLC18A2	6571	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		12890883
SLC18A2	6571	Parkinson Disease	MESH:D010300	marker/mechanism		NA		16112329
SLC18A2	6571	Parkinsonian Disorders	MESH:D020734	therapeutic		NA		16269145
SLC18A3	6572	Myasthenic Syndromes, Congenital	MESH:D020294	marker/mechanism		NA	617239	
SLC19A1	6573	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
SLC19A1	6573	Adenoma	MESH:D000236	marker/mechanism		NA		16963246
SLC19A1	6573	Autistic Disorder	MESH:D001321	marker/mechanism		NA		16917939|20468076
SLC19A1	6573	Cleft Lip	MESH:D002971	marker/mechanism		NA		21254359
SLC19A1	6573	Cleft Palate	MESH:D002972	marker/mechanism		NA		21254359
SLC19A1	6573	Clinical Deterioration	MESH:D000075902	marker/mechanism		NA		27602772
SLC19A1	6573	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15705887
SLC19A1	6573	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		16963246
SLC19A1	6573	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
SLC19A1	6573	Down Syndrome	MESH:D004314	marker/mechanism		NA		16845273|17431899
SLC19A1	6573	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		21064136
SLC19A1	6573	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		21064136
SLC19A1	6573	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		17255265
SLC19A1	6573	Recurrence	MESH:D012008	marker/mechanism		NA		17255265
SLC19A1	6573	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		21760912
SLC19A2	10560	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SLC19A2	10560	Thiamine responsive megaloblastic anemia syndrome	MESH:C536510	marker/mechanism		NA	249270	
SLC19A3	80704	Basal ganglia disease, biotin-responsive	MESH:C537658	marker/mechanism		NA	607483	15871139
SLC19A3	80704	Basal Ganglia Diseases	MESH:D001480	marker/mechanism		NA		19387023
SLC1A1	6505	Atrophy	MESH:D001284	marker/mechanism		NA		22575539
SLC1A1	6505	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		31209396
SLC1A1	6505	Brain Diseases	MESH:D001927	marker/mechanism		NA		22575539
SLC1A1	6505	Cognition Disorders	MESH:D003072	marker/mechanism		NA		22575539
SLC1A1	6505	Dicarboxylicaminoaciduria	MESH:C536171	marker/mechanism		NA	222730	
SLC1A1	6505	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
SLC1A1	6505	Epilepsy	MESH:D004827	marker/mechanism		NA		12151515
SLC1A1	6505	Epilepsy, Temporal Lobe	MESH:D004833	marker/mechanism		NA		11906504
SLC1A1	6505	Low Tension Glaucoma	MESH:D057066	marker/mechanism		NA		28703795
SLC1A1	6505	Malformations of Cortical Development	MESH:D054220	marker/mechanism		NA		11906504
SLC1A1	6505	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		28703795
SLC1A1	6505	Retinal Degeneration	MESH:D012162	marker/mechanism		NA		28703795
SLC1A1	6505	Schizophrenia	MESH:D012559	marker/mechanism		NA	615232	
SLC1A1	6505	Seizures	MESH:D012640	marker/mechanism		NA		23262392
SLC1A2	6506	Amyotrophic Lateral Sclerosis	MESH:D000690	marker/mechanism		NA		11723166
SLC1A2	6506	Cocaine-Related Disorders	MESH:D019970	therapeutic		NA		19625514
SLC1A2	6506	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		30718926
SLC1A2	6506	Epilepsy	MESH:D004827	marker/mechanism		NA		19853022
SLC1A2	6506	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41	OMIM:617105	marker/mechanism		NA	617105	
SLC1A2	6506	Nerve Degeneration	MESH:D009410	therapeutic		NA		22645130
SLC1A2	6506	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21471434
SLC1A3	6507	Autistic Disorder	MESH:D001321	marker/mechanism		NA		11706102
SLC1A3	6507	Epilepsy	MESH:D004827	marker/mechanism		NA		19853022
SLC1A3	6507	Episodic Ataxia, Type 6	MESH:C567207	marker/mechanism		NA	612656	
SLC20A1	6574	Aortic Valve, Calcification of	MESH:C562942	marker/mechanism		NA		23308213
SLC20A1	6574	Bone Diseases, Metabolic	MESH:D001851	marker/mechanism		NA		26773408
SLC20A1	6574	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
SLC20A1	6574	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SLC20A2	6575	Basal Ganglia Diseases	MESH:D001480	marker/mechanism		NA		25938945
SLC20A2	6575	Calcinosis	MESH:D002114	marker/mechanism		NA		25938945
SLC20A2	6575	Fahr's disease	MESH:C536275	marker/mechanism		NA	213600	22327515
SLC22A1	6580	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
SLC22A1	6580	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
SLC22A1	6580	Obesity	MESH:D009765	marker/mechanism		NA		20956498
SLC22A10	387775	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560|30705370
SLC22A10	387775	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		30705370
SLC22A10	387775	Glioblastoma	MESH:D005909	marker/mechanism		NA		30705370
SLC22A10	387775	Lymphatic Metastasis	MESH:D008207	marker/mechanism		NA		30705370
SLC22A10	387775	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		30705370
SLC22A12	116085	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		14655203
SLC22A12	116085	Renal hypouricemia	MESH:C537757	marker/mechanism		NA	220150	14655203|14694169|22132990
SLC22A15	55356	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		21278247
SLC22A16	85413	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
SLC22A18	5002	Breast Neoplasms	MESH:D001943	marker/mechanism		NA	114480	
SLC22A18	5002	Lung Neoplasms	MESH:D008175	marker/mechanism		NA	211980	
SLC22A18	5002	Rhabdomyosarcoma 1	MESH:C537883	marker/mechanism		NA	268210	
SLC22A2	6582	Kidney Diseases	MESH:D007674	therapeutic		NA		22525860
SLC22A2	6582	Obesity	MESH:D009765	marker/mechanism		NA		27401566
SLC22A2	6582	Poisoning	MESH:D011041	therapeutic		NA		22525860
SLC22A23	63027	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SLC22A24	283238	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		23649842|26230185
SLC22A3	6581	Coxsackievirus Infections	MESH:D003384	marker/mechanism		NA		21641380
SLC22A3	6581	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28869590
SLC22A3	6581	Myocarditis	MESH:D009205	marker/mechanism		NA		21641380
SLC22A3	6581	Obesity	MESH:D009765	marker/mechanism		NA		27401566
SLC22A3	6581	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17173048
SLC22A3	6581	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		17010131
SLC22A4	6583	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA	180300	
SLC22A4	6583	Coxsackievirus Infections	MESH:D003384	marker/mechanism		NA		21641380
SLC22A4	6583	Enterovirus Infections	MESH:D004769	marker/mechanism		NA		21641380
SLC22A4	6583	Myocarditis	MESH:D009205	marker/mechanism		NA		21641380
SLC22A5	6584	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		21641380
SLC22A5	6584	Coxsackievirus Infections	MESH:D003384	marker/mechanism		NA		21641380
SLC22A5	6584	Inflammation	MESH:D007249	marker/mechanism		NA		21641380
SLC22A5	6584	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
SLC22A5	6584	Myocarditis	MESH:D009205	marker/mechanism		NA		21641380
SLC22A5	6584	Systemic carnitine deficiency	MESH:C536778	marker/mechanism		NA	212140	17703373
SLC22A6	9356	Calcinosis	MESH:D002114	marker/mechanism		NA		12803500
SLC22A8	9376	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
SLC22A8	9376	Fatty Liver	MESH:D005234	marker/mechanism		NA		25226513
SLC22A8	9376	Influenza, Human	MESH:D007251	marker/mechanism		NA		23129053
SLC22A8	9376	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		25226513
SLC22A8	9376	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SLC23A1	9963	Cholestasis	MESH:D002779	marker/mechanism		NA		18706437
SLC23A1	9963	Intracranial Hemorrhages	MESH:D020300	marker/mechanism		NA		11984597
SLC23A1	9963	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SLC23A1	9963	Respiratory Insufficiency	MESH:D012131	marker/mechanism		NA		11984597
SLC23A2	9962	Cholestasis	MESH:D002779	marker/mechanism		NA		18706437
SLC24A1	9187	Night blindness, congenital stationary	MESH:C536122	marker/mechanism		NA	613830	
SLC24A3	57419	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
SLC24A3	57419	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
SLC24A4	123041	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA5	OMIM:615887	marker/mechanism		NA	615887	
SLC24A5	283652	Skin-Hair-Eye Pigmentation, Variation In, 4	MESH:C567300	marker/mechanism		NA	113750	
SLC25A1	6576	2-Hydroxyglutaricaciduria	MESH:C535306	marker/mechanism		NA	615182	
SLC25A10	1468	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
SLC25A10	1468	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
SLC25A10	1468	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
SLC25A11	8402	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
SLC25A12	8604	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		12833524
SLC25A12	8604	Autistic Disorder	MESH:D001321	marker/mechanism		NA		15056512|18348195
SLC25A12	8604	Hypomyelination, Global Cerebral	MESH:C567847	marker/mechanism		NA	612949	
SLC25A13	10165	Adult-onset citrullinemia type 2	MESH:C538053	marker/mechanism		NA	603471	16449956
SLC25A13	10165	Fractures, Bone	MESH:D050723	marker/mechanism		NA		22504420
SLC25A13	10165	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SLC25A13	10165	Neonatal-onset citrullinemia type 2	MESH:C536398	marker/mechanism		NA	605814	
SLC25A15	10166	HHH syndrome	MESH:C538380	marker/mechanism		NA	238970	
SLC25A19	60386	Amish lethal microcephaly	MESH:C538247	marker/mechanism		NA	607196	
SLC25A19	60386	THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY TYPE)	OMIM:613710	marker/mechanism		NA	613710	
SLC25A20	788	Carnitine-Acylcarnitine Translocase Deficiency	MESH:C562812	marker/mechanism		NA	212138	
SLC25A22	79751	Epileptic Encephalopathy, Early Infantile, 3	MESH:C562695	marker/mechanism		NA	609304	
SLC25A24	29957	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SLC25A26	115286	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	OMIM:616794	marker/mechanism		NA	616794	
SLC25A29	123096	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
SLC25A3	5250	Mitochondrial Phosphate Carrier Deficiency	MESH:C563665	marker/mechanism		NA	610773	
SLC25A30	253512	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SLC25A37	51312	Anemia	MESH:D000740	marker/mechanism		NA		22253756
SLC25A38	54977	Anemia, Sideroblastic	MESH:D000756	marker/mechanism		NA		19412178
SLC25A38	54977	Anemia, Sideroblastic, Pyridoxine-Refractory, Autosomal Recessive	MESH:C567145	marker/mechanism		NA	205950	
SLC25A4	291	Diabetic Cardiomyopathies	MESH:D058065	therapeutic		NA		18945756
SLC25A4	291	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SLC25A4	291	MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT	OMIM:617184	marker/mechanism		NA	617184	
SLC25A4	291	MITOCHONDRIAL DNA DEPLETION SYNDROME 12B (CARDIOMYOPATHIC TYPE), AUTOSOMAL RECESSIVE	OMIM:615418	marker/mechanism		NA	615418	
SLC25A4	291	Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 2	MESH:C563750	marker/mechanism		NA	609283	
SLC25A45	283130	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
SLC25A46	91137	Charcot-Marie-Tooth Disease	MESH:D002607	marker/mechanism		NA		26168012
SLC25A46	91137	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB, WITH OPTIC ATROPHY	OMIM:616505	marker/mechanism		NA	616505	
SLC25A46	91137	Optic Atrophy	MESH:D009896	marker/mechanism		NA		26168012
SLC25A47	283600	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
SLC26A1	10861	Hyperoxaluria	MESH:D006959	marker/mechanism		NA		20160351
SLC26A1	10861	Nephrocalcinosis	MESH:D009397	marker/mechanism		NA		20160351
SLC26A1	10861	Nephrolithiasis, Calcium Oxalate	MESH:C563477	marker/mechanism		NA	167030	
SLC26A1	10861	Urolithiasis	MESH:D052878	marker/mechanism		NA		19002488|20160351
SLC26A2	1836	Achondrogenesis type 1B	MESH:C536016	marker/mechanism		NA	600972	
SLC26A2	1836	Atelosteogenesis type 2	MESH:C535395	marker/mechanism		NA	256050	
SLC26A2	1836	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		18925670
SLC26A2	1836	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		18925670
SLC26A2	1836	Diastrophic dysplasia	MESH:C536170	marker/mechanism		NA	222600	
SLC26A2	1836	Ear Diseases	MESH:D004427	marker/mechanism		NA		18925670
SLC26A2	1836	Epiphyseal dysplasia, multiple, 4	MESH:C535504	marker/mechanism		NA	226900	
SLC26A2	1836	Kyphosis	MESH:D007738	marker/mechanism		NA		18925670
SLC26A3	1811	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		19915573
SLC26A3	1811	Congenital chloride diarrhea	MESH:C536210	marker/mechanism		NA	214700	
SLC26A4	5172	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT	OMIM:600791	marker/mechanism		NA	600791	
SLC26A4	5172	Goiter	MESH:D006042	marker/mechanism		NA		15279074|16053392|17322586
SLC26A4	5172	Hearing Loss	MESH:D034381	marker/mechanism		NA		22116360|29320412
SLC26A4	5172	Hearing Loss, Sensorineural	MESH:D006319	marker/mechanism		NA		15279074|16053392|17322586
SLC26A4	5172	Pendred syndrome	MESH:C536648	marker/mechanism		NA	274600	10644529|17697873
SLC26A4	5172	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
SLC26A5	375611	Deafness	MESH:D003638	marker/mechanism		NA		12719379
SLC26A5	375611	DEAFNESS, AUTOSOMAL RECESSIVE 61	OMIM:613865	marker/mechanism		NA	613865	
SLC26A6	65010	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
SLC26A7	115111	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
SLC26A8	116369	Azoospermia, Nonobstructive	MESH:C564665	marker/mechanism		NA	606766	
SLC26A8	116369	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
SLC26A9	115019	CYSTIC FIBROSIS, MODIFIER OF, 1	OMIM:603855	marker/mechanism		NA		22466613
SLC26A9	115019	Intestinal Obstruction	MESH:D007415	marker/mechanism		NA		22466613
SLC27A2	11001	Fibrosis	MESH:D005355	marker/mechanism		NA		28871336
SLC27A4	10999	Ichthyosis prematurity syndrome	MESH:C536271	marker/mechanism		NA	608649	
SLC27A6	28965	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
SLC28A1	9154	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16837820
SLC29A1	2030	Alcohol Withdrawal Seizures	MESH:D020270	marker/mechanism		NA		21283641
SLC29A1	2030	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27567601
SLC29A1	2030	Huntington Disease	MESH:D006816	marker/mechanism		NA		27567601
SLC29A1	2030	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		18728667
SLC29A3	55315	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		19336477|20140240
SLC29A3	55315	Hearing Loss	MESH:D034381	marker/mechanism		NA		20140240
SLC29A3	55315	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		20140240
SLC29A3	55315	Hepatomegaly	MESH:D006529	marker/mechanism		NA		20140240
SLC29A3	55315	Histiocytosis	MESH:D015614	marker/mechanism		NA		22238637
SLC29A3	55315	Histiocytosis, Sinus	MESH:D015618	marker/mechanism		NA		20140240
SLC29A3	55315	Histiocytosis with joint contractures and sensorineural deafness	MESH:C538322	marker/mechanism		NA	602782	20140240
SLC29A3	55315	Hyperpigmentation	MESH:D017495	marker/mechanism		NA		19336477|20140240
SLC29A3	55315	Hypertrichosis	MESH:D006983	marker/mechanism		NA		19336477|20140240
SLC29A3	55315	Hypogonadism	MESH:D007006	marker/mechanism		NA		20140240
SLC2A1	6513	Ataxia	MESH:D001259	marker/mechanism		NA		11603379
SLC2A1	6513	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20197467
SLC2A1	6513	Carcinoma, Ductal	MESH:D044584	marker/mechanism		NA		20526721
SLC2A1	6513	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		8364915
SLC2A1	6513	Carcinoma, Intraductal, Noninfiltrating	MESH:D002285	marker/mechanism		NA		20526721
SLC2A1	6513	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		7921415
SLC2A1	6513	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		11953883
SLC2A1	6513	Choreoathetosis-Spasticity, Episodic	MESH:C563401	marker/mechanism		NA	601042	
SLC2A1	6513	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		11953883
SLC2A1	6513	Cryohydrocytosis, Stomatin-Deficient, with Mental Retardation, Seizures, Cataracts, and Massive Hepatosplenomegaly	MESH:C563840	marker/mechanism		NA	608885	
SLC2A1	6513	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		10980529|11603379|9462754
SLC2A1	6513	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		9589670
SLC2A1	6513	Glut1 Deficiency Syndrome	MESH:C536830	marker/mechanism		NA	606777	10980529|11603379|17489814|9462754
SLC2A1	6513	GLUT1 DEFICIENCY SYNDROME 2	OMIM:612126	marker/mechanism		NA	612126	
SLC2A1	6513	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
SLC2A1	6513	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		26943884
SLC2A1	6513	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		22784439
SLC2A1	6513	Metabolism, Inborn Errors	MESH:D008661	marker/mechanism		NA		23452774
SLC2A1	6513	Microcephaly	MESH:D008831	marker/mechanism		NA		10980529|9462754
SLC2A1	6513	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		23452774
SLC2A1	6513	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18973239
SLC2A1	6513	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		20138251
SLC2A1	6513	Peritoneal Neoplasms	MESH:D010534	marker/mechanism		NA		22784439
SLC2A1	6513	Seizures	MESH:D012640	marker/mechanism		NA		10980529|11603379|9462754
SLC2A10	81031	Arterial Tortuosity Syndrome	MESH:C565942	marker/mechanism		NA	208050	
SLC2A10	81031	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25151356
SLC2A13	114134	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
SLC2A14	144195	Parkinson Disease	MESH:D010300	marker/mechanism		NA		25475535
SLC2A2	6514	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19579870
SLC2A2	6514	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		8364915
SLC2A2	6514	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		16123366
SLC2A2	6514	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA	125853	16123366
SLC2A2	6514	Fanconi Syndrome	MESH:D005198	marker/mechanism		NA	227810	11810292
SLC2A2	6514	Fatty Liver	MESH:D005234	marker/mechanism		NA		12048068
SLC2A3	6515	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
SLC2A3	6515	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17374397
SLC2A3	6515	Lipidoses	MESH:D008064	marker/mechanism		NA		15342952|16919414
SLC2A3	6515	Neoplasms, Germ Cell and Embryonal	MESH:D009373	marker/mechanism		NA		16168501
SLC2A4	6517	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		24055495
SLC2A4	6517	Cardiomegaly	MESH:D006332	marker/mechanism		NA		22221582
SLC2A4	6517	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		11947963|14563825|18266981|22138235
SLC2A4	6517	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		11947963|17107852|22384078|31626838
SLC2A4	6517	Insulin Resistance	MESH:D007333	therapeutic		NA		11947963
SLC2A5	6518	Breast Neoplasms	MESH:D001943	therapeutic		NA		15449313
SLC2A9	56606	Gout	MESH:D006073	marker/mechanism		NA		18327256|18327257
SLC2A9	56606	Hyperuricemia	MESH:D033461	marker/mechanism		NA		18989453
SLC2A9	56606	Hypouricemia, Renal, 2	MESH:C567426	marker/mechanism		NA	612076	
SLC2A9	56606	Renal hypouricemia	MESH:C537757	marker/mechanism		NA		18989453|22132990
SLC30A1	7779	Seizures	MESH:D012640	marker/mechanism		NA		23266720
SLC30A10	55532	Cholestasis	MESH:D002779	marker/mechanism		NA		27989131
SLC30A10	55532	Dystonia	MESH:D004421	marker/mechanism		NA		22926781
SLC30A10	55532	HYPERMANGANESEMIA WITH DYSTONIA 1	OMIM:613280	marker/mechanism		NA	613280	
SLC30A10	55532	Hypermanganesemia with Dystonia Polycythemia and Cirrhosis	MESH:C548016	marker/mechanism		NA		22341971|22926781
SLC30A10	55532	Hypothyroidism	MESH:D007037	marker/mechanism		NA		28860195
SLC30A10	55532	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		22926781
SLC30A10	55532	Manganese Poisoning	MESH:D020149	marker/mechanism		NA		28860195|29429640
SLC30A10	55532	Parkinson Disease	MESH:D010300	marker/mechanism		NA		25149416
SLC30A10	55532	Parkinsonian Disorders	MESH:D020734	marker/mechanism		NA		26220508
SLC30A10	55532	Polycythemia	MESH:D011086	marker/mechanism		NA		22926781
SLC30A2	7780	Zinc Deficiency, Neonatal, due to Low Breast Milk Zinc	MESH:C564286	marker/mechanism		NA	608118	17065149
SLC30A4	7782	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		16580781
SLC30A4	7782	Respiratory Hypersensitivity	MESH:D012130	marker/mechanism		NA		17085522
SLC30A6	55676	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		16580781
SLC30A7	148867	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		17068819
SLC30A8	169026	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism|therapeutic		NA	125853	19479076|19542200|20424817|21461562|21779873|24584071
SLC31A1	1317	Congenital Abnormalities	MESH:D000013	marker/mechanism		NA		11391004
SLC31A1	1317	Embryo Loss	MESH:D020964	marker/mechanism		NA		11391004
SLC31A1	1317	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		24614111
SLC31A1	1317	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
SLC31A1	1317	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		23792645
SLC31A1	1317	Manganese Poisoning	MESH:D020149	marker/mechanism		NA		22465424
SLC31A1	1317	Necrosis	MESH:D009336	marker/mechanism		NA		19144690
SLC31A1	1317	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		25320179
SLC33A1	9197	Cataract	MESH:D002386	marker/mechanism		NA		22243965
SLC33A1	9197	CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION	OMIM:614482	marker/mechanism		NA	614482	
SLC33A1	9197	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		22243965
SLC33A1	9197	Hearing Loss	MESH:D034381	marker/mechanism		NA		22243965
SLC33A1	9197	Spastic Paraplegia 42, Autosomal Dominant	MESH:C567262	marker/mechanism		NA	612539	
SLC34A1	6569	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		9560283
SLC34A1	6569	Fanconi Syndrome	MESH:D005198	marker/mechanism		NA	613388	
SLC34A1	6569	Hypercalcemia	MESH:D006934	marker/mechanism		NA		9560283
SLC34A1	6569	Hypercalcemia, Infantile	MESH:C562999	marker/mechanism		NA	616963	
SLC34A1	6569	Hypercalciuria	MESH:D053565	marker/mechanism		NA		9560283
SLC34A1	6569	Hypophosphatemia	MESH:D017674	marker/mechanism		NA		9560283
SLC34A1	6569	NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1	OMIM:612286	marker/mechanism		NA	612286	
SLC34A2	10568	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		22617245|22919003
SLC34A2	10568	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		15805072
SLC34A2	10568	Pulmonary Alveolar Microlithiasis	MESH:C562405	marker/mechanism		NA	265100	
SLC34A3	142680	Hypophosphatemic Rickets with Hypercalciuria, Hereditary	MESH:C562793	marker/mechanism		NA	241530	
SLC35A1	10559	Congenital Disorder Of Glycosylation, Type IIF	MESH:C567040	marker/mechanism		NA	603585	
SLC35A2	7355	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm	OMIM:300896	marker/mechanism		NA	300896	
SLC35A3	23443	ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	OMIM:615553	marker/mechanism		NA	615553	
SLC35C1	55343	Congenital disorder of glycosylation, type 2C	MESH:C535755	marker/mechanism		NA	266265	
SLC35D1	23169	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		16759393
SLC35D1	23169	Schneckenbecken dysplasia	MESH:C536637	marker/mechanism		NA	269250	
SLC35F1	222553	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
SLC35F3	148641	Diverticular Diseases	MESH:D000076385	marker/mechanism		NA		30177863
SLC35G2	80723	Melanoma	MESH:D008545	marker/mechanism		NA		16778180
SLC36A2	153201	HYPERGLYCINURIA	OMIM:138500	marker/mechanism		NA	138500	
SLC36A2	153201	Iminoglycinuria	MESH:C536285	marker/mechanism		NA	242600	
SLC37A4	2542	Glycogen Storage Disease IB	MESH:C562594	marker/mechanism		NA	232220	
SLC37A4	2542	Glycogen Storage Disease IC	MESH:C562805	marker/mechanism		NA	232240	
SLC37A4	2542	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
SLC38A8	146167	Foveal Hypoplasia and Anterior Segment Dysgenesis	MESH:C563774	marker/mechanism		NA	609218	
SLC38A9	153129	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
SLC39A1	27173	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16700911|19208208
SLC39A1	27173	Respiratory Hypersensitivity	MESH:D012130	marker/mechanism		NA		17085522
SLC39A10	57181	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		17359283
SLC39A12	221074	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
SLC39A13	91252	Bone Diseases	MESH:D001847	marker/mechanism		NA		22228435
SLC39A13	91252	Connective Tissue Diseases	MESH:D003240	marker/mechanism		NA		18985159|22228435
SLC39A13	91252	Ehlers-Danlos Syndrome	MESH:D004535	marker/mechanism		NA		18985159
SLC39A13	91252	Kyphosis	MESH:D007738	marker/mechanism		NA		18985159
SLC39A13	91252	Spondylocheirodysplasia, Ehlers-Danlos Syndrome-Like	MESH:C567340	marker/mechanism		NA	612350	
SLC39A13	91252	Tooth Abnormalities	MESH:D014071	marker/mechanism		NA		18985159|22228435
SLC39A14	23516	HYPERMANGANESEMIA WITH DYSTONIA 2	OMIM:617013	marker/mechanism		NA	617013	
SLC39A14	23516	Manganese Poisoning	MESH:D020149	marker/mechanism		NA		28860195
SLC39A14	23516	Respiratory Hypersensitivity	MESH:D012130	marker/mechanism		NA		17085522
SLC39A4	55630	Acrodermatitis	MESH:D000169	marker/mechanism		NA		16714095|16819703|16889938|17190629|17202136
SLC39A4	55630	Acrodermatitis enteropathica	MESH:C538178	marker/mechanism		NA	201100	12068297|14709598|15358787|17483098
SLC39A4	55630	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		20957146
SLC39A4	55630	Prenatal Injuries	MESH:D049188	marker/mechanism		NA		17483098
SLC39A4	55630	Respiratory Hypersensitivity	MESH:D012130	marker/mechanism		NA		17085522
SLC39A5	283375	MYOPIA 24, AUTOSOMAL DOMINANT	OMIM:615946	marker/mechanism		NA	615946	
SLC39A6	25800	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		12839489
SLC39A6	25800	Esophageal Squamous Cell Carcinoma	MESH:D000077277	therapeutic		NA		23644492
SLC39A6	25800	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SLC39A6	25800	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		12839489
SLC39A8	64116	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn	OMIM:616721	marker/mechanism		NA	616721	
SLC39A8	64116	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SLC39A8	64116	Manganese Poisoning	MESH:D020149	marker/mechanism		NA		29429640
SLC3A1	6519	Cystinuria	MESH:D003555	marker/mechanism		NA	220100	
SLC3A1	6519	Hypotonia-Cystinuria Syndrome	MESH:C564710	marker/mechanism		NA		26247364
SLC3A2	6520	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		26621329
SLC40A1	30061	Anemia	MESH:D000740	marker/mechanism		NA		16434484
SLC40A1	30061	Autistic Disorder	MESH:D001321	marker/mechanism		NA		15446388
SLC40A1	30061	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		21785164
SLC40A1	30061	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
SLC40A1	30061	Familial apoceruloplasmin deficiency	MESH:C536004	marker/mechanism		NA		20655381
SLC40A1	30061	Hemochromatosis	MESH:D006432	marker/mechanism		NA		16457665|21411349
SLC40A1	30061	Hemochromatosis, type 4	MESH:C537249	marker/mechanism		NA	606069	
SLC40A1	30061	Hemolysis	MESH:D006461	marker/mechanism		NA		25247420
SLC40A1	30061	Iron Overload	MESH:D019190	marker/mechanism		NA		17052926
SLC40A1	30061	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		21785164
SLC43A2	124935	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SLC43A3	29015	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		25133636
SLC44A2	57153	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SLC45A2	51151	Carcinoma, Basal Cell	MESH:D002280	marker/mechanism		NA		19578363
SLC45A2	51151	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		19578363
SLC45A2	51151	Melanoma	MESH:D008545	marker/mechanism		NA		18563784|21559390
SLC45A2	51151	Oculocutaneous Albinism, Type IV	MESH:C564696	marker/mechanism		NA	606574	
SLC45A2	51151	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
SLC46A1	113235	Anemia	MESH:D000740	marker/mechanism		NA		21346251
SLC46A1	113235	Folate Malabsorption, Hereditary	MESH:C562799	marker/mechanism		NA	229050	21346251
SLC46A1	113235	Hyperhomocysteinemia	MESH:D020138	marker/mechanism		NA		19204075
SLC46A1	113235	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SLC46A1	113235	Malabsorption Syndromes	MESH:D008286	marker/mechanism		NA		17129779|17446347
SLC46A1	113235	Pancytopenia	MESH:D010198	marker/mechanism		NA		21346251
SLC47A1	55244	Kidney Diseases	MESH:D007674	marker/mechanism		NA		24001450
SLC4A1	6521	Acidosis, Renal Tubular	MESH:D000141	marker/mechanism		NA	179800	23460825|9312167
SLC4A1	6521	Anemia, Hemolytic	MESH:D000743	marker/mechanism		NA		16227998
SLC4A1	6521	Elliptocytosis, Hereditary	MESH:D004612	marker/mechanism		NA		1737855
SLC4A1	6521	Hematologic Diseases	MESH:D006402	marker/mechanism		NA		8343110
SLC4A1	6521	Malaria	MESH:D008288	marker/mechanism		NA	611162	
SLC4A1	6521	Ovalocytosis, Malaysian-Melanesian-Filipino Type	MESH:C566230	marker/mechanism		NA	166900	
SLC4A1	6521	Pseudohyperkalemia Cardiff	MESH:C535827	marker/mechanism		NA	185020	
SLC4A1	6521	Renal Tubular Acidosis, Distal, With Hemolytic Anemia	MESH:C566910	marker/mechanism		NA	611590	
SLC4A1	6521	Spherocytosis, Hereditary	MESH:D013103	marker/mechanism		NA		1378323
SLC4A1	6521	Spherocytosis, Type 4	MESH:C567208	marker/mechanism		NA	612653	
SLC4A10	57282	Cognition Disorders	MESH:D003072	marker/mechanism		NA		18413482
SLC4A10	57282	Epilepsy	MESH:D004827	therapeutic		NA		18165320
SLC4A10	57282	Epilepsy, Frontal Lobe	MESH:D017034	marker/mechanism		NA		18413482
SLC4A10	57282	Intellectual Disability	MESH:D008607	marker/mechanism		NA		18413482
SLC4A10	57282	Intracranial Hypertension	MESH:D019586	therapeutic		NA		18165320
SLC4A11	83959	Corneal dystrophy and perceptive deafness	MESH:C535473	marker/mechanism		NA	217400	
SLC4A11	83959	Corneal Dystrophy, Fuchs Endothelial, 4	MESH:C567677	marker/mechanism		NA	613268	
SLC4A11	83959	Corneal endothelial dystrophy type 2	MESH:C536439	marker/mechanism		NA	217700	
SLC4A2	6522	Choledochal Cyst	MESH:D015529	marker/mechanism		NA		18988797
SLC4A2	6522	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		18188457
SLC4A2	6522	Polycystic Kidney, Autosomal Recessive	MESH:D017044	marker/mechanism		NA		18988797
SLC4A2	6522	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
SLC4A3	6508	Heart Diseases	MESH:D006331	marker/mechanism		NA		16844662
SLC4A4	8671	Acidosis, Renal Tubular	MESH:D000141	marker/mechanism		NA		18614622
SLC4A4	8671	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
SLC4A4	8671	Cataract	MESH:D002386	marker/mechanism		NA		18614622
SLC4A4	8671	Corneal Opacity	MESH:D003318	marker/mechanism		NA		18614622
SLC4A4	8671	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		18614622
SLC4A4	8671	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
SLC4A4	8671	Glaucoma	MESH:D005901	marker/mechanism		NA		18614622
SLC4A4	8671	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SLC4A4	8671	Renal Tubular Acidosis, Proximal, With Ocular Abnormalities And Mental Retardation	MESH:C567038	marker/mechanism		NA	604278	
SLC4A7	9497	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
SLC4A7	9497	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
SLC51A	200931	Cholestasis	MESH:D002779	marker/mechanism		NA		16423920|22461449
SLC51A	200931	Cognition Disorders	MESH:D003072	marker/mechanism		NA		29382564
SLC51A	200931	Diabetes Complications	MESH:D048909	marker/mechanism		NA		29382564
SLC51A	200931	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		16423920
SLC51B	123264	Cholestasis	MESH:D002779	marker/mechanism		NA		16423920|22461449
SLC51B	123264	Cognition Disorders	MESH:D003072	marker/mechanism		NA		29382564
SLC51B	123264	Diabetes Complications	MESH:D048909	marker/mechanism		NA		29382564
SLC51B	123264	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		16423920
SLC52A1	55065	Riboflavin Deficiency	MESH:D012257	marker/mechanism		NA	615026	
SLC52A2	79581	Brown-Vialetto-Van Laere syndrome	MESH:C537111	marker/mechanism		NA	614707	
SLC52A3	113278	Brown-Vialetto-Van Laere syndrome	MESH:C537111	marker/mechanism		NA	211530	
SLC52A3	113278	Bulbar Palsy, Progressive	MESH:D010244	marker/mechanism		NA	211500	
SLC52A3	113278	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		20729853
SLC52A3	113278	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		28220687
SLC5A1	6523	Glucose-Galactose Malabsorption	MESH:C562602	marker/mechanism		NA	606824	
SLC5A2	6524	Glycosuria, Renal	MESH:D006030	marker/mechanism		NA	233100	
SLC5A3	6526	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		16420717
SLC5A3	6526	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		25401301
SLC5A5	6528	Breast Neoplasms	MESH:D001943	therapeutic		NA		12489024
SLC5A5	6528	Carcinoma, Hepatocellular	MESH:D006528	therapeutic		NA		15347726|15520214
SLC5A5	6528	Cholangiocarcinoma	MESH:D018281	marker/mechanism		NA		17408651
SLC5A5	6528	Glioma	MESH:D005910	therapeutic		NA		12489024
SLC5A5	6528	Kidney Neoplasms	MESH:D007680	therapeutic		NA		12489024
SLC5A5	6528	Melanoma	MESH:D008545	therapeutic		NA		12489024
SLC5A5	6528	Neoplasms	MESH:D009369	therapeutic		NA		15522214
SLC5A5	6528	Ovarian Neoplasms	MESH:D010051	therapeutic		NA		12489024
SLC5A5	6528	Prostatic Neoplasms	MESH:D011471	therapeutic		NA		12489024|14633711
SLC5A5	6528	Thyroid Dyshormonogenesis 1	MESH:C564766	marker/mechanism		NA	274400	
SLC5A5	6528	Thyroid Neoplasms	MESH:D013964	marker/mechanism|therapeutic		NA		16954431|17045167
SLC5A7	60482	Myasthenic Syndromes, Congenital	MESH:D020294	marker/mechanism		NA	617143	
SLC5A7	60482	Neuropathy, Distal Hereditary Motor, Type VIIA	MESH:C563562	marker/mechanism		NA	158580	
SLC5A8	160728	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15090606|16670197
SLC5A8	160728	Hyperuricemia	MESH:D033461	marker/mechanism		NA		20589576
SLC6A1	6529	Amyotrophic Lateral Sclerosis	MESH:D000690	marker/mechanism		NA		20132478
SLC6A1	6529	Epilepsy	MESH:D004827	marker/mechanism		NA		29942082
SLC6A1	6529	MYOCLONIC-ATONIC EPILEPSY	OMIM:616421	marker/mechanism		NA	616421	
SLC6A1	6529	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889|29942082
SLC6A1	6529	Schizophrenia	MESH:D012559	marker/mechanism		NA		18923069
SLC6A1	6529	Seizures	MESH:D012640	marker/mechanism		NA		11074187
SLC6A1	6529	Substance Withdrawal Syndrome	MESH:D013375	therapeutic		NA		14598306
SLC6A11	6538	Melanoma	MESH:D008545	marker/mechanism		NA		21499247
SLC6A12	6539	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		26213588
SLC6A14	11254	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
SLC6A14	11254	CYSTIC FIBROSIS, MODIFIER OF, 1	OMIM:603855	marker/mechanism		NA		22466613
SLC6A14	11254	Intestinal Obstruction	MESH:D007415	marker/mechanism		NA		22466613
SLC6A17	388662	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48	OMIM:616269	marker/mechanism		NA	616269	
SLC6A18	348932	Hypertension	MESH:D006973	marker/mechanism		NA		15121838
SLC6A19	340024	Hartnup Disease	MESH:D006250	marker/mechanism		NA	234500	
SLC6A19	340024	HYPERGLYCINURIA	OMIM:138500	marker/mechanism		NA	138500	
SLC6A19	340024	Iminoglycinuria	MESH:C536285	marker/mechanism		NA	242600	
SLC6A2	6530	Hypertension	MESH:D006973	marker/mechanism		NA		22533655
SLC6A2	6530	Orthostatic Intolerance	MESH:D054971	marker/mechanism		NA	604715	11458707
SLC6A2	6530	Seizures	MESH:D012640	marker/mechanism		NA		15911120
SLC6A20	54716	HYPERGLYCINURIA	OMIM:138500	marker/mechanism		NA	138500	
SLC6A20	54716	Iminoglycinuria	MESH:C536285	marker/mechanism		NA	242600	21572414
SLC6A20	54716	Mesothelioma	MESH:D008654	marker/mechanism		NA		17659810
SLC6A20B	22599	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
SLC6A3	6531	Alcoholism	MESH:D000437	marker/mechanism		NA		27219321
SLC6A3	6531	Alcohol Withdrawal Delirium	MESH:D000430	marker/mechanism		NA		27219321
SLC6A3	6531	Alcohol Withdrawal Seizures	MESH:D020270	marker/mechanism		NA		27219321
SLC6A3	6531	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		12931138
SLC6A3	6531	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		19120712
SLC6A3	6531	Attention Deficit Disorder with Hyperactivity	MESH:D001289	marker/mechanism		NA		12699766|15059031|19120712|22034972
SLC6A3	6531	Cocaine-Related Disorders	MESH:D019970	marker/mechanism|therapeutic		NA		11320258|11746736|16537431|19602552
SLC6A3	6531	Dementia	MESH:D003704	marker/mechanism		NA		18579413
SLC6A3	6531	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		27219321
SLC6A3	6531	Hyperkinesis	MESH:D006948	marker/mechanism		NA		18347339|18588534
SLC6A3	6531	Memory Disorders	MESH:D008569	marker/mechanism		NA		17992686
SLC6A3	6531	Micronuclei, Chromosome-Defective	MESH:D048629	marker/mechanism		NA		20875051
SLC6A3	6531	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		12871582|18206288
SLC6A3	6531	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		12890883
SLC6A3	6531	Paranoid Disorders	MESH:D010259	marker/mechanism		NA		8825631
SLC6A3	6531	Parkinson Disease	MESH:D010300	marker/mechanism		NA		16112329|16963468|19590691|9763484
SLC6A3	6531	Parkinsonism-Dystonia, Infantile	MESH:C567730	marker/mechanism		NA	613135	27555326
SLC6A3	6531	Psychoses, Substance-Induced	MESH:D011605	marker/mechanism		NA		12931138
SLC6A3	6531	Schizophrenia	MESH:D012559	marker/mechanism		NA		16762269
SLC6A3	6531	Sleep Wake Disorders	MESH:D012893	marker/mechanism		NA		24403155
SLC6A3	6531	Tic Disorders	MESH:D013981	marker/mechanism		NA		19120712
SLC6A3	6531	TOBACCO ADDICTION, SUSCEPTIBILITY TO	OMIM:188890	marker/mechanism		NA	188890	
SLC6A4	6532	Alcoholism	MESH:D000437	marker/mechanism		NA		15520362|17000009
SLC6A4	6532	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		19689456
SLC6A4	6532	Anxiety Disorders	MESH:D001008	marker/mechanism		NA	607834	18686203
SLC6A4	6532	Asperger Syndrome	MESH:D020817	marker/mechanism		NA		18197083
SLC6A4	6532	Autistic Disorder	MESH:D001321	marker/mechanism		NA		16721604|17203304|17280648|20649385|9152989
SLC6A4	6532	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		11772685|16395126
SLC6A4	6532	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		11320258
SLC6A4	6532	Cognition Disorders	MESH:D003072	marker/mechanism		NA		23209555
SLC6A4	6532	Depressive Disorder	MESH:D003866	marker/mechanism		NA		12898347|18458677|18686203|21843009
SLC6A4	6532	Depressive Disorder, Major	MESH:D003865	marker/mechanism		NA		16055263
SLC6A4	6532	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		18506000
SLC6A4	6532	Memory Disorders	MESH:D008569	marker/mechanism		NA		18661256|18686203
SLC6A4	6532	Mood Disorders	MESH:D019964	marker/mechanism		NA		19878141
SLC6A4	6532	Obsessive-Compulsive Disorder	MESH:D009771	marker/mechanism		NA	164230	18197083
SLC6A4	6532	Personality Disorders	MESH:D010554	marker/mechanism		NA		17000009
SLC6A4	6532	Schizophrenia	MESH:D012559	marker/mechanism		NA		18583979
SLC6A4	6532	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		19272758
SLC6A4	6532	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		17000009
SLC6A4	6532	Sudden Infant Death	MESH:D013398	marker/mechanism		NA		12599191
SLC6A5	9152	Apnea	MESH:D001049	marker/mechanism		NA		25480793
SLC6A5	9152	Brain Diseases	MESH:D001927	marker/mechanism		NA		25480793
SLC6A5	9152	Hyperexplexia hereditary	MESH:C538136	marker/mechanism		NA	614618	25480793
SLC6A6	6533	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
SLC6A8	6535	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18461508
SLC6A8	6535	Creatine deficiency, X-linked	MESH:C535598	marker/mechanism		NA	300352	11326334|12210795|17465020
SLC6A8	6535	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		11326334
SLC6A8	6535	Mental Retardation, X-Linked	MESH:D038901	marker/mechanism		NA		18350323
SLC6A9	6536	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		17582620
SLC6A9	6536	GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	OMIM:617301	marker/mechanism		NA	617301	
SLC7A1	6541	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SLC7A1	6541	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		11401523
SLC7A11	23657	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
SLC7A11	23657	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19015640
SLC7A14	57709	RETINITIS PIGMENTOSA 68	OMIM:615725	marker/mechanism		NA	615725	
SLC7A5	8140	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17374397
SLC7A5	8140	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		26621329
SLC7A7	9056	Amino Acid Metabolism, Inborn Errors	MESH:D000592	marker/mechanism		NA		11544277
SLC7A7	9056	Lysinuric Protein Intolerance	MESH:C562687	marker/mechanism		NA	222700	
SLC7A8	23428	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
SLC7A9	11136	Cystinuria	MESH:D003555	marker/mechanism		NA	220100	
SLC7A9	11136	Kidney Diseases	MESH:D007674	marker/mechanism		NA		21572414
SLC8A1	6546	Megacolon	MESH:D008531	marker/mechanism		NA		15185227|17560225
SLC8A1	6546	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
SLC8A1	6546	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		15215644
SLC8A1	6546	Seizures	MESH:D012640	marker/mechanism		NA		20888801
SLC8A1	6546	Status Epilepticus	MESH:D013226	marker/mechanism		NA		20888801
SLC8A3	6547	Seizures	MESH:D012640	marker/mechanism		NA		20888801
SLC8A3	6547	Status Epilepticus	MESH:D013226	marker/mechanism		NA		20888801
SLC9A1	6548	Barrett Esophagus	MESH:D001471	marker/mechanism		NA		21127259
SLC9A1	6548	Cardiomyopathy, Hypertrophic	MESH:D002312	marker/mechanism		NA		19111554
SLC9A1	6548	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		20003708
SLC9A1	6548	Edema	MESH:D004487	marker/mechanism		NA		20553904
SLC9A1	6548	Heart Failure	MESH:D006333	marker/mechanism		NA		19027022
SLC9A1	6548	LICHTENSTEIN-KNORR SYNDROME	OMIM:616291	marker/mechanism		NA	616291	
SLC9A1	6548	Pain	MESH:D010146	marker/mechanism		NA		19248819
SLC9A1	6548	Reperfusion Injury	MESH:D015427	therapeutic		NA		19027022
SLC9A1	6548	Shock, Hemorrhagic	MESH:D012771	marker/mechanism		NA		17724433
SLC9A1	6548	Ventricular Remodeling	MESH:D020257	marker/mechanism		NA		20886221
SLC9A2	6549	Edema	MESH:D004487	marker/mechanism		NA		20553904
SLC9A3	6550	CYSTIC FIBROSIS, MODIFIER OF, 1	OMIM:603855	marker/mechanism		NA		22466613
SLC9A3	6550	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		20003708
SLC9A3	6550	Diarrhea	MESH:D003967	marker/mechanism		NA		26564064
SLC9A3	6550	DIARRHEA 8, SECRETORY SODIUM, CONGENITAL	OMIM:616868	marker/mechanism		NA	616868	
SLC9A3	6550	Edema	MESH:D004487	marker/mechanism		NA		20553904
SLC9A3	6550	Hypotension	MESH:D007022	marker/mechanism		NA		26564064
SLC9A3	6550	Intestinal Obstruction	MESH:D007415	marker/mechanism		NA		22466613
SLC9A3R1	9368	Carcinoma, Ductal, Breast	MESH:D018270	marker/mechanism		NA		28235801
SLC9A3R1	9368	NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2	OMIM:612287	marker/mechanism		NA	612287	
SLC9A3R2	9351	Hypertension	MESH:D006973	marker/mechanism		NA		22228705
SLC9A4	389015	Acidosis	MESH:D000138	marker/mechanism		NA		20484819
SLC9A6	10479	Mental Retardation, X-Linked, Syndromic, Christianson Type	MESH:C567484	marker/mechanism		NA	300243	
SLC9A8	23315	Dementia	MESH:D003704	marker/mechanism		NA		19234771
SLC9A9	285195	Autistic Disorder	MESH:D001321	marker/mechanism		NA	613410	18621663
SLC9B1	150159	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
SLCO1A1	28248	Cholestasis	MESH:D002779	marker/mechanism		NA		22461449
SLCO1A1	28248	Liver Diseases	MESH:D008107	marker/mechanism		NA		22461449
SLCO1A4	28250	Cholestasis	MESH:D002779	marker/mechanism		NA		22461449
SLCO1A5	108096	Epilepsy	MESH:D004827	marker/mechanism		NA		19570321
SLCO1B1	10599	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21457551
SLCO1B1	10599	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		32259555
SLCO1B1	10599	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		21387541
SLCO1B1	10599	HYPERBILIRUBINEMIA, ROTOR TYPE	OMIM:237450	marker/mechanism		NA	237450	
SLCO1B1	10599	Muscular Diseases	MESH:D009135	marker/mechanism		NA		15681900|18650507|19238167|19833260|21243006
SLCO1B2	28253	Hyperbilirubinemia	MESH:D006932	marker/mechanism		NA		18296417
SLCO1B3	28234	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		22326869|25625007
SLCO1B3	28234	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		29491222
SLCO1B3	28234	HYPERBILIRUBINEMIA, ROTOR TYPE	OMIM:237450	marker/mechanism		NA	237450	
SLCO1B3	28234	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		22326869|25625007
SLCO2A1	6578	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		30510241
SLCO2A1	6578	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		15805072
SLCO2A1	6578	Osteoarthropathy, Primary Hypertrophic	MESH:D010004	marker/mechanism		NA	614441	
SLFN14	342618	BLEEDING DISORDER, PLATELET-TYPE, 20	OMIM:616913	marker/mechanism		NA	616913	
SLFN2	20556	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SLIT2	9353	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		19100240
SLIT2	9353	Epilepsy, Temporal Lobe	MESH:D004833	marker/mechanism		NA		20153733
SLIT2	9353	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941188
SLIT3	6586	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
SLIT3	6586	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		17436238
SLITRK1	114798	Tourette Syndrome	MESH:D005879	marker/mechanism		NA	137580	
SLITRK1	114798	Trichotillomania	MESH:D014256	marker/mechanism		NA	613229	
SLITRK5	26050	Obsessive-Compulsive Disorder	MESH:D009771	marker/mechanism		NA		20418887
SLITRK6	84189	DEAFNESS AND MYOPIA	OMIM:221200	marker/mechanism		NA	221200	
SLK	9748	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
SLPI	6590	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		17984051
SLPI	6590	Reperfusion Injury	MESH:D015427	therapeutic		NA		8215636
SLU7	10569	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
SLURP1	57152	Keratoderma, Palmoplantar	MESH:D007645	marker/mechanism		NA	248300	25168896
SLX4	84464	Fanconi Anemia	MESH:D005199	marker/mechanism		NA		21240275|21240276|21240277
SLX4	84464	FANCONI ANEMIA, COMPLEMENTATION GROUP P	OMIM:613951	marker/mechanism		NA	613951	
SMAD1	4086	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		30158054
SMAD1	4086	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		30158054
SMAD2	4087	Acromicric dysplasia	MESH:C535662	marker/mechanism		NA		18677313
SMAD2	4087	Copper-Overload Cirrhosis	MESH:C566858	marker/mechanism		NA		22879914
SMAD2	4087	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		15183723|9655392
SMAD2	4087	Hepatitis, Chronic	MESH:D006521	marker/mechanism		NA		22879914
SMAD2	4087	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		16570350
SMAD2	4087	Ventricular Remodeling	MESH:D020257	marker/mechanism		NA		16635409
SMAD3	4088	Aneurysm, Dissecting	MESH:D000784	marker/mechanism		NA		21217753
SMAD3	4088	Aortic Aneurysm	MESH:D001014	marker/mechanism		NA		21217753
SMAD3	4088	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
SMAD3	4088	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		27422367
SMAD3	4088	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		30510241
SMAD3	4088	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		15183723|21217753
SMAD3	4088	Crohn Disease	MESH:D003424	marker/mechanism		NA		21102463
SMAD3	4088	Leiomyoma	MESH:D007889	marker/mechanism		NA		22228119
SMAD3	4088	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		21605584
SMAD3	4088	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		23274713
SMAD3	4088	Loeys-Dietz Syndrome	MESH:D055947	marker/mechanism		NA	613795	22772368
SMAD3	4088	Osteoarthritis	MESH:D010003	marker/mechanism		NA		21217753|22772368
SMAD3	4088	Osteoarthritis, Hip	MESH:D015207	marker/mechanism		NA		30374069
SMAD3	4088	Ureteral Obstruction	MESH:D014517	marker/mechanism		NA		28318631
SMAD3	4088	Uterine Neoplasms	MESH:D014594	marker/mechanism		NA		22228119
SMAD3	4088	Ventricular Remodeling	MESH:D020257	marker/mechanism		NA		16635409
SMAD4	4089	Adenocarcinoma Of Esophagus	MESH:C562730	marker/mechanism		NA		23525077|24952744
SMAD4	4089	Brachydactyly	MESH:D059327	marker/mechanism		NA		22158539
SMAD4	4089	Carcinoma, Ductal, Breast	MESH:D018270	marker/mechanism		NA		20565773
SMAD4	4089	Cholangiocarcinoma	MESH:D018281	marker/mechanism		NA		22561520
SMAD4	4089	Cognition Disorders	MESH:D003072	marker/mechanism		NA		22158539
SMAD4	4089	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		16144935|20565773|25944804
SMAD4	4089	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		22158539
SMAD4	4089	Deafness	MESH:D003638	marker/mechanism		NA		22158539
SMAD4	4089	Growth mental deficiency syndrome of Myhre	MESH:C537620	marker/mechanism		NA	139210	22158539
SMAD4	4089	Juvenile polyposis syndrome	MESH:C537702	marker/mechanism		NA	174900	
SMAD4	4089	Juvenile Polyposis with Hereditary Hemorrhagic Telangiectasia	MESH:C563412	marker/mechanism		NA	175050	
SMAD4	4089	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		16570350
SMAD4	4089	Liver Diseases, Parasitic	MESH:D008109	marker/mechanism		NA		22561520
SMAD4	4089	Muscular Diseases	MESH:D009135	marker/mechanism		NA		22158539
SMAD4	4089	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA	260350	
SMAD4	4089	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21105199
SMAD5	4090	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		30158054
SMAD5	4090	Diabetes Mellitus, Type 2	MESH:D003924	therapeutic		NA		20079400
SMAD5	4090	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		30158054
SMAD6	4091	AORTIC VALVE DISEASE 2	OMIM:614823	marker/mechanism		NA	614823	
SMAD6	4091	Bicuspid Aortic Valve	MESH:C562388	marker/mechanism		NA		30455415
SMAD6	4091	Craniosynostoses	MESH:D003398	marker/mechanism		NA	617439	
SMAD7	4092	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
SMAD7	4092	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	612229	17934461
SMAD7	4092	Paraquat lung	MESH:C537171	therapeutic		NA		23590892
SMAD7	4092	Pulmonary Fibrosis	MESH:D011658	therapeutic		NA		23590892
SMAD9	4093	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		30510241
SMAD9	4093	Familial Primary Pulmonary Hypertension	MESH:D065627	marker/mechanism		NA	615342	
SMARCA1	6594	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
SMARCA2	6595	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
SMARCA2	6595	Coffin-Siris syndrome	MESH:C536436	marker/mechanism		NA		22426308
SMARCA2	6595	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
SMARCA2	6595	Nicolaides Baraitser syndrome	MESH:C536116	marker/mechanism		NA	601358	22366787
SMARCA4	6597	Burkitt Lymphoma	MESH:D002051	marker/mechanism		NA		23143597
SMARCA4	6597	Carcinoma, Small Cell	MESH:D018288	marker/mechanism		NA		24658001|24658002|24658004|26343384
SMARCA4	6597	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		27422367
SMARCA4	6597	Coffin-Siris syndrome	MESH:C536436	marker/mechanism		NA	614609	22426308
SMARCA4	6597	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		24658001|24658002|24658004|26343384
SMARCA4	6597	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054218	marker/mechanism		NA		28671688
SMARCA4	6597	Rhabdoid Tumor Predisposition Syndrome 2	MESH:C567643	marker/mechanism		NA	613325	
SMARCA4	6597	Sarcoma	MESH:D012509	marker/mechanism		NA		26343384
SMARCA4	6597	Sezary Syndrome	MESH:D012751	marker/mechanism		NA		26551667
SMARCA4	6597	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		26343384
SMARCA4	6597	Thoracic Neoplasms	MESH:D013899	marker/mechanism		NA		26343384
SMARCAD1	56916	Basan syndrome	MESH:C537659	marker/mechanism		NA	129200	
SMARCAD1	56916	Fingerprints, Absence of	MESH:C565010	marker/mechanism		NA	136000	
SMARCAD1	56916	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
SMARCAD1	56916	Sclerotylosis	MESH:C537526	marker/mechanism		NA	181600	
SMARCAL1	50485	Schimke immunoosseous dysplasia	MESH:C536629	marker/mechanism		NA	242900	16237566
SMARCB1	6598	Coffin-Siris syndrome	MESH:C536436	marker/mechanism		NA	614608	22426308
SMARCB1	6598	Rhabdoid Tumor	MESH:D018335	marker/mechanism		NA		25009291|26343384
SMARCB1	6598	Rhabdoid Tumor Predisposition Syndrome 1	MESH:C563738	marker/mechanism		NA	609322	
SMARCB1	6598	Schwannomatosis	MESH:C536641	marker/mechanism		NA	162091	24362817
SMARCC1	6599	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		21552421
SMARCC1	6599	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
SMARCC1	6599	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
SMARCC1	6599	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SMARCC1	6599	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		21552421
SMARCD2	6603	Leukemia, Myeloid	MESH:D007951	marker/mechanism		NA		28369036
SMARCD2	6603	Neutropenia	MESH:D009503	marker/mechanism		NA		28369036
SMARCD2	6603	Specific Granule Deficiency	MESH:C562873	marker/mechanism		NA		28369034|28369036
SMARCE1	6605	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
SMARCE1	6605	Coffin-Siris syndrome	MESH:C536436	marker/mechanism		NA	616938	22426308
SMARCE1	6605	Meningioma, familial	MESH:C537443	marker/mechanism		NA	607174	23377182
SMC1A	8243	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
SMC1A	8243	De Lange Syndrome	MESH:D003635	marker/mechanism		NA	300590	
SMC1A	8243	Epilepsy	MESH:D004827	marker/mechanism		NA		29942082
SMC1A	8243	Leukemia, Myeloid	MESH:D007951	marker/mechanism		NA		23955599
SMC1A	8243	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		29942082
SMC1A	8243	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		24121791
SMC1B	27127	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		24121791
SMC2	10592	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SMC2	10592	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
SMC3	9126	De Lange Syndrome	MESH:D003635	marker/mechanism		NA	610759	
SMC3	9126	Leukemia, Myeloid	MESH:D007951	marker/mechanism		NA		23955599
SMC3	9126	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
SMC5	23137	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SMCHD1	23347	Arhinia, choanal atresia, and microphthalmia	MESH:C537429	marker/mechanism		NA	603457	28067909|28067911
SMCHD1	23347	Facioscapulohumeral Muscular Dystrophy 1B	MESH:C563557	marker/mechanism		NA	158901	23143600|28067909|28067911
SMF-3	177044	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		23106139
SMG9	56006	HEART AND BRAIN MALFORMATION SYNDROME	OMIM:616920	marker/mechanism		NA	616920	
SMIM43	132332	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28869590
SMN1	6606	Infant Death	MESH:D066088	marker/mechanism		NA		27111068
SMN1	6606	Muscular Atrophy, Spinal	MESH:D009134	marker/mechanism		NA		15862279|19150990|21350916|21819082|27111068
SMN1	6606	Spinal Muscular Atrophies of Childhood	MESH:D014897	marker/mechanism		NA	253300|253400|253550	17924536
SMN1	6606	Spinal muscular atrophy 4	MESH:C538417	marker/mechanism		NA	271150	
SMN2	6607	Muscular Atrophy, Spinal	MESH:D009134	therapeutic		NA		21350916
SMN2	6607	Spinal Muscular Atrophies of Childhood	MESH:D014897	marker/mechanism		NA	253400	
SMO	6608	Ameloblastoma	MESH:D000564	marker/mechanism		NA		24859340
SMO	6608	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		9581815
SMO	6608	Carcinoma, Basal Cell	MESH:D002280	marker/mechanism		NA	605462	26950094|9581815
SMO	6608	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
SMO	6608	Hypothalamic hamartomas	MESH:C537158	marker/mechanism		NA	241800	
SMO	6608	Infertility, Female	MESH:D007247	marker/mechanism		NA		28560483
SMO	6608	Jaw Abnormalities	MESH:D007569	marker/mechanism		NA		16580747
SMO	6608	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		23867347
SMO	6608	Maxillary Neoplasms	MESH:D008441	marker/mechanism		NA		24859340
SMO	6608	Meningioma	MESH:D008579	marker/mechanism		NA		23334667
SMO	6608	Neuroectodermal Tumors, Primitive	MESH:D018242	marker/mechanism		NA		9581815
SMO	6608	Osteoarthritis, Hip	MESH:D015207	marker/mechanism		NA		30374069
SMO	6608	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		9581815
SMO	6608	Winter Shortland Temple syndrome	MESH:C536735	marker/mechanism		NA	601707	
SMOC1	64093	Anophthalmos with limb anomalies	MESH:C537769	marker/mechanism		NA	206920	
SMOC1	64093	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SMOC2	64094	Dentin dysplasia, type 1	MESH:C538215	marker/mechanism		NA	125400	
SMOC2	64094	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SMOX	54498	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		30576531
SMOX	54498	Stroke	MESH:D020521	marker/mechanism		NA		16269634
SMPD1	6609	Kidney Diseases	MESH:D007674	therapeutic		NA		26980705
SMPD1	6609	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		24951586
SMPD1	6609	Niemann-Pick Diseases	MESH:D009542	marker/mechanism		NA		12631268
SMPD1	6609	Niemann-Pick Disease, Type A	MESH:D052536	marker/mechanism		NA	257200	
SMPD1	6609	Niemann-Pick Disease, Type B	MESH:D052537	marker/mechanism		NA	607616	
SMPD3	55512	Leukemia	MESH:D007938	marker/mechanism		NA		18283525
SMPD3	55512	Myelodysplastic Syndromes	MESH:D009190	marker/mechanism		NA		18283525
SMPDL3A	10924	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
SMPX	23676	Deafness, X-Linked 4	MESH:C564723	marker/mechanism		NA	300066	
SMS	6611	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		19192274
SMS	6611	Snyder Robinson syndrome	MESH:C536678	marker/mechanism		NA	309583	
SMURF1	57154	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		30158054
SMURF1	57154	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		30158054
SMYD2	56950	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		25825497
SMYD3	64754	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
SMYD4	114826	Medulloblastoma	MESH:D008527	marker/mechanism		NA		19270706
SNAI1	6615	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
SNAI1	6615	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		11850205|24014025
SNAI1	6615	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		24014025
SNAI1	6615	Cholestasis	MESH:D002779	marker/mechanism		NA		21224055
SNAI1	6615	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		22580338|24014025
SNAI1	6615	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		22580338|23219715
SNAI1	6615	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
SNAI1	6615	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
SNAI1	6615	Ureteral Obstruction	MESH:D014517	marker/mechanism		NA		28318631
SNAI2	6591	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		11850205
SNAI2	6591	Calcinosis	MESH:D002114	marker/mechanism		NA		29358327
SNAI2	6591	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		17068819
SNAI2	6591	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		22580338
SNAI2	6591	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		22580338
SNAI2	6591	Piebaldism	MESH:D016116	marker/mechanism		NA	172800	
SNAI2	6591	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
SNAI2	6591	Waardenburg Syndrome, Type 2D	MESH:C563839	marker/mechanism		NA	608890	
SNAI3	333929	Enterocolitis, Necrotizing	MESH:D020345	marker/mechanism		NA		18806098
SNAP23	8773	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SNAP23	8773	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
SNAP25	6616	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		14708030
SNAP25	6616	Depressive Disorder	MESH:D003866	marker/mechanism		NA		14708030
SNAP25	6616	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		16123366
SNAP25	6616	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		16123366
SNAP25	6616	Epilepsy	MESH:D004827	marker/mechanism		NA		29942082
SNAP25	6616	Myasthenic Syndromes, Congenital	MESH:D020294	marker/mechanism		NA	616330	
SNAP25	6616	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		29942082
SNAP25	6616	Neuromuscular Manifestations	MESH:D020879	marker/mechanism		NA		17023870
SNAP25	6616	Psychotic Disorders	MESH:D011618	marker/mechanism		NA		14708030
SNAP25	6616	Tics	MESH:D020323	marker/mechanism		NA		17023870
SNAP29	9342	Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome	MESH:C537943	marker/mechanism		NA	609528	
SNAP29	9342	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SNAR-I	100170222	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		30320580
SNCA	6622	Alcoholism	MESH:D000437	marker/mechanism		NA		18055133
SNCA	6622	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		15542733|32278788
SNCA	6622	Ataxia	MESH:D001259	therapeutic		NA		31783120
SNCA	6622	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		18055133
SNCA	6622	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		21892157|26075822
SNCA	6622	Gaucher Disease	MESH:D005776	marker/mechanism		NA		19576930
SNCA	6622	Hepatolenticular Degeneration	MESH:D006527	marker/mechanism		NA		23519153
SNCA	6622	Lameness, Animal	MESH:D007794	marker/mechanism		NA		23219665
SNCA	6622	Lewy Body Disease	MESH:D020961	marker/mechanism		NA	127750	16141792|19628769
SNCA	6622	Manganese Poisoning	MESH:D020149	marker/mechanism		NA		23934647
SNCA	6622	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		21039522|23106139|27585560
SNCA	6622	Neurobehavioral Manifestations	MESH:D019954	marker/mechanism		NA		32278788
SNCA	6622	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		17296847|18514411|22430071|26075822
SNCA	6622	Parkinson Disease	MESH:D010300	marker/mechanism		NA		11535288|12151787|12732244|12885775|14535945|15099020|17131421|17690948|18322262|18353766|18841091|19915575|19915576|20664293|20711177|21245015|21892157|22043175|22110584|22166454|22185909|22355530|24509835|24833599|25064009|25106480|25149416|25475535|25631236
SNCA	6622	PARKINSON DISEASE 1, AUTOSOMAL DOMINANT	OMIM:168601	marker/mechanism		NA	168601	
SNCA	6622	Parkinson Disease 4, Autosomal Dominant Lewy Body	MESH:C565324	marker/mechanism		NA	605543	
SNCA	6622	Parkinsonian Disorders	MESH:D020734	marker/mechanism		NA		20464527|22319455|23046578|23295396|26075822|26558463|26687234|27026137|27324791
SNCA	6622	Psychoses, Substance-Induced	MESH:D011605	marker/mechanism		NA		15542733
SNCA	6622	Weight Loss	MESH:D015431	marker/mechanism		NA		32278788
SNCAIP	9627	PARKINSON DISEASE, LATE-ONSET	OMIM:168600	marker/mechanism		NA	168600	
SNCB	6620	Lewy Body Disease	MESH:D020961	marker/mechanism		NA	127750	
SNCG	6623	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20595634
SNCG	6623	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
SNCG	6623	Hyperkinesis	MESH:D006948	marker/mechanism		NA		18588534
SNCG	6623	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
SNCG	6623	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
SND1	27044	Autistic Disorder	MESH:D001321	marker/mechanism		NA		20442744
SND1	27044	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		25940438
SNF4AGAMMA	42515	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		22266106
SNHG11	128439	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		17114358
SNORA16B	692157	Creutzfeldt-Jakob Syndrome	MESH:D007562	marker/mechanism		NA		23349890
SNORD115-1	338433	Prader-Willi Syndrome	MESH:D011218	marker/mechanism		NA	176270	
SNORD116-1	100033413	Prader-Willi Syndrome	MESH:D011218	marker/mechanism		NA	176270	
SNORD118	727676	Leukoencephalopathy Brain Calcifications and Cysts	MESH:C000598644	marker/mechanism		NA	614561	
SNORD22	9304	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
SNORD22	9304	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
SNORD3A	780851	Creutzfeldt-Jakob Syndrome	MESH:D007562	marker/mechanism		NA		23349890
SNORD50A	26799	Carcinogenesis	MESH:D063646	marker/mechanism		NA		26595770
SNORD50A	26799	Neoplasms	MESH:D009369	marker/mechanism		NA		26595770
SNORD50B	692088	Carcinogenesis	MESH:D063646	marker/mechanism		NA		26595770
SNORD50B	692088	Neoplasms	MESH:D009369	marker/mechanism		NA		26595770
SNRNP200	23020	Retinitis Pigmentosa 33	MESH:C563676	marker/mechanism		NA	610359	
SNRNP27	11017	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
SNRPB	6628	Cerebrocostomandibular Syndrome	MESH:C562538	marker/mechanism		NA	117650	
SNRPB	6628	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
SNRPB	6628	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
SNRPD3	6634	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
SNRPD3	6634	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
SNRPD3	6634	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
SNRPD3	6634	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
SNRPE	6635	Hypotrichosis	MESH:D007039	marker/mechanism		NA	615059	
SNRPG	6637	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
SNRPG	6637	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
SNRPN	6638	Autistic Disorder	MESH:D001321	marker/mechanism		NA	209850	
SNRPN	6638	Prader-Willi Syndrome	MESH:D011218	marker/mechanism		NA	176270	
SNTA1	6640	Long Qt Syndrome 12	MESH:C567842	marker/mechanism		NA	612955	
SNTA1	6640	Status Epilepticus	MESH:D013226	marker/mechanism		NA		20886625
SNTG2	54221	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		20808228
SNTG2	54221	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17292328
SNX10	29887	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		28108177
SNX10	29887	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8	OMIM:615085	marker/mechanism		NA	615085	
SNX14	57231	Cerebellar Ataxia	MESH:D002524	marker/mechanism		NA		25848753
SNX14	57231	Intellectual Disability	MESH:D008607	marker/mechanism		NA		25848753
SNX14	57231	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA	616354	
SNX18	112574	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		17984051
SNX32	254122	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
SNX5	27131	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
SNX5	27131	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
SNX7	51375	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SOAT1	6646	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SOAT2	8435	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
SOBP	55084	MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS	OMIM:613671	marker/mechanism		NA	613671	
SOCS1	8651	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		16033404
SOCS1	8651	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		15197228
SOCS1	8651	Liver Diseases	MESH:D008107	marker/mechanism		NA		15197228
SOCS1	8651	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		15197228
SOCS1	8651	Reperfusion Injury	MESH:D015427	therapeutic		NA		25780291
SOCS1A	445073	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		26297436
SOCS2	8835	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
SOCS2	8835	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		16033404
SOCS2	8835	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SOCS2	8835	Narcolepsy	MESH:D009290	marker/mechanism		NA		17521418
SOCS3	9021	Atherosclerosis	MESH:D050197	marker/mechanism		NA		19330073
SOCS3	9021	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		16831601
SOCS3	9021	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		16804899
SOCS3	9021	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
SOCS3	9021	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
SOCS3A	335409	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		26297436
SOCS4	122809	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		26297436
SOCS7	30837	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		30365097
SOD1	6647	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		28885000
SOD1	6647	Amyotrophic Lateral Sclerosis	MESH:D000690	marker/mechanism		NA		10025816|10930589|11220737|11590119|11723166|12586733|12626432|16495328|17097207|17319283|17496168|18233996|19635794|19929749|20132483|20177826|20348957|20515040|21867702|23583883|24885036|25164820|30503815|7887412|9065559
SOD1	6647	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA	105400	10764647|11181815|11346368|11675877|11796754|11951178|12127151|15096637|15264227|15522870|16105836|19227972|20485746|21140194|23612299|24163136|24256636|26694608|8967745
SOD1	6647	Anemia, Iron-Deficiency	MESH:D018798	marker/mechanism		NA		17057260
SOD1	6647	Aortic Diseases	MESH:D001018	marker/mechanism		NA		25101153
SOD1	6647	Asphyxia Neonatorum	MESH:D001238	marker/mechanism		NA		17963755
SOD1	6647	Asthma	MESH:D001249	marker/mechanism		NA		22867017
SOD1	6647	Atherosclerosis	MESH:D050197	marker/mechanism		NA		20720404
SOD1	6647	Brain Ischemia	MESH:D002545	therapeutic		NA		11756504
SOD1	6647	Cell Transformation, Neoplastic	MESH:D002471	therapeutic		NA		21742780|2982513
SOD1	6647	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		20623750|27349771
SOD1	6647	Deficiency Diseases	MESH:D003677	marker/mechanism		NA		12514262
SOD1	6647	Depressive Disorder	MESH:D003866	marker/mechanism		NA		19605942
SOD1	6647	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
SOD1	6647	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		23786522
SOD1	6647	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		23090186
SOD1	6647	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		15531508
SOD1	6647	Diabetic Retinopathy	MESH:D003930	therapeutic		NA		19074809
SOD1	6647	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		12586733|19227972|20177826|21867702|23583883|24885036
SOD1	6647	Down Syndrome	MESH:D004314	marker/mechanism		NA		11181815
SOD1	6647	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		28885000
SOD1	6647	Fatty Liver	MESH:D005234	marker/mechanism		NA		27349771
SOD1	6647	Fatty Liver, Alcoholic	MESH:D005235	marker/mechanism		NA		19951287
SOD1	6647	Fetal Growth Retardation	MESH:D005317	marker/mechanism		NA		21893188
SOD1	6647	Gait Disorders, Neurologic	MESH:D020233	marker/mechanism		NA		21867702
SOD1	6647	Glioma	MESH:D005910	therapeutic		NA		11861405
SOD1	6647	Hearing Loss	MESH:D034381	therapeutic		NA		11474137
SOD1	6647	Heart Failure	MESH:D006333	marker/mechanism		NA		20304815
SOD1	6647	Hemolysis	MESH:D006461	marker/mechanism		NA		25247420
SOD1	6647	Hepatitis, Chronic	MESH:D006521	marker/mechanism		NA		25053573
SOD1	6647	Hypertension	MESH:D006973	marker/mechanism|therapeutic		NA		25101153|32165127|9024144
SOD1	6647	Hyperthyroidism	MESH:D006980	marker/mechanism		NA		19914224
SOD1	6647	Hypotension	MESH:D007022	marker/mechanism		NA		9024144
SOD1	6647	Hypothermia	MESH:D007035	marker/mechanism		NA		11731100
SOD1	6647	Inflammation	MESH:D007249	marker/mechanism		NA		22867017
SOD1	6647	Ischemia	MESH:D007511	therapeutic		NA		10698074
SOD1	6647	Ischemic Attack, Transient	MESH:D002546	therapeutic		NA		12629175|15829915|16538228|16868554
SOD1	6647	Kidney Calculi	MESH:D007669	marker/mechanism		NA		24360074
SOD1	6647	Liver Diseases	MESH:D008107	marker/mechanism		NA		17877538
SOD1	6647	Marfan Syndrome	MESH:D008382	marker/mechanism		NA		25101153
SOD1	6647	MELAS Syndrome	MESH:D017241	marker/mechanism		NA		11907800
SOD1	6647	Meningomyelocele	MESH:D008591	marker/mechanism		NA		22972774
SOD1	6647	Motor Neuron Disease	MESH:D016472	marker/mechanism		NA		16702190
SOD1	6647	Muscular Atrophy	MESH:D009133	marker/mechanism		NA		24163136
SOD1	6647	Myocardial Infarction	MESH:D009203	therapeutic		NA		21600015
SOD1	6647	Necrosis	MESH:D009336	therapeutic		NA		9548797
SOD1	6647	Nephrosis	MESH:D009401	therapeutic		NA		2273594
SOD1	6647	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		17581637|19243126|24885036
SOD1	6647	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		11158245
SOD1	6647	Obesity	MESH:D009765	marker/mechanism		NA		24042701
SOD1	6647	Ophthalmoplegia, Chronic Progressive External	MESH:D017246	marker/mechanism		NA		11907800
SOD1	6647	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		16179351
SOD1	6647	Parkinson Disease	MESH:D010300	marker/mechanism|therapeutic		NA		15824117|16353238|21318773
SOD1	6647	Protein Deficiency	MESH:D011488	therapeutic		NA		16214328
SOD1	6647	Proteinuria	MESH:D011507	therapeutic		NA		2273594
SOD1	6647	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		26699812
SOD1	6647	Radiation Injuries, Experimental	MESH:D011833	therapeutic		NA		22247605
SOD1	6647	Reperfusion Injury	MESH:D015427	marker/mechanism|therapeutic		NA		15364863|16397181|23061969|23743330
SOD1	6647	Retinal Degeneration	MESH:D012162	marker/mechanism|therapeutic		NA		16741961|19074809
SOD1	6647	Schistosomiasis mansoni	MESH:D012555	marker/mechanism		NA		16564582
SOD1	6647	Scrapie	MESH:D012608	marker/mechanism		NA		11701772
SOD1	6647	Spinal Cord Injuries	MESH:D013119	therapeutic		NA		17457363
SOD1	6647	Stroke	MESH:D020521	marker/mechanism		NA		10698074
SOD1	6647	Turner Syndrome	MESH:D014424	marker/mechanism		NA		25101153
SOD1	6647	Ureteral Calculi	MESH:D014514	marker/mechanism		NA		24360074
SOD1	6647	Weight Loss	MESH:D015431	marker/mechanism		NA		24163136
SOD2	6648	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		21751358
SOD2	6648	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		12907644
SOD2	6648	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		19381893
SOD2	6648	Adenomatous Polyposis Coli	MESH:D011125	marker/mechanism		NA		12907644
SOD2	6648	Adrenoleukodystrophy	MESH:D000326	marker/mechanism		NA		16319717
SOD2	6648	Albuminuria	MESH:D000419	marker/mechanism		NA		17942768
SOD2	6648	Alveolitis, Extrinsic Allergic	MESH:D000542	marker/mechanism		NA		10673208
SOD2	6648	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		19374891
SOD2	6648	Amyotrophic Lateral Sclerosis	MESH:D000690	marker/mechanism		NA		8866423
SOD2	6648	Anemia	MESH:D000740	marker/mechanism		NA		20800516
SOD2	6648	Anemia, Sideroblastic	MESH:D000756	marker/mechanism		NA		16910769|21326867
SOD2	6648	Aortic Aneurysm, Abdominal	MESH:D017544	marker/mechanism		NA		17196988
SOD2	6648	Aortic Diseases	MESH:D001018	marker/mechanism		NA		25101153
SOD2	6648	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
SOD2	6648	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		12833524|15292528|24313545
SOD2	6648	Asphyxia Neonatorum	MESH:D001238	marker/mechanism		NA		17963755
SOD2	6648	Atherosclerosis	MESH:D050197	marker/mechanism|therapeutic		NA		12677255|20720404
SOD2	6648	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		21850155
SOD2	6648	Brain Injuries	MESH:D001930	therapeutic		NA		24462953
SOD2	6648	Brain Ischemia	MESH:D002545	marker/mechanism		NA		15060315|17901229|19429140
SOD2	6648	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		21749277
SOD2	6648	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17965603|19385967|19756960|20562527
SOD2	6648	Carcinoma	MESH:D002277	marker/mechanism		NA		10853026|11053990
SOD2	6648	Carcinoma, Ductal, Breast	MESH:D018270	marker/mechanism		NA		23964924
SOD2	6648	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		16767786|18760346|19731237|21472284
SOD2	6648	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		11731445|17094902
SOD2	6648	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		15108329
SOD2	6648	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism|therapeutic		NA		12543247|15274141
SOD2	6648	Cardiomegaly	MESH:D006332	marker/mechanism		NA		19293248
SOD2	6648	Cardiomyopathies	MESH:D009202	therapeutic		NA		23536361
SOD2	6648	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		16155095|21195081
SOD2	6648	Cataract and cardiomyopathy	MESH:C538280	marker/mechanism		NA		23266196
SOD2	6648	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism|therapeutic		NA		20516118|21742780|23964924|25448439|9067545
SOD2	6648	Central Nervous System Diseases	MESH:D002493	marker/mechanism		NA		10942521
SOD2	6648	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
SOD2	6648	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		25279216
SOD2	6648	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		10853026|12907644
SOD2	6648	Depressive Disorder, Major	MESH:D003865	marker/mechanism		NA		20471444
SOD2	6648	Diabetes, Gestational	MESH:D016640	marker/mechanism		NA		23956348|30738174
SOD2	6648	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism|therapeutic		NA		15855331|23090186
SOD2	6648	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		15531508
SOD2	6648	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		24819633
SOD2	6648	Disease Progression	MESH:D018450	marker/mechanism|therapeutic		NA		10673208|11283936|16081686|18930813|20618948|21749277|22547077
SOD2	6648	Endotoxemia	MESH:D019446	marker/mechanism		NA		16741687
SOD2	6648	Enterocolitis, Necrotizing	MESH:D020345	marker/mechanism		NA		18806098
SOD2	6648	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		11053990|15986332
SOD2	6648	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		18167182|21517111
SOD2	6648	Esophageal Stenosis	MESH:D004940	therapeutic		NA		11121210
SOD2	6648	Esophagitis	MESH:D004941	therapeutic		NA		11121210
SOD2	6648	Farber Lipogranulomatosis	MESH:D055577	marker/mechanism		NA		10428046
SOD2	6648	Fatty Liver	MESH:D005234	marker/mechanism		NA		10860543
SOD2	6648	Fever	MESH:D005334	therapeutic		NA		11165872
SOD2	6648	Fibrosis	MESH:D005355	marker/mechanism		NA		19293248
SOD2	6648	Granuloma, Respiratory Tract	MESH:D015769	marker/mechanism		NA		10673208
SOD2	6648	Heart Failure	MESH:D006333	marker/mechanism		NA		16105639|16155095|20304815|21195081|21284947
SOD2	6648	Hypertension	MESH:D006973	marker/mechanism		NA		11834524|21593737|25101153
SOD2	6648	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		20110409
SOD2	6648	Hyperthyroidism	MESH:D006980	marker/mechanism		NA		19914224
SOD2	6648	Hypoglycemia	MESH:D007003	marker/mechanism		NA		20620209
SOD2	6648	Hypoxia	MESH:D000860	marker/mechanism		NA		18258771|19579223
SOD2	6648	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		21940958
SOD2	6648	Infertility, Male	MESH:D007248	marker/mechanism		NA		22206979
SOD2	6648	Insulin Resistance	MESH:D007333	therapeutic		NA		22829583
SOD2	6648	Ischemia	MESH:D007511	therapeutic		NA		11328670|18227068
SOD2	6648	Ischemic Attack, Transient	MESH:D002546	marker/mechanism		NA		11333366
SOD2	6648	Kidney Diseases	MESH:D007674	marker/mechanism		NA		19917352|21571061
SOD2	6648	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		25279216
SOD2	6648	Kidney Tubular Necrosis, Acute	MESH:D007683	therapeutic		NA		19917352
SOD2	6648	Lewy Body Disease	MESH:D020961	marker/mechanism		NA		16141792
SOD2	6648	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		32659284
SOD2	6648	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		19731237
SOD2	6648	Lung Diseases	MESH:D008171	marker/mechanism		NA		8063194
SOD2	6648	Lung Diseases, Interstitial	MESH:D017563	marker/mechanism		NA		10673208
SOD2	6648	Lymphatic Metastasis	MESH:D008207	marker/mechanism		NA		10853026|19381893|20618948
SOD2	6648	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		16081686
SOD2	6648	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		23964924
SOD2	6648	Marfan Syndrome	MESH:D008382	marker/mechanism		NA		25101153
SOD2	6648	MELAS Syndrome	MESH:D017241	marker/mechanism		NA		11907800
SOD2	6648	Meningomyelocele	MESH:D008591	marker/mechanism		NA		22972774
SOD2	6648	Mesothelioma	MESH:D008654	marker/mechanism		NA		11283936|15039138|17290392|9533946
SOD2	6648	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		20617513
SOD2	6648	Methylmalonic acidemia	MESH:C537358	marker/mechanism		NA		16823967
SOD2	6648	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6	OMIM:612634	marker/mechanism		NA	612634	
SOD2	6648	Mitochondrial Diseases	MESH:D028361	marker/mechanism		NA		9917329
SOD2	6648	Mouth Neoplasms	MESH:D009062	marker/mechanism|therapeutic		NA		12543247|15274141
SOD2	6648	Multiple Chemical Sensitivity	MESH:D018777	marker/mechanism		NA		23967348
SOD2	6648	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		15908783
SOD2	6648	Myocardial Infarction	MESH:D009203	therapeutic		NA		12160945
SOD2	6648	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
SOD2	6648	Nasopharyngeal Carcinoma	MESH:D000077274	marker/mechanism		NA		20461718
SOD2	6648	Necrosis	MESH:D009336	marker/mechanism|therapeutic		NA		19293248|9548797
SOD2	6648	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		10853026|11053990|15048980|15654357|21749277|22580338
SOD2	6648	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		12538496|18930813|19487542|22580338
SOD2	6648	Neoplasms	MESH:D009369	marker/mechanism|therapeutic		NA		11165872|11278550|11853549|12032862|17632733|19676086
SOD2	6648	Nephrotic Syndrome	MESH:D009404	marker/mechanism		NA		9152291
SOD2	6648	Nerve Degeneration	MESH:D009410	therapeutic		NA		11146106
SOD2	6648	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		10942521|12709579|15964507
SOD2	6648	Obesity	MESH:D009765	marker/mechanism		NA		16317704|23956348|30738174
SOD2	6648	Ophthalmoplegia, Chronic Progressive External	MESH:D017246	marker/mechanism		NA		11907800|14680979
SOD2	6648	Osteoarthritis	MESH:D010003	marker/mechanism		NA		15292528|18784066|22108257
SOD2	6648	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
SOD2	6648	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		16179351|18594523
SOD2	6648	Pancreatic Carcinoma	MESH:C562463	marker/mechanism		NA		11328670
SOD2	6648	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		17895890
SOD2	6648	Papilloma	MESH:D010212	marker/mechanism		NA		11507057
SOD2	6648	Parkinson Disease	MESH:D010300	marker/mechanism		NA		17188257|18353766|25279756
SOD2	6648	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		20864405
SOD2	6648	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		15986332|21472284
SOD2	6648	Premature Birth	MESH:D047928	marker/mechanism		NA		26055944
SOD2	6648	Prostatic Neoplasms	MESH:D011471	marker/mechanism|therapeutic		NA		12592389|17465268|17646272|18829485|19074884|22564066|23315858|26468117
SOD2	6648	Psoriasis	MESH:D011565	marker/mechanism		NA		7744320
SOD2	6648	Psychoses, Substance-Induced	MESH:D011605	marker/mechanism		NA		16807759
SOD2	6648	Radiation Injuries	MESH:D011832	therapeutic		NA		16540396|21945096
SOD2	6648	Radiation Injuries, Experimental	MESH:D011833	therapeutic		NA		11121210|20726721
SOD2	6648	Reperfusion Injury	MESH:D015427	marker/mechanism|therapeutic		NA		16682413|19193722|19917352|21940958|23743330|8215636
SOD2	6648	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
SOD2	6648	Reticulocytosis	MESH:D045262	marker/mechanism		NA		20800516
SOD2	6648	Sarcoidosis	MESH:D012507	marker/mechanism		NA		10673208
SOD2	6648	Seizures	MESH:D012640	marker/mechanism		NA		20446108
SOD2	6648	Shock, Cardiogenic	MESH:D012770	marker/mechanism		NA		21062213
SOD2	6648	Skin Abnormalities	MESH:D012868	marker/mechanism		NA		24494196
SOD2	6648	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
SOD2	6648	Skin Neoplasms	MESH:D012878	marker/mechanism|therapeutic		NA		11507057|20454814|22009531|25362851
SOD2	6648	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		20618948
SOD2	6648	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		10853026|14503839|19424620|25279216
SOD2	6648	Thyroid Carcinoma, Anaplastic	MESH:D065646	marker/mechanism		NA		15887859
SOD2	6648	Tongue Neoplasms	MESH:D014062	marker/mechanism		NA		20618948
SOD2	6648	Turner Syndrome	MESH:D014424	marker/mechanism		NA		25101153
SOD2	6648	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		14729580|18930813
SOD2	6648	Uveitis	MESH:D014605	marker/mechanism		NA		19578012|21850155
SOD2	6648	Vascular Diseases	MESH:D014652	marker/mechanism		NA		18596060
SOD2	6648	Ventricular Dysfunction, Left	MESH:D018487	marker/mechanism		NA		19293248
SOD3	6649	Chemical and Drug Induced Liver Injury	MESH:D056486	therapeutic		NA		11529661
SOD3	6649	Dermatitis, Contact	MESH:D003877	therapeutic		NA		17392825
SOD3	6649	Disease Progression	MESH:D018450	marker/mechanism		NA		16081686
SOD3	6649	Heart Failure	MESH:D006333	marker/mechanism		NA		20304815
SOD3	6649	Hypertension	MESH:D006973	marker/mechanism|therapeutic		NA		16864745|17023265
SOD3	6649	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		16081686
SOD3	6649	Necrosis	MESH:D009336	therapeutic		NA		11529661
SOD3	6649	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		16399992|16467073
SOD3	6649	Pulmonary Fibrosis	MESH:D011658	therapeutic		NA		15298984
SON	6651	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
SON	6651	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
SON	6651	ZTTK SYNDROME	OMIM:617140	marker/mechanism		NA	617140	
SORBS2	8470	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
SORD	6652	Charcot-Marie-Tooth Disease	MESH:D002607	marker/mechanism		NA		32367058
SORD	6652	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		12763371
SORD	6652	Enterocolitis, Necrotizing	MESH:D020345	marker/mechanism		NA		18806098
SORD	6652	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		18549825
SORL1	6653	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
SORL1	6653	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		26881866
SORL1	6653	Cholestasis	MESH:D002779	marker/mechanism		NA		26881866
SORL1	6653	Cognitive Dysfunction	MESH:D060825	marker/mechanism		NA		30503753
SORL1	6653	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		26213588
SORT1	6272	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		25805502
SORT1	6272	Cholestasis	MESH:D002779	marker/mechanism		NA		28453831
SORT1	6272	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		21378990
SORT1	6272	Liver Diseases	MESH:D008107	marker/mechanism		NA		28453831
SOS1	6654	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27158780
SOS1	6654	FIBROMATOSIS, GINGIVAL, 1	OMIM:135300	marker/mechanism		NA	135300	
SOS1	6654	Noonan Syndrome	MESH:D009634	marker/mechanism		NA		17603482|17603483
SOS1	6654	Noonan Syndrome 4	MESH:C548082	marker/mechanism		NA	610733	
SOS2	6655	NOONAN SYNDROME 9	OMIM:616559	marker/mechanism		NA	616559	
SOST	50964	Craniodiaphyseal Dysplasia, Autosomal Dominant	MESH:C567275	marker/mechanism		NA	122860	
SOST	50964	Osteochondrodysplasias	MESH:D010009	marker/mechanism		NA	239100	
SOST	50964	Sclerosteosis	MESH:C537525	marker/mechanism		NA	269500	
SOX10	6663	Peripheral Demyelinating Neuropathy, Central Dysmyelination, Waardenburg Syndrome, and Hirschsprung Disease	MESH:C563789	marker/mechanism		NA	609136	
SOX10	6663	Waardenburg syndrome type 2	MESH:C536463	marker/mechanism		NA	611584	
SOX10	6663	Waardenburg Syndrome, Type 4c	MESH:C567679	marker/mechanism		NA	613266	
SOX11	6664	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
SOX11	6664	Coffin-Siris syndrome	MESH:C536436	marker/mechanism		NA	615866	
SOX11	6664	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		26213588
SOX11	6664	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
SOX15	6665	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
SOX15	6665	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
SOX17	64321	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18413743
SOX17	64321	Teratogenesis	MESH:D064793	marker/mechanism		NA		24154490
SOX17	64321	Vesico-Ureteral Reflux	MESH:D014718	marker/mechanism		NA	613674	
SOX18	54345	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
SOX18	54345	HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME	OMIM:137940	marker/mechanism		NA	137940	
SOX18	54345	Hypotrichosis-Lymphedema-Telangiectasia Syndrome	MESH:C564327	marker/mechanism		NA	607823	
SOX18	54345	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
SOX2	6657	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		25184679
SOX2	6657	Anophthalmos	MESH:D000853	marker/mechanism		NA		21532573
SOX2	6657	Ataxia	MESH:D001259	marker/mechanism		NA		29732603
SOX2	6657	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		27935819
SOX2	6657	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		19801978
SOX2	6657	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		19801978
SOX2	6657	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		19801978
SOX2	6657	Microphthalmia, Syndromic 3	MESH:C565948	marker/mechanism		NA	206900	
SOX2	6657	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		27415467
SOX2	6657	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		27415467
SOX2	6657	Sarcoma	MESH:D012509	marker/mechanism		NA		26343384
SOX2	6657	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941189
SOX2	6657	Thoracic Neoplasms	MESH:D013899	marker/mechanism		NA		26343384
SOX2	6657	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		29396848
SOX3	6658	Mental Retardation, X-Linked, With Panhypopituitarism	MESH:C567485	marker/mechanism		NA	300123	
SOX3	6658	Panhypopituitarism X-linked	MESH:C538613	marker/mechanism		NA	312000	
SOX30	11063	Lung Neoplasms	MESH:D008175	therapeutic		NA		25435374
SOX4	6659	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
SOX4	6659	Cardiomegaly	MESH:D006332	marker/mechanism		NA		29394407
SOX4	6659	Heart Failure	MESH:D006333	marker/mechanism		NA		29394407
SOX4	6659	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SOX4	6659	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		21147764
SOX4	6659	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
SOX5	6660	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		20062060
SOX5	6660	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		20808228
SOX5	6660	LAMB-SHAFFER SYNDROME	OMIM:616803	marker/mechanism		NA	616803	
SOX8	30812	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		20864405
SOX9	6662	Anonychia congenita	MESH:C536377	marker/mechanism		NA		19639023
SOX9	6662	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		20868653
SOX9	6662	Campomelic Dysplasia	MESH:D055036	marker/mechanism		NA	114290	
SOX9	6662	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
SOX9	6662	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		11807034
SOX9	6662	Hand Deformities, Congenital	MESH:D006228	marker/mechanism		NA		19639023
SOX9	6662	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
SOX9	6662	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
SOX9	6662	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
SOX9	6662	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		32682831
SOX9	6662	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		32682831
SOX9	6662	Pierre Robin Syndrome	MESH:D010855	marker/mechanism		NA		19234473
SOX9A	60641	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		27935819
SOX9A	60641	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		16759393
SOX9B	60642	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		30398377
SP1	6667	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22009531
SP1	6667	Hyperglycemia	MESH:D006943	marker/mechanism		NA		11696579
SP1	6667	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		26317792
SP1	6667	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		12538496
SP1	6667	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		22009531
SP110	3431	Hepatic venoocclusive disease with immunodeficiency	MESH:C537257	marker/mechanism		NA	235550	
SP110	3431	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO	OMIM:607948	marker/mechanism		NA	607948	
SP140	11262	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		18758461
SP140	11262	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SP4	6671	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		19401786
SP4	6671	Schizophrenia	MESH:D012559	marker/mechanism		NA		19401786
SP5	389058	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
SP7	121340	OSTEOGENESIS IMPERFECTA, TYPE XII	OMIM:613849	marker/mechanism		NA	613849	
SPAG1	6674	CILIARY DYSKINESIA, PRIMARY, 28	OMIM:615505	marker/mechanism		NA	615505	
SPAG5	10615	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
SPARC	6678	Adrenocortical Carcinoma	MESH:D018268	marker/mechanism		NA		22156929
SPARC	6678	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		17397030
SPARC	6678	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18458674
SPARC	6678	Hepatitis	MESH:D006505	marker/mechanism		NA		23408952
SPARC	6678	Hyperalgesia	MESH:D006930	marker/mechanism		NA		20714283
SPARC	6678	Intervertebral Disc Degeneration	MESH:D055959	marker/mechanism		NA		20714283
SPARC	6678	Kidney Diseases	MESH:D007674	marker/mechanism		NA		12660331
SPARC	6678	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		18206229
SPARC	6678	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		23408952
SPARC	6678	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism|therapeutic		NA		18615449|25380136
SPARC	6678	Low Back Pain	MESH:D017116	marker/mechanism		NA		20714283
SPARC	6678	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		18172295
SPARC	6678	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
SPARC	6678	Necrosis	MESH:D009336	marker/mechanism		NA		23408952
SPARC	6678	Neoplasms, Experimental	MESH:D009374	therapeutic		NA		20164124
SPARC	6678	Osteogenesis Imperfecta	MESH:D010013	marker/mechanism		NA		1793673
SPARC	6678	OSTEOGENESIS IMPERFECTA, TYPE XVII	OMIM:616507	marker/mechanism		NA	616507	
SPARC	6678	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		19177197
SPARC	6678	Thrombocytopenia	MESH:D013921	marker/mechanism		NA		27725143
SPARC	6678	Uremia	MESH:D014511	marker/mechanism		NA		19092814
SPARC	6678	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
SPARCL1	8404	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
SPARCL1	8404	Epilepsy	MESH:D004827	marker/mechanism		NA		18488994
SPART	23111	Adenocarcinoma Of Esophagus	MESH:C562730	marker/mechanism		NA		23525077
SPART	23111	Spastic paraplegia 20, autosomal recessive	MESH:C536858	marker/mechanism		NA	275900	
SPAST	6683	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
SPAST	6683	Spastic paraplegia 4, autosomal dominant	MESH:C536865	marker/mechanism		NA	182601	
SPATA16	83893	SPERMATOGENIC FAILURE 6	OMIM:102530	marker/mechanism		NA	102530	
SPATA18	132671	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
SPATA18	132671	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
SPATA21	374955	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
SPATA21	374955	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
SPATA5	166378	EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME	OMIM:616577	marker/mechanism		NA	616577	
SPATA5	166378	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
SPATA7	55812	Leber Congenital Amaurosis	MESH:D057130	marker/mechanism		NA		19268277
SPATA7	55812	Leber Congenital Amaurosis 3	MESH:C565814	marker/mechanism		NA	604232	
SPATA7	55812	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA		19268277
SPATS2L	26010	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
SPC25	57405	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
SPDEF	25803	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		18567002
SPECC1L	23384	Hypertelorism with esophageal abnormality and hypospadias	MESH:C538387	marker/mechanism		NA	145410	
SPECC1L	23384	Oculomaxillofacial dysostosis	MESH:C537736	marker/mechanism		NA	600251	
SPEG	10290	Myopathy, Centronuclear, Autosomal Recessive	MESH:C562934	marker/mechanism		NA	615959	
SPEN	23013	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
SPG11	80208	Amyotrophic Lateral Sclerosis 5	MESH:C566576	marker/mechanism		NA	602099	
SPG11	80208	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X	OMIM:616668	marker/mechanism		NA	616668	
SPG11	80208	Spastic paraplegia 11, autosomal recessive	MESH:C537483	marker/mechanism		NA	604360	
SPG21	51324	MAST Syndrome	MESH:C565409	marker/mechanism		NA	248900	
SPG7	6687	Paraplegia	MESH:D010264	marker/mechanism		NA		11549317
SPG7	6687	Spastic Paraplegia 7, Autosomal Recessive	MESH:C564599	marker/mechanism		NA	607259	
SPHK1	8877	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		24055189
SPHK1	8877	Fibrosis	MESH:D005355	therapeutic		NA		19657322
SPHK1	8877	Leukemia	MESH:D007938	marker/mechanism		NA		18283525
SPHK1	8877	Myelodysplastic Syndromes	MESH:D009190	marker/mechanism		NA		18283525
SPHK2	56848	Infarction, Middle Cerebral Artery	MESH:D020244	therapeutic		NA		23043544
SPHK2	56848	Memory Disorders	MESH:D008569	marker/mechanism		NA		24859201
SPI1	6688	Leukemia, Myeloid	MESH:D007951	therapeutic		NA		17361223
SPI1	6688	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		26237430
SPI1	6688	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054218	marker/mechanism		NA		28671687
SPIB	6689	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		20639880
SPIN2A	54466	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		16099942
SPIN2A	54466	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
SPINK1	6690	Hereditary pancreatitis	MESH:C537262	marker/mechanism		NA	167800	
SPINK1	6690	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		19896093
SPINK1	6690	Pancreatitis	MESH:D010195	marker/mechanism		NA		23143602
SPINK1	6690	Pancreatitis, Chronic	MESH:D050500	marker/mechanism		NA		18206817
SPINK1	6690	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		25735316
SPINK1	6690	Tropical Calcific Pancreatitis	MESH:C564276	marker/mechanism		NA	608189	
SPINK5	11005	Netherton Syndrome	MESH:D056770	marker/mechanism		NA	256500	20657595
SPINK5	11005	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
SPINT2	10653	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
SPINT2	10653	Diarrhea 3, Secretory Sodium, Congenital	MESH:C562576	marker/mechanism		NA	270420	
SPINT2	10653	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
SPINT2	10653	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
SPINT2	10653	Neural Tube Defects	MESH:D009436	marker/mechanism		NA		24722141
SPINT2	10653	Placenta Diseases	MESH:D010922	marker/mechanism		NA		24722141
SPINT2	10653	Prenatal Injuries	MESH:D049188	marker/mechanism		NA		24722141
SPMD1	100035378	Alcohol-Related Disorders	MESH:D019973	marker/mechanism		NA		28000031
SPMD1	100035378	Depressive Disorder	MESH:D003866	marker/mechanism		NA		28000031
SPMD1	100035378	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		28000031
SPMD1	100035378	Niemann-Pick Diseases	MESH:D009542	marker/mechanism		NA		28000031
SPN	6693	Calcinosis	MESH:D002114	marker/mechanism		NA		21335463
SPN	6693	Heart Valve Diseases	MESH:D006349	marker/mechanism		NA		21335463
SPOCK1	6695	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17929269
SPON2	10417	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		19208208
SPOP	8405	Carcinoma, Ductal	MESH:D044584	marker/mechanism		NA		29295717
SPOP	8405	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		23104009
SPOP	8405	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		22610119|29295717|29610475
SPP1	6696	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		11274264|20623750
SPP1	6696	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		20495387|21552421
SPP1	6696	Asbestosis	MESH:D001195	marker/mechanism		NA		16221779|21514415
SPP1	6696	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		16651633
SPP1	6696	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18949741|22531848
SPP1	6696	Calcinosis	MESH:D002114	marker/mechanism		NA		21193197|21335463
SPP1	6696	Carotid Stenosis	MESH:D016893	marker/mechanism		NA		26564003
SPP1	6696	Cerebral Hemorrhage	MESH:D002543	therapeutic		NA		20440599
SPP1	6696	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		20623750
SPP1	6696	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		14555839
SPP1	6696	Diabetic Cardiomyopathies	MESH:D058065	marker/mechanism		NA		16980342
SPP1	6696	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		15805072
SPP1	6696	Glioma	MESH:D005910	marker/mechanism		NA		16651633
SPP1	6696	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA		9294829
SPP1	6696	Heart Diseases	MESH:D006331	marker/mechanism		NA		23558518
SPP1	6696	Heart Valve Diseases	MESH:D006349	marker/mechanism		NA		21335463
SPP1	6696	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
SPP1	6696	Kidney Calculi	MESH:D007669	marker/mechanism		NA		10890885|8325891
SPP1	6696	Kidney Diseases	MESH:D007674	marker/mechanism		NA		27026710
SPP1	6696	Leukoencephalopathies	MESH:D056784	marker/mechanism		NA		11868353
SPP1	6696	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		16221502
SPP1	6696	Liver Diseases, Alcoholic	MESH:D008108	marker/mechanism		NA		18703563
SPP1	6696	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		11420682
SPP1	6696	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		21552421|22481206
SPP1	6696	Mammary Neoplasms, Experimental	MESH:D008325	therapeutic		NA		15318939
SPP1	6696	Mesothelioma	MESH:D008654	marker/mechanism		NA		16221779|18550471
SPP1	6696	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		22407340
SPP1	6696	Neoplasms, Experimental	MESH:D009374	therapeutic		NA		21852811
SPP1	6696	Osteolysis	MESH:D010014	marker/mechanism		NA		22407340
SPP1	6696	Pancreatic Diseases	MESH:D010182	marker/mechanism		NA		20495387
SPP1	6696	Pleural Neoplasms	MESH:D010997	marker/mechanism		NA		16221779
SPP1	6696	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
SPP1	6696	Proteinuria	MESH:D011507	marker/mechanism		NA		11972865
SPP1	6696	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		25216247
SPP1	6696	Uremia	MESH:D014511	marker/mechanism		NA		19092814
SPP1	6696	Vascular System Injuries	MESH:D057772	marker/mechanism		NA		11868353
SPP1	6696	Wounds and Injuries	MESH:D014947	therapeutic		NA		9525990
SPR	6697	Dystonia, Dopa-Responsive, due to Sepiapterin Reductase Deficiency	MESH:C562657	marker/mechanism		NA	612716	25526675
SPRED1	161742	Cafe-au-Lait Spots	MESH:D019080	marker/mechanism		NA		17704776
SPRED1	161742	Legius syndrome	MESH:C548032	marker/mechanism		NA	611431	
SPRED1	161742	Nervous System Malformations	MESH:D009421	marker/mechanism		NA		17704776
SPRED1	161742	Neurofibromatosis 1	MESH:D009456	marker/mechanism		NA		17704776
SPRED2	200734	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		20453842|23143596
SPRR1A	6698	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		8617999
SPRR1A	6698	Papilloma	MESH:D010212	marker/mechanism		NA		8617999
SPRR2A	6700	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
SPRR2B	6701	Asthma	MESH:D001249	marker/mechanism		NA		21912604
SPRTN	83932	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		25261934
SPRTN	83932	Genomic Instability	MESH:D042822	marker/mechanism		NA		25261934
SPRTN	83932	Progeria	MESH:D011371	marker/mechanism		NA		25261934
SPRTN	83932	RUIJS-AALFS SYNDROME	OMIM:616200	marker/mechanism		NA	616200	
SPRY2	10253	Cleft Lip	MESH:D002971	marker/mechanism		NA		17576140
SPRY2	10253	Cleft Palate	MESH:D002972	marker/mechanism		NA		17576140
SPRY2	10253	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		17576140
SPRY2	10253	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA	616818	
SPRY2	10253	Lung Diseases	MESH:D008171	marker/mechanism		NA		24210189
SPRY2	10253	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		15136453
SPRY4	81848	HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA	OMIM:615266	marker/mechanism		NA	615266	
SPRY4	81848	Idiopathic Hypogonadotropic Hypogonadism	MESH:C562785	marker/mechanism		NA	146110	
SPRY4	81848	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		25822087
SPSB4	92369	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SPTA1	6708	Elliptocytosis 2	MESH:C565058	marker/mechanism		NA	130600	
SPTA1	6708	Pyropoikilocytosis, Hereditary	MESH:C563004	marker/mechanism		NA	266140	
SPTA1	6708	Spherocytosis, Type 3	MESH:C567489	marker/mechanism		NA	270970	
SPTAN1	6709	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 5	OMIM:613477	marker/mechanism		NA	613477	
SPTAN1	6709	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SPTAN1	6709	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		25015659
SPTB	6710	Anemia, Hemolytic	MESH:D000743	marker/mechanism		NA		9005995
SPTB	6710	Anemia, Neonatal	MESH:D000751	marker/mechanism		NA		9005995
SPTB	6710	Elliptocytosis, Hereditary	MESH:D004612	marker/mechanism		NA		1975598
SPTB	6710	Spherocytosis, Hereditary	MESH:D013103	marker/mechanism		NA		19538529|8102379
SPTB	6710	SPHEROCYTOSIS, TYPE 2	OMIM:616649	marker/mechanism		NA	616649	
SPTBN1	6711	Fractures, Bone	MESH:D050723	marker/mechanism		NA		22504420
SPTBN1	6711	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
SPTBN2	6712	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA	600224|615386	
SPTBN4	57731	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		22138691
SPTBN4	57731	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
SPTLC1	10558	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA	OMIM:162400	marker/mechanism		NA	162400	
SPTLC2	9517	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC	OMIM:613640	marker/mechanism		NA	613640	
SPZ1	84654	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
SQLE	6713	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		11420682
SQSTM1	8878	Amyotrophic Lateral Sclerosis	MESH:D000690	marker/mechanism		NA		19765191
SQSTM1	8878	Distal myopathy, Nonaka type	MESH:C536816	marker/mechanism		NA	617158	
SQSTM1	8878	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3	OMIM:616437	marker/mechanism		NA	616437	
SQSTM1	8878	Macular Degeneration	MESH:D008268	marker/mechanism		NA		23922739
SQSTM1	8878	NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	OMIM:617145	marker/mechanism		NA	617145	
SQSTM1	8878	Osteitis Deformans	MESH:D010001	marker/mechanism		NA	167250	
SQSTM1	8878	Spinal Cord Injuries	MESH:D013119	marker/mechanism		NA		29793971
SRA1	10011	Idiopathic Hypogonadotropic Hypogonadism	MESH:C562785	marker/mechanism		NA	146110	
SRAB-21	188653	Hypoxia	MESH:D000860	therapeutic		NA		19936206
SRC	6714	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21357651
SRC	6714	Cardiomegaly	MESH:D006332	marker/mechanism		NA		18194989
SRC	6714	Colitis	MESH:D003092	marker/mechanism		NA		17551092
SRC	6714	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		14569062
SRC	6714	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	114500	
SRC	6714	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		18844224|21291860
SRC	6714	Polycystic Kidney, Autosomal Recessive	MESH:D017044	marker/mechanism		NA		18385429
SRC	6714	Status Epilepticus	MESH:D013226	marker/mechanism		NA		16600505
SRC	6714	THROMBOCYTOPENIA 6	OMIM:616937	marker/mechanism		NA	616937	
SRC	6714	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		11723127|17093206
SRCAP	10847	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
SRCAP	10847	Floating-harbor syndrome	MESH:C537062	marker/mechanism		NA	136140	
SRCAP	10847	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
SRCIN1	80725	Cocaine-Related Disorders	MESH:D019970	therapeutic		NA		27506785
SRD5A1	6715	Endometriosis	MESH:D004715	marker/mechanism		NA		21232532|23183084
SRD5A1	6715	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SRD5A1	6715	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543|22381227
SRD5A1	6715	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		18500220|20564326
SRD5A2	6716	Alopecia	MESH:D000505	marker/mechanism		NA		17136762
SRD5A2	6716	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		23200943
SRD5A2	6716	Endometriosis	MESH:D004715	marker/mechanism		NA		21232532
SRD5A2	6716	Prostatic Hyperplasia	MESH:D011470	marker/mechanism		NA		20823678
SRD5A2	6716	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16998812|17136762|17823934|18306354|18500220
SRD5A2	6716	Pseudovaginal Perineoscrotal Hypospadias	MESH:C535830	marker/mechanism		NA	264600	7554313
SRD5A3	79644	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq	OMIM:612379	marker/mechanism		NA	612379	
SRD5A3	79644	Creutzfeldt-Jakob Syndrome	MESH:D007562	marker/mechanism		NA		23349890
SRD5A3	79644	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
SRD5A3	79644	Kahrizi Syndrome	MESH:C567196	marker/mechanism		NA	612713	
SREBF1	6720	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		14563831|21147110
SREBF1	6720	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		10900012|23090186
SREBF1	6720	Fatty Liver	MESH:D005234	marker/mechanism		NA		24469900
SREBF1	6720	Insulin Resistance	MESH:D007333	marker/mechanism		NA		22658938
SREBF1	6720	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19878707
SREBF1	6720	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SREBF1	6720	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		23603006|24633463
SREBF1	6720	Obesity	MESH:D009765	marker/mechanism		NA		10900012
SREBF2	6721	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		30394316
SREBF2	6721	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21147110
SREBF2	6721	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
SREBF2	6721	Insulin Resistance	MESH:D007333	marker/mechanism		NA		20699619
SREBF2	6721	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19878707
SREBF2	6721	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		30394316
SREBF2	6721	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
SRF	6722	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
SRF	6722	Neoplasms	MESH:D009369	therapeutic		NA		17116645
SRGAP1	57522	Thyroid cancer, follicular	MESH:C572845	marker/mechanism		NA	188470	
SRGAP3	9901	Chromosome 3, monosomy 3p25	MESH:C536807	marker/mechanism		NA		21082655
SRGAP3	9901	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21082655
SRGAP3	9901	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
SRGN	5552	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SRI	6717	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SRM	6723	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
SRM	6723	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
SRMS	6725	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
SRP54	6729	Shwachman-Diamond Syndrome	MESH:D000081003	marker/mechanism		NA	260400	
SRP68	6730	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
SRP68	6730	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		16759393
SRP68	6730	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
SRP72	6731	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		26881866
SRP72	6731	Cholestasis	MESH:D002779	marker/mechanism		NA		26881866
SRP72	6731	Congenital Bone Marrow Failure Syndromes	MESH:D000080984	marker/mechanism		NA	614675	
SRPK2	6733	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		31043756
SRPX	8406	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
SRPX2	27286	Rolandic Epilepsy, Mental Retardation, and Speech Dyspraxia, X-Linked	MESH:C564467	marker/mechanism		NA	300643	
SRR	63826	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
SRR	63826	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
SRR	63826	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SRRM4	84530	Hearing Disorders	MESH:D006311	marker/mechanism		NA		17613114
SRRM4	84530	Vestibular Diseases	MESH:D015837	marker/mechanism		NA		17613114
SRRT	51593	Glioblastoma	MESH:D005909	marker/mechanism		NA		30542699
SRSF1	6426	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
SRSF1	6426	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17085005
SRSF1	6426	Schizophrenia	MESH:D012559	marker/mechanism		NA		16223876
SRSF10	10772	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		21072693
SRSF10	10772	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		21072693
SRSF10	10772	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
SRSF2	6427	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
SRSF2	6427	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
SRSF2	6427	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
SRSF2	6427	Supranuclear Palsy, Progressive	MESH:D013494	marker/mechanism		NA		25402454
SRSF5	6430	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
SRSF5	6430	Neurotoxicity Syndromes	MESH:D020258	marker/mechanism		NA		19784758
SRSF9	8683	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
SRY	6736	46,XX SEX REVERSAL 1	OMIM:400045	marker/mechanism		NA	400045	
SRY	6736	46,XY SEX REVERSAL 1	OMIM:400044	marker/mechanism		NA	400044	
SRY	6736	Gonadal Dysgenesis, 46,XY	MESH:D006061	marker/mechanism		NA		27576690
SS18	6760	Sarcoma, Synovial	MESH:D013584	marker/mechanism		NA		27572315|9428816
SSBP1	6742	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
SSBP1	6742	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
SSBP2	23635	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		31043756
SSBP2	23635	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		18559593
SSPN	8082	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
SSR2	6746	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
SSR4	6748	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy	OMIM:300934	marker/mechanism		NA	300934	
SST	6750	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
SST	6750	Barrett Esophagus	MESH:D001471	marker/mechanism		NA		17999418
SST	6750	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
SST	6750	Esophageal and Gastric Varices	MESH:D004932	therapeutic		NA		1385068
SST	6750	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		17999418
SST	6750	Hypokalemia	MESH:D007008	therapeutic		NA		2563217
SST	6750	Ischemia	MESH:D007511	therapeutic		NA		18624922
SST	6750	Mood Disorders	MESH:D019964	marker/mechanism		NA		25600109
SST	6750	Multiple Organ Failure	MESH:D009102	therapeutic		NA		15834315
SST	6750	Neoplasms	MESH:D009369	therapeutic		NA		21692635
SST	6750	Pancreatic Neoplasms	MESH:D010190	therapeutic		NA		2868874
SST	6750	Pancreatitis	MESH:D010195	therapeutic		NA		7911442
SST	6750	Seizures	MESH:D012640	marker/mechanism|therapeutic		NA		16771832|20134357|7913897
SST	6750	Vipoma	MESH:D003969	therapeutic		NA		2868874
SSTR1	6751	Neuroendocrine Tumors	MESH:D018358	marker/mechanism		NA		17625444
SSTR1	6751	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		17625444
SSTR1	6751	Status Epilepticus	MESH:D013226	marker/mechanism		NA		18951627
SSTR2	6752	Neuroendocrine Tumors	MESH:D018358	marker/mechanism		NA		17625444
SSTR2	6752	Pancreatic Neoplasms	MESH:D010190	marker/mechanism|therapeutic		NA		15259086|17625444|19917848
SSTR2	6752	Paraganglioma	MESH:D010235	marker/mechanism		NA		29163802
SSTR2	6752	Seizures	MESH:D012640	therapeutic		NA		16771832
SSTR2	6752	Status Epilepticus	MESH:D013226	marker/mechanism		NA		18951627
SSTR3	6753	Neuroendocrine Tumors	MESH:D018358	marker/mechanism		NA		17625444
SSTR3	6753	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		17625444
SSTR3	6753	Status Epilepticus	MESH:D013226	marker/mechanism		NA		18951627
SSTR4	6754	Status Epilepticus	MESH:D013226	marker/mechanism		NA		18951627
SSTR5	6755	Status Epilepticus	MESH:D013226	marker/mechanism		NA		18951627
SSX1	6756	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
SSX1	6756	Sarcoma, Synovial	MESH:D013584	marker/mechanism		NA	300813	27572315|9428816
SSX2	6757	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17929270
SSX2	6757	Sarcoma, Synovial	MESH:D013584	marker/mechanism		NA	300813	9428816
ST14	6768	Ichthyosis with hypotrichosis, autosomal recessive	MESH:C536273	marker/mechanism		NA	602400	17273967|18445049
ST14	6768	Idiopathic Pulmonary Fibrosis	MESH:D054990	marker/mechanism		NA		26599507
ST14	6768	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ST14	6768	Netherton Syndrome	MESH:D056770	marker/mechanism		NA		20657595
ST14	6768	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
ST3GAL1	6482	Enterovirus Infections	MESH:D004769	marker/mechanism		NA		28446605
ST3GAL3	6487	Mental Retardation, Autosomal Recessive 12	MESH:C567019	marker/mechanism		NA	611090	
ST3GAL4	6484	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
ST3GAL4	6484	Enterovirus Infections	MESH:D004769	marker/mechanism		NA		28446605
ST3GAL4	6484	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
ST3GAL5	8869	Amish Infantile Epilepsy Syndrome	MESH:C563799	marker/mechanism		NA	609056	
ST6GAL1	6480	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		16033404
ST6GAL1	6480	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		21874001
ST6GALNAC2	10610	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		17480010
ST6GALNAC5	81849	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		17379860|17568789
ST8SIA1	6489	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
ST8SIA1	6489	Neurotoxicity Syndromes	MESH:D020258	marker/mechanism		NA		19784758
ST8SIA2	8128	Autistic Disorder	MESH:D001321	marker/mechanism		NA		20663923
STAB1	23166	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
STAB2	55576	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
STAB2	55576	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
STAC	6769	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		16033404
STAC3	246329	Hepatomegaly	MESH:D006529	marker/mechanism		NA		28108177
STAC3	246329	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
STAC3	246329	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		28108177
STAC3	246329	Native American myopathy	MESH:C538343	marker/mechanism		NA	255995	
STAG1	10274	Intellectual Disability	MESH:D008607	marker/mechanism		NA		28191889
STAG2	10735	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		24121792
STAG2	10735	Leukemia, Megakaryoblastic, of Down Syndrome	MESH:C566025	marker/mechanism		NA		24056718
STAG2	10735	Leukemia, Myeloid	MESH:D007951	marker/mechanism		NA		23955599
STAG2	10735	Myelodysplastic Syndromes	MESH:D009190	marker/mechanism		NA		27992414
STAG2	10735	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		24121789|24121791|24121792
STAG3	10734	PREMATURE OVARIAN FAILURE 8	OMIM:615723	marker/mechanism		NA	615723	
STAG3L1	54441	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
STAG3L1	54441	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
STAMBP	10617	Brain Diseases	MESH:D001927	marker/mechanism		NA		23542699
STAMBP	10617	Capillary Malformation-Arteriovenous Malformation	MESH:C564254	marker/mechanism		NA		23542699
STAMBP	10617	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		23542699
STAMBP	10617	Epilepsy	MESH:D004827	marker/mechanism		NA		23542699
STAMBP	10617	Microcephaly	MESH:D008831	marker/mechanism		NA		23542699
STAMBP	10617	MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	OMIM:614261	marker/mechanism		NA	614261	
STAR	6770	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		23200943
STAR	6770	Lipoid congenital adrenal hyperplasia	MESH:C537027	marker/mechanism		NA	201710	11502818|22028173
STAR	6770	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21262361
STARD10	10809	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
STARD13	90627	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
STARD3	10948	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881|17592021
STARD7	56910	Epilepsy, Myoclonic, Benign Adult Familial, Type 2	MESH:C564313	marker/mechanism		NA	607876	
STARD8	9754	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18507500
STARD8	9754	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18507500|21278247
STARD9	57519	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		31043756
STAT1	6772	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		15188379
STAT1	6772	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		12833524
STAT1	6772	Candidiasis, Chronic Mucocutaneous	MESH:D002178	marker/mechanism		NA		21714643
STAT1	6772	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		22488367
STAT1	6772	Cytomegalovirus Infections	MESH:D003586	marker/mechanism		NA		16688530
STAT1	6772	Disease Progression	MESH:D018450	marker/mechanism		NA		22488367
STAT1	6772	Hearing Loss	MESH:D034381	marker/mechanism		NA		20712533
STAT1	6772	IMMUNODEFICIENCY 31A	OMIM:614892	marker/mechanism		NA	614892	
STAT1	6772	IMMUNODEFICIENCY 31B	OMIM:613796	marker/mechanism		NA	613796	
STAT1	6772	IMMUNODEFICIENCY 31C	OMIM:614162	marker/mechanism		NA	614162	
STAT1	6772	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
STAT1	6772	Liver Cirrhosis	MESH:D008103	therapeutic		NA		17133483
STAT1	6772	Mycobacterium Infections	MESH:D009164	marker/mechanism		NA		11452125
STAT1	6772	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		29147627
STAT1	6772	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054218	marker/mechanism		NA		23471820
STAT2	6773	IMMUNODEFICIENCY 44	OMIM:616636	marker/mechanism		NA	616636	
STAT3	6774	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		19028472|26432044
STAT3	6774	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		15188379|21937456
STAT3	6774	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
STAT3	6774	Atherosclerosis	MESH:D050197	marker/mechanism		NA		19330073
STAT3	6774	Atrophy	MESH:D001284	marker/mechanism		NA		16391472
STAT3	6774	AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1	OMIM:615952	marker/mechanism		NA	615952	
STAT3	6774	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		25038750
STAT3	6774	Brain Ischemia	MESH:D002545	marker/mechanism		NA		17901229
STAT3	6774	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		14975756
STAT3	6774	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
STAT3	6774	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		21549414
STAT3	6774	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		17566705|26432044
STAT3	6774	Cardiomegaly	MESH:D006332	marker/mechanism		NA		10618415|19299911|24448315
STAT3	6774	Cardiomyopathies	MESH:D009202	marker/mechanism|therapeutic		NA		10618415|24448315
STAT3	6774	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		25970160
STAT3	6774	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		18438405|20228799
STAT3	6774	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		19028472
STAT3	6774	Copper-Overload Cirrhosis	MESH:C566858	marker/mechanism		NA		22879914
STAT3	6774	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		25038750
STAT3	6774	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		25812446
STAT3	6774	Fever	MESH:D005334	marker/mechanism		NA		25429137
STAT3	6774	Fibrosis	MESH:D005355	marker/mechanism		NA		24448315
STAT3	6774	Hepatitis, Chronic	MESH:D006521	marker/mechanism		NA		22879914
STAT3	6774	Hernias, Diaphragmatic, Congenital	MESH:D065630	marker/mechanism		NA		25812446
STAT3	6774	Hyper-Ige Recurrent Infection Syndrome, Autosomal Dominant	MESH:C567925	marker/mechanism		NA	147060	
STAT3	6774	Idiopathic Pulmonary Fibrosis	MESH:D054990	marker/mechanism		NA		30481203
STAT3	6774	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		21940958
STAT3	6774	Inflammation	MESH:D007249	marker/mechanism|therapeutic		NA		20943775|21937456|24448315
STAT3	6774	Job Syndrome	MESH:D007589	marker/mechanism		NA		25038750
STAT3	6774	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		24090995
STAT3	6774	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		19796711
STAT3	6774	Leukemia, T-Cell	MESH:D015458	marker/mechanism		NA		19796711
STAT3	6774	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		12957465
STAT3	6774	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		26297436|28100771
STAT3	6774	Lymphatic Metastasis	MESH:D008207	marker/mechanism		NA		21549414
STAT3	6774	Lymphoma, Large-Cell, Anaplastic	MESH:D017728	marker/mechanism		NA		22155737
STAT3	6774	Lymphoma, T-Cell	MESH:D016399	marker/mechanism		NA		26192917
STAT3	6774	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
STAT3	6774	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
STAT3	6774	Medulloblastoma	MESH:D008527	marker/mechanism		NA		19001435
STAT3	6774	Memory Disorders	MESH:D008569	therapeutic		NA		17928813
STAT3	6774	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		21937440|23382965
STAT3	6774	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		29507229
STAT3	6774	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		21909139
STAT3	6774	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		22348037|23845849
STAT3	6774	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		26297436
STAT3	6774	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D015452	marker/mechanism		NA		19796711
STAT3	6774	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		14975756|16427044|25970160
STAT3	6774	Psoriasis	MESH:D011565	marker/mechanism		NA		23143594
STAT3	6774	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		30658076
STAT3	6774	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		21940958
STAT3	6774	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		27064016
STAT3	6774	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		23382965
STAT3	6774	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		25061499
STAT4	6775	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		20453842|23143596
STAT4	6775	Asthma	MESH:D001249	marker/mechanism		NA		28807506
STAT4	6775	Behcet Syndrome	MESH:D001528	marker/mechanism		NA		23291587
STAT4	6775	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		23242368
STAT4	6775	Disease Susceptibility	MESH:D004198	marker/mechanism		NA		27444301
STAT4	6775	Hepatitis B	MESH:D006509	marker/mechanism		NA		27444301
STAT4	6775	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		21399635
STAT4	6775	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA	612253	18204446|19838193
STAT4	6775	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		24076602
STAT4	6775	Scleroderma, Systemic	MESH:D012595	marker/mechanism		NA		20383147
STAT4	6775	Sjogren's Syndrome	MESH:D012859	marker/mechanism		NA		24097066|24097067
STAT5A	6776	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		20235097|21552421
STAT5A	6776	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		15609129
STAT5A	6776	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462|16316942|17173897
STAT5A	6776	Carcinoma, Ductal	MESH:D044584	marker/mechanism		NA		15609129
STAT5A	6776	Carcinoma, Intraductal, Noninfiltrating	MESH:D002285	marker/mechanism		NA		15609129
STAT5A	6776	Carcinoma, Lobular	MESH:D018275	marker/mechanism		NA		15609129
STAT5A	6776	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		21552421
STAT5A	6776	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462|15609129|16316942|17173897|20235097
STAT5A	6776	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462|15609129|16316942
STAT5A	6776	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		15746188
STAT5A	6776	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		15609129
STAT5B	6777	Enteropathy-Associated T-Cell Lymphoma	MESH:D058527	marker/mechanism		NA		29200404
STAT5B	6777	Laron syndrome type 2	MESH:C537871	marker/mechanism		NA	245590	17030597
STAT5B	6777	Leukemia, Large Granular Lymphocytic	MESH:D054066	marker/mechanism		NA		26192916|29200404
STAT5B	6777	Leukemia, Prolymphocytic, T-Cell	MESH:D015461	marker/mechanism		NA		29200404
STAT5B	6777	Lymphoma, Extranodal NK-T-Cell	MESH:D054391	marker/mechanism		NA		29200404
STAT5B	6777	Lymphoma, T-Cell	MESH:D016399	marker/mechanism		NA		26192917
STAT5B	6777	Lymphoma, T-Cell, Cutaneous	MESH:D016410	marker/mechanism		NA		26192916
STAT5B	6777	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054218	marker/mechanism		NA		29200404
STAT5B	6777	Splenomegaly	MESH:D013163	marker/mechanism		NA		29200404
STAT5B	6777	T-Lymphocytopenia	MESH:C536783	marker/mechanism		NA		17030597
STAT6	6778	Dermatitis, Atopic	MESH:D003876	therapeutic		NA		15306842
STAT6	6778	Edema	MESH:D004487	therapeutic		NA		15306842
STAT6	6778	Head and Neck Neoplasms	MESH:D006258	marker/mechanism		NA		21765211
STAT6	6778	Pulmonary Fibrosis	MESH:D011658	therapeutic		NA		26699812
STAT6	6778	Solitary Fibrous Tumors	MESH:D054364	marker/mechanism		NA		23313952|23313954
STATH	6779	Autistic Disorder	MESH:D001321	marker/mechanism		NA		19367726
STAU2	27067	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
STC2	8614	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18492817
STC2	8614	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
STC2	8614	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		24097666
STEAP3	55240	Anemia, Hypochromic Microcytic, With Iron Overload	MESH:C567144	marker/mechanism		NA	615234	
STEAP4	79689	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
STEAP4	79689	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		25320179
STG	43466	Eye Abnormalities	MESH:D005124	therapeutic		NA		17517339
STIL	6491	Microcephaly, Primary Autosomal Recessive, 7	MESH:C567198	marker/mechanism		NA	612703	
STIM1	6786	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
STIM1	6786	Hypertension	MESH:D006973	marker/mechanism		NA		19897708
STIM1	6786	Immune dysfunction with T-cell inactivation due to calcium entry defect 2	MESH:C557827	marker/mechanism		NA	612783	
STIM1	6786	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27863410
STIM1	6786	Myopathies, Structural, Congenital	MESH:D020914	marker/mechanism		NA	160565	
STIM1	6786	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		27863410
STIM2	57620	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
STING1	340061	Chilblain lupus 1	MESH:C535924	marker/mechanism		NA		27566796
STING1	340061	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		25129146
STING1	340061	STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET	OMIM:615934	marker/mechanism		NA	615934	
STIP1	10963	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
STK10	6793	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
STK11	6794	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		17676035
STK11	6794	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		24793789
STK11	6794	Carcinoma, Pancreatic Ductal	MESH:D021441	marker/mechanism		NA		26887594
STK11	6794	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		17676035
STK11	6794	Hypertension	MESH:D006973	marker/mechanism		NA		19289642
STK11	6794	Hypertrophy, Left Ventricular	MESH:D017379	marker/mechanism		NA		19289642
STK11	6794	Intestinal Polyposis	MESH:D044483	marker/mechanism		NA		18311138
STK11	6794	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17676035
STK11	6794	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA	260350	26098869
STK11	6794	Peutz-Jeghers Syndrome	MESH:D010580	marker/mechanism		NA	175200	26887594
STK11	6794	Testicular Germ Cell Tumor	MESH:C563236	marker/mechanism		NA	273300	
STK19	8859	Carcinoma, Basal Cell	MESH:D002280	marker/mechanism		NA		26950094
STK36	27148	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
STK39	27347	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
STK39	27347	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18348195
STK39	27347	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
STK39	27347	Hypertension	MESH:D006973	therapeutic		NA		22949526
STK4	6789	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		31043756
STK4	6789	T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AND AUTOIMMUNITY WITH OR WITHOUT CARDIAC MALFORMATIONS	OMIM:614868	marker/mechanism		NA	614868	
STMN1	3925	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17659439
STMN1	3925	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
STMN1	3925	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
STMN1	3925	Glioma	MESH:D005910	marker/mechanism		NA		17440165
STMN1	3925	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
STMN1	3925	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
STMN1	3925	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17455228
STN1	79991	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		28346442
STN1	79991	Cerebroretinal Microangiopathy with Calcifications and Cysts	MESH:C567401	marker/mechanism		NA	617341	
STN1	79991	Idiopathic Pulmonary Fibrosis	MESH:D054990	marker/mechanism		NA		23583980
STN1	79991	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		28604730
STOML2	30968	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
STOX1	219736	Pre-Eclampsia	MESH:D011225	marker/mechanism		NA	609404	
STRA6	64220	Alveolar capillary dysplasia	MESH:C536590	marker/mechanism		NA		17273977
STRA6	64220	Anophthalmia with pulmonary hypoplasia	MESH:C537768	marker/mechanism		NA	601186	17503335|18316031
STRA6	64220	Anophthalmos	MESH:D000853	marker/mechanism		NA		17273977
STRA6	64220	Cardiovascular Abnormalities	MESH:D018376	marker/mechanism		NA		18316031
STRA6	64220	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		18316031
STRA6	64220	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		17273977
STRA6	64220	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		17273977
STRA6	64220	Intellectual Disability	MESH:D008607	marker/mechanism		NA		17273977
STRA6	64220	Lung Diseases	MESH:D008171	marker/mechanism		NA		17273977
STRA6	64220	Microphthalmos	MESH:D008850	marker/mechanism		NA		18316031
STRADA	92335	Medulloblastoma	MESH:D008527	marker/mechanism		NA		21652733
STRADA	92335	Polyhydramnios, Megalencephaly, And Symptomatic Epilepsy	MESH:C567020	marker/mechanism		NA	611087	
STRAP	11171	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		15720808
STRBP	55342	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
STRBP	55342	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
STRC	161497	Deafness, Autosomal Recessive 16	MESH:C566339	marker/mechanism		NA	603720	
STRC	161497	Deafness, Sensorineural, And Male Infertility	MESH:C567010	marker/mechanism		NA	611102	
STRC	161497	Spermatogenic Failure 7	MESH:C567832	marker/mechanism		NA	612997	
STS	412	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		19192274
STS	412	Attention Deficit Disorder with Hyperactivity	MESH:D001289	marker/mechanism		NA		18413370
STS	412	Diabetes Mellitus, Experimental	MESH:D003921	therapeutic		NA		24497646
STS	412	Fatty Liver	MESH:D005234	therapeutic		NA		24497646
STS	412	Hepatitis, Alcoholic	MESH:D006519	marker/mechanism		NA		26220752
STS	412	Ichthyosis, X-Linked	MESH:D016114	marker/mechanism		NA	308100	10679952|14641695|9623797
STS	412	Inflammation	MESH:D007249	therapeutic		NA		24497646
STS	412	Insulin Resistance	MESH:D007333	therapeutic		NA		24497646
STS	412	Obesity	MESH:D009765	therapeutic		NA		24497646
STS	412	Weight Gain	MESH:D015430	therapeutic		NA		24497646
STT3A	3703	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw	OMIM:615596	marker/mechanism		NA	615596	
STT3B	201595	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix	OMIM:615597	marker/mechanism		NA	615597	
STUB1	10273	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA	615768	
STX11	8676	Hemophagocytic lymphohistiocytosis, familial, 4	MESH:C537252	marker/mechanism		NA	603552	
STX16	8675	Pseudohypoaldosteronism	MESH:D011546	marker/mechanism		NA	603233	
STX17	55014	Alopecia Areata	MESH:D000506	marker/mechanism		NA		20596022
STX17	55014	Melanoma	MESH:D008545	marker/mechanism		NA		18641652
STX1A	6804	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18593506
STX1B	112755	Epilepsy	MESH:D004827	marker/mechanism		NA		25362483
STX1B	112755	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9	OMIM:616172	marker/mechanism		NA	616172	
STX1B	112755	Seizures, Febrile	MESH:D003294	marker/mechanism		NA		25362483
STX2	2054	Infertility, Male	MESH:D007248	marker/mechanism		NA		18277055
STX4A	20909	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
STX6	10228	Ceroid Lipofuscinosis, Neuronal, 6	MESH:C566627	marker/mechanism		NA		23516525
STX6	10228	Supranuclear Palsy, Progressive	MESH:D013494	marker/mechanism		NA		21685912
STXBP1	6812	Epilepsies, Myoclonic	MESH:D004831	marker/mechanism		NA		18469812
STXBP1	6812	Epilepsy	MESH:D004827	marker/mechanism		NA		29942082
STXBP1	6812	Epileptic Encephalopathy, Early Infantile, 4	MESH:C567404	marker/mechanism		NA	612164	
STXBP1	6812	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889|29942082
STXBP2	6813	Blood Platelet Disorders	MESH:D001791	marker/mechanism		NA		30696774
STXBP2	6813	Carotid Artery Thrombosis	MESH:D002341	therapeutic		NA		30696774
STXBP2	6813	Hemophagocytic Lymphohistiocytosis, Familial, 5	MESH:C567752	marker/mechanism		NA	613101	
STXBP2	6813	Hemorrhage	MESH:D006470	marker/mechanism		NA		30696774
STXBP4	252983	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
STXBP6	29091	Autistic Disorder	MESH:D001321	marker/mechanism		NA		20071347
SUCLA2	8803	MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA)	OMIM:612073	marker/mechanism		NA	612073	
SUCLA2	8803	Obesity	MESH:D009765	marker/mechanism		NA		20882379
SUCLG1	8802	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
SUCLG1	8802	MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA)	OMIM:245400	marker/mechanism		NA	245400	
SUCLG1	8802	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
SUCLG2	8801	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
SUCLG2	8801	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
SUCLG2	8801	Endometriosis	MESH:D004715	marker/mechanism		NA		23284138
SUCLG2	8801	Methylmalonic acidemia	MESH:C537358	marker/mechanism		NA		16823967
SUCLG2	8801	Obesity	MESH:D009765	marker/mechanism		NA		20882379
SUFU	51684	Basal Cell Nevus Syndrome	MESH:D001478	marker/mechanism		NA	109400	
SUFU	51684	Carcinoma, Basal Cell	MESH:D002280	marker/mechanism		NA		26950094
SUFU	51684	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
SUFU	51684	Medulloblastoma	MESH:D008527	marker/mechanism		NA	155255	
SUFU	51684	Meningioma, familial	MESH:C537443	marker/mechanism		NA	607174	
SUGCT	79783	Glutaric Aciduria III	MESH:C562818	marker/mechanism		NA	231690	
SUGCT	79783	Migraine Disorders	MESH:D008881	marker/mechanism		NA		23793025
SUGCT	79783	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		26098869
SUGCT	79783	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
SULF1	23213	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		17310998
SULF1	23213	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		30127996
SULF2	55959	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642|21063030
SULT1A1	6817	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		30120701
SULT1A1	6817	Chromosome Aberrations	MESH:D002869	marker/mechanism		NA		16537716
SULT1A1	6817	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
SULT1A1	6817	Genomic Instability	MESH:D042822	marker/mechanism		NA		28326452
SULT1A1	6817	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
SULT1A1	6817	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		14973106
SULT1A1	6817	Recurrence	MESH:D012008	marker/mechanism		NA		30120701
SULT1A1	6817	Urologic Neoplasms	MESH:D014571	marker/mechanism		NA		18006944
SULT1A2	6799	Chromosome Aberrations	MESH:D002869	marker/mechanism		NA		16537716
SULT1C3	442038	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
SULT1E1	6783	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
SULT1E1	6783	Hepatitis, Alcoholic	MESH:D006519	marker/mechanism		NA		26220752
SULT1E1	6783	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
SULT1E1	6783	Liver Diseases	MESH:D008107	marker/mechanism		NA		25922074
SULT1E1	6783	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
SULT1E1	6783	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		25922074
SULT2A1	6822	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17072980
SULT2A1	6822	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		21716162
SULT2B1	6820	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		27052460
SULT2B1	6820	Cholestasis	MESH:D002779	marker/mechanism		NA		27052460
SULT2B1	6820	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		29766219
SULT2B1	6820	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		25437045
SULT2B1	6820	Inflammation	MESH:D007249	marker/mechanism		NA		27052460
SULT2B1	6820	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		21716162
SULT3A1	57430	Micronuclei, Chromosome-Defective	MESH:D048629	marker/mechanism		NA		25376053
SUMF1	285362	Multiple Sulfatase Deficiency Disease	MESH:D052517	marker/mechanism		NA	272200	17657823
SUMO1	7341	Cleft Lip	MESH:D002971	marker/mechanism		NA		16990542
SUMO1	7341	Cleft Palate	MESH:D002972	marker/mechanism		NA		16990542
SUMO1	7341	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		15048980
SUMO1	7341	Orofacial Cleft 10	MESH:C566605	marker/mechanism		NA	613705	
SUMO4	387082	Diabetes Mellitus, Insulin-Dependent, 5	MESH:C563958	marker/mechanism		NA	600320	
SUN1	23353	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
SUN5	140732	SPERMATOGENIC FAILURE 16	OMIM:617187	marker/mechanism		NA	617187	
SUOX	6821	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
SUOX	6821	Sulfite oxidase deficiency	MESH:C538141	marker/mechanism		NA	272300	
SUPV3L1	6832	Alopecia	MESH:D000505	marker/mechanism		NA		19145458
SUPV3L1	6832	Ichthyosis	MESH:D007057	marker/mechanism		NA		19145458
SUPV3L1	6832	Sarcopenia	MESH:D055948	marker/mechanism		NA		19145458
SUPV3L1	6832	Skin Abnormalities	MESH:D012868	marker/mechanism		NA		19145458
SU(R)	31858	Purine-Pyrimidine Metabolism, Inborn Errors	MESH:D011686	marker/mechanism		NA		16361227
SURF1	6834	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K	OMIM:616684	marker/mechanism		NA	616684	
SURF1	6834	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		16765830
SURF1	6834	Cytochrome-c Oxidase Deficiency	MESH:D030401	marker/mechanism		NA	220110	
SURF1	6834	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
SURF1	6834	Leigh Disease	MESH:D007888	marker/mechanism		NA		16765830
SURF1	6834	Leigh syndrome , French Canadian type	MESH:C537004	marker/mechanism		NA		16326995
SURF4	6836	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
SUV39H1	6839	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		29391238
SUV39H1	6839	Chromosome Breakage	MESH:D019457	marker/mechanism		NA		29391238
SUZ12	23512	Adenoma	MESH:D000236	marker/mechanism		NA		25119042
SUZ12	23512	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		18264096
SUZ12	23512	Glioblastoma	MESH:D005909	marker/mechanism		NA		25119042
SUZ12	23512	Glioma	MESH:D005910	marker/mechanism		NA		25119042
SUZ12	23512	Melanoma	MESH:D008545	marker/mechanism		NA		25119042
SUZ12	23512	Nerve Sheath Neoplasms	MESH:D018317	marker/mechanism		NA		25240281|25305755
SUZ12	23512	Neurilemmoma	MESH:D009442	marker/mechanism		NA		25119042
SUZ12	23512	Neurofibroma	MESH:D009455	marker/mechanism		NA		25119042
SUZ12	23512	Nevus, Pigmented	MESH:D009508	marker/mechanism		NA		25119042
SV2B	9899	Kidney Diseases	MESH:D007674	marker/mechanism		NA		16943307
SVIL	6840	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
SYCE1	93426	PREMATURE OVARIAN FAILURE 12	OMIM:616947	marker/mechanism		NA	616947	
SYCE1	93426	SPERMATOGENIC FAILURE 15	OMIM:616950	marker/mechanism		NA	616950	
SYCP1	6847	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		14991579
SYCP1	6847	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		14991579
SYCP3	50511	Abortion, Habitual	MESH:D000026	marker/mechanism		NA		19110213
SYCP3	50511	Azoospermia	MESH:D053713	marker/mechanism		NA		14643120
SYCP3	50511	SPERMATOGENIC FAILURE 4	OMIM:270960	marker/mechanism		NA	270960	
SYK	6850	Melanoma	MESH:D008545	marker/mechanism		NA		17145863
SYK	6850	Mesothelioma	MESH:D008654	marker/mechanism		NA		17659810
SYMPK	8189	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
SYMPK	8189	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
SYN1	6853	Epilepsy, X-Linked, with Variable Learning Disabilities and Behavior Disorders	MESH:C564505	marker/mechanism		NA	300491	
SYN2	6854	Hyperalgesia	MESH:D006930	marker/mechanism		NA		18701217
SYN2	6854	Schizophrenia	MESH:D012559	marker/mechanism		NA	181500	
SYN2	6854	Seizures	MESH:D012640	marker/mechanism		NA		18701217
SYNCRIP	10492	Leukemia	MESH:D007938	therapeutic		NA		28436985
SYNE1	23345	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18507500
SYNE1	23345	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18507500|21278247
SYNE1	23345	Muscular Dystrophy, Emery-Dreifuss	MESH:D020389	marker/mechanism		NA	612998	
SYNE1	23345	Nasopharyngeal Carcinoma	MESH:D000077274	marker/mechanism		NA		24952746
SYNE1	23345	Spinocerebellar Ataxia, Autosomal Recessive 8	MESH:C565188	marker/mechanism		NA	610743	
SYNE1	23345	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
SYNE2	23224	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		22544366|29892015
SYNE2	23224	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		22138691
SYNE2	23224	Muscular Dystrophy, Emery-Dreifuss	MESH:D020389	marker/mechanism		NA	612999	
SYNE4	163183	DEAFNESS, AUTOSOMAL RECESSIVE 76	OMIM:615540	marker/mechanism		NA	615540	
SYNGAP1	8831	Autistic Disorder	MESH:D001321	marker/mechanism		NA		20531469
SYNGAP1	8831	Epilepsy	MESH:D004827	marker/mechanism		NA		23708187|29942082
SYNGAP1	8831	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21076407
SYNGAP1	8831	Mental Retardation, Autosomal Dominant 5	MESH:C567234	marker/mechanism		NA	612621	
SYNGAP1	8831	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889|29942082
SYNGR1	9145	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
SYNGR1	9145	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		26808113
SYNJ1	8867	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53	OMIM:617389	marker/mechanism		NA	617389	
SYNJ1	8867	PARKINSON DISEASE 20, EARLY-ONSET	OMIM:615530	marker/mechanism		NA	615530	
SYNJ2	8871	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037
SYNPO2	171024	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		25581431
SYNPO2L	79933	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
SYNRG	11276	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
SYP	6855	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		21595568
SYP	6855	Ceroid lipofuscinosis, neuronal 1, infantile	MESH:C537948	marker/mechanism		NA		21224254
SYP	6855	Ceroid Lipofuscinosis, Neuronal, 6	MESH:C566627	marker/mechanism		NA		23516525
SYP	6855	Learning Disabilities	MESH:D007859	marker/mechanism		NA		21295146
SYP	6855	Memory Disorders	MESH:D008569	marker/mechanism		NA		21295146
SYP	6855	Mental Retardation, X-Linked	MESH:D038901	marker/mechanism		NA		19377476
SYP	6855	MENTAL RETARDATION, X-LINKED 96	OMIM:300802	marker/mechanism		NA	300802	
SYP	6855	Schizophrenia	MESH:D012559	marker/mechanism		NA		11483314
SYT13	57586	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		18438686
SYT14	255928	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA	614229	
SYT2	127833	Myasthenic Syndromes, Congenital	MESH:D020294	marker/mechanism		NA	616040	
SYT4	6860	Melanoma	MESH:D008545	marker/mechanism		NA		21499247
SZT2	23334	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 18	OMIM:615476	marker/mechanism		NA	615476	
TAB1	10454	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
TAB2	23118	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 2	OMIM:614980	marker/mechanism		NA	614980	
TAC1	6863	Amnesia	MESH:D000647	therapeutic		NA		20600432|7562510|9521815
TAC1	6863	Anorexia	MESH:D000855	marker/mechanism		NA		30336258
TAC1	6863	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		9259450
TAC1	6863	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		15845098
TAC1	6863	Bradycardia	MESH:D001919	marker/mechanism		NA		2445440|8960879
TAC1	6863	Bronchial Hyperreactivity	MESH:D016535	marker/mechanism		NA		16777450
TAC1	6863	Corneal Diseases	MESH:D003316	therapeutic		NA		12824234
TAC1	6863	Depressive Disorder, Major	MESH:D003865	marker/mechanism		NA		15845098
TAC1	6863	Drug Eruptions	MESH:D003875	marker/mechanism		NA		1371395
TAC1	6863	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		21233199
TAC1	6863	Edema	MESH:D004487	marker/mechanism		NA		7508328
TAC1	6863	Extravasation of Diagnostic and Therapeutic Materials	MESH:D005119	marker/mechanism		NA		8938667|9622145
TAC1	6863	Fibrosis	MESH:D005355	marker/mechanism		NA		28647476
TAC1	6863	Gastroesophageal Reflux	MESH:D005764	marker/mechanism		NA		20616304
TAC1	6863	Hyperalgesia	MESH:D006930	marker/mechanism		NA		10499367|12351280|12787826|15626726|16259764|18234883|19231294|8864563|9714424
TAC1	6863	Hyperemia	MESH:D006940	therapeutic		NA		10564113|7507874
TAC1	6863	Hypersensitivity	MESH:D006967	marker/mechanism		NA		11160071
TAC1	6863	Hypotension	MESH:D007022	marker/mechanism		NA		20138590|2445440
TAC1	6863	Inflammation	MESH:D007249	marker/mechanism		NA		14499429|21294877|30116771|8880065
TAC1	6863	Migraine without Aura	MESH:D020326	marker/mechanism		NA		11304026
TAC1	6863	Narcolepsy	MESH:D009290	marker/mechanism		NA		17521418
TAC1	6863	Neuralgia	MESH:D009437	marker/mechanism		NA		18400411
TAC1	6863	Neurogenic Inflammation	MESH:D020078	marker/mechanism		NA		17257769|17961222|20138590|21570423|9291295
TAC1	6863	Pain	MESH:D010146	marker/mechanism		NA		10445233|7694222
TAC1	6863	Pruritus	MESH:D011537	marker/mechanism		NA		19652466
TAC1	6863	Schizophrenia	MESH:D012559	marker/mechanism		NA		15845098
TAC1	6863	Sialorrhea	MESH:D012798	marker/mechanism		NA		8938667
TAC3	6866	Hypogonadism	MESH:D007006	marker/mechanism		NA		19079066
TAC3	6866	HYPOGONADOTROPIC HYPOGONADISM 10 WITH OR WITHOUT ANOSMIA	OMIM:614839	marker/mechanism		NA	614839	
TACC3	10460	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
TACC3	10460	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		24121792
TACC3	10460	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		24121792
TACO1	51204	Cytochrome-c Oxidase Deficiency	MESH:D030401	marker/mechanism		NA		19503089
TACO1	51204	Leigh Disease	MESH:D007888	marker/mechanism		NA		19503089
TACR1	6869	Alcoholism	MESH:D000437	marker/mechanism		NA		19204064
TACR1	6869	Attention Deficit Disorder with Hyperactivity	MESH:D001289	marker/mechanism		NA		19204064
TACR1	6869	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		19204064
TACR1	6869	Bradycardia	MESH:D001919	therapeutic		NA		9696263
TACR1	6869	Bronchial Diseases	MESH:D001982	marker/mechanism		NA		15774269
TACR1	6869	Hyperalgesia	MESH:D006930	marker/mechanism		NA		15964684|17123731
TACR1	6869	Hypertension	MESH:D006973	marker/mechanism		NA		21294877
TACR1	6869	Neurogenic Inflammation	MESH:D020078	marker/mechanism		NA		17257769|21570423
TACR1	6869	Substance Withdrawal Syndrome	MESH:D013375	marker/mechanism		NA		7692360
TACR1	6869	Vomiting	MESH:D014839	marker/mechanism		NA		15680276
TACR2	6865	Bronchial Diseases	MESH:D001982	marker/mechanism		NA		15774269
TACR3	6870	Alcoholism	MESH:D000437	marker/mechanism		NA		18422838
TACR3	6870	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		18422838
TACR3	6870	Hypogonadism	MESH:D007006	marker/mechanism		NA		19079066
TACR3	6870	HYPOGONADOTROPIC HYPOGONADISM 11 WITH OR WITHOUT ANOSMIA	OMIM:614840	marker/mechanism		NA	614840	
TACSTD2	4070	Corneal dystrophy, gelatinous drop-like	MESH:C535480	marker/mechanism		NA	204870	
TACSTD2	4070	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
TAF1	6872	Dystonia 3, Torsion, X-Linked	MESH:C564048	marker/mechanism		NA	314250	
TAF1	6872	MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	OMIM:300966	marker/mechanism		NA	300966	
TAF13	6884	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	OMIM:617432	marker/mechanism		NA	617432	
TAF15	8148	Chondrosarcoma, Extraskeletal Myxoid	MESH:C563195	marker/mechanism		NA	612237	
TAF15	8148	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
TAF15	8148	Osteosarcoma	MESH:D012516	marker/mechanism		NA		14767549
TAF15	8148	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
TAF1C	9013	Autistic Disorder	MESH:D001321	marker/mechanism		NA		20663923
TAF1D	79101	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
TAF1D	79101	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
TAF1L	138474	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
TAF2	6873	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
TAF2	6873	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40	OMIM:615599	marker/mechanism		NA	615599	
TAF4B	6875	SPERMATOGENIC FAILURE 13	OMIM:615841	marker/mechanism		NA	615841	
TAF6	6878	ALAZAMI-YUAN SYNDROME	OMIM:617126	marker/mechanism		NA	617126	
TAF9	6880	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
TAFA2	338811	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		29339520
TAFA2	338811	Cognitive Dysfunction	MESH:D060825	marker/mechanism		NA		29339520
TAFA4	151647	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		15818620
TAGAP	117289	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		20453842|23143596
TAGAP	117289	Crohn Disease	MESH:D003424	marker/mechanism		NA		21102463
TAGAP	117289	Psoriasis	MESH:D011565	marker/mechanism		NA		23143594
TAGLN	6876	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
TAGLN	6876	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
TAGLN	6876	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
TAGLN	6876	Keloid	MESH:D007627	marker/mechanism		NA		20128793
TAGLN	6876	Lipidoses	MESH:D008064	marker/mechanism		NA		15342952|16919414|17175557
TAGLN2	8407	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
TAGLN2	8407	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		15108329
TAGLN2	8407	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
TAGLN2	8407	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		25226513
TAGLN2	8407	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TAL1	6886	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA	613065	
TAL1	6886	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054218	marker/mechanism		NA		19246562|24394663
TAL2	6887	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA	613065	
TALDO1	6888	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		19436114
TALDO1	6888	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		19436114
TALDO1	6888	Parkinson Disease	MESH:D010300	marker/mechanism		NA		23233872
TALDO1	6888	Transaldolase Deficiency	MESH:C563207	marker/mechanism		NA	606003	
TANC2	26115	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
TANK	10010	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037
TAOK1	57551	Hearing Loss, Noise-Induced	MESH:D006317	marker/mechanism		NA		23472202
TAP1	6890	Bare Lymphocyte Syndrome, Type I	MESH:C565759	marker/mechanism		NA	604571	
TAP1	6890	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
TAP1	6890	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
TAP2	6891	Bare Lymphocyte Syndrome, Type I	MESH:C565759	marker/mechanism		NA	604571	
TAP2	6891	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TAPBP	6892	Bare Lymphocyte Syndrome, Type I	MESH:C565759	marker/mechanism		NA	604571	
TAPT1	202018	OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	OMIM:616897	marker/mechanism		NA	616897	
TARBP2	6895	Microsatellite Instability	MESH:D053842	marker/mechanism		NA		25701956
TARDBP	23435	Amyotrophic Lateral Sclerosis	MESH:D000690	marker/mechanism		NA		18372902|21167262|22879928|23104007|24019256|24252504
TARDBP	23435	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		24477737
TARDBP	23435	Amyotrophic Lateral Sclerosis 10	MESH:C567429	marker/mechanism		NA	612069	
TARDBP	23435	Frontotemporal Lobar Degeneration	MESH:D057174	marker/mechanism		NA		24019256|24252504|24477737
TARS1	6897	Myositis	MESH:D009220	marker/mechanism		NA		23425968
TARS2	80222	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	OMIM:615918	marker/mechanism		NA	615918	
TAS1R3	83756	Infertility, Male	MESH:D007248	marker/mechanism		NA		23818598
TAS2R16	50833	Alcoholism	MESH:D000437	marker/mechanism		NA		16385453|17250611
TAS2R38	5726	Alcoholism	MESH:D000437	marker/mechanism		NA		17250611
TAS2R38	5726	THIOUREA TASTING	OMIM:171200	marker/mechanism		NA	171200	
TAS2R60	338398	Melanoma	MESH:D008545	marker/mechanism		NA		21499247
TAT	6898	Tyrosinemias	MESH:D020176	marker/mechanism		NA	276600	
TATDN1	83940	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
TAX1BP3	30851	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TAZ	6901	Barth Syndrome	MESH:D056889	marker/mechanism		NA	302060	18430085|25185984
TBC1D1	23216	Obesity	MESH:D009765	marker/mechanism		NA		16893906|18325908|18931681
TBC1D2	55357	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
TBC1D20	128637	Warburg Sjo Fledelius syndrome	MESH:C536681	marker/mechanism		NA	615663	
TBC1D24	57465	DEAFNESS, AUTOSOMAL DOMINANT 65	OMIM:616044	marker/mechanism		NA	616044	
TBC1D24	57465	DEAFNESS, AUTOSOMAL RECESSIVE 86	OMIM:614617	marker/mechanism		NA	614617	
TBC1D24	57465	Epilepsy, rolandic with paroxysmal exercise-induced dystonia and writer's cramp	MESH:C535499	marker/mechanism		NA	608105	
TBC1D24	57465	Myoclonic Epilepsies, Progressive	MESH:D020191	marker/mechanism		NA		25401298
TBC1D24	57465	MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	OMIM:605021	marker/mechanism		NA	605021	
TBC1D4	9882	TYPE 2 DIABETES 5	OMIM:616087	marker/mechanism		NA	616087	
TBC1D9	23158	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TBCA	6902	Cardiomyopathy, Hypertrophic	MESH:D002312	marker/mechanism		NA		9527842
TBCB	1155	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17085005
TBCD	6904	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		27666370
TBCD	6904	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM	OMIM:617193	marker/mechanism		NA	617193	27666370|27666374
TBCD	6904	Intellectual Disability	MESH:D008607	marker/mechanism		NA		27666370
TBCD	6904	Malformations of Cortical Development	MESH:D054220	marker/mechanism		NA		27666370
TBCD	6904	Microcephaly	MESH:D008831	marker/mechanism		NA		27666370|27666374
TBCD	6904	Muscle Weakness	MESH:D018908	marker/mechanism		NA		27666374
TBCD	6904	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		27666370
TBCD	6904	Optic Atrophy	MESH:D009896	marker/mechanism		NA		27666370
TBCD	6904	Quadriplegia	MESH:D011782	marker/mechanism		NA		27666370
TBCD	6904	Respiratory Insufficiency	MESH:D012131	marker/mechanism		NA		27666374
TBCD	6904	Seizures	MESH:D012640	marker/mechanism		NA		27666370
TBCE	6905	Bacterial Infections	MESH:D001424	marker/mechanism		NA		12389028
TBCE	6905	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		12389028
TBCE	6905	ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY	OMIM:617207	marker/mechanism		NA	617207	
TBCE	6905	Facies	MESH:D019066	marker/mechanism		NA		12389028
TBCE	6905	Hypoparathyroidism-retardation-dysmorphism syndrome	MESH:C537157	marker/mechanism		NA	241410	12389028
TBCE	6905	Kenny-Caffey syndrome, Type 1	MESH:C537021	marker/mechanism		NA	244460	
TBCE	6905	Kenny-Caffey syndrome, type 2	MESH:C537020	marker/mechanism		NA		12389028
TBCE	6905	Osteosclerosis	MESH:D010026	marker/mechanism		NA		12389028
TBCK	93627	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3	OMIM:616900	marker/mechanism		NA	616900	
TBK1	29110	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4	OMIM:616439	marker/mechanism		NA	616439	
TBK1	29110	Severe Acute Respiratory Syndrome	MESH:D045169	marker/mechanism		NA		26861016
TBKBP1	9755	Spondylitis, Ankylosing	MESH:D013167	marker/mechanism		NA		21743469
TBL1X	6907	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		22050706
TBL1XR1	79718	MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	OMIM:616944	marker/mechanism		NA	616944	
TBL1XR1	79718	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
TBL1XR1	79718	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
TBL1XR1	79718	Plantar Lipomatosis, Unusual Facies, and Developmental Delay	MESH:C566559	marker/mechanism		NA	602342	
TBL1XR1	79718	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29662167
TBP	6908	PARKINSON DISEASE, LATE-ONSET	OMIM:168600	marker/mechanism		NA	168600	
TBP	6908	Spinocerebellar Ataxia 17	MESH:C564616	marker/mechanism		NA	607136	
TBR1	10716	Autistic Disorder	MESH:D001321	marker/mechanism		NA	606053	
TBR1	10716	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
TBX1	6899	CONOTRUNCAL HEART MALFORMATIONS	OMIM:217095	marker/mechanism		NA	217095	
TBX1	6899	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		15190012|17000704
TBX1	6899	DiGeorge Syndrome	MESH:D004062	marker/mechanism		NA	188400|192430	15190012|16399080|17000704
TBX1	6899	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		17000704
TBX1	6899	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
TBX1	6899	Tetralogy of Fallot	MESH:D013771	marker/mechanism		NA	187500	25093829
TBX15	6913	COUSIN SYNDROME	OMIM:260660	marker/mechanism		NA	260660	
TBX15	6913	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		19068278
TBX15	6913	Growth Disorders	MESH:D006130	marker/mechanism		NA		19068278
TBX15	6913	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		26213588
TBX15	6913	Pelviscapular dysplasia	MESH:C535550	marker/mechanism		NA		19068278
TBX18	9096	Multicystic renal dysplasia, bilateral	MESH:C537373	marker/mechanism		NA	143400	
TBX19	9095	ACTH Deficiency, Isolated	MESH:C562707	marker/mechanism		NA	201400	16390921
TBX19	9095	Alcoholism	MESH:D000437	marker/mechanism		NA		18438686
TBX2	6909	Neuroblastoma	MESH:D009447	marker/mechanism		NA		30127528
TBX20	57057	Atrial Septal Defect 4	MESH:C566963	marker/mechanism		NA	611363	
TBX20	57057	Cardiomegaly	MESH:D006332	marker/mechanism		NA		29394407
TBX20	57057	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		29394407
TBX20	57057	Heart Failure	MESH:D006333	marker/mechanism		NA		29394407
TBX20	57057	Ventricular Remodeling	MESH:D020257	marker/mechanism		NA		29394407
TBX21	30009	Asthma	MESH:D001249	marker/mechanism		NA		15806396
TBX21	30009	Asthma, Aspirin-Induced	MESH:D055963	marker/mechanism		NA		16502481
TBX21	30009	Asthma, Nasal Polyps, And Aspirin Intolerance	MESH:C565935	marker/mechanism		NA	208550	
TBX21	30009	Inflammation	MESH:D007249	marker/mechanism		NA		22325453
TBX21	30009	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		26970513
TBX22	50945	Abruzzo Erickson syndrome	MESH:C535559	marker/mechanism		NA	302905	
TBX22	50945	Cleft palate X-linked	MESH:C536426	marker/mechanism		NA	303400	
TBX3	6926	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21098263
TBX3	6926	Limb Deformities, Congenital	MESH:D017880	marker/mechanism		NA		9207801
TBX3	6926	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29662167
TBX3	6926	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
TBX3	6926	Stroke	MESH:D020521	marker/mechanism		NA		29531354
TBX3	6926	Thyroid Diseases	MESH:D013959	marker/mechanism		NA		23397585
TBX3	6926	Tooth Abnormalities	MESH:D014071	marker/mechanism		NA		9207801
TBX3	6926	Ulnar-mammary syndrome	MESH:C536937	marker/mechanism		NA	181450	9207801
TBX4	9496	Ischiopatellar dysplasia	MESH:C535540	marker/mechanism		NA	147891	
TBX5	6910	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
TBX5	6910	Holt-Oram syndrome	MESH:C535326	marker/mechanism		NA	142900	15735645
TBX6	6911	Cakut	MESH:C566906	marker/mechanism		NA		30578417
TBX6	6911	SPONDYLOCOSTAL DYSOSTOSIS 5	OMIM:122600	marker/mechanism		NA	122600	
TBXA2R	6915	Asthma, Aspirin-Induced	MESH:D055963	marker/mechanism		NA		16502481|20485159
TBXA2R	6915	Bleeding Disorder due to Defective Thromboxane A2 Receptor	MESH:C566055	marker/mechanism		NA	614009	
TBXA2R	6915	Blood Platelet Disorders	MESH:D001791	marker/mechanism		NA		19828703|7929844
TBXA2R	6915	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		22206755
TBXA2R	6915	Hemorrhagic Disorders	MESH:D006474	marker/mechanism		NA		19828703
TBXA2R	6915	Necrosis	MESH:D009336	marker/mechanism		NA		22206755
TBXA2R	6915	Pulmonary Embolism	MESH:D011655	marker/mechanism		NA		7740511
TBXA2R	6915	Rhinitis	MESH:D012220	marker/mechanism		NA		12167471
TBXAS1	6916	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		21449675
TBXAS1	6916	Ghosal Hematodiaphyseal Dysplasia	MESH:C565551	marker/mechanism		NA	231095	18264100
TBXAS1	6916	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		22919386
TBXT	6862	Chordoma	MESH:D002817	marker/mechanism		NA		19801981|23064415
TBXT	6862	Neural Tube Defects	MESH:D009436	marker/mechanism		NA	182940	
TCAP	8557	Cardiomyopathy, Dilated, 1N	MESH:C564388	marker/mechanism		NA	607487	
TCAP	8557	Muscular Dystrophy, Limb-Girdle, Type 2G	MESH:C566599	marker/mechanism		NA	601954	
TCEA2	6919	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
TCEAL7	56849	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		19208208
TCERG1L	256536	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		21278247
TCF12	6938	Craniosynostoses	MESH:D003398	marker/mechanism		NA	615314	23354436
TCF15	6939	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
TCF19	6941	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
TCF19	6941	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15059925
TCF20	6942	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TCF21	6943	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		21378990|22751097
TCF3	6929	Agammaglobulinemia	MESH:D000361	marker/mechanism		NA	616941	
TCF3	6929	Burkitt Lymphoma	MESH:D002051	marker/mechanism		NA		17244677|1967982
TCF3	6929	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D015452	marker/mechanism		NA		19246562
TCF3	6929	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		26214592
TCF4	6925	Corneal Dystrophy, Fuchs Endothelial, 3	MESH:C567678	marker/mechanism		NA	613267	
TCF4	6925	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		17436254
TCF4	6925	Heart Diseases	MESH:D006331	marker/mechanism		NA		16844662
TCF4	6925	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TCF4	6925	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
TCF4	6925	Microcephaly	MESH:D008831	marker/mechanism		NA		18728071
TCF4	6925	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
TCF4	6925	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		21228734
TCF4	6925	Pitt-Hopkins syndrome	MESH:C537403	marker/mechanism		NA	610954	17436254|18728071
TCF4	6925	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
TCF4	6925	Seizures	MESH:D012640	marker/mechanism		NA		18728071
TCF7	6932	Crohn Disease	MESH:D003424	marker/mechanism		NA		24994854
TCF7	6932	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		26808113
TCF7L1	83439	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		23811263
TCF7L2	6934	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		21892161
TCF7L2	6934	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
TCF7L2	6934	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		29394407
TCF7L2	6934	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		21383188
TCF7L2	6934	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		21892161|24836286
TCF7L2	6934	Coronary Disease	MESH:D003327	marker/mechanism		NA		28869590
TCF7L2	6934	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA	125853	17460697|23104008|28869590
TCF7L2	6934	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		29394407
TCF7L2	6934	Hyperplasia	MESH:D006965	marker/mechanism		NA		21383188
TCF7L2	6934	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		29394407
TCF7L2	6934	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
TCF7L2	6934	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
TCF7L2	6934	Ventricular Remodeling	MESH:D020257	marker/mechanism		NA		29394407
TCHH	7062	Uncombable hair syndrome	MESH:C536939	marker/mechanism		NA	617252	
TCIM	56892	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
TCIRG1	10312	Osteopetrosis, Autosomal Recessive 1	MESH:C564915	marker/mechanism		NA	259700	
TCL1B	9623	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20228224
TCL1B	9623	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		20228224
TCL1B	9623	Parkinson Disease	MESH:D010300	marker/mechanism		NA		25475535
TCN1	6947	Anemia, Megaloblastic	MESH:D000749	marker/mechanism		NA		4627864
TCN2	6948	Adenoma	MESH:D000236	marker/mechanism		NA		17389618
TCN2	6948	Anemia, Megaloblastic	MESH:D000749	marker/mechanism		NA		4627864
TCN2	6948	Autistic Disorder	MESH:D001321	marker/mechanism		NA		16917939
TCN2	6948	Cleft Lip	MESH:D002971	marker/mechanism		NA		16470748
TCN2	6948	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17389618
TCN2	6948	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		15753437
TCN2	6948	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		29379198
TCN2	6948	Leukoencephalopathies	MESH:D056784	marker/mechanism		NA		15753437
TCN2	6948	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
TCN2	6948	TRANSCOBALAMIN II DEFICIENCY	OMIM:275350	marker/mechanism		NA	275350	
TCOF1	6949	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		16938878
TCOF1	6949	Mandibulofacial Dysostosis	MESH:D008342	marker/mechanism		NA	154500	16938878
TCP1	6950	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17566973
TCRA	21473	Lupus Erythematosus, Cutaneous	MESH:D008178	marker/mechanism		NA		15086387
TCTN1	79600	Agenesis of Cerebellar Vermis	MESH:C536293	marker/mechanism		NA		21725307
TCTN1	79600	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		17984051
TCTN3	26123	Orofaciodigital syndrome 4	MESH:C537133	marker/mechanism		NA	258860	
TCTP	41341	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
TDGF1	6997	Heterotaxy Syndrome	MESH:D059446	marker/mechanism		NA		11062482
TDGF1	6997	Holoprosencephaly	MESH:D016142	marker/mechanism		NA		12073012
TDO2	6999	Autistic Disorder	MESH:D001321	marker/mechanism		NA		14755447
TDO2	6999	Starvation	MESH:D013217	marker/mechanism		NA		7306070
TDP1	55775	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy	MESH:C537313	marker/mechanism		NA	607250	
TDP2	51567	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA	616949	
TDRD7	23424	Cataract	MESH:D002386	marker/mechanism		NA		21436445
TDRD7	23424	CATARACT 36	OMIM:613887	marker/mechanism		NA	613887	
TDRD7	23424	Glaucoma	MESH:D005901	marker/mechanism		NA		21436445
TDRD7	23424	Infertility, Male	MESH:D007248	marker/mechanism		NA		21436445
TDRD7	23424	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
TEAD1	7003	Sveinsson Chorioretinal Atrophy	MESH:C566236	marker/mechanism		NA	108985	
TEAD1B	100006454	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		27935819
TEAD2	8463	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
TECPR2	9895	Neuroaxonal Dystrophies	MESH:D019150	marker/mechanism		NA		26555167
TECPR2	9895	Paraparesis, Spastic	MESH:D020336	marker/mechanism		NA		23176824
TECPR2	9895	SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	OMIM:615031	marker/mechanism		NA	615031	
TECPR2	9895	Spastic Paraplegia, Hereditary	MESH:D015419	marker/mechanism		NA		23176824
TECR	9524	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	OMIM:614020	marker/mechanism		NA	614020	
TECRL	253017	Polymorphic catecholergic ventricular tachycardia	MESH:C536334	marker/mechanism		NA	614021	
TECTA	7007	Deafness, Autosomal Dominant 12	MESH:C563295	marker/mechanism		NA	601543	
TECTA	7007	Deafness, Autosomal Recessive 21	MESH:C566353	marker/mechanism		NA	603629	
TEDC2	80178	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
TEK	7010	Epilepsy, Temporal Lobe	MESH:D004833	marker/mechanism		NA		17533168
TEK	7010	GLAUCOMA 3, PRIMARY CONGENITAL, E	OMIM:617272	marker/mechanism		NA	617272	
TEK	7010	Glaucoma 3, primary infantile, B	MESH:C536824	marker/mechanism		NA	600975	
TEK	7010	Hemangiosarcoma	MESH:D006394	marker/mechanism		NA		17569031
TEK	7010	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		11956651
TEK	7010	Neovascularization, Pathologic	MESH:D009389	marker/mechanism		NA		17533168
TEK	7010	Venous Malformations, Multiple Cutaneous and Mucosal	MESH:C563977	marker/mechanism		NA	600195	19079259
TEKT5	146279	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
TELO2	9894	YOU-HOOVER-FONG SYNDROME	OMIM:616954	marker/mechanism		NA	616954	
TENM2	57451	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
TENM3	55714	Asthma, Occupational	MESH:D059366	marker/mechanism		NA		25918132
TENM3	55714	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		18438686
TENM3	55714	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9	OMIM:615145	marker/mechanism		NA	615145	
TENM4	26011	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		21926972
TENM4	26011	TREMOR, HEREDITARY ESSENTIAL, 5	OMIM:616736	marker/mechanism		NA	616736	
TEP1	7011	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		11323394
TERC	7012	Carcinoma, Squamous Cell	MESH:D002294	therapeutic		NA		16051514
TERC	7012	Dyskeratosis Congenita	MESH:D019871	marker/mechanism		NA		17785587
TERC	7012	Dyskeratosis Congenita, Autosomal Dominant	MESH:C565079	marker/mechanism		NA	127550	
TERC	7012	Idiopathic Pulmonary Fibrosis	MESH:D054990	marker/mechanism		NA		17392301|17460043|23535734
TERC	7012	Prostatic Neoplasms	MESH:D011471	therapeutic		NA		16520278
TERC	7012	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 2	OMIM:614743	marker/mechanism		NA	614743	
TERC	7012	Tongue Neoplasms	MESH:D014062	therapeutic		NA		16051514
TERF2	7014	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		17643074
TERT	7015	Adrenocortical Carcinoma	MESH:D018268	marker/mechanism		NA		24747642
TERT	7015	Anemia, Aplastic	MESH:D000741	marker/mechanism		NA	609135	15814878
TERT	7015	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		23535731
TERT	7015	Carcinoma, Basal Cell	MESH:D002280	marker/mechanism		NA		19151717
TERT	7015	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		16651430|22634754|25362482|25822088
TERT	7015	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		21252717
TERT	7015	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		16890917
TERT	7015	Cri-du-Chat Syndrome	MESH:D003410	marker/mechanism		NA		12629597
TERT	7015	Disease Progression	MESH:D018450	marker/mechanism		NA		21252717
TERT	7015	Dyskeratosis Congenita	MESH:D019871	marker/mechanism		NA		16247010|17785587|18042801
TERT	7015	Dyskeratosis Congenita, Autosomal Dominant	MESH:C565079	marker/mechanism		NA	127550	
TERT	7015	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2	OMIM:613989	marker/mechanism		NA	613989	
TERT	7015	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		29047144
TERT	7015	Glioma	MESH:D005910	marker/mechanism		NA		18021753|19578367
TERT	7015	Hoyeraal Hreidarsson syndrome	MESH:C536068	marker/mechanism		NA		17785587
TERT	7015	Idiopathic Pulmonary Fibrosis	MESH:D054990	marker/mechanism		NA	178500	17392301|17460043|23535734|23583980|30203795
TERT	7015	Kidney Diseases	MESH:D007674	marker/mechanism		NA		16968891
TERT	7015	Leukemia, Lymphoid	MESH:D007945	marker/mechanism		NA		24292274
TERT	7015	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	MESH:D015464	marker/mechanism		NA		17157168
TERT	7015	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA	601626	
TERT	7015	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		27064257
TERT	7015	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		11323394|19151717
TERT	7015	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		26808113
TERT	7015	Melanoma	MESH:D008545	therapeutic		NA		20856939
TERT	7015	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 9	OMIM:615134	marker/mechanism		NA	615134	
TERT	7015	Myeloproliferative Disorders	MESH:D009196	marker/mechanism		NA		29047144
TERT	7015	Neoplasms	MESH:D009369	marker/mechanism		NA		25261935
TERT	7015	Neuroblastoma	MESH:D009447	marker/mechanism		NA		26523776
TERT	7015	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		23535731
TERT	7015	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		25086665|26098869
TERT	7015	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		19151717|21743467
TERT	7015	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1	OMIM:614742	marker/mechanism		NA	614742	
TERT	7015	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		16968891
TERT	7015	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		25383969
TERT	7015	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		19151717
TERT	7015	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		19151717
TES	26136	Glioblastoma	MESH:D005909	marker/mechanism		NA		16909125
TES	26136	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TET1	80312	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		25290267
TET2	54790	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		23797736
TET2	54790	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		30510241
TET2	54790	Immunoblastic Lymphadenopathy	MESH:D007119	marker/mechanism		NA		24413737
TET2	54790	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		26285909
TET2	54790	Lymphoma, T-Cell, Peripheral	MESH:D016411	marker/mechanism		NA		24413734|24413737
TET2	54790	Myelodysplastic Syndromes	MESH:D009190	marker/mechanism		NA	614286	19483684|27992414
TET2	54790	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		26285909
TET2	54790	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		23593118
TET2	54790	Sezary Syndrome	MESH:D012751	marker/mechanism		NA		26551667
TET3	200424	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		25290267
TEX11	56159	SPERMATOGENIC FAILURE, X-LINKED, 2	OMIM:309120	marker/mechanism		NA	309120	
TEX41	401014	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
TF	7018	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		28885000
TF	7018	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		19381893
TF	7018	Alcoholism	MESH:D000437	marker/mechanism		NA		11000917|21792595
TF	7018	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		15060098|17192785
TF	7018	Anemia, hypochromic microcytic	MESH:C536357	marker/mechanism		NA		11110675
TF	7018	Autistic Disorder	MESH:D001321	marker/mechanism		NA		15363659
TF	7018	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942|9879772
TF	7018	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		16099942
TF	7018	Congenital atransferrinemia	MESH:C538259	marker/mechanism		NA	209300	11110675|12111369
TF	7018	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		28885000
TF	7018	Echinococcosis	MESH:D004443	marker/mechanism		NA		24270252
TF	7018	Fatty Liver	MESH:D005234	marker/mechanism		NA		20008134|21907177
TF	7018	Hepatitis	MESH:D006505	marker/mechanism		NA		21907177
TF	7018	Inflammation	MESH:D007249	marker/mechanism		NA		20008134
TF	7018	Iron Overload	MESH:D019190	marker/mechanism		NA		11110675
TF	7018	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942|9879772
TF	7018	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942|9879772
TF	7018	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		26818092
TF	7018	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		20390345
TF	7018	Nephrotic Syndrome	MESH:D009404	marker/mechanism		NA		17178036
TF	7018	Obesity	MESH:D009765	marker/mechanism		NA		20882379
TF	7018	Paratuberculosis	MESH:D010283	marker/mechanism		NA		22633222
TF	7018	Restless Legs Syndrome	MESH:D012148	marker/mechanism		NA		16930377
TFAM	7019	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		17192785
TFAM	7019	Bowen's Disease	MESH:D001913	marker/mechanism		NA		21514422
TFAM	7019	Ceroid lipofuscinosis, neuronal 1, infantile	MESH:C537948	marker/mechanism		NA		21224254
TFAM	7019	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		28595911
TFAM	7019	MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE)	OMIM:617156	marker/mechanism		NA	617156	
TFAM	7019	Parkinson Disease, Secondary	MESH:D010302	marker/mechanism		NA		28595911
TFAP2A	7020	Branchio-Oto-Renal Syndrome	MESH:D019280	marker/mechanism		NA	113620	19685247
TFAP2A	7020	Breast Neoplasms	MESH:D001943	therapeutic		NA		16204029
TFAP2A	7020	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		14534133|19685247
TFAP2A	7020	Eye Abnormalities	MESH:D005124	marker/mechanism		NA		19685247
TFAP2A	7020	Kidney Diseases	MESH:D007674	marker/mechanism		NA		19685247
TFAP2B	7021	Body Weight	MESH:D001835	marker/mechanism		NA		22344219
TFAP2B	7021	Char syndrome	MESH:C566815	marker/mechanism		NA	169100	
TFAP2B	7021	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		10802654
TFAP2B	7021	Ductus Arteriosus, Patent	MESH:D004374	marker/mechanism		NA	617035	10802654|19336370
TFAP2B	7021	Hand Deformities, Congenital	MESH:D006228	marker/mechanism		NA		10802654
TFAP2C	7022	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
TFDP1	7027	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
TFDP2	7029	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
TFE3	7030	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA	300854	
TFEC	22797	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TFF1	7031	Acute Lung Injury	MESH:D055371	marker/mechanism		NA		19880587
TFF1	7031	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
TFF1	7031	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		21283680
TFF2	7032	Acute Lung Injury	MESH:D055371	marker/mechanism		NA		19880587
TFF3	7033	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		23052191
TFF3	7033	Hepatitis, Animal	MESH:D006520	marker/mechanism		NA		18559427
TFF3	7033	Kidney Diseases	MESH:D007674	marker/mechanism		NA		24863737
TFF3	7033	Mucositis	MESH:D052016	therapeutic		NA		19636011
TFG	10342	Neuropathy, hereditary motor and sensory, Okinawa type	MESH:C535717	marker/mechanism		NA	604484	
TFG	10342	SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE	OMIM:615658	marker/mechanism		NA	615658	
TFPI	7035	Activated Protein C Resistance	MESH:D020016	marker/mechanism		NA		11703344
TFPI	7035	Airway Obstruction	MESH:D000402	therapeutic		NA		23727623
TFPI	7035	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
TFPI	7035	Hypoxia	MESH:D000860	therapeutic		NA		23727623
TFPI	7035	Purpura, Thrombotic Thrombocytopenic	MESH:D011697	marker/mechanism		NA		7740478
TFPI	7035	Venous Thrombosis	MESH:D020246	therapeutic		NA		18480984
TFPI2	7980	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		15292528|17379860
TFPI2	7980	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037
TFPI2	7980	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		17464989|28284560
TFPI2	7980	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		19435926
TFPI2	7980	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TFPI2	7980	Melanoma	MESH:D008545	marker/mechanism		NA		17372906
TFPI2	7980	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17372906
TFPI2	7980	Osteoarthritis	MESH:D010003	marker/mechanism		NA		15292528
TFPI2	7980	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		16965396
TFR2	7036	beta-Thalassemia	MESH:D017086	marker/mechanism		NA		16755567
TFR2	7036	Hemochromatosis	MESH:D006432	marker/mechanism		NA		16935854|17241880|21411349|22383097
TFR2	7036	Hemochromatosis, type 3	MESH:C537248	marker/mechanism		NA	604250	
TFRC	7037	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
TFRC	7037	Anemia, Iron-Deficiency	MESH:D018798	marker/mechanism		NA		16733738|17162259|17163184
TFRC	7037	Arenaviridae Infections	MESH:D001117	therapeutic		NA		17287727
TFRC	7037	beta-Thalassemia	MESH:D017086	marker/mechanism		NA		16755567
TFRC	7037	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16904380|19238537
TFRC	7037	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		21785164
TFRC	7037	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		16111806
TFRC	7037	Glioma	MESH:D005910	marker/mechanism		NA		16904380
TFRC	7037	Helicobacter Infections	MESH:D016481	marker/mechanism		NA		16733738|17163184
TFRC	7037	IMMUNODEFICIENCY 46	OMIM:616740	marker/mechanism		NA	616740	
TFRC	7037	Inflammation	MESH:D007249	marker/mechanism		NA		16603144
TFRC	7037	Iron Metabolism Disorders	MESH:D019189	marker/mechanism		NA		17163184|17254562
TFRC	7037	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		16904380
TFRC	7037	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		16904380
TFRC	7037	Lymphoma, Non-Hodgkin	MESH:D008228	marker/mechanism		NA		16904380
TFRC	7037	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
TFRC	7037	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		18549825
TFRC	7037	Obesity	MESH:D009765	marker/mechanism		NA		17062801|20882379
TFRC	7037	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
TFRC	7037	Severe Combined Immunodeficiency	MESH:D016511	marker/mechanism		NA		26642240
TFRC	7037	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		16904380
TG	7038	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		30373627
TG	7038	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		27869686
TG	7038	Depressive Disorder	MESH:D003866	marker/mechanism		NA		30373627
TG	7038	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		30373627
TG	7038	Dwarfism	MESH:D004392	marker/mechanism		NA		24582622
TG	7038	Goiter	MESH:D006042	marker/mechanism		NA		24582622|8094490
TG	7038	Hashimoto Disease	MESH:D050031	marker/mechanism		NA		30373627
TG	7038	Thyroid Dyshormonogenesis 3	MESH:C562769	marker/mechanism		NA	274700	
TG	7038	Thyroiditis, Autoimmune	MESH:D013967	marker/mechanism		NA	608175	29385629
TGDS	23483	CATEL-MANZKE SYNDROME	OMIM:616145	marker/mechanism		NA	616145	
TGFA	7039	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		15565109|9029167
TGFA	7039	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		16230376
TGFA	7039	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		14514962
TGFA	7039	Head and Neck Neoplasms	MESH:D006258	marker/mechanism		NA		15342401
TGFA	7039	Hepatoblastoma	MESH:D018197	marker/mechanism		NA		11560253
TGFA	7039	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		18424623
TGFA	7039	Hypertrophy, Right Ventricular	MESH:D017380	marker/mechanism		NA		18424623
TGFA	7039	Inflammation	MESH:D007249	therapeutic		NA		11919079
TGFA	7039	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		8807143
TGFA	7039	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		9079223
TGFA	7039	Lung Injury	MESH:D055370	therapeutic		NA		11919079
TGFA	7039	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		8603490
TGFA	7039	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		8603490
TGFA	7039	Mucositis	MESH:D052016	therapeutic		NA		18803016
TGFA	7039	Nerve Degeneration	MESH:D009410	therapeutic		NA		9263032
TGFA	7039	Nonsyndromic Deafness	MESH:C580334	marker/mechanism		NA		27356075
TGFA	7039	Papilloma	MESH:D010212	marker/mechanism		NA		8603490
TGFA	7039	Prostatic Neoplasms	MESH:D011471	therapeutic		NA		17136230
TGFA	7039	Psoriasis	MESH:D011565	marker/mechanism		NA		7519033
TGFA	7039	Pulmonary Edema	MESH:D011654	therapeutic		NA		11919079
TGFA	7039	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		18424623
TGFA	7039	Stomach Neoplasms	MESH:D013274	therapeutic		NA		15723263
TGFB1	7040	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
TGFB1	7040	Acromicric dysplasia	MESH:C535662	marker/mechanism		NA		18677313
TGFB1	7040	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		10469268
TGFB1	7040	Acute Lung Injury	MESH:D055371	marker/mechanism		NA		16100012
TGFB1	7040	Adenocarcinoma	MESH:D000230	therapeutic		NA		17418594
TGFB1	7040	Aortic Valve Insufficiency	MESH:D001022	marker/mechanism		NA		21216836
TGFB1	7040	Asthma	MESH:D001249	marker/mechanism		NA		16365456|19138248
TGFB1	7040	Asthma, Occupational	MESH:D059366	marker/mechanism		NA		25721048
TGFB1	7040	Berylliosis	MESH:D001607	marker/mechanism		NA		15750822|17785866
TGFB1	7040	Brain Diseases	MESH:D001927	marker/mechanism		NA		29483653
TGFB1	7040	Calcinosis	MESH:D002114	marker/mechanism		NA		24142982
TGFB1	7040	Camurati-Engelmann Syndrome	MESH:D003966	marker/mechanism		NA	131300	
TGFB1	7040	Carcinoma	MESH:D002277	therapeutic		NA		12417722
TGFB1	7040	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		9029167
TGFB1	7040	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		20852150
TGFB1	7040	Carcinosarcoma	MESH:D002296	marker/mechanism		NA		15132766
TGFB1	7040	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		20172950
TGFB1	7040	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		28789951|30026087
TGFB1	7040	Cleft Palate	MESH:D002972	marker/mechanism		NA		25450421
TGFB1	7040	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		24836286
TGFB1	7040	Copper-Overload Cirrhosis	MESH:C566858	marker/mechanism		NA		22879914
TGFB1	7040	Cystic Fibrosis	MESH:D003550	marker/mechanism		NA	219700	
TGFB1	7040	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		17177138|23090186
TGFB1	7040	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		23500658
TGFB1	7040	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		18682491|19960420
TGFB1	7040	Diabetic Neuropathies	MESH:D003929	marker/mechanism		NA		16696316
TGFB1	7040	Dry Eye Syndromes	MESH:D015352	marker/mechanism		NA		22194977
TGFB1	7040	Duodenal Ulcer	MESH:D004381	therapeutic		NA		12868675
TGFB1	7040	Endomyocardial Fibrosis	MESH:D004719	marker/mechanism		NA		25450231
TGFB1	7040	Epilepsy	MESH:D004827	marker/mechanism		NA		29483653
TGFB1	7040	Fibrosis	MESH:D005355	marker/mechanism		NA		10469268|16306446|17947678|18705752|24142982|26054450|27870162|30809271
TGFB1	7040	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		11728950
TGFB1	7040	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA		16191423|18682491|20493835
TGFB1	7040	Hepatic Insufficiency	MESH:D048550	marker/mechanism		NA		30026087
TGFB1	7040	Hepatitis, Autoimmune	MESH:D019693	marker/mechanism		NA		21227906
TGFB1	7040	Hepatitis, Chronic	MESH:D006521	marker/mechanism		NA		22879914
TGFB1	7040	Hepatomegaly	MESH:D006529	marker/mechanism		NA		30026087
TGFB1	7040	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		10646786
TGFB1	7040	Hyperplasia	MESH:D006965	marker/mechanism		NA		20172950
TGFB1	7040	Hypersensitivity	MESH:D006967	marker/mechanism		NA		19138248|21625544
TGFB1	7040	Hypertension	MESH:D006973	marker/mechanism		NA		11682445|19018797
TGFB1	7040	Infant, Newborn, Diseases	MESH:D007232	marker/mechanism		NA		29483653
TGFB1	7040	Inflammation	MESH:D007249	marker/mechanism|therapeutic		NA		19138248|20172950
TGFB1	7040	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA		29483653
TGFB1	7040	Intervertebral Disc Degeneration	MESH:D055959	therapeutic		NA		21351055
TGFB1	7040	Kidney Diseases	MESH:D007674	marker/mechanism|therapeutic		NA		11682445|14675041|18390891
TGFB1	7040	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19420110
TGFB1	7040	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		21037076
TGFB1	7040	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		23274713
TGFB1	7040	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		30026087
TGFB1	7040	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism|therapeutic		NA		12586293|15772939|16579972|26806094|27605418
TGFB1	7040	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		28100771
TGFB1	7040	Lung Diseases	MESH:D008171	marker/mechanism		NA		11472967
TGFB1	7040	Lung Neoplasms	MESH:D008175	marker/mechanism|therapeutic		NA		11074608|11641043|17418594
TGFB1	7040	Lymphomatoid Papulosis	MESH:D017731	therapeutic		NA		11594583
TGFB1	7040	Muscular Diseases	MESH:D009135	marker/mechanism		NA		21152098
TGFB1	7040	Muscular Dystrophy, Duchenne	MESH:D020388	marker/mechanism		NA		21641384
TGFB1	7040	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		16310260
TGFB1	7040	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		23992306|24727557|24793912|25884904|26896736
TGFB1	7040	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		23146760|23992306|26896736|31381904
TGFB1	7040	Neoplasm Regression, Spontaneous	MESH:D009365	marker/mechanism		NA		11594583
TGFB1	7040	Nephrosclerosis	MESH:D009400	marker/mechanism		NA		30818366
TGFB1	7040	Nephrotic Syndrome	MESH:D009404	marker/mechanism		NA		10515446|1281619|8023968
TGFB1	7040	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		21664615
TGFB1	7040	Occupational Diseases	MESH:D009784	marker/mechanism		NA		24142982
TGFB1	7040	Oral Submucous Fibrosis	MESH:D009914	marker/mechanism		NA		16311067
TGFB1	7040	Osteoarthritis	MESH:D010003	marker/mechanism		NA		30664745
TGFB1	7040	Osteoporosis	MESH:D010024	marker/mechanism		NA		12706579
TGFB1	7040	Osteoporosis, Postmenopausal	MESH:D015663	marker/mechanism		NA		10750555
TGFB1	7040	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		23992306
TGFB1	7040	Papilloma	MESH:D010212	marker/mechanism		NA		20172950
TGFB1	7040	Penile Induration	MESH:D010411	marker/mechanism		NA		14996430
TGFB1	7040	Peritoneal Fibrosis	MESH:D056627	marker/mechanism		NA		17199790
TGFB1	7040	Pleural Diseases	MESH:D010995	marker/mechanism		NA		24142982
TGFB1	7040	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
TGFB1	7040	Posterior Leukoencephalopathy Syndrome	MESH:D054038	marker/mechanism		NA		29483653
TGFB1	7040	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		15159307|18082198
TGFB1	7040	Proteinuria	MESH:D011507	marker/mechanism		NA		12937228
TGFB1	7040	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		16365456|31349846
TGFB1	7040	Pulmonary Emphysema	MESH:D011656	therapeutic		NA		12634787
TGFB1	7040	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		15286001|16324872|16365456|17266442|19817698|24762191|26817844
TGFB1	7040	Sarcoidosis	MESH:D012507	marker/mechanism		NA		17785866
TGFB1	7040	Sepsis	MESH:D018805	marker/mechanism		NA		16003065
TGFB1	7040	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		8148055
TGFB1	7040	Stroke	MESH:D020521	marker/mechanism		NA		12374626
TGFB1	7040	Thrombocythemia, Essential	MESH:D013920	marker/mechanism		NA		15682418
TGFB1	7040	Uremia	MESH:D014511	marker/mechanism		NA		19092814
TGFB1	7040	Ureteral Obstruction	MESH:D014517	marker/mechanism		NA		17164399
TGFB1	7040	Urticaria	MESH:D014581	marker/mechanism		NA		19138248
TGFB1	7040	Ventricular Remodeling	MESH:D020257	marker/mechanism		NA		16635409
TGFB1A	359834	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		27935819
TGFB2	7042	Aortic Aneurysm, Thoracic	MESH:D017545	marker/mechanism		NA		22772368|22772371
TGFB2	7042	Aortic Valve Insufficiency	MESH:D001022	marker/mechanism		NA		21216836
TGFB2	7042	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		25055964
TGFB2	7042	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		9217007
TGFB2	7042	Cholangitis	MESH:D002761	marker/mechanism		NA		25055964
TGFB2	7042	Cleft Palate	MESH:D002972	marker/mechanism		NA		25450421
TGFB2	7042	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		9217007
TGFB2	7042	Cyanosis	MESH:D003490	marker/mechanism		NA		9217007
TGFB2	7042	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
TGFB2	7042	Eye Abnormalities	MESH:D005124	marker/mechanism		NA		9217007
TGFB2	7042	Glaucoma	MESH:D005901	marker/mechanism		NA		20375339
TGFB2	7042	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		9217007
TGFB2	7042	Limb Deformities, Congenital	MESH:D017880	marker/mechanism		NA		9217007
TGFB2	7042	Loeys-Dietz Syndrome	MESH:D055947	marker/mechanism		NA	614816	22772368
TGFB2	7042	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
TGFB2	7042	Musculoskeletal Abnormalities	MESH:D009139	marker/mechanism		NA		9217007
TGFB2	7042	Respiratory System Abnormalities	MESH:D015619	marker/mechanism		NA		9217007
TGFB2	7042	Ureteral Obstruction	MESH:D014517	marker/mechanism		NA		17164399
TGFB2	7042	Urogenital Abnormalities	MESH:D014564	marker/mechanism		NA		9217007
TGFB3	7043	Arrhythmogenic Right Ventricular Dysplasia, Familial, 1	MESH:C566254	marker/mechanism		NA	107970	
TGFB3	7043	Cleft Palate	MESH:D002972	marker/mechanism		NA		26971374|7493022
TGFB3	7043	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TGFB3	7043	Loeys-Dietz Syndrome	MESH:D055947	marker/mechanism		NA	615582	
TGFB3	7043	Nonsyndromic Deafness	MESH:C580334	marker/mechanism		NA		27356075
TGFB3	7043	Respiratory System Abnormalities	MESH:D015619	marker/mechanism		NA		7493022
TGFBI	7045	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
TGFBI	7045	Corneal dystrophy Avellino type	MESH:C535474	marker/mechanism		NA	607541	
TGFBI	7045	Corneal dystrophy, epithelial basement membrane	MESH:C535477	marker/mechanism		NA	121820	
TGFBI	7045	Corneal Dystrophy, Lattice Type IIIA	MESH:C563923	marker/mechanism		NA	608471	
TGFBI	7045	Corneal dystrophy of Bowman layer, type 1	MESH:C535476	marker/mechanism		NA	608470	
TGFBI	7045	Corneal dystrophy, Thiel-Behnke type	MESH:C535942	marker/mechanism		NA	602082	
TGFBI	7045	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		18682491
TGFBI	7045	Groenouw type I corneal dystrophy	MESH:C537304	marker/mechanism		NA	121900	
TGFBI	7045	Lattice corneal dystrophy type 1	MESH:C537881	marker/mechanism		NA	122200	
TGFBI	7045	Sepsis	MESH:D018805	marker/mechanism		NA		27887929
TGFBR1	7046	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
TGFBR1	7046	Aneurysm, Dissecting	MESH:D000784	marker/mechanism		NA		22772368
TGFBR1	7046	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28560358
TGFBR1	7046	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18703712
TGFBR1	7046	Keratoacanthoma familial	MESH:C536150	marker/mechanism		NA	132800	21358634
TGFBR1	7046	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		28560358
TGFBR1	7046	Loeys-Dietz Syndrome	MESH:D055947	marker/mechanism		NA	609192	20358619|22772368
TGFBR1	7046	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		21358634
TGFBR1	7046	Uremia	MESH:D014511	marker/mechanism		NA		19092814
TGFBR2	7048	Aneurysm, Dissecting	MESH:D000784	marker/mechanism		NA		16027248|16885183
TGFBR2	7048	Aortic Aneurysm	MESH:D001014	marker/mechanism		NA		16885183
TGFBR2	7048	Aortic Aneurysm, Thoracic	MESH:D017545	marker/mechanism		NA		16027248
TGFBR2	7048	Bone Diseases	MESH:D001847	marker/mechanism		NA		20358619
TGFBR2	7048	Bone Neoplasms	MESH:D001859	therapeutic		NA		16489006
TGFBR2	7048	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		27935819
TGFBR2	7048	Carcinoma	MESH:D002277	marker/mechanism		NA		10789724
TGFBR2	7048	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		7761852
TGFBR2	7048	Colorectal Cancer, Hereditary Nonpolyposis, Type 6	MESH:C566039	marker/mechanism		NA	614331	
TGFBR2	7048	Colorectal Neoplasms, Hereditary Nonpolyposis	MESH:D003123	marker/mechanism		NA		9590282
TGFBR2	7048	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		16368934|16885183
TGFBR2	7048	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		15496156
TGFBR2	7048	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA	133239	10789724
TGFBR2	7048	Eye Abnormalities	MESH:D005124	marker/mechanism		NA		16885183
TGFBR2	7048	Fatigue	MESH:D005221	marker/mechanism		NA		16885183
TGFBR2	7048	Fractures, Bone	MESH:D050723	marker/mechanism		NA		20358619
TGFBR2	7048	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
TGFBR2	7048	Hernia, Inguinal	MESH:D006552	marker/mechanism		NA		16885183
TGFBR2	7048	Liver Cirrhosis, Experimental	MESH:D008106	therapeutic		NA		15942678|16627068
TGFBR2	7048	Loeys-Dietz Syndrome	MESH:D055947	marker/mechanism		NA		15235604|18084123|19006214|20358619|22772368
TGFBR2	7048	LOEYS-DIETZ SYNDROME 2	OMIM:610168	marker/mechanism		NA	610168	
TGFBR2	7048	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		11074608
TGFBR2	7048	Marfan Syndrome	MESH:D008382	marker/mechanism		NA		15235604
TGFBR2	7048	Microsatellite Instability	MESH:D053842	marker/mechanism		NA		25701956|7761852
TGFBR2	7048	Migraine Disorders	MESH:D008881	marker/mechanism		NA		16885183
TGFBR2	7048	Neoplasm Metastasis	MESH:D009362	therapeutic		NA		16489006
TGFBR2	7048	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		18381416
TGIF1	7050	Holoprosencephaly	MESH:D016142	marker/mechanism		NA		16705179
TGIF1	7050	Holoprosencephaly 4	MESH:C564180	marker/mechanism		NA	142946	
TGIF1	7050	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		25791921
TGIF1	7050	Neoplasm Metastasis	MESH:D009362	therapeutic		NA		29746904
TGM1	7051	Chloracne	MESH:D054506	marker/mechanism		NA		21237254
TGM1	7051	Dry Eye Syndromes	MESH:D015352	marker/mechanism		NA		16146918
TGM1	7051	Ichthyosis, Lamellar	MESH:D017490	marker/mechanism		NA	242300	
TGM1	7051	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
TGM1	7051	Neurotoxicity Syndromes	MESH:D020258	marker/mechanism		NA		19784758
TGM1	7051	Vitamin A Deficiency	MESH:D014802	marker/mechanism		NA		16146918
TGM2	7052	Brain Neoplasms	MESH:D001932	therapeutic		NA		16170020
TGM2	7052	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19579870
TGM2	7052	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		15108329
TGM2	7052	Celiac Disease	MESH:D002446	marker/mechanism		NA		17190764
TGM2	7052	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		17068819
TGM2	7052	Glioblastoma	MESH:D005909	marker/mechanism|therapeutic		NA		16170020|17099729
TGM2	7052	Hypertension	MESH:D006973	marker/mechanism		NA		17898543
TGM2	7052	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
TGM2	7052	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		30108682
TGM3	7053	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
TGM3	7053	Uncombable hair syndrome	MESH:C536939	marker/mechanism		NA	617251	
TGM5	9333	Peeling skin syndrome, acral type	MESH:C536316	marker/mechanism		NA	609796	
TGM6	343641	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA	613908	
TGOLN1	22134	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
TGOLN2	10618	Thyroid Diseases	MESH:D013959	marker/mechanism		NA		23397585
TH	7054	Brain Diseases	MESH:D001927	therapeutic		NA		7842013
TH	7054	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
TH	7054	Catalepsy	MESH:D002375	marker/mechanism		NA		10984662|9822156
TH	7054	Dyskinesia, Drug-Induced	MESH:D004409	therapeutic		NA		15659429
TH	7054	Dystonia	MESH:D004421	marker/mechanism		NA		15505183
TH	7054	Heart Diseases	MESH:D006331	marker/mechanism		NA		9822156
TH	7054	Hyperkinesis	MESH:D006948	marker/mechanism		NA		9822156
TH	7054	Hypertension	MESH:D006973	marker/mechanism		NA		27659729|32147540|32165127
TH	7054	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
TH	7054	Learning Disabilities	MESH:D007859	marker/mechanism		NA		10984662|9822156
TH	7054	Lewy Body Disease	MESH:D020961	marker/mechanism		NA		30236862
TH	7054	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		12871582
TH	7054	Neuroblastoma	MESH:D009447	marker/mechanism		NA		25174395
TH	7054	Parkinson Disease	MESH:D010300	marker/mechanism		NA		30236862
TH	7054	Parkinsonian Disorders	MESH:D020734	marker/mechanism		NA		11246459|8817341
TH	7054	Pheochromocytoma	MESH:D010673	marker/mechanism		NA		22569243
TH	7054	Segawa syndrome, autosomal recessive	MESH:C537537	marker/mechanism		NA	605407	8528210|8817341
THADA	63892	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		18372903
THAP1	55145	Dystonia	MESH:D004421	marker/mechanism		NA		23222958
THAP1	55145	Dystonia 6, torsion	MESH:C538003	marker/mechanism		NA	602629	19182804
THAP1	55145	Dystonic Disorders	MESH:D020821	marker/mechanism		NA		23222958
THAP3	90326	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
THAS	7055	Anencephaly	MESH:D000757	marker/mechanism		NA		4039891
THAS	7055	Cleft Lip	MESH:D002971	marker/mechanism		NA		4039891
THAS	7055	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		2139758|4039891
THAS	7055	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		2139758
THAS	7055	Hernia, Ventral	MESH:D006555	marker/mechanism		NA		2139758
THAS	7055	Hydrocephalus	MESH:D006849	marker/mechanism		NA		4039891
THAS	7055	Kidney Diseases	MESH:D007674	marker/mechanism		NA		4039891
THAS	7055	Lung Diseases	MESH:D008171	marker/mechanism		NA		2139758
THAS	7055	Pentalogy of Cantrell	MESH:D058502	marker/mechanism		NA		2139758
THAS	7055	Thoracic Diseases	MESH:D013896	marker/mechanism		NA		2139758
THBD	7056	Atypical Hemolytic Uremic Syndrome	MESH:D065766	marker/mechanism		NA	612926	19625716
THBD	7056	Disseminated Intravascular Coagulation	MESH:D004211	therapeutic		NA		9134660
THBD	7056	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	therapeutic		NA		27474498
THBD	7056	Hyperalgesia	MESH:D006930	therapeutic		NA		27474498
THBD	7056	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		16206674
THBD	7056	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
THBD	7056	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		10627464|9843165
THBD	7056	Neuropathy, Painful	MESH:C564945	therapeutic		NA		27474498
THBD	7056	Pulmonary Embolism	MESH:D011655	marker/mechanism		NA		7811989
THBD	7056	Purpura, Thrombotic Thrombocytopenic	MESH:D011697	marker/mechanism		NA		7740478
THBD	7056	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		12707536
THBD	7056	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
THBD	7056	Thrombophilia	MESH:D019851	marker/mechanism		NA		12139752
THBD	7056	Thrombophilia due to Thrombomodulin Defect	MESH:C566057	marker/mechanism		NA	614486	
THBD	7056	Thrombosis	MESH:D013927	marker/mechanism		NA		11132655|11518727
THBS1	7057	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
THBS1	7057	Breast Neoplasms	MESH:D001943	therapeutic		NA		9309585
THBS1	7057	Diabetic Angiopathies	MESH:D003925	marker/mechanism		NA		25381014
THBS1	7057	Diabetic Retinopathy	MESH:D003930	marker/mechanism		NA		17117553
THBS1	7057	Fibrosis	MESH:D005355	marker/mechanism		NA		16005714
THBS1	7057	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		18407596
THBS1	7057	Nephritis, Interstitial	MESH:D009395	marker/mechanism		NA		16005714
THBS1	7057	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		16526316
THBS1	7057	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
THBS2	7058	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		23723366
THBS2	7058	Diabetic Angiopathies	MESH:D003925	marker/mechanism		NA		25381014
THBS2	7058	Intervertebral disc disease	MESH:C535531	marker/mechanism		NA	603932	
THEG5	100507527	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
THEM4	117145	Carcinoma, Hepatocellular	MESH:D006528	therapeutic		NA		23392203
THEMIS	387357	Celiac Disease	MESH:D002446	marker/mechanism		NA		20190752
THEMIS2	9473	Breast Neoplasms	MESH:D001943	therapeutic		NA		19942713
THG1L	54974	Fibrosis	MESH:D005355	marker/mechanism		NA		21784897
THG1L	54974	Kidney Diseases	MESH:D007674	marker/mechanism		NA		21784897
THOC2	57187	MENTAL RETARDATION, X-LINKED 12	OMIM:300957	marker/mechanism		NA	300957	
THOC6	79228	BEAULIEU-BOYCOTT-INNES SYNDROME	OMIM:613680	marker/mechanism		NA	613680	
THPO	7066	Cardiomyopathies	MESH:D009202	therapeutic		NA		16651473
THPO	7066	Thrombocytosis	MESH:D013922	marker/mechanism		NA	187950	15813844
THRA	7067	Endometriosis	MESH:D004715	marker/mechanism		NA		22138541
THRA	7067	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		11685700
THRA	7067	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6	OMIM:614450	marker/mechanism		NA	614450	
THRB	7068	Adenocarcinoma, Follicular	MESH:D018263	marker/mechanism		NA		27440272
THRB	7068	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
THRB	7068	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		10660344
THRB	7068	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		11685700
THRB	7068	Thyroid Hormone Resistance, Generalized, Autosomal Dominant	MESH:C567934	marker/mechanism		NA	188570	
THRB	7068	Thyroid Hormone Resistance, Generalized, Autosomal Recessive	MESH:C567936	marker/mechanism		NA	274300	
THRB	7068	Thyroid Hormone Resistance, Selective Pituitary	MESH:C564154	marker/mechanism		NA	145650	
THRB	7068	Thyroid Hormone Resistance Syndrome	MESH:D018382	marker/mechanism		NA		10660344|9349583
THRSP	7069	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
THRSP	7069	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
THRSP	7069	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
THSD4	79875	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
THSD7A	221981	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		31043756
THY1	7070	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
THY1	7070	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		23075401
THY1	7070	Retinal Diseases	MESH:D012164	marker/mechanism		NA		23075401
THYN1	29087	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
THYN1	29087	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
TIA1	7072	Welander distal myopathy, Swedish type	MESH:C536690	marker/mechanism		NA	604454	
TIAL1	7073	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TIAM1	7074	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
TIAM1	7074	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		27862620
TIAM1	7074	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		27862620
TIAM2	26230	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
TICAM1	148022	Encephalitis, Herpes Simplex	MESH:D020803	marker/mechanism		NA	614850	
TICAM1	148022	Pneumoconiosis	MESH:D011009	marker/mechanism		NA		25445010
TICAM1	148022	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		25780291
TICAM1	148022	Respiratory Syncytial Virus Infections	MESH:D018357	marker/mechanism		NA		24478430
TICAM2	353376	Brain Injuries	MESH:D001930	marker/mechanism		NA		21549006
TICAM2	353376	Severe Acute Respiratory Syndrome	MESH:D045169	marker/mechanism		NA		26861016
TICRR	90381	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
TIMD4	91937	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
TIMD4	91937	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
TIMM10	26519	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
TIMM10	26519	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
TIMM10	26519	Rhabdomyosarcoma	MESH:D012208	marker/mechanism		NA		16669873
TIMM8A	1678	Jensen syndrome	MESH:C537568	marker/mechanism		NA		11803487
TIMM8A	1678	Mohr-Tranebjaerg syndrome	MESH:C535808	marker/mechanism		NA	304700	11803487
TIMM8A1	30058	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
TIMM8A1	30058	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
TIMP1	7076	Aortic Valve Insufficiency	MESH:D001022	marker/mechanism		NA		21216836
TIMP1	7076	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		25055964
TIMP1	7076	Calcinosis	MESH:D002114	marker/mechanism		NA		21335463
TIMP1	7076	Cholangitis	MESH:D002761	marker/mechanism		NA		25055964
TIMP1	7076	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		28789951
TIMP1	7076	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		21963884
TIMP1	7076	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		16023759
TIMP1	7076	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		21051829
TIMP1	7076	Female Urogenital Diseases	MESH:D052776	marker/mechanism		NA		16002989
TIMP1	7076	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		25133636
TIMP1	7076	Heart Diseases	MESH:D006331	marker/mechanism		NA		23558518
TIMP1	7076	Heart Valve Diseases	MESH:D006349	marker/mechanism		NA		21335463
TIMP1	7076	Hepatolenticular Degeneration	MESH:D006527	marker/mechanism		NA		26241054
TIMP1	7076	Hypertension	MESH:D006973	marker/mechanism		NA		21051829
TIMP1	7076	Inflammation	MESH:D007249	marker/mechanism		NA		17569694
TIMP1	7076	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		23274713
TIMP1	7076	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		16507762|16718785|16762003|21163135|25380136
TIMP1	7076	Neoplasm Invasiveness	MESH:D009361	therapeutic		NA		1318976
TIMP1	7076	Oral Submucous Fibrosis	MESH:D009914	marker/mechanism		NA		16311067
TIMP1	7076	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		21468558
TIMP1	7076	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
TIMP1	7076	Varicose Veins	MESH:D014648	marker/mechanism		NA		17643059
TIMP1	7076	Vascular Diseases	MESH:D014652	marker/mechanism		NA		17569694
TIMP2	7077	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
TIMP2	7077	Calcinosis	MESH:D002114	marker/mechanism		NA		24142982
TIMP2	7077	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		28789951
TIMP2	7077	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		21963884
TIMP2	7077	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TIMP2	7077	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		24358288
TIMP2	7077	Occupational Diseases	MESH:D009784	marker/mechanism		NA		24142982
TIMP2	7077	Pleural Diseases	MESH:D010995	marker/mechanism		NA		24142982
TIMP2	7077	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		30548095
TIMP3	7078	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
TIMP3	7078	Asthma	MESH:D001249	marker/mechanism		NA		16926187
TIMP3	7078	Colitis	MESH:D003092	marker/mechanism		NA		24548422
TIMP3	7078	Fundus Dystrophy, Pseudoinflammatory, Of Sorsby	MESH:C564992	marker/mechanism		NA	136900	
TIMP3	7078	Liver Diseases	MESH:D008107	marker/mechanism		NA		19784758
TIMP3	7078	Macular Degeneration	MESH:D008268	marker/mechanism		NA		26691988
TIMP3	7078	Neoplasm Invasiveness	MESH:D009361	therapeutic		NA		23109338
TIMP3	7078	Neurotoxicity Syndromes	MESH:D020258	marker/mechanism		NA		19784758
TIMP3	7078	Schistosomiasis	MESH:D012552	marker/mechanism		NA		23527093
TIMP3	7078	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
TIMP3	7078	Urinary Bladder Diseases	MESH:D001745	marker/mechanism		NA		23527093
TIMP4	7079	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
TINAG	27283	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		19634143
TINF2	26277	Bone Marrow Diseases	MESH:D001855	marker/mechanism		NA		18252230
TINF2	26277	Cerebellar Diseases	MESH:D002526	marker/mechanism		NA		18252230
TINF2	26277	Dyskeratosis Congenita	MESH:D019871	marker/mechanism		NA		18252230
TINF2	26277	Dyskeratosis Congenita, Autosomal Dominant	MESH:C565079	marker/mechanism		NA	127550	
TINF2	26277	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3	OMIM:613990	marker/mechanism		NA	613990	
TINF2	26277	Growth Disorders	MESH:D006130	marker/mechanism		NA		18252230
TINF2	26277	Nail Diseases	MESH:D009260	marker/mechanism		NA		18252230
TINF2	26277	Revesz Debuse syndrome	MESH:C538371	marker/mechanism		NA	268130	18252230
TIPARP	25976	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		20852632
TIRAP	114609	Bacteremia	MESH:D016470	marker/mechanism		NA	614382	17322885
TIRAP	114609	Malaria	MESH:D008288	marker/mechanism		NA	611162	17322885
TIRAP	114609	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO	OMIM:607948	marker/mechanism		NA	607948	
TIRAP	114609	Pneumococcal Infections	MESH:D011008	marker/mechanism		NA		17322885
TIRAP	114609	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16284379
TIRAP	114609	Severe Acute Respiratory Syndrome	MESH:D045169	marker/mechanism		NA		26861016
TIRAP	114609	Tuberculosis	MESH:D014376	marker/mechanism		NA		17322885
TJP2	9414	Cholestasis, Intrahepatic	MESH:D002780	marker/mechanism		NA		24614073
TJP2	9414	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4	OMIM:615878	marker/mechanism		NA	615878	
TJP2	9414	Hearing Loss	MESH:D034381	marker/mechanism		NA		21782914
TJP2	9414	Hypercholanemia, Familial	MESH:C564336	marker/mechanism		NA	607748	
TJP3	27134	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
TK1	7083	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
TK1	7083	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
TK1	7083	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		15814641
TK1	7083	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
TK1	7083	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		11420682
TK2	7084	MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	OMIM:609560	marker/mechanism		NA	609560	
TK2	7084	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	OMIM:617069	marker/mechanism		NA	617069	
TKFC	26007	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TKT	7086	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
TKT	7086	Hypoxia	MESH:D000860	marker/mechanism		NA		19579223
TKT	7086	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
TKT	7086	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
TKT	7086	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		15654357
TKT	7086	Wernicke Encephalopathy	MESH:D014899	marker/mechanism		NA		3762968
TLCD5	219902	Exfoliation Syndrome	MESH:D017889	marker/mechanism		NA		28553957
TLE3	7090	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
TLE3	7090	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		23143596
TLE3	7090	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19075277
TLE4	7091	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
TLE4	7091	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
TLE4	7091	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
TLE4	7091	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
TLE5	166	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
TLE6	79816	PREIMPLANTATION EMBRYONIC LETHALITY 1	OMIM:616814	marker/mechanism		NA	616814	
TLK1	9874	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
TLK1	9874	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		17481512
TLL1	7092	Atrial Septal Defect 6	MESH:C567764	marker/mechanism		NA	613087	
TLN1	7094	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		21291860
TLN1	7094	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
TLR1	7096	Brain Injuries	MESH:D001930	marker/mechanism		NA		21549006
TLR1	7096	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		18466103
TLR1	7096	Leprosy	MESH:D007918	marker/mechanism		NA	613223	
TLR2	7097	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		29286200
TLR2	7097	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		19192274
TLR2	7097	Brain Injuries	MESH:D001930	marker/mechanism		NA		21549006
TLR2	7097	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		15505089
TLR2	7097	Cardiotoxicity	MESH:D066126	marker/mechanism		NA		29959987
TLR2	7097	Cholestasis	MESH:D002779	marker/mechanism		NA		27989131
TLR2	7097	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	114500	16879199|17892325
TLR2	7097	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		18466103|31557154
TLR2	7097	Eosinophilia	MESH:D004802	marker/mechanism		NA		26882889
TLR2	7097	Eye Infections, Bacterial	MESH:D015818	marker/mechanism		NA		23661603
TLR2	7097	Heart Failure	MESH:D006333	marker/mechanism		NA		29959987
TLR2	7097	Inflammation	MESH:D007249	marker/mechanism		NA		22178603
TLR2	7097	Keratitis	MESH:D007634	marker/mechanism		NA		23661603
TLR2	7097	Leprosy	MESH:D007918	marker/mechanism		NA	246300	
TLR2	7097	Mite Infestations	MESH:D008924	marker/mechanism		NA		29253318
TLR2	7097	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO	OMIM:607948	marker/mechanism		NA	607948	
TLR2	7097	Myelodysplastic Syndromes	MESH:D009190	marker/mechanism		NA		28963909
TLR2	7097	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		25780291
TLR2	7097	Staphylococcal Infections	MESH:D013203	marker/mechanism		NA		23661603
TLR3	7098	Encephalitis, Herpes Simplex	MESH:D020803	marker/mechanism		NA	613002	
TLR3	7098	HIV Infections	MESH:D015658	marker/mechanism		NA	609423	
TLR4	7099	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		20981132
TLR4	7099	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		29286200
TLR4	7099	Adenocarcinoma Of Esophagus	MESH:C562730	marker/mechanism		NA		23525077
TLR4	7099	Angina, Stable	MESH:D060050	marker/mechanism		NA		20981132
TLR4	7099	Atherosclerosis	MESH:D050197	marker/mechanism		NA		12124407
TLR4	7099	Brain Injuries	MESH:D001930	marker/mechanism		NA		21549006
TLR4	7099	Carcinoma	MESH:D002277	marker/mechanism		NA		22180778
TLR4	7099	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		27022031
TLR4	7099	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		28789951
TLR4	7099	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		16879199|22180778
TLR4	7099	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		20524934
TLR4	7099	Crohn Disease	MESH:D003424	marker/mechanism		NA		17914947
TLR4	7099	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		18725520
TLR4	7099	Diabetic Neuropathies	MESH:D003929	marker/mechanism		NA		14693986
TLR4	7099	Enterocolitis, Necrotizing	MESH:D020345	marker/mechanism		NA		23650378
TLR4	7099	Eosinophilia	MESH:D004802	marker/mechanism		NA		26882889
TLR4	7099	Fatty Liver	MESH:D005234	marker/mechanism		NA		18641190|27022031
TLR4	7099	Fibrosis	MESH:D005355	marker/mechanism		NA		27585667
TLR4	7099	Hearing Loss	MESH:D034381	marker/mechanism		NA		21148032
TLR4	7099	Hypertension	MESH:D006973	marker/mechanism		NA		27292124|32147540
TLR4	7099	Inflammation	MESH:D007249	marker/mechanism		NA		16651628|22053092|22178603|22300504
TLR4	7099	Learning Disabilities	MESH:D007859	marker/mechanism		NA		29107071
TLR4	7099	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TLR4	7099	Lung Injury	MESH:D055370	marker/mechanism		NA		22300504
TLR4	7099	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		19925653
TLR4	7099	Macular Degeneration	MESH:D008268	marker/mechanism		NA		15829498
TLR4	7099	Melanoma	MESH:D008545	marker/mechanism		NA		22842228
TLR4	7099	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		21473897
TLR4	7099	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		22180778
TLR4	7099	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		21616060
TLR4	7099	Pneumonia	MESH:D011014	marker/mechanism		NA		26882889
TLR4	7099	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17301271
TLR4	7099	Renal Insufficiency	MESH:D051437	marker/mechanism		NA		27585667
TLR4	7099	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		25780291|27064547
TLR4	7099	Respiratory Hypersensitivity	MESH:D012130	marker/mechanism		NA		10835634
TLR4	7099	Sepsis	MESH:D018805	marker/mechanism		NA		20624996
TLR4	7099	Ventricular Dysfunction, Left	MESH:D018487	marker/mechanism		NA		27442881
TLR4	7099	Weight Loss	MESH:D015431	marker/mechanism		NA		31442584
TLR5	7100	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		30508503
TLR5	7100	Hyperammonemia	MESH:D022124	marker/mechanism		NA		30508503
TLR5	7100	Legionnaires' Disease	MESH:D007877	marker/mechanism		NA	608556	
TLR5	7100	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA	601744	
TLR5	7100	Melioidosis	MESH:D008554	marker/mechanism		NA	615557	
TLR5	7100	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16284379
TLR6	10333	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16537705
TLR7	51284	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		24990399
TLR7	51284	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		16033404
TLR7	51284	Hepatitis C	MESH:D006526	marker/mechanism		NA		27385120
TLR7	51284	Orthomyxoviridae Infections	MESH:D009976	marker/mechanism		NA		22916010
TLR8	51311	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
TLR8	51311	Hepatitis C	MESH:D006526	marker/mechanism		NA		27385120
TLR9	54106	Brain Injuries	MESH:D001930	marker/mechanism		NA		21549006
TLR9	54106	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		24990399
TLR9	54106	Crohn Disease	MESH:D003424	marker/mechanism		NA		15236225|17914947
TLR9	54106	Granuloma, Foreign-Body	MESH:D015745	marker/mechanism		NA		19797157
TLR9	54106	Granuloma, Respiratory Tract	MESH:D015769	marker/mechanism		NA		19797157
TLR9	54106	Inflammation	MESH:D007249	marker/mechanism		NA		19797157
TLR9	54106	Schistosomiasis mansoni	MESH:D012555	marker/mechanism		NA		19797157
TLR9	54106	Triple Negative Breast Neoplasms	MESH:D064726	therapeutic		NA		24273604
TLX1	3195	Aneuploidy	MESH:D000782	marker/mechanism		NA		20972433
TLX1	3195	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		20972433
TLX1	3195	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		1717256
TLX1	3195	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054218	marker/mechanism		NA		20972433
TLX1	3195	Splenic Diseases	MESH:D013158	marker/mechanism		NA		7908720
TM4SF20	79853	SPECIFIC LANGUAGE IMPAIRMENT 5	OMIM:615432	marker/mechanism		NA	615432	
TM4SF4	7104	Liver Diseases	MESH:D008107	marker/mechanism		NA		17069928
TM6SF1	53346	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TM6SF2	53345	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		26482880
TM6SF2	53345	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		24633158
TM6SF2	53345	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		24531328
TMBIM1	64114	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TMBIM4	51643	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
TMC1	117531	Deafness, Autosomal Dominant 36	MESH:C564675	marker/mechanism		NA	606705	
TMC1	117531	Deafness, Autosomal Recessive 7	MESH:C563417	marker/mechanism		NA	600974	
TMC6	11322	Epidermodysplasia Verruciformis	MESH:D004819	marker/mechanism		NA	226400	
TMCO1	54499	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		20018682
TMCO1	54499	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		20018682
TMCO1	54499	Glaucoma, Open-Angle	MESH:D005902	marker/mechanism		NA		21532571
TMCO1	54499	Intellectual Disability	MESH:D008607	marker/mechanism		NA		20018682
TMCO1	54499	Musculoskeletal Abnormalities	MESH:D009139	marker/mechanism		NA		20018682
TMCO1	54499	Tooth Abnormalities	MESH:D014071	marker/mechanism		NA		20018682
TMED2	10959	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
TMED7	51014	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		26881866
TMED7	51014	Cholestasis	MESH:D002779	marker/mechanism		NA		26881866
TMEFF2	23671	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
TMEFF2	23671	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		23405127
TMEM106A	113277	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TMEM106B	54664	Frontotemporal Lobar Degeneration	MESH:D057174	marker/mechanism		NA		20154673
TMEM117	84216	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		26881866
TMEM117	84216	Cholestasis	MESH:D002779	marker/mechanism		NA		26881866
TMEM126A	84233	Optic Atrophy 7	MESH:C567833	marker/mechanism		NA	612989	
TMEM127	55654	Pheochromocytoma	MESH:D010673	marker/mechanism		NA	171300	20154675
TMEM132B	114795	Melanoma	MESH:D008545	marker/mechanism		NA		21499247
TMEM132D	121256	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
TMEM132D	121256	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		19233941
TMEM132D	121256	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941189
TMEM135	65084	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		30705370
TMEM135	65084	Glioblastoma	MESH:D005909	marker/mechanism		NA		30705370
TMEM135	65084	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
TMEM139	135932	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		26213588
TMEM151A	256472	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
TMEM151B	441151	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
TMEM164	84187	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
TMEM165	55858	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIk	OMIM:614727	marker/mechanism		NA	614727	
TMEM165	55858	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TMEM17	200728	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
TMEM178	68027	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TMEM18	129787	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28869590
TMEM18	129787	Obesity	MESH:D009765	marker/mechanism		NA		19079261
TMEM184B	25829	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TMEM199	147007	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIp	OMIM:616829	marker/mechanism		NA	616829	
TMEM216	51259	Joubert syndrome 2	MESH:C536294	marker/mechanism		NA	608091	
TMEM216	51259	Meckel syndrome type 2	MESH:C536131	marker/mechanism		NA	603194	
TMEM230	29058	Parkinson Disease	MESH:D010300	marker/mechanism		NA		27270108
TMEM231	79583	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
TMEM238L	100289255	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		30510241
TMEM240	339453	Spinocerebellar ataxia 21	MESH:C537200	marker/mechanism		NA	607454	
TMEM25	84866	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19776672
TMEM30B	161291	Melanoma	MESH:D008545	marker/mechanism		NA		16778180
TMEM37	140738	Carcinoma	MESH:D002277	marker/mechanism		NA		21489049
TMEM37	140738	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		21489049
TMEM38B	55151	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
TMEM38B	55151	OSTEOGENESIS IMPERFECTA, TYPE XIV	OMIM:615066	marker/mechanism		NA	615066	
TMEM43	79188	Arrhythmogenic Right Ventricular Dysplasia, Familial, 5	MESH:C565776	marker/mechanism		NA	604400	
TMEM43	79188	Death, Sudden, Cardiac	MESH:D016757	marker/mechanism		NA		20435227
TMEM43	79188	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TMEM43	79188	Muscular Dystrophy, Emery-Dreifuss	MESH:D020389	marker/mechanism		NA	614302	
TMEM45A	55076	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27935865
TMEM59L	25789	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
TMEM63A	9725	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
TMEM63A	9725	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
TMEM65	157378	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TMEM67	91147	Bardet-Biedl Syndrome	MESH:D020788	marker/mechanism		NA		18327255
TMEM67	91147	Bardet-Biedl Syndrome 14	MESH:C567141	marker/mechanism		NA	615991	
TMEM67	91147	COACH syndrome	MESH:C536430	marker/mechanism		NA	216360	
TMEM67	91147	Joubert syndrome 6	MESH:C537689	marker/mechanism		NA	610688	
TMEM67	91147	Kidney Diseases, Cystic	MESH:D052177	marker/mechanism		NA		19508969
TMEM67	91147	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		19508969
TMEM67	91147	Meckel syndrome type 3	MESH:C536132	marker/mechanism		NA	607361	
TMEM67	91147	NEPHRONOPHTHISIS 11	OMIM:613550	marker/mechanism		NA	613550	
TMEM70	54968	Adenoma, Liver Cell	MESH:D018248	marker/mechanism		NA		27914986
TMEM70	54968	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		27914986
TMEM70	54968	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		18953340
TMEM70	54968	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2	OMIM:614052	marker/mechanism		NA	614052	
TMEM70	54968	Mitochondrial Encephalomyopathies	MESH:D017237	marker/mechanism		NA		18953340
TMEM98	26022	NANOPHTHALMOS 4	OMIM:615972	marker/mechanism		NA	615972	
TMF1	7110	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
TMF1	7110	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		19208208
TMIE	259236	Deafness, Autosomal Recessive 6	MESH:C563418	marker/mechanism		NA	600971	
TMLHE	55217	Autistic Disorder	MESH:D001321	marker/mechanism		NA	300872	
TMOD1	7111	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
TMOD1	7111	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
TMPO	7112	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		12833524
TMPO	7112	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		16247757
TMPO	7112	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
TMPRSS11D	9407	Coronavirus Infections	MESH:D018352	marker/mechanism		NA		24227843
TMPRSS11D	9407	Influenza, Human	MESH:D007251	marker/mechanism		NA		20237084|23072892
TMPRSS11D	9407	Severe Acute Respiratory Syndrome	MESH:D045169	marker/mechanism		NA		24227843
TMPRSS15	5651	Enterokinase Deficiency	MESH:C562649	marker/mechanism		NA	226200	
TMPRSS2	7113	Cancer Pain	MESH:D000072716	marker/mechanism		NA		25734995
TMPRSS2	7113	Coronavirus Infections	MESH:D018352	marker/mechanism		NA		24027332|24227843|27550352|27733646|28778717
TMPRSS2	7113	COVID-19	MESH:C000657245	marker/mechanism		NA		32142651|32165541|32404436
TMPRSS2	7113	Influenza, Human	MESH:D007251	marker/mechanism|therapeutic		NA		20237084|21123387|23072892|26889029|28778717|31391268
TMPRSS2	7113	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		18798265|25735316|28783165|29610475
TMPRSS2	7113	Severe Acute Respiratory Syndrome	MESH:D045169	marker/mechanism		NA		22496216|24227843|30626688
TMPRSS3	64699	DEAFNESS, AUTOSOMAL RECESSIVE 8	OMIM:601072	marker/mechanism		NA	601072	
TMPRSS3	64699	Pneumoconiosis	MESH:D011009	marker/mechanism		NA		25445010
TMPRSS4	56649	COVID-19	MESH:C000657245	marker/mechanism		NA		32404436
TMPRSS4	56649	Influenza, Human	MESH:D007251	marker/mechanism		NA		26889029
TMPRSS6	164656	Anemia, Iron-Deficiency	MESH:D018798	marker/mechanism		NA		18408718|22169218
TMPRSS6	164656	Iron-Refractory Iron Deficiency Anemia	MESH:C562385	marker/mechanism		NA	206200	
TMPRSS7	344805	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
TMSB10	9168	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		17597826
TMSB10	9168	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TMSB4X	7114	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
TMSB4X	7114	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17916567
TMTC2	160335	Deafness	MESH:D003638	marker/mechanism		NA		27311106
TMTC3	160418	Lissencephaly	MESH:D054082	marker/mechanism		NA	617255	
TNC	3371	Asthma	MESH:D001249	marker/mechanism		NA		16115819
TNC	3371	DEAFNESS, AUTOSOMAL DOMINANT 56	OMIM:615629	marker/mechanism		NA	615629	
TNC	3371	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
TNC	3371	Lung Injury	MESH:D055370	marker/mechanism		NA		18978301
TNC	3371	Melanoma	MESH:D008545	marker/mechanism		NA		22842228
TNC	3371	Osteoarthritis, Hip	MESH:D015207	marker/mechanism		NA		30374069
TNC	3371	Pleural Diseases	MESH:D010995	marker/mechanism		NA		10950882
TNC	3371	Varicose Veins	MESH:D014648	marker/mechanism		NA		17643059
TNF	7124	Acquired Hyperostosis Syndrome	MESH:D020083	therapeutic		NA		27108452
TNF	7124	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		20981132
TNF	7124	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		16595132|18460982|20623750
TNF	7124	Adenocarcinoma	MESH:D000230	marker/mechanism|therapeutic		NA		1733439|19028472
TNF	7124	Albuminuria	MESH:D000419	marker/mechanism		NA		17167242
TNF	7124	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		17192785
TNF	7124	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
TNF	7124	Anemia	MESH:D000740	marker/mechanism		NA		16566752
TNF	7124	Anemia, Refractory	MESH:D000753	marker/mechanism		NA		10870480
TNF	7124	Anemia, Sickle Cell	MESH:D000755	marker/mechanism		NA		14965870
TNF	7124	Angina, Stable	MESH:D060050	marker/mechanism		NA		20981132
TNF	7124	Anorexia	MESH:D000855	marker/mechanism		NA		25392278
TNF	7124	Anthracosis	MESH:D055008	marker/mechanism		NA		20005085
TNF	7124	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		20194079
TNF	7124	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
TNF	7124	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		19203382|19330884|19765281|20131233|20974942|21452922|22450443|7589090|9598899
TNF	7124	Arthritis, Infectious	MESH:D001170	marker/mechanism		NA		19203382
TNF	7124	Arthritis, Psoriatic	MESH:D015535	marker/mechanism		NA		12746914|19732956
TNF	7124	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism|therapeutic		NA		12566094|2001072|22450443|8391952
TNF	7124	Asbestosis	MESH:D001195	marker/mechanism		NA		20486865
TNF	7124	Asthma	MESH:D001249	marker/mechanism		NA	600807	12356572|14681301|16456144|17450233|20049212
TNF	7124	Asthma, Occupational	MESH:D059366	marker/mechanism		NA		25721048
TNF	7124	Atherosclerosis	MESH:D050197	marker/mechanism		NA		20720404
TNF	7124	Berylliosis	MESH:D001607	marker/mechanism		NA		12449171|15127972|16980557|8428540
TNF	7124	Brain Edema	MESH:D001929	marker/mechanism		NA		21276434
TNF	7124	Brain Injuries	MESH:D001930	marker/mechanism		NA		19800810|21549006
TNF	7124	Brain Injuries, Traumatic	MESH:D000070642	marker/mechanism		NA		28642177
TNF	7124	Brain Ischemia	MESH:D002545	marker/mechanism		NA		15756928
TNF	7124	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037|17516992|19446661
TNF	7124	Bronchiectasis	MESH:D001987	marker/mechanism		NA		17931847
TNF	7124	Burns	MESH:D002056	marker/mechanism		NA		18277951
TNF	7124	Cachexia	MESH:D002100	marker/mechanism		NA		17878525
TNF	7124	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		27022031
TNF	7124	Carcinoma, Transitional Cell	MESH:D002295	therapeutic		NA		3361654
TNF	7124	Cardiomegaly	MESH:D006332	marker/mechanism		NA		15302781|17337591|18034274
TNF	7124	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		10716473
TNF	7124	Cardiotoxicity	MESH:D066126	marker/mechanism		NA		29959987|32068018
TNF	7124	Cardiovirus Infections	MESH:D018188	marker/mechanism		NA		10609881
TNF	7124	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism|therapeutic		NA		17709330|19638433|20623750|21984482|7532385|9696492
TNF	7124	Chlamydia Infections	MESH:D002690	marker/mechanism		NA		19203382
TNF	7124	Cholestasis	MESH:D002779	marker/mechanism		NA		20626112
TNF	7124	Cholestasis, Extrahepatic	MESH:D001651	marker/mechanism		NA		28789951
TNF	7124	Colitis	MESH:D003092	marker/mechanism		NA		23810507|24548422
TNF	7124	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		19617644|20452301|22119283
TNF	7124	Colonic Neoplasms	MESH:D003110	marker/mechanism|therapeutic		NA		12842827|19028472
TNF	7124	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		23431386
TNF	7124	Coronary Restenosis	MESH:D023903	marker/mechanism		NA		16319143
TNF	7124	COVID-19	MESH:C000657245	marker/mechanism		NA		31986264
TNF	7124	Coxsackievirus Infections	MESH:D003384	marker/mechanism		NA		25396421
TNF	7124	Crohn Disease	MESH:D003424	marker/mechanism		NA		10700533|21829567
TNF	7124	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		15849067
TNF	7124	Dermatomyositis	MESH:D003882	marker/mechanism		NA		19035492
TNF	7124	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		12123627|12193562|19478208|20388520|22138235|24513509
TNF	7124	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		23640034
TNF	7124	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		24513509
TNF	7124	Diabetic Cardiomyopathies	MESH:D058065	marker/mechanism		NA		17909696
TNF	7124	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27093858
TNF	7124	Drug Eruptions	MESH:D003875	marker/mechanism		NA		31150805
TNF	7124	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		11294926|20485159
TNF	7124	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		31557154
TNF	7124	Edema	MESH:D004487	marker/mechanism		NA		19874808
TNF	7124	Fanconi Anemia	MESH:D005199	marker/mechanism		NA		22628295
TNF	7124	Fatty Liver	MESH:D005234	marker/mechanism		NA		23348005
TNF	7124	Fever	MESH:D005334	marker/mechanism		NA		10379864|11852909|15384034
TNF	7124	Fibromatosis, Aggressive	MESH:D018222	therapeutic		NA		19944662
TNF	7124	Fibrosis	MESH:D005355	marker/mechanism		NA		18034274
TNF	7124	Glioma	MESH:D005910	marker/mechanism		NA		22199285
TNF	7124	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		10910440|9403216
TNF	7124	Heart Arrest	MESH:D006323	marker/mechanism		NA		9806674
TNF	7124	Heart Failure	MESH:D006333	marker/mechanism		NA		15135663|15231041|17337591|18034274|29959987
TNF	7124	Heat Stroke	MESH:D018883	marker/mechanism		NA		16878031|24039931
TNF	7124	Hemochromatosis	MESH:D006432	marker/mechanism		NA		16793930
TNF	7124	Hemolytic-Uremic Syndrome	MESH:D006463	marker/mechanism		NA		15384034
TNF	7124	Hepatic Encephalopathy	MESH:D006501	marker/mechanism		NA		16338762|9696492
TNF	7124	Hepatitis, Alcoholic	MESH:D006519	marker/mechanism		NA		12586603
TNF	7124	Hepatolenticular Degeneration	MESH:D006527	marker/mechanism		NA		25002079
TNF	7124	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		10541330
TNF	7124	HIV Wasting Syndrome	MESH:D019247	marker/mechanism		NA		7979221
TNF	7124	Hyperalgesia	MESH:D006930	marker/mechanism		NA		10401557|12727271|16472913|17320857|18463260|18582539|20383154|26141506|27093858|7582491|7881729
TNF	7124	Hyperbilirubinemia	MESH:D006932	marker/mechanism		NA		10379864
TNF	7124	Hypercalcemia	MESH:D006934	marker/mechanism		NA		10638776
TNF	7124	Hyperhomocysteinemia	MESH:D020138	marker/mechanism		NA		12615666
TNF	7124	Hyperinsulinism	MESH:D006946	marker/mechanism		NA		29035695
TNF	7124	Hypersensitivity	MESH:D006967	marker/mechanism		NA		16095146|21625544
TNF	7124	Hypertension	MESH:D006973	marker/mechanism		NA		18605955|27292124|27659729|27847271|32147540
TNF	7124	Hypertension, Pulmonary	MESH:D006976	therapeutic		NA		2518282
TNF	7124	Hypoglycemia	MESH:D007003	marker/mechanism		NA		8774068
TNF	7124	Hypotension	MESH:D007022	marker/mechanism		NA		10379864|15384034
TNF	7124	Hypothermia	MESH:D007035	marker/mechanism		NA		16369138
TNF	7124	Infections	MESH:D007239	marker/mechanism		NA		16513158
TNF	7124	Inflammation	MESH:D007249	marker/mechanism		NA		11181422|12843254|14970111|16001271|16227999|19324842|19803787|20167660|20943792|21146893|21467745|22452660|23348408|23371441|23795810
TNF	7124	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA		15086448|27793764
TNF	7124	Insulin Resistance	MESH:D007333	marker/mechanism		NA		16493877|20943792
TNF	7124	Intrahepatic Cholestasis of Pregnancy	MESH:C535932	marker/mechanism		NA		23627780
TNF	7124	Kidney Failure, Chronic	MESH:D007676	marker/mechanism		NA		19539174
TNF	7124	Leishmaniasis	MESH:D007896	marker/mechanism		NA		16540374
TNF	7124	Leishmaniasis, Cutaneous	MESH:D016773	marker/mechanism		NA		20102417
TNF	7124	Leishmaniasis, Visceral	MESH:D007898	marker/mechanism		NA		1901333|22461696
TNF	7124	Listeriosis	MESH:D008088	marker/mechanism		NA		16751399
TNF	7124	Liver Cirrhosis, Alcoholic	MESH:D008104	marker/mechanism		NA		23274713
TNF	7124	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		16085334
TNF	7124	Liver Diseases	MESH:D008107	marker/mechanism		NA		15946935
TNF	7124	Liver Failure, Acute	MESH:D017114	marker/mechanism		NA		19505222
TNF	7124	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		24183702
TNF	7124	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		28100771
TNF	7124	Lung Diseases	MESH:D008171	marker/mechanism		NA		11472967
TNF	7124	Lung Injury	MESH:D055370	therapeutic		NA		2518282|26243812
TNF	7124	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		14587096|22369883
TNF	7124	Malaria	MESH:D008288	marker/mechanism		NA	611162	
TNF	7124	Manganese Poisoning	MESH:D020149	marker/mechanism		NA		18041089
TNF	7124	Melanoma	MESH:D008545	therapeutic		NA		10379864|18388930|9794839|9843018
TNF	7124	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	OMIM:157300	marker/mechanism		NA	157300	
TNF	7124	Mitochondrial Myopathies	MESH:D017240	marker/mechanism		NA		7979221
TNF	7124	Multiple Organ Failure	MESH:D009102	marker/mechanism		NA		10890648|9696492
TNF	7124	Muscular Atrophy	MESH:D009133	marker/mechanism		NA		24534773
TNF	7124	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		15883752|16310260
TNF	7124	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533|16775501
TNF	7124	Myocardial Stunning	MESH:D017682	marker/mechanism		NA		11927517
TNF	7124	Myocarditis	MESH:D009205	marker/mechanism		NA		18627770|25396421
TNF	7124	Nausea	MESH:D009325	marker/mechanism		NA		10379864
TNF	7124	Necrosis	MESH:D009336	marker/mechanism		NA		10631206|10909967|22345571|24548419
TNF	7124	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		22199285|23431386|23899529|24613819
TNF	7124	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		23431386|8032535
TNF	7124	Neoplasms, Experimental	MESH:D009374	therapeutic		NA		12627504|1674182|3361654
TNF	7124	Nerve Degeneration	MESH:D009410	marker/mechanism|therapeutic		NA		15153526|22921461|9710261
TNF	7124	Nervous System Diseases	MESH:D009422	therapeutic		NA		14999072
TNF	7124	Neuralgia	MESH:D009437	marker/mechanism		NA		20846523
TNF	7124	Neurogenic Inflammation	MESH:D020078	marker/mechanism		NA		21570423
TNF	7124	Obesity	MESH:D009765	marker/mechanism		NA		11328671|20141834|29035695|9502777
TNF	7124	Oral Submucous Fibrosis	MESH:D009914	marker/mechanism		NA		16311067
TNF	7124	Osteolysis	MESH:D010014	marker/mechanism		NA		15878362
TNF	7124	Osteoporosis, Postmenopausal	MESH:D015663	marker/mechanism		NA		9032749
TNF	7124	Pain	MESH:D010146	marker/mechanism		NA		18582539|20383154
TNF	7124	Pancreatic Neoplasms	MESH:D010190	therapeutic		NA		16211219
TNF	7124	Parkinson Disease	MESH:D010300	marker/mechanism		NA		21318773
TNF	7124	Placenta Diseases	MESH:D010922	marker/mechanism		NA		16007645
TNF	7124	Pleural Effusion	MESH:D010996	therapeutic		NA		2518282
TNF	7124	Pleurisy	MESH:D010998	marker/mechanism		NA		11181422|15380531
TNF	7124	Pneumonia	MESH:D011014	marker/mechanism|therapeutic		NA		21625544|28917655
TNF	7124	Polymyositis	MESH:D017285	marker/mechanism		NA		7979221
TNF	7124	Pregnancy Complications, Cardiovascular	MESH:D011249	marker/mechanism		NA		10716473
TNF	7124	Premature Birth	MESH:D047928	marker/mechanism		NA		27748297
TNF	7124	Psoriasis	MESH:D011565	marker/mechanism		NA		16844318|7744320
TNF	7124	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		15337792|29497291
TNF	7124	Pulmonary Edema	MESH:D011654	therapeutic		NA		21188088
TNF	7124	Pulmonary Emphysema	MESH:D011656	marker/mechanism		NA		25106431
TNF	7124	Pulmonary Fibrosis	MESH:D011658	marker/mechanism		NA		11394717|16324872|17266442|25216247|26368622
TNF	7124	Radiation Injuries, Experimental	MESH:D011833	marker/mechanism		NA		11121210
TNF	7124	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		10706834|12024109|15829914|16971220|17112405|18460982|19058328|23743330|23875703|24898700
TNF	7124	Respiratory Hypersensitivity	MESH:D012130	marker/mechanism		NA		18394133
TNF	7124	Respiratory Tract Diseases	MESH:D012140	marker/mechanism		NA		22414385
TNF	7124	Retinal Diseases	MESH:D012164	marker/mechanism		NA		19324842
TNF	7124	Sarcoma	MESH:D012509	therapeutic		NA		15675481|16767912|17203757|9794839
TNF	7124	Schizophrenia	MESH:D012559	marker/mechanism		NA		16478754
TNF	7124	Scleroderma, Localized	MESH:D012594	marker/mechanism		NA		9843018
TNF	7124	Sepsis	MESH:D018805	marker/mechanism		NA		15489642|8741040|9806674
TNF	7124	Shock, Hemorrhagic	MESH:D012771	marker/mechanism		NA		21192278
TNF	7124	Shock, Septic	MESH:D012772	marker/mechanism		NA		20054000
TNF	7124	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
TNF	7124	Soft Tissue Neoplasms	MESH:D012983	therapeutic		NA		16767912|17203757
TNF	7124	Spinal Cord Compression	MESH:D013117	marker/mechanism		NA		15135227
TNF	7124	Status Epilepticus	MESH:D013226	marker/mechanism		NA		18455351
TNF	7124	Stomach Neoplasms	MESH:D013274	marker/mechanism|therapeutic		NA		15201584|1733439
TNF	7124	Stomach Ulcer	MESH:D013276	marker/mechanism		NA		15138204
TNF	7124	Stroke	MESH:D020521	marker/mechanism		NA		10950380
TNF	7124	Subarachnoid Hemorrhage	MESH:D013345	marker/mechanism		NA		27157545
TNF	7124	Tachycardia	MESH:D013610	marker/mechanism		NA		10379864
TNF	7124	Thrombosis	MESH:D013927	marker/mechanism		NA		19691487
TNF	7124	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		26037280
TNF	7124	Trigeminal Neuralgia	MESH:D014277	marker/mechanism		NA		27093858
TNF	7124	Urinary Bladder Neoplasms	MESH:D001749	therapeutic		NA		1674182
TNF	7124	Urticaria	MESH:D014581	marker/mechanism		NA		12121561|19250144|20485159
TNF	7124	Vascular Diseases	MESH:D014652	marker/mechanism		NA		14965870
TNF	7124	Vascular System Injuries	MESH:D057772	marker/mechanism		NA		19234301
TNF	7124	Venous Thromboembolism	MESH:D054556	marker/mechanism		NA		22473048
TNF	7124	Ventricular Dysfunction	MESH:D018754	marker/mechanism		NA		20626112
TNF	7124	Vitiligo	MESH:D014820	marker/mechanism		NA		28836394
TNF	7124	Weight Gain	MESH:D015430	marker/mechanism		NA		20521320
TNF	7124	Wounds and Injuries	MESH:D014947	marker/mechanism		NA		21192278
TNFAIP1	7126	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		20665664
TNFAIP2	7127	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		19192274
TNFAIP3	7128	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		18794853|20453842|21841782|23143596|30224649
TNFAIP3	7128	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		24453940
TNFAIP3	7128	AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE	OMIM:616744	marker/mechanism		NA	616744	
TNFAIP3	7128	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		24362818
TNFAIP3	7128	Hereditary Autoinflammatory Diseases	MESH:D056660	marker/mechanism		NA		26642243
TNFAIP3	7128	Inflammation	MESH:D007249	marker/mechanism		NA		24453940
TNFAIP3	7128	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		19165918|19165919|19838193|21336280
TNFAIP3	7128	Lymphoma, Follicular	MESH:D008224	marker/mechanism		NA		24362818
TNFAIP3	7128	Lymphoma, T-Cell, Cutaneous	MESH:D016410	marker/mechanism		NA		26192916
TNFAIP3	7128	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		24076602
TNFAIP3	7128	Psoriasis	MESH:D011565	marker/mechanism		NA		19169254|20953190
TNFAIP3	7128	Sjogren's Syndrome	MESH:D012859	marker/mechanism		NA		24097066|24097067
TNFAIP6	7130	Acute Lung Injury	MESH:D055371	therapeutic		NA		26313688
TNFAIP6	7130	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
TNFAIP6	7130	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
TNFAIP6	7130	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		16033404|17374397
TNFAIP6	7130	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		12374626
TNFAIP6	7130	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
TNFAIP6	7130	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
TNFAIP8	25816	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
TNFAIP8	25816	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21969086
TNFAIP8	25816	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TNFAIP8	25816	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		21969086
TNFRSF10A	8797	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		21472143
TNFRSF10A	8797	Alopecia	MESH:D000505	marker/mechanism		NA		19652058
TNFRSF10A	8797	Anemia	MESH:D000740	marker/mechanism		NA		19652058
TNFRSF10A	8797	Anorexia	MESH:D000855	marker/mechanism		NA		19652058
TNFRSF10A	8797	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		17075118
TNFRSF10A	8797	Drug Hypersensitivity	MESH:D004342	marker/mechanism		NA		19652058
TNFRSF10A	8797	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		21472143
TNFRSF10A	8797	Fatigue	MESH:D005221	marker/mechanism		NA		19652058
TNFRSF10A	8797	Macular Degeneration	MESH:D008268	marker/mechanism		NA		21909106
TNFRSF10A	8797	Nausea	MESH:D009325	marker/mechanism		NA		19652058
TNFRSF10A	8797	Neoplasms	MESH:D009369	therapeutic		NA		19652058
TNFRSF10A	8797	Neutropenia	MESH:D009503	marker/mechanism		NA		19652058
TNFRSF10A	8797	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		19652058
TNFRSF10A	8797	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
TNFRSF10A	8797	Thrombocytopenia	MESH:D013921	marker/mechanism		NA		19652058
TNFRSF10B	8795	Liver Neoplasms, Experimental	MESH:D008114	therapeutic		NA		18079962
TNFRSF10B	8795	Pancreatic Neoplasms	MESH:D010190	therapeutic		NA		18089714
TNFRSF10B	8795	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA	275355	
TNFRSF10C	8794	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
TNFRSF11A	8792	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		16270354
TNFRSF11A	8792	Osteitis Deformans	MESH:D010001	marker/mechanism		NA	602080	20436471
TNFRSF11A	8792	Osteopetrosis, Autosomal Recessive 7	MESH:C567354	marker/mechanism		NA	612301	
TNFRSF11A	8792	Polyostotic osteolytic dysplasia, hereditary expansile	MESH:C536335	marker/mechanism		NA	174810	
TNFRSF11B	4982	Arthritis, Experimental	MESH:D001169	therapeutic		NA		23333834
TNFRSF11B	4982	Arthritis, Rheumatoid	MESH:D001172	therapeutic		NA		23333834
TNFRSF11B	4982	Bone Resorption	MESH:D001862	marker/mechanism|therapeutic		NA		15845617|18496637|23333834
TNFRSF11B	4982	Carotid Stenosis	MESH:D016893	marker/mechanism		NA		26564003
TNFRSF11B	4982	Hyperalgesia	MESH:D006930	therapeutic		NA		16769263
TNFRSF11B	4982	Hypercalcemia	MESH:D006934	therapeutic		NA		15845617
TNFRSF11B	4982	Inflammation	MESH:D007249	therapeutic		NA		23333834
TNFRSF11B	4982	Osteolysis	MESH:D010014	therapeutic		NA		12548581
TNFRSF11B	4982	Osteoporosis	MESH:D010024	marker/mechanism		NA		17667143
TNFRSF11B	4982	PAGET DISEASE OF BONE 5, JUVENILE-ONSET	OMIM:239000	marker/mechanism		NA	239000	
TNFRSF11B	4982	Uremia	MESH:D014511	marker/mechanism		NA		19092814
TNFRSF12A	51330	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		23052191
TNFRSF12A	51330	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TNFRSF12A	51330	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		20082609
TNFRSF13B	23495	Brain Injuries	MESH:D001930	marker/mechanism		NA		23159883
TNFRSF13B	23495	Common Variable Immunodeficiency	MESH:D017074	marker/mechanism		NA	240500	
TNFRSF13B	23495	Immunoglobulin a deficiency 2	MESH:C536291	marker/mechanism		NA	609529	
TNFRSF13B	23495	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		23955597
TNFRSF13C	115650	Brain Injuries	MESH:D001930	marker/mechanism		NA		23159883
TNFRSF13C	115650	Common Variable Immunodeficiency	MESH:D017074	marker/mechanism		NA	240500|613494	
TNFRSF14	8764	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		20453842
TNFRSF14	8764	Brain Injuries	MESH:D001930	marker/mechanism		NA		23159883
TNFRSF14	8764	Celiac Disease	MESH:D002446	marker/mechanism		NA		20190752
TNFRSF18	8784	Leishmaniasis	MESH:D007896	marker/mechanism		NA		20139272
TNFRSF19	55504	Melanoma	MESH:D008545	marker/mechanism		NA		17187358
TNFRSF19	55504	Nasopharyngeal Neoplasms	MESH:D009303	marker/mechanism		NA		20512145
TNFRSF1A	7132	Anorexia	MESH:D000855	therapeutic		NA		18801959
TNFRSF1A	7132	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		21074606
TNFRSF1A	7132	Brain Injuries	MESH:D001930	marker/mechanism		NA		21549006
TNFRSF1A	7132	Brain Ischemia	MESH:D002545	marker/mechanism		NA		15829914
TNFRSF1A	7132	Cachexia	MESH:D002100	therapeutic		NA		18801959
TNFRSF1A	7132	Cystic Fibrosis	MESH:D003550	marker/mechanism		NA		16463024
TNFRSF1A	7132	Diabetes Mellitus, Experimental	MESH:D003921	therapeutic		NA		12193562
TNFRSF1A	7132	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		11882518
TNFRSF1A	7132	Fever	MESH:D005334	marker/mechanism		NA		11175303
TNFRSF1A	7132	Heart Failure	MESH:D006333	marker/mechanism		NA		16360360
TNFRSF1A	7132	Hyperoxia	MESH:D018496	marker/mechanism		NA		10781441
TNFRSF1A	7132	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
TNFRSF1A	7132	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		21399635
TNFRSF1A	7132	Lung Injury	MESH:D055370	marker/mechanism		NA		10781441
TNFRSF1A	7132	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA	614810	19525953|24076602
TNFRSF1A	7132	Periodic fever, familial, autosomal dominant	MESH:C536657	marker/mechanism		NA	142680	
TNFRSF1A	7132	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
TNFRSF1B	7133	Autistic Disorder	MESH:D001321	marker/mechanism		NA		16139734
TNFRSF1B	7133	Brain Ischemia	MESH:D002545	marker/mechanism		NA		15829914
TNFRSF1B	7133	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		11882518
TNFRSF1B	7133	Fractures, Bone	MESH:D050723	marker/mechanism		NA		15071724
TNFRSF1B	7133	Hypersensitivity	MESH:D006967	marker/mechanism		NA		21625544
TNFRSF1B	7133	Hypoalbuminemia	MESH:D034141	marker/mechanism		NA		15044820
TNFRSF1B	7133	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		20353583
TNFRSF1B	7133	Mycosis Fungoides	MESH:D009182	marker/mechanism		NA		26258847
TNFRSF1B	7133	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		20353583
TNFRSF1B	7133	Obesity	MESH:D009765	marker/mechanism		NA		11782876
TNFRSF1B	7133	Pneumonia	MESH:D011014	marker/mechanism		NA		21625544
TNFRSF1B	7133	Sezary Syndrome	MESH:D012751	marker/mechanism		NA		26258847
TNFRSF21	27242	Amyotrophic Lateral Sclerosis	MESH:D000690	marker/mechanism		NA		24113175
TNFRSF21	27242	Gliosis	MESH:D005911	marker/mechanism		NA		24113175
TNFRSF21	27242	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		11753679
TNFRSF26	244237	Brain Injuries	MESH:D001930	marker/mechanism		NA		23159883
TNFRSF4	7293	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		9766631
TNFRSF4	7293	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		12031769
TNFRSF4	7293	IMMUNODEFICIENCY 16	OMIM:615593	marker/mechanism		NA	615593	
TNFRSF4	7293	Myocarditis	MESH:D009205	marker/mechanism		NA		12031769
TNFRSF4	7293	Virus Diseases	MESH:D014777	marker/mechanism		NA		12031769
TNFRSF8	943	AIDS-Related Opportunistic Infections	MESH:D017088	marker/mechanism		NA		9379333
TNFRSF8	943	Carcinoma, Embryonal	MESH:D018236	marker/mechanism		NA		9111512
TNFRSF8	943	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		12031769
TNFRSF8	943	Ectromelia, Infectious	MESH:D004482	therapeutic		NA		12235215
TNFRSF8	943	Emphysema	MESH:D004646	therapeutic		NA		29984229
TNFRSF8	943	Gingivitis	MESH:D005891	marker/mechanism		NA		9379333
TNFRSF8	943	Graft vs Host Disease	MESH:D006086	marker/mechanism		NA		15322151
TNFRSF8	943	Graves Disease	MESH:D006111	marker/mechanism		NA		16372246
TNFRSF8	943	Hashimoto Disease	MESH:D050031	marker/mechanism		NA		16372246
TNFRSF8	943	Hemorrhage	MESH:D006470	therapeutic		NA		29984229
TNFRSF8	943	HIV Infections	MESH:D015658	marker/mechanism		NA		8811349
TNFRSF8	943	Hodgkin Disease	MESH:D006689	marker/mechanism		NA		10908157|12358914|12453859|16879607|17261581|7621881|8701986
TNFRSF8	943	Lymphoma, Large-Cell, Anaplastic	MESH:D017728	marker/mechanism		NA		10908157|17261581
TNFRSF8	943	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		23056237
TNFRSF8	943	Mycobacterium Infections	MESH:D009164	therapeutic		NA		15316035
TNFRSF8	943	Myocarditis	MESH:D009205	marker/mechanism		NA		12031769
TNFRSF8	943	Nasopharyngeal Carcinoma	MESH:D000077274	marker/mechanism		NA		27543511
TNFRSF8	943	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		29984229
TNFRSF8	943	Virus Diseases	MESH:D014777	marker/mechanism		NA		12031769|9826579
TNFRSF9	3604	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		12031769
TNFRSF9	3604	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
TNFRSF9	3604	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		25279216
TNFRSF9	3604	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		25279216
TNFRSF9	3604	Myocarditis	MESH:D009205	marker/mechanism		NA		12031769
TNFRSF9	3604	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		25279216
TNFRSF9	3604	Virus Diseases	MESH:D014777	marker/mechanism		NA		12031769
TNFSF10	8743	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
TNFSF10	8743	Adenocarcinoma of Lung	MESH:D000077192	therapeutic		NA		24345465
TNFSF10	8743	Brain Injuries	MESH:D001930	marker/mechanism		NA		23159883
TNFSF10	8743	Breast Neoplasms	MESH:D001943	therapeutic		NA		18483385
TNFSF10	8743	Carcinoma, Hepatocellular	MESH:D006528	therapeutic		NA		17326159
TNFSF10	8743	Carcinoma, Renal Cell	MESH:D002292	therapeutic		NA		20403343
TNFSF10	8743	Colonic Neoplasms	MESH:D003110	therapeutic		NA		15993848
TNFSF10	8743	Colorectal Neoplasms	MESH:D015179	therapeutic		NA		17273769
TNFSF10	8743	Endometrial Neoplasms	MESH:D016889	therapeutic		NA		20071162
TNFSF10	8743	Glioblastoma	MESH:D005909	therapeutic		NA		21877938
TNFSF10	8743	Glioma	MESH:D005910	therapeutic		NA		16820965|19229339
TNFSF10	8743	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
TNFSF10	8743	Kidney Neoplasms	MESH:D007680	therapeutic		NA		16985049
TNFSF10	8743	Leukemia	MESH:D007938	therapeutic		NA		17204177
TNFSF10	8743	Leukemia, Myeloid, Acute	MESH:D015470	therapeutic		NA		12780785
TNFSF10	8743	Liver Neoplasms	MESH:D008113	therapeutic		NA		18980244
TNFSF10	8743	Mammary Neoplasms, Experimental	MESH:D008325	therapeutic		NA		21252285
TNFSF10	8743	Neoplasm Metastasis	MESH:D009362	therapeutic		NA		21209944
TNFSF10	8743	Neoplasms, Experimental	MESH:D009374	therapeutic		NA		17767197|24345465
TNFSF10	8743	Neovascularization, Pathologic	MESH:D009389	therapeutic		NA		19509267|21209944
TNFSF10	8743	Neuroblastoma	MESH:D009447	therapeutic		NA		16820965
TNFSF10	8743	Ovarian Neoplasms	MESH:D010051	therapeutic		NA		21616060
TNFSF10	8743	Pancreatic Neoplasms	MESH:D010190	therapeutic		NA		11234897
TNFSF10	8743	Prostatic Neoplasms	MESH:D011471	therapeutic		NA		16368536|17636462|17718901|21209944
TNFSF11	8600	Alveolar Bone Loss	MESH:D016301	marker/mechanism		NA		19249596
TNFSF11	8600	Bone Resorption	MESH:D001862	marker/mechanism		NA		26319416
TNFSF11	8600	Chronic Periodontitis	MESH:D055113	marker/mechanism		NA		20731768
TNFSF11	8600	Hypercalcemia	MESH:D006934	marker/mechanism		NA		15845617
TNFSF11	8600	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		16270354
TNFSF11	8600	Osteolysis	MESH:D010014	marker/mechanism		NA		18606716
TNFSF11	8600	Osteopetrosis	MESH:D010022	marker/mechanism		NA		17632511
TNFSF11	8600	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2	OMIM:259710	marker/mechanism		NA	259710	
TNFSF11	8600	Osteoporosis	MESH:D010024	therapeutic		NA		17882678
TNFSF12	8742	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
TNFSF12	8742	Brain Injuries	MESH:D001930	marker/mechanism		NA		23159883
TNFSF13	8741	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
TNFSF13	8741	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18423122
TNFSF13	8741	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		22197929
TNFSF14	8740	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		20008919
TNFSF14	8740	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		24076602
TNFSF15	9966	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		20228799
TNFSF15	9966	Enteritis	MESH:D004751	marker/mechanism		NA		20980995
TNFSF15	9966	Inflammation	MESH:D007249	marker/mechanism		NA		20980995
TNFSF15	9966	Inflammatory Bowel Diseases	MESH:D015212	marker/mechanism		NA		26192919
TNFSF15	9966	Osteoarthritis	MESH:D010003	marker/mechanism		NA		30664745
TNFSF4	7292	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		12031769
TNFSF4	7292	Leishmaniasis	MESH:D007896	marker/mechanism		NA		10637281
TNFSF4	7292	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		18059267|19838193
TNFSF4	7292	Myocardial Infarction	MESH:D009203	marker/mechanism		NA	608446	
TNFSF4	7292	Myocarditis	MESH:D009205	marker/mechanism		NA		12031769
TNFSF4	7292	Virus Diseases	MESH:D014777	marker/mechanism		NA		12031769
TNFSF8	944	Carcinogenesis	MESH:D063646	marker/mechanism		NA		11552987
TNFSF8	944	Carcinoma, Embryonal	MESH:D018236	marker/mechanism		NA		9111512
TNFSF8	944	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		12031769
TNFSF8	944	Coxsackievirus Infections	MESH:D003384	marker/mechanism		NA		11745696
TNFSF8	944	Diabetes Mellitus, Congenital Autoimmune	MESH:C565730	marker/mechanism		NA		12930356
TNFSF8	944	Disease Progression	MESH:D018450	marker/mechanism		NA		11552987
TNFSF8	944	Ectromelia, Infectious	MESH:D004482	therapeutic		NA		12235215
TNFSF8	944	Endodermal Sinus Tumor	MESH:D018240	marker/mechanism		NA		9111512
TNFSF8	944	Graft vs Host Disease	MESH:D006086	marker/mechanism		NA		15322151
TNFSF8	944	Graves Disease	MESH:D006111	marker/mechanism		NA		16372246
TNFSF8	944	Hashimoto Disease	MESH:D050031	marker/mechanism		NA		16372246
TNFSF8	944	Hodgkin Disease	MESH:D006689	marker/mechanism		NA		10908157|11552987|12358914|7621881|8656679|8701986|8896393|9058727
TNFSF8	944	Hypereosinophilic Syndrome	MESH:D017681	marker/mechanism		NA		8896393
TNFSF8	944	Leprosy	MESH:D007918	marker/mechanism		NA		25320285
TNFSF8	944	Leukemia, Hairy Cell	MESH:D007943	marker/mechanism		NA		9058727
TNFSF8	944	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		9058727
TNFSF8	944	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		9058727
TNFSF8	944	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		10512160|11918534|9058727
TNFSF8	944	Leukemia, Prolymphocytic, T-Cell	MESH:D015461	marker/mechanism		NA		9058727
TNFSF8	944	Listeriosis	MESH:D008088	marker/mechanism|therapeutic		NA		16177108|21699557
TNFSF8	944	Lymphoma, B-Cell	MESH:D016393	marker/mechanism		NA		9058727
TNFSF8	944	Lymphoma, T-Cell, Peripheral	MESH:D016411	marker/mechanism		NA		9058727
TNFSF8	944	Lymphomatoid Papulosis	MESH:D017731	therapeutic		NA		11594583
TNFSF8	944	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		9058727
TNFSF8	944	Mycobacterium Infections	MESH:D009164	marker/mechanism|therapeutic		NA		15316035|18941223
TNFSF8	944	Mycobacterium tuberculosis, susceptibility to infection by	MESH:C536092	marker/mechanism		NA		30202016
TNFSF8	944	Myocarditis	MESH:D009205	marker/mechanism		NA		11745696|12031769
TNFSF8	944	Neoplasm Regression, Spontaneous	MESH:D009365	marker/mechanism		NA		11594583
TNFSF8	944	Neuralgia	MESH:D009437	marker/mechanism		NA		31432094
TNFSF8	944	Pleurisy	MESH:D010998	marker/mechanism		NA		15380531
TNFSF8	944	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D015452	marker/mechanism		NA		9058727
TNFSF8	944	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		29984229
TNFSF8	944	Virus Diseases	MESH:D014777	marker/mechanism		NA		12031769
TNFSF9	8744	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		12031769
TNFSF9	8744	Coxsackievirus Infections	MESH:D003384	marker/mechanism		NA		11745696
TNFSF9	8744	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
TNFSF9	8744	Myocarditis	MESH:D009205	marker/mechanism		NA		11745696|12031769
TNFSF9	8744	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
TNFSF9	8744	Virus Diseases	MESH:D014777	marker/mechanism		NA		12031769
TNIK	23043	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
TNIK	23043	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
TNIK	23043	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	OMIM:617028	marker/mechanism		NA	617028	
TNIK	23043	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
TNIP1	10318	Asthma	MESH:D001249	marker/mechanism		NA		24453940
TNIP1	10318	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16298037
TNIP1	10318	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		19838193|19838195
TNIP1	10318	Psoriasis	MESH:D011565	marker/mechanism		NA		19169254|20953190
TNIP1	10318	Scleroderma, Systemic	MESH:D012595	marker/mechanism		NA		21750679
TNIP1	10318	Sjogren's Syndrome	MESH:D012859	marker/mechanism		NA		24097067
TNK2	10188	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
TNK2	10188	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		19233941
TNNC1	7134	Cardiomyopathy, Dilated, 1z	MESH:C567506	marker/mechanism		NA	611879	
TNNC1	7134	Cardiomyopathy, Familial Hypertrophic, 13	MESH:C567686	marker/mechanism		NA	613243	
TNNI2	7136	Distal arthrogryposis type 2B	MESH:C538400	marker/mechanism		NA	601680	
TNNI2	7136	Muscular Diseases	MESH:D009135	marker/mechanism		NA		19628585
TNNI3	7137	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		15966572
TNNI3	7137	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		17587482
TNNI3	7137	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		15070570
TNNI3	7137	Cardiomyopathy, Dilated, 1FF	MESH:C567654	marker/mechanism		NA	613286	
TNNI3	7137	Cardiomyopathy, Dilated, 2a	MESH:C567505	marker/mechanism		NA	611880	
TNNI3	7137	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7	OMIM:613690	marker/mechanism		NA	613690	
TNNI3	7137	Cardiomyopathy, Familial Restrictive, 1	MESH:C566168	marker/mechanism		NA	115210	
TNNI3	7137	Cardiomyopathy, Hypertrophic, Familial	MESH:D024741	marker/mechanism		NA		11801593|11815426|9241277
TNNI3	7137	Cardiomyopathy, Restrictive	MESH:D002313	marker/mechanism		NA		12531876
TNNI3	7137	Heart Diseases	MESH:D006331	marker/mechanism		NA		19549929
TNNI3	7137	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		12359538
TNNI3K	51086	CARDIAC CONDUCTION DISEASE WITH OR WITHOUT DILATED CARDIOMYOPATHY	OMIM:616117	marker/mechanism		NA	616117	
TNNT1	7138	Nemaline myopathy 5	MESH:C538397	marker/mechanism		NA	605355	
TNNT2	7139	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		15966572
TNNT2	7139	Cardiomegaly	MESH:D006332	marker/mechanism		NA		17556660
TNNT2	7139	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		14745153|17587482
TNNT2	7139	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		17556660|19477965
TNNT2	7139	Cardiomyopathy, Dilated, 1D	MESH:C563306	marker/mechanism		NA	601494	
TNNT2	7139	Cardiomyopathy, Familial Hypertrophic, 2	MESH:C566171	marker/mechanism		NA	115195	
TNNT2	7139	Cardiomyopathy, Familial Restrictive, 3	MESH:C567316	marker/mechanism		NA	612422	
TNNT2	7139	Cardiomyopathy, Hypertrophic	MESH:D002312	marker/mechanism		NA		19087273
TNNT2	7139	Cardiomyopathy, Hypertrophic, Familial	MESH:D024741	marker/mechanism		NA		12600890|9241277
TNNT2	7139	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		14761428
TNNT2	7139	Death, Sudden, Cardiac	MESH:D016757	marker/mechanism		NA		17556660
TNNT2	7139	Glycogen Storage Disease Type II	MESH:D006009	marker/mechanism		NA		26787432
TNNT2	7139	Heart Diseases	MESH:D006331	marker/mechanism		NA		17848144
TNNT2	7139	Heart Failure	MESH:D006333	marker/mechanism		NA		12322705|17698733
TNNT2	7139	Heart Injuries	MESH:D006335	marker/mechanism		NA		19854236
TNNT2	7139	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		10789933
TNNT2	7139	Necrosis	MESH:D009336	marker/mechanism		NA		17848144
TNNT2	7139	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		18068611
TNNT2	7139	Respiratory Distress Syndrome, Newborn	MESH:D012127	marker/mechanism		NA		10789933
TNNT2	7139	Tachycardia, Ventricular	MESH:D017180	marker/mechanism		NA		12600890
TNNT2	7139	Ventricular Dysfunction, Left	MESH:D018487	marker/mechanism		NA		14618274
TNPO2	30000	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
TNPO3	23534	Muscular Dystrophy, Limb-Girdle, Type 1F	MESH:C564242	marker/mechanism		NA	608423	
TNR	7143	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
TNR	7143	Gliosis	MESH:D005911	marker/mechanism		NA		15120744
TNRC6A	27327	Epilepsies, Myoclonic	MESH:D004831	marker/mechanism		NA		29507423
TNRC6B	23112	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
TNRC6B	23112	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
TNS1A	565181	Mitral Valve Insufficiency	MESH:D008944	marker/mechanism		NA		26301497
TNXB	7148	Ehlers-Danlos syndrome caused by tenascin-X deficiency	MESH:C536193	marker/mechanism		NA	606408	
TNXB	7148	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		29379198
TNXB	7148	Vesico-Ureteral Reflux	MESH:D014718	marker/mechanism		NA	615963	
TOB1	10140	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
TOB1	10140	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
TOB1	10140	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		12756225
TOB2	10766	Vitiligo	MESH:D014820	marker/mechanism		NA		22561518
TOE1	114034	Pontocerebellar Hypoplasia	MESH:C580383	marker/mechanism		NA		28092684
TOE1	114034	PONTOCEREBELLAR HYPOPLASIA, TYPE 7	OMIM:614969	marker/mechanism		NA	614969	
TOM1L1	10040	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
TOMM40	10452	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
TOMM40	10452	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		27023435|29107063|30319691|30320580
TOMM40	10452	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
TOMM40	10452	Dyslipidemias	MESH:D050171	marker/mechanism		NA		29670124
TONSL	4796	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
TONSL	4796	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
TOP1	7150	Disease Progression	MESH:D018450	marker/mechanism		NA		30132517
TOP1	7150	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		19931604
TOP1	7150	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		30132517
TOP1	7150	Neoplasms	MESH:D009369	marker/mechanism		NA		11598410
TOP1	7150	Recurrence	MESH:D012008	marker/mechanism		NA		30132517
TOP2A	7153	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
TOP2A	7153	Adrenocortical Carcinoma	MESH:D018268	marker/mechanism		NA		23533247
TOP2A	7153	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		11583189|12006526|16234514|22204715
TOP2A	7153	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
TOP2A	7153	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
TOP2A	7153	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
TOP2A	7153	Disease Progression	MESH:D018450	marker/mechanism		NA		22204715|30132517
TOP2A	7153	Glioma	MESH:D005910	marker/mechanism		NA		18402387
TOP2A	7153	Leukemia	MESH:D007938	marker/mechanism		NA		15833037
TOP2A	7153	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		30132517
TOP2A	7153	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
TOP2A	7153	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17363613
TOP2A	7153	Recurrence	MESH:D012008	marker/mechanism		NA		20079691|22204715|30132517
TOP2A	7153	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
TOP2A	7153	Sepsis	MESH:D018805	marker/mechanism		NA		27978524
TOP2B	7155	Leukemia, Myeloid	MESH:D007951	therapeutic		NA		16932348
TOP2B	7155	Prostatic Intraepithelial Neoplasia	MESH:D019048	marker/mechanism		NA		20601956
TOPBP1	11073	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		18006695
TOPORS	10210	Osteosarcoma	MESH:D012516	marker/mechanism		NA		14767549
TOPORS	10210	Retinitis Pigmentosa 31	MESH:C563685	marker/mechanism		NA	609923	
TOR1A	1861	Dystonia	MESH:D004421	marker/mechanism		NA		20227500|21078339|23222958
TOR1A	1861	Dystonia musculorum deformans type 1	MESH:C538005	marker/mechanism		NA	128100	
TOR1A	1861	Dystonic Disorders	MESH:D020821	marker/mechanism		NA		23222958
TOR1A	1861	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
TOR1AIP1	26092	MYOPATHY, AUTOSOMAL RECESSIVE, WITH RIGID SPINE AND DISTAL JOINT CONTRACTURES	OMIM:617072	marker/mechanism		NA	617072	
TOR1B	27348	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
TOR4A	54863	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TOX3	27324	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17529967
TOX3	27324	Breast Neoplasms, Male	MESH:D018567	marker/mechanism		NA		23001122
TOX3	27324	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		28108177
TP53	7157	Acquired Hyperostosis Syndrome	MESH:D020083	marker/mechanism		NA		19779722
TP53	7157	Acute erythroleukemia	MESH:C535673	marker/mechanism		NA		30926971
TP53	7157	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		20603111
TP53	7157	Adenocarcinoma	MESH:D000230	marker/mechanism|therapeutic		NA		10797276|11798837|22484628
TP53	7157	Adenocarcinoma, Clear Cell	MESH:D018262	marker/mechanism		NA		9754764
TP53	7157	Adenocarcinoma Of Esophagus	MESH:C562730	marker/mechanism		NA		23525077
TP53	7157	Adenoma	MESH:D000236	marker/mechanism		NA		21946351
TP53	7157	Adrenal Gland Neoplasms	MESH:D000310	marker/mechanism		NA		24747643
TP53	7157	Adrenocortical Carcinoma	MESH:D018268	marker/mechanism		NA		23585556|24747642|9815696
TP53	7157	Adrenocortical Carcinoma, Hereditary	MESH:C565972	marker/mechanism		NA	202300	
TP53	7157	Amyotrophic Lateral Sclerosis	MESH:D000690	marker/mechanism		NA		17434459
TP53	7157	Aortic Valve, Calcification of	MESH:C562942	marker/mechanism		NA		29358327
TP53	7157	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		18621066|19203779
TP53	7157	Balkan Nephropathy	MESH:D001449	marker/mechanism		NA		22071594
TP53	7157	Brain Ischemia	MESH:D002545	marker/mechanism		NA		19095966
TP53	7157	Breast Neoplasms	MESH:D001943	marker/mechanism		NA	114480	15802278|16968874|17388661|26192916|26229107|30381462
TP53	7157	Calcinosis	MESH:D002114	marker/mechanism		NA		29358327
TP53	7157	Carcinoma	MESH:D002277	marker/mechanism		NA		17450239|9626339
TP53	7157	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
TP53	7157	Carcinoma, Basal Cell	MESH:D002280	marker/mechanism		NA	614740	11511317|21946351|26950094
TP53	7157	Carcinoma, Ductal	MESH:D044584	marker/mechanism		NA		29295717
TP53	7157	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism|therapeutic		NA	114550	17191126|18477611|22675488|25822088|8033108|9029167
TP53	7157	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		17290066|23435014|24688052|30381462
TP53	7157	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		25535366
TP53	7157	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		17275163|22138691|23797736|25401301
TP53	7157	Carcinoma, Small Cell	MESH:D018288	marker/mechanism		NA		17290066
TP53	7157	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		17979968|24224046
TP53	7157	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		22929185
TP53	7157	Cardiomyopathies	MESH:D009202	therapeutic		NA		31618665
TP53	7157	Cardiomyopathy, Hypertrophic	MESH:D002312	marker/mechanism		NA		22000973
TP53	7157	Cardiotoxicity	MESH:D066126	marker/mechanism		NA		30009776
TP53	7157	Carotid Artery Diseases	MESH:D002340	marker/mechanism		NA		16973168
TP53	7157	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		15550242
TP53	7157	Central Nervous System Neoplasms	MESH:D016543	marker/mechanism		NA		26192916
TP53	7157	Cholangiocarcinoma	MESH:D018281	marker/mechanism		NA		22561520
TP53	7157	Chromosome 17 deletion	MESH:C538045	marker/mechanism		NA		14961032
TP53	7157	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		17075118|17192441|26192916
TP53	7157	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA	114500	12645814|15172127|15814641|16110022|16524972|17949449|18676755|21946351
TP53	7157	Demyelinating Diseases	MESH:D003711	marker/mechanism		NA		18550754
TP53	7157	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		23792339
TP53	7157	Disease Progression	MESH:D018450	marker/mechanism		NA		30381462
TP53	7157	Emphysema	MESH:D004646	marker/mechanism		NA		22276220
TP53	7157	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		17634542|26192916
TP53	7157	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		25151357
TP53	7157	Gallbladder Neoplasms	MESH:D005706	marker/mechanism		NA		24185509|24997986
TP53	7157	Glioma	MESH:D005910	marker/mechanism		NA	137800	16899598|21946351|24705251
TP53	7157	Hemangiosarcoma	MESH:D006394	marker/mechanism		NA		10626228
TP53	7157	Hypertension	MESH:D006973	marker/mechanism		NA		22228705
TP53	7157	Infertility, Female	MESH:D007247	marker/mechanism		NA		22532853
TP53	7157	Infertility, Male	MESH:D007248	marker/mechanism		NA		22773013
TP53	7157	Ischemia	MESH:D007511	marker/mechanism		NA		15172883
TP53	7157	Keratosis	MESH:D007642	marker/mechanism		NA		16930632|28785074
TP53	7157	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		16439677
TP53	7157	Leukemia, Megakaryoblastic, of Down Syndrome	MESH:C566025	marker/mechanism		NA		24056718
TP53	7157	Li-Fraumeni Syndrome	MESH:D016864	marker/mechanism		NA	151623	25860607
TP53	7157	Liver Diseases, Parasitic	MESH:D008109	marker/mechanism		NA		22561520
TP53	7157	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		12378512|16410370
TP53	7157	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		10626228
TP53	7157	Lung Neoplasms	MESH:D008175	marker/mechanism|therapeutic		NA		11798837|16410370|17325666|20727180|26192916
TP53	7157	Lymphoma, T-Cell	MESH:D016399	marker/mechanism		NA		26192917
TP53	7157	Lymphoma, T-Cell, Cutaneous	MESH:D016410	marker/mechanism		NA		26192916
TP53	7157	Melanoma	MESH:D008545	marker/mechanism		NA		17210701|21691232|22842228|29574239
TP53	7157	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		26928227
TP53	7157	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		24224046
TP53	7157	Myelodysplastic Syndromes	MESH:D009190	marker/mechanism		NA		27992414
TP53	7157	Myeloproliferative Disorders	MESH:D009196	marker/mechanism		NA		29370077
TP53	7157	Nasopharyngeal Carcinoma	MESH:D000077274	marker/mechanism		NA	607107	24952746
TP53	7157	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17949449
TP53	7157	Osteosarcoma	MESH:D012516	marker/mechanism|therapeutic		NA	259500	16211088
TP53	7157	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		30258081
TP53	7157	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA	260350	
TP53	7157	Papilloma, Choroid Plexus	MESH:D020288	marker/mechanism		NA	260500	
TP53	7157	Penile Neoplasms	MESH:D010412	marker/mechanism		NA		9626339
TP53	7157	Polyploidy	MESH:D011123	marker/mechanism		NA		25125259
TP53	7157	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		23334668
TP53	7157	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16434975|17202838|20875869|21946351|25735316|26005866|29295717|29610475
TP53	7157	Psoriasis	MESH:D011565	marker/mechanism		NA		10384915
TP53	7157	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		17274270
TP53	7157	Sarcoma	MESH:D012509	marker/mechanism		NA		20601955
TP53	7157	Schizophrenia	MESH:D012559	marker/mechanism		NA		18583979
TP53	7157	Sezary Syndrome	MESH:D012751	marker/mechanism		NA		26551667|26551670
TP53	7157	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		12635827
TP53	7157	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941188|22941189
TP53	7157	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		25086664|30594912
TP53	7157	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		22484628|24816253
TP53	7157	Thymoma	MESH:D013945	marker/mechanism		NA		24974848
TP53	7157	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		16940797
TP53	7157	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		12376482|15906354|22929185|29644616|9610789
TP53	7157	Urogenital Neoplasms	MESH:D014565	marker/mechanism		NA		17300232
TP53	7157	Urologic Neoplasms	MESH:D014571	marker/mechanism		NA		22071594
TP53	7157	Vulvar Lichen Sclerosus	MESH:D007724	marker/mechanism		NA		17300232
TP53	7157	Wilms Tumor	MESH:D009396	marker/mechanism		NA		28825729
TP53BP1	7158	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		30705370
TP53BP1	7158	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		30705370
TP53BP1	7158	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		30705370
TP53BP1	7158	Glioblastoma	MESH:D005909	marker/mechanism		NA		30705370
TP53BP1	7158	Lymphatic Metastasis	MESH:D008207	marker/mechanism		NA		30705370
TP53BP1	7158	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		30705370
TP53BP2	7159	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		28650484
TP53BP2	7159	Carcinoma, Lobular	MESH:D018275	marker/mechanism		NA		28650484
TP53BP2	7159	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		28650484
TP53I3	9540	Carcinoma	MESH:D002277	marker/mechanism		NA		21489049
TP53I3	9540	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		21489049
TP53RK	112858	Galloway Mowat syndrome	MESH:C537548	marker/mechanism		NA		28805828
TP53TG1	11257	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17892325
TP63	8626	Abnormalities, Multiple	MESH:D000015	marker/mechanism		NA		21466819
TP63	8626	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		20871597
TP63	8626	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		24880342
TP63	8626	Breast Diseases	MESH:D001941	marker/mechanism		NA		11462173
TP63	8626	Carcinoma	MESH:D002277	marker/mechanism		NA		23271742
TP63	8626	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		21527555
TP63	8626	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22011395
TP63	8626	Cleft Lip	MESH:D002971	marker/mechanism		NA		16688749
TP63	8626	Cleft Palate	MESH:D002972	marker/mechanism		NA		11462173
TP63	8626	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		15875781
TP63	8626	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		10227294
TP63	8626	Ectrodactyly-cleft lip-palate syndrome	MESH:C536189	marker/mechanism		NA		11462173
TP63	8626	Ectrodactyly, Ectodermal Dysplasia, and Cleft Lip-Palate Syndrome 3	MESH:C565799	marker/mechanism		NA	604292	12161593
TP63	8626	Female Urogenital Diseases	MESH:D052776	marker/mechanism		NA		16002989
TP63	8626	Foot Deformities, Congenital	MESH:D005532	marker/mechanism		NA		11462173
TP63	8626	Hand Deformities, Congenital	MESH:D006228	marker/mechanism		NA		11462173
TP63	8626	Hay-Wells syndrome	MESH:C535847	marker/mechanism		NA	106260	19239083|19676059
TP63	8626	Limb Deformities, Congenital	MESH:D017880	marker/mechanism		NA		10227294
TP63	8626	Limb-mammary syndrome	MESH:C535903	marker/mechanism		NA	603543	11462173
TP63	8626	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		20871597|21725308
TP63	8626	Nasopharyngeal Carcinoma	MESH:D000077274	marker/mechanism		NA		27543511
TP63	8626	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		15875781
TP63	8626	Neoplasms, Squamous Cell	MESH:D018307	marker/mechanism		NA		23271742
TP63	8626	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		21266360
TP63	8626	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		26098869
TP63	8626	Propping Zerres syndrome	MESH:C538052	marker/mechanism		NA	103285	
TP63	8626	Rapp-Hodgkin syndrome	MESH:C535289	marker/mechanism		NA	129400	15748593|19239083|19676059
TP63	8626	Skin Abnormalities	MESH:D012868	marker/mechanism		NA		10227294
TP63	8626	Split-Hand-Foot Malformation 4	MESH:C565344	marker/mechanism		NA	605289	16688749
TP63	8626	Sweat Gland Neoplasms	MESH:D013544	marker/mechanism		NA		20740144
TP73	7161	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		28212736
TP73	7161	Inflammation	MESH:D007249	marker/mechanism		NA		28212736
TP73	7161	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		26437031
TP73	7161	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		28212736
TP73	7161	Rhabdomyosarcoma, Alveolar	MESH:D018232	marker/mechanism		NA		21245298
TP73-AS1	57212	Oligodendroglioma	MESH:D009837	marker/mechanism		NA		20477830
TPBG	7162	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
TPCN1	53373	Oligospermia	MESH:D009845	marker/mechanism		NA		24451262
TPD52	7163	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		27415467
TPD52	7163	Prostatic Neoplasms	MESH:D011471	marker/mechanism|therapeutic		NA		17875733|27415467
TPD52L1	7164	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
TPH1	7166	Hypertension, Pulmonary	MESH:D006976	marker/mechanism		NA		18506000
TPH1	7166	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		28321044
TPH1	7166	Schizophrenia	MESH:D012559	marker/mechanism		NA		18583979
TPH2	121278	Attention Deficit Disorder with Hyperactivity	MESH:D001289	marker/mechanism		NA	613003	
TPH2	121278	Autistic Disorder	MESH:D001321	marker/mechanism		NA		15768392
TPH2	121278	Depressive Disorder	MESH:D003866	marker/mechanism		NA		17950541
TPH2	121278	Depressive Disorder, Major	MESH:D003865	marker/mechanism		NA	608516	
TPH2	121278	Fever	MESH:D005334	marker/mechanism		NA		20722968
TPI	43582	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
TPI	43582	Clinical Deterioration	MESH:D000075902	marker/mechanism		NA		27602772
TPI1	7167	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
TPI1	7167	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		19374891
TPI1	7167	Anemia, Hemolytic	MESH:D000743	marker/mechanism		NA		2876430
TPI1	7167	Anemia, Hemolytic, Congenital Nonspherocytic	MESH:D000746	marker/mechanism		NA		8503454
TPI1	7167	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		15274141
TPI1	7167	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
TPI1	7167	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
TPI1	7167	Metabolism, Inborn Errors	MESH:D008661	marker/mechanism		NA		2876430|8503454
TPI1	7167	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		15274141
TPI1	7167	Neuromuscular Diseases	MESH:D009468	marker/mechanism		NA		8503454
TPI1	7167	Neuromuscular Manifestations	MESH:D020879	marker/mechanism		NA		2876430|8503454
TPI1	7167	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
TPI1	7167	Triosephosphate Isomerase Deficiency	MESH:C566029	marker/mechanism		NA	615512	
TPK1	27010	THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	OMIM:614458	marker/mechanism		NA	614458	
TPM1	7168	Cardiomyopathy, Dilated, 1y	MESH:C567507	marker/mechanism		NA	611878	
TPM1	7168	Cardiomyopathy, Familial Hypertrophic, 3	MESH:C566170	marker/mechanism		NA	115196	
TPM1	7168	Cardiomyopathy, Hypertrophic, Familial	MESH:D024741	marker/mechanism		NA		9241277
TPM1	7168	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		15986332
TPM1	7168	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
TPM1	7168	Hypertension	MESH:D006973	marker/mechanism		NA		22228705
TPM1	7168	Keloid	MESH:D007627	marker/mechanism		NA		20128793
TPM1	7168	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TPM2	7169	ARTHROGRYPOSIS, DISTAL, TYPE 1A	OMIM:108120	marker/mechanism		NA	108120	
TPM2	7169	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
TPM2	7169	Myopathies, Structural, Congenital	MESH:D020914	marker/mechanism		NA	255310	
TPM2	7169	Nemaline myopathy 4	MESH:C538351	marker/mechanism		NA	609285	
TPM3	7170	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		15378696
TPM3	7170	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462|16316942
TPM3	7170	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		19369484
TPM3	7170	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TPM3	7170	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462|16316942
TPM3	7170	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462|16316942
TPM3	7170	Myopathies, Structural, Congenital	MESH:D020914	marker/mechanism		NA	255310	
TPM3	7170	Nemaline myopathy 1	MESH:C538348	marker/mechanism		NA	609284	
TPM3	7170	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		15378696
TPM3	7170	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		23811263
TPM4	7171	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		21751358
TPM4	7171	Asbestosis	MESH:D001195	marker/mechanism		NA		22537621
TPM4	7171	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		15986332
TPM4	7171	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TPM4	7171	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17085005
TPM4	7171	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
TPM4	7171	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		15986332
TPM4	7171	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
TPMT	7172	HEARING LOSS, CISPLATIN-INDUCED, SUSCEPTIBILITY TO	OMIM:613290	marker/mechanism		NA		19898482
TPMT	7172	Leukopenia	MESH:D007970	marker/mechanism		NA		18662289|22535280|25108385
TPMT	7172	Neutropenia	MESH:D009503	marker/mechanism		NA		18662289
TPMT	7172	Thiopurine S methyltranferase deficiency	MESH:C536512	marker/mechanism		NA	610460	
TPO	7173	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		27869686
TPO	7173	Congenital Hypothyroidism	MESH:D003409	marker/mechanism		NA		12564727|14751036|16187919|17381485
TPO	7173	Goiter	MESH:D006042	marker/mechanism		NA		12564727|14751036|17547680
TPO	7173	Thyroid Dyshormonogenesis 2A	MESH:C563206	marker/mechanism		NA	274500	
TPP1	1200	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		10320038
TPP1	1200	Ceroid Lipofuscinosis, Neuronal, 2	MESH:C566857	marker/mechanism		NA	204500	
TPP1	1200	Neuronal Ceroid-Lipofuscinoses	MESH:D009472	marker/mechanism		NA		10320038|11589009
TPP1	1200	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
TPP1	1200	Spinocerebellar Ataxia, Autosomal Recessive 7	MESH:C563753	marker/mechanism		NA	609270	
TPR	7175	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		23811263
TPRKB	51002	Galloway Mowat syndrome	MESH:C537548	marker/mechanism		NA		28805828
TPRN	286262	Deafness, Autosomal Recessive 79	MESH:C567651	marker/mechanism		NA	613307	
TPSAB1	7177	Connective Tissue Diseases	MESH:D003240	marker/mechanism		NA		27749843
TPSAB1	7177	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
TPSAB1	7177	Flushing	MESH:D005483	marker/mechanism		NA		27749843
TPSAB1	7177	Irritable Bowel Syndrome	MESH:D043183	marker/mechanism		NA		27749843
TPSAB1	7177	Primary Dysautonomias	MESH:D054969	marker/mechanism		NA		27749843
TPSAB1	7177	Pruritus	MESH:D011537	marker/mechanism		NA		27749843
TPSB2	64499	Keloid	MESH:D007627	marker/mechanism		NA		20128793
TPT1	7178	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		28321044
TPT1	7178	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
TPX2	22974	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
TRA	6955	Narcolepsy	MESH:D009290	marker/mechanism		NA		19412176
TRA2A	29896	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
TRA2A	29896	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
TRA2B	6434	Supranuclear Palsy, Progressive	MESH:D013494	marker/mechanism		NA		25402454
TRAC	28755	T-CELL RECEPTOR-ALPHA/BETA DEFICIENCY	OMIM:615387	marker/mechanism		NA	615387	
TRAF1	7185	Abortion, Spontaneous	MESH:D000022	marker/mechanism		NA		18539642
TRAF1	7185	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		18794853|23143596
TRAF1	7185	Ductus Arteriosus, Patent	MESH:D004374	marker/mechanism		NA		19336370
TRAF1	7185	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
TRAF3	7187	Encephalitis, Herpes Simplex	MESH:D020803	marker/mechanism		NA	614849	
TRAF3IP2	10758	Arthritis, Psoriatic	MESH:D015535	marker/mechanism		NA		20953186|20953188
TRAF3IP2	10758	CANDIDIASIS, FAMILIAL, 8	OMIM:615527	marker/mechanism		NA	615527	
TRAF3IP2	10758	Psoriasis	MESH:D011565	marker/mechanism		NA	614070	20953186|20953188|20953190
TRAF4	9618	Brain Injuries	MESH:D001930	marker/mechanism		NA		23159883
TRAF6	7189	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		20453842|23143596
TRAF6	7189	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		20524934
TRAF7	84231	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		26928227
TRAFD1	10906	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TRAIP	10293	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
TRAIP	10293	Dwarfism	MESH:D004392	marker/mechanism		NA		26595769
TRAIP	10293	Microcephaly	MESH:D008831	marker/mechanism		NA		26595769
TRAK1	22906	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
TRAK2	66008	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TRANK1	9881	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		31043756
TRAP1	10131	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
TRAP1	10131	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
TRAP1	10131	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
TRAPPC10	7109	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
TRAPPC10	7109	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
TRAPPC11	60684	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18	OMIM:615356	marker/mechanism		NA	615356	
TRAPPC2	6399	Osteochondrodysplasias	MESH:D010009	marker/mechanism		NA	313400	
TRAPPC9	83696	Mental Retardation, Autosomal Recessive 13	MESH:C567714	marker/mechanism		NA	613192	
TRDN	10345	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
TRDN	10345	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY	OMIM:604772	marker/mechanism		NA	604772	
TRDN	10345	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 5, WITH OR WITHOUT MUSCLE WEAKNESS	OMIM:615441	marker/mechanism		NA	615441	
TREH	11181	Trehalase Deficiency	MESH:C562603	marker/mechanism		NA	612119	
TREM	42392	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy	MESH:C536329	marker/mechanism		NA		17430113
TREM1	54210	Liver Diseases	MESH:D008107	marker/mechanism		NA		12651611
TREM2	54209	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		24663666|28714976
TREM2	54209	Dementia	MESH:D003704	marker/mechanism		NA		18546367
TREML1	340205	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
TRERF1	55809	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19075277
TREX1	11277	Aicardi-Goutieres syndrome	MESH:C535607	marker/mechanism		NA	225750	16845398
TREX1	11277	Brain Diseases	MESH:D001927	marker/mechanism		NA		16845398
TREX1	11277	Chilblain lupus 1	MESH:C535924	marker/mechanism		NA	610448	27566796
TREX1	11277	Inflammation	MESH:D007249	marker/mechanism		NA		16845398
TREX1	11277	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
TREX1	11277	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA	152700	17660818
TREX1	11277	Vasculopathy, Retinal, With Cerebral Leukodystrophy	MESH:C566007	marker/mechanism		NA	192315	17660820
TRF	22041	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		15650968
TRH	7200	Amnesia	MESH:D000647	therapeutic		NA		7562510|7617693|8405091
TRH	7200	Arrhythmias, Cardiac	MESH:D001145	marker/mechanism		NA		6813757
TRH	7200	Bradycardia	MESH:D001919	therapeutic		NA		6350720|6813757
TRH	7200	Catalepsy	MESH:D002375	therapeutic		NA		2547386
TRH	7200	Coma, Post-Head Injury	MESH:D020207	therapeutic		NA		8690305
TRH	7200	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
TRH	7200	Hypertension	MESH:D006973	marker/mechanism		NA		6350720
TRH	7200	Hypothermia	MESH:D007035	marker/mechanism		NA		6350720
TRH	7200	Learning Disabilities	MESH:D007859	therapeutic		NA		8405091
TRH	7200	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		18206229
TRH	7200	Narcolepsy	MESH:D009290	marker/mechanism		NA		2845442
TRH	7200	Pain	MESH:D010146	therapeutic		NA		6409194
TRH	7200	Respiratory Insufficiency	MESH:D012131	therapeutic		NA		1305443|1833029
TRH	7200	Seizures	MESH:D012640	marker/mechanism		NA		10443546|15781040
TRH	7200	Stereotypic Movement Disorder	MESH:D019956	marker/mechanism		NA		8736133
TRH	7200	Stupor	MESH:D053608	therapeutic		NA		416961|8690305
TRH	7200	Tachycardia	MESH:D013610	marker/mechanism		NA		6350720
TRH	7200	THYROTROPIN-RELEASING HORMONE DEFICIENCY	OMIM:275120	marker/mechanism		NA	275120	
TRH	7200	Tremor	MESH:D014202	marker/mechanism|therapeutic		NA		103733|416961
TRH	7200	Unconsciousness	MESH:D014474	therapeutic		NA		6281507
TRHR	7201	Hypothyroidism	MESH:D007037	marker/mechanism		NA		9141550
TRHR	7201	Thyroid Hormone Resistance Syndrome	MESH:D018382	marker/mechanism		NA		9141550
TRIB1	10221	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		24097064
TRIB3	57761	Insulin Resistance	MESH:D007333	marker/mechanism		NA		20461355
TRIB3	57761	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TRIB3	57761	Metabolic Syndrome	MESH:D024821	marker/mechanism		NA		18497449
TRIB3	57761	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		29289645
TRIM10	10107	Dermatitis, Irritant	MESH:D017453	marker/mechanism		NA		27258892
TRIM12A	76681	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25330770
TRIM2	23321	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R	OMIM:615490	marker/mechanism		NA	615490	
TRIM2	23321	Osteoarthritis	MESH:D010003	marker/mechanism		NA		17568789
TRIM22	10346	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
TRIM24	8805	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		18026104
TRIM24	8805	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TRIM24	8805	Prostatic Neoplasms, Castration-Resistant	MESH:D064129	marker/mechanism		NA		27238081
TRIM28	10155	Atherosclerosis	MESH:D050197	marker/mechanism		NA		31351049
TRIM28	10155	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		30510241
TRIM29	23650	Glioma	MESH:D005910	marker/mechanism		NA		30929997
TRIM31	11074	Dermatitis, Irritant	MESH:D017453	marker/mechanism		NA		27258892
TRIM32	22954	Bardet-Biedl Syndrome 11	MESH:C565920	marker/mechanism		NA	615988	
TRIM32	22954	Limb-girdle muscular dystrophy type 2H	MESH:C535897	marker/mechanism		NA	254110	
TRIM36	55521	Anencephaly	MESH:D000757	marker/mechanism		NA	206500	
TRIM37	4591	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		14757854
TRIM37	4591	Fibrous Dysplasia of Bone	MESH:D005357	marker/mechanism		NA		14757854
TRIM37	4591	Hepatomegaly	MESH:D006529	marker/mechanism		NA		14757854
TRIM37	4591	Mulibrey Nanism	MESH:D050336	marker/mechanism		NA	253250	14757854
TRIM40	135644	Dermatitis, Irritant	MESH:D017453	marker/mechanism		NA		27258892
TRIM44	54765	Aniridia	MESH:D015783	marker/mechanism		NA	617142	
TRIM47	91107	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		31981573
TRIM47	91107	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		31981573
TRIM47	91107	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		31981573
TRIM5	85363	HIV Infections	MESH:D015658	therapeutic		NA		15249687
TRIM59	286827	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TRIM63	84676	Atrophy	MESH:D001284	marker/mechanism		NA		19168726
TRIM63	84676	Cardiomegaly	MESH:D006332	therapeutic		NA		19168726
TRIM63	84676	Cardiomyopathies	MESH:D009202	therapeutic		NA		19168726
TRIM63	84676	Muscular Atrophy	MESH:D009133	marker/mechanism		NA		21139329
TRIO	7204	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 44, WITH MICROCEPHALY	OMIM:617061	marker/mechanism		NA	617061	
TRIO	7204	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		18206229
TRIO	7204	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
TRIO	7204	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
TRIO	7204	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		19233941
TRIOBP	11078	Deafness, Autosomal Recessive 28	MESH:C565218	marker/mechanism		NA	609823	
TRIP11	9321	Achondrogenesis type 1A	MESH:C536015	marker/mechanism		NA	200600	
TRIP12	9320	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
TRIP13	9319	Aneuploidy	MESH:D000782	marker/mechanism		NA		28553959
TRIP13	9319	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
TRIP13	9319	Mosaic variegated aneuploidy syndrome	MESH:C536987	marker/mechanism		NA		28553959
TRIP13	9319	Neoplasms, Germ Cell and Embryonal	MESH:D009373	marker/mechanism		NA		28553959
TRIP13	9319	Wilms Tumor	MESH:D009396	marker/mechanism		NA		28553959
TRIP4	9325	MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE	OMIM:617066	marker/mechanism		NA	617066	
TRIP4	9325	SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1	OMIM:616866	marker/mechanism		NA	616866	
TRIT1	54802	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21472284
TRMT1	55621	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
TRMT10A	93587	MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1	OMIM:616033	marker/mechanism		NA	616033	
TRMT10C	54931	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	OMIM:616974	marker/mechanism		NA	616974	
TRMT11	60487	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		30705370
TRMT11	60487	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		30705370
TRMT11	60487	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		30705370
TRMT11	60487	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		30705370
TRMT11	60487	Glioblastoma	MESH:D005909	marker/mechanism		NA		30705370
TRMT11	60487	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		30705370
TRMT11	60487	Lymphatic Metastasis	MESH:D008207	marker/mechanism		NA		30705370
TRMT11	60487	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		30705370
TRMT5	57570	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26	OMIM:616539	marker/mechanism		NA	616539	
TRMU	55687	Deafness, Aminoglycoside-Induced	MESH:C564013	marker/mechanism		NA	580000	
TRMU	55687	LIVER FAILURE, INFANTILE, TRANSIENT	OMIM:613070	marker/mechanism		NA	613070	
TRNC	4511	MELAS Syndrome	MESH:D017241	marker/mechanism		NA	540000	
TRNF	4558	MELAS Syndrome	MESH:D017241	marker/mechanism		NA	540000	
TRNF	4558	MERRF Syndrome	MESH:D017243	marker/mechanism		NA	545000	
TRNI	4565	MERRF Syndrome	MESH:D017243	marker/mechanism		NA	545000	
TRNK	4566	MELAS Syndrome	MESH:D017241	marker/mechanism		NA	540000	
TRNK	4566	MERRF Syndrome	MESH:D017243	marker/mechanism		NA	545000	
TRNL1	4567	Acidosis, Lactic	MESH:D000140	marker/mechanism		NA		17018649
TRNL1	4567	MELAS Syndrome	MESH:D017241	marker/mechanism		NA	540000	17018649|19027590
TRNL1	4567	MERRF Syndrome	MESH:D017243	marker/mechanism		NA	545000	
TRNL1	4567	Mitochondrial Encephalomyopathies	MESH:D017237	marker/mechanism		NA		17018649
TRNL1	4567	Noninsulin-dependent diabetes mellitus with deafness	MESH:C536246	marker/mechanism		NA		17018649
TRNN	4570	Cytochrome-c Oxidase Deficiency	MESH:D030401	marker/mechanism		NA	220110	
TRNP	4571	MERRF Syndrome	MESH:D017243	marker/mechanism		NA	545000	
TRNQ	4572	MELAS Syndrome	MESH:D017241	marker/mechanism		NA	540000	
TRNS1	4574	Cytochrome-c Oxidase Deficiency	MESH:D030401	marker/mechanism		NA	220110	
TRNS1	4574	Deafness, Aminoglycoside-Induced	MESH:C564013	marker/mechanism		NA	580000	
TRNS1	4574	Deafness, Sensorineural, Autosomal-Mitochondrial Type	MESH:C565637	marker/mechanism		NA	500008	
TRNS1	4574	MELAS Syndrome	MESH:D017241	marker/mechanism		NA	540000	17894844
TRNS2	4575	MELAS Syndrome	MESH:D017241	marker/mechanism		NA	540000	
TRNT	4576	Myopathy, Mitochondrial, Lethal Infantile	MESH:C564017	marker/mechanism		NA	551000	
TRNT	4576	Parkinson Disease, Mitochondrial	MESH:C564015	marker/mechanism		NA	556500	
TRNT1	51095	RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS	OMIM:616959	marker/mechanism		NA	616959	
TRNV	4577	MELAS Syndrome	MESH:D017241	marker/mechanism		NA	540000	
TRNW	4578	MELAS Syndrome	MESH:D017241	marker/mechanism		NA	540000	
TRNW	4578	Mitochondrial Myopathies	MESH:D017240	marker/mechanism		NA	251900	
TROAP	10024	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
TRP53	22059	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		16247444|7955072
TRP53	22059	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		26206333
TRP53	22059	Aortic Valve, Calcification of	MESH:C562942	marker/mechanism		NA		29358327
TRP53	22059	Astrocytoma	MESH:D001254	marker/mechanism		NA		20176786
TRP53	22059	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		9493073
TRP53	22059	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		16860786
TRP53	22059	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		12165863
TRP53	22059	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		16651430|19919837
TRP53	22059	Carcinoma, Pancreatic Ductal	MESH:D021441	marker/mechanism		NA		29844410
TRP53	22059	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		16543248|19435901|25125259|27923803
TRP53	22059	Cardiomyopathies	MESH:D009202	marker/mechanism		NA		16013437
TRP53	22059	Cardiotoxicity	MESH:D066126	marker/mechanism		NA		30009776
TRP53	22059	Cecal Neoplasms	MESH:D002430	marker/mechanism		NA		14688030
TRP53	22059	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		22009531
TRP53	22059	Cholangiocarcinoma	MESH:D018281	marker/mechanism		NA		16818635
TRP53	22059	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		9493073
TRP53	22059	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		21078376
TRP53	22059	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		23873029
TRP53	22059	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		9369336
TRP53	22059	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		7955072
TRP53	22059	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		12706858
TRP53	22059	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		16543248
TRP53	22059	Glioma	MESH:D005910	marker/mechanism		NA		25119042
TRP53	22059	Heart Failure	MESH:D006333	marker/mechanism		NA		21284947
TRP53	22059	Hemangiosarcoma	MESH:D006394	marker/mechanism		NA		10930038|13678655|20737008
TRP53	22059	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		25822087
TRP53	22059	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		28100771
TRP53	22059	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		16247444|26390243
TRP53	22059	Lymphoma	MESH:D008223	marker/mechanism		NA		19258306
TRP53	22059	Lymphoma, T-Cell	MESH:D016399	marker/mechanism		NA		29438700
TRP53	22059	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		24809783
TRP53	22059	Mesothelioma	MESH:D008654	marker/mechanism		NA		12151629
TRP53	22059	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		19435901
TRP53	22059	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		24358288
TRP53	22059	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		22009531|23873029|27137931
TRP53	22059	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		12756225|27137931
TRP53	22059	Nerve Sheath Neoplasms	MESH:D018317	marker/mechanism		NA		20176786
TRP53	22059	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		9369336
TRP53	22059	Neuroblastoma	MESH:D009447	marker/mechanism		NA		15814359
TRP53	22059	Osteosarcoma	MESH:D012516	marker/mechanism		NA		27137931
TRP53	22059	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		23873029|26390243
TRP53	22059	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		21317887
TRP53	22059	Sarcoma	MESH:D012509	marker/mechanism		NA		19258306
TRP53	22059	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		22009531|27923803
TRP53	22059	Thymus Neoplasms	MESH:D013953	marker/mechanism		NA		10850423
TRP53	22059	Tongue Neoplasms	MESH:D014062	marker/mechanism		NA		16543248
TRP53	22059	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		11376694|12706858
TRP63	22061	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25739959
TRP63	22061	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		25739959
TRP63	22061	Prostatic Intraepithelial Neoplasia	MESH:D019048	marker/mechanism		NA		22581815
TRP63	22061	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		22581815
TRP73	22062	Nervous System Malformations	MESH:D009421	marker/mechanism		NA		24190996
TRP73	22062	Neurologic Manifestations	MESH:D009461	marker/mechanism		NA		24190996
TRPA1	8989	Asthma	MESH:D001249	marker/mechanism		NA		19458046
TRPA1	8989	Bronchial Hyperreactivity	MESH:D016535	marker/mechanism		NA		19458046
TRPA1	8989	Cough	MESH:D003371	marker/mechanism		NA		27545873
TRPA1	8989	EPISODIC PAIN SYNDROME, FAMILIAL, 1	OMIM:615040	marker/mechanism		NA	615040	
TRPA1	8989	Hyperalgesia	MESH:D006930	marker/mechanism		NA		18234885|21481532|23523557
TRPA1	8989	Inflammation	MESH:D007249	marker/mechanism		NA		20601631
TRPA1	8989	Pain	MESH:D010146	marker/mechanism		NA		20601631
TRPA1	8989	Sneezing	MESH:D012912	marker/mechanism		NA		27545873
TRPA1	8989	Urinary Bladder, Overactive	MESH:D053201	marker/mechanism|therapeutic		NA		21367919|23523557
TRPC1	7220	Cardiomegaly	MESH:D006332	marker/mechanism		NA		17174323
TRPC3	7222	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		23602965
TRPC3	7222	Hypertension	MESH:D006973	marker/mechanism		NA		17351372
TRPC3	7222	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA	616410	
TRPC5	7224	Hypertension	MESH:D006973	marker/mechanism		NA		17351372
TRPC6	7225	Disease Susceptibility	MESH:D004198	marker/mechanism		NA		20130021
TRPC6	7225	Focal Segmental Glomerulosclerosis 2	MESH:C565831	marker/mechanism		NA	603965	
TRPC6	7225	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA		26892346
TRPC6	7225	Hypertrophy	MESH:D006984	marker/mechanism		NA		20177073
TRPC6	7225	Mental Disorders	MESH:D001523	marker/mechanism		NA		21059368
TRPM1	4308	Night blindness, congenital stationary	MESH:C536122	marker/mechanism		NA	613216	
TRPM2	7226	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		23602965
TRPM2	7226	Parkinson Disease	MESH:D010300	marker/mechanism		NA		27957685
TRPM3	80036	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
TRPM4	54795	Progressive Familial Heart Block, Type Ib	MESH:C567037	marker/mechanism		NA	604559	
TRPM4	54795	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
TRPM6	140803	Hypomagnesemia 1, Intestinal	MESH:C566593	marker/mechanism		NA	602014	
TRPM7	54822	Adenoma	MESH:D000236	marker/mechanism		NA		17823441
TRPM7	54822	AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1	OMIM:105500	marker/mechanism		NA	105500	
TRPM7	54822	Colonic Polyps	MESH:D003111	marker/mechanism		NA		17823441
TRPM7	54822	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17823441
TRPM7	54822	Immune System Diseases	MESH:D007154	marker/mechanism		NA		30770447
TRPM7	54822	Infant Death	MESH:D066088	marker/mechanism		NA		30770447
TRPM7	54822	Kidney Calculi	MESH:D007669	marker/mechanism		NA		24291744
TRPM7	54822	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		25150141
TRPM7	54822	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		30710498
TRPM7	54822	Paralysis	MESH:D010243	marker/mechanism		NA		24291744
TRPM8	79054	Migraine Disorders	MESH:D008881	marker/mechanism		NA		21666692
TRPM8	79054	Migraine without Aura	MESH:D020326	marker/mechanism		NA		22683712
TRPS1	7227	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		19759027
TRPS1	7227	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
TRPS1	7227	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		11708946|19759027
TRPS1	7227	Langer-Giedion Syndrome	MESH:D015826	marker/mechanism		NA		11708946
TRPS1	7227	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
TRPS1	7227	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
TRPS1	7227	Trichorhinophalangeal Syndrome, Type I	MESH:C536820	marker/mechanism		NA	190350	
TRPS1	7227	Trichorhinophalangeal Syndrome, Type III	MESH:C566033	marker/mechanism		NA	190351	
TRPV1	7442	Atherosclerosis	MESH:D050197	marker/mechanism		NA		21908651
TRPV1	7442	Cough	MESH:D003371	marker/mechanism		NA		27545873
TRPV1	7442	Epilepsy, Temporal Lobe	MESH:D004833	marker/mechanism		NA		20144892
TRPV1	7442	Esophageal Diseases	MESH:D004935	marker/mechanism		NA		19566590
TRPV1	7442	Esophagitis	MESH:D004941	marker/mechanism		NA		16091555
TRPV1	7442	Heartburn	MESH:D006356	marker/mechanism		NA		19566590
TRPV1	7442	Hyperalgesia	MESH:D006930	marker/mechanism		NA		12151517|18234885|18774343|23006841
TRPV1	7442	Inflammation	MESH:D007249	marker/mechanism		NA		17575321|20712533
TRPV1	7442	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		17043671
TRPV1	7442	Neoplasms	MESH:D009369	marker/mechanism		NA		21349818
TRPV1	7442	Obesity	MESH:D009765	marker/mechanism		NA		17347480
TRPV1	7442	Pain	MESH:D010146	marker/mechanism|therapeutic		NA		16996476|17575321|20422007|23006841
TRPV1	7442	Pancreatitis	MESH:D010195	marker/mechanism		NA		17698068
TRPV1	7442	Sneezing	MESH:D012912	marker/mechanism		NA		27545873
TRPV1	7442	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		19502594
TRPV3	162514	PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTIC PLAQUES	OMIM:614594	marker/mechanism		NA	614594	
TRPV3	162514	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL 2	OMIM:616400	marker/mechanism		NA	616400	
TRPV4	59341	Bone Diseases	MESH:D001847	marker/mechanism		NA		21964574|22187434
TRPV4	59341	Brachyolmia Type 3	MESH:C562963	marker/mechanism		NA	113500	
TRPV4	59341	Charcot-Marie-Tooth Disease	MESH:D002607	marker/mechanism		NA		22187434
TRPV4	59341	Digital Arthropathy-Brachydactyly, Familial	MESH:C564656	marker/mechanism		NA	606835	
TRPV4	59341	Femur Head Necrosis	MESH:D005271	marker/mechanism		NA	617383	
TRPV4	59341	Hereditary Motor And Sensory Neuropathy, Type IIC	MESH:C565261	marker/mechanism		NA	606071	20037586|20037587|20037588
TRPV4	59341	Hyperalgesia	MESH:D006930	marker/mechanism		NA		18234883
TRPV4	59341	Hyponatremia	MESH:D007010	marker/mechanism		NA		19666518
TRPV4	59341	Metatropic dwarfism	MESH:C537356	marker/mechanism		NA	156530	20425821
TRPV4	59341	Muscular Atrophy, Spinal	MESH:D009134	marker/mechanism		NA		22187434
TRPV4	59341	Osteoarthritis	MESH:D010003	marker/mechanism		NA		21964574
TRPV4	59341	Osteochondrodysplasias	MESH:D010009	marker/mechanism		NA		18587396
TRPV4	59341	Parastremmatic dwarfism	MESH:C537172	marker/mechanism		NA	168400	
TRPV4	59341	Pulmonary Disease, Chronic Obstructive	MESH:D029424	marker/mechanism		NA		21245013
TRPV4	59341	SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY	OMIM:181405	marker/mechanism		NA	181405	20037587|20037588
TRPV4	59341	SODIUM SERUM LEVEL QUANTITATIVE TRAIT LOCUS 1	OMIM:613508	marker/mechanism		NA	613508	
TRPV4	59341	Spinal Muscular Atrophy, Distal, Congenital Nonprogressive	MESH:C563981	marker/mechanism		NA	600175	20037588
TRPV4	59341	SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE	OMIM:184095	marker/mechanism		NA	184095	
TRPV4	59341	Spondylometaphyseal dysplasia, Kozlowski type	MESH:C535797	marker/mechanism		NA	184252	
TRPV4	59341	Urination Disorders	MESH:D014555	marker/mechanism		NA		20956320
TRPV6	55503	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
TRRAP	8295	Melanoma	MESH:D008545	marker/mechanism		NA		21499247
TRRAP	8295	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266|23042115
TSC1	7248	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18067135
TSC1	7248	Brain Diseases	MESH:D001927	marker/mechanism		NA		21062901
TSC1	7248	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21499249
TSC1	7248	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		22138691
TSC1	7248	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		18538015
TSC1	7248	Cognition Disorders	MESH:D003072	marker/mechanism		NA		18067135
TSC1	7248	Epilepsy	MESH:D004827	marker/mechanism		NA		12112044|21062901
TSC1	7248	Focal cortical dysplasia of Taylor	MESH:C537067	marker/mechanism		NA	607341	12112044|28215400
TSC1	7248	Lymphangioleiomyomatosis	MESH:D018192	marker/mechanism		NA	606690	32078667
TSC1	7248	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		18538015
TSC1	7248	Myoclonic Epilepsies, Progressive	MESH:D020191	marker/mechanism		NA		17484760
TSC1	7248	Seizures	MESH:D012640	marker/mechanism		NA		28215400
TSC1	7248	Spasms, Infantile	MESH:D013036	marker/mechanism		NA		18345974
TSC1	7248	Tuberous Sclerosis	MESH:D014402	marker/mechanism		NA		18345974|21062901|21345208
TSC1	7248	Tuberous Sclerosis 1	MESH:C565346	marker/mechanism		NA	191100	
TSC2	7249	Autistic Disorder	MESH:D001321	marker/mechanism		NA		14627686
TSC2	7249	Brain Diseases	MESH:D001927	marker/mechanism		NA		21062901
TSC2	7249	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		18538015
TSC2	7249	Epilepsy	MESH:D004827	marker/mechanism		NA		21062901
TSC2	7249	Focal cortical dysplasia of Taylor	MESH:C537067	marker/mechanism		NA	607341	28215400
TSC2	7249	Inflammation	MESH:D007249	marker/mechanism		NA		26297436
TSC2	7249	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		11170505|12110509|21693435
TSC2	7249	Leiomyoma	MESH:D007889	marker/mechanism		NA		15937110
TSC2	7249	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		19250671
TSC2	7249	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		30008631
TSC2	7249	Lymphangioleiomyomatosis	MESH:D018192	marker/mechanism		NA	606690	32078667
TSC2	7249	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		18538015
TSC2	7249	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		21419848
TSC2	7249	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		19917848
TSC2	7249	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		26297436
TSC2	7249	Seizures	MESH:D012640	marker/mechanism		NA		21062901|28215400
TSC2	7249	Spasms, Infantile	MESH:D013036	marker/mechanism		NA		18345974
TSC2	7249	Tuberous Sclerosis	MESH:D014402	marker/mechanism		NA		10732801|18345974|21062901|21345208
TSC2	7249	Tuberous Sclerosis 2	MESH:C566021	marker/mechanism		NA	613254	10732801
TSC22D1	8848	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
TSC22D1	8848	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		15089088
TSC22D1	8848	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TSC22D1	8848	Liver Neoplasms, Experimental	MESH:D008114	marker/mechanism		NA		15833021|17533171
TSC22D1	8848	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
TSC22D1	8848	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
TSC22D3	1831	Hyperinsulinism	MESH:D006946	marker/mechanism		NA		22556341
TSC22D3	1831	Infertility, Male	MESH:D007248	marker/mechanism		NA		22556341
TSC22D3	1831	Testicular Diseases	MESH:D013733	marker/mechanism		NA		22556341
TSC22D3	1831	Weight Loss	MESH:D015431	marker/mechanism		NA		22556341
TSEN15	116461	PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	OMIM:617026	marker/mechanism		NA	617026	
TSEN2	80746	Deglutition Disorders	MESH:D003680	marker/mechanism		NA		18711368
TSEN2	80746	Intellectual Disability	MESH:D008607	marker/mechanism		NA		18711368
TSEN2	80746	Microcephaly	MESH:D008831	marker/mechanism		NA		18711368
TSEN2	80746	Movement Disorders	MESH:D009069	marker/mechanism		NA		18711368
TSEN2	80746	Pontocerebellar Hypoplasia Type 2B	MESH:C567325	marker/mechanism		NA	612389	
TSEN2	80746	Vision Disorders	MESH:D014786	marker/mechanism		NA		18711368
TSEN2	80746	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
TSEN34	79042	Deglutition Disorders	MESH:D003680	marker/mechanism		NA		18711368
TSEN34	79042	Intellectual Disability	MESH:D008607	marker/mechanism		NA		18711368
TSEN34	79042	Microcephaly	MESH:D008831	marker/mechanism		NA		18711368
TSEN34	79042	Movement Disorders	MESH:D009069	marker/mechanism		NA		18711368
TSEN34	79042	Pontocerebellar Hypoplasia Type 2C	MESH:C567324	marker/mechanism		NA	612390	
TSEN34	79042	Vision Disorders	MESH:D014786	marker/mechanism		NA		18711368
TSEN54	283989	Deglutition Disorders	MESH:D003680	marker/mechanism		NA		18711368
TSEN54	283989	Intellectual Disability	MESH:D008607	marker/mechanism		NA		18711368
TSEN54	283989	Microcephaly	MESH:D008831	marker/mechanism		NA		18711368
TSEN54	283989	Movement Disorders	MESH:D009069	marker/mechanism		NA		18711368
TSEN54	283989	Pontocerebellar Hypoplasia Type 2A	MESH:C564738	marker/mechanism		NA	277470	
TSEN54	283989	PONTOCEREBELLAR HYPOPLASIA, TYPE 4	OMIM:225753	marker/mechanism		NA	225753	
TSEN54	283989	Vision Disorders	MESH:D014786	marker/mechanism		NA		18711368
TSFM	10102	Combined Oxidative Phosphorylation Deficiency 3	MESH:C566467	marker/mechanism		NA	610505	
TSHB	7252	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		6455462
TSHB	7252	Coma	MESH:D003128	marker/mechanism		NA		24729111
TSHB	7252	Hypothermia	MESH:D007035	marker/mechanism		NA		6350720
TSHB	7252	Hypothyroidism	MESH:D007037	marker/mechanism		NA		18031379|24729111
TSHB	7252	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	OMIM:275100	marker/mechanism		NA	275100	
TSHR	7253	Adenoma	MESH:D000236	marker/mechanism		NA		8413627
TSHR	7253	Adrenal Gland Neoplasms	MESH:D000310	marker/mechanism		NA		19131502
TSHR	7253	Carcinoma	MESH:D002277	marker/mechanism		NA		9062474
TSHR	7253	Congenital Hypothyroidism	MESH:D003409	marker/mechanism		NA		12629076
TSHR	7253	Graves Disease	MESH:D006111	marker/mechanism		NA		1955520|21841780
TSHR	7253	Graves Ophthalmopathy	MESH:D049970	marker/mechanism		NA		31705858
TSHR	7253	Hyperthyroidism	MESH:D006980	marker/mechanism		NA		7800007|8413627|8964822
TSHR	7253	Hyperthyroidism, Familial Gestational	MESH:C566384	marker/mechanism		NA	603373	
TSHR	7253	Hyperthyroidism, Nonautoimmune	MESH:C563786	marker/mechanism		NA	609152	
TSHR	7253	Hypothyroidism, Congenital, Nongoitrous, 1	MESH:C576976	marker/mechanism		NA	275200	
TSHR	7253	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		9062474
TSHR	7253	Lymphatic Metastasis	MESH:D008207	marker/mechanism		NA		9062474
TSHR	7253	Thyroiditis, Autoimmune	MESH:D013967	marker/mechanism		NA		17952073
TSHR	7253	Thyroid Neoplasms	MESH:D013964	marker/mechanism		NA		8413627|9062474
TSHR	7253	Thyrotoxicosis	MESH:D013971	marker/mechanism		NA		9062474
TSHZ1	10194	Aural Atresia, Congenital	MESH:C564321	marker/mechanism		NA	607842	
TSHZ1	10194	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
TSHZ3	57616	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		27668656
TSLP	85480	Albuminuria	MESH:D000419	marker/mechanism		NA		17686814
TSLP	85480	Asthma	MESH:D001249	marker/mechanism		NA		21804549
TSLP	85480	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
TSLP	85480	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		16880407|22355542|23688403|27869817
TSLP	85480	Eosinophilic Esophagitis	MESH:D057765	marker/mechanism		NA		20208534
TSLP	85480	Glomerulonephritis, Membranoproliferative	MESH:D015432	marker/mechanism		NA		17686814
TSLP	85480	Inflammation	MESH:D007249	therapeutic		NA		28329851
TSLP	85480	Respiratory Hypersensitivity	MESH:D012130	therapeutic		NA		28329851
TSPAN12	23554	Disease Susceptibility	MESH:D004198	marker/mechanism		NA		20130021
TSPAN12	23554	Exudative Vitreoretinopathy 5	MESH:C567648	marker/mechanism		NA	613310	
TSPAN18	90139	Schizophrenia	MESH:D012559	marker/mechanism		NA		22037552
TSPAN2	10100	Stroke	MESH:D020521	marker/mechanism		NA		29531354
TSPAN7	7102	Mental Retardation, X-Linked 58	MESH:C564566	marker/mechanism		NA	300210	
TSPAN8	7103	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TSPAN8	7103	Respiratory Distress Syndrome, Adult	MESH:D012128	marker/mechanism		NA		25070658
TSPEAR	54084	DEAFNESS, AUTOSOMAL RECESSIVE 98	OMIM:614861	marker/mechanism		NA	614861	
TSPO	706	End Stage Liver Disease	MESH:D058625	marker/mechanism		NA		15025246
TSPO	706	Hepatic Encephalopathy	MESH:D006501	marker/mechanism		NA		10206825|10564534
TSPO	706	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TSPYL1	7259	Sudden Infant Death with Dysgenesis of the Testes Syndrome	MESH:C563856	marker/mechanism		NA	608800	
TSPYL2	64061	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		23104009
TSPYL4	23270	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
TSR2	90121	DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS	OMIM:300946	marker/mechanism		NA	300946	
TSSK1	22114	Autoimmune Diseases	MESH:D001327	marker/mechanism		NA		15140057
TST	7263	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21472284
TST	7263	Colitis	MESH:D003092	marker/mechanism		NA		19647029
TST	7263	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
TSTD3	100130890	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TTBK2	146057	Spinocerebellar Ataxia 11	MESH:C565772	marker/mechanism		NA	604432	
TTBK2	146057	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA		18037885
TTC19	54902	Gait Disorders, Neurologic	MESH:D020233	marker/mechanism		NA		21278747
TTC19	54902	Infertility	MESH:D007246	marker/mechanism		NA		21278747
TTC19	54902	Mitochondrial Complex III Deficiency	MESH:C565128	marker/mechanism		NA	615157	21278747
TTC19	54902	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		21278747
TTC19	54902	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		21278747
TTC21B	79809	Jeune syndrome	MESH:C537571	marker/mechanism		NA		21258341
TTC21B	79809	Kidney Diseases	MESH:D007674	marker/mechanism		NA		21258341
TTC21B	79809	NEPHRONOPHTHISIS 12	OMIM:613820	marker/mechanism		NA	613820	
TTC21B	79809	Short Rib-Polydactyly Syndrome	MESH:D012779	marker/mechanism		NA	613819	
TTC21B	79809	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
TTC28	23331	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
TTC36	143941	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
TTC36	143941	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TTC37	9652	Trichohepatoenteric Syndrome	MESH:C565627	marker/mechanism		NA	222470	
TTC39A	22996	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		17114358
TTC7A	57217	Intestinal Atresia, Multiple	MESH:C562441	marker/mechanism		NA	243150	
TTC8	123016	Bardet-Biedl Syndrome 8	MESH:C565917	marker/mechanism		NA	615985	
TTC8	123016	RETINITIS PIGMENTOSA 51	OMIM:613464	marker/mechanism		NA	613464	
TTC9	23508	Opioid-Related Disorders	MESH:D009293	marker/mechanism		NA		18438686
TTC9C	283237	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
TTF1	7270	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		25851810
TTI2	80185	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
TTI2	80185	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39	OMIM:615541	marker/mechanism		NA	615541	
TTK	7272	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
TTK	7272	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
TTLL5	23093	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
TTLL5	23093	CONE-ROD DYSTROPHY 19	OMIM:615860	marker/mechanism		NA	615860	
TTLL9	164395	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
TTLL9	164395	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
TTLL9	164395	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		19233941
TTN	7273	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
TTN	7273	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		11846417|17444505|27869827
TTN	7273	Cardiomyopathy, Dilated, 1g	MESH:C565824	marker/mechanism		NA	604145	
TTN	7273	Cardiomyopathy, Familial Hypertrophic, 9	MESH:C566044	marker/mechanism		NA	613765	10462489|22335739
TTN	7273	Distal Myopathies	MESH:D049310	marker/mechanism		NA	600334	12145747
TTN	7273	Familial dilated cardiomyopathy	MESH:C536231	marker/mechanism		NA		11788824
TTN	7273	Hereditary Myopathy with Early Respiratory Failure	MESH:C566343	marker/mechanism		NA	603689	
TTN	7273	Muscle Weakness	MESH:D018908	marker/mechanism		NA		17444505
TTN	7273	Muscular Diseases	MESH:D009135	marker/mechanism		NA		15802564
TTN	7273	Muscular Dystrophy, Limb-Girdle, Type 2J	MESH:C563854	marker/mechanism		NA	608807	
TTN	7273	Myopathy, Early-Onset, with Fatal Cardiomyopathy	MESH:C567129	marker/mechanism		NA	611705	
TTN-AS1	100506866	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
TTPA	7274	Ataxia with vitamin E deficiency	MESH:C535393	marker/mechanism		NA	277460	10896705|11752462|12470185|15300460|18458655|19566498
TTPA	7274	Atherosclerosis	MESH:D050197	marker/mechanism		NA		11095717
TTPA	7274	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		11095717|11752462
TTPA	7274	Hearing Disorders	MESH:D006311	marker/mechanism		NA		10896705
TTPA	7274	Muscular Atrophy	MESH:D009133	marker/mechanism		NA		10896705
TTPA	7274	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		11752462
TTPA	7274	Reflex, Abnormal	MESH:D012021	marker/mechanism		NA		10896705
TTPA	7274	Retinal Diseases	MESH:D012164	marker/mechanism		NA		11752462
TTPA	7274	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA		10896705
TTPA	7274	Somatosensory Disorders	MESH:D020886	marker/mechanism		NA		10896705
TTPA	7274	Speech Disorders	MESH:D013064	marker/mechanism		NA		10896705
TTPA	7274	Urination Disorders	MESH:D014555	marker/mechanism		NA		10896705
TTPA	7274	Vision Disorders	MESH:D014786	marker/mechanism		NA		10896705
TTPA	7274	Vitamin E Deficiency	MESH:D014811	marker/mechanism		NA		11095717
TTR	7276	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		28885000
TTR	7276	Amyloid Neuropathies, Familial	MESH:D028227	marker/mechanism		NA		10529370|12707074|15469931|20030258
TTR	7276	Amyloidosis	MESH:D000686	marker/mechanism		NA		25595224
TTR	7276	Amyloidosis, Familial	MESH:D028226	marker/mechanism		NA		17701470|18326041
TTR	7276	Amyloidosis, Hereditary, Transthyretin-Related	MESH:C567782	marker/mechanism		NA	105210	9717013
TTR	7276	Carpal Tunnel Syndrome	MESH:D002349	marker/mechanism		NA	115430	
TTR	7276	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		16099942
TTR	7276	Drug Eruptions	MESH:D003875	marker/mechanism		NA		21055120
TTR	7276	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		28885000
TTR	7276	Dystransthyretinemic Euthyroidal Hyperthyroxinemia	MESH:C567719	marker/mechanism		NA	145680	
TTR	7276	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17902193|19180532
TUB	7275	RETINAL DYSTROPHY AND OBESITY	OMIM:616188	marker/mechanism		NA	616188	
TUBA1A	7846	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
TUBA1A	7846	Lissencephaly 3	MESH:C566908	marker/mechanism		NA	611603	
TUBA1A	7846	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
TUBA1B	10376	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
TUBA1C	84790	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		21751358
TUBA1C	84790	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
TUBA1C	84790	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		19424620
TUBA4A	7277	AMYOTROPHIC LATERAL SCLEROSIS 22 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA	OMIM:616208	marker/mechanism		NA	616208	
TUBA8	51807	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
TUBA8	51807	Polymicrogyria With Optic Nerve Hypoplasia	MESH:C567715	marker/mechanism		NA	613180	
TUBB	203068	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6	OMIM:615771	marker/mechanism		NA	615771	
TUBB1	81027	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		21751358
TUBB1	81027	Macrothrombocytopenia, Autosomal Dominant, Tubb1-Related	MESH:C567747	marker/mechanism		NA	613112	
TUBB2A	7280	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
TUBB2A	7280	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5	OMIM:615763	marker/mechanism		NA	615763	
TUBB2A	7280	Creutzfeldt-Jakob Syndrome	MESH:D007562	marker/mechanism		NA		23349890
TUBB2A	7280	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		17330099
TUBB2B	347733	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
TUBB2B	347733	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	OMIM:610031	marker/mechanism		NA	610031	
TUBB2B	347733	Malformations of Cortical Development	MESH:D054220	marker/mechanism		NA		19465910
TUBB2B	347733	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
TUBB2B	347733	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
TUBB3	10381	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21781528
TUBB3	10381	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	OMIM:614039	marker/mechanism		NA	614039	
TUBB3	10381	Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement	MESH:C567572	marker/mechanism		NA	600638	
TUBB3	10381	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		18497984
TUBB4A	10382	Whispering dysphonia, hereditary	MESH:C536698	marker/mechanism		NA	128101	
TUBB4B	10383	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
TUBB5	22154	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		16155095
TUBB5	22154	Enterocolitis, Necrotizing	MESH:D020345	marker/mechanism		NA		18806098
TUBB5	22154	Heart Failure	MESH:D006333	marker/mechanism		NA		16155095
TUBB6	84617	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TUBB8	347688	OOCYTE MATURATION DEFECT 2	OMIM:616780	marker/mechanism		NA	616780	
TUBG1	7283	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4	OMIM:615412	marker/mechanism		NA	615412	
TUBG1	7283	Malformations of Cortical Development	MESH:D054220	marker/mechanism		NA		23603762
TUBG1	7283	Microcephaly	MESH:D008831	marker/mechanism		NA		23603762
TUBGCP4	27229	Microcephaly with Chorioretinopathy, Autosomal Recessive	MESH:C565379	marker/mechanism		NA	616335	
TUBGCP6	85378	Microcephaly with Chorioretinopathy, Autosomal Recessive	MESH:C565379	marker/mechanism		NA	251270	
TUFM	7284	Combined Oxidative Phosphorylation Deficiency 4	MESH:C565690	marker/mechanism		NA	610678	
TUFM	7284	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		15986332
TULP1	7287	LEBER CONGENITAL AMAUROSIS 15	OMIM:613843	marker/mechanism		NA	613843	
TULP1	7287	Retinitis Pigmentosa 14	MESH:C563992	marker/mechanism		NA	600132	
TULP3	7289	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
TUSC3	7991	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TUSC3	7991	Mental Retardation, Autosomal Recessive 7	MESH:C567016	marker/mechanism		NA	611093	
TWF1	5756	Lymphoma	MESH:D008223	marker/mechanism		NA		19783987
TWIST1	7291	Acrocephalosyndactylia	MESH:D000168	marker/mechanism		NA	101400	15923834|23354436
TWIST1	7291	Craniosynostoses	MESH:D003398	marker/mechanism		NA	123100	12221714
TWIST1	7291	Lymphoma, Large-Cell, Anaplastic	MESH:D017728	marker/mechanism		NA		22155737
TWIST1	7291	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		22155737
TWIST1	7291	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19806464
TWIST1	7291	Robinow Sorauf syndrome	MESH:C537183	marker/mechanism		NA	180750	
TWIST1	7291	Saethre-Chotzen Syndrome with Eyelid Anomalies	MESH:C566325	marker/mechanism		NA		11474656
TWIST1	7291	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		19806464
TWIST2	117581	Ablepharon macrostomia syndrome	MESH:C535557	marker/mechanism		NA	200110	
TWIST2	117581	Barber Say syndrome	MESH:C537908	marker/mechanism		NA	209885	
TWIST2	117581	Facial ectodermal dysplasia	MESH:C536385	marker/mechanism		NA	227260	
TWNK	56652	MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	OMIM:271245	marker/mechanism		NA	271245	
TWNK	56652	Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 3	MESH:C563747	marker/mechanism		NA	609286	
TWNK	56652	Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis	MESH:C537583	marker/mechanism		NA	607459	
TWSG1	57045	Holoprosencephaly	MESH:D016142	marker/mechanism		NA		15013800
TWSG1	57045	Jaw Abnormalities	MESH:D007569	marker/mechanism		NA		15013800
TXN	7295	Acute Lung Injury	MESH:D055371	therapeutic		NA		16298680
TXN	7295	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		30396169
TXN	7295	Bronchopulmonary Dysplasia	MESH:D001997	therapeutic		NA		20812253
TXN	7295	Congenital Abnormalities	MESH:D000013	therapeutic		NA		31310794
TXN	7295	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
TXN	7295	Hydrocephalus	MESH:D006849	marker/mechanism		NA		31310794
TXN	7295	Liver Diseases	MESH:D008107	therapeutic		NA		16996028
TXN	7295	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		27032653
TXN	7295	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		15048980
TXN	7295	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		30396169
TXN	7295	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		28574600
TXN1	22166	Cardiomyopathies	MESH:D009202	therapeutic		NA		12221060
TXN1	22166	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	therapeutic		NA		11462148
TXN2	25828	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29	OMIM:616811	marker/mechanism		NA	616811	
TXN2	25828	Spinal Dysraphism	MESH:D016135	marker/mechanism		NA		19165900
TXNDC17	84817	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		21517111
TXNDC5	81567	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		23326410
TXNDC5	81567	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		23326410
TXNDC5	81567	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17085005
TXNDC5	81567	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
TXNIP	10628	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		19192274
TXNIP	10628	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		17582205
TXNIP	10628	Disease Progression	MESH:D018450	marker/mechanism		NA		16081686
TXNIP	10628	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
TXNIP	10628	Lymphoma, Large B-Cell, Diffuse	MESH:D016403	marker/mechanism		NA		16081686
TXNL4A	10907	Burn-Mckeown syndrome	MESH:C537411	marker/mechanism		NA	608572	
TXNRD1	7296	Adenoma	MESH:D000236	marker/mechanism		NA		18483336
TXNRD1	7296	Carcinoma, Lewis Lung	MESH:D018827	marker/mechanism		NA		16565519
TXNRD1	7296	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18483336
TXNRD1	7296	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
TXNRD1	7296	Epilepsy	MESH:D004827	marker/mechanism		NA		19499324
TXNRD1	7296	Mesothelioma	MESH:D008654	marker/mechanism		NA		17316382
TXNRD1	7296	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
TXNRD1	7296	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
TXNRD2	10587	Glaucoma, Open-Angle	MESH:D005902	marker/mechanism		NA		26752265
TXNRD2	10587	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		21716162
TYK2	7297	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		23143596|30224649
TYK2	7297	Autistic Disorder	MESH:D001321	marker/mechanism		NA		20957522
TYK2	7297	Cocaine-Related Disorders	MESH:D019970	marker/mechanism		NA		18438686
TYK2	7297	Crohn Disease	MESH:D003424	marker/mechanism		NA		21102463
TYK2	7297	Diabetes Mellitus, Type 1	MESH:D003922	marker/mechanism		NA		30224649
TYK2	7297	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		22961000
TYK2	7297	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		19525955
TYK2	7297	Paranoid Disorders	MESH:D010259	marker/mechanism		NA		18438686
TYK2	7297	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054218	marker/mechanism		NA		23471820
TYK2	7297	Psoriasis	MESH:D011565	marker/mechanism		NA		20953190
TYK2	7297	Tyrosine Kinase 2 Deficiency	MESH:C566928	marker/mechanism		NA	611521	
TYMP	1890	Carcinoma	MESH:D002277	marker/mechanism		NA		11103787|12565868
TYMP	1890	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		18652704
TYMP	1890	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		15706408|17047489
TYMP	1890	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		11641616
TYMP	1890	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE)	OMIM:603041	marker/mechanism		NA	603041	
TYMP	1890	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		11103787
TYMP	1890	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		17443278
TYMP	1890	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		18652704
TYMP	1890	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		11103787|15841086
TYMP	1890	Visceral myopathy familial external ophthalmoplegia	MESH:C536350	marker/mechanism		NA		16972839|22977166
TYMS	7298	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
TYMS	7298	Anemia	MESH:D000740	marker/mechanism		NA		19648163
TYMS	7298	Brain Diseases	MESH:D001927	marker/mechanism		NA		20714149
TYMS	7298	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16723031|19020767|21501481
TYMS	7298	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		18019677|18230555
TYMS	7298	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		16280240
TYMS	7298	Cleft Lip	MESH:D002971	marker/mechanism		NA		21254359
TYMS	7298	Cleft Palate	MESH:D002972	marker/mechanism		NA		21254359
TYMS	7298	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15355913|16284371|16609021|18192902|18652704|19105824
TYMS	7298	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		15222106|15386371|15500737|16141798|16943523|17047489|17943475|18607850|18676755|19020767|25944804
TYMS	7298	Digestive System Neoplasms	MESH:D004067	marker/mechanism		NA		18281538
TYMS	7298	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
TYMS	7298	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		19648163|21064136|25007187|26077125
TYMS	7298	Head and Neck Neoplasms	MESH:D006258	marker/mechanism		NA		19020767
TYMS	7298	Hyperammonemia	MESH:D022124	marker/mechanism		NA		20714149
TYMS	7298	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		18281538|19020767
TYMS	7298	Lymphoma, Follicular	MESH:D008224	marker/mechanism		NA		16410450
TYMS	7298	Lymphoma, Non-Hodgkin	MESH:D008228	marker/mechanism		NA		16365025
TYMS	7298	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		18192902
TYMS	7298	Nervous System Diseases	MESH:D009422	marker/mechanism		NA		21064136
TYMS	7298	Neuroendocrine Tumors	MESH:D018358	marker/mechanism		NA		18281538
TYMS	7298	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		21795601
TYMS	7298	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		19020767
TYMS	7298	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		15999119
TYMS	7298	Rectal Neoplasms	MESH:D012004	marker/mechanism		NA		16931962
TYMS	7298	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		15837757|18505590|18652704|19020767
TYMS	7298	Tongue Neoplasms	MESH:D014062	marker/mechanism		NA		16280240
TYR	7299	Albinism, Oculocutaneous	MESH:D016115	marker/mechanism		NA		2511845|9158138
TYR	7299	Carcinoma, Basal Cell	MESH:D002280	marker/mechanism		NA		18488027
TYR	7299	Melanoma	MESH:D008545	marker/mechanism		NA		18488027|19578364|21559390|26640592
TYR	7299	Oculocutaneous albinism type 1	MESH:C537728	marker/mechanism		NA	203100	11781109
TYR	7299	Oculocutaneous albinism type 1B	MESH:C537729	marker/mechanism		NA	606952	
TYR	7299	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		18488027
TYRO3	7301	Thrombosis	MESH:D013927	marker/mechanism		NA		15733062
TYROBP	7305	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
TYROBP	7305	Liver Diseases	MESH:D008107	marker/mechanism		NA		12651611
TYROBP	7305	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy	MESH:C536329	marker/mechanism		NA	221770	17430113
TYRP1	7306	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		21552421
TYRP1	7306	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		21552421
TYRP1	7306	Melanoma	MESH:D008545	marker/mechanism		NA		26640592
TYRP1	7306	Oculocutaneous albinism type 3	MESH:C537731	marker/mechanism		NA	203290	
U2AF1	7307	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
U2AF1	7307	Myelodysplastic Syndromes	MESH:D009190	marker/mechanism		NA		22158538
U2AF1	7307	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
U2AF1	7307	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
U2SURP	23350	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
UBA1	7317	Arthrogryposis multiplex congenita, distal, X-linked	MESH:C535380	marker/mechanism		NA	301830	
UBA1	7317	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		19014429
UBA5	79876	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		26881866
UBA5	79876	Cholestasis	MESH:D002779	marker/mechanism		NA		26881866
UBA5	79876	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	OMIM:617132	marker/mechanism		NA	617132	
UBA5	79876	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA	617133	
UBA7	7318	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		19014429
UBASH3A	53347	Cholangitis, Sclerosing	MESH:D015209	marker/mechanism		NA		27992413
UBD	10537	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
UBD	10537	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		19363144
UBD	10537	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
UBD	10537	Hepatitis, Animal	MESH:D006520	marker/mechanism		NA		18559427
UBD	10537	Liver Cirrhosis, Biliary	MESH:D008105	marker/mechanism		NA		18422935
UBD	10537	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
UBE2A	7319	MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE	OMIM:300860	marker/mechanism		NA	300860	
UBE2C	11065	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17659439
UBE2C	11065	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
UBE2C	11065	Chromosome Aberrations	MESH:D002869	therapeutic		NA		27129209
UBE2E1	7324	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
UBE2E1	7324	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
UBE2E1	7324	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
UBE2E2	7325	Adenoma, Liver Cell	MESH:D018248	marker/mechanism		NA		27914986
UBE2E2	7325	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		27914986
UBE2E2	7325	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		20818381
UBE2H	7328	Autistic Disorder	MESH:D001321	marker/mechanism		NA		14639049
UBE2H	7328	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
UBE2I	7329	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
UBE2I	7329	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
UBE2I	7329	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
UBE2L3	7332	Hepatitis B, Chronic	MESH:D019694	marker/mechanism		NA		24162738
UBE2L6	9246	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
UBE2N	7334	Embryo Loss	MESH:D020964	marker/mechanism		NA		16738225
UBE2T	29089	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
UBE2T	29089	FANCONI ANEMIA, COMPLEMENTATION GROUP T	OMIM:616435	marker/mechanism		NA	616435	
UBE2T	29089	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		28321044
UBE3A	7337	Angelman Syndrome	MESH:D017204	marker/mechanism		NA	105830	15878204
UBE3A	7337	Autistic Disorder	MESH:D001321	marker/mechanism		NA		11543639|19404257|20609483
UBE3A	7337	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		15878204
UBE3A	7337	Epilepsy	MESH:D004827	marker/mechanism		NA		15878204
UBE3B	89910	Kaufman oculocerebrofacial syndrome	MESH:C537013	marker/mechanism		NA	244450	28003368
UBE3C	9690	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
UBE4B	10277	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
UBE4B	10277	Brain Injuries, Traumatic	MESH:D000070642	therapeutic		NA		27822499
UBE4B	10277	Neurobehavioral Manifestations	MESH:D019954	therapeutic		NA		27822499
UBE4B	10277	Wallerian Degeneration	MESH:D014855	therapeutic		NA		27822499
UBIAD1	29914	Corneal Dystrophy, Crystalline, of Schnyder	MESH:C535475	marker/mechanism		NA	121800	
UBIAD1	29914	Edema, Cardiac	MESH:D004489	marker/mechanism		NA		23533172
UBIAD1	29914	Intracranial Hemorrhages	MESH:D020300	marker/mechanism		NA		23533172
UBLCP1	134510	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
UBQLN1	29979	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		24747970
UBQLN2	29978	AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA	OMIM:300857	marker/mechanism		NA	300857	
UBR1	197131	Johanson Blizzard syndrome	MESH:C535880	marker/mechanism		NA	243800	
UBR7	55148	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
UBXN1	51035	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
UBXN1	51035	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
UCHL1	7345	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		18666234
UCHL1	7345	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		17094902
UCHL1	7345	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		15930319
UCHL1	7345	Gallbladder Neoplasms	MESH:D005706	marker/mechanism		NA		16965602
UCHL1	7345	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		18958481
UCHL1	7345	PARKINSON DISEASE 5, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO	OMIM:613643	marker/mechanism		NA	613643	
UCHL1	7345	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		16797537
UCHL1	7345	SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE	OMIM:615491	marker/mechanism		NA	615491	
UCHL3	7347	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17085005
UCK2	7371	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
UCK2	7371	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
UCK2	7371	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		24763052
UCMAA	100037325	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		21839171
UCMAA	100037325	Prenatal Injuries	MESH:D049188	marker/mechanism		NA		21839171
UCN	7349	Anxiety Disorders	MESH:D001008	marker/mechanism		NA		16488545
UCN	7349	Hypertension	MESH:D006973	therapeutic		NA		20237592
UCN	7349	Hypotension	MESH:D007022	marker/mechanism		NA		10213916
UCN	7349	Inflammation	MESH:D007249	therapeutic		NA		10213916
UCN2	90226	Anorexia	MESH:D000855	marker/mechanism		NA		17627984
UCN2	90226	Heart Failure	MESH:D006333	therapeutic		NA		16330704
UCN3	114131	Inflammation	MESH:D007249	therapeutic		NA		16855006
UCN3	114131	Lung Diseases	MESH:D008171	therapeutic		NA		16855006
UCP1	7350	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		26670611
UCP1	7350	Heart Failure	MESH:D006333	marker/mechanism		NA		26670611
UCP1	7350	Obesity	MESH:D009765	therapeutic		NA		15592485
UCP2	7351	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 4	OMIM:607447	marker/mechanism		NA	607447	
UCP2	7351	Brain Injuries	MESH:D001930	therapeutic		NA		12858170
UCP2	7351	Brain Ischemia	MESH:D002545	marker/mechanism		NA		17052689
UCP2	7351	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
UCP2	7351	Cardiomegaly	MESH:D006332	therapeutic		NA		25703824
UCP2	7351	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		14563825|16123366
UCP2	7351	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		15562023|16123366
UCP2	7351	Fatty Liver	MESH:D005234	marker/mechanism		NA		10860543
UCP2	7351	Hypertension	MESH:D006973	marker/mechanism		NA		16685210
UCP2	7351	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
UCP2	7351	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
UCP2	7351	Obesity	MESH:D009765	marker/mechanism		NA		11381268
UCP2	7351	Stroke	MESH:D020521	therapeutic		NA		12858170
UCP3	7352	Obesity	MESH:D009765	marker/mechanism		NA	601665	
UCP3	7352	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		22919386
UFD1	7353	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		10024240
UFD1	7353	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		10024240
UFSP2	55325	Hip Dysplasia, Beukes Type	MESH:C564185	marker/mechanism		NA	142669	
UGCG	7357	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
UGCG	7357	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
UGDH	7358	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		17114358
UGT1A	7361	Gilbert Disease	MESH:D005878	marker/mechanism		NA		22213127
UGT1A1	54658	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		3864191
UGT1A1	54658	Carcinoma, Small Cell	MESH:D018288	marker/mechanism		NA		20946520
UGT1A1	54658	Crigler-Najjar Syndrome	MESH:D003414	marker/mechanism		NA	218800	25370011
UGT1A1	54658	Crigler Najjar syndrome, type 2	MESH:C536213	marker/mechanism		NA	606785	
UGT1A1	54658	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
UGT1A1	54658	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	therapeutic		NA		19931604
UGT1A1	54658	Gilbert Disease	MESH:D005878	marker/mechanism		NA	143500	10421657|15180166|15297419
UGT1A1	54658	Hodgkin Disease	MESH:D006689	marker/mechanism		NA		18768784
UGT1A1	54658	Hyperbilirubinemia	MESH:D006932	marker/mechanism		NA		20194756|21983082|23950218|25370011|27060662
UGT1A1	54658	Hyperbilirubinemia, Neonatal	MESH:D051556	marker/mechanism		NA		28167773
UGT1A1	54658	Hyperbilirubinemia, Transient Familial Neonatal	MESH:C562692	marker/mechanism		NA	237900	
UGT1A1	54658	Kernicterus	MESH:D007647	marker/mechanism		NA		20194756|28167773
UGT1A1	54658	Neutropenia	MESH:D009503	marker/mechanism		NA		17549067
UGT1A3	54659	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
UGT1A4	54657	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
UGT1A6	54578	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
UGT1A9	54600	Acute Kidney Injury	MESH:D058186	marker/mechanism		NA		20623750
UGT1A9	54600	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		20623750
UGT2B	24862	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
UGT2B10	7365	Melanoma	MESH:D008545	marker/mechanism		NA		21499247
UGT2B15	7366	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16859836
UGT2B17	7367	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		17416778
UGT2B17	7367	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12	OMIM:612560	marker/mechanism		NA	612560	
UGT2B17	7367	Graft vs Host Disease	MESH:D006086	marker/mechanism		NA		19935662
UGT2B17	7367	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17416778
UGT2B17	7367	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17826523
UGT2B7	7364	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		15615884
UHRF1	29128	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		23685749
UHRF1	29128	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
UHRF1BP1	54887	Lupus Erythematosus, Systemic	MESH:D008180	marker/mechanism		NA		19838195
UHRF1BP1	54887	Prostate cancer, familial	MESH:C537243	marker/mechanism		NA		29892016
UHRF1BP1L	23074	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
ULBP2	80328	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
ULBP3	79465	Alopecia Areata	MESH:D000506	marker/mechanism		NA		20596022
ULK2	9706	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		26928227
ULK4	54986	Multiple Myeloma	MESH:D009101	marker/mechanism		NA		22120009
UMOD	7369	Glomerulocystic Kidney Disease with Hyperuricemia and Isosthenuria	MESH:C563693	marker/mechanism		NA	609886	
UMOD	7369	Hypertension	MESH:D006973	marker/mechanism		NA		22228705
UMOD	7369	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1	OMIM:162000	marker/mechanism		NA	162000	
UMOD	7369	Kidney Diseases	MESH:D007674	marker/mechanism		NA		19430482|8486146
UMOD	7369	Medullary Cystic Kidney Disease 2	MESH:C548033	marker/mechanism		NA	603860	
UMPS	7372	Anemia, Hypoplastic, Congenital	MESH:D029502	marker/mechanism		NA		38827
UMPS	7372	Anemia, Sickle Cell	MESH:D000755	marker/mechanism		NA		38827
UMPS	7372	beta-Thalassemia	MESH:D017086	marker/mechanism		NA		38827
UMPS	7372	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19020767|19151563
UMPS	7372	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		18230555
UMPS	7372	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		16757204
UMPS	7372	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		18652704
UMPS	7372	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		15814641|19020767
UMPS	7372	Leukemia, Erythroblastic, Acute	MESH:D004915	marker/mechanism		NA		38827
UMPS	7372	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		16757204
UMPS	7372	Oroticaciduria 1	MESH:C537136	marker/mechanism		NA	258900	
UMPS	7372	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		15999119|19082440
UMPS	7372	Spherocytosis, Hereditary	MESH:D013103	marker/mechanism		NA		38827
UMPS	7372	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16912530|17089033|18652704
UNC119	9094	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA		11006213
UNC119	9094	T-Lymphocytopenia, Idiopathic CD4-Positive	MESH:D018344	marker/mechanism		NA	615518	
UNC13A	23025	Amyotrophic Lateral Sclerosis	MESH:D000690	marker/mechanism		NA		19734901
UNC13D	201294	Hemophagocytic lymphohistiocytosis, familial, 3	MESH:C537251	marker/mechanism		NA	608898	
UNC13D	201294	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
UNC45B	146862	CATARACT 43	OMIM:616279	marker/mechanism		NA	616279	
UNC45B	146862	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		17189627
UNC45B	146862	Heart Diseases	MESH:D006331	marker/mechanism		NA		17189627
UNC45B	146862	Paralysis	MESH:D010243	marker/mechanism		NA		17189627
UNC5B	219699	Subarachnoid Hemorrhage	MESH:D013345	marker/mechanism		NA		29162556
UNC5C	8633	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		21600761
UNC5CL	222643	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
UNC80	285175	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		28191889
UNC80	285175	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2	OMIM:616801	marker/mechanism		NA	616801	
UNC93B1	81622	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
UNC93B1	81622	Encephalitis, Herpes Simplex	MESH:D020803	marker/mechanism		NA	610551	
UNC93B1	81622	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		25226513
UNC93B1	81622	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
UNG	7374	Bloom Syndrome	MESH:D001816	marker/mechanism		NA		2106500
UNG	7374	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		15814641
UNG	7374	Hyper-IgM Immunodeficiency Syndrome	MESH:D053306	marker/mechanism		NA	608106	
UOX	391051	Acute Kidney Injury	MESH:D058186	therapeutic		NA		16313266
UOX	391051	Oliguria	MESH:D009846	therapeutic		NA		16313266
UOX	391051	Ovarian Cysts	MESH:D010048	marker/mechanism		NA		21239663
UOX	391051	Tumor Lysis Syndrome	MESH:D015275	therapeutic		NA		16313266
UP	104073	Parkinson Disease	MESH:D010300	marker/mechanism		NA		18353766
UPB1	51733	Autistic Disorder	MESH:D001321	marker/mechanism		NA		18853477
UPB1	51733	Beta-Ureidopropionase Deficiency	MESH:C563210	marker/mechanism		NA	613161	
UPB1	51733	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
UPB1	51733	Metabolic Diseases	MESH:D008659	marker/mechanism		NA		18853477
UPB1	51733	Spasms, Infantile	MESH:D013036	marker/mechanism		NA		18853477
UPF3B	65109	Mental Retardation, X-Linked	MESH:D038901	marker/mechanism		NA		17704778
UPF3B	65109	Mental Retardation, X-Linked, Syndromic 14	MESH:C567063	marker/mechanism		NA	300676	
UPK1B	7348	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25330770
UPP1	7378	Dermatitis, Allergic Contact	MESH:D017449	marker/mechanism		NA		16033404
UPP1	7378	Respiratory Hypersensitivity	MESH:D012130	marker/mechanism		NA		24211530
UPP2	151531	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		21151189
UQCC2	84300	Mitochondrial Complex III Deficiency	MESH:C565128	marker/mechanism		NA	615824	
UQCC3	790955	Mitochondrial Complex III Deficiency	MESH:C565128	marker/mechanism		NA	616111	
UQCR11	10975	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		19233941
UQCRB	7381	Mitochondrial Complex III Deficiency	MESH:C565128	marker/mechanism		NA	615158	
UQCRC2	7385	Mitochondrial Complex III Deficiency	MESH:C565128	marker/mechanism		NA	615160	
UQCRC2	7385	Obesity	MESH:D009765	marker/mechanism		NA		20882379
UQCRFS1	7386	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
UQCRQ	27089	Mitochondrial Complex III Deficiency	MESH:C565128	marker/mechanism		NA	615159	
URI1	8725	Carcinoma	MESH:D002277	marker/mechanism		NA		21397856
URI1	8725	Neoplasms, Experimental	MESH:D009374	marker/mechanism		NA		21397856
URI1	8725	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		21397856
URM1	81605	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
URM1	81605	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
UROC1	131669	Ataxia	MESH:D001259	marker/mechanism		NA		19304569
UROC1	131669	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
UROC1	131669	Intellectual Disability	MESH:D008607	marker/mechanism		NA		19304569
UROC1	131669	Urocanase deficiency	MESH:C536479	marker/mechanism		NA	276880	19304569
UROD	7389	Head and Neck Neoplasms	MESH:D006258	marker/mechanism		NA		21270338
UROD	7389	Porphyria Cutanea Tarda	MESH:D017119	marker/mechanism		NA	176100	12030801|17360334
UROS	7390	Porphyria, Erythropoietic	MESH:D017092	marker/mechanism		NA	263700	
USB1	79650	Poikiloderma with Neutropenia	MESH:C565820	marker/mechanism		NA	604173	
USF1	7391	Hyperlipidemia, Familial Combined	MESH:D006950	marker/mechanism		NA	602491	
USH1C	10083	DEAFNESS, AUTOSOMAL RECESSIVE 18A	OMIM:602092	marker/mechanism		NA	602092	
USH1C	10083	Usher syndrome, type 1B	MESH:C536485	marker/mechanism		NA	276900	
USH1C	10083	Usher syndrome, type 1C	MESH:C536486	marker/mechanism		NA	276904	12136232
USH1G	124590	Hearing Loss	MESH:D034381	marker/mechanism		NA		30029624
USH1G	124590	Usher Syndrome, Type IG	MESH:C564643	marker/mechanism		NA	606943	
USH2A	7399	Autism Spectrum Disorder	MESH:D000067877	marker/mechanism		NA		31209396
USH2A	7399	Retinitis Pigmentosa	MESH:D012174	marker/mechanism		NA		10775529|15025721|9624053
USH2A	7399	RETINITIS PIGMENTOSA 39	OMIM:613809	marker/mechanism		NA	613809	
USH2A	7399	Usher syndrome, type 2A	MESH:C536490	marker/mechanism		NA	276901	15025721|9624053
USO1	8615	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
USO1	8615	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
USO1	8615	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
USP13	8975	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
USP13	8975	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
USP18	11274	Aicardi-Goutieres syndrome	MESH:C535607	marker/mechanism		NA	617397	
USP18	11274	Leiomyosarcoma	MESH:D007890	marker/mechanism		NA		26555296
USP18	11274	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		27980214
USP2	9099	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21147110
USP27X	389856	MENTAL RETARDATION, X-LINKED 105	OMIM:300984	marker/mechanism		NA	300984	
USP28	57646	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475|29662167
USP3	9960	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
USP32	84669	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		28811376
USP34	9736	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
USP48	84196	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
USP48	84196	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		30718926
USP5	8078	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
USP6NL	9712	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
USP7	7874	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
USP7	7874	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		26039340
USP8	9101	ACTH-Secreting Pituitary Adenoma	MESH:D049913	marker/mechanism		NA	219090	25485838
USP8	9101	Pituitary ACTH Hypersecretion	MESH:D047748	marker/mechanism		NA		25485838
USP9X	8239	MENTAL RETARDATION, X-LINKED 99	OMIM:300919	marker/mechanism		NA	300919	
USP9X	8239	MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	OMIM:300968	marker/mechanism		NA	300968	
USP9Y	8287	Spermatogenic Failure, Nonobstructive, Y-Linked	MESH:C564030	marker/mechanism		NA	415000	
UST	10090	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
UST	10090	Endometriosis	MESH:D004715	marker/mechanism		NA		20864642
UST5R	171398	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
UST5R	171398	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		25226513
UST5R	171398	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
UTP25	27042	Hirschsprung Disease	MESH:D006627	marker/mechanism		NA		25007945
UTS2	10911	Bradycardia	MESH:D001919	marker/mechanism		NA		16160878
UTS2	10911	Feeding and Eating Disorders	MESH:D001068	marker/mechanism		NA		16160878
UTS2	10911	Hypertension	MESH:D006973	marker/mechanism		NA		16160878
UTS2	10911	Movement Disorders	MESH:D009069	marker/mechanism		NA		16160878
UTS2	10911	Water Intoxication	MESH:D014869	marker/mechanism		NA		16160878
UVSSA	57654	UV-Sensitive Syndrome	MESH:C563466	marker/mechanism		NA	614640	22466610|22466612
UXS1	80146	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		16759393
UXT	8409	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		19318562
VAC14	55697	STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	OMIM:617054	marker/mechanism		NA	617054	
VAMP1	6843	Ataxia, Spastic, 1, Autosomal Dominant	MESH:C566993	marker/mechanism		NA	108600	
VAMP7	6845	Papillomavirus Infections	MESH:D030361	marker/mechanism		NA		23358896
VAMP7	6845	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		23358896
VAMP8	8673	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
VAMP8	8673	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
VAMP8	8673	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
VANGL1	81839	Neural Tube Defects	MESH:D009436	marker/mechanism		NA	182940	17409324|19319979
VANGL1	81839	Sacral defect and anterior sacral meningocele	MESH:C537221	marker/mechanism		NA	600145	
VANGL2	57216	Neural Tube Defects	MESH:D009436	marker/mechanism		NA	182940	2373757
VANGL2	57216	Spinal Dysraphism	MESH:D016135	marker/mechanism		NA		21404367
VAPB	9217	Amyotrophic Lateral Sclerosis 8	MESH:C563895	marker/mechanism		NA	608627	
VAPB	9217	Spinal Muscular Atrophy, Proximal, Adult, Autosomal Dominant	MESH:C566672	marker/mechanism		NA	182980	
VARS2	57176	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	OMIM:615917	marker/mechanism		NA	615917	
VASN	114990	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		25826090
VASP	7408	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
VAV1	7409	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27158780
VAV1	7409	Leukemia-Lymphoma, Adult T-Cell	MESH:D015459	marker/mechanism		NA		26437031
VAV1	7409	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
VAV1	7409	Medulloblastoma	MESH:D008527	marker/mechanism		NA		19270706
VAV3	10451	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		25305756
VAV3	10451	Hypertension	MESH:D006973	marker/mechanism		NA		21115475
VAV3	10451	Hyperventilation	MESH:D006985	marker/mechanism		NA		21115475
VAV3	10451	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17909013
VAV3	10451	Tachycardia	MESH:D013610	marker/mechanism		NA		21115475
VAX1	11023	MICROPHTHALMIA, SYNDROMIC 11	OMIM:614402	marker/mechanism		NA	614402	
VCAM1	7412	Anemia, Sickle Cell	MESH:D000755	marker/mechanism		NA		16916123
VCAM1	7412	Arteriosclerosis	MESH:D001161	marker/mechanism		NA		28569748
VCAM1	7412	Atherosclerosis	MESH:D050197	marker/mechanism		NA		12677255
VCAM1	7412	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		22922871
VCAM1	7412	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		16332659|25575156
VCAM1	7412	Cholestasis	MESH:D002779	marker/mechanism		NA		21224055
VCAM1	7412	Colitis, Ulcerative	MESH:D003093	marker/mechanism		NA		15553846
VCAM1	7412	Dermatitis	MESH:D003872	marker/mechanism		NA		27206134
VCAM1	7412	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		12759764
VCAM1	7412	Hypercholesterolemia	MESH:D006937	marker/mechanism		NA		14602771
VCAM1	7412	Hypertension	MESH:D006973	marker/mechanism		NA		11834524|19018797
VCAM1	7412	Intrahepatic Cholestasis of Pregnancy	MESH:C535932	marker/mechanism		NA		28851649
VCAM1	7412	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		20175758
VCAM1	7412	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
VCAM1	7412	Primary Graft Dysfunction	MESH:D055031	marker/mechanism		NA		28569748
VCAM1	7412	Uremia	MESH:D014511	marker/mechanism		NA		17347482
VCAM1	7412	Urticaria	MESH:D014581	marker/mechanism		NA		12121561
VCAN	1462	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
VCAN	1462	Endometriosis	MESH:D004715	marker/mechanism		NA		21063030
VCAN	1462	Hyaloideoretinal degeneration of Wagner	MESH:C536075	marker/mechanism		NA	143200	
VCAN	1462	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
VCL	7414	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		21751358
VCL	7414	Cardiomyopathy, Dilated, 1w	MESH:C566954	marker/mechanism		NA	611407	
VCL	7414	Cardiomyopathy, Familial Hypertrophic, 15	MESH:C567681	marker/mechanism		NA	613255	
VCL	7414	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
VCP	7415	AMYOTROPHIC LATERAL SCLEROSIS 14 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA	OMIM:613954	marker/mechanism		NA	613954	
VCP	7415	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y	OMIM:616687	marker/mechanism		NA	616687	
VCP	7415	Cytomegalovirus Infections	MESH:D003586	marker/mechanism		NA		28494016
VCP	7415	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		25884947
VCP	7415	Disease Progression	MESH:D018450	marker/mechanism		NA		29693262
VCP	7415	Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia	MESH:C563476	marker/mechanism		NA	167320	25884947
VCP	7415	Muscle Weakness	MESH:D018908	marker/mechanism		NA		25884947
VCP	7415	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29693262
VCP	7415	Stevens-Johnson Syndrome	MESH:D013262	marker/mechanism		NA		25811541
VCY	9084	Spermatogenic Failure, Nonobstructive, Y-Linked	MESH:C564030	marker/mechanism		NA	415000	
VDAC1	7416	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		19634143
VDAC1	7416	Epilepsy	MESH:D004827	marker/mechanism		NA		17893921
VDAC1	7416	Mitochondrial Myopathies	MESH:D017240	marker/mechanism		NA		8726225
VDAC1	7416	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		25488258
VDAC1	7416	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		25488258
VDAC1	7416	Psychomotor Disorders	MESH:D011596	marker/mechanism		NA		8726225
VDAC1	7416	Ventricular Dysfunction, Left	MESH:D018487	marker/mechanism		NA		25488258
VDAC2	7417	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		15274141
VDAC2	7417	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		19634143
VDAC2	7417	Epilepsy	MESH:D004827	marker/mechanism		NA		17893921
VDAC2	7417	Mouth Neoplasms	MESH:D009062	marker/mechanism		NA		15274141
VDAC2	7417	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
VDR	7421	Alopecia	MESH:D000505	marker/mechanism		NA		1338926|22466564
VDR	7421	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		16280049|22892281
VDR	7421	Carcinoma, Transitional Cell	MESH:D002295	marker/mechanism		NA		16080513
VDR	7421	Cerebral Infarction	MESH:D002544	marker/mechanism		NA		25498546
VDR	7421	Epilepsy, Temporal Lobe	MESH:D004833	marker/mechanism		NA		18534255
VDR	7421	Genetic Diseases, Inborn	MESH:D030342	marker/mechanism		NA		17451081
VDR	7421	Hypertension	MESH:D006973	marker/mechanism		NA		11335187
VDR	7421	Lead Poisoning	MESH:D007855	marker/mechanism		NA		20692022|23433214
VDR	7421	Leukemia, Lymphocytic, Chronic, B-Cell	MESH:D015451	marker/mechanism		NA		12446453
VDR	7421	Multiple Sclerosis	MESH:D009103	marker/mechanism		NA		25853421
VDR	7421	Neoplasms	MESH:D009369	marker/mechanism		NA		10389917
VDR	7421	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		20347977
VDR	7421	Rickets	MESH:D012279	marker/mechanism		NA		1338926|17451081|22466564
VDR	7421	Uremia	MESH:D014511	marker/mechanism		NA		19092814
VDR	7421	Vitamin D Deficiency	MESH:D014808	marker/mechanism		NA		9525346
VDR	7421	Vitamin D-Dependent Rickets, Type 2A	MESH:C562794	marker/mechanism		NA	277440	
VEGF	100136118	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		11289497
VEGFA	7422	Acute Kidney Injury	MESH:D058186	marker/mechanism|therapeutic		NA		20943766|22808199
VEGFA	7422	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		26432044
VEGFA	7422	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		15732116
VEGFA	7422	Arthritis, Experimental	MESH:D001169	marker/mechanism		NA		26221077|9598899
VEGFA	7422	Arthritis, Rheumatoid	MESH:D001172	marker/mechanism		NA		16368150
VEGFA	7422	Asthma	MESH:D001249	marker/mechanism		NA		11907124|15201500|19263519
VEGFA	7422	Atherosclerosis	MESH:D050197	marker/mechanism		NA		15937083
VEGFA	7422	Brain Injuries	MESH:D001930	therapeutic		NA		18065154
VEGFA	7422	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		20932960
VEGFA	7422	Bronchitis, Chronic	MESH:D029481	marker/mechanism		NA		19263519
VEGFA	7422	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		15956251
VEGFA	7422	Carcinoma, Pancreatic Ductal	MESH:D021441	marker/mechanism		NA		17481528
VEGFA	7422	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		15956251|26432044
VEGFA	7422	Cerebral Hemorrhage	MESH:D002543	marker/mechanism		NA		17888890
VEGFA	7422	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
VEGFA	7422	Choroidal Neovascularization	MESH:D020256	marker/mechanism		NA		16680105
VEGFA	7422	Clear-cell metastatic renal cell carcinoma	MESH:C538445	marker/mechanism		NA		25239121
VEGFA	7422	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		18987561
VEGFA	7422	Corneal Neovascularization	MESH:D016510	marker/mechanism		NA		9301478
VEGFA	7422	Coronary Artery Disease	MESH:D003324	marker/mechanism|therapeutic		NA		14668888|15937083
VEGFA	7422	Dermatitis, Contact	MESH:D003877	marker/mechanism		NA		25724174
VEGFA	7422	Diabetes Complications	MESH:D048909	marker/mechanism		NA		26073000
VEGFA	7422	Diabetes Mellitus, Experimental	MESH:D003921	marker/mechanism		NA		22191573
VEGFA	7422	Diabetic Nephropathies	MESH:D003928	marker/mechanism		NA		18630688
VEGFA	7422	Diabetic Retinopathy	MESH:D003930	marker/mechanism		NA		11978667|15788408|20577866
VEGFA	7422	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		17380299
VEGFA	7422	Epilepsy, Temporal Lobe	MESH:D004833	marker/mechanism		NA		17533168
VEGFA	7422	Erectile Dysfunction	MESH:D007172	marker/mechanism		NA		12002441
VEGFA	7422	Glioblastoma	MESH:D005909	marker/mechanism		NA		16356833
VEGFA	7422	Gliosarcoma	MESH:D018316	marker/mechanism		NA		16533777
VEGFA	7422	Head and Neck Neoplasms	MESH:D006258	marker/mechanism		NA		16499871
VEGFA	7422	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		26073000
VEGFA	7422	Heart Diseases	MESH:D006331	marker/mechanism		NA		16844662
VEGFA	7422	Heart Failure	MESH:D006333	marker/mechanism		NA		15732037|15880336
VEGFA	7422	Hemangiosarcoma	MESH:D006394	marker/mechanism		NA		17569031
VEGFA	7422	Hypertension, Portal	MESH:D006975	therapeutic		NA		18416461
VEGFA	7422	Hypoxia-Ischemia, Brain	MESH:D020925	marker/mechanism		NA		23694759
VEGFA	7422	Inflammation	MESH:D007249	marker/mechanism		NA		19324842
VEGFA	7422	Learning Disabilities	MESH:D007859	therapeutic		NA		20801723
VEGFA	7422	Leukemia, Myeloid	MESH:D007951	marker/mechanism		NA		21535412
VEGFA	7422	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		11981751
VEGFA	7422	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism|therapeutic		NA		18416461|18458672
VEGFA	7422	Liver Failure	MESH:D017093	therapeutic		NA		16757304
VEGFA	7422	Lung Diseases	MESH:D008171	marker/mechanism		NA		23618901
VEGFA	7422	Macular Degeneration	MESH:D008268	marker/mechanism		NA		15788408
VEGFA	7422	Macular Edema	MESH:D008269	marker/mechanism		NA		20577866
VEGFA	7422	Memory Disorders	MESH:D008569	therapeutic		NA		20801723
VEGFA	7422	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 1	OMIM:603933	marker/mechanism		NA	603933	
VEGFA	7422	Myocardial Ischemia	MESH:D017202	marker/mechanism|therapeutic		NA		14503966|14583313|15347709|16214533|9860779
VEGFA	7422	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		22050707
VEGFA	7422	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		15659795|18930813|20158913
VEGFA	7422	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		20158913
VEGFA	7422	Neoplasms	MESH:D009369	marker/mechanism		NA		18494554
VEGFA	7422	Neoplasms, Experimental	MESH:D009374	marker/mechanism|therapeutic		NA		20376344|20932960|28574600
VEGFA	7422	Neovascularization, Pathologic	MESH:D009389	marker/mechanism		NA		12399228|17533168
VEGFA	7422	Osteochondrodysplasias	MESH:D010009	therapeutic		NA		24235232
VEGFA	7422	Osteosarcoma	MESH:D012516	marker/mechanism		NA		20158913
VEGFA	7422	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		12399228
VEGFA	7422	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		12893367|16606632|16908180|20052738
VEGFA	7422	Proteinuria	MESH:D011507	marker/mechanism		NA		22808199
VEGFA	7422	Psoriasis	MESH:D011565	marker/mechanism		NA		16385345
VEGFA	7422	Respiratory Hypersensitivity	MESH:D012130	marker/mechanism		NA		30608172
VEGFA	7422	Retinal Diseases	MESH:D012164	marker/mechanism		NA		19324842
VEGFA	7422	Retinal Vein Occlusion	MESH:D012170	marker/mechanism		NA		16680105
VEGFA	7422	Rhabdomyosarcoma	MESH:D012208	marker/mechanism		NA		16116481
VEGFA	7422	Spinal Cord Injuries	MESH:D013119	marker/mechanism		NA		21092735
VEGFA	7422	Status Epilepticus	MESH:D013226	marker/mechanism		NA		17533168
VEGFA	7422	Stomach Ulcer	MESH:D013276	marker/mechanism		NA		11353854
VEGFA	7422	Thrombotic Microangiopathies	MESH:D057049	marker/mechanism		NA		22808199
VEGFA	7422	Urologic Neoplasms	MESH:D014571	marker/mechanism		NA		23009795
VEGFA	7422	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		26432044
VEGFAA	30682	Cerebrovascular Disorders	MESH:D002561	therapeutic		NA		24128854
VEGFB	7423	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		23146280
VEGFB	7423	Disease Progression	MESH:D018450	marker/mechanism		NA		23146280
VEGFB	7423	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		24604347
VEGFC	7424	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18509974|26124351
VEGFC	7424	Hemangiosarcoma	MESH:D006394	marker/mechanism		NA		17569031
VEGFC	7424	LYMPHATIC MALFORMATION 4	OMIM:615907	marker/mechanism		NA	615907	
VEGFC	7424	Melanoma	MESH:D008545	marker/mechanism		NA		17562445
VEGFC	7424	Recurrence	MESH:D012008	marker/mechanism		NA		26124351
VEGFD	2277	Lymphangioleiomyomatosis	MESH:D018192	marker/mechanism		NA		20038814
VEGFD	2277	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		16526316
VENTX	27287	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		30431698
VGF	7425	Hyperphagia	MESH:D006963	therapeutic		NA		12177191
VGF	7425	Obesity	MESH:D009765	therapeutic		NA		12177191
VGF	7425	Stomach Ulcer	MESH:D013276	therapeutic		NA		20805684
VGLL2	245806	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
VHL	7428	Adenoma	MESH:D000236	marker/mechanism		NA		16061637
VHL	7428	Carcinoma	MESH:D002277	marker/mechanism		NA		16061637
VHL	7428	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA	144700	10340905|11171960|15177666|19473641|21097529|22138691|23797736|24755467|9137812
VHL	7428	Erythrocytosis, Familial, 2	MESH:C563918	marker/mechanism		NA	263400	
VHL	7428	Kidney Neoplasms	MESH:D007680	marker/mechanism		NA		11880179
VHL	7428	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		16061637
VHL	7428	Pheochromocytoma	MESH:D010673	marker/mechanism		NA	171300	9215674
VHL	7428	von Hippel-Lindau Disease	MESH:D006623	marker/mechanism		NA	193300	11171960
VHL	7428	Wilms Tumor	MESH:D009396	marker/mechanism		NA		11880179
VIL1	7429	Cholestasis	MESH:D002779	marker/mechanism		NA		27989131
VIM	7431	Acute Coronary Syndrome	MESH:D054058	marker/mechanism		NA		21751358
VIM	7431	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
VIM	7431	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21501481|24014025|25330770|27811057
VIM	7431	Carcinosarcoma	MESH:D002296	marker/mechanism		NA		15132766
VIM	7431	Cataract	MESH:D002386	marker/mechanism		NA		19126778
VIM	7431	Cataract, Nuclear Diffuse Nonprogressive	MESH:C566157	marker/mechanism		NA	116300	
VIM	7431	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		24014025
VIM	7431	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
VIM	7431	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		16831193
VIM	7431	Fibrosis	MESH:D005355	marker/mechanism		NA		31697999
VIM	7431	Kidney Diseases	MESH:D007674	marker/mechanism		NA		31697999
VIM	7431	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		25226513|26396155|32659284
VIM	7431	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
VIM	7431	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		22784439
VIM	7431	Motor Neuron Disease	MESH:D016472	marker/mechanism		NA		16831193
VIM	7431	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		27811057
VIM	7431	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17085005
VIM	7431	Nephrosis	MESH:D009401	marker/mechanism		NA		16418842
VIM	7431	Neurodegenerative Diseases	MESH:D019636	marker/mechanism		NA		16831193
VIM	7431	Osteoarthritis	MESH:D010003	marker/mechanism		NA		16876394|18784066
VIM	7431	Peritoneal Neoplasms	MESH:D010534	marker/mechanism		NA		22784439
VIM	7431	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17566973|24763052
VIM	7431	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		23075401
VIM	7431	Retinal Diseases	MESH:D012164	marker/mechanism		NA		23075401
VIM	7431	Sarcoma, Synovial	MESH:D013584	marker/mechanism		NA		15043115
VIM	7431	Severe Acute Respiratory Syndrome	MESH:D045169	marker/mechanism		NA		26801988
VIM	7431	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
VIP	7432	Acute Lung Injury	MESH:D055371	therapeutic		NA		8643465
VIP	7432	Autistic Disorder	MESH:D001321	marker/mechanism		NA		17521630
VIP	7432	Bronchial Hyperreactivity	MESH:D016535	marker/mechanism		NA		15127121|15144609
VIP	7432	Cognition Disorders	MESH:D003072	therapeutic		NA		8208360
VIP	7432	Down Syndrome	MESH:D004314	marker/mechanism		NA		16289943
VIP	7432	Edema	MESH:D004487	marker/mechanism		NA		7508328
VIP	7432	Erectile Dysfunction	MESH:D007172	therapeutic		NA		10233493
VIP	7432	Flushing	MESH:D005483	marker/mechanism		NA		10233493
VIP	7432	Hyperalgesia	MESH:D006930	marker/mechanism		NA		12787826
VIP	7432	Hypotension	MESH:D007022	marker/mechanism		NA		9881641
VIP	7432	Intellectual Disability	MESH:D008607	marker/mechanism		NA		11357950
VIP	7432	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		19189304
VIP	7432	Pain	MESH:D010146	therapeutic		NA		9920454
VIP	7432	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		19189304
VIP	7432	Rhinitis	MESH:D012220	marker/mechanism		NA		12746121|14680090
VIP	7432	Tachycardia	MESH:D013610	marker/mechanism		NA		3261545
VIP	7432	Urinary Bladder Diseases	MESH:D001745	marker/mechanism		NA		18299998
VIPAS39	63894	Arthrogryposis renal dysfunction cholestasis syndrome	MESH:C535382	marker/mechanism		NA	613404	20190753
VIPR1	7433	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
VIPR1	7433	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
VIPR2	7434	Schizophrenia	MESH:D012559	marker/mechanism		NA		21285140
VKORC1	79001	Aortic Rupture	MESH:D001019	marker/mechanism		NA		16549638
VKORC1	79001	Blood Coagulation Disorders	MESH:D001778	marker/mechanism		NA		19141161
VKORC1	79001	Coronary Disease	MESH:D003327	marker/mechanism		NA		16549638
VKORC1	79001	Coumarin Resistance	MESH:C563039	marker/mechanism		NA	122700	14765194|20210733|20386359|20497562|20579077
VKORC1	79001	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		26445138
VKORC1	79001	Hemorrhage	MESH:D006470	marker/mechanism		NA		20597268|26445138
VKORC1	79001	Stroke	MESH:D020521	marker/mechanism		NA		16549638
VKORC1	79001	Thrombosis	MESH:D013927	marker/mechanism		NA		29581108
VKORC1	79001	Vascular Diseases	MESH:D014652	marker/mechanism		NA		16549638
VKORC1	79001	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 2	OMIM:607473	marker/mechanism		NA	607473	14765194
VLDLR	7436	Autistic Disorder	MESH:D001321	marker/mechanism		NA		15820235
VLDLR	7436	Dysequilibrium syndrome	MESH:C535731	marker/mechanism		NA	224050	
VLDLR	7436	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		29289645
VLDLR	7436	Obesity	MESH:D009765	marker/mechanism		NA		20975297
VMA21	203547	Myopathy, X-Linked, with Excessive Autophagy	MESH:C564093	marker/mechanism		NA	310440	
VMAT	3346192	Infertility	MESH:D007246	marker/mechanism		NA		16189511
VMO1	284013	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		23797736
VN1R31P	100312787	Skin Diseases	MESH:D012871	marker/mechanism		NA		28720099
VNN1	8876	Celiac Disease	MESH:D002446	marker/mechanism		NA		30097691
VNN1	8876	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		19322213
VNN1	8876	Dyslipidemias	MESH:D050171	marker/mechanism		NA		17873875
VNN1	8876	Inflammatory Bowel Diseases	MESH:D015212	therapeutic		NA		17145956
VNN1	8876	Psoriasis	MESH:D011565	marker/mechanism		NA		19322213
VNN2	8875	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		19322213
VNN2	8875	Psoriasis	MESH:D011565	marker/mechanism		NA		19322213
VNN3	55350	Psoriasis	MESH:D011565	marker/mechanism		NA		19322213
VOPP1	81552	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		18206229
VOPP1	81552	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
VPREB1	7441	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		26214592
VPS11	55823	LEUKODYSTROPHY, HYPOMYELINATING, 12	OMIM:616683	marker/mechanism		NA	616683	
VPS13A	23230	Neuroacanthocytosis	MESH:D054546	marker/mechanism		NA	200150	
VPS13B	157680	Cohen syndrome	MESH:C536438	marker/mechanism		NA	216550	12730828|15154116|17990063
VPS13C	54832	PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET	OMIM:616840	marker/mechanism		NA	616840	
VPS13D	55187	Spinocerebellar ataxia, autosomal recessive 4	MESH:C537310	marker/mechanism		NA	607317	
VPS13D	55187	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
VPS26A	9559	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		21874001
VPS33A	65082	MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME	OMIM:617303	marker/mechanism		NA	617303	
VPS33B	26276	Arthrogryposis renal dysfunction cholestasis syndrome	MESH:C535382	marker/mechanism		NA	208085	
VPS35	55737	Parkinson Disease	MESH:D010300	marker/mechanism		NA		25149416
VPS35	55737	PARKINSON DISEASE 17	OMIM:614203	marker/mechanism		NA	614203	
VPS35	55737	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
VPS37A	137492	SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	OMIM:614898	marker/mechanism		NA	614898	
VPS39	23339	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21466612
VPS39	23339	Schizophrenia	MESH:D012559	marker/mechanism		NA		23042115
VPS45	11311	Familial myelofibrosis	MESH:C536848	marker/mechanism		NA		23599270
VPS45	11311	NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE	OMIM:615285	marker/mechanism		NA	615285	
VPS45	11311	Neutropenia, Severe Congenital, Autosomal Recessive 3	MESH:C537592	marker/mechanism		NA		23599270
VPS52	6293	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		24763052
VPS53	55275	PONTOCEREBELLAR HYPOPLASIA, TYPE 2E	OMIM:615851	marker/mechanism		NA	615851	
VPS54	51542	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		19693665
VRK1	7443	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
VRK1	7443	Pontocerebellar Hypoplasia Type 1	MESH:C548069	marker/mechanism		NA	607596	
VSIG4	11326	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
VSIG4	11326	Glomerulonephritis, IGA	MESH:D005922	marker/mechanism		NA		25133636
VSIG4	11326	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		18206229
VSIR	64115	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
VSNL1	7447	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		25806004
VSX1	30813	Auditory Perceptual Disorders	MESH:D001308	marker/mechanism		NA		15051220
VSX1	30813	Corneal Dystrophies, Hereditary	MESH:D003317	marker/mechanism		NA		11978762
VSX1	30813	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		15051220
VSX1	30813	CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME	OMIM:614195	marker/mechanism		NA	614195	
VSX1	30813	Empty Sella Syndrome	MESH:D004652	marker/mechanism		NA		15051220
VSX1	30813	Eye Abnormalities	MESH:D005124	marker/mechanism		NA		15051220
VSX1	30813	Keratoconus	MESH:D007640	marker/mechanism		NA		11978762|15623752
VSX1	30813	Keratoconus 1	MESH:C563649	marker/mechanism		NA	148300	
VSX1	30813	Retinal Diseases	MESH:D012164	marker/mechanism		NA		15051220
VSX2	338917	Microphthalmia, Isolated 2	MESH:C566446	marker/mechanism		NA	610093	
VSX2	338917	Microphthalmia, Isolated, with Coloboma 3	MESH:C566447	marker/mechanism		NA	610092	
VTG	100190880	Hypoxia	MESH:D000860	marker/mechanism		NA		18258771
VTI1A	143187	Adenocarcinoma	MESH:D000230	marker/mechanism		NA		21892161
VTI1A	143187	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		21892161
VTN	7448	Crohn Disease	MESH:D003424	marker/mechanism		NA		19751734
VTN	7448	Liver Cirrhosis	MESH:D008103	marker/mechanism		NA		26396155
VWA3A	146177	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		26039340
VWA3B	200403	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA	616948	
VWA8	23078	Autistic Disorder	MESH:D001321	marker/mechanism		NA		20663923
VWF	7450	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		17890461
VWF	7450	Cardiovascular Diseases	MESH:D002318	marker/mechanism		NA		16332659
VWF	7450	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		28527913
VWF	7450	Heart Failure	MESH:D006333	marker/mechanism		NA		22352330
VWF	7450	Hypertension	MESH:D006973	marker/mechanism		NA		12149661|12425201|22352330
VWF	7450	Intracranial Thrombosis	MESH:D020767	marker/mechanism		NA		3111251
VWF	7450	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		28527913
VWF	7450	Thrombosis	MESH:D013927	marker/mechanism		NA		22352330|3875694
VWF	7450	von Willebrand Disease, Type 1	MESH:D056725	marker/mechanism		NA	193400	
VWF	7450	von Willebrand Disease, Type 2	MESH:D056728	marker/mechanism		NA	613554	
VWF	7450	von Willebrand Disease, Type 3	MESH:D056729	marker/mechanism		NA	277480	
WAC	51322	DESANTO-SHINAWI SYNDROME	OMIM:616708	marker/mechanism		NA	616708	
WAC	51322	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
WAC	51322	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		28319090
WAP	22373	Carcinoma	MESH:D002277	marker/mechanism		NA		16316942
WAP	22373	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		16316942
WAP	22373	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		16316942
WARS1	7453	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
WAS	7454	Neutropenia, Severe Congenital, X-Linked	MESH:C564539	marker/mechanism		NA	300299	17724125
WAS	7454	Thrombocytopenia 1	MESH:C564052	marker/mechanism		NA	313900	
WAS	7454	Wiskott-Aldrich Syndrome	MESH:D014923	marker/mechanism		NA	301000	11598004
WASF3	10810	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
WASF3	10810	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
WASHC4	23325	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43	OMIM:615817	marker/mechanism		NA	615817	
WASHC5	9897	3C syndrome	MESH:C535313	marker/mechanism		NA	220210	
WASHC5	9897	Spastic Paraplegia Type 8	MESH:C580458	marker/mechanism		NA	603563	
WASL	8976	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
WDFY3	23001	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
WDFY4	57705	Autistic Disorder	MESH:D001321	marker/mechanism		NA		30559488
WDFY4	57705	Developmental Disabilities	MESH:D002658	marker/mechanism		NA		30559488
WDPCP	51057	BARDET-BIEDL SYNDROME 15	OMIM:615992	marker/mechanism		NA	615992	
WDPCP	51057	Orstavik Lindemann Solberg syndrome	MESH:C537137	marker/mechanism		NA	217085	
WDR1	9948	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
WDR1	9948	Inflammation	MESH:D007249	marker/mechanism		NA		17515402
WDR1	9948	Osteoporosis	MESH:D010024	marker/mechanism		NA		18924182
WDR1	9948	Thrombocytopenia	MESH:D013921	marker/mechanism		NA		17515402
WDR11	55717	HYPOGONADOTROPIC HYPOGONADISM 14 WITH OR WITHOUT ANOSMIA	OMIM:614858	marker/mechanism		NA	614858	
WDR11	55717	Idiopathic Hypogonadotropic Hypogonadism	MESH:C562785	marker/mechanism		NA	146110	
WDR11	55717	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
WDR11	55717	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
WDR12	55759	Cardiomyopathy, Dilated	MESH:D002311	marker/mechanism		NA		25915632
WDR12	55759	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		21378990
WDR12	55759	Myocardial Infarction	MESH:D009203	marker/mechanism		NA		19198609|25915632
WDR17	116966	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
WDR19	57728	Cranioectodermal Dysplasia	MESH:C562966	marker/mechanism		NA	614378	
WDR20	91833	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
WDR-23	172518	Gait Disorders, Neurologic	MESH:D020233	marker/mechanism		NA		23555279
WDR35	57539	Cranioectodermal Dysplasia	MESH:C562966	marker/mechanism		NA	613610	
WDR35	57539	Craniosynostoses	MESH:D003398	marker/mechanism		NA		20817137
WDR35	57539	Short Rib-Polydactyly Syndrome	MESH:D012779	marker/mechanism		NA	614091	
WDR36	134430	Asthma	MESH:D001249	marker/mechanism		NA		19198610
WDR36	134430	Glaucoma 1, Open Angle, G	MESH:C563692	marker/mechanism		NA	609887	
WDR36	134430	Glaucoma, Open-Angle	MESH:D005902	marker/mechanism		NA		21059646
WDR45	11152	Epilepsy	MESH:D004827	marker/mechanism		NA		29942082
WDR45	11152	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
WDR45	11152	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5	OMIM:300894	marker/mechanism		NA	300894	
WDR45	11152	Neurodegeneration with brain iron accumulation (NBIA)	MESH:C538421	marker/mechanism		NA		23435086
WDR45	11152	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889|29942082
WDR45B	56270	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
WDR46	9277	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
WDR46	9277	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
WDR62	284403	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
WDR62	284403	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
WDR62	284403	Malformations of Cortical Development	MESH:D054220	marker/mechanism		NA		23341463
WDR62	284403	Microcephaly	MESH:D008831	marker/mechanism		NA		20890278|20890279
WDR62	284403	Microcephaly, Primary Autosomal Recessive, 2	MESH:C565794	marker/mechanism		NA	604317	
WDR72	256764	Amelogenesis Imperfecta, Hypomaturation Type, Iia3	MESH:C567706	marker/mechanism		NA	613211	
WDR73	84942	Galloway Mowat syndrome	MESH:C537548	marker/mechanism		NA	251300	25466283
WDR74	54663	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
WDR74	54663	Neoplasms	MESH:D009369	marker/mechanism		NA		25261935
WDR76	79968	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
WDR77	79084	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		22022581
WDR81	124997	Cerebellar Ataxia, Mental Retardation, And Dysequilibrium Syndrome 2	MESH:C567656	marker/mechanism		NA	610185	
WEE1	7465	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		25125259
WFDC1	58189	Melanoma	MESH:D008545	marker/mechanism		NA		17145863
WFDC2	10406	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
WFDC21	66107	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
WFS1	7466	CATARACT 41	OMIM:116400	marker/mechanism		NA	116400	
WFS1	7466	Deafness, Autosomal Dominant 6	MESH:C563421	marker/mechanism		NA	600965	
WFS1	7466	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA	125853	17603484
WFS1	7466	Wolfram-Like Syndrome, Autosomal Dominant	MESH:C565631	marker/mechanism		NA	614296	
WFS1	7466	Wolfram Syndrome	MESH:D014929	marker/mechanism		NA	222300	24705017
WHCR	7467	Wolf-Hirschhorn Syndrome	MESH:D054877	marker/mechanism		NA	194190	
WHRN	25861	Deafness, Autosomal Recessive 31	MESH:C564629	marker/mechanism		NA	607084	
WHRN	25861	USHER SYNDROME, TYPE IID	OMIM:611383	marker/mechanism		NA	611383	
WIF1	11197	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17923031
WIF1	11197	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		17384664
WIF1	11197	Nasopharyngeal Neoplasms	MESH:D009303	marker/mechanism		NA		17384664
WIF1	11197	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
WIPF1	7456	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
WIPF1	7456	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
WIPF1	7456	Wiskott-Aldrich Syndrome	MESH:D014923	marker/mechanism		NA	614493	
WIPI1	55062	Cholestasis	MESH:D002779	marker/mechanism		NA		27989131
WIPI1	55062	Lipidoses	MESH:D008064	marker/mechanism		NA		15342952|16919414|17175557
WLS	79971	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
WNK1	65125	Hypertension	MESH:D006973	marker/mechanism		NA		22949526
WNK1	65125	Kidney Diseases	MESH:D007674	marker/mechanism		NA		21865292
WNK1	65125	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA	OMIM:201300	marker/mechanism		NA	201300	
WNK1	65125	Pseudohypoaldosteronism	MESH:D011546	marker/mechanism		NA		22949526
WNK1	65125	Pseudohypoaldosteronism, Type IIc	MESH:C564162	marker/mechanism		NA	614492	
WNK4	65266	Hypertension	MESH:D006973	marker/mechanism		NA		22949526
WNK4	65266	Pseudohypoaldosteronism	MESH:D011546	marker/mechanism		NA		22949526
WNK4	65266	Pseudohypoaldosteronism, Type IIb	MESH:C564161	marker/mechanism		NA	614491	
WNT1	7471	OSTEOGENESIS IMPERFECTA, TYPE XV	OMIM:615220	marker/mechanism		NA	615220	
WNT1	7471	Osteoporosis	MESH:D010024	marker/mechanism		NA	615221	
WNT10A	80326	Lymphoma, Mantle-Cell	MESH:D020522	marker/mechanism		NA		18787224
WNT10A	80326	Odontoonychodermal dysplasia	MESH:C537742	marker/mechanism		NA	257980	
WNT10A	80326	Schopf-Schulz-Passarge Syndrome	MESH:C565607	marker/mechanism		NA	224750	
WNT10A	80326	Tooth Agenesis, Selective, 4	MESH:C563634	marker/mechanism		NA	150400	
WNT10B	7480	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		12437293
WNT10B	7480	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		27415467
WNT10B	7480	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		27415467
WNT10B	7480	Split-Hand-Foot Malformation 6	MESH:C567616	marker/mechanism		NA	225300	
WNT10B	7480	TOOTH AGENESIS, SELECTIVE, 8	OMIM:617073	marker/mechanism		NA	617073	
WNT11	7481	Abnormalities, Drug-Induced	MESH:D000014	marker/mechanism		NA		25783350
WNT11	7481	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		25783350
WNT11	7481	Hernias, Diaphragmatic, Congenital	MESH:D065630	marker/mechanism		NA		25783350
WNT2	7472	Autistic Disorder	MESH:D001321	marker/mechanism		NA		11449391|19895723
WNT2	7472	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		25061499
WNT2B	7482	Stroke	MESH:D020521	marker/mechanism		NA		29531354
WNT3	7473	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		30061737
WNT3	7473	Lymphoma, Mantle-Cell	MESH:D020522	marker/mechanism		NA		18787224
WNT3	7473	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
WNT3	7473	Tetra-amelia autosomal recessive	MESH:C536498	marker/mechanism		NA	273395	
WNT3A	89780	Obesity	MESH:D009765	marker/mechanism		NA		28242765
WNT3A	89780	Reperfusion Injury	MESH:D015427	therapeutic		NA		23875703
WNT4	54361	46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS	OMIM:611812	marker/mechanism		NA	611812	
WNT4	54361	Carcinoma, Ovarian Epithelial	MESH:D000077216	marker/mechanism		NA		25581431
WNT4	54361	Dwarfism	MESH:D004392	marker/mechanism		NA		17505543
WNT4	54361	Female Urogenital Diseases	MESH:D052776	marker/mechanism		NA		16002989
WNT4	54361	Kidney Diseases	MESH:D007674	marker/mechanism		NA		11832423
WNT4	54361	Mullerian Aplasia and Hyperandrogenism	MESH:C567186	marker/mechanism		NA	158330	
WNT4	54361	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17013881
WNT5A	7474	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		19061910
WNT5A	7474	Female Urogenital Diseases	MESH:D052776	marker/mechanism		NA		16002989
WNT5A	7474	Idiopathic Pulmonary Fibrosis	MESH:D054990	marker/mechanism		NA		28726637
WNT5A	7474	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		23349696
WNT5A	7474	Robinow Syndrome	MESH:C562492	marker/mechanism		NA	180700	
WNT5A	7474	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		25061499
WNT5B	81029	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
WNT5B	81029	Leiomyoma	MESH:D007889	marker/mechanism		NA		15972578
WNT5B	81029	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
WNT7A	7476	Al Awadi syndrome	MESH:C535612	marker/mechanism		NA	276820	
WNT7A	7476	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
WNT7A	7476	Female Urogenital Diseases	MESH:D052776	marker/mechanism		NA		16002989
WNT7A	7476	Fuhrmann syndrome	MESH:C538189	marker/mechanism		NA	228930	
WNT7A	7476	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		25174399
WNT7A	7476	Urogenital Neoplasms	MESH:D014565	marker/mechanism		NA		15751030
WNT8A	7478	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		22544366
WRAP53	55135	Body Weight	MESH:D001835	marker/mechanism		NA		31243981
WRAP53	55135	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 3	OMIM:613988	marker/mechanism		NA	613988	
WRN	7486	Aging, Premature	MESH:D019588	marker/mechanism		NA		21267443
WRN	7486	DNA Repair-Deficiency Disorders	MESH:D049914	marker/mechanism		NA		29616805
WRN	7486	Werner Syndrome	MESH:D014898	marker/mechanism		NA	277700	21267443|22766507
WSCD1	23302	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
WSCD1	23302	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		19233941
WT1	7490	Aniridia	MESH:D015783	marker/mechanism		NA	106210	
WT1	7490	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		14961577
WT1	7490	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		14961577
WT1	7490	Denys-Drash Syndrome	MESH:D030321	marker/mechanism		NA	194080	
WT1	7490	Frasier Syndrome	MESH:D052159	marker/mechanism		NA	136680	
WT1	7490	Glioblastoma	MESH:D005909	marker/mechanism		NA		20820871
WT1	7490	Glomerulonephritis	MESH:D005921	marker/mechanism		NA		20962747
WT1	7490	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		17436238
WT1	7490	Hernias, Diaphragmatic, Congenital	MESH:D065630	marker/mechanism		NA		21072664
WT1	7490	Leukemia	MESH:D007938	marker/mechanism		NA		14961577
WT1	7490	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	MESH:D015464	marker/mechanism		NA		17157168
WT1	7490	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		19822134|27992414
WT1	7490	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		26285909
WT1	7490	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		14961577
WT1	7490	Meacham Winn Culler syndrome	MESH:C538162	marker/mechanism		NA	608978	
WT1	7490	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA	156240	22784439
WT1	7490	NEPHROTIC SYNDROME, TYPE 4	OMIM:256370	marker/mechanism		NA	256370	
WT1	7490	Neurilemmoma	MESH:D009442	therapeutic		NA		25474318
WT1	7490	Osteosarcoma	MESH:D012516	marker/mechanism		NA		28107196
WT1	7490	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		19196508
WT1	7490	Peritoneal Neoplasms	MESH:D010534	marker/mechanism		NA		22784439
WT1	7490	Primary Ovarian Insufficiency	MESH:D016649	marker/mechanism		NA		26358501
WT1	7490	WAGR Syndrome	MESH:D017624	marker/mechanism		NA	194072	
WT1	7490	Wilms Tumor	MESH:D009396	marker/mechanism		NA	194070	15591903|28825729
WTRS	619509	Wittwer syndrome	MESH:C536737	marker/mechanism		NA		25251057
WTRS	619509	Wolf-Hirschhorn Syndrome	MESH:D054877	marker/mechanism		NA		25251057
WWC1	23286	Mesothelioma, Malignant	MESH:C562839	marker/mechanism		NA		25756049
WWOX	51741	Alzheimer Disease	MESH:D000544	marker/mechanism		NA		30820047
WWOX	51741	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
WWOX	51741	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		17200365
WWOX	51741	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		17575124
WWOX	51741	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 28	OMIM:616211	marker/mechanism		NA	616211	
WWOX	51741	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA	133239	
WWOX	51741	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		25526675
WWOX	51741	Spinocerebellar Ataxias	MESH:D020754	marker/mechanism		NA	614322	
WWOX	51741	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		17575124
WWOX	51741	Urologic Neoplasms	MESH:D014571	marker/mechanism		NA		23618899
WWP2	11060	Osteoarthritis, Knee	MESH:D020370	marker/mechanism		NA		30374069
WWTR1	25937	Muscular Atrophy	MESH:D009133	therapeutic		NA		24550007
WWTR1	25937	Rhabdomyosarcoma, Alveolar	MESH:D018232	marker/mechanism		NA		31494105
XAF1	54739	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		15843754|17087954
XAF1	54739	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		17570219
XAF1	54739	Glioma	MESH:D005910	marker/mechanism		NA		28122345
XAF1	54739	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
XAF1	54739	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		17087954
XAGE1A	653220	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		24648988
XAGE1B	653067	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
XBP1	7494	Fatty Liver	MESH:D005234	marker/mechanism		NA		24097666
XBP1	7494	Glioma	MESH:D005910	marker/mechanism		NA		21138464
XBP1	7494	Glucose Intolerance	MESH:D018149	therapeutic		NA		27325692
XBP1	7494	Insulin Resistance	MESH:D007333	therapeutic		NA		27325692
XBP1	7494	Major Affective Disorder 7	MESH:C567529	marker/mechanism		NA	612371	
XBP1	7494	Non-alcoholic Fatty Liver Disease	MESH:D065626	marker/mechanism		NA		24097666
XBP1	7494	Spinal Cord Injuries	MESH:D013119	marker/mechanism		NA		29793971
XDH	7498	Autistic Disorder	MESH:D001321	marker/mechanism		NA		15205966
XDH	7498	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
XDH	7498	Depressive Disorder, Major	MESH:D003865	marker/mechanism		NA		20471444
XDH	7498	Gout	MESH:D006073	marker/mechanism		NA		29071757
XDH	7498	Heart Diseases	MESH:D006331	marker/mechanism		NA		17217956
XDH	7498	Heart Failure	MESH:D006333	marker/mechanism		NA		19933411
XDH	7498	Hyperuricemia	MESH:D033461	marker/mechanism		NA		29071757
XDH	7498	Infarction, Middle Cerebral Artery	MESH:D020244	marker/mechanism		NA		12374626
XDH	7498	Ischemia	MESH:D007511	marker/mechanism		NA		22688000
XDH	7498	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
XDH	7498	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
XDH	7498	Multiple Organ Failure	MESH:D009102	marker/mechanism		NA		26968635
XDH	7498	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		9147382
XDH	7498	Pulmonary Embolism	MESH:D011655	marker/mechanism		NA		2510358
XDH	7498	Reperfusion Injury	MESH:D015427	marker/mechanism		NA		12910483
XDH	7498	Thrombocytopenia	MESH:D013921	marker/mechanism		NA		2510358
XDH	7498	Xanthinuria, Type I	MESH:C562584	marker/mechanism		NA	278300	
XIAP	331	Amyotrophic lateral sclerosis 1	MESH:C531617	marker/mechanism		NA		11796754
XIAP	331	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		17611394
XIAP	331	Lymphoproliferative Disorders	MESH:D008232	marker/mechanism		NA	308240	
XIAP	331	Lymphoproliferative Syndrome, X-Linked, 2	MESH:C564469	marker/mechanism		NA	300635	
XIAP	331	Mammary Neoplasms, Experimental	MESH:D008325	therapeutic		NA		12766084
XIAP	331	Myocardial Reperfusion Injury	MESH:D015428	marker/mechanism		NA		14998631
XIAP	331	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		21442130
XIRP1	165904	Poisoning	MESH:D011041	marker/mechanism		NA		21964422
XIST	7503	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
XIST	7503	X Inactivation, Familial Skewed, 1	MESH:C564716	marker/mechanism		NA	300087	
XK	7504	Hematologic Diseases	MESH:D006402	marker/mechanism		NA		8004674|8619554
XK	7504	Mental Disorders	MESH:D001523	marker/mechanism		NA		11261514
XK	7504	Movement Disorders	MESH:D009069	marker/mechanism		NA		11261514
XK	7504	Neuroacanthocytosis	MESH:D054546	marker/mechanism		NA		11761473|8619554
XK	7504	Neuroacanthocytosis, Mcleod Type	MESH:C564038	marker/mechanism		NA	300842	
XK	7504	Neuromuscular Diseases	MESH:D009468	marker/mechanism		NA		8004674|8619554
XK	7504	Peripheral Nervous System Diseases	MESH:D010523	marker/mechanism		NA		11761473
XKR4	114786	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
XKRY	9082	Spermatogenic Failure, Nonobstructive, Y-Linked	MESH:C564030	marker/mechanism		NA	415000	
XPA	7507	Carcinoma, Basal Cell	MESH:D002280	marker/mechanism		NA		17687452
XPA	7507	Intestinal Neoplasms	MESH:D007414	marker/mechanism		NA		16962818
XPA	7507	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		24084170
XPA	7507	Micronuclei, Chromosome-Defective	MESH:D048629	marker/mechanism		NA		21216194|9885240
XPA	7507	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		10755388|16962818
XPA	7507	Xeroderma Pigmentosum	MESH:D014983	marker/mechanism		NA	278700	24084170
XPC	7508	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		21327329|27777383
XPC	7508	Amino Acid Metabolism, Inborn Errors	MESH:D000592	marker/mechanism		NA		9804340
XPC	7508	Autistic Disorder	MESH:D001321	marker/mechanism		NA		9804340
XPC	7508	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		27777383
XPC	7508	Carcinoma, Squamous Cell	MESH:D002294	marker/mechanism		NA		27777383
XPC	7508	Chromosome Aberrations	MESH:D002869	marker/mechanism		NA		20106949
XPC	7508	Disease Progression	MESH:D018450	marker/mechanism		NA		27777383
XPC	7508	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		24084170
XPC	7508	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		17325666|24084170
XPC	7508	Micronuclei, Chromosome-Defective	MESH:D048629	marker/mechanism		NA		21216194
XPC	7508	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		27777383
XPC	7508	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		27777383
XPC	7508	Xeroderma Pigmentosum	MESH:D014983	marker/mechanism		NA		24084170
XPC	7508	Xeroderma Pigmentosum, Complementation Group C	MESH:C567886	marker/mechanism		NA	278720	
XPD	37414	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		26295053
XPNPEP2	7512	Angioedema	MESH:D000799	marker/mechanism		NA		16175507
XPNPEP2	7512	ANGIOEDEMA INDUCED BY ACE INHIBITORS, SUSCEPTIBILITY TO	OMIM:300909	marker/mechanism		NA	300909	
XPNPEP2	7512	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
XPNPEP2	7512	Primary Ovarian Insufficiency	MESH:D016649	marker/mechanism		NA		25568306
XPNPEP3	63929	NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	OMIM:613159	marker/mechanism		NA	613159	
XPO1	7514	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
XPO1	7514	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475
XPO5	57510	Lead Poisoning	MESH:D007855	marker/mechanism		NA		28042866
XPO5	57510	Microsatellite Instability	MESH:D053842	marker/mechanism		NA		25701956
XPO5	57510	Nephrotic syndrome, idiopathic, steroid-resistant	MESH:C536404	marker/mechanism		NA		26878725
XPO5	57510	Wilms Tumor	MESH:D009396	marker/mechanism		NA		28825729
XPO6	23214	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
XPO7	23039	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
XPR1	9213	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6	OMIM:616413	marker/mechanism		NA	616413	
XPR1	9213	Basal Ganglia Diseases	MESH:D001480	marker/mechanism		NA		25938945
XPR1	9213	Calcinosis	MESH:D002114	marker/mechanism		NA		25938945
XRCC1	7515	Birth Weight	MESH:D001724	marker/mechanism		NA		27592400
XRCC1	7515	Erythema	MESH:D004890	marker/mechanism		NA		24594932
XRCC1	7515	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		16639733
XRCC1	7515	Glioma	MESH:D005910	marker/mechanism		NA		25227852
XRCC1	7515	Mesothelioma	MESH:D008654	marker/mechanism		NA		16564556|20705543
XRCC1	7515	Micronuclei, Chromosome-Defective	MESH:D048629	marker/mechanism		NA		20223788|21351625
XRCC1	7515	Occupational Diseases	MESH:D009784	marker/mechanism		NA		15612468
XRCC1	7515	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054198	marker/mechanism		NA		21983886
XRCC1	7515	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		16406883|17196815|17486273
XRCC1	7515	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		22452940
XRCC1	7515	Stomatitis	MESH:D013280	marker/mechanism		NA		24594932
XRCC2	7516	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		12023982
XRCC2	7516	FANCONI ANEMIA, COMPLEMENTATION GROUP U	OMIM:617247	marker/mechanism		NA	617247	
XRCC3	7517	Breast Neoplasms	MESH:D001943	marker/mechanism		NA	114480	12023982
XRCC3	7517	Carcinoma, Basal Cell	MESH:D002280	marker/mechanism		NA		16501254
XRCC3	7517	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		21347786
XRCC3	7517	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		22613844
XRCC3	7517	Head and Neck Neoplasms	MESH:D006258	marker/mechanism		NA		22613844
XRCC3	7517	Lead Poisoning	MESH:D007855	marker/mechanism		NA		23803535
XRCC3	7517	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		21283680
XRCC3	7517	Melanoma	MESH:D008545	marker/mechanism		NA		11059748
XRCC3	7517	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 6	OMIM:613972	marker/mechanism		NA	613972	
XRCC3	7517	Mesothelioma	MESH:D008654	marker/mechanism		NA		16564556
XRCC3	7517	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		21283680
XRCC3	7517	Skin Neoplasms	MESH:D012878	marker/mechanism		NA		11059748|16501254
XRCC3	7517	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21347786
XRCC4	7518	Chromosome Aberrations	MESH:D002869	marker/mechanism		NA		20726224
XRCC5	7520	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
XRCC5	7520	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
XRCC6	2547	Adenocarcinoma of Lung	MESH:D000077192	marker/mechanism		NA		27602772
XRCC6	2547	Disease Models, Animal	MESH:D004195	marker/mechanism		NA		27602772
XXYLT1	152002	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015|30061737
XYLB	9942	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25231249
XYLT1	64131	Desbuquois syndrome	MESH:C535943	marker/mechanism		NA	615777	
XYLT1	64131	Pseudoxanthoma Elasticum	MESH:D011561	marker/mechanism		NA	264800	
XYLT1	64131	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
XYLT2	64132	Pseudoxanthoma Elasticum	MESH:D011561	marker/mechanism		NA	264800	16571645
YAP1	10413	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		27935819
YAP1	10413	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		28114269
YAP1	10413	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		29698666
YAP1	10413	COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION	OMIM:120433	marker/mechanism		NA	120433	
YAP1	10413	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		30510241
YAP1	10413	Disease Progression	MESH:D018450	marker/mechanism		NA		30703373
YAP1	10413	Hemangioma	MESH:D006391	marker/mechanism		NA		31351048
YAP1	10413	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		28114269
YAP1	10413	Neuroblastoma	MESH:D009447	marker/mechanism		NA		26121086
YAP1	10413	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		20947521
YAP1	10413	Recurrence	MESH:D012008	marker/mechanism		NA		26121086
YAP1	10413	Rhabdomyosarcoma, Embryonal	MESH:D018233	marker/mechanism		NA		31494105
YAP1	10413	Squamous Cell Carcinoma of Head and Neck	MESH:D000077195	marker/mechanism		NA		20729916
YAP1	10413	Triple Negative Breast Neoplasms	MESH:D064726	marker/mechanism		NA		30703373
YARS1	8565	Charcot-Marie-Tooth Disease, Dominant Intermediate C	MESH:C564257	marker/mechanism		NA	608323	
YARS2	51067	Myopathy with lactic acidosis and sideroblastic anemia	MESH:C536101	marker/mechanism		NA	613561	
YBX1	4904	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		15703814
YBX1	4904	Colonic Neoplasms	MESH:D003110	marker/mechanism		NA		28077578
YBX1	4904	Liver Cirrhosis, Experimental	MESH:D008106	therapeutic		NA		16012952
YBX1	4904	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		15703814
YEATS4	8089	Liposarcoma	MESH:D008080	therapeutic		NA		20601955
YES1	7525	Double Outlet Right Ventricle	MESH:D004310	marker/mechanism		NA		24478334
YES1	7525	Heart Septal Defects, Ventricular	MESH:D006345	marker/mechanism		NA		24478334
YES1	7525	Prenatal Injuries	MESH:D049188	marker/mechanism		NA		24478334
YES1	7525	Vascular Malformations	MESH:D054079	marker/mechanism		NA		24478334
YIF1A	10897	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
YIF1A	10897	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		19233941
YIPF3	25844	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		23797736
YJEFN3	374887	Urinary Bladder Neoplasms	MESH:D001749	marker/mechanism		NA		26039340
YME1L1	10730	OPTIC ATROPHY 11	OMIM:617302	marker/mechanism		NA	617302	
YPEL3	83719	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
YTHDF2	51441	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28104805
YWHAE	7531	Neoplasm Metastasis	MESH:D009362	marker/mechanism		NA		17085005
YWHAG	7532	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
YWHAH	7533	Cardiomyopathies	MESH:D009202	therapeutic		NA		18342293
YWHAH	7533	Diabetes Mellitus, Experimental	MESH:D003921	therapeutic		NA		18342293
YWHAQ	10971	Osteoarthritis	MESH:D010003	marker/mechanism		NA		18784066
YWHAZ	7534	Carcinoma	MESH:D002277	marker/mechanism		NA		12376462
YWHAZ	7534	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
YWHAZ	7534	Mammary Neoplasms, Animal	MESH:D015674	marker/mechanism		NA		12376462
YWHAZ	7534	Mammary Neoplasms, Experimental	MESH:D008325	marker/mechanism		NA		12376462
YWHAZ	7534	Neoplasm Recurrence, Local	MESH:D009364	marker/mechanism		NA		16849584
YY1	7528	Disease Progression	MESH:D018450	marker/mechanism		NA		21792014
YY1	7528	HIV Infections	MESH:D015658	marker/mechanism		NA		15308739
YY1	7528	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21076407
YY1	7528	Neoplasms	MESH:D009369	marker/mechanism		NA		22467534
YY1	7528	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		21792014
YY1AP1	55249	Arterial Occlusive Disease, Progressive, with Hypertension, Heart Defects, Bone Fragility, and Brachysyndactyly	MESH:C566529	marker/mechanism		NA	602531	
ZAP70	7535	AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2	OMIM:617006	marker/mechanism		NA	617006	
ZAP70	7535	IMMUNODEFICIENCY 48	OMIM:269840	marker/mechanism		NA	269840	
ZAP70	7535	Immunologic Deficiency Syndromes	MESH:D007153	marker/mechanism		NA		17767948
ZAP70	7535	Severe Combined Immunodeficiency	MESH:D016511	marker/mechanism		NA		8202713
ZAP70	7535	T cell immunodeficiency primary	MESH:C536780	marker/mechanism		NA		8124727
ZBED1	9189	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
ZBTB11	27107	Gastrointestinal Stromal Tumors	MESH:D046152	marker/mechanism		NA		27793025
ZBTB16	7704	Leukemia, Promyelocytic, Acute	MESH:D015473	marker/mechanism		NA		23208507
ZBTB16	7704	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		26213588
ZBTB16	7704	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		24763052
ZBTB16	7704	Skeletal Defects, Genital Hypoplasia, And Mental Retardation	MESH:C567306	marker/mechanism		NA	612447	
ZBTB18	10472	MENTAL RETARDATION, AUTOSOMAL DOMINANT 22	OMIM:612337	marker/mechanism		NA	612337	
ZBTB20	26137	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		28220687
ZBTB20	26137	Primrose syndrome	MESH:C536420	marker/mechanism		NA	259050	25017102
ZBTB20	26137	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		28319090
ZBTB20	26137	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		22037551
ZBTB24	9841	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 2	OMIM:614069	marker/mechanism		NA	614069	
ZBTB4	57659	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ZBTB40	9923	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
ZBTB42	100128927	LETHAL CONGENITAL CONTRACTURE SYNDROME 6	OMIM:616248	marker/mechanism		NA	616248	
ZBTB7A	51341	Glioblastoma	MESH:D005909	marker/mechanism		NA		25875864
ZBTB7A	51341	Leukemia, Myeloid, Acute	MESH:D015470	marker/mechanism		NA		27798625
ZBTB7A	51341	Prostatic Neoplasms	MESH:D011471	therapeutic		NA		23727861
ZBTB7B	51043	Obesity	MESH:D009765	marker/mechanism		NA		29273807
ZBTB8OS	339487	Precancerous Conditions	MESH:D011230	marker/mechanism		NA		19233941
ZC3H11A	9877	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		25038754
ZC3H12A	80149	Arterial Occlusive Diseases	MESH:D001157	marker/mechanism		NA		22196138
ZC3H12C	85463	Psoriasis	MESH:D011565	marker/mechanism		NA		23143594
ZC3H14	79882	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 56	OMIM:617125	marker/mechanism		NA	617125	
ZC3H4	23211	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
ZC3HC1	51530	Coronary Artery Disease	MESH:D003324	marker/mechanism		NA		21378990
ZC3HC1	51530	Coronary Disease	MESH:D003327	marker/mechanism		NA		28869590
ZC3HC1	51530	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		28869590
ZC4H2	55906	Arthrogryposis multiplex congenita, distal, X-linked	MESH:C535380	marker/mechanism		NA		23623388
ZC4H2	55906	Microcephaly	MESH:D008831	marker/mechanism		NA		26056227
ZC4H2	55906	Miles-Carpenter x-linked mental retardation syndrome	MESH:C537472	marker/mechanism		NA		26056227
ZC4H2	55906	Wieacker syndrome	MESH:C536703	marker/mechanism		NA	314580	
ZCCHC12	170261	Esophageal Squamous Cell Carcinoma	MESH:D000077277	marker/mechanism		NA		30431698
ZCCHC14	23174	Stroke	MESH:D020521	marker/mechanism		NA		29531354
ZCCHC2	54877	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		31043756
ZCCHC2	54877	Influenza, Human	MESH:D007251	marker/mechanism		NA		23326326
ZCCHC6	100857368	Drug-Related Side Effects and Adverse Reactions	MESH:D064420	marker/mechanism		NA		31557154
ZCCHC8	55596	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
ZDBF2	57683	Small Cell Lung Carcinoma	MESH:D055752	marker/mechanism		NA		22941189
ZDHHC13	54503	Alopecia	MESH:D000505	marker/mechanism		NA		20548961
ZDHHC13	54503	Amyloidosis	MESH:D000686	marker/mechanism		NA		20548961
ZDHHC13	54503	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ZDHHC13	54503	Osteoporosis	MESH:D010024	marker/mechanism		NA		20548961
ZDHHC2	51201	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ZDHHC2	51201	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		25058030|28108177
ZDHHC2	51201	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
ZDHHC23	254887	Chemical and Drug Induced Liver Injury	MESH:D056486	marker/mechanism		NA		25226513
ZDHHC9	51114	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, RAYMOND TYPE	OMIM:300799	marker/mechanism		NA	300799	
ZEB1	6935	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19839049|21501481
ZEB1	6935	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		21954225
ZEB1	6935	Corneal Dystrophy, Fuchs Endothelial, 6	MESH:C567675	marker/mechanism		NA	613270	
ZEB1	6935	Corneal Dystrophy, Posterior Polymorphous, 3	MESH:C563788	marker/mechanism		NA	609141	
ZEB1	6935	Disease Progression	MESH:D018450	marker/mechanism		NA		19839049
ZEB1	6935	Endometrial Neoplasms	MESH:D016889	marker/mechanism		NA		18622689
ZEB1	6935	Lymphoma, T-Cell, Cutaneous	MESH:D016410	marker/mechanism		NA		26192916
ZEB1	6935	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
ZEB1	6935	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		21954225
ZEB1	6935	Oral Submucous Fibrosis	MESH:D009914	marker/mechanism		NA		26934322
ZEB1	6935	Ovarian Neoplasms	MESH:D010051	marker/mechanism		NA		18622689
ZEB1	6935	Sezary Syndrome	MESH:D012751	marker/mechanism		NA		26551670
ZEB1	6935	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
ZEB1B	114425	Brain Neoplasms	MESH:D001932	marker/mechanism		NA		27935819
ZEB2	9839	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		19839049
ZEB2	9839	Cell Transformation, Neoplastic	MESH:D002471	marker/mechanism		NA		21954225
ZEB2	9839	Cerebellar Diseases	MESH:D002526	marker/mechanism		NA		29326173
ZEB2	9839	Disease Progression	MESH:D018450	marker/mechanism		NA		19839049
ZEB2	9839	Heart Defects, Congenital	MESH:D006330	marker/mechanism		NA		17478475
ZEB2	9839	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ZEB2	9839	Motor Disorders	MESH:D000068079	marker/mechanism		NA		29326173
ZEB2	9839	Mowat-Wilson syndrome	MESH:C536990	marker/mechanism		NA	235730	15006694|17103451|17478475
ZEB2	9839	Neoplasm Invasiveness	MESH:D009361	marker/mechanism		NA		21954225
ZEB2	9839	Thyroid Cancer, Papillary	MESH:D000077273	marker/mechanism		NA		28030816
ZFAND3	60685	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
ZFAND3	60685	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		22158537
ZFAND5	7763	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
ZFAND6	54469	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
ZFAND6	54469	Delayed Emergence from Anesthesia	MESH:D055191	marker/mechanism		NA		16115977
ZFAND6	54469	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
ZFAT	57623	Thyroiditis, Autoimmune	MESH:D013967	marker/mechanism		NA	608175	
ZFC3H1	196441	Arthritis, Juvenile	MESH:D001171	marker/mechanism		NA		19565504
ZFHX3	463	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		19597491|19597492|22544366|29892015|30061737
ZFHX3	463	Cerebral Infarction	MESH:D002544	marker/mechanism		NA		19597491
ZFHX3	463	Obesity	MESH:D009765	marker/mechanism		NA		29273807
ZFHX3	463	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA	176807	16637072|17013881|29610475
ZFHX3	463	Stroke	MESH:D020521	marker/mechanism		NA		29531354
ZFHX4	79776	Ptosis, Hereditary Congenital 1	MESH:C566737	marker/mechanism		NA	178300	
ZFP110	65020	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		18815271
ZFP36	7538	Alopecia	MESH:D000505	marker/mechanism		NA		15944294
ZFP36	7538	Arthritis	MESH:D001168	marker/mechanism		NA		15944294
ZFP36	7538	Cachexia	MESH:D002100	marker/mechanism		NA		12756304|15944294
ZFP36	7538	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
ZFP36	7538	Dermatitis	MESH:D003872	marker/mechanism		NA		15944294
ZFP36	7538	Hyperplasia	MESH:D006965	marker/mechanism		NA		15944294
ZFP36	7538	Inflammation	MESH:D007249	marker/mechanism		NA		12756304
ZFP36	7538	Myocardial Ischemia	MESH:D017202	marker/mechanism		NA		16214533
ZFP36	7538	Neoplasm Invasiveness	MESH:D009361	therapeutic		NA		25556371
ZFP366	238803	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21122099
ZFP36L2	678	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		25944804
ZFP36L2	678	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MESH:D054218	marker/mechanism		NA		28671688
ZFP36L2	678	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
ZFP37	7539	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ZFP532	328977	Heart Failure, Diastolic	MESH:D054144	marker/mechanism		NA		29556499
ZFP57	346171	Diabetes Mellitus	MESH:D003920	marker/mechanism		NA		18622393
ZFP57	346171	Diabetes Mellitus, Transient Neonatal, 1	MESH:C563322	marker/mechanism		NA	601410	
ZFPM2	23414	46,XY SEX REVERSAL 9	OMIM:616067	marker/mechanism		NA	616067	
ZFPM2	23414	Diaphragmatic Hernia 3	MESH:C565710	marker/mechanism		NA	610187	
ZFPM2	23414	Hernia, Diaphragmatic	MESH:D006548	marker/mechanism		NA		17436238
ZFPM2	23414	Tetralogy of Fallot	MESH:D013771	marker/mechanism		NA	187500	
ZFR2	23217	Obesity	MESH:D009765	marker/mechanism		NA		29273807
ZFYVE16	9765	Liver Cirrhosis, Experimental	MESH:D008106	marker/mechanism		NA		25380136
ZFYVE26	23503	Spastic paraplegia 15, autosomal recessive	MESH:C536642	marker/mechanism		NA	270700	
ZFYVE27	118813	Spastic Paraplegia 33, Autosomal Dominant	MESH:C565214	marker/mechanism		NA	610244	
ZIC1	7545	Craniosynostoses	MESH:D003398	marker/mechanism		NA	616602	
ZIC2	7546	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
ZIC2	7546	Holoprosencephaly 5	MESH:C566464	marker/mechanism		NA	609637	
ZIC2	7546	Neural Tube Defects	MESH:D009436	marker/mechanism		NA		15136147
ZIC2	7546	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17173048
ZIC3	7547	Bone Diseases, Developmental	MESH:D001848	marker/mechanism		NA		17127413
ZIC3	7547	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		17127413
ZIC3	7547	Dextrocardia	MESH:D003914	marker/mechanism		NA		17127413
ZIC3	7547	Facial Asymmetry	MESH:D005146	marker/mechanism		NA		17127413
ZIC3	7547	Heterotaxy, visceral, X-linked	MESH:C538116	marker/mechanism		NA	306955	
ZIC3	7547	VACTERL Association With Hydrocephalus	MESH:C564751	marker/mechanism		NA	314390	
ZIC4	84107	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
ZIC5	85416	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
ZIC5	85416	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		15136147
ZIC5	85416	Neural Tube Defects	MESH:D009436	marker/mechanism		NA		15136147
ZIM2	23619	Carcinoma, Adenoid Cystic	MESH:D003528	marker/mechanism		NA		16762588
ZIM2	23619	Salivary Gland Neoplasms	MESH:D012468	marker/mechanism		NA		16762588
ZK262.8	191270	Hypoxia	MESH:D000860	therapeutic		NA		19936206
ZKSCAN3	80317	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18519692
ZKSCAN4	387032	Schizophrenia	MESH:D012559	marker/mechanism		NA		22037552
ZMAT3	64393	Nerve Degeneration	MESH:D009410	marker/mechanism		NA		17234339
ZMIZ1	57178	Celiac Disease	MESH:D002446	marker/mechanism		NA		20190752
ZMIZ1	57178	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		24836286
ZMPSTE24	10269	Acro-Osteolysis	MESH:D030981	marker/mechanism		NA		12913070|17152860
ZMPSTE24	10269	Craniofacial Abnormalities	MESH:D019465	marker/mechanism		NA		17152860
ZMPSTE24	10269	Glomerulosclerosis, Focal Segmental	MESH:D005923	marker/mechanism		NA		17152860
ZMPSTE24	10269	HIV-Associated Lipodystrophy Syndrome	MESH:D039682	marker/mechanism		NA		18230615
ZMPSTE24	10269	Lipodystrophy	MESH:D008060	marker/mechanism		NA		12913070
ZMPSTE24	10269	Mandibular Diseases	MESH:D008336	marker/mechanism		NA		12913070
ZMPSTE24	10269	Mandibuloacral dysplasia with type B lipodystrophy	MESH:C535706	marker/mechanism		NA	608612	
ZMPSTE24	10269	Progeria	MESH:D011371	marker/mechanism		NA		23217256
ZMPSTE24	10269	Tight skin contracture syndrome, lethal	MESH:C536920	marker/mechanism		NA	275210	
ZMYM2	7750	Intellectual Disability	MESH:D008607	marker/mechanism		NA		28191889
ZMYM2	7750	Myeloproliferative Disorders	MESH:D009196	marker/mechanism		NA		22875613
ZMYM3	9203	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		24763052|29610475|29662167
ZMYM5	9205	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
ZMYND10	51364	CILIARY DYSKINESIA, PRIMARY, 22	OMIM:615444	marker/mechanism		NA	615444	
ZMYND11	10771	Autistic Disorder	MESH:D001321	marker/mechanism		NA		25217958
ZMYND11	10771	MENTAL RETARDATION, AUTOSOMAL DOMINANT 30	OMIM:616083	marker/mechanism		NA	616083	
ZMYND15	84225	SPERMATOGENIC FAILURE 14	OMIM:615842	marker/mechanism		NA	615842	
ZNF148	7707	GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES	OMIM:617260	marker/mechanism		NA	617260	
ZNF160	90338	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		17199135
ZNF160	90338	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		19424620
ZNF169	169841	Obesity	MESH:D009765	marker/mechanism		NA		29273807
ZNF177	7730	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
ZNF205	7755	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
ZNF217	7764	Prostatic Neoplasms, Castration-Resistant	MESH:D064129	marker/mechanism		NA		29581250
ZNF23	7571	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		21965783
ZNF257	113835	Diabetes Mellitus, Type 2	MESH:D003924	marker/mechanism		NA		30718926
ZNF267	10308	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
ZNF267	10308	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
ZNF292	23036	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		25559195
ZNF292	23036	Neurodevelopmental Disorders	MESH:D065886	marker/mechanism		NA		28191889
ZNF292	23036	Prostatic Neoplasms	MESH:D011471	marker/mechanism		NA		29610475|29662167
ZNF331	55422	Arsenic Poisoning	MESH:D020261	marker/mechanism		NA		16835338
ZNF331	55422	Skin Diseases	MESH:D012871	marker/mechanism		NA		16835338
ZNF335	63925	MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE	OMIM:615095	marker/mechanism		NA	615095	
ZNF365	22891	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		21278746
ZNF365	22891	Dermatitis, Atopic	MESH:D003876	marker/mechanism		NA		23042114
ZNF365	22891	NEPHROLITHIASIS, URIC ACID, SUSCEPTIBILITY TO	OMIM:605990	marker/mechanism		NA	605990	
ZNF366	167465	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		20008677
ZNF366	167465	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
ZNF367	195828	Prostatic Neoplasms, Castration-Resistant	MESH:D064129	marker/mechanism		NA		29581250
ZNF385D	79750	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
ZNF385D	79750	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
ZNF404	342908	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
ZNF408	79797	EXUDATIVE VITREORETINOPATHY 6	OMIM:616468	marker/mechanism		NA	616468	
ZNF408	79797	RETINITIS PIGMENTOSA 72	OMIM:616469	marker/mechanism		NA	616469	
ZNF41	7592	Cognition Disorders	MESH:D003072	marker/mechanism		NA		14628291
ZNF41	7592	Mental Retardation, X-Linked	MESH:D038901	marker/mechanism		NA		14628291
ZNF423	23090	Amphetamine-Related Disorders	MESH:D019969	marker/mechanism		NA		18316681
ZNF423	23090	NEPHRONOPHTHISIS 14	OMIM:614844	marker/mechanism		NA	614844	
ZNF430	80264	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
ZNF432	9668	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		18507500
ZNF432	9668	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		18507500
ZNF438	220929	Melanoma	MESH:D008545	marker/mechanism		NA		22535842
ZNF462	58499	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
ZNF462	58499	Carcinoma, Non-Small-Cell Lung	MESH:D002289	marker/mechanism		NA		29059373
ZNF469	84627	Brittle cornea syndrome 1	MESH:C536192	marker/mechanism		NA	229200	18452888
ZNF469	84627	Corneal Diseases	MESH:D003316	marker/mechanism		NA		18452888
ZNF469	84627	Joint Instability	MESH:D007593	marker/mechanism		NA		18452888
ZNF469	84627	Skin Abnormalities	MESH:D012868	marker/mechanism		NA		18452888
ZNF480	147657	Schizophrenia	MESH:D012559	marker/mechanism		NA		21743468
ZNF513	130557	RETINITIS PIGMENTOSA 58	OMIM:613617	marker/mechanism		NA	613617	
ZNF526	116115	Intellectual Disability	MESH:D008607	marker/mechanism		NA		21937992
ZNF530	348327	Schizophrenia	MESH:D012559	marker/mechanism		NA		21822266
ZNF536	9745	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		23797736
ZNF559	84527	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		16367923
ZNF565	147929	Schizophrenia	MESH:D012559	marker/mechanism		NA		21743468
ZNF569	148266	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		21278247
ZNF592	9640	Bipolar Disorder	MESH:D001714	marker/mechanism		NA		31043756
ZNF592	9640	Spinocerebellar ataxia, autosomal recessive 5	MESH:C537311	marker/mechanism		NA		20531441
ZNF593	51042	Disease Progression	MESH:D018450	marker/mechanism		NA		21364753
ZNF593	51042	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		21364753
ZNF595	152687	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		29054765
ZNF595	152687	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		29054765
ZNF606	80095	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
ZNF644	84146	MYOPIA 21, AUTOSOMAL DOMINANT	OMIM:614167	marker/mechanism		NA	614167	
ZNF658	26149	Skin Diseases	MESH:D012871	marker/mechanism		NA		28720099
ZNF667-AS1	100128252	Bile Duct Neoplasms	MESH:D001650	marker/mechanism		NA		29707199
ZNF667-AS1	100128252	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		28690657
ZNF667-AS1	100128252	Carcinosarcoma	MESH:D002296	marker/mechanism		NA		29707199
ZNF667-AS1	100128252	Esophageal Neoplasms	MESH:D004938	marker/mechanism		NA		29707199
ZNF667-AS1	100128252	Mesothelioma	MESH:D008654	marker/mechanism		NA		29707199
ZNF667-AS1	100128252	Sarcoma	MESH:D012509	marker/mechanism		NA		29707199
ZNF667-AS1	100128252	Stomach Neoplasms	MESH:D013274	marker/mechanism		NA		29707199
ZNF667-AS1	100128252	Uterine Cervical Neoplasms	MESH:D002583	marker/mechanism		NA		29707199
ZNF668	79759	Ependymoma	MESH:D004806	marker/mechanism		NA		26075792
ZNF674	641339	Mental Retardation, X-Linked	MESH:D038901	marker/mechanism		NA		16385466
ZNF676	163223	Thyroid Diseases	MESH:D013959	marker/mechanism		NA		23397585
ZNF683	257101	Chloracne	MESH:D054506	marker/mechanism		NA		17101203
ZNF687	57592	Osteitis Deformans	MESH:D010001	marker/mechanism		NA	616833	
ZNF711	7552	Mental Retardation, X-Linked	MESH:D038901	marker/mechanism		NA		19377476
ZNF750	79755	Seborrhea-Like Dermatitis with Psoriasiform Elements	MESH:C565217	marker/mechanism		NA	610227	
ZNF765	91661	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		25401301
ZNF804A	91752	Carcinoma, Renal Cell	MESH:D002292	marker/mechanism		NA		22138691
ZNF804A	91752	Schizophrenia	MESH:D012559	marker/mechanism		NA		18677311
ZNF804A	91752	Substance-Related Disorders	MESH:D019966	marker/mechanism		NA		20098672
ZNF812P	729648	Genetic Predisposition to Disease	MESH:D020022	marker/mechanism		NA		29054765
ZNF812P	729648	Lung Neoplasms	MESH:D008175	marker/mechanism		NA		29054765
ZNF816	125893	Psoriasis	MESH:D011565	marker/mechanism		NA		20953187|24212883
ZNF831	128611	Melanoma	MESH:D008545	marker/mechanism		NA		21499247
ZNHIT3	9326	PEHO syndrome	MESH:C536317	marker/mechanism		NA	260565	
ZNRF3	84133	Adrenocortical Carcinoma	MESH:D018268	marker/mechanism		NA		24747642
ZNRF3	84133	Pancreatic Neoplasms	MESH:D010190	marker/mechanism		NA		25086665|26098869
ZP1	22917	OOCYTE MATURATION DEFECT 1	OMIM:615774	marker/mechanism		NA	615774	
ZPBP2	124626	Atrial Fibrillation	MESH:D001281	marker/mechanism		NA		29892015
ZRSR2	8233	Leukemia, Myelomonocytic, Juvenile	MESH:D054429	marker/mechanism		NA		26457647
ZRSR2	8233	Myelodysplastic Syndromes	MESH:D009190	marker/mechanism		NA		27992414
ZSCAN22	342945	Liver Neoplasms	MESH:D008113	marker/mechanism		NA		19233941
ZSWIM5	57643	Breast Neoplasms	MESH:D001943	marker/mechanism		NA		29915430
ZSWIM6	57688	Acromelic Frontonasal Dysostosis	MESH:C566345	marker/mechanism		NA	603671	
ZSWIM9	374920	Polycystic Ovary Syndrome	MESH:D011085	marker/mechanism		NA		21411543
ZW10	9183	Osteosarcoma	MESH:D012516	marker/mechanism		NA		14767549
ZWILCH	55055	Weight Gain	MESH:D015430	marker/mechanism		NA		19030233
ZWINT	11130	Carcinoma, Hepatocellular	MESH:D006528	marker/mechanism		NA		28284560
ZYX	7791	Colorectal Neoplasms	MESH:D015179	marker/mechanism		NA		30697742
